FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kale, NS
   Rao, VR
AF Kale, Nitin S.
   Rao, V. Ramgopal
TI Design and fabrication issues in affinity cantilevers for bioMEMS
   applications
SO JOURNAL OF MICROELECTROMECHANICAL SYSTEMS
LA English
DT Article
DE affinity cantilevers; antibody immobilization; bioMEMS; hotwire CVD;
   neutral axis; polymeric cantilevers; surface stress
ID CHEMICAL-VAPOR-DEPOSITION; THIN-FILMS
AB Microfabricated cantilevers are widely used for biomedical sensing applications. In this paper, for the first time, design guidelines have been provided for composite polymeric microcantilevers with embedded piezoresistors. Optimization guidelines have been provided from the point of reducing their stiffness and to increase their deflection and the Delta R/R response. Choice of the piezoresistive material and the location of this layer with respect to the neutral axis are shown to impact the stiffness and Delta R/R of a microcantilever. Differences in the behavior of Delta R/R and deflection, when surface stresses are applied to polymer based microcantilevers and oxide/nitride based ones, are brought out. We also show that it is essential to have the immobilization layer and the piezoresistor on the same side of the neutral axis particularly when these microcantivelers are used for sensing small surface stresses in the order of a few mN/m, typical of many molecular markers used in biomedical applications.
C1 Indian Inst Technol, Dept Elect Engn, Bombay 400076, Maharashtra, India.
RP Kale, NS (reprint author), Indian Inst Technol, Dept Elect Engn, Bombay 400076, Maharashtra, India.
EM nsk@ee.iitb.ac.in; rrao@ee.iitb.ac.in
OI Rao, V. RAMGOPAL/0000-0001-9157-957X
CR Arntz Y, 2003, NANOTECHNOLOGY, V14, P86, DOI 10.1088/0957-4484/14/1/319
   Conde JP, 2001, THIN SOLID FILMS, V395, P105, DOI 10.1016/S0040-6090(01)01222-6
   EATON D, 1997, THESIS U NEW MEXICO
   FRENCH P, 1981, SOLID STATE ELECT, V32, P1
   Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316
   *IIT BOMB, 2004, 1264MUM2004
   KELE N, UNPUB
   Moutinho HR, 2003, THIN SOLID FILMS, V430, P135, DOI 10.1016/S0040-6090(03)00096-8
   Sahu L, 2006, THIN SOLID FILMS, V501, P117, DOI 10.1016/j.tsf.2005.07.136
   Serre C, 1999, SENSOR ACTUAT A-PHYS, V74, P134, DOI 10.1016/S0924-4247(98)00347-1
   Sung MM, 1999, J VAC SCI TECHNOL A, V17, P540, DOI 10.1116/1.581616
   THAYSEN J, 2001, THESIS MIC DTU
NR 12
TC 9
Z9 9
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1057-7157
J9 J MICROELECTROMECH S
JI J. Microelectromech. Syst.
PD DEC
PY 2006
VL 15
IS 6
BP 1789
EP 1794
DI 10.1109/JMEMS.2006.886031
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 118ZZ
UT WOS:000242983300040
DA 2018-10-20
ER

PT J
AU Lewis, JA
   Smay, JE
   Stuecker, J
   Cesarano, J
AF Lewis, Jennifer A.
   Smay, James E.
   Stuecker, John
   Cesarano, Joseph, III
TI Direct ink writing of three-dimensional ceramic structures
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID SOLID FREEFORM FABRICATION; PERIODIC STRUCTURES; FUSED DEPOSITION;
   COLLOIDAL INKS; COMPOSITES; SUSPENSIONS; COMPONENTS; SCAFFOLDS;
   PROTOTYPES; CRYSTALS
AB The ability to pattern ceramic materials in three dimensions (3D) is critical for structural, functional, and biomedical applications. One facile approach is direct ink writing (DIW), in which 3D structures are built layer-by-layer through the deposition of colloidal- or polymer-based inks. This approach allows one to design and rapidly fabricate ceramic materials in complex 3D shapes without the need for expensive tooling, dies, or lithographic masks. In this feature article, we present both droplet- and filament-based DIW techniques. We focus on the various ink designs and their corresponding rheological behavior, ink deposition mechanics, potential shapes and the toolpaths required, and representative examples of 3D ceramic structures assembled by each technique. The opportunities and challenges associated with DIW are also highlighted.
C1 Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.
   Oklahoma State Univ, Dept Chem Engn, Stillwater, OK 74078 USA.
   Sandia Natl Labs, Albuquerque, NM 87185 USA.
RP Lewis, JA (reprint author), Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, 1304 W Green St, Urbana, IL 61801 USA.
EM jalewis@uiuc.edu
CR *3D SYST INC, 1989, STEREOLITHOGRAPHY IN
   Agarwala MK, 1996, AM CERAM SOC BULL, V75, P60
   Allahverdi M, 2001, J EUR CERAM SOC, V21, P1485, DOI 10.1016/S0955-2219(01)00047-4
   Bhatti AR, 2001, J MATER SCI LETT, V20, P1245, DOI 10.1023/A:1010987209703
   BUSCALL R, 1993, J RHEOL, V37, P621, DOI 10.1122/1.550387
   Calvert P, 2002, PHILOS T ROY SOC A, V360, P199, DOI 10.1098/rsta.2001.0925
   Cesarano III J., 1998, CERAM IND, V148, P94
   Cesarano III Joseph, 2000, FREEFORMING OBJECTS
   Cesarano J, 2005, INT J APPL CERAM TEC, V2, P212, DOI 10.1111/j.1744-7402.2005.02026.x
   CESARANO J, 1997, 8 SOL FREEF FABR SFF
   CESARANO J, 1999, S SOL FREEF ADD FABR
   Channell GM, 2000, AICHE J, V46, P72, DOI 10.1002/aic.690460110
   Chrisey DB, 2000, SCIENCE, V289, P879, DOI 10.1126/science.289.5481.879
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   CORRAL EL, 2002, S RAP PROT MAT COL O
   Dellinger JG, 2006, J BIOMED MATER RES A, V76A, P366, DOI 10.1002/jbm.a.30523
   DELLINGER JG, 2005, THESIS U ILLINOIS UR
   Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026
   Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a
   GREUL M, 1996, ADV POWDER METALL PA, V2
   GREUL M, 1997, ADV POWDER METALL PA, V3
   He G., 2000, 24 INT C EXP ENG CER
   He GP, 2001, CERAM TRANS, V114, P325
   Held M, 1991, COMPUTATIONAL GEOMET
   Herschel WH, 1926, KOLLOID Z, V39, P291, DOI 10.1007/BF01432034
   HUNTER RJ, 1992, FDN COLLOID SCI, V1
   Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0
   KALYON DM, 1993, J RHEOL, V37, P35, DOI 10.1122/1.550435
   Lee DH, 2004, J EUR CERAM SOC, V24, P1069, DOI 10.1016/S0955-2219(03)00421-7
   Lee W, 2004, LANGMUIR, V20, P5262, DOI 10.1021/la035694e
   Lenk R, 2000, ADV ENG MATER, V2, P40, DOI 10.1002/(SICI)1527-2648(200002)2:1/2<40::AID-ADEM40>3.0.CO;2-Z
   Lewis JA, 2002, CURR OPIN SOLID ST M, V6, P245, DOI 10.1016/S1359-0286(02)00031-1
   Lewis JA, 2000, J AM CERAM SOC, V83, P2341
   Lewis JA, 2004, MATER TODAY, V7, P32, DOI 10.1016/S1369-7021(04)00344-X
   Li Q, 2003, ADV MATER, V15, P1639, DOI 10.1002/adma.200305413
   Lous GM, 2000, J AM CERAM SOC, V83, P124, DOI 10.1111/j.1151-2916.2000.tb01159.x
   Marchi CS, 2003, SCRIPTA MATER, V49, P861, DOI 10.1016/S1359-6462(03)00441-X
   McNulty TF, 1999, J AM CERAM SOC, V82, P1757, DOI 10.1111/j.1151-2916.1999.tb01996.x
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Moon J, 2002, J AM CERAM SOC, V85, P755
   Morissette SL, 2000, J AM CERAM SOC, V83, P2409
   Morissette SL, 2001, J AM CERAM SOC, V84, P2462, DOI 10.1111/j.1151-2916.2001.tb01036.x
   Nadkarni SS, 2006, J AM CERAM SOC, V89, P96, DOI 10.1111/j.1551-2916.2005.00646.x
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Qiu D, 2001, RAPID PROTOTYPING J, V7, P18, DOI 10.1108/13552540110365126
   Rangarajan S, 2000, J AM CERAM SOC, V83, P1663
   Rao MP, 1999, SCIENCE, V286, P102, DOI 10.1126/science.286.5437.102
   Rao RB, 2005, ADV MATER, V17, P289, DOI 10.1002/adma.200400514
   Reis N, 2005, J AM CERAM SOC, V88, P802, DOI 10.1111/j.1551-2916.2005.00138.x
   Sachs E., 1992, Manufacturing Review, V5, P117
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Safari A, 2006, FERROELECTRICS, V331, P153, DOI 10.1080/00150190600737727
   Seerden KAM, 2001, J AM CERAM SOC, V84, P2514, DOI 10.1111/j.1151-2916.2001.tb01045.x
   Smay JE, 2002, J APPL PHYS, V92, P6119, DOI 10.1063/1.1513202
   Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135
   Smay JE, 2002, ADV MATER, V14, P1279, DOI 10.1002/1521-4095(20020916)14:18<1279::AID-ADMA1279>3.0.CO;2-A
   SMAY JE, THESIS U ILLINOIS UR
   Song JH, 1999, J AM CERAM SOC, V82, P3374
   Soundararajan R, 2001, J AM CERAM SOC, V84, P509, DOI 10.1111/j.1151-2916.2001.tb00691.x
   Stuecker JN, 2003, J MATER PROCESS TECH, V142, P318, DOI 10.1016/S0924-0136(03)00586-7
   STUECKER JN, 1999, THESIS NEW MEXICO I
   Teng WD, 1997, J AM CERAM SOC, V80, P486
   Teng WD, 1998, J AM CERAM SOC, V81, P1033
   Tohver V, 2001, P NATL ACAD SCI USA, V98, P8950, DOI 10.1073/pnas.151063098
   Tressler JF, 1999, COMPOS PART A-APPL S, V30, P477, DOI 10.1016/S1359-835X(98)00137-7
   Tuttle BA, 2001, J AM CERAM SOC, V84, P872, DOI 10.1111/j.1151-2916.2001.tb00756.x
   Vaidyanathan R, 2000, JOM-J MIN MET MAT S, V52, P34, DOI 10.1007/s11837-000-0066-4
   Vlasov YA, 2001, NATURE, V414, P289, DOI 10.1038/35104529
   Wang TM, 2005, J AM CERAM SOC, V88, P2053, DOI 10.1111/j.1551-2916.2005.00406.x
   XU J, 2006, UNPUB J AM CERAM SOC
   Xu MJ, 2006, SOFT MATTER, V2, P205, DOI 10.1039/b517278k
   Zhao XL, 2002, J AM CERAM SOC, V85, P2113, DOI 10.1111/j.1151-2916.2002.tb00414.x
NR 72
TC 228
Z9 233
U1 23
U2 172
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD DEC
PY 2006
VL 89
IS 12
BP 3599
EP 3609
DI 10.1111/j.1551-2916.2006.01382.x
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA 108HY
UT WOS:000242232100001
DA 2018-10-20
ER

PT J
AU Balamurugan, A
   Sockalingum, G
   Michel, J
   Faure, J
   Banchet, V
   Wortham, L
   Bouthors, S
   Laurent-Maquin, D
   Balossier, G
AF Balamurugan, A.
   Sockalingum, G.
   Michel, J.
   Faure, J.
   Banchet, V.
   Wortham, L.
   Bouthors, S.
   Laurent-Maquin, D.
   Balossier, G.
TI Synthesis and characterisation of sol gel derived bioactive glass for
   biomedical applications
SO MATERIALS LETTERS
LA English
DT Article
DE sol gel; bioglass; bioactive
ID IN-VITRO; DISSOLUTION; 45S5
AB Bioactive glasses have been used successfully as bone-filling materials in orthopaedic and dental surgery, but their poor mechanical strength limits their applications in load-bearing positions. Approaches to strengthen materials decrease their bioactivity. In order to realize the optimal matching between mechanical and biological properties, the sol-gel-self propagating method is adopted to prepare gel-derived bioglass bulk: 58S in the system SiO2-CaO-P2O5. The obtained glass was analysed for its composition, crystalinity and morphology through FT-IR, Raman, XRD, STEM and X-ray microanalysis. (c) 2006 Elsevier B.V All rights reserved.
C1 Univ Reims, Lab Microscopie Electron Analyt, INSERM ERM 0203, F-51685 Reims 2, France.
   Univ Reims, CNRS UMR 6142, UFR Pharm, Unite MeDIAN, F-51096 Reims, France.
   Ecole Cent Lyon, UMR CNRS 5513, Dept STMS, Lab Tribol & Dynam Surfaces, F-69134 Ecully, France.
RP Balamurugan, A (reprint author), Univ Reims, Lab Microscopie Electron Analyt, INSERM ERM 0203, 21 Rue Clement Ader, F-51685 Reims 2, France.
EM abmurugan@yahoo.co.in
CR Banchet V, 2003, J PHYS D APPL PHYS, V36, P1599, DOI 10.1088/0022-3727/36/13/326
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Devreux F, 2001, J NUCL MATER, V298, P145, DOI 10.1016/S0022-3115(01)00579-7
   Greenspan D.C., 1994, BIOCERAMICS, V7, P28
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Qin D, 1998, APPL SPECTROSC, V52, P488, DOI 10.1366/0003702981943950
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 10
TC 92
Z9 95
U1 1
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD DEC
PY 2006
VL 60
IS 29-30
BP 3752
EP 3757
DI 10.1016/j.matlet.2006.03.102
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 111QN
UT WOS:000242469000071
DA 2018-10-20
ER

PT J
AU Chapman, RR
AF Chapman, Rachel R.
TI Chikotsa - Secrets, silence, and hiding: Social risk and reproductive
   vulnerability in central Mozambique
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Article
DE social risk; prenatal care; gender; inequality; Mozambique
ID ANTENATAL CARE; PRENATAL-CARE; WOMENS PERCEPTIONS; PREGNANCY; NIGERIA;
   PERSPECTIVES; COMMUNITIES; MOTHERHOOD; DELIVERY; CHURCHES
AB In this article, I examine pregnancy narratives and patterns of reproductive health seeking among women of fertile age in central Mozambique. I map the interplay between gendered economic marginalization, maternal risk perceptions, and pregnancy management strategies. By interpreting my data in light of Shona illness theories, I illuminate the ways that embodied experiences of reproductive vulnerability, risk perceptions, and social inequalities are linked: women attribute the most serious maternal complications to human- or spirit-induced reproductive threats of witchcraft and sorcery. This construction of reproductive vulnerability as social threats related to material and social competition significantly influences prenatal health seeking. Data reveal the structural and cognitive gap between biomedical constructions of risk and lay social threat perceptions. Plural health care systems are strategically utilized by women seeking to minimize both social and biological harm. On-the-ground ethnography shows that maternal health initiatives must take this plurality into full and accommodative account to achieve viable improvements in reproductive care and outcomes.
C1 Univ Washington, Dept Anthropol, Seattle, WA 98195 USA.
RP Chapman, RR (reprint author), Univ Washington, Dept Anthropol, Seattle, WA 98195 USA.
CR ADETUNJI JA, 1992, SOC SCI MED, V35, P1171, DOI 10.1016/0277-9536(92)90229-J
   Ahmed FU, 1992, INTEGRATION, V33, P50
   Alexander J., 1994, LAND POLITICAL AUTHO
   Allen Denise Roth, 2002, MANAGING MOTHERHOOD
   AsowaOmorodion FI, 1997, SOC SCI MED, V44, P1817, DOI 10.1016/S0277-9536(96)00291-2
   BACKETT EM, 1984, WHO PUBLIC HLTH PAPE, V76, P1
   Baker D, 1997, SOC SCI MED, V45, P1325, DOI 10.1016/S0277-9536(97)00059-2
   Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1
   Bledsoe CH, 2002, CONTINGENT LIVES FER
   Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38
   BOLTON P, 1989, WOMEN INT DEV ANN, V1, P57
   BOURDILLON D, 1991, SHONA PEOPLES ETHNOG
   Browner C. H., 1996, MED ANTHR CONT THEOR, P219
   Browner CH, 2000, AM ANTHROPOL, V102, P773, DOI 10.1525/aa.2000.102.4.773
   CHAPMAN R, 1998, THESIS U CALIFORNIA
   Chapman Rachel R, 2004, Med Anthropol, V23, P229, DOI 10.1080/01459740490487107
   Chapman RR, 2003, SOC SCI MED, V57, P355, DOI 10.1016/S0277-9536(02)00363-5
   Cliff J., 1991, Women and health in Africa., P15
   CoriaSoto IL, 1996, INT J QUAL HEALTH C, V8, P13, DOI 10.1093/intqhc/8.1.13
   DAS V, 1995, RUMORS PERFORMATIVE
   Davis-Floyd R, 2003, SOC SCI MED, V56, P1911, DOI 10.1016/S0277-9536(02)00213-7
   DEMBLE DM, 2002, BLACK WOMEN GLOBALIZ, P72
   DESJEUX D, 1987, STRATEGIES PAYSANNES
   DUJARDIN B, 1995, SOC SCI MED, V40, P529, DOI 10.1016/0277-9536(94)E0095-A
   Eggleston E, 2000, SOC SCI MED, V51, P1011, DOI 10.1016/S0277-9536(00)00010-1
   Etuk SJ, 1999, E AFR MED J, V76, P639
   FELDMANSAVELSBERG P, 1994, SOC SCI MED, V39, P463, DOI 10.1016/0277-9536(94)90090-6
   GELFAND M, 1992, GENUINE SHONA
   Gelfand M, 1979, GROWING SHONA SOC
   Geschiere P., 1997, MODERNITY WITCHCRAFT
   Gunewardena N., 2002, VOICES           DEC, P14
   HANLON J, 1997, MULTINATION MONI JUL, P17
   Inhorn MC, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P57
   JELLEY D, 1983, J TROP MED HYG, V86, P229
   JELLEY D, 1983, J EPIDEMIOL COMMUN H, V37, P111, DOI 10.1136/jech.37.2.111
   Jenkins GL, 2003, SOC SCI MED, V56, P1831, DOI 10.1016/S0277-9536(02)00207-1
   Jok J. M., 1998, MILITARIZATION GENDE
   Jolly Margaret, 2002, BIRTHING PACIFIC TRA, P148
   LAFORT Y, 1994, FINAL REPORT PRENATA
   LUPTON D., 1999, RISK
   Madhavan S., 2001, CULTURE HLTH SEXUALI, V3, P451, DOI 10.1080/13691050110074219
   Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5
   MARSHALL J, 1988, STRUCTURAL ADJUSTMEN
   Martin Emily, 1990, UNCERTAIN TERMS NEGO, P300
   *MOZ AGR RUR REC P, 1993, REV AGR STRAT RESP I
   *MOZ MIN HLTH, 1993, B NUTR
   Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X
   Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94
   Nelkin D, 2003, RISK CULTURE HLTH IN, pvii
   Nichter M, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P13
   Nichter M., 2002, NEW HORIZONS MED ANT, P81
   Oaks L, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P3
   Pfeiffer J, 2002, MED ANTHROPOL Q, V16, P176, DOI 10.1525/maq.2002.16.2.176
   Pfeiffer J., 1997, THESIS U CALIFORNIA
   POVEY G, 1990, SAFE MOTHERHOOD MOZA
   RHODE JE, 1995, INT J GYNECOL OBSTET, V5, pS3
   Root R, 2001, CULT MED PSYCHIAT, V25, P195, DOI 10.1023/A:1010665726205
   SARGENT C, 1991, HUM ORGAN, V50, P179, DOI 10.17730/humo.50.2.r8186w0526076v03
   Sargent C, 2003, SOC SCI MED, V56, P1961, DOI 10.1016/S0277-9536(02)00216-2
   Sargent CF., 1989, MATERNITY MED POWER
   SCHEPERHUGHES N, 1982, ANTHR HUMAN BIRTH, P267
   SENANAYAKE P, 1995, J GYNECOL OBSTET S2, V50, pS11
   Sesia PaolaM, 1997, CHILDBIRTH AUTHORITA, P397
   STEWART J, 1999, LEGAL SITUATION SOME, P165
   Stewart Pamela J., 2003, WITCHCRAFT SORCERY R
   SWANTZ ML, 1979, SOC SCI MED-MED ANTH, V13, P169, DOI 10.1016/0160-7987(79)90031-0
   Tesh S. N., 1988, HIDDEN ARGUMENTS
   *UNDP, 1998, MOZ UN NAT DEV PROG
   White PM, 2002, J MIDWIFERY WOM HEAL, V47, P239, DOI 10.1016/S1526-9523(02)00266-0
   *WHO, 1985, 1 INT M PREV MAT MOR
   WHO, 1994, WHOFHEMSM9411
   *WHO UNICEF, 1997, STAT WORLDS CHIDLR R
   *WHO UNICEF, 1980, COUNTR DEC MAK ACH O
   *WHO UNICEF UNFPA, 2004, MAT MORT 2004 EST DE
   WLT G, 1983, MOZAMBIQUE PEOPLES H
   World Health Organization, 1978, RISK APPR MAT CHILD
NR 76
TC 24
Z9 24
U1 0
U2 10
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 2200 WILSON BLVD, STE 600, ARLINGTON, VA 22201 USA
SN 0745-5194
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD DEC
PY 2006
VL 20
IS 4
BP 487
EP 515
DI 10.1525/maq.2006.20.4.487
PG 29
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA 117FG
UT WOS:000242857600004
PM 17225656
DA 2018-10-20
ER

PT J
AU Rzigalinski, BA
   Meehan, K
   Davis, RM
   Xu, Y
   Miles, WC
   Cohen, CA
AF Rzigalinski, Beverly A.
   Meehan, Kathleen
   Davis, Richey M.
   Xu, Yang
   Miles, William C.
   Cohen, Courtney A.
TI Radical nanomedicine
SO NANOMEDICINE
LA English
DT Review
DE aging; anti-inflammatory; antioxidants; cerium oxide; free radicals;
   inflammation; nanotechnology; neuroprotection; oxidative stress;
   reactive oxygen species
ID OXIDE NANOPARTICLES; OXIDATIVE STRESS; RAT-BRAIN; CERIUM; CELLS;
   ANTIOXIDANTS; REDUCTION; TOXICITY; SIZE
AB Nanotechnology has made significant advances in the reduction of free radical damage in the field of materials science. Cross-disciplinary interactions and the application of this technology to biological systems has led to the elucidation of novel nanoparticle antioxidants, which are the subject of this review. Recent reports,suggest that cerium oxide and other nanoparticles are potent, and probably regenerative, free radical scavengers in vitro and in vivo. The neuroprotective, longevity-enhancing and anti-inflammatory properties of nanoparticles are summarized and hypotheses regarding their unique mechanism of action are presented. The chemical and physical properties of antioxidant nanoparticles are discussed in an interdisciplinary manner, with emphasis on biological properties and biomedical applications. Additionally, the need for alterations in traditional pharmacological parameters of dose and absorption, distribution, metabolism, and excretion are discussed and future directions necessary for bringing nanoparticle antioxidants into the realm of clinical reality are presented.
C1 Virginia Coll Osteopath Med, Blacksburg, VA 24060 USA.
   Virginia Polytech & State Univ, NanoNeuro Lab, Blacksburg, VA 24060 USA.
   Virginia Polytech & State Univ, Bradley Dept Elect & Comp Engn, Blacksburg, VA 24060 USA.
   Virginia Polytech & State Univ, Dept Chem Engn, Blacksburg, VA 24060 USA.
RP Rzigalinski, BA (reprint author), Virginia Coll Osteopath Med, Res 2 Bldg,1861 Pratt Dr, Blacksburg, VA 24060 USA.
EM brzigali@vcom.vt.edu; kameehan@vt.edu; rmdavis@vt.edu; wcmiles@vt.edu;
   cohenca@vt.edu
FU NINDS NIH HHS [NS40490]; NIA NIH HHS [AG022617]
CR ANEGGI E, 2005, J ALLOY COMPD, P406
   ANEGGI E, 2005, J ALLOY COMPD, P1096
   Bailey D., 2003, NAT BIOTECHNOL, V14, P112
   Benini O, 1996, J CHEM EDUC, V73, P865, DOI 10.1021/ed073p865
   CALLAGHAN P, 2003, J NEUROTRAUM, V20, P1053
   Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63
   Corona-Morales AA, 2003, J NEUROSCI RES, V71, P121, DOI 10.1002/jnr.10456
   Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X
   Ellison A, 2003, J NEUROTRAUM, V20, P1105
   Emerich DF, 2006, BIOMOL ENG, V23, P171, DOI 10.1016/j.bioeng.2006.05.026
   FENOGLIO I, 2006, IN PRESS FREE RADIC
   Guo X, 2006, PROG MATER SCI, V51, P151, DOI 10.1016/j.pmatsci.2005.07.001
   GYORGYI L, 1990, J PHYS CHEM-US, V94, P7162, DOI 10.1021/j100381a039
   Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Harris LA, 2003, CHEM MATER, V15, P1367, DOI 10.1021/cm020994n
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S, P585
   Hong JH, 2006, J BIOL CHEM, V281, P13057, DOI 10.1074/jjbc.M601726200
   Howes RM, 2006, ANN NY ACAD SCI, V1067, P22, DOI 10.1196/annals.1354.004
   LAACHIR A, 1991, J CHEM SOC FARADAY T, V87, P1601, DOI 10.1039/ft9918701601
   Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o
   Lin AMY, 1999, J NEUROCHEM, V72, P1634, DOI 10.1046/j.1471-4159.1999.721634.x
   Lin AMY, 2002, NEUROSCI RES, V43, P317, DOI 10.1016/S0168-0102(02)00056-1
   Muller J, 2004, TOXICOL APPL PHARM, V197, P305
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   OLGUN S, 2005, AM ASS IMM ANN M BOS
   Patsalas P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035104
   Pham DQ, 2005, ANN PHARMACOTHER, V39, P1870, DOI 10.1345/aph.1G211
   Rodrigo J, 2005, FREE RADICAL BIO MED, V39, P26, DOI 10.1016/j.freeadbiomed.2005.02.010
   Rosado JA, 2006, MINI-REV MED CHEM, V6, P409, DOI 10.2174/138955706776361466
   RZIGALINSKI B, 2006, TISSUE CELL ORGAN EN
   Rzigalinski BA, 2005, TECHNOL CANCER RES T, V4, P651, DOI 10.1177/153303460500400609
   RZIGALINSKI BA, 2005, Patent No. 60693930
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Spanier JE, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245407
   Strawn ET, 2006, FASEB J, V20, pA1356
   Suzuki T, 2001, J AM CERAM SOC, V84, P2007
   Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f
   Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016
   Trovarelli A, 2002, CATALYSIS CERIA RELA
   Violi Francesco, 2005, Curr Opin Investig Drugs, V6, P895
   Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022
   Zhang F, 2002, APPL PHYS LETT, V80, P127, DOI 10.1063/1.1430502
   Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921
NR 45
TC 92
Z9 97
U1 3
U2 31
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD DEC
PY 2006
VL 1
IS 4
BP 399
EP 412
DI 10.2217/17435889.1.4.399
PG 14
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 172MP
UT WOS:000246808700011
PM 17716143
DA 2018-10-20
ER

PT J
AU Schuler, M
   Trentin, D
   Textor, M
   Tosatti, SGP
AF Schuler, Martin
   Trentin, Diana
   Textor, Marcus
   Tosatti, Samuele G. P.
TI Biomedical interfaces: titanium surface technology for implants and cell
   carriers
SO NANOMEDICINE
LA English
DT Review
DE bioligand; biomimetic; drug delivery; implant; nonfouling; peptide;
   polyethylene glycol; surface (bio)chemistry; surface modification;
   surface topography; titanium
ID SELF-ASSEMBLED MONOLAYERS; METAL-OXIDE SURFACES;
   POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS; HUMAN OSTEOPROGENITOR
   CELLS; ENHANCED BONE APPOSITION; PROTEIN ADSORPTION; OSTEOBLAST
   ADHESION; DRUG-DELIVERY; COLLAGEN-I; ALKANEPHOSPHATE MONOLAYERS
AB Titanium and its alloys have become key materials for biomedical applications, mainly owing to their compatibility with human tissues and their mechanical strength. Effects of surface topography on cell and tissue response have been investigated extensively in the past, while (bio)chemical surface modification and its combination with designed topographies have remained largely unexplored. The following report describes some of the strategies used or intended to modify titanium surfaces, based on biological principles, with a focus on ultrathin biomimetic adlayers. One of the visions behind such approaches is to achieve improved healing and integration responses after implantation for patients, especially for those suffering from deficiencies, for example, diabetes or osteoporosis, two diseases that have increased drastically in our society during the last century.
C1 ETH, Dept Mat, Lab surface Sci & Technol Biointerface Grp, CH-8093 Zurich, Switzerland.
RP Tosatti, SGP (reprint author), ETH, Dept Mat, Lab surface Sci & Technol Biointerface Grp, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM martin.schuler@mat.ethz.ch; diana.trentin@mat.ethz.ch;
   marcus.textor@mat.ethz.ch; samuele.tosatti@mat.ethz.ch
RI Textor, Marcus/A-6200-2012
OI Textor, Marcus/0000-0002-0178-1801
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Barber TA, 2005, BIOMATERIALS, V26, P6897, DOI 10.1016/j.biomaterials.2005.04.043
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bernhardt R, 2005, BIOMATERIALS, V26, P3009, DOI 10.1016/j.biomaterials.2004.08.030
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P421, DOI 10.1002/jbm.a.10080
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P431, DOI 10.1002/jbm.a.10084
   Boyan B. D., 2001, TITANIUM MED, P561
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Brunette D. M., 2001, TITANIUM MED
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Castano AP, 2005, PHOTODIAGN PHOTODYN, V2, P1, DOI 10.1016/S1572-1000(05)00030-X
   Catauro M, 2006, J BIOMED MATER RES A, V77A, P340, DOI 10.1002/jbm.a.30617
   Chauvy PF, 2003, APPL SURF SCI, V208, P165, DOI 10.1016/S0169-4332(02)01361-2
   Chauvy PF, 2001, ELECTROCHEM SOLID ST, V4, pC31, DOI 10.1149/1.1359057
   Chen SF, 2006, LANGMUIR, V22, P2418, DOI 10.1021/la052851w
   CHEN ZY, 1994, ACTA PHYS SIN-OV ED, V3, P1
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   DALTON BA, 1995, J CELL SCI, V108, P2083
   DAVIES JE, 1999, BONE ENG
   Davis FF, 2002, ADV DRUG DELIVER REV, V54, P457, DOI 10.1016/S0169-409X(02)00021-2
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ferguson SJ, 2006, J BIOMED MATER RES A, V78A, P291, DOI 10.1002/jbm.a.30678
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   GARCIA AJ, 2002, BIOMIMETIC MAT DESIG, P29
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   GRUNER H, 2001, TITANIUM MED, P375
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Healy K., 2000, BONE ENG, P268
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOFFMAN AS, 2001, BIOARTIFICIAL ORGANS, V3, P62
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Jaeger N.A.F., 2001, TITANIUM MED, P343
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Ku Y, 2005, BIOMATERIALS, V26, P5153, DOI 10.1016/j.biomaterials.2005.01.060
   KUNZLER TP, 2006, IN PRESS APPL SURF S
   Langer R, 1998, NATURE, V392, P5
   Lausmaa J., 2001, TITANIUM MED, P231
   Leyens C, 2003, TITANIUM TITANIUM AL
   Liu Y, 2006, PHILOS T ROY SOC A, V364, P233, DOI 10.1098/rsta.2005.1685
   MADDIKERI RR, 2005, BIOS 6 TISS SURF INT
   Maege I, 1998, PROG ORG COAT, V34, P1
   Maege I, 1998, MACROMOL SY, V126, P7, DOI 10.1002/masy.19981260104
   MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morra M, 2005, INT J ORAL MAX IMPL, V20, P23
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   MORRA M, 2006, EUR CELL MAT, V24, P1
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   O'Toole GC, 2004, J ORTHOPAED RES, V22, P641, DOI 10.1016/j.orthres.2003.09.005
   Pallu S, 2005, BIOMATERIALS, V26, P6932, DOI 10.1016/j.biomaterials.2005.04.054
   Palmaz JC, 2004, J ENDOVASC THER, V11, P200, DOI 10.1583/04-1363.1
   Pasche S, 2005, LANGMUIR, V21, P6508, DOI 10.1021/la050386x
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Piotrowicz A, 2006, BIOMATERIALS, V27, P2018, DOI 10.1016/j.biomaterials.2005.09.042
   PIVETEAU LD, 2001, TITANIUM MED, P267
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Porter Judith A, 2005, Gen Dent, V53, P423
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Ratner B. D., 2001, TITANIUM MED, P1
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rossetti FF, 2005, LANGMUIR, V21, P6443, DOI 10.1021/la0509100
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   SAEKI S, 1976, POLYMER, V17, P685, DOI 10.1016/0032-3861(76)90208-1
   SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Scacchi M, 2000, CLIN ORAL IMPLAN RES, V11, P22, DOI 10.1034/j.1600-0501.2000.011S1022.x
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Scharnweber D, 2004, BIOMATERIALS, V25, P2371, DOI 10.1016/j.biomaterials.2003.09.025
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   SCHULER M, 2005, BIOS 6 TISS SURF INT
   SCHULER M, 2005, 19 EUR C BIOM SORR N
   Schwartz J, 2003, MAT SCI ENG C-BIO S, V23, P395, DOI 10.1016/S0928-4931(02)00310-7
   Senyah N, 2005, ANAL BIOANAL CHEM, V383, P758, DOI 10.1007/s00216-005-3274-5
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   Serruys Patrick W., 2002, HDB CORONARY STENTS
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   SLACK SM, 1995, PROTEINS INTERFACES, V2, P112
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   TENGVALL P, 2001, TITANIUM MED, P457
   Textor M., 2001, TITANIUM MED, P171
   TEXTOR M, 2003, BIOIMPLANT INTERFACE
   THULL R, 2001, TITANIUM MED, P283
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wennerberg A, 1993, Int J Oral Maxillofac Implants, V8, P622
   *WHO, 2002, WHO TECHN REP SER, V916
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
   Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163
   Wieland M, 2000, BONE ENG
   WIELAND M, 1999, DEP MAT
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242
   Zainuddin, 2002, J RADIOANAL NUCL CH, V253, P339, DOI 10.1023/A:1020406930244
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
   Zwahlen M, 2002, LANGMUIR, V18, P3957, DOI 10.1021/la015692z
NR 128
TC 70
Z9 73
U1 2
U2 39
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD DEC
PY 2006
VL 1
IS 4
BP 449
EP 463
DI 10.2217/17435889.1.4.449
PG 15
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 172MP
UT WOS:000246808700015
PM 17716147
DA 2018-10-20
ER

PT J
AU Kale, SN
   Arora, S
   Bhayani, KR
   Paknikar, KM
   Jani, M
   Wagh, UV
   Kulkarni, SD
   Ogale, SB
AF Kale, Sangeeta N.
   Arora, Sumit
   Bhayani, Kavita R.
   Paknikar, Kishore M.
   Jani, Mona
   Wagh, Ulhas V.
   Kulkarni, Shailaja D.
   Ogale, Satish B.
TI Cerium doping and stoichiometry control for biomedical use of
   La0.7Sr0.3MnO3 nanoparticles: microwave absorption and cytotoxicity
   study
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
AB La0.7Sr0.3MnO3 nanoparticles doped with cerium (La0.7-xCexSr0.3MnO3 where 0 <= x <= 0.7) as well as the La1-ySryMnO3 nanoparticles with different values of y (La/Sr ratio) are evaluated for cytotoxicity and heating application. Considering hyperthermia as one of the possible application domains of such materials, the cytotoxicity studies were done on human skin carcinoma and human fibrosarcoma cell lines. All the samples showed the desired heating effect when subjected to highfrequency exposure at 2.45 GHz. Cytotoxicity studies revealed extremely low cytotoxicity in Ce-doped samples as well as in samples with a reduced La/Sr ratio. A maximum percentage cell viability on exposure to these nanoparticles was 95% and 85% for the two groups of samples, respectively, with a dose of 20 mu g/mL for the x = 0.4 sample. The issues of dopant solubility and nonstoichiometry are discussed. (C) 2006 Elsevier Inc. All rights reserved.
C1 Agharkar Res Inst, Nanobiotecnol Grp, Pune, Maharashtra, India.
   Fergusson Coll, Comp Sci Unit, Pune, Maharashtra, India.
   Interact Res Sch Hlth Affairs, Pune, Maharashtra, India.
   Ctr Mat Characterizat, Natl Chem Lab, Pune, Maharashtra, India.
   Phys & Mat Chem Div, Natl Chem Lab, Pune, Maharashtra, India.
EM kpaknikar@gmail.com
RI Paknikar, Kishore/A-4963-2010
OI Paknikar, Kishore/0000-0001-5602-7518; Kale,
   Sangeeta/0000-0002-5842-0310
CR ALEJANDRO G, 2006, PHYS REV B, V73, P7
   Baur C, 1998, NANOTECHNOLOGY, V9, P360, DOI 10.1088/0957-4484/9/4/011
   Chen HY, 2003, J MAGN MAGN MATER, V257, P254, DOI 10.1016/S0304-8853(02)01176-9
   FRASER SJ, 2001, ACCOUNTS CHEM RES, V34, P410
   GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hergt R, 2004, J MAGN MAGN MATER, V280, P358, DOI 10.1016/j.jmmm.2004.03.034
   Jakupec MA, 2005, REV PHYSIOL BIOCH P, V153, P101, DOI 10.1007/s10254-004-0024-6
   Kim DK, 2005, J APPL PHYS, P97
   MANAFO WW, 1976, SURGERY, V80, P465
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pankhurst Q A., 2003, J PHYS D, V36, DOI DOI 10.1088/0022-3727/36/13/201
   RAVI V, 2006, IN PRESS CER INT
   ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U
   Srinivasu VV, 1999, J APPL PHYS, V86, P1067, DOI 10.1063/1.371146
   Timko M, 2004, CZECH J PHYS, V54, pD599, DOI 10.1007/s10582-004-0153-9
   Uskokovic V, 2006, INT J APPL CERAM TEC, V3, P134, DOI 10.1111/j.1744-7402.2006.02065.x
   Wada S, 2003, ORAL DIS, V9, P218, DOI 10.1034/j.1601-0825.2003.02839.x
   WARREN C, 2006, BIONANOTECHNOL PROGR, V12, P87
   YANAGIDA A, 2006, J APPL PHYS, V99, P53908
   Yanagida T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184437
NR 22
TC 25
Z9 25
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD DEC
PY 2006
VL 2
IS 4
BP 217
EP 221
DI 10.1016/j.nano.2006.10.001
PG 5
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 120VR
UT WOS:000243115000003
PM 17292146
DA 2018-10-20
ER

PT J
AU Hartmann, CH
   Klein, CA
AF Hartmann, Claudia H.
   Klein, Christoph A.
TI Gene expression profiling of single cells on large-scale oligonucleotide
   arrays
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID RNA AMPLIFICATION; MICROARRAY ANALYSIS; CDNA; TRANSCRIPTOME
AB Over the last decade, important insights into the regulation of cellular responses to various stimuli were gained by global gene expression analyses of cell populations. More recently, specific cell functions and underlying regulatory networks of rare cells isolated from their natural environment moved to the center of attention. However, low cell numbers still hinder gene expression profiling of rare ex vivo material in biomedical research. Therefore, we developed a robust method for gene expression profiling of single cells on high-density oligonucleotide arrays with excellent coverage of low abundance transcripts. The protocol was extensively tested with freshly isolated single cells of very low mRNA content including single epithelial, mature and immature dendritic cells and hematopoietic stem cells. Quantitative PCR confirmed that the PCR-based global amplification method did not change the relative ratios of transcript abundance and unsupervised hierarchical cluster analysis revealed that the histogenetic origin of an individual cell is correctly reflected by the gene expression profile. Moreover, the gene expression data from dendritic cells demonstrate that cellular differentiation and pathway activation can be monitored in individual cells.
C1 Univ Munich, Inst Immunol, D-80336 Munich, Germany.
RP Klein, CA (reprint author), Univ Munich, Inst Immunol, Goethestr 31, D-80336 Munich, Germany.
EM christoph.klein@med.uni-muenchen.de
CR Alberts B, 2002, MOL BIOL CELL
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805
   Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546
   BRADY G, 1993, METHOD ENZYMOL, V225, P611
   Dixon AK, 2000, TRENDS PHARMACOL SCI, V21, P65, DOI 10.1016/S0165-6147(99)01433-9
   EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010
   Feldman AL, 2002, BIOTECHNIQUES, V33, P906, DOI 10.2144/02334mt04
   Freeman TC, 1999, CURR OPIN BIOTECH, V10, P579, DOI 10.1016/S0958-1669(99)00036-1
   Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797
   Heil SG, 2003, BIOTECHNIQUES, V35, P502, DOI 10.2144/03353st03
   HEIL SG, 2003, BIOTECHNIQUES, V35, P506
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Klein CA, 2002, J EXP MED, V196, P359, DOI 10.1084/jem.20011838
   Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387
   Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050
   Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241
   Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8
   Li JN, 2003, CR BIOL, V326, P1021, DOI 10.1016/j.crvi.2003.09.015
   Mahadevappa M, 1999, NAT BIOTECHNOL, V17, P1134, DOI 10.1038/15124
   Park PJ, 2004, J BIOTECHNOL, V112, P225, DOI 10.1016/j.jbiotec.2004.05.006
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570
   Saghizadeh M, 2003, BIOMOL ENG, V20, P97, DOI 10.1016/S1389-0344(03)00006-6
   Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561
   Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663
NR 28
TC 42
Z9 47
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD DEC
PY 2006
VL 34
IS 21
AR e143
DI 10.1093/nar/gkl740
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 115EE
UT WOS:000242716800001
PM 17071717
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lahann, J
AF Lahann, Joerg
TI Vapor-based polymer coatings for potential biomedical applications
SO POLYMER INTERNATIONAL
LA English
DT Review
DE biomedical coatings; immobilization; surface engineering; biomaterials;
   surface analysis
ID SURFACE-TETHERED POLYPEPTIDE; THROMBIN-SPECIFIC INHIBITOR; THIN-FILMS;
   POLY(P-PHENYLENE VINYLENE); DEPOSITION POLYMERIZATION; MICROFLUIDIC
   CHANNELS; R-HIRUDIN; CONFORMATIONAL TRANSITION; RADICAL POLYMERIZATION;
   IMMOBILIZATION
AB Over the last decade, biology and biotechnology have witnessed an extraordinary development spanning genomics, proteomics, and metabolics. This progress was so rapid and definite that it not only changed the face of modern biology, but indeed altered the way day-to-day business is done in biology and related fields. This scientific advancement came with a need for concurrent technological advances. In this context, the ability to interface sophisticated devices with relevant biological microenvironments has emerged as a critical challenge. Already, novel biomaterials are on the horizon that promise to fulfill the rigid criteria of being both biocompatible under the conditions of a versatile range of biological applications and compatible with the increasing demands for miniaturization, integration, and throughput of future device architectures. As currently employed solvent-based polymer coatings are increasingly reaching their limits, a range of unconventional materials, such as vapor-based polymer coatings, are discussed as attractive alternatives. One of the main features of vapor-based polyreactions is their versatility in synthesizing both simple and complex polymers with relative ease and at generally low temperatures. The advantages of the chemical vapor deposition (CVD) technique also include control of the composition and architecture of the resulting materials, high accuracy, solvent-free environments, excellent adhesion, and the ability to accommodate custom-tailored surface modifications. For further illustration, selected examples of polymer-based surface engineering approaches using vapor-based polyreactions are discussed in this review. For instance, reactive coating technology uses CVD polymerization to deposit a wide range of chemically functionalized polymer coatings on various substrate materials. Its simplicity in providing chemically reactive groups and its applicability to three-dimensional geometries (e.g. for microfluidics) enables exact tailoring of surface properties and the preparation of biologically relevant microenvironments. CVD-based reactive coatings are compatible with soft lithographic processes allowing for patterning of proteins, DNA, cytokines, and mammalian cells. (C) 2006 Society of Chemical Industry.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Lahann, J (reprint author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
EM lahann@unimich.edu
RI Lahann, Joerg/J-7663-2013
CR Calderon JG, 1998, MACROMOLECULES, V31, P3216, DOI 10.1021/ma970924f
   CHANG JY, 1983, FEBS LETT, V164, P307, DOI 10.1016/0014-5793(83)80307-X
   Chang YC, 1996, LANGMUIR, V12, P5824, DOI 10.1021/la950686m
   CHANG YC, 1997, POLYM PREPRINTS, V38, P945
   Chen HY, 2006, J AM CHEM SOC, V128, P374, DOI 10.1021/ja057082h
   Chen HY, 2005, ANAL CHEM, V77, P6909, DOI 10.1021/ac050964e
   CHRISEY D, 2003, CHEM REV, P553
   Christman KL, 2005, LANGMUIR, V21, P8389, DOI 10.1021/la050646a
   DODT J, 1984, FEBS LETT, V165, P180, DOI 10.1016/0014-5793(84)80165-9
   Dolbier WR, 2003, J FLUORINE CHEM, V122, P97, DOI 10.1016/S0022-1139(03)00100-3
   FENG J, 2004, COLLOID SURFACE B, V3, P177
   Fu DG, 2002, ADV MATER, V14, P339, DOI 10.1002/1521-4095(20020304)14:5<339::AID-ADMA339>3.0.CO;2-Q
   Ganguli S, 1997, J VAC SCI TECHNOL A, V15, P3138, DOI 10.1116/1.580858
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   GORHAM WF, 1966, J POLYM SCI A1, V4, P3027, DOI 10.1002/pol.1966.150041209
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Herrera-Alonso M, 2004, LANGMUIR, V20, P9184, DOI 10.1021/la049025s
   Iguchi N, 1997, PACE, V20, P372, DOI 10.1111/j.1540-8159.1997.tb06188.x
   Ishaque M, 2002, E-POLYMERS
   KLEE D, 2004, PARACYCLOPHANES
   Kokane S, 2003, SYNTHETIC MET, V132, P235, DOI 10.1016/S0379-6779(02)00456-3
   KUBONO A, 1992, JPN J APPL PHYS 2, V31, pL1195, DOI 10.1143/JJAP.31.L1195
   Lahann J, 2003, ANAL CHEM, V75, P2117, DOI 10.1021/ac020557s
   Lahann J, 2002, MACROMOL BIOSCI, V2, P82
   Lahann J, 2002, LANGMUIR, V18, P3632, DOI 10.1021/la011464t
   Lahann J, 2002, MACROMOLECULES, V35, P4380, DOI 10.1021/ma011769e
   Lahann J, 2001, J MATER SCI-MATER M, V12, P807, DOI 10.1023/A:1013929103147
   Lahann J, 2001, MACROMOL RAPID COMM, V22, P968
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   Lahann J, 2001, ANGEW CHEM INT EDIT, V40, P726, DOI 10.1002/1521-3773(20010216)40:4<726::AID-ANIE7260>3.0.CO;2-X
   Lahann J, 2001, ANGEW CHEM INT EDIT, V40, P3166, DOI 10.1002/1521-3773(20010903)40:17<3166::AID-ANIE3166>3.0.CO;2-#
   Lahann J, 1998, MACROMOL RAPID COMM, V19, P441, DOI 10.1002/(SICI)1521-3927(19980901)19:9<441::AID-MARC441>3.0.CO;2-G
   LAHANN J, IN PRESS CHEM ENG CO
   Lee NH, 2003, LANGMUIR, V19, P1295, DOI 10.1021/la020432i
   Li J, 2005, LANGMUIR, V21, P9562, DOI 10.1021/la051109t
   Mao Y, 2004, LANGMUIR, V20, P2484, DOI 10.1021/la0359427
   McKamey RP, 2000, J MATER SCI-MATER M, V11, P407, DOI 10.1023/A:1008983808008
   Murthy SK, 2002, MACROMOLECULES, V35, P1967, DOI 10.1021/ma011286a
   Murthy SK, 2004, J APPL POLYM SCI, V91, P2176, DOI 10.1002/app.13342
   Nandivada H, 2005, MACROMOL RAPID COMM, V26, P1794, DOI 10.1002/marc.200500449
   Nandivada H, 2006, ANGEW CHEM INT EDIT, V45, P3360, DOI 10.1002/anie.200600357
   Nichols M F, 1993, Biomed Sci Instrum, V29, P77
   NOWLIN TE, 1980, J APPL POLYM SCI, V25, P1619, DOI 10.1002/app.1980.070250809
   OLAH GA, 1978, SYNTHESIS-STUTTGART, P690
   Ryu KS, 2004, LAB CHIP, V4, P608, DOI 10.1039/b403305a
   Schiller S, 2002, CHEM MATER, V14, P235, DOI 10.1021/cm011139r
   Schmidt C, 1998, ACTA POLYM, V49, P232, DOI 10.1002/(SICI)1521-4044(199805)49:5<232::AID-APOL232>3.0.CO;2-L
   SHEN M, 2002, J BIOMATER RES POLYM, V12, P961
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shen WW, 2001, BIOMACROMOLECULES, V2, P70, DOI 10.1021/bm005581z
   SHIRAI M, 1993, CHEM MATER, V5, P98, DOI 10.1021/cm00025a019
   Simon P, 1998, MACROMOLECULES, V31, P8775, DOI 10.1021/ma9808070
   Smith JP, 2005, ANAL CHEM, V77, p412A
   Suh KY, 2004, ADV MATER, V16, P1401, DOI 10.1002/adma.200400101
   Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637
   Takeuchi S, 2005, LAB CHIP, V5, P519, DOI 10.1039/b417497f
   TATSUO K, 1987, APPL PHYS LETT, V51, P1957
   Tsukagoshi K, 2002, SURF SCI, V514, P48, DOI 10.1016/S0039-6028(02)01606-0
   Tulinsky A, 1996, SEMIN THROMB HEMOST, V22, P117, DOI 10.1055/s-2007-998998
   UTLEY JHP, 1995, J MATER CHEM, V5, P1297, DOI 10.1039/jm9950501297
   Vaeth KM, 1998, MACROMOLECULES, V31, P6789, DOI 10.1021/ma9805755
   Vaeth KM, 1997, APPL PHYS LETT, V71, P2091, DOI 10.1063/1.119351
   Wang YL, 2003, MACROMOLECULES, V36, P6503, DOI 10.1021/ma034092z
   Wang YL, 2003, MACROMOLECULES, V36, P6511, DOI 10.1021/ma034093r
   Wang YL, 2003, J AM CHEM SOC, V125, P6376, DOI 10.1021/ja034428k
   Wang YL, 2002, LANGMUIR, V18, P9859, DOI 10.1021/la026343n
   WATERS JF, 1991, J POLYM SCI POL CHEM, V29, P1917, DOI 10.1002/pola.1991.080291311
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
   Wu QG, 2003, J VAC SCI TECHNOL A, V21, P388, DOI 10.1116/1.1539086
   Wu QG, 2003, PLASMAS POLYM, V8, P31, DOI 10.1023/A:1022813808367
   Yasutake M, 2003, MACROMOLECULES, V36, P5974, DOI 10.1021/ma021795s
   Yeo WS, 2004, ADV MATER, V16, P1352, DOI 10.1002/adma.200400591
   YOU L, 1993, J VAC SCI TECHNOL A, V11, P3047, DOI 10.1116/1.578295
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   INSTRUCTIONS USE CYP
NR 76
TC 85
Z9 85
U1 0
U2 39
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2006
VL 55
IS 12
BP 1361
EP 1370
DI 10.1002/pi.2098
PG 10
WC Polymer Science
SC Polymer Science
GA 112CP
UT WOS:000242503100003
DA 2018-10-20
ER

PT J
AU Stempfle, P
   Brendle, M
AF Stempfle, Philippe
   Brendle, Marcel
TI Tribological behaviour of nacre - Influence of the environment on the
   elementary wear processes
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 32nd Leeds-Lyon Symposium on Tribology
CY SEP 06-09, 2005
CL Inst Natl Sci Applicat Lyon, Lyon, FRANCE
HO Inst Natl Sci Applicat Lyon
DE sheet nacre; friction; wear; AFM; biomedical; prosthesis design
ID ORGANIC MATRIX LAYERS; MECHANICAL-PROPERTIES; PINCTADA-MAXIMA;
   MULTISCALE STRUCTURE; CRYSTAL ORIENTATION; THIN-FILM; FRACTURE;
   TOUGHNESS; PEARL; MODEL
AB Nacre (so-called mother-of-pearl) is a natural organic/inorganic nanocomposite displaying exceptional high mechanical properties to weight ratio and a good biocompatibility with the human bones. Consequently, it becomes an attractive material for prosthesis design. These properties are ascribed to its highly ordered layered 'bricks and mortar' microstructure. This work studies the tribological behaviour of sheet nacre, rubbing on itself in dry conditions and in the presence of a liquid medium, in relation with its multiscale structure. The results show that the coefficient of friction, rather high under dry conditions (0.45), is even increasing under wet conditions (0.78). Aside a significant dissymmetry between pin and disc, the wear rates were shown to display the same trends. These changes are associated with marked differences in surface topography and in the extent of third body. The systematic study of the microstructure (by AFM, image analysis, SEM and TEM) of the worn surfaces and third bodies allows us to propose a particle detachment model where the role of the inter- and intracrystalline organic material and their interactions with the environment are emphasized. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Ecole Natl Ingn Tarbes, Lab Genie Prod, F-65016 Tarbes, France.
   ICSI, F-68057 Mulhouse, France.
RP Stempfle, P (reprint author), Ecole Natl Ingn Tarbes, Lab Genie Prod, 47 Ave Azereix, F-65016 Tarbes, France.
EM philippe.stempfle@enit.fr
CR Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010
   Aime JP, 2001, J CHEM PHYS, V114, P4945, DOI 10.1063/1.1349179
   Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   CALVERT P, 1990, MATER RES SOC SYMP P, V180, P619, DOI 10.1557/PROC-180-619
   CALVERT P, 1992, MRS BULL, V17, P37, DOI 10.1557/S0883769400046467
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   CURREY JD, 1974, J ZOOL, V173, P395
   CURREY JD, 1976, J ZOOL, V180, P445
   de Gennes PG, 2000, CR ACAD SCI IV-PHYS, V1, P257
   Dumbleton JH, 1981, TRIBOLOGY SERIES
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   Falini G, 2003, CALCIFIED TISSUE INT, V72, P548, DOI 10.1007/s00223-002-1055-0
   Feng QL, 1999, J MATER SCI LETT, V18, P1547, DOI 10.1023/A:1006687627323
   Feng QL, 2000, MAT SCI ENG C-BIO S, V11, P19, DOI 10.1016/S0928-4931(00)00138-7
   He JL, 1997, J MATER RES, V12, P3140, DOI 10.1557/JMR.1997.0410
   He JL, 1998, SURF COAT TECH, V104, P109, DOI 10.1016/S0257-8972(98)00382-X
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   HUANG LJ, 1990, MATER RES SOC SYMP P, V174, P101
   *IM METR, 2002, SCANN PROB IM PROC S
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   JACKSON AP, 1989, COMPOS SCI TECHNOL, V36, P255, DOI 10.1016/0266-3538(89)90024-9
   JACKSON AP, 1986, J MATER SCI LETT, V5, P975, DOI 10.1007/BF01730253
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   Katti DR, 2001, J MATER SCI, V36, P1411, DOI 10.1023/A:1017528209162
   Kim YW, 2002, BIOMATERIALS, V23, P2089, DOI 10.1016/S0142-9612(01)00340-4
   Kotha SP, 2001, J MATER SCI, V36, P2001, DOI 10.1023/A:1017526830874
   LARAIA VJ, 1990, MATER RES SOC SYMP P, V174, P125
   Lawn B., 1992, NATO ASI SER, P137
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5
   Liu CH, 1996, J MATER RES, V11, P2231, DOI 10.1557/JMR.1996.0283
   Liu CH, 1996, MAT SCI ENG C-BIOMIM, V4, P139, DOI 10.1016/S0928-4931(96)00145-2
   Magonov SN, 1997, SURF SCI, V375, P385
   Mutvei H., 1970, BIOMINERALISATION, V2, P48
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P113, DOI 10.1016/j.msec.2005.01.004
   NICHOLSON PS, 1995, CAN CERAM QUART, P24
   Nukala PKVV, 2005, BIOMATERIALS, V26, P6087, DOI 10.1016/j.biomaterials.2005.03.013
   Okumura K, 2002, EUR PHYS J E, V7, P303, DOI 10.1140/epje/i2001-10096-4
   Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   Rousseau M, 2005, KEY ENG MAT, V284-286, P705, DOI 10.4028/www.scientific.net/KEM.284-286.705
   Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   SARIKAYA M, 1994, MICROSC RES TECHNIQ, V27, P360, DOI 10.1002/jemt.1070270503
   SARIKAYA M, 1990, MATER RES SOC SYMP P, V174, P109
   SARIKAYA M, 1992, BIOPOLYMERS, P1
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1
   Song F, 2002, J MATER RES, V17, P1567, DOI 10.1557/JMR.2002.0233
   STEMPFLE PH, 2005, IN PRESS WEAR
   Wang CA, 2000, MAT SCI ENG C-BIO S, V11, P9, DOI 10.1016/S0928-4931(00)00133-8
   WANG RZ, 1995, J MATER SCI, V30, P2299, DOI 10.1007/BF01184577
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   WEINREICH U, 1997, EAWOP NEWSLETTER, V7, P5
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WISE S JR, 1970, Eclogae Geologicae Helvetiae, V63, P775
   Wu JZ, 1998, J BIOMECH, V31, P165
   YASREBI M, 1990, MATER RES SOC SYMP P, V180, P625, DOI 10.1557/PROC-180-625
   Zhang SM, 2004, MATER LETT, V58, P2266, DOI 10.1016/j.matlet.2004.01.030
   Zhang SM, 2002, ACTA CHIM SINICA, V60, P1497
NR 66
TC 18
Z9 18
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
EI 1879-2464
J9 TRIBOL INT
JI Tribol. Int.
PD DEC
PY 2006
VL 39
IS 12
SI SI
BP 1485
EP 1496
DI 10.1016/j.triboint.2006.01.011
PG 12
WC Engineering, Mechanical
SC Engineering
GA 088NM
UT WOS:000240818400002
DA 2018-10-20
ER

PT J
AU Gupta, S
   Boojh, R
AF Gupta, Saurabh
   Boojh, Ram
TI Report: Biomedical waste management practices at Balrampur Hospital,
   Lucknow, India
SO WASTE MANAGEMENT & RESEARCH
LA English
DT Article
DE biomedical waste; disinfection; healthcare establishment; infectious
   waste; waste management; wmr 965-3
AB Biomedical waste has become a serious health hazard in many countries, including India. Careless and indiscriminate disposal of this waste by healthcare establishments and research institutions can contribute to the spread of serious diseases such as hepatitis and AIDS (HIV) among those who handle it and also among the general public. The present study pertains to the biomedical waste management practices at Balrampur Hospital, a premier healthcare establishment in Lucknow, in North India. The study shows that infectious and non-infectious wastes are dumped together within the hospital premises, resulting in a mixing of the two, which are then disposed of with municipal waste at the dumping sites in the city. All types of wastes are collected in common bins placed outside the patients wards. For disposal of this waste the hospital depends on the generosity of the Lucknow Municipal Corporation, whose employees generally collect it every 2 or 3 days. The hospital does not have any treatment facility for infectious waste. The laboratory waste materials, which are disposed of directly into the municipal sewer without proper disinfection of pathogens, ultimately reach the Gomti River. All disposable plastic items are segregated by the rag pickers from the hospital as well as municipal bins and dumps. The waste is deposited either inside the hospital grounds, or outside in the community bin for further transportation and disposal along with municipal solid waste. The open dumping of the waste makes it freely accessible to rag pickers who become exposed to serious health hazards due to injuries from sharps, needles and other types of material used when giving injections. The results of the study demonstrate the need for strict enforcement of legal provisions and a better environmental management system for the disposal of biomedical waste in the Balrampur Hospital, as well as other healthcare establishments in Lucknow.
C1 Adm Staff Coll, Ctr Energy Environm & Technol, Hyderabad 50008, Andhra Pradesh, India.
   Ctr Environm Educ, Lucknow, Uttar Pradesh, India.
RP Gupta, S (reprint author), Adm Staff Coll, Ctr Energy Environm & Technol, Bella vista,Raj Bhavan Rd, Hyderabad 50008, Andhra Pradesh, India.
EM sguptalko@rediffmail.com
CR ALMUNEEF M, 2003, AM J INFECT CONTROL, V13, P188
   [Anonymous], 2000, MAN HOSP WAST MAN
   Baveja G., 2000, HOSP TODAY, V5, P485
   BDOUR A, 2004, GUIDELINE SAFE MANAG
   CHARY VS, 1998, MED WASTE MANAGEMENT
   *INF NUGG, 2003, HOSP WAST MAN BIOD W
   Kelkar R., 1998, IND SAF CHRON    OCT, P67
   LAKSHMI K, 2003, NORMS GIVEN GO BY GO
   Patil AD, 2001, J ENVIRON MANAGE, V63, P211, DOI 10.1066/jema.2001.0453
   PATIL GV, 2004, WASTE MANAGE, V25, P592
   Saini R. S., 1995, J IAEM, V22, P172
   Tudor TL, 2005, WASTE MANAGE, V25, P606, DOI 10.1016/j.wasman.2004.10.004
NR 12
TC 27
Z9 27
U1 1
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0734-242X
J9 WASTE MANAGE RES
JI Waste Manage. Res.
PD DEC
PY 2006
VL 24
IS 6
BP 584
EP 591
DI 10.1177/0734242X06068342
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 114QB
UT WOS:000242679600010
PM 17253005
DA 2018-10-20
ER

PT J
AU Bellin, I
   Kelch, S
   Langer, R
   Lendlein, A
AF Bellin, I.
   Kelch, S.
   Langer, R.
   Lendlein, A.
TI Polymeric triple-shape materials
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE active polymer; polymer network; shape-memory polymer; stimuli-sensitive
   polymer; two-step programming process
ID MEMORY POLYMER; BIOMEDICAL APPLICATIONS; NETWORKS; TEMPERATURE
AB Shape-memory polymers represent a promising class of materials that can move from one shape to another in response to a stimulus such as heat. Thus far, these systems are dual-shape materials. Here, we report a triple-shape polymer able to change from a first shape (A) to a second shape (B) and from there to a third shape (C). Shapes B and C are recalled by subsequent temperature increases. Whereas shapes A and B are fixed by physical cross-links, shape C is defined by covalent cross-links established during network formation. The triple-shape effect is a general concept that requires the application of a two-step programming process to suitable polymers and can be realized for various polymer networks whose molecular structure allows formation of at least two separated domains providing pronounced physical cross-links. These domains can act as the switches, which are used in the two-step programming process for temporarily fixing shapes A and B. It is demonstrated that different combinations of shapes A and B for a polymer network in a given shape C can be obtained by adjusting specific parameters of the programming process. Dual-shape materials have already found various applications. However, as later discussed and illustrated by two examples, the ability to induce two shape changes that are not limited to be unidirectional rather than one could potentially offer unique opportunities, such as in medical devices or fasteners.
C1 GKSS Forschungszentrum Geesthacht GmbH, Polymer Res Inst, D-14513 Teltow, Germany.
   MIT, Cambridge, MA 02139 USA.
RP Langer, R (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM rlanger@mit.edu; lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR AOYAGI T, 1994, J CONTROL RELEASE, V32, P87
   Choi NY, 2006, ADV ENG MATER, V8, P439, DOI 10.1002/adem.200600020
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Flory PJ, 1943, J CHEM PHYS, V11, P512, DOI 10.1063/1.1723791
   FLORY PJ, 1985, SELECTED WORKS P J F
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Goethals EJ, 1998, MACROMOL SYMP, V132, P57, DOI 10.1002/masy.19981320108
   HAYASHI S, 1995, PLAST ENG, V51, P29
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Li FK, 1999, J APPL POLYM SCI, V71, P1063, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1063::AID-APP4>3.0.CO;2-A
   Liu GQ, 2005, MACROMOL RAPID COMM, V26, P649, DOI 10.1002/marc.200400640
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Monkman GJ, 2000, MECHATRONICS, V10, P489, DOI 10.1016/S0957-4158(99)00068-9
   Reyntjens WG, 1999, MACROMOL RAPID COMM, V20, P251, DOI 10.1002/(SICI)1521-3927(19990501)20:5<251::AID-MARC251>3.0.CO;2-2
   Tobushi H, 1996, SMART MATER STRUCT, V5, P483, DOI 10.1088/0964-1726/5/4/012
   WU S, 1992, J APPL POLYM SCI, V46, P619, DOI 10.1002/app.1992.070460408
   Zhu G, 2003, J APPL POLYM SCI, V90, P1589, DOI 10.1002/app.12736
NR 19
TC 287
Z9 294
U1 11
U2 113
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 28
PY 2006
VL 103
IS 48
BP 18043
EP 18047
DI 10.1073/pnas.0608586103
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 111PJ
UT WOS:000242465200005
PM 17116879
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Jing, FJ
   Wang, L
   Liu, YW
   Fu, RKY
   Zhao, XB
   Shen, R
   Huang, N
   Chu, PK
AF Jing, F. J.
   Wang, L.
   Liu, Y. W.
   Fu, R. K. Y.
   Zhao, X. B.
   Shen, R.
   Huang, N.
   Chu, Paul K.
TI Hemocompatibility of lanthanum oxide films fabricated by dual plasma
   deposition
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 33rd International Conference on Metallurgical Coatings and Thin Films
CY MAY 01-05, 2006
CL San Diego, CA
SP Amer Vacuum Soc, Adv Surface Engn Div
DE lanthanum oxide; dual plasma deposition; blood platelets; endothelial
   cells
ID THIN-FILMS; CELLS; XPS; IDENTIFICATION; SPECTROSCOPY; PRECURSOR; GROWTH;
   LINES
AB Lantbanum oxide films were fabricated using dual plasma deposition. X-ray photoelectron spectroscopy (XPS) showed that La existed in the +3 oxidation state. X-ray diffraction (XRD) revealed a (101) oriented hexagonal structure. Blood platelet adhesion tests and endothelial cell cultures were used to evaluate the hemocompatibility of the as-deposited films. Scanning electron microscopy (SEM) and optical microscopy were employed to evaluate the surface morphology of the blood platelets and endothelial cells on the films. The results showed that the number of adhered, aggregated and morphologically changed platelets was reduced compared to that observed on low-temperature isotropic carbon (LTIC). Endothelial cells culture tests indicated good adhesion and proliferation of human umbilical vein endothelial (HUVE) cells ill vitro. Our study suggests that lanthanum oxide films are potential blood-contacting biomedical materials. (c) 2006 Elsevier B.V All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Arenas MA, 2004, CORROS SCI, V46, P1033, DOI 10.1016/S0010-938X(03)00193-8
   Aspinall HC, 2004, CHEM VAPOR DEPOS, V10, P13, DOI 10.1002/cvde.200304164
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   Copel M, 2001, APPL PHYS LETT, V78, P1607, DOI 10.1063/1.1355002
   Dai YC, 2002, IN VITRO CELL DEV-AN, V38, P373
   Evans C. H., 1990, BIOCH LANTHANIDES
   Feng LC, 2001, J SUPERCRIT FLUID, V21, P111, DOI 10.1016/S0896-8446(01)00091-2
   Galtayries A, 1999, SURF INTERFACE ANAL, V27, P941, DOI 10.1002/(SICI)1096-9918(199910)27:10<941::AID-SIA657>3.3.CO;2-P
   GONZALEZELIPE AR, 1990, APPL SURF SCI, V45, P103, DOI 10.1016/0169-4332(90)90060-D
   Gougousi T, 2003, J APPL PHYS, V93, P1691, DOI 10.1063/1.1531818
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jakupec MA, 2005, REV PHYSIOL BIOCH P, V153, P101, DOI 10.1007/s10254-004-0024-6
   Kale SS, 2005, MATER LETT, V59, P3007, DOI 10.1016/j.matlet.2005.02.091
   KOSZTOLANYI G, 1977, Haematologia, V11, P155
   Nieminen M, 2001, APPL SURF SCI, V174, P155, DOI 10.1016/S0169-4332(01)00149-0
   Pawlak DA, 2002, J PHYS CHEM B, V106, P504, DOI 10.1021/jp012040a
   SAUERHEBER RD, 1980, J MEMBRANE BIOL, V52, P201, DOI 10.1007/BF01869190
   SMITH JB, 1984, BIOSCIENCE REP, V4, P777, DOI 10.1007/BF01128819
   Tian XB, 2003, REV SCI INSTRUM, V74, P5137, DOI 10.1063/1.1626012
   WAGNER CD, 1980, ANAL CHEM, V52, P1445, DOI 10.1021/ac50059a017
   Zhang JC, 2004, J RARE EARTH, V22, P891
NR 23
TC 17
Z9 19
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 25
PY 2006
VL 515
IS 3
BP 1219
EP 1222
DI 10.1016/j.tsf.2006.07.137
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 114AR
UT WOS:000242639600074
DA 2018-10-20
ER

PT J
AU Seo, J
   Lee, LP
AF Seo, Jeonggi
   Lee, Luke P.
TI Effects on wettability by surfactant accumulation/depletion in bulk
   polydimethylsiloxane (PDMS)
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE polydimethylsiloxane (PDMS); microfluidics; surface modification; triton
   X-100; contact angle measurement
ID SOLID-SURFACES; POLYELECTROLYTE MULTILAYERS; MICROFLUIDIC DEVICES;
   CONTACT-ANGLE; EVAPORATION; POLY(DIMETHYLSILOXANE); CHIP; FLOW;
   MICRODROPLETS; SYSTEMS
AB Polydimethylsiloxane (PDMS) is an appealing silicone elastomer as a base material for microfluidic biomedical applications. Its ability to easily cross-link as well as its favorable physical and chemical properties has enabled a large number of micro- and nano-cast applications. However, PDMS' hydrophobic surface can be problematic. Two methods presented here address the wettability of PDMS by accumulating or depleting surfactant in PDMS. The surfactant in the cross-linked PDMS matrix is released and activated upon contacting with an aqueous solution and assists the solution wetting of PDMS. Wettability was enhanced as a function of surfactant concentration. With the addition of 3% Triton TX-100 (a nonionic surfactant), the contact angle of deionized water on PDMS decreased up to 40 degrees in 90 s, compared with a decrease of only 3 degrees on unmodified PDMS. Dynamic measurements of contact angle and contact line radii showed wettability change due to the transfer of surfactant to the interface of the aqueous solution/PDMS. The stability of the modified PDMS was quantified by contact angle measurements over a 30-day duration. Immersing the modified PDMS in water for long time periods before the measurement depletes the surfactant; the resulting wettability becomes a function of immersion duration. The surface wettability can also be controlled with a function of immersion duration even after the PDMS is cured. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Bioengn, Berkeley, CA 94720 USA.
RP Lee, LP (reprint author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Bioengn, Berkeley, CA 94720 USA.
EM lplee@berkeley.edu
CR Adamson A. W., 1997, PHYS CHEM SURFACE
   Adamson A. W., 1997, PHYS CHEM SURFACES
   Barker SLR, 2000, ANAL CHEM, V72, P5925, DOI 10.1021/ac0008690
   BIRDI KS, 1989, J PHYS CHEM-US, V93, P3702, DOI 10.1021/j100346a065
   BOURGESMONNIER C, 1995, LANGMUIR, V11, P2820, DOI 10.1021/la00007a076
   Dou YH, 2002, ELECTROPHORESIS, V23, P3558, DOI 10.1002/1522-2683(200210)23:20<3558::AID-ELPS3558>3.0.CO;2-#
   Erbil HY, 2002, LANGMUIR, V18, P2636, DOI 10.1021/la011470p
   Hillborg H, 2000, POLYMER, V41, P6851, DOI 10.1016/S0032-3861(00)00039-2
   Hu H, 2002, J PHYS CHEM B, V106, P1334, DOI 10.1021/jp0118322
   Karagunduz A, 2001, SOIL SCI SOC AM J, V65, P1392, DOI 10.2136/sssaj2001.6551392x
   Lee H, 2001, MACROMOLECULES, V34, P4572, DOI 10.1021/ma001278e
   LI D, 1992, J COLLOID INTERF SCI, V148, P190, DOI 10.1016/0021-9797(92)90127-8
   Linder V, 2001, ANAL CHEM, V73, P4181, DOI 10.1021/ac010421e
   Liu Y, 2000, ANAL CHEM, V72, P5939, DOI 10.1021/ac000932l
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McHale G, 1998, J PHYS CHEM B, V102, P1964, DOI 10.1021/jp972552i
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Ocvirk G, 2000, ELECTROPHORESIS, V21, P107, DOI 10.1002/(SICI)1522-2683(20000101)21:1<107::AID-ELPS107>3.0.CO;2-Y
   Rowan SM, 1997, J PHYS CHEM B, V101, P1265, DOI 10.1021/jp962795v
   ROWAN SM, 1995, J PHYS CHEM-US, V99, P13268, DOI 10.1021/j100035a034
   Seo J, 2004, SENSOR ACTUAT B-CHEM, V99, P615, DOI 10.1016/j.snb.2003.11.014
   Seo J, 2004, APPL PHYS LETT, V84, P1973, DOI 10.1063/1.1650035
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Wu HK, 2003, J AM CHEM SOC, V125, P554, DOI 10.1021/ja021045y
   Xia YN, 1997, LANGMUIR, V13, P2059, DOI 10.1021/la960936e
   Yamamoto T, 2002, LAB CHIP, V2, P197, DOI 10.1039/b205010b
NR 27
TC 60
Z9 61
U1 3
U2 64
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD NOV 24
PY 2006
VL 119
IS 1
BP 192
EP 198
DI 10.1016/j.snb.2005.12.019
PG 7
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 093VB
UT WOS:000241197300029
DA 2018-10-20
ER

PT J
AU Vermonden, T
   Besseling, NAM
   van Steenbergen, MJ
   Hennink, WE
AF Vermonden, Tina
   Besseling, Nicolaas A. M.
   van Steenbergen, Mies J.
   Hennink, Wim E.
TI Rheological studies of thermosensitive triblock copolymer hydrogels
SO LANGMUIR
LA English
DT Article
ID AQUEOUS-SOLUTIONS; GEL POINT; POLY(ETHYLENE GLYCOL); POLYMERIC MICELLES;
   VISCOELASTICITY; DEPENDENCE; SYSTEMS
AB Hydrogel formation by physical cross-linking is a developing area of research toward materials suitable for pharmaceutical and biomedical applications. Polymers exhibiting lower critical solution temperature (LCST) behavior in aqueous solution are used in this study to prepare hydrogels. Four triblock copolymers (ABA) with thermosensitive poly(N-(2-hydroxypropyl) methacrylamide lactate) A-blocks and a hydrophilic poly( ethylene glycol) B-block have been synthesized. The molecular weight of the hydrophilic PEG block was fixed at 10 kDa, whereas the molecular weight of the pHPMAm-lactate block was varied between 10 and 20 kDa. The rheological characteristics of these polymer hydrogels were studied as a function of temperature, concentration, and the length of the thermosensitive blocks. Gelation occurred rapidly upon increasing the temperature to 37 degrees C, which makes this system suitable as an injectable formulation. The gels became stronger with increasing temperature and concentration, and moreover they behaved as critical gels, which means that G' and G'' follow power laws over the network, which increases with decreasing length of the thermosensitive blocks.
C1 Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands.
   Univ Wageningen & Res Ctr, Lab Phys Chem & Colloid Sci, NL-6703 HB Wageningen, Netherlands.
RP Vermonden, T (reprint author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, POB 80082, NL-3508 TB Utrecht, Netherlands.
EM t.vermonden@pharm.uu.nl
RI Vermonden, Tina/I-9491-2016
OI Vermonden, Tina/0000-0002-6047-5900
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   Aubry T, 2003, J RHEOL, V47, P577, DOI 10.1122/1.1545077
   CHAMBON F, 1986, MACROMOLECULES, V19, P2146, DOI 10.1021/ma00162a007
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   IZUKA A, 1992, MACROMOLECULES, V25, P2422, DOI 10.1021/ma00035a020
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Lee Y. K, 2001, CHEM REV, V101, P1869
   Li SM, 2003, MACROMOL BIOSCI, V3, P657, DOI 10.1002/rnabi.200350032
   LOCCUFIER J, 1991, POLYM BULL, V27, P201, DOI 10.1007/BF00296031
   MATSUMOTO T, 1992, MACROMOLECULES, V25, P5430, DOI 10.1021/ma00046a047
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   Neradovic D, 2003, MACROMOLECULES, V36, P7491, DOI 10.1021/ma034381n
   Neradovic D, 2001, MACROMOLECULES, V34, P7589, DOI 10.1021/ma011198q
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Pham QT, 1999, MACROMOLECULES, V32, P5139, DOI 10.1021/ma990215x
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   SCANLAN JC, 1991, MACROMOLECULES, V24, P47, DOI 10.1021/ma00001a008
   Sivakova S, 2005, J AM CHEM SOC, V127, P18202, DOI 10.1021/ja055245w
   Soga O, 2004, LANGMUIR, V20, P9388, DOI 10.1021/la048354h
   Soga O, 2004, BIOMACROMOLECULES, V5, P818, DOI 10.1021/bm049955q
   Tew GN, 2005, SOFT MATTER, V1, P253, DOI 10.1039/b509800a
   VALLES EM, 1990, RHEOL ACTA, V29, P535, DOI 10.1007/BF01329300
   Vermonden T, 2004, J AM CHEM SOC, V126, P15802, DOI 10.1021/ja0458928
   WALDERHAUG H, 1993, J PHYS CHEM-US, V97, P8336, DOI 10.1021/j100133a033
   Yu JM, 1996, MACROMOLECULES, V29, P5384, DOI 10.1021/ma951911+
   ZOLZER U, 1992, J PHYS II, V2, P2207
NR 30
TC 75
Z9 76
U1 5
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 21
PY 2006
VL 22
IS 24
BP 10180
EP 10184
DI 10.1021/la062224m
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 105HX
UT WOS:000242022100057
PM 17107019
DA 2018-10-20
ER

PT J
AU Tomasulo, M
   Yildiz, I
   Kaanumalle, SL
   Raymo, FM
AF Tomasulo, Massimiliano
   Yildiz, Ibrahim
   Kaanumalle, Sireesha L.
   Raymo, Francisco M.
TI pH-sensitive ligand for luminescent quantum dots
SO LANGMUIR
LA English
DT Article
ID RESONANCE ENERGY-TRANSFER; LOW-DIMENSIONAL SYSTEMS; SEMICONDUCTOR
   NANOCRYSTALS; MONODISPERSE NANOCRYSTALS; BIOLOGICAL APPLICATIONS;
   ELECTRONIC-STRUCTURE; DEPENDENT PROPERTIES; MATERIALS SCIENCE; CDS
   NANOCRYSTALS; FLUORESCENCE
AB We developed a strategy to switch the luminescence of semiconductor quantum dots with chemical stimulations. It is based on the photoinduced transfer of either energy from CdSe-ZnS core-shell quantum dots to [1,3] oxazine ligands or electrons from the organic to the inorganic components. The organic ligands incorporate a dithiolane anchoring group, an electron-rich indole, and a 4-nitrophenylazophenoxy chromophore in their molecular skeleton. Their adsorption on the surface of the quantum dots results in partial luminescence quenching. Electron transfer from the indole fragment to the nanoparticles is mainly responsible for the decrease in luminescence intensity. Upon addition of base, the [1,3] oxazine ring of the ligands opens to generate a 4-nitrophenylazophenolate chromophore, which absorbs in the range of wavelengths where the quantum dots emit. This transformation activates an energy-transfer pathway from the excited nanoparticles to the ligands. In addition, the oxidation potential of the ligand shifts in the negative direction, improving the efficiency of electron transfer. The overall result is a decrease in the luminescence quantum yield of 83%. Addition of acid also opens the [1,3] oxazine ring of the ligands. However, the resulting 4-nitrophenylazophenol does not absorb in the visible region and cannot accept energy from the excited nanoparticles. Furthermore, the oxidation potential shifts in the positive direction, lowering the electron- transfer efficiency. In fact, the luminescence quantum yield increases by 33% as a result of this transformation. These changes are fully reversible and can be exploited to probe the pH of aqueous solutions from 3 to 11. Indeed, our sensitive quantum dots adjust their luminescence in response to variations in pH within this particular range of values. Thus, our general design strategy can eventually lead to the development of pH-sensitive luminescent probes for biomedical applications based on the unique photophysical properties of semiconductor quantum dots.
C1 Univ Miami, Dept Chem, Ctr Supramol Sci, Coral Gables, FL 33146 USA.
RP Raymo, FM (reprint author), Univ Miami, Dept Chem, Ctr Supramol Sci, 1301 Mem Dr, Coral Gables, FL 33146 USA.
EM fraymo@miami.edu
RI yildiz, ibrahim/D-8053-2013
OI yildiz, ibrahim/0000-0003-3321-0306
CR Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432
   Alivisatos AP, 1997, ENDEAVOUR, V21, P56, DOI 10.1016/S0160-9327(97)01018-1
   Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506
   Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Alivisatos P, 2000, PURE APPL CHEM, V72, P3, DOI 10.1351/pac200072010003
   Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Bakalova R, 2005, J AM CHEM SOC, V127, P11328, DOI 10.1021/ja051089h
   BAWENDI MG, 1990, ANNU REV PHYS CHEM, V41, P477, DOI 10.1146/annurev.pc.41.100190.002401
   Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chen CY, 2006, CHEM COMMUN, P263, DOI 10.1039/b512677k
   Clapp AR, 2006, CHEMPHYSCHEM, V7, P47, DOI 10.1002/cphc.200500217
   Clarke SJ, 2006, NAT MATER, V5, P409, DOI 10.1038/nmat1631
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   de Silva AP, 2005, J MATER CHEM, V15, P2637, DOI 10.1039/b506632h
   Desvergne J. P., 1997, CHEMOSENSORS ION MOL
   Dyadyusha L, 2005, CHEM COMMUN, P3201, DOI 10.1039/b500664c
   Efros AL, 2000, ANNU REV MATER SCI, V30, P475, DOI 10.1146/annurev.matsci.30.1.475
   El-Sayed MA, 2004, ACCOUNTS CHEM RES, V37, P326, DOI 10.1021/ar020204f
   Ellis AB, 2000, CHEM REV, V100, P2477, DOI 10.1021/cr990025k
   Empedocles S, 1999, ACCOUNTS CHEM RES, V32, P389, DOI 10.1021/ar9501939
   Eychmuller A, 2000, PURE APPL CHEM, V72, P179, DOI 10.1351/pac200072010179
   Fabbrizzi L, 2000, COORDIN CHEM REV, V205, P1, DOI 10.1016/S0010-8545(00)00235-6
   Gao XH, 2003, TRENDS BIOTECHNOL, V21, P371, DOI 10.1016/S0167-7799(03)00209-9
   Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003
   Geissbuehler I, 2005, ANGEW CHEM INT EDIT, V44, P1388, DOI 10.1002/anie.200461491
   Gill R, 2005, J PHYS CHEM B, V109, P23715, DOI 10.1021/jp054874p
   Goldman ER, 2005, J AM CHEM SOC, V127, P6744, DOI 10.1021/ja0436771
   Green M, 2004, ANGEW CHEM INT EDIT, V43, P4129, DOI 10.1002/anie.200301758
   Green M, 1999, CHEM COMMUN, P2235, DOI 10.1039/a904202d
   HENGLEIN A, 1987, J CHIM PHYS PCB, V84, P1043, DOI 10.1051/jcp/1987841043
   HENGLEIN A, 1989, CHEM REV, V89, P1861, DOI 10.1021/cr00098a010
   HILDEBRANDT N, 2005, ANGEW CHEM INT EDIT, V44, P1
   Hohng S, 2005, CHEMPHYSCHEM, V6, P956, DOI 10.1002/cphc.200400557
   Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Lidke DS, 2004, PHYSIOLOGY, V19, P322, DOI 10.1152/physiol.00030.2004
   MATTOUSSI H, 2002, OPTICAL BIOSENSORS P, P537
   Medintz IL, 2005, ADV MATER, V17, P2450, DOI 10.1002/adma.200500722
   Medintz IL, 2006, J PHYS CHEM B, V110, P10683, DOI 10.1021/jp060611z
   Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Michalet X, 2001, SINGLE MOL, V2, P261, DOI 10.1002/1438-5171(200112)2:4<261::AID-SIMO261>3.0.CO;2-P
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Murphy CJ, 2002, ANAL CHEM, V74, p520A, DOI 10.1021/ac022124v
   Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545
   Nagasaki Y, 2004, LANGMUIR, V20, P6396, DOI 10.1021/la036034c
   Niemeyer CM, 2003, ANGEW CHEM INT EDIT, V42, P5796, DOI 10.1002/anie.200301703
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Nirmal M, 1999, ACCOUNTS CHEM RES, V32, P407, DOI 10.1021/ar9700320
   Oh E, 2005, J AM CHEM SOC, V127, P3270, DOI 10.1021/ja0433323
   Palaniappan K, 2006, CHEM MATER, V18, P1275, DOI 10.1021/cm051602q
   Parak WJ, 2003, NANOTECHNOLOGY, V14, pR15, DOI 10.1088/0957-4484/14/7/201
   Patolsky F, 2003, J AM CHEM SOC, V125, P13918, DOI 10.1021/ja035848c
   Pellegrino T, 2005, SMALL, V1, P48, DOI 10.1002/smll.200400071
   Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m
   Penner RM, 2000, ACCOUNTS CHEM RES, V33, P78, DOI 10.1021/ar9702839
   Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018
   RICCO AJ, 1998, ACCOUNTS CHEM RES, V31, P199
   Riegler J, 2004, ANAL BIOANAL CHEM, V379, P913, DOI 10.1007/s00216-004-2706-y
   Rogach AL, 2002, ADV FUNCT MATER, V12, P653, DOI 10.1002/1616-3028(20021016)12:10<653::AID-ADFM653>3.0.CO;2-V
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Sandros MG, 2005, J AM CHEM SOC, V127, P12198, DOI 10.1021/ja054166h
   STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003
   STEIGERWALD ML, 1989, ANNU REV MATER SCI, V19, P471, DOI 10.1146/annurev.ms.19.080189.002351
   Sutherland AJ, 2002, CURR OPIN SOLID ST M, V6, P365, DOI 10.1016/S1359-0286(02)00081-5
   Tomasulo M, 2006, AUST J CHEM, V59, P175, DOI 10.1071/CH05332
   Tomasulo M, 2006, J ORG CHEM, V71, P744, DOI 10.1021/jo052096r
   Tomasulo M, 2006, J PHYS CHEM B, V110, P3853, DOI 10.1021/jp060185h
   Tomasulo M, 2005, ORG LETT, V7, P4633, DOI 10.1021/ol051750m
   Tomasulo M, 2005, J ORG CHEM, V70, P8180, DOI 10.1021/jo051417w
   Tomasulo M, 2005, J MATER CHEM, V15, P4354, DOI 10.1039/b508732e
   Tomasulo M, 2005, ORG LETT, V7, P1109, DOI 10.1021/ol050045a
   TOMASULO M, 2006, IN PRESS INORG CHIM, V359
   Tran PT, 2002, PHYS STATUS SOLIDI B, V229, P427, DOI 10.1002/1521-3951(200201)229:1<427::AID-PSSB427>3.0.CO;2-K
   Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p
   Wang SP, 2002, NANO LETT, V2, P817, DOI [10.1021/nl0255193, 10.1021/n10255193]
   Watson A, 2003, BIOTECHNIQUES, V34, P296, DOI 10.2144/03342bi01
   Weller H, 1998, CURR OPIN COLLOID IN, V3, P194, DOI 10.1016/S1359-0294(98)80013-7
   WELLER H, 1993, ADV MATER, V5, P88, DOI 10.1002/adma.19930050204
   Willard DM, 2001, NANO LETT, V1, P469, DOI 10.1021/nl015565n
   Wise FW, 2000, ACCOUNTS CHEM RES, V33, P773, DOI 10.1021/ar970220q
   Wu XY, 2004, METHOD CELL BIOL, V75, P171
   Yiidiz I, 2006, P NATL ACAD SCI USA, V103, P11457, DOI 10.1073/pnas.0602384103
   Yildiz I, 2006, J MATER CHEM, V16, P1118, DOI 10.1039/b600523c
   Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165
   Yoffe AD, 2001, ADV PHYS, V50, P1, DOI 10.1080/00018730010006608
   YOFFE AD, 1993, ADV PHYS, V42, P173, DOI 10.1080/00018739300101484
   Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k
   Zhang CY, 2005, NAT MATER, V4, P826, DOI 10.1038/nmat1508
   Zhang CY, 2006, J AM CHEM SOC, V128, P5324, DOI 10.1021/ja060537y
NR 92
TC 92
Z9 94
U1 4
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 21
PY 2006
VL 22
IS 24
BP 10284
EP 10290
DI 10.1021/la0618014
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 105HX
UT WOS:000242022100072
PM 17107034
DA 2018-10-20
ER

PT J
AU Favia, P
   Lopez, LC
   Sardella, E
   Gristina, R
   Nardulli, M
   d'Agostino, R
AF Favia, P.
   Lopez, L. C.
   Sardella, E.
   Gristina, R.
   Nardulli, M.
   d'Agostino, R.
TI Low temperature plasma processes for biomedical applications and
   membrane processing
SO DESALINATION
LA English
DT Article; Proceedings Paper
CT Conference of the European-Membrane-Society (EUROMEMBRANE 2006)
CY SEP 24-28, 2006
CL Giardini Naxos, ITALY
SP Inst Membrane Technol, Natl Res Council Italy, Univ Calabria, Ctr Excellence CEMIF CAL, ITM-CNR
DE plasma deposition; plasma treatments; molecules immobilization
ID SURFACE MODIFICATION; CULTURE
AB Low temperature plasma deposition and treatment processes can be successfully employed in order to modify surfaces of biomedical interest, as well as to improve membrane properties. In particular, plasma processes can be used to improve the adhesion, spreading and proliferation of cells at the surface of materials, to tune the hydrophilic/hydrophobic and non fouling properties, and to provide surfaces suitable for immobilizing molecules (catalysts, biomolecules, etc.).
C1 Univ Bari, Dept Chem, I-70126 Bari, Italy.
   CNR, Ist Metodol Inorgan & Plasmi, Bari, Italy.
   Univ Bari, Palma Solut SRL, I-70126 Bari, Italy.
RP Favia, P (reprint author), Univ Bari, Dept Chem, Via Orabona 4, I-70126 Bari, Italy.
EM favia@chimica.uniba.it
OI SARDELLA, ELOISA/0000-0002-6776-8327
CR d'Agostino R, 2004, PLASMA PROCESS POLYM, V1, P11, DOI 10.1002/ppap.200490000
   D'Agostino R., 2005, PLASMA PROCESSES POL
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   DAGOSTINO R, 1997, NATO ASI SERIES E, V346
   De Bartolo L, 2005, BIOMATERIALS, V26, P4432, DOI 10.1016/j.biomaterials.2004.11.009
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   FAVIA P, 2003, SURF COAT TECH, V707, P169
   FAVIA P, 2002, VIDE, V1, P203
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   Ratner BD, 1990, PLASMA DEPOSITION TR
   Steen ML, 2001, J MEMBRANE SCI, V188, P97, DOI 10.1016/S0376-7388(01)00375-1
   Steen ML, 2002, J MEMBRANE SCI, V204, P341, DOI 10.1016/S0376-7388(02)00061-3
   Wavhal DS, 2003, LANGMUIR, V19, P79, DOI 10.1021/la020653o
NR 13
TC 23
Z9 23
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
J9 DESALINATION
JI Desalination
PD NOV 20
PY 2006
VL 199
IS 1-3
BP 268
EP 270
DI 10.1016/j.desal.2006.03.064
PG 3
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 108YU
UT WOS:000242275900101
DA 2018-10-20
ER

PT J
AU Geringer, J
   Forest, B
   Combrade, P
AF Geringer, Jean
   Forest, Bernard
   Combrade, Pierre
TI Wear analysis of materials used as orthopaedic implants
SO WEAR
LA English
DT Article; Proceedings Paper
CT 49th Annual Congress of the European-Federation-of-Corrosion (EUROCORR
   2004)
CY 2004
CL Nice, FRANCE
SP European Federat Corros
DE tribocorrosion; fretting corrosion; wear; orthopaedic implants
ID CORROSION
AB In the biomedical field, about 6% of the hip total prostheses must be replaced after 9 years. One of the main causes of the aseptic loosening may be attributed to fretting corrosion between the prosthesis and the bone cement. To understand this degradation, a fretting test between a stainless steel, 316L and PMMA has been used in Ringer solution. Fretting maps for the contact 316L/PMMA were determined in air and in Ringer solution. It has been shown that the lubricant effect of the aqueous environment shifts the gross slip/partial slip transition towards larger normal forces or lower displacements.
   To understand the fretting degradation behaviour of 316L against PMMA, fretting corrosion experiments have been investigated under constant applied potential. The first conclusion is that the dissipated energy is maximum at about -600 mV/SCE. The wear on PMMA does not depend on the applied potential. Moreover, the wear coefficient is lower than that in air due to the lubricant effect of the Ringer solution. Wear on 316L depends on the applied potential. The wear volume is minimum at -600 mV/SCE although the dissipated energy is maximum. The wear on 316L in Ringer solution is attributed to a dissolution process due to the local destruction of the passive film by fretting. The effect of potential on the wear of 316L may be accounted for by changes in the aqueous environment confined in the contact zone due to a restricted mass transport from the bulk solution and to the large local current densities consecutive to the destruction of the passive film. Accordingly, the wear volume on 316L is correlated to the time. Finally, the proton reduction, inside the contact, is believed to contribute significantly to the dissolution process. (c) 2006 Elsevier B.V. All rights reserved.
C1 Ecole Natl Super Mines, CNRS, UMR 5146, F-42023 St Etienne 2, France.
   Ctr Tech Framatome ANP, F-71205 Le Creusot, France.
RP Geringer, J (reprint author), Ecole Natl Super Mines, CNRS, UMR 5146, 158 Cours Fauriel, F-42023 St Etienne 2, France.
EM jgeringer@voila.fr
OI geringer, jean/0000-0002-4843-2844
CR BRIGHAM RJ, 1989, CORROS SCI, V29, P995, DOI 10.1016/0010-938X(89)90089-9
   COMBRADE P, 2002, CREVICE CORROSION ME, P372
   FOUVRY S, 1997, THESIS ECOLE CENTRAL
   Geringer J, 2005, WEAR, V259, P943, DOI 10.1016/j.wear.2004.11.027
   GUERRETPIECOURT C, 2001, CR ACAD SCI IV-PHYS, P761
   HAUDRECHY P, 1993, CORROS SCI, V35, P329, DOI 10.1016/0010-938X(93)90164-C
   HIEMENZ PC, 1997, PRINCIPLES COLLOID S, P502
   KOVACS P, 1992, AM SOC TEST MATER, V1144, P160, DOI 10.1520/STP14863S
   Lohmann CH, 2002, BIOMATERIALS, V23, P1855, DOI 10.1016/S0142-9612(01)00312-X
   Pidhorz L., 1993, CAHIERS ENSEIGNEMENT, P31
   RUBIN PJ, 1993, J BIOMECH, V26, P725, DOI 10.1016/0021-9290(93)90035-D
   VINGSBO O, 1988, WEAR, V126, P131, DOI 10.1016/0043-1648(88)90134-2
   VINGSBO O, 1993, WEAR, V162, P347, DOI 10.1016/0043-1648(93)90518-Q
   WATERHOUSE RB, 1982, ASTM SPECIAL TECHNIC, V780, P3
NR 14
TC 34
Z9 36
U1 0
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD NOV 20
PY 2006
VL 261
IS 9
BP 971
EP 979
DI 10.1016/j.wear.2006.03.022
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 112RI
UT WOS:000242544200006
DA 2018-10-20
ER

PT J
AU Gheith, MK
   Pappas, TC
   Liopo, AV
   Sinani, VA
   Shim, BS
   Motamedi, M
   Wicksted, JR
   Kotov, NA
AF Gheith, Mithammed K.
   Pappas, Todd C.
   Liopo, Anton V.
   Sinani, Vladimir A.
   Shim, Bong Sup
   Motamedi, Massoud
   Wicksted, James R.
   Kotov, Nicholas A.
TI Stimulation of neural cells by lateral layer-by-layer films of
   single-walled currents in conductive carbon nanotubes
SO ADVANCED MATERIALS
LA English
DT Article
ID NEURONAL GROWTH; ELECTRICAL-STIMULATION; FIELD-EMISSION; SENSORS;
   TRANSISTORS; ADSORPTION; DEVICES; TRANSLOCATION; OSTEOGENESIS;
   COMPOSITES
AB The first example of neural stimulation through a SWNT material assembled by layer-by-layer deposition is described (see figure). Excitation by lateral currents in the nanotube coating results in the opening of voltage -dependent Na' ion channels. The experimental observations indicate the possibility of engineering of implantable biomedical devices from SWNT/polymer multilayers to be used for neuron prosthesis, pain management, and muscle stimulation.
C1 Univ Michigan, Dept Chem Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA.
   Univ Texas, Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA.
RP Kotov, NA (reprint author), Univ Michigan, Dept Chem Engn, Dept Biomed Engn, 2300 Hayward St, Ann Arbor, MI 48109 USA.
EM kotov@umich.edu
OI Shim, Bong Sup/0000-0003-3205-6191; Kotov, Nicholas/0000-0002-6864-5804
CR Ammer H, 1997, NEUROSCI LETT, V230, P143, DOI 10.1016/S0304-3940(97)00495-3
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bianco A, 2005, J AM CHEM SOC, V127, P58, DOI 10.1021/ja044293y
   BLACK J, 1984, BIOELECTROCH BIOENER, V12, P323, DOI 10.1016/0302-4598(84)87012-9
   Bradley K, 2004, NANO LETT, V4, P253, DOI 10.1021/nl0349855
   Braun D, 2001, PHYS REV LETT, V86, P2905, DOI 10.1103/PhysRevLett.86.2905
   Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001
   Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Chopra S, 2003, APPL PHYS LETT, V83, P2280, DOI 10.1063/1.1610251
   Fu Q, 2005, J PHYS CHEM B, V109, P13406, DOI 10.1021/jp0525686
   FURAKAWA T, 1963, J NEUROPHYSIOL, V26, P140
   Gheith MK, 2005, ADV MATER, V17, P2663, DOI 10.1002/adma.200500366
   Hamprecht B, 1977, Int Rev Cytol, V49, P99
   Hertzberg T, 1995, NEUROREPORT, V7, P233, DOI 10.1097/00001756-199512000-00056
   Hille B., 2001, ION CHANNELS EXCITAB
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   Javey A, 2004, NANO LETT, V4, P1319, DOI 10.1021/nl049222b
   Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Lee CY, 2005, LANGMUIR, V21, P5192, DOI 10.1021/la046867i
   Lee NS, 2001, DIAM RELAT MATER, V10, P265, DOI 10.1016/S0925-9635(00)00478-7
   Li J, 2003, NANO LETT, V3, P929, DOI 10.1021/nl034220x
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lu Q, 2004, NANO LETT, V4, P2473, DOI 10.1021/nl048326j
   Mamedov AA, 2000, LANGMUIR, V16, P5530, DOI 10.1021/1a000560b
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Manohara HM, 2005, NANO LETT, V5, P1469, DOI 10.1021/nl050829h
   Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   McCaig CD, 2002, TRENDS NEUROSCI, V25, P354, DOI 10.1016/S0166-2236(02)02174-4
   ODONNELL ME, 1982, J CELL PHYSIOL, V113, P405, DOI 10.1002/jcp.1041130308
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Qi P., 2003, NANO LETT, V3, P347, DOI DOI 10.1021/NL034010K
   Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039
   Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94
   Saito Y, 2000, CARBON, V38, P169, DOI 10.1016/S0008-6223(99)00139-6
   Shim BS, 2005, LANGMUIR, V21, P9381, DOI 10.1021/la050992s
   Sinani VA, 2005, J AM CHEM SOC, V127, P3463, DOI 10.1021/ja045670+
   Star A, 2003, NANO LETT, V3, P459, DOI 10.1021/nl0340172
   SUPRONOWICZ PR, 2002, J BIOMED MATER RES, V5, P499
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Voelker M, 2005, SMALL, V1, P206, DOI 10.1002/smll.200400077
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Yonemori K, 1996, BONE, V19, P173, DOI 10.1016/8756-3282(96)00169-X
   Zhou YX, 2004, NANO LETT, V4, P2031, DOI 10.1021/nl048905o
NR 50
TC 104
Z9 106
U1 2
U2 53
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD NOV 17
PY 2006
VL 18
IS 22
BP 2975
EP +
DI 10.1002/adma.200600878
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 113LO
UT WOS:000242599600009
DA 2018-10-20
ER

PT J
AU Yang, ZM
   Xu, B
AF Yang, Zhimou
   Xu, Bing
TI Using enzymes to control molecular hydrogelation
SO ADVANCED MATERIALS
LA English
DT Article
ID SUPRAMOLECULAR HYDROGELS; ENZYMATIC FORMATION; BIOMATERIALS
AB The expression and distribution of enzymes differ by the types and states of cells, tissues, and organs, thus leading to diverse extracellular and intracellular environments. Using an enzymatic reaction to convert a precursor into a hydrogelator or vice versa, one can control the delivery, functions, and responses of a hydrogel according to a specific biological condition or environment, thus providing an accessible route to creating sophisticated soft materials for potential biomedical applications.
C1 Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China.
RP Xu, B (reprint author), Hong Kong Univ Sci & Technol, Dept Chem, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.
EM chbingxu@ust.hk
RI Yang, Zhimou/F-1798-2010; XU, Bing/A-7828-2008
OI XU, Bing/0000-0002-4639-387X
CR den Hertog J, 2003, EMBO REP, V4, P1027, DOI 10.1038/sj.embor.7400009
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LODISH H, 2003, MOL CELL BIOL
   PEPPAS NA, 2004, ADV CHEM ENG, V29
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yang ZM, 2004, CHEM COMMUN, P2424, DOI 10.1039/b408897b
   Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang Y, 2004, J AM CHEM SOC, V126, P15028, DOI 10.1021/ja044401g
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
NR 19
TC 52
Z9 55
U1 2
U2 34
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD NOV 17
PY 2006
VL 18
IS 22
BP 3043
EP 3046
DI 10.1002/adma.200600400
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 113LO
UT WOS:000242599600024
DA 2018-10-20
ER

PT J
AU Alexis, F
   Venkatraman, S
   Rath, SK
   Gan, LH
AF Alexis, Frank
   Venkatraman, Subbu
   Rath, Santosh Kumar
   Gan, Leong-Huat
TI Some insight into hydrolytic scission mechanisms in bioerodible
   polyesters
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; biomaterials; Monte Carlo simulation; degradation
ID MOLECULAR-WEIGHT; ACID) MICROSPHERES; IN-VIVO; DEGRADATION;
   POLYLACTIDES; COPOLYMERS; POLY(LACTIDE-CO-GLYCOLIDE); POLYMERS; INVITRO;
   INVIVO
AB PLLA, PDLLA, and PLGA copolymers have been studied to understand the details of their degradation behavior. All polymers exhibited a homogeneous mode of degradation, with uniform rates of degradation throughout the film. Crystallinity inhibited water absorption and hence retarded degradation. The degradation rate was increased by the presence of glycolic acid units in the PLGA copolymer; this effect overwhelms any decrease in degradation rate because of increased crystallinity due to the additional GA units. This effect is demonstrated quantitatively in this study. In PLGA polymers, there is evidence of unusual recrystallization behavior as degradation proceeds, due mainly to the higher rate of hydrolytic scission of the glycolide linkage compared with the lactide, as verified quantitatively with the use of H-1 NMR studies. Application of a Monte Carlo model to the degradation results, however, appears to show a random scission process. The details of the mechanistic study of different factors influencing the process of degradation, as reported here, may have important implications in terms of selecting the right material for specific biomedical applications. (c) 2006 Wiley Periodicals, Inc.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
   Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
   Nanyang Technol Univ, Natl Inst Educ, Singapore 637616, Singapore.
RP Venkatraman, S (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
EM assubbu@ntu.edu.sg
RI Venkatraman, Subramanian/A-2228-2011
OI Venkatraman, Subramanian/0000-0002-8693-1070
CR CHIANTORE O, 1993, APPL POLYM SYMP SER, V52, P1
   CHU CC, 1981, J BIOMED MATER RES, V15, P19, DOI 10.1002/jbm.820150106
   FUKUZAKI H, 1990, BIOMATERIALS, V11, P441, DOI 10.1016/0142-9612(90)90102-V
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Hakkarainen M, 1996, POLYM DEGRAD STABIL, V52, P283, DOI 10.1016/0141-3910(96)00009-2
   KAMEI S, 1992, BIOMATERIALS, V13, P953, DOI 10.1016/0142-9612(92)90120-D
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   Lee KH, 1999, J POLYM SCI POL CHEM, V37, P3558, DOI 10.1002/(SICI)1099-0518(19990915)37:18<3558::AID-POLA2>3.0.CO;2-4
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   MAKINO K, 1996, MICROENCAPSULATION, V3, P293
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   Tsuji H, 2000, POLYM DEGRAD STABIL, V67, P179, DOI 10.1016/S0141-3910(99)00111-1
   WANG N, 1998, ACS SYM SER, V709, P243
   Weiler W, 1996, BIOMATERIALS, V17, P529, DOI 10.1016/0142-9612(96)82728-1
   Witt C, 2001, EUR J PHARM BIOPHARM, V51, P171, DOI 10.1016/S0939-6411(01)00130-8
NR 17
TC 31
Z9 31
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 15
PY 2006
VL 102
IS 4
BP 3111
EP 3117
DI 10.1002/app.23888
PG 7
WC Polymer Science
SC Polymer Science
GA 091CP
UT WOS:000241004000004
DA 2018-10-20
ER

PT J
AU Rowe, SL
   Stegemann, JP
AF Rowe, Shaneen L.
   Stegemann, Jan P.
TI Interpenetrating collagen-fibrin composite matrices with varying protein
   contents and ratios
SO BIOMACROMOLECULES
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   IN-VITRO; CULTURE; NETWORKS; CONTRACTION; PHENOTYPE; MIGRATION
AB Pure and composite hydrogel matrices of collagen type I and fibrin were produced by simultaneous polymerization of each biopolymer in the presence of vascular smooth muscle cells. The ratio of collagen to fibrin in composite matrices was varied from 1:1 to 1:4, with corresponding absolute protein concentrations of 1.0-5.0 mg/mL. Constructs cultured for 7 days were subjected to uniaxial tensile testing, analysis of cell content, as well as scanning electron and confocal microscopic imaging. Gel compaction over time in culture decreased with increasing protein content but was augmented by the presence of fibrin. Material properties (modulus, ultimate tensile stress, and toughness) were highly correlated with gel compaction, protein density, and cell concentration. Maximum force at failure was dependent on absolute protein concentration. This study examined the interrelationships between protein type, ratio, and density in composite biopolymer matrices and contributes to the understanding of structure-function relationships in such materials.
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Biotech BMED 2, Troy, NY 12180 USA.
RP Stegemann, JP (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Biotech BMED 2, 110 8th St, Troy, NY 12180 USA.
EM stegemann@rpi.edu
FU NIBIB NIH HHS [1R21-EB003978, R21 EB003978]
CR ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145
   CHAMLEYCAMPBELL JH, 1981, J CELL BIOL, V89, P379, DOI 10.1083/jcb.89.2.379
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   Hirose M, 1999, J BIOCHEM-TOKYO, V125, P991, DOI 10.1093/oxfordjournals.jbchem.a022407
   JOCKENHOEVEL S, 2001, THORAC CARDIOVASC SU, V5, P287
   Kosmala JD, 2000, BIOMATERIALS, V21, P2019, DOI 10.1016/S0142-9612(00)00057-0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu LS, 2004, BIOMATERIALS, V25, P3201, DOI 10.1016/j.biomaterials.2003.10.036
   Riley SL, 2001, J MATER SCI-MATER M, V12, P983, DOI 10.1023/A:1012817317296
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   ROWE SL, IN PRESS ACTA BIOMAT
   Roy P, 1999, ANN BIOMED ENG, V27, P721, DOI 10.1114/1.227
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   SCHREIBER DI, 2001, EXP CELL RES, V266, P155
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Song J, 2000, IN VITRO CELL DEV-AN, V36, P600
   Sperling L. H., 1981, INTERPENETRATING POL
   Spotnitz William D, 2005, J Long Term Eff Med Implants, V15, P245, DOI 10.1615/JLongTermEffMedImplants.v15.i3.20
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Xin XJ, 2004, J BIOMAT SCI-POLYM E, V15, P1223, DOI 10.1163/1568562041753025
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
NR 26
TC 68
Z9 69
U1 1
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV 13
PY 2006
VL 7
IS 11
BP 2942
EP 2948
DI 10.1021/bm0602233
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 104FI
UT WOS:000241941600004
PM 17096517
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Arshak, K
   Morris, D
   Arshak, A
   Korostynska, O
   Moore, E
AF Arshak, K.
   Morris, D.
   Arshak, A.
   Korostynska, O.
   Moore, E.
TI PVB, PVAc and PS pressure sensors with interdigitated electrodes
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT 19th European Conference on Solid-State Transducers
CY SEP 11-14, 2005
CL Barcelona, SPAIN
DE interdigitated capacitors; polymer/carbon-black composites; pressure
   sensors; drop coating; temperature effects
ID THICK-FILMS; ELECTRICAL-PROPERTIES; COMPOSITES; BEHAVIOR; RESISTIVITY;
   CAPACITORS; RESIN
AB Miniature sensors, which are rugged and reliable in nature, are essential to meet the growing demand for environmental and biomedical monitoring systems. Developing such sensors using screen-printing and drop coating techniques allows the combination of two cost effective and flexible technologies. Using this approach, a wide variety of materials could be combined to produce sensors with the desired physical properties. Silver electrodes were screen-printed onto alumina substrates, while polymer/carbon-black composites based on polyvinyl butyral, polyvinyl acetate and polystyrene were deposited by drop coating. The addition of surfactant resulted in a more even dispersion of carbon-black throughout the composites, which was observed by TEM. The frequency dependence of the composites also confirmed this result. Pressure was applied using a Lloyd Instruments LR50k in the range 0-2500 kPa and the sensitivity was taken to be the slope of the graph. It was found that the materials displayed a high sensitivity to pressure with good repeatability. Detailed studies of the composites temperature dependency showed that each material has a negative temperature coefficient and were particularly sensitive when the temperature was brought below room temperature. This was improved by coating the sample surface. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland.
   Univ Limerick, Dept Phys, Limerick, Ireland.
RP Arshak, K (reprint author), Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland.
EM khalil.arshak@ul.ie
RI Korostynska, Olga/C-9858-2014
OI Korostynska, Olga/0000-0003-0387-6609
CR Al-Shareef HN, 1997, J ELECTROCERAM, V1, P145
   Altenburg H, 2002, PURE APPL CHEM, V74, P2083, DOI 10.1351/pac200274112083
   Arshak A, 2005, SENSOR ACTUAT A-PHYS, V122, P242, DOI 10.1016/j.sna.2005.06.004
   Arshak A, 2005, MED ENG PHYS, V27, P347, DOI 10.1016/j.medengphy.2004.11.002
   Arshak K, 2005, COMPOS PART A-APPL S, V36, P487, DOI 10.1016/j.compositesa.2004.10.015
   Arshak K, 2005, MAT SCI ENG B-SOLID, V118, P44, DOI 10.1016/j.mseb.2004.12.061
   Arshak K, 2004, SENSOR ACTUAT A-PHYS, V115, P196, DOI 10.1016/j.sna.2004.01.033
   ARSHAK KI, 1995, SENSOR ACTUAT A-PHYS, V49, P41, DOI 10.1016/0924-4247(95)01012-P
   ARSHAK KI, 2004, E-POLYMERS, V61, P1
   ARSHANK A, 2005, MRS SPRING M SAN FRA
   BLASZKIEWICZ M, 1991, J MATER SCI, V26, P5899, DOI 10.1007/BF01130131
   Chekanov Y, 1999, J MATER SCI, V34, P5589, DOI 10.1023/A:1004737217503
   CHLISTUNOFF J, 1995, THIN SOLID FILMS, V257, P166, DOI 10.1016/0040-6090(94)05703-6
   FILANCBOWEN TR, 2002, P IEEE SENSORS, V2, P1648
   Gevorgian SS, 1996, IEEE T MICROW THEORY, V44, P896, DOI 10.1109/22.506449
   Ha SC, 2005, SENSOR ACTUAT B-CHEM, V105, P549, DOI 10.1016/j.snb.2004.01.019
   Haes AJ, 2003, P SOC PHOTO-OPT INS, V5221, P47, DOI 10.1117/12.508308
   Hussain M, 2001, COMPOS PART A-APPL S, V32, P1689, DOI 10.1016/S1359-835X(01)00035-5
   Igreja R, 2004, SENSOR ACTUAT A-PHYS, V112, P291, DOI 10.1016/j.sna.2004.01.040
   Kalyon DM, 2002, POLYM ENG SCI, V42, P1609, DOI 10.1002/pen.11056
   Kim DU, 2005, SENSOR ACTUAT B-CHEM, V110, P321, DOI 10.1016/j.snb.2005.02.010
   Kim S, 2005, INT J ADHES ADHES, V25, P456, DOI 10.1016/j.ijadhadh.2005.01.001
   Kovacik J, 1998, SCRIPTA MATER, V39, P153, DOI 10.1016/S1359-6462(98)00147-X
   Mamishev AV, 2004, P IEEE, V92, P808, DOI 10.1109/JPROC.2004.826603
   MCLACHLAN DS, 1990, J AM CERAM SOC, V73, P2187, DOI 10.1111/j.1151-2916.1990.tb07576.x
   Monroy F, 2000, EUR PHYS J B, V13, P745, DOI 10.1007/s100510050094
   Osswald T. A., 2003, MAT SCI POLYM ENG
   Sichel E. K., 1982, CARBON BLACK POLYM C, V3
   White NM, 1997, MEAS SCI TECHNOL, V8, P1, DOI 10.1088/0957-0233/8/1/002
   Yi XS, 2001, COMPOS SCI TECHNOL, V61, P949, DOI 10.1016/S0266-3538(00)00191-3
   Zagnoni A, 2005, SENSOR ACTUAT A-PHYS, V123-24, P240, DOI 10.1016/j.sna.2005.03.049
NR 31
TC 15
Z9 15
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD NOV 8
PY 2006
VL 132
IS 1
SI SI
BP 199
EP 206
DI 10.1016/j.sna.2006.02.018
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 106UI
UT WOS:000242126800030
DA 2018-10-20
ER

PT J
AU Singh, D
   Lorenzo-Martin, MD
   Gutierrez-Mora, F
   Routbort, JL
   Case, ED
AF Singh, D.
   Lorenzo-Martin, M. de la Cinta
   Gutierrez-Mora, F.
   Routbort, J. L.
   Case, E. D.
TI Self-joining of zirconia/hydroxyapatite composites using plastic
   deformation process
SO ACTA BIOMATERIALIA
LA English
DT Article
DE hydroxyapatite; zirconia; composite; joining; deformation
ID CALCIUM-PHOSPHATE CERAMICS; BIOMEDICAL APPLICATIONS; HYDROXYAPATITE;
   ZIRCONIA; COATINGS; OSTEOBLASTS; SUPERPLASTICITY; BIOCERAMICS;
   SUBSTITUTES; ALUMINA
AB A plastic deformation process was demonstrated to self-join 3 mol.% yttria partially stabilized zirconia (3Y-TZP)/hydroxyapatite (HA) composites. The 3Y-TZP/40 vol.% HA composites were fabricated by conventional ceramic processing by cold pressing premixed 3Y-TZP and HA powders into pellets. Densification (approximate to 90%) of composites was achieved by sintering composite powder compacts at 1450 degrees C for 5 h. Optimum self-joining of 3Y-TZP/40 vol.% HA composites was obtained at 1300 degrees C for a strain rate of 5 x 10(-5)/s. The flow stress during joining was 40 MPa. Microstructural and mechanical characterizations of the joint interface demonstrated that there were no discernible differences between the joint and the composite material away from the interface. (c) 2006 Acta Materialia Inc. All rights reserved.
C1 Argonne Natl Lab, Div Energy Technol, Argonne, IL 60439 USA.
   Univ Sevilla, Dept Fis Mat Condensada, E-41080 Seville, Spain.
   Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
RP Singh, D (reprint author), Argonne Natl Lab, Div Energy Technol, 9700 S Cass Ave, Argonne, IL 60439 USA.
EM dsingh@anl.gov
RI Gutierrez-Mora, Felipe/H-4625-2015
OI Gutierrez-Mora, Felipe/0000-0003-3632-7163
CR Ahn ES, 2005, J AM CERAM SOC, V88, P3374, DOI 10.1111/j.1551-2916.2005.00636.x
   Aizawa M, 2005, J CERAM SOC JPN, V113, P245, DOI 10.2109/jcersj.113.245
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   CHOKSHI AH, 1993, MAT SCI ENG R, V10, P237, DOI 10.1016/0927-796X(93)90009-R
   COLMES RE, 1987, INT J ORAL MAXILLOF, V16, P718
   Goretta KC, 2003, MAT SCI ENG A-STRUCT, V341, P158, DOI 10.1016/S0921-5093(02)00212-5
   GROSS V, 1987, BIOCERAMICS MAT CHAR
   GUTIERREZMORA F, 1999, SCRIPTA MATER, V41, P445
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Inuzuka M, 2004, SOLID STATE IONICS, V172, P509, DOI 10.1016/j.ssi.2004.01.054
   Kim H, 2005, J MATER SCI-MATER M, V16, P961, DOI 10.1007/s10856-005-4430-3
   Kim HW, 2004, J AM CERAM SOC, V87, P2135
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   LANGDON TG, 1995, PLASTIC DEFORMATION, P251
   Langstaff S, 1999, BIOMATERIALS, V20, P1727, DOI 10.1016/S0142-9612(99)00086-1
   LAVERNIA C, 1991, AM CERAM SOC BULL, V70, P95
   Lee TM, 2004, J BIOMED MATER RES A, V71A, P652, DOI 10.1002/jbm.a.30190
   Lee TM, 2002, J MATER SCI-MATER M, V13, P281, DOI 10.1023/A:1014010901423
   Lee W, 1996, ACTA MATER, V44, P3905, DOI 10.1016/S1359-6454(96)00068-7
   LI JG, 1993, J AM CERAM SOC, V76, P2685, DOI 10.1111/j.1151-2916.1993.tb04002.x
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Peelen J. G. J., 1978, Ceramurgia International, V4, P71, DOI 10.1016/0390-5519(78)90122-9
   SCOTT C, 1985, AM CERAM SOC BULL, V64, P1129
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   Singh D., 2004, Ceramic Engineering and Science Proceedings, V25, P113
   Singh D, 2005, INT J APPL CERAM TEC, V2, P247, DOI 10.1111/j.1744-7402.2005.02024.x
   UNDERWOOD EE, 1970, QUANTITATIVE STEREOL
   VANWAZER JR, 1958, CHEMISTRY, V1, P527
   WAKAI F, 1990, J AM CERAM SOC, V73, P457, DOI 10.1111/j.1151-2916.1990.tb06537.x
   Wakai F., 1986, ADV CERAM MATER, V1, P259
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   XUE LA, 1990, J AM CERAM SOC, V73, P3518, DOI 10.1111/j.1151-2916.1990.tb06489.x
   YE J, 1995, SCRIPTA METALL MATER, V33, P441, DOI 10.1016/0956-716X(95)00206-B
   Yoshida K, 2006, J EUR CERAM SOC, V26, P515, DOI 10.1016/j.jeurceramsoc.2005.07.047
NR 36
TC 12
Z9 12
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2006
VL 2
IS 6
BP 669
EP 675
DI 10.1016/j.actbio.2006.06.004
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 103SW
UT WOS:000241908000008
PM 16935578
DA 2018-10-20
ER

PT J
AU Kurella, A
   Dahotre, NB
AF Kurella, Anil
   Dahotre, Narendra B.
TI Laser induced hierarchical calcium phosphate structures
SO ACTA BIOMATERIALIA
LA English
DT Article
DE titanium alloy; calcium phosphate; multi-scale; self-assembly
AB The surface properties of biomedical implant materials control the dynamic interactions at tissue-implant interfaces. At such interfaces, if the nanoscale features influence protein interactions, those of the microscale and mesoscale aid cell orientation and provide tissue integration.. respectively. It seems imperative that the synthetic materials expected to replace natural hard tissues are engineered to mimic the complexity of their hierarchical assembly. However, the current surface engineering approaches are single scaled. It is demonstrated that using laser surface engineering a controlled multiscale surface can be synthesized for bioactive functions. A systematic organization of bioactive calcium phosphate coating with multiphase composition on Ti-alloy substrate ranging from nano- to mesoscale has been achieved by effectively controlling the thermo physical interactions during laser processing. The morphology of the coating consisted of a periodic arrangement of Ti-rich and Ca-P-deficient star-like phases uniformly distributed inside a Ca-P-rich self-assembled cellular structure with the presence of CaO, alpha-tricalcium phosphate, CaTiO3, TiO2 and Ti phase in the coating matrix. The cellular structures ranged in diameter from 2.5 mu m to 10 mu m as an assembly of cuboid shaped particles of dimensions of similar to 200 nm x 1 mu m. The multiscale texture also included nanoscale particles that are the precursors for many of these phases. The rapid cooling associated with the laser processing resulted in formation, organization and controlling dimensions of the Ca-P-rich glassy phase into a micron scale cellular morphology and submicron scale clusters of CaTiO3 phase inside the cellular structures. The self-assembly of the coating into multiscale structure was influenced by chemical and physical interactions among the multiphases that evolved during laser processing. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Oak Ridge Natl Lab, Div Met & Ceram, Oak Ridge, TN 37831 USA.
RP Dahotre, NB (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM ndahotre@utk.edu
CR Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233
   CHIANG M, 1997, PRINCIPLES CERAMICS, P1
   DIASA AG, 2005, J NONCRYST SOLIDS, P810
   Kralchevsky PA, 2001, CURR OPIN COLLOID IN, V6, P383, DOI 10.1016/S1359-0294(01)00105-4
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   LAWRENCE A, Patent No. 6846853
   Lima RS, 2005, MAT SCI ENG A-STRUCT, V396, P181, DOI 10.1016/j.msea.2005.01.037
   Lusquinos F, 2005, APPL SURF SCI, V247, P486, DOI 10.1016/j.apsusc.2005.01.134
   Lusquinos F, 2003, J BIOMED MATER RES A, V64A, P630, DOI 10.1002/jbm.a.10440
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
NR 13
TC 38
Z9 38
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2006
VL 2
IS 6
BP 677
EP 683
DI 10.1016/j.actbio.2006.05.001
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 103SW
UT WOS:000241908000009
PM 16844439
DA 2018-10-20
ER

PT J
AU Kim, S
   Kim, Y
   Kim, P
   Ha, JM
   Kim, K
   Sohn, M
   Yoo, JS
   Lee, J
   Kwon, JA
   Lee, KN
AF Kim, Soyoun
   Kim, Youngdeuk
   Kim, Philseok
   Ha, Jeongmin
   Kim, Kyunyoung
   Sohn, Mijin
   Yoo, Jin-San
   Lee, Jungeun
   Kwon, Jung-ah
   Lee, Kap No
TI Improved sensitivity and physical properties of sol-gel protein chips
   using large-scale material screening and selection
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID PORE-SIZE; MICROARRAYS; SILICA; ARRAYS; MEMBRANE; POLYMERS;
   QUANTIFICATION; BIOLOGICALS; TECHNOLOGY; PROTEOMICS
AB Protein chips are a powerful emerging technology with extensive biomedical applications. However, the development of optimal, economical surface materials capable of maintaining the activity of embedded proteins is a challenge. Here, we introduce a new optimized, low-cost, sol-gel biomaterial for use in protein chips with femtogram-level sensitivity. A novel protein chip material with significantly improved physical properties and sensitivity was produced using unique screening and selection methods. Using this platform, the sensitive, specific detection of the interactions between an HIV antigen and its antibody and between a cyclin-kinase protein pair was observed. This study is the first to demonstrate the detection of protein-protein interactions on sol-gel microarrays and describes an important improvement in the physical properties of sol-gel-derived protein chip materials for biomedical research.
C1 Dongguk Univ, Dept Chem, Seoul, South Korea.
   LG Chem Ltd, Taejon, South Korea.
   LG Life Sci, Taejon, South Korea.
   Kuro Korea Univ Hosp, Diag Div, Seoul, South Korea.
   Minist Sci & Technol, Natl Res Lab, NanoBio Technol Lab, Seoul, South Korea.
RP Kim, S (reprint author), Dongguk Univ, Dept Chem, Seoul, South Korea.
EM skim@dongguk.edu
CR Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6
   Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363
   Besanger TR, 2004, ANAL CHEM, V76, P6470, DOI 10.1021/ac0488210
   Boury B, 2000, ADV MATER, V12, P989, DOI 10.1002/1521-4095(200006)12:13<989::AID-ADMA989>3.3.CO;2-B
   Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8
   Cho EJ, 2002, ANAL CHEM, V74, P1462, DOI 10.1021/ac010907v
   Copeland S, 2004, J IMMUNOL METHODS, V284, P99, DOI 10.1016/j.jim.2003.10.011
   Fujii T, 2001, J MEMBRANE SCI, V187, P171, DOI 10.1016/S0376-7388(01)00338-6
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Gogotsi Y, 2003, NAT MATER, V2, P591, DOI 10.1038/nmat957
   Haab BB, 2001, GENOME BIOL, V2
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim YD, 2001, BIOTECHNOL BIOENG, V73, P331, DOI 10.1002/bit.1066
   Kusakabe K, 1999, SEP PURIF TECHNOL, V16, P139, DOI 10.1016/S1383-5866(98)00120-8
   LIVAGE J, 2001, J PHYS-CONDENS MAT, V13, P673
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 2001, NAT BIOTECHNOL, V19, P828, DOI 10.1038/nbt0901-828
   MacBeath G, 2000, SCIENCE, V289, P1760
   MACBEATH G, 2001, GENOME BIOL, V2
   Park CB, 2002, BIOTECHNOL BIOENG, V78, P229, DOI 10.1002/bit.10238
   Price CP, 2001, CLIN CHEM, V47, P1345
   Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000
   RichaletSecordel PM, 1996, CLIN DIAGN VIROL, V5, P111, DOI 10.1016/0928-0197(96)00212-7
   Rupcich N, 2003, CHEM MATER, V15, P1803, DOI 10.1021/cm030028k
   Suh CW, 2004, J BIOTECHNOL, V112, P267, DOI 10.1016/j.jbiotec.2004.05.005
   Wiese R, 2001, CLIN CHEM, V47, P1451
   Zhu H, 2000, NAT GENET, V26, P283
   Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4
NR 30
TC 34
Z9 35
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD NOV 1
PY 2006
VL 78
IS 21
BP 7392
EP 7396
DI 10.1021/ac0520487
PG 5
WC Chemistry, Analytical
SC Chemistry
GA 100LG
UT WOS:000241670000019
PM 17073404
DA 2018-10-20
ER

PT J
AU Petrie, TA
   Capadona, JR
   Reyes, CD
   Garcia, AJ
AF Petrie, Timothy A.
   Capadona, Jeffrey R.
   Reyes, Catherine D.
   Garcia, Andres J.
TI Integrin specificity and enhanced cellular activities associated with
   surfaces presenting a recombinant fibronectin fragment compared to RGD
   supports
SO BIOMATERIALS
LA English
DT Article
DE biomimetic; integrins; cell adhesion; focal adhesion; FAK;
   self-assembled monolayers
ID EXTRACELLULAR-MATRIX PROTEINS; OSTEOBLAST DIFFERENTIATION; BIOMATERIAL
   SURFACES; ADHESIVE SURFACES; MIMETIC PEPTIDE; BONE-FORMATION; SYNERGY
   SITE; IN-VIVO; BINDING; DOMAINS
AB Biomimetic strategies focusing on presenting short bioadhesive oligopeptides, including the arginine-glycine-aspartic acid (RGD) motif present in numerous adhesive proteins, on a non-fouling support have emerged as promising approaches to improve cellular activities and healing responses. Nevertheless, these bio-inspired strategies are limited by low activity of the oligopeptides compared to the native ligand due to the absence of complementary or modulatory domains. In the present analysis, we generated well-defined biointerfaces presenting RGD-based ligands of increasing complexity to directly compare their biological activities in terms of cell adhesion strength, integrin binding and signaling. Mixed self-assembled monolayers of alkanethiols on gold were optimized to engineer robust supports that present anchoring groups for ligand tethering within a non-fouling, protein adsorption-resistant background. Controlled bioadhesive interfaces were generated by tethering adhesive ligands via standard peptide chemistry. On a molar basis, biointerfaces functionalized with the FNIII7-10 recombinant fragment presenting the RGD and PHSRN adhesive motifs in the correct structural context exhibited significantly higher adhesion strength, FAK activation, and cell proliferation rate than supports presenting RGD ligand or RGD-PHSRN, an oligopeptide presenting these two sites separated by a polyglycine linker. Moreover, FNIII7-10 functionalized surfaces displayed specificity for alpha(5)beta(1) integrin, while cell adhesion to supports presenting RGD or RGD-PHSRN was primarily mediated by alpha(v)beta(3) integrin. These results are significant to the rational engineering of bioactive materials that convey integrin binding specificity for directed cellular and tissue responses in biomedical and biotechnological applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,2314 IBB, Atlanta, GA 30332 USA.
EM gtg415p@mail.gatech.edu; capadona@fes.case.edu; CDReyes@aol.com;
   andres.garcia@me.gatech.edu
RI Sanguansri, Luz/B-6630-2011; Capadona, Jeffrey/G-4772-2010
OI Sanguansri, Luz/0000-0003-1908-7604; 
FU NIBIB NIH HHS [R01 EB-004496]
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Capadona JR, 2005, ADV MATER, V17, P2604, DOI 10.1002/adma.200500959
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   HANKS SK, 2003, FRONT BIOSCI, V8, P982
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mardilovich A, 2006, LANGMUIR, V22, P3259, DOI 10.1021/la052756n
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mi J, 2005, BIOCHEM BIOPH RES CO, V338, P956, DOI 10.1016/j.bbrc.2005.10.043
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reichardt L. F., 1999, GUIDEBOOK EXTRACELLU, P335
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
NR 52
TC 176
Z9 181
U1 3
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 31
BP 5459
EP 5470
DI 10.1016/j.biomaterials.2006.06.027
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 085NO
UT WOS:000240611000013
PM 16846640
DA 2018-10-20
ER

PT J
AU Lu, XB
   Wen, ZH
   Li, JH
AF Lu, Xianbo
   Wen, Zhenhai
   Li, Jinghong
TI Hydroxyl-containing antimony oxide bromide nanorods combined with
   chitosan for biosensors
SO BIOMATERIALS
LA English
DT Article
DE biosensor; direct electron transfer; antimony oxide bromide; chitosan;
   nanorods; horseradish peroxidase
ID PYROLYTIC-GRAPHITE ELECTRODES; TEMPERATURE IONIC LIQUID; DIRECT
   ELECTROCHEMISTRY; HORSERADISH-PEROXIDASE; HEME-PROTEINS; FILMS;
   ELECTROCATALYSIS; GEL; BIOELECTROCATALYSIS; NANOPARTICLES
AB A hydroxyl-containing antimony oxide bromide (AOB) nanorods was synthesized by a hydrothermal method. TEM and SEM images showed that the as-prepared AOB nanorods were very copious with diameters of about 50 nm. The AOB nanorods could be easily combined with biopolymer chitosan (Chi) to form an organic-inorganic hybrid material, and a biocompatible, crack-free and porous Chi-AOB composite film could be readily obtained. Horseradish peroxidase (HRP) was chosen as a model protein to construct a reagentless mediator-free third-generation HRP biosensor. UV-visible and FTIR spectroscopy revealed that HRP entrapped in the composite film could retain its native secondary structure. A pair of stable and well-defined redox peaks of HRP with a formal potential of about -0.24V (vs. Ag/AgCl) in a pH 7.0 phosphate-buffered solution (PBS) were obtained at the HRP-Chi-AOB composite film modified glassy carbon (GC) electrode. With advantages of organic-inorganic hybrid materials, dramatically facilitated direct electron transfer of HRP and excellent bioelectrocatalytic activity towards H2O2 were demonstrated. The apparent Michaelis-Menten constant K-M(app) was calculated to be 7.5 mu M, indicating that HRP entrapped in the composite film possessed high affinity to H2O2 and exhibited high enzymatic activity. The prepared biosensor displayed good sensitivity and reproducibility, wide linear range, low detection limit, fast response and excellent long-term stability. The Chi-AOB composite film could be used efficiently for the entrapment of other redox-active proteins and may find wide potential applications in biosensors, biocatalysis, biomedical devices and bioelectronics. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Chem, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
   Univ Sci & Technol China, Dept Chem, Anhua 230026, Peoples R China.
RP Li, JH (reprint author), Tsing Hua Univ, Dept Chem, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
EM jhli@mail.tsinghua.edu.cn
RI Li, Jinghong/D-4283-2012; wen, zhenhai/D-7165-2011; lu,
   xianbo/F-4363-2011
OI Li, Jinghong/0000-0002-0750-7352; wen, zhenhai/0000-0002-0397-4156; lu,
   xianbo/0000-0003-3983-7812
CR ARMSTRONG FA, 1988, ACCOUNTS CHEM RES, V21, P407, DOI 10.1021/ar00155a004
   Cai WY, 2006, CHEM MATER, V18, P279, DOI 10.1021/cm051442i
   Chen J, 2006, BIOMATERIALS, V27, P2313, DOI 10.1016/j.biomaterials.2005.11.004
   Chen XY, 2005, MATER RES BULL, V40, P469, DOI 10.1016/j.materresbull.2004.11.007
   Corma A, 2002, ADV MATER, V14, P71, DOI 10.1002/1521-4095(20020104)14:1<71::AID-ADMA71>3.0.CO;2-W
   Dai ZH, 2005, ELECTROANAL, V17, P862, DOI 10.1002/elan.200403163
   DAS G, 1990, ENZYME MICROB TECH, V12, P625, DOI 10.1016/0141-0229(90)90138-G
   EDSTRAND M, 1955, ARK KEMI, V8, P279
   Ferapontova EE, 2004, ELECTROANAL, V16, P1101, DOI 10.1002/elan.200403003
   Fu RL, 2005, FRONT BIOSCI, V10, P2841, DOI 10.2741/1740
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   HARBURY HA, 1957, J BIOL CHEM, V225, P1009
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Huang H, 2002, ANAL BIOCHEM, V308, P141, DOI 10.1016/S0003-2697(02)00242-7
   Jia NQ, 2005, J ELECTROANAL CHEM, V580, P213, DOI 10.1016/j.jelechem.2005.03.029
   KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   Liu AH, 2005, ANAL CHEM, V77, P8068, DOI 10.1021/ac051640t
   Liu HH, 2004, BIOSENS BIOELECTRON, V20, P294, DOI 10.1016/j.bios.2004.01.015
   Liu HY, 2004, LANGMUIR, V20, P10700, DOI 10.1021/la0488598
   Lu XB, 2006, BIOMACROMOLECULES, V7, P975, DOI 10.1021/bm050933t
   Lu XB, 2006, ELECTROCHEM COMMUN, V8, P874, DOI 10.1016/j.elecom.2006.03.026
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   Rusling JF, 1998, ACCOUNTS CHEM RES, V31, P363, DOI 10.1021/ar970254y
   THEORELL H, 1951, ACTA CHEM SCAND, V5, P823, DOI 10.3891/acta.chem.scand.05-0823
   Wang J, 2005, ANALYST, V130, P421, DOI 10.1039/b414248a
   Yang J, 1999, BIOELECTROCH BIOENER, V48, P117, DOI 10.1016/S0302-4598(98)00222-0
   Yang MH, 2006, BIOMATERIALS, V27, P246, DOI 10.1016/j.biomaterials.2005.05.077
   Zhang Y, 2004, ELECTROCHIM ACTA, V49, P1981, DOI 10.1016/j.electacta.2003.12.028
   Zhang YX, 2004, NANOTECHNOLOGY, V15, P762, DOI 10.1088/0957-4484/15/7/007
NR 30
TC 97
Z9 98
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 33
BP 5740
EP 5747
DI 10.1016/j.biomaterials.2006.07.026
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092XR
UT WOS:000241131500014
PM 16901539
DA 2018-10-20
ER

PT J
AU Cosqueric, G
   Sebag, A
   Ducolombier, C
   Thomas, C
   Piette, F
   Weill-Engerer, S
AF Cosqueric, Gaelle
   Sebag, Aline
   Ducolombier, Cyril
   Thomas, Caroline
   Piette, Francois
   Weill-Engerer, Sebastien
TI Sarcopenia is predictive of nosocomial infection in care of the elderly
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE protein-energy malnutrition; aged; frail elderly; nosocomial infection;
   sarcopenia
ID X-RAY ABSORPTIOMETRY; HOSPITAL-ACQUIRED INFECTIONS; PROTEIN-ENERGY
   MALNUTRITION; NATIONAL PREVALENCE SURVEY; BIOELECTRICAL-IMPEDANCE
   ANALYSIS; RISK-FACTORS; BODY-COMPOSITION; NUTRITIONAL-STATUS; OLDER
   PERSONS; PNEUMONIA
AB Protein-energy malnutrition and nosocomial infection (NI) are frequent in elderly patients, and a causal link between the two has often been suggested. The aim of the present study was to identify the nutritional parameters predictive of NI in elderly patients. We assessed on admission 101 patients (sixty-six women, thirty-five men, aged over 65 years) admitted to an acute care of the elderly department. Sarcopenia was detected by dual-energy X-ray absorptiometry, with appendicular skeletal muscle mass expressed with respect to body area. Weight, BMI, albuminaemia, serum transthyretin and C-reactive protein values were also determined on admission, and known risk factors, such as functional dependence and invasive biomedical material, were also evaluated. After up to 3 weeks of hospitalisation, patients were classified according to whether they had developed an NI. After 3 weeks of hospitalisation, we found that twenty-nine patients had suffered an NI, occurring after a mean of 16.1 d. Patients who were sarcopenic on admission had a significantly higher risk of contracting an NI (relative risk 2.1, 95 % CI 1.1, 3.8). None of the other morphometric or biological parameters differed significantly between the two groups of patients on admission. Patients who experienced an NI were also more likely, on admission, to have a medical device (P=0.02 to P=0.001 depending on the device), to have swallowing problems (P=0.002) or to have restricted autonomy (P < 0.01). Sarcopenia on admission to an acute care of the elderly unit, as measured by X-ray absorptiometry, was therefore associated with a doubled risk of NI during the first 3 weeks of hospitalisation.
C1 Hop Rothschild, AH HP, Serv Geriat, F-75571 Paris, France.
   Hop Rothschild, AH HP, Serv Radiol, F-75571 Paris, France.
   Hop St Antoine, AH HP, Serv Geriat, Paris, France.
RP Weill-Engerer, S (reprint author), Hop Rothschild, AH HP, Serv Geriat, F-75571 Paris, France.
EM sebastien.weill-engerer@rth.aphp.fr
CR Astagneau P, 2000, J HOSP INFECT, V46, P186, DOI 10.1053/jhin.2000.0833
   Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755
   BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307
   Baumgartner RN, 1999, AM J EPIDEMIOL, V149, P1161
   Bedogni G, 2003, EUR J CLIN NUTR, V57, P1068, DOI 10.1038/sj.ejcn.1601643
   BIENIA R, 1982, J AM GERIATR SOC, V30, P433, DOI 10.1111/j.1532-5415.1982.tb03378.x
   Campbell WW, 2001, J GERONTOL A-BIOL, V56, pM373, DOI 10.1093/gerona/56.6.M373
   CASSOU B, 2000, CONTROLING NOSOCOMIA
   Cederholm T, 2000, J INTERN MED, V247, P715, DOI 10.1046/j.1365-2796.2000.00691.x
   CHANDRA RK, 1992, J NUTR, V122, P597, DOI 10.1093/jn/122.suppl_3.597
   CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x
   CONSTANS T, 1992, J AM GERIATR SOC, V40, P263, DOI 10.1111/j.1532-5415.1992.tb02080.x
   Cunnion KM, 1996, AM J RESP CRIT CARE, V153, P158, DOI 10.1164/ajrccm.153.1.8542110
   Dormenval V, 1995, Gerodontology, V12, P73, DOI 10.1111/j.1741-2358.1995.tb00134.x
   Eckhardt CL, 2003, OBES RES, V11, P1553, DOI 10.1038/oby.2003.207
   Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121
   Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9
   *EPINE WORK GROUP, 1992, J HOSP INFECT, V20, P1
   Erselcan T, 2000, ANN NUTR METAB, V44, P243, DOI 10.1159/000046691
   Fuller NJ, 2001, BRIT J NUTR, V86, P45, DOI 10.1079/BJN2001387
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   Gastmeier P., 1998, Journal of Hospital Infection, V38, P37, DOI 10.1016/S0195-6701(98)90173-6
   Gikas A, 2004, INFECT CONT HOSP EP, V25, P319, DOI 10.1086/502399
   Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7
   GOOD RA, 1992, INT J IMMUNOPHARMACO, V14, P361, DOI 10.1016/0192-0561(92)90165-H
   HANSON LC, 1992, AM J MED, V92, P161, DOI 10.1016/0002-9343(92)90107-M
   HARKNESS GA, 1990, AM J MED, V89, P457, DOI 10.1016/0002-9343(90)90376-O
   Houtkooper LB, 2000, AM J CLIN NUTR, V72, P401
   Hussain M, 1996, J HOSP INFECT, V32, P117, DOI 10.1016/S0195-6701(96)90053-5
   Kampf G, 1997, J HOSP INFECT, V37, P103, DOI 10.1016/S0195-6701(97)90180-8
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   Klavs I, 2003, J HOSP INFECT, V54, P149, DOI 10.1016/S0195-6701(03)00112-9
   Klein S, 1990, Gastroenterology, V99, P1845
   Kyle UG, 2001, BRIT J NUTR, V86, P725, DOI 10.1079/BJN2001470
   LEMONNIER D, 1991, EUR J CLIN NUTR, V45, P281
   Lesourd B, 1999, P NUTR SOC, V58, P685, DOI 10.1017/S0029665199000907
   LIPSCHITZ DA, 1986, J GERONTOL, V41, P690, DOI 10.1093/geronj/41.6.690
   Mazari L, 1998, MECH AGEING DEV, V104, P25, DOI 10.1016/S0047-6374(98)00047-5
   MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106
   MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945
   Melton LJ, 2000, J AM GERIATR SOC, V48, P625
   MOWE M, 1994, AM J CLIN NUTR, V59, P317
   Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x
   Omran ML, 2000, NUTRITION, V16, P131, DOI 10.1016/S0899-9007(99)00251-8
   PINCHCOFSKY GD, 1985, J AM COLL NUTR, V4, P471, DOI 10.1080/07315724.1985.10720089
   Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554
   POTTER J, 1995, AGE AGEING, V24, P131, DOI 10.1093/ageing/24.2.131
   Potter MA, 1999, CLIN INVEST MED, V22, P44
   REUBEN DB, 1995, J AM GERIATR SOC, V43, P415, DOI 10.1111/j.1532-5415.1995.tb05818.x
   Rosenthal AJ, 1998, J GERONTOL A-BIOL, V53, pM81, DOI 10.1093/gerona/53A.2.M81
   Rothan-Tondeur M, 2003, J AM GERIATR SOC, V51, P997, DOI 10.1046/j.1365-2389.2003.51314.x
   SAVITEER SM, 1988, AM J MED, V84, P661, DOI 10.1016/0002-9343(88)90101-5
   Scheel O, 1999, J HOSP INFECT, V41, P331, DOI 10.1053/jhin.1998.0520
   Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152
   Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013
   Sun G, 2005, AM J CLIN NUTR, V81, P74
   Tanko LB, 2002, METABOLISM, V51, P69, DOI 10.1053/meta.2002.28960
   Vaque J, 1999, J HOSP INFECT, V43, pS105, DOI 10.1016/S0195-6701(99)90073-7
   Wischnewski N, 1998, INT SURG, V83, P93
NR 60
TC 103
Z9 107
U1 1
U2 9
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD NOV
PY 2006
VL 96
IS 5
BP 895
EP 901
DI 10.1017/BJN20061943
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 103IN
UT WOS:000241879000015
PM 17092379
OA Bronze
DA 2018-10-20
ER

PT J
AU Cirkva, V
   Duchek, J
   Kaplanek, R
   Paleta, O
   Michalek, J
   Pradny, M
   Chmelikova, D
   Wichterlova, J
AF Cirkva, Vladimir
   Duchek, Jan
   Kaplanek, Robert
   Paleta, Oldrich
   Michalek, Jiri
   Pradny, Martin
   Chmelikova, Dana
   Wichterlova, Jana
TI New perfluoroalkylated amphiphilic methacrylates bearing sulfinyl group
   as monomers for biomedical applications: water content and oxygen
   permeability of their copolymers with DEGMA
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE poly(fluoroalkylsulfinyl methacrylates); DEGMA copolymers; wettability
   of fluoroalkyl methacrylate copolymers; oxygen permeability of
   fluorinated polymers
ID ACTIVE POLYMERS; REGIOSELECTIVITY; RESORPTION; ACRYLATES; CONTACT
AB Perfluoroalkylated methacrylates 7a-c bearing sulfinyl group within a straight-chain ester group, i.e. CH2=C(CH3)CO2CH2CH2S(O)CH2CH2CF2(CF2CF2)(n)CF3 (n = 1-3) were prepared by two alternative synthetic sequences from 2-[(polyfluoroalkyl)sulfanyl]ethanols HOCH2CH2SCH2CH2CF2(CF2CF2)(n)CF3 (n = 1-3) in overall yields of 88-91%. Copolymers of 7a-c with diethylene glycol methacrylate (DEGMA) prepared in bulk under radical conditions display high transparency, increased water content and good oxygen permeability properties, which are advantageous for their application in ophthalmology and as prosthetic materials. (c) 2006 Elsevier Masson SAS. All rights reserved.
C1 Acad Sci Czech Republ, Inst Chem Proc Fundamentals, Prague 16206 6, Czech Republic.
   Prague Inst Chem Technol, Dept Organ Chem, Prague 16628 6, Czech Republic.
   Acad Sci Czech Republ, Inst Macromol Chem, Prague 16206 6, Czech Republic.
   Charles Univ, Ctr Cell Therapy & Tissue Repair, Prague 11636 1, Czech Republic.
   Tech Univ Ostrava, Fac Met & Mat Engn, VSB, CS-70833 Ostrava, Czech Republic.
RP Paleta, O (reprint author), Acad Sci Czech Republ, Inst Chem Proc Fundamentals, Rozvojova 135, Prague 16206 6, Czech Republic.
EM oldrich.paleta@vscht.cz; jiri@imc.cas.cz
RI Pradny, Martin/H-8496-2014; Cirkva, Vladimir/H-5005-2014; Michalek,
   Jiri/D-7251-2013; Kaplanek, Robert/G-7246-2011
OI Cirkva, Vladimir/0000-0001-5351-4003; Kaplanek,
   Robert/0000-0002-5759-882X
CR BATZ HG, 1973, MAKROMOL CHEM, V169, P323
   Cirkva V, 1997, J FLUORINE CHEM, V84, P53, DOI 10.1016/S0022-1139(97)00032-8
   Cirkva V, 1999, J FLUORINE CHEM, V94, P141, DOI 10.1016/S0022-1139(98)00356-X
   EFRON N, 1993, INT CONTACT LENS YB, P53
   FORD MW, 1997, CONTACT LENSES, P154
   HOFMANN V, 1975, MAKROMOL CHEM, V176, P1929
   HORAK D, 1992, CHEM LISTY, V86, P681
   Kaplanek R, 2005, J FLUORINE CHEM, V126, P595, DOI 10.1016/j.jfluchem.2005.01.004
   Mukkamala R, 2003, ACS SYM SER, V833, P163
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Paleta O, 2002, J FLUORINE CHEM, V114, P51, DOI 10.1016/S0022-1139(01)00562-0
   Pees B., 2001, J FLUORINE CHEM, V108, P133
   RONDESTVEDT CS, 1977, J ORG CHEM, V42, P2680, DOI 10.1021/jo00436a005
   SWEENEY DF, 2000, SILICONE HYDROGELS R, P20
   SZONYI F, 1987, J FLUORINE CHEM, V36, P195, DOI 10.1016/S0022-1139(00)81027-1
   TIGHE B, 1992, CHEM BRIT, V28, P241
   TIGHE B, 2002, CONTACT LENS PRACTIS, P78
NR 17
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0223-5234
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD NOV
PY 2006
VL 41
IS 11
BP 1320
EP 1326
DI 10.1016/j.ejmech.2006.06.003
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 111LT
UT WOS:000242454100011
PM 16889874
DA 2018-10-20
ER

PT J
AU Valappil, SP
   Misra, SK
   Boccaccini, AR
   Roy, I
AF Valappil, Sabeel P.
   Misra, Superb K.
   Boccaccini, Aldo R.
   Roy, Ipsita
TI Biomedical applications of polyhydroxyalkanoates, an overview of animal
   testing and in vivo responses
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE animal testing; in vivo tissue responses; PHA medical devices;
   polyhydroxyalkanoates; tissue engineering
ID PERIPHERAL-NERVE REGENERATION; ABSORBABLE POLYMER PATCHES; TRILEAFLET
   HEART-VALVES; TERM MEDICATION DOSAGE; BIODEGRADABLE PATCH; TETRACYCLINE
   HYDROCHLORIDE; PSEUDOMONAS-OLEOVORANS; DEGRADABLE COMPOSITES;
   ALCALIGENES-EUTROPHUS; PERIODONTAL-DISEASE
AB Polyhydroxyalkanoates (PHAs) have been established as biodegradable polymers since the second half of the twentieth century. Altering monomer composition of PHAs allows the development of polymers with favorable mechanical properties, biocompatibility and desirable degradation rates, under specific physiological conditions. Hence, the medical applications of PHAs have been explored extensively in recent years. PHAs have been used to develop devices, including sutures, nerve repair devices, repair patches, slings, cardiovascular patches, orthopedic pins, adhesion barriers, stents, guided tissue repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, bone-marrow scaffolds, tissue engineered cardiovascular devices and wound dressings. So far, various tests on animal models have shown polymers, from the PHA family, to be compatible with a range of tissues. Often, pyrogenic contaminants copurified with PHAs limit their pharmacological application rather than the monomeric composition of the PHAs and thus the purity of the PHA material is critical. This review summarizes the animal testing, tissue response, in vivo molecular stability and challenges of using PHAs for medical applications. In future, PHAs may become the materials of choice for various medical applications.
C1 Univ Westminster, Dept Mol & Appl Biosci, London W1W 6UW, England.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
RP Roy, I (reprint author), Univ Westminster, Dept Mol & Appl Biosci, 115 New Cavendish St, London W1W 6UW, England.
EM royi@wmin.ac.uk
RI Valappil, Sabeel/A-1460-2009; Boccaccini, Aldo/C-7905-2013
FU Engineering and Physical Sciences Research Council [EP/C515617/1]
CR ALLEYNE CH, 1994, J NEUROSURG, V81, P610, DOI 10.3171/jns.1994.81.4.0610
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   Baptist J. N., 1965, Method of making absorbable surgical sutures from poly beta hydroxy acids, Patent No. [US3225766 A, 3225766]
   BEHREND D, 1999, MED BIOL ENG COMPUT, V37, P1510
   Bissery MC, 1985, P INT S CONTROLLED R, V12, P181
   Bowald SF, 1990, A novel surgical material, Patent No. [EP 0349505 A 2, 0349505]
   BROPHY MR, 1986, INT J PHARM, V29, P223, DOI 10.1016/0378-5173(86)90119-5
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   COLLINS AEM, 1989, INT J PHARM, V51, P103, DOI 10.1016/0378-5173(89)90244-5
   DAVIS AE, 1988, CLIN OTOLARYNGOL, V13, P159, DOI 10.1111/j.1365-2273.1988.tb00757.x
   DEASY PB, 1989, J PHARM PHARMACOL, V41, P694, DOI 10.1111/j.2042-7158.1989.tb06343.x
   DESMET MJ, 1983, J BACTERIOL, V154, P870
   DOI Y, 1987, MAKROMOL CHEM-RAPID, V8, P631
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   ELDRIDGE JH, 1990, J CONTROL RELEASE, V11, P205, DOI 10.1016/0168-3659(90)90133-E
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Fukuda S, 2001, AURIS NASUS LARYNX, V28, pS71, DOI 10.1016/S0385-8146(01)00083-9
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   GOTFREDSEN K, 1994, CLIN ORAL IMPLAN RES, V5, P83, DOI 10.1034/j.1600-0501.1994.050204.x
   Hasirci V, 1998, BIOMEDICAL SCIENCE AND TECHNOLOGY, P183
   HASIRCI VN, 2005, Patent No. 2005007195
   Hazari A, 1999, J HAND SURG-BRIT EUR, V24B, P291, DOI 10.1054/jhsb.1998.0001
   Hazari A, 1999, BRIT J PLAST SURG, V52, P653, DOI 10.1054/bjps.1999.3184
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   HOLMES PA, 1981, Patent No. 52459
   HUDSON R, 1999, CLIN PLAST SURG, V4, P617
   ISHIKAWA K, 1996, Patent No. 5480394
   Janousek P, 2006, INT J PEDIATR OTORHI, V70, P1103, DOI 10.1016/j.ijporl.2005.03.057
   JONES NL, 2000, SYNTHETIC BIOABSORBA, P69
   JONES RD, 1994, J CONTROL RELEASE, V30, P35, DOI 10.1016/0168-3659(94)90042-6
   Kamath KR, 2006, ADV DRUG DELIVER REV, V58, P412, DOI 10.1016/j.addr.2006.01.023
   KASSAB AC, 1997, J BIOMAT SCI-POLYM E, V8, P941
   KAWAGUCHI T, 1992, J PHARM SCI, V81, P508, DOI 10.1002/jps.2600810606
   KNOWLES J C, 1991, Clinical Materials, V8, P155, DOI 10.1016/0267-6605(91)90024-A
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   KNOWLES JC, 1993, J MED ENG TECH, V17, P120
   KNOWLES JC, 1993, P 1 INT C INT MAT LA, P495
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Korkusuz F, 2001, J BIOMED MATER RES, V55, P217, DOI 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y
   KORSATKO W, 1983, PHARM IND, V45, P525
   KORSATKO W, 1983, PHARM IND, V45, P1004
   KORSATKO W, 1987, P 3 EUR C BIOPH PHAR, P234
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   KUNIOKA M, 1988, POLYM COMMUN, V29, P174
   LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762
   Leenstra TS, 1998, J MATER SCI-MATER M, V9, P249, DOI 10.1023/A:1008848509911
   LEMOIGNE M, 1926, B SOC CHIM BIOL, V8, P770
   LJUNGBERG C, 1999, MICROSURG, V19, P250
   Lobler M., 2003, J BIOMED MATER RES, V61, P165
   Luklinska ZB, 2003, J MICROSC-OXFORD, V211, P121, DOI 10.1046/j.1365-2818.2003.01204.x
   Lutke-Eversloh T, 2001, MICROBIOL-UK, V147, P11
   MALM T, 1992, J THORAC CARDIOV SUR, V104, P600
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   Maquet V, 2000, J BIOMED MATER RES, V52, P639, DOI 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.0.CO;2-G
   Marois Y, 1999, TISSUE ENG, V5, P369, DOI 10.1089/ten.1999.5.369
   Marois Y., 2000, SYNTHETIC BIOABSORBA, P12
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MCLEOD BJ, 1988, ANIM REPROD SCI, V17, P33, DOI 10.1016/0378-4320(88)90043-7
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Morosco Gregory J, 2002, Prev Cardiol, V5, P31, DOI 10.1111/j.1520-037X.2002.0552.x
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Newcombe RL, 1996, MED J AUSTRALIA, V164, P603
   Nobes GAR, 1998, DRUG DELIV, V5, P167, DOI 10.3109/10717549809052032
   NOISSHIKI Y, 1995, Patent No. 7275344
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Opitz F, 2004, ANN BIOMED ENG, V32, P212, DOI 10.1023/B:ABME.0000012741.85600.f1
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Scholz C, 2000, ACS SYM SER, V764, P328
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   SINGH S, 2006, PRAC RES CLIN OBST G, V20, P41
   Smaill BH, 2000, J THORAC CARDIOV SUR, V120, P1053, DOI 10.1067/mtc.2000.110187
   Sodian R, 2000, CIRCULATION, V102, P22
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   STEINBUCHEL A, 2003, BIOCH ENG J, V4, P165
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Sudesh K, 2000, POLYM ADVAN TECHNOL, V11, P865, DOI 10.1002/1099-1581(200008/12)11:8/12<865::AID-PAT34>3.0.CO;2-Z
   TERENGHI G, 2005, Patent No. 200502825
   Unverdorben M, 2002, CARDIOVASC INTER RAD, V25, P127, DOI 10.1007/s00270-001-0118-3
   VAINIONPAA S, 1986, ACTA ORTHOP SCAND, V57, P237, DOI 10.3109/17453678608994386
   VALAPPIL SP, 2006, IN PRESS A VANLEEUWE
   Volova T, 2003, BIOCHEM ENG J, V16, P125, DOI 10.1016/S1369-703X(03)00038-X
   von Fraunhofer JA, 1997, WOUND CLOSURE BIOMAT, P107
   WALLEN LL, 1974, ENVIRON SCI TECHNOL, V8, P576, DOI 10.1021/es60091a007
   WANG KK, 1993, MICROSURG, V14, P608, DOI 10.1002/micr.1920140914
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Williams SF, 2005, BIOPOLYMERS MED PHAR, V1, P89
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   Yang C, 2006, ANN THORAC SURG, V81, P57, DOI 10.1016/j.athoracsur.2005.07.013
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 106
TC 115
Z9 121
U1 0
U2 61
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2006
VL 3
IS 6
BP 853
EP 868
DI 10.1586/17434440.3.6.853
PG 16
WC Engineering, Biomedical
SC Engineering
GA 124DT
UT WOS:000243348400024
PM 17280548
DA 2018-10-20
ER

PT J
AU Densmore, A
   Xu, DX
   Waldron, P
   Janz, S
   Cheben, P
   Lapointe, J
   Delage, A
   Lamontagne, B
   Schmid, JH
   Post, E
AF Densmore, A.
   Xu, D. X.
   Waldron, P.
   Janz, S.
   Cheben, P.
   Lapointe, J.
   Delage, A.
   Lamontagne, B.
   Schmid, J. H.
   Post, E.
TI A silicon-on-insulator photonic wire based evanescent field sensor
SO IEEE PHOTONICS TECHNOLOGY LETTERS
LA English
DT Article
DE biomedical transducers; integrated optics; nanotechnology;
   silicon-on-insulator technology
ID SENSITIVITY; BIOSENSOR
AB We demonstrate a new, highly sensitive evanescent field sensor using silicon-on-insulator (SOI) photonic wire waveguides. Theoretical analysis shows that thin SOI waveguides can provide higher sensitivity over devices based in all other common planar waveguide material systems for the probing of both thin adsorbed biomolecular layers and bulk homogeneous solutions. A Si photonic wire waveguide was incorporated into a Mach-Zehnder interferometer based sensor, configured to monitor the index change of a homogeneous solution. High effective index change of 0.31 per refractive index unit (RIU) change of the solution was measured, confirming theoretical predictions.
C1 Natl Res Council Canada, Inst Microstruct Sci, Ottawa, ON K1A 0R6, Canada.
RP Densmore, A (reprint author), Natl Res Council Canada, Inst Microstruct Sci, Ottawa, ON K1A 0R6, Canada.
EM adam.densmore@nrc.ca
CR Almeida VR, 2003, OPT LETT, V28, P1302, DOI 10.1364/OL.28.001302
   Blanco FJ, 2006, J MICROMECH MICROENG, V16, P1006, DOI 10.1088/0960-1317/16/5/018
   HEIDEMAN RG, 1993, SENSOR ACTUAT B-CHEM, V10, P209, DOI 10.1016/0925-4005(93)87008-D
   Hunsperger R. G., 1991, INTEGRATED OPTICS TH, V3rd
   KOGELNIK H, 1990, GUIDED WAVE OPTOELEC, P7
   Ksendzov A, 2005, OPT LETT, V30, P3344, DOI 10.1364/OL.30.003344
   Luff BJ, 1996, OPT LETT, V21, P618, DOI 10.1364/OL.21.000618
   Parriaux O, 1998, J LIGHTWAVE TECHNOL, V16, P573, DOI 10.1109/50.664066
   PING H, 2001, P C LAS EL OPT CLEO, V1
   Prieto F, 2003, NANOTECHNOLOGY, V14, P907, DOI 10.1088/0957-4484/14/8/312
   SHIPPER EF, 1997, SENSOR ACTUAT B-CHEM, V40, P147
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Veldhuis GJ, 2000, J LIGHTWAVE TECHNOL, V18, P677, DOI 10.1109/50.842082
   Yalcin A, 2006, IEEE J SEL TOP QUANT, V12, P148, DOI 10.1109/JSTQE.2005.863003
NR 14
TC 169
Z9 170
U1 7
U2 48
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1041-1135
J9 IEEE PHOTONIC TECH L
JI IEEE Photonics Technol. Lett.
PD NOV-DEC
PY 2006
VL 18
IS 21-24
BP 2520
EP 2522
DI 10.1109/LPT.2006.887374
PG 3
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 121QY
UT WOS:000243173300109
DA 2018-10-20
ER

PT J
AU Meng, J
   Song, L
   Meng, J
   Kong, H
   Zhu, GJ
   Wang, CY
   Xu, LH
   Xie, SS
   Xu, HY
AF Meng, Jie
   Song, Li
   Meng, Jie
   Kong, Hua
   Zhu, Guangjin
   Wang, Chaoying
   Xu, Lianghua
   Xie, Sishen
   Xu, Haiyan
TI Using single-walled carbon nanotubes nonwoven films as scaffolds to
   enhance long-term cell proliferation in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE single-walled carbon nanotubes; scaffold; cell growth; cell-cell
   communication; tissue regeneration
ID POLYMER-DEMIXED NANOTOPOGRAPHY; TOPOGRAPHY; FUNCTIONALIZATION
AB Carbon nanotabes have attracted intensive interests in biomedical research in recent years. In this study, a novel type of carbon nanotubes material so called nonwoven single-walled carbon nanotubes (SWNTs) with nanotopographic structure and macroscopic volume was used as cell growing scaffold. The morphology and surface chemistry of nonwoven SWNTs were observed and characterized through scanning electron microscopy and X-ray photoelectron spectroscopy, respectively. The cells were cultivated in nonwoven SWNTs and in other types of substrate as control. The cells growth behaviors including adhesion, protiferation, and cytoskeletal development was investigated by using cell viability assay and confocal observation. The experimental results indicated that nonwoven SWNTs exhibited significant enhancement to the cells adhesion and proliferation in at least 3 weeks. Numerous and highly organized cytoskeletal structures were observed when the cells were cultured in nonwoven SWNTs. Furthermore, an obvious promotional influence of the cells cultivated in nonwoven SWNTs scaffold upon the proliferation of those growing in the other kind of substrate through cell-cell communication had been found. The results obtained in this work are of significance to in vitro cell amplification in large scale, tissue regeneration, or guided repair, as well as biomedical device application. (c) 2006 Wiley Periodicals, Inc.
C1 Chinese Acad Med Sci, Inst Basic Med, Dept Biomed Engn, Beijing 100005, Peoples R China.
   Peking Union Med Coll, Beijing 100005, Peoples R China.
   Chinese Acad Med Sci, Dept Pathophysiol, Inst Basic Med, Beijing 100005, Peoples R China.
   Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China.
   Beijing Univ Chem Technol, Dept Carbon & Composite, Beijing 100029, Peoples R China.
RP Xu, HY (reprint author), Chinese Acad Med Sci, Inst Basic Med, Dept Biomed Engn, Beijing 100005, Peoples R China.
EM xu.haiyanxx@263.net
RI Song, Li/B-1950-2010
OI Song, Li/0000-0003-0585-8519
CR Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   GALLAGHER JO, 2002, IEEE T NANOBIOSCI, V3, P24
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song L, 2004, ADV MATER, V16, P1529, DOI 10.1002/adma.200306393
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 17
TC 62
Z9 63
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2006
VL 79A
IS 2
BP 298
EP 306
DI 10.1002/jbm.a.30787
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092YB
UT WOS:000241132500010
PM 16817220
DA 2018-10-20
ER

PT J
AU Millon, LE
   Wan, WK
AF Millon, L. E.
   Wan, W. K.
TI The polyvinyl alcohol-bacterial cellulose system as a new nanocomposite
   for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hydrogel; composite/soft tissue; mechanical properties; heart valve;
   vascular prosthesis
ID POLY(VINYL ALCOHOL); VISCOELASTIC PROPERTIES; SHEAR PROPERTIES;
   AORTIC-VALVE; HYDROGELS; REVASCULARIZATION; FIXATION; LEAFLETS; FIBERS;
   ROOT
AB Finding materials suitable for soft tissue replacement is an important aspect for medical devices design and fabrication. There is a need to develop a material that will not only display similar mechanical properties as the tissue it is replacing, but also shows improved life span, biocompatibility, nonthrombogenic, and low degree of calcification. Polyvinyl alcohol (PVA) is a hydrophilic biocompatible polymer with various characteristics desired for biomedical applications. PVA can be transformed into a solid hydrogel with good mechanical properties by physical crosslinking, using freeze-thaw cycles. Hydrophilic bacterial cellulose (BC) fibers of an average diameter of 50 nm are produced by the bacterium Acetobacter xylinum, using a fermentation process. They are used in combination with PVA to form biocompatible nanocomposites. The resulting nanocomposites possess a broad range of mechanical properties and can be made with mechanical properties similar to that of cardiovascular tissues, such as aorta and heart valve leaflets. The stress-strain properties for porcine aorta are matched by at least one type of PVA-BC nanocomposite in both the circumferential and the axial tissue directions. A PVA-BC nanocomposite with similar properties as heart valve tissue is also developed. Relaxation properties of all samples, which are important for cardiovascular applications, were also studied and found to relax at a faster rate and to a lower residual stress than the tissues they might replace. The new PVA-BC composite is a promising material for cardiovascular soft tissue replacement applications. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Western Ontario, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
EM wkwan@uwo.ca
CR Askeland DR, 1996, SCI ENG MAT
   Boughner DR, 2000, J HEART VALVE DIS, V9, P752
   Carew EO, 2004, ANN BIOMED ENG, V32, P563, DOI 10.1023/B:ABME.0000019176.49650.19
   CASCONE MG, 1995, J MATER SCI-MATER M, V6, P71, DOI 10.1007/BF00120410
   *CDCP CDC, 2005, PREV HEART DIS STROK
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   GORDON MJ, 1999, CONTROLLING MECH PRO
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   HANSEN B, 1995, ANN THORAC SURG, V60, pS384, DOI 10.1016/0003-4975(95)00262-J
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   HAYASH K, 2001, BIOMECHANICAL TECHNI, V2, P2
   Hernandez R, 2004, POLYMER, V45, P5543, DOI 10.1016/j.polymer.2004.05.061
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Joseph G, 2003, J CHEM TECHNOL BIOT, V78, P964, DOI 10.1002/jctb.869
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   KLEMM D, 2001, Patent No. 20010610IL
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   Leeson-Dietrich J, 1995, J Heart Valve Dis, V4, P88
   LOCKIE KJ, 1993, ANN THORAC SURG, V56, P125, DOI 10.1016/0003-4975(93)90415-E
   Luprano VAM, 1997, J MATER SCI-MATER M, V8, P175, DOI 10.1023/A:1018527304576
   MacLean NF, 1999, J VASC SURG, V29, P703, DOI 10.1016/S0741-5214(99)70317-4
   MAYNE ASD, 1989, J THORAC CARDIOV SUR, V98, P170
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Moustapha A, 2000, CURR OPIN CARDIOL, V15, P463, DOI 10.1097/00001573-200011000-00012
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   PARK H, 1994, ACS SYM SER, V627, P2
   Popma JJ, 2000, AM J CARDIOL, V86, p18H, DOI 10.1016/S0002-9149(00)01096-1
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   STAMMEN JA, 2001, BIOMATERIALS, V22, P37
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   THUBRIKAR M, 1980, AM HEART J, V99, P217, DOI 10.1016/0002-8703(80)90768-1
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
   Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3
NR 38
TC 121
Z9 129
U1 7
U2 107
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 245
EP 253
DI 10.1002/jbm.b.30535
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800006
PM 16680717
DA 2018-10-20
ER

PT J
AU Millon, LE
   Mohammadi, H
   Wan, WK
AF Millon, L. E.
   Mohammadi, H.
   Wan, W. K.
TI Anisotropic polyvinyl alcohol hydrogel for cardiovascular applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hydrogel; mechanical properties; anisotropy; soft tissue; vascular
   prosthesis
ID POLY(VINYL ALCOHOL); MECHANICAL-PROPERTIES; MORPHOLOGY; FIXATION; FILMS;
   NMR
AB Polyvinyl alcohol (PVA) is a hydrophilic polymer with various characteristics desired for biomedical applications and can be transformed into a solid hydrogel by physical crosslinking, using a low-temperature thermal cycling process. As with most polymeric materials, the mechanical properties of the resultant PVA are isotropic, as oppose to most soft tissues, which are anisotropic. The objective of this research is to develop a PVA-based hydrogel that not only mimics the nonlinear mechanical properties displayed by cardiovascular tissues, but also their anisotropic behavior. By applying a controlled strain to the PVA samples, while undergoing low-temperature thermal cycling, we were able to create oriented mechanical properties in PVA hydrogels. The oriented stress-strain properties of porcine aorta were matched simultaneously by a PVA hydrogel prepared (10% PVA, cycle 3, 75% initial strain). This novel technique allows the controlled introduction of anisotropy to PVA hydrogel, and gives a broad range of control of its mechanical properties, for specific medical device applications. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Western Ontario, Grad Program Biomed Engn, London, ON, Canada.
   Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Grad Program Biomed Engn, London, ON, Canada.
EM wkwan@uwo.ca
CR Bin Y, 2001, POLYMER, V42, P1183, DOI 10.1016/S0032-3861(00)00423-7
   Boughner DR, 2000, J HEART VALVE DIS, V9, P752
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   HANSEN B, 1995, ANN THORAC SURG, V60, pS384, DOI 10.1016/0003-4975(95)00262-J
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Kaneko T, 2004, CHEM MATER, V16, P5596, DOI 10.1021/cm0490975
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   Matsuo M, 2001, POLYMER, V42, P4687, DOI 10.1016/S0032-3861(00)00847-8
   MAYNE ASD, 1989, J THORAC CARDIOV SUR, V98, P170
   MILLON LE, IN PRESS J BIOMED B
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   SPEGT P, 1985, J POLYM SCI POL PHYS, V23, P315, DOI 10.1002/pol.1985.180230207
   STAMMEN JA, 2001, BIOMATERIALS, V22, P37
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
NR 18
TC 85
Z9 86
U1 4
U2 43
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 305
EP 311
DI 10.1002/jbm.b.30543
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800014
PM 16680682
DA 2018-10-20
ER

PT J
AU Hench, LL
AF Hench, Larry L.
TI The story of Bioglass (R)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1985 ANNUAL CONVENTION OF THE AMERICAN PSYCHOLOGICAL ASSOC
CY 1985
CL LOS ANGELES, CA
SP AMER PSYCHOL ASSOC
ID BIOACTIVE GLASS PARTICULATE; CALCIUM SILICATE-GLASSES; BONE-GROWTH
   BEHAVIOR; IN-VITRO; HUMAN OSTEOBLASTS; BIOMEDICAL MATERIALS; CAO-SIO2
   SYSTEM; IONIC PRODUCTS; 45S5; DISSOLUTION
AB Historically the function of biomaterials has been to replace diseased or damaged tissues. First generation biomaterials were selected to be as bio-inert as possible and thereby minimize formation of scar tissue at the interface with host tissues. Bioactive glasses were discovered in 1969 and provided for the first time an alternative; second generation, interfacial bonding of an implant with host tissues. Tissue regeneration and repair using the gene activation properties of Bioglass(R) provide a third generation of biomaterials. This article reviews the 40 year history of the development of bioactive glasses, with emphasis on the first composition, 45S5 Bioglass(R), that has been in clinical use since 1985. The steps of discovery, characterization, in vivo and in vitro evaluation, clinical studies and product development are summarized along with the technology transfer processes.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat & Tissue Engn, London SW7 2AZ, England.
   Univ London Imperial Coll Sci Technol & Med, Regenerat Med Ctr, London SW7 2AZ, England.
RP Hench, LL (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat & Tissue Engn, Prince Consort Rd, London SW7 2AZ, England.
CR Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   AITASALO K, 1997, BIOCERAMICS, V10, P429
   Anderegg CR, 1999, J PERIODONTOL, V70, P384, DOI 10.1902/jop.1999.70.4.384
   ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   BEILBY RC, 2004, TISSUE ENG, V11, P479
   BEILBY RC, 2004, TISSUE ENG, V10
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   Bielby RC, 2004, TISSUE ENG, V10, P1018, DOI 10.1089/1076327041887664
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Clupper DC, 2001, J MATER SCI-MATER M, V12, P917, DOI 10.1023/A:1012836426866
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   DOUEK E, 1991, BIOCERAMIS, V4
   Fetner A E, 1994, Compendium, V15, P935
   Fujishiro Y, 1997, BIOCERAMICS, VOL 10, P283, DOI 10.1016/B978-008042692-1/50067-4
   Gillman LN, 2004, AUSTRAL ECOL, V29, P305, DOI 10.1111/j.1442-9993.2004.01367.x
   Gough JE, 2004, KEY ENG MAT, V254-2, P985, DOI 10.4028/www.scientific.net/KEM.254-256.985
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   Greenspan DC, 1999, CURR OPIN SOLID ST M, V4, P389, DOI 10.1016/S1359-0286(99)00021-2
   GRISS P, 1976, J BIOMED MATER RES, V10, P511, DOI 10.1002/jbm.820100406
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRITICAL REV BIOCOMP, V4
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   Hattar S., 2002, European Cells & Materials, V4, P61
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench L L, 1973, Med Instrum, V7, P136
   Hench L. L., 1991, MAT SCI MONOGR, V69, P259
   Hench L. L., 1972, INT J NONCRYST SOL, V8-10, P837
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1991, MRS BULL, V16, P62
   HENCH LL, 1990, ANNU REV MATER SCI, V20, P269
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2003, GLASS TECHNOL, V44, P1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1977, J BIOMED MATER RES, V11, P267, DOI 10.1002/jbm.820110211
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1970, INT J NONCRYST SOL, V1, P250
   Hench LL., 2001, KEY ENG MATER, V192-195, P575
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hench LL, 1981, FUNDAMENTAL ASPECTS, P67
   HENCH LL, 1998, SOL GEL SILICA
   HENCH LL, 2007, BREAKING BIOCOMPATIB
   HENCH LL, 1996, CLIN PERFORMANCE SKE
   HENCH LL, 1978, ORTHOPEDIC MECHANICS, P287
   HENCH LL, 1995, CERAMICS SOC, P71
   HENCH LL, 1982, BIOCOMPATIBILITY ORT, V2
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Johnson MW, 1997, INT J ORAL MAX IMPL, V12, P835
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   KANGASNIEMI K, 1990, HDB BIOACTIVE CERAMI, V1, P97
   Karatzas S, 1999, INT J PERIODONT REST, V19, P489
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Lobel K. D., 2000, COMPUTER TECHNOLOGY, P45
   Lobel KD, 1996, MAR BIOL, V126, P353, DOI 10.1007/BF00354617
   Lobel KD, 1998, J BIOMED MATER RES, V39, P575, DOI 10.1002/(SICI)1097-4636(19980315)39:4<575::AID-JBM11>3.0.CO;2-6
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   LOTY C, 1998, BIOCERAMICS, V11, P327
   Lovelace TB, 1998, J PERIODONTOL, V69, P1027, DOI 10.1902/jop.1998.69.9.1027
   Low SB, 1997, INT J PERIODONT REST, V17, P359
   Merwin GE, 1990, HDB BIOACTIVE CERAMI, V1, P323
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nedelec JM, 2000, J NON-CRYST SOLIDS, V277, P106, DOI 10.1016/S0022-3093(00)00306-9
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   OONISHI H, 1997, J CLIN ORTHOP REL RE, V334, P316
   Peltola MJ, 2001, J BIOMED MATER RES, V58, P54, DOI 10.1002/1097-4636(2001)58:1<54::AID-JBM80>3.3.CO;2-K
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   Rea S.M., 2004, J AUST CERAM SOC, V40, P43
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P14, DOI 10.1016/S0022-3093(02)01882-3
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Shapoff C A, 1997, Compend Contin Educ Dent, V18, P352
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Stanley HR, 1997, INT J ORAL MAX IMPL, V12, P95
   Stanley HR, 2001, AM J DENT, V14, P227
   THOMPSON I, 2000, COMPREHENSIVE COMPOS, V6, P727
   WALKER RD, 1992, J UROLOGY, V148, P645, DOI 10.1016/S0022-5347(17)36680-6
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   WEINSTEIN AM, 1980, J BIOMED MATER RES, V14, P23, DOI 10.1002/jbm.820140104
   Wheeler DL, 2000, J ORTHOPAED RES, V18, P140, DOI 10.1002/jor.1100180120
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILSON J, 1987, BIOMATERIALS CLIN AP, P223
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1
   Wilson June, 1992, BIOCERAMICS, V5
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   XYNOS ID, 2001, P INT C GLASS, V1, P226
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P89
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 103
TC 901
Z9 940
U1 16
U2 281
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2006
VL 17
IS 11
BP 967
EP 978
DI 10.1007/s10856-006-0432-z
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109GM
UT WOS:000242295900003
PM 17122907
DA 2018-10-20
ER

PT J
AU Anderson, JM
AF Anderson, James M.
TI The future of biomedical materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1985 ANNUAL CONVENTION OF THE AMERICAN PSYCHOLOGICAL ASSOC
CY 1985
CL LOS ANGELES, CA
SP AMER PSYCHOL ASSOC
AB The purpose of this communication is to present the author's perspectives on the future of biomedical materials that were presented at the Larry L. Hench Retirement Symposium held at Imperial College, London, in late September 2005. The author has taken a broad view of the future of biomedical materials and has presented key ideas, concepts, and perspectives necessary for the future research and development of biomedical polymers and their future role as an enabling technology for the continuing progress of tissue engineering, regenerative medicine, prostheses, and medical devices. This communication, based on the oral presentation, is meant to be provocative and generate discussion. In addition, it is targeted for students and young scientists who will play an ever-increasing role in the future of biomedical materials.
C1 Case Western Reserve Univ, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Cleveland, OH 44106 USA.
EM jma6@case.edu
NR 0
TC 34
Z9 34
U1 1
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2006
VL 17
IS 11
BP 1025
EP 1028
DI 10.1007/s10856-006-0439-5
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109GM
UT WOS:000242295900010
PM 17122914
DA 2018-10-20
ER

PT J
AU Nayar, S
   Sinha, MK
   Basu, D
   Sinha, A
AF Nayar, Suprabha
   Sinha, M. K.
   Basu, D.
   Sinha, Arvind
TI Synthesis and sintering of biomimetic hydroxyapatite nanoparticles for
   biomedical applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1985 ANNUAL CONVENTION OF THE AMERICAN PSYCHOLOGICAL ASSOC
CY 1985
CL LOS ANGELES, CA
SP AMER PSYCHOL ASSOC
ID BOVINE SERUM-ALBUMIN; SIMULATED BODY-FLUID; CALCIUM PHOSPHATES;
   CRYSTALLIZATION; COMPOSITE; CERAMICS; TITANIUM
AB Synthesis of monodisperse nanoparticles with uniform morphology and narrow size distribution as achieved by nature is a challenge to materials scientists. Mimicking the process of biomineralization has led to the development of biomolecules mediated synthesis of nanoparticles that overcomes many of the problems associated with nanoparticle synthesis. Termed as biomimetics this paradigm shift in the philosophy of synthesis of materials is very advantageous for the design-based synthesis of nanoparticles. The effect of concentration of a protein named bovine serum albumin on particle size, morphology and degree of crystallinity of biomimetically synthesized hydroxyapatite particles, has been studied. Results establish 0.5% protein as the required concentration to produce 30-40 nm sized hydroxyapatite particles with an optimum degree of crystallinity as required for biomedical applications. These particles synthesized under certain stringent conditions are found to have stoichiometric calcium:phosphorus ratio of 1.67 and exhibit restricted grain growth during sintering.
C1 Natl Met Lab, Jamshedpur 831007, Bihar, India.
   Cent Glass & Ceram Res Inst, Kolkata, India.
RP Nayar, S (reprint author), Natl Met Lab, Jamshedpur 831007, Bihar, India.
RI Sahu, Anjani/E-7590-2015
CR Dorozhkin SV, 2003, COLLOID SURFACE A, V215, P191, DOI 10.1016/S0927-7757(02)00438-7
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   FLADE K, 2001, CHEM MATER, V13, P596
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286
   Nayar S, 2004, COLLOID SURFACE B, V35, P29, DOI 10.1016/j.colsurfb.2004.01.013
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   REGI MV, 2004, PROG SOLID STATE CHE, V32, P1
   Rhee SH, 2001, BIOMATERIALS, V22, P2843, DOI 10.1016/S0142-9612(01)00028-X
   Sinha A, 2003, J AM CERAM SOC, V86, P357, DOI 10.1111/j.1151-2916.2003.tb00024.x
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   Tadic D, 2003, BIOMATERIALS, V24, P4565, DOI 10.1016/S0142-9612(03)00281-3
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wen HB, 1999, J BIOMED MATER RES, V46, P245, DOI 10.1002/(SICI)1097-4636(199908)46:2<245::AID-JBM14>3.0.CO;2-A
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
NR 19
TC 35
Z9 37
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2006
VL 17
IS 11
BP 1063
EP 1068
DI 10.1007/s10856-006-0532-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109GM
UT WOS:000242295900016
PM 17122920
DA 2018-10-20
ER

PT J
AU Ouchi, T
   Kontani, T
   Aoki, R
   Saito, T
   Ohya, Y
AF Ouchi, Tatsuro
   Kontani, Tomohiro
   Aoki, Rie
   Saito, Toshifumi
   Ohya, Yuichi
TI Characteristic properties of film prepared from poly(L-lactide)-grafted
   dextran of a relatively high sugar unit content as a degradable
   biomaterial
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE biodegradable; biomaterials; degradability; films; graft copolymers;
   polylactide-grafted dextran; water absorption ability; wettable surface
ID POLYLACTIDE-GRAFTED DEXTRAN; TRIMETHYLSILYL PROTECTION METHOD; DELIVERY
   SYSTEMS; BLOCK-COPOLYMER; DRUG-DELIVERY; L-LACTIDE; IN-VITRO;
   SUPPRESSION; PULLULAN; ADHESION
AB To develop novel biomedical soft materials with degradability, amphiphilic poly(L-lactide)-grafted dextrans (Dex-g-PLLAs) of relatively high sugar unit contents were synthesized with the trimethylsilyl protection method. The characteristic properties of solution-cast films prepared from the obtained Dex-g-PLLAs were investigated. The water absorption and degradation rate of the Dex-g-PLLA films increased with increasing sugar unit content. The morphology of the bulk phase and top surface of the Dex-g-PLLA films was evaluated with transmission electron microscopy and atomic force microscopy, respectively. The bulk phase of the Dex-g-PLLA films with a sugar unit content of 16-25 wt % was found by transmission electron microscopy to form a lamellar type of phase-separated structure composed of approximately 80-100-nm-wide nanodomains because of their amphiphilic and branched structures. The hydrophobic top surface for a Dex-g-PLLA film with a sugar unit content of 25 wt % covered with PLLA segments was confirmed by atomic force microscopy phase images to be easily converted to a wettable top surface covered with hydrophilic dextran aggregates showing an 8-10-nm-wide honeycomb pattern by means of annealing in water. (c) 2006 Wiley Periodicals, Inc.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM touchi@ipcku.kansai-u.ac.jp; yohya@ipcku.kansai-u.ac.jp
CR CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Donabedian DH, 1998, MACROMOLECULES, V31, P1032, DOI 10.1021/ma961741g
   Erdodi G, 2005, J POLYM SCI POL CHEM, V43, P4953, DOI 10.1002/pola.20978
   Gudipati CS, 2004, J POLYM SCI POL CHEM, V42, P6193, DOI 10.1002/pola.20466
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Heller J, 1984, Crit Rev Ther Drug Carrier Syst, V1, P39
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEOUNG SY, 1986, ARCH PHARM RES, V9, P63
   Jong S. J., 2000, MACROMOLECULES, V33, P3680
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   Kricheldorf HR, 1996, MACROMOL SYMP, V103, P85
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   Nagahama K, 2006, MACROMOL BIOSCI, V6, P412, DOI 10.1002/mabi.200500249
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039
   Ouchi T, 2005, J BIOMAT SCI-POLYM E, V16, P1035, DOI 10.1163/1568562054414649
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   WOOD DA, 1980, INT J PHARM, V7, P1, DOI 10.1016/0378-5173(80)90094-0
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
NR 27
TC 13
Z9 13
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD NOV 1
PY 2006
VL 44
IS 21
BP 6402
EP 6409
DI 10.1002/pola.21750
PG 8
WC Polymer Science
SC Polymer Science
GA 096HR
UT WOS:000241368700021
DA 2018-10-20
ER

PT J
AU Gadow, R
   Kern, F
AF Gadow, Rainer
   Kern, Frank
TI Pressureless sintering of injection molded zirconia toughened alumina
   nanocomposites
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE ceramic injection molding; zirconia toughened alumina; nanocomposites;
   compounding
ID FRACTURE-TOUGHNESS; CERAMICS; GROWTH
AB Ceramic injection molding (CIM) is the most suitable shaping method for mass production of small ceramic components with complex shape in near net shape quality. Due to its high strength and fracture toughness zirconia toughened alumina (ZTA) is an interesting material for ceramic machine components and for biomedical applications. The ability to sinter ZTA to full density while retaining an extremely fine grained microstructure is the prerequisite to exploit the potential of the material. CIM components of ZTA which have much lower powder packing density and a lower homogeneity than e.g. isopressed or cast components normally show a very sluggish sintering behaviour even if very fine sub-mu m or even nanosized powders are used. In this study a tailored pressureless sintering process for ZTA microcomponents was developed in order to be able to exploit the full technical and economic potential of the near-net-shape manufacturing process. Depending on the feedstock recipe a reduction in sintering temperature by more than 100 K was achieved and even higher densities reached than by conventional sintering. This leads to a refinement in microstructure and a reduction in alumina grain size by a factor of 2-3.
C1 Inst Mfg Technol Ceram Components & Composites, D-70569 Stuttgart, Germany.
RP Kern, F (reprint author), Inst Mfg Technol Ceram Components & Composites, Allmandring 7B, D-70569 Stuttgart, Germany.
EM frank.kern@ifkb.unistuttgart.de
CR BECHER PF, 1983, J AM CERAM SOC, V66, P485, DOI 10.1111/j.1151-2916.1983.tb10587.x
   Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548
   CLAUSSEN N, 1977, AM CERAM SOC BULL, V56, P559
   CLAUSSEN N, 1976, J AM CERAM SOC, V59, P49, DOI 10.1111/j.1151-2916.1976.tb09386.x
   CLAUSSEN N, 1985, ADV CERAMICS, V12
   Claussen N., 1984, ADV CERAM, V12, P325
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Green D. J., 1989, TRANSFORMATION TOUGH
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   HEUER AH, 1981, ADV CERAMICS, V3
   Jayaseelan DD, 2002, J AM CERAM SOC, V85, P2870
   LANGE FF, 1982, J MATER SCI, V17, P255, DOI 10.1007/BF00809061
   Lin FJT, 1997, J AM CERAM SOC, V80, P2269
   NIIHARA K, 1993, MATER RES SOC S P, P403
   RUHLE M, 1987, ACTA METALL MATER, V35, P2701, DOI 10.1016/0001-6160(87)90269-0
   SOMIYA S, 1988, ADV CERAMICS, V24
   TIMOSCHENKO S, 1976, STRENGTH MAT 1, P365
   Zhao Z, 2004, KEY ENG MAT, V264-268, P2297, DOI 10.4028/www.scientific.net/KEM.264-268.2297
NR 18
TC 10
Z9 10
U1 1
U2 11
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD NOV
PY 2006
VL 114
IS 1335
BP 958
EP 962
DI 10.2109/jcersj.114.958
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 108XS
UT WOS:000242273100016
OA Bronze
DA 2018-10-20
ER

PT J
AU Gaudilliere, JP
AF Gaudilliere, Jean-Paul
TI Normal pathways: Controlling isotopes and building biomedical research
   in postwar France
SO JOURNAL OF THE HISTORY OF BIOLOGY
LA English
DT Article
DE biomedical research; radioisotopes; regulation; international exchanges;
   contemporary France
ID DANS LEMBRYON; TRADITIONS; BIOLOGY; TAURINE; POULET; RAT
AB During the late 1940s and 1950s, radioisotopes became important resources for biological and medical research. This article explores the strategies used by French researchers to get access to this material, either from the local Atomic Energy Commission (CEA) or from suppliers in the United States or United Kingdom. It focuses on two aspects of this process: the transatlantic circulation of both isotopes and associated instrumentation; the regulation of use and access by the administrative bodies governing research in France. Analyzing the investigations conducted within laboratories associated either with the atomic energy agency or with the local National Institute of Health (INH), the paper discusses the part played by the new tools in the postwar transformation of biomedical research. It contrasts the INH successful development of biological studies and metabolic tracing with the mixed results of CEA in advancing cancer radiotherapy, thus highlighting locally defined "normal paths" to radiobiology.
C1 Ctr Rech Med Sci Sante & Soc, INSERM, Site CNRS, F-94801 Villejuif, France.
RP Gaudilliere, JP (reprint author), Ctr Rech Med Sci Sante & Soc, INSERM, Site CNRS, 7 Rue Guy Moquet, F-94801 Villejuif, France.
EM gaudilli@vjf.cnrs.fr
CR BERGER M, 1953, Sem Hop, V29, P1507
   BOUDIA S, 2001, M CURIE LAB SCI IND
   BURIAN RM, 1988, J HIST BIOL, V21, P357, DOI 10.1007/BF00144087
   CHAPEVILLE F, 1957, BIOCHIM BIOPHYS ACTA, V26, P538, DOI 10.1016/0006-3002(57)90102-6
   CHAPEVILLE F, 1956, B SOC CHIM BIOL, V38, P1143
   CHAPEVILLE F, 1956, B SOC CHIM BIOL, V38, P1153
   CHEVALLIER F., 1960, REV CANADIENNE BIOL, V19, P95
   CHEVALLIER F, 1958, Prog Nucl Energy 6 Biol Sci, V2, P164
   CHEVALLIER F, 1957, CR SOC BIOL, V151, P892
   CHEVALLIER F, 1960, B SOC CHIM BIOL, V42, P611
   CHEVALLIER F, 1960, B SOC CHIM BIOL, V42, P623
   COURSAGET J, 1952, B SOC CHIM BIOL, V34, P1078
   COURSAGET J, 1952, J Urol Medicale Chir, V58, P782
   COURSAGET J, 1957, Therapie, V12, P685
   DARGENT M, 1953, J ELECTRORADIOLOGIE, V32, P347
   DUBERT JM, 1951, B SOC CHIM BIOL, V33, P1692
   Fragu P, 2003, B HIST MED, V77, P393, DOI 10.1353/bhm.2003.0063
   FROMAGEOT P, 1959, Rev Pathol Gen Physiol Clin, V59, P713
   Gaudilliere J-P, 1992, SCI SOC SANTE, V10, P107
   Gaudilliere Jean-Paul, 2002, INVENTER BIOMEDECINE
   GAUDILLIERE JP, 1992, HIST PHIL LIFE SCI, V14, P23
   GAUDILLIERE JP, 1993, J HIST BIOL, V26, P473, DOI 10.1007/BF01062058
   GAUDILLIERE JP, 2002, STUD HIST PHILOS M P, V33, P457
   GAUDILLIERE JP, 1996, J HIST BIOL, V29, P312
   GROS F, 1952, B SOC CHIM BIOL, V34, P1074
   GROS F, 1952, B SOC CHIM BIOL, V34, P1070
   Hecht G., 1998, RADIANCE FRANCE NUCL
   JACQ F, 1909, THESIS ECOLE NATL MI
   Kohler R. E., 1977, HIST STUD PHYS BIOL, V8, P257
   Krige J, 2005, HIST STUD PHYS BIOL, V36, P71, DOI 10.1525/hsps.2005.36.1.71
   LAMARQUE P, 1953, J ELECTRORADIOLOGIE, V32, P274
   LAMARQUE P, 1953, J ELECTRORADIOLOGIE, P499
   LINAZASORO JM, 1958, J EXP MED, V107, P813, DOI 10.1084/jem.107.6.813
   MACHEBOEUF M, 1954, EXPT MED SURG, V12, P161
   Mazumdar P. M. H., 1989, IMMUNOLOGY 1930 1980
   MOULIN AM, 1991, PASTEUR SIDA DERNIER
   Pinault M., 2000, F JOLIOT CURIE
   PINELL P, 1994, NAISSANCE FLEAU LUTT
   Rasmussen N, 1997, HIST SCI, V35, P245, DOI 10.1177/007327539703500301
   Rasmussen Nicolas, 1997, PICTURE CONTROL ELEC
   SCHAPIRA G, 1953, B SOC CHIM BIOL, V35, P130
   VINCENT B, 1999, THESIS U PARIS 7
   Weisz G., 2005, DIVIDE CONQUER COMP
NR 43
TC 15
Z9 15
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-5010
J9 J HIST BIOL
JI J. Hist. Biol.
PD NOV
PY 2006
VL 39
IS 4
BP 737
EP 764
DI 10.1007/s10739-006-9111-7
PG 28
WC Biology; History & Philosophy Of Science
SC Life Sciences & Biomedicine - Other Topics; History & Philosophy of
   Science
GA 096LY
UT WOS:000241379800005
PM 17575957
DA 2018-10-20
ER

PT J
AU Elliott, J
   Hancock, B
AF Elliott, James
   Hancock, Bruno
TI Pharmaceutical materials science: An active new frontier in materials
   research
SO MRS BULLETIN
LA English
DT Article
DE biomedical; crystallization; nanoscale; particle
AB The discipline of materials science has most commonly been associated with the study of structural or functional materials for engineering applications, such as metals, ceramics, and composites, but there are now, increasingly, great opportunities involving applications to soft matter, including polymers, powders, and biomaterials. The emerging discipline of pharmaceutical materials science attempts to apply physical principles common in materials science to challenges in such areas as drug delivery, control of drug form, manufacture and processing of nanoscopic and microscopic particle systems, and the structure and properties of bulk powders and their assemblies (e.g., tablets) for use in pharmaceutical applications. In this issue of MRS Bulletin, we have attempted to capture a snapshot of this rapidly developing new area of materials research, in order to bring it to the attention of the wider materials science community.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   Univ Cambridge, Dept Chem, Cambridge CB2 1NJ, England.
   GlaxoSmithKline Inc, Particle Sci Grp, King Of Prussia, PA 19406 USA.
   IIT, Off Provost, Chicago, IL 60616 USA.
   Univ Texas, Dept Chem & Biomed Engn, Austin, TX 78712 USA.
   Jones Day, Int Law Firm, New York, NY 10017 USA.
   Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.
RP Elliott, J (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
EM jae1001@cam.ac.uk; hancock@pfizer.com
RI Elliott, James/A-4135-2009
OI Elliott, James/0000-0002-4887-6250
CR Craig DQM, 1997, J PHARM PHARMACOL, V49, P119, DOI 10.1111/j.2042-7158.1997.tb06764.x
   FRANKS F, 1991, BIOPHARM-TECHNOL BUS, V4, P38
   HIGUCHI T, 1953, J AM PHARM ASSOC SCI, V42, P157, DOI 10.1002/jps.3030420311
   Lyndall G., 1936, U. S. Patent No, Patent No. [2,041, 869, 2041869]
NR 4
TC 13
Z9 13
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2006
VL 31
IS 11
BP 869
EP 873
DI 10.1557/mrs2006.205
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 108FO
UT WOS:000242225900012
OA Bronze
DA 2018-10-20
ER

PT J
AU Jones, W
   Motherwell, S
   Trask, AV
AF Jones, William
   Motherwell, Samuel
   Trask, Andrew V.
TI Pharmaceutical cocrystals: An emerging approach to physical property
   enhancement
SO MRS BULLETIN
LA English
DT Article
DE biomedical; crystal growth; crystaffine
ID CAMBRIDGE STRUCTURAL DATABASE; CRYSTALLINE SOLIDS; SALT SELECTION;
   SOLVENT; PHASES; ACIDS; MECHANOCHEMISTRY; PREDICTION; HYDRATION; DRUGS
AB Pharmaceutical cocrystals are crystalline molecular complexes containing therapeutic molecules. They represent an emerging class of pharmaceutical materials offering the. prospect of optimized physical properties. This article highlights important opportunities and challenges associated with the design and synthesis of pharmaceutical cocrystals. Cocrystallization is first placed into context with the more established approaches to physical property optimization of polymorph, hydrate, and salt selection. A directed, intermolecular-interaction-based approach to cocrystal design is described. The enhancement of specific physical properties, such as dissolution rate and physical stability, is illustrated by summarizing several recent reports. Synthetic approaches to cocrystallization are considered; in particular, the selectivity and screening-related opportunities afforded by solid-state grinding and solvent-drop grinding methods are discussed. Finally, an outlook on future developments summarizes the growth potential in this field, especially with regard to targeted informatics-driven cocrystal screening approaches.
CR Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   Almarsson O, 2004, CHEM COMMUN, P1889, DOI 10.1039/b402150a
   Bastin RJ, 2000, ORG PROCESS RES DEV, V4, P427, DOI 10.1021/op000018u
   Bernstein J, 2002, POLYMORPHISM MOL CRY
   Bighley L. D., 1996, ENCY PHARM TECHNOLOG, V13
   Byrn S. R., 1999, SOLID STATE CHEM DRU
   CAIRA MR, 1995, J CHEM SOC PERK T 2, P2213, DOI 10.1039/p29950002213
   Chemburkar SR, 2000, ORG PROCESS RES DEV, V4, P413, DOI 10.1021/op000023y
   Childs SL, 2004, J AM CHEM SOC, V126, P13335, DOI 10.1021/ja048114o
   Datta S, 2004, NAT REV DRUG DISCOV, V3, P42, DOI 10.1038/nrd1280
   ETTER MC, 1991, J PHYS CHEM-US, V95, P4601, DOI 10.1021/j100165a007
   ETTER MC, 1990, ACCOUNTS CHEM RES, V23, P120, DOI 10.1021/ar00172a005
   Fleischman SG, 2003, CRYST GROWTH DES, V3, P909, DOI 10.1021/cg034035x
   Gillon AL, 2003, CRYST GROWTH DES, V3, P663, DOI 10.1021/cg034088e
   GOULD PL, 1986, INT J PHARM, V33, P201, DOI 10.1016/0378-5173(86)90055-4
   KHANKARI RK, 1995, THERMOCHIM ACTA, V248, P61, DOI 10.1016/0040-6031(94)01952-D
   McCrone W., 1965, PHYS CHEM ORGANIC SO, V2
   Morissette Sherry L., 2004, Advanced Drug Delivery Reviews, V56, P275, DOI 10.1016/j.addr.2003.10.020
   Motherwell WDS, 2002, ACTA CRYSTALLOGR B, V58, P647, DOI 10.1107/S0108768102005669
   Oswald IDH, 2002, ACTA CRYSTALLOGR B, V58, P1057, DOI 10.1107/S0108768102015987
   Remenar JF, 2003, J AM CHEM SOC, V125, P8456, DOI 10.1021/ja035776p
   Rodriguez-Spong B, 2004, ADV DRUG DELIVER REV, V56, P241, DOI 10.1016/j.addr.2003.10.005
   Shan N, 2002, CHEM COMMUN, P2372, DOI 10.1039/b207369m
   Stahl P. H., 2002, HDB PHARM SALTS PROP
   Trask AV, 2006, CHEM COMMUN, P51, DOI 10.1039/b512626f
   Trask AV, 2005, CRYST GROWTH DES, V5, P2233, DOI 10.1021/cg0501682
   Trask AV, 2005, TOP CURR CHEM, V254, P41, DOI 10.1007/b100995
   Trask AV, 2005, CHEM COMMUN, P880, DOI 10.1039/b416980h
   Trask AV, 2005, CRYST GROWTH DES, V5, P1013, DOI 10.1021/cg0496540
   Trask AV, 2004, CHEM COMMUN, P890, DOI 10.1039/b400978a
   Vippagunta SR, 2001, ADV DRUG DELIVER REV, V48, P3, DOI 10.1016/S0169-409X(01)00097-7
   Walsh RDB, 2003, CHEM COMMUN, P186, DOI 10.1039/b208574g
NR 32
TC 193
Z9 196
U1 3
U2 68
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2006
VL 31
IS 11
BP 875
EP 879
DI 10.1557/mrs2006.206
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 108FO
UT WOS:000242225900013
DA 2018-10-20
ER

PT J
AU Peppas, NA
AF Peppas, Nicholas A.
TI Intelligent biomaterials as pharmaceutical carriers in microfabricated
   and nanoscale devices
SO MRS BULLETIN
LA English
DT Article
DE biomaterials; biomedical; diffusion; nanoscale
ID DRUG-DELIVERY; HYDROGELS; EQUILIBRIUM
AB The emergence of micro- and nanoscale science and engineering has provided new avenues for engineering materials with macromolecular and even molecular-scale precision, leading to diagnostic and therapeutic technologies that will revolutionize the way healthcare is administered. Biomaterials have evolved from off-the-shelf products to materials designed with molecular precision to exhibit the desired properties for a specific application, often mimicking biological systems. Controlling interactions at the level of natural building blocks, from proteins to cells, facilitates the novel exploration, manipulation, and application of living systems and biological phenomena. In addition, polymer networks with precisely engineered binding sites have been created via molecular imprinting, where functional monomers are preassembled with a target molecule and then the structure is locked with network formation. Nanoscale science and engineering have accelerated the development of novel drug delivery systems and led to enhanced control over how a given pharmaceutical is administered, helping biological potential to be transformed into medical reality. Micro- and nanoscale devices have been fabricated using integrated-circuit processing techniques, enabling strict temporal control over drug release. The advantages of these microdevices include simple release mechanisms, very accurate dosing, the capability of complex release patterns, the potential for local delivery, and possible biological drug stability enhancement by means of storage in a microvolume that can be precisely controlled. In particular, the development of polymer systems that are able to interact with their environment in a thermodynamically responsive manner has led to novel intelligent biomaterials and applications. Intelligent biomedical materials can be used for the delivery of drugs, peptides, and proteins; as targeting agents for site-specific delivery; or as components for the preparation of protein or drug conjugates. These intelligent materials are attractive options as functional components in micro- and nanodevices because of the ease with which recognition and actuation properties can be precisely tailored. Recent developments in intelligent materials and nano- or microdevices for drug delivery systems are the emphasis of this review, which addresses the use of intelligent biomedical materials as carders for the development of novel pharmaceutical formulations.
CR Baumgartner S, 2002, PHARMACEUT RES, V19, P1084, DOI 10.1023/A:1019891105250
   Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093
   Brannon-Peppas L., 1997, MED PLAST BIOMATER, V4, P34
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Hilt JZ, 2005, INT J PHARMACEUT, V306, P15, DOI 10.1016/j.ijpharm.2005.09.022
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   KHARE AR, 1995, BIOMATERIALS, V16, P559, DOI 10.1016/0142-9612(95)91130-Q
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   Narasimhan B, 1997, CONTROLLED DRUG DELI, P529
   Park K, 1997, CONTROLLED DRUG DELI, P485
   Park K, 1997, CONTROLLED RELEASE C
   Peppas N. A., 1987, HYDROGELS MED PHARM
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Tu RS, 2004, ADV DRUG DELIVER REV, V56, P1537, DOI 10.1016/j.addr.2003.10.047
   Vakkalanka SK, 1996, J BIOMAT SCI-POLYM E, V8, P119, DOI 10.1163/156856296X00192
   Venkatesh Siddarth, 2005, Expert Opin Drug Deliv, V2, P1085, DOI 10.1517/17425247.2.6.1085
NR 21
TC 19
Z9 20
U1 0
U2 9
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2006
VL 31
IS 11
BP 888
EP 893
DI 10.1557/mrs2006.208
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 108FO
UT WOS:000242225900015
DA 2018-10-20
ER

PT J
AU Shah, P
AF Shah, Parag
TI Use of nanotechnologies for drug delivery
SO MRS BULLETIN
LA English
DT Article
DE biomedical; nanoscale; particle
ID POORLY SOLUBLE DRUGS; RAPID EXPANSION; CARBON-DIOXIDE; SUPERCRITICAL
   ANTISOLVENT; PARTICLE FORMATION; SIZE-REDUCTION; NANOPARTICLES;
   NANOCRYSTALS; WATER; FORMULATION
AB The emerging field of nanotechnology has an enormous potential contribution to make to the field of pharmaceutical materials science. The advantages of drug nanoparticles can be as simple as dissolution rate enhancement through increased surface area or as complex as targeted delivery through novel pathways. However, the application of many nanoscale technologies has been slow because of difficulties controlling the drug form with decreasing particle size and maintaining chemical and physical stability upon storage. Advancing beyond these limitations requires a unique understanding of both the material properties of the active ingredients as well as the physical chemistry of the nano-sized particle. This article will examine the current challenges facing the pharmaceutical industry in applying nanotechnology, with a focus on the deficiencies in understanding that need to be addressed to move forward.
CR Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Bilati U, 2005, EUR J PHARM SCI, V24, P67, DOI 10.1016/j.ejps.2004.09.011
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Bustami RT, 2000, PHARMACEUT RES, V17, P1360, DOI 10.1023/A:1007551006782
   Chattopadhyay P, 2006, J PHARM SCI-US, V95, P667, DOI 10.1002/jps.20555
   Chattopadhyay P, 2002, AICHE J, V48, P235, DOI 10.1002/aic.690480207
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Holmes JD, 1999, LANGMUIR, V15, P6613, DOI 10.1021/la990510a
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Jiang BB, 2005, INT J PHARM, V304, P220, DOI 10.1016/j.ijpharm.2005.08.008
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Keck CM, 2006, EUR J PHARM BIOPHARM, V62, P3, DOI 10.1016/j.ejpb.2005.05.009
   LIVERSIDGE GG, 1995, INT J PHARM, V125, P91, DOI 10.1016/0378-5173(95)00122-Y
   Merisko-Liversidge E, 2003, EUR J PHARM SCI, V18, P113, DOI 10.1016/S0928-0987(02)00251-8
   Muller RH, 1998, INT J PHARMACEUT, V160, P229, DOI 10.1016/S0378-5173(97)00311-6
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Noyes A. A., 1897, J AM CHEM SOC, V19, P930, DOI DOI 10.1021/JA02086A003
   Pathak P, 2004, J AM CHEM SOC, V126, P10842, DOI 10.1021/ja046914t
   Pileni MP, 1997, LANGMUIR, V13, P3266, DOI 10.1021/la960319q
   Reverchon E, 1999, POWDER TECHNOL, V106, P23, DOI 10.1016/S0032-5910(99)00062-5
   Shah PS, 2004, J PHYS CHEM B, V108, P9574, DOI 10.1021/jp049827w
   Shah PS, 2002, J PHYS CHEM B, V106, P12178, DOI 10.1021/jp026180b
   SHAH U, 2006, PHARM TECHNOL, V30, P96
   SHAH U, 2006, Patent No. 2006003504
   Sun YP, 2001, LANGMUIR, V17, P5707, DOI 10.1021/la0103057
   Thakur R, 2006, INT J PHARM, V308, P190, DOI 10.1016/j.ijpharm.2005.11.005
   TOM JW, 1991, J AEROSOL SCI, V22, P555, DOI 10.1016/0021-8502(91)90013-8
   Vasir JK, 2005, CURR NANOSCI, V1, P47, DOI 10.2174/1573413052953110
   Vemavarapu C, 2005, INT J PHARMACEUT, V292, P1, DOI 10.1016/j.ijpharm.2004.07.021
   Wang ZL, 1998, J PHYS CHEM B, V102, P6145, DOI 10.1021/jp981594j
   Wautelet M, 1998, PHYS LETT A, V246, P341, DOI 10.1016/S0375-9601(98)00538-6
   Young TJ, 2000, BIOTECHNOL PROGR, V16, P402, DOI 10.1021/bp000032q
   Zhang Z, 2000, MATER LETT, V44, P261, DOI 10.1016/S0167-577X(00)00040-9
NR 34
TC 20
Z9 20
U1 1
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2006
VL 31
IS 11
BP 894
EP 899
DI 10.1557/mrs2006.209
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 108FO
UT WOS:000242225900016
DA 2018-10-20
ER

PT J
AU Wassgren, C
   Curtis, JS
AF Wassgren, Carl
   Curtis, Jennifer Sinclair
TI The application of computational modeling to pharmaceutical materials
   science
SO MRS BULLETIN
LA English
DT Article
DE biomedical; particle; powder; simulation
ID DISCRETE-PARTICLE SIMULATIONS; CELLULAR-AUTOMATON MODEL; SOLID
   FLUIDIZED-BEDS; GRANULAR FLOW; COMPUTER-SIMULATION;
   NUMERICAL-SIMULATION; DEM SIMULATION; SPRAY DRYERS; CHUTE FLOWS;
   SEGREGATION
AB Computational modeling is a ubiquitous technique in materials science, but until recently this approach has not been widely applied to the drug development process. The formation of particles, their kinematics, and their response to processing stresses are increasingly being studied using computational techniques (computational fluid dynamics and discrete element analysis). These computational techniques can be predictive tools to guide scientists who are designing pharmaceutical dosage forms with specific macroscopic properties. This article gives an overview of the types of computational methods that are used in pharmaceutical materials science and provides examples of their application to some problems from the literature and the authors' own work.
OI Curtis, Jennifer/0000-0001-5584-0099
CR Allen GM, 2004, J BIOMECH ENG-T ASME, V126, P604, DOI 10.1115/1.1800554
   BAXTER GW, 1990, PHYS REV A, V42, P1017, DOI 10.1103/PhysRevA.42.1017
   CAMPBELL CS, 1985, J APPL MECH-T ASME, V52, P172, DOI 10.1115/1.3168990
   CAMPBELL CS, 1985, J FLUID MECH, V151, P167, DOI 10.1017/S002211208500091X
   CHHABRA R, 1999, POWDER TECHNOL, V101, P88
   Chung T. J., 2002, COMPUTATIONAL FLUID
   Cleary PW, 2002, APPL MATH MODEL, V26, P89, DOI 10.1016/S0307-904X(01)00050-6
   Coates MS, 2004, J PHARM SCI-US, V93, P2863, DOI 10.1002/jps.20201
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   DAVIDSON DL, 2001, P 6 WORLD C CHEM ENG
   DEHAAN W, 2003, J AEROSOL SCI, V35, P309
   Di Renzo A, 2004, CHEM ENG SCI, V59, P525, DOI 10.1016/j.ces.2003.09.037
   ELGHOBASHI SE, 1983, PHYS FLUIDS, V26, P931, DOI 10.1063/1.864243
   Fan R, 2004, POWDER TECHNOL, V139, P7, DOI 10.1016/j.powtech.2003.10.005
   FITT AD, 1992, PHYS REV A, V45, P2383, DOI 10.1103/PhysRevA.45.2383
   Gemci T, 2003, J AEROSOL SCI, V34, P1175, DOI 10.1016/S0021-8502(03)00094-6
   Gera D, 1998, POWDER TECHNOL, V98, P38, DOI 10.1016/S0032-5910(98)00017-5
   Ghadiri M, 2002, CHEM ENG SCI, V57, P3659, DOI 10.1016/S0009-2509(02)00240-3
   Goula AM, 2004, DRY TECHNOL, V22, P1107, DOI 10.1081/drt-120038583
   HAN R, 2000, AAAR 2000 ST LOUIS M
   Han T, 2003, POWDER TECHNOL, V129, P92, DOI 10.1016/S0032-5910(02)00252-8
   Hemmingsson J, 1997, J PHYS I, V7, P291, DOI 10.1051/jp1:1997146
   Herbst JA, 2004, POWDER TECHNOL, V143, P144, DOI 10.1016/j.powtec.2004.04.036
   Hirshfeld D, 2001, EUR PHYS J E, V4, P193, DOI 10.1007/s101890170128
   Hrenya CM, 1997, AICHE J, V43, P853, DOI 10.1002/aic.690430402
   Huilin L., 2003, POWDER TECHNOL, V134, P86
   JACKSON R, 1982, THEORY DISPERSED MUL, P291
   JULLIEN R, 1992, PHYS REV LETT, V69, P640, DOI 10.1103/PhysRevLett.69.640
   Kafui KD, 2000, POWDER TECHNOL, V109, P113, DOI 10.1016/S0032-5910(99)00231-4
   KETTERHAGEN WR, 2005, AICHE ANN M CINC OH
   KETTERHAGEN WR, 2005, PHYS REV, V71, DOI UNSP 061307
   Khakhar DV, 1999, CHAOS, V9, P594, DOI 10.1063/1.166433
   Kleinstreuer C, 2003, J BIOMECH ENG-T ASME, V125, P197, DOI 10.1115/1.1543548
   Kozicki J, 2005, GRANUL MATTER, V7, P45, DOI 10.1007/s10035-004-0190-x
   Ktitarev DV, 1999, COMPUT PHYS COMMUN, V121, P303, DOI 10.1016/S0010-4655(99)00339-2
   Kuo HP, 2002, CHEM ENG SCI, V57, P3621, DOI 10.1016/S0009-2509(02)00086-6
   Kwapinska M, 2006, POWDER TECHNOL, V161, P69, DOI 10.1016/j.powtec.2005.08.038
   Langrish TAG, 2003, DRY TECHNOL, V21, P197, DOI 10.1081/DRT-120017743
   Langston PA, 2004, CHEM ENG SCI, V59, P425, DOI 10.1016/j.ces.2003.10.008
   Lasinski ME, 2004, PHYS FLUIDS, V16, P265, DOI 10.1063/1.1633264
   Li HM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021305
   MASTERS K, 1994, DRY TECHNOL, V12, P235, DOI 10.1080/07373939408959955
   MASTERS K, 1996, P 10 INT DRYING S ID, P52
   Matida EA, 2004, J AEROSOL SCI, V35, P823, DOI 10.1016/j.jaerosci.2004.01.003
   Moakher M, 2000, POWDER TECHNOL, V109, P58, DOI 10.1016/S0032-5910(99)00227-2
   Moreno R, 2003, POWDER TECHNOL, V130, P132, DOI 10.1016/S0032-5910(02)00256-5
   MORSE RD, 1951, CHEM ENG PROG, V47, P199
   Neil AU, 1999, POWDER TECHNOL, V106, P37, DOI 10.1016/S0032-5910(99)00064-9
   OAKLEY DE, 1991, DRYING 91, P303
   Papadopulos D.G., 1998, 3 WORLD C PART TECHN
   Potapov AV, 1996, PHYS FLUIDS, V8, P2884, DOI 10.1063/1.869069
   POTAPOV AV, 1994, POWDER TECHNOL, V81, P207, DOI 10.1016/0032-5910(94)02907-5
   Potapov AV, 1997, POWDER TECHNOL, V94, P109, DOI 10.1016/S0032-5910(97)03277-4
   ROSATO A, 1986, POWDER TECHNOL, V49, P59, DOI 10.1016/0032-5910(86)85005-7
   ROSATO AD, 1991, POWDER TECHNOL, V66, P149, DOI 10.1016/0032-5910(91)80096-2
   Rotter JM, 1998, PHILOS T R SOC A, V356, P2685
   Schafer J, 1996, J PHYS I, V6, P5, DOI 10.1051/jp1:1996129
   Shinbrot T, 2001, POWDER TECHNOL, V116, P224, DOI 10.1016/S0032-5910(00)00394-6
   Shishodia N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.084302
   SHISHODIA N, 2001, PHYS REV LETT, V88
   SOUTHWELL DB, 1999, P 1 AS AUSTR DRYING, P626
   Stewart RL, 2001, CHEM ENG SCI, V56, P5457, DOI 10.1016/S0009-2509(01)00190-7
   Sudah OS, 2005, AICHE J, V51, P836, DOI 10.1002/aic.10448
   TANAKA T, 1988, T IRON STEEL I JPN, V28, P907
   Thornton C, 1996, J PHYS D APPL PHYS, V29, P424, DOI 10.1088/0022-3727/29/2/021
   TING JM, 1993, INT J NUMER ANAL MET, V17, P603, DOI 10.1002/nag.1610170902
   Tsimring LS, 1999, PHYS REV E, V60, P7126, DOI 10.1103/PhysRevE.60.7126
   van der Hoef MA, 2004, CHEM ENG SCI, V59, P5157, DOI 10.1016/j.ces.2004.07.013
   vanWachem B.G., 2001, AICHE J, V47, P1291
   WALTON OR, 1986, J RHEOL, V30, P949, DOI 10.1122/1.549893
   WASSGREN CR, 2005, PHYS FLUIDS, V15, P3318
   Weber MW, 2004, GRANUL MATTER, V6, P239, DOI 10.1007/s10035-004-0179-5
   Yanagita T, 1999, PHYS REV LETT, V82, P3488, DOI 10.1103/PhysRevLett.82.3488
   Zhang Y, 2004, J AEROSOL SCI, V35, P789, DOI 10.1016/j.jaerosci.2003.12.006
NR 74
TC 12
Z9 12
U1 0
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2006
VL 31
IS 11
BP 900
EP 904
DI 10.1557/mrs2006.210
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 108FO
UT WOS:000242225900017
DA 2018-10-20
ER

PT J
AU Barrett, CR
AF Barrett, Craig R.
TI The digital evolution
SO MRS BULLETIN
LA English
DT Article
DE biomedical; education; laser microelectronics; photoconductivity;
   semiconducting; Si
AB The following article is an edited transcript based on the plenary address given by Craig R. Barrett, chair of the board of Intel Corp., on April 19, 2006, at the 2006 Materials Research Society Spring Meeting in San Francisco. Since before the industrial revolution, technology has changed lives, opportunities, and economies. Similarly, the digital evolution has touched nearly every aspect of modern life and is reshaping economies around the world. As more and more of the world's people engage in the digital economy, both competition and opportunities will grow. Competitiveness in the global economy will be determined by how people and nations position themselves in the digital evolution. What lies ahead for us in the next 10 years? What new technologies will alter the technology landscape? What are the opportunities going forward, and how do we prepare? How can materials research and development help us to move forward faster?
C1 Intel Corp, Santa Clara, CA 95051 USA.
RP Barrett, CR (reprint author), Intel Corp, Santa Clara, CA 95051 USA.
NR 0
TC 8
Z9 9
U1 0
U2 4
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD NOV
PY 2006
VL 31
IS 11
BP 906
EP 913
DI 10.1557/mrs2006.211
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 108FO
UT WOS:000242225900018
DA 2018-10-20
ER

PT J
AU Chiellini, E
   Corti, A
   D'Antone, S
   Baciu, R
AF Chiellini, E.
   Corti, A.
   D'Antone, S.
   Baciu, R.
TI Oxo-biodegradable carbon backbone polymers - Oxidative degradation of
   polyethylene under accelerated test conditions
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE polyethylene; thermal degradation; carbonyl index; oxidative cleavage;
   HT-GPC
ID THERMAL-OXIDATION; PROOXIDANT SYSTEM; POLYOLEFINS; STATE; FILMS;
   THERMOOXIDATION; PHOTOOXIDATION; REEXAMINATION; LDPE; TOOL
AB Oxo-biodegradation of carbon-only backbone polymers is receiving ever increasing attention for the practical implications that some reengineered thermoplastic polymer formulations based on conventional biostable polymeric materials may satisfy in terms of environmental friendliness and acceptance by commodity plastic manufacturers.
   In this respect, as part of our continuing activity in the area of bioactive polymeric materials for biomedical and environmental applications, we report the results of an investigation of the effects of different degradation conditions on the oxidative degradation of polyethylene (PE) film samples containing pro-oxidant additives and formulated according to a proprietary technology. The effects of temperature and relative humidity have been evaluated by monitoring, with time, several parameters associated to oxidation and cleavage of the macromolecules, such as the weight variation due to oxygen uptake, film wettability, carboryl index, molecular weight and the extractability with polar solvents of oxidized PE samples. (c) 2006 Published by Elsevier Ltd.
C1 Univ Pisa, Dept Chem & Ind Chem, I-56126 Pisa, Italy.
   Environm Plast Inc, Vancouver, BC V6J 1Y1, Canada.
RP Chiellini, E (reprint author), Univ Pisa, Dept Chem & Ind Chem, Via Risorgimento 35, I-56126 Pisa, Italy.
EM emochie@dcci.unipi.it
CR ALBERTSSON AC, 1995, POLYMER, V36, P3075, DOI 10.1016/0032-3861(95)97868-G
   ARNAUD R, 1994, POLYM DEGRAD STABIL, V46, P211, DOI 10.1016/0141-3910(94)90053-1
   Burman L, 2005, POLYM DEGRAD STABIL, V89, P50, DOI 10.1016/j.polymdegradstab.2005.01.002
   Chiellini E, 2003, POLYM DEGRAD STABIL, V81, P341, DOI 10.1016/S0141-3910(03)00105-8
   Chiellini E, 1999, POLYM DEGRAD STABIL, V64, P305, DOI 10.1016/S0141-3910(98)00206-7
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   CHIELLINI E, 2000, P ICS UNIDO C ENV DE, V1, P1
   CHIELLINI E, UNPUB PROG POLYM SCI
   Erlandsson B, 1997, POLYM DEGRAD STABIL, V55, P237, DOI 10.1016/S0141-3910(96)00139-5
   Gugumus F, 1996, POLYM DEGRAD STABIL, V52, P131, DOI 10.1016/0141-3910(95)00229-4
   Gugumus F, 2002, POLYM DEGRAD STABIL, V77, P147, DOI 10.1016/S0141-3910(02)00093-9
   Gugumus F, 2001, POLYM DEGRAD STABIL, V74, P327, DOI 10.1016/S0141-3910(01)00165-3
   Guillet J., 1973, POLYM ECOLOGICAL PRO
   HAINES JR, 1974, APPL MICROBIOL, V28, P1084
   HINSKEN H, 1991, POLYM DEGRAD STABIL, V34, P279, DOI 10.1016/0141-3910(91)90123-9
   IRING M, 1986, POLYM DEGRAD STABIL, V14, P319, DOI 10.1016/0141-3910(86)90036-4
   Karlsson S, 1997, MACROMOLECULES, V30, P7721, DOI 10.1021/ma961489c
   Kawai F, 1999, MACROMOL SYMP, V144, P73, DOI 10.1002/masy.19991440108
   Khabbaz F, 1999, POLYM DEGRAD STABIL, V63, P127, DOI 10.1016/S0141-3910(98)00082-2
   Khabbaz F, 2000, BIOMACROMOLECULES, V1, P665, DOI 10.1021/bm000050w
   LEE BT, 1991, APPL ENVIRON MICROB, V57, P678
   POTTS JE, 1972, POLYM PREPR, V13, P629
   Ragnarsson L, 2003, BIOMACROMOLECULES, V4, P900, DOI 10.1021/bm025752v
   Scott G, 2001, BIOMACROMOLECULES, V2, P615, DOI 10.1021/bm010099h
   SCOTT G, 1994, BIODGRADABLE PLASTIC
   Setnescu R, 1998, POLYM DEGRAD STABIL, V60, P377, DOI 10.1016/S0141-3910(97)00096-7
   VANOS G, 2001, EPF SPECIAL ISSUE, P19
   WEILAND M, 1994, POLYM DEGRAD STABIL, V45, P371, DOI 10.1016/0141-3910(94)90207-0
   Wiles DM, 2005, BIODEGRADABLE POLYM
   WINSLOW FH, 1977, PURE APPL CHEM, V49, P495, DOI 10.1351/pac197749040495
NR 30
TC 94
Z9 94
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD NOV
PY 2006
VL 91
IS 11
BP 2739
EP 2747
DI 10.1016/j.polymdegradstab.2006.03.022
PG 9
WC Polymer Science
SC Polymer Science
GA 097UK
UT WOS:000241474300024
DA 2018-10-20
ER

PT J
AU Olah, L
   Filipczak, K
   Jaegermann, Z
   Czigany, T
   Borbas, L
   Sosnowski, S
   Ulanski, P
   Rosiak, JM
AF Olah, Laszlo
   Filipczak, Katarzyna
   Jaegermann, Zbigniew
   Czigany, Tibor
   Borbas, Lajos
   Sosnowski, Stanislaw
   Ulanski, Piotr
   Rosiak, Janusz M.
TI Synthesis, structural and mechanical properties of porous polymeric
   scaffolds for bone tissue regeneration based on neat
   poly(epsilon-caprolactone) calcium carbonate
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 8th International Symposium on Polymers for Advanced Technologies
CY SEP 13-16, 2005
CL Budapest, HUNGARY
SP IUPAC, European Polymer Federat, Soc Polymer Sci Japan, Chem Soc Japan, Amer Chem Soc, Polymer & PMSE Div, Hungarian Acad Sci, Budapest Univ Technol & Econ
DE composites; biomaterials; mechanical properties; macroporous polymers;
   synthesis
ID BIOMEDICAL APPLICATIONS; COMPOSITES; IMPLANTS
AB The aim of the present study was to develop new materials which could be applicable as bone substitutes or be used in bone tissue engineering. Two types of porous scaffolds based on poly(epsilon-caprolactone) (PCL) were investigated. Type 1 scaffolds were prepared by solvent casting/particulate leaching technique, using NaCl with the grain size 250-500 mu m as a porogen. In the case of Type 2 scaffolds, the biodegradable polymer was blended with calcium carbonate, which, in contrast to NaCl, is not leached out from the product during manufacture, either in the form of calcite powder or aragonite (needle-like crystals). Influence of manufacturing technique and initial substrate composition on product properties was investigated. The tests involved porosity measurements, structure analysis by optical and scanning electron microscopy and mechanical studies (determination of compression strength and modulus). The results indicate the important role of the phase exchange process in the formation of micropores. In this process PCL precipitated from its acetone solution in the presence of water creating microporous three-dimensional polymer structures. The Type 1 scaffolds possessed both micropores and macropores. Good interconnectivity between the pores was observed for samples of the initial porogen content higher than 33%. Microporous samples containing inorganic filler have lower porosity and higher compression strength. For Type 2 scaffolds the shape of filler particles has an important influence on mechanical properties-replacing powder with needle-like crystals (in the same weight amount) results in a three- to five-fold increase in compression modulus. (c) 2006 John Wiley & Sons, Ltd.
C1 Budapest Univ Technol & Econ, Dept Polymer Engn, H-1111 Budapest, Hungary.
   Budapest Univ Technol & Econ, Ctr Biomech Studies, H-1111 Budapest, Hungary.
   Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
   Inst Glass & Ceram, PL-02676 Warsaw, Poland.
   Polish Acad Sci, Ctr Mol & Macromol Studies, PL-90363 Lodz, Poland.
RP Olah, L (reprint author), Budapest Univ Technol & Econ, Dept Polymer Engn, Muegyetem Rkp 3, H-1111 Budapest, Hungary.
EM olah@pt.bme.hu
RI Ulanski, Piotr/S-9103-2018; Olah, Laszlo/E-7250-2011; Czigany,
   Tibor/A-5301-2008
OI Ulanski, Piotr/0000-0002-4310-3574; Czigany, Tibor/0000-0002-5138-0141
CR Bronzino J D, 2000, BIOMEDICAL ENG HDB
   Calandrelli L, 2004, J BIOACT COMPAT POL, V19, P301, DOI 10.1177/0883911504045234
   Chawla KK, 2001, COMPOSITE MAT SCI EN
   FILIPCZAK K, 2005, E POLYMERS
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Gachter R., 1990, PLASTICS ADDITIVES H
   GOLDBERG VM, 2004, ORTHOPEDIC TISSUE EN
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   KWEON HY, 2001, BIOMATERIALS, V24, P801
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Lieberman J. R., 2005, BONE REGENERATION RE
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rieu J., 1993, Clinical Materials, V12, P211, DOI 10.1016/0267-6605(93)90075-I
   Schiller C, 2004, BIOMATERIALS, V25, P1239, DOI 10.1016/j.biomaterials.2003.08.047
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Ural E, 2000, BIOMATERIALS, V21, P2147, DOI 10.1016/S0142-9612(00)00098-3
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Walsh WR, 2003, J ORTHOP RES, V21, P655, DOI 10.1016/S0736-0266(03)00012-3
NR 19
TC 20
Z9 20
U1 3
U2 15
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD NOV-DEC
PY 2006
VL 17
IS 11-12
BP 889
EP 897
DI 10.1002/pat.768
PG 9
WC Polymer Science
SC Polymer Science
GA 123OH
UT WOS:000243304700011
DA 2018-10-20
ER

PT J
AU Fan, JY
   Wu, XL
   Chu, PK
AF Fan, J. Y.
   Wu, X. L.
   Chu, Paul K.
TI Low-dimensional SiC nanostructures: Fabrication, luminescence, and
   electrical properties
SO PROGRESS IN MATERIALS SCIENCE
LA English
DT Review
ID CHEMICAL-VAPOR-DEPOSITION; POROUS SILICON-CARBIDE; FIELD-EMISSION
   PROPERTIES; LIGHT-INDUCED LUMINESCENCE; HIGH-TENSILE STRENGTH;
   C+-IMPLANTED SILICON; SIO2 GLASS-FILMS; VISIBLE PHOTOLUMINESCENCE;
   OPTICAL CHARACTERIZATION; LOW-TEMPERATURE
AB Nanostructured silicon carbide has unique properties that make it useful in microelectronics, optoelectronics, and biomedical engineering. In this paper, the fabrication methods as well as optical and electrical characteristics of silicon carbide nanocrystals, nanowires, nanotubes, and nanosized films are reviewed. Silicon carbide nanocrystals are generally produced using two techniques, electrochemical etching of bulk materials to form porous SiC or embedding SiC crystallites in a matrix such as Si. Luminescence from SiC crystallites prepared by these two methods is generally believed to stem from surface or defect states. Stable colloidal 3C-SiC nanocrystals which exhibit intense visible photoluminescence arising from the quantum confinement effects have recently be produced. The field electron emission and photoluminescence characteristics of silicon carbide nanostructures as well as theoretical studies of the structural and electronic properties of the materials are described. (C) 2006 Elsevier Ltd. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China.
   Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China.
RP Wu, XL (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM hkxlwu@nju.edu.cn; paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; Wu, Xinglong/0000-0002-2787-3069; Fan,
   Jiyang/0000-0003-1894-036X
CR An ZH, 2003, J VAC SCI TECHNOL B, V21, P1375, DOI 10.1116/1.1591741
   Appell D, 2002, NATURE, V419, P553, DOI 10.1038/419553a
   Bailey RE, 2004, PHYSICA E, V25, P1, DOI 10.1016/j.physe.2004.07.013
   Belomoin G, 2002, APPL PHYS LETT, V80, P841, DOI 10.1063/1.1435802
   BORDERS JA, 1971, APPL PHYS LETT, V18, P509, DOI 10.1063/1.1653516
   Borowiak-Palen E, 2005, J APPL PHYS, V97, DOI 10.1063/1.1853493
   Boucle J, 2005, OPT COMMUN, V246, P415, DOI 10.1016/j.optcom.2004.11.004
   Brillson LJ, 2004, J PHYS-CONDENS MAT, V16, pS1733, DOI 10.1088/0953-8984/16/17/015
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   BRUS LE, 1983, J CHEM PHYS, V79, P5566, DOI 10.1063/1.445676
   BRUS LE, 1995, J AM CHEM SOC, V117, P2915, DOI 10.1021/ja00115a025
   Buschmann V, 1998, J CRYST GROWTH, V193, P335, DOI 10.1016/S0022-0248(98)00537-5
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   CANHAM LT, 1994, NATURE, V368, P133, DOI 10.1038/368133a0
   CARRABBA MM, 1989, EL SOC EXT ABSTR, V89, P727
   Carter GE, 2000, MATER SCI FORUM, V338-3, P1149, DOI 10.4028/www.scientific.net/MSF.338-342.1149
   CAUCHETIER M, 1988, ADV CERAM MATER, V3, P548
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chen D, 1995, SURF SCI, V344, P23, DOI 10.1016/0039-6028(95)00840-3
   Chen DH, 2003, OPT MATER, V23, P65, DOI 10.1016/S0925-3467(03)00061-2
   Chen ZM, 2000, MAT SCI ENG B-SOLID, V75, P180, DOI 10.1016/S0921-5107(00)00358-5
   Choi HJ, 2004, J CRYST GROWTH, V269, P472, DOI 10.1016/j.jcrysgro.2004.05.094
   CHOYKE WJ, 1970, PHYS REV B, V2, P4959, DOI 10.1103/PhysRevB.2.4959
   CHOYKE WJ, 1988, J APPL PHYS, V64, P3163, DOI 10.1063/1.341532
   Cicero G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.016102
   Cullis AG, 1997, J APPL PHYS, V82, P909, DOI 10.1063/1.366536
   DAI HJ, 1995, NATURE, V375, P769, DOI 10.1038/375769a0
   Danishevskii AM, 1998, SEMICOND SCI TECH, V13, P1111, DOI 10.1088/0268-1242/13/10/010
   Danishevskii AM, 1997, SEMICONDUCTORS+, V31, P354, DOI 10.1134/1.1187162
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   Derycke V, 2003, NAT MATER, V2, P253, DOI 10.1038/nmat835
   Devaty RP, 1997, PHYS STATUS SOLIDI A, V162, P5, DOI 10.1002/1521-396X(199707)162:1<5::AID-PSSA5>3.0.CO;2-J
   DIMARIA DJ, 1984, J APPL PHYS, V56, P401, DOI 10.1063/1.333979
   EFROS AL, 1982, SOV PHYS SEMICOND+, V16, P772
   Fan JY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1914962
   Feng DH, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035334
   Feng DH, 2003, SOLID STATE COMMUN, V128, P295, DOI 10.1016/j.ssc.2003.08.025
   FOJTIK A, 1987, CHEM PHYS LETT, V134, P477, DOI 10.1016/0009-2614(87)87176-2
   Fu ZP, 2002, J MATER RES, V17, P570, DOI 10.1557/JMR.2002.0080
   Gao YH, 1997, J MATER RES, V12, P1640, DOI 10.1557/JMR.1997.0224
   Gundiah G, 2002, J MATER CHEM, V12, P1606, DOI 10.1039/b200161f
   Guo YP, 2001, CHEM PHYS LETT, V339, P319, DOI 10.1016/S0009-2614(01)00308-6
   GUPTA P, 1988, PHYS REV B, V37, P8234, DOI 10.1103/PhysRevB.37.8234
   HAMZA AV, 1994, SURF SCI, V317, pL1129, DOI 10.1016/0039-6028(94)90279-8
   Han WQ, 1997, CHEM PHYS LETT, V265, P374, DOI 10.1016/S0009-2614(96)01441-8
   Harris CI, 2001, APPL SURF SCI, V184, P393, DOI 10.1016/S0169-4332(01)00525-6
   Hassen F, 2001, MAT SCI ENG C-BIO S, V15, P113, DOI 10.1016/S0928-4931(01)00252-1
   Heera V, 2000, APPL PHYS LETT, V77, P226, DOI 10.1063/1.126932
   HEINRICH JL, 1992, SCIENCE, V255, P66, DOI 10.1126/science.255.5040.66
   HENKE S, 1995, J APPL PHYS, V78, P2070, DOI 10.1063/1.360184
   Ho GW, 2004, NANOTECHNOLOGY, V15, P996, DOI 10.1088/0957-4484/15/8/023
   Hu JQ, 2000, J PHYS CHEM B, V104, P5251, DOI 10.1021/jp000124y
   IKEDA M, 1980, PHYS REV B, V22, P2842, DOI 10.1103/PhysRevB.22.2842
   *INT CTR DIFFR DAT, 1982, 291129 JCPDS INT CTR
   ITO T, 1991, PHYSICA B, V170, P535, DOI 10.1016/0921-4526(91)90172-B
   JENNINGS VJ, 1969, MAT RES B, V4, P199
   Jessensky O, 1997, THIN SOLID FILMS, V297, P224, DOI 10.1016/S0040-6090(96)09419-9
   Kassiba A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155317
   Kato M, 2003, JPN J APPL PHYS 1, V42, P4233, DOI 10.1143/JJAP.42.4233
   Kim HY, 2003, CHEM COMMUN, P256, DOI 10.1039/b210027d
   Kim K, 1996, APPL PHYS LETT, V69, P3908, DOI 10.1063/1.117566
   Kim S, 2000, JPN J APPL PHYS 1, V39, P5875, DOI 10.1143/JJAP.39.5875
   KOCH F, 1993, J LUMIN, V57, P271, DOI 10.1016/0022-2313(93)90145-D
   KONSTANTINOV AO, 1994, APPL PHYS LETT, V65, P2699, DOI 10.1063/1.112610
   KONSTANTINOV AO, 1995, APPL PHYS LETT, V66, P2250, DOI 10.1063/1.113182
   Lai HL, 2000, APPL PHYS LETT, V76, P294, DOI 10.1063/1.125636
   Ledoux G, 2002, APPL PHYS LETT, V80, P4834, DOI 10.1063/1.1485302
   Lee KH, 2000, B KOR CHEM SOC, V21, P769
   LEHMANN V, 1990, J ELECTROCHEM SOC, V137, P653, DOI 10.1149/1.2086525
   LEHMANN V, 1991, APPL PHYS LETT, V58, P856, DOI 10.1063/1.104512
   Li XT, 2001, MATER LETT, V48, P242, DOI 10.1016/S0167-577X(00)00310-4
   Li YB, 2002, CHEM PHYS LETT, V356, P325
   Liang CH, 2000, CHEM PHYS LETT, V329, P323, DOI 10.1016/S0009-2614(00)01023-X
   LIAO LS, 1995, APPL PHYS LETT, V66, P2382, DOI 10.1063/1.113990
   Liu JW, 2001, CHEM PHYS LETT, V348, P357, DOI 10.1016/S0009-2614(01)01113-7
   Liu RC, 1998, SOLID STATE COMMUN, V106, P211, DOI 10.1016/S0038-1098(98)00005-2
   LOCKWOOD DJ, 1992, CAN J PHYS, V70, P1184, DOI 10.1139/p92-191
   Lu QY, 1999, APPL PHYS LETT, V75, P507, DOI 10.1063/1.124431
   Madelung O., 2004, SEMICONDUCTORS DATA
   MAKAROV VV, 1972, SOV PHYS-SOLID STATE, V13, P1774
   Masri P, 2002, SURF SCI REP, V48, P1, DOI 10.1016/S0167-5729(02)00099-7
   Masuda H, 1997, APPL PHYS LETT, V71, P2770, DOI 10.1063/1.120128
   MATSUMOTO T, 1994, APPL PHYS LETT, V64, P226, DOI 10.1063/1.111979
   McIlroy DN, 2001, APPL PHYS LETT, V79, P1540, DOI 10.1063/1.1400079
   Meng GW, 1998, SOLID STATE COMMUN, V106, P215, DOI 10.1016/S0038-1098(98)00018-0
   MORKOC H, 1994, J APPL PHYS, V76, P1363, DOI 10.1063/1.358463
   Moro L, 1997, J APPL PHYS, V81, P6141, DOI 10.1063/1.364395
   Nakamura D, 2004, NATURE, V430, P1009, DOI 10.1038/nature02810
   Nychyporuk T, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115402
   OKADA K, 1993, Patent No. 60388
   OSAKA Y, 1992, JPN J APPL PHYS 2, V31, pL365, DOI 10.1143/JJAP.31.L365
   Palmour J. W., 1987, Science and Technology of Microfabrication Symposium, P185
   Pan ZW, 2000, ADV MATER, V12, P1186, DOI 10.1002/1521-4095(200008)12:16<1186::AID-ADMA1186>3.0.CO;2-F
   PARKHUIK VP, 1997, THIN SOLID FILMS, V279, P229
   PATRICK L, 1969, MATER RES B S, V4, P129
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Perez-Rodriguez A, 2003, J APPL PHYS, V94, P254, DOI 10.1063/1.1578172
   PETROVAKOCH V, 1995, THIN SOLID FILMS, V255, P107, DOI 10.1016/0040-6090(94)05632-N
   Puzder A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157405
   Rajagopalan T, 2003, J APPL PHYS, V94, P5252, DOI 10.1063/1.1609631
   Reboredo FA, 2004, NANO LETT, V4, P801, DOI 10.1021/nl049876k
   REGOHLE L, 2001, APPL SURF SCI, V184, P156
   RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550
   Rittenhouse TL, 2004, J APPL PHYS, V95, P490, DOI 10.1063/1.1634369
   Rittenhouse TL, 2003, SOLID STATE COMMUN, V126, P245, DOI [10.1016/S0038-1098(03)00130-3, 10.1016/s0038-1098(03)00130-3]
   Rozhin AG, 2002, MAT SCI ENG C-BIO S, V19, P229, DOI 10.1016/S0928-4931(01)00473-8
   Rurali R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205405
   Seeger T, 2000, ADV MATER, V12, P279, DOI 10.1002/(SICI)1521-4095(200002)12:4<279::AID-ADMA279>3.0.CO;2-1
   Shen GZ, 2003, CHEM PHYS LETT, V375, P177, DOI 10.1016/S0009-2614(03)00877-7
   Shi WS, 2000, J AM CERAM SOC, V83, P3228, DOI 10.1111/j.1151-2916.2000.tb01714.x
   Shim HW, 1997, APPL PHYS LETT, V70, P1757, DOI 10.1063/1.118648
   Shishkin Y, 2005, J APPL PHYS, V97, DOI 10.1063/1.1849432
   Shishkin Y, 2004, J APPL PHYS, V96, P2311, DOI 10.1063/1.1768612
   SHOR JS, 1993, APPL PHYS LETT, V62, P2836, DOI 10.1063/1.109226
   SHOR JS, 1994, J APPL PHYS, V76, P4045, DOI 10.1063/1.357352
   SHOR JS, 1992, J ELECTROCHEM SOC, V139, P1213, DOI 10.1149/1.2069369
   SHOR JS, 1992, APPL PHYS LETT, V60, P1001, DOI 10.1063/1.106502
   SMITH RL, 1992, J APPL PHYS, V71, pR1, DOI 10.1063/1.350839
   Song HZ, 1998, APPL PHYS LETT, V72, P356, DOI 10.1063/1.120735
   Soukiassian P, 2002, MAT SCI ENG B-SOLID, V96, P115, DOI 10.1016/S0921-5107(02)00302-1
   Starke U, 1997, PHYS STATUS SOLIDI B, V202, P475, DOI 10.1002/1521-3951(199707)202:1<475::AID-PSSB475>3.0.CO;2-E
   Sun XH, 2002, J AM CHEM SOC, V124, P14464, DOI 10.1021/ja0273997
   TAHUCHI T, 2005, J AM CERAM SOC, V88, P459
   TAKAGI H, 1990, APPL PHYS LETT, V56, P2379, DOI 10.1063/1.102921
   TAKAZAWA A, 1993, JPN J APPL PHYS 1, V32, P3148, DOI 10.1143/JJAP.32.3148
   Torchynska TV, 2005, MICROELECTRON J, V36, P536, DOI 10.1016/j.mejo.2005.02.116
   WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975
   Wang CH, 2005, ADV MATER, V17, P419, DOI 10.1002/adma.200400939
   Wang JN, 1999, APPL PHYS LETT, V74, P923, DOI 10.1063/1.123411
   WEINBERG ZA, 1979, PHYS REV B, V19, P3107, DOI 10.1103/PhysRevB.19.3107
   Weishart H, 2005, J APPL PHYS, V98, DOI 10.1063/1.2009073
   Williamson AJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196803
   WOLF JP, 1982, PHYSICS TODAY    MAR, P46
   Wolkin MV, 1999, PHYS REV LETT, V82, P197, DOI 10.1103/PhysRevLett.82.197
   Wong KW, 1999, APPL PHYS LETT, V75, P2918, DOI 10.1063/1.125189
   Wu XL, 2000, APPL PHYS LETT, V77, P1292, DOI 10.1063/1.1290153
   Wu XL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026102
   Wu XL, 2000, PHYS REV B, V62, pR7759, DOI 10.1103/PhysRevB.62.R7759
   Wu ZS, 2002, APPL PHYS LETT, V80, P3829, DOI 10.1063/1.1476703
   Xie EQ, 2003, OPT MATER, V23, P157, DOI 10.1016/S0925-3467(03)00078-8
   Xu J, 2005, SOLID STATE COMMUN, V133, P565, DOI 10.1016/j.ssc.2004.12.036
   Xu SJ, 2000, APPL PHYS LETT, V76, P2550, DOI 10.1063/1.126382
   YAJIMA S, 1976, NATURE, V261, P683, DOI 10.1038/261683a0
   YAJIMA S, 1975, CHEM LETT, P931, DOI 10.1246/cl.1975.931
   YAMAMOTO M, 1991, JPN J APPL PHYS 1, V30, P136, DOI 10.1143/JJAP.30.136
   Yang TH, 2003, CHEM PHYS LETT, V379, P155, DOI 10.1016/j.cplett.2003.08.001
   Yang WY, 2004, CHEM PHYS LETT, V383, P441, DOI 10.1016/j.cplett.2003.11.031
   Yu MB, 2000, J APPL PHYS, V87, P8155, DOI 10.1063/1.373511
   Yu MB, 2000, THIN SOLID FILMS, V377, P177, DOI 10.1016/S0040-6090(00)01426-7
   Yu YH, 1998, PHYS STATUS SOLIDI A, V168, P531, DOI 10.1002/(SICI)1521-396X(199808)168:2<531::AID-PSSA531>3.0.CO;2-V
   Zangooie S, 2000, J MATER RES, V15, P1860, DOI 10.1557/JMR.2000.0268
   Zhang DQ, 2003, NANO LETT, V3, P983, DOI 10.1021/nl034288c
   Zhang HT, 2004, THIN SOLID FILMS, V446, P99, DOI 10.1016/S0040-6090(03)00815-0
   Zhang Y, 1999, SCIENCE, V285, P1719, DOI 10.1126/science.285.5434.1719
   Zhang YF, 2002, J APPL PHYS, V91, P6066, DOI 10.1063/1.1468278
   Zhang Z, 1998, MICROSC RES TECHNIQ, V40, P163, DOI 10.1002/(SICI)1097-0029(19980201)40:3<163::AID-JEMT1>3.3.CO;2-H
   Zhao J, 1998, APPL PHYS LETT, V73, P1838, DOI 10.1063/1.122299
   ZHOU D, 1994, CHEM PHYS LETT, V222, P233, DOI 10.1016/0009-2614(94)00342-4
   Zhou XT, 1999, APPL PHYS LETT, V74, P3942, DOI 10.1063/1.124231
   Zhou XT, 2000, CHEM PHYS LETT, V318, P58, DOI 10.1016/S0009-2614(99)01398-6
NR 160
TC 247
Z9 254
U1 5
U2 184
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6425
EI 1873-2208
J9 PROG MATER SCI
JI Prog. Mater. Sci.
PD NOV
PY 2006
VL 51
IS 8
BP 983
EP 1031
DI 10.1016/j.pmatsci.2006.02.001
PG 49
WC Materials Science, Multidisciplinary
SC Materials Science
GA 100AE
UT WOS:000241638600001
DA 2018-10-20
ER

PT J
AU Teng, YD
   Liao, WL
   Choi, H
   Konya, D
   Sabbarwal, S
   Langer, R
   Sidman, RL
   Synder, EY
   Frontera, WR
AF Teng, Yang D.
   Liao, Wei-Lee
   Choi, Howard
   Konya, Deniz
   Sabbarwal, Sunil
   Langer, Robert
   Sidman, Richard L.
   Synder, Evan Y.
   Frontera, Walter R.
TI Physical activity-mediated functional recovery after spinal cord injury:
   potential roles of neural stem cells
SO REGENERATIVE MEDICINE
LA English
DT Review
DE neural plasticity; neural stem cell; physical activity; regenerative;
   medicine; rehabilitation; spinal cord injury
ID CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; SUBVENTRICULAR ZONE; DENTATE GYRUS;
   ENVIRONMENTAL ENRICHMENT; STEM/PROGENITOR CELLS; FACTOR EXPRESSION;
   PROGENITOR CELLS; PRECURSOR CELLS; IN-VIVO
AB As data elucidating the complexity of spinal cord injury pathophysiology emerge, it is increasingly being recognized that successful repair will probably require a multifaceted approach that combines tactics from various biomedical disciplines, including pharmacology, cell transplantation, gene therapy and material sciences. Recently, new evidence highlighting the benefit of physical activity and rehabilitation interventions during the post-injury phase has provided novel possibilities in realizing effective repair after spinal cord injury. However, before a comprehensive therapeutic strategy that optimally utilizes the benefits of each of these disciplines can be designed, the basic mechanisms by which these various interventions act must be thoroughly explored and important synergistic and antagonistic interactions identified. In examining the mechanisms by which physical activity-based functional recovery after spinal cord injury is effected, enclogenous neural stem cells, in our opinion, engender a potentially key role. Multipotent neural stem cells possess many faculties that abet recovery, including the ability to assess the local microenvironment and deliver biofactors that promote neuroplasticity and regeneration, as well as the potential to replenish damaged or eradicated cellular elements. Encouragingly, the functional recovery owing to physical activity-based therapies appears relatively robust, even when therapy is initiated in the chronic stage of spinal cord injury. In this article, we review experimental outcomes related to our hypothesis that enclogenous neural stem cells mediate the functional recovery noted in spinal cord injury following physical activity-based treatments. Overall, the data advocates the incorporation of increased physical activity as a component of the multidimensional treatment of spinal cord injury and underscores the critical need to employ research-based mechanistic approaches for developing future advances in the rehabilitation of neurological injury and disorders.
C1 Harvard Univ, Brigham & Womens Hosp, Dept Neurosurg, Sch Med, Boston, MA 02115 USA.
   Childrens Hosp, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02114 USA.
   VA Boston Healthcare Syst, SGI Res & SCI Serv, Roxbury, MA 02132 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.
   Burnham Inst, Stem Cell Program, La Jolla, CA 92037 USA.
RP Teng, YD (reprint author), Harvard Univ, Brigham & Womens Hosp, Dept Neurosurg, Sch Med, Boston, MA 02115 USA.
EM yang_teng@hms.harvard.edu
FU NINDS NIH HHS [R21 NS053935-01A1, R21 NS053935]
CR ADRIAN EK, 1962, J NEUROPATH EXP NEUR, V21, P597, DOI 10.1097/00005072-196210000-00007
   Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Barbeau H, 1999, ARCH PHYS MED REHAB, V80, P225, DOI 10.1016/S0003-9993(99)90126-0
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915
   Behrman A L, 2000, Phys Ther, V80, P688
   Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2
   Bolshakov KV, 2003, J NEUROCHEM, V87, P56, DOI 10.1046/j.1471-4159.2003.01956.x
   Bregman BS, 2002, PROG BRAIN RES, V137, P257
   Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x
   Calza L, 1998, P NATL ACAD SCI USA, V95, P3209, DOI 10.1073/pnas.95.6.3209
   Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005
   CAO QL, 2004, EXP NEUROL, V177, P349
   Choi H, 2005, J NEUROSCI, V25, P4550, DOI 10.1523/JNEUROSCI.5135-04.2005
   Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100
   Danzer SC, 2004, HIPPOCAMPUS, V14, P345, DOI 10.1002/hipo.10190
   de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329
   Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308
   Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x
   Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473
   FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453
   Frontera WR, 2006, ARCH PHYS MED REHAB, V87, P148, DOI 10.1016/j.apmr.2005.10.021
   Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002
   Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002
   Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002
   GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245
   Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451
   Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3
   Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992
   Ikeda O, 2001, ACTA NEUROPATHOL, V102, P239
   Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924
   Johansson CB, 2003, J CELL PHYSIOL, V196, P409, DOI 10.1002/jcp.10293
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   JOYNES RL, 1999, SOC NEUROSCI
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0
   Kempermann G, 2000, Prog Brain Res, V127, P35
   Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262
   KRECH D, 1960, J COMP PHYSIOL PSYCH, V53, P509, DOI 10.1037/h0045402
   Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028
   Lai K, 2003, NAT NEUROSCI, V6, P645, DOI 10.1038/nn0603-645
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   LIAO WL, 2006, SOC NEUR ANN M 2006
   LIE DC, 2002, J NEUROSCI, V22, P6634
   Magavi SS, 2000, NATURE, V405, P951
   Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004
   MATTHEWS MA, 1979, ACTA NEUROPATHOL, V45, P27, DOI 10.1007/BF00691801
   McDonald JW, 2002, J NEUROSURG, V97, P252, DOI 10.3171/spi.2002.97.2.0252
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005
   Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011
   Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0
   Ohlsson M, 2004, J NEURO-OPHTHALMOL, V24, P11, DOI 10.1097/00041327-200403000-00003
   Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552
   Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1007/BF03206629
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Roy RR, 1999, MUSCLE NERVE, V22, P230, DOI 10.1002/(SICI)1097-4598(199902)22:2<230::AID-MUS11>3.0.CO;2-R
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Setoguchi T, 2004, EXP NEUROL, V189, P33, DOI 10.1016/j.expneurol.2003.12.007
   Shihabuddin LS, 2000, J NEUROSCI, V20, P8727
   Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697
   Shihabuddin LS, 1999, MOL MED TODAY, V5, P474, DOI 10.1016/S1357-4310(99)01596-8
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292
   Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185
   Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TENG YD, 2006, IN PRESS PRINCIPLES
   Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580
   Van Meeteren NLU, 2003, J NEUROTRAUM, V20, P1029, DOI 10.1089/089771503770195876
   van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427
   van Praag H, 1999, NAT NEUROSCI, V2, P266
   van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Wirz M, 2001, J NEUROL NEUROSUR PS, V71, P93, DOI 10.1136/jnnp.71.1.93
   Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798
   Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001
   Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X
   YU D, 2005, SOC NEUR ANN M 2005
   Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3
NR 90
TC 26
Z9 28
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD NOV
PY 2006
VL 1
IS 6
BP 763
EP 776
DI 10.2217/17460751.1.6.763
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 142UL
UT WOS:000244675600010
PM 17465758
DA 2018-10-20
ER

PT J
AU Cheng, Y
   Zheng, YF
AF Cheng, Y.
   Zheng, Y. F.
TI Formation of TiN films on biomedical NiTi shape memory alloy by PIIID
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE TiN film; NiTi alloy; shape memory alloy; plasma immersion ion
   implantation and deposition
ID IMMERSION ION-IMPLANTATION; CORROSION BEHAVIOR; TITANIUM; DEPOSITION;
   COATINGS; WEAR; PERFORMANCE; PACVD
AB TiN coatings with the characteristics of excellent corrosion and wear resistance, high hardness and good biocompatibility, have received much attention in biomedical applications. Plasma immersion ion implantation and deposition (PHID) is a novel method that can not only ensure excellent bonding between the coating and underlying material, but also overcome the line-in-sight shortcoming. The aim of the present study is to deposit TiN coatings on the surface of Ti-50.6 at.% Ni alloy by the advanced PIIID method to improve the wear resistance and hardness of a NiTi alloy surface.
   Two process parameters, i.e. voltage, and flows of Ar and N-2 were varied in the present experiments. The chemical composition, mechanical and corrosion resistance properties of the samples were investigated using XPS, nanoindentation and electrochemical method. The XPS results showed that the flows of Ar and N2 had a great influence on the composition of the TiN films. The hardness and elastic modulus of the TiN films increased with an increase of pulse bias voltage and reached a maximum value for films deposited at -20 kV when the flow rate ratio of Ar to N2 was 2/1. The experimental results revealed that the film preparation parameters directly affected the microstructure of the TiN, and thus influenced the mechanical and corrosion properties of the NiTi alloy, open circuit potential (OCP) values of the specimens increased with the negative pulse bias voltage and reached its maximum value when the flow rate of Ar/N-2 was 2/1. Combined with the results of Tafel and anodic polarization curves, an excellent corrosion resistant TiN coating by PIIID technique could be obtained by varying the process parameters. (c) 2006 Elsevier B.V. All rights reserved.
C1 Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Wagner, Martin/A-6880-2008
OI Zheng, Yufeng/0000-0002-7402-9979; 
CR Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   Chen JY, 2000, MATER CHEM PHYS, V65, P310, DOI 10.1016/S0254-0584(00)00255-8
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Huber P, 2003, SURF COAT TECH, V174, P1243, DOI 10.1016/S0257-8972(03)00458-4
   Hubler R, 2001, SURF COAT TECH, V142, P1078, DOI 10.1016/S0257-8972(01)01321-4
   HUBLER R, 2000, SURF COAT TECH, V158, P680
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Li XD, 2002, MATER CHARACT, V48, P11
   Lin HC, 1997, SURF COAT TECH, V92, P178, DOI 10.1016/S0257-8972(97)00105-9
   Liu C, 2003, SURF COAT TECH, V163, P597, DOI 10.1016/S0257-8972(02)00630-8
   Lu FH, 2000, SURF COAT TECH, V130, P290, DOI 10.1016/S0257-8972(00)00710-6
   Mogensen KS, 1998, SURF COAT TECH, V99, P140, DOI 10.1016/S0257-8972(97)00420-9
   Park J, 2003, THIN SOLID FILMS, V435, P102, DOI 10.1016/S0040-6090(03)00412-7
   Piscanec S, 2004, ACTA MATER, V52, P1237, DOI 10.1016/j.actamat.2003.11.020
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   RAWDANOWICZ TA, 1999, COMPOSITES B, P657
   Ren CS, 2004, SURF COAT TECH, V185, P210, DOI 10.1016/j.surfcoat.2003.12.030
   Rocher P, 2004, SCRIPTA MATER, V50, P255, DOI 10.1016/j.scriptamat.2003.09.028
   RYHANEN E, 1997, J BIOMED MATER RES, V35, P451
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Tsyganov I, 2004, APPL SURF SCI, V235, P156, DOI 10.1016/j.apsusc.2004.05.134
   Wu SK, 1999, SURF COAT TECH, V113, P17, DOI 10.1016/S0257-8972(98)00811-1
NR 23
TC 11
Z9 11
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD OCT 25
PY 2006
VL 434
IS 1-2
BP 99
EP 104
DI 10.1016/j.msea.200607.057
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 089QU
UT WOS:000240896400016
DA 2018-10-20
ER

PT J
AU Yu, YB
   Piddington, C
   Fitzpatrick, D
   Twomey, B
   Xu, R
   Swanson, SJ
   Jing, SQ
AF Yu, Yanbin
   Piddington, Christopher
   Fitzpatrick, Dan
   Twomey, Brian
   Xu, Ren
   Swanson, Steven J.
   Jing, Shuqian
TI A novel method for detecting neutralizing antibodies against therapeutic
   proteins by measuring gene expression
SO JOURNAL OF IMMUNOLOGICAL METHODS
LA English
DT Article
DE bioassay; mRNA profiling; nonradioactive method; PIM-1 expression
ID RECOMBINANT-HUMAN-ERYTHROPOIETIN; VIRUS TYPE-1 RNA; SIGNAL-TRANSDUCTION;
   GROWTH; PROLIFERATION; ACTIVATION; SURVIVAL; 3-KINASE; KINASES; TISSUE
AB The presence of neutralizing antibodies against protein therapeutics is a concern in the biomedical field. Such antibodies not only reduce the efficacy of protein therapeutics, but also impose potential dangers to the patients receiving them. To date, a small number of in vitro cell-based bioassays for detecting neutralizing antibodies against therapeutic proteins have been developed. Most of the existing assays, however, either involve the use of radioactive materials or have limited sensitivities and/or poor specificities. With advances in mRNA profiling and detection techniques, we have established a novel and non-radioactive bioassay system using branched DNA (bDNA) technology for detecting protein-therapeutic neutralizing antibodies in patient serum. Our assay measures the variations of target gene expression that reflect the biologic effect of the therapeutic agent and the capability of the antibodies, if present, to neutralize the therapeutics. Compared with most existing assays, the new assay is more sensitive and specific, and completely eliminates the use of radioactive materials. Application of the new assay system can be widely expanded if new target genes and responding cell lines for other therapeutics are identified or engineered. (c) 2006 Elsevier B.V. All rights reserved.
C1 Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA.
   Amgen Inc, Dept Funct Genom, Thousand Oaks, CA 91320 USA.
RP Swanson, SJ (reprint author), Amgen Inc, Dept Clin Immunol, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.
EM swanson@amgen.com; sjing@amgen.com
CR Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0
   Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931
   Dhanasekaran N, 1998, ONCOGENE, V17, P1329, DOI 10.1038/sj.onc.1202170
   EghbaliFatourechi G, 1996, ENDOCRINOLOGY, V137, P1894, DOI 10.1210/en.137.5.1894
   Eisen MB, 1999, METHOD ENZYMOL, V303, P179
   Elbeik T, 2000, J CLIN MICROBIOL, V38, P1113
   IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0
   Kenny D, 2002, J HISTOCHEM CYTOCHEM, V50, P1219, DOI 10.1177/002215540205000909
   KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6
   KOMATSU N, 1991, CANCER RES, V51, P341
   KUMENACKER JS, 2001, J NEUROIMMUNOL, V133, P249
   MEEKER TC, 1987, J CELL BIOCHEM, V35, P105, DOI 10.1002/jcb.240350204
   Mire-Sluis AR, 2001, PHARMACEUT RES, V18, P1239, DOI 10.1023/A:1013067424248
   Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034
   Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8
   Sawyer ST, 2000, J HEMATOTH STEM CELL, V9, P21, DOI 10.1089/152581600319586
   SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F
   Swanson SJ, 2004, NEPHRON CLIN PRACT, V96, P88, DOI 10.1159/000076746
   Uddin S, 2000, BIOCHEM BIOPH RES CO, V275, P16, DOI 10.1006/bbrc.2000.3266
   URDEA M, 2000, NONRADIOACTIVE ANAL, P388
   VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241
   Wang Z, 2001, J Vet Sci, V2, P167
   Wei X, 2004, J IMMUNOL METHODS, V293, P115, DOI 10.1016/j.jim.2004.07.007
   Weisinger G, 1999, BBA-GENE STRUCT EXPR, V1446, P225, DOI 10.1016/S0167-4781(99)00091-3
   Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1
NR 25
TC 9
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-1759
J9 J IMMUNOL METHODS
JI J. Immunol. Methods
PD OCT 20
PY 2006
VL 316
IS 1-2
BP 8
EP 17
DI 10.1016/j.jim.2006.06.016
PG 10
WC Biochemical Research Methods; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 105KU
UT WOS:000242029600002
PM 16989855
DA 2018-10-20
ER

PT J
AU Nunes, JS
   de Vasconcelos, CL
   Cabral, FAO
   de Araujo, JH
   Pereira, MR
   Fonseca, JLC
AF Nunes, J. S.
   de Vasconcelos, C. L.
   Cabral, F. A. O.
   de Araujo, J. H.
   Pereira, M. R.
   Fonseca, J. L. C.
TI Synthesis and characterization of poly(ethyl methacrylate-co-methacrylic
   acid) magnetic particles via miniemulsion polymerization
SO POLYMER
LA English
DT Article
DE poly(ethyl methacrylate); magnetite; magnetic latex
ID ANGLE NEUTRON-SCATTERING; HYBRID MATERIALS; X-RAY; NANOPARTICLES;
   DISPERSIONS; SURFACE; NANOSTRUCTURES; NANOCOMPOSITES; POLYURETHANE;
   FERROFLUIDS
AB Magnetic particles are very important systems with potential use in drug delivery systems, ferrofluids, and effluent treatment. In many situations, such as in biomedical applications, it is necessary to cover inorganic magnetic particles with an organic material, such as polymers. In this work, latices based on magnetite covered by poly(ethyl methacrylate-co-methacrylic acid) were obtained via miniermalsion polymerization. The resultant latices had particles in the nanometric range and presented a pronounced superparamagnetic behavior. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Norte, Dept Quim, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Fis Toer & Expt, BR-59072970 Natal, RN, Brazil.
RP Fonseca, JLC (reprint author), Univ Fed Rio Grande do Norte, Dept Quim, Campus Univ, BR-59078970 Natal, RN, Brazil.
EM jlcfonseca@uol.com.br
OI Pereira, Marcia/0000-0001-8074-1359
CR Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4
   Ambashta RD, 2003, J MAGN MAGN MATER, V267, P335, DOI 10.1016/S0304-8853(03)00401-3
   Asua JM, 2002, PROG POLYM SCI, V27, P1283, DOI 10.1016/S0079-6700(02)00010-2
   Avdeev MV, 2006, J COLLOID INTERF SCI, V295, P100, DOI 10.1016/j.jcis.2005.07.048
   Bamakov YA, 2004, J PHYS CHEM SOLIDS, V65, P1005, DOI 10.1016/j.jpcs.2003.10.070
   Bouanani F, 2005, POLYM BULL, V55, P429, DOI 10.1007/s00289-005-0441-y
   Castelvetro V, 2004, ADV COLLOID INTERFAC, V108, P167, DOI 10.1016/j.cis.2003.10.017
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Csetneki I, 2004, J POLYM SCI POL CHEM, V42, P4802, DOI 10.1002/pola.20300
   de Medeiros DWO, 2005, J DISPER SCI TECHNOL, V26, P267, DOI 10.1081/DIS-200049560
   Deng Y, 2003, J MAGN MAGN MATER, V257, P69, DOI 10.1016/S0304-8853(02)00987-3
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   Esteves ACC, 2004, QUIM NOVA, V27, P798, DOI 10.1590/S0100-40422004000500020
   Hiergeist R, 1999, J MAGN MAGN MATER, V201, P420, DOI 10.1016/S0304-8853(99)00145-6
   HOFFMANN D, 2001, MAGNETOHYDRODYNAMICS, V37, P217
   Horng HE, 2001, J PHYS CHEM SOLIDS, V62, P1749, DOI 10.1016/S0022-3697(01)00108-1
   Khrenov V, 2005, MACROMOL CHEM PHYSIC, V206, P95, DOI 10.1002/macp.200400213
   Kim EH, 2005, J MAGN MAGN MATER, V289, P328, DOI 10.1016/j.jmmm.2004.11.093
   Kohler N, 2005, LANGMUIR, V21, P8858, DOI 10.1021/la0503451
   Kunze C, 2003, BIOMATERIALS, V24, P967, DOI 10.1016/S0142-9612(02)00433-7
   Lin CR, 2006, MATER LETT, V60, P447, DOI 10.1016/j.matlet.2005.09.009
   Liu QX, 1996, J APPL PHYS, V79, P4702, DOI 10.1063/1.361711
   Liu XQ, 2004, LANGMUIR, V20, P10278, DOI 10.1021/la0491908
   Long YZ, 2005, PHYSICA B, V370, P121, DOI 10.1016/j.physb.2005.09.009
   Ma M, 2003, COLLOID SURFACE A, V212, P219, DOI 10.1016/S0927-7757(02)00305-9
   Ma ZY, 2005, J POLYM SCI POL CHEM, V43, P3433, DOI 10.1002/pola.20803
   Mooney KE, 2004, CHEM MATER, V16, P3155, DOI 10.1021/cm040012
   Nunes JS, 2006, COLLOID SURFACE A, V275, P148, DOI 10.1016/j.colsurfa.2005.09.033
   Nunes RCR, 2000, POLYM TEST, V19, P93, DOI 10.1016/S0142-9418(98)00075-0
   Nunes RCR, 2001, POLYM TEST, V20, P707, DOI 10.1016/S0142-9418(01)00007-1
   Peng ZG, 2004, J COLLOID INTERF SCI, V271, P277, DOI 10.1016/j.jcis.2003.12.022
   Pich A, 2005, POLYMER, V46, P4596, DOI 10.1016/j.polymer.2005.01.017
   Qiu WL, 2003, POLYMER, V44, P5821, DOI 10.1016/S0032-3861(03)00627-X
   RAJ K, 1995, J MAGN MAGN MATER, V149, P174, DOI 10.1016/0304-8853(95)00365-7
   Ramirez LP, 2003, MACROMOL CHEM PHYSIC, V204, P22, DOI 10.1002/macp.200290052
   Sahu P, 2006, INTERMETALLICS, V14, P180, DOI 10.1016/j.internet.2005.05.004
   Sargent EH, 2005, ADV MATER, V17, P515, DOI 10.1002/adma.200401552
   Sinsawat A, 2003, J POLYM SCI POL PHYS, V41, P3272, DOI 10.1002/polb.10696
   Soares JM, 2002, APPL PHYS LETT, V80, P2532, DOI 10.1063/1.1468274
   Spanova A, 2004, J CHROMATOGR B, V800, P27, DOI 10.1016/j.jchromb.2003.09.010
   STUART B, 1996, MODERN INFRARED SPEC, P106
   Woo BH, 2001, PHARMACEUT RES, V18, P1600, DOI 10.1023/A:1013090700443
   Yamaura M, 2004, J MAGN MAGN MATER, V279, P210, DOI 10.1016/j.jmmm.2004.01.094
   Zhang ZM, 2005, NANOTECHNOLOGY, V16, P2827, DOI 10.1088/0957-4484/16/12/016
   Zheng WM, 2005, J MAGN MAGN MATER, V288, P403, DOI 10.1016/j.jmmm.2004.09.125
   Zhong WH, 2005, ACTA MATER, V53, P3207, DOI 10.1016/j.actamat.2005.03.025
NR 46
TC 34
Z9 35
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD OCT 18
PY 2006
VL 47
IS 22
BP 7646
EP 7652
DI 10.1016/j.polymer.2006.09.006
PG 7
WC Polymer Science
SC Polymer Science
GA 099PV
UT WOS:000241608600006
DA 2018-10-20
ER

PT J
AU Chan, KLA
   Kazarian, SG
AF Chan, K. L. A.
   Kazarian, S. G.
TI Macro FTIR imaging in transmission under a controlled environment
SO VIBRATIONAL SPECTROSCOPY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Advanced Vibrational Spectroscopy
   (ICAVS-3)
CY AUG 14-19, 2005
CL Delavan, WI
DE FTIR imaging; drugs; polymorphism; humidity
ID SOLVENT-INDUCED CRYSTALLIZATION; POLYMER DISSOLUTION; PHARMACEUTICAL
   FORMULATIONS; CONTROLLED HUMIDITY; IR SPECTROSCOPY; DRUG-RELEASE;
   DIFFUSION; MIXTURES; RAMAN
AB New development in macro FTIR imaging with the use of a specially built accessory has been demonstrated. This accessory expands the possible applications of using macro FTIR imaging in the study of samples under a controlled environment. This new accessory enables the samples (such as films) to be measured in the horizontal position with macro FTIR imaging in transmission. This adds to the flexibility of the sample arrangement and provides the opportunity to use the controlled environment cell for macro FTIR imaging. Using this approach, the crystallisation and the polymorphic changes of amorphous nifedipine film has been monitored by using FTIR imaging over an area of 3.8 mm x 3.8 mm under a controlled humidity and temperature environment. The demonstrated imaging approach may impact areas as diverse as polymeric and biomedical materials, pharmaceuticals and high-throughput analysis. (C) 2005 Elsevier B.V. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England.
RP Kazarian, SG (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England.
EM s.kazarian@imperial.ac.uk
RI Kazarian, Sergei/C-1259-2013
OI Kazarian, Sergei/0000-0003-1768-9134
FU Engineering and Physical Sciences Research Council [GR/T08746/01,
   EP/D066859/1]
CR Artyushkova K, 2001, J VAC SCI TECHNOL A, V19, P2791, DOI 10.1116/1.1405512
   Bhargava R., 2003, ADV POLYM SCI, V163, P13
   Chan KLA, 2004, VIB SPECTROSC, V35, P45, DOI 10.1016/j.vibspec.2003.11.005
   Chan KLA, 2004, J RAMAN SPECTROSC, V35, P353, DOI 10.1002/jrs.1139
   Chan KLA, 2005, J COMB CHEM, V7, P185, DOI 10.1021/cc049840q
   Chan KLA, 2003, ANAL CHEM, V75, P2140, DOI 10.1021/ac026456b
   Chan KLA, 2003, APPL SPECTROSC, V57, P381, DOI 10.1366/00037020360625907
   Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080
   Gupper A, 2004, MACROMOLECULES, V37, P6498, DOI 10.1021/ma049313v
   Gupper A, 2005, MACROMOLECULES, V38, P2327, DOI 10.1021/ma0476590
   Gupper A, 2002, APPL SPECTROSC, V56, P1515, DOI 10.1366/000370202321115959
   Jervis H, 2004, VIB SPECTROSC, V35, P225, DOI 10.1016/j.vibspec.2004.02.002
   Kazarian SG, 2003, MACROMOLECULES, V36, P9866, DOI 10.1021/ma035210l
   Kazarian SG, 2005, FOOD BIOPROD PROCESS, V83, P127, DOI 10.1205/fbp.04399
   Koenig J, 2002, ADV MATER, V14, P457, DOI 10.1002/1521-4095(20020318)14:6<457::AID-ADMA457>3.0.CO;2-8
   Koenig JL, 1998, MICROSCOPIC IMAGING
   Miller-Chou BA, 2002, MACROMOLECULES, V35, P440, DOI 10.1021/ma0115038
   Ribar T, 2001, MACROMOLECULES, V34, P8340, DOI 10.1021/ma011152x
   Roggo Y, 2005, ANAL CHIM ACTA, V535, P79, DOI 10.1016/j.aca.2004.12.037
   Salzer R, 2000, FRESEN J ANAL CHEM, V366, P712, DOI 10.1007/s002160051565
   Snively CM, 1999, J POLYM SCI POL PHYS, V37, P2261, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2261::AID-POLB28>3.0.CO;2-N
   Snively CM, 1999, J POLYM SCI POL PHYS, V37, P2353, DOI 10.1002/(SICI)1099-0488(19990901)37:17<2353::AID-POLB6>3.0.CO;2-Y
   Sommer AJ, 2001, APPL SPECTROSC, V55, P252, DOI 10.1366/0003702011951803
   Tahtouh M, 2005, J FORENSIC SCI, V50, P64
   Van der Weerd J, 2005, J PHARM SCI-US, V94, P2096, DOI 10.1002/jps.20428
NR 25
TC 11
Z9 12
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-2031
J9 VIB SPECTROSC
JI Vib. Spectrosc.
PD OCT 18
PY 2006
VL 42
IS 1
SI SI
BP 130
EP 134
DI 10.1016/j.vibspec.2005.10.005
PG 5
WC Chemistry, Analytical; Chemistry, Physical; Spectroscopy
SC Chemistry; Spectroscopy
GA 101DU
UT WOS:000241719900019
DA 2018-10-20
ER

PT J
AU Yang, KK
   Zheng, L
   Wang, YZ
   Zeng, JB
   Wang, XL
   Chen, SC
   Zeng, Q
   Li, B
AF Yang, Ke-Ke
   Zheng, Li
   Wang, Yu-Zhong
   Zeng, Jian-Bing
   Wang, Xiu-Li
   Chen, Si-Chong
   Zeng, Qiang
   Li, Bin
TI ABA triblock copolymers from poly(p-dioxanone) and poly(ethylene glycol)
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE poly(ethylene glycol); poly(p-dioxanone); triblock copolymer;
   crystallization; thermal stability; water absorption
ID BLOCK-COPOLYMERS; DELIVERY SYSTEM; L-LACTIDE; 1,4-DIOXAN-2-ONE;
   CRYSTALLIZATION; POLYLACTONES; D,L-LACTIDE
AB Poly(p-dioxanone)-poly(ethylene glycol)-poly (p-dioxanone) ABA triblock copolymers (PEDO) were synthesized by ring-opening polymerization from p-dioxanone using poly(ethylene glycol) (PEG) with different molecular weights as macroinitiators in N-2 atmosphere. The copolymer was characterized by H-1 NMR spectroscope. The thermal behavior, crystallization, and thermal stability of these copolymers were investigated by differential scanning calorimetry and thermogravimetric measurements. The water absorption of these copolymers was also measured. The results indicated that the content and length of PEG chain have a greater effect on the properties of copolymers. This kind of biodegradable copolymer will find a potential application in biomedical materials. (c) 2006 Wiley Periodicals, Inc.
C1 Sichuan Univ, Ctr Degradable & Flame Retardant Polymer Mat, Coll Chem, Chengdu 610064, Peoples R China.
RP Wang, YZ (reprint author), Sichuan Univ, Ctr Degradable & Flame Retardant Polymer Mat, Coll Chem, Chengdu 610064, Peoples R China.
EM yzwang@mail.sc.cninfo.net
RI wang, xiuli/H-9720-2016; Zeng, Jian-Bing/G-9583-2016; Wang,
   Yu-Zhong/E-3633-2013; Yang, Ke-Ke/G-6131-2018
OI wang, xiuli/0000-0002-2732-9477; Zeng, Jian-Bing/0000-0003-1822-446X;
   Wang, Yu-Zhong/0000-0001-7535-7635; Yang, Ke-Ke/0000-0002-7019-6059
CR CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Chen DR, 2000, POLYM INT, V49, P269, DOI 10.1002/(SICI)1097-0126(200003)49:3<269::AID-PI358>3.3.CO;2-Q
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   DU YJ, 1995, MACROMOLECULES, V28, P2124, DOI 10.1021/ma00111a004
   FORSCHNER TC, 1997, Patent No. 9721753
   Harris J. M., 1997, ACS S SERIES
   KIRCHELDORF HR, 1995, POLYMER, V36, P1253
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P1089, DOI 10.1002/macp.1998.021990624
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   LIPINSKY ES, 1993, Patent No. 5767222
   Loo YL, 2002, MACROMOLECULES, V35, P2365, DOI 10.1021/ma011824j
   MOHAMMADIROVSHA.J, 2004, J APPL POLYM SCI, V74, P1999
   Muller AJ, 2002, MACROMOLECULES, V35, P3048, DOI 10.1021/ma012026w
   Nishida H, 2000, POLYM DEGRAD STABIL, V70, P485, DOI 10.1016/S0141-3910(00)00145-2
   Qian ZY, 2004, POLYM DEGRAD STABIL, V83, P93, DOI 10.1016/S0141-3910(03)00229-5
   Raquez JM, 2000, MACROMOL RAPID COMM, V21, P1063, DOI 10.1002/1521-3927(20001001)21:15<1063::AID-MARC1063>3.0.CO;2-B
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Sandner B, 1997, POLYMER, V38, P2515, DOI 10.1016/S0032-3861(96)00809-9
   Wang H, 1998, J APPL POLYM SCI, V68, P2121, DOI 10.1002/(SICI)1097-4628(19980627)68:13<2121::AID-APP8>3.0.CO;2-E
   WANG SG, 1993, ACTA POLYM SIN, V5, P620
   XIONG CD, 1995, J APPL POLYM SCI, V55, P869
   YANG KK, 2002, J MACROMOL SCI POL C, V43, P373
NR 23
TC 16
Z9 18
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 15
PY 2006
VL 102
IS 2
BP 1092
EP 1097
DI 10.1002/app.24273
PG 6
WC Polymer Science
SC Polymer Science
GA 079VX
UT WOS:000240207100021
DA 2018-10-20
ER

PT J
AU Linford, R
   Schlindwein, W
AF Linford, Roger
   Schlindwein, Walkiria
TI Medical applications of solid state lonics
SO SOLID STATE IONICS
LA English
DT Article; Proceedings Paper
CT 15th International Conference on Solid State Ionics
CY 2005
CL Baden Baden, GERMANY
DE drug delivery; iontophoretic devices; bioelectrochernistry; biological
   fuel cells; biomedical devices
ID IONTOPHORETIC DRUG-DELIVERY; POLYMER ELECTROLYTES; BIOFUEL CELLS;
   BIOMEDICAL APPLICATIONS; OSMIC ACID; SYSTEMS; BATTERIES; DEVICES;
   LITHIUM
AB Solid state ionic materials and devices are being used in medicine in many ways. A brief initial introduction to the materials, the devices and the pertinent electrophysiological and clinical aspects is presented. To exemplify the breadth of SSI material and device applications, an overview is given of three main areas: Biomedical applications of solid state power sources; biofuel cells; and iontophoretic and related devices used for controlled transdermal drug delivery and monitoring of physiological parameters. (c) 2006 Elsevier B.V. All rights reserved.
C1 De Montfort Univ, Res Off, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Sch Pharm, Leicester LE1 9BH, Leics, England.
RP Linford, R (reprint author), De Montfort Univ, Res Off, Leicester LE1 9BH, Leics, England.
EM rgl@dmu.ac.uk
CR Agarwal A, 2005, ANNU REV MED, V56, P475, DOI 10.1146/annurev.med.56.082103.104656
   AKERS NL, 2004, FUEL CELL SCI ENG TE, P497
   Antonioli G, 1973, Minerva Med, V64, P2298
   ARMAND M, 1978, 2ND INT C SOL EL ST
   Armand M. B., 1979, Fast Ion Transport in Solids. Electrodes and Electrolytes, P131
   Ayral X, 2001, HAEMOPHILIA, V7, P20, DOI 10.1046/j.1365-2516.2001.00104.x
   Baker KB, 2005, J MAGN RESON IMAGING, V21, P72, DOI 10.1002/jmri.20224
   BANGA AJ, 1998, ELECT ASSISTED TRANS
   Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k
   Barton SC, 2005, ELECTROCHIM ACTA, V50, P2145, DOI 10.1016/j.electacta.2004.09.022
   Bessant R, 2003, RHEUMATOLOGY, V42, P1036, DOI 10.1093/rheumatology/keg283
   Boulatov R, 2004, PURE APPL CHEM, V76, P303, DOI 10.1351/pac200476020303
   DACUNHA FOV, IN PRESS FUNCTIONAL
   Denet AR, 2004, ADV DRUG DELIVER REV, V56, P659, DOI 10.1016/j.addr.2003.10.027
   Fitzgerald E, 2004, SURG-J R COLL SURG E, V2, P311, DOI 10.1016/S1479-666X(04)80028-3
   Gong WS, 2000, ANN BIOMED ENG, V28, P572, DOI 10.1114/1.293
   Greatbatch W, 1996, PACE, V19, P1836, DOI 10.1111/j.1540-8159.1996.tb03236.x
   GREATBATCH W, 1959, P NEW ENGL RES ENG M, V1, P8
   Groen J, 2005, NEUROUROL URODYNAM, V24, P226, DOI 10.1002/nau.20131
   Heller A, 2005, AICHE J, V51, P1054, DOI 10.1002/aic.10489
   Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a
   Helmstadter A, 2001, PHARMAZIE, V56, P583
   HOLMES CF, 2003, INTERFACE, V12, P19
   Johnson AM, 2005, J ELECTROCHEM SOC, V152, pH6, DOI 10.1149/1.1824045
   Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   Katz E, 2005, J AM CHEM SOC, V127, P3979, DOI 10.1021/ja044157t
   KATZ E, 2003, HDB FUEL CELLS FUNDA, V1, P355
   Klefenz H, 2004, ENG LIFE SCI, V4, P211, DOI 10.1002/elsc.200402090
   Kossoff EH, 2004, EPILEPSIA, V45, P1560, DOI 10.1111/j.0013-9580.2004.26104.x
   Latham R, 2004, SOLID STATE IONICS, V172, P7, DOI 10.1016/j.ssi.2004.04.024
   Latham RJ, 2002, SOLID STATE IONICS: TRENDS IN THE NEW MILLENNIUM, PROCEEDINGS, P283, DOI 10.1142/9789812776259_0030
   Latham RJ, 2003, IONICS, V9, P41, DOI 10.1007/BF02376535
   Leboulanger B, 2004, PHYSIOL MEAS, V25, pR35, DOI 10.1088/0967-3334/25/R01
   Mano N, 2002, J AM CHEM SOC, V124, P12962, DOI 10.1021/ja028514g
   MINIER M, 1983, SOLID STATE IONICS, V9-10, P1125, DOI 10.1016/0167-2738(83)90141-8
   Mitragotri S, 2004, ADV DRUG DELIVER REV, V56, P589, DOI 10.1016/j.addr.2003.10.024
   Okamoto E, 2003, ARTIF ORGANS, V27, P184, DOI 10.1046/j.1525-1594.2003.t01-1-06993.x
   PHIPPS JB, 2004, 205 M EL SOC SAN ANT, P714
   Sahota TS, 1999, DRUG DEV IND PHARM, V25, P307, DOI 10.1081/DDC-100102175
   Sahota TS, 2000, DRUG DEV IND PHARM, V26, P1039, DOI 10.1081/DDC-100100267
   Schmidt CL, 2001, J POWER SOURCES, V97-8, P742, DOI 10.1016/S0378-7753(01)00648-6
   SCHOENFISCH MH, 1999, J BIOMED MATER RES, V51, P209
   SCHOTT I, 2003, CHEM ENG NEWS, V81, P146
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   SHARMA A, 2004, 205 M EL SOC SAN ANT, P720
   Skarstad PM, 2004, J POWER SOURCES, V136, P263, DOI 10.1016/j.powscour.2004.03.010
   Takeuchi ES, 2002, MRS BULL, V27, P624, DOI 10.1557/mrs2002.199
   Tayhas G., 1994, ACS SYM SER, V566, P271
   Tsujimura S, 2002, ELECTROCHEMISTRY, V70, P940
   Tsujimura S, 2001, PHYS CHEM CHEM PHYS, V3, P1331, DOI 10.1039/b009539g
   Yamada M, 2005, ELECTROCHIM ACTA, V50, P2837, DOI 10.1016/j.electacta.2004.11.031
NR 52
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-2738
J9 SOLID STATE IONICS
JI Solid State Ion.
PD OCT 15
PY 2006
VL 177
IS 19-25
BP 1559
EP 1565
DI 10.1016/j.ssi.2005.12.026
PG 7
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 112VH
UT WOS:000242555200003
DA 2018-10-20
ER

PT J
AU Cho, J
   Grant, J
   Piquette-Miller, M
   Allen, C
AF Cho, Jaepyoung
   Grant, Justin
   Piquette-Miller, Micheline
   Allen, Christine
TI Synthesis and physicochemical and dynamic mechanical properties of a
   water-soluble chitosan derivative as a biomaterial
SO BIOMACROMOLECULES
LA English
DT Article
ID MOLECULAR-WEIGHT DISTRIBUTION; RELAXATION-TIME SPECTRUM; GENE DELIVERY
   VECTORS; INTRINSIC-VISCOSITY; POLYMER-SOLUTIONS; QUATERNARY AMMONIUM;
   VISCOELASTIC PROPERTIES; REGULARIZATION METHOD; POLYELECTROLYTES;
   BEHAVIOR
AB The physicochemical and rheological properties of a water-soluble chitosan (WSC) derivative were characterized in order to facilitate its use as a novel material for biomedical applications. The WSC was prepared by conjugating glycidyltrimethylammonium chloride (GTMAC) onto chitosan chains. Varying the molar ratio of GTMAC to chitosan from 3: 1 to 6: 1 produced WSCs with a degree of substitution (DS) that ranged from 56% to 74%. The WSC with the highest DS was soluble in water up to concentrations of 25g/dL at room temperature. An increase in the polymer concentration gradually increased both the pH and conductivity of the WSC solutions. The rheological properties of the WSC solutions were found to be dependent on the salt and polymer concentrations as well as the DS value. In the absence of salt, the rheological behavior of the WSC was found to be typical of that for a polyelectrolyte in the dilute solution regime. However, the addition of salt decreased the viscosity of the polymer solution due to the reduction of electrostatic repulsions by the positively charged trimethylated ammonium groups of the WSC. In the concentrated regime, the viscosity of the WSCs was found to follow a power-law expression. The lowest DS WSC had the more favorable viscoelastic properties that were attributed to its high molecular weight, as confirmed by the stress relaxation spectra and intrinsic viscosity measurements. The effect of DS on the degree of interaction between WSC and the lipid egg phosphatidylcholine was investigated by FTIR analysis. Overall, the lower DS WSC had enhanced rheological properties and was capable of engaging in stronger intermolecular physical interactions.
C1 Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 2S2, Canada.
   Univ Toronto, Dept Chem, Toronto, ON M5S 2S2, Canada.
RP Allen, C (reprint author), Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, 19 Russell St, Toronto, ON M5S 2S2, Canada.
EM cj.allen@utoronto.ca
CR Alberty R. A., 1997, PHYS CHEM
   Allan G., 1984, CHITIN CHITOSAN RELA
   AMIJI MM, 1995, CARBOHYD POLYM, V26, P211, DOI 10.1016/0144-8617(94)00095-B
   Antonietti M, 1996, J CHEM PHYS, V105, P7795, DOI 10.1063/1.472605
   Antonietti M, 1997, MACROMOLECULES, V30, P2700, DOI 10.1021/ma9617025
   ARAI K, 1968, B TOKAI REGIONAL FIS, V56, P89
   Brugnerotto J, 2001, MACROMOL SYMP, V168, P1, DOI 10.1002/1521-3900(200103)168:1<1::AID-MASY1>3.0.CO;2-W
   Carreau P. J., 1997, RHEOLOGY POLYM SYSTE
   Chen RH, 1998, INT J BIOL MACROMOL, V23, P135, DOI 10.1016/S0141-8130(98)00036-1
   Chen WR, 2002, CANCER RES, V62, P4295
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Cho JY, 2006, J FOOD ENG, V74, P500, DOI 10.1016/j.jfoodeng.2005.01.047
   COLBY RH, 1991, MACROMOLECULES, V24, P3873, DOI 10.1021/ma00013a021
   Connors K.A., 1979, CHEM STABILITY PHARM
   Coury L., 1999, CURR SEP, V18, p[3, 91]
   COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812
   Desbrieres J, 2002, BIOMACROMOLECULES, V3, P342, DOI 10.1021/bm010151+
   DOBRYNIN AV, 1995, MACROMOLECULES, V28, P1859, DOI 10.1021/ma00110a021
   DOMARD A, 1987, INT J BIOL MACROMOL, V9, P98, DOI 10.1016/0141-8130(87)90033-X
   FUOSS RM, 1949, J POLYM SCI, V4, P96, DOI 10.1002/pol.1949.120040111
   FUOSS RM, 1948, J POLYM SCI, V3, P603, DOI 10.1002/pol.1948.120030414
   Gastaud JM, 1998, CR ACAD SCI III-VIE, V321, P5, DOI 10.1016/S0764-4469(97)89619-9
   Grant J, 2006, ACS SYM SER, V934, P201
   Grant J, 2005, J PHARM SCI-US, V94, P1512, DOI 10.1002/jps.20379
   Heo Y, 2005, J RHEOL, V49, P1117, DOI 10.1122/1.1993595
   HONERKAMP J, 1993, RHEOL ACTA, V32, P65, DOI 10.1007/BF00396678
   Hwang J. K., 2000, KOREA-AUST RHEOL J, V12, P175
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6
   Kasaai MR, 2000, J POLYM SCI POL PHYS, V38, P2591, DOI 10.1002/1099-0488(20001001)38:19<2591::AID-POLB110>3.0.CO;2-6
   Kean T, 2005, J CONTROL RELEASE, V103, P643, DOI 10.1016/j.jconrel.2004.01.001
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   KIENZLESTERZER C, 1982, J APPL POLYM SCI, V27, P4467, DOI 10.1002/app.1982.070271133
   Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012
   Kulicke W.-M., 2004, VISCOSIMETRY POLYM P
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Liaw DJ, 1997, J APPL POLYM SCI, V63, P175, DOI 10.1002/(SICI)1097-4628(19970110)63:2<175::AID-APP5>3.3.CO;2-6
   Lide D. R., 2004, CRC HDB CHEM PHYS
   Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES
   Maeda Y, 2004, J NUTR, V134, P945
   MIYA M, 1980, INT J BIOL MACROMOL, V2, P323, DOI 10.1016/0141-8130(80)90056-2
   MIYAMOTO S, 1981, MACROMOL CHEM PHYS, V182, P483
   Morel FMM, 1993, PRINCIPLES APPL AQUA
   Nam CW, 2001, J APPL POLYM SCI, V82, P1620, DOI 10.1002/app.2001.abs
   Painter P. C, 1997, FUNDAMENTALS POLYM S
   Park JH, 2003, BIOMACROMOLECULES, V4, P1087, DOI 10.1021/bm034094r
   Qin CQ, 2004, INT J BIOL MACROMOL, V34, P121, DOI 10.1016/j.ijbiomac.2004.03.009
   Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8
   REMYHEINTZ N, 1993, CR ACAD SCI III-VIE, V316, P1363
   Roberts G, 1992, CHITIN CHEM
   Roths T, 2000, RHEOL ACTA, V39, P163, DOI 10.1007/s003970050016
   Sandford P.A., 1987, IND POLYSACCHARIDES
   SANFORD PA, 1989, CHITIN CHITOSAN
   Sashiwa H, 2003, CARBOHYD RES, V338, P557, DOI 10.1016/S0008-6215(02)00492-5
   Savarmand S, 2003, J RHEOL, V47, P1133, DOI 10.1122/1.1603237
   Seong HS, 2000, J APPL POLYM SCI, V76, P2009, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2009::AID-APP3>3.0.CO;2-W
   Sieval AB, 1998, CARBOHYD POLYM, V36, P157, DOI 10.1016/S0144-8617(98)00009-5
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Stepanek P, 1998, MACROMOLECULES, V31, P1889, DOI 10.1021/ma970458u
   TAKAHASHI A, 1967, J PHYS CHEM-US, V71, P2001, DOI 10.1021/j100866a600
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thimm W, 1999, J RHEOL, V43, P1663, DOI 10.1122/1.551066
   Tsaih ML, 1999, J APPL POLYM SCI, V71, P1905, DOI 10.1002/(SICI)1097-4628(19990314)71:11<1905::AID-APP21>3.0.CO;2-J
   Vega JF, 2004, J RHEOL, V48, P663, DOI 10.1122/1.1718367
   Wood-Adams PM, 1996, J RHEOL, V40, P761, DOI 10.1122/1.550763
   Wood-Adams PM, 2001, ABSTR PAP AM CHEM S, V221, pU396
   Xu F, 1999, MED PHYS, V26, P1371, DOI 10.1118/1.598633
   Yang HY, 2005, EUR POLYM J, V41, P329, DOI 10.1016/j.eurpolymj.2004.10.002
   Young R.J., 1991, INTRO POLYM
NR 70
TC 68
Z9 70
U1 2
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT 9
PY 2006
VL 7
IS 10
BP 2845
EP 2855
DI 10.1021/bm060436s
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 092OG
UT WOS:000241106600021
PM 17025361
DA 2018-10-20
ER

PT J
AU Mart, RJ
   Osborne, RD
   Stevens, MM
   Ulijn, RV
AF Mart, Robert J.
   Osborne, Rachel D.
   Stevens, Molly M.
   Ulijn, Rein V.
TI Peptide-based stimuli-responsive biomaterials
SO SOFT MATTER
LA English
DT Review
ID ELASTIN-LIKE POLYPEPTIDE; AZOBENZENE CROSS-LINKER; SELF-ASSEMBLED
   NANOFIBERS; TARGETED DRUG-DELIVERY; AMPHIPHILE NANOFIBERS; DESIGNED
   PEPTIDE; HELIX CONTENT; PHOTO-CONTROL; COILED-COIL; SUPRAMOLECULAR
   HYDROGELS
AB This article explores recent advances in the design and engineering of materials wholly or principally constructed from peptides. We focus on materials that are able to respond to changes in their environment (pH, ionic strength, temperature, light, oxidation/reduction state, presence of small molecules or the catalytic activity of enzymes) by altering their macromolecular structure. Such peptide-based responsive biomaterials have exciting prospects for a variety of biomedical and bionanotechnology applications in drug delivery, bio-sensing and regenerative medicine.
C1 MIB, Manchester M1 7HS, Lancs, England.
   Sch Mat, Manchester M1 7HS, Lancs, England.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
RP Stevens, MM (reprint author), MIB, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM M.Stevens@imperial.ac.uk; R.Ulijn@manchester.ac.uk
RI wang, chuanjun/K-4578-2013; Mart, Robert/C-4200-2011; Ulijn,
   Rein/C-3998-2009
OI Mart, Robert/0000-0003-2196-5840; 
CR Aggeli A, 2003, ANGEW CHEM INT EDIT, V42, P5603, DOI 10.1002/anie.200352207
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Borisenko V, 2005, J PHOTOCH PHOTOBIO A, V173, P21, DOI 10.1016/j.jphotochem.2004.12.026
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   Burns DC, 2004, BIOCHEMISTRY-US, V43, P15329, DOI 10.1021/bi048152k
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Cerasoli E, 2005, J AM CHEM SOC, V127, P15008, DOI 10.1021/ja0543604
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Ciani B, 2002, J BIOL CHEM, V277, P10150, DOI 10.1074/jbc.M107663200
   Collier JH, 2004, ADV MATER, V16, P907, DOI 10.1002/adma.200306379
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Diehl MR, 2006, SCIENCE, V311, P1468, DOI 10.1126/science.1122125
   Dong H, 2006, BIOMACROMOLECULES, V7, P691, DOI 10.1021/bm050833n
   Dos Santos S, 2005, J AM CHEM SOC, V127, P11888, DOI 10.1021/ja052083v
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801
   Dutta K, 2003, PROTEIN SCI, V12, P257, DOI 10.1110/ps.0223903
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Flint DG, 2002, CHEM BIOL, V9, P391, DOI 10.1016/S1074-5521(02)00109-6
   Frey W, 2003, LANGMUIR, V19, P1641, DOI 10.1021/la026359d
   Furgeson DY, 2006, J CONTROL RELEASE, V110, P362, DOI 10.1016/j.jconrel.2005.10.006
   Furlan RLE, 2002, P NATL ACAD SCI USA, V99, P4801, DOI 10.1073/pnas.055643699
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong Y, 2005, COLLOID SURFACE B, V46, P152, DOI 10.1016/j.colsurfb.2005.11.004
   Hong YS, 2004, J ADHESION, V80, P913, DOI 10.1080/00218460490508616
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   JEONG B, 2002, TRENDS BIOTECHNOL, V7, P305
   Jun HW, 2006, SOFT MATTER, V2, P177, DOI 10.1039/b516805h
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kayser V, 2004, J AM CHEM SOC, V126, P336, DOI 10.1021/ja035340+
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Koga T, 2005, J AM CHEM SOC, V127, P17596, DOI 10.1021/ja0558387
   Kogiso M, 2004, J COLLOID INTERF SCI, V273, P394, DOI 10.1016/j.jcis.2004.01.062
   Kogiso M, 2000, BBA-GEN SUBJECTS, V1475, P346, DOI 10.1016/S0304-4165(00)00088-X
   Kovaric BC, 2006, J AM CHEM SOC, V128, P4166, DOI 10.1021/ja056357q
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Kumita JR, 2002, PROTEIN ENG, V15, P561, DOI 10.1093/protein/15.7.561
   Kumita JR, 2003, FARADAY DISCUSS, V122, P89, DOI 10.1039/b200897a
   Kumita JR, 2000, P NATL ACAD SCI USA, V97, P3803, DOI 10.1073/pnas.97.8.3803
   Lamm MS, 2005, J AM CHEM SOC, V127, P16692, DOI 10.1021/ja05472ff
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Matsui H, 2000, J PHYS CHEM B, V104, P3383, DOI 10.1021/jp994117p
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Meyer DE, 2001, BIOTECHNOL PROGR, V17, P720, DOI 10.1021/bp010049o
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   Meyer DE, 2001, CANCER RES, V61, P1548
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nath N, 2003, ANAL CHEM, V75, P709, DOI 10.1021/ac0261855
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   Nath N, 2001, J AM CHEM SOC, V123, P8197, DOI 10.1021/ja015585r
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Pagel K, 2005, ORG BIOMOL CHEM, V3, P3843, DOI 10.1039/b510098d
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Plunkett KN, 2005, BIOMACROMOLECULES, V6, P632, DOI 10.1021/bm049349v
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Pozhidaeva N, 2004, BIOCONJUGATE CHEM, V15, P1297, DOI 10.1021/bc049855h
   Rajagopal K, 2006, EUR BIOPHYS J BIOPHY, V35, P162, DOI 10.1007/s00249-005-0017-7
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Rao GVR, 2002, LANGMUIR, V18, P1819, DOI 10.1021/la011188i
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Raucher D, 2001, CANCER RES, V61, P7163
   Reches M, 2004, NANO LETT, V4, P581, DOI 10.1021/nl035159z
   Reches M, 2005, ISRAEL J CHEM, V45, P363, DOI 10.1560/5MC0-V3DX-KE0B-YF3J
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Ryadnov MG, 2005, J AM CHEM SOC, V127, P12407, DOI 10.1021/ja052972i
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Schenning APHJ, 2005, CHEM COMMUN, P3245, DOI 10.1039/b501804h
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989
   Smith AM, 2005, ANGEW CHEM INT EDIT, V44, P325, DOI 10.1002/anie.200461599
   Smith AM, 2006, ADV FUNCT MATER, V16, P1022, DOI 10.1002/adfm.200500568
   Smith E, 2003, J POLYM SCI POL CHEM, V41, P3989, DOI 10.1002/pola.10965
   Sone ED, 2004, J AM CHEM SOC, V126, P12756, DOI 10.1021/ja0499344
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Stevens MM, 2004, LANGMUIR, V20, P7747, DOI 10.1021/la030440e
   Stevens MM, 2004, ADV MATER, V16, P915, DOI 10.1002/adma.200306430
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   TAYLOR JP, 1991, SCIENCE, V296
   Thornton PD, 2005, CHEM COMMUN, P5913, DOI 10.1039/b511005j
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Tsonchev S, 2004, NANO LETT, V4, P427, DOI 10.1021/nl0351439
   Tsonchev S, 2003, NANO LETT, V3, P623, DOI 10.1021/nl0340531
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   van Bommel KJC, 2004, ANGEW CHEM INT EDIT, V43, P1663, DOI 10.1002/anie.200352396
   WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Woolley GA, 2005, ACCOUNTS CHEM RES, V38, P486, DOI 10.1021/ar040091v
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yang ZM, 2004, CHEM COMMUN, P2424, DOI 10.1039/b408897b
   Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340
   Yu B.Y, 2005, CHEM MATER, V17, P6583
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang Y, 2004, J AM CHEM SOC, V126, P15028, DOI 10.1021/ja044401g
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
   Zhang ZH, 2003, BIOCONJUGATE CHEM, V14, P824, DOI 10.1021/bc0340161
   Zimenkov Y, 2006, J AM CHEM SOC, V128, P6770, DOI 10.1021/ja0605974
NR 122
TC 372
Z9 381
U1 14
U2 325
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PD OCT 7
PY 2006
VL 2
IS 10
BP 822
EP 835
DI 10.1039/b607706d
PG 14
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 096ES
UT WOS:000241361000003
DA 2018-10-20
ER

PT J
AU Huang, J
   Ren, LX
   Zhu, H
   Chen, YM
AF Huang, Jin
   Ren, Lixia
   Zhu, Hui
   Chen, Yongming
TI Hydrophilic block copolymer aggregation in solution induced by selective
   threading of cyclodextrins
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE block copolymers; inclusion chemistry; self-assembly
ID OXIDE) TRIBLOCK COPOLYMERS; BIODEGRADABLE AMPHIPHILIC POLY(ETHYLENE;
   ALPHA-CYCLODEXTRIN; INCLUSION COMPLEXATION; DIBLOCK COPOLYMERS; GLYCOL);
   POLYPSEUDOROTAXANE; MICELLES; POLYROTAXANES; COALESCENCE
AB The inclusion of polymer chains by cyclodextrins (CDs) may generate column-like supramolecules. Herein, we report that the selective threading of cyclodextrin rings onto one segment of a double hydrophilic diblock copolymer in water generates spherical aggregates. Poly(ethylene oxide)-blockpoly((dimethylamino)ethyl methacrylate) (PEO-b-PDMA) may dissolve in water to form a homogeneous solution. However, when alpha-CDs are introduced, they thread onto the PEO segments to form pseudopolyrotaxanes, which tend to aggregate. Instead of forming a precipitate, novel supramolecular particles are generated which are attributed to the stabilization of the soluble PDMA segments. The organization process and the assembly structure were characterized by dynamic fight scattering, X-ray diffraction, electron microscopy and 1D NOE NMR spectra. Such novel particles are biocompatible and could have potential applications as biomedical and stimulus-response materials.
C1 Chinese Acad Sci, Inst Chem, Joint Lab Polymer Sci & Mat, State Key Lab Polymer Phys & Chem, Beijing 100080, Peoples R China.
   Wuhan Univ Technol, Coll Chem Engn, Wuhan 430070, Peoples R China.
RP Chen, YM (reprint author), Chinese Acad Sci, Inst Chem, Joint Lab Polymer Sci & Mat, State Key Lab Polymer Phys & Chem, Beijing 100080, Peoples R China.
EM ymchen@iccas.ac.cn
RI Li, Yuyan/G-8762-2013; Huang, Jin/E-4537-2011; Chen,
   Yongming/E-3656-2015
OI Chen, Yongming/0000-0003-2843-5543
CR Alexandridis P., 2000, AMPHIPHILIC BLOCK CO
   Cameron NS, 1999, CAN J CHEM, V77, P1311, DOI 10.1139/v99-141
   Chen DY, 2005, ACCOUNTS CHEM RES, V38, P494, DOI 10.1021/ar040113d
   Cheng CX, 2005, MACROMOL RAPID COMM, V26, P744, DOI 10.1002/marc.200400655
   Choi HS, 2005, MACROMOLECULES, V38, P9878, DOI 10.1021/ma051400f
   Choi HS, 2003, MACROMOLECULES, V36, P9313, DOI 10.1021/ma035200k
   DISCHER DE, 2002, SCIENCE, V295, P967
   Du JZ, 2003, J AM CHEM SOC, V125, P14710, DOI 10.1021/ja0368610
   Fujita H, 1999, MACROMOL CHEM PHYSIC, V200, P706, DOI 10.1002/(SICI)1521-3935(19990401)200:4<706::AID-MACP706>3.0.CO;2-2
   Fujita N, 2005, ANGEW CHEM INT EDIT, V44, P1257, DOI 10.1002/anie.200461174
   GAITANO GG, 2002, J INCL PHENOM MACRO, V44, P101
   Hamley I. W, 1998, PHYS BLOCK COPOLYMER
   Harada A, 1997, ADV POLYM SCI, V133, P141
   He LH, 2005, MACROMOLECULES, V38, P3845, DOI 10.1021/ma0475333
   Hu ZJ, 2005, J AM CHEM SOC, V127, P6526, DOI 10.1021/ja050053m
   Huang FH, 2005, PROG POLYM SCI, V30, P982, DOI 10.1016/j.progpolymsci.2005.07.003
   Huh KM, 2004, MACROMOL BIOSCI, V4, P92, DOI 10.1002/mabi.200300037
   Huh KM, 2001, MACROMOLECULES, V34, P8657, DOI 10.1021/ma0106649
   Lee HF, 2005, MACROMOLECULES, V38, P6551, DOI 10.1021/ma050254a
   Lee SC, 2004, MACROMOLECULES, V37, P7464, DOI 10.1021/ma048666r
   Li J, 2004, POLYMER, V45, P1777, DOI 10.1016/j.polymer.2004.01.021
   Li J, 2003, MACROMOLECULES, V36, P2661, DOI 10.1021/ma025725x
   Li J, 2001, MACROMOLECULES, V34, P7236, DOI 10.1021/ma010742s
   Li X, 2003, MACROMOLECULES, V36, P1209, DOI 10.1021/ma0213347
   Li X, 2004, POLYMER, V45, P6845, DOI 10.1016/j.polymer.2004.07.038
   Maskos M, 2006, POLYMER, V47, P1172, DOI 10.1016/j.polymer.2005.12.045
   Panova I. G., 2001, RUSS CHEM REV, V70, P23
   Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Sabadini E, 2003, LANGMUIR, V19, P9680, DOI 10.1021/la0353273
   Shuai XT, 2005, BIOCONJUGATE CHEM, V16, P322, DOI 10.1021/bc0498471
   Shuai XT, 2002, MACROMOLECULES, V35, P2401, DOI 10.1021/ma012085+
   Shuai XT, 2001, MACROMOLECULES, V34, P7355, DOI 10.1021/ma0109626
   Shuai XT, 2002, BIOMACROMOLECULES, V3, P201, DOI 10.1021/bm015609m
   Wang XS, 2000, MACROMOLECULES, V33, P6640, DOI 10.1021/ma000671h
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Yan DY, 2004, SCIENCE, V303, P65, DOI 10.1126/science.1090763
   Yoshida E, 2002, MACROMOLECULES, V35, P6665, DOI 10.1021/ma020275u
NR 38
TC 25
Z9 26
U1 4
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD OCT 2
PY 2006
VL 207
IS 19
BP 1764
EP 1772
DI 10.1002/macp.200600144
PG 9
WC Polymer Science
SC Polymer Science
GA 095DR
UT WOS:000241288900007
DA 2018-10-20
ER

PT J
AU You, X
   Connolley, T
   McHugh, PE
   Cuddy, H
   Motz, C
AF You, X.
   Connolley, T.
   McHugh, P. E.
   Cuddy, H.
   Motz, C.
TI A combined experimental and computational study of deformation in grains
   of biomedical grade 316LVM stainless steel
SO ACTA MATERIALIA
LA English
DT Article
DE orientation imaging microscopy (OIM); tension test; plastic deformation;
   micromechanical modelling
ID FINITE-ELEMENT SIMULATION; SLOTTED TUBE STENT; POLYCRYSTALLINE ALUMINUM;
   MECHANICAL-BEHAVIOR; CRYSTAL PLASTICITY; STRAIN; EXPANSION; COMPRESSION;
   TENSION; MODELS
AB In this work three-dimensional crystal plasticity finite element models are used to simulate the tensile deformation of a thin 316LVM stainless steel specimen. Such models are of interest for predicting the mechanical response of cardiovascular stents, typically made from thin struts of this material. Detailed experimental analysis of the mechanical response of the specimen during deformation is performed using scanning electron microscopy, digital photogrammetry and orientation imaging microscopy to examine microscale strain distribution, plastic slip and grain reorientation. At the macroscale, the models are found to give good predictions of the stress-strain response of the specimen, andat the microscale the models are found to give good predictions of the strain distribution and the active slip systems in the different grains. The models are less successful in predicting grain reorientations. This, however, is shown to be quite sensitive to the choice of latent hardening ratio. (c) 2006 Acta Matcrialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Natl Univ Ireland, Dept Mech & Biomed Engn, Galway, Ireland.
   Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   Austrian Acad Sci, Erich Schmid Inst, A-8700 Leoben, Austria.
RP McHugh, PE (reprint author), Natl Univ Ireland, Dept Mech & Biomed Engn, Univ Rd, Galway, Ireland.
EM peter.mchugh@nuigalway.ie
OI Connolley, Thomas/0000-0002-1851-3467
CR ASARO RJ, 1983, J APPL MECH-T ASME, V50, P921, DOI 10.1115/1.3167205
   *ASTM, 1997, F13897 ASTM
   *ASTM, 1996, E11296E2 ASTM STAND
   Auricchio F, 2001, COMPUTER METHODS BIO, V4, P249, DOI DOI 10.1080/10255840108908007
   BASSANI JL, 1990, APPL MECH REV, V43, P320
   Bhattacharyya A, 2001, INT J PLASTICITY, V17, P861, DOI 10.1016/S0749-6419(00)00072-3
   Buchheit TE, 2005, INT J PLASTICITY, V21, P221, DOI 10.1016/j.ijplas.2003.10.009
   Chua SND, 2004, J MATER PROCESS TECH, V155, P1772, DOI 10.1016/j.jmatprotec.2004.04.396
   Chua SND, 2004, J MATER PROCESS TECH, V155, P1764, DOI 10.1016/j.jmatprotec.2004.04.395
   Chua SND, 2002, J MATER PROCESS TECH, V120, P335, DOI 10.1016/S0924-0136(01)01127-X
   CONNOLLEY T, UNPUB
   Delaire F, 2000, ACTA MATER, V48, P1075, DOI 10.1016/S1359-6454(99)00408-5
   Dumoulin C, 2000, J BIOMECH, V33, P1461, DOI 10.1016/S0021-9290(00)00098-1
   FRANCIOSI P, 1985, ACTA METALL MATER, V33, P1601, DOI 10.1016/0001-6160(85)90154-3
   Holzapfel G, 2005, J BIOMECH ENG-T ASME, V127, P166, DOI 10.1115/1.1835362
   Hong HK, 2002, J ENG MATER-T ASME, V124, P314, DOI 10.1115/1.1479355
   Huang Y., 1991, 178 MECH HARV U
   Kalidindi SR, 2004, P ROY SOC A-MATH PHY, V460, P1935, DOI 10.1098/rspa.2003.1260
   McGarry JP, 2004, COMP MATER SCI, V31, P421, DOI 10.1016/j.commatsci.2004.05.001
   MCGARRY JP, 2006, IN PRESS J APPL MECH
   MCHUGH PE, 1993, ACTA METALL MATER, V41, P1461, DOI 10.1016/0956-7151(93)90255-Q
   MCHUGH PE, 2004, MECH MICROSTRUCTURED, V464, P125
   Migliavacca F, 2002, J BIOMECH, V35, P803, DOI 10.1016/S0021-9290(02)00033-7
   Murphy BP, 2006, J MATER SCI-MATER M, V17, P1, DOI 10.1007/s10856-006-6323-5
   Murphy BP, 2003, ANN BIOMED ENG, V31, P686, DOI 10.1114/1.1569268
   Okamoto K, 2000, MATER T JIM, V41, P806, DOI 10.2320/matertrans1989.41.806
   Panchanadeeswaran S, 1996, ACTA MATER, V44, P1233, DOI 10.1016/1359-6454(95)00186-7
   PEIRCE D, 1983, ACTA METALL MATER, V31, P1951, DOI 10.1016/0001-6160(83)90014-7
   Perry M, 2002, MINIM INVASIV THER, V11, P165, DOI 10.1080/136457002760273377
   Poncin P., 2003, P MAT PROC MED DEV C, P253
   PONCIN P, 2005, P C MAT PROC MED DEV, P274
   Sachtleber M, 2002, MAT SCI ENG A-STRUCT, V336, P81, DOI 10.1016/S0921-5093(01)01974-8
   Savage P, 2004, ANN BIOMED ENG, V32, P202, DOI 10.1023/B:ABME.0000012740.47963.9e
   Schroeter DM, 2003, INT J PLASTICITY, V19, P1355, DOI 10.1016/S0749-6419(02)00040-2
   Tan LB, 2001, INT J CARDIOL, V78, P51, DOI 10.1016/S0167-5273(00)00472-1
   Tatschl A, 2003, MAT SCI ENG A-STRUCT, V339, P265, DOI 10.1016/S0921-5093(02)00111-9
   Tatschl A, 2003, MAT SCI ENG A-STRUCT, VA 356, P447
   Taylor GI, 1938, J I MET, V62, P307
NR 38
TC 13
Z9 13
U1 2
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6454
EI 1873-2453
J9 ACTA MATER
JI Acta Mater.
PD OCT
PY 2006
VL 54
IS 18
BP 4825
EP 4840
DI 10.1016/j.actamat.2006.06.021
PG 16
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 097GT
UT WOS:000241435900018
DA 2018-10-20
ER

PT J
AU De Smet, AA
   Tuite, MJ
AF De Smet, Arthur A.
   Tuite, Michael J.
TI Use of the "two-slice-touch" rule for the MRI diagnosis of meniscal
   tears
SO AMERICAN JOURNAL OF ROENTGENOLOGY
LA English
DT Article
DE biomedical statistics; knee; meniscal tears; MRI; musculoskeletal
   imaging
ID FAST SPIN-ECHO; ANTERIOR CRUCIATE LIGAMENT; ARTHROSCOPIC CORRELATION;
   IMAGING EVALUATION; KNEE; ACCURACY; PATTERNS
AB OBJECTIVE. We reviewed our experience with knee MRI to determine if using the "two-slice-touch" rule increased our positive predictive value for diagnosing meniscal tears. This rule classifies a meniscus as torn if there are two or more MR images with abnormal findings and as possibly torn if there is only one MR image with an abnormal finding. We also compared our sensitivity and specificity using fast spin-echo imaging with previously reported studies.
   MATERIALS AND METHODS. We reviewed the medical records of 174 patients who had knee MR examinations and correlative knee arthroscopy to determine our accuracy when we diagnosed menisci as torn, possibly torn, or intact using knee arthroscopy as the gold standard.
   RESULTS. Our positive predictive value increased from 91% to 94% (P = 0.37) for medial meniscal tears and from 83% to 96% (p = 0.02) for lateral meniscal tears when using, the two-slice-touch rule compared with the standard criterion of diagnosing a meniscus as torn if one or more images are abnormal. When using the standard criterion, we had 95% sensitivity and 85% specificity for diagnosing medial meniscal tears and 77% sensitivity and 89% specificity for diagnosing lateral meniscal tears.
   CONCLUSION. When using the two-slice-touch rule, we had an increased positive predictive value for diagnosing menisci as torn, which was statistically significant for the lateral meniscus. Our accuracy using the standard criterion with fast spin-echo imaging was comparable to that reported in previous studies with spin-echo imaging.
C1 Univ Wisconsin Med Sch & Hosp, Dept Radiol, Madison, WI 53792 USA.
RP De Smet, AA (reprint author), Univ Wisconsin Med Sch & Hosp, Dept Radiol, E3-311,600 Highland Ave, Madison, WI 53792 USA.
CR ANDERSON MW, 1995, ACAD RADIOL, V2, P209, DOI 10.1016/S1076-6332(05)80166-7
   Blackmon GB, 2005, AM J ROENTGENOL, V184, P1740, DOI 10.2214/ajr.184.6.01841740
   Blankenbaker DG, 2002, AM J ROENTGENOL, V178, P579, DOI 10.2214/ajr.178.3.1780579
   Cheung LP, 1997, RADIOLOGY, V203, P508, DOI 10.1148/radiology.203.2.9114113
   CRUES JV, 1987, RADIOLOGY, V164, P445, DOI 10.1148/radiology.164.2.3602385
   DESMET AA, 1993, AM J ROENTGENOL, V160, P555, DOI 10.2214/ajr.160.3.8430552
   DESMET AA, 1994, AM J ROENTGENOL, V162, P905, DOI 10.2214/ajr.162.4.8141016
   DESMET AA, 1993, AM J ROENTGENOL, V161, P101, DOI 10.2214/ajr.161.1.8517286
   Escobedo EM, 1996, AM J ROENTGENOL, V167, P1223, DOI 10.2214/ajr.167.5.8911185
   FISCHER SP, 1991, J BONE JOINT SURG AM, V73A, P2, DOI 10.2106/00004623-199173010-00002
   JUSTICE WW, 1995, RADIOLOGY, V196, P617, DOI 10.1148/radiology.196.3.7644620
   Kaplan PA, 1999, RADIOLOGY, V211, P747, DOI 10.1148/radiology.211.3.r99jn30747
   Kojima KY, 1996, MAGN RESON IMAGING, V14, P1017, DOI 10.1016/S0730-725X(96)00144-0
   Kowalchuk RM, 2000, SKELETAL RADIOL, V29, P520, DOI 10.1007/s002560000212
   MINK JH, 1988, RADIOLOGY, V167, P769, DOI 10.1148/radiology.167.3.3363138
   QUINN SF, 1991, RADIOLOGY, V181, P843, DOI 10.1148/radiology.181.3.1947108
   Rubin D A, 2000, Magn Reson Imaging Clin N Am, V8, P243
   RUBIN DA, 1994, AM J ROENTGENOL, V162, P1131, DOI 10.2214/ajr.162.5.8165997
   Rubin DA, 1998, AM J ROENTGENOL, V170, P1207, DOI 10.2214/ajr.170.5.9574586
   Vande Berg BC, 2005, RADIOLOGY, V234, P842, DOI 10.1148/radiol.2343031601
NR 20
TC 83
Z9 84
U1 0
U2 0
PU AMER ROENTGEN RAY SOC
PI RESTON
PA 1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA
SN 0361-803X
J9 AM J ROENTGENOL
JI Am. J. Roentgenol.
PD OCT
PY 2006
VL 187
IS 4
BP 911
EP 914
DI 10.2214/AJR.05.1354
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 088EL
UT WOS:000240794200014
PM 16985134
DA 2018-10-20
ER

PT J
AU Lutzow, K
   Weigel, T
   Lendlein, A
AF Luetzow, Karola
   Weigel, Thomas
   Lendlein, Andreas
TI Poly(ether imide) scaffolds as multifunctional materials for potential
   applications in regenerative medicine
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 43rd Tutzing Symposium on Regenerative Medicine - Membranes and
   Scaffolds
CY NOV 20-23, 2005
CL Tutzing, GERMANY
SP DECHEMA
DE scaffolds; poly(ether imide); extracorporeal blood detoxification;
   porous microparticles; hollow fibers; separation; biocompatibility
ID HOLLOW-FIBER MEMBRANES; SHAPE-MEMORY; BIOMEDICAL APPLICATIONS; IN-VITRO;
   POLYETHERIMIDE; BIOCOMPATIBILITY; POLYMER; BIOMATERIALS; ADSORPTION;
   MIXTURES
AB This article gives an overview of scaffolds that can be prepared from poly(ether imide) (PEI). These scaffolds were developed for extracorporeal blood detoxification processes in which specific compounds from blood or plasma are removed selectively. Both the preparation of porous microparticles and the preparation of hollow fibers are described. Commercially available particulate support materials have the disadvantage of a low accessibility of the internal pore system, a poor flow-through behavior and low adsorption specificity. Thus, novel support materials with optimally adapted properties profiles are needed. The second part of this article shows some recently developed highly asymmetric PEI hollow fibers. PEI scaffolds can be considered multifunctional because they combine separation characteristics, biocompatibility, sufficient biostability, and the possibility of creating tailor-made biofunctional surfaces.
C1 GKSS Res Ctr GMBH, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr GMBH, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Albrecht W, 2006, J MEMBRANE SCI, V273, P106, DOI 10.1016/j.memsci.2005.09.043
   Albrecht W, 2005, J MEMBRANE SCI, V262, P69, DOI 10.1016/j.memsci.2005.03.042
   Albrecht W, 2003, MACROMOL CHEM PHYSIC, V204, P510, DOI 10.1002/macp.200390016
   Albrecht W, 2001, J MEMBRANE SCI, V192, P217, DOI 10.1016/S0376-7388(01)00504-X
   Altankov G, 2005, J BIOMAT SCI-POLYM E, V16, P23, DOI 10.1163/1568562052843320
   Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   De Santis R, 2000, J INORG BIOCHEM, V79, P97, DOI 10.1016/S0162-0134(99)00228-7
   Klinkmann H, 2001, NEPHROL DIAL TRANSPL, V16, P97, DOI 10.1093/ndt/16.suppl_6.97
   KNEIFEL K, 1992, J MEMBRANE SCI, V65, P295, DOI 10.1016/0376-7388(92)87030-2
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Loeb S, 1962, ADV CHEM SER, V38, P117
   Merolli A, 1999, J MATER SCI-MATER M, V10, P265, DOI 10.1023/A:1008949311714
   Mulder M., 1996, BASIC PRINCIPLES MEM
   Nunes SP, 2001, MEMBRANE TECHNOLOGY
   Peinemann KV, 1998, POLYMER, V39, P3411, DOI 10.1016/S0032-3861(97)10067-2
   PELUSO G, 1994, J MATER SCI-MATER M, V5, P738, DOI 10.1007/BF00120367
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Santoso F, 2003, J MEMBRANE SCI, V223, P171, DOI 10.1016/S0376-7388(03)00321-1
   Seifert B, 2002, ARTIF ORGANS, V26, P189, DOI 10.1046/j.1525-1594.2002.06876.x
   Tao CT, 2006, J MEMBRANE SCI, V269, P66, DOI 10.1016/j.memsci.2005.06.019
   Trimpert C, 2006, MACROMOL BIOSCI, V6, P274, DOI 10.1002/mabi.200500238
   Tzoneva R, 2002, J BIOMAT SCI-POLYM E, V13, P1033, DOI 10.1163/156856202760319171
   Vienken J, 2002, ARTIF ORGANS, V26, P152, DOI 10.1046/j.1525-1594.2002.06854.x
   WEIGEL T, 1993, ACTA POLYM, V44, P87, DOI 10.1002/actp.1993.010440205
NR 27
TC 10
Z9 10
U1 2
U2 8
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD OCT
PY 2006
VL 30
IS 10
BP 764
EP 769
DI 10.1111/j.1525-1594.2006.00298.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 090ZT
UT WOS:000240995800005
PM 17026575
DA 2018-10-20
ER

PT J
AU Jones, JR
   Ehrenfried, LM
   Hench, LL
AF Jones, JR
   Ehrenfried, LM
   Hench, LL
TI Optimising bioactive glass scaffolds for bone tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE scaffold; porosity; bioactive glass; mechanical properties; in vitro
   test
ID BIOMEDICAL MATERIALS; SURFACE; BIOCERAMICS; BEHAVIOR; 45S5; CELL
AB A 3D scaffold has been developed that has the potential to fulfil the criteria for an ideal scaffold for bone tissue engineering. Sol-gel derived bioactive glasses of the 70S30C (70mol% SiO2, 30mol% CaO) composition have been foamed to produce 3D bioactive scaffolds with hierarchical interconnected pore morphologies similar to trabecular bone. The scaffolds consist of a hierarchical pore network with macropores in excess of 500 mu m connected by pore windows with diameters in excess of 100 mu m, which is thought to be the minimum pore diameter required for tissue ingrowth and vasularisation in the human body. The scaffolds also have textural porosity in the mesopore range (10-20 nm). The scaffolds were sintered at 600, 700, 800 and 1000 degrees C. As sintering temperature was increased to 800 degrees C the compressive strength increased from 0.34 to 2.26 MPa due to a thickening of the pore walls and a reduction in the textural porosity. The compressive strength is in the range of that of trabecular bone (2-12 MPa). Importantly, the modal interconnected pore diameter (98 pm) was still suitable for tissue engineering applications and bioactivity is maintained. Bioactive glass foam scaffolds sintered at 800 degrees C for 2 h fulfill the criteria for an ideal scaffold for tissue engineering applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   Tech Univ Munich, Zentral Inst Med Tech, D-8000 Munich, Germany.
RP Jones, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, S Kensington Campus, London SW7 2AZ, England.
EM julian.r.jones@imperial.ac.uk
RI Jones, Julian/B-1007-2012
OI Jones, Julian/0000-0002-2647-8024
CR [Anonymous], 1377912000 BS ISO
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   Coleman NJ, 2000, CERAM INT, V26, P171, DOI 10.1016/S0272-8842(99)00037-1
   De Boer J., 1958, STRUCTURE PROPERTIES, P68
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Jones J.R., 2003, J MATER SCI, V38, P1, DOI DOI 10.1023/A:1025988301542
   Jones JR, 2004, J BIOMED MATER RES B, V68B, P36, DOI 10.1002/jbm.b.10071
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Kleitz F, 2001, MICROPOR MESOPOR MAT, V44, P95, DOI 10.1016/S1387-1811(01)00173-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LOWELL S, 1984, POWDER TECHNOL, V38, P121, DOI 10.1016/0032-5910(84)80041-8
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Okii N, 2001, NEUROL MED-CHIR, V41, P100, DOI 10.2176/nmc.41.100
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Richet P, 1998, PHYS CHEM MINER, V25, P401, DOI 10.1007/s002690050130
   Roman J, 2003, CHEM MATER, V15, P798, DOI 10.1021/cm021325c
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Takezawa T, 2003, BIOMATERIALS, V24, P2267, DOI 10.1016/S0142-9612(03)00038-3
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 29
TC 393
Z9 409
U1 10
U2 126
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 7
BP 964
EP 973
DI 10.1016/j.biomaterials.2005.07.017
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 996BB
UT WOS:000234148300003
PM 16102812
DA 2018-10-20
ER

PT J
AU Situma, C
   Hashimoto, M
   Soper, SA
AF Situma, Catherine
   Hashimoto, Masahiko
   Soper, Steven A.
TI Merging microfluidics with microarray-based bioassays
SO BIOMOLECULAR ENGINEERING
LA English
DT Review
DE microfluidics; microarrays; DNA diagnostics; protein arrays; cell arrays
ID NUCLEIC-ACID HYBRIDIZATION; TOTAL ANALYSIS SYSTEMS; DNA HYBRIDIZATION;
   POLY(METHYL METHACRYLATE); CAPILLARY-ELECTROPHORESIS; MICROANALYTICAL
   DEVICES; SURFACE MODIFICATION; COVALENT ATTACHMENT; PROTEIN MICROARRAYS;
   CELL MICROARRAYS
AB Microarray technologies provide powerful tools for biomedical researchers and medicine, since arrays can be configured to monitor the presence of molecular signatures in a highly parallel fashion and can be configured to search either for nucleic acids (DNA microarrays) or proteins (antibody-based microarrays) as well as different types of cells. Microfluidics on the other hand, provides the ability to analyze small volumes (micro-, nano- or even pico-liters) of sample and minimize costly reagent consumption as well as automate sample preparation and reduce sample processing time. The marriage of microarray technologies with the emerging field of microfluidics provides a number of advantages such as, reduction in reagent cost, reductions in hybridization assay times, high-throughput sample processing, and integration and automation capabilities of the front-end sample processing steps. However, this potential marriage is also fraught with some challenges as well, such as developing low-cost manufacturing methods of the fluidic chips, providing good interfaces to the macro-world, minimizing non-specific analyte/wall interactions due to the high surface-to-volurne ratio associated with microfluidics, the development of materials that accommodate the optical readout phases of the assay and complete integration of peripheral components (optical and electrical) to the microfluidic to produce autonomous systems appropriate for point-of-care testing. In this review, we provide an overview and recent advances on the coupling of DNA, protein and cell microarrays to microfluidics and discuss potential improvements required for the implementation of these technologies into biomedical and clinical applications. (c) 2006 Published by Elsevier B.V.
C1 Louisiana State Univ, Dept Chem, Ctr Biomol Multiscale Syst, Baton Rouge, LA 70803 USA.
RP Soper, SA (reprint author), Louisiana State Univ, Dept Chem, Ctr Biomol Multiscale Syst, Baton Rouge, LA 70803 USA.
EM chsope@lsu.edu
FU NIBIB NIH HHS [R01-EB00215]
CR Ahn S, 2005, ANAL CHEM, V77, P5041, DOI 10.1021/ac0505270
   Ali MF, 2003, ANAL CHEM, V75, P4732, DOI 10.1021/ac034106z
   Anderson JR, 2000, ANAL CHEM, V72, P3158, DOI 10.1021/ac9912294
   Anderson MC, 2000, J WOMENS HIST, V12, P60
   Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t
   BANER J, 2003, NUCLEIC ACIDS RES, V31, DOI UNSP E103/1-E03/7
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Benoit V, 2001, ANAL CHEM, V73, P2412, DOI 10.1021/ac000946r
   BOERNER MW, 1996, MICROELECTRON ENG, V30, P505
   BRADLEY LP, 2003, BMC GENOM ELECT RESO, V4, P23
   Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484
   Burns MA, 1996, P NATL ACAD SCI USA, V93, P5556, DOI 10.1073/pnas.93.11.5556
   Bussow K, 2000, GENOMICS, V65, P1, DOI 10.1006/geno.2000.6141
   Bynum MA, 2004, ANAL CHEM, V76, P7039, DOI 10.1021/ac048840+
   Cheek BJ, 2001, ANAL CHEM, V73, P5777, DOI 10.1021/ac0108616
   Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439
   Chung YC, 2004, J MICROMECH MICROENG, V14, P1376, DOI 10.1088/0960-1317/14/10/012
   Chung YC, 2003, LAB CHIP, V3, P228, DOI 10.1039/b307954f
   CSAKI A, 2001, NUCLEIC ACIDS RES, V29, DOI UNSP E81/1-E81/5
   Dimalanta ET, 2004, ANAL CHEM, V76, P5293, DOI 10.1021/ac0496401
   Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434
   Edman CF, 1997, NUCLEIC ACIDS RES, V25, P4907, DOI 10.1093/nar/25.24.4907
   Erali M, 2003, CLIN CHEM, V49, P732, DOI 10.1373/49.5.732
   Erickson D, 2004, ANAL CHEM, V76, P7269, DOI 10.1021/ac049396d
   Fan ZH, 1999, ANAL CHEM, V71, P4851, DOI 10.1021/ac9902190
   Fixe F, 2004, LAB CHIP, V4, P191, DOI 10.1039/b316616c
   FIXE F, 2004, NUCL ACIDS RES, V32
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Ford SM, 1999, J BIOMECH ENG-T ASME, V121, P13, DOI 10.1115/1.2798035
   Friedrich CR, 1997, MICROELECTRON ENG, V35, P367, DOI 10.1016/S0167-9317(96)00198-0
   Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330
   GINGERAS TR, 1987, NUCLEIC ACIDS RES, V15, P5373, DOI 10.1093/nar/15.13.5373
   Gong YK, 2005, J BIOMED MATER RES A, V72A, P1, DOI 10.1002/jba.a.30135
   Grass B, 2001, SENSOR ACTUAT B-CHEM, V72, P249, DOI 10.1016/S0925-4005(00)00643-2
   Grimm V, 2004, J CLIN MICROBIOL, V42, P4918, DOI 10.1128/JCM.42.10.4918.2004
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Hashimoto M, 2006, BIOSENS BIOELECTRON, V21, P1915, DOI 10.1016/j.bios.2006.01.014
   He B, 1999, ANAL CHEM, V71, P1464, DOI 10.1021/ac981010+
   Henry AC, 2000, ANAL CHEM, V72, P5331, DOI 10.1021/ac000685l
   Horvath J, 2001, ELECTROPHORESIS, V22, P644, DOI 10.1002/1522-2683(200102)22:4<644::AID-ELPS644>3.0.CO;2-3
   Hu SW, 2004, ANAL CHEM, V76, P1865, DOI 10.1021/ac049937z
   Ihlemann J, 2000, APPL SURF SCI, V154, P587, DOI 10.1016/S0169-4332(99)00464-X
   Ishikawa S, 2005, BIOCHEM BIOPH RES CO, V333, P1309, DOI 10.1016/j.bbrc.2005.06.040
   Joos B, 1997, ANAL BIOCHEM, V247, P96, DOI 10.1006/abio.1997.2017
   Kanda V, 2004, ANAL CHEM, V76, P7257, DOI 10.1021/ac049318q
   KAPUR R, 2005, MICROARRAY TECHNOL A, P335
   Keramas G, 2004, LAB CHIP, V4, P152, DOI 10.1039/b313472e
   Khademhosseini A, 2004, LAB CHIP, V4, P425, DOI 10.1039/b404842c
   Kim HL, 2003, EXP MOL MED, V35, P460, DOI 10.1038/emm.2003.60
   Koh WG, 2003, ANAL CHEM, V75, P5783, DOI 10.1021/ac034773s
   KOHARA Y, 2002, NUCL ACIDS RES, V30
   Lebrun S. J., 2005, PHARM DISCOV S, P53
   Lee HJ, 2001, ANAL CHEM, V73, P5525, DOI 10.1021/ac010762s
   Lee KB, 2003, J PHARM SCI, V92, P933, DOI 10.1002/jps.10556
   Lenigk R, 2002, ANAL BIOCHEM, V311, P40, DOI 10.1016/S0003-2697(02)00391-3
   Li JJ, 1999, ANAL CHEM, V71, P3036, DOI 10.1021/ac981420y
   Lilliehorn T, 2005, SENSOR ACTUAT B-CHEM, V106, P851, DOI 10.1016/j.snb.2004.07.003
   Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069
   Lipsitt DR, 1999, GEN HOSP PSYCHIAT, V21, P1
   Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407
   Liu Jie, 2004, Journal of Pharmacological and Toxicological Methods, V50, P67, DOI 10.1016/j.vascn.2004.02.001
   Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029
   Liu RH, 2003, ANAL CHEM, V75, P1911, DOI 10.1021/ac026267t
   Liu YJ, 2003, ANAL BIOCHEM, V317, P76, DOI 10.1016/S0003-2697(03)00051-4
   Love JC, 2001, LANGMUIR, V17, P6005, DOI 10.1021/la010655t
   Lovmar L, 2003, J CLIN MICROBIOL, V41, P5153, DOI 10.1128/JCM.41.11.5153-5158.2003
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 2000, SCIENCE, V289, P1760
   Marquette CA, 2004, ANAL CHIM ACTA, V506, P127, DOI 10.1016/j.aca.2003.11.015
   Martynova L, 1997, ANAL CHEM, V69, P4783, DOI 10.1021/ac970558y
   McCarley RL, 2005, J AM CHEM SOC, V127, P842, DOI 10.1021/ja0454135
   McClain MA, 2003, ANAL CHEM, V75, P5646, DOI 10.1021/ac0346510
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027
   Moorcroft M. J., 2005, NUCL ACIDS RES, V33
   Nagamine K, 2005, ANAL CHEM, V77, P4278, DOI 10.1021/ac048278n
   Noerholm M, 2004, LAB CHIP, V4, P28, DOI 10.1039/b311991b
   Nuzzo RG, 2003, NAT MATER, V2, P207, DOI 10.1038/nmat872
   Okamoto T, 2000, NAT BIOTECHNOL, V18, P438
   Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o
   Pal R, 2005, LAB CHIP, V5, P1024, DOI 10.1039/b505994a
   PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022
   Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163
   Qi SZ, 2002, LAB CHIP, V2, P88, DOI [10.1039/b200370h, 10.1039/b20037h]
   Ressine A, 2003, ANAL CHEM, V75, P6968, DOI 10.1021/ac034425q
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Rossier JS, 1999, ELECTROPHORESIS, V20, P727, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<727::AID-ELPS727>3.3.CO;2-1
   Sato K, 2001, ANAL CHEM, V73, P1213, DOI 10.1021/ac000991z
   Sebra RP, 2005, LANGMUIR, V21, P10907, DOI 10.1021/la052101m
   Shadpour H, 2006, J CHROMATOGR A, V1111, P238, DOI 10.1016/j.chroma.2005.08.083
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   Situma C, 2005, ANAL BIOCHEM, V340, P123, DOI 10.1016/j.ab.2005.01.044
   Soper S.A., 2000, ANAL CHEM, V72, p643A
   Sosnowski RG, 1997, P NATL ACAD SCI USA, V94, P1119, DOI 10.1073/pnas.94.4.1119
   SOUTHERN EM, 1994, NUCLEIC ACIDS RES, V22, P1368, DOI 10.1093/nar/22.8.1368
   Steel AB, 2000, BIOPHYS J, V79, P975, DOI 10.1016/S0006-3495(00)76351-X
   Su J, 2005, J AM CHEM SOC, V127, P7280, DOI 10.1021/ja061371o
   Tani H, 2004, ANAL CHEM, V76, P6693, DOI 10.1021/ac049401d
   Thompson DM, 2004, ANAL CHEM, V76, P4098, DOI 10.1021/ac0354241
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Vanderhoeven J, 2004, ELECTROPHORESIS, V25, P3677, DOI 10.1002/elps.200406116
   Waddell E, 2000, ANAL CHEM, V72, P5907, DOI 10.1021/ac0009705
   Wang Y, 2003, ANAL CHEM, V75, P1130, DOI 10.1021/ac020683w
   Wei CW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni078
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1
   Xu H. X., 2003, NUCL ACIDS RES, V31
   Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o
   Yaralioglu GG, 2004, ANAL CHEM, V76, P3694, DOI 10.1021/ac035220k
   Yuen PK, 2003, LAB CHIP, V3, P46, DOI 10.1039/b210274a
   ZHANG Y, 1991, NUCLEIC ACIDS RES, V19, P3929, DOI 10.1093/nar/19.14.3929
NR 115
TC 122
Z9 126
U1 4
U2 83
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD OCT
PY 2006
VL 23
IS 5
BP 213
EP 231
DI 10.1016/j.bioeng.2006.03.002
PG 19
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 088EY
UT WOS:000240795600001
PM 16905357
DA 2018-10-20
ER

PT J
AU Allcock, HR
AF Allcock, Harry R.
TI Recent developments in polyphosphazene materials science
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
DE polymers; hybrid materials; phosphazenes; synthesis; materials design
ID LIVING CATIONIC-POLYMERIZATION; AMBIENT-TEMPERATURE POLYMERIZATION;
   OPENING METATHESIS POLYMERIZATION; LIQUID-CRYSTALLINE PHOSPHAZENES;
   SKELETAL TISSUE REGENERATION; OXIDE) BLOCK-COPOLYMERS; HIGH
   REFRACTIVE-INDEXES; METHANOL FUEL-CELLS; SIDE-GROUPS; TELECHELIC
   POLYPHOSPHAZENES
AB The expanding scope of polyphosphazenes in materials science is described. This expansion involves new methods of synthesis that provide access to novel polymer architectures, and materials with useful combinations of properties that include superhydrophobic surfaces, biomedical materials, responsive membranes, photonic materials, battery electrolytes, fuel cell membranes, fire-resistant polymers, and new systems that generate micelles, stars, and dendrimers. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
RP Allcock, HR (reprint author), Penn State Univ, Dept Chem, 152 Davey Lab, University Pk, PA 16802 USA.
EM hra@chem.psu.edu
CR Allcock H. R., 2002, ACS SYM SER, V833, P82
   Allcock H.R., 2003, CHEM APPL POLYPHOSPH
   Allcock HR, 2006, MACROMOLECULES, V39, P8334, DOI 10.1021/ma061531w
   Allcock HR, 2006, J POLYM SCI POL PHYS, V44, P2358, DOI 10.1002/polb.20864
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   Allcock HR, 1999, MACROMOLECULES, V32, P5736, DOI 10.1021/ma990318f
   Allcock HR, 2006, POLYM INT, V55, P621, DOI 10.1002/pi.2030
   Allcock HR, 2006, SOLID STATE IONICS, V177, P741, DOI 10.1016/j.ssi.2006.01.039
   Allcock HR, 2006, SOLID STATE IONICS, V177, P569, DOI 10.1016/j.ssi.2005.11.017
   Allcock HR, 1999, MACROMOLECULES, V32, P7999, DOI 10.1021/ma990969b
   Allcock HR, 2004, PHOSPHAZENES: A WORLDWIDE INSIGHT, P49
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2841, DOI 10.1021/ma00010a031
   Allcock HR, 2005, MACROMOLECULES, V38, P10406, DOI 10.1021/ma051709z
   Allcock HR, 1997, MACROMOLECULES, V30, P2213, DOI 10.1021/ma961639j
   Allcock HR, 2000, MACROMOLECULES, V33, P3999, DOI 10.1021/ma991890+
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2846, DOI 10.1021/ma00010a032
   ALLCOCK HR, 1966, INORG CHEM, V5, P1716, DOI 10.1021/ic50044a017
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   Allcock HR, 2004, MACROMOLECULES, V37, P7163, DOI 10.1021/ma049364s
   Allcock HR, 2004, MACROMOLECULES, V37, P5824, DOI 10.1021/ma040049f
   Allcock HR, 1997, MACROMOLECULES, V30, P50, DOI 10.1021/ma961215p
   Allcock HR, 1996, MACROMOLECULES, V29, P7740, DOI 10.1021/ma960876j
   Allcock HR, 1998, MACROMOLECULES, V31, P8026, DOI 10.1021/ma9804491
   Allcock HR, 1998, MACROMOLECULES, V31, P753, DOI 10.1021/ma971666p
   Allcock HR, 2003, MACROMOLECULES, V36, P3563, DOI 10.1021/ma0217478
   Allcock HR, 2003, CHEM MATER, V15, P473, DOI 10.1021/cm020912v
   Allcock HR, 1997, MACROMOLECULES, V30, P3184, DOI 10.1021/ma9616423
   Allcock HR, 2002, J MEMBRANE SCI, V201, P47, DOI 10.1016/S0376-7388(01)00702-5
   Allcock HR, 2002, MACROMOLECULES, V35, P40, DOI 10.1021/ma011012n
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   Allcock HR, 2001, MACROMOLECULES, V34, P787, DOI 10.1021/ma001166n
   Allcock HR, 2001, MACROMOLECULES, V34, P5140, DOI 10.1021/ma010084b
   Allcock HR, 2001, SOLID STATE IONICS, V143, P297, DOI 10.1016/S0167-2738(01)00872-4
   Allcock HR, 2001, SOLID STATE IONICS, V139, P27, DOI 10.1016/S0167-2738(00)00807-9
   Allcock HR, 2001, MACROMOLECULES, V34, P5463, DOI 10.1021/ma00185lu
   Allcock HR, 2001, MACROMOLECULES, V34, P6858, DOI 10.1021/ma010088g
   Allcock HR, 2001, MACROMOLECULES, V34, P3896, DOI 10.1021/ma001735r
   Allcock HR, 2001, MACROMOLECULES, V34, P2757, DOI 10.1021/ma001686i
   Allcock HR, 2001, MACROMOLECULES, V34, P748, DOI 10.1021/ma000574o
   Allcock HR, 1999, INORG CHEM, V38, P5535, DOI 10.1021/ic9904541
   Allcock HR, 1999, MACROMOLECULES, V32, P7719, DOI 10.1021/ma990752h
   ALLCOCK HR, 1990, MACROMOLECULES, V23, P3881, DOI 10.1021/ma00219a003
   Allcock HR, 1996, BIOMATERIALS, V17, P2295, DOI 10.1016/0142-9612(96)00073-7
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P2596, DOI 10.1021/ma00196a009
   ALLCOCK HR, 2007, LANGMUIR, V2, P8103
   ALLCOCK HR, 2003, POLYM ADV TECHNOLOGY, P132
   ALLCOCK HR, 2005, CHEM MATER, V6, P1689
   ALLCOCK HR, 2006, J POLYM SCI, V44, P69
   ALLCOCK HR, 2002, MACROMOLECULES, V35, P3483
   ALLEN CW, 1979, IND ENG CHEM PROD RD, V18, P80, DOI 10.1021/i360069a018
   ALLEN W, 2007, J INORG ORGANOMET P, V17, P339
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   AMBROSIO AMA, 1999, P SOC BIOMATER, V25, P9
   Barrett EW, 2005, BIOMACROMOLECULES, V6, P1689, DOI 10.1021/bm049193z
   BARRETT EW, 2004, PMSE, V91, P633
   BENNETT JL, 1989, CHEM MATER, V1, P14
   Bhattacharyya S, 2005, MATER RES SOC SYMP P, V845, P91
   BHATTACHARYYA S, 2005, P MAT RES SOC, V845, P291
   BHATTACHARYYA S, 2004, P MAT RES SOC
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   Brown JL, 2007, MATER LETT, V61, P3692, DOI 10.1016/j.matlet.2006.12.020
   Chang Y, 2002, BIOMACROMOLECULES, V3, P1364, DOI 10.1021/bm0200087b
   Chang Y, 2001, MACROMOLECULES, V34, P269, DOI 10.1021/ma992036l
   CHANG Y, 2003, POLYM PREPR, V44, P922
   Chang YK, 2005, J POLYM SCI POL CHEM, V43, P2912, DOI 10.1002/pola.20748
   Chang YK, 2003, MACROMOLECULES, V36, P2568, DOI 10.1021/ma021490d
   Chang YY, 2002, MACROMOLECULES, V35, P8556, DOI 10.1021/ma0206063
   Cho SY, 2007, MACROMOLECULES, V40, P3115, DOI 10.1021/ma062582w
   CHO SY, 2007, UNPUB NOVEL HIGHLY F
   Conner DA, 2007, MACROMOLECULES, V40, P322, DOI 10.1021/ma061916e
   DEMBEK AA, 1990, CHEM MATER, V2, P97, DOI 10.1021/cm00008a005
   Fedkin MV, 2002, MATER LETT, V52, P192, DOI 10.1016/S0167-577X(01)00391-3
   Fei ST, 2006, SOFT MATTER, V2, P397, DOI 10.1039/b516972k
   Frech R, 2004, MACROMOLECULES, V37, P8699, DOI 10.1021/ma040067x
   Gao L, 2002, ELECTROCHIM ACTA, V47, P3863, DOI 10.1016/S0013-4686(02)00327-4
   GLERIA M, 2004, POLYPHOSPHAZENES WOR
   Greish YE, 2006, J BIOMED MATER RES A, V77A, P416, DOI 10.1002/jbm.a.30145
   GREISH YE, 2004, BIOMATERIALS, V26, P1
   HARRY R, 2006, J INORG ORGANOMET P, V16, P271
   Hartle TJ, 2000, MACROMOLECULES, V33, P4307, DOI 10.1021/ma000089t
   Hofmann MA, 2002, MACROMOLECULES, V35, P6490, DOI 10.1021/ma020330z
   HONEYMAN CH, 1995, J AM CHEM SOC, V117, P7035, DOI 10.1021/ja00131a040
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Klein RJ, 2007, MACROMOLECULES, V40, P3990, DOI 10.1021/ma070357o
   LAKSHMI S, 2006, J BIOMATER RES A, V76, P206
   LAKSHMI S, 2003, P ANN M ORTH RES SOC, P937
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   LAURENCIN CT, 1998, SOC BIOMATER, P436
   LAURENCIN CT, 1997, BIOACT MAT, V24, P971
   LAURENCIN CT, 1998, P 1997 PORTL BON S, P490
   LAURENCIN CT, 1998, SOCBIOMATER ABSTR
   Lvov S. N., 2000, P INT S EN ENG 21 CE, P1483
   Morford RV, 2006, SOLID STATE IONICS, V177, P721, DOI 10.1016/j.ssi.2006.01.014
   Morford RV, 2000, SOLID STATE IONICS, V133, P171, DOI 10.1016/S0167-2738(00)00741-4
   Nair LS, 2006, J BIOMED MATER RES A, V76A, P206, DOI 10.1002/jbm.a.30532
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Nelson JM, 1998, MACROMOLECULES, V31, P947, DOI 10.1021/ma9716995
   Nelson JM, 1997, MACROMOLECULES, V30, P3191, DOI 10.1021/ma961875u
   Nelson JM, 1997, MACROMOLECULES, V30, P1854, DOI 10.1021/ma961619h
   Olshavsky M, 1997, MACROMOLECULES, V30, P4179, DOI 10.1021/ma961628q
   OLSHAVSKY MA, 1995, MACROMOLECULES, V28, P6188, DOI 10.1021/ma00122a028
   Prange R, 1999, MACROMOLECULES, V32, P6390, DOI 10.1021/ma991136o
   Prange R, 2000, MACROMOLECULES, V33, P5763, DOI 10.1021/ma000573w
   Singh A, 2006, BIOMACROMOLECULES, V7, P914, DOI 10.1021/bm050752r
   Singh A, 2005, LANGMUIR, V21, P11604, DOI 10.1021/la052110v
   SINGH A, 2005, POLYM PREPR ACS DIV, V46, P599
   STEELY L, 2007, UNPUB FOAM FORMATION
   Stone D. A., 2004, POLYM PREPR AM CHEM, V45, P696
   Stone DA, 2006, J POLYM SCI POL CHEM, V44, P69, DOI 10.1002/pola.21140
   Stone DA, 2007, CHEM MATER, V19, P2473, DOI 10.1021/cm062528u
   Stone DA, 2006, MACROMOLECULES, V39, P4935, DOI 10.1021/ma061079g
   SWAMINATHAN S, 2006, J BIOMED RES, V77, P679
   Tang H, 2001, J APPL POLYM SCI, V79, P49, DOI 10.1002/1097-4628(20010103)79:1<49::AID-APP60>3.0.CO;2-J
   Welna DT, 2006, CHEM MATER, V18, P4486, DOI 10.1021/cm060691j
   WELNA DT, 2005, POLYM PREPRINTS, V46, P1055
   WELNA DT, 2005, MATER RES SOC S, V848
   York S, 2001, ELECTROCHIM ACTA, V46, P1553, DOI 10.1016/S0013-4686(00)00752-0
   ZHOU X, 2001, P ELECTROCHEM SOC, P34
   Zhou XY, 2003, ELECTROCHIM ACTA, V48, P2173, DOI 10.1016/S0013-4686(03)00201-9
NR 121
TC 55
Z9 65
U1 6
U2 84
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD OCT-DEC
PY 2006
VL 10
IS 5-6
BP 231
EP 240
DI 10.1016/j.cossms.2007.06.001
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 223VT
UT WOS:000250401300004
DA 2018-10-20
ER

PT J
AU Sui, JH
   Cai, W
AF Sui, J. H.
   Cai, W.
TI Effect of diamond-like carbon (DLC) on the properties of the NiTi alloys
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE NiTi shape memory alloys; diamond-like carbon (DLC); plasma immersion
   ion implantation and deposition; corrosion resistance;
   hemocompatibility; protein adsorption
ID SHAPE-MEMORY ALLOY; IMMERSION ION-IMPLANTATION; CORROSION-RESISTANCE;
   TITANIUM NITRIDE; IMMUNE-RESPONSE; SURGICAL ALLOY; NICKEL RELEASE;
   SURFACE; PLASMA; BIOCOMPATIBILITY
AB NiTi alloy has found wide application in the biomedical field due to its unique shape memory effect, superelasticity and biocompatibility. However, the materials are vulnerable to surface corrosion and the most serious issue is out-diffusion of toxic Ni ions from the substrate into body tissues and fluids. In this paper, NiTi alloys were coated with diamond-like carbon (DLC) fabricated by plasma immersion ion implantation and deposition (PIIID) to improve their corrosion resistance and blood compatibility without sacrificing their shape memory effect and superelasticity. The structure of the films and the depth profiles between the films and substrate were studied using Raman spectroscopy and XPS, respectively. The phase transformation temperature, superelasticity, anticorrosion behavior and Ni ions release of the coated and uncoated sample were investigated by DSC, tensile tests, potentiodynamic polarization and AAS, respectively. The hemocompatibilty of the coated and uncoated samples was measured using clotting time and platelet adhesion. The results shows that the films is DLC accompanying with the formation of the mixing layer, and the DLC films can markedly improve the corrosion resistance and the hemocompatibility, obviously increase the ratio of albumin-to-fibrinogen and effectively block the Ni ions release of the NiTi alloys without sacrificing its superelasticity and changing its phase transformation temperature. The research results suggest DLC films prepared by PIIID could improve the in vivo performance of NiTi alloys implanted into the human body. (c) 2006 Elsevier B.V. All rights reserved.
C1 Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Cai, W (reprint author), Harbin Inst Technol, Sch Mat Sci & Engn, POB 405, Harbin 150001, Peoples R China.
EM suijiehe@hit.edu.cn; weicai@hit.edu.cn
CR Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Cheng Y, 2004, SURF COAT TECH, V176, P261, DOI 10.1016/S0257-8972(03)00745-X
   Chu CL, 2005, SCRIPTA MATER, V52, P1117, DOI 10.1016/j.scriptamat.2005.02.002
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Cui ZD, 2005, SURF COAT TECH, V192, P347, DOI 10.1016/j.surfcoat.2004.06.033
   Cui ZD, 2003, APPL SURF SCI, V208, P388, DOI 10.1016/S0169-4332(02)01414-9
   Deng JG, 1996, DIAM RELAT MATER, V5, P478, DOI 10.1016/0925-9635(96)80063-X
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   DION I, 1992, INT J ARTIF ORGANS, V15, P617
   DOMERREISEL A, 2004, SURF COAT TECH, V177, P830
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Fu Y, 2000, APPL SURF SCI, V157, P167, DOI 10.1016/S0169-4332(99)00494-8
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kobayashi S, 2005, DIAM RELAT MATER, V14, P1094, DOI 10.1016/j.diamond.2004.11.036
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Man HC, 2001, SCRIPTA MATER, V45, P1447, DOI 10.1016/S1359-6462(01)01182-4
   O'Brien B, 2002, BIOMATERIALS, V23, P1739, DOI 10.1016/S0142-9612(01)00299-X
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Rondelli G, 2000, J BIOMED MATER RES, V51, P47, DOI 10.1002/(SICI)1097-4636(200007)51:1<47::AID-JBM7>3.3.CO;2-G
   RONDELLI G, 1990, CORROS SCI, V30, P805, DOI 10.1016/0010-938X(90)90004-O
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Tan L, 2003, BIOMATERIALS, V24, P3931, DOI 10.1016/S0142-9612(03)00271-0
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   YOSHINO N, 1991, SURF COAT TECH, V47, P84, DOI 10.1016/0257-8972(91)90270-7
NR 32
TC 41
Z9 42
U1 1
U2 24
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD OCT
PY 2006
VL 15
IS 10
BP 1720
EP 1726
DI 10.1016/j.diamond.2006.03.004
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 094FD
UT WOS:000241224000034
DA 2018-10-20
ER

PT J
AU Buckley, PR
   McKinley, GH
   Wilson, TS
   Small, W
   Benett, WJ
   Bearinger, JP
   McElfresh, MW
   Maitland, DJ
AF Buckley, Patrick R.
   McKinley, Gareth H.
   Wilson, Thomas S.
   Small, Ward
   Benett, William J.
   Bearinger, Jane P.
   McElfresh, Michael W.
   Maitland, Duncan J.
TI Inductively heated shape memory polymer for the magnetic actuation of
   medical devices
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE Curie temperature; inductive heating magnetic particle; medical device;
   shape memory polymer (SMP)
ID BIOMEDICAL APPLICATIONS; FLUID HYPERTHERMIA; PARTICLES; NANOPARTICLES;
   POLYURETHANE; STROKE; SYSTEM; MODEL
AB Presently, there is interest in making medical devices such as expandable stents and intravascular microactuators from shape memory polymer (SMP). One of the key challenges in realizing SNIP medical devices is the implementation of a safe and effective method of thermally actuating various device geometries in vivo. A novel scheme of actuation by Curie-thermoregulated inductive heating is presented Prototype medical devices made from SNIP loaded with nickel zinc ferrite ferromagnetic particles were actuated in air by applying an alternating magnetic field to induce heating. Dynamic mechanical thermal analysis was performed on both the particle-loaded and neat SMP materials to assess the impact of the ferrite particles on the mechanical properties of the samples. Calorimetry was used to quantify the rate of heat generation as a function of particle size and volumetric loading of ferrite particles in the SNIP. These tests demonstrated the feasibility of SMP actuation by inductive heating. Rapid and uniform heating was achieved in complex device geometries and particle loading up to 10% volume content did not interfere with the shape recovery of the SMP.
C1 Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   MIT, Cambridge, MA 02139 USA.
RP Buckley, PR (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
EM buckley@alum.mit.edu; gareth@mit.edu; wilson97@llnl.gov;
   small3@llnl.gov; benett1@llnl.gov; bearingerl@llnl.gov;
   mcelfresl@llnl.gov; maitlandl@llnl.gov
RI McKinley, Gareth/G-4872-2011
OI McKinley, Gareth/0000-0001-8323-2779
FU NIBIB NIH HHS [R01 EB000462]
CR *AM, 2000, 8019096 AM
   ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372
   Bertmer M, 2005, MACROMOLECULES, V38, P3793, DOI 10.1021/ma0501489
   BLIZNAKOV E.D., 2000, J APPL POLYM SCI, V77, P3320
   Cetas TC, 1998, IEEE T BIO-MED ENG, V45, P68, DOI 10.1109/10.650354
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Gall K, 2002, ACTA MATER, V50, P5115, DOI 10.1016/S1359-6454(02)00368-3
   Giri J, 2003, BIO-MED MATER ENG, V13, P387
   Goldman A, 1990, MODERN FERRITE TECHN
   GRAY, 2003, Patent No. 659923
   Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537
   JORDAN A, 1993, INT J HYPERTHER, V9, P51, DOI 10.3109/02656739309061478
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   JUNG YC, 2004, P SMART STRUCT MAT 2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   KITTEL C, 1949, REV MOD PHYS, V21, P541, DOI 10.1103/RevModPhys.21.541
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lin JR, 1999, J APPL POLYM SCI, V73, P1305, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1305::AID-APP24>3.0.CO;2-5
   LIU Y, 2003, ADV MATER PROCESS, V161, P31
   *M H I LTD, 1992, PROC INSTR SHAP MEM
   MA M, 2004, J MAGN MAGN MATER, P33
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Metzger MF, 2002, BIOMED MICRODEVICES, V4, P89, DOI 10.1023/A:1014674912979
   Otsuka K., 1998, SHAPE MEMORY MAT
   Paulus JA, 1995, U.S. Patent, Patent No. [5,429,583, 5429583]
   Ramachandran N, 2004, ANN NY ACAD SCI, V1027, P99, DOI 10.1196/annals.1324.010
   Rudnev V., 2003, HDB INDUCTION HEATIN
   SCHETKY LM, 1979, SCI AM, V241, P74, DOI 10.1038/scientificamerican1179-74
   Sperling L. H., 1986, INTRO PHYS POLYM SCI
   STAUFFER PR, 1984, IEEE T BIO-MED ENG, V31, P76, DOI 10.1109/TBME.1984.325373
   SWAIN MV, 1986, NATURE, V322, P234, DOI 10.1038/322234a0
   Virden AE, 2005, J MAGN MAGN MATER, V290, P868, DOI 10.1016/j.jmmm.2004.11.398
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wetzel ED, 2001, FEASIBILITY MAGNETIC
   Yang B, 2005, SCRIPTA MATER, V53, P105, DOI 10.1016/j.scriptamat.2005.03.009
   Zhang XK, 2003, J APPL PHYS, V93, P7124, DOI 10.1063/1.1557309
NR 39
TC 202
Z9 206
U1 7
U2 75
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD OCT
PY 2006
VL 53
IS 10
BP 2075
EP 2083
DI 10.1109/TBME.2006.877113
PG 9
WC Engineering, Biomedical
SC Engineering
GA 086UP
UT WOS:000240698800024
PM 17019872
DA 2018-10-20
ER

PT J
AU Lin, JH
   Chang, CH
   Chen, CL
   Lou, CW
AF Lin, Jia-Horng
   Chang, Chia-Hao
   Chen, Cai-Lian
   Lou, Ching-Wen
TI Preparation and characteristics of wound dressing with weft-knitted
   fabric coated with chitosan
SO JOURNAL OF ADVANCED MATERIALS
LA English
DT Article
AB Synthetic materials used for medical purpose and biomechanics are defined as biomedical materials. In biomedical materials, fibrous textiles combine with biomedical engineering or tissue engineering to form medical articles. Tissue engineering significantly influences regenerated tissue or organs. As a result, porous materials are investigated for making a scaffold for cells to grow upon and adhere to the surface.
   Because knitted fabrics have porosity and softness resulting from their structure, they have been widely applied to tissue engineering. Woven samples with different structures and yam conditions were coated with chitosan in this study. Additionally, the basic mechanical properties and release rate of weft-knitted fabrics are investigated.
   According to the results of experiments, the horizontal double tucking and horizontal-vertical double tucking structure of the samples had the largest tensile tenacity in the warp direction, the lowest tensile tenacity in the weft direction and higher porosity as well. However, the trend of structure plain, tuck, and vertical double tucking were opposite to the structure of horizontal double tucking and that of horizontal-vertical double tucking. After being coated, the fabric tenacity of group D slightly decreased approximately 3%. Moreover, the chitosan was released with two stages in day two and day six.
C1 Feng Chia Univ, Inst Text Engn, Lab Fiber Applicat & Mfg, Taichung, Taiwan.
   Chungtai Inst Hlth Sci & Technol, Inst Biomed Engn & Mat Sci, Taichung, Taiwan.
RP Lin, JH (reprint author), Feng Chia Univ, Inst Text Engn, Lab Fiber Applicat & Mfg, Taichung, Taiwan.
CR BRINE CJ, 1992, ADV CHITIN CHITOSAN, P206
   Carrello Gomez B., 1997, INT J PHARMACEUT, V148, P231
   CELINE M, 1997, J BIOMED MATER RES, V35, P459
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   MINAMI S, 1999, CHITIN CHITINASES, V87, P265
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
NR 6
TC 8
Z9 8
U1 3
U2 10
PU SAMPE PUBLISHERS
PI COVINA
PA 1161 PARKVIEW DRIVE, COVINA, CA 91722 USA
SN 1070-9789
J9 J ADV MATER-COVINA
JI J. Adv. Mater.
PD OCT
PY 2006
VL 38
IS 4
BP 46
EP 50
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 100MR
UT WOS:000241673700006
DA 2018-10-20
ER

PT J
AU Albornoz, C
   Jacobo, SE
AF Albornoz, C
   Jacobo, SE
TI Preparation of a biocompatible magnetic film from an aqueous ferrofluid
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE superparamagnetic iron nanoparticles (SPION); nanocomposites;
   nanoparticles application; magnetic fluid; magnetic gel
ID GELS
AB Very promising nanoparticles for biomedical applications or in medical drug targeting are superparamagnetic nanoparticles based on a core consisting of iron oxides (SPION) that can be targeted through external magnets. Polyvinyl alcohol (PVA) is a unique synthetic biocompatible polymer that can be chemically cross-linked to form a gel. Biotechnology applications of magnetic gels include biosensors, targeted drug delivery, artificial muscles and magnetic buckles. These gels are produced by incorporating magnetic materials in the polymer composites. In this paper we report the synthesis of an aqueous ferrofluid and the preparation of a biocompatible magnetic gel with polyvinyl alcohol and glutharaldehyde (GTA). HClO4 was used to induce the peptization since this kind of ferrofluid does not have surfactant. The magnetic gel was dried to generate a biocompatible film. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Buenos Aires, Fac Ingn, LAFMACEL, RA-1063 Buenos Aires, DF, Argentina.
RP Jacobo, SE (reprint author), Univ Buenos Aires, Fac Ingn, LAFMACEL, Paseo Colon 85, RA-1063 Buenos Aires, DF, Argentina.
EM siacobo@fi.uba.ar
CR Albornoz C, 2004, PHYSICA B, V354, P149, DOI 10.1016/j.physb.2004.09.038
   CHANTRELL RW, 1978, IEEE T MAGN, V14, P975, DOI 10.1109/TMAG.1978.1059918
   HORKAY F, 1982, MACROMOLECULES, V15, P1306, DOI 10.1021/ma00233a018
   *JCPDS, 1979, INORGANIC
   KHOKHLOV AR, 1991, POLYM B, V25, P373
   Osada Y, 1998, ADV MATER, V10, P827, DOI 10.1002/(SICI)1521-4095(199808)10:11<827::AID-ADMA827>3.0.CO;2-L
   OSADA Y, 1985, CHEM LETT, P1285, DOI 10.1246/cl.1985.1285
   ROSENWEIG RE, 1985, FERROHIDROBODY DINAM
   Schutt W, 1997, HYBRIDOMA, V16, P109, DOI 10.1089/hyb.1997.16.109
   Zrinyi M, 1997, POLYM GELS NETW, V5, P415, DOI 10.1016/S0966-7822(97)00010-5
NR 10
TC 81
Z9 81
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD OCT 1
PY 2006
VL 305
IS 1
BP 12
EP 15
DI 10.1016/j.jmmm.2005.11.021
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 059FE
UT WOS:000238717900003
DA 2018-10-20
ER

PT J
AU Vadiraj, A
   Kamaraj, M
AF Vadiraj, Aravind
   Kamaraj, M.
TI Fretting fatigue studies of titanium nitride-coated biomedical titanium
   alloys
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biomaterials; fretting fatigue; physical vapor deposition (PVD)
   coatings; titanium alloys
ID MECHANICAL-PROPERTIES; COATINGS; CORROSION; BEHAVIOR
AB Fretting fatigue is an adhesive wear mechanism caused by repetitive tangential micro-oscillation between two contacting materials pressed together under cyclic load. Bioimplants, such as hip joints and bone plates, are prone to undergo fretting fatigue failures during their service within the body. This article presents the fretting fatigue damage characterization of physical vapor deposition (PVD) TiN-coated biomedical titanium alloys (Ti-6Al-4V and Ti-6Al-7Nb) subjected to cyclic loads. The PVD TiN layer delayed the damage because of superior tribological properties compared with uncoated alloys. Delamination and abrasive wear damage of TiN at contact caused failure of the alloy. Friction coefficient curves of the PVD TiN-coated pair showed an irregular pattern caused by the influence of wear particulates and Ringer fluid at the contact.
C1 Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
RP Vadiraj, A (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM kamaraj@iitm.ac.in
OI M, Kamaraj/0000-0002-7170-3083
CR Antoniou RA, 1997, MAT SCI ENG A-STRUCT, V237, P229, DOI 10.1016/S0921-5093(97)00419-X
   Chou WJ, 2002, SURF COAT TECH, V149, P7, DOI 10.1016/S0257-8972(01)01382-2
   Duisabeau L, 2004, WEAR, V256, P805, DOI 10.1016/S0043-1648(03)00522-2
   Hallab NJ, 2003, CORROS REV, V21, P183
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mudali UK, 2003, CORROS REV, V21, P231
   NAN H, 1996, SURF COAT TECH, V88, P127
   Ohmura T, 2003, SURF COAT TECH, V169, P728, DOI 10.1016/S0257-8972(03)00210-X
   Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008
   Shenhar A, 2000, SURF COAT TECH, V126, P210, DOI 10.1016/S0257-8972(00)00524-7
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Sumita M., 2003, COMPR STRUCT INTEGRI, V9, P131
   Takeda J, 2004, INT J FATIGUE, V26, P1003, DOI 10.1016/j.ijfatigue.2003.12.007
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thair L, 2003, CORROS SCI, V45, P1951, DOI 10.1016/S0010-938X(03)00027-1
   Waterhouse R. B., 1972, FRETTING CORROSION
NR 16
TC 9
Z9 9
U1 1
U2 13
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9495
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD OCT
PY 2006
VL 15
IS 5
BP 553
EP 557
DI 10.1361/105994906X136115
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 093DW
UT WOS:000241148900007
DA 2018-10-20
ER

PT J
AU Spowage, AC
   Shacklock, AP
   Malcolm, AA
   May, SL
   Tong, L
   Kennedy, AR
AF Spowage, Andrew C.
   Shacklock, Andrew P.
   Malcolm, Andrew A.
   May, Sim Lay
   Tong, Liu
   Kennedy, Andrew R.
TI Development of characterisation methodologies for macroporous materials
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Materials for Advanced Technologies
   (ICMAT-2005)/9th International Conference on Advanced Materials (ICAM
   2005)
CY JUL 03-08, 2005
CL Singapore, SINGAPORE
SP Int Union Mat Res Soc, Mat Res Soc Singapore, Suntec Int Convent & Exhibit Ctr
DE computed tomography (CT); macroporous biomaterials; porosity
   characterisation; X-ray imaging
ID CALCIUM-PHOSPHATE CERAMICS; POROUS HYDROXYAPATITE; OSTEOBLAST ADHESION;
   BONE; BIOCERAMICS; SCAFFOLDS; BIOMATERIALS; FABRICATION; TOMOGRAPHY
AB The exceptional property sets of macroporous materials are leading to an increasing number of applications, particularly in the biomedical sector. Apart from the underlying material properties, it is the characteristics of the porous structure that dictate the properties of fabricated devices. Conventional methods of examining the pore structure have a number of inherent disadvantages such as low sampling volume, laborious and frequently destructive sample preparation, tedious and subjective image analysis. Recently, industrial microtomographic methods have become important tools for interrogating porous materials. However, one of the limitations of micro-CT methods is the non-specific nature of commercially available image analysis software coupled with the complicated nature of the key parameters. This paper presents some progress towards the development of a novel analysis tool that aims to characterise specific parameters over a wide range of macroporous materials. This paper focuses on aspects directly relevant to the characterisation of Hydroxyapatite macroporous (HA) foams and demonstrates the capability to obtain statistically meaningful parameters essential for process development and pre-implantation quality assurance.
C1 Singapore Inst Mfg Technol, Singapore, Singapore.
   Univ Nottingham, Nottingham NG7 2RD, England.
   Singapore Inst Mfg Technol, Precis Measurements Grp, Singapore 638075, Singapore.
RP Spowage, AC (reprint author), Singapore Inst Mfg Technol, Singapore, Singapore.
EM andyspowage@hotmail.com
RI spowage, Andrew/A-2939-2012
OI spowage, Andrew/0000-0003-4095-5365; Kennedy, Andrew/0000-0002-0443-8275
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Ashby M. F., 1998, CELLULAR METALS DESI
   Bart-Smith H, 1998, ACTA MATER, V46, P3583, DOI 10.1016/S1359-6454(98)00025-1
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Budiansky B, 1999, INT J SOLIDS STRUCT, V36, P3677, DOI 10.1016/S0020-7683(98)00169-3
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   EVANS AG, 1999, PROG MATER SCI, V43, P171
   FILMON R, 2003, J BIOMATER SCI POLY, V13, P1105
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KALWITER JJ, 1976, J BIOMED MATER RES, V10, P311
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Liu DM, 1996, BIOMATERIALS, V17, P1955, DOI 10.1016/0142-9612(95)00301-0
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Lu TJ, 1998, ACTA MATER, V46, P3619, DOI 10.1016/S1359-6454(98)00031-7
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739
   SE IP, 1999, CAN METALL QUART, V38, P81
   Shanley F. R, 1960, WEIGHT STRENGTH ANAL
   SPOWAGE AC, 2005, P 4 WORLD C IND PROC, P226
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Zoghlami K, 2004, MICROSC RES TECHNIQ, V65, P270, DOI 10.1002/jemt.20119
NR 30
TC 10
Z9 12
U1 1
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
J9 J POROUS MAT
JI J. Porous Mat.
PD OCT
PY 2006
VL 13
IS 3-4
BP 431
EP 438
DI 10.1007/s10934-006-8042-1
PG 8
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 066CM
UT WOS:000239207300041
DA 2018-10-20
ER

PT J
AU Xie, TQ
   Guo, SG
   Zhang, J
   Chen, ZP
   Peavy, GM
AF Xie, Tuqiang
   Guo, Shuguang
   Zhang, Jun
   Chen, Zhongping
   Peavy, George M.
TI Determination of characteristics of degenerative joint disease using
   optical coherence tomography and polarization sensitive optical
   coherence tomography
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE articular cartilage; birefringence; biomedical imaging; optical
   coherence tomography (OCT); optical imaging; osteoarthritis; phase
   retardation; polarization sensitive optical coherence tomography
   (PS-OCT)
ID RABBIT ARTICULAR-CARTILAGE; FULL-THICKNESS DEFECTS; AXIS ORIENTATION;
   TURBID MEDIA; HIGH-SPEED; OSTEOARTHRITIS; COLLAGEN; BIREFRINGENCE;
   ORGANIZATION; RESOLUTION
AB Background and Objectives: Previous studies have demonstrated that optical coherence tomography (OCT) could be used to delineate alterations in the microstructure of cartilage, and have suggested that changes in the polarization state of light as detected by OCT could provide information on the birefringence properties of articular cartilage as influenced by disease. In this study we have used both OCT and polarization sensitive optical coherence tomography (PS-OCT) technologies to evaluate normal and abnormal bovine articular cartilage according to established structural, organizational, and birefringent characteristics of degenerative joint disease (DJD) in order to determine if this technology can be used to differentiate various stages of DJD as a minimally invasive imaging tool.
   Materials and Methods: Fresh bovine femoral-tibial joints were obtained from an abattoir, and 45 cartilage specimens were harvested from 8 tibial plateaus. Whole ex vivo specimens of normal and degenerative articular cartilage were imaged by both OCT and PS-OCT, then fixed and processed for histological evaluation. OCT/PS-OCT images and corresponding histology sections of each specimen were scored according to a modified Mankin structural grading scale and compared.
   Results: OCT and PS-OCT imaging allowed structural evaluation of intact articular cartilage along a 6 mm surface length to a depth of 2 mm with a transverse resolution of 12 pm and an axial resolution of 10 mu m. The OCT and PS-OCT images demonstrated characteristic alterations in the structure of articular cartilage with a high correlation to histological evaluation (kappa = 0.776). The OCT images were able to demonstrate early to advanced structural changes of articular cartilage while the optical phase retardation images obtained by PS-OCT imaging were able to discriminate areas where disorganization of the cartilage matrix was present, however, these characteristics are much different than those reported where OCT images alone were used to characterize tissue birefringence. No evidence of differences in OCT or PS-OCT images were detected between specimens of similar structural characteristics where proteoglycan was judged present or absent by safranin-O Fast Green staining.
   Conclusions: The combined use of OCT and PS-OCT technologies to obtain images from a single system is able to demonstrate and discriminate between characteristics of very early stages of surface irregularities not previously reported for OCT imaging, to deep clefts and collagen matrix disorganization for tissue at depths of up to 2 mm with good correlation to histology. PS-OCT and accumulated optical phase retardation images of articular cartilage as constructed from alterations in Stokes vector parameters appear to give a valuable but different assessment of alterations in tissue birefringence and organization than have been reported for OCT images obtained with the use of polarized or non-polarized light sources. This is the first time that alterations in the polarization state of light reflected from within the tissue have been demonstrated to be consistent with changes observed in the orientation and organization of the collagen matrix in advanced stages of DJD. The degree of phase transformation of light reflected from within the tissue as determined by PS-OCT imaging does not appear to be altered by the presence or absence of proteoglycan.
C1 Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92612 USA.
RP Peavy, GM (reprint author), Univ Calif Irvine, Beckman Laser Inst, 1002 Hlth Sci Rd E, Irvine, CA 92612 USA.
EM z.chen@uci.edu; gpeavy@uci.edu
RI Zhang, Jun/A-1801-2014
FU NCI NIH HHS [CA 91717]; NCRR NIH HHS [RR-01192]; NIBIB NIH HHS
   [EB-00293]
CR Aguirre AD, 2003, OPT LETT, V28, P2064, DOI 10.1364/OL.28.002064
   ALTMAN RD, 1992, ANN RHEUM DIS, V51, P1056, DOI 10.1136/ard.51.9.1056
   AYRAL X, 2003, OSTEOARTHRITIS, P451
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   Bouma BE, 2002, HDB OPTICAL COHERENC
   CHAN WP, 1991, AM J ROENTGENOL, V157, P799, DOI 10.2214/ajr.157.4.1892040
   Chu CR, 2004, AM J SPORT MED, V32, P699, DOI 10.1177/0363546503261736
   CLARK JM, 1985, J ORTHOP RES, V3, P17, DOI 10.1002/jor.1100030102
   CLARK JM, 1990, J ANAT, V171, P117
   de Boer JF, 1999, OPT LETT, V24, P300, DOI 10.1364/OL.24.000300
   de Boer JF, 2002, J BIOMED OPT, V7, P359, DOI 10.1117/1.1483879
   Drexler W, 2001, J RHEUMATOL, V28, P1311
   DUNHAM J, 1988, J ANAT, V157, P89
   FELSON DT, 1993, RHEUM DIS CLIN N AM, V19, P607
   Fercher A. F., 2002, PROG OPTICS, P215
   Fleiss JL., 1973, STAT METHODS RATES P
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I
   Guo SG, 2004, OPT LETT, V29, P2025, DOI 10.1364/OL.29.002025
   Han CW, 2003, OSTEOARTHR CARTILAGE, V11, P111, DOI 10.1053/joca.2002.0862
   Herrmann JM, 1999, J RHEUMATOL, V26, P627
   Hitzenberger CK, 2001, OPT EXPRESS, V9, P780, DOI 10.1364/OE.9.000780
   HOWELL DS, 1986, AM J MED, V80, P24, DOI 10.1016/0002-9343(86)90075-6
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   JEFFERY AK, 1991, J BONE JOINT SURG BR, V73, P795
   Kemp NJ, 2005, OPT EXPRESS, V13, P4507, DOI 10.1364/OPEX.13.004507
   Kemp NJ, 2005, J OPT SOC AM A, V22, P552, DOI 10.1364/JOSAA.22.000552
   LEE P, 1974, Seminars in Arthritis and Rheumatism, V3, P189, DOI 10.1016/0049-0172(74)90019-5
   Li XM, 2005, ASIAN J ANDROL, V7, P323, DOI 10.1111/j.1745-7262.2005.00044.x
   MACCONAILL MA, 1951, J BONE JOINT SURG BR, V33, P251
   MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009
   MYERS SL, 1995, J RHEUMATOL, V22, P109
   Pan YT, 2003, J BIOMED OPT, V8, P648, DOI 10.1117/1.1609201
   Park BH, 2001, J BIOMED OPT, V6, P474, DOI 10.1117/1.1413208
   Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007
   Roberts MJ, 2003, ANAL BIOANAL CHEM, V377, P1003, DOI 10.1007/s00216-003-2225-2
   Rogowska J, 2003, J OPT SOC AM A, V20, P357, DOI 10.1364/JOSAA.20.000357
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Simon L S, 1999, Clin Cornerstone, V2, P26, DOI 10.1016/S1098-3597(99)90012-1
   SPEER KP, 1991, AM J SPORT MED, V19, P396, DOI 10.1177/036354659101900414
   Todorovic M, 2004, OPT LETT, V29, P2402, DOI 10.1364/OL.29.002402
   Tyler J A, 1995, Acta Orthop Scand Suppl, V266, P130
   Ugryumova N, 2005, J PHYS D APPL PHYS, V38, P2612, DOI 10.1088/0022-3727/38/15/012
   *US NIH, 2002, OST
   WEISS C, 1968, J BONE JOINT SURG AM, VA 50, P663, DOI 10.2106/00004623-196850040-00002
   Xia Y, 2003, J MAGN RESON IMAGING, V17, P365, DOI 10.1002/jmri.10269
   Zhang J, 2003, OPT EXPRESS, V11, P3262, DOI 10.1364/OE.11.003262
NR 49
TC 49
Z9 51
U1 4
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PD OCT
PY 2006
VL 38
IS 9
BP 852
EP 865
DI 10.1002/lsm.20394
PG 14
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 102XN
UT WOS:000241846900007
PM 16998913
DA 2018-10-20
ER

PT J
AU Ben-Nissan, B
   Choi, AH
AF Ben-Nissan, Besim
   Choi, Andy H.
TI Sol-gel production of bioactive nanocoatings for medical applications.
   Part 1: an introduction
SO NANOMEDICINE
LA English
DT Article
DE bioactive; hydroxyapatite; implants; nanocoating; sol-gel
ID LITHIUM ALUMINOSILICATE GELS; SILICON-CARBIDE; THIN-FILMS; COATINGS;
   HYDROLYSIS; TITANIUM
AB Coatings offer the possibility of modifying the surface properties of surgical-grade materials to achieve improvements in performance, reliability and biocompatibility. Sol-gel-derived coatings demonstrate promise owing to their relative ease of production, ability to form a physically and chemically pure and uniform coating over complex geometric shapes and potential to deliver exceptional mechanical properties owing to their nanocrystalline structure. other advantages unique to sol-gel include the production of a homogeneous material, since mixing takes place on the atomic scale, and its relatively low processing temperature avoids decomposition of the coating materials and limits the damage to metallic substrate materials as a result of exposure to elevated temperatures. A range of materials can be adapted easily for a number of biomedical and engineering applications.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Sydney, NSW 2007, Australia.
RP Ben-Nissan, B (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, POB 123, Sydney, NSW 2007, Australia.
EM b.ben-nissan@uts.edu.au
CR Anast M., 1996, THESIS U TECHNOLOGY
   ANDERSON P, 1987, J NON-CRYST SOLIDS, V93, P415, DOI 10.1016/S0022-3093(87)80186-2
   BARTLETT JR, 1990, MATER RES SOC SYMP P, V180, P191, DOI 10.1557/PROC-180-191
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Berndt C. C., 1990, Materials Forum, V14, P161
   Bradley D.C, 1978, METAL ALKOXIDES
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Chai C. S., 1998, J AUST CERAM SOC, V34, P263
   CHEN TS, 1994, J MATER RES, V9, P1284, DOI 10.1557/JMR.1994.1284
   COLBY MW, 1988, J NON-CRYST SOLIDS, V99, P129, DOI 10.1016/0022-3093(88)90465-6
   DELAMBILLY H, 1989, J NON-CRYST SOLIDS, V109, P69, DOI 10.1016/0022-3093(89)90444-4
   Dislich H., 1988, SOL GEL TECHNOLOGY T, P50
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   Eichorst D. J., 1988, Better Ceramics Through Chemistry III. Symposium, P773
   FLOCH GH, 1995, AM CERAM SOC B, V1, P60
   FLOCH HG, 1995, AM CERAM SOC BULL, V74, P48
   Gabriel A. O., 1997, CERAM ENG SCI P, V18, P713
   Gan L, 1997, COMP MATER SCI, V8, P273, DOI 10.1016/S0927-0256(97)00040-2
   Gao JM, 1997, T NONFERR METAL SOC, V7, P21
   GOTTARDI V, 1984, J NON-CRYST SOLIDS, V63, P71, DOI 10.1016/0022-3093(84)90387-9
   Harris M. T., 1988, Better Ceramics Through Chemistry III. Symposium, P287
   Hasegawa I, 1997, J SOL-GEL SCI TECHN, V8, P577, DOI 10.1007/BF02436902
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   JIMENEZ C, 1994, SURF COAT TECH, V68, P249, DOI 10.1016/0257-8972(94)90169-4
   Kirk PB, 1999, J MATER SCI, V34, P3967, DOI 10.1023/A:1004695427839
   Kokubo T., 2000, J AUST CERAM SOC, V36, P37
   KRAUS GT, 1996, COVALENT CERAMICS, V3, P410
   LEE JW, 1993, J MATER RES, V8, P3151, DOI 10.1557/JMR.1993.3151
   Mazdiyasni K. S., 1982, Ceramics International, V8, P42, DOI 10.1016/0272-8842(82)90014-1
   Melpolder S. M., 1988, BETTER CERAMICS CHEM, P811
   Miao X, 2000, J MATER SCI, V35, P497, DOI 10.1023/A:1004740005893
   ORCEL G, 1986, J NON-CRYST SOLIDS, V79, P177, DOI 10.1016/0022-3093(86)90045-1
   Percy MJ, 2000, J SOL-GEL SCI TECHN, V19, P315, DOI 10.1023/A:1008781515324
   PETTIT RB, 1988, SOL GEL TECHNOLOGY T, P80
   RAMAN V, 1995, J MATER SCI, V30, P2686, DOI 10.1007/BF00362153
   Roest R, 2004, KEY ENG MAT, V254-2, P455, DOI 10.4028/www.scientific.net/KEM.254-256.455
   ROY DM, 1954, AM MINERAL, V39, P957
   SAKKA S, 1984, J NON-CRYST SOLIDS, V63, P223, DOI 10.1016/0022-3093(84)90401-0
   SCHMIDT H, 1988, MATER RES SOC S P, V121, P743
   Schroder H., 1966, VETRO SILICATI, V10, P10
   Schroeder H., 1965, PAINT VARNISH PROD, V55, P31
   SCHWARTZ I, 1986, J NON-CRYST SOLIDS, V83, P391, DOI 10.1016/0022-3093(86)90250-4
   STRAWBRIDGE I, 1986, J NON-CRYST SOLIDS, V82, P366, DOI 10.1016/0022-3093(86)90153-5
   Striven L., 1988, MATER RES SOC S P, V121, DOI [10.1557/PROC-121-717, DOI 10.1557/PR0C-121-717]
   Thomas IM, 1988, SOL GEL TECHNOLOGY T, P2
   TURNER CW, 1991, AM CERAM SOC BULL, V70, P1487
   Wallace S., 1984, CERAM ENG SCI P, V5, P568
   YOLDAS BE, 1984, APPL OPTICS, V23, P1418, DOI 10.1364/AO.23.001418
   Zheng H., 1988, BETTER CERAMICS CHEM, P537
   1946, ANN CHIM PHYS SER 3, V57, P319
NR 50
TC 51
Z9 51
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD OCT
PY 2006
VL 1
IS 3
BP 311
EP 319
DI 10.2217/17435889.1.3.311
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 130YM
UT WOS:000243834900014
PM 17716161
DA 2018-10-20
ER

PT J
AU Yoshida, M
   Langer, R
   Lendlein, A
   Lahann, J
AF Yoshida, Mutsumi
   Langer, Robert
   Lendlein, Andreas
   Lahann, Joerg
TI From advanced biomedical coatings to multi-functionalized biomaterials
SO POLYMER REVIEWS
LA English
DT Review
DE biointerface; shape-memory polymer; multifunctionalization; responsive
   materials
ID CHEMICAL-VAPOR-DEPOSITION; SELF-ASSEMBLED MONOLAYERS; ENDOTHELIAL-CELL
   SHEETS; SHAPE-MEMORY POLYMERS; RESPONSIVE CULTURE DISHES; ELASTIN-LIKE
   POLYPEPTIDE; DRUG-DELIVERY-SYSTEMS; N-ISOPROPYLACRYLAMIDE; THIN-FILMS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS
AB In this review, current activities in the development of active biomaterials related to bio-interfacial design as well as novel concepts for smart polymer systems are highlighted. For instance, advanced biomedical coatings, including vapor-based polymer coatings for the controlled attachment of biomolecules, and temperature-responsive coatings for tissue engineering are outlined. Moreover, recent trends with the fabrication of "smart," switchable surfaces, such as conformationally switching monolayers, will be reviewed. Specific focus will further be given to multi- functionalized biomaterials including shape-memory polymers that undergo specific changes in shape in response to stimuli like heat or light. This novel class of intelligent materials highlights a recent trend in biomaterial development targeting is the extension of this concept to multi-functionalization. In particular, the combination of biodegradability and shape-memory effects opens a range of opportunities for biomedical applications including intelligent sutures or stents.
C1 Univ Michigan, Dept Chem Engn Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   MIT, Dept Chem Engn, Cambridge, MA USA.
   GKSS Forschungszentrum Geesthacht GmbH, Inst Polymer Res, Teltow, Germany.
RP Lahann, J (reprint author), Univ Michigan, Dept Chem Engn Mat Sci & Engn, 2300 Hayward St, Ann Arbor, MI 48109 USA.
EM lahann@umich.edu
RI Lendlein, Andreas/K-9553-2013; Lahann, Joerg/J-7663-2013
OI Lendlein, Andreas/0000-0003-4126-4670; 
CR ABBOTT NL, 1994, LANGMUIR, V10, P1493, DOI 10.1021/la00017a029
   ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005
   Abbott S, 1999, LANGMUIR, V15, P8923, DOI 10.1021/la990558o
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526
   Ayaro E, 2005, J CHROMATOGR A, V1069, P281, DOI 10.1016/j.chroma.2005.01.100
   Biercuk MJ, 2002, APPL PHYS LETT, V80, P2767, DOI 10.1063/1.1469696
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   Bunker BC, 2003, NANO LETT, V3, P1723, DOI 10.1021/nl034759v
   Canavan HE, 2005, J BIOMED MATER RES A, V75A, P1, DOI 10.1002/jbm.a.30297
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen HY, 2006, J AM CHEM SOC, V128, P374, DOI 10.1021/ja057082h
   Chen HY, 2005, ANAL CHEM, V77, P6909, DOI 10.1021/ac050964e
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chilkoti A, 2005, MRS BULL, V30, P175, DOI 10.1557/mrs2005.48
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   *CORD CORP, 2003, INSTR US CYPH SIR EL
   DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827
   Desponds A, 2005, BIOTECHNOL BIOENG, V91, P583, DOI 10.1002/bit.20479
   Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   Ebara M, 2004, TISSUE ENG, V10, P1125, DOI 10.1089/ten.2004.10.1125
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Ebara M, 2003, BIOMACROMOLECULES, V4, P344, DOI 10.1021/bm025692t
   Eberhart RC, 2003, J BIOMAT SCI-POLYM E, V14, P299, DOI 10.1163/156856203321478838
   Fare S, 2005, J BIOMED MATER RES A, V73A, P1, DOI 10.1002/jbm.a.30193
   Fong RB, 2002, BIOTECHNOL BIOENG, V79, P271, DOI 10.1002/bit.10315
   Fu DG, 2002, ADV MATER, V14, P339, DOI 10.1002/1521-4095(20020304)14:5<339::AID-ADMA339>3.0.CO;2-Q
   Fu Q, 2004, J AM CHEM SOC, V126, P8904, DOI 10.1021/ja047895q
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Gao D, 2006, J AM CHEM SOC, V128, P676, DOI 10.1021/ja056364e
   GEWEHR M, 1992, MAKROMOL CHEM, V193, P249
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Herrera-Alonso M, 2004, LANGMUIR, V20, P9184, DOI 10.1021/la049025s
   HOSOYA K, 1994, MACROMOLECULES, V27, P3973, DOI 10.1021/ma00092a042
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Hyun J, 2004, J AM CHEM SOC, V126, P7330, DOI 10.1021/ja049721e
   Ibusuki S, 2003, TISSUE ENG, V9, P1133, DOI 10.1089/10763270360728044
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624
   Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005
   Iguchi N, 1997, PACE, V20, P372, DOI 10.1111/j.1540-8159.1997.tb06188.x
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Jiang WH, 2005, CHEM COMMUN, P3550, DOI 10.1039/b504479k
   Kanazawa H, 1997, J PHARMACEUT BIOMED, V15, P1545, DOI 10.1016/S0731-7085(96)02004-3
   Kanazawa H, 2002, ANAL SCI, V18, P45, DOI 10.2116/analsci.18.45
   Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j
   Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k
   Kanazawa H, 2000, ANAL CHEM, V72, P5961, DOI 10.1021/ac0004658
   Katz E, 2004, J AM CHEM SOC, V126, P15520, DOI 10.1021/ja045465u
   Kavanagh CA, 2004, PHARMACOL THERAPEUT, V102, P1, DOI 10.1016/j.pharmthera.2003.01.001
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Kim JY, 2005, BIOTECHNOL BIOENG, V90, P373, DOI 10.1002/bit.20451
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7
   Lahann J, 2005, MRS BULL, V30, P185, DOI 10.1557/mrs2005.50
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Lahann J, 2001, J MATER SCI-MATER M, V12, P807, DOI 10.1023/A:1013929103147
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   LAHANN J, 2006, POLYM INT       0606
   Lahann J, 2006, CHEM ENG COMMUN, V193, P1457, DOI 10.1080/00986440500511619
   Lake N, 2005, LANGMUIR, V21, P11922, DOI 10.1021/la051457v
   Lakhiari H, 1998, BBA-GEN SUBJECTS, V1379, P303, DOI 10.1016/S0304-4165(97)00110-4
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Li FK, 2000, J APPL POLYM SCI, V75, P68, DOI 10.1002/(SICI)1097-4628(20000103)75:1<68::AID-APP8>3.0.CO;2-I
   Li J, 2005, LANGMUIR, V21, P9562, DOI 10.1021/la051109t
   LIU C, 2003, ANN TECHN C SOC PLAS, V61, P1962
   Liu Y, 2004, CHEM COMMUN, P1194, DOI 10.1039/b400776j
   Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Malmstadt N, 2004, LAB CHIP, V4, P412, DOI 10.1039/b315394k
   Malmstadt N, 2003, ANAL CHEM, V75, P2943, DOI 10.1021/ac034274r
   Mao Y, 2004, LANGMUIR, V20, P2484, DOI 10.1021/la0359427
   Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Min CC, 2005, POLYM ADVAN TECHNOL, V16, P608, DOI 10.1002/pat.624
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Mrksich M, 2005, MRS BULL, V30, P180, DOI 10.1557/mrs2005.49
   Murthy SK, 2002, MACROMOLECULES, V35, P1967, DOI 10.1021/ma011286a
   Murthy SK, 2004, J APPL POLYM SCI, V91, P2176, DOI 10.1002/app.13342
   Naito H, 2004, ASAIO J, V50, P344, DOI 10.1097/01.MAT.0000132656.42232.E3
   Nandivada H, 2005, MACROMOL RAPID COMM, V26, P1794, DOI 10.1002/marc.200500449
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nath N, 2003, ANAL CHEM, V75, P709, DOI 10.1021/ac0261855
   Nath N, 2001, J AM CHEM SOC, V123, P8197, DOI 10.1021/ja015585r
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   NOWLIN TE, 1980, J APPL POLYM SCI, V25, P1619, DOI 10.1002/app.1980.070250809
   Okajima S, 2005, BIOTECHNOL BIOENG, V91, P237, DOI 10.1002/bit.20512
   Okajima S, 2005, LANGMUIR, V21, P4043, DOI 10.1021/la046994e
   Okamura A, 2005, BIOMATERIALS, V26, P1287, DOI 10.1016/j.biomaterials.2004.04.028
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   Park KH, 2004, J BIOSCI BIOENG, V97, P374, DOI 10.1263/jbb.97.374
   Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Riskin M, 2006, J AM CHEM SOC, V128, P1253, DOI 10.1021/ja0561183
   Rousseau IA, 2003, J AM CHEM SOC, V125, P15300, DOI 10.1021/ja039001s
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman WM, 2000, PRINCIPLES TISSUE EN
   Schultz ZD, 2005, ANAL CHEM, V77, P7373, DOI 10.1021/ac0511593
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimoboji T, 2002, BIOCONJUGATE CHEM, V13, P915, DOI 10.1021/bc010057q
   Shimoboji T, 2001, BIOCONJUGATE CHEM, V12, P314, DOI 10.1021/bc000107b
   Shin JY, 1999, LANGMUIR, V15, P4404, DOI 10.1021/la981477f
   Smith JP, 2005, ANAL CHEM, V77, p412A
   SONDAGHUETHORST JAM, 1994, LANGMUIR, V10, P4380, DOI 10.1021/la00023a074
   Soppimath KS, 2002, DRUG DEV IND PHARM, V28, P957, DOI 10.1081/DDC-120006428
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Suh KY, 2004, ADV MATER, V16, P1401, DOI 10.1002/adma.200400101
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Trabbic-Carlson K, 2004, PROTEIN ENG DES SEL, V17, P57, DOI 10.1093/protein/gzh006
   Tsuda Y, 2005, BIOMATERIALS, V26, P1885, DOI 10.1016/j.biomaterials.2004.06.005
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang XM, 2003, ELECTROCHEM COMMUN, V5, P814, DOI 10.1016/j.elecom.2003.07.002
   Wang XM, 2003, CHEM COMMUN, P1542, DOI 10.1039/b303845a
   Yamaguchi S, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/07/047
   Yamato M, 2003, J BIOMED MATER RES A, V67A, P1065, DOI 10.1002/jbm.a.10078
   Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.3.CO;2-O
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang H, 2004, ANAL CHEM, V76, P1537, DOI 10.1021/ac035270p
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yasutake M, 2003, MACROMOLECULES, V36, P5974, DOI 10.1021/ma021795s
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Yu YL, 2005, MACROMOL CHEM PHYS, V206, P1705, DOI 10.1002/macp.200500318
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
NR 148
TC 89
Z9 90
U1 6
U2 115
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1558-3724
EI 1558-3716
J9 POLYM REV
JI Polym. Rev.
PD OCT-DEC
PY 2006
VL 46
IS 4
BP 347
EP 375
DI 10.1080/15583720600945394
PG 29
WC Polymer Science
SC Polymer Science
GA 108AS
UT WOS:000242212700003
DA 2018-10-20
ER

PT J
AU Kharlampieva, E
   Sukhishvili, SA
AF Kharlampieva, Eugenia
   Sukhishvili, Svetlana A.
TI Hydrogen-bonded layer-by-layer polymer films
SO POLYMER REVIEWS
LA English
DT Review
DE layer-by-layer assembly; hydrogen-bonding; weak polyelectrolytes;
   responsive films
ID MICROGEL THIN-FILMS; POLY(ACRYLIC ACID); POLY(ETHYLENE OXIDE);
   INTERMACROMOLECULAR COMPLEXES; THERMORESPONSIVE POLYMERS; INTERPOLYMER
   COMPLEXES; BONDING INTERACTIONS; IONIC-STRENGTH; MULTILAYERS; BEHAVIOR
AB New developments in the area of hydrogen-bonded layer-by-layer assembly composed of weak polyelectrolytes are reviewed, with emphasis on self-assembly in an aqueous environment. Advances in fundamental understanding of polymer layering at surfaces are addressed. The effects of molecular weight of polymers, ionic strength, pH, and temperature on growth and post-self-assembly response of hydrogen-bonded films are summarized and contrasted with trends known for electrostatically assembled films. Deposition of hydrogen-bonded films onto particulate substrates and properties of produced capsules are discussed. Strategies to stabilize hydrogen-bonded multilayers at neutral and basic pH through crosslinking and response properties of produced ultrathin hydrogel films deposited onto flat substrates or comprising the wall of capsules are also described. The potential of hydrogen-bonding self-assembly in surface modification and functionalization, in construction of responsive functional containers and membranes, or as solid-state matrices demonstrating superior ion conductivity make these materials promising for future biomedical and device applications.
C1 Stevens Inst Technol, Dept Chem & Chem Biol, Hoboken, NJ 07030 USA.
RP Kharlampieva, E (reprint author), Stevens Inst Technol, Dept Chem & Chem Biol, Hoboken, NJ 07030 USA.
CR Bai SL, 2004, LANGMUIR, V20, P11828, DOI 10.1021/la047968j
   BAILEY FE, 1964, J POLYM SCI PART A, V2, P845, DOI 10.1002/pol.1964.100020221
   BEKTUROV EA, 1981, ADV POLYM SCI, V41, P99
   Benjamin I, 1998, J MATER CHEM, V8, P919, DOI 10.1039/a707365h
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Binder WH, 2005, MONATSH CHEM, V136, P1, DOI 10.1007/s00706-004-0236-0
   BOSMAN AW, 2004, MATER TODAY, P34
   Cho J, 2003, MACROMOLECULES, V36, P2845, DOI 10.1021/ma021049n
   Chu LY, 2005, ANGEW CHEM INT EDIT, V44, P2124, DOI 10.1002/anie.200462687
   Clark SL, 2000, LANGMUIR, V16, P10206, DOI 10.1021/la000418a
   COLEMAN MM, 1989, MACROMOLECULES, V22, P586, DOI 10.1021/ma00192a013
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 2003, MULTILAYER THIN FILM, P151
   DeLongchamp DM, 2004, LANGMUIR, V20, P5403, DOI 10.1021/la049777m
   FU Y, 2002, MACROMOLECULES, V35, P451
   GARGALLO L, 2004, J MACROMOL SCI PHY B, V43, P913, DOI DOI 10.1081/LMSB33255
   Glinel K, 2002, LANGMUIR, V18, P1408, DOI 10.1021/la0113670
   Glinel K, 2003, MACROMOL CHEM PHYSIC, V204, P1784, DOI 10.1002/macp.200350033
   Haggman L, 2003, J AM CHEM SOC, V125, P3631, DOI 10.1021/ja021012i
   HONG JD, 1992, THIN SOLID FILMS, V831, P210
   Hosoya K, 2004, J CHROMATOGR A, V1030, P237, DOI 10.1016/j.chroma.2003.11.078
   IKAWA T, 1975, J POLYM SCI POL CHEM, V13, P1505, DOI 10.1002/pol.1975.170130703
   Izumrudov V, 2004, MACROMOLECULES, V37, P8400, DOI 10.1021/ma048907v
   Izumrudov VA, 1999, MACROMOL CHEM PHYS, V200, P2533, DOI 10.1002/(SICI)1521-3935(19991101)200:11<2533::AID-MACP2533>3.0.CO;2-R
   Jaber JA, 2005, MACROMOLECULES, V38, P1300, DOI 10.1021/ma0485235
   Jin SP, 2005, EUR POLYM J, V41, P2406, DOI 10.1016/j.europolymj.2005.05.006
   Kharlampieva E, 2004, LANGMUIR, V20, P9677, DOI 10.1021/la048763d
   Kharlampieva E, 2005, MACROMOLECULES, V38, P10523, DOI 10.1021/ma0516891
   Kharlampieva E, 2004, LANGMUIR, V20, P10712, DOI 10.1021/la0484321
   Khutoryanskiy VV, 2004, J APPL POLYM SCI, V93, P1946, DOI 10.1002/app.20661
   Khutoryanskiy VV, 2004, LANGMUIR, V20, P3785, DOI 10.1021/la049807l
   Kohler K, 2005, J PHYS CHEM B, V109, P18250, DOI 10.1021/jp052208i
   Kohler K, 2004, MACROMOLECULES, V37, P9546, DOI 10.1021/ma048474w
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   Kozlovskaya V, 2006, CHEM MATER, V18, P328, DOI 10.1021/cm0517364
   Kozlovskaya V, 2003, MACROMOLECULES, V36, P8590, DOI 10.1021/ma035084l
   KOZLOVSKAYA V, 2005, POLYM MAT SCI ENG, V93, P86
   Kuo SW, 2003, MACROMOLECULES, V36, P6653, DOI 10.1021/ma034695a
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lutkenhaus JL, 2005, J AM CHEM SOC, V127, P17228, DOI 10.1021/ja053472s
   Maeda Y, 2001, LANGMUIR, V17, P1737, DOI 10.1021/la001346q
   Nolan CM, 2004, BIOMACROMOLECULES, V5, P1940, DOI 10.1021/bm049750h
   OSADA Y, 1976, J POLYM SCI POL LETT, V14, P129, DOI 10.1002/pol.1976.130140302
   Papisov I. M., 1974, POLYM SCI USSR, V16, P1311
   Quinn JF, 2005, MACROMOLECULES, V38, P3414, DOI 10.1021/ma047414n
   Quinn JF, 2004, LANGMUIR, V20, P20, DOI 10.1021/la0360310
   Rackaitis M, 2002, J POLYM SCI POL PHYS, V40, P2339, DOI 10.1002/polb.10284
   Serizawa T, 2002, LANGMUIR, V18, P8381, DOI 10.1021/la0204491
   Serizawa T, 2004, MACROMOLECULES, V37, P6531, DOI 10.1021/ma049154f
   Serizawa T, 2002, MACROMOLECULES, V35, P2184, DOI 10.1021/ma011465s
   Serpe MJ, 2005, BIOMACROMOLECULES, V6, P408, DOI 10.1021/bm049455x
   Serpe MJ, 2003, LANGMUIR, V19, P8759, DOI 10.1021/la034391h
   Staikos G, 1997, MACROMOL CHEM PHYSIC, V198, P2905, DOI 10.1002/macp.1997.021980920
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   SUBRAMANIAN R, 1984, J POLYM SCI POL CHEM, V22, P437, DOI 10.1002/pol.1984.170220215
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sukhishvili SA, 2005, CURR OPIN COLLOID IN, V10, P37, DOI 10.1016/j.cocis.2005.05.001
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sung Y. Y., 2002, J AM CHEM SOC, V124, P2100
   Takano M, 1998, POLYM GELS NETW, V6, P217, DOI 10.1016/S0966-7822(98)00015-X
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   Wang LY, 1997, MACROMOL RAPID COMM, V18, P509, DOI 10.1002/marc.1997.030180609
   Wang LY, 2000, LANGMUIR, V16, P10490, DOI 10.1021/la000733x
   Yang SG, 2004, MACROMOLECULES, V37, P10059, DOI 10.1021/ma048182v
   Yang SY, 2004, LANGMUIR, V20, P5978, DOI 10.1021/la0490442
   Yanul NA, 2000, J THERM ANAL CALORIM, V62, P7, DOI 10.1023/A:1010180624147
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P27, DOI 10.1021/bm050832v
   Zhang HY, 2004, LANGMUIR, V20, P9366, DOI 10.1021/la048685u
   Zhang HY, 2003, LANGMUIR, V19, P8497, DOI 10.1021/la035036u
   Zheng XY, 2004, SPECTROCHIM ACTA A, V60, P1085, DOI 10.1016/S1386-1425(03)00341-X
NR 70
TC 136
Z9 136
U1 11
U2 165
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1558-3724
J9 POLYM REV
JI Polym. Rev.
PD OCT-DEC
PY 2006
VL 46
IS 4
BP 377
EP 395
DI 10.1080/15583720600945386
PG 19
WC Polymer Science
SC Polymer Science
GA 108AS
UT WOS:000242212700004
DA 2018-10-20
ER

PT J
AU Fagaly, RL
AF Fagaly, R. L.
TI Superconducting quantum interference device instruments and applications
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Review
ID LTS-SQUID MICROSCOPE; HIGH-T-C; DC-SQUID; MAGNETIC-SHIELDS; HTS SQUID;
   INVERSE PROBLEM; ACTION CURRENTS; MAGNETOMETER; NOISE; SYSTEM
AB Superconducting quantum interference devices (SQUIDs) have been a key factor in the development and commercialization of ultrasensitive electric and magnetic measurement systems. In many cases, SQUID instrumentation offers the ability to make measurements where no other methodology is possible. We review the main aspects of designing, fabricating, and operating a number of SQUID measurement systems. While this article is not intended to be an exhaustive review on the principles of SQUID sensors and the underlying concepts behind the Josephson effect, a qualitative description of the operating principles of SQUID sensors and the properties of materials used to fabricate SQUID sensors is presented. The difference between low and high temperature SQUIDs and their suitability for specific applications is discussed. Although SQUID electronics have the capability to operate well above 1 MHz, most applications tend to be at lower frequencies. Specific examples of input circuits and detection coil configuration for different applications and environments, along with expected performance, are described. In particular, anticipated signal strength, magnetic field environment (applied field and external noise), and cryogenic requirements are discussed. Finally, a variety of applications with specific examples in the areas of electromagnetic, material property, nondestructive test and evaluation, and geophysical and biomedical measurements are reviewed. (c) 2006 American Institute of Physics.
C1 Tristan Technol, San Diego, CA 92121 USA.
RP Fagaly, RL (reprint author), Tristan Technol, 6185 Cornerstone Court E,Suite 106, San Diego, CA 92121 USA.
CR Akerib DS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.211301
   *AM CORP, UNPUB DEF GUID MAGN
   Amaya K, 1998, J PHYS-CONDENS MAT, V10, P11179, DOI 10.1088/0953-8984/10/49/008
   ANDER ME, 1980, GEOTHERMAL RESOURCES, V4, P5
   Anderberg J, 2003, IEEE T APPL SUPERCON, V13, P231, DOI 10.1109/TASC.2003.813692
   BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175
   BASTUSCHECK CM, 1985, J APPL PHYS, V58, P3896, DOI 10.1063/1.335609
   Baudenbacher F, 2002, PHYSICA C, V368, P24, DOI 10.1016/S0921-4534(01)01134-0
   BAUM E, 1991, J MAGN MAGN MATER, V101, P69, DOI 10.1016/0304-8853(91)90682-Z
   BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701
   Bennemann K. H., 2003, PHYS SUPERCONDUCTORS, VII
   Bennemann K. H., 2003, PHYS SUPERCONDUCTORS, VI
   BORDONI F, 1978, J PHYS-PARIS, V39, P1213
   BORK J, 2001, BIOMAG 2000, P970
   Bradley R, 2003, REV MOD PHYS, V75, P777, DOI 10.1103/RevModPhys.75.777
   Bradshaw LA, 1999, IEEE T BIO-MED ENG, V46, P959, DOI 10.1109/10.775406
   BRITTENHAM GM, 1982, NEW ENGL J MED, V307, P1671, DOI 10.1056/NEJM198212303072703
   BUCHANAN DS, 1988, ADV CRYOGEN ENG, V33, P97
   CABRERA B, 1982, PHYS REV LETT, V48, P1378, DOI 10.1103/PhysRevLett.48.1378
   Clarke J., 2004, SQUID HDB, V1
   CLARKE J, 1997, SQUID SENSORS FUNDAM, P1
   CLARKE JC, COMMUNICATION
   Claycomb JR, 1999, REV SCI INSTRUM, V70, P4562, DOI 10.1063/1.1150113
   CLEM TR, 1997, SQUID SENSORS FUNDAM, P517
   COHEN D, 1979, SCIENCE, V204, P514, DOI 10.1126/science.432655
   COHEN D, 1970, REV PHYS APPL, V5, P53, DOI 10.1051/rphysap:019700050105300
   COHEN D, 1970, APPL PHYS LETT, V16, P278, DOI 10.1063/1.1653195
   Cohen D., 2002, P 13 INT C BIOM
   COHEN D, 1972, SCIENCE, V175, P64
   DAY EP, 1987, BIOPHYS J, V52, P837, DOI 10.1016/S0006-3495(87)83277-0
   DRUNG D, 1995, J APPL PHYS, V77, P4088, DOI 10.1063/1.359607
   Drung D, 2005, IEEE T APPL SUPERCON, V15, P777, DOI 10.1109/TASC.2005.850057
   Drung D, 2003, SUPERCOND SCI TECH, V16, P1320, DOI 10.1088/0953-2048/16/12/002
   DRUNG D, 1990, APPL PHYS LETT, V57, P406, DOI 10.1063/1.103650
   Dunlop D. J., 1997, ROCK MAGNETISM FUNDA
   ENGELHARDT R, 2004, NEUROLOGY CLIN NEURO, V32, P1
   Fagaly R L, 1990, Adv Neurol, V54, P11
   Fagaly R. L., 1996, Sensors, V13, p18, 20, 22, 24, 26
   FAGALY RL, 1989, IEEE T MAGN, V25, P1216, DOI 10.1109/20.92514
   FAGALY RL, 1987, SCI PROGRESS-UK, V71, P181
   Faley MI, 2006, J PHYS CONF SER, V43, P1199, DOI 10.1088/1742-6596/43/1/292
   Faley MI, 1999, IEEE T APPL SUPERCON, V9, P3386, DOI 10.1109/77.783756
   FARRELL DE, 1999, B AM PHYS SOC, V44, P1553
   FENICI R, 2004, NEUROLOGY CLIN NEURO, P13
   Feynman RP, 1965, FEYNMAN LECT PHYS, VIII, P1
   Foley CP, 1999, IEEE T APPL SUPERCON, V9, P3786, DOI 10.1109/77.783852
   FONER S, 1959, REV SCI INSTRUM, V30, P548, DOI 10.1063/1.1716679
   Fong LE, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1884025
   GAMBLE TD, 1979, GEOPHYSICS, V37, P98
   GERBER C, 2001, Patent No. 6211673
   Giffard RP, 1972, J LOW TEMP PHYS, V6, P533, DOI 10.1007/BF00644085
   Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201
   Grover F. W., 1962, INDUCTANCE CALCULATI
   HASHIMOTO I, 1994, ELECTROEN CLIN NEURO, V93, P459, DOI 10.1016/0168-5597(94)90154-6
   HEBARD AF, 1971, P 12 INT C LOW TEMP, P855
   HEIDEN C, 1997, SQUID SENSORS FUNDAM, P289
   HILBERT C, 1985, APPL PHYS LETT, V47, P637, DOI 10.1063/1.96042
   HOBURG JF, 1995, IEEE T ELECTROMAGN C, V37, P575
   HOLLENHORST JN, 1999, IEEE T MAGN, V15, P474
   ILMONIEMI R, 1989, PROGR LOW TEMPERATUR, V12, P1
   JAWORSKI FB, 1981, SQUID APPLICATIONS G, P19
   Jenks WG, 1997, J PHYS D APPL PHYS, V30, P293, DOI 10.1088/0022-3727/30/3/002
   JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0
   KADO H, 2004, BIOL IMAGING SENSING, P117
   KAMERLINGHONNES H, 1911, AKAD WETENSCHAPPEN, V14, P818
   KETCHEN MB, 1982, APPL PHYS LETT, V40, P736, DOI 10.1063/1.93210
   Kirtley J, 1996, IEEE SPECTRUM, V33, P40, DOI 10.1109/6.546498
   Klemme BJ, 1999, J LOW TEMP PHYS, V116, P133, DOI 10.1023/A:1021883011172
   KNUUTILA J, 1987, REV SCI INSTRUM, V58, P2145, DOI 10.1063/1.1139478
   Koelle D, 1999, REV MOD PHYS, V71, P631, DOI 10.1103/RevModPhys.71.631
   KUCHNIR M, 1985, IEEE T MAGN, V21, P997, DOI 10.1109/TMAG.1985.1063601
   Larbalestier D, 2001, NATURE, V414, P368, DOI 10.1038/35104654
   Leslie KE, 2003, IEEE T APPL SUPERCON, V13, P759, DOI 10.1109/TASC.2003.814032
   Leslie KE, 2001, IEEE T APPL SUPERCON, V11, P252, DOI 10.1109/77.919331
   LEVY B, 1979, REV SCI INSTRUM, V50, P655, DOI 10.1063/1.1135867
   Li JY, 1998, J LOW TEMP PHYS, V110, P261, DOI 10.1023/A:1022568213093
   Lockhart J. M., 1986, P SOC PHOTO-OPT INS, V619, P148
   LOCKHART JM, 1997, IEEE T APPL SUPERCON, V7, P2354
   Lounasmaa O.V., 1974, EXPT PRINCIPLES METH
   LYNAM P, 1969, CRYOGENICS, V9, P242, DOI 10.1016/0011-2275(69)90229-X
   MA YP, 1998, REV PROGR QNDE, V17, P1067
   MATHAI A, 1992, APPL PHYS LETT, V61, P598, DOI 10.1063/1.107848
   MCELFRESH M, 1994, UNPUB FUNDAMENTALS M
   Meissner W, 1933, NATURWISSENSCHAFTEN, V21, P787, DOI 10.1007/BF01504252
   Moller W, 2004, J APPL PHYSIOL, V97, P2200, DOI 10.1152/japplphysiol.00970.2003
   Moller W, 2001, J MAGN MAGN MATER, V225, P218, DOI 10.1016/S0304-8853(00)01261-0
   Moller W, 2001, EXP LUNG RES, V27, P547, DOI 10.1080/019021401753181827
   Mosher JC, 2003, PROCEEDINGS OF THE 2003 IEEE WORKSHOP ON STATISTICAL SIGNAL PROCESSING, P294
   Muck M, 2001, REV SCI INSTRUM, V72, P3691, DOI 10.1063/1.1389498
   Muck M, 2001, APPL PHYS LETT, V78, P967, DOI 10.1063/1.1347384
   OHTA H, 2004, NEUROLOGY CLIN NEURO, P58
   OKADA Y, 2006, REV SCI INSTRUM, V77
   Oppenlander J, 2002, PHYSICA C, V368, P119, DOI 10.1016/S0921-4534(01)01151-0
   Orlando T. P., 1991, FDN APPL SUPERCONDUC
   Ornelas PH, 2003, SUPERCOND SCI TECH, V16, P427, DOI 10.1088/0953-2048/16/4/301
   Panaitov G, 2001, IEEE T APPL SUPERCON, V11, P888, DOI 10.1109/77.919487
   PAULSON DN, 1987, IEEE T MAGN, V23, P1315, DOI 10.1109/TMAG.1987.1065048
   PAULSON DN, 1991, IEEE T MAGN, V27, P3249, DOI 10.1109/20.133904
   PELIZZONE M, 1981, APPL PHYS, V24, P375, DOI 10.1007/BF00899737
   PHILO JS, 1977, REV SCI INSTRUM, V48, P1529, DOI 10.1063/1.1134952
   QUINN DJ, 1962, J APPL PHYS, V33, P748, DOI 10.1063/1.1702504
   Ripka P, 2001, MAGNETIC SENSORS MAG
   Robinson S. E., 1999, RECENT ADV BIOMAGNET, P302
   ROBINSON SE, 1989, P AM SOC MECH ENG AE, P7
   Robinson SE, 1989, ADV BIOMAGNETISM
   ROMANI GL, 1982, REV SCI INSTRUM, V53, P1815, DOI 10.1063/1.1136907
   SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004
   SARWINSKI R, COMMUNICATION
   SARWINSKI RE, 1977, CRYOGENICS, V17, P671, DOI 10.1016/0011-2275(77)90223-5
   SATA K, 1999, RECENT ADV BIOMAGNET, P63
   Sato S., 1990, ADV NEUROLOGY, V54
   Schambach J, 1999, IEEE T APPL SUPERCON, V9, P3527, DOI 10.1109/77.783791
   Schneider CW, 2004, EUROPHYS LETT, V68, P86, DOI 10.1209/epl/i2004-10165-x
   SCHOPOHL N, 2005, IEEE T APPL SUPERCON, V15, P936
   SIMMONDS MB, 1979, IEEE T MAGN, V15, P478, DOI 10.1109/TMAG.1979.1060155
   SOLOMONSON N, 1977, REV SCI INSTRUM, V65, P174
   STAHLHOFEN W, 1993, RADIAT ENVIRON BIOPH, V32, P221, DOI 10.1007/BF01209772
   STEPHENS RB, 1991, CRYOGENICS, V31, P988, DOI 10.1016/0011-2275(91)90225-L
   STROINK G, 1981, REV SCI INSTRUM, V52, P463, DOI 10.1063/1.1136612
   SUTHERLING W, COMMUNICATION
   TELSCHOW K, UNPUB
   TESCHE CD, 1977, J LOW TEMP PHYS, V29, P301, DOI 10.1007/BF00655097
   TIMMERHAUS KD, 1989, CRYOGENIC PROCESS EN, pCH7
   Van Duzer T., 1981, PRINCIPLES SUPERCOND
   VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056
   VRBA J, 1997, SQUID SENSORS FUNDAM, P117
   WAKAI RT, 1994, AM J OBSTET GYNECOL, V170, P770, DOI 10.1016/S0002-9378(94)70280-2
   WAKAI RT, 1988, APPL PHYS LETT, V52, P1182, DOI 10.1063/1.99197
   Walker G., 1989, MINIATURE REFRIGERAT
   Wang C., 2002, ADV CRYOGEN ENG, V47, P641
   Watanabe T, 2004, SUPERCOND SCI TECH, V17, pS450, DOI 10.1088/0953-2048/17/5/073
   WEBB RA, 1977, REV SCI INSTRUM, V48, P1585, DOI 10.1063/1.1134950
   WEINSTOCK HI, COMMUNICATION
   Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791
   Wikswo J. P.  Jr., 1988, Advances in Cryogenic Engineering. Vol.33. Proceedings of the 1987 Cryogenic Engineering Conference, P107
   WIKSWO JP, 1988, ELECTROEN CLIN NEURO, V69, P266, DOI 10.1016/0013-4694(88)90135-6
   WIKSWO JP, 1982, REV SCI INSTRUM, V53, P1846, DOI 10.1063/1.1136908
   Wikswo JP, 1996, NATO ADV SCI I E-APP, V329, P307
   WIKSWO JP, 1978, AIP C P, V44, P145
   WILLIAMSON SJ, 1981, J MAGN MAGN MATER, V22, P129, DOI 10.1016/0304-8853(81)90078-0
   WOLD R, 2000, DEV STANDOFF UXO DET
   Woltgens PJM, 2000, REV SCI INSTRUM, V71, P1529, DOI 10.1063/1.1150490
   WYNN WM, 1975, IEEE T MAGN, VMA11, P701, DOI 10.1109/TMAG.1975.1058672
   Zakosarenko V, 2001, IEEE T APPL SUPERCON, V11, P896, DOI 10.1109/77.919489
   ZIMMERMAN JE, 1970, J APPL PHYS, V41, P1572, DOI 10.1063/1.1659074
   ZIMMERMAN JE, 1971, J APPL PHYS, V42, P4483, DOI 10.1063/1.1659798
   1983, Patent No. 4389612
NR 147
TC 109
Z9 110
U1 6
U2 80
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD OCT
PY 2006
VL 77
IS 10
AR 101101
DI 10.1063/1.2354545
PG 45
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 101EU
UT WOS:000241722800001
DA 2018-10-20
ER

PT J
AU Prashantha, K
   Rashmi, BJ
   Venkatesha, TV
   Lee, JH
AF Prashantha, K.
   Rashmi, B. J.
   Venkatesha, T. V.
   Lee, Joong-Hee
TI Spectral characterization of apatite formation on poly
   (2-hydroxyethylmethacrylate)-TiO2 nanocomposite film prepared by sol-gel
   process
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE PHEMA; TiO2; nanocomposites; biomimetic; hydroxyapatite
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE-MATERIALS;
   MECHANICAL-PROPERTIES; NANOPHASE CERAMICS; COATINGS; TIO2; METHACRYLATE;
   OSTEOBLAST; HYDROGEL; ADHESION
AB Poly(2-hydroxyethylmethacrylate) films incorporated with titanium dioxide nanoparticles were successfully synthesized by an in situ sol-gel process. The in vitro bioactive properties of the films were assessed after immersion in simulated body fluid for up to 21 days through biomimetic method. Hydroxyapatite formation was observed on the surfaces of nanocomposites. This indicates that prepared composites are bioactive. Fourier transforms infrared spectroscopy, X-ray diffraction patterns, X-ray photoelectron spectroscopy and scanning electron microscope images confirm the hydroxyapatite formation on nanocomposite. The present study provides an analytical method for the assessment of titanium dioxide nanoparticles filled poly(2-hydroxyethylmethacrylate) polymer nanocomposites for biomedical applications. (c) 2006 Elsevier B.V. All rights reserved.
C1 Chonbuk Natl Univ, Div Adv Mat Engn, Dept Polymer Sci & Technol, Jeonju 561756, Jeonbuk, South Korea.
   Kuvempu Univ, Dept Chem, Jnana Sahyadri 577451, Karnataka, India.
RP Prashantha, K (reprint author), Chonbuk Natl Univ, Div Adv Mat Engn, Dept Polymer Sci & Technol, Duckjin Dong 1Ga 664-14, Jeonju 561756, Jeonbuk, South Korea.
EM prashantha.k@gmail.com
RI Prashantha, Kalappa/B-5274-2013; Lee, Joong Hee/D-1643-2011
OI Prashantha, Kalappa/0000-0001-8350-3970
CR Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Chen XC, 2002, J MATER SCI LETT, V21, P1637, DOI 10.1023/A:1020871830587
   GUISEPPIELIE A, 1998, ELECT OPTICAL POLYM, P1187
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Johnson BD, 2004, MAT SCI ENG C-BIO S, V24, P575, DOI 10.1016/j.msec.2003.11.002
   Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
   KABRA BG, 1991, J APPL POLYM SCI, V42, P2409, DOI 10.1002/app.1991.070420906
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Khor KA, 2003, BIOMATERIALS, V24, P723, DOI 10.1016/S0142-9612(02)00404-0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Moritz N, 2003, J BIOMED MATER RES A, V65A, P9, DOI 10.1002/jbm.a.10434
   Prashantha K, 2002, J APPL POLYM SCI, V84, P983, DOI 10.1002/app.10299
   PRASHANTHA K, 2001, B MATER SCI, V24, P531
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Takadama H, 2001, SCI TECHNOL ADV MAT, V2, P389
   Tanahashi M., 1992, BIOCERAMICS, P57
   Wang SX, 1999, J MATER SCI LETT, V18, P2009, DOI 10.1023/A:1006646219253
   Webster TJ, 2003, AM CERAM SOC BULL, V82, P23
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Young CD, 1998, BIOMATERIALS, V19, P1745, DOI 10.1016/S0142-9612(98)00083-0
   Zheng MP, 2000, J MATER SCI LETT, V19, P433, DOI 10.1023/A:1006703224379
NR 29
TC 12
Z9 13
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD OCT
PY 2006
VL 65
IS 2
BP 340
EP 344
DI 10.1016/j.saa.2005.11.001
PG 5
WC Spectroscopy
SC Spectroscopy
GA 086SD
UT WOS:000240692400013
PM 16503415
DA 2018-10-20
ER

PT J
AU Yi, JH
   Bernard, C
   Variola, F
   Zalzal, SF
   Wuest, JD
   Rosei, F
   Nanci, A
AF Yi, Ji-Hyun
   Bernard, Caroline
   Variola, Fabio
   Zalzal, Sylvia F.
   Wuest, James D.
   Rosei, Federico
   Nanci, Antonio
TI Characterization of a bioactive nanotextured surface created by
   controlled chemical oxidation of titanium
SO SURFACE SCIENCE
LA English
DT Article
DE nanotopography; titanium oxides; chemical oxidation; SEM; AFM; FTIR; XPS
ID GEL-DERIVED COATINGS; BIOMEDICAL APPLICATIONS; OSTEOBLAST ADHESION;
   HYDROGEN-PEROXIDE; FORCE MICROSCOPY; VAPOR-DEPOSITION; OXIDE-FILMS;
   IN-VITRO; TIO2; IMPLANTS
AB Events at bone-implant interfaces are influenced by implant surface properties. Our previous work has revealed that osteogenic activity is enhanced by a nanotextured Ti surface, obtained by controlled chemical oxidation using a H2SO4/H2O2 mixture. To better understand the origin of this biological effect, we have carried out a characterization of the modified surface at the nanoscale. In particular, the morphology, structure, and chemical composition of the Ti surface were examined thoroughly. X-ray photoelectron spectroscopy (XPS), combined with grazing-angle Fourier-transform infrared (FTIR) spectroscopy, revealed that the oxidized Ti surface consists of almost pure TiO2 with Ti:O ratio ranging between 1:2.02 and 1:2.08. Raman spectroscopy and X-ray diffraction (XRD) indicated that the chemically treated Ti surface is mainly composed of amorphous titania. Scanning electron microscopy (SEM) clearly showed that the treated Ti substrate becomes highly porous and has a surface consisting of nano-sized pits, which have average diameters and fractal dimensions ranging between 20-22 nm and 1.11-1.17, respectively. Atomic force microscopy (AFM) revealed a three-fold increase in surface roughness. The thickness of the oxide layer on the treated Ti surface is estimated to be similar to 32-40 nm. Together, these observations provide a detailed characterization of chemically oxidized Ti surfaces at the nanoscale and offer new prospects for understanding and controlling the relationship between the properties of materials and their interactions with cells. Our work brings us closer to the creation of "intelligent" implant surfaces, capable of selectively influencing cell behavior. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Montreal, Fac Med Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ H3C 3J7, Canada.
   Univ Quebec, EMT, INRS, Varennes, PQ J3X 1S2, Canada.
   Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada.
RP Nanci, A (reprint author), Univ Montreal, Fac Med Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ H3C 3J7, Canada.
EM antonio.nanci@umontreal.ca
RI Variola, Fabio/G-9615-2013
OI Variola, Fabio/0000-0002-5519-6915
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   BRIGGS D, 1990, PRACTICAL SURFACE AN
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Choi HC, 2005, VIB SPECTROSC, V37, P33, DOI [10.1016/j.vibspec.2004.05.006, 10.1019/j.vibspec.2004.05.006]
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Davis KM, 1996, J NON-CRYST SOLIDS, V201, P177, DOI 10.1016/0022-3093(95)00631-1
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   DEGATICA NLH, 1993, APPL SURF SCI, V68, P107, DOI 10.1016/0169-4332(93)90220-6
   Dhage SR, 2004, MATER LETT, V58, P2310, DOI 10.1016/j.matlet.2004.02.021
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Gallas B, 2002, J APPL PHYS, V92, P1922, DOI 10.1063/1.1494843
   Gao XT, 1999, CATAL TODAY, V51, P233, DOI 10.1016/S0920-5861(99)00048-6
   Giavaresi G, 2004, BIOMATERIALS, V25, P5583, DOI 10.1016/j.biomaterials.2004.01.017
   Hengsberger S., 2001, European Cells & Materials, V1, P12
   Ishigaki T, 2001, THIN SOLID FILMS, V390, P20, DOI 10.1016/S0040-6090(01)00935-X
   Kenkel N., 1996, COENOSES, V11, P77
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   MARTIN P, 1992, J APPL PHYS, V72, P2907, DOI 10.1063/1.351492
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749
   Nakamura M, 2001, J MATER RES, V16, P621, DOI 10.1557/JMR.2001.0089
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   NANCI A, 1998, BIOL MECH TOOTH ERUP, P87
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RICHERT L, 2006, 52 ANN M ORTH RES SO
   Rosei F., 2004, J PHYS-CONDENS MAT, V16, P1373
   Sirghi L, 2003, SURF REV LETT, V10, P345, DOI 10.1142/S0218625X03005141
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Stuart B., 1996, MODERN INFRARED SPEC
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Urlaub R, 2000, J NON-CRYST SOLIDS, V265, P276, DOI 10.1016/S0022-3093(00)00003-X
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Watson S, 2004, J NANOPART RES, V6, P193, DOI 10.1023/B:NANO.0000034623.33083.71
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Xu J, 2003, J BIOMED MATER RES A, V67A, P719, DOI 10.1002/jbm.a.10109
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhang WF, 2000, J PHYS D APPL PHYS, V33, P912, DOI 10.1088/0022-3727/33/8/305
   Zhang WJ, 2004, SURF COAT TECH, V182, P192, DOI 10.1016/j.surfcoat.2003.08.050
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zuruzi AS, 2005, ADV FUNCT MATER, V15, P396, DOI 10.1002/adfm.200400135
NR 57
TC 63
Z9 65
U1 2
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2006
VL 600
IS 19
BP 4613
EP 4621
DI 10.1016/j.susc.2006.07.053
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 097YT
UT WOS:000241486900030
DA 2018-10-20
ER

PT J
AU Yu, WW
   Chang, E
   Drezek, R
   Colvin, VL
AF Yu, William W.
   Chang, Emmanuel
   Drezek, Rebekah
   Colvin, Vicki L.
TI Water-soluble quantum dots for biomedical applications
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Review
DE water-soluble; semiconductor nanocrystal; quantum dot; cytotoxicity
ID SEMICONDUCTOR NANOCRYSTALS; CDSE NANOCRYSTALS; NONCOORDINATING SOLVENT;
   PHOTODYNAMIC THERAPY; BIOLOGICAL DETECTION; SCANNING MICROSCOPY; II-VI;
   NANOPARTICLES; LUMINESCENT; SILICA
AB Semiconductor nanocrystals are 1-10 nm inorganic particles with unique size-dependent optical and electrical properties due to quantum confinement (so they are also called quantum dots). Quantum dots are new types of fluorescent materials for biological labeling with high quantum efficiency, long-term photostability, narrow emission, and continuous absorption spectra. Here, we discuss the recent development in making water-soluble quantum dots and related cytotoxicity for biomedical applications. (c) 2006 Elsevier Inc. All rights reserved.
C1 Rice Univ, Dept Chem, Houston, TX 77005 USA.
   Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RP Yu, WW (reprint author), Rice Univ, Dept Chem, Houston, TX 77005 USA.
EM wyu@rice.edu
RI Drezek, Rebekah/A-5101-2012
CR Aldana J, 2001, J AM CHEM SOC, V123, P8844, DOI 10.1021/ja016424q
   Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432
   Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Bailey RE, 2004, J NANOSCI NANOTECHNO, V4, P569, DOI 10.1166/jnn.2004.004
   Bailey RE, 2003, J AM CHEM SOC, V125, P7100, DOI 10.1021/ja035000o
   Bakalova R, 2004, NANO LETT, V4, P1567, DOI 10.1021/nl049627w
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Battaglia D, 2002, NANO LETT, V2, P1027, DOI 10.1021/nl025687v
   BOUDENE C, 1982, Toxicological European Research, V4, P143
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Celik A, 2005, TOXICOL IND HEALTH, V21, P243, DOI 10.1191/0748233705th237oa
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   CHANG E, 2006, UNPUB
   CHANG E, 2006, IN PRESS SMALL
   Chang E, 2005, J BIOMED NANOTECHNOL, V1, P397, DOI 10.1166/jbn.2005.053
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Eastman PS, 2006, NANO LETT, V6, P1059, DOI 10.1021/nl060795t
   Fan HY, 2005, NANO LETT, V5, P645, DOI 10.1021/nl050017l
   Ferrara DE, 2006, AM J PHYSIOL-REG I, V290, pR114, DOI 10.1152/ajpregu.00449.2005
   Fischer Anna Barbara, 2001, Arhiv za Higijenu Rada i Toksikologiju, V52, P333
   Fu AH, 2004, J AM CHEM SOC, V126, P10832, DOI 10.1021/ja04647x
   Gao XH, 2002, J BIOMED OPT, V7, P532, DOI 10.1117/1.1506706
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488
   Gomez DE, 2005, SMALL, V1, P238, DOI 10.1002/smll.200400019
   Green M, 2005, CHEM COMMUN, P121, DOI 10.1039/b413175d
   Guo WZ, 2003, CHEM MATER, V15, P3125, DOI 10.1021/cm034341y
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Ipe BI, 2005, SMALL, V1, P706, DOI 10.1002/smll.200500105
   Kho R, 2000, J COLLOID INTERF SCI, V227, P561, DOI 10.1006/jcis.2000.6894
   Kim S, 2003, J AM CHEM SOC, V125, P14652, DOI 10.1021/ja0368094
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kim SW, 2005, J AM CHEM SOC, V127, P10526, DOI 10.1021/ja0434331
   Kim SW, 2005, J AM CHEM SOC, V127, P4556, DOI 10.1021/ja043511f
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008
   Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C
   Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Michalet X, 2001, SINGLE MOL, V2, P261, DOI 10.1002/1438-5171(200112)2:4<261::AID-SIMO261>3.0.CO;2-P
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Miyawaki A., 2003, NAT CELL BIOL, V5, pS1
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Mulvaney P, 2000, J MATER CHEM, V10, P1259, DOI 10.1039/b000136h
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   Nann T, 2004, ANGEW CHEM INT EDIT, V43, P5393, DOI 10.1002/anie.200460752
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Parak WJ, 2003, NANOTECHNOLOGY, V14, pR15, DOI 10.1088/0957-4484/14/7/201
   Patel HM, 1998, ADV DRUG DELIV REV, V32, P45
   Pathak S, 2006, J NEUROSCI, V26, P1893, DOI 10.1523/JNEUROSCI.3847-05.2006
   Pathak S, 2001, J AM CHEM SOC, V123, P4103, DOI 10.1021/ja0058334
   Patrakka J, 2002, PEDIATR RES, V52, P349, DOI 10.1203/01.PDR.0000025285.72240.11
   Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j
   Peng XG, 2000, NATURE, V404, P59
   Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425
   Peng ZA, 2001, J AM CHEM SOC, V123, P1389, DOI 10.1021/ja0027766
   Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m
   Pinaud F, 2004, J AM CHEM SOC, V126, P6115, DOI 10.1021/ja031691c
   Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018
   Pradhan N, 2005, J AM CHEM SOC, V127, P17586, DOI 10.1021/ja055557z
   Rogach AL, 2000, CHEM MATER, V12, P2676, DOI 10.1021/cm000244i
   Samia ACS, 2003, J AM CHEM SOC, V125, P15736, DOI 10.1021/ja0386905
   Selvan ST, 2005, ADV MATER, V17, P1620, DOI 10.1002/adma.200401960
   Selvan ST, 2001, ADV MATER, V13, P985, DOI 10.1002/1521-4095(200107)13:12/13<985::AID-ADMA985>3.0.CO;2-W
   Shimizu KT, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205316
   So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188
   Steckel JS, 2003, ADV MATER, V15, P1862, DOI 10.1002/adma.200305449
   Tan WH, 2004, MED RES REV, V24, P621, DOI 10.1002/med.20003
   Tansil NC, 2006, NANO TODAY, V1, P28, DOI 10.1016/S1369-7021(06)71363-3
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Wang F, 2006, NANOTECHNOLOGY, V17, pR1, DOI 10.1088/0957-4484/17/1/R01
   Wang Y, 2004, J PHYS CHEM B, V108, P15461, DOI 10.1021/jp048948t
   Winter JO, 2001, ADV MATER, V13, P1673, DOI 10.1002/1521-4095(200111)13:22<1673::AID-ADMA1673>3.0.CO;2-6
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Wuister SF, 2003, NANO LETT, V3, P503, DOI 10.1021/nl034054t
   Xu HX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng043
   Yu WW, 2004, CHEM MATER, V16, P3318, DOI 10.1021/cm049476y
   Yu WW, 2003, CHEM MATER, V15, P4300, DOI 10.1021/cm034729t
   Yu WW, 2004, CHEM MATER, V16, P560, DOI 10.1021/cm033007z
   Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k
   Yu WW, 2002, ANGEW CHEM INT EDIT, V41, P2368, DOI 10.1002/1521-3773(20020703)41:13<2368::AID-ANIE2368>3.0.CO;2-G
   Zhuang JQ, 2003, J MATER CHEM, V13, P1853, DOI 10.1039/b303287f
NR 88
TC 293
Z9 308
U1 10
U2 112
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 29
PY 2006
VL 348
IS 3
BP 781
EP 786
DI 10.1016/j.bbrc.2006.07.160
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 079HM
UT WOS:000240166500001
PM 16904647
DA 2018-10-20
ER

PT J
AU Brunke, O
   Odenbach, S
   Jurgons, R
   Alexiou, C
   Hilger, I
   Beckmann, F
AF Brunke, O.
   Odenbach, S.
   Jurgons, R.
   Alexiou, C.
   Hilger, I.
   Beckmann, F.
TI Determination of the magnetic particle distribution in tumour tissue by
   means of X-ray tomography
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Article
ID LOCOREGIONAL CANCER-TREATMENT; HYPERTHERMIA
AB In biomedical applications of ferrofluids, the resulting distribution of the magnetic nanoparticles is a crucial parameter for the effect of the therapeutic approach. In order to increase the efficacy of local cancer treatments incorporating ferrofluids likemagnetic drug targeting and hyperthermia, the biodistribution of theses fluids in the respective tissue has to be optimized. Usually, the distribution of particles is determined by histological cuts of the investigated specimen, a technique which provides only local information about the overall distribution of the magnetic material, e. g. in a tumour. Radioscopic techniques based on gamma or x- rays are well established, suitable for in vivo examination and non- destructive, but only provide two- dimensional integral information in the direction of the beam. Here we have used micro- tomography incorporating a conventional x- ray tube as well as monochromatic synchrotron radiation - as a tool for a three- dimensional analysis of the distribution of magnetic nanoparticles in biological applications. Compared to biological matter, the iron- based magnetic nanoparticles provide sufficiently high absorption for x- rays and thus serve as an intrinsic contrast agent for the examinations. The results show the principle feasibility of the method for a quantitative determination of the agglomeration behaviour of the nanoparticles within carcinogenic tissue after intravascular or intratumoural injection.
C1 Tech Univ Dresden, Lehrstuhl Magnetofluiddynam, D-01062 Dresden, Germany.
   Univ Klinikum Erlangen, Klin & Poliklin Hals Nasen & Ohrenkranke, Erlangen, Germany.
   Univ Jena, Inst Diagnost & Intervent Readiol, D-6900 Jena, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, D-21502 Geesthacht, Germany.
RP Brunke, O (reprint author), Tech Univ Dresden, Lehrstuhl Magnetofluiddynam, D-01062 Dresden, Germany.
EM Oliver.Brunke@tu-dresden.de
RI Odenbach, Stefan/D-4542-2009; Beckmann, Felix/E-1940-2016
OI Beckmann, Felix/0000-0002-2266-9173
CR Alexiou C, 2006, EUR BIOPHYS J BIOPHY, V35, P446, DOI 10.1007/s00249-006-0042-1
   Alexiou C, 2003, J DRUG TARGET, V11, P139, DOI 10.1080/1061186031000150791
   Alexiou C, 2000, CANCER RES, V60, P6641
   Baruchel J., 2000, XRAY TOMOGRAPHY MAT
   BONSE U, 2004, SPIE DEV XRAY TOMOGR, V4
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   DONATH T, 2004, SPIE DEV XRAY TOMOGR, V4
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   Gupta P.K., 1994, MICROSPHERES REGIONA, P71
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   Kak A. C., 1999, PRINCIPLES COMPUTERI
   Muller B, 2006, NUCL INSTRUM METH B, V246, P254, DOI 10.1016/j.nimb.2005.12.048
   Murray TG, 1997, INT J HYPERTHER, V13, P423, DOI 10.3109/02656739709046543
   Nazarian A, 2004, J BIOMECH, V37, P55, DOI 10.1016/S0021-9290(03)00254-9
   SCHNEIDERS N J, 1978, Medical Physics (Woodbury), V5, P31, DOI 10.1118/1.594401
   Thurner P, 2004, J PHYS-CONDENS MAT, V16, pS3499, DOI 10.1088/0953-8984/16/33/011
   Widder K. J., 1979, ADV PHARMACOL CHEMOT, P213
NR 18
TC 21
Z9 21
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
EI 1361-648X
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD SEP 27
PY 2006
VL 18
IS 38
SI SI
BP S2903
EP S2917
DI 10.1088/0953-8984/18/38/S25
PG 15
WC Physics, Condensed Matter
SC Physics
GA 094RX
UT WOS:000241257800026
DA 2018-10-20
ER

PT J
AU Elias, LM
   Schneider, SG
   Schneider, S
   Silva, HM
   Malvisi, E
AF Elias, L. M.
   Schneider, S. G.
   Schneider, S.
   Silva, H. M.
   Malvisi, E.
TI Microstructural and mechanical characterization of biomedical
   Ti-Nb-Zr(-Ta) alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biomaterial; Ti-Nb-Zr(-Ta) alloys; mechanical properties
ID TI-TA ALLOYS; TITANIUM-ALLOYS; BEHAVIOR; ELEMENTS
AB In recent years there has been a significant development of novel implant alloys based on beta-Ti such as Ti-Nb-Zr and Ti-Nb-Zr-Ta alloys systems. The purpose of this work is to provide characterization of Ti-35.3Nb-5.1Ta-7.1Zr and Ti-41.lNb-7.1Zr alloys, in which Nb will substitute the atomic amount of Ta, with emphasis in the property-microstructure-composition relationships. These alloys are produced from commercially pure materials (Ti, Nb, Zr and Ta) by an arc melting method. All ingots were submitted to sequences of heat treatment (1000 degrees C/2 h - WQ), cold working by swaging procedures and other heat treatment (1000 degrees C/2 h - WQ). Specimens, in as cast and heat-treated condition, were examined by light and scanning electron microscopy (SEM). These results suggested the presence of beta- and omega-phases. Mechanical properties were based on tensile and hardness tests. These alloys exhibit a lower modulus than that of conventional Ti alloys and the other mechanical properties are suitable for biomedical applications. (c) 2006 Elsevier B.V. All rights reserved.
C1 FAENQUIL DEMAR, Fac Engn Quim, BR-12600970 Lorena, SP, Brazil.
   ITA, BR-12228904 Sao Jose Dos Campos, Brazil.
RP Schneider, SG (reprint author), FAENQUIL DEMAR, Fac Engn Quim, Gleba A1-6,CP 116, BR-12600970 Lorena, SP, Brazil.
EM sandra@demar.faenquil.br
RI Schneider, Sandra/E-6087-2015
CR Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Hill B. N., 1944, 927 NACA
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   Rasmussen KJR, 2003, J CONSTR STEEL RES, V59, P47, DOI 10.1016/S0143-974X(02)00018-4
   Schneider Sergio, 2005, Mat. Res., V8, P435, DOI 10.1590/S1516-14392005000400013
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   van den Berg GJ, 2000, J CONSTR STEEL RES, V54, P135, DOI 10.1016/S0143-974X(99)00053-X
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 12
TC 97
Z9 102
U1 0
U2 40
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 25
PY 2006
VL 432
IS 1-2
BP 108
EP 112
DI 10.1016/j.msea.2006.06.013
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 087CV
UT WOS:000240721000015
DA 2018-10-20
ER

PT J
AU Erdemir, A
   Donnet, C
AF Erdemir, Ali
   Donnet, Christophe
TI Tribology of diamond-like carbon films: recent progress and future
   prospects
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Review
ID CHEMICAL-VAPOR-DEPOSITION; PULSED-LASER DEPOSITION; AMORPHOUS-CARBON;
   WEAR PROPERTIES; DLC COATINGS; THIN-FILMS; SUPERLOW-FRICTION;
   NANOCOMPOSITE COATINGS; NITRIDE COATINGS; MECHANICAL-PROPERTIES
AB During the past two decades, diamond-like carbon (DLC) films have attracted an overwhelming interest from both industry and the research community. These films offer a wide range of exceptional physical, mechanical, biomedical and tribological properties that make them scientifically very fascinating and commercially essential for numerous industrial applications. Mechanically, certain DLC films are extremely hard (as hard as 90 GPa) and resilient, while tribologically they provide some of the lowest known friction and wear coefficients. Their optical and electrical properties are also extraordinary and can be tailored to meet the specific requirements of a given application. Because of their excellent chemical inertness, these films are resistant to corrosive and/or oxidative attacks in acidic and saline media. The combination of such a wide range of outstanding properties in one material is rather uncommon, so DLC can be very useful in meeting the multifunctional application needs of advanced mechanical systems. In fact, these films are now used in numerous industrial applications, including razor blades, magnetic hard discs, critical engine parts, mechanical face seals, scratch-resistant glasses, invasive and implantable medical devices and microelectromechanical systems. DLC films are primarily made of carbon atoms that are extracted or derived from carbon-containing sources, such as solid carbon targets and liquid and gaseous forms of hydrocarbons and fullerenes. Depending on the type of carbon source being used during the film deposition, the type of bonds (i.e. sp(1), sp(2), sp(3)) that hold carbon atoms together in DLC may vary a great deal and can affect their mechanical, electrical, optical and tribological properties. Recent systematic studies of DLC films have confirmed that the presence or absence of certain elemental species, such as hydrogen, nitrogen, sulfur, silicon, tungsten, titanium and fluorine, in their microstructure can also play significant roles in their properties. The main goal of this review paper is to highlight the most recent developments in the synthesis, characterization and application of DLC films. We will also discuss the progress made in understanding the fundamental mechanisms that control their very unique friction and wear behaviours. Novel design concepts and the principles of superlubricity in DLC films are also presented.
C1 Argonne Natl Lab, Div Energy Technol, Argonne, IL 60439 USA.
   Univ St Etienne, St Etienne, France.
   Univ Inst France, Lab Traitement Signal & Instrumentat, UMR 5516, St Etienne, France.
RP Erdemir, A (reprint author), Argonne Natl Lab, Div Energy Technol, 9700 S Cass Ave, Argonne, IL 60439 USA.
RI Erdemir, Ali/P-7643-2018
OI Erdemir, Ali/0000-0002-6489-9620
CR AGREEV VP, 1991, P SOC PHOTO-OPT INS, V1503, P453
   Alzoubi MF, 2002, LUBR ENG, V58, P21
   Andersson J, 2003, WEAR, V254, P1070, DOI 10.1016/S0043-1648(03)00336-3
   Andersson J, 2003, SURF COAT TECH, V163, P535, DOI 10.1016/S0257-8972(02)00617-5
   ANDERSSON LP, 1981, THIN SOLID FILMS, V86, P193, DOI 10.1016/0040-6090(81)90288-1
   ANGUS JC, 1994, SYNTHETIC DIAMOND EM, P21
   Aoki Y, 2004, TRIBOL INT, V37, P941, DOI 10.1016/j.triboint.2004.07.011
   ARNOLDUSSEN TC, 1985, ANNU REV MATER SCI, V15, P379
   Ban M, 2002, WEAR, V253, P331, DOI 10.1016/S0043-1648(02)00156-4
   Benchikh N, 2006, SURF COAT TECH, V200, P6272, DOI 10.1016/j.surfcoat.2005.11.056
   Benchikh N, 2005, THIN SOLID FILMS, V482, P287, DOI 10.1016/j.tsf.2004.11.162
   BOWDEN FP, 1951, PROC R SOC LON SER-A, V208, P444, DOI 10.1098/rspa.1951.0173
   BUBENZER A, 1983, J VAC SCI TECHNOL A, V1, P305
   BURTON RA, 1989, P 35 M IEEE HOLM C E, P31
   Cao DM, 2001, APPL PHYS LETT, V79, P329, DOI 10.1063/1.1384477
   CHANDRASEKAR S, 1992, WEAR, V153, P79, DOI 10.1016/0043-1648(92)90262-7
   Cohen ML, 1996, MAT SCI ENG A-STRUCT, V209, P1, DOI 10.1016/0921-5093(95)10120-9
   Cuong NK, 2003, SURF COAT TECH, V174, P1024, DOI 10.1016/S0257-8972(03)00360-8
   Cutiongco EC, 1996, J TRIBOL-T ASME, V118, P543, DOI 10.1115/1.2831572
   Czigany Z, 2003, ULTRAMICROSCOPY, V94, P163, DOI 10.1016/S0304-3991(02)00261-9
   Dag S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241401
   de Barros'Bouchet MI, 2005, TRIBOL INT, V38, P257, DOI 10.1016/j.triboint.2004.08.009
   DERYAGIN BV, 1975, SCI AM, V233, P102
   Dickrell PL, 2005, J TRIBOL-T ASME, V127, P82, DOI 10.1115/1.1829719
   DONNET C, 1994, SURF COAT TECH, V68, P626, DOI 10.1016/0257-8972(94)90228-3
   Donnet C, 1998, SURF COAT TECH, V100, P180, DOI 10.1016/S0257-8972(97)00611-7
   Donnet C, 1997, SURF COAT TECH, V94-5, P456, DOI 10.1016/S0257-8972(97)00275-2
   Donnet C, 2000, TRIBOL LETT, V9, P137, DOI 10.1023/A:1018800719806
   Donnet C, 1998, TRIBOL LETT, V4, P259, DOI 10.1023/A:1019140213257
   Dumitru G, 2003, DIAM RELAT MATER, V12, P1034, DOI 10.1016/S0925-9635(02)00372-2
   DUMITRU G, 2001, P WLT LAS, P351
   EISENBERG S, 1984, J VAC SCI TECHNOL, V2, P369
   EISENBERG S, 1971, J APPL PHYS, V42, P2953
   ENKE K, 1980, APPL PHYS LETT, V36, P291, DOI 10.1063/1.91465
   Erdemir A, 1995, SURF COAT TECH, V76-77, P559, DOI 10.1016/0257-8972(95)02518-9
   Erdemir A, 2004, SURF COAT TECH, V188, P588, DOI 10.1016/j.surfcoat.2004.07.052
   ERDEMIR A, 1994, DIAM RELAT MATER, V3, P119, DOI 10.1016/0925-9635(94)90042-6
   ERDEMIR A, 1991, SURF COAT TECH, V50, P17, DOI 10.1016/0257-8972(91)90187-2
   Erdemir A, 1996, TRIBOL T, V39, P735, DOI 10.1080/10402009608983591
   Erdemir A, 2001, SURF COAT TECH, V146, P292, DOI 10.1016/S0257-8972(01)01417-7
   Erdemir A, 2000, SURF COAT TECH, V133, P448, DOI 10.1016/S0257-8972(00)00968-3
   Erdemir A, 2000, DIAM RELAT MATER, V9, P632, DOI 10.1016/S0925-9635(99)00361-1
   Erdemir A, 1996, TRIBOL T, V39, P787, DOI 10.1080/10402009608983596
   Erdemir A, 1996, SURF COAT TECH, V86-7, P692, DOI 10.1016/S0257-8972(96)03073-3
   Erdemir A, 1999, SURF COAT TECH, V120, P589, DOI 10.1016/S0257-8972(99)00444-2
   Erdemir A, 2000, J VAC SCI TECHNOL A, V18, P1987, DOI 10.1116/1.582459
   ERDEMIR A, NANOMATERIALS HDB, P685
   ERDEMIR A, 2000, MODERN TRIBOLOGY HDB, P871
   ERDEMIR A, 2006, WEAR MAT MECH PRACTI, P191
   Feng B, 2001, THIN SOLID FILMS, V398, P210, DOI 10.1016/S0040-6090(01)01427-4
   Fernandez A, 2003, SURF COAT TECH, V163, P527, DOI 10.1016/S0257-8972(02)00615-1
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Fontaine J, 2004, TRIBOL INT, V37, P869, DOI 10.1016/j.triboint.2004.07.002
   FUSARO RL, 1970, ASLE TRANS, V13, P56
   Gahlin R, 2001, WEAR, V249, P302, DOI 10.1016/S0043-1648(01)00565-8
   Gangopadhyay AK, 1997, TRIBOL INT, V30, P9, DOI 10.1016/0301-679X(96)00017-5
   Gao F, 2005, TRIBOL LETT, V20, P221, DOI 10.1007/s11249-005-8549-7
   GARDOS MN, 1990, J MATER RES, V5, P2599, DOI 10.1557/JMR.1990.2599
   GARDOS MN, 1994, ELECTROCHEM SOC MONO, P419
   Garrelie F, 2003, SURF COAT TECH, V163, P306, DOI 10.1016/S0257-8972(02)00481-4
   Gilmore R, 2001, THIN SOLID FILMS, V398, P199, DOI 10.1016/S0040-6090(01)01437-7
   GRILL A, 1991, SURF COAT TECH, V49, P530, DOI 10.1016/0257-8972(91)90112-A
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Grill A, 1997, SURF COAT TECH, V94-5, P507, DOI 10.1016/S0257-8972(97)00458-1
   GUPTA BK, 1994, J TRIBOL-T ASME, V116, P445, DOI 10.1115/1.2928862
   Hauert R, 2004, TRIBOL INT, V37, P991, DOI 10.1016/j.triboint.2004.07.017
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hauert R, 1999, ADV MATER, V11, P175, DOI 10.1002/(SICI)1521-4095(199902)11:2<175::AID-ADMA175>3.0.CO;2-#
   Heimberg JA, 2001, APPL PHYS LETT, V78, P2449, DOI 10.1063/1.1366649
   Hershberger J, 2004, SURF COAT TECH, V179, P237, DOI 10.1016/S0257-8972(03)00859-4
   HOLLAND L, 1976, THIN SOLID FILMS, V38, pL17, DOI 10.1016/0040-6090(76)90214-5
   HORSFALL RH, 1998, P 41 ANN TECHN C SOC, P60
   Hovsepian PE, 2004, THIN SOLID FILMS, V447, P7, DOI 10.1016/j.tsf.2003.09.009
   IMAMURA A, 1988, SURF COAT TECH, V36, P161, DOI 10.1016/0257-8972(88)90146-6
   Johnson KE, 1996, IBM J RES DEV, V40, P511, DOI 10.1147/rd.405.0511
   Johnston SV, 2005, SURF ENG, V21, P67, DOI 10.1179/174329405X30039
   Kalin M, 2005, WEAR, V259, P1270, DOI 10.1016/j.wear.2005.02.028
   Kano M, 2005, TRIBOL LETT, V18, P245, DOI 10.1007/s11249-004-2749-4
   Kato K, 2003, WEAR, V254, P1062, DOI 10.1016/S0043-1648(03)00334-X
   Kato K, 2000, WEAR, V238, P40, DOI 10.1016/S0043-1648(99)00338-5
   KHAN MR, 1988, IEEE T MAGN, V24, P2647, DOI 10.1109/20.92200
   Khurshudov AG, 1996, SURF COAT TECH, V86-7, P664, DOI 10.1016/S0257-8972(96)03072-1
   KIM DS, 1991, SURF COAT TECH, V49, P537, DOI 10.1016/0257-8972(91)90113-B
   Kim HI, 2006, TRIBOL LETT, V21, P53, DOI 10.1007/s11249-005-9008-1
   KING FK, 1981, IEEE T MAGN, V17, P1376, DOI 10.1109/TMAG.1981.1061234
   Kononenko TV, 2000, APPL PHYS A-MATER, V71, P627, DOI 10.1007/s003390000572
   Le Harzic R, 2002, APPL PHYS LETT, V80, P3886, DOI 10.1063/1.1481195
   Lettington AH, 1998, CARBON, V36, P555, DOI 10.1016/S0008-6223(98)00062-1
   Lian GD, 2002, DIAM RELAT MATER, V11, P1890, DOI 10.1016/S0925-9635(02)00165-6
   Liu Y, 1997, SURF COAT TECH, V94-5, P463, DOI 10.1016/S0257-8972(97)00450-7
   Loir AS, 2005, APPL SURF SCI, V247, P225, DOI 10.1016/j.apsusc.2005.01.129
   Meng WJ, 1998, J APPL PHYS, V84, P4314, DOI 10.1063/1.368650
   Meng WJ, 2000, THIN SOLID FILMS, V377, P222, DOI 10.1016/S0040-6090(00)01300-6
   MESSIER R, 1987, THIN SOLID FILMS, V153, P1, DOI 10.1016/0040-6090(87)90164-7
   MIYOSHI K, 1993, J APPL PHYS, V74, P4446, DOI 10.1063/1.354386
   MIYOSHI K, 1992, DIAM RELAT MATER, V1, P639
   Moon MW, 2002, J MECH PHYS SOLIDS, V50, P2355, DOI 10.1016/S0022-5096(02)00034-0
   Nakayama K, 2004, SURF COAT TECH, V188, P599, DOI 10.1016/j.surfcoat.2004.07.103
   Neidhardt J, 2004, DIAM RELAT MATER, V13, P1882, DOI 10.1016/j.diamond.2004.05.012
   OGURI K, 1990, J MATER RES, V5, P2567, DOI 10.1557/JMR.1990.2567
   Perriere J, 2002, J APPL PHYS, V91, P690, DOI 10.1063/1.1426250
   Podgornik B, 2005, THIN SOLID FILMS, V476, P92, DOI 10.1016/j.tsf.2004.09.028
   Qi J, 2001, SURF COAT TECH, V145, P38, DOI 10.1016/S0257-8972(01)01312-3
   Qian F, 1999, J APPL PHYS, V86, P2281, DOI 10.1063/1.371043
   Rabinowicz E., 1964, WEAR, V7, P298
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   RONKAINEN H, 1992, DIAM RELAT MATER, V1, P639, DOI 10.1016/0925-9635(92)90182-N
   RONKAINEN H, 1992, SURF COAT TECH, V55, P428
   Rowe G., 1960, WEAR, V3, P274, DOI [DOI 10.1016/0043-1648(60)90292-1, 10.1016/0043-1648(60)90292-1]
   RUFF AW, 2000, MODERN TRIBOLOGY HDB, P523
   Sanchez-Lopez JC, 2003, SURF COAT TECH, V163, P444, DOI 10.1016/S0257-8972(02)00641-2
   SAVAGE RH, 1948, J APPL PHYS, V19, P1, DOI 10.1063/1.1697867
   Scharf TW, 2002, TRIBOL T, V45, P363, DOI 10.1080/10402000208982561
   SCHMELLENMEIER H, 1954, EXP TECHNIK PHYS, V1, P49
   SPENCER EG, 1976, APPL PHYS LETT, V29, P118, DOI 10.1063/1.88963
   SPITSYN BV, 1988, PROG CRYST GROWTH CH, V17, P79, DOI 10.1016/0146-3535(88)90001-9
   Strondl C, 2001, SURF COAT TECH, V142, P707, DOI 10.1016/S0257-8972(01)01179-3
   Su C, 1998, SURF SCI, V406, P149, DOI 10.1016/S0039-6028(98)00107-1
   Sullivan JP, 2001, MRS BULL, V26, P309, DOI 10.1557/mrs2001.68
   Talke FE, 1995, WEAR, V190, P232, DOI 10.1016/0043-1648(95)06730-2
   TSAI HC, 1987, J VAC SCI TECHNOL A, V5, P3287, DOI 10.1116/1.574188
   Vander Wal RL, 2005, WEAR, V259, P738, DOI 10.1016/j.wear.2005.02.082
   Vercammen K, 2004, TRIBOL INT, V37, P983, DOI 10.1016/j.triboint.2004.07.016
   Voevodin AA, 1998, DIAM RELAT MATER, V7, P463, DOI 10.1016/S0925-9635(97)00214-8
   Voevodin AA, 1997, SURF COAT TECH, V92, P42, DOI 10.1016/S0257-8972(97)00007-8
   Voevodin AA, 1998, SURF COAT TECH, V107, P12, DOI 10.1016/S0257-8972(98)00543-X
   Wang EG, 1997, PROG MATER SCI, V41, P241, DOI 10.1016/S0079-6425(97)00027-3
   WEISSMANTEL C, 1979, THIN SOLID FILMS, V61, pL1, DOI 10.1016/0040-6090(79)90451-6
   Wu WJ, 1998, DIAM RELAT MATER, V7, P1478, DOI 10.1016/S0925-9635(98)00213-1
   Wu WJ, 1999, SURF COAT TECH, V111, P134, DOI 10.1016/S0257-8972(98)00719-1
   Zehnder T, 2000, SURF COAT TECH, V133, P138, DOI 10.1016/S0257-8972(00)00888-4
   Zhang W, 2005, DIAM RELAT MATER, V14, P1361, DOI 10.1016/j.diamond.2005.02.010
   Zhou F, 2005, TRIBOL LETT, V18, P153, DOI 10.1007/s11249-004-1771-x
NR 134
TC 473
Z9 488
U1 24
U2 425
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
EI 1361-6463
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD SEP 21
PY 2006
VL 39
IS 18
BP R311
EP R327
DI 10.1088/0022-3727/39/18/R01
PG 17
WC Physics, Applied
SC Physics
GA 101UU
UT WOS:000241767100001
DA 2018-10-20
ER

PT J
AU Wang, LA
   Ha, XH
   Yuan, Z
AF Wang, Liang
   Ha, Xiaohua
   Yuan, Zhi
TI Synthesis and characterization of novel functionalized polylactides with
   pendent hydroxyl arms
SO POLYMER
LA English
DT Article
DE DL-lactide; RS-benzyloxyethyl-beta-malotactonate;
   poly(DL-lactide-co-RS-hydroxyethyl-beta-matolactonate)
ID POLYMER SURFACES; BIOMEDICAL APPLICATIONS; EPSILON-CAPROLACTONE;
   POLY(LACTIC ACID); PLASMA TREATMENT; COPOLYMER; DEGRADATION; ENTRAPMENT;
   BIOMATERIALS; IMPROVEMENT
AB A class of polyesters have been synthesized by the ring-opening copolymerization of DL-lactide (DLLA) and RS-benzyloxyethyl-beta-malolactonate (MABE) using different monomer feeding doses. The compositions and structures Of poly(DL-lactide-co-RS-benzyloxyethyl-beta-malolactonate) (poly(DLLA-co-MABE)) were determined by H-1 and C-13 NMR measurements. GPC measurement showed that the molecular weight of the copolymers decreased as the MABE content increases. After catalytic hydrogenation of the benzyl ether functions, the desired copolymers with pendent hydroxyl arms, poly(DL-lactide-co-RS-hydroxyethyl-beta-malolactonate) (poly(DLLA-co-MAHE)), were recovered. Thermal properties of poly(DLLA-co-MABE) and poly(DLLA-co-MAHE) copolymers were examined by differential scanning calorimetry (DSC) measurement. Single glass transition temperature appeared in the DSC spectra, which confirmed that the copolymers were true copolymers and not blends. The hydrophilicity of poly(DLLA-co-MAHE) copolymer was tunable, which increased with the increase in MAHE content. Furthermore, the hydrolytic degradation of poly(DLLA-co-MAHE) material was investigated and the results showed that faster degradation was observed in the copolymer film containing more MAHE content. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Nankai Univ, Inst Polymer Chem, Key Lab Funct Polymer Mat, Minist Educ, Tianjin 300071, Peoples R China.
RP Yuan, Z (reprint author), Nankai Univ, Inst Polymer Chem, Key Lab Funct Polymer Mat, Minist Educ, Tianjin 300071, Peoples R China.
EM zhiy@nankai.edu.cn
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Bizzarri R, 2002, MACROMOLECULES, V35, P1215, DOI 10.1021/ma0111257
   BOUTAULT K, 1995, MACROMOLECULES, V28, P3516, DOI 10.1021/ma00114a004
   Braud C., 1994, MACROMOL REP A, p[723, A31]
   Busby W, 2002, POLYM INT, V51, P871, DOI 10.1002/pi.934
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   Catiker E, 2000, POLYM INT, V49, P728, DOI 10.1002/1097-0126(200007)49:7<728::AID-PI443>3.0.CO;2-3
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cordova A, 1999, POLYMER, V40, P6709, DOI 10.1016/S0032-3861(99)00017-8
   Coulembier O, 2005, MACROMOLECULES, V38, P3141, DOI 10.1021/ma047928m
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   del Rio C, 2005, POLYMER, V46, P3975, DOI 10.1016/j.polymer.2005.03.033
   Gohy JF, 2002, MACROMOL RAPID COMM, V23, P555, DOI 10.1002/1521-3927(20020601)23:9<555::AID-MARC555>3.0.CO;2-K
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   He B, 2003, POLYM ADVAN TECHNOL, V14, P645, DOI 10.1002/pat.387
   He B, 2003, POLYMER, V44, P989, DOI 10.1016/S0032-3861(02)00831-5
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P2713
   Khang G, 1999, POLYM-KOREA, V23, P861
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083
   Kumar R, 2002, MACROMOLECULES, V35, P6835, DOI 10.1021/ma020041a
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lee SJ, 2002, J BIOMAT SCI-POLYM E, V13, P197, DOI 10.1163/156856202317414375
   Li SM, 1999, BIOMATERIALS, V20, P35, DOI 10.1016/S0142-9612(97)00226-3
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mizutani M, 2002, BIOMACROMOLECULES, V3, P668, DOI 10.1021/bm0101670
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Nederberg F, 2004, MACROMOLECULES, V37, P954, DOI 10.1021/ma035433b
   NISHIDA H, 1994, CHEM LETT, P421, DOI 10.1246/cl.1994.421
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   OUCHI T, 1989, MAKROMOL CHEM, V190, P1523
   Penczek S, 1998, MACROMOL SYMP, V132, P441, DOI 10.1002/masy.19981320141
   Quirk RA, 2001, LANGMUIR, V17, P2817, DOI 10.1021/la001509a
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   ZHOU QX, 1990, MACROMOLECULES, V23, P3399, DOI 10.1021/ma00216a002
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 41
TC 18
Z9 18
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD SEP 20
PY 2006
VL 47
IS 20
BP 6978
EP 6985
DI 10.1016/j.polymer.2006.08.007
PG 8
WC Polymer Science
SC Polymer Science
GA 097BM
UT WOS:000241421300009
DA 2018-10-20
ER

PT J
AU Arcos, D
   Sanchez-Salcedo, S
   Izquierdo-Barba, I
   Ruiz, L
   Gonzalez-Calbet, J
   Vallet-Regi, M
AF Arcos, D.
   Sanchez-Salcedo, S.
   Izquierdo-Barba, I.
   Ruiz, L.
   Gonzalez-Calbet, J.
   Vallet-Regi, M.
TI Crystallochemistry, textural properties, and in vitro biocompatibility
   of different silicon-doped calcium phosphates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silicon; calcium phosphate; cell cultures; biocompatibility
ID SUBSTITUTED HYDROXYAPATITES; TRICALCIUM PHOSPHATE; ALKALINE-PHOSPHATASE;
   BIOMEDICAL MATERIALS; BONE; BIOCERAMICS; TRANSFORMATION; FIBROBLASTS
AB Three silicon-doped calcium phosphates (SiCaPs) were synthesized by heating precipitated silicondoped apatite via different thermal treatments. Temperatures of 700 degrees C, 900 degrees C, and 1100 degrees C led to an apatite-glass biphasic material, nanocrystalline Si-cloped apatite (SiHA), and Si-doped apatite-alpha tricalcium phosphate biphasic material, respectively. Structure, microstructure, textural properties, and chemical differences were determined for the three bioceramics. Biocompatibility tests were carried out by seeding osteblast-like cells onto the three substrates. Si-CaP treated at 700 degrees C and 900 degrees C led to Ca decrease in the culture media, partially impeding the cell proliferation over them. However, the proliferation capability is restored when additional culture medium is added. Finally, cytotoxicity results indicated that cell damage is much lower in osteblastlike cells seeded onto SiHA and SiHA-(c) tricalcium phosphate samples than in plastic culture control. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
   CSIC, CENIM, E-28040 Madrid, Spain.
   Univ Complutense, Fac CC Quim, Dept Quim Inorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI SANCHEZ-SALCEDO, SANDRA/N-4501-2014; IZQUIERDO-BARBA,
   ISABEL/M-9921-2014; Arcos, Daniel/L-6167-2014; Gonzalez-Calbet,
   Jose/K-8047-2014; Vallet-Regi, Maria/M-3378-2014
OI SANCHEZ-SALCEDO, SANDRA/0000-0002-1889-2057; IZQUIERDO-BARBA,
   ISABEL/0000-0002-4139-4646; Arcos, Daniel/0000-0002-5367-7272;
   Gonzalez-Calbet, Jose/0000-0002-6481-6506; Vallet-Regi,
   Maria/0000-0002-6104-4889; RUIZ GONZALEZ, MARIA
   LUISA/0000-0003-3546-2347
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   Arcos D, 2004, SOLID STATE SCI, V6, P987, DOI 10.1016/j.solidstatesciences.2004.05.001
   Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Balzar D., 1999, DEFECT MICROSTRUCTUR, P94
   Best S. M., 1996, International Patent Appl, Patent No. [PCT/GB 97/02325, 9702325]
   Brinker C.J., 1990, SOL GEL SCI PHYS CHE, P522
   CHAVASSIEUX PM, 1990, J BONE MINER RES, V5, P337, DOI 10.1002/jbmr.5650050406
   Frayssinet P, 1997, J BIOMED MATER RES, V35, P337, DOI 10.1002/(SICI)1097-4636(19970605)35:3<337::AID-JBM8>3.3.CO;2-H
   Gibson I, 1999, BIOCERAMICS, V12, P191
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hing K. A., 2004, T 7 WORLD BIOM C AUS, P108
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim S. R., 2002, KEY ENG MATER, V85, P218
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   MARQUES PA, 2001, KEY ENG MATER, V247, P192
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Ong JL, 1998, J BIOMED MATER RES, V39, P176, DOI 10.1002/(SICI)1097-4636(199802)39:2<176::AID-JBM2>3.0.CO;2-M
   ORLY I, 1989, J BIOMED MATER RES, V23, P1433, DOI 10.1002/jbm.820231206
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   REDDI AH, 1972, P SOC EXP BIOL MED, V140, P807
   RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I
   Ruys AJ, 1993, J AUST CERAM SOC, V29, P71
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   TANIZAWA Y, 1995, J CHEM SOC FARADAY T, V91, P3499, DOI 10.1039/ft9959103499
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Vallet-Regis M., 2001, J CHEM SOC DA, V2, P97
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yin XL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829995
NR 36
TC 19
Z9 19
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2006
VL 78A
IS 4
BP 762
EP 771
DI 10.1002/jbm.a.30790
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076BU
UT WOS:000239932800014
PM 16739108
DA 2018-10-20
ER

PT J
AU Loizou, E
   Weisser, JT
   Dundigalla, A
   Porcar, L
   Schmidt, G
   Wilker, JJ
AF Loizou, Elena
   Weisser, Jaime T.
   Dundigalla, Avinash
   Porcar, Lionel
   Schmidt, Gudrun
   Wilker, Jonathan J.
TI Structural effects of crosslinking a biopolymer hydrogel derived from
   marine mussel adhesive protein
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE crosslinking; hydrogels; microscopy; scattering; viscoelasticity
ID MYTILUS-EDULIS; PEPTIDE; COMPLEXES
AB In an effort to explore new biocompatible substrates for biomedical technologies, we present a structural study on a crosslinked gelatinous protein extracted from marine mussels. Prior studies have shown the importance of iron in protein crosslinking and mussel adhesive formation. Here, the structure and properties of an extracted material were examined both before and after crosslinking with iron. The structures of these protein hydrogels were studied by SEM, SANS, and SAXS. Viscoelasticity was tested by rheological means. The starting gel was found to have a heterogenous porous structure on a micrometer scale and, surprisingly, a regular structure on the micron to nanometer scale. However, disorder, or "no periodic structure", was deduced from scattering on nanometer length scales at very high q. Crosslinking with iron condensed the structure on a micrometer level. On nanometer length scales at high q, small angle neutron scattering showed no significant differences between the samples, possibly due to strong heterogeneity. X-ray scattering also confirmed the absence of any defined periodic structure. Partial crosslinking transformed the viscoelastic starting gel into one with more rigid and elastic properties.
C1 Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   NIST, Gaithersburg, MD 20899 USA.
RP Schmidt, G (reprint author), Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.
EM gudrun@purdue.edu; wilker@purdue.edu
CR Baldan A, 2004, J MATER SCI, V39, P4729, DOI 10.1023/B:JMSC.0000035317.87118.ab
   Burzio LO, 1997, CURR OPIN BIOTECH, V8, P309, DOI 10.1016/S0958-1669(97)80008-0
   COOMBS TL, 1981, AQUAT TOXICOL, V1, P291, DOI 10.1016/0166-445X(81)90023-0
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Frank BP, 2002, BIOTECHNOL PROGR, V18, P580, DOI 10.1021/bp010140s
   GEORGE SG, 1976, J EXP MAR BIOL ECOL, V23, P71, DOI 10.1016/0022-0981(76)90086-1
   Glinka CJ, 1998, J APPL CRYSTALLOGR, V31, P430, DOI 10.1107/S0021889897017020
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Monahan J, 2004, LANGMUIR, V20, P3724, DOI 10.1021/la0362728
   MONAHAN J, 2003, CHEM COMMUN, P167
   Ninan L, 2003, BIOMATERIALS, V24, P4091, DOI 10.1016/S0142-9612(03)00257-6
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Pochan DJ, 2002, MACROMOLECULES, V35, P5358, DOI 10.1021/ma025526d
   Rollison D., 2003, SCIENCE, V299, P1698
   Rzepecki L.M., 1991, Bioorganic Marine Chemistry, V4, P119
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Sever MJ, 2006, DALTON T, P813, DOI 10.1039/b509586g
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008
   WAITE JH, 1995, METHOD ENZYMOL, V258, P1
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
NR 24
TC 34
Z9 34
U1 1
U2 34
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 15
PY 2006
VL 6
IS 9
BP 711
EP 718
DI 10.1002/mabi.200600097
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 089SA
UT WOS:000240899800003
PM 16967473
DA 2018-10-20
ER

PT J
AU Gutierrez, A
   Munuera, C
   Lopez, MF
   Jimenez, JA
   Morant, C
   Matzelle, T
   Kruse, N
   Ocal, C
AF Gutierrez, Alejandro
   Munuera, Carmen
   Lopez, Maria Francisca
   Jimenez, Jose Antonio
   Morant, Carmen
   Matzelle, Thomas
   Kruse, Norbert
   Ocal, Carmen
TI Surface microstructure of the oxide protective layers grown on
   vanadium-free Ti alloys for use in biomedical applications
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 23rd European Conference on Surface Science (ECOSS-23)
CY SEP 04-09, 2005
CL Freie Univ, Berlin, GERMANY
HO Freie Univ
DE SFM; oxidation; biomaterials; Ti alloys
ID TITANIUM-ALLOYS; CORROSION; BIOMATERIALS; AL
AB In this work, we present a surface study by SFM (scanning force microscopy) of three new Ti alloys of composition (in wt%) Ti-7Nb-6A1, Ti-13Nb-13Zr and Ti-15Zr-4Nb, developed for biomedical applications. V was not included in these alloys since this element has been reported to be cytotoxic. The surface of these materials has been modified by a thermal treatment in air at 750 degrees C for different times. As a consequence of this treatment an oxide layer develops on the surface, resulting in both an improvement of the corrosion resistance and an increase of the roughness, which enhances the adhesion of the tissue cells to the implant. SFM has been used to characterize the surface structure and topography of the oxide layers grown on the three alloys. The surface roughness analysis obtained by SFM points to a correlation between the mean square roughness, the thickness of the oxide layer, and the alpha-phase/beta-phase ratio in the base material. (c) 2006 Published by Elsevier B.V.
C1 Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
   Inst Ciencia Mat, CSIC, E-28049 Madrid, Spain.
   CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
   Univ Libre Bruxelles, B-1050 Brussels, Belgium.
RP Gutierrez, A (reprint author), Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
EM a.gutierrez@uam.es
RI Gutierrez, Alejandro/A-9092-2011; Munuera, Carmen/J-9928-2014; Jimenez,
   Jose/H-2644-2015; Lopez, Maria/C-4571-2011; Ocal, Carmen/G-8590-2013
OI Gutierrez, Alejandro/0000-0002-1150-0719; Munuera,
   Carmen/0000-0001-8524-9304; Jimenez, Jose/0000-0003-4272-6873; Lopez,
   Maria/0000-0001-7894-566X; Ocal, Carmen/0000-0001-8790-8844
CR BREME HJ, 1998, METALS BIOMATERIALS, pCH2
   Freese H. L., 2001, TITANIUM MED, P25
   Gutierrez A, 2004, SURF INTERFACE ANAL, V36, P977, DOI 10.1002/sia.1816
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Klapetek P, 2004, MICROCHIM ACTA, V147, P175, DOI 10.1007/s00604-004-0188-4
   KOHN DH, 1992, SERIE MAT SCI TECHNO, V14, pCH2
   Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Lopez MF, 2002, SURF INTERFACE ANAL, V33, P570, DOI 10.1002/sia.1422
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3
   Munuera C, 2004, J CRYST GROWTH, V264, P70, DOI 10.1016/j.jcrysgro.2003.12.056
   MUNUERA C, UNPUB CARMEN OCAL
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Steinemann S., 1980, EVALUATION BIOMATERI
NR 15
TC 9
Z9 9
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD SEP 15
PY 2006
VL 600
IS 18
SI SI
BP 3780
EP 3784
DI 10.1016/j.susc.2006.01.082
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 097LZ
UT WOS:000241450600054
DA 2018-10-20
ER

PT J
AU Adebajo, MO
AF Adebajo, Moses O.
TI Development of nanostructured materials (metal oxides, zeolites,
   mesoprorous materials, hydrotalcites and gold/supported gold
   nanoparticles) for catalytic, photocatalytic and biomedical applications
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Adebajo, Moses O.] Queensland Univ Technol, Inorgan Mat Res Program, Sch Phys & Chem Sci, Brisbane, Qld 4001, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 43-AEI
BP 29
EP 29
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DB
UT WOS:000207781600027
DA 2018-10-20
ER

PT J
AU Shim, JH
   Joo, JH
   Choi, JH
   Yoon, JS
AF Shim, Jae Hun
   Joo, Jung Hiuk
   Choi, Jae Hoon
   Yoon, Jin-San
TI PMSE 589-Design of new biomedical materials with targeted properties
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Shim, Jae Hun; Joo, Jung Hiuk; Choi, Jae Hoon; Yoon, Jin-San] Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 288-PMSE
BP 598
EP 598
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DC
UT WOS:000207781700589
DA 2018-10-20
ER

PT J
AU Hsiao, BS
   Chu, B
AF Hsiao, Benjamin S.
   Chu, Benjamin
TI HIST 4-Nanofibrous materials for biomedical and environmental
   applications
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Hsiao, Benjamin S.; Chu, Benjamin] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 4-HIST
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DB
UT WOS:000207781603766
DA 2018-10-20
ER

PT J
AU Ohya, Y
   Kontani, T
   Saito, T
   Ouchi, T
AF Ohya, Yuichi
   Kontani, Tomohiro
   Saito, Toshifumi
   Ouchi, Tatsuro
TI POLY 645-Preparation and evaluation of polylactide-grafted dextran as
   biodegradable biomedical material
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Ohya, Yuichi; Kontani, Tomohiro; Saito, Toshifumi; Ouchi, Tatsuro] Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 645-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DC
UT WOS:000207781701085
DA 2018-10-20
ER

PT J
AU Gong, CB
   Lam, MHW
   Yu, HX
AF Gong, Chengbin
   Lam, Michael Hon-Wah
   Yu, Hongxia
TI The fabrication of a photoresponsive molecularly imprinted polymer for
   the photoregulated uptake and release of caffeine
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID STIMULI-RESPONSIVE POLYMERS; DRUG-DELIVERY; MAIN-CHAIN; BIOMEDICAL
   APPLICATIONS; SENSITIVE HYDROGELS; AZOBENZENE CHROMOPHORES; RECOGNITION;
   MEMBRANES; GELS; PHOTOISOMERIZATION
AB A photoresponsive molecularly imprinted polymer (MIP) material is successfully fabricated from an azobenzene-based functional monomer, 4-[(4-methacryloyloxy)phenylazo]benzoic acid (MPABA), using caffeine as a molecular template. The transcis photoisomerization properties of MPABA are retained after incorporation into the rigid 3D crosslinked polymer matrix. Substrate affinity of the MIP receptor sites is photoswitchable. This can be attributed to the photoisomerization of azobenzene chromophores within the MIP receptors, resulting in the alteration of their geometry and the spatial arrangement of their binding functionalities. The favorable binding constant of the MIP receptors for caffeine is 5.48 x 10(4) M-1 in dimethylsulfoxide. The density of the caffeine-specific receptor sites in the MIP material is 0.95 mu mol (g MIP)(-1). Upon irradiation at 365 urn, 58.3% of receptor-bound caffeine is released from the MIP material. Subsequent irradiation at 440 nm causes 96.4% of the released caffeine to be rebound by the MIP material. This near-quantitative uptake of the released caffeine is evidence of the reversibility of the receptor-site configuration and substrate affinity during the photoswitching of the azobenzene chromophores. Although the photoregulated substrate release and uptake processes are generally repeatable, a gradual reduction in the extent of substrate release and rebinding is observed. This may be caused by the slow deformation of MIP receptors during the course of repetitive photoswitching. The results of this work demonstrate the potential of stimuli-responsive MIP materials as smart chemicals and as drug-delivery systems.
C1 City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.
   Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210093, Peoples R China.
RP Gong, CB (reprint author), City Univ Hong Kong, Dept Biol & Chem, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM bhmhwlam@cityu.edu.hk; hongxiayu01@hotmail.com
OI LAM, Hon Wah Michael/0000-0003-1213-3874
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   ALTOMARE A, 1983, POLYMER, V24, P95, DOI 10.1016/0032-3861(83)90088-5
   Angiolini L, 2000, POLYMER, V41, P4767, DOI 10.1016/S0032-3861(99)00701-6
   Angiolini L, 1998, POLYMER, V39, P6621, DOI 10.1016/S0032-3861(98)00161-X
   ANZAI JI, 1994, TETRAHEDRON, V50, P4039, DOI 10.1016/S0040-4020(01)86704-1
   BARTSCH RA, 1998, MOL IONIC RECOGNITIO
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Cai QY, 2004, ANAL CHEM, V76, P4038, DOI 10.1021/ac0498516
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   CHOW CF, 2002, ANAL CHIM ACTA, V456, P17
   Chu LY, 2002, ADV MATER, V14, P386, DOI 10.1002/1521-4095(20020304)14:5<386::AID-ADMA386>3.0.CO;2-I
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   de Lange JJ, 1939, PROC R SOC LON SER-A, V171, P0398, DOI 10.1098/rspa.1939.0073
   Dentini M, 1999, MACROMOLECULES, V32, P7109, DOI 10.1021/ma9907901
   Dos Santos DS, 2000, CHEM PHYS LETT, V317, P1, DOI 10.1016/S0009-2614(99)01368-8
   Ebarvia BS, 2004, ANAL BIOANAL CHEM, V378, P1331, DOI 10.1007/s00216-003-2433-9
   El Halabieh RH, 2004, PURE APPL CHEM, V76, P1445, DOI 10.1351/pac200476071445
   Endo M, 2003, TETRAHEDRON LETT, V44, P6903, DOI 10.1016/S0040-4039(03)01697-6
   Everlof GJ, 2000, POLYMER, V41, P6527, DOI 10.1016/S0032-3861(99)00893-9
   Filipcsei G, 2000, J MOL STRUCT, V554, P109, DOI 10.1016/S0022-2860(00)00564-0
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819
   Goessl A, 2004, J BIOMAT SCI-POLYM E, V15, P895, DOI 10.1163/1568562041271039
   Goswami S, 1999, TETRAHEDRON LETT, V40, P1735, DOI 10.1016/S0040-4039(98)02678-1
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Haitjema HJ, 1996, EUR POLYM J, V32, P1437, DOI 10.1016/S0014-3057(96)00076-6
   Holtz JH, 1997, NATURE, V389, P829
   Howe LA, 1998, J POLYM SCI POL CHEM, V36, P2827, DOI 10.1002/(SICI)1099-0518(19981130)36:16<2827::AID-POLA1>3.0.CO;2-Q
   Ikegami T, 2004, ANAL CHIM ACTA, V504, P131, DOI 10.1016/j.aca.2003.08.032
   Inouye M, 1996, COORDIN CHEM REV, V148, P265, DOI 10.1016/0010-8545(95)01171-4
   INOUYE M, 1990, J AM CHEM SOC, V112, P8977, DOI 10.1021/ja00180a051
   Irvin DJ, 2001, CHEM MATER, V13, P1143, DOI 10.1021/cm000792w
   Izumi A, 2001, MACROMOLECULES, V34, P4342, DOI 10.1021/ma002101n
   Janus K, 2005, J PHYS CHEM B, V109, P93, DOI 10.1021/jp0483268
   Jaycox GD, 2004, J POLYM SCI POL CHEM, V42, P566, DOI 10.1002/pola.10806
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   Kobayashi T, 2001, ANAL CHIM ACTA, V435, P141, DOI 10.1016/S0003-2670(00)01281-2
   KOMIYAMA M, 2003, MOL IMPRINTING FUNDA
   Kontturi K, 1996, MACROMOLECULES, V29, P5740, DOI 10.1021/ma960501y
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   KUMAR GS, 1989, CHEM REV, V89, P1915, DOI 10.1021/cr00098a012
   Lee AS, 2002, MACROMOLECULES, V35, P8540, DOI 10.1021/ma0114842
   Li YB, 2005, LANGMUIR, V21, P6567, DOI 10.1021/la050082a
   Liang CD, 1999, ANALYST, V124, P1781, DOI 10.1039/a905112k
   Liu SQ, 2004, ANAL CHEM, V76, P4579, DOI 10.1021/ac0495283
   MARXTIBBON S, 1994, J CHEM SOC CHEM COMM, P1261, DOI 10.1039/c39940001261
   MATSUI J, 1995, ANAL CHEM, V67, P4404, DOI 10.1021/ac00119a032
   Matsui J, 1996, ANAL LETT, V29, P2071
   Minoura N, 2004, MACROMOLECULES, V37, P9571, DOI 10.1021/ma040010a
   Minoura N, 2003, CHEM MATER, V15, P4703, DOI 10.1021/cm0305608
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   MOSS RA, 1995, LANGMUIR, V11, P4217, DOI 10.1021/la00011a010
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   Park JS, 2004, MACROMOLECULES, V37, P6786, DOI 10.1021/ma049677n
   PARK TG, 1994, BIOTECHNOL PROGR, V10, P82, DOI 10.1021/bp00025a010
   Peppas NA, 2004, J BIOMAT SCI-POLYM E, V15, P125, DOI 10.1163/156856204322793539
   Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rao GVR, 2002, CHEM MATER, V14, P5075, DOI 10.1021/cm020627b
   Richter A, 2004, SENSOR ACTUAT B-CHEM, V99, P579, DOI 10.1016/j.snb.2004.01.011
   Roy I, 2003, CHEM BIOL, V10, P1161, DOI 10.1016/j.chembiol.2003.12.004
   Ruan CM, 2003, ANAL CHIM ACTA, V497, P123, DOI 10.1016/j.aca.2003.08.051
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Sharma S, 2003, BIOMACROMOLECULES, V4, P330, DOI 10.1021/bm0256799
   Shimanouchi T, 2000, J CHROMATOGR B, V743, P85, DOI 10.1016/S0378-4347(00)00061-X
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   SIAMPIRINGUE N, 1987, J PHOTOCHEM, V37, P185, DOI 10.1016/0047-2670(87)85039-6
   Smuleac V, 2004, CHEM MATER, V16, P2762, DOI 10.1021/cm035323j
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Szczubialka K, 2003, J MATER SCI-MATER M, V14, P699, DOI 10.1023/A:1024911716152
   Tachibana Y, 2003, BIOMACROMOLECULES, V4, P1132, DOI 10.1021/bm034123y
   Tamada K, 2003, LANGMUIR, V19, P2306, DOI 10.1021/la0258493
   Theodoridis G, 2002, J CHROMATOGR A, V948, P163, DOI 10.1016/S0021-9673(01)01457-1
   Tonge SR, 2001, ADV DRUG DELIVER REV, V53, P109, DOI 10.1016/S0169-409X(01)00223-X
   Wang J, 2004, MACROMOLECULES, V37, P670, DOI 10.1021/ma035453d
   XIE S, 1993, CHEM MATER, V5, P403, DOI 10.1021/cm00028a003
   Yagai S, 2005, CHEM-EUR J, V11, P4054, DOI 10.1002/chem.200401323
   Yao L, 2003, MACROMOLECULES, V36, P2055, DOI 10.1021/ma021326q
   Yoshii K, 1999, J NON-CRYST SOLIDS, V246, P90, DOI 10.1016/S0022-3093(99)00025-3
   Zhu YF, 2005, ANGEW CHEM INT EDIT, V44, P5083, DOI 10.1002/anie.200501500
   Zollinger H., 1961, AZO DIAZOCHEMISTRY
   Zrinyi M, 2000, COLLOID POLYM SCI, V278, P98, DOI 10.1007/s003960050017
NR 85
TC 95
Z9 100
U1 4
U2 82
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD SEP 5
PY 2006
VL 16
IS 13
BP 1759
EP 1767
DI 10.1002/adfm.200500907
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 084UU
UT WOS:000240560700014
DA 2018-10-20
ER

PT J
AU Vigneshwaran, N
   Nachane, RP
   Balasubramanya, RH
   Varadarajan, PV
AF Vigneshwaran, N.
   Nachane, R. P.
   Balasubramanya, R. H.
   Varadarajan, P. V.
TI A novel one-pot 'green' synthesis of stable silver nanoparticles using
   soluble starch
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE amylose-iodine complex; green chemistry; photoluminescence; silver
   nanoparticles; soluble starch
ID METAL; GOLD; CLUSTERS; PHASE; DNA
AB Stable silver nanoparticles have been synthesized by using soluble starch as both the reducing and stabilizing agents; this reaction was carried out in an autoclave at 15 psi, 121 degrees C for 5 min. Nanoparticles thus prepared are found to be stable in aqueous solution over a period of three months at room temperature (similar to 25 degrees C). The size of these nanoparticles was found to be in the range of 10-34 nm as analyzed using transmission electron micrographs. The X-ray diffraction analysis revealed the face-centred cubic (fcc) geometry of silver nanoparticles. lodometric titration confirmed the entrapment of silver nanoparticles inside the helical amylose chain. These silver nanoparticles embedded in soluble starch produced a typical emission peak at 553 nm when excited at 380 nm. The use of environmentally benign and renewable materials like soluble starch offers numerous benefits of eco-friendliness and compatibility for pharmaceutical and biomedical applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Cent Inst Res Cotton Technol, Nanotechnol Res Grp, Bombay 400019, Maharashtra, India.
RP Vigneshwaran, N (reprint author), Cent Inst Res Cotton Technol, Nanotechnol Res Grp, Adenwala Rd, Bombay 400019, Maharashtra, India.
EM nvw75@yahoo.com
RI Nadanathangam, Vigneshwaran/C-3361-2008
OI Nadanathangam, Vigneshwaran/0000-0002-2330-8273
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   ANATAS PT, 1998, GREEN CHEM THEORY PR
   Aoki K, 2003, LANGMUIR, V19, P9904, DOI 10.1021/la035144g
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   Chalmers J.M., 2002, HDB VIBRATIONAL SPEC
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   DeSimone JM, 2002, SCIENCE, V297, P799, DOI 10.1126/science.1069622
   Doi S, 2002, CHEM COMMUN, P2632, DOI 10.1039/b207780a
   Greenwood C. T., 1975, STARCH ITS COMPONENT
   Han JA, 2003, CEREAL CHEM, V80, P323, DOI 10.1094/CCHEM.2003.80.3.323
   HENGLEIN A, 1989, CHEM REV, V89, P1861, DOI 10.1021/cr00098a010
   Huang HZ, 2004, CARBOHYD RES, V339, P2627, DOI 10.1016/j.carres.2004.08.005
   Huang HZ, 2004, COLLOID SURFACE B, V39, P31, DOI 10.1016/j.colsurfb.2004.08.014
   Jiang ZL, 2005, SPECTROCHIM ACTA A, V61, P2488, DOI 10.1016/j.saa.2004.09.014
   Klabunde K.J., 2001, NANOSCALE MAT CHEM
   KLEEMANN W, 1993, INT J MOD PHYS B, V7, P2469, DOI 10.1142/S0217979293002912
   LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006
   Mandal S, 2005, CURR APPL PHYS, V5, P118, DOI 10.1016/j.cap.2004.06.006
   Nath S, 2004, INDIAN J CHEM A, V43, P1147
   Poliakoff M, 2001, NATURE, V413, P257, DOI 10.1038/35095133
   Prasad V, 2006, SPECTROCHIM ACTA A, V65, P173, DOI 10.1016/j.saa.2005.10.001
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c
   Sarma TK, 2004, LANGMUIR, V20, P4733, DOI 10.1021/la0495884
   SKOOG DA, 1996, FUNDAMENTALS ANAL CH
   Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757
   TEMGIRE MK, 2001, RADIAT PHYS CHEM, V71, P1039
   Vigneshwaran N, 2005, SPECTROCHIM ACTA A, V61, P163, DOI 10.1016/j.saa.2004.03.027
   WALTER RH, 1998, POLYSACCHARIDE ASS S
   ZOBEL HF, 1988, STARCH-STARKE, V40, P44, DOI 10.1002/star.19880400203
NR 30
TC 374
Z9 383
U1 5
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD SEP 4
PY 2006
VL 341
IS 12
BP 2012
EP 2018
DI 10.1016/j.carres.2006.04.042
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 068MG
UT WOS:000239377600005
PM 16716274
DA 2018-10-20
ER

PT J
AU Liao, S
   Li, BJ
   Ma, ZW
   Wei, H
   Chan, C
   Ramakrishna, S
AF Liao, Susan
   Li, Bojun
   Ma, Zuwei
   Wei, He
   Chan, Casey
   Ramakrishna, Seeram
TI Biomimetic electrospun nanofibers for tissue regeneration
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID NORMAL HUMAN KERATINOCYTES; MESENCHYMAL STEM-CELLS; COLLAGEN TYPE-II;
   IN-VITRO; HYALURONIC-ACID; CARBON NANOFIBERS; POLYMER NANOFIBERS;
   SCAFFOLDS; FIBERS; COMPOSITE
AB Nanofibers exist widely in human tissue with different patterns. Electrospinning nanotechnology has recently gained a new impetus due to the introduction of the concept of biomimetic nanofibers for tissue regeneration. The advanced electrospinning technique is a promising method to fabricate a controllable continuous nanofiber scaffold similar to the natural extracellular matrix. Thus, the biomedical field has become a significant possible application field of electrospun fibers. Although electrospinning has developed rapidly over the past few years, electrospun nanofibers are still at a premature research stage. Further comprehensive and deep studies on electrospun nanofibers are essential for promoting their biomedical applications. Current electrospun fiber materials include natural polymers, synthetic polymers and inorganic substances. This review briefly describes several typically electrospun nanofiber materials or composites that have great potential for tissue regeneration, and describes their fabrication, advantages, drawbacks and future prospects.
C1 Natl Univ Singapore, Fac Engn, NUSNNI, Singapore 117576, Singapore.
RP Liao, S (reprint author), Natl Univ Singapore, Fac Engn, NUSNNI, Singapore 117576, Singapore.
EM bieliaos@nus.edu.sg
RI Liao, Susan/B-6403-2009
CR Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   BOLAND ED, 2001, J MACROMOL SCI PURE, V38, P1232
   Bornat A., 1987, U.S. Patent, Patent No. [US 4689186 A, 4689186]
   Boudriot U, 2005, MACROMOL SYMP, V225, P9, DOI 10.1002/masy.200550702
   Buer A, 2001, TEXT RES J, V71, P323, DOI 10.1177/004051750107100408
   Choi SS, 2003, J MATER SCI LETT, V22, P891, DOI 10.1023/A:1024475022937
   Dalton PD, 2005, POLYMER, V46, P611, DOI 10.1016/j.polymer.2004.11.075
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   DZENIS YA, MAT RES SOC S P, V702
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Fennessey SF, 2004, POLYMER, V45, P4217, DOI 10.1016/j.polymer.2004.04.001
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HENCH LL, 1998, J AM CERAM SOC, V81, P1785
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023
   Inai R, 2005, NANOTECHNOLOGY, V16, P208, DOI 10.1088/0957-4484/16/2/005
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kim HW, 2006, J BIOMED MATER RES B, V77B, P323, DOI 10.1002/jbm.b.30376
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   Li JX, 2006, MACROMOL RAPID COMM, V27, P114, DOI 10.1002/marc.200500726
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lyons J, 2004, POLYMER, V45, P7597, DOI 10.1016/j.polymer.2004.08.071
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Mason C, 2005, Med Device Technol, V16, P22
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   Tan EPS, 2005, BIOMATERIALS, V26, P1453, DOI 10.1016/j.biomaterials.2004.05.021
   Tan EPS, 2004, APPL PHYS LETT, V84, P1603, DOI 10.1063/1.1651643
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Teo WE, 2005, NANOTECHNOLOGY, V16, P918, DOI 10.1088/0957-4484/16/6/049
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Van E. L., 2006, BIOMATERIALS, V27, P2042
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Wang XF, 2005, POLYMER, V46, P4853, DOI 10.1016/j.polymer.2005.03.058
   Wang Y, 2003, SYNTHETIC MET, V138, P423, DOI 10.1016/S0379-6779(02)00472-1
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   You Y, 2005, J APPL POLYM SCI, V95, P193, DOI 10.1002/app.21116
   ZHANG YZ, J BIOMED MAT RES, V72, P156
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
NR 76
TC 149
Z9 154
U1 2
U2 71
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2006
VL 1
IS 3
BP R45
EP R53
DI 10.1088/1748-6041/1/3/R01
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LE
UT WOS:000249597000002
PM 18458387
DA 2018-10-20
ER

PT J
AU Zhang, W
   Chu, PK
   Ji, JH
   Zhang, YH
   Ng, SC
   Yan, Q
AF Zhang, Wei
   Chu, Paul K.
   Ji, Junhui
   Zhang, Yihe
   Ng, Shuk Ching
   Yan, Qing
TI Surface antibacterial characteristics of plasma-modified polyethylene
SO BIOPOLYMERS
LA English
DT Article
DE bacterial biofilm; plasma immersion ion implantation; polyethylene
ID IMMERSION ION-IMPLANTATION; BACTERIAL ADHESION;
   STAPHYLOCOCCUS-EPIDERMIDIS; MICROBIAL BIOFILMS; INFECTIONS; MECHANISMS;
   RESISTANCE; TRICLOSAN; CHLORIDE; PERFORMANCE
AB The antibacterial characteristics of triclosan- or bronopol-coated and plasma-modified polyethylene (PE) are investigated. The modified PE samples exhibit excellent bactericidal effects against Escherichia coli and Staphylococcus aureus even when the bacteria concentration in the suspension is 10(6) colony forming units (CFU)/mL. However, when the concentration exceeds 10(8) CFU/mL, the materials fail to develop noticeable resistance to large amount of bacteria because of the formation of a bacterial biofilm on their surfaces. The PE treated by this relatively simple technique possesses excellent antimicrobial properties and is useful in biomedical and disinfection applications because the bacteria concentrations in most situations are well below 10(6) CFU/mL. (c) 2006 Wiley Periodicals, Inc.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.
   Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100101, Peoples R China.
   China Univ Geosci, Sch Mat Sci & Technol, Beijing 100083, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Archibald LK, 1997, INFECT DIS CLIN N AM, V11, P245, DOI 10.1016/S0891-5520(05)70354-8
   Bento WCA, 2003, PLASMAS POLYM, V8, P1, DOI 10.1023/A:1022827307458
   Braoudaki M, 2005, INT J ANTIMICROB AG, V25, P31, DOI 10.1016/j.ijantimicag.2004.07.016
   Briandet R, 2001, COLLOID SURFACE B, V21, P299, DOI 10.1016/S0927-7765(00)00213-7
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chu PK, 2004, J VAC SCI TECHNOL B, V22, P289, DOI 10.1116/1.1632920
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cloete TE, 2003, INT BIODETER BIODEGR, V51, P277, DOI 10.1016/S0964-8305(03)00042-8
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Edge M, 2001, PROG ORG COAT, V43, P10, DOI 10.1016/S0300-9440(01)00244-2
   Fu RKY, 2004, SURF SCI, V573, P426, DOI 10.1016/j.susc.2004.10.007
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Kennedy JF, 2001, CARBOHYD POLYM, V44, P175
   Lian HZ, 1997, J PHARMACEUT BIOMED, V15, P667, DOI 10.1016/S0731-7085(96)01895-X
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   Nichols RL, 1999, DIAGN MICR INFEC DIS, V33, P121, DOI 10.1016/S0732-8893(98)00144-8
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1016/S0378-1097(01)00273-7
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Walker M, 2003, BIOMATERIALS, V24, P883, DOI 10.1016/S0142-9612(02)00414-3
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
   Zacheus OM, 2000, WATER RES, V34, P63, DOI 10.1016/S0043-1354(99)00113-X
   Zhang W, 2006, POLYMER, V47, P931, DOI 10.1016/j.polymer.2005.12.009
   Zhang W, 2006, BIOMATERIALS, V27, P44, DOI 10.1016/j.biomaterials.2005.05.067
   ZHANG W, 2006, IN PRESS APPL SURF S
NR 33
TC 21
Z9 21
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD SEP
PY 2006
VL 83
IS 1
BP 62
EP 68
DI 10.1002/bip.20527
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 071QS
UT WOS:000239617300007
PM 16639708
DA 2018-10-20
ER

PT J
AU Mathieu, LM
   Bourban, PE
   Manson, JAE
AF Mathieu, L. M.
   Bourban, P. -E.
   Manson, J. -A. E.
TI Processing of homogeneous ceramic/polymer blends for bioresorbable
   composites
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE polymer-matrix composites; ceramics; bioresorbable
ID GLASS-REINFORCED HYDROXYAPATITE; POLY-L-LACTIDE; BIOMEDICAL
   APPLICATIONS; MECHANICAL-PROPERTIES; POLYLACTIDE FOAMS; POLY(LACTIC
   ACID); SURFACE-TENSION; TISSUE; SCAFFOLDS; DEGRADATION
AB Three methods to mix ceramic fillers, hydroxyapatite or P-tricalcium phosphate, with a polymer matrix, a Poly L-lactic acid, are investigated as a first step prior to supercritical foaming to prepare porous composite structures for biomedical applications. First the dry process consists in mixing ceramic powder and polymer pellets before a compression molding step. The second technique is based on the dispersion of ceramic fillers into a polymer-solvent solution. The third method is a melt extrusion of a ceramic/polymer powder mixture. Each technique is first optimized by defining the processing parameters suitable for the bioresorbable materials considered. Then comparison of the three methods shows that solvent or melt processing results in a more homogeneous filler distribution than the dry technique. Extrusion leads to composites with a higher modulus than solvent prepared compounds and is a solvent-free approach. The former technique is therefore selected to prepare ceramic/polymer blends before supercritical CO2 foaming. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Ecole Polytech Fed Lausanne, Lab Technol Composities & Polymeres, CH-1015 Lausanne, Switzerland.
RP Manson, JAE (reprint author), Ecole Polytech Fed Lausanne, Lab Technol Composities & Polymeres, MXG-341,Bat MXG,Stn 12, CH-1015 Lausanne, Switzerland.
EM jan-anders.manson@epfl.ch
CR Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   BONFIELD NH, 1993, INTRO BIOCERAMICS, P299
   Bouchet J, 2000, POLYM ENG SCI, V40, P36, DOI 10.1002/pen.11137
   BOURBAN PE, 2004, MAT COMPOSITES MATRI
   CHEN L, 2001, ANTEC, P1732
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Dee GT, 1998, ADV PHYS, V47, P161, DOI 10.1080/000187398243546
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Forman S, 1999, J BIOCHEM MOL TOXIC, V13, P11, DOI 10.1002/(SICI)1099-0461(1999)13:1<11::AID-JBT2>3.0.CO;2-R
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Laurencin C. T., 2000, BONE ENG, P462
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Lopes MA, 2000, BIOMATERIALS, V21, P749, DOI 10.1016/S0142-9612(99)00248-3
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   MATHIEU L, 2004, 7 WORLD BIOM C SYDN, P1276
   Mathieu LM, 2005, J BIOMED MATER RES A, V75A, P89, DOI 10.1002/jbm.a.30385
   MICHAELI W, 1994, ANTEC, P796
   MIGLIARESI C, 1991, Clinical Materials, V8, P111, DOI 10.1016/0267-6605(91)90018-B
   OEPEN RV, 1992, CLIN MAT, V10, P21
   Perego G, 1996, J APPL POLYM SCI, V59, P37, DOI 10.1002/(SICI)1097-4628(19960103)59:1<37::AID-APP6>3.3.CO;2-7
   Pluta M, 2002, J APPL POLYM SCI, V86, P1497, DOI 10.1002/app.11309
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Wachsen O, 1997, POLYM DEGRAD STABIL, V57, P87, DOI 10.1016/S0141-3910(96)00226-1
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 39
TC 45
Z9 46
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD SEP
PY 2006
VL 66
IS 11-12
BP 1606
EP 1614
DI 10.1016/j.compscitech.2005.11.012
PG 9
WC Materials Science, Composites
SC Materials Science
GA 065DD
UT WOS:000239138700012
DA 2018-10-20
ER

PT J
AU Shea, JL
AF Shea, Jeanne L.
TI Cross-cultural comparison of women's midlife symptom-reporting: A China
   study
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
DE symptoms; midlife women; menopause; cross-cultural comparisons; Eastern
   versus Western; biology versus culture
ID POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; BREAST-CANCER; HOT FLASHES;
   DIETARY SOY; JAPANESE WOMEN; PHYTOESTROGENS; TRIAL; SUPPLEMENTATION;
   ISOFLAVONES
AB Drawing on ethnographic and survey research conducted by the author in a general population sample in mainland China, this article presents findings on Chinese women's midlife symptom reporting in comparison with pivotal studies conducted by Lock, Kaufert, and McKinlay in Japan, Canada, and the U.S. Analysis of the China survey data (N = 156 women, age 45-55) reveals for sixteen core symptoms a reporting frequency that is much lower than depicted in classic biomedical models of menopause. At the same time, however, the China data indicates problems with the popular extrapolation that midlife Asian women are virtually symptom-free compared to their North American peers. Finding the Chinese level of symptom-reporting low to moderate depending on the symptom, the article reveals important differences between Chinese and Japanese women in their level and pattern of symptom reporting, as well as substantial overlap with North American women in this regard. Referencing ethnographic materials on Chinese women and the cross-cultural literature on menopause, the article assesses potential explanations for the cross-cultural variation observed, including: local reproductive endocrinology, phytoestrogen consumption, aspects of East Asian culture, the nature of social change, the cultural acceptability of monitoring and voicing symptoms, and differences in dominant conceptions of midlife.
C1 Univ Vermont, Dept Anthropol, Burlington, VT 05405 USA.
RP Shea, JL (reprint author), Univ Vermont, Dept Anthropol, 515 William Hall,72 Univ Pl, Burlington, VT 05405 USA.
EM jeanne.shea@uvm.edu
OI Shea, Jeanne/0000-0002-5875-1072
CR Albertazzi P, 2002, MATURITAS, V42, P173, DOI 10.1016/S0378-5122(02)00024-5
   Albertazzi P, 1999, OBSTET GYNECOL, V94, P229, DOI 10.1016/S0029-7844(99)00275-6
   [Anonymous], 2002, INT POS PAP WOM HLTH
   ASO T, 1997, DEMOGRAPHY MENOPAUSE
   AVIS NE, 1993, BAILLIERE CLIN ENDOC, V7, P17, DOI 10.1016/S0950-351X(05)80268-X
   Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7
   Baber R J, 1999, Climacteric, V2, P85, DOI 10.3109/13697139909025571
   BAIRD DD, 1995, J CLIN ENDOCR METAB, V80, P1685, DOI 10.1210/jc.80.5.1685
   Balk JL, 2002, J SOC GYNECOL INVEST, V9, P238, DOI 10.1016/S1071-5576(02)00152-1
   Barentsen R, 2001, MATURITAS, V38, P123, DOI 10.1016/S0378-5122(00)00212-7
   Berger GF, 1999, MENOPAUSE CULTURE
   BOULET MJ, 1994, MATURITAS, V19, P157, DOI 10.1016/0378-5122(94)90068-X
   BRODER JM, 1997, NEW YORK TIMES  0621, P8
   Brzezinski A, 1997, MENOPAUSE, V4, P89
   Bulbeck Ch., 2001, SPEAKING MENOPAUSE I
   CABOT S, 1995, SMART MED MENOPAUSE
   COLLINS A, 2002, INT POSITION PAPER W, P65
   Dalais F S, 1998, Climacteric, V1, P124, DOI 10.3109/13697139809085527
   DEUTSCH H, 1945, PSYCHOL WOMEN PSYCHO, V2
   di Leonardo Micaela, 1991, GENDER CROSSROADS KN
   Dickson G. L., 1993, MENOPAUSE MIDLIFE PA, P36
   Fitzpatrick LA, 1999, MAYO CLIN PROC, V74, P601, DOI 10.4065/74.6.601
   GE MY, 1994, FUNU GENGNIANQI JIAN, V3, P21
   GINGRICH A, 2002, ANTHROPOLOGY COMPARI
   Greendale GA, 2002, AM J EPIDEMIOL, V155, P746, DOI 10.1093/aje/155.8.746
   GREENE JG, 1992, MATURITAS, V14, P157, DOI 10.1016/0378-5122(92)90007-Q
   GREENE JG, 1992, MATURITAS, V14, P95, DOI 10.1016/0378-5122(92)90002-L
   Han KK, 2002, OBSTET GYNECOL, V99, P389, DOI 10.1016/S0029-7844(01)01744-6
   Haraway D, 1991, SIMIANS CYBORG WOMEN
   Hilditch J R, 1999, Climacteric, V2, P164, DOI 10.3109/13697139909038058
   KAUFERT P, 1986, SOC SCI MED, V22, P1285, DOI 10.1016/0277-9536(86)90196-6
   KAUFERT P, 1981, SOC SCI MED-MED PSYC, V15, P173, DOI 10.1016/0271-5384(81)90011-9
   KAUFERT P, 1982, SOCIOLOGY HLTH ILLNE, V4, P141, DOI DOI 10.1111/1467-9566.EP11339905
   KEY TJA, 1990, BRIT J CANCER, V62, P631, DOI 10.1038/bjc.1990.344
   KLEINMAN A, 1986, SOCIAL ORIGINS DISTR
   Knight D C, 2001, Climacteric, V4, P13, DOI 10.1080/713605031
   Kotsopoulos D, 2000, Climacteric, V3, P161, DOI 10.1080/13697130008500108
   Kronenberg F, 2002, ANN INTERN MED, V137, P805, DOI 10.7326/0003-4819-137-10-200211190-00009
   KURZER MS, 2003, J NUTR, V134, pS1246
   Lasley BL, 2002, J CLIN ENDOCR METAB, V87, P3760, DOI 10.1210/jc.87.8.3760
   Leng K. W, 1997, REINTERPRETING MENOP, P255
   LOCK M, 1991, LANCET, V337, P1270, DOI 10.1016/0140-6736(91)92931-Q
   LOCK M, 1988, AM ETHNOL, V15, P43, DOI 10.1525/ae.1988.15.1.02a00040
   LOCK M, 1994, EXP GERONTOL, V29, P307, DOI 10.1016/0531-5565(94)90011-6
   Lock M, 2001, AM J HUM BIOL, V13, P494, DOI 10.1002/ajhb.1081
   Lock M, 1998, PSYCHOSOM MED, V60, P410, DOI 10.1097/00006842-199807000-00005
   LOCK M, 1998, CASTIGATIONS SELFISH
   LOCK M, 1993, ENCOUNTERS AGING MYT
   MARTIN MC, 1993, AM J OBSTET GYNECOL, V168, P1839, DOI 10.1016/0002-9378(93)90699-J
   Martinez-Hernaez A, 2000, WHATS SYMPTOM PSYCHI
   MCKINLAY SM, 1986, SOC SCI MED, V23, P531, DOI 10.1016/0277-9536(86)90014-6
   Mercer Catherine, 1999, Age and Ageing, V28, P12
   Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297
   Nagata C, 2001, AM J EPIDEMIOL, V153, P790, DOI 10.1093/aje/153.8.790
   NIH, 2005, NIH STAT SCI C MAN M
   Nikander E, 2003, OBSTET GYNECOL, V101, P1213, DOI 10.1016/S0029-7844(03)00232-1
   NOTELOVITZ M, 1993, MENOPAUSE MIDLIFE HL
   OBEYESEKERE G, 1985, CULTURE DEPRESSION
   Penotti M, 2003, FERTIL STERIL, V79, P1112, DOI 10.1016/S0015-0282(03)00158-4
   Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068
   Randolph JF, 2003, J CLIN ENDOCR METAB, V88, P1516, DOI 10.1210/jc.2002-020777
   ROBERTS H, 1984, PATIENT PATIENTS WOM
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   SAID E, 1978, ORITENALISM
   Scambia G, 2000, MENOPAUSE, V7, P105, DOI 10.1097/00042192-200007020-00006
   Schwarcz V, 1996, DAEDALUS, V125, P119
   Sen Amartya, 1994, HLTH SOCIAL CHANGE I
   SEXTON SM, 2003, AM FAM PHYSICIAN, V67, P834
   SHEA J, 1998, THESIS HARVARD U
   SHEEHY G, 1992, MENOPAUSE SILENT PAS
   St Germain A, 2001, MENOPAUSE, V8, P17, DOI 10.1097/00042192-200101000-00005
   TANG H, 1988, J PRACTICAL OBSTET G, V4, P198
   Upmalis DH, 2000, MENOPAUSE, V7, P236, DOI 10.1097/00042192-200007040-00005
   Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449
   Vincent A, 2000, MAYO CLIN PROC, V75, P1174, DOI 10.4065/75.11.1174
   Washburn S, 1999, MENOPAUSE, V6, P7
   WILSON RA, 1966, FEMININE FOREVER
   WOODS M, 2000, J NUTR, V130, pS671
   Xu L., 1993, J REPROD MED, V2, P23
   Zeserson JM, 2001, MED ANTHROPOL Q, V15, P189, DOI 10.1525/maq.2001.15.2.189
   Zhao G, 2000, Climacteric, V3, P135, DOI 10.3109/13697130009167615
NR 81
TC 7
Z9 8
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD SEP
PY 2006
VL 30
IS 3
BP 331
EP 362
DI 10.1007/s11013-006-9020-4
PG 32
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA 107BR
UT WOS:000242146200003
PM 17048096
DA 2018-10-20
ER

PT J
AU Lanone, S
   Boczkowski, J
AF Lanone, Sophie
   Boczkowski, Jorge
TI Biomedical applications and potential health risks of nanomaterials:
   Molecular mechanisms
SO CURRENT MOLECULAR MEDICINE
LA English
DT Review
ID WALL CARBON NANOTUBES; DIESEL EXHAUST PARTICLES; ULTRASMALL
   SUPERPARAMAGNETIC PARTICLES; SEMICONDUCTOR QUANTUM DOTS; PARTICULATE
   AIR-POLLUTION; INDUCE OXIDATIVE STRESS; ULTRAFINE PARTICLES; PULMONARY
   TOXICITY; EPITHELIAL-CELLS; PYROLYSIS PRODUCTS
AB Nanotechnologies, defined as techniques aimed to conceive, characterize and produce material at the nanometer scale, represent a fully expanding domain, and one can predict without risk that production and utilization of nanomaterials will increase exponentially in the coming years. Applications of nanotechnologies are numerous, in constant development, and their potential use in the medical field as diagnosis and therapeutics tools is very attractive. The size particularity of these nanomaterials gives them novel properties, allowing them to adopt new comportments because of the laws of quantum physics that exist at this scale. However, worries are expressed regarding the exact properties that make these nanomaterials attractive, and questions are raised regarding their potential toxicity, their long-term secondary effects or their biodegradability, particularly when thinking of their use in the (nano)medical field. These questions are justified by the knowledge of the toxic effects of atmospheric pollution micrometric particles on health, and the fear to get an amplification of these effects because of the size of the materials blamed.
   In this paper, we first expose the sensed medical applications of nanomaterials, and the physicochemical and molecular determinants potentially responsible for nanornaterials biological effects. Finally, we present a synthesis of the actual knowledge regarding toxicological effects of nanornaterials.
   It is clear that, in regard to the almost empty field of what is known on the subject, there's an urge to better understand biological effects of nanornaterials, which will allow their safe use, in particular in the nanomedicine field.
C1 Univ Paris 07, INSERM, U700, Fac Med, Paris, France.
   Hop Bichat, APHP, F-75018 Paris, France.
RP Lanone, S (reprint author), INSERM 700, Fac X Bichat, BP416, F-75870 Paris 18, France.
EM sophynet@bichat.inserm.fr; jbb2@bichat.inserm.fr
RI Lanone, Sophie/I-4042-2016
OI Lanone, Sophie/0000-0003-2509-8799
CR Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x
   Amato I, 1989, SCI NEWS, V136, P108
   Arimoto T, 2005, AM J RESP CRIT CARE, V171, P379, DOI 10.1164/rccm.200402-248OC
   AUCLAIR F, 1983, Toxicological European Research, V5, P43
   Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642
   Ball BR, 2000, INHAL TOXICOL, V12, P209, DOI 10.1080/089583700750019576
   Baulig A, 2003, AM J PHYSIOL-LUNG C, V285, pL671, DOI 10.1152/ajplung.00419.2002
   Borm PJA, 2002, INHAL TOXICOL, V14, P311, DOI 10.1080/08958370252809086
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Brown JS, 2002, AM J RESP CRIT CARE, V166, P1240, DOI 10.1164/rccm.00205-399OC
   CAVAGNA G, 1961, Med Lav, V52, P251
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8
   COLEMAN WE, 1968, AM IND HYG ASSOC J, V29, P54, DOI 10.1080/00028896809342981
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525
   de Jalon EG, 2001, INT J PHARM, V226, P181, DOI 10.1016/S0378-5173(01)00811-0
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Donaldson K, 2002, J AEROSOL MED, V15, P213, DOI 10.1089/089426802320282338
   Donko A, 2005, PHILOS T ROY SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767
   Driscoll KE, 1996, TOXICOL APPL PHARM, V136, P372, DOI 10.1006/taap.1996.0045
   FERIN J, 1992, AM J RESP CELL MOL, V6, P535, DOI 10.1165/ajrcmb/6.5.535
   Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X
   FRANCO MC, 2005, J BIOL CHEM
   Galli S, 2003, CANCER RES, V63, P6370
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   GOLDSTEIN M, 1987, J OCCUP ENVIRON MED, V29, P746
   Greim H, 2001, INHAL TOXICOL, V13, P737, DOI 10.1080/089583701316941285
   GRIFFITH FD, 1973, AM IND HYG ASSOC J, V34, P176, DOI 10.1080/0002889738506828
   Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749
   Heckel K, 2004, AM J PHYSIOL-LUNG C, V287, pL867, DOI 10.1152/ajplung.00078.2004
   Hoet P.H., 2004, J NANOBIOTECHNOLOGY, V2
   Hussain N, 2001, ADV DRUG DELIVER REV, V50, P107, DOI 10.1016/S0169-409X(01)00152-1
   International Commission on Radiological Protection (ICRP), 1994, ANN ICRP, V24, P1
   Jaffer FA, 2004, CIRC RES, V94, P433, DOI 10.1161/01.RES.0000119321.18573.5A
   Jain TK, 2005, MOL PHARMACEUT, V2, P194, DOI 10.1021/mp0500014
   Jaiswal JK, 2004, NAT METHODS, V1, P73, DOI 10.1038/nmeth1004-73
   JANI P, 1990, J PHARM PHARMACOL, V42, P821, DOI 10.1111/j.2042-7158.1990.tb07033.x
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Johnston CJ, 2000, TOXICOL APPL PHARM, V168, P208, DOI 10.1006/taap.2000.9037
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kato T, 2003, CELL TISSUE RES, V311, P47, DOI 10.1007/s00441-002-0647-3
   Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612
   Kendall M, 2004, INHAL TOXICOL, V16, P99, DOI 10.1080/08958370490443187
   Khan AA, 2005, ARCH ENVIRON CON TOX, V49, P410, DOI 10.1007/s00244-004-0244-4
   Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000
   Lucarelli M, 2004, EUR CYTOKINE NETW, V15, P339
   MacNee W, 2003, Eur Respir J Suppl, V40, p47s
   Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966
   MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8
   Medinsky MA, 2001, TOXICOLOGY, V160, P165, DOI 10.1016/S0300-483X(00)00448-0
   MILLS NL, 2006, AM J RESP CRIT CARE, V174, P426
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008
   Nagaveni K, 2004, ENVIRON SCI TECHNOL, V38, P1600, DOI 10.1021/es034696i
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036
   NUTTALL JB, 1964, AEROSPACE MED, V35, P676
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658
   OBERDORSTER G, 1992, ENVIRON HEALTH PERSP, V97, P193, DOI 10.2307/3431353
   OBERDORSTER G, 1995, INHAL TOXICOL, V7, P111, DOI 10.3109/08958379509014275
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   OBERDORSTER G, 1990, J AEROSOL SCI, V21, P384, DOI 10.1016/0021-8502(90)90065-6
   OBERDORSTER G, 1990, J AEROSOL SCI, V21, pS397, DOI 10.1016/0021-8502(90)90265-Y
   OBERDORSTER G, 2000, RES REP HLTH EFF I, V5
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Pekkanen J, 2002, CIRCULATION, V106, P933, DOI 10.1161/01.CIR.0000027561.41736.3C
   Penttinen P, 2001, ENVIRON HEALTH PERSP, V109, P319, DOI 10.2307/3454889
   Penttinen P, 2001, EUR RESPIR J, V17, P428, DOI 10.1183/09031936.01.17304280
   Peters A, 1997, AM J RESP CRIT CARE, V155, P1376, DOI 10.1164/ajrccm.155.4.9105082
   PRYOR WA, 1994, FREE RADICAL BIO MED, V17, P451, DOI 10.1016/0891-5849(94)90172-4
   Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42
   Rancan F, 2002, J PHOTOCH PHOTOBIO B, V67, P157, DOI 10.1016/S1011-1344(02)00320-2
   Ray PC, 2006, ANGEW CHEM INT EDIT, V45, P1151, DOI 10.1002/anie.200503114
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Ruehm SG, 2001, CIRCULATION, V103, P415
   Russell-Jones GJ, 1999, INT J PHARM, V179, P247, DOI 10.1016/S0378-5173(98)00394-9
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027
   Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005
   Shvedova AA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P23, DOI 10.1023/B:BIRY.0000016347.35373.39
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561
   Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210
   Szentkuti L, 1997, J CONTROL RELEASE, V46, P233, DOI 10.1016/S0168-3659(96)01600-8
   Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200
   Takano H, 2002, ARCH TOXICOL, V76, P146, DOI 10.1007/s00204-002-0323-0
   Taton TA, 2001, J AM CHEM SOC, V123, P5164, DOI 10.1021/ja0102639
   Tran CL, 2000, INHAL TOXICOL, V12, P1113, DOI 10.1080/08958370050166796
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Wang B, 2006, TOXICOL LETT, V161, P115, DOI 10.1016/j.toxlet.2005.08.007
   Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146
   Warheit DB, 2003, EXP LUNG RES, V29, P593, DOI 10.1080/01902140390240104
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   WARITZ RS, 1968, AM IND HYG ASSOC J, V29, P19, DOI 10.1080/00028896809342976
   Watanabe M, 2002, J TOXICOL ENV HEAL A, V65, P1047, DOI 10.1080/00984100290071081
   Watson A, 2003, BIOTECHNIQUES, V34, P296, DOI 10.2144/03342bi01
   Whitekus MJ, 2002, J IMMUNOL, V168, P2560, DOI 10.4049/jimmunol.168.5.2560
   Wottrich R, 2004, INT J HYG ENVIR HEAL, V207, P353, DOI 10.1078/1438-4639-00300
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Yamakoshi Y, 2003, J AM CHEM SOC, V125, P12803, DOI 10.1021/ja0355574
   Zuhorn IS, 2002, J BIOL CHEM, V277, P18021, DOI 10.1074/jbc.M111257200
NR 108
TC 230
Z9 237
U1 2
U2 66
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
J9 CURR MOL MED
JI Curr. Mol. Med.
PD SEP
PY 2006
VL 6
IS 6
BP 651
EP 663
DI 10.2174/156652406778195026
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 073NX
UT WOS:000239751000004
PM 17022735
DA 2018-10-20
ER

PT J
AU Gericke, M
   Pinches, A
AF Gericke, M.
   Pinches, A.
TI Biological synthesis of metal nanoparticles
SO HYDROMETALLURGY
LA English
DT Article; Proceedings Paper
CT 16th International Biohydrometallurgy Symposium (IBS2005)
CY SEP 25-29, 2005
CL Cape Town, SOUTH AFRICA
DE gold; nanoparticles; biological; synthesis
ID GOLD NANOPARTICLES; EXTRACELLULAR BIOSYNTHESIS; SILVER NANOPARTICLES;
   BIOREDUCTION; PALLADIUM; FUNGUS; AU
AB The development of techniques for the controlled synthesis of nanoparticles of well-defined size, shape and composition, to be used in the biomedical field and areas such as optics and electronics, is a big challenge. The use of the highly structured physical and biosynthetic activities of microbial cells for the synthesis of nanosized materials has recently emerged as a novel approach for the synthesis of metal nanoparticles. A number of different organisms, including bacteria, yeast and fungi, were screened for their ability to produce gold nanoparticles and examples of results demonstrating the formation of gold nanoparticles of different sizes and shapes are presented. The cellular mechanism leading to the reduction of the gold ions and formation of gold nanoparticles is not well understood and therefore the potential to manipulate key parameters, which control growth and other cellular activities, to achieve controlled size and shape of the nanoparticles was investigated. The results provided some insight as to which parameters may impact on the cellular mechanism involved in the reduction of gold ions and formation of gold nanoparticles. (C) 2006 Elsevier B.V. All rights reserved.
C1 MINTEK, Div Biotechnol, ZA-2125 Randburg, South Africa.
RP Gericke, M (reprint author), MINTEK, Div Biotechnol, Private Bag X3015, ZA-2125 Randburg, South Africa.
EM mariekieg@mintek.co.za
CR Ahmad A, 2003, LANGMUIR, V19, P3550, DOI 10.1021/la026772l
   Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Beveridge TJ, 1997, ADV MICROB PHYSIOL, V38, P177
   BIRYUZOVA V I, 1987, Mikrobiologiya, V56, P209
   Blum AS, 2004, NANO LETT, V4, P867, DOI 10.1021/nl0497474
   Brown S, 2000, J MOL BIOL, V299, P725, DOI 10.1006/jmbi.2000.3682
   Brust M, 2002, COLLOID SURFACE A, V202, P175, DOI 10.1016/S0927-7757(01)01087-1
   Huang HZ, 2005, COLLOID SURFACE A, V255, P11, DOI 10.1016/j.colsurfa.2004.12.020
   Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611
   Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6
   Kowshik M, 2003, NANOTECHNOLOGY, V14, P95, DOI 10.1088/0957-4484/14/1/321
   KOWSHIK M, 2003, BIOTECHNOL BIOENG, V78, P583
   Li CC, 2004, MATER LETT, V58, P196, DOI 10.1016/S0167-577X(03)00444-0
   Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001
   MANDAL S, 2005, CURRENT APPL PHYS, V5, P1127
   Mukherjee P, 2001, ANGEW CHEM INT EDIT, V40, P3585, DOI 10.1002/1521-3773(20011001)40:19<3585::AID-ANIE3585>3.0.CO;2-K
   Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164
   Nakajima A, 2003, WORLD J MICROB BIOT, V19, P369, DOI 10.1023/A:1023944905364
   Roh Y, 2001, SOLID STATE COMMUN, V118, P529, DOI 10.1016/S0038-1098(01)00146-6
   Savvaidis I, 1998, BIOMETALS, V11, P69, DOI 10.1023/B:BIOM.0000030925.56070.56
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Wahl R, 2001, ADV MATER, V13, P736, DOI 10.1002/1521-4095(200105)13:10<736::AID-ADMA736>3.0.CO;2-N
   Yong P, 2002, BIOTECHNOL BIOENG, V80, P369, DOI 10.1002/bit.10369
NR 23
TC 234
Z9 240
U1 0
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-386X
J9 HYDROMETALLURGY
JI Hydrometallurgy
PD SEP
PY 2006
VL 83
IS 1-4
SI SI
BP 132
EP 140
DI 10.1016/j.hydromet.2006.03.019
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 077LG
UT WOS:000240030200019
DA 2018-10-20
ER

PT J
AU Sase, I
   Takatsuki, A
   Seki, J
   Yanagida, T
   Seiyama, A
AF Sase, Ichiro
   Takatsuki, Akira
   Seki, Junji
   Yanagida, Toshio
   Seiyama, Akitoshi
TI Noncontact backscatter-mode near-infrared time-resolved imaging system:
   preliminary study for functional brain mapping
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE biomedical optics; imaging; laser applications; infrared imaging;
   optical systems; optical testing
ID TISSUE OPTICAL-PROPERTIES; NONINVASIVE MEASUREMENT; CEREBRAL
   HEMODYNAMICS; SPECTROSCOPY; CORTEX; TOMOGRAPHY; ACTIVATION;
   SCHIZOPHRENIA; INTENSITY; PHOTONS
AB To improve the spatial resolution and to obtain the depth information of absorbers buried in highly scattering material, we developed a noncontact backscatter-mode near-infrared time-resolved imaging system (noncontact B-TRIS) that is intended for functional human brain mapping. It consists of mode-locked Ti-sapphire lasers as light sources and a charge-coupled device camera equipped with a time-resolved intensifier as a detector. The system was tested with a white polyacetal phantom as a light-scattering medium and black polyacetal particles as absorbers. Illumination and detection of light through an objective lens system (phi=150 mm) enabled us to capture images from an area whose diameter is about 70 mm without coming into contact with it. The scattering and absorption coefficients of the white phantom obtained by B-TRIS were similar to those obtained by a conventional time-resolved spectroscopy. Although the imaged diameter of an absorber buried within a phantom was considerably larger than the actual diameter, the center position of the absorber coincided with the actual position with accuracy < 2 mm. Furthermore, the depth information can be also detected by the noncontact B-TRIS. These results suggest a potential of noncontact B-TRIS for imaging cognitive human brain function. (c) 2006 Society of Photo-Optical Instrumentation Engineers.
C1 Osaka Univ, Grad Sch Med, Div Physiol & Biosignaling, Suita, Osaka 5650871, Japan.
   Kansai Adv Res Ctr, Natl Inst Informat & Commun Technol, Brain Informat Grp, Nishi Ku, Kobe, Hyogo 6512492, Japan.
RP Seiyama, A (reprint author), Osaka Univ, Grad Sch Med, Div Physiol & Biosignaling, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM aseiyama@phys1.med.osaka-u.ac.jp
RI Yanagida, Toshio/D-1919-2009
OI Seki, Junji/0000-0002-1896-7944
CR Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939
   BOAS AD, 2004, NEUROIMAGE, V23, P5275
   Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674
   DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008
   Eda H, 1999, REV SCI INSTRUM, V70, P3595, DOI 10.1063/1.1149965
   Franceschini MA, 2004, NEUROIMAGE, V21, P372, DOI 10.1016/j.neuroimage.2003.09.040
   HERRMANN MJ, 2003, BRAIN RES B, V30, P51
   Higashi T, 2004, J BIOMED OPT, V9, P788, DOI 10.1117/1.1755233
   Kusaka T, 2004, HUM BRAIN MAPP, V22, P122, DOI 10.1002/hbm.20020
   Liebert A, 2004, APPL OPTICS, V43, P3037, DOI 10.1364/AO.43.003037
   MACKERT BM, 2004, NEUROREPORT, V19, P63
   Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905
   Montcel B, 2005, APPL OPTICS, V44, P1942, DOI 10.1364/AO.44.001942
   Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6
   Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29
   Oda M, 1999, P SOC PHOTO-OPT INS, V3597, P611, DOI 10.1117/12.356809
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   Paulesu E, 1997, HUMAN BRAIN FUNCTION, P183
   Petrovic P, 2002, NEUROIMAGE, V16, P1142, DOI 10.1006/nimg.2002.1069
   Richardson J. T. E., 1999, IMAGERY
   Roy R, 2005, IEEE T MED IMAGING, V24, P137, DOI 10.1109/TMI.2004.839359
   Schulz RB, 2004, IEEE T MED IMAGING, V23, P492, DOI 10.1109/TMI.2004.825633
   Schulz RB, 2003, OPT LETT, V28, P1701, DOI 10.1364/OL.28.001701
   Seiyama A, 2004, NEUROIMAGE, V21, P1204, DOI 10.1016/j.neuroimage.2003.12.002
   Selb J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852553
   Steinbrink J, 2000, NEUROSCI LETT, V291, P105, DOI 10.1016/S0304-3940(00)01395-1
   Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008
   Thompson AB, 2003, APPL OPTICS, V42, P4125, DOI 10.1364/AO.42.004125
   Turner GM, 2005, OPT LETT, V30, P409, DOI 10.1364/OL.30.000409
   Uludag K, 2004, NEUROIMAGE, V22, P109, DOI 10.1016/j.neuroimage.2003.09.053
   Watanabe A, 2004, SCHIZOPHRENIA BULL, V30, P435, DOI 10.1093/oxfordjournals.schbul.a007090
   Wolf M, 2002, NEUROIMAGE, V17, P1868, DOI 10.1006/nimg.2002.1261
NR 32
TC 11
Z9 11
U1 1
U2 2
PU SPIE-INT SOCIETY OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD SEP-OCT
PY 2006
VL 11
IS 5
AR 054006
DI 10.1117/1.2363359
PG 7
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 113DB
UT WOS:000242576900010
PM 17092155
DA 2018-10-20
ER

PT J
AU Arshak, K
   Morris, D
   Arshak, A
   Korostynska, O
AF Arshak, K.
   Morris, D.
   Arshak, A.
   Korostynska, O.
TI Development of high sensitivity oxide based strain gauges and pressure
   sensors
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID THICK-FILM RESISTORS; STAINLESS-STEEL; TRANSDUCERS; SUBSTRATE
AB Strain gauges and pressure sensors are necessary tools for automotive, aerospace and biomedical monitoring applications. Of the various types of material, which can be used in their fabrication, oxides allow a degree of flexibility in their design. Furthermore, these devices are more rugged and cost effective than semiconductor sensors and have a higher sensitivity than metal-foil gauges. In this paper, the development of thin and thick film sensors based on oxides such as V2O5, CeO2, Bi2O3, In2O3, RuO2, TiO2, MgO and Nb2O5 is discussed. The devices are evaluated in terms of their sensitivity or gauge factor, linearity, hysteresis and long term stability. Furthermore, different device configurations, planar and sandwich are compared. It is found that the devices presented in this work have sensitivity comparable to that of semiconductor gauges, with good long-term stability. This is particularly true of the sandwich devices. It is observed that oxide based strain gauges may offer an alternative to existing commercial gauges, for example, in applications involving load cells, torque wrenches and limb implants.
C1 Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland.
   Univ Limerick, Dept Phys, Limerick, Ireland.
RP Arshak, K (reprint author), Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland.
EM khalil.arshak@ul.ie
RI Korostynska, Olga/C-9858-2014
OI Korostynska, Olga/0000-0003-0387-6609
CR Altenburg H, 2002, PURE APPL CHEM, V74, P2083, DOI 10.1351/pac200274112083
   ANSARI F, 1994, DESIGN MODELING THIC
   Arshak A, 2005, SENSOR ACTUAT A-PHYS, V122, P242, DOI 10.1016/j.sna.2005.06.004
   ARSHAK A, 2005, P MRS SPRING M SAN F
   ARSHAK K, 1993, J PHYS D APPL PHYS, V26, P1098, DOI 10.1088/0022-3727/26/7/014
   ARSHAK K, 1993, SENSOR ACTUAT A-PHYS, V36, P73, DOI 10.1016/0924-4247(93)80143-5
   Arshak K. I., 1994, Materials & Design, V15, P149, DOI 10.1016/0261-3069(94)90114-7
   ARSHAK KI, 1994, INT J ELECTRON, V77, P387, DOI 10.1080/00207219408926071
   ARSHAK KI, 1994, INT J ELECTRON, V76, P365, DOI 10.1080/00207219408925933
   Arshak KI, 1997, MEAS SCI TECHNOL, V8, P58, DOI 10.1088/0957-0233/8/1/009
   ARSHAK KI, 1994, INT J ELECTRON, V76, P1011, DOI 10.1080/00207219408926012
   BELAVIC D, 2000, P IMAPS
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   CATTANEO A, 1980, IEEE T COMPON HYBR
   CHITALE S, 1989, HYBRID CIRCUIT T JUN, P45
   Collins DG, 1996, MICROELECTR J, V27, P59, DOI 10.1016/0026-2692(95)00096-8
   Crescini D, 1997, MEAS SCI TECHNOL, V8, P71, DOI 10.1088/0957-0233/8/1/010
   Figliola RS, 2000, THEORY DESIGN MECH M
   FILANCBOWEN TR, 2002, P IEEE SENSORS, V2, P1648
   FRADEN J, 1996, HDB MODERN SENSORS P
   GUO J, 2004, P SOL STAT SENS ACT
   Harper C. A., 1974, HDB THICK FILM HYBRI
   HOLMES PJ, 1973, MICROELECTRON RELIAB, V12, P395, DOI 10.1016/0026-2714(73)90335-1
   Hrovat M, 2003, SENSOR ACTUAT A-PHYS, V107, P261, DOI 10.1016/j.sna.2003.07.003
   Hrovat M, 2003, J EUR CERAM SOC, V23, P1441, DOI 10.1016/S0955-2219(02)00355-2
   Huge A, 1998, J SURG RES, V74, P112, DOI 10.1006/jsre.1997.5245
   Igreja R, 2004, SENSOR ACTUAT A-PHYS, V112, P291, DOI 10.1016/j.sna.2004.01.040
   Licari James J., 1988, HYBRID MICROCIRCUIT
   Mamishev AV, 2004, P IEEE, V92, P808, DOI 10.1109/JPROC.2004.826603
   Mott N. F., 1968, Journal of Non-Crystalline Solids, V1, P1, DOI 10.1016/0022-3093(68)90002-1
   Papakostas TV, 2000, J PHYS D APPL PHYS, V33, pL73, DOI 10.1088/0022-3727/33/14/101
   PERREM RL, 1993, THIN FILM STRAIN GAU
   PUERS R, 1993, SENSOR ACTUAT A-PHYS, V37-8, P93, DOI 10.1016/0924-4247(93)80019-D
   White NM, 1997, MEAS SCI TECHNOL, V8, P1, DOI 10.1088/0957-0233/8/1/002
   Window A., 1982, STRAIN GAUGE TECHNOL
   Yang C, 2003, BIOSENS BIOELECTRON, V19, P51, DOI 10.1016/S0956-5663(03)00131-3
NR 36
TC 8
Z9 8
U1 1
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD SEP
PY 2006
VL 17
IS 9
BP 767
EP 778
DI 10.1007/s10854-006-0013-4
PG 12
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA 087HU
UT WOS:000240734300012
DA 2018-10-20
ER

PT J
AU Kumbar, SG
   Nair, LS
   Bhattacharyya, S
   Laurencin, CT
AF Kumbar, Sangamesh G.
   Nair, Lakshmi S.
   Bhattacharyya, Subhabrata
   Laurencin, Cato T.
TI Polymeric nanofibers as novel carriers for the delivery of therapeutic
   molecules
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE electrospinning; nanofibers; drug delivery; antibiotics; antifungal;
   antimicrobial; anticancer; core-shell nanofiber; proteins
ID TISSUE-ENGINEERING SCAFFOLDS; AMORPHOUS DRUG DISPERSIONS; ELECTROSPUN
   NANOFIBERS; CONTROLLED-RELEASE; SUSTAINED-RELEASE; ADHESION BARRIER;
   FIBERS; FABRICATION; NANOPARTICLES; MEMBRANE
AB Nanotechnology and nanoscience are relatively new technological endeavors that encompass the study, control, manipulation, and assembly of multifarious nanoscale components into materials, systems and devices to serve human interest and needs.(1) Among the various currently used nanostructures for high technology applications polymeric nanofibers have received immense interest due to the ease of fabrication, controllable size/shape, and properties. Polymeric nanofibers have been extensively investigated for diversified applications, including filtration, barrier fabrics, wipes, personal care, biomedical, and pharmaceutical applications. This review mainly focuses on the fabrication of therapeutic agent loaded polymeric nanofibers and their controlled/sustained release behavior for the delivery of these active agents for various therapeutic applications. The nonwoven biodegradable polymeric nanofiber matrices are currently being reported as topical/local therapeutic agent delivery systems and as resorbable/biodegradable gauze for wound healing applications.
C1 Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.
   Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA.
   Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA.
RP Laurencin, CT (reprint author), Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.
CR APELQVIST J, 1990, INT ANGIOL, V9, P120
   Berne RW, 2004, SCI ENG ETHICS, V10, P627, DOI 10.1007/s11948-004-0043-3
   BHIDE M, 2003, 35 GREAT LAK REG M A, P251
   Bognitzki M, 2000, ADV MATER, V12, P637, DOI 10.1002/(SICI)1521-4095(200005)12:9<637::AID-ADMA637>3.0.CO;2-W
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Bornat A., 1987, U.S. Patent, Patent No. [US 4689186 A, 4689186]
   Brewster ME, 2004, PHARMAZIE, V59, P387
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   BURKE JF, 1961, SURGERY, V50, P161
   Burns JM, 1995, J SURG RES, V59, P644, DOI 10.1006/jsre.1995.1218
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   CHAIKOF EL, 2004, Patent No. 1422242
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Chronakis IS, 2005, J MATER PROCESS TECH, V167, P283, DOI 10.1016/j.jmatprotec.2005.06.053
   Couvreur P, 1986, POLYM NANOPARTICLES
   Dai HQ, 2002, NANOTECHNOLOGY, V13, P674, DOI 10.1088/0957-4484/13/5/327
   Dai L., 2004, ENCY NANOSCIENCE NAN, P763
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Dersch R, 2005, POLYM ADVAN TECHNOL, V16, P276, DOI 10.1002/pat.568
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Ferland R, 2001, HUM REPROD, V16, P2718, DOI 10.1093/humrep/16.12.2718
   FONG H, 2000, STRUCTURE FORMATION
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Ghosh TK, 1997, TRANSDERMAL TOPICAL
   Gibson PW, 1999, AICHE J, V45, P190, DOI 10.1002/aic.690450116
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Groiztsch D., 1986, US Patent, Patent No. [4,618,524, 4618524]
   HOLSCHNEIDER CH, 1991, J SURG RES, V72, P138
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   IGNATIOUS F, 2004, Patent No. 200414304
   Jang JS, 2001, CHEM COMMUN, P83, DOI 10.1039/b006197m
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   JING X, 2004, Patent No. 1543929
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   KAZIM A, 2005, Patent No. 2005021843
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   KENAWY ER, 2002, POLYM PREPR AM CHEM, V43, P457
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Kidane A, 2005, CURR OPIN CHEM BIOL, V9, P347, DOI 10.1016/j.cbpa.2005.06.006
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   KIM K, 2003, POLYM PREPR, V44, P98
   Knight CG, 1981, LIPOSOMES PHYS STRUC
   Ko FK, 2002, STRUCT DYN MAT C, V3, P1779
   Kreuter J, 1994, NANOPARTICLES COLLOI, P219
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Langer R, 1998, NATURE, V392, P5
   Laurencin CT, 2004, NATO SCI SER II MATH, V169, P283
   LEGRAND EK, 1995, J INVEST SURG, V8, P187, DOI 10.3109/08941939509023141
   LEONG KW, 1987, ADV DRUG DELIVERY RE, V1, P199
   Liu GJ, 1996, MACROMOLECULES, V29, P5508, DOI 10.1021/ma9604653
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   MartinezDeJesus FR, 1997, ARCH MED RES, V28, P95
   MATHOWITZ E, 1999, ENCY CONTROLED DRUG, V1
   Meis JFGM, 2001, DRUGS, V61, P13, DOI 10.2165/00003495-200161001-00002
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   Menzies D, 1992, Surg Annu, V24 Pt 1, P27
   Monfardini C, 1998, BIOCONJUGATE CHEM, V9, P418, DOI 10.1021/bc970184f
   Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208
   NAIR LS, 2003, ADV DRUG DELIV REV, V55, P467
   Nalwa H. S., 2000, HDB NANOSTRUCTURED M
   Norris ID, 2000, SYNTHETIC MET, V114, P109, DOI 10.1016/S0379-6779(00)00217-4
   Ondarcuhu T, 1998, EUROPHYS LETT, V42, P215, DOI 10.1209/epl/i1998-00233-9
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Park C, 2002, MATER RES SOC SYMP P, V706, P91
   Peeters J, 2002, J PHARM SCI, V91, P1414, DOI 10.1002/jps.10126
   Peppas LB, 1995, INT J PHARMACEUT, V116, P1
   Ranney DF, 2000, BIOCHEM PHARMACOL, V59, P105, DOI 10.1016/S0006-2952(99)00316-0
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 2001, NEW FRONTIERS FIBER
   Robinson SN, 2002, IN VIVO, V16, P535
   Sanders EH, 2003, MACROMOLECULES, V36, P3803, DOI 10.1021/ma021771l
   Schaefer H., 1996, SKIN BARRIER PRINCIP
   Schreuder-Gibson H, 2002, J ADV MATER-COVINA, V34, P44
   SEKIBA K, 1992, OBSTET GYNECOL, V79, P518
   Setterstrom J. A., 1984, RECENT ADV DRUG DELI, P185
   Shamnugasundaram S, 2004, PROCEEDINGS OF THE IEEE 30TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P140
   Shao CL, 2002, MATER LETT, V56, P24, DOI 10.1016/S0167-577X(02)00411-1
   Shi M, 2003, J CONTROL RELEASE, V89, P167, DOI 10.1016/S0168-3659(02)00493-5
   SIMPSON DG, 2002, Patent No. 2002090725
   SIMPSON DG, 2002, Patent No. 2002040242
   SIMPSON DG, 2003, Patent No. 2003099230
   SIMPSON DG, 2002, Patent No. 714255
   SON WK, 2003, KOBUNJA KWAHAK KWA K, V14, P274
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Spasova M, 2004, E-POLYMERS
   Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   Torchilin VP, 1998, J MICROENCAPSUL, V15, P1, DOI 10.3109/02652049809006831
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WNEK GE, 2002, 223 ACS NAT M ORL FL
   WNEK GE, 2003, Patent No. 2003086290
   Xu XL, 2005, J CONTROL RELEASE, V108, P33, DOI 10.1016/j.jconrel.2005.07.021
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   ZIMMER A, 1995, ADV DRUG DELIVER REV, V16, P61, DOI 10.1016/0169-409X(95)00017-2
   ZONG X, 2004, ANN SURG, V910, P240
   ZONG X, 2003, 226 ACM NAT M NEW YO
NR 112
TC 67
Z9 69
U1 2
U2 56
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD SEP-OCT
PY 2006
VL 6
IS 9-10
BP 2591
EP 2607
DI 10.1166/jnn.2006.462
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 089FO
UT WOS:000240865900002
PM 17048469
DA 2018-10-20
ER

PT J
AU Alexiou, C
   Jurgons, R
   Seliger, C
   Iro, H
AF Alexiou, C.
   Jurgons, R.
   Seliger, C.
   Iro, H.
TI Medical applications of magnetic nanoparticles
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
ID SUPERPARAMAGNETIC IRON-OXIDE; WHOLE-BODY HYPERTHERMIA; LOCOREGIONAL
   CANCER-TREATMENT; TARGETING GENE DELIVERY; LYMPH-NODE METASTASES;
   LOW-DOSE DOXORUBICIN; TUMOR-BEARING MICE; IN-VITRO; DRUG-DELIVERY;
   ALBUMIN MICROSPHERES
AB In recent years biomedical research indicated, that magnetic nanoparticles can be a promising tool for several applications in vitro and in vivo. In medicine many approaches were investigated for diagnosis and therapy and offered a great variety of applications. Magnetic cell separation, magnetic resonance imaging (MRI), magnetic targeted delivery of therapeutics or magnetically induced hyperthermia are approaches of particular clinical relevance. For medical use, especially for in vivo application it is of great importance that these particles do not have any toxic effects or incompatibility with biological organism. Investigations on applicable particles induced a variability of micro- and nanostructures with different materials, sizes, and specific surface chemistry.
C1 Univ Erlangen Nurnberg, Dept Otorhinolaryngol Head & Neck Surg, D-8520 Erlangen, Germany.
RP Alexiou, C (reprint author), Univ Erlangen Nurnberg, Dept Otorhinolaryngol Head & Neck Surg, D-8520 Erlangen, Germany.
CR Alexiou C, 2006, Z PHYS CHEM, V220, P235, DOI 10.1524/zpch.2006.220.2.235
   Alexiou C, 2005, J MAGN MAGN MATER, V293, P389, DOI 10.1016/j.jmmm.2005.02.036
   Alexiou C, 2005, HNO, V53, P618, DOI 10.1007/s00106-004-1146-5
   Alexiou C, 2003, J DRUG TARGET, V11, P139, DOI 10.1080/1061186031000150791
   Alexiou C, 2000, CANCER RES, V60, P6641
   Alexiou C, 2001, J MAGN MAGN MATER, V225, P187, DOI 10.1016/S0304-8853(00)01256-7
   ALEXIOU C, 2006, EUR BIOPHYS J   0131
   ALEXIOU C, IN PRESS IEEE T APPL
   ALEXIOU C, IN PRESS ANTICANCER
   Alexiou C., 2001, MAGNETOHYDRODYNAMICS, V37, P318
   ALKSNE JF, 1966, SURGERY, V60, P212
   Asmatulu R, 2005, J MAGN MAGN MATER, V292, P108, DOI 10.1016/j.jmmm.2004.10.103
   Bilkenroth U, 2001, INT J CANCER, V92, P577, DOI 10.1002/ijc.1217
   Brigger I, 2004, J CONTROL RELEASE, V100, P29, DOI 10.1016/j.jconrel.2004.07.019
   Brigger I, 2002, J PHARMACOL EXP THER, V303, P928, DOI 10.1124/jpet.102.039669
   Brigger I, 2001, INT J PHARM, V214, P37, DOI 10.1016/S0378-5173(00)00628-1
   Brooimans RA, 2005, J BIOL REG HOMEOS AG, V19, P84
   BULL JMC, 1982, CA-CANCER J CLIN, V32, P123, DOI 10.3322/canjclin.32.2.123
   BULL JMC, 1984, CANCER RES, V44, P4853
   Bulte JWM, 2003, METHOD ENZYMOL, V373, P175
   Bulte JWM, 1999, J MAGN RESON IMAGING, V9, P329, DOI 10.1002/(SICI)1522-2586(199902)9:2<329::AID-JMRI27>3.0.CO;2-Z
   Chen BT, 2005, UROLOGY, V65, P616, DOI 10.1016/j.urology.2004.10.053
   COLLINS JM, 1984, J CLIN ONCOL, V2, P498, DOI 10.1200/JCO.1984.2.5.498
   DECUYPER M, 1993, J MAGN MAGN MATER, V122, P340, DOI 10.1016/0304-8853(93)91105-G
   Deponte S, 2004, ANAL BIOANAL CHEM, V379, P419, DOI 10.1007/s00216-004-2622-1
   DEVINENI D, 1995, BIOCONJUGATE CHEM, V6, P203, DOI 10.1021/bc00032a008
   DRISCOLL CF, 1984, MICROVASC RES, V27, P353, DOI 10.1016/0026-2862(84)90065-7
   Durcova-Hills G, 1999, Cloning, V1, P217, DOI 10.1089/15204559950019852
   ENGELHARDT R, 1983, STRAHLENTHER ONKOL, V159, P99
   Gao Y., 2005, BIOFUNCTIONALIZATION, P72
   GLEICH B, 2005, BIOMED TECHNOL, V50, P609
   GLEICH B, 2004, IEEE C P NANO, V255
   Goodwin SC, 2001, TOXICOL SCI, V60, P177, DOI 10.1093/toxsci/60.1.177
   GORDON RT, 1979, MED HYPOTHESES, V5, P83, DOI 10.1016/0306-9877(79)90063-X
   GUPTA PK, 1990, LIFE SCI, V46, P471, DOI 10.1016/0024-3205(90)90002-9
   GUPTA PK, 1990, J PHARM SCI, V79, P949, DOI 10.1002/jps.2600791102
   GUPTA PK, 1990, J MICROENCAPSUL, V7, P85, DOI 10.3109/02652049009028426
   Hafeli UO, 2001, MICROSPHERES MICROCA, V3, P559
   Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749
   Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008
   Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1
   Jain TK, 2005, MOL PHARMACEUT, V2, P194, DOI 10.1021/mp0500014
   Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Jordan A, 1996, INT J HYPERTHER, V12, P705, DOI 10.3109/02656739609027678
   JORDAN J, 2005, INT J OBESITY, V29, P1
   Kohler N, 2005, LANGMUIR, V21, P8858, DOI 10.1021/la0503451
   Krotz F, 2003, MOL THER, V7, P700, DOI 10.1016/S1525-0016(03)00065-0
   Kubo T, 2000, INT J ONCOL, V17, P309
   Leakakos T, 2003, CANCER CHEMOTH PHARM, V51, P445, DOI 10.1007/s00280-003-0597-9
   Lekowska-Kochaniak Aneta, 2002, Acta Microbiol Pol, V51, P327
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   LUBBE AS, 2000, RESENT RES DEV CANC, V2, P183
   MCNEIL RG, 1995, IEEE T BIO-MED ENG, V42, P793, DOI 10.1109/10.398640
   Muller RH, 2001, ADV DRUG DELIVER REV, V47, P3, DOI 10.1016/S0169-409X(00)00118-6
   Mykhaylyk O, 2005, J MAGN MAGN MATER, V293, P473, DOI 10.1016/j.jmmm.2005.01.063
   Nakashima Y, 2005, INT J ONCOL, V27, P965
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   OLSVIK O, 1994, CLIN MICROBIOL REV, V7, P43
   Oyewumi MO, 2004, J CONTROL RELEASE, V95, P613, DOI 10.1016/j.jconrel.2004.01.002
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Petri-Fink A, 2005, BIOMATERIALS, V26, P2685, DOI 10.1016/j.biomaterials.2004.07.023
   Plank C, 2003, J LIPOSOME RES, V13, P29, DOI 10.1081/LPR-120017486
   Plank C, 2003, EXPERT OPIN BIOL TH, V3, P745, DOI 10.1517/eobt.3.5.745.21225
   POULIQUEN D, 1989, MAGN RESON IMAGING, V7, P619, DOI 10.1016/0730-725X(89)90530-4
   Rudge S, 2001, J CONTROL RELEASE, V74, P335, DOI 10.1016/S0168-3659(01)00344-3
   Sachdeva M S, 1998, Expert Opin Investig Drugs, V7, P1849, DOI 10.1517/13543784.7.11.1849
   Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7
   Safarikova M, 2001, LETT APPL MICROBIOL, V33, P36, DOI 10.1046/j.1472-765X.2001.00941.x
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schulze K, 2005, J MAGN MAGN MATER, V293, P419, DOI 10.1016/j.jmmm.2005.02.075
   Shinkai M, 2004, ADV BIOCHEM ENG BIOT, V91, P191
   Shinkai M, 2001, JPN J CANCER RES, V92, P1138, DOI 10.1111/j.1349-7006.2001.tb01070.x
   SHINKAI M, 1995, BIOTECHNOL APPL BIOC, V21, P125, DOI 10.1111/j.1470-8744.1995.tb00329.x
   STARK DD, 1988, RADIOLOGY, V168, P297, DOI 10.1148/radiology.168.2.3393649
   Stechell Ch., 1985, J CHEM TECHNOL BIO B, V35, P175
   STORRIE B, 1995, PR MED BIOL, V3, P1
   SUZUKI M, 1996, BRAIN TUMOR PATHOL, V13, P127
   TAUPITZ M, 1993, ACTA RADIOL, V34, P10
   Tiefenauer LX, 1996, MAGN RESON IMAGING, V14, P391, DOI 10.1016/0730-725X(95)02106-4
   TORCHILIN VP, 1995, ADV DRUG DELIVER REV, V16, P141, DOI 10.1016/0169-409X(95)00022-Y
   Torchilin VP., 2000, EUR J PHARM SCI, P81
   TRELEAVEN JG, 1984, LANCET, V70
   Varshney M, 2005, J FOOD PROTECT, V68, P1804, DOI 10.4315/0362-028X-68.9.1804
   Vasir JK, 2005, TECHNOL CANCER RES T, V4, P363, DOI 10.1177/153303460500400405
   Viroonchatapan E, 1998, J DRUG TARGET, V5, P379, DOI 10.3109/10611869808997865
   Viroonchatapan E, 1996, LIFE SCI, V58, P2251, DOI 10.1016/0024-3205(96)00220-2
   Voltairas PA, 2002, J BIOMECH, V35, P813, DOI 10.1016/S0021-9290(02)00034-9
   Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140
   WEISSLEDER R, 1987, AM J ROENTGENOL, V149, P723, DOI 10.2214/ajr.149.4.723
   WEYH T, 2004, IEEE C P NANO, V477
   WIDDER KJ, 1983, EUR J CANCER CLIN ON, V19, P135, DOI 10.1016/0277-5379(83)90408-X
   WIDDER KJ, 1978, P SOC EXP BIOL MED, V158, P141
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Wilson MW, 2004, RADIOLOGY, V230, P287, DOI 10.1148/radiol.2301021493
   WONDERGEM J, 1988, CANCER RES, V48, P440
   Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5
   YOSHIMI A, 2004, TOP MAGN RESON IMAG, V15, P103
NR 99
TC 93
Z9 100
U1 0
U2 33
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD SEP-OCT
PY 2006
VL 6
IS 9-10
BP 2762
EP 2768
DI 10.1166/jnn.2006.464
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 089FO
UT WOS:000240865900013
PM 17048480
DA 2018-10-20
ER

PT J
AU Clode, PL
AF Clode, Peta L.
TI Charge contrast imaging of biomaterials in a variable pressure scanning
   electron microscope
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE biomineralization; variable pressure scanning electron microscopy;
   charge contrast imaging; biological structure; environmental SEM
ID GIBBSITE; SEM
AB Charge contrast imaging (CCI) is a dynamic phenomenon recently reported in insulating and semiconducting materials imaged with low vacuum or variable pressure scanning electron microscopes (SEM). Data presented in this paper illustrates that CCI can also be applied to biominerals and biological soft-tissues and that useful and unique structural information can be obtained from routine samples. Various resin-embedded samples were considered and example images from several different biomaterials are presented. Due to the diverse nature of samples that appear to exhibit charge contrast, this imaging technique has prospective application in a wide range of biological and biomedical research. This work represents the first application of CCI to biomaterials and in particular, highlights a new method for investigating the formation, structure and growth of biominerals. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Western Australia, Ctr Microscopy & Microanal, Crawley, WA 6009, Australia.
RP Clode, PL (reprint author), Univ Western Australia, Ctr Microscopy & Microanal, Crawley, WA 6009, Australia.
EM pclode@cmm.uwa.edu.au
RI Clode, Peta/C-4482-2011
OI Clode, Peta/0000-0002-5188-4737
CR Baroni TC, 2000, MICROSC MICROANAL, V6, P49
   Baroni TC, 2002, SCANNING, V24, P18
   Cazaux J, 2004, MICROSC MICROANAL, V10, P670, DOI 10.1017/S1431927604040619
   Cuthbert SJ, 2005, AM MINERAL, V90, P701, DOI 10.2138/am.2005.1572
   Gauvin R, 2003, SCANNING, V25, P240
   Griffin BJ, 2000, SCANNING, V22, P234
   GRIFFIN BJ, 2005, SCANNING, V17, P58
   Howie A, 2004, MICROSC MICROANAL, V10, P685, DOI 10.1017/S1431927604040747
   Lee AP, 1998, J BIOL INORG CHEM, V3, P614, DOI 10.1007/s007750050274
   MARSHALL AT, 1991, J MICROSC-OXFORD, V162, P341, DOI 10.1111/j.1365-2818.1991.tb03145.x
   Robertson K, 2004, MICROSC MICROANAL, V10, P721, DOI 10.1017/S1431927604040590
   Stokes DJ, 2003, PHILOS T ROY SOC A, V361, P2771, DOI 10.1098/rsta.2003.1279
   Thiel BL, 2004, MICROSC MICROANAL, V10, P711, DOI 10.1017/S14319276040400656
   Toth M, 2002, J APPL PHYS, V91, P4479, DOI 10.1063/1.1448875
   Toth M, 2002, J MICROSC-OXFORD, V205, P86, DOI 10.1046/j.0022-2720.2001.00968.x
   Watt GR, 2000, AM MINERAL, V85, P1784
   Williams SJ, 2004, J MICROSC-OXFORD, V216, P241, DOI 10.1111/j.0022-2720.2004.01417.x
NR 17
TC 6
Z9 7
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD SEP
PY 2006
VL 155
IS 3
BP 505
EP 511
DI 10.1016/j.jsb.2006.04.004
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 093KU
UT WOS:000241168000010
PM 16737830
DA 2018-10-20
ER

PT J
AU Landi, E
   Tampieri, A
   Mattioli-Belmonte, M
   Celotti, G
   Sandri, M
   Gigante, A
   Fava, P
   Biagini, G
AF Landi, Elena
   Tampieri, Anna
   Mattioli-Belmonte, Monica
   Celotti, Giancarlo
   Sandri, Monica
   Gigante, Antonio
   Fava, Paola
   Biagini, Graziella
TI Biomimetic Mg- and Mg,CO3-substituted hydroxyapatites: synthesis
   characterization and in vitro behaviour
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE powders-chemical preparation; biomimetic materials; apatite; biomedical
   applications
ID SURFACE-ROUGHNESS; STEM-CELLS; MAGNESIUM; BONE; DIFFERENTIATION;
   CERAMICS; GROWTH
AB The doping of the apatite with carbonate or/and Mg ions in biologically-like amounts (6 and 1 wt.%, respectively) was performed. Chemicophysical characterizations and cell culture tests were carried out onto the synthetic Mg- and Mg,CO3-substituted (similar to 30-40 nm particle size) powders in comparison with stoichiometric HA (similar to 160 nm particle size) to determine as mesenchymal stem cells (MSCs) can directly use the mineral microenvironment to stimulate their own proliferation and differentiation activities. At the same time the growth of human osteoblast like cells (MG-63) was evaluated to determine the compatibility of the synthetic doped apatites for bone substitution. Cell morphology analysis by SEM as well as MTT and ALP tests were performed.
   The peculiar chemico-physical properties of the doped (Mg- and Mg,CO3-substituted) materials improved the behaviours of MSC and MG-63 cells in term of adhesion, proliferation and metabolic activation compared to stoichiometric HA. (c) 2005 Elsevier Ltd. All rights reserved.
C1 CNR, ISTEC, Inst Sci & Technol Ceram, I-48018 Faenza, RA, Italy.
   Univ Politecn Marche, Ist Morfol Umana Normale, I-60020 Ancona, Italy.
   Univ Politecn Marche, Dipartimento Patol Mol & Terapie Innovat, I-60020 Ancona, Italy.
RP Landi, E (reprint author), CNR, ISTEC, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, RA, Italy.
EM elena@istec.cnr.it
RI Mattioli-Belmonte, Monica/J-5861-2012
OI Landi, Elena/0000-0003-4495-129X; GIGANTE, ANTONIO/0000-0003-0772-563X
CR BARAVELLI S, 1984, J INORG BIOCHEM, V20, P1, DOI 10.1016/0162-0134(84)80001-X
   BIGI A, 1992, CALCIFIED TISSUE INT, V50, P439, DOI 10.1007/BF00296775
   BIGI A, 1993, J INORG BIOCHEM, V49, P69, DOI 10.1016/0162-0134(93)80049-F
   Bigi A, 1996, ACTA CRYSTALLOGR B, V52, P87, DOI 10.1107/S0108768195008615
   BIGI A, 1981, J INORG BIOCHEM, V5, P317
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Correia RN, 1996, J MATER SCI-MATER M, V7, P501, DOI 10.1007/BF00705432
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   Fadeev IV, 2003, INORG MATER+, V39, P947, DOI 10.1023/A:1025509305805
   Fanovich MA, 1999, CERAM INT, V25, P517, DOI 10.1016/S0272-8842(97)00087-4
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Gibson IR, 2002, J MATER SCI-MATER M, V13, P685, DOI 10.1023/A:1015793927364
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Huss R, 2002, BRIT J HAEMATOL, V118, P305, DOI 10.1046/j.1365-2141.2002.03587.x
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Landi E, 2004, BIOMATERIALS, V25, P1763, DOI 10.1016/j.biomaterials.2003.08.026
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LeGeros RZ, 1991, MONOGRAPHS ORAL SCI, V15, P82
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Percival M., 1999, APPL NUTR SCI REP, V5, P1
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   Ryu HS, 2004, BIOMATERIALS, V25, P393, DOI 10.1016/S0142-9612(03)00538-6
   Tampieri A, 2004, KEY ENG MAT, V264-268, P2051, DOI 10.4028/www.scientific.net/KEM.264-268.2051
   TenHuisen KS, 1997, J BIOMED MATER RES, V36, P306, DOI 10.1002/(SICI)1097-4636(19970905)36:3<306::AID-JBM5>3.0.CO;2-I
   Yasukawa A, 1996, J MATER CHEM, V6, P1401, DOI 10.1039/jm9960601401
NR 29
TC 139
Z9 144
U1 0
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD SEP
PY 2006
VL 26
IS 13
BP 2593
EP 2601
DI 10.1016/j.jeurceramsoc.2005.06.040
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 073VL
UT WOS:000239770600021
DA 2018-10-20
ER

PT J
AU Tokarev, VN
AF Tokarev, V. N.
TI Viscous liquid expulsion in nanosecond UV laser ablation: From "clean"
   ablation to nanostructures
SO LASER PHYSICS
LA English
DT Review
ID KRF EXCIMER-LASER; BETA-TITANIUM ALLOYS; SINGLE-PULSE; BIOMEDICAL
   APPLICATIONS; BIOLOGICAL TISSUE; ORGANIC POLYMERS; THIN-FILMS; SURFACE;
   IRRADIATION; METALS
AB This paper reviews recent results on modeling UV nanosecond laser ablation. Particular attention is given to a viscous liquid flow driven by ablation pressure. Based on the analysis of the Navier-Stokes equation, various strongly different manifestations of this phenomenon are explained. These are (i) a "clean" laser ablation, when the laser spot has a clean sharp spot border free of resolidified melt dross; (ii) a new form of material removal in laser ablation, expulsion on a poly(methyl methacrylate) target of long (up to 1 mm) nanofibers with a radius about 150-200 nm to the exterior of the spot under the action of a single pulse of a KrF excimer laser; and (iii) a new method of laser surface nanostructuring, the formation of a surface foam having a structure of micropores interconnected by nanofilaments with diameters of about 100 nm as a result of single-pulse KrF laser ablation of biopolymer films.
C1 Russian Acad Sci, Prokhorov Gen Phys Inst, Ctr Nat Sci, Moscow 119991, Russia.
RP Tokarev, VN (reprint author), Russian Acad Sci, Prokhorov Gen Phys Inst, Ctr Nat Sci, Ul Vavilova 38, Moscow 119991, Russia.
EM vtokarev56@mail.ru
RI Tokarev, Vladimir/I-3144-2018
CR Akhmanov S. A., 1985, Soviet Physics - Uspekhi, V28, P1084, DOI 10.1070/PU1985v028n12ABEH003986
   ALBAGLI D, 1994, OPT LETT, V19, P1684, DOI 10.1364/OL.19.001684
   Anisimov SI, 1995, INSTABILITIES LASER
   ARNOLD J, P ICALEO 1991, P414
   Arutyunyan R. V., 1987, Soviet Physics - Doklady, V32, P76
   Autric M, 1998, P SOC PHOTO-OPT INS, V3574, P415, DOI 10.1117/12.334465
   BATANOV VA, 1973, JETP LETT+, V17, P247
   Bauerle D., 1996, LASER PROCESSING CHE
   Bauerle D., 2000, LASER PROCESSING CHE
   BECK M, 1989, EUR SCI LAS WORKSH M, P201
   BERGER P, 1992, P SOC PHOTO-OPT INS, V1810, P554
   BHATTACHARYA D, 1991, J APPL PHYS, V70, P5433, DOI 10.1063/1.350201
   BRANDRUP J, 1989, POLYM HADB
   BREUER J, 1994, P SOC PHOTO-OPT INS, V2207, P534
   Bruchon J., 2003, MEC IND, V4, P331
   CHAN CL, 1987, J APPL PHYS, V62, P4579, DOI 10.1063/1.339053
   Chen L. C., 1994, PULSED LASER DEPOSIT, P167
   Chivel' Yu. A., 1991, Soviet Journal of Quantum Electronics, V21, P1104, DOI 10.1070/QE1991v021n10ABEH004296
   CORFE AG, 1998, HDB EUROLASER ACAD, V2, P523
   DINGUS RS, 1991, P SOC PHOTO-OPT INS, V1427, P45, DOI 10.1117/12.44088
   DULEY WW, 1993, P MAT RES SOC S, V285, P145
   DYER PE, 1986, APPL PHYS LETT, V48, P445, DOI 10.1063/1.96526
   DYER PE, 1996, J PHYS D, V29, P2555
   Emel'yanov VI, 2003, MICROELECTRON ENG, V69, P435, DOI 10.1016/S0167-9317(03)00332-0
   FOLKES JA, P ICALEO 1991, P402
   Funada T, 2003, J NON-NEWTON FLUID, V111, P87, DOI 10.1016/S0377-0257(03)00013-2
   GEOHEGAN D, 1994, NATO ASI SERIES E, V256, P165
   Goncharov V. K., 1988, Soviet Journal of Quantum Electronics, V18, P1619, DOI 10.1070/QE1988v018n12ABEH012777
   Guillemot F, 2004, APPL PHYS A-MATER, V79, P811, DOI 10.1007/s00339-004-2688-9
   Guillemot F, 2003, APPL PHYS A-MATER, V77, P899, DOI 10.1007/s00339-003-2162-0
   HARE DE, 1995, J APPL PHYS, V77, P5950, DOI 10.1063/1.359177
   HIRAOKA H, 1991, MICRO ENGN, V13, P429, DOI 10.1016/0167-9317(91)90126-X
   HUGEL H, 1992, STRAHLWERKZEUG LASER
   Itina TE, 1997, J CHEM PHYS, V106, P8905, DOI 10.1063/1.473948
   ITINA TE, 1995, P 11 M MATH MOD MAT
   KAPLAN AFH, 1998, HDB EUROLASER ACAD, V2, P473
   Karabutov AA, 1996, APPL PHYS B-LASERS O, V63, P545
   KELLY R, 1985, NUCL INSTRUM METH B, V9, P329, DOI 10.1016/0168-583X(85)90760-8
   KELLY R, 1985, NUCL INSTRUM METH B, V7-8, P755, DOI 10.1016/0168-583X(85)90464-1
   KELVIN, 1898, PHILOS MAG, V24, P503
   KITAI MS, 1990, MAKROMOL CHEM-M SYMP, V37, P257, DOI 10.1002/masy.19900370122
   KLEMENS PG, 1976, J APPL PHYS, V47, P2165, DOI 10.1063/1.322866
   KONDRATYEV VN, 1972, ZH PRIKL MEKH TEKH, V5, P49
   KONOV VI, 1993, SPIE, V1882, P396
   Kudryashov SI, 2004, J APPL PHYS, V95, P5820, DOI 10.1063/1.1697620
   LANDAU LD, 1974, FLUID MECH, V6
   Lazare S, 1996, APPL OPTICS, V35, P4471, DOI 10.1364/AO.35.004471
   Lazare S, 2005, APPL PHYS A-MATER, V81, P465, DOI 10.1007/s00339-005-3260-y
   LAZARE S, 1988, J APPL PHYS, V63, P2110, DOI 10.1063/1.341091
   LAZARE S, 2006, RECENT ADV LASER PRO, pCH5
   LEVCHENKO EB, 1982, ZH PRIKL MECH TECHN, V6, P144
   LUKYANCHUK B, 1993, APPL PHYS A-MATER, V57, P367, DOI 10.1007/BF00332291
   Mahapatro A, 1998, CELL POLYM, V17, P252
   Marine W, 2000, APPL SURF SCI, V154, P345, DOI 10.1016/S0169-4332(99)00450-X
   MOMMA C, 1996, P 6 EUR C LAS TREATM, V2, P759
   MONTAGNE JE, 1993, APPL SURF SCI, V69, P108, DOI 10.1016/0169-4332(93)90490-3
   ORAEVSKY AA, 1995, J APPL PHYS, V78, P1281, DOI 10.1063/1.360370
   Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c
   PEDRAZA AJ, 1992, METALL TRANS A, V23, P1095, DOI 10.1007/BF02665041
   PETIT GH, 1993, APPL PHYS A, V56, P51
   PHIPPS CR, 1988, J APPL PHYS, V64, P1083, DOI 10.1063/1.341867
   Prokhorov A. M., 1990, LASER HEATING METALS
   Rode AV, 2000, APPL PHYS A-MATER, V70, P135, DOI 10.1007/s003390050025
   SAUERBREY R, 1989, APPL PHYS LETT, V55, P421, DOI 10.1063/1.101884
   SCHUBERT E, 1993, LASER ENG, V2, P111
   Schuocker D., 1983, P SOC PHOTO-OPT INS, V455, P88
   Seifert N, 1996, APPL SURF SCI, V103, P63, DOI 10.1016/0169-4332(96)00469-2
   SOWADA U, 1989, LASER OPTOELEKTRONIK, V21, P107
   SRINIVASAN R, 1986, SCIENCE, V234, P559, DOI 10.1126/science.3764428
   SRINIVASAN R, 1986, MACROMOLECULES, V19, P917
   Tokarev VN, 2004, APPL PHYS A-MATER, V79, P717, DOI 10.1007/s00339-004-2693-z
   Tokarev VN, 1999, J PHYS D APPL PHYS, V32, P1526, DOI 10.1088/0022-3727/32/13/314
   TOKAREV VN, 1994, J APPL PHYS, V76, P800, DOI 10.1063/1.357752
   Tokarev VN, 1998, LASER ENG, V7, P295
   TOKAREV VN, 1995, J APPL PHYS, V78, P1241, DOI 10.1063/1.360365
   TOKAREV VN, 1995, J APPL PHYS, V77, P4714, DOI 10.1063/1.359440
   TOKAREV VN, 1995, P 11 M MATH MOD MAT
   TOKAREV VN, 1991, SOV J QUANTUM ELECTR, V21, P442
   TOKAREV VN, 1992, P LAS ADV MAT PROC C, V2, P1067
   URSU I, 1985, J APPL PHYS, V58, P3909, DOI 10.1063/1.335611
   VARGA T, 1998, HDB EUROLASER ACAD, V2, P103
   VESELOVSKIY IA, 1985, 277 IOFAN
   VONALLMEN M, 1976, J APPL PHYS, V47, P5460, DOI 10.1063/1.322578
   WAGNER NJ, 1992, PHYS REV A, V45, P8457, DOI 10.1103/PhysRevA.45.8457
   Weaver I, 1996, APPL SURF SCI, V96-8, P663, DOI 10.1016/0169-4332(95)00594-3
   WEHNER M, 1993, WERKSTOFFBEARBEITUNG, P180
   Weisbuch F, 2004, THIN SOLID FILMS, V453, P394, DOI 10.1016/j.tsf.2003.11.182
   Weisbuch F, 2003, APPL PHYS A-MATER, V76, P613, DOI 10.1007/s00339-002-2050-z
   Weisbuch F, 2002, APPL SURF SCI, V186, P95, DOI 10.1016/S0169-4332(01)00595-5
   Weisbuch F, 2002, APPL PHYS A-MATER, V75, P677, DOI 10.1007/s00339-002-1454-0
   Zhigilei LV, 2000, J APPL PHYS, V88, P1281, DOI 10.1063/1.373816
   ZNOTINS TA, 1987, LASER FOCUS WORLD, V23, P54
   ZWEIG AD, 1991, J APPL PHYS, V70, P1684, DOI 10.1063/1.349537
NR 93
TC 11
Z9 11
U1 2
U2 17
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1054-660X
J9 LASER PHYS
JI Laser Phys.
PD SEP
PY 2006
VL 16
IS 9
BP 1291
EP 1307
DI 10.1134/S1054660X06090027
PG 17
WC Optics; Physics, Applied
SC Optics; Physics
GA 131YC
UT WOS:000243907600002
DA 2018-10-20
ER

PT J
AU Oki, A
   Qiu, XD
   Alawode, O
   Foley, B
AF Oki, Aderemi
   Qiu, Xiangdong
   Alawode, Olajide
   Foley, Bridget
TI Synthesis of organic-inorganic hybrid composite and its thermal
   conversion to porous bioactive glass monolith
SO MATERIALS LETTERS
LA English
DT Article
DE composite materials; glass; polymers; biomedical applications; sol-gel
   preparation
ID SCAFFOLDS
AB We report the synthesis and bioactivity studies of 3-dimensional macro-porous material produced by thermal treatment of organic-inorganic hybrid composite. This is prepared by sol-gel processing of co-poly(methylmethacrylate (MMA)-vinyltriethoxysilane (VTS)) with tetraethoxysilane (TEOS), calcium nitrate and zinc nitrate, ([CH2C(CH3)(CO2CH3)](0.8n)-[CH2-CH(Si(OEt)(3)](0.2n)-SiO2-CaO-ZnO) (1). Thermal treatment of this polymer at 600 degrees C yielded macro-porous bioglass monolith, with pore size distribution between 1 and 5 mu m and showed excellent bone bonding ability in simulated body fluid. The ratio of VTS:MMA in the organic polymer can easily be controlled. Since the VTS is the bonding agent, the amount of VTS in the co-polymer can be utilized to increase or decrease the porosity of the hybrid composite. This may be a convenient approach for preparation of bioglass scaffolds especially in tissue engineering of bone. (c) 2006 Elsevier B.V. All rights reserved.
C1 Prairie View A&M Univ, Dept Chem, Prairie View, TX 77446 USA.
RP Oki, A (reprint author), Prairie View A&M Univ, Dept Chem, Prairie View, TX 77446 USA.
EM Aroki@pvamu.edu
CR BUCK BE, 1989, CLIN ORTHOP RELAT R, P129
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEPPENSTALL RB, 1980, BONE GRAFTING FRACTU, P97
   KIM SS, 2006, POLY LACTIDE COGLYCO, V27, P1399
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Laurencin C. T., 1999, CURR OPIN ORTHOP, V10, P445, DOI DOI 10.1097/00001433-199912000-00005
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   Li N, 2005, CHINESE J INORG CHEM, V21, P95
   Li N, 2004, MATER LETT, V58, P2747, DOI 10.1016/j.matlet.2004.03.049
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Wei Y, 1998, MAT SCI ENG C-BIO S, V6, P91, DOI 10.1016/S0928-4931(98)00041-1
   WEI Y, 1994, ADV MATER, V6, P372, DOI 10.1002/adma.19940060505
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 16
TC 21
Z9 21
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP
PY 2006
VL 60
IS 21-22
BP 2751
EP 2755
DI 10.1016/j.matlet.2006.01.084
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 066TP
UT WOS:000239253300047
DA 2018-10-20
ER

PT J
AU Fuseya, M
   Nakahata, T
   Hyun, SK
   Fujimoto, S
   Nakajima, H
AF Fuseya, Minoru
   Nakahata, Takuji
   Hyun, Soong-Keun
   Fujimoto, Shinji
   Nakajima, Hideo
TI Electrochemical behaviour of lotus-type porous SUS304L and SUS316L
   stainless steels
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Porous Metals and Metal Foaming
   Technology (MetFoam 2005)
CY SEP 21-23, 2005
CL Kyoto, JAPAN
DE corrosion; polarization curve; porous metal; stainless steel
ID ZONE-MELTING TECHNIQUE; UNIDIRECTIONAL SOLIDIFICATION; FABRICATION;
   ATMOSPHERE; HYDROGEN
AB Lotus-type porous metals are expected to be used in various applications such as lightweight structural materials and biomedical materials. Lotus-type porous stainless steel is particularly promising as a structural material because stainless steel has useful properties such as high corrosion resistance, high workability, low cost and so on. However, there is a possibility that dissolved hydrogen or the microstructure of lotus-type porous stainless steel affects its corrosion behaviour. In this study, the electrochemical corrosion behaviour of lotus-type porous SUS304L and SUS316L stainless steels fabricated by the continuous zone melting technique under pressurized hydrogen was investigated using a potentiodynamic polarization in 0.1-kmol/m(3) sulphuric acid solution. The current density of lotus-type porous SUS304L was higher than that of nonporous SUS304L at around -100mV (-100mV peak), while it was similar to that of nonporous stainless steel in the passive and transpassive regions. The specific current peak observed for the porous SUS304L at around -100mV disappears when the pores are filled with epoxy resin or the specimens are dehydrogenated. Thus, it is concluded that the -100mV peak is attributed to the dissolved hydrogen at pore surface. In the case of lotus-type porous SUS316L, corrosion behaviour is similar to that of SUS304L.
C1 Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan.
   Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan.
RP Hyun, SK (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan.
EM hyun23@sanken.osaka-u.ac.jp
OI Fujimoto, Shinji/0000-0002-7787-4190
CR Banhart J, 2002, PHYS TODAY, V55, P37, DOI 10.1063/1.1506749
   HASEGAWA M, 1960, STAINLESS STEEL HDB
   Hyun SK, 2002, MATER TRANS, V43, P526, DOI 10.2320/matertrans.43.526
   Hyun SK, 2003, MAT SCI ENG A-STRUCT, V340, P258, DOI 10.1016/S0921-5093(02)00181-8
   Hyun SK, 2001, MAT SCI ENG A-STRUCT, V299, P241, DOI 10.1016/S0921-5093(00)01402-7
   Ikeda T, 2005, METALL MATER TRANS A, V36A, P77, DOI 10.1007/s11661-005-0140-1
   Ikeda T, 2004, TETSU TO HAGANE, V90, P9, DOI 10.2355/tetsutohagane1955.90.1_9
   Ikeda T, 2002, MATER TRANS, V43, P2678, DOI 10.2320/matertrans.43.2678
   IKEDA T, 2002, J JAPAN FOUND ENG SO, V74, P812
   NAKAJIMA H, 2003, J SOC POWDER TECHNOL, V40, P108
   NAKAYAMA T, 2002, RIKEN REV, V45, P3
   Yamamura S, 2001, MAT SCI ENG A-STRUCT, V318, P137, DOI 10.1016/S0921-5093(01)01263-1
NR 12
TC 2
Z9 2
U1 1
U2 3
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD SEP
PY 2006
VL 47
IS 9
BP 2229
EP 2232
DI 10.2320/matertrans.47.2229
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 103QA
UT WOS:000241900600022
OA Bronze
DA 2018-10-20
ER

PT J
AU Wingren, C
   Borrebaeck, CAK
AF Wingren, Christer
   Borrebaeck, Carl A. K.
TI Antibody microarrays: Current status and key technological advances
SO OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
LA English
DT Review
ID ROLLING-CIRCLE AMPLIFICATION; DNA-DIRECTED IMMOBILIZATION; HUMAN SERUM
   PROTEOME; MASS-SPECTROMETRY; VERSATILE PLATFORM; COMPLEX PROTEOMES;
   SUPPORT MATERIALS; ANTIGEN-DETECTION; PLASMA-PROTEOME; SURFACE
AB Antibody-based microarrays are among the novel classes of rapidly evolving proteomic technologies that holds great promise in biomedicine. Miniaturized microarrays (< 1 cm(2)) can be printed with thousands of individual antibodies carrying the desired specificities, and with biological sample (e.g., an entire proteome) added, virtually any specifically bound analytes can be detected. While consuming only minute amounts (<mu L scale) of reagents, ultra-sensitive assays (zeptomol range) can readily be performed in a highly multiplexed manner. The microarray patterns generated can then be transformed into proteomic maps, or detailed molecular fingerprints, revealing the composition of the proteome. Thus, protein expression profiling and global proteome analysis using this tool will offer new opportunities for drug target and biomarker discovery, disease diagnostics, and insights into disease biology. Adopting the antibody microarray technology platform, several biomedical applications, ranging from focused assays to proteome-scale analysis will be rapidly emerging in the coming years. This review will discuss the current status of the antibody microarray technology focusing on recent technological advances and key issues in the process of evolving the methodology into a high-performing proteomic research tool.
C1 Lund Univ, Dept Immunotechnol, SE-22184 Lund, Sweden.
RP Wingren, C (reprint author), Lund Univ, Dept Immunotechnol, BMC D13, SE-22184 Lund, Sweden.
EM christer.wingren@immun.lth.se
CR Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200
   Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200
   Angenendt P, 2005, PROTEOMICS, V5, P420, DOI 10.1002/pmic.200400955
   Angenendt P, 2004, ANAL CHEM, V76, P2916, DOI 10.1021/ac035357a
   Angenendt P, 2004, ANAL CHEM, V76, P1844, DOI 10.1021/ac035114i
   Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6
   Angenendt P, 2002, ANAL BIOCHEM, V309, P253, DOI 10.1016/S0003-2697(02)00257-9
   Arntz Y, 2003, NANOTECHNOLOGY, V14, P86, DOI 10.1088/0957-4484/14/1/319
   Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102
   BEATOR J, 2002, BIOTECH INT      DEC, P20
   Belov L, 2003, PROTEOMICS, V3, P2147, DOI 10.1002/pmic.200300599
   Belov L, 2001, CANCER RES, V61, P4483
   Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962
   Blank K, 2004, ANAL BIOANAL CHEM, V379, P974, DOI 10.1007/s00216-004-2607-0
   Blank K, 2003, P NATL ACAD SCI USA, V100, P11356, DOI 10.1073/pnas.1934928100
   Bock C, 2004, PROTEOMICS, V4, P609, DOI 10.1002/pmic.200300631
   Borrebaeck CAK, 2001, BIOTECHNIQUES, V30, P1126, DOI 10.2144/01305dd05
   Borrebaeck CAK, 2000, IMMUNOL TODAY, V21, P379, DOI 10.1016/S0167-5699(00)01683-2
   BORREBAECK CAK, 2006, IN PRESS EXP OPIN BI
   Bruckbauer A, 2004, J AM CHEM SOC, V126, P6508, DOI 10.1021/ja0317426
   CHENG MMC, 2005, CURR OPIN CHEM BIOL, V10, P1
   Choi YS, 2005, BIOCHEM BIOPH RES CO, V329, P1315, DOI 10.1016/j.bbrc.2005.01.167
   Dahlin A, 2005, J AM CHEM SOC, V127, P5043, DOI 10.1021/ja043672o
   Delehanty JB, 2004, ANAL CHEM, V76, P7323, DOI 10.1021/ac049259g
   Demers LM, 2002, SCIENCE, V296, P1836, DOI 10.1126/science.1071480
   DEXLIN L, 2006, UNPUB MEMBRANE PROTE
   Dutta P, 2003, ANAL CHEM, V75, P2342, DOI 10.1021/ac034031z
   Ellmark P, 2006, PROTEOMICS, V6, P1791, DOI 10.1002/pmic.200500468
   ELLMARK P, 2006, UNPUB PROTEIN EXPRES
   Espina V, 2004, J IMMUNOL METHODS, V290, P121, DOI 10.1016/j.jim.2004.04.013
   Finnskog D, 2004, J PROTEOME RES, V3, P988, DOI 10.1021/pr0499287
   Finnskog D, 2006, ELECTROPHORESIS, V27, P1093, DOI 10.1002/elps.200500751
   Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473
   Gao WM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-110
   Gavin IM, 2005, BIOTECHNIQUES, V39, P99, DOI 10.2144/05391RR02
   GHATNEKARNILSSO.S, 2006, UNPUB DESIGN ATTOVIA
   Gilbert L, 2004, PROTEOMICS, V4, P1417, DOI 10.1002/pmic.200300736
   Guilleaume B, 2005, PROTEOMICS, V5, P4705, DOI 10.1002/pmic.200401324
   Haab B., 2001, GENOME BIOL, V2
   Haab BB, 2005, PROTEOMICS, V5, P3278, DOI 10.1002/pmic.200401276
   Haab BB, 2003, PROTEOMICS, V3, P2116, DOI 10.1002/pmic.200300595
   Hamelinck D, 2005, MOL CELL PROTEOMICS, V4, P773, DOI 10.1074/mcp.M400180-MCP200
   HANASH S, 2003, NATURE, V13, P226
   He MY, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e73
   Heidari B, 1999, J VAC SCI TECHNOL B, V17, P2961, DOI 10.1116/1.590934
   Hoff JD, 2004, NANO LETT, V4, P853, DOI 10.1021/nl049758x
   Ingvarsson J, 2006, J PROTEOME RES, V5, P170, DOI 10.1021/pr050301d
   INGVARSSON J, 2006, UNPUB DESIGN RECOMBI
   Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563
   JI HF, 2004, EXPERT REV MOL DIAGN, V47, P859
   Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006
   Kingsmore SF, 2003, CURR OPIN BIOTECH, V14, P74, DOI 10.1016/S0958-1669(02)00019-8
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Klenin KV, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1927510
   Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444
   Ko IK, 2005, BIOMATERIALS, V26, P4882, DOI 10.1016/j.biomaterials.2004.11.049
   Ko IK, 2005, BIOMATERIALS, V26, P687, DOI 10.1016/j.biomaterials.2004.03.014
   Kusnezow W, 2006, EXPERT REV MOL DIAGN, V6, P111, DOI 10.1586/14737159.6.1.111
   Kusnezow W, 2003, J MOL RECOGNIT, V16, P165, DOI 10.1002/jmr.625
   KUSNEZOW W, 2002, BIOTECHNIQUES S, V33, P14
   KUSNEZOW W, 2005, PROTEOMICS, V6, P794
   KVEZEVIC V, 2001, PROTEOMICS, V1, P1271
   Larsson C, 2005, ANAL BIOCHEM, V345, P72, DOI 10.1016/j.ab.2005.05.031
   Lian W, 2004, ANAL BIOCHEM, V334, P135, DOI 10.1016/j.ab.2004.08.005
   Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467
   Lueking A, 2005, DRUG DISCOV TODAY, V10, P789, DOI 10.1016/S1359-6446(05)03449-5
   Lynch M, 2004, PROTEOMICS, V4, P1695, DOI 10.1002/pmic.200300701
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 2000, SCIENCE, V289, P1760
   Miller JC, 2003, PROTEOMICS, V3, P56, DOI 10.1002/pmic.200390009
   Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225
   Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306
   Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072
   Olle EW, 2005, MOL CELL PROTEOMICS, V4, P1664, DOI 10.1074/mcp.M500052-MCP200
   Orchekowski R, 2005, CANCER RES, V65, P11193, DOI 10.1158/0008-5472.CAN-05-1436
   Pavlickova P, 2003, BIOTECHNIQUES, V34, P124, DOI 10.2144/03341rr03
   Pavlickova P, 2004, CLIN CHIM ACTA, V343, P17, DOI 10.1016/j.cccn.2004.01.009
   Pawlak M, 2002, PROTEOMICS, V2, P383, DOI 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E
   Peluso P, 2003, ANAL BIOCHEM, V312, P113, DOI 10.1016/S0003-2697(02)00442-6
   Perlee L., 2004, PROTEOME SCI, V2, P1
   PHIZICKY E, 2004, NATURE, V422, P208
   Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449
   POETZ O, 2004, MECH AGEING DEV, V126, P161
   Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639
   Ramachandran N, 2005, FEBS J, V272, P5412, DOI 10.1111/j.1742-4685.2005.04971.x
   Renberg B, 2005, ANAL BIOCHEM, V341, P334, DOI 10.1016/j.ab.2005.03.039
   Ressine A, 2003, ANAL CHEM, V75, P6968, DOI 10.1021/ac034425q
   Ressine R., 2005, NANOBIOTECHNOLOGY, V1, P93
   Rubina A.Y., 2003, BIOTECHNIQUES, V34, P1016
   Rubina A.Y., 2003, BIOTECHNIQUES, V34, P1022
   Rubina AY, 2003, BIOTECHNIQUES, V34, P1008, DOI 10.2144/03345rr01
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Sanchez-Carbayo M, 2006, AM J PATHOL, V168, P93, DOI 10.2353/ajpath.2006.050601
   Schulte L, 2005, EXPERT REV MOL DIAGN, V5, P145, DOI 10.1586/14737159.5.2.145
   Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197
   Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359
   Scrivener E, 2003, PROTEOMICS, V3, P122, DOI 10.1002/pmic.200390020
   Service RF, 2001, SCIENCE, V294, P2080, DOI 10.1126/science.294.5549.2080
   Shen Z, 2005, ANAL CHEM, V77, P797, DOI 10.1021/ac048665w
   Sheridan C, 2005, NAT BIOTECHNOL, V23, P3, DOI 10.1038/nbt0105-3
   Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458
   Song SP, 2004, ANAL CHIM ACTA, V510, P147, DOI 10.1016/j.aca.2004.01.020
   Sreekumar A, 2001, CANCER RES, V61, P7585
   Stamou D, 2003, ANGEW CHEM INT EDIT, V42, P5580, DOI 10.1002/anie.200351866
   Staudt LM, 2002, ANNU REV MED, V53, P303, DOI 10.1146/annurev.med.53.082901.103941
   Steinhauer C, 2005, ANAL BIOCHEM, V341, P204, DOI 10.1016/j.ab.2004.10.036
   STEINHAUER C, 2002, BIOTECHNIQUES, V33, P38
   Stillman BA, 2000, BIOTECHNIQUES, V29, P630, DOI 10.2144/00293pf01
   Svedhem S, 2003, CHEMBIOCHEM, V4, P339, DOI 10.1002/cbic.200390055
   Szodoray P, 2004, SCAND J IMMUNOL, V59, P592, DOI 10.1111/j.0300-9475.2004.01432.x
   Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200
   Tomizaki Kin-ya, 2005, Chembiochem, V6, P782, DOI 10.1002/cbic.200400232
   TOMPSON M, 2005, BIONSENSORS BIOELECT, V20, P1471
   Usui-Aoki K, 2005, PROTEOMICS, V5, P2396, DOI 10.1002/pmic.200401171
   Wacker R, 2004, ANAL BIOCHEM, V330, P281, DOI 10.1016/j.ab.2004.03.017
   Wacker R, 2004, CHEMBIOCHEM, V5, P453, DOI 10.1002/cbic.200300788
   Wang CC, 2002, J PROTEOME RES, V1, P337, DOI 10.1021/pr0255203
   Warren EN, 2004, ANAL CHEM, V76, P4082, DOI 10.1021/ac049880g
   Weeks BL, 2003, SCANNING, V25, P297
   Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856
   Wilson DS, 2003, ANGEW CHEM INT EDIT, V42, P494, DOI 10.1002/anie.200390150
   Wingren C, 2005, PROTEOMICS, V5, P1281, DOI 10.1002/pmic.200401009
   Wingren C, 2003, NAT BIOTECHNOL, V21, P223, DOI 10.1038/nbt0303-223
   Wingren C, 2004, EXPERT REV PROTEOMIC, V1, P355, DOI 10.1586/14789450.1.3.355
   WINGREN C, 2004, PROTEIN MICROARRAYS, P339
   WINGREN C, 2006, SCREENING TRENDS DRU, V2, P13
   WINGREN C, 2006, UNPUB DESIGN RECOMBI
   WINGREN C, 2005, BIOARRAYS BASICS DIA
   Yanagida M, 2002, J CHROMATOGR B, V771, P89, DOI 10.1016/S1570-0232(02)00074-0
   Zhou X, 2004, J TURBUL, V5, DOI 10.1088/1468-5248/5/1/028
   Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511
   Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191
   Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4
NR 133
TC 86
Z9 92
U1 0
U2 9
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1536-2310
J9 OMICS
JI OMICS
PD SEP
PY 2006
VL 10
IS 3
BP 411
EP 427
DI 10.1089/omi.2006.10.411
PG 17
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 100KA
UT WOS:000241666200012
PM 17069517
DA 2018-10-20
ER

PT J
AU Reuter, S
   Wesskamp, B
   Buscher, R
   Fischer, A
   Barden, B
   Loer, F
   Buck, V
AF Reuter, S.
   Wesskamp, B.
   Buescher, R.
   Fischer, A.
   Barden, B.
   Loeer, F.
   Buck, V.
TI Correlation of structural properties of commercial DLC-coatings to their
   tribological performance in biomedical applications
SO WEAR
LA English
DT Article
DE DLC; hip endoprostheses; wear; disc on pin; Raman spectroscopy;
   profilometry
ID RAMAN-SPECTROSCOPY; CARBON
AB Diamond-like carbon (DLC) films are used increasingly for coating of hip endoprostheses. The term DLC describes not a single material, but a class of materials, each material showing unique properties. Five commercially available DLC-coatings along with conventional thin films used for coating of implants (TiN and CrN) are tested on their wear behaviour by disc on pin test, as well as on their structural composition by multiwavelength Raman spectroscopy. The wear track is analysed by profilometry and weight measurements. The structural analysis includes an estimation of the H-content and the sp(3)/sp(2)-ratio by Raman spectroscopy. It is shown that the commercial coatings differ significantly from each other not only in their structure, but also in their tribological performance. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Duisburg Essen, Thin Film Technol Grp, FB 7, Essen, Germany.
   Univ Duisburg Essen, Dept Orthopaed Surg, Essen, Germany.
   Univ Duisburg Essen, Mat Technol IPE, Essen, Germany.
RP Reuter, S (reprint author), Univ Duisburg Essen, Thin Film Technol Grp, FB 7, Essen, Germany.
EM Stephan.Reuter@uni-essen.de
RI Reuter, Stephan/D-2890-2014
OI Reuter, Stephan/0000-0002-4858-1081
CR Angus J. C., 1991, Diamond and Related Materials, V1, P61, DOI 10.1016/0925-9635(91)90012-Y
   BUESCHER R, 2004, WEAR, V257, P284
   Buscher R, 2005, J BIOMED MATER RES B, V72B, P206, DOI 10.1002/jbm.b.30132
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Ferrari AC, 2002, DIAM RELAT MATER, V11, P1053, DOI 10.1016/S0925-9635(01)00730-0
   Marchon B, 1997, IEEE T MAGN, V33, P3148, DOI 10.1109/20.617873
NR 6
TC 18
Z9 19
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD AUG 30
PY 2006
VL 261
IS 3-4
BP 419
EP 425
DI 10.1016/j.wear.2005.12.009
PG 7
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 072MU
UT WOS:000239678300021
DA 2018-10-20
ER

PT J
AU Zhang, L
   Furst, EM
   Kiick, KL
AF Zhang, Le
   Furst, Eric M.
   Kiick, Kristi L.
TI Manipulation of hydrogel assembly and growth factor delivery via the use
   of peptide-polysaccharide interactions
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 3rd International Nanomedicine and Drug Delivery Symposium
CY SEP 26-27, 2005
CL Baltimore, MD
DE coiled-coil peptide; polysaccharide; hydrogel assembly; mechanical
   properties; basic fibroblast growth factor
ID HEPARINIZED COLLAGEN MATRICES; GLYCOL) STAR COPOLYMER; LEUCINE-ZIPPER
   PEPTIDE; COILED-COIL PEPTIDE; PLATELET FACTOR 4; CONTROLLED-RELEASE;
   PROTEIN INTERACTIONS; POLY(ETHYLENE GLYCOL); HEPARAN-SULFATE;
   CROSS-LINKING
AB The design of materials in which assembly, mechanical response, and biological properties are controlled by protein-polysaccharide interactions could provide materials that mimic the biological environment and find use in the delivery of growth factors. In the investigations reported here, a heparin-binding, coiled-coil peptide, PF4(ZIP), was employed to mediate the assembly of heparinized polymers. The heparin-binding affinity of this peptide was compared with that of other heparin-binding peptides (HBP) via heparin-sepharose chromatography and surface plasmon resonance (SPR) experiments. Results from these experiments indicate that PF4(ZIP) demonstrates a higher heparin-binding affinity and heparin association rate when compared to the heparin-binding domains of antithrombin III (ATIII) and heparin-interacting protein (HIP). Viscoelastic hydrogels were formed upon the association of PF4(ZIP)-functionalized star poly(ethylene glycol) (PEG-PF4(ZIP)) with low-molecular-weight heparin-functionalized star PEG (PEG-LMWH). The viscoelastic properties of the hydrogels can be altered via variations in the ratio of LMWH to PF4(ZIP). bFGF release from these gels have also been investigated. Comparison of the bFGF release profiles with the hydrogel erosion profiles indicates that bFGF delivery from this class of hydrogels is mainly an erosion-controlled process and the rates of bFGF release can be modulated via choice of HBP or via variations in the mechanical properties of the hydrogels. Manipulation of hydrogel physical properties and erosion profiles will provide novel materials for controlled growth factor delivery and other biomedical applications. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
RP Kiick, KL (reprint author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
EM kiik@UDel.edu
OI Furst, Eric/0000-0002-8849-4484
FU NIBIB NIH HHS [1 R01 EB003172, R01 EB003172, R01 EB003172-01]; NCRR NIH
   HHS [5 P20 RR15588, P20 RR015588-01, P20 RR015588]
CR BOURKE SL, 2003, AAPS PHARMSCI, V5
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Brown CD, 2005, J BIOMAT SCI-POLYM E, V16, P189, DOI 10.1163/1568562053115471
   Butcher DJ, 1997, FEBS LETT, V409, P183, DOI 10.1016/S0014-5793(97)00504-8
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   Chinen N, 2003, J BIOMED MATER RES A, V67A, P61, DOI 10.1002/jbm.a.10061
   Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7
   d'Avignon DA, 1999, BIOPHYS J, V76, P2752
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   DEUEL TF, 1977, P NATL ACAD SCI USA, V74, P2256, DOI 10.1073/pnas.74.6.2256
   DiGabriele AD, 1998, NATURE, V393, P812
   Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116
   Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V346, P252, DOI 10.1006/abbi.1997.0299
   Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147
   Gosal WS, 2002, LANGMUIR, V18, P7174, DOI 10.1021/la025531a
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Holtzer ME, 2001, BIOPHYS J, V80, P939
   Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069
   IBEL K, 1986, BIOCHIM BIOPHYS ACTA, V870, P58, DOI 10.1016/0167-4838(86)90008-7
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Jeon O, 2005, J CONTROL RELEASE, V105, P249, DOI 10.1016/j.jconrel.2005.03.023
   Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776
   Kamei K, 2001, ANAL BIOCHEM, V295, P203, DOI 10.1006/abio.2001.5193
   Knappenberger JA, 2002, J MOL BIOL, V321, P1, DOI 10.1016/S0022-2836(02)00592-2
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lindblad MS, 2005, BIOMACROMOLECULES, V6, P684, DOI 10.1021/bm049515z
   Liu SC, 1997, P NATL ACAD SCI USA, V94, P1739, DOI 10.1073/pnas.94.5.1739
   Loveless DM, 2005, MACROMOLECULES, V38, P10171, DOI 10.1021/ma0518611
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Moffat KL, 2004, J BIOMED MATER RES B, V71B, P181, DOI 10.1002/jbm.b.30070
   Moran LB, 1999, P NATL ACAD SCI USA, V96, P10699, DOI 10.1073/pnas.96.19.10699
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   MULLOY B, 1994, CARBOHYD RES, V255, P1, DOI 10.1016/S0008-6215(00)90968-6
   Nivasu VM, 2004, POLYM ADVAN TECHNOL, V15, P128, DOI 10.1002/pat.415
   Ohta M, 2004, J BIOMED MATER RES A, V71A, P661, DOI 10.1002/jbm.a.30194
   Peppas NA, 2004, EXPERT OPIN BIOL TH, V4, P881, DOI 10.1517/14712598.4.6.881
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   ROGHANI M, 1994, J BIOL CHEM, V269, P3976
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9
   Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sosnick TR, 1996, PROTEINS, V24, P427
   SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
   Yount WC, 2005, J AM CHEM SOC, V127, P14488, DOI 10.1021/ja054298a
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
   ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025
   Zheng YJ, 2002, MACROMOLECULES, V35, P5228, DOI 10.1021/ma012263z
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042
   Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507
NR 69
TC 83
Z9 85
U1 3
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 28
PY 2006
VL 114
IS 2
SI SI
BP 130
EP 142
DI 10.1016/j.jconrel.2006.06.005
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 089BN
UT WOS:000240855000002
PM 16890321
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Son, SJ
   Bai, X
   Nan, A
   Ghandehari, H
   Lee, SB
AF Son, Sang Jun
   Bai, Xia
   Nan, Anjan
   Ghandehari, Hamidreza
   Lee, Sang Bok
TI Template synthesis of multifunctional nanotubes for controlled release
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 3rd International Nanomedicine and Drug Delivery Symposium
CY SEP 26-27, 2005
CL Baltimore, MD
DE nanotube; magnetic nanotube; targeted drug delivery; template synthesis;
   nanomedicine
ID WALLED CARBON NANOTUBES; IN-VIVO; MAGNETIC NANOCRYSTALS; DRUG-DELIVERY;
   SILICA NANOPARTICLES; GENE DELIVERY; LIVE CELLS; CANCER; THERAPY; GOLD
AB In the past few decades, nanoscale materials have been widely used for controlled release applications. Importantly, many researches have focused on multifunctional nanoparticles for targeted delivery of bioactive and imaging agents as therapeutics and diagnostics. Recent advances in nanotechnology have made possible the design and development of tubular nanoscale particles called nanotubes. The tubular shape of such particles is highly attractive since it is possible to differentially functionalize the inner and outer surfaces to facilitate drug loading, biocompatibility and biorecognition. Novel synthetic strategies allow the fabrication of tubular structures with well-defined diameters and lengths. This can have important implications in biodistribution, subcellular trafficking and drug release. In this article the biomedical applications of nanotubes will be discussed with emphasis on the template synthesis of composite nanotubes containing silica and iron oxide that have potential use in drug delivery, magnetic resonance imaging (MRI), and chemical and biochemical separations. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
   Univ Maryland, Ctr Nanomed & Cellular Delivery, Baltimore, MD 21201 USA.
   Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.
RP Lee, SB (reprint author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
EM slee@umd.edu
RI Lee, Sang Bok/B-4421-2009; Son, Sang Jun/E-2714-2012
CR Anzai Yoshimi, 2004, Top Magn Reson Imaging, V15, P103, DOI 10.1097/01.rmr.0000130602.65243.87
   AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   Azamian BR, 2002, J AM CHEM SOC, V124, P12664, DOI 10.1021/ja0272989
   Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Brongersma ML, 2003, NAT MATER, V2, P296, DOI 10.1038/nmat891
   Buehler SS, 2001, ENVIRON SCI TECHNOL, V35, P2417, DOI 10.1021/es001805+
   Chen CC, 2005, ADV MATER, V17, P404, DOI 10.1002/adma.200400966
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Cheon JW, 2004, J AM CHEM SOC, V126, P1950, DOI 10.1021/ja038722o
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   ENZEL P, 1999, J CHEM EDUC, V76, P943
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hou SF, 2005, J AM CHEM SOC, V127, P8586, DOI 10.1021/ja042343t
   Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kovtyukhova NI, 2003, ADV MATER, V15, P780, DOI 10.1002/adma.200304701
   Lal M, 2000, CHEM MATER, V12, P2632, DOI 10.1021/cm000178k
   LEE H, 1988, J PHYS CHEM-US, V92, P2597, DOI 10.1021/j100320a040
   Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Loo C, 2004, TECHNOL CANCER RES T, V3, P33, DOI 10.1177/153303460400300104
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Mitchell DT, 2002, J AM CHEM SOC, V124, P11864, DOI 10.1021/ja027247b
   NAN A, 2006, AM CHEM SOC ANN FALL
   Nikolaev P, 1999, CHEM PHYS LETT, V313, P91, DOI 10.1016/S0009-2614(99)01029-5
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Okamoto K, 2004, NANO LETT, V4, P233, DOI 10.1021/nl034954+
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Park J, 2005, ANGEW CHEM INT EDIT, V44, P2872, DOI 10.1002/anie.200461665
   Roy I, 2003, J AM CHEM SOC, V125, P7860, DOI 10.1021/ja0343095
   Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c
   Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011
   Sharma RK, 2005, J COLLOID INTERF SCI, V284, P358, DOI 10.1016/j.jcis.2004.10.006
   SHIMADA M, 1995, ANTICANCER RES, V15, P109
   Son SJ, 2005, J AM CHEM SOC, V127, P7316, DOI 10.1021/ja0517365
   Song HT, 2005, J AM CHEM SOC, V127, P9992, DOI 10.1021/ja051833y
   Spector MS, 1998, LANGMUIR, V14, P3493, DOI 10.1021/la980086y
   Steinle ED, 2002, ANAL CHEM, V74, P2416, DOI 10.1021/ac020024j
   Sun YG, 2003, ANALYST, V128, P686, DOI 10.1039/b212437h
   Tan WH, 2004, MED RES REV, V24, P621, DOI 10.1002/med.20003
   WEETALL HH, 1970, BIOCHIM BIOPHYS ACTA, V212, P1, DOI 10.1016/0005-2744(70)90171-3
   Won J, 2005, SCIENCE, V309, P121, DOI 10.1126/science.1112869
   Wong SS, 1998, NATURE, V394, P52
   Zhang M, 2002, APPL PHYS LETT, V80, P491, DOI 10.1063/1.1434309
   Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911
NR 59
TC 94
Z9 94
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 28
PY 2006
VL 114
IS 2
SI SI
BP 143
EP 152
DI 10.1016/j.jconrel.2006.06.004
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 089BN
UT WOS:000240855000003
PM 16870299
DA 2018-10-20
ER

PT J
AU Lee, IC
   Young, TH
AF Lee, I-Chi
   Young, Tai-Horng
TI PREPARATION OF PLLA MEMBRANES WITH DIFFERENT MORPHOLOGIES FOR CULTURE OF
   LIGAMENT CELLS
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE poly-L-lactide (PLLA); medial collateral ligament cells (MCLs); collagen
   type I; fibronectin
AB Poly (lactic acid) is a biodegradable biomedical material that has been used for connective tissue reconstruction. In this work, poly-L-lactide (PLLA) membranes with different morphologies were prepared by phase separation method. Otherwise, biomaterials coated with various extracellular matrix (ECM) have been shown to promote cell adhesion, proliferation, and differentiation. In addition, the in vitro interaction of medial collateral ligament cells (MCLs) and PLLA membranes with dense, porous and particulate morphologies and with ECM coating was investigated. It was found that the cell compatibility of three types of PLLA membranes almost the same before coating ECM. The results also revealed that collagen type I could improve ligament cells adhesion and fibronectin could improve ligament cells growth, and this effect was most obvious in particulate membrane. Therefore, because the PLLA materials with particulate structure could adsorb more ECM which in turn influenced the cell adhesion and cell growth. The PLLA membrane with the particulate morphology satisfies the biomaterial requirement necessary for temporary scaffold to transplanted ligament cells and provides a means for the architectural design of more complex tissue-engineered systems.
C1 [Lee, I-Chi; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med & Engn, Taipei 100, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med & Engn, Taipei 100, Taiwan.
EM thyoung@ha.mc.ntu.edu.tw
FU National Taiwan University Hospital; National Science Council of the
   Republic of China
FX The authors thank the National Taiwan University Hospital and the
   National Science Council of the Republic of China for their financial
   support.
CR AMIEL D, 1990, MATRIX, V9, P421, DOI 10.1016/S0934-8832(11)80010-7
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   Carlstedt C. A., 1989, BASIC BIOMECHANICS M, P59
   CONNOR NS, 1983, J CELL SCI, V63, P233
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Goulet F, 1997, PRINCIPLES TISSUE EN, P633
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBLE J, 1995, BIOCHEM J, V311, P917, DOI 10.1042/bj3110917
   JACKSON DW, 1994, ARTHROSCOPY, V10, P442, DOI 10.1016/S0749-8063(05)80197-5
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Liu HC, 2004, BIOMATERIALS, V25, P4047, DOI 10.1016/j.biomaterials.2003.10.098
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   MAKISALO SE, 1989, INJURY, V20, P72, DOI 10.1016/0020-1383(89)90143-5
   Ohya Y, 2003, J BIOMED MATER RES A, V65A, P79, DOI 10.1002/jbm.a.10446
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
NR 15
TC 4
Z9 4
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD AUG 25
PY 2006
VL 18
IS 4
DI 10.4015/S1016237206000294
PG 5
WC Engineering, Biomedical
SC Engineering
GA V98ID
UT WOS:000213392200004
OA Bronze
DA 2018-10-20
ER

PT J
AU Panessa-Warren, BJ
   Warren, JB
   Wong, SS
   Misewich, JA
AF Panessa-Warren, B. J.
   Warren, J. B.
   Wong, S. S.
   Misewich, J. A.
TI Biological cellular response to carbon nanoparticle toxicity
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Article; Proceedings Paper
CT International School and Workshop on Nanoscience and Nanotechnology
CY NOV 14-16, 2005
CL Monte Porzio Catone, ITALY
ID TITANIUM-DIOXIDE; RESEARCH STRATEGIES; PULMONARY TOXICITY; SAFETY
   EVALUATION; OXIDATIVE STRESS; QUANTUM DOTS; NANOMATERIALS; PARTICLES;
   NANOTUBES; CYTOTOXICITY
AB Recent advances in nanotechnology have increased the development and production of many new nanomaterials with unique characteristics for industrial and biomedical uses. The size of these new nanoparticles (< 100 nm) with their high surface area and unusual surface chemistry and reactivity poses unique problems for biological cells and the environment. This paper reviews the current research on the reactivity and interactions of carbon nanoparticles with biological cells in vivo and in vitro, with ultrastructural images demonstrating evidence of human cell cytotoxicity to carbon nanoparticles characteristic of lipid membrane peroxidation, gene down regulation of adhesive proteins, and increased cell death ( necrosis, apoptosis), as well as images of nontoxic carbon nanoparticle interactions with human cells. Although it is imperative that nanomaterials be systematically tested for their biocompatibility and safety for industrial and biomedical use, there are now ways to develop and redesign these materials to be less cytotoxic, and even benign to cell systems. With this new opportunity to utilize the unique properties of nanoparticles for research, industry and medicine, there is a responsibility to test and optimize these new nanomaterials early during the development process, to eliminate or ameliorate identified toxic characteristics.
C1 Brookhaven Natl Lab, Condensed Matter Phys & Mat Div, Upton, NY 11973 USA.
   Brookhaven Natl Lab, Instrumentat Div, Upton, NY 11974 USA.
   SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
RP Panessa-Warren, BJ (reprint author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Div, POB 5000, Upton, NY 11973 USA.
EM bpanessa@bnl.gov; warren@bnl.gov; sswong@bnl.gov; misewich@bnl.gov
CR Baggs RB, 1997, VET PATHOL, V34, P592, DOI 10.1177/030098589703400607
   Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019
   Boland S., 1999, AM J PHYSIOL, V276, P604
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   BOTTINI M, 2004, COMMUNICATION
   COLVIN VL, 2003, NAT BIOTECHNOL, V10, P1166
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Da Ros T, 1999, CHEM COMMUN, P663
   Donaldson K, 2002, INHAL TOXICOL, V14, P5, DOI 10.1080/089583701753338613
   DONALDSON K, 2005, OCCUP ENVIRON MED, V61, P727
   *EUR SCI FDN CHAIR, 2003, LOOK FORW IN NAN
   Goho A., 2004, SCI NEWS, V165, P211
   Hoet P. M., 2004, J NANOBIOTECHNOL, V2, P12, DOI DOI 10.1186/1477-3155-2-12
   Hoet PHM, 2004, NAT BIOTECHNOL, V22, P19, DOI 10.1038/nbt0104-19
   Holsapple MP, 2005, TOXICOL SCI, V88, P12, DOI 10.1093/toxsci/kfi293
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Lademann J, 1999, SKIN PHARMACOL APPL, V12, P247, DOI 10.1159/000066249
   LAM C, 2003, TOXICOL SCI PUBL ONL, V26
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Lovric J, 2005, J MOL MED, V83, P377, DOI 10.1007/s00109-004-0629-x
   Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966
   MATTSON M, 2001, J MOL NEUROSCI, V14, P175
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   MAYNARD AD, 2005, TOXICOLOGIST CD OFFI, V84, P649
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   MONTEIRORIVIERE NA, 2005, TOXICOLOGIST, V84, P2183
   MULLER J, 2005, CARBON, V44, P1048
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   *NIEHS, 2003, 03 NIEHS OPPE
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Oberdorster G, 2002, INHAL TOXICOL, V14, P29, DOI 10.1080/089583701753338622
   Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597
   Oberdorster Gunter, 2005, Part Fibre Toxicol, V2, P8, DOI 10.1186/1743-8977-2-8
   PANESSAWARREN B, 2002, MICROSCOPY MICROA S2, V8, P726
   PANESSAWARREN B, 2003, INFECT IMMUN S2, V9, P1378
   Pflucker F, 2001, SKIN PHARMACOL APPL, V14, P92, DOI 10.1159/000056396
   Robert F., 2003, SCIENCE, V300, P243
   Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027
   Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586
   Schvedova A., 2003, J TOXICOL ENV HEAL A, V66, P1909
   SCHVEDOVA A, 2005, AM J PHYSIOL-LUNG C, V289, pL698
   Shiohara A, 2004, MICROBIOL IMMUNOL, V48, P669, DOI 10.1111/j.1348-0421.2004.tb03478.x
   TAKACS J, 2004, MICROSC MICROANAL, V10, P1530
   Thomas K, 2005, TOXICOL SCI, V87, P316, DOI 10.1093/toxsci/kfi270
   Tinkle SS, 2003, ENVIRON HEALTH PERSP, V111, P1202, DOI 10.1289/ehp.5999
   TRAN C, 2000, INHAL TOXICOL, V112, P1113
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Yamakoshi YN, 1996, J ORG CHEM, V61, P7236, DOI 10.1021/jo961210q
   2004, BUCKYBALLS PHARM
NR 49
TC 65
Z9 67
U1 1
U2 20
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD AUG 23
PY 2006
VL 18
IS 33
SI SI
BP S2185
EP S2201
DI 10.1088/0953-8984/18/33/S34
PG 17
WC Physics, Condensed Matter
SC Physics
GA 070XD
UT WOS:000239558800036
DA 2018-10-20
ER

PT J
AU Deshpande, K
   Dave, BC
   Gebert, MS
AF Deshpande, Kiranmayi
   Dave, Bakul C.
   Gebert, Mark S.
TI Controlled dissolution of organosilica sol-gels as a means for
   water-regulated release/delivery of actives in fabric care applications
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID CONTROLLED-RELEASE; GAMMA-AMINOPROPYLTRIETHOXYSILANE; BIOMEDICAL
   APPLICATIONS; DETERGENT FORMULATIONS; SILICA; PROTEINS; STABILITY;
   HYDROGELS; ENCAPSULATION; MICROSPHERES
AB Organosilica sol-gels functionalized with amino groups are used for the controlled release of encapsulated molecules including biomolecules. These gels prepared by hydrolysis of aminosilane precursors are characterized by water-induced changes in network formation and dissolution and as a result can be used as controlled release matrixes on the basis of the water content of the medium. The gels were initially evaluated for release of simple organic dyes such as Congo red as a result of the water-induced dissolution of gels. These gels can also be used as a means for controlled release of encapsulated entities including enzymes such as proteases that are used in fabric care applications. The rapid dissolution of these gels when placed in water-rich media provides an effective strategy for release and/or delivery of actives with potential utility in fabric care applications. The encapsulated enzymes are able to retain their activity and remain stable for extended periods. The gels were characterized by FTIR spectroscopy, which indicates the formation of a loosely held network of hydrogen-bonded particles in these gels. The results indicate potential utility of these materials as versatile delivery matrixes where the release of actives can be initiated by facile water-induced dissolution of these organosilica sol-gels.
C1 So Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA.
   Genencor Int, Palo Alto, CA 94304 USA.
RP Dave, BC (reprint author), So Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA.
EM dave@chem.siu.edu
CR AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BANAKER UV, 1994, ADV CONTROLLED DELIV, P132
   Becker T, 1997, ENZYMES DETERGENCY, P299
   Besanger TR, 2004, ANAL CHEM, V76, P6470, DOI 10.1021/ac0488210
   Bhatia RB, 2000, CHEM MATER, V12, P2434, DOI 10.1021/cm000260f
   BOERIO FJ, 1978, J APPL POLYM SCI, V22, P203, DOI 10.1002/app.1978.070220114
   Chen Q, 1998, J AM CHEM SOC, V120, P4582, DOI 10.1021/ja971750k
   CHIANG CH, 1980, J COLLOID INTERF SCI, V74, P396, DOI 10.1016/0021-9797(80)90209-X
   CHMEL A, 1990, J NON-CRYST SOLIDS, V122, P285, DOI 10.1016/0022-3093(90)90993-V
   Cleary J, 2003, LANGMUIR, V19, P9162, DOI 10.1021/la034822w
   DAKHIL S, 1982, CANCER, V50, P631, DOI 10.1002/1097-0142(19820815)50:4<631::AID-CNCR2820500403>3.0.CO;2-M
   Dave B. C., 1998, IMMOBILIZED BIOMOLEC, P113
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   DEGALDO M, 2002, BIOMACROMOLECULES, V3, P262
   ESTELL DA, 1993, J BIOTECHNOL, V28, P25, DOI 10.1016/0168-1656(93)90122-4
   FLANDROY P, 1990, NEURORADIOLOGY, V32, P311, DOI 10.1007/BF00593051
   Flora KK, 2001, CHEM MATER, V13, P4170, DOI [10.1021/cm010155l, 10.1021/cm0101551]
   Galante YA, 2003, CURR ORG CHEM, V7, P1399, DOI 10.2174/1385272033486468
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P469, DOI 10.1016/S0167-7799(00)01493-1
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   GUPTA PK, 1990, J PHARM SCI, V79, P949, DOI 10.1002/jps.2600791102
   Heller J, 1998, J AM CHEM SOC, V120, P4586, DOI 10.1021/ja973911q
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Iler R. K., 1979, CHEM SILICA
   Jameela SR, 1997, J BIOMAT SCI-POLYM E, V8, P457, DOI 10.1163/156856297X00380
   Jin W, 2002, ANAL CHIM ACTA, V461, P1, DOI 10.1016/S0003-2670(02)00229-5
   JONES MN, 1992, CHEM SOC REV, V21, P127, DOI 10.1039/cs9922100127
   JORDAN JD, 1995, ANAL CHEM, V67, P2436, DOI 10.1021/ac00110a019
   Kashyap N, 2005, CRIT REV THER DRUG, V22, P107, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   Lenza R.F., 2001, MAT RES, V4, P189, DOI DOI 10.1590/S1516-14392001000300008
   Lewis DH, 1990, BIODEGRADABLE POLYM, V45, P1
   Liu NG, 2003, CHEM COMMUN, P1146, DOI 10.1039/b301910a
   Malmos H, 1990, CHEM IND, V6, P183
   MARKOVICH RJ, 1991, ANAL CHEM, V63, P1851, DOI 10.1021/ac00017a034
   MAULDING H V, 1987, Journal of Controlled Release, V6, P167, DOI 10.1016/0168-3659(87)90074-5
   MURAMATSU H, 1987, ANAL CHEM, V59, P2760, DOI 10.1021/ac00150a007
   NARANG U, 1994, CHEM MATER, V6, P1596, DOI 10.1021/cm00046a004
   Oh SJ, 2002, LANGMUIR, V18, P1764, DOI 10.1021/la0113522
   ORCEL G, 1986, J NON-CRYST SOLIDS, V88, P114, DOI 10.1016/S0022-3093(86)80092-8
   Plueddemann EP, 1982, SILANE COUPLING AGEN
   Rao MS, 2003, J AM CHEM SOC, V125, P11826, DOI 10.1021/ja0352348
   Rao MS, 1998, J AM CHEM SOC, V120, P13270, DOI 10.1021/ja982468w
   Rao MS, 2003, J SOL-GEL SCI TECHN, V26, P553, DOI 10.1023/A:1020763719171
   REEZE MT, 1996, BIOTECHNOL BIOENG, V49, P527
   Robinson DN, 2002, MACROMOLECULES, V35, P3668, DOI 10.1021/ma011525u
   Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6
   Shabat D, 1997, CHEM MATER, V9, P2258, DOI 10.1021/cm970193y
   Stoner MR, 2004, ENZYME MICROB TECH, V34, P114, DOI 10.1016/j.enzmictec.2003.09.008
   Sui XH, 2005, CHEM MATER, V17, P1174, DOI 10.1021/cm048166c
   Suratwala T, 1998, J SOL-GEL SCI TECHN, V13, P553, DOI 10.1023/A:1008674723646
   Tang YQ, 2003, BIOMACROMOLECULES, V4, P1636, DOI 10.1021/bm030026t
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Viart N, 1997, J SOL-GEL SCI TECHN, V8, P183, DOI 10.1023/A:1026425304873
   VONDEROSTEN C, 1993, J BIOTECHNOL, V28, P55, DOI 10.1016/0168-1656(93)90125-7
   Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137
NR 58
TC 5
Z9 5
U1 0
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD AUG 22
PY 2006
VL 18
IS 17
BP 4055
EP 4064
DI 10.1021/cm060588u
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 073QS
UT WOS:000239758300020
DA 2018-10-20
ER

PT J
AU Sarra-Bournet, C
   Turgeon, S
   Mantovani, D
   Laroche, G
AF Sarra-Bournet, C.
   Turgeon, S.
   Mantovani, D.
   Laroche, G.
TI A study of atmospheric pressure plasma discharges for surface
   functionalization of PTFE used in biomedical applications
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article
ID DIELECTRIC BARRIER DISCHARGE; GLOW-DISCHARGE; CHEMICAL DERIVATIZATION;
   TREATED POLYPROPYLENE; NITROGEN; POLYETHYLENE; CHEMISTRY; AMMONIA;
   PHYSICS; CORONA
AB Plasma polymer surface modification is widely used in the biomedical field to tailor the surface properties of materials to improve their biocompatibility. Most of these treatments are performed using low pressure plasma systems but recently, filamentary dielectric barrier discharge (FDBD) and atmospheric pressure glow discharge (APGD) have appeared as interesting alternatives. The aim of this paper is to evaluate the potential of surface modifications realized with FDBD and APGD in different atmospheres (N(2)+ H(2) and N(2)+ NH(3) mixtures) on poly(tetrafluoroethylene) to determine the relative influence of both the discharge regime and the gas nature on the surface transformations. From XPS analysis, it is shown that the discharge regime can have a significant effect on the surface transformation; FDBDs operating in H(2)/N(2) lead to a high concentration of amino-groups with high specificity but also important damaging on the surface. Glow discharges in both H(2)/N(2) and NH(3)/N(2) lead to lower concentrations of amino-groups with lower specificity but lower surface damaging. Therefore, this simple surface treatment seems to be an effective, low cost method for the production of uniform surface modification with amino-groups that can subsequently be used to graft various chemical functionalities used for biomaterial compatibility.
C1 Univ Laval, Dept Min Met & Mat Engn, Surface Engn Lab, Ste Foy, PQ G1K 7P4, Canada.
   St Francis Assisi Hosp, Univ Hosp Res Ctr, Quebec City, PQ G1L 3L5, Canada.
   Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Ste Foy, PQ G1K 7P4, Canada.
RP Sarra-Bournet, C (reprint author), Univ Laval, Dept Min Met & Mat Engn, Surface Engn Lab, Ste Foy, PQ G1K 7P4, Canada.
EM Gaetan.Laroche@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR ANDERSON JM, 1986, NATO ASI SER E, V106, P29
   Arefi-Khonsari F, 1997, NATO ADV SCI I E-APP, V346, P165
   Badey JP, 1996, POLYMER, V37, P1377, DOI 10.1016/0032-3861(96)81135-9
   Beamson G., 1992, HIGH RESOLUTION XPS
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   CROQUESEL E, 2001, 15 INT S PLASM CHEM
   d'Agostino R, 1997, PLASMA PROCESSING PO, V346
   Dorai R, 2003, J PHYS D APPL PHYS, V36, P666, DOI 10.1088/0022-3727/36/6/309
   Dumitrascu N., 2002, Entropie, V38, P168
   ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P309, DOI 10.1109/27.106829
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01
   Gauvreau V, 2004, BIOCONJUGATE CHEM, V15, P1146, DOI 10.1021/bc049858u
   GEGENBACH TR, 1994, J ADHES SCI TECHNOL, V8, P305
   Gerenser L.J., 1994, PLASMA SURFACE MODIF, P43
   Gerenser LJ, 2000, SURF INTERFACE ANAL, V29, P12, DOI 10.1002/(SICI)1096-9918(200001)29:1<12::AID-SIA687>3.3.CO;2-Z
   Gessner C, 2004, THIN SOLID FILMS, V459, P118, DOI 10.1016/j.tsf.2003.12.112
   GHERARDI N, 2003, 16 INT S PLASM CHEM
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Griesser H. J., 1990, Materials Forum, V14, P192
   Guimond S, 2002, PLASMAS POLYM, V7, P71, DOI 10.1023/A:1015274118642
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   Ishikawa S, 2000, SURF COAT TECH, V130, P52, DOI 10.1016/S0257-8972(00)00688-5
   Klages CP, 1999, MATERIALWISS WERKST, V30, P767, DOI 10.1002/(SICI)1521-4052(199912)30:12<767::AID-MAWE767>3.0.CO;2-S
   KLEMBERGSAPIEHA JE, 1991, J VAC SCI TECHNOL A, V9, P2975, DOI 10.1116/1.577158
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385
   Kozlov KV, 2005, J PHYS D APPL PHYS, V38, P518, DOI 10.1088/0022-3727/38/4/003
   Markkula TK, 2002, SURF INTERFACE ANAL, V34, P583, DOI 10.1002/sia.1365
   Massines F, 2005, PLASMA PHYS CONTR F, V47, pB577, DOI 10.1088/0741-3335/47/12B/S42
   Massines F, 1998, J PHYS D APPL PHYS, V31, P3411, DOI 10.1088/0022-3727/31/24/003
   Massines F, 2003, SURF COAT TECH, V174, P8, DOI 10.1016/S0257-8972(03)00540-1
   Massines F., 2001, Plasmas and Polymers, V6, P35, DOI 10.1023/A:1011365306501
   Massines F., 1998, Plasmas and Polymers, V3, P43, DOI 10.1023/A:1022582017499
   Medard N, 2002, LANGMUIR, V18, P2246, DOI 10.1021/la011481i
   Miralai S F, 2000, PLASMAS POLYM, V5, P63
   O'Hare LA, 2002, SURF INTERFACE ANAL, V33, P335, DOI 10.1002/sia.1217
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   OKAZAKI S, 1993, J PHYS D APPL PHYS, V26, P889, DOI 10.1088/0022-3727/26/5/025
   Pringle SD, 1996, SURF INTERFACE ANAL, V24, P821, DOI 10.1002/(SICI)1096-9918(199611)24:12<821::AID-SIA189>3.0.CO;2-B
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   Roth JR, 2005, J PHYS D APPL PHYS, V38, P555, DOI 10.1088/0022-3727/38/4/007
   RYAN ME, 1995, MACROMOLECULES, V28, P1377, DOI 10.1021/ma00109a008
   SARRABOURNET C, 2006, IN PRESS PLASMA PROC
   SEEBOCK R, 2000, PLASMAS POLYM, V5, P103
   Simon C, 2000, J LONG-TERM EFF MED, V10, P127
   Sira M, 2005, J PHYS D APPL PHYS, V38, P621, DOI 10.1088/0022-3727/38/4/015
   STROBEL M, 1989, J ADHES SCI TECHNOL, V3, P321, DOI 10.1163/156856189X00245
   Tanaka K, 2003, INT J ADHES ADHES, V23, P515, DOI 10.1016/S0143-7496(03)00094-0
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
NR 52
TC 70
Z9 76
U1 7
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD AUG 21
PY 2006
VL 39
IS 16
BP 3461
EP 3469
DI 10.1088/0022-3727/39/16/S03
PG 9
WC Physics, Applied
SC Physics
GA 071PI
UT WOS:000239613700004
DA 2018-10-20
ER

PT J
AU Georgiev, G
   Dyankova, K
   Vassileva, E
   Friedrich, K
AF Georgiev, George
   Dyankova, Konstantina
   Vassileva, Elena
   Friedrich, Klaus
TI High synthesis and some mechanical properties of polysulfobetaine -
   Polyacrylamide double networks
SO E-POLYMERS
LA English
DT Article
ID HYDROGELS
AB Double polymer networks (DNs) with poly(N-(3-sulfopropyl)-N-methacroyloxyethyl-N, N- dimethylammonium betaine) component as a high density cross-linking agent were synthesized by thermoinitiated cross-linking polymerization. Good mechanical properties of the produced DNs were established. These, in combination with an excellent biocompatibility of polyzwitterions, open a possibility for wide biomedical applications of these materials. It is also shown that the mechanical properties could be controlled by the factors (cross-linking agent and monomer concentrations, temperature and time for the cross-linking polymerization, order of single network formation) influencing the junction point densities of the two single networks and on the microphase separation taking place during the formation of the second single network. Specific dipole-dipole interaction between polyzwitterion monomer units as a reason for this separation is a distinct peculiarity of poly(N-(3-sulfopropyl)-N-methacroyloxyethyl- N,N-dimethylammoniumbetaine)/ poly( acrylamide) double networks in comparison to poly(2-acrylamido-2-methylpropanesulfonic- acid)/ poly( acrylamide) ones.
C1 Univ Sofia, Fac Chem, Sofia 1164, Bulgaria.
   Univ Kaiserslautern, Inst Composite Mat, D-67663 Kaiserslautern, Germany.
RP Georgiev, G (reprint author), Univ Sofia, Fac Chem, 1 J Bourchier Ave, Sofia 1164, Bulgaria.
EM georgs@chem.uni-sofia.bg; klaus.friedrich@ivw.uni-kl.de
RI Friedrich, Klaus/F-6094-2011; Vassileva, Elena/A-7324-2015
OI Friedrich, Klaus/0000-0001-9236-8694; 
CR Georgiev GS, 2006, BIOMACROMOLECULES, V7, P1329, DOI 10.1021/bm050938q
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   HENDERSON GVS, 1985, J CHEM EDUC, V62, P269, DOI 10.1021/ed062p269
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Lowe AB, 2000, J BIOMED MATER RES, V52, P88, DOI 10.1002/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#
   Mott PH, 2000, MACROMOLECULES, V33, P4132, DOI 10.1021/ma000145q
   SAWYER LC, 1987, POLYM MICROSCOPY, P95
   Schwarz UD, 2003, J COLLOID INTERF SCI, V261, P99, DOI 10.1016/S0021-9797(03)00049-3
   Tamagawa H, 2004, J COLLOID INTERF SCI, V275, P107, DOI 10.1016/j.jcis.2004.01.039
   Tsukeshiba H, 2005, J PHYS CHEM B, V109, P16304, DOI 10.1021/jp052419n
NR 10
TC 1
Z9 1
U1 0
U2 8
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD AUG 20
PY 2006
AR 054
PG 12
WC Polymer Science
SC Polymer Science
GA 074XO
UT WOS:000239845300001
DA 2018-10-20
ER

PT J
AU Tanaka, M
   Nishikawa, K
   Okubo, H
   Kamachi, H
   Kawai, T
   Matsushita, M
   Todo, S
   Shimomura, M
AF Tanaka, Masaru
   Nishikawa, Kazutaka
   Okubo, Hisashi
   Kamachi, Hirofumi
   Kawai, Tomoaki
   Matsushita, Michiaki
   Todo, Satoru
   Shimomura, Masatsugu
TI Control of hepatocyte adhesion and function on self-organized
   honeycomb-patterned polymer film
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Organized Molecular Films
CY JUN 26-30, 2005
CL Sapporo, JAPAN
DE cell adhesion; hepatocyte; self-organization; hepatic function; cell
   surface interaction
ID QUARTZ-CRYSTAL MICROBALANCE; POLY(2-METHOXYETHYL ACRYLATE);
   BLOOD-COMPATIBILITY; PROTEIN ADSORPTION; IR SPECTROSCOPY;
   WATER-STRUCTURE; PMEA SURFACE; BISPHENOL-A; THIN-FILMS; FABRICATION
AB Hepatocytes were cultured on a honeycomb-patterned polymer film (honeycomb film) formed by self-organization in order to investigate the influence of the honeycomb pattern on cell behavior. The changes in cell morphologies and actin filaments were observed by optical, fluorescence, and scanning electron microscopy. Hepatocytes were flattened, and the actin filaments appeared conspicuously in the spreading regions on a flat film. In contrast, the hepatocytes that were cultured on the honeycomb film were observed to form a spherical shape, and the actin filaments were localized inside the edge of the spheroid. The spheroids were observed within several hours after seeding on the honeycomb film; they were attached and the spheroid shape was maintained without any deformation. The spheroids expressed a higher level of liver specific function than the cell monolayers on the flat film. These results suggest that the honeycomb film is a suitable material for tissue engineering scaffolds and biomedical devices. (c) 2005 Elsevier B.V. All rights reserved.
C1 Hokkaido Univ, CRIS, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
   Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan.
   Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0010021, Japan.
   Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.
   Hokkaido Univ, Res Inst Elect Sci, Nanotechnol Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
RP Tanaka, M (reprint author), Hokkaido Univ, CRIS, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
EM tanaka@poly.es.hokudai.ac.jp
RI Shimomura, Masatsugu/E-5091-2010
OI Tanaka, Masaru/0000-0002-1115-2080
CR Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CLARK P, 1993, J CELL SCI, V105, P203
   Fukuhira Y, 2006, BIOMATERIALS, V27, P1797, DOI 10.1016/j.biomaterials.2005.10.019
   Griffith LG, 1997, ANN NY ACAD SCI, V831, P382
   Gutsche AT, 1996, BIOMATERIALS, V17, P387, DOI 10.1016/0142-9612(96)85577-3
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HIROTA E, 2006, J BIOMED MATER RES A, V76, P550
   Ichikawa K, 2001, J POLYM SCI POL PHYS, V39, P2175, DOI 10.1002/polb.1191
   Ide M, 2003, LANGMUIR, V19, P429, DOI 10.1021/1a020617p
   Kam L, 2001, BIOMATERIALS, V22, P1049, DOI 10.1016/S0142-9612(00)00352-5
   Karthaus O, 2000, LANGMUIR, V16, P6071, DOI 10.1021/la0001732
   Kitano H, 2005, LANGMUIR, V21, P11932, DOI 10.1021/la0515571
   Kitano H, 2005, MACROMOL BIOSCI, V5, P314, DOI 10.1002/mabi.200400212
   Kitano H, 2001, J COLLOID INTERF SCI, V242, P133, DOI 10.1006/jcis.2001.7785
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   Li GF, 2004, ANAL CHEM, V76, P788, DOI 10.1021/ac0348874
   MARSH WH, 1965, CLIN CHEM, V11, P624
   Maruyama N, 1998, THIN SOLID FILMS, V327, P854, DOI 10.1016/S0040-6090(98)00777-9
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nemoto J, 2005, BIORESOURCE TECHNOL, V96, P1955, DOI 10.1016/j.biortech.2005.01.034
   Nishikawa T, 2002, LANGMUIR, V18, P5734, DOI 10.1021/la011451f
   Nishimura S, 1997, J AM CHEM SOC, V119, P10555, DOI 10.1021/ja971786c
   Ranucci CS, 2000, BIOMATERIALS, V21, P783, DOI 10.1016/S0142-9612(99)00238-0
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Sato K, 2002, INT J NANOSCI SER, V1, P689, DOI 10.1142/S0219581X02000905
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2004, BIO-MED MATER ENG, V14, P439
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2002, COLLOID SURFACE A, V203, P195, DOI 10.1016/S0927-7757(01)01100-1
   Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3
   TANAKA M, 2000, JPN J ARTIF ORGANS, V9, P209
   TSURUMA A, 2005, J SURF SCI NANOTECH, V3, P159
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Yabu H, 2003, LANGMUIR, V19, P6297, DOI 10.1021/la034454w
   Yabu H, 2005, LANGMUIR, V21, P3235, DOI 10.1021/la050013w
   Ye S, 2003, MACROMOLECULES, V36, P5694, DOI 10.1021/ma026007d
NR 47
TC 56
Z9 59
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD AUG 15
PY 2006
VL 284
SI SI
BP 464
EP 469
DI 10.1016/j.colsurfa.2005.11.098
PG 6
WC Chemistry, Physical
SC Chemistry
GA 060GX
UT WOS:000238791800088
DA 2018-10-20
ER

PT J
AU Sardella, E
   Favia, P
   Gristina, R
   Nardulli, M
   d'Agostino, R
AF Sardella, Eloisa
   Favia, Pietro
   Gristina, Roberto
   Nardulli, Marina
   d'Agostino, Riccardo
TI Plasma-aided micro- and nanopatterning processes for biomedical
   applications
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Review
DE cell patterning; composites; micropatterning; nanostructures
ID CELL-BASED BIOSENSORS; IN-VITRO; SURFACE-PROPERTIES; ACRYLIC-ACID;
   NANOSPHERE LITHOGRAPHY; RADIOFREQUENCY PLASMAS; COLLOIDAL LITHOGRAPHY;
   FLUOROCARBON COATINGS; ENDOTHELIAL-CELLS; POLYMER-FILMS
AB Micro- and nanofabrication methods are essential today in microelectronics, optoelectronics, catalysis, and analytics. Recent advances in biomaterials show that micro- and nanofeatures, either at the surface or embedded in materials, can drive specific responses both in in vivo and in vitro biological systems. With such an approach, scientists can understand better, and possibly exploit, biological responses stimulated by properly designed biomedical surfaces. Because of their versatility, plasma treatment, deposition, and etching processes are often part of procedures optimized to create micro- and nanofeatures of different shape, size, and position, onto and inside materials. Presented here are recent examples of such processes developed in our group for biomedical applications.
C1 Univ Bari, Dept Chem, I-70126 Bari, Italy.
   CNR, Inst Inorgan Methodol & Plasmas Bari, I-70126 Bari, Italy.
   Univ Bari, Plasma Solut Srl, I-70126 Bari, Italy.
RP Sardella, E (reprint author), Univ Bari, Dept Chem, Via Orabona 4, I-70126 Bari, Italy.
EM sardella@chimica.uniba.it
OI SARDELLA, ELOISA/0000-0002-6776-8327; Favia, Pietro/0000-0002-5896-895X
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Agarwal B. D., 1990, ANAL PERFORMANCE FIB
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   [Anonymous], 2005, PURE APPL CHEM, V77
   Arefi-Khonsari F, 2001, SURF COAT TECH, V142, P437, DOI 10.1016/S0257-8972(01)01240-3
   BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BAILEY FE, 1976, POLYETHYLENE OXYDE
   BALAZS DJ, 2005, PLASMA PROCESS POLYM, V2, P351
   Biederman H., 1990, PLASMA MAT INTERACTI, DOI New York
   BIEDERMAN H, 1992, PLASMA POLYM PROCESS, P5
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Bullett NA, 2001, SURF INTERFACE ANAL, V31, P1074, DOI 10.1002/sia.1146
   Burmeister F, 1997, LANGMUIR, V13, P2983, DOI 10.1021/la9621123
   BURRIDGE K, 1996, ANNU REV CELL DEV BI, V12, P3745
   Carotenuto G, 2004, COMPOS PART B-ENG, V35, P385, DOI 10.1016/j.compositesb.2004.02.005
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen XL, 1996, CHEM MATER, V8, P1067, DOI 10.1021/cm9504854
   CHO DL, 1990, J APPL POLYM SCI, V41, P1373, DOI 10.1002/app.1990.070410702
   COBURN JW, 1979, J VAC SCI TECHNOL, V16, P391, DOI 10.1116/1.569958
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   CURTIS A, 1999, BIOCH SOC S, V65, P15
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   DAGOSTINO R, 1991, PLASMA CHEM PLASMA P, V11, P1, DOI 10.1007/BF01447031
   DAGOSTINO R, 1993, HIGH TEMP CHEM P, V2, P287
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Daw R., 1999, PLASMAS POLYM, V4, P113
   DECKMAN HW, 1983, J VAC SCI TECHNOL B, V1, P1109, DOI 10.1116/1.582644
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Dimitrov AS, 1996, LANGMUIR, V12, P1303, DOI 10.1021/la9502251
   DUNN GA, 1991, BIOESSAYS, V13, P541, DOI 10.1002/bies.950131008
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fan LT, 1989, CONTROLLED RELEASE Q
   Favia P, 2003, SURF COAT TECH, V169, P609, DOI 10.1016/S0257-8972(03)00123-3
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   FAVIA P, 2003, SURF COAT TECH, V170, P707
   FAVIA P, 2005, PLASMA PROCESS POLYM, V2, P271
   FAVIA P, 2004, PLASMA POLYM FILMS, P25
   FEWSTER SD, 1994, NANOBIOLOGY, V3, P1255
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FOX CL, 1974, ANTIMICROB AGENTS CH, V5, P582, DOI 10.1128/AAC.5.6.582
   Fracassi F, 1996, THIN SOLID FILMS, V272, P60, DOI 10.1016/0040-6090(95)06971-2
   France RM, 1998, CHEM MATER, V10, P1176, DOI 10.1021/cm970761+
   Gadegaard N, 2004, ADV MATER, V16, P1857, DOI 10.1002/adma.200400408
   Gengenbach T. R., 1997, Plasmas and Polymers, V2, P91, DOI 10.1007/BF02766026
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P271, DOI 10.1002/(SICI)1096-9918(199604)24:4<271::AID-SIA116>3.3.CO;2-A
   GILCHRIST T, 1991, BIOMATERIALS, V12, P76, DOI 10.1016/0142-9612(91)90136-X
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Goessl A, 2001, J BIOMED MATER RES, V57, P15, DOI 10.1002/1097-4636(200110)57:1<15::AID-JBM1136>3.0.CO;2-N
   Goessl A, 2001, J BIOMAT SCI-POLYM E, V12, P721, DOI 10.1163/156856201750411620
   GOLDHABER PAUL, 1961, PROC AMER ASSOC CANCER RES, V3, P228
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   GRISTINA R, 2004, EUR CELLS MATER, V7, P1
   GRISTINA R, 2004, EUR CELLS MAT, V7, P8
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Han LCM, 2000, J VAC SCI TECHNOL B, V18, P799, DOI 10.1116/1.591279
   Hanarp P, 2003, COLLOID SURFACE A, V214, P23, DOI 10.1016/S0927-7757(02)00367-9
   HARRIS JM, 1992, POLYETHYLEN GLICOL
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   HAUERT R, 1997, POLYM PREPR AM CHEM, V38, P994
   HELLER J, 2004, BIOMATER SCI, V7, P628
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HULTEEN JC, 1995, J VAC SCI TECHNOL A, V13, P1553, DOI 10.1116/1.579726
   Hulteen JC, 1999, J PHYS CHEM B, V103, P3854, DOI 10.1021/jp9904771
   JANG P, 1999, CHEM MATER, V11, P2132
   JANSEN JA, 2004, BIOMATER SCI, V2, P218
   Jeon HJ, 2003, BIOMATERIALS, V24, P4921, DOI 10.1016/S0142-9612(03)00415-0
   JOHNSTON EE, 1997, NATO ADV SCI INST E, P346
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kawahara K, 2000, DENT MATER, V16, P452, DOI 10.1016/S0109-5641(00)00050-6
   KAY E, 1980, TOP CURR CHEM, P94
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   KITCHING KJ, 2004, PLASMA POLYM FILMS, V10, P325
   Labelle CB, 1999, J VAC SCI TECHNOL A, V17, P3419, DOI 10.1116/1.582076
   Limb S. J., 1999, Plasmas and Polymers, V4, P21, DOI 10.1023/A:1021899414807
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Mennig M, 1997, J SOL-GEL SCI TECHN, V8, P1035
   Milella A, 2004, PLASMA PROCESS POLYM, V1, P164, DOI 10.1002/ppap.200400021
   Morra M., 2001, WATER BIOMATERIALS S, P307
   MORRIS NS, 1997, BR J UROL, P80
   MOTA RP, 1998, VUOTO 27, V2, P6
   MULLIGAN AM, 2003, BIOMATERIALS, P1797
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   OSTERMANN PAW, 1993, CLIN ORTHOP RELAT R, P295
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   PANCHALINGAM V, 1993, J BIOMAT SCI-POLYM E, V5, P131
   Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697, DOI 10.1114/1.225
   Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ratner B.D., 2001, PLASMAS POLYM, V6, P189
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Rosso F, 2006, J CELL PHYSIOL, V207, P636, DOI 10.1002/jcp.20595
   RUNGBY J, 1987, ARCH TOXICOL, V61, P40, DOI 10.1007/BF00324546
   SALTZMAN WM, 1997, PRINCIPLES TISSUE EN, P225
   Santini JT, 1999, NATURE, V397, P335
   Sardella E, 2005, SURF COAT TECH, V200, P51, DOI 10.1016/j.surfcoat.2005.02.063
   Sardella E, 2004, PLASMA PROCESS POLYM, V1, P63, DOI 10.1002/ppap.200400013
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   SIPEHIA R, 1990, BIOMATER ARTIF CELL, V18, P437, DOI 10.3109/10731199009117319
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Tien J, 1997, LANGMUIR, V13, P5349, DOI 10.1021/la970454i
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   WAHLBERG JE, 1965, ARCH ENVIRON HEALTH, V11, P201, DOI 10.1080/00039896.1965.10664198
   Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   Yasuda H., 1985, PLASMA POLYM
   Zhang X, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P149
   Ziegler C, 2000, FRESEN J ANAL CHEM, V366, P552, DOI 10.1007/s002160051550
   2004, ADV MAT, V16
NR 130
TC 113
Z9 113
U1 5
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD AUG 15
PY 2006
VL 3
IS 6-7
BP 456
EP 469
DI 10.1002/ppap.200600041
PG 14
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 082JG
UT WOS:000240382100006
DA 2018-10-20
ER

PT J
AU Laroussi, M
   Tendero, C
   Lu, X
   Alla, S
   Hynes, WL
AF Laroussi, Mounir
   Tendero, Claire
   Lu, Xinpei
   Alla, Sudhakar
   Hynes, Wayne L.
TI Inactivation of bacteria by the plasma pencil
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE bacteria; cold plasma; plasma processing; plume; radicals; sterilization
ID ATMOSPHERIC-PRESSURE PLASMAS; STERILIZATION; DECONTAMINATION
AB A device capable of generating a relatively long cold plasma plume has recently been developed. The advantages of this device are: plasma controllability and stability, room temperature and atmospheric pressure operation, and low power consumption. These features are what is required from a plasma source to be used reliably in material processing applications, including the biomedical applications. In this communication we describe the device and we present evidence that it can be used successfully to inactivate Escherechia coli in a targeted fashion. More recent experiments have shown that this device inactivates other bacteria also, but these will be reported in the future.
C1 Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.
   Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.
   Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.
EM mlarouss@odu.edu
RI Lu, XinPei/M-5570-2013
OI Lu, XinPei/0000-0003-0676-9585; Hynes, Wayne/0000-0003-3998-7781
CR Birmingham JG, 2000, IEEE T PLASMA SCI, V28, P51, DOI 10.1109/27.842862
   Hermann H.W., 1999, PHYS PLASMAS, V6, P2284
   Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078
   Laroussi M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2045549
   Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863
   LAROUSSI M, 1995, INT J INFRARED MILLI, V16, P2069, DOI 10.1007/BF02073410
   Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Massines F., 1992, Proceedings of the Tenth International Conference on Gas Discharges and Their Applications, P730
   MASUYA G, 1993, J PROPUL POWER, V9, P176, DOI 10.2514/3.23606
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   Scutze A, 1998, IEEE T PLASMA SCI, V26, P1685
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
NR 15
TC 140
Z9 145
U1 1
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD AUG 15
PY 2006
VL 3
IS 6-7
BP 470
EP 473
DI 10.1002/ppap.200600005
PG 4
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 082JG
UT WOS:000240382100007
DA 2018-10-20
ER

PT J
AU Misra, SK
   Valappil, SP
   Roy, I
   Boccaccini, AR
AF Misra, Superb K.
   Valappil, Sabeel P.
   Roy, Ipsita
   Boccaccini, Aldo R.
TI Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue
   engineering applications
SO BIOMACROMOLECULES
LA English
DT Review
ID RECOMBINANT ESCHERICHIA-COLI; IN-VIVO DEGRADATION; POLYHYDROXYBUTYRATE
   COMPOSITE; MECHANICAL-PROPERTIES; BACTERIAL POLYHYDROXYALKANOATES;
   CRYSTALLIZATION KINETICS; HYDROLYTIC DEGRADATION; MEDICAL APPLICATIONS;
   POLY(VINYL ACETATE); BIODEGRADABLE PATCH
AB Polyhydroxyalkanoates are emerging as a class of biodegradable polymers for applications in tissue engineering. Members of the polyhydroxyalkanoates family encompass a wide variety of materials, from hard and brittle materials to soft and elastomeric. Over the years, efforts have been made to extend the group of polyhydroxyalkanoates and to investigate their use in numerous biomedical applications, such as sutures, cardiovascular patches, wound dressings, guided tissue repair/regeneration devices, and tissue engineering scaffolds. Along with the development of polyhydroxyalkanoates, researchers have looked into the possibility of designing composites in combination with inorganic phases to further improve the mechanical properties, rate of degradation, and also impart bioactivity. Poly(3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate), and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) are some of the polymers which have been studied extensively to fabricate composites in combination with hydroxyapatite, bioactive glass, and glass-ceramic fillers or coatings. This paper reviews international research carried out toward development of polyhydroxyalkanoates/inorganic phase composites in terms of systems investigated, microstructures, properties achieved, and applications, with special focus on tissue engineering scaffolds. A comparison between different composite systems developed in the past few years is presented. The paper also addresses the prospect of potential further development of polyhydroxyalkanoates/inorganic phase composites with optimized microstructure and properties for improved tissue engineering scaffolds.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2BP, England.
   Univ Westminster, Dept Mol & Appl Biosci, London W1W 6UW, England.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
EM a.boccaccini@imperial.ac.uk
RI Valappil, Sabeel/A-1460-2009; Boccaccini, Aldo/C-7905-2013
CR An YX, 1997, EUR POLYM J, V33, P1449, DOI 10.1016/S0014-3057(97)00015-3
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Baptist J. N., 1965, Method of making absorbable surgical sutures from poly beta hydroxy acids, Patent No. [US3225766 A, 3225766]
   Baptist J.N., 1962, US Patent, Patent No. [3,044,942, 3044942, 3, 044,942]
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Boccaccini AR, 2003, J BIOMED MATER RES B, V67B, P618, DOI 10.1002/jbm.b.10047
   BOEREE NR, 1993, BIOMATERIALS, V14, P793, DOI 10.1016/0142-9612(93)90046-5
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Byrom D., 1994, PLASTICS MICROBES MI, P5
   Chaput C, 1995, MATER RES SOC SYMP P, V394, P111, DOI 10.1557/PROC-394-111
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOI Y, 2002, BIOPOLYMERS, V4, pCH8
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Ferreira BMP, 2001, MAT RES, V4, P34, DOI DOI 10.1590/S1516-14392001000100008
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   Gassner F, 1996, POLYM INT, V39, P215, DOI 10.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-0
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Gursel I, 2002, J MICROENCAPSUL, V19, P153, DOI 10.1080/02652040110065413
   HAHN SK, 1995, APPL ENVIRON MICROB, V61, P34
   HASIRCI V, 2000, BIOMATERIALS BIOENGI, P141
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Holmes P. A., 1988, DEV CRYSTALLINE POLY, P1
   Iannace S, 2001, POLYMER, V42, P3799, DOI 10.1016/S0032-3861(00)00744-8
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Kai Z, 2003, BIOCH ENG J, V16, P115
   KAWAGUCHI Y, 1990, FEMS MICROBIOL LETT, V79, P151
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KORSATKO W, 1983, PHARM IND, V45, P1004
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V36, P241, DOI 10.1016/0141-3910(92)90062-A
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   Kusaka S, 1997, APPL MICROBIOL BIOT, V47, P140, DOI 10.1007/s002530050902
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Leenstra TS, 1998, J MATER SCI-MATER M, V9, P249, DOI 10.1023/A:1008848509911
   LEMOIGNE M, 1926, B SOC CHIM BIOL, V8, P770
   Li HY, 2005, J CONTROL RELEASE, V107, P463, DOI 10.1016/j.jconrel.2005.05.019
   Li HY, 2005, J BIOMATER APPL, V20, P137, DOI 10.1177/0885328205049472
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lobler M, 2002, J BIOMED MATER RES, V61, P165, DOI 10.1002/jbm.10155
   Luklinska ZB, 2003, J MICROSC-OXFORD, V211, P121, DOI 10.1046/j.1365-2818.2003.01204.x
   Luklinska ZB, 1997, J MATER SCI-MATER M, V8, P379, DOI 10.1023/A:1018589018205
   Madden LA, 2000, POLYMER, V41, P3499, DOI 10.1016/S0032-3861(99)00611-4
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   Martin D. P., 1999, US Patent Appl, Patent No. 359086
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   NOKIKOV LN, 2002, BIOMATERIALS, V23, P3369
   OLSENCLAIRE J, IN PRESS MAT WISS WE
   REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   RIVARD CH, 1996, ANN CHIR, V50, P9
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   Sendil D, 1999, J CONTROL RELEASE, V59, P207, DOI 10.1016/S0168-3659(98)00195-3
   Shepperd JAN, 2005, J BONE JOINT SURG BR, V87B, P1046, DOI 10.1302/0301-620X.87B8.16692
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sodian R, 2000, CIRCULATION, V102, P22
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   TANNER KE, 1990, ADV BIOMAT, V9, P149
   Tesema Y, 2004, J APPL POLYM SCI, V93, P2445, DOI 10.1002/app.20787
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   TORUN KG, 2003, BIOMATERIALS, V24, P4999
   TORUN KG, 2003, BIMATERIALS, V24, P1949
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Unverdorben M, 2002, CARDIOVASC INTER RAD, V25, P127, DOI 10.1007/s00270-001-0118-3
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   WEBB, 1965, Patent No. 8523824
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Williams SF, 2002, BIOPOLYMERS, V4
   WILLIAMSON DH, 1958, J GEN MICROBIOL, V19, P198, DOI 10.1099/00221287-19-1-198
   Wu G, 2005, KEY ENG MATER, V288-289, P87, DOI 10.4028/www.scientific.net/KEM.288-289.87
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   [杨吟野 Yang Yinye], 2002, [生物医学工程学杂志, Journal of Biomedical Engineering], V19, P25
   You JW, 2003, POLYMER, V44, P4355, DOI 10.1016/S0032-3861(03)00348-3
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 96
TC 209
Z9 218
U1 4
U2 74
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG 14
PY 2006
VL 7
IS 8
BP 2249
EP 2258
DI 10.1021/bm060317c
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 073DN
UT WOS:000239723100001
PM 16903667
DA 2018-10-20
ER

PT J
AU Tan, W
   Oldenburg, AL
   Norman, JJ
   Desai, TA
   Boppart, SA
AF Tan, Wei
   Oldenburg, Amy L.
   Norman, James J.
   Desai, Tejal A.
   Boppart, Stephen A.
TI Optical coherence tomography of cell dynamics in three-dimensional
   tissue models
SO OPTICS EXPRESS
LA English
DT Article
ID IN-VIVO; FLUORESCENCE SPECTROSCOPY; MICROSCOPY; SYSTEM; BONE; SKIN; OCT
AB Three-dimensional cell-based tissue models have been increasingly useful in the fields of tissue engineering, drug discovery, and cell biology. While techniques for building these tissue models have been advanced, there have been increasing demands for imaging techniques that are capable of assessing complex dynamic three-dimensional cell behavior in real-time and at larger depths in highly-scattering scaffolds. Understanding these cell behaviors requires advanced imaging tools to progress from characterizing two-dimensional cell cultures to complex, highly-scattering, thick three-dimensional tissue constructs. Optical coherence tomography (OCT) is an emerging biomedical imaging technique that can perform cellular-resolution imaging in situ and in real-time. In this study, we demonstrate that it is possible to use OCT to evaluate dynamic cell behavior and function in a quantitative fashion in four dimensions (three-dimensional space plus time). We investigated and characterized in thick tissue models a variety of cell processes, such as chemotaxis migration, proliferation, de-adhesion, and cell-material interactions. This optical imaging technique was developed and utilized in order to gain new insights into how chemical and/or mechanical microenvironments influence cellular dynamics in multiple dimensions. With deep imaging penetration and increased spatial and temporal resolution in three-dimensional space, OCT will be a useful tool for improving our understanding of complex biological interactions at the cellular level.
C1 Univ Illinois, Dept Elect & Comp Engn, Biophoton Imaging Lab,Dept Bioengn,Dept Internal, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.
   Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Tan, W (reprint author), Univ Illinois, Dept Elect & Comp Engn, Biophoton Imaging Lab,Dept Bioengn,Dept Internal, Beckman Inst Adv Sci & Technol, 1406 W Green St, Urbana, IL 61801 USA.
EM boppart@uiuc.edu
RI Oldenburg, Amy/H-2635-2013; Boppart, Stephen/C-7338-2009
OI Boppart, Stephen/0000-0002-9386-5630
FU NIBIB NIH HHS [1 R01 EB00108]
CR Boppart SA, 1997, P NATL ACAD SCI USA, V94, P4256, DOI 10.1073/pnas.94.9.4256
   Boppart SA, 1996, DEV BIOL, V177, P54, DOI 10.1006/dbio.1996.0144
   Boppart SA, 1998, NAT MED, V4, P861, DOI 10.1038/nm0798-861
   Bouma B.E., 2001, HDB OPTICAL COHERENC
   Breuls RGM, 2003, TISSUE ENG, V9, P269, DOI 10.1089/107632703764664738
   Constantididis I, 2002, ANN NY ACAD SCI, V961, P298, DOI 10.1111/j.1749-6632.2002.tb03106.x
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DIMILLA PA, 1992, AICHE J, V38, P1092, DOI 10.1002/aic.690380712
   Friedrich MJ, 2003, JAMA-J AM MED ASSOC, V290, P1977, DOI 10.1001/jama.290.15.1977
   Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892
   Gareau DS, 2004, J BIOMED OPT, V9, P254, DOI 10.1117/1.1645798
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   L'Heureux N, 1998, FASEB J, V12, P47
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Marks DL, 2002, OPT LETT, V27, P2010, DOI 10.1364/OL.27.002010
   Mason C, 2004, PHYS MED BIOL, V49, P1097, DOI 10.1088/0031-9155/49/7/002
   Masters BR, 1998, ANN NY ACAD SCI, V838, P58, DOI 10.1111/j.1749-6632.1998.tb08187.x
   MICHNA H, 1989, CELL TISSUE RES, V255, P423
   Ouyang HW, 2005, J BIOMED MATER RES B, V75B, P264, DOI 10.1002/jbm.b.30281
   Podoleanu AG, 2000, OPT EXPRESS, V7, P292, DOI 10.1364/OE.7.000292
   Ralston TS, 2006, J OPT SOC AM A, V23, P1027, DOI 10.1364/JOSAA.23.001027
   Schmitt JM, 1999, IEEE J SEL TOP QUANT, V5, P1205, DOI 10.1109/2944.796348
   So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399
   STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463
   Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   Xu XQ, 2003, EUR BIOPHYS J BIOPHY, V32, P355, DOI 10.1007/s00249-003-0285-z
NR 28
TC 59
Z9 62
U1 0
U2 10
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD AUG 7
PY 2006
VL 14
IS 16
BP 7159
EP 7171
DI 10.1364/OE.14.007159
PG 13
WC Optics
SC Optics
GA 075CU
UT WOS:000239861100019
PM 19529086
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Borisov, SM
   Vasylevska, AS
   Krause, C
   Wolfbeis, OS
AF Borisov, Sergey M.
   Vasylevska, Anna S.
   Krause, Christian
   Wolfbeis, Otto S.
TI Composite luminescent material for dual sensing of oxygen and
   temperature
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID PRESSURE-SENSITIVE PAINT; RESPONSE CHARACTERISTICS; OPTICAL SENSORS;
   METAL-COMPLEXES; POLYMER-FILMS; THIN-FILM; LIFETIME; DEPENDENCE;
   BIOSENSORS
AB A novel kind of composite material is presented that contains two indicators incorporated into a single polymer matrix, thus allowing simultaneous determination of oxygen partial pressure and temperature. The temperature-sensitive dye (ruthenium tris-1,10-phenanthroline) was chosen for its highly temperature-dependent luminescence which is the highest among the Run polypyridyl complexes. A fluorinated palladium(II) tetraphenylporphyrin served as the oxygen probe. The indicators were incorporated into either poly(styrene-co-acrylonitrile) microparticles (to sense oxygen) or into poly(acrylonitrile) (for temperature sensing, since this polymer is virtually impermeable to oxygen). The luminescence of both dyes can be separated either spectrally (due to different absorption and emission spectra of the indicators) or via luminescence decay time. The material is suitable for temperature-compensated oxygen sensing, for example, in high-resolution oxygen profiling, and for imaging temperature in the range between 0 and 60 degrees C. This enables one to "see" (rather than to "feel") temperature in this important range. Simultaneous imaging of pressure and temperature also has been achieved. It enables contactless imaging of the two parameters, for example, in wind tunnels. Due to the use of a biocompatible hydrogel matrix, the material conceivably is suited for biomedical applications.
C1 Univ Regensburg, Inst Analyt Chem Chemo & Biosensors, D-93040 Regensburg, Germany.
   Presens GmbH, D-3053 Regensburg, Germany.
RP Wolfbeis, OS (reprint author), Univ Regensburg, Inst Analyt Chem Chemo & Biosensors, D-93040 Regensburg, Germany.
EM Otto.Wolfbeis@chemie.uni-regensburg.de
RI Borisov, Sergey/N-3610-2013
OI Borisov, Sergey/0000-0001-9318-8273
CR Amao Y, 2000, ANAL CHIM ACTA, V421, P167, DOI 10.1016/S0003-2670(00)01048-5
   Amao Y, 2000, ANALYST, V125, P1601, DOI 10.1039/b004065g
   Amao Y, 2000, ANALYST, V125, P871, DOI 10.1039/b000702l
   Amao Y, 2001, J FLUORINE CHEM, V107, P101, DOI 10.1016/S0022-1139(00)00352-3
   Berry MT, 1996, J PHYS CHEM-US, V100, P9216, DOI 10.1021/jp953702x
   Brandrup J., 1999, POLYM HDB
   CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007
   Coyle LM, 1999, SENSOR ACTUAT B-CHEM, V61, P92, DOI 10.1016/S0925-4005(99)00289-0
   Demas JN, 1999, ANAL CHEM, V71, p793A, DOI 10.1021/ac9908546
   Douglas P, 2002, SENSOR ACTUAT B-CHEM, V82, P200, DOI 10.1016/S0925-4005(01)01006-1
   Gouterman M, 2004, MEAS SCI TECHNOL, V15, P1986, DOI 10.1088/0957-0233/15/10/007
   Gouterman M, 1997, J CHEM EDUC, V74, P697, DOI 10.1021/ed074p697
   Hartmann P, 1996, ANAL CHEM, V68, P2615, DOI 10.1021/ac960008k
   Hradil J, 2002, MEAS SCI TECHNOL, V13, P1552, DOI 10.1088/0957-0233/13/10/307
   Jorge PAS, 2004, SENSOR ACTUAT B-CHEM, V103, P290, DOI 10.1016/j.snb.2004.04.086
   Khalil GE, 2004, SENSOR ACTUAT B-CHEM, V97, P13, DOI 10.1016/S0925-4005(03)00484-2
   Khalil GE, 2004, REV SCI INSTRUM, V75, P192, DOI 10.1063/1.1632997
   Klimant I, 1997, SENSOR ACTUAT B-CHEM, V38, P29, DOI 10.1016/S0925-4005(97)80168-2
   Klimant I., 2001, NEW TRENDS FLUORESCE, P257
   Koese M. E., 2005, LANGMUIR, V21, P9121
   Kurner JM, 2001, BIOCONJUGATE CHEM, V12, P883, DOI 10.1021/bc000130x
   Lee SK, 1997, ANAL COMMUN, V34, P185, DOI 10.1039/a701130j
   Liebsch G, 2000, APPL SPECTROSC, V54, P548, DOI 10.1366/0003702001949726
   Liebsch G, 1999, ADV MATER, V11, P1296, DOI 10.1002/(SICI)1521-4095(199910)11:15<1296::AID-ADMA1296>3.3.CO;2-2
   LIPPITSCH ME, 1993, SENSOR ACTUAT B-CHEM, V11, P97, DOI 10.1016/0925-4005(93)85243-4
   Liu TS, 2001, AIAA J, V39, P103, DOI 10.2514/2.1276
   LU X, 2001, NEW TRENDS FLUORESCE, P229
   Mills A, 1997, ANALYST, V122, P63, DOI 10.1039/a606124i
   Mills A, 1997, ANAL CHEM, V69, P4653, DOI 10.1021/ac970430g
   NEURAUTER G, 2000, THESIS U REGENSBURG, P106
   ROSENZWEIG Z, 1995, ANAL CHEM, V67, P2650, DOI 10.1021/ac00111a024
   SACKSTEDER LA, 1993, ANAL CHEM, V65, P3480, DOI 10.1021/ac00071a024
   Schanze KS, 1997, AIAA J, V35, P306, DOI 10.2514/2.92
   SPELLANE PJ, 1980, INORG CHEM, V19, P386, DOI 10.1021/ic50204a021
   Wolfbeis OS, 2004, ANAL CHEM, V76, P3269, DOI 10.1021/ac040049d
   WOLFBEIS OS, 1985, ANAL CHEM, V57, P2556, DOI 10.1021/ac00290a028
   Wolfbeis OS, 2000, BIOSENS BIOELECTRON, V15, P69, DOI 10.1016/S0956-5663(99)00073-1
   WOLFBEIS OS, 1983, ANAL CHEM, V55, P1994
   Yekta A, 1995, CAN J CHEM, V73, P2021, DOI 10.1139/v95-250
   Zelelow B, 2003, SENSOR ACTUAT B-CHEM, V96, P304, DOI 10.1016/S0925-4005(03)00547-1
NR 40
TC 128
Z9 131
U1 2
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 4
PY 2006
VL 16
IS 12
BP 1536
EP 1542
DI 10.1002/adfm.200500778
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 076JE
UT WOS:000239952400002
DA 2018-10-20
ER

PT J
AU Sambhy, V
   MacBride, MM
   Peterson, BR
   Sen, A
AF Sambhy, Varun
   MacBride, Megan M.
   Peterson, Blake R.
   Sen, Ayusman
TI Silver bromide nanoparticle/polymer composites: Dual action tunable
   antimicrobial materials
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Review
ID TRANSFER RADICAL POLYMERIZATION; STAPHYLOCOCCUS-AUREUS ADHESION; CENTRAL
   VENOUS CATHETER; DE-NOVO DESIGN; ANTIBIOTIC-RESISTANCE; BIOFILM
   FORMATION; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITIES; METHACRYLATE
   POLYMERS; BACTERIAL BIOFILMS
AB We present a simple method of fabricating highly potent dual action antibacterial composites consisting of a cationic polymer matrix and embedded silver bromide nanoparticles. A simple and novel technique of on-site precipitation of AgBr was used to synthesize the polymer/nanoparticle composites. The synthesized composites have potent antibacterial activity toward both gram-positive and gram-negative bacteria. The materials form good coatings on surfaces and kill both airborne and waterborne bacteria. Surfaces coated with these composites resist biofilm formation. These composites are different from other silver-containing antibacterial materials both in the ease of synthesis and in the use of a silver salt nanoparticle instead of elemental silver or complex silver compounds. We also demonstrate the ability to tune the release of biocidal Ag(+) ions from these composites by controlling the size of the embedded AgBr nanoparticles. These composites are potentially useful as antimicrobial coatings in a wide variety of biomedical and general use applications.
C1 Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
RP Sen, A (reprint author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
EM asen@psu.edu
RI Sen, Ayusman/A-9406-2009; Peterson, Blake/O-2497-2016
OI Sen, Ayusman/0000-0002-0556-9509; Peterson, Blake/0000-0001-8251-3579
CR Affinito J, 1995, THIN SOLID FILMS, V270, P43, DOI 10.1016/0040-6090(95)06853-8
   Alasino RV, 2005, MACROMOL BIOSCI, V5, P207, DOI 10.1002/mabi.200400168
   Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004
   Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   Aymonier C, 2002, CHEM COMMUN, P3018, DOI 10.1039/b208575e
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Beech IB, 2000, BIOFOULING, V16, P93, DOI 10.1080/08927010009378435
   Brady MJ, 2003, AM J INFECT CONTROL, V31, P208, DOI 10.1067/mic.2003.23
   Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a
   Changez M, 2005, BIOMATERIALS, V26, P2095, DOI 10.1016/j.biomaterials.2004.06.008
   Chauhan BPS, 2005, J AM CHEM SOC, V127, P5790, DOI 10.1021/ja042824c
   Chauhan BPS, 2004, MACROMOLECULES, V37, P5136, DOI 10.1021/ma0496798
   Chauhan BPS, 2004, J AM CHEM SOC, V126, P8493, DOI 10.1021/ja049604j
   Chen YJ, 2003, IND ENG CHEM RES, V42, P280, DOI 10.1021/ie020266+
   Cioffi N, 2005, CHEM MATER, V17, P5255, DOI 10.1021/cm0505244
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dizman B, 2005, BIOMACROMOLECULES, V6, P514, DOI 10.1021/bm049383+
   Dizman B, 2004, J APPL POLYM SCI, V94, P635, DOI 10.1002/app.20872
   Dowling DP, 2003, SURF COAT TECH, V163, P637, DOI 10.1016/S0257-8972(02)00689-8
   Dowling DP, 2001, THIN SOLID FILMS, V398, P602, DOI 10.1016/S0040-6090(01)01326-8
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Gerrard JJ, 2005, SURF COAT INT PT B-C, V88, P83, DOI 10.1007/BF02699538
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Greenberg CB, 2005, THIN SOLID FILMS, V484, P324, DOI 10.1016/j.tsf.2005.03.008
   GUISEPPIELIE A, 1995, LANGMUIR, V11, P1768, DOI 10.1021/la00005a055
   Hachem RY, 2003, BIOMATERIALS, V24, P3619, DOI 10.1016/S0142-9612(03)00185-6
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Heilmann A, 2002, POLYM FILMS EMBEDDED
   Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4
   Ho CH, 2004, ADV MATER, V16, P957, DOI 10.1002/adma.200306253
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hollinger MA, 1996, CRIT REV TOXICOL, V26, P255, DOI 10.3109/10408449609012524
   Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542
   Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1111/j.1574-6968.1999.tb13514.x
   Iconomopoulou SM, 2005, J CONTROL RELEASE, V103, P451, DOI 10.1016/j.jconrel.2004.12.014
   Ignatova M, 2006, LANGMUIR, V22, P255, DOI 10.1021/la051954b
   Ilker MF, 2004, J AM CHEM SOC, V126, P15870, DOI 10.1021/ja045664d
   Ilker MF, 2004, MACROMOLECULES, V37, P694, DOI 10.1021/ma035407d
   Jiang HQ, 2004, J APPL POLYM SCI, V93, P1411, DOI 10.1002/app.20561
   Joly S, 2000, LANGMUIR, V16, P1354, DOI 10.1021/la991089t
   Jones GL, 2006, J ANTIMICROB CHEMOTH, V57, P266, DOI 10.1093/jac/dki447
   Kasuga N. C., 2004, J CHEM SOC DA, V21, P3732
   Kim HJ, 2000, BIOMATERIALS, V21, P131, DOI 10.1016/S0142-9612(99)00140-4
   Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001
   Kohnen W, 2003, BIOMATERIALS, V24, P4865, DOI 10.1016/S0142-9612(03)00379-X
   Kuroda K, 2005, J AM CHEM SOC, V127, P4128, DOI 10.1021/ja044205+
   LAMOTTA EJ, 1982, J ENV ENG DIV-ASCE, V108, P1326
   Landry RM, 2006, MOL MICROBIOL, V59, P142, DOI 10.1111/j.1365-2958.2005.04941.x
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Li GJ, 1998, J APPL POLYM SCI, V67, P1761, DOI 10.1002/(SICI)1097-4628(19980307)67:10<1761::AID-APP9>3.0.CO;2-H
   Lide D. R., 2002, CRC HDB CHEM PHYS
   Lin J, 2003, BIOTECHNOL LETT, V25, P1661, DOI 10.1023/A:1025613814588
   Liu DH, 2001, J AM CHEM SOC, V123, P7553, DOI 10.1021/ja0107475
   Lu Y, 2005, NANO LETT, V5, P5, DOI 10.1021/nl048965u
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   McDonnell AMP, 2005, ADV FUNCT MATER, V15, P336, DOI 10.1002/adfm.200400183
   Meaume S, 2005, J Wound Care, V14, P411
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   Millsap KW, 1997, BIOMATERIALS, V18, P87, DOI 10.1016/S0142-9612(96)00105-6
   Morrier JJ, 1998, DENT MATER, V14, P150, DOI 10.1016/S0109-5641(98)00022-0
   Moskowitz SM, 2005, J ANTIMICROB CHEMOTH, V56, P879, DOI 10.1093/jac/dki338
   Multanen M, 2000, UROL RES, V28, P327, DOI 10.1007/s002400000133
   Multanen M, 2001, UROL RES, V29, P113, DOI 10.1007/s002400000166
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Nablo BJ, 2001, J AM CHEM SOC, V123, P9712, DOI 10.1021/ja0165077
   Nuzzo RG, 2003, NAT MATER, V2, P207, DOI 10.1038/nmat872
   O'Toole GA, 2005, NAT BIOTECHNOL, V23, P1378, DOI 10.1038/ndt1105-1378
   OLOFFS A, 1994, BIOMATERIALS, V15, P753, DOI 10.1016/0142-9612(94)90028-0
   Parikh DV, 2005, TEXT RES J, V75, P134, DOI 10.1177/004051750507500208
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   Porel S, 2005, CHEM MATER, V17, P9, DOI 10.1021/cm0485963
   PRICE WR, 1966, AM J SURG, V112, P674, DOI 10.1016/0002-9610(66)90103-6
   Raad II, 2005, ANTIMICROB AGENTS CH, V49, P5046, DOI 10.1128/AAC.49.12.5046-5050.2005
   Ramage G, 2001, J CLIN MICROBIOL, V39, P3234, DOI 10.1128/JCM.39.9.3234-3240.2001
   Rathore R, 2003, J AM CHEM SOC, V125, P8712, DOI 10.1021/ja035518s
   Robbins ME, 2004, LANGMUIR, V20, P10296, DOI 10.1021/la048368n
   Rosato AE, 2004, AM J INFECT CONTROL, V32, P486, DOI 10.1016/j.ajic.2004.06.002
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   Rupp ME, 2005, ANN INTERN MED, V143, P570, DOI 10.7326/0003-4819-143-8-200510180-00007
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sun YY, 2004, IND ENG CHEM RES, V43, P5015, DOI 10.1021/ie030846m
   TAKAHASHI H, 1987, J PHYS SOC JPN, V56, P3593, DOI 10.1143/JPSJ.56.3593
   Tang HZ, 2005, CHEM COMMUN, P1537, DOI 10.1039/b413679a
   Tashiro T, 2001, MACROMOL MATER ENG, V286, P63
   Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tolker-Nielsen T, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P547
   Tsukada M, 2003, J APPL POLYM SCI, V89, P638, DOI 10.1002/app.11911
   Ueshige M, 1999, J DENT, V27, P517, DOI 10.1016/S0300-5712(99)00009-3
   Wang XS, 2005, J AM CHEM SOC, V127, P8924, DOI 10.1021/ja0511365a
   Weickmann H, 2005, MACROMOL MATER ENG, V290, P875, DOI 10.1002/mame.200500153
   Yoshida K, 1999, J BIOMED MATER RES, V47, P516, DOI 10.1002/(SICI)1097-4636(19991215)47:4<516::AID-JBM7>3.0.CO;2-E
   Zachariadis CP, 2004, EUR J INORG CHEM, V7, P1420
   2003, NCCLS APPROVED STAND
NR 102
TC 444
Z9 453
U1 14
U2 341
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD AUG 2
PY 2006
VL 128
IS 30
BP 9798
EP 9808
AR JA061442Z
DI 10.1021/ja061442z
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 067CH
UT WOS:000239278600057
PM 16866536
DA 2018-10-20
ER

PT J
AU Malek, CGK
AF Malek, Chantal G. Khan
TI Laser processing for bio-microfluidics applications (part I)
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE laser; micromachining; bio-MEMS; mu TAS; microfluidics; polymers
ID EXCIMER-LASER; POLYMER MICROCHANNELS; SURFACE MODIFICATION; BIOMEDICAL
   APPLICATIONS; BIODEGRADABLE POLYMERS; ELECTROOSMOTIC FLOW; FEMTOSECOND
   LASERS; MASS-SPECTROMETRY; ABLATION; FABRICATION
AB This paper reviews applications of laser-based techniques to the fabrication of microfluidic devices for biochips and addresses some of the challenges associated with the manufacture of these devices. Special emphasis is placed on the use of lasers for the rapid prototyping and production of biochips in particular for applications in which silicon is not the preferred material base. Part I of this review addresses applications and devices using UV lasers for laser ablation and surface treatment of microchannels, in particular in polymers.
C1 CNRS, UMR 6174, Dept LPMO, Lab FEMTO ST, F-25044 Besancon, France.
RP Malek, CGK (reprint author), CNRS, UMR 6174, Dept LPMO, Lab FEMTO ST, 32 Ave Observ, F-25044 Besancon, France.
EM chantal.khan-malek@lpmo.edu
CR Aguilar CA, 2005, BIOMATERIALS, V26, P7642, DOI 10.1016/j.biomaterials.2005.04.053
   Andrews JR, 2004, P SOC PHOTO-OPT INS, V5345, P147, DOI 10.1117/12.524547
   Atkin M, 2002, P SOC PHOTO-OPT INS, V4937, P125, DOI 10.1117/12.469052
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Bianchi F, 2001, ANAL CHEM, V73, P3845, DOI 10.1021/ac010262z
   Bremus-Kobberling E, 2003, P SOC PHOTO-OPT INS, V5063, P217, DOI 10.1117/12.541084
   Brokmann U, 2002, MICROSYST TECHNOL, V8, P102, DOI 10.1007/S00542-001-0134-x
   Burt JPH, 2002, P SOC PHOTO-OPT INS, V4637, P305, DOI 10.1117/12.470637
   Chen S, 2003, INT J MATER PROD TEC, V18, P457, DOI 10.1504/IJMPT.2003.002502
   DUNCAN AC, 2000, P 1 INT IEEE EMBS SP, P542
   Gillner A, 2001, P SOC PHOTO-OPT INS, V4274, P411, DOI 10.1117/12.432535
   Gower M, 2000, P SOC PHOTO-OPT INS, V4065, P452, DOI 10.1117/12.407367
   Heckele M, 2004, J MICROMECH MICROENG, V14, pR1, DOI 10.1088/0960-1317/14/3/R01
   HEITZ J, 2005, P SOC PHOTO-OPT INS, V5958, P466
   HELJAVIAN H, 2000, SPIE P, V4088, P319
   Henry AC, 2002, ELECTROPHORESIS, V23, P791, DOI 10.1002/1522-2683(200203)23:5<791::AID-ELPS791>3.0.CO;2-K
   Holm I, 2002, INT FOR LIT, V63, P69
   Johnson TJ, 2001, APPL SURF SCI, V181, P149, DOI 10.1016/S0169-4332(01)00384-1
   Johnson TJ, 2001, ANAL CHEM, V73, P3656, DOI 10.1021/ac010269g
   Kancharla VV, 2002, BIOMED MICRODEVICES, V4, P105, DOI 10.1023/A:1014679013888
   Karnakis DM, 2005, P SOC PHOTO-OPT INS, V5718, P216, DOI 10.1117/12.588194
   Khorasani MT, 2005, APPL SURF SCI, V242, P339, DOI 10.1016/j.apsusc.2004.08.035
   Khorasani MT, 1999, RADIAT PHYS CHEM, V55, P685, DOI 10.1016/S0969-806X(99)00212-1
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   KILLEEN K, 2001, P MUTAS 2001 MONT CA
   Kim DY, 2003, P SOC PHOTO-OPT INS, V5063, P66, DOI 10.1117/12.541064
   Kim J, 2004, P SOC PHOTO-OPT INS, V5339, P1, DOI 10.1117/12.537860
   Kim J, 2003, P SOC PHOTO-OPT INS, V4977, P324, DOI 10.1117/12.479239
   Kim JH, 2003, PROC SPIE, V4982, P73, DOI 10.1117/12.478144
   Lee HJ, 1997, J ELECTROANAL CHEM, V440, P73, DOI 10.1016/S0022-0728(97)00052-1
   LIN Y, 1999, 3 INT C MICR TECHN I, P451
   Lin YH, 1999, P SOC PHOTO-OPT INS, V3877, P28, DOI 10.1117/12.359351
   Martin PM, 1999, P SOC PHOTO-OPT INS, V3680, P826, DOI 10.1117/12.341279
   Matson DW, 1997, P SOC PHOTO-OPT INS, V3223, P253, DOI 10.1117/12.284495
   McNeely MR, 1999, PROC SPIE, V3877, P210, DOI 10.1117/12.359339
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   Niino H, 2004, P SOC PHOTO-OPT INS, V5339, P112, DOI 10.1117/12.529864
   Niino H, 2003, P SOC PHOTO-OPT INS, V5063, P193, DOI 10.1117/12.540486
   Nikumb S, 2005, THIN SOLID FILMS, V477, P216, DOI 10.1016/j.tsf.2004.08.136
   Pethig R, 1998, J MICROMECH MICROENG, V8, P57, DOI 10.1088/0960-1317/8/2/004
   Pfleging W, 2003, P SOC PHOTO-OPT INS, V4977, P346, DOI 10.1117/12.479406
   Pugmire DL, 2002, ANAL CHEM, V74, P871, DOI 10.1021/ac011026r
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Rossier J, 2002, ELECTROPHORESIS, V23, P858, DOI 10.1002/1522-2683(200203)23:6<858::AID-ELPS858>3.0.CO;2-3
   Rossier JS, 1999, LANGMUIR, V15, P5173, DOI 10.1021/la9809877
   Rossier JS, 1999, ANAL CHEM, V71, P4294, DOI 10.1021/ac981382i
   Rossier JS, 2000, LANGMUIR, V16, P8489, DOI 10.1021/la0006667
   Sabbert D, 1999, APPL SURF SCI, V150, P185, DOI 10.1016/S0169-4332(98)00334-1
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   Suriyage NU, 2003, P SOC PHOTO-OPT INS, V5275, P149, DOI 10.1117/12.521576
   Thissen H, 2002, P SOC PHOTO-OPT INS, V4937, P107, DOI 10.1117/12.469160
   Thissen H, 2001, P SOC PHOTO-OPT INS, V4590, P57, DOI 10.1117/12.454588
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Thomson D, 2003, P SOC PHOTO-OPT INS, V5275, P161, DOI 10.1117/12.524675
   Verpoorte E, 2003, P IEEE, V91, P930, DOI 10.1109/JPROC.2003.813570
   Waddell E. A., 2002, JALA, V7, P78
   Wagner F, 1999, APPL PHYS A-MATER, V69, pS841, DOI 10.1007/s003390051543
   WRIGHT JP, 2001, SPIE P, V4590, P345
   Xu NX, 1998, ANAL CHEM, V70, P3553, DOI 10.1021/ac980233x
   Yao LY, 2005, BIOMED MICRODEVICES, V7, P253, DOI 10.1007/s10544-005-3999-0
   Yoshida Y, 2003, P SOC PHOTO-OPT INS, V5063, P189, DOI 10.1117/12.540471
   YOSHIDA Y, 2004, P ASME 7 BIENN C ENG, P1
   YU H, 2005, IEEE P MEMS, P654
NR 64
TC 80
Z9 81
U1 1
U2 49
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD AUG
PY 2006
VL 385
IS 8
BP 1351
EP 1361
DI 10.1007/s00216-006-0514-2
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 072AE
UT WOS:000239644200003
PM 16773304
DA 2018-10-20
ER

PT J
AU Perez-Pomares, JM
   Foty, RA
AF Perez-Pomares, Jose M.
   Foty, Ramsey A.
TI Tissue fusion and cell sorting in embryonic development and disease:
   biomedical implications
SO BIOESSAYS
LA English
DT Review
ID BUCCOPHARYNGEAL MEMBRANE FORMATION; MOLECULE N-CAM; EPH RECEPTOR;
   CADHERIN EXPRESSION; VERTEBRAL COLUMN; MESENCHYMAL CELL; SURFACE
   TENSIONS; CLOACAL MEMBRANE; OUTFLOW TRACT; NEURAL-TUBE
AB Throughout embryonic development, segregated epithelial and/or mesenchymal cell populations make contact and fuse to shape new tissue units. This process, known as tissue fusion, is a key event in many essential morphogenetic mechanisms and its disruption can lead to congenital malformations. Another mechanism whereby complex tissues can arise involves a cell sorting process in which originally intermixed cells de-mix to generate distinct phases or layers. Different organisms use a combination of tissue fusion and cell sorting to acquire shape. Although the two processes appear to differ mechanistically, they are intricately linked inasmuch as they both involve the same molecular determinants and contribute to the same body plan. We aim to discuss the role of adhesion molecules and cell dynamics in tissue fusion and cell sorting, providing examples of their impact in embryonic development. Finally, we will advance the concept that malignant invasion may be viewed as cell sorting in reverse. Supplementary material.
C1 Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain.
   UMDNJ, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA.
RP Perez-Pomares, JM (reprint author), Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain.
EM jmperezp@uma.es
RI Perez-Pomares, Jose/G-7885-2015
OI Perez-Pomares, Jose/0000-0001-5487-7252
CR Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289
   Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069
   Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9
   BAGNALL KM, 1988, DEVELOPMENT, V103, P69
   Bard J, 1990, MORPHOGENESIS CELLUL
   Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186
   BODMER R, 1993, DEVELOPMENT, V118, P719
   Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Carstens MH, 2002, J CRANIOFAC SURG, V13, P129, DOI 10.1097/00001665-200201000-00032
   Christ B, 2000, ANAT EMBRYOL, V202, P179, DOI 10.1007/s004290000114
   Chung LWK, 1996, MOL BIOL REP, V23, P13, DOI 10.1007/BF00357069
   CIRULLI V, 1994, J CELL SCI, V107, P1429
   Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144
   Cuervo R, 2004, DEVELOPMENT, V131, P15, DOI 10.1242/dev.00907
   Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741
   De Arcangelis A, 1999, DEVELOPMENT, V126, P3957
   de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb
   Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101
   DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657
   Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027
   Drawbridge J, 2000, DEV BIOL, V223, P27, DOI 10.1006/dbio.2000.9712
   Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7
   Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096
   EPPLEY BL, 2002, PLAST RECONSTR SURG, V115, P101
   Ericson J, 1998, DEVELOPMENT, V125, P1005
   Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325
   FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896
   FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585
   Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annutev.med.57.121304.131306
   Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9
   Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf
   Foty RA, 1996, DEVELOPMENT, V122, P1611
   Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012
   FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298
   Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3
   Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7
   Gelb BD, 2004, CURR OPIN CARDIOL, V19, P110, DOI 10.1097/00001573-200403000-00007
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Hay E.D., 1990, Seminars in Developmental Biology, V1, P347
   Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345
   Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315
   Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6
   Hodor PG, 1998, DEV BIOL, V199, P111, DOI 10.1006/dbio.1998.8924
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Holmberg J, 2000, NATURE, V408, P203
   HUANG RJ, 1994, ANAT EMBRYOL, V190, P243
   Inoue T, 2001, DEVELOPMENT, V128, P561
   Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101
   Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993
   KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411
   Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478
   KELLER RE, 1987, DEV BIOL, V120, P12, DOI 10.1016/0012-1606(87)90099-6
   Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5
   Kim HJ, 2006, J CELL PHYSIOL, V207, P114, DOI 10.1002/jcp.20552
   Kostetskii I, 2001, DEV BIOL, V234, P72, DOI 10.1006/dbio.2001.0250
   KUNDU M, 2002, NAT GENET, V32, P547
   Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589
   LINASK KK, 1993, DEV DYNAM, V196, P62, DOI 10.1002/aja.1001960108
   Lopacznski W, 2001, UROLOGY, V57, P194, DOI 10.1016/S0090-4295(00)00973-0
   Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172
   Manni L, 2002, DEV DYNAM, V224, P303, DOI 10.1002/dvdy.10112
   MILLER SA, 1989, ANAT REC, V223, P204, DOI 10.1002/ar.1092230213
   Miller SA, 1998, ANN NY ACAD SCI, V857, P268, DOI 10.1111/j.1749-6632.1998.tb10129.x
   Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409
   Mjaatvedt GH, 1999, HEART DEV, P159
   MORENORODRIGUEZ RA, 2005, DEV DYNAM, V235, P191
   Nievelstein RAJ, 1998, TERATOLOGY, V57, P70, DOI 10.1002/(SICI)1096-9926(199802)57:2<70::AID-TERA5>3.0.CO;2-A
   Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662
   Qayyum SR, 2001, ANAT RECORD, V264, P273, DOI 10.1002/ar.1162
   Qi BQ, 2000, J UROLOGY, V164, P2070
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Rizzoti K, 2005, REV ENDOCR METAB DIS, V6, P161, DOI 10.1007/s11154-005-3047-7
   ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7
   ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W
   Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838
   SCHOENWOLF GC, 1989, DEVELOPMENT, V106, P427
   SHULER CF, 1995, CRIT REV ORAL BIOL M, V6, P202, DOI 10.1177/10454411950060030301
   STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9
   Steinberg M, 1964, CELLULAR MEMBRANES D, P321
   STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401
   STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206
   TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352
   Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8
   TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105
   van den Hoff MJB, 2004, BIOESSAYS, V26, P248, DOI 10.1002/bies.20006
   Van der Werff JFA, 2000, TERATOLOGY, V61, P172, DOI 10.1002/(SICI)1096-9926(200003)61:3<172::AID-TERA4>3.0.CO;2-B
   WATANABE K, 1984, ANAT REC, V210, P513, DOI 10.1002/ar.1092100312
   WATERMAN RE, 1977, DEV BIOL, V58, P219, DOI 10.1016/0012-1606(77)90088-4
   WATERMAN RE, 1982, FORMATION MOUTH OPEN, P1249
   Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129
   Wessels A, 1996, CIRC RES, V78, P110, DOI 10.1161/01.RES.78.1.110
   Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204
   Yajima H, 2002, INT J DEV BIOL, V46, P897
   Yajima H, 1999, DEV DYNAM, V216, P274, DOI 10.1002/(SICI)1097-0177(199911)216:3<274::AID-DVDY6>3.0.CO;2-S
   Yang JT, 1999, DEV BIOL, V215, P264, DOI 10.1006/dbio.1999.9451
   YANG JT, 1995, DEVELOPMENT, V121, P549
   YANG JT, 1993, DEVELOPMENT, V119, P1093
NR 99
TC 66
Z9 68
U1 1
U2 10
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0265-9247
J9 BIOESSAYS
JI Bioessays
PD AUG
PY 2006
VL 28
IS 8
BP 809
EP 821
DI 10.1002/bies.20442
PG 13
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 082NV
UT WOS:000240394500006
PM 16927301
DA 2018-10-20
ER

PT J
AU Kremer, F
   Richtering, W
AF Kremer, F.
   Richtering, W.
TI Biomedical and Life Sciences, Chemistry and Materials Science and
   Physics and Astronomy
SO COLLOID AND POLYMER SCIENCE
LA English
DT Editorial Material
C1 Univ Leipzig, Fak Phys & Geowissensch, D-04103 Leipzig, Germany.
   Rhein Westfal TH Aachen, Lehrstuhl Phys Chem 2, D-52056 Aachen, Germany.
RP Kremer, F (reprint author), Univ Leipzig, Fak Phys & Geowissensch, Linnestr 5, D-04103 Leipzig, Germany.
EM kremer@physik.uni-leipzig.de; richtering@rwth-aachen.de
NR 0
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD AUG
PY 2006
VL 284
IS 11
BP 1199
EP 1201
DI 10.1007/s00396-006-1520-9
PG 3
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 080OB
UT WOS:000240256200001
DA 2018-10-20
ER

PT J
AU Huh, YM
   Kim, YJ
AF Huh, Yong-Min
   Kim, Young Jin
TI Nanomedical imaging: In vivo imaging with smart nanohybrid
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE Nanocrystals; Nanocrystalline materials; Chemical synthesis methods;
   Biomedical applications of nanotechnology
AB The unique optical, magnetic, and electronic properties of nanocrystals enable them to be key probes and vectors in the next generation of biomedical applications.
   Semiconductor quantum dots have been demonstrated as excellent fluorescent probes. However, they suffer from the intrinsic limitations of optical imaging systems such as low penetration depth and large background fluorescence. Magnetic nanocrystals are now emerging in biomedical applications with new possibilities. We have demonstrated the production of high quality water-soluble iron oxide (WSIO) nanocrystals by thermal decomposition method.
   One of the current challenges now is how to develop well-defined magnetic nanocrystals with optimal nanoscale magnetism, high biostability to withstand harsh biological conditions, Conjugation of biologically functional molecules to nanocrystals produce nanohybrids that have multi-functionality such as detection, diagnosis, and therapeutics. However, further development of in vivo imaging applications of these molecules has been very limited with very few successful in vivo demonstrations. In addition to therapeutic antibody, the ability to incorporate genes or drugs into detectable site-targeted nanosystems may represent a whole new paradigm in therapeutics.
   The application for molecular and cellar imaging in nanoscience have not been fully developed. However, it has enormous potential for development and nanocrystals will bring improvement in bio-medical sciences. (C) 2006 Elsevier B.V. All rights reserved.
C1 [Huh, Yong-Min; Kim, Young Jin] Yonsei Univ, Coll Med, Dept Radiol, Nanomed Imaging Lab, CPO Box 8044, Seoul, South Korea.
RP Huh, YM (reprint author), Yonsei Univ, Coll Med, Dept Radiol, Nanomed Imaging Lab, CPO Box 8044, Seoul, South Korea.
EM ymhuh@yumc.yonsei.ac.kr
CR Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697
   Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192
   Huh Y. M., J AM CHEM S IN PRESS
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Lee SJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1853933
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   Song HT, 2005, J AM CHEM SOC, V127, P9992, DOI 10.1021/ja051833y
   Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Zeng H, 2002, NATURE, V420, P395, DOI 10.1038/nature01208
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
NR 27
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD AUG
PY 2006
VL 6
SU 1
BP E22
EP E25
DI 10.1016/j.cap.2006.01.005
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA V44MD
UT WOS:000209752200006
DA 2018-10-20
ER

PT J
AU Groth, P
   Weiss, B
AF Groth, Philip
   Weiss, Bertram
TI Phenotype data: A neglected resource in biomedical research?
SO CURRENT BIOINFORMATICS
LA English
DT Review
DE phenotype; genotype; comparative phenomics; database; RNA interference;
   analysis
ID DROSOPHILA GENOME PROJECTS; GENE MUTATION DATABASE; PHARMACOGENOMICS
   KNOWLEDGE-BASE; ONLINE MENDELIAN INHERITANCE; LOCUS-SPECIFIC
   KNOWLEDGEBASE; INFORMATION NETWORK ZFIN; MODEL ORGANISM DATABASE;
   MEDICAL LANGUAGE SYSTEM; CAENORHABDITIS-ELEGANS; RNA INTERFERENCE
AB To a great extent, our phenotype is determined by our genetic material. Many genotypic modifications may ultimately become manifest in more or less pronounced changes in phenotype. Despite the importance of how specific genetic alterations contribute to the development of diseases, surprisingly little effort has been made towards exploiting systematically the current knowledge of genotype-phenotype relationships. In the past, genes were characterized with the help of so-called "forward genetics" studies in model organisms, relating a given phenotype to a genetic modification. Analogous studies in higher organisms were hampered by the lack of suitable high-throughput genetic methods. This situation has now changed with the advent of new screening methods, especially RNA interference (RNAi) which allows to specifically silence gene by gene and to observe the phenotypic outcome. This ongoing large-scale characterization of genes in mammalian in-vitro model systems will increase phenotypic information exponentially in the very near future. But will our knowledge grow equally fast? As in other scientific areas, data integration is a key problem. It is thus still a major bioinformatics challenge to interpret the results of large-scale functional screens, even more so if sets of heterogeneous data are to be combined. It is now time to develop strategies to structure and use these data in order to transform the wealth of information into knowledge and, eventually, into novel therapeutic approaches. In light of these developments, we thoroughly surveyed the available phenotype resources and reviewed different approaches to analyzing their content. We discuss hurdles yet to be overcome, i.e. the lack of data integration, the missing adequate phenotype ontologics and the shortage of appropriate analytical tools. This review aims to assist researchers keen to understand and make effective use of these highly valuable data.
C1 Schering AG, Res Labs, D-13442 Berlin, Germany.
RP Weiss, B (reprint author), Schering AG, Res Labs, Muellerstr 178, D-13442 Berlin, Germany.
EM bertram.weiss@schering.de
OI Weiss, Bertram/0000-0002-6975-9344
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Ayme S, 2000, EUR J PEDIATR, V159, pS183, DOI 10.1007/PL00014399
   Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210
   Beroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4
   Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047
   Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113
   Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91
   BLSACHKE C, 2005, BMC BIOINFORMATIC S1, V6, pS16
   Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4
   Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090
   Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125
   BUSSE S, 1999, FEDERATED INFORM SYS, P1
   Camon EB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S17
   CANTOR MN, 2004, MEDINFO, V11, P753
   Carroll PM, 2003, PHARMACOL THERAPEUT, V99, P183, DOI 10.1016/S0163-7258(03)00059-7
   CHAUDHURI BB, 1993, IEE PROC-E, V140, P233, DOI 10.1049/ip-e.1993.0034
   Chen JH, 2005, J DENT, V33, P3, DOI 10.1016/j.jdent.2004.06.008
   Chen NS, 2004, GENOME RES, V14, P2155, DOI 10.1101/gr.2521304
   CHERRY JM, 2005, NUCLEIC ACIDS RES, V33, pD364
   Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486
   Clare A, 2002, BIOINFORMATICS, V18, P160, DOI 10.1093/bioinformatics/18.1.160
   Claustres M, 2002, GENOME RES, V12, P680, DOI 10.1101/gr.217702
   Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285
   Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540
   de la Cruz N, 2005, NUCLEIC ACIDS RES, V33, pD485, DOI 10.1093/nar/gki050
   DISILVESTRE D, 1991, AM J HUM GENET, V48, P1014
   Dolin R H, 2001, Proc AMIA Symp, P139
   Downward J, 2004, ONCOGENE, V23, P8376, DOI 10.1038/sj.onc.1208073
   Drysdale R, 2001, Brief Bioinform, V2, P68, DOI 10.1093/bib/2.1.68
   Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046
   Dujon B, 1998, ELECTROPHORESIS, V19, P617, DOI 10.1002/elps.1150190427
   Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379
   Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113
   Fenton Susan H, 2005, J AHIMA, V76, P60
   Fernandez- Ricaud L, 2005, NUCLEIC ACIDS RES, V33, pD369, DOI 10.1093/nar/gki126
   *FLY BAS CONS, 2003, NUCLEIC ACIDS RES, V31, P172
   Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517
   Fredman D, 2004, NUCLEIC ACIDS RES, V32, pD516, DOI 10.1093/nar/gkh111
   Fredman D, 2002, NUCLEIC ACIDS RES, V30, P387, DOI 10.1093/nar/30.1.387
   Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15
   Frezal J, 1998, CR ACAD SCI III-VIE, V321, P805, DOI 10.1016/S0764-4469(99)80021-3
   Friedman A, 2004, CURR OPIN GENET DEV, V14, P470, DOI 10.1016/j.gde.2004.07.010
   Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85
   Gelbart WM, 2002, NUCLEIC ACIDS RES, V30, P106
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Gkoutos G V, 2004, Pac Symp Biocomput, P178
   Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8
   GKOUTOS GV, 2004, BIOINFORMATICS
   Goldowitz D, 2004, MOL BRAIN RES, V132, P105, DOI 10.1016/j.molbrainres.2004.09.016
   Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526
   Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299
   Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876
   Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110
   Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514
   Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Harris TW, 2003, NUCLEIC ACIDS RES, V31, P133, DOI 10.1093/nar/gkg053
   Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066
   Herbert Ian, 2005, Inform Prim Care, V13, P61
   Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163
   Horaitis O, 2004, HUM MUTAT, V23, P447, DOI 10.1002/humu.20038
   Hubbard T, 2002, BIOINFORMATICS, V18, pS140, DOI 10.1093/bioinformatics/18.suppl_2.S140
   HUMPHREYS BL, 1993, B MED LIBR ASSOC, V81, P170
   Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1
   JOHANNSEN W, 1911, AM NAT, V14, P531
   Kahraman A, 2005, BIOINFORMATICS, V21, P418, DOI 10.1093/bioinformatics/bti010
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kim J M, 2001, Proc AMIA Symp, P314
   KLARE R, 1997, GREAT MINDS SCI, P128
   Klein T. E., 2001, Pharmacogenomics Journal, V1, P167
   Klein TE, 2004, PHARMACOGENOMICS J, V4, P1, DOI 10.1038/sj.tpj.6500230
   Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017
   Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134
   Krauthammer M, 2004, J BIOMED INFORM, V37, P512, DOI 10.1016/j.jbi.2004.08.004
   Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T
   Kreppel L, 2004, NUCLEIC ACIDS RES, V32, pD332, DOI 10.1093/nar/gkh138
   Kudla K M, 2001, J AHIMA, V72, P64
   Kumar A, 2000, NUCLEIC ACIDS RES, V28, P81, DOI 10.1093/nar/28.1.81
   Kumar A, 2002, NUCLEIC ACIDS RES, V30, P73, DOI 10.1093/nar/30.1.73
   Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168
   Leabman MK, 2003, PHARMACOL REV, V55, P399, DOI 10.1124/pr.55.3.6
   Lieberman Michael I, 2003, AMIA Annu Symp Proc, P910
   Lindberg C, 1990, J Am Med Rec Assoc, V61, P40
   LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281
   Lussier Y A, 2004, Pac Symp Biocomput, P202
   Lutz Michael W, 2005, Drug Discov Today Technol, V2, P197, DOI 10.1016/j.ddtec.2005.08.001
   Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662
   MARTINETZ TM, 1993, IEEE T NEURAL NETWOR, V4, P558, DOI 10.1109/72.238311
   Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092
   Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31
   Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28
   Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074
   Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x
   NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0
   O'Brien TP, 2004, J PHYSIOL-LONDON, V554, P13, DOI 10.1113/jphysiol.2003/049494
   Oliver Diane E, 2002, Pac Symp Biocomput, P65
   Oliver S, 1996, TRENDS GENET, V12, P241, DOI 10.1016/0168-9525(96)30053-X
   Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730
   Patrinos GP, 2005, TRENDS GENET, V21, P333, DOI 10.1016/j.tig.2005.04.004
   Perez AJ, 2004, BIOINFORMATICS, V20, P2084, DOI 10.1093/bioinformatics/bth207
   Perez-Iratxeta C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-45
   Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002
   Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5
   Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0
   Prank K, 2005, EUR J ENDOCRINOL, V153, P301, DOI 10.1530/eje.1.01957
   Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527
   Rodin A, 2005, J COMPUT BIOL, V12, P1, DOI 10.1089/cmb.2005.12.1
   Roux-Rouquie M, 1999, MOL GENET METAB, V67, P261, DOI 10.1006/mgme.1999.2867
   Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604
   Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01482
   Schadt EE, 2003, BIOCHEM SOC T, V31, P437, DOI 10.1042/BST0310437
   SCHOOLMAN HM, 1988, ANN AM ACAD POLIT SS, V495, P117, DOI 10.1177/0002716288495001011
   Schuetz E G, 2004, Pharmacol Rev, V56, P159, DOI 10.1124/pr.56.2.1
   SCRIVER CR, 1994, ANNU REV GENET, V28, P141
   Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200
   Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8
   Scriver CR, 2000, HUM MUTAT, V15, P99, DOI 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P
   Searls DB, 2005, NAT REV DRUG DISCOV, V4, P45, DOI 10.1038/nrd1608
   Shastry BS, 2003, INT J MOL MED, V11, P379
   Shi Y, 2003, TRENDS GENET, V19, P9, DOI 10.1016/S0168-9525(02)00005-7
   Shu Yan, 2004, Pharmacol Rev, V56, P161, DOI 10.1124/pr.56.2.2
   Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809
   Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012
   Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7
   Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353
   Spackman K A, 1998, Proc AMIA Symp, P740
   Spackman Kent A, 2004, Healthc Inform, V21, P56
   Sprague J, 2003, NUCLEIC ACIDS RES, V31, P241, DOI 10.1093/nar/gkg027
   Sprague J, 2001, NUCLEIC ACIDS RES, V29, P87, DOI 10.1093/nar/29.1.87
   Stearns M Q, 2001, Proc AMIA Symp, P662
   Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82
   Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065
   Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212
   Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571
   Tao Y, 2005, BIOINFORMATICS, V21, P1659, DOI 10.1093/bioinformatics/bti210
   Theodoratos D, 2000, J INTELL INF SYST, V15, P7, DOI 10.1023/A:1008773527263
   Thorn CF, 2005, METH MOL B, V311, P179
   Treacy E, 1996, J INHERIT METAB DIS, V19, P595, DOI 10.1007/BF01799832
   Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100
   Tuschl T, 2003, NATURE, V421, P220, DOI 10.1038/421220a
   Tuschl Thomas, 2002, Mol Interv, V2, P158, DOI 10.1124/mi.2.3.158
   Twigger S, 2002, NUCLEIC ACIDS RES, V30, P125, DOI 10.1093/nar/30.1.125
   TWIGGER SN, 2005, PHYSL GENOMICS
   Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465
   van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033
   Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545
   Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042
   Wang AY, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P845
   Wang AY, 2001, J AM MED INFORM ASSN, P741
   Waters PJ, 2003, HUM MUTAT, V21, P357, DOI 10.1002/humu.10197
   Weatherall D, 1999, PHILOS T ROY SOC B, V354, P1995, DOI 10.1098/rstb.1999.0539
   Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062
   Zhou GD, 2004, BIOINFORMATICS, V20, P1178, DOI 10.1093/bioinformatics/bth060
   ZHOU GD, 2005, INT J MED INFORM
NR 156
TC 11
Z9 11
U1 0
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-8936
EI 2212-392X
J9 CURR BIOINFORM
JI Curr. Bioinform.
PD AUG
PY 2006
VL 1
IS 3
BP 347
EP 358
DI 10.2174/157489306777828008
PG 12
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 139PL
UT WOS:000244444300008
DA 2018-10-20
ER

PT J
AU Vallet-Regi, M
   Arcos, D
AF Vallet-Regi, Maria
   Arcos, Daniel
TI Nanostructured hybrid materials for bone tissue regeneration
SO CURRENT NANOSCIENCE
LA English
DT Review
DE hybrid materials; biomaterials; sol-gel; bone; bioactivity; ormosils
ID SOL-GEL GLASSES; MODIFIED CAO-SIO2-TIO2 HYBRIDS; APATITE-FORMING
   ABILITY; GELATIN-SILOXANE HYBRIDS; ORGANIC-INORGANIC NANOCOMPOSITES;
   CALCIUM-PHOSPHATE FORMATION; MECHANICAL-PROPERTIES; IN-VITRO;
   POLY(EPSILON-CAPROLACTONE)/SILICA HYBRID; COMPOSITIONAL DEPENDENCE
AB The study of materials for bone tissue repair is one of the most important subjects in the field of materials research for biomedical applications. Bone can be considered as a biological hybrid material composed of an organic component, collagen, and an inorganic one, nanocrystalline carbonate hydroxyapatite (CHA). Both phases integrate each other into a nano-metrical scale in such a way that the crystallite size, nanofibers orientation, short range order between both components, etc. determine its nanostructure and therefore the function and mechanical properties of each kind of bone. On the basis of bone regeneration, new biomaterials have been developed. These materials stimulate the bone tissue formation by promoting the osteoblast proliferation and differentiation. One of the most promising alternatives is to apply materials with similar nanostructure to that of natural bone tissue. In this sense, the nanotechnology and the development of organic-inorganic hybrid materials provide excellent possibilities for improving the conventional bone implants. The present article reviews the advances in silicate-containing hybrids for bone tissue repair, as well as the chemical methodologies that allow to control the material nanostructure. Special attention is paid to bioactive hybrid materials, which are able to produce biological apatites on their surfaces when they are in contact with physiological fluids.
C1 Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; Arcos, Daniel/L-6167-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889; Arcos,
   Daniel/0000-0002-5367-7272
CR Aburatani Y, 2002, MAT SCI ENG C-BIO S, V20, P195, DOI 10.1016/S0928-4931(02)00032-2
   Arcos D, 2003, J BIOMED MATER RES A, V65A, P344, DOI 10.1002/jbm.a.10503
   Arcos D, 2002, CHEM MATER, V14, P1515, DOI [10.1021/cm011119p, 10.1021/cmO11119p]
   AVNIR D, 1984, J PHYS CHEM-US, V88, P5956, DOI 10.1021/j150668a042
   Chen Q, 2000, J BIOMED MATER RES, V51, P605, DOI 10.1002/1097-4636(20000915)51:4<605::AID-JBM8>3.0.CO;2-U
   Chen Q, 2003, J AM CERAM SOC, V86, P806, DOI 10.1111/j.1151-2916.2003.tb03379.x
   Chen Q, 2000, J SOL-GEL SCI TECHN, V19, P101, DOI 10.1023/A:1008774524468
   Chen Q, 2001, J MATER SCI-MATER M, V12, P515, DOI 10.1023/A:1011267612849
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   CHUJO Y, 1992, ADV POLYM SCI, V100, P11
   DEMAEYER EAP, 1993, INORG CHEM, V32, P5709, DOI 10.1021/ic00077a011
   Giraud-Guille MM, 2004, CR PALEVOL, V3, P503, DOI 10.1016/j.crpv.2004.07.004
   Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9
   GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P161
   Glimcher M. J., 1981, CHEM BIOL MINERALIZE, P618
   GLIMCHER MJ, 1998, METABOLIC BONE DIS C, P23
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   Hench L. L., 1993, BIOACTIVE GLASSES IN, P41
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1992, BIOCERAMICS, V5, P67
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hijon N, 2005, CHEM MATER, V17, P1591, DOI 10.1021/cm048755i
   Izquierdo-Barba I, 1999, J BIOMED MATER RES, V47, P243, DOI 10.1002/(SICI)1097-4636(199911)47:2<243::AID-JBM15>3.0.CO;2-S
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   JONES SM, 1994, J MATER SCI, V29, P4075, DOI 10.1007/BF00355973
   Kamitakahara M, 2003, J MATER SCI-MATER M, V14, P1067, DOI 10.1023/B:JMSM.0000004003.41223.36
   Kamitakahara M, 2003, BIOMATERIALS, V24, P1357, DOI 10.1016/S0142-9612(02)00513-6
   Kamitakahara M, 2002, J MATER SCI-MATER M, V13, P1015, DOI 10.1023/A:1020324101682
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEE DD, 1991, J MOL BIOL, V217, P487, DOI 10.1016/0022-2836(91)90752-R
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   LIVAGE J, 1988, PROG SOLID STATE CH, V18, P259, DOI 10.1016/0079-6786(88)90005-2
   Mackenzie JD, 1996, J SOL-GEL SCI TECHN, V7, P151, DOI 10.1007/BF00401034
   MACKENZIE JD, 1992, J NON-CRYST SOLIDS, V147, P271, DOI 10.1016/S0022-3093(05)80629-5
   Mackenzie JD, 1994, J SOL-GEL SCI TECHN, V2, P81, DOI 10.1007/BF00486217
   MANZANO M, P E MRS 2005 SPRING
   Marie P, 2001, M S-MED SCI, V17, P1252, DOI 10.1051/medsci/200117121252
   Martin AI, 2005, J EUR CERAM SOC, V25, P3533, DOI 10.1016/j.jeurceramsoc.2004.09.030
   Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16
   Michalczyk M. J., 1995, US Patent, Patent No. [5378790, 5,378,790]
   Michelini E, 2005, CLIN CHEM, V51, P1995, DOI 10.1373/clinchem.2005.053017
   Miyata N, 2004, BIOMATERIALS, V25, P1, DOI 10.1016/S0142-9612(03)00463-0
   Miyata N, 2003, J CERAM SOC JPN, V111, P555, DOI 10.2109/jcersj.111.555
   Miyata N, 2002, BIOMATERIALS, V23, P3033, DOI 10.1016/S0142-9612(02)00065-0
   Miyazaki T, 2003, J NANOSCI NANOTECHNO, V3, P511, DOI 10.1166/jnn.2003.221
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MOTAKEF S, 1994, J NON-CRYST SOLIDS, V178, P37, DOI 10.1016/0022-3093(94)90262-3
   Murugan R., 2005, HDB NANOSTRUCTURED B, V2, P141
   NOVAK BM, 1993, ADV MATER, V5, P422, DOI 10.1002/adma.19930050603
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Ohtsuki C, 2002, MAT SCI ENG C-BIO S, V22, P27, DOI 10.1016/S0928-4931(02)00109-1
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   PEREIRA APV, 2000, J NONCRYST SOLIDS, V11, P180
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Porter D, 2004, MAT SCI ENG A-STRUCT, V365, P38, DOI 10.1016/j.msea.2003.09.005
   Ren L, 2003, J SOL-GEL SCI TECHN, V26, P1137, DOI 10.1023/A:1020775227716
   Ren L, 2001, J NON-CRYST SOLIDS, V285, P116, DOI 10.1016/S0022-3093(01)00441-0
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   REN L, 2001, J SOL-GEL SCI TECHN, V21, P121
   Rhee SH, 2004, BIOMATERIALS, V25, P1167, DOI 10.1016/j.biomaterials.2003.08.004
   Rhee SH, 2003, J BIOMED MATER RES A, V67A, P1131, DOI 10.1002/jbm.a.20054
   Rhee SH, 2002, J AM CERAM SOC, V85, P1318
   Rhee SH, 2002, BIOMATERIALS, V23, P4915, DOI 10.1016/S0142-9612(02)00251-X
   Riggs BL, 1995, BONE S5, V17, P505
   Salinas AJ, 2004, KEY ENG MAT, V254-2, P481, DOI 10.4028/www.scientific.net/KEM.254-256.481
   SANCHEZ C, 1994, NEW J CHEM, V18, P1007
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Sanchez C, 2003, ADV MATER, V15, P1969, DOI 10.1002/adma.200300389
   Sanchez-Chaves M, 1998, POLYMER, V39, P2751, DOI 10.1016/S0032-3861(97)00601-0
   SCHIRALDI C, 2004, BIOMATERIALS, V23, P3645
   SCHMIDT H, 1985, J NON-CRYST SOLIDS, V73, P681, DOI 10.1016/0022-3093(85)90388-6
   Schmidt H., 1982, J PHYS, V12, P275
   SCHUBERT U, 1995, CHEM MATER, V7, P2010, DOI 10.1021/cm00059a007
   Sharp KG, 1998, ADV MATER, V10, P1243, DOI 10.1002/(SICI)1521-4095(199810)10:15<1243::AID-ADMA1243>3.0.CO;2-6
   Sharp KG, 1997, J SOL-GEL SCI TECHN, V8, P541, DOI 10.1023/A:1018379000697
   SOPPIMATH KS, 2000, J BIOMAT SCI-POLYM E, V273, P180
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Vallet-Regi M, 2005, CHEM MATER, V17, P1874, DOI 10.1021/cm047956j
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   VEBEECK RMH, 1995, INORG CHEM, V34, P2084
   WEI Y, 1997, POLYM PREPR AM CHEM, V38, P122
   WILKES GL, 1985, POLYM B, V14, P557
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1, P283
   Wilson RM, 1999, AM MINERAL, V84, P1406
   Yamamoto S, 1998, POLYM BULL, V40, P243, DOI 10.1007/s002890050248
   Yang JM, 1997, J BIOMED MATER RES, V38, P143
   Yang JM, 2003, J BIOMED MATER RES A, V64A, P138, DOI 10.1002/jbm.a.10245
   Yoo JJ, 2004, J BIOMED MATER RES A, V68A, P401, DOI 10.1002/jbm.a.20038
   YOUNG RA, 1980, MATER RES BULL, V15, P17, DOI 10.1016/0025-5408(80)90155-5
NR 102
TC 43
Z9 44
U1 0
U2 45
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
J9 CURR NANOSCI
JI Curr. Nanosci.
PD AUG
PY 2006
VL 2
IS 3
BP 179
EP 189
PG 11
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 063LW
UT WOS:000239020700003
DA 2018-10-20
ER

PT J
AU Huang, FC
   Liao, CS
   Lee, GB
AF Huang, Fu-Chun
   Liao, Chia-Sheng
   Lee, Gwo-Bin
TI An integrated microfluidic chip for DNA/RNA amplification,
   electrophoresis separation and on-line optical detection
SO ELECTROPHORESIS
LA English
DT Article
DE capillary electrophoresis; laser induced fluorescence; microfluidics;
   PCR/RT-PCR
ID POLYMERASE-CHAIN-REACTION; CAPILLARY-ELECTROPHORESIS; DNA AMPLIFICATION;
   WAVE-GUIDES; ABSORBENCY DETECTION; PCR AMPLIFICATION; ANALYSIS SYSTEM;
   PLASTIC CHIPS; DEVICES; GLASS
AB This study presents an integrated microfluidic chip capable of performing DNA/RNA (deoxyribonucleic acid/ribonucleic acid) amplification, electrokinetic sample injection and separation, and on-line optical detection of nucleic acid products in an automatic mode. In the proposed device, DNA/RNA samples are first replicated using a micro-machine-based PCR module or reverse transcription PCR (RT-PCR) module and then transported by a pneumatic micropump to a sample reservoir. The samples are subsequently driven electrokinetically into a microchannel, where they are separated electrophoretically and then detected optically by a buried optical fiber. The various modules of the integrated microfluidic chip are fabricated from cheap bio-compatible materials, such as PDMS, polymethylmethacrylate, and soda-lime glass. The functionality of the proposed device is demonstrated through its successful application to the DNA-based bacterial detection of Streptococcus pneumoniae and the RNA-based detection of Dengue-2 virus. It is shown that the low thermal inertia of the PCR/RT-PCR modules reduces the sample and reagent consumption and shortens the reaction time. With less human intervention, the subsequent DNA separation and detection could be performed in an automatic mode. The integrated microfluidic device proposed in this study represents a crucial contribution to the fields of molecular biology, genetic analysis, infectious disease detection, and other biomedical applications.
C1 Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Inst Microelectromech Syst Engn, Tainan 70101, Taiwan.
RP Lee, GB (reprint author), Natl Cheng Kung Univ, Dept Engn Sci, 1 Univ Rd, Tainan 701, Taiwan.
EM gwobin@mail.ncku.edu.tw
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR Daniel JH, 1998, SENSOR ACTUAT A-PHYS, V71, P81, DOI 10.1016/S0924-4247(98)00158-7
   Fu LM, 2003, ANAL CHEM, V75, P1905, DOI 10.1021/ac020741d
   Fujii T, 2002, MICROELECTRON ENG, V61-2, P907, DOI 10.1016/S0167-9317(02)00494-X
   Grewe M, 2000, APPL PHYS B-LASERS O, V70, P839, DOI 10.1007/PL00021143
   Grosse A, 2001, J MICROMECH MICROENG, V11, P257, DOI 10.1088/0960-1317/11/3/315
   Hanning A, 2000, ANAL CHEM, V72, P3423, DOI 10.1021/ac000326q
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   Hsiung SK, 2005, ELECTROPHORESIS, V26, P1122, DOI 10.1002/elps.200410034
   Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a
   Koh CG, 2003, ANAL CHEM, V75, P4591, DOI 10.1021/ac0343836
   Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6
   Lagally ET, 2001, LAB CHIP, V1, P102, DOI 10.1039/b109031n
   Lee GB, 2001, SENSOR ACTUAT B-CHEM, V75, P142, DOI 10.1016/S0925-4005(00)00745-0
   LEE GB, 2001, J CHIN CHEM SOC-TAIP, V48, pB6
   LEE GB, 2003, IEEE 16 INT MICR EL, P423
   Lee M, 2002, BMC MUSCULOSKEL DIS, V3, DOI 10.1186/1471-2474-3-3
   Liang ZH, 1996, ANAL CHEM, V68, P1040, DOI 10.1021/ac950768f
   Liao CS, 2005, BIOSENS BIOELECTRON, V20, P1341, DOI 10.1016/j.bios.2004.05.006
   Lin CC, 2002, ELECTROPHORESIS, V23, P3550, DOI 10.1002/1522-2683(200210)23:20<3550::AID-ELPS3550>3.0.CO;2-A
   Lin CH, 2003, SENSOR ACTUAT A-PHYS, V107, P125, DOI 10.1016/S0924-4247(03)00351-0
   Lin CH, 2004, BIOSENS BIOELECTRON, V20, P83, DOI 10.1016/j.bios.2003.09.011
   Lin CH, 2001, J MICROMECH MICROENG, V11, P726, DOI 10.1088/0960-1317/11/6/316
   LIU HS, 1995, J VIROL METHODS, V51, P55, DOI 10.1016/0166-0934(94)00111-S
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   Mogensen KB, 2001, ELECTROPHORESIS, V22, P3930, DOI 10.1002/1522-2683(200110)22:18<3930::AID-ELPS3930>3.0.CO;2-Q
   Northrup M. A., 1993, TRANSDUCERS 93, P924
   Northrup M. A., 1995, TRANSDUCERS 95, P764
   Ogura M, 1998, CLIN CHEM, V44, P2249
   Ro KW, 2005, ANAL CHEM, V77, P5160, DOI 10.1021/ac050420c
   Rodriguez I, 2003, ELECTROPHORESIS, V24, P172, DOI 10.1002/elps.200390010
   WALEED AAS, 2001, J CLIN MICROBIOL, V39, P485
   Wang CH, 2005, BIOSENS BIOELECTRON, V21, P419, DOI 10.1016/j.bios.2004.11.004
   Wang HY, 1997, SENSOR ACTUAT B-CHEM, V45, P199, DOI 10.1016/S0925-4005(97)00294-3
   Wang SL, 2001, ANAL CHEM, V73, P4545, DOI 10.1021/ac010341a
   Waters LC, 1998, ANAL CHEM, V70, P158, DOI 10.1021/ac970642d
   Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q
   Xu F, 2002, ELECTROPHORESIS, V23, P3608, DOI 10.1002/1522-2683(200210)23:20<3608::AID-ELPS3608>3.0.CO;2-3
NR 38
TC 83
Z9 85
U1 4
U2 45
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD AUG
PY 2006
VL 27
IS 16
BP 3297
EP 3305
DI 10.1002/elps.200600458
PG 9
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 081RB
UT WOS:000240333600017
PM 16865670
DA 2018-10-20
ER

PT J
AU Ho, SM
   Young, AM
AF Ho, Sze-Man
   Young, Anne M.
TI Synthesis, polymerisation and degradation of poly(lactide-co-propylene
   glycol) dimethacrylate adhesives
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE injectable; biodegradable; adhesive; polymerisation
ID DELIVERY; PHOTOPOLYMERIZATION; CONVERSION; PROFILES; NETWORKS; KINETICS;
   SYSTEMS; FTIR; DNA
AB Fluid ABA triblock poly(lactide-co-propylene glycol-co-lactide)s with 7, 17 or 34 propylene glycol and 2, 4, or 8 lactic acid units in each B and A block, respectively, end capped with methacrylate groups were prepared and polymerisation rates upon blue light exposure for 60, 120 or 240 s using 0.5, 1 or 2 wt.% initiators determined. The shortest monomer formulation, with 0.5 wt.% initiators, was most promising as an injectable degradable adhesive for biomedical applications, achieving 96% polymerisation by 120 s after the start of 60 s illumination, forming then a semi-rigid polymer that in water released linearly with time poly(methacrylic-co-lactic) acid degradation products. Over 14 weeks, 2 turn thick specimens largely maintained their dimensions as water sorption balanced the 19 wt.% material loss. Raising initiator concentration or monomer length reduced polymerisation rate on the lower surface of samples. Increasing the number of lactic acid units in each A block from 2 to 8 also enhanced photocrosslinked polymer water sorption and increased average total mass loss to 60 wt.% over 14 weeks but acid product release rate decreased with time. Monomers produced with longer polypropylene glycol B blocks required longer periods of light exposure for full cure and the final polymers exhibited slower non-linear hydrolytic degradation. (c) 2006 Elsevier Ltd. All rights reserved.
C1 UCL, Eastman Dent Inst, London WC1X 8L, England.
RP Young, AM (reprint author), UCL, Eastman Dent Inst, 256 Grays Inn Rd, London WC1X 8L, England.
EM a.young@eastman.ucl.ac.uk
RI Young, Anne/B-7755-2009
FU Medical Research Council [MC_U117533887]
CR Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Corchon MAG, 2006, BIOMATERIALS, V27, P1778, DOI 10.1016/j.biomaterials.2005.10.015
   Ellman PI, 2005, J SURG RES, V125, P161, DOI 10.1016/j.jss.2004.12.014
   Gauthier MA, 2005, BIOMATERIALS, V26, P6440, DOI 10.1016/j.biomaterials.2005.04.039
   Goraltchouk A, 2005, BIOMATERIALS, V26, P7555, DOI 10.1016/j.biomaterials.2005.05.026
   Gorst NJS, 2006, ACTA BIOMATER, V2, P95, DOI 10.1016/j.actbio.2005.09.001
   Haglund BO, 1996, J CONTROL RELEASE, V41, P229, DOI 10.1016/0168-3659(96)01333-8
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   Leiggener CS, 2006, BIOMATERIALS, V27, P202, DOI 10.1016/j.biomaterials.2005.05.068
   Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014
   Li LC, 2002, ADV DRUG DELIVER REV, V54, P963
   Lovestead TM, 2005, POLYMER, V46, P6226, DOI 10.1016/j.polymer.2005.03.112
   Moszner N, 2005, DENT MATER, V21, P895, DOI 10.1016/j.dental.2005.05.001
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Proikakis CS, 2006, POLYM DEGRAD STABIL, V91, P614, DOI 10.1016/j.polymdegradstab.2005.01.060
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quick DJ, 2004, J CONTROL RELEASE, V97, P333, DOI 10.1016/j.jconrel.2004.03.001
   Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8
   Thonemann B, 2002, DENT MATER, V18, P318, DOI 10.1016/S0109-5641(01)00056-2
   Usumez S, 2003, AM J ORTHOD DENTOFAC, V123, P641, DOI 10.1016/S0889-5406(03)00201-4
   Wei HL, 2005, EUR POLYM J, V41, P948, DOI 10.1016/j.eurpolymj.2004.11.041
   WENIGER K, 2005, MED LASER APPL, V20, P71
   Young AM, 2004, BIOMATERIALS, V25, P823, DOI 10.1016/S0142-9612(03)00599-4
NR 25
TC 30
Z9 31
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD AUG
PY 2006
VL 42
IS 8
BP 1775
EP 1785
DI 10.1016/j.eurpolymj.2006.03.018
PG 11
WC Polymer Science
SC Polymer Science
GA 087FA
UT WOS:000240727000008
DA 2018-10-20
ER

PT J
AU Heo, K
   Yoon, J
   Jin, KS
   Jin, S
   Ree, M
AF Heo, K.
   Yoon, J.
   Jin, K. S.
   Jin, S.
   Ree, M.
TI Characterisation of pore structures in nanoporous materials for advanced
   bionanotechnology
SO IEE PROCEEDINGS-NANOBIOTECHNOLOGY
LA English
DT Article
ID X-RAY-SCATTERING; ANNIHILATION LIFETIME SPECTROSCOPY; DIELECTRIC
   THIN-FILMS; DIFFUSION BARRIER INTEGRITY; GRAZING-INCIDENCE;
   ELLIPSOMETRIC POROSIMETRY; CONSTANT MATERIALS; SIZE DISTRIBUTION;
   POSITRONIUM; MEMBRANES
AB Porous materials are potential candidates for applications in various fields, such as bionanotechnology, gas separation, catalysts and micro-electronics. In particular, their applications in bionanotechnology include biosensors, biomedical implants and microdevices, biosupporters, bio-encapsules, biomolecule separations and biomedical therapy. All these bionanotechnology applications utilise the shape, size and size distribution of pores in porous materials. Therefore the controlled creation of pores with desired shape, size and size distribution is most important in the development of nanoporous materials. Accordingly, the accurate evaluation of pore structure is necessary in the development of nanoporous materials and their applications. This article reviews recent developments in analytical techniques to characterise the pore structures of nanoporous materials.
C1 Pohang Univ Sci & Technol, Pohang Accelerator Lab, Ctr Integrated Mol Syst, Polymer Res Inst,Natl Res Lab Polymer Synth & Phy, Pohang 790784, South Korea.
   Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea.
RP Heo, K (reprint author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Ctr Integrated Mol Syst, Polymer Res Inst,Natl Res Lab Polymer Synth & Phy, Pohang 790784, South Korea.
EM ree@postech.edu
RI Ree, Moonhor/F-5347-2013
OI Heo, Kyuyoung/0000-0001-6365-6363
CR Baklanov MR, 2000, J VAC SCI TECHNOL B, V18, P1385, DOI 10.1116/1.591390
   BAKLANOV MR, 1989, THIN SOLID FILMS, V171, P43, DOI 10.1016/0040-6090(89)90032-1
   Baklanov MR, 2002, MICROELECTRON ENG, V64, P335, DOI 10.1016/S0167-9317(02)00807-9
   BAKLANOV MR, 1988, POVERKHNOST, V11, P145
   Bolze J, 2001, LANGMUIR, V17, P6683, DOI 10.1021/la010451c
   Chamard V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245416
   de Morais TD, 1999, ADV MATER, V11, P107, DOI 10.1002/(SICI)1521-4095(199902)11:2<107::AID-ADMA107>3.0.CO;2-J
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Dull TL, 2001, J PHYS CHEM B, V105, P4657, DOI 10.1021/jp004182v
   Dultsev FN, 1999, ELECTROCHEM SOLID ST, V2, P192, DOI 10.1149/1.1390780
   Fissell WH, 2003, TRANSPLANT P, V35, P2837, DOI 10.1016/j.transproceed.2003.10.008
   Gidley D.W., 1999, PHYS REV B, V60, P5157
   GREGG SJ, 1982, ADSORPTION SURFACE A
   Grill A, 2003, J APPL PHYS, V94, P3427, DOI 10.1063/1.1599957
   Harmer MA, 1996, J AM CHEM SOC, V118, P7708, DOI 10.1021/ja9541950
   Hedden RC, 2004, LANGMUIR, V20, P6658, DOI 10.1021/la036334u
   Hedrick JL, 1998, ADV MATER, V10, P1049, DOI 10.1002/(SICI)1521-4095(199809)10:13<1049::AID-ADMA1049>3.0.CO;2-F
   Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048
   Huang E, 2002, APPL PHYS LETT, V81, P2232, DOI 10.1063/1.1507841
   Kim JS, 2005, POLYMER, V46, P7394, DOI 10.1016/j.polymer.2005.06.024
   Kim Y, 2006, NAT MATER, V5, P197, DOI 10.1038/nmat1574
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Lazzari R, 2002, J APPL CRYSTALLOGR, V35, P406, DOI 10.1107/S0021889802006088
   Lee B, 2005, MACROMOLECULES, V38, P4311, DOI 10.1021/ma047562d
   Lee B, 2005, MACROMOLECULES, V38, P3395, DOI 10.1021/ma048214e
   Lee B, 2005, MACROMOLECULES, V38, P8991, DOI 10.1021/ma0501951
   LEE B, 2003, THESIS POHANG U SCI
   LEE B, 2005, ADV MATER, V17, P969
   Lee BD, 2005, NAT MATER, V4, P147, DOI 10.1038/nmat1291
   Lee HJ, 2002, CHEM MATER, V14, P1845, DOI 10.1021/cm011569h
   Lee J, 2004, J MATER CHEM, V14, P478, DOI 10.1039/b311541k
   Leoni L, 2001, IEEE T BIO-MED ENG, V48, P1335, DOI 10.1109/10.959329
   LEV O, 1995, ANAL CHEM, V67, pA22, DOI 10.1021/ac00097a001
   Lin EK, 2002, APPL PHYS LETT, V81, P607, DOI 10.1063/1.1495079
   Liu J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2072739
   Maex K, 2003, J APPL PHYS, V93, P8793, DOI 10.1063/1.1567460
   Maier G, 2001, PROG POLYM SCI, V26, P3, DOI 10.1016/S0079-6700(00)00043-5
   Miller RD, 1999, SCIENCE, V286, P421, DOI 10.1126/science.286.5439.421
   Morgen M, 2000, ANNU REV MATER SCI, V30, P645, DOI 10.1146/annurev.matsci.30.1.645
   Oh W, 2003, POLYMER, V44, P2519, DOI 10.1016/S0032-3861(03)00129-0
   OH W, 2003, THESIS POHANG U SCI
   Oh W., 2002, MACROMOL CHEM PHYS, V203, P791
   Oh WT, 2004, LANGMUIR, V20, P6932, DOI 10.1021/la049581m
   Pan SL, 2003, NANO LETT, V3, P811, DOI 10.1021/nl034055l
   Park I, 2005, MACROMOLECULES, V38, P10532, DOI 10.1021/ma051137i
   Park JM, 2002, J ELECTROCHEM SOC, V149, pF92, DOI 10.1149/1.1490539
   Peng HG, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1886905
   Pietsch U, 1999, HIGH RESOLUTION XRAY
   Rajagopalan T, 2003, APPL PHYS LETT, V82, P4328, DOI 10.1063/1.1583139
   Ramsay JDF, 1999, MRS BULL, V24, P36
   Rao MB, 1996, J MEMBRANE SCI, V110, P109, DOI 10.1016/0376-7388(95)00241-3
   Rauscher M, 1995, PHYS REV B, V52, P16855, DOI 10.1103/PhysRevB.52.16855
   Ree MH, 2006, J MATER CHEM, V16, P685, DOI 10.1039/b511301f
   Rottman C, 1999, J AM CHEM SOC, V121, P8533, DOI 10.1021/ja991269p
   SCHLOMKA JP, 1995, PHYS REV B, V51, P2311, DOI 10.1103/PhysRevB.51.2311
   Shamiryan D, 2003, J VAC SCI TECHNOL B, V21, P220, DOI 10.1116/1.1539067
   Sotiropoulou S, 2005, BIOSENS BIOELECTRON, V20, P1674, DOI 10.1016/j.bios.2004.07.019
   Sun JN, 2003, J ELECTROCHEM SOC, V150, pF97, DOI 10.1149/1.1566415
   Sun JN, 2002, APPL PHYS LETT, V81, P1447, DOI 10.1063/1.1501767
   Sun JN, 2001, J APPL PHYS, V89, P5138, DOI 10.1063/1.1360704
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   Tian D, 1998, LANGMUIR, V14, P1905, DOI 10.1021/la970841s
   Vaseashta A, 2005, SCI TECHNOL ADV MAT, V6, P312, DOI 10.1016/j.stam.2005.02.018
   Wu WL, 2000, J APPL PHYS, V87, P1193, DOI 10.1063/1.371997
   Yang S, 2003, RADIAT PHYS CHEM, V68, P351, DOI 10.1016/S0969-806X(03)00183-X
   Yang S, 2001, CHEM MATER, V13, P2762, DOI 10.1021/cm0102786
NR 66
TC 13
Z9 13
U1 0
U2 4
PU INSTITUTION ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1478-1581
J9 IEE PROC-NANOBIOTECH
JI IEE Proc-Nanobiotechnol.
PD AUG
PY 2006
VL 153
IS 4
BP 121
EP 128
DI 10.1049/ip-nbt:20050020
PG 8
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 089EJ
UT WOS:000240862800009
PM 16948496
DA 2018-10-20
ER

PT J
AU Gregory, AP
   Clarke, RN
AF Gregory, Andrew P.
   Clarke, Robert N.
TI A review of RF and microwave techniques for dielectric measurements on
   polar liquids
SO IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION
LA English
DT Review
DE biomedical measurements; dielectric liquids; dielectric materials;
   dielectric measurements; microwave measurements; millimetre-wave
   measurements; moisture measurement; permittivity measurement;
   transmission-line measurements; UHF measurements
ID ENDED COAXIAL LINE; TIME-DOMAIN SPECTROSCOPY; COMPLEX PERMITTIVITY
   MEASUREMENTS; APERTURE ELECTROMAGNETIC SENSOR; RECTANGULAR WAVE-GUIDE;
   AQUEOUS NACL SOLUTIONS; BROAD-BAND; BIOLOGICAL TISSUES;
   TRANSMISSION-LINES; WATER MIXTURES
AB The requirements for dielectric measurements on polar liquids lie largely in two areas. First there is scientific interest in revealing the structure of and interactions between the molecules - this can be studied through dielectric spectroscopy. Secondly, polar liquids are widely used as dielectric reference and tissue equivalent materials for biomedical studies and for mobile telecommunications, health and safety related measurements. This review discusses these roles for polar liquids and surveys the techniques available for the measurement of their complex permittivity at RF and Microwave frequencies. One aim of the review is to guide researchers and metrologists in the choice of measurement methods and in their optimization. Particular emphasis is placed on the importance of traceability in these measurements to international standards.
C1 Natl Phys Lab, Enabling Metrol Div, Teddington TW11 0LW, Middx, England.
RP Gregory, AP (reprint author), Natl Phys Lab, Enabling Metrol Div, Hampton Rd, Teddington TW11 0LW, Middx, England.
CR *ASTM INT, D556895 ASTM INT
   ATHEY TW, 1982, IEEE T MICROW THEORY, V30, P82, DOI 10.1109/TMTT.1982.1131021
   AXADOV YY, 1972, DIELECTRIC PROPERTIE
   Baker-Jarvis J., 2004, 1536 NIST
   Baker-Jarvis J., 1990, 1341 NIST
   BAKERJARVIS J, 1990, IEEE T MICROW THEORY, V38, P1096, DOI 10.1109/22.57336
   BAKERJARVIS J, 1993, 5001 NISTIR
   BARKER RE, 1985, T IEEE ELEC INSULATI, V20, P927
   BARTHEL J, 1991, PURE APPL CHEM, V63, P1473, DOI 10.1351/pac199163101473
   BELHADJTAHAR NE, 1986, IEEE T MICROW THEORY, V34, P346, DOI 10.1109/TMTT.1986.1133342
   Berberian JG, 2002, J NON-CRYST SOLIDS, V305, P10, DOI 10.1016/S0022-3093(02)01082-7
   Bezman RD, 1997, J MOL LIQ, V73-4, P397, DOI 10.1016/S0167-7322(97)00082-2
   bin Khalid K, 1998, MEAS SCI TECHNOL, V9, P1191, DOI 10.1088/0957-0233/9/8/008
   Blackham DV, 1997, IEEE T INSTRUM MEAS, V46, P1093, DOI 10.1109/19.676718
   BLACKHAM DV, 1993, MICR S DIGEST, V3, P1247
   BOIS K, 1997, 8 INT S NOND CHAR MA, V8, P291
   BOSE TK, 1987, PHYS REV A, V36, P5767, DOI 10.1103/PhysRevA.36.5767
   Boughriet A., 1999, 1 WORLD C IND PROC T, P318
   Boughriet AH, 1997, IEEE T MICROW THEORY, V45, P52, DOI 10.1109/22.552032
   Bringhurst S, 1996, MATER RES SOC SYMP P, V430, P237, DOI 10.1557/PROC-430-237
   Buchner R, 1999, J PHYS CHEM A, V103, P1, DOI 10.1021/jp982977k
   Buckley F., 1958, 589 NBS
   BYOUNGJOONG B, 2004, IEEE MTT S INT S, V3, P1441
   CASTLE GSP, 1974, P IEEE, V62, P103, DOI 10.1109/PROC.1974.9390
   *CENELEC, 503612001 CENELEC EN
   CHAN TYA, 1993, IEE C PUBLICATIONS, V363, P366
   Chen T, 2003, J PHYS CHEM A, V107, P4025, DOI 10.1021/jp026429p
   Clarke R.N., 1995, P BRIT EL MEAS C BEM
   CLARKE RN, 1996, MICROWAVE AQUAMETRY, pCH19
   COLE RH, 1989, J APPL PHYS, V66, P793, DOI 10.1063/1.343499
   DELANGHE P, 1994, IEEE T INSTRUM MEAS, V43, P810, DOI 10.1109/19.368062
   DELECKI ZA, 1989, T IEEE INSTRUM MEAS, V38, P902
   Duhamel F, 1997, IEEE MTT-S, P107, DOI 10.1109/MWSYM.1997.604532
   Ellison WJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003213
   Eremenko ZE, 2005, MEAS SCI TECHNOL, V16, P1619, DOI 10.1088/0957-0233/16/8/011
   Evans S, 1995, MEAS SCI TECHNOL, V6, P1721, DOI 10.1088/0957-0233/6/12/011
   EVANS S, 1997, BRIT EL MEAS C BEMC
   Facer GR, 2001, APPL PHYS LETT, V78, P996, DOI 10.1063/1.1347020
   FAN S, 1990, STUDY METAL FLANGED, P43
   Feldman Y, 1996, REV SCI INSTRUM, V67, P3208, DOI 10.1063/1.1147444
   Feldman Y, 1998, PHYS REV E, V58, P7561, DOI 10.1103/PhysRevE.58.7561
   FITZPATRICK J, 1978, MICROWAVE J, V21, P63
   FOLGERO K, 1995, MEAS SCI TECHNOL, V6, P995, DOI 10.1088/0957-0233/6/7/022
   Friiso T, 1997, MEAS SCI TECHNOL, V8, P1295, DOI 10.1088/0957-0233/8/11/015
   GABRIEL C, 1994, PHYS MED BIOL, V39, P2183, DOI 10.1088/0031-9155/39/12/004
   GARDIOL FE, 1985, ADV ELECTRON EL PHYS, V63, P139
   Gottmann O, 1996, MEAS SCI TECHNOL, V7, P525, DOI 10.1088/0957-0233/7/4/010
   GRANT EH, 1978, MONOGRAPHS PHYS BIOC, pCH3
   GRANT JP, 1988, PHYS MED BIOL, V33, P607, DOI 10.1088/0031-9155/33/5/008
   GREEN AD, 1995, MEASUREMENTS DISPERS
   Gregory AP, 2005, MEAS SCI TECHNOL, V16, P1506, DOI 10.1088/0957/-0233/16/7/013
   GREGORY AP, 2002, P C PREC EL MEAS CPE
   GREGORY AP, 1993, 125 DES NAT PHYS LAB
   GREGORY AP, 2001, 33 CETM NAT PHYS LAB
   Hamelin J, 1998, REV SCI INSTRUM, V69, P255, DOI 10.1063/1.1148505
   Hamelin J, 1998, INT J THERMOPHYS, V19, P1359, DOI 10.1023/A:1021979401680
   Hirano M, 2001, ELECTRON COMM JPN 2, V84, P59, DOI 10.1002/ecjb.1022
   HODGETTS TE, 1989, 4331 ROYAL SIGN RAD
   HODGETTS TE, 1981, 3422 ROYAL SIGN RAD
   HONG KH, 1974, J APPL PHYS, V45, P2452, DOI 10.1063/1.1663613
   Hoshina S, 2001, IEEE T MAGN, V37, P3311, DOI 10.1109/20.952602
   Huang Y, 2001, MEAS SCI TECHNOL, V12, P111, DOI 10.1088/0957-0233/12/1/315
   HUYNH J, 2004, IEEE C INFR MILL WAV, P215
   HYDE PJ, 1970, P I ELECTR ENG, V117, P1891, DOI 10.1049/piee.1970.0336
   HYEONSEK H, 2003, IEEE MTT S INT MICR, V1, P399
   IEEE, 15282003 IEEE
   IMC, 2003, GUID CHAR DIEL MAT R
   *IMC NPL, 1999, GUID MEAS RES IMP BE
   International Electrotechnical Commission (IEC), 2005, 622091 IEC
   JARVIS JB, 2004, 2004 ANN REP C EL IN, P17
   JENKINS S, 1990, ELECTRON LETT, V26, P234, DOI 10.1049/el:19900158
   JENKINS S, 1992, IEE PROC-H, V139, P179, DOI 10.1049/ip-h-2.1992.0033
   JENKINS S, 1990, MEAS SCI TECHNOL, V1, P691, DOI 10.1088/0957-0233/1/8/005
   Jose KA, 2001, MICROW OPT TECHN LET, V30, P75, DOI 10.1002/mop.1225
   KAATZE U, 1989, J PHYS CHEM-US, V93, P5623, DOI 10.1021/j100351a057
   Kaatze U, 2006, MEAS SCI TECHNOL, V17, pR17, DOI 10.1088/0957-0233/17/2/R01
   KAATZE U, 1995, MEAS SCI TECHNOL, V6, P1201, DOI 10.1088/0957-0233/6/8/016
   KAATZE U, 1995, RADIAT PHYS CHEM, V45, P549, DOI 10.1016/0969-806X(94)00070-Z
   KAATZE U, 1989, J CHEM ENG DATA, V34, P371, DOI 10.1021/je00058a001
   KAATZE U, 1980, J PHYS E SCI INSTRUM, V13, P133, DOI 10.1088/0022-3735/13/2/001
   KAJFEZ D, 1975, T IEEE INSTRUM MEAS, V24, P4
   Kawabata H, 2003, 33RD EUROPEAN MICROWAVE CONFERENCE, VOLS 1-3, CONFERENCE PROCEEDINGS, P759
   KENT M, 1989, J PHYS E SCI INSTRUM, V22, P269, DOI 10.1088/0022-3735/22/4/012
   KIENITZ H, 1981, PURE APPL CHEM, V53, P1847, DOI 10.1351/pac198153101847
   Kim JM, 2005, J MICROMECH MICROENG, V15, P543, DOI 10.1088/0960-1317/15/3/015
   Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g
   KRASZEWSKI A, 1983, IEEE T INSTRUM MEAS, V32, P385, DOI 10.1109/TIM.1983.4315084
   Kremer F., 2002, BROADBAND DIELECTRIC
   KRUPKA J, 2004, C PREC EL MEAS CPEM
   Kwok RS, 1999, IEEE T MICROW THEORY, V47, P111, DOI 10.1109/22.740093
   Lamkaouchi K, 2003, MEAS SCI TECHNOL, V14, P444, DOI 10.1088/0957-0233/14/4/307
   LANE JA, 1952, PROC R SOC LON SER-A, V213, P400, DOI 10.1098/rspa.1952.0134
   LANGHE PD, 1993, IEEE T INSTRUM MEAS, V42, P879
   Lanzi L, 2002, REV SCI INSTRUM, V73, P3085, DOI 10.1063/1.1494870
   Letosa J, 1996, IEEE T MAGN, V32, P958, DOI 10.1109/20.497401
   Maryott A., 1951, 514 NBS
   MCAVOY JG, 1984, J PHYS D APPL PHYS, V17, P2081, DOI 10.1088/0022-3727/17/10/019
   MISRA DK, 1987, IEEE T MICROW THEORY, V35, P925, DOI 10.1109/TMTT.1987.1133782
   MOPSIK FI, 1984, REV SCI INSTRUM, V55, P79, DOI 10.1063/1.1137594
   MOSIG JR, 1981, IEEE T INSTRUM MEAS, V30, P46, DOI 10.1109/TIM.1981.6312437
   NELSON SO, 1974, IEEE T INSTRUM MEAS, VIM23, P455, DOI 10.1109/TIM.1974.4314333
   NEU JM, 1968, REV PHYS APPL, V3, P400, DOI 10.1051/rphysap:0196800304040000
   NEUBAUER H, 1969, MICROWAVE J, V6, P57
   NEVELS RD, 1985, IEEE T MICROW THEORY, V33, P314, DOI 10.1109/TMTT.1985.1133083
   NICOLSON AM, 1970, IEEE T INSTRUM MEAS, VIM19, P377, DOI 10.1109/TIM.1970.4313932
   Nortemann K, 1997, J PHYS CHEM A, V101, P6864, DOI 10.1021/jp971623a
   NOZAKI R, 1992, PHYS REV A, V46, P773
   OHWI K, 1998, P 1998 INT C MICR MI, P193
   OKONIEWSKI M, 1995, IEEE T MICROW THEORY, V43, P1986, DOI 10.1109/22.402291
   Olmi R, 2004, J ELECTROMAGNET WAVE, V18, P217, DOI 10.1163/156939304323062103
   OTTO GP, 1991, IEEE T INSTRUM MEAS, V40, P742, DOI 10.1109/19.85345
   Park MY, 2002, MICROW OPT TECHN LET, V35, P401, DOI 10.1002/mop.10619
   Paulter NG, 2003, REV SCI INSTRUM, V74, P5204, DOI 10.1063/1.1622981
   Petong P, 1999, J PHYS CHEM A, V103, P6114, DOI 10.1021/jp991046l
   Piotrowski J. K., 2000, 30th European Microwave Conference 2000. Conference Proceedings, P365
   Pokovic K., 1997, Proceedings ICECOM '97. 14th International Conference on Applied Electromagetics and Communications, P120
   Popovic D, 2005, IEEE T MICROW THEORY, V53, P1713, DOI 10.1109/TMTT.2005.847111
   Popovic D, 2002, IEEE MICROW WIREL CO, V12, P401, DOI 10.1109/LMWC.2002.803192
   Pournaropoulos CL, 1997, MEAS SCI TECHNOL, V8, P1191, DOI 10.1088/0957-0233/8/11/001
   POURNAROPOULOS CL, 1994, IEEE T INSTRUM MEAS, V43, P111, DOI 10.1109/19.293405
   Raj A, 2001, IEEE T INSTRUM MEAS, V50, P905, DOI 10.1109/19.948297
   RAMO S, 1965, FIELDS WAVES COMMUNI
   RAVEENDRANATH U, 2000, T IEEE INSTRUM MEAS, V49, P1305
   Regier M, 2000, J MICROWAVE POWER EE, V35, P25
   ROBERTS J, 1993, J MICROWAVE POWER EE, V28, P196
   ROBERTS S, 1946, J APPL PHYS, V17, P610, DOI 10.1063/1.1707760
   Ronne C, 1997, J CHEM PHYS, V107, P5319, DOI 10.1063/1.474242
   Sato T, 2000, J CHEM PHYS, V112, P2924, DOI 10.1063/1.480865
   Sato T, 1999, J CHEM PHYS, V110, P2508, DOI 10.1063/1.477956
   SHEPPARD RJ, 1972, J PHYS E SCI INSTRUM, V5, P1208, DOI 10.1088/0022-3735/5/12/023
   Shibata K, 2004, IEICE T ELECTRON, VE87C, P689
   Sibbald C. L., 1992, International Journal of Numerical Modelling: Electronic Networks, Devices and Fields, V5, P259, DOI 10.1002/jnm.1660050407
   SMITH G, 1995, J PHARM SCI-US, V84, P1029, DOI 10.1002/jps.2600840902
   SPHICOPOULOS T, 1985, J MICROWAVE POWER EE, V20, P165
   STEEL M, 1984, J PHYS E SCI INSTRUM, V17, P30, DOI 10.1088/0022-3735/17/1/006
   STEEL MC, 1987, J PHYS E SCI INSTRUM, V20, P872, DOI 10.1088/0022-3735/20/7/009
   STOGRYN A, 1971, IEEE T MICROW THEORY, VMT19, P733, DOI 10.1109/TMTT.1971.1127617
   Stuchly SS, 1998, MEAS SCI TECHNOL, V9, P1324, DOI 10.1088/0957-0233/9/8/027
   SUBRAMANIAN V, 1993, REV SCI INSTRUM, V64, P231, DOI 10.1063/1.1144442
   SURBER WH, 1948, J APPL PHYS, V19, P514, DOI 10.1063/1.1698166
   SZWARNOWSKI S, 1982, J PHYS E SCI INSTRUM, V15, P1068, DOI 10.1088/0022-3735/15/10/027
   Tofighi MR, 2002, IEEE T INSTRUM MEAS, V51, P1170, DOI 10.1109/TIM.2002.808014
   Tofighi MR, 2002, IEEE T MICROW THEORY, V50, P2217, DOI 10.1109/TMTT.2002.803432
   Toropainen A, 2000, ELECTRON LETT, V36, P32, DOI 10.1049/el:20000126
   UEDA N, 2004, AS PAC RAD SCI C AP, P537
   VANGEMERT MJ, 1973, PHILIPS RES REP, V28, P530
   VANLOON R, 1974, REV SCI INSTRUM, V45, P523, DOI 10.1063/1.1686676
   VANLOON R, 1975, J PHYS D APPL PHYS, V8, P1232, DOI 10.1088/0022-3727/8/10/012
   VANLOON R, 1973, REV SCI INSTRUM, V44, P1204, DOI 10.1063/1.1686354
   VANZURA EJ, 1994, IEEE T MICROW THEORY, V42, P2063, DOI 10.1109/22.330120
   VIJ JK, 1991, MOL PHYS, V72, P353, DOI 10.1080/00268979100100281
   VOSS G, 1984, J PHYS E SCI INSTRUM, V17, P981, DOI 10.1088/0022-3735/17/11/017
   Wakamatsu H, 1997, HEWLETT-PACKARD J, V48, P37
   Wang Y, 2003, PROG EL RES, V42, P131, DOI 10.2528/PIER03010602
   WARHAM AGP, 1989, 15289 DITC NAT PHYS
   WEI YZ, 1991, IEEE T MICROW THEORY, V39, P526, DOI 10.1109/22.75296
   WEIR WB, 1974, P IEEE, V62, P33, DOI 10.1109/PROC.1974.9382
   Williams G., 1998, PHENOMENOLOGICAL MOL
   Wu MZ, 2000, MEAS SCI TECHNOL, V11, P1617, DOI 10.1088/0957-0233/11/11/311
   Yu KB, 2000, IEEE T MICROW THEORY, V48, P2159, DOI 10.1109/22.884209
   YUSUN J, 2004, IEEE ANTENN PROPAG M, V4, P4543
   Zakharov AV, 2003, J CHEM PHYS, V118, P4253, DOI 10.1063/1.1542597
   ZANFORLIN L, 1983, IEEE T MICROW THEORY, V31, P417, DOI 10.1109/TMTT.1983.1131514
NR 163
TC 79
Z9 79
U1 0
U2 27
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1070-9878
J9 IEEE T DIELECT EL IN
JI IEEE Trns. Dielectr. Electr. Insul.
PD AUG
PY 2006
VL 13
IS 4
BP 727
EP 743
DI 10.1109/TDEI.2006.1667730
PG 17
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 072XF
UT WOS:000239705700006
DA 2018-10-20
ER

PT J
AU Wan, GJ
   Huang, N
   Kwok, SCH
   Shao, ZY
   Zhao, AS
   Yang, P
   Chu, PK
AF Wan, G. J.
   Huang, N.
   Kwok, S. C. H.
   Shao, Z. Y.
   Zhao, A. S.
   Yang, P.
   Chu, P. K.
TI Si-N-O films synthesized by plasma immersion ion implantation and
   deposition (PIII&D) for blood-contacting biomedical applications
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article
DE films; implantable biomedical devices; plasma materials-processing
   applications; silicon compounds; surface treatment
ID SILICON-NITRIDE; ENZYME IMMUNOASSAYS; PLATELET-ADHESION;
   HEMOCOMPATIBILITY; ADSORPTION; SURFACES; GROWTH
AB Silicon-Oxynitride (Si-N-O) films were fabricated on silicon wafers by silicon cathodic arc combined with plasma immersion ion implantation and deposition. The blood compatibility of the films was assessed by platelet-adhesion test and fibrinogen conformational change measurements to evaluate the viability of the materials in biomedical engineering. Significantly, a better platelet-adhesion behavior, as manifested by a smaller number and weaker aggregation as well as pseudopodium, was observed on the Si-N-O samples compared to the low-temperature isotropic pyrolytic carbon, which is the most common material used in blood-contacting biomedical devices such as artificial heart valves. Enzyme-linked-immunoassay measurements that disclose fibrinogen conformational changes show results that are consistent with the platelets' behavior, which is believed to be involved in the activation process. The good blood compatibility of the films can be attributed to the high hydrophilicity and surface free energy arising from the Si-N, Si-N-O, and Si-O bonding states. The interfacial reactions between fibrinogen, platelets, and material surface are discussed from the perspective of thermodynamics. The promising blood compatibility of the Si-N-O films is of both scientific and commercial interests in biomedical engineering.
C1 SW Jiaotong Univ, Coll Mat Sci & Engn, Key Lab Adv Technol Mat, China Educ Minist, Chengdu 610031, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
RP Wan, GJ (reprint author), SW Jiaotong Univ, Coll Mat Sci & Engn, Key Lab Adv Technol Mat, China Educ Minist, Chengdu 610031, Peoples R China.
EM superwgj@263.net; paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013; Wan, Guojiang/A-6651-2013
OI Chu, Paul/0000-0002-5581-4883; Wan, Guojiang/0000-0002-1636-5405
CR AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BENMAKROHA Y, 1995, MED BIOL ENG COMPUT, V33, P811, DOI 10.1007/BF02523013
   BUSTARRET E, 1988, PHYS REV B, V38, P8171, DOI 10.1103/PhysRevB.38.8171
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   Ciarlo DR, 2002, BIOMED MICRODEVICES, V4, P63, DOI 10.1023/A:1014275913962
   FINSTER J, 1990, VACUUM, V41, P1586, DOI 10.1016/0042-207X(90)94025-L
   Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Gusev EP, 1999, IBM J RES DEV, V43, P265, DOI 10.1147/rd.433.0265
   HABRAKEN FHPM, 1994, MAT SCI ENG R, V12, P123, DOI 10.1016/0927-796X(94)90006-X
   Hernandez PR, 1998, SENSOR ACTUAT B-CHEM, V46, P133, DOI 10.1016/S0925-4005(98)00099-9
   INGO GM, 1989, HIGH TEMP SCI, V28, P137
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   KANDA Y, 1981, ELECTRON LETT, V17, P558, DOI 10.1049/el:19810391
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lattemann M, 2003, SURF COAT TECH, V174, P365, DOI 10.1016/S0257-8972(03)00695-9
   MOHRI H, 1993, THROMB HAEMOSTASIS, V69, P490
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Wan GJ, 2005, SURF COAT TECH, V200, P1945, DOI 10.1016/j.surfcoat.2005.08.068
   Wan GJ, 2006, NUCL INSTRUM METH B, V242, P296, DOI 10.1016/j.nimb.2005.08.034
   Wan GJ, 2005, J VAC SCI TECHNOL A, V23, P1346, DOI 10.1116/1.1991870
   WAN GJ, IN PRESS DIAMOND REL
   WANG RR, 1996, J BIOMED MATER RES, V46, P262
   WEISENBERG BA, 2002, J BIOMED MATER RES, V60, P261
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Zhao AS, 2005, KEY ENG MATER, V288-289, P515, DOI 10.4028/www.scientific.net/KEM.288-289.515
NR 33
TC 6
Z9 7
U1 0
U2 7
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0093-3813
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD AUG
PY 2006
VL 34
IS 4
BP 1160
EP 1165
DI 10.1109/TPS.2006.881509
PN 1
PG 6
WC Physics, Fluids & Plasmas
SC Physics
GA 076RR
UT WOS:000239975900020
DA 2018-10-20
ER

PT J
AU Sladek, REJ
   Baede, TA
   Stoffels, E
AF Sladek, Raymond E. J.
   Baede, Tom A.
   Stoffels, Eva
TI Plasma-needle treatment of substrates with respect to wettability and
   growth of Escherichia coli and Streptococcus mutans
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on Nonthermal Medical/Biological Treatments
   Using Electromagnetic Fields and Ionized Gases
CY MAY, 2005
CL Portland, OR
DE adhesion; atmospheric; Escherichia coli; growth; microplasma;
   nonthermal; plasma needle; Streptococcus mutans
ID BIOMEDICAL APPLICATIONS; SURFACE-TREATMENT; MAMMALIAN-CELLS
AB In this paper, surface modification of various materials exposed to a nonthermal atmospheric plasma is investigated. The used source is the plasma needle: a radio-frequency-driven nonthermal atmospheric microplasma. A number of substrates (Perspex and polystyrene) were treated with the plasma needle. The modification of materials was subsequently identified as hydrophilization of the surface and was experimentally validated by water-contact-angle measurements. Furthermore, the effect of this modification on the growth of two bacterial species, which are the Escherichia coli and Streptococcus mutans, is studied. The bacteria were cultured on treated and nontreated polystyrene 96-well plates; the growth of E. coli on the treated substrates was enhanced, while for S. mutans, it was reduced. An explanation of these effects is provided.
C1 Eindhoven Univ Technol, Fac Biomed Engn, NL-5612 AZ Eindhoven, Netherlands.
   Eindhoven Univ Technol, Fac Mech Engn, NL-5612 AZ Eindhoven, Netherlands.
RP Sladek, REJ (reprint author), Eindhoven Univ Technol, Fac Biomed Engn, NL-5612 AZ Eindhoven, Netherlands.
EM R.E.J.Sladek@tue.nl; E.Stoffels.Adamowicz@tue.nl
CR Barker Susan L., 1994, Journal of Tissue Culture Methods, V16, P151, DOI 10.1007/BF01540642
   Brok WJM, 2005, J APPL PHYS, V98, DOI 10.1063/1.1944218
   KARA D, IN PRESS EUR J ORAL
   KARA D, 2005, JOINT M CONT EUR DIV
   Kieft IE, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/149
   Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005
   KIEFT IE, 2005, P PLASM PROC POL 16, V22, P295
   KOGOMA M, 1987, J PHYS D APPL PHYS, V20, P147, DOI 10.1088/0022-3727/20/1/022
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Larrieu J, 2003, EUR PHYS J-APPL PHYS, V22, P61, DOI 10.1051/epjap:2003010
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012
   Sladek REJ, 2004, IEEE T PLASMA SCI, V32, P1540, DOI 10.1109/TPS.2004.832636
   Sosnin EA, 2004, IEEE T PLASMA SCI, V32, P1544, DOI 10.1109/TPS.2004.833401
   Stoffels E, 2004, PLASMA PHYS CONTR F, V46, pB167, DOI 10.1088/0741-3335/46/12B/015
   Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
   Stoffels E, 2002, HIGH TEMP MATER P-US, V6, P191
   van den Bendem LJM, 2005, P 27 ICPIG VELDH NET, P18
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
NR 21
TC 16
Z9 17
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0093-3813
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD AUG
PY 2006
VL 34
IS 4
BP 1325
EP 1330
DI 10.1109/TPS.2006.878991
PN 2
PG 6
WC Physics, Fluids & Plasmas
SC Physics
GA 076RU
UT WOS:000239976200012
DA 2018-10-20
ER

PT J
AU Qiu, JH
AF Qiu, Jinhao
TI Special issue on papers presented at the International Symposium on
   Smart Materials for Engineering and Biomedical Applications - Preface
SO JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES
LA English
DT Editorial Material
C1 Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Qiu, JH (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.
EM qiu@ifs.tohoku.ac.jp
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1045-389X
J9 J INTEL MAT SYST STR
JI J. Intell. Mater. Syst. Struct.
PD AUG-SEP
PY 2006
VL 17
IS 8-9
BP 651
EP 651
DI 10.1177/1045389X06069542
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA 078FY
UT WOS:000240089100001
DA 2018-10-20
ER

PT J
AU Agrawal, SK
   Sanabria-DeLong, N
   Tew, GN
   Bhatia, SR
AF Agrawal, Sarvesh K.
   Sanabria-DeLong, Naomi
   Tew, Gregory N.
   Bhatia, Surita R.
TI Rheological characterization of biocompatible associative polymer
   hydrogels with crystalline and amorphous endblocks
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID ABA-TRIBLOCK COPOLYMERS; ENDED POLY(ETHYLENE GLYCOL); TRANSIENT NETWORK
   THEORY; AQUEOUS-SOLUTION; LINEAR VISCOELASTICITY; POLY(L-LACTIC ACID);
   B-BLOCKS; A-BLOCKS; THERMOREVERSIBLE GELATION; HYDROLYTIC DEGRADATION
AB Control over mechanical properties of hydrogels is of primary importance for the use of these materials in drug delivery and tissue engineering applications. We demonstrate here that crystallinity and block length of poly(lactide) (PLA) can be used to tune the elastic modulus of associative network gels of poly(lactide)-poly(ethylene oxide)-poly(lactide) over several orders of magnitude. Polymers made with crystalline L lactic acid blocks formed very stiff hydrogels at 25 wt% concentration with an elastic modulus that was almost an order of magnitude higher than hydrogels of polymers with a similar molecular weight but containing amorphous D/L-lactic acid blocks. The relaxation behavior and crosslink density of gels are also significantly influenced by crystallinity of PLA and are again a function of PLA block length. Using these variables we can design new tailor-made materials for biomedical applications with precise control over their structure and mechanical properties.
C1 Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
   Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RP Tew, GN (reprint author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
EM tew@mail.pse.umass.edu; sbhatia@ecs.umass.edu
RI Bhatia, Surita/B-4536-2008
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   Agrawal SK, 2005, MATER RES SOC SYMP P, V844, P327
   ANNABLE T, 1993, J RHEOL, V37, P695, DOI 10.1122/1.550391
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Bi JJ, 2004, J BIOMAT SCI-POLYM E, V15, P905, DOI 10.1163/1568562041271084
   Calvet D, 2003, MACROMOLECULES, V36, P449, DOI 10.1021/ma011729a
   Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2
   Castelletto V, 2005, SOFT MATTER, V1, P138, DOI 10.1039/b419103j
   Cathebras N, 1998, MACROMOLECULES, V31, P1305, DOI 10.1021/ma9709011
   Choi SK, 2002, J APPL POLYM SCI, V83, P435, DOI 10.1002/app.10072
   Clement F, 2000, MACROMOLECULES, V33, P6148, DOI 10.1021/ma991962x
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Durrschmidt T, 2001, COLLOID POLYM SCI, V279, P1005, DOI 10.1007/s003960100532
   Engler AJ, 2005, BIOPHYS J, V88, p500A
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Erkamp RQ, 1998, ULTRASONIC IMAGING, V20, P17, DOI 10.1177/016173469802000102
   FRANK EH, 1987, J BIOMECH, V20, P629, DOI 10.1016/0021-9290(87)90283-1
   GREEN MS, 1946, J CHEM PHYS, V14, P80, DOI 10.1063/1.1724109
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Inomata K, 2003, POLYMER, V44, P5303, DOI 10.1016/S0032-3861(03)00534-2
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee HT, 2002, MACROMOL RES, V10, P359, DOI 10.1007/BF03218330
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LI YX, 1993, J CONTROL RELEASE, V27, P247
   LI YX, 1994, J CONTROL RELEASE, V32, P121
   LIN YG, 1991, MACROMOLECULES, V24, P850, DOI 10.1021/ma00004a006
   Liu L, 1999, POLYM J, V31, P845, DOI 10.1295/polymj.31.845
   MISRA S, 1994, MACROMOLECULES, V27, P5037, DOI 10.1021/ma00096a028
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   Ng WK, 2000, J RHEOL, V44, P137, DOI 10.1122/1.551078
   NGUYENMISRA M, 1995, MACROMOLECULES, V28, P6976, DOI 10.1021/ma00124a039
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Pham QT, 1999, MACROMOLECULES, V32, P5139, DOI 10.1021/ma990215x
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   Ricciardi R, 2005, MACROMOLECULES, V38, P6629, DOI 10.1021/ma0506031
   RICHTERING HW, 1992, MACROMOLECULES, V25, P2429, DOI 10.1021/ma00035a021
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Sanabria-DeLong N, 2006, MACROMOLECULES, V39, P1308, DOI 10.1021/ma052243n
   Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032
   SEMENOV AN, 1995, MACROMOLECULES, V28, P1066, DOI 10.1021/ma00108a038
   Serero Y, 1998, PHYS REV LETT, V81, P5584, DOI 10.1103/PhysRevLett.81.5584
   Shim MS, 2002, J BIOMED MATER RES, V61, P188, DOI 10.1002/jbm.10164
   Stockwell R., 1979, ADULT ARTICULAR CART
   Tae G, 2001, MACROMOLECULES, V34, P6409, DOI 10.1021/ma0107511
   Tae GY, 2002, MACROMOLECULES, V35, P4448, DOI 10.1021/ma011809e
   TANAKA F, 1992, MACROMOLECULES, V25, P1516, DOI 10.1021/ma00031a024
   Tew GN, 2005, SOFT MATTER, V1, P253, DOI 10.1039/b509800a
   Vernon RB, 2005, BIOMATERIALS, V26, P1109, DOI 10.1016/j.biomaterials.2004.04.019
   Winnik MA, 1997, CURR OPIN COLLOID IN, V2, P424, DOI 10.1016/S1359-0294(97)80088-X
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Xu B, 1997, LANGMUIR, V13, P2447, DOI 10.1021/la960799l
   Yasugi K, 1999, J CONTROL RELEASE, V62, P89, DOI 10.1016/S0168-3659(99)00028-0
   YASZEMSKI MJ, 2004, TISSUE ENG NOVEL DEL, pR7
   YU QL, 1993, AM J PHYSIOL, V265, pH52
NR 66
TC 19
Z9 19
U1 6
U2 43
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD AUG
PY 2006
VL 21
IS 8
BP 2118
EP 2125
DI 10.1557/JMR.2006.0261
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 072LL
UT WOS:000239674800030
DA 2018-10-20
ER

PT J
AU Happe, KE
AF Happe, Kelly E.
TI Heredity, gender and the discourse of ovarian cancer
SO NEW GENETICS AND SOCIETY
LA English
DT Article
ID PRIMARY PERITONEAL CARCINOMA; HORMONE REPLACEMENT THERAPY;
   BREAST-CANCER; PROPHYLACTIC OOPHORECTOMY; DECISION-ANALYSIS; BRCA2
   MUTATIONS; INHERITED MUTATIONS; ESTROGEN-RECEPTOR; LIFE EXPECTANCY;
   FAMILY-HISTORY
AB Healthy women have elected to undergo preventive, or "prophylactic" surgery in order to lower perceived risk for ovarian cancer for some time. The development and commercialization of cancer susceptibility tests has altered the justification for prophylactic surgery. As a result, the rationale for undergoing oophorectomies (the removal of the ovaries) has taken on greater significance in biomedical discourse as a reasonable course of action for women who have been told they have a significant risk for these cancers. Although new in many respects, cancer susceptibility genetic tests are incorporated into old frameworks for defining, understanding, and treating disease. This essay addresses what some of those discursive/material conditions are, in part by addressing fundamental assumptions that inform the ways in which genetic medicine is interpreted and crafted in response to women's cancers. BRCA research, I argue, represents the powerful intersection of heredity and gender bias in biomedicine. The result is a new, "rational" discourse of diseasing women's reproductive organs.
C1 No Illinois Univ, Dept Commun, De Kalb, IL 60115 USA.
RP Happe, KE (reprint author), No Illinois Univ, Dept Commun, De Kalb, IL 60115 USA.
EM khappe@niu.edu
CR AITKEN JM, 1973, BRIT MED J, V2, P325, DOI 10.1136/bmj.2.5862.325
   ALIYU HM, 2005, J NATL MED ASSOC, V97, P799
   *AM CANC SOC, 2005, CANC STAT 2005
   Armstrong K, 2004, J CLIN ONCOL, V22, P1045, DOI 10.1200/JCO.2004.06.090
   BOURNE TH, 1991, GYNECOL ONCOL, V43, P92, DOI 10.1016/0090-8258(91)90051-6
   Boyd J, 2001, GYNECOL ONCOL, V80, P337, DOI 10.1006/gyno.2001.6131
   Broder MS, 2000, OBSTET GYNECOL, V95, P199, DOI 10.1016/S0029-7844(99)00519-0
   Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997
   Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310
   *CDC, 2006, OV CANC FAC CHALL 20
   COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801
   Colgan TJ, 2001, AM J SURG PATHOL, V25, P1283, DOI 10.1097/00000478-200110000-00009
   DEWAILLY E, 1994, J NATL CANCER I, V86, P232, DOI 10.1093/jnci/86.3.232
   Dewailly E, 1997, J NATL CANCER I, V89, P888, DOI 10.1093/jnci/89.12.888
   EHRENREICH B, 1978, HER OWN GOOD 150 YEA
   Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980
   Eisen A, 1998, J NATL CANCER I, V90, P797, DOI 10.1093/jnci/90.11.797
   Fasouliotis S J, 2000, Obstet Gynecol Surv, V55, P373, DOI 10.1097/00006254-200006000-00023
   Fausto-Sterling A., 1992, MYTHS GENDER BIOL TH
   GALLION HH, 1995, J NATL CANC I MONOG, V17, P103
   Garber JE, 2004, J CLIN ONCOL, V22, P978, DOI 10.1200/JCO.2004.01.926
   Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101
   Haber D, 2002, NEW ENGL J MED, V346, P1660, DOI 10.1056/NEJMed020044
   HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482
   Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201
   Healy B, 1997, NEW ENGL J MED, V336, P1448, DOI 10.1056/NEJM199705153362009
   Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087
   Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298
   HUBBARD R, 1996, WASHINGTON POST 0528
   HUGGINS C, 1953, JAMA-J AM MED ASSOC, V151, P1388
   Hunter DJ, 1997, NEW ENGL J MED, V337, P1253, DOI 10.1056/NEJM199710303371801
   Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303
   Karlan BY, 2004, GYNECOL ONCOL, V92, P519, DOI 10.1016/j.ygyno.2003.12.009
   Katz Rothman B, 1998, GENETIC MAPS HUMAN I
   Kauff ND, 2004, GYNECOL ONCOL, V93, P277, DOI 10.1016/j.ygyno.2004.03.016
   Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119
   King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251
   King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759
   KRIEGER N, 1994, JNCI-J NATL CANCER I, V86, P589, DOI 10.1093/jnci/86.8.589
   KRIEGER N, 1989, BREAST CANCER RES TR, V13, P205, DOI 10.1007/BF02106571
   Lavie O, 2004, GYNECOL ONCOL, V92, P521, DOI 10.1016/j.ygyno.2003.11.009
   Lerner B. H., 2001, BREAST CANC WARS HOP
   Levine DA, 2003, J CLIN ONCOL, V21, P4222, DOI 10.1200/JCO.2003.04.131
   Liede A, 2002, J CLIN ONCOL, V20, P1570, DOI 10.1200/JCO.20.6.1570
   *MA BREAST CANC CO, 2000, 1 MASS BREAST CANC C
   MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17
   MARTIN E, 1987, WOMEN BODY CULTURAL
   MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954
   NAROD SA, 1991, LANCET, V338, P82
   Olopade Olufunmilayo I, 2004, Breast J, V10 Suppl 1, pS5, DOI 10.1111/j.1524-4741.2004.101S3.x
   Patterson JT, 1987, DREAD DIS CANC MODER
   PIVER MS, 1993, CANCER, V71, P582
   PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J
   Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158
   Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787
   Roberts D., 1999, KILLING BLACK BODY R
   Rosen B, 2004, GYNECOL ONCOL, V93, P280, DOI 10.1016/j.ygnyo.2004.02.013
   Rubin SC, 2003, CANCER, V97, P2127, DOI 10.1002/cncr.11341
   RUNOWICZ CD, 1999, APPENDIX 8 PROPHYLAC
   Samuels Suzanne V., 1996, WOMENS RIGHTS LAW RE, V17, P209
   Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022
   SELTZER V, 1995, JAMA-J AM MED ASSOC, V273, P491, DOI 10.1001/jama.1995.03520300065039
   Spear SL, 1999, PLAST RECONSTR SURG, V103, P548, DOI 10.1097/00006534-199902000-00027
   Steingraber Sandra, 1998, LIVING DOWNSTREAM SC
   Struewing JP, 1995, J NATL CANC I MONOGR, V17, P33
   TOBACMAN JK, 1982, LANCET, V2, P795
   van Nagell J R Jr, 1991, Gynecol Oncol, V43, P89, DOI 10.1016/0090-8258(91)90050-F
   WOLFF MS, 1993, JNCI-J NATL CANCER I, V85, P648, DOI 10.1093/jnci/85.8.648
   WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0
NR 69
TC 6
Z9 6
U1 1
U2 1
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1463-6778
J9 NEW GENET SOC
JI New Genet. Soc.
PD AUG
PY 2006
VL 25
IS 2
BP 171
EP 196
DI 10.1080/14636770600855226
PG 26
WC Biotechnology & Applied Microbiology; Genetics & Heredity; History &
   Philosophy Of Science; Social Issues; Social Sciences, Biomedical
SC Biotechnology & Applied Microbiology; Genetics & Heredity; History &
   Philosophy of Science; Social Issues; Biomedical Social Sciences
GA 100PF
UT WOS:000241680300004
DA 2018-10-20
ER

PT J
AU Belli, G
   De Vecchi, C
   Giroletti, E
   Guida, R
   Musitelli, G
   Nardo, R
   Necchi, MM
   Pagano, D
   Ratti, SP
   Sani, G
   Vicini, A
   Vitulo, P
   Viviani, C
AF Belli, G.
   De Vecchi, C.
   Giroletti, E.
   Guida, R.
   Musitelli, G.
   Nardo, R.
   Necchi, M. M.
   Pagano, D.
   Ratti, S. P.
   Sani, G.
   Vicini, A.
   Vitulo, P.
   Viviani, C.
TI RPCs in biomedical applications
SO NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS
LA English
DT Article; Proceedings Paper
CT 8th Workshop on Resistive Plate Chambers and Related Detectors
CY OCT 10-12, 2005
CL Korea Univ, Seoul, SOUTH KOREA
HO Korea Univ
ID SENSITIVITY
AB We are studying possible applications of Resistive Plate Chambers (RPCs) in the biomedical domain such as Positron Emission Tomography (PET).
   The use of RPCs in PET can provide several improvements on the usual scintillation-based detectors. The most striking features are the extremely good spatial and time resolutions. They can be as low as 50 mu m and 25 ps respectively, to be compared to the much higher intrinsic limits in bulk detectors.
   Much efforts have been made to investigate suitable materials to make RPCs sensitive to 511 keV photons. For this reason, we are studying different types of coating employing high Z materials with proper electrical resistivity. Later investigations explored the possibility of coating glass electrodes by mean of serigraphy techniques, employing oxide based mixtures with a high density of high Z materials; the efficiency is strongly dependent on its thickness and it reaches a maximum for a characteristic value that is a function of the compound (usually a few hundred microns). The most promising mixtures seem to be PbO, Bi2O3 and Tl2O.
   Preliminary gamma efficiency measurements for a Multigap RPC prototype (MRPC) are presented as well as simulations using GEANT4-based framework. The MRPC has 5 gas gaps; their spacings are kept by 0.3 mm diameter nylon fishing line, electrodes are made of thin glasses (1 mm for the outer electrodes, 0.15 - 0.4 mm for the inner ones). The detector is enclosed in a metallic gas-tight box, filled with a C2H2F4 92.5%, SF6 2.5%, C4H10 5% mixture. Different gas mixtures are being studied increasing the SF6 percentage and results of efficiency as a function of the new mixtures will be presented.
C1 Ist Nazl Fis Nucl, Dipartimento Fis Nucl & Teor, I-27100 Pavia, Italy.
RP Necchi, MM (reprint author), Ist Nazl Fis Nucl, Dipartimento Fis Nucl & Teor, Via A Bassi 6, I-27100 Pavia, Italy.
EM monica.necchi@pv.infn.it
CR Abbrescia M, 2003, NUCL INSTRUM METH A, V508, P79, DOI 10.1016/S0168-9002(03)01281-6
   Abbrescia M, 2003, NUCL INSTRUM METH A, V508, P120, DOI 10.1016/S0168-9002(03)01290-7
   AKINDINOV A, 1999, 99166 CERNEP
   *ALICE COLL, 2002, CERNTDR8ADD1
   *ALICE COLL, 2002, CERNLHCC2000016
   *ALICE COLL, CERNLHCC2004025, P9006
   Altieri S, 2000, NUCL INSTRUM METH A, V456, P99, DOI 10.1016/S0168-9002(00)00971-2
   ANTONIAZZI L, 1995, NUCL INSTRUM METH A, V360, P334, DOI 10.1016/0168-9002(95)00103-4
   *ARGO COLL, 1999, NUCL PHYS B, V78, P38
   *ATLAS COLL, CERNLHCC9722
   *BABAR COLL, 1995, TECHN DES REP
   *BELLE COLL, 1995, 951 KEK BELLLE COLL
   BENDRIEM B, 1999, REV LACOMEN, V5
   BLANCO A, RESOLUTION STUDIES S
   BRESSI G, 1987, NUCL INSTRUM METH A, V261, P449, DOI 10.1016/0168-9002(87)90353-6
   *CMS COLL, CERNLHCC9732 CMS TDR
   CROSETTO DB, 2001, SAVING LIVES THROUGH
   FONTE P, 2000, LIP0004
   FONTE P, 2000, NUCL INSTRUM METH A, V449, P259
   GUDA R, 2003, NUCL INSTRUM METH A, V50, P101
   GUIDA R, 2003, NUCL INSTRUM METHODS, V506, P101
   NECCHI M, SCI ACTA
   RATTI SP, 1992, NUCL I NSTR METH A, V315, P45
   RATTI SP, 1989, PHYS LETT B, V231, P509
   RATTI SP, 1994, NUCL INSTRUM METH A, V344, P350
   1996, P 3 INT WORKSH RPC R
NR 26
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0920-5632
J9 NUCL PHYS B-PROC SUP
JI Nucl. Phys. B-Proc. Suppl.
PD AUG
PY 2006
VL 158
BP 166
EP 174
DI 10.1016/j.nuclphysbps.2006.07.007
PG 9
WC Physics, Particles & Fields
SC Physics
GA 099ZR
UT WOS:000241637300032
DA 2018-10-20
ER

PT J
AU Coulembier, O
   Degee, P
   Hedrick, JL
   Dubois, P
AF Coulembier, Olivier
   Degee, Philippe
   Hedrick, James L.
   Dubois, Philippe
TI From controlled ring-opening polymerization to biodegradable aliphatic
   polyester: Especially poly(beta-malic acid) derivatives
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE ring-opening polymerization; biodegradable polyesters; living
   polymerization; poly(malic acid); carbene catalysis; amphiphilic
   copolymers
ID INTERMOLECULAR CHAIN TRANSFER; ALUMINUM ISOPROPOXIDE TRIMER; CYCLIC
   ESTERS POLYMERIZATION; N-HETEROCYCLIC CARBENES; BETA-LACTONES;
   MALIC-ACID; ANIONIC-POLYMERIZATION; EPSILON-CAPROLACTONE; LIVING
   POLYMERIZATION; LACTIC-ACID
AB Biodegradable polymers represent a class of extremely useful materials for many biomedical and pharmaceutical applications, as exemplified by drug delivery systems, which in recent years have taken advantage of (bio)degradable polymeric matrices. However, before being selected for any biomedical application, a biodegradable polymer requires careful investigation of its interactions and compatibility within the human body. To date, polyesters, both natural and synthetic, constitute the most fully developed class of degradable biontaterials. Poly(epsilon-caprolactone) (PCL) and polylactides (PLAs), recognized as biocompatible and biodegradable polyesters, are very promising for controlled drug delivery devices. Bacterial polyesters and malic acid-based polymers (poly(malic acid), PMLA and derivatives) are poly (beta-hydroxyacid)-type polyesters that represent excellent alternatives for temporary therapeutic applications. Although these polyesters can be produced by polycondensation, high molecular weight structures have, until now, been produced almost exclusively by ring-opening polymerization (ROP) of the corresponding cyclic monomers. The ability of aluminum alkoxides (AlRx(OR')(3-x)) and tin(II) bis(2-ethylhexanoate) (Sn(Oct)(2)) to control the ROP of (di)lactones in terms of molecular parameters has opened the way to a wide range of molecular structures and topologies. Beyond the mechanistic and thermodynamic aspects of ROP of (di)lactones using organometallic compounds, this review is focused on new non-organometallic N-heterocyclic carbenes recently reported as catalysts for the controlled ROP of cyclic esters. Interestingly, the use of these simple organic molecules as catalysts or promoters in asymmetric polymer synthesis has provided organocatalytic alternatives to traditional organometallic reagents. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Mons, LPCM, B-7000 Mons, Belgium.
   IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA.
RP Dubois, P (reprint author), Univ Mons, LPCM, Pl Parc 20, B-7000 Mons, Belgium.
EM philippe.dubois@umh.ac.be
RI DUBOIS, Philippe/B-9983-2008
OI Coulembier, Olivier/0000-0001-5753-7851; Dubois,
   Philippe/0000-0003-1534-1564
CR Abdellaoui K, 1998, EUR J PHARM SCI, V6, P61, DOI 10.1016/S0928-0987(97)00069-9
   Abdellaoui K, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P57
   AJIOKA M, 1995, J ENVIRON POLYM DEGR, V3, P225, DOI 10.1007/BF02068677
   Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   ALBERTSSON AC, 1994, CHEM TECHNOLOGY BIOD, P48
   ALDER RW, 1995, J CHEM SOC CHEM COMM, P1267, DOI 10.1039/c39950001267
   ARNOLD SC, 1986, MAKROMOL CHEM-M SYMP, V6, P285, DOI 10.1002/masy.19860060128
   BAJWA JS, 1983, J ORG CHEM, V48, P1114, DOI 10.1021/jo00155a042
   Baran J, 1997, MACROMOL RAPID COMM, V18, P325, DOI 10.1002/marc.1997.030180409
   Barbaud C, 2003, DES MONOMERS POLYM, V6, P353, DOI 10.1163/156855503771816822
   Barbosa MEM, 2004, BIOMACROMOLECULES, V5, P137, DOI 10.1021/bm0300608
   BARTLETT PD, 1951, J AM CHEM SOC, V73, P4273, DOI 10.1021/ja01153a072
   BENTHIN S, 1995, APPL MICROBIOL BIOT, V42, P826, DOI 10.1007/s002530050337
   BENVENUTI M, 1991, J POLYM SCI POL CHEM, V29, P793, DOI 10.1002/pola.1991.080290602
   Biela T, 2006, MACROMOLECULES, V39, P3710, DOI 10.1021/ma060264r
   BIELA T, 2002, MACROMOL S, V165, P1
   Bizzarri R, 2002, MACROMOL CHEM PHYSIC, V203, P1684, DOI 10.1002/1521-3935(200207)203:10/11<1684::AID-MACP1684>3.0.CO;2-L
   Bogaert JC, 2000, MACROMOL SYMP, V153, P287, DOI 10.1002/1521-3900(200003)153:1<287::AID-MASY287>3.0.CO;2-E
   BOUTAULT K, 1995, MACROMOLECULES, V28, P3516, DOI 10.1021/ma00114a004
   BRAUD C, 1984, POLYM BIOMATERIALS
   BRODE GL, 1972, J MACROMOL SCI CHEM, VA  6, P1109, DOI 10.1080/10601327208056888
   BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   CAMMAS S, 1993, MACROMOLECULES, V26, P4681, DOI 10.1021/ma00069a041
   CAMMAS S, 1993, TETRAHEDRON-ASYMMETR, V4, P1925, DOI 10.1016/S0957-4166(00)80433-4
   Cammas-Marion S, 2000, MACROMOL CHEM PHYSIC, V201, P355, DOI 10.1002/(SICI)1521-3935(20000201)201:3<355::AID-MACP355>3.0.CO;2-9
   CHERDRON VH, 1962, MAKROMOL CHEM, V56, P187
   Chisholm MH, 2002, INORG CHEM, V41, P2785, DOI 10.1021/ic020148e
   CHISHOLM MH, 2001, J CHEM SOC DA, V3, P222
   Connor EF, 2002, J AM CHEM SOC, V124, P914, DOI 10.1021/ja0173324
   Coulembier O, 2006, MACROMOLECULES, V39, P4001, DOI 10.1021/ma060552n
   Coulembier O, 2005, ANGEW CHEM INT EDIT, V44, P4964, DOI 10.1002/anie.200500723
   Coulembier O, 2005, MACROMOLECULES, V38, P3141, DOI 10.1021/ma047928m
   Coulembier O, 2004, POLYM BULL, V51, P365, DOI 10.1007/s00289-004-0230-z
   Coulembier O, 2002, MACROMOLECULES, V35, P9896, DOI 10.1021/ma0209500
   COULEMBIER O, 2005, THESIS U MONSHAINAUT
   Coulembier O, 2006, MACROMOLECULES, V39, P5617, DOI 10.1021/ma0611366
   DALE J, 1986, ACTA CHEM SCAND B, V40, P559, DOI 10.3891/acta.chem.scand.40b-0559
   DECRIAUDCALMON A, 1998, ADV POLYM SCI, V135, P207
   DEFFIEUX A, 1976, MACROMOLECULES, V9, P369, DOI 10.1021/ma60050a041
   DOI YJ, 1995, MACROMOLECULES, V28, P2124
   Dove AP, 2001, CHEM COMMUN, P283, DOI 10.1039/b008770j
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   DUDA A, 1995, MACROMOLECULES, V28, P5981, DOI 10.1021/ma00122a001
   Duda A, 1998, POLYM DEGRAD STABIL, V59, P215, DOI 10.1016/S0141-3910(97)00167-5
   Duda A, 2002, MACROMOLECULES, V35, P4266, DOI 10.1021/ma012207y
   Duda A, 2002, BIOPOLYMERS B, V3B, P371
   Edlund U, 2002, ADV POLYM SCI, V157, P67
   FISCHER H, 1989, BIOCHEMISTRY-US, V28, P5219, DOI 10.1021/bi00438a045
   Gadzinowski M, 1996, MACROMOLECULES, V29, P6404, DOI 10.1021/ma9600466
   Getzler YDYL, 2002, J AM CHEM SOC, V124, P1174, DOI 10.1021/ja017434u
   Gross RA, 2001, APPL MICROBIOL BIOT, V55, P655, DOI 10.1007/s002530100617
   GROSS RA, 1988, MACROMOLECULES, V21, P2657, DOI 10.1021/ma00187a002
   GUERIN P, 1986, MAKROMOL CHEM-M SYMP, V6, P305, DOI 10.1002/masy.19860060129
   GUERIN P, 1985, POLYM BULL, V14, P187, DOI 10.1007/BF00708479
   HALL HK, 1969, MACROMOLECULES, V2, P488, DOI 10.1021/ma60011a008
   He B, 2003, POLYMER, V44, P989, DOI 10.1016/S0032-3861(02)00831-5
   HEMERY P, 1971, EUR POLYM J, V7, P1581, DOI 10.1016/0014-3057(71)90027-9
   Heun G, 1999, J CONTROL RELEASE, V58, P189, DOI 10.1016/S0168-3659(98)00153-9
   HOFMAN A, 1984, MAKROMOL CHEM, V185, P91
   HOLLER E, 1992, EUR J BIOCHEM, V206, P1, DOI 10.1111/j.1432-1033.1992.tb16894.x
   Holler E., 1997, HDB ENG POLYM MAT, P93
   Holten C. H., 1971, LACTIC ACID PROPERTI
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Jeanbat-Mimaud V, 1999, CR ACAD SCI II C, V2, P393, DOI 10.1016/S1387-1609(00)88551-5
   JEDLINSKI Z, 1991, MACROMOLECULES, V24, P1218, DOI 10.1021/ma00005a042
   JEDLINSKI Z, 1991, MAKROMOL CHEM, V192, P2051
   JEDLINSKI Z, 1985, MACROMOLECULES, V18, P2679, DOI 10.1021/ma00154a052
   JOHNS DB, 1984, POLYM PREPRINTS, V25, P220
   Kajiyama T, 2004, BIOMACROMOLECULES, V5, P169, DOI 10.1021/bm0342990
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   KIMURA Y, 2006, Patent No. 200658
   KLEINE J, 1959, MAKROMOLEKUL CHEM, V30, P23
   KOWALCZUK M, 1992, J ORG CHEM, V57, P389, DOI 10.1021/jo00027a070
   Kowalski A, 1998, MACROMOLECULES, V31, P2114, DOI 10.1021/ma971737k
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   Kowalski A, 2005, MACROMOLECULES, V38, P8170, DOI 10.1021/ma050752j
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   KRICHELDORF HR, 1994, POLYMER, V35, P4175, DOI 10.1016/0032-3861(94)90593-2
   KRICHELDORF HR, 1989, J MACROMOL SCI CHEM, VA26, P951, DOI 10.1080/00222338908052023
   Kurcok P, 2002, J POLYM SCI POL CHEM, V40, P2184, DOI 10.1002/pola.10285
   Kurcok P, 1996, POLYM INT, V41, P479, DOI 10.1002/(SICI)1097-0126(199612)41:4<479::AID-PI652>3.0.CO;2-W
   LEBORGNE A, 1994, MACROMOL RAPID COMM, V15, P955
   LeboucherDurand MA, 1996, POLYM BULL, V36, P35, DOI 10.1007/BF00296005
   Lenz R. W., 1979, POLYM PREPR, V20, P608
   LIPINSKY ES, 1981, SCIENCE, V212, P1465, DOI 10.1126/science.212.4502.1465
   LOFGREN A, 1995, J MACROMOL SCI R M C, VC35, P379
   LUNDBERG RD, 1969, RING OPENING POLYM, V2, P247
   Mabille C, 1998, POLYM BULL, V40, P381, DOI 10.1007/s002890050266
   Majerska K, 2000, MACROMOL RAPID COMM, V21, P1327, DOI 10.1002/1521-3927(20001201)21:18<1327::AID-MARC1327>3.0.CO;2-9
   MAUDUIT J, 1995, J BIOMAT SCI-POLYM E, V7, P207
   McLain S. J., 1992, POLYM PREPR, V33, P174
   McLain S. J., 1992, POLYM PREPR AM CHEM, V33, P463
   Mecerreyes D, 1999, ADV POLYM SCI, V147, P1
   Moine L, 1997, POLYMER, V38, P3121, DOI 10.1016/S0032-3861(96)01097-X
   Moon S.-II, 2001, HIGH PERFORM POLYM, V13, P189, DOI DOI 10.1088/0954-0083/13/2/317
   Nagata M, 1999, MACROMOLECULES, V32, P7762, DOI 10.1021/ma990907l
   Nakashima R., 1977, REP FAC ENG TOTTORI, V8, P124
   Nayak PL, 2000, J MACROMOL SCI R M C, VC40, P1, DOI 10.1081/MC-100100576
   NIEUWENHUIS J, 1992, Clinical Materials, V10, P59, DOI 10.1016/0267-6605(92)90086-9
   Ouhadi T., 1975, MAKROMOL CHEM S, V1, P191
   PAUL DE, 1956, J AM CHEM SOC, V78, P2676
   PAULET R, 1967, IND CHIM BELG, V32, P385
   Penczek S, 1998, MACROMOL SYMP, V132, P441, DOI 10.1002/masy.19981320141
   Penczek S, 2000, MACROMOL SYMP, V157, P61, DOI 10.1002/1521-3900(200007)157:1<61::AID-MASY61>3.0.CO;2-6
   Penczek S, 2000, MACROMOL RAPID COMM, V21, P941, DOI 10.1002/1521-3927(20000901)21:14<941::AID-MARC941>3.0.CO;2-R
   Ponsart S, 2000, BIOMACROMOLECULES, V1, P275, DOI 10.1021/bm005521t
   RAMIANDRASOA P, 1993, POLYM BULL, V30, P501, DOI 10.1007/BF00296467
   Renard E, 1996, POLYM BULL, V36, P585, DOI 10.1007/BF00342450
   RICHARDS DH, 1959, T FARADAY SOC, V55, P1644, DOI 10.1039/tf9595501644
   Rieth LR, 2002, J AM CHEM SOC, V124, P15239, DOI 10.1021/ja020978r
   SCHEVE LG, 1984, ELEMENTS BIOCH, P462
   SHIMADA K, 1969, AGR BIOL CHEM TOKYO, V33, P544, DOI 10.1080/00021369.1969.10859348
   SIPOS L, 1992, POLYM BULL, V27, P495, DOI 10.1007/BF00300596
   SLOMKOWSKI S, 1980, MACROMOLECULES, V13, P229, DOI 10.1021/ma60074a005
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   Sosnowski S, 1996, MACROMOLECULES, V29, P4556, DOI 10.1021/ma951542h
   SPAANS CJ, 2000, THESIS U GRONINGEN N
   SPASSKY N, 1991, MAKROMOL CHEM-M SYMP, V42-3, P15, DOI 10.1002/masy.19910420104
   Stridsberg KM, 2002, ADV POLYM SCI, V157, P41
   Suvorova A. I., 2000, RUSS CHEM REV, V69, P451
   SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0
   TANZI MC, 1994, J MATER SCI-MATER M, V5, P393, DOI 10.1007/BF00058971
   Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062
   Tuominen J, 2000, MACROMOLECULES, V33, P3530, DOI 10.1021/ma991676l
   Vert M, 1998, POLYM DEGRAD STABIL, V59, P169, DOI 10.1016/S0141-3910(97)00158-4
   Vert M, 2000, MACROMOL SYMP, V153, P333, DOI 10.1002/1521-3900(200003)153:1<333::AID-MASY333>3.0.CO;2-9
   VERT M, 1986, MAKROMOL CHEM-M SYMP, V6, P109, DOI 10.1002/masy.19860060113
   VERT M, 1986, CRC CRITICAL REV THE
   Wang XL, 2003, J MACROMOL SCI-POL R, VC43, P385, DOI 10.1081/MC-120023911
   Wang YB, 2000, MACROMOLECULES, V33, P7395, DOI 10.1021/ma0007177
   WILSON E, 2001, AM CHEM SOC, V79, P14
   WISE DL, 1976, Patent No. 19763978203
   Wu B, 1998, MACROMOLECULES, V31, P3473, DOI 10.1021/ma9717698
   Ziegler K, 1936, ANGEW CHEM-GER EDIT, V49, P0499, DOI 10.1002/ange.19360493003
NR 135
TC 236
Z9 241
U1 11
U2 190
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD AUG
PY 2006
VL 31
IS 8
BP 723
EP 747
DI 10.1016/j.progpolymsci.2006.08.004
PG 25
WC Polymer Science
SC Polymer Science
GA 112ES
UT WOS:000242509100002
DA 2018-10-20
ER

PT J
AU Jun, YW
   Jang, JT
   Cheon, J
AF Jun, Young-wook
   Jang, Jung-tak
   Cheon, Jinwoo
TI Nanocrystals and their biomedical applications
SO BULLETIN OF THE KOREAN CHEMICAL SOCIETY
LA English
DT Article
DE nanocrystals; shape control; anisotropic nanostructures; Nano-MRI
ID IRON-OXIDE; CDSE NANOCRYSTALS; QUANTUM DOTS; SEMICONDUCTOR NANOWIRES;
   MAGNETIC NANOCRYSTALS; SOLVENTLESS SYNTHESIS; SULFIDE NANORODS; SHAPE
   EVOLUTION; PHASE-CONTROL; NANOPARTICLES
AB Shape controlled synthesis of inorganic nanocrystals is one of the important issues in materials chemistry due to their novel shape dependent properties. Although various shapes of nanocrystals have been developed, a systematic account on the shape control of these nanocrystals still remains an important subject in materials chemistry. In this article, we will overview the recent developments in the geometrical shape evolution of semiconductor and metal oxide nanocrystals obtained by nonhydrolytic synthetic methods. Many structurally unprecedented motifs have appeared as zero-dimesional (D) polyhedrons, one-D rods and wires, two-D plates and prisms, and other advanced shapes such as branched rods, stars, and inorganic dendrites. Important parameters which determine the geometrical shapes of nanocrystals are also illustrated. In addition, as a possible application of such nanocrystals for biomedical sciences, we further describe their utilizations for cancer diagnosis through nanocrystal-assisted magnetic resonance imaging (MRI).
C1 Yonsei Univ, Dept Chem, Seoul 120749, South Korea.
RP Cheon, J (reprint author), Yonsei Univ, Dept Chem, Seoul 120749, South Korea.
EM jcheon@yonsei.ac.kr
RI Jang, Jung-tak/B-3317-2009; Jun, Young-wook/A-4141-2008
CR Ahrenkiel SP, 2003, NANO LETT, V3, P833, DOI 10.1021/nl034152e
   Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Alivisatos AP, 2004, NAT BIOTECHNOL, V22, P47, DOI DOI 10.1038/NBT927
   Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406
   Bakkers EPAM, 2003, J AM CHEM SOC, V125, P3440, DOI 10.1021/ja0299102
   Cao YC, 2004, J AM CHEM SOC, V126, P7456, DOI 10.1021/ja0481676
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Cheon JW, 2004, J AM CHEM SOC, V126, P1950, DOI 10.1021/ja038722o
   CHESTNOY N, 1986, J CHEM PHYS, V85, P2237, DOI 10.1063/1.451119
   Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s
   Cozzoli PD, 2005, CHEM MATER, V17, P1296, DOI 10.1021/cm047874v
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Fauconnier N, 1997, J COLLOID INTERF SCI, V194, P427, DOI 10.1006/jcis.1997.5125
   Gao PX, 2004, J PHYS CHEM B, V108, P7534, DOI 10.1021/jp049657n
   Gerion D, 2004, NANO LETT, V4, P597, DOI 10.1021/nl035231t
   Ghezelbash A, 2004, NANO LETT, V4, P537, DOI 10.1021/nl035067+
   Goldberger J, 2003, NATURE, V422, P599, DOI 10.1038/nature01551
   Hu JT, 2001, SCIENCE, V292, P2060, DOI 10.1126/science.1060810
   HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165
   Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c
   Jana NR, 2004, CHEM MATER, V16, P3931, DOI 10.1021/cm049221k
   Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541
   Joo J, 2003, J AM CHEM SOC, V125, P11100, DOI 10.1021/ja0357902
   JUN Y, 2001, J AM CHEM SOC, V123, P615
   Jun YW, 2002, J AM CHEM SOC, V124, P615, DOI 10.1021/ja016887w
   Jun YW, 2003, J AM CHEM SOC, V125, P15981, DOI 10.1021/ja0369515
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kim YH, 2002, J AM CHEM SOC, V124, P13656, DOI 10.1021/ja02757b
   Kohli P, 2005, J DRUG DELIV SCI TEC, V15, P49, DOI 10.1016/S1773-2247(05)50006-6
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Larsen TH, 2003, J AM CHEM SOC, V125, P5638, DOI 10.1021/ja0342087
   Law M, 2004, ANNU REV MATER RES, V34, P83, DOI 10.1146/annurev.matsci.34.040203.112300
   Lee K, 2003, J AM CHEM SOC, V125, P3408, DOI 10.1021/ja034011e
   Lee SM, 2002, J AM CHEM SOC, V124, P11244, DOI 10.1021/ja026805j
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   Lifshitz E, 2003, NANO LETT, V3, P857, DOI 10.1021/nl0342085
   Lu J, 2001, CHEM MATER, V13, P2169, DOI 10.1021/cm010049j
   Macintyre J. E., 1992, DICT INORGANIC COMPO
   Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+
   Manna L, 2003, NAT MATER, V2, P382, DOI 10.1038/nmat902
   Markovich G, 1999, ACCOUNTS CHEM RES, V32, P415, DOI 10.1021/ar980039x
   MICIC OI, 1995, J PHYS CHEM-US, V99, P7754, DOI 10.1021/j100019a063
   MOUGE M, 2003, ANGEW CHEM INT EDIT, V42, P5321
   Murray CB, 2001, IBM J RES DEV, V45, P47, DOI 10.1147/rd.451.0047
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   Niederberger M, 2002, J AM CHEM SOC, V124, P13642, DOI 10.1021/ja027115i
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Park J, 2004, J PHYS CHEM B, V108, P13594, DOI 10.1021/jp048229e
   Park JI, 2002, CHEMPHYSCHEM, V3, P543, DOI 10.1002/1439-7641(20020617)3:6<543::AID-CPHC543>3.0.CO;2-E
   Peng XG, 2000, NATURE, V404, P59
   Peng ZA, 2002, J AM CHEM SOC, V124, P3343, DOI 10.1021/ja0173167
   Peng ZA, 2001, J AM CHEM SOC, V123, P1389, DOI 10.1021/ja0027766
   Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720
   Pileni MP, 1997, LANGMUIR, V13, P3266, DOI 10.1021/la960319q
   Puntes VF, 2002, J AM CHEM SOC, V124, P12874, DOI 10.1021/ja027262g
   Saito Y, 1998, NATURE, V392, P237, DOI 10.1038/32555
   Seo JW, 2005, J PHYS CHEM B, V109, P5389, DOI 10.1021/jp0501291
   SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504
   Song Q, 2004, J AM CHEM SOC, V126, P6164, DOI 10.1021/ja049931r
   STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003
   Sugimoto T., 2001, MONODISPERSED PARTIC
   Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086
   Urban JJ, 2002, J AM CHEM SOC, V124, P1186, DOI 10.1021/ja017694b
   Veiseh O, 2005, NANO LETT, V5, P1003, DOI 10.1021/nl0502569
   WEISSLEDER R, 1992, RADIOLOGY, V182, P381, DOI 10.1148/radiology.182.2.1732953
   WEISSLEDER R, 1991, RADIOLOGY, V181, P245, DOI 10.1148/radiology.181.1.1887040
   Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219
   Yang PD, 2005, MRS BULL, V30, P85, DOI 10.1557/mrs2005.26
   YEH CY, 1992, PHYS REV B, V46, P10086, DOI 10.1103/PhysRevB.46.10086
   Yin M, 2004, J AM CHEM SOC, V126, P6206, DOI 10.1021/ja031696
   ZELAYAANGEL O, 1994, APPL PHYS LETT, V64, P291, DOI 10.1063/1.111184
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
NR 74
TC 28
Z9 28
U1 1
U2 9
PU KOREAN CHEMICAL SOC
PI SEOUL
PA 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 0253-2964
J9 B KOR CHEM SOC
JI Bull. Korean Chem. Soc.
PD JUL 20
PY 2006
VL 27
IS 7
BP 961
EP 971
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 088EE
UT WOS:000240793500001
DA 2018-10-20
ER

PT J
AU Mi, LX
AF Mi, Lixin
TI Molecular cloning of protein-based polymers
SO BIOMACROMOLECULES
LA English
DT Article
ID EXTRACELLULAR-MATRIX PROTEINS; ELASTIN-LIKE POLYPEPTIDE;
   ESCHERICHIA-COLI; CHAIN-REACTION; CELL-ADHESION; EXPRESSION; GENES;
   SILK; PURIFICATION; DESIGN
AB Protein-based biopolymers have become a promising class of materials for both biomedical and pharmaceutical applications, as they have well-defined molecular weights, monomer compositions, as well as tunable chemical, biological, and mechanical properties. Using standard molecular biology tools, it is possible to design and construct genes encoding artificial proteins or protein-based polymers containing multiple repeats of amino acid sequences. This article reviews some of the traditional methods used for constructing DNA duplexes encoding these repeat-containing genes, including monomer generation, concatemerization, iterative oligomerization, and seamless cloning. A facile and versatile method, called modules of degenerate codons (MDC), which uses PCR and codon degeneracy to overcome some of the disadvantages of traditional methods, is introduced. Re-engineering of the random coil spacer domain of a bioactive protein, WPT2-3R, is used to demonstrate the utility of the MDC method. MDC re-constructed coding sequences facilitate further manipulations, such as insertion, deletion, and swapping of various sequence modules. A summary of some promising emerging techniques for synthesizing repetitive sequence-containing artificial proteins is also provided.
C1 Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
RP Mi, LX (reprint author), Georgetown Univ, Lombardi Comprehens Canc Ctr, 3800 Reservoir Rd, Washington, DC 20057 USA.
CR Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Coljee VW, 2000, NAT BIOTECHNOL, V18, P789
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   DOEL MT, 1980, NUCLEIC ACIDS RES, V8, P4575, DOI 10.1093/nar/8.20.4575
   Donahue WF, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf094
   DOUGHERTY MJ, 1993, MACROMOLECULES, V26, P1779, DOI 10.1021/ma00059a045
   Goeden-Wood NL, 2002, BIOMACROMOLECULES, V3, P874, DOI 10.1021/bm0255342
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Kobatake E, 1999, BIOTECHNOL TECH, V13, P23, DOI 10.1023/A:1008809415499
   Kostal J, 2001, MACROMOLECULES, V34, P2257, DOI 10.1021/ma001973m
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   MCGRATH KP, 1990, BIOTECHNOL PROGR, V6, P188, DOI 10.1021/bp00003a004
   MCGRATH KPA, 1999, PROTEIN BASED MAT
   McMillan RA, 1999, MACROMOLECULES, V32, P3643, DOI 10.1021/ma981660f
   MCPHERSON DT, 1992, BIOTECHNOL PROGR, V8, P347, DOI 10.1021/bp00016a012
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   OCHMAN H, 1990, BIO-TECHNOL, V8, P759, DOI 10.1038/nbt0890-759
   Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Petka WA, 1999, MATER RES SOC SYMP P, V550, P23
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PETKA WA, 1997, THESIS U MASSACHUSET
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666
   Roberts RJ, 2005, NUCLEIC ACIDS RES, V33, pD230
   SHULDINER AR, 1991, ANAL BIOCHEM, V194, P9, DOI 10.1016/0003-2697(91)90144-I
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   YOSHIKAWA E, 1994, MACROMOLECULES, V27, P5471, DOI 10.1021/ma00097a029
   Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417
   Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449
NR 40
TC 14
Z9 15
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL 10
PY 2006
VL 7
IS 7
BP 2099
EP 2107
DI 10.1021/bm050158h
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 061CM
UT WOS:000238848800005
PM 16827576
DA 2018-10-20
ER

PT J
AU Jayakumar, R
   Reis, RL
   Mano, JF
AF Jayakumar, R.
   Reis, R. L.
   Mano, J. F.
TI Chemistry and applications of phosphorylated chitin and chitosan
SO E-POLYMERS
LA English
DT Review
ID CALCIUM-PHOSPHATE CEMENTS; PARTIALLY DEACETYLATED CHITIN; METHYLENE
   PHOSPHONIC CHITOSAN; DRUG-DELIVERY SYSTEMS; L-LACTIC ACID; IN-VITRO;
   BONE REPAIR; BIOMEDICAL APPLICATIONS; CYCLODEXTRIN CAVITIES; FUNCTIONAL
   POLYMERS
AB Chitin and chitosan are natural based non-toxic, biodegradable and biocompatible polymers and have been used in biomedical areas in the form of sutures, wound healing materials and artificial skin, and for the sustained release of drugs as well as in various industrial applications. However, practical use of these polymers has been mainly confined to the unmodified forms. Recently, there has been a growing interest in chemical modification of chitin and chitosan to improve their solubility and widen their applications. Among them, phosphorylated chitin and chitosan have attracted considerable interest because of their various advantages: anti-inflammatory property, ability to form metal complexes, blood compatibility and formation of anionic polyelectrolyte hydrogels. The purpose of this review is to take a closer look of different synthetic methods of phosphorylated chitin and chitosan and their potential applications in environmental, food, fuel cell, and biomedical fields. Based on current research and existing products, some new and futuristic approaches in this context area are discussed.
C1 Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Jayakumar, R (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Campus Gualtar, P-4710057 Braga, Portugal.
EM jayakumar77@yahoo.com
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Reis,
   Rui L./0000-0002-4295-6129
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   AGULLO E, 2000, Patent No. 000101260
   AMARAL IF, 2004, KEY ENG MATER, P254
   Andrew C. A. Wan, 1998, Biomaterials, V19, P1309
   AOBA T, 1985, J COLLOID INTERF SCI, V106, P110, DOI 10.1016/0021-9797(85)90386-8
   Aoki H, 1994, MED APPL HYDROXYAPAT, P156
   BANOS S. B., 2006, CROP PROT, V25, P108
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BINDERMAN I, 1990, CRC HDB BIOACTIVE CE, P45
   BLUMENTHAL NC, 1989, CLIN ORTHOP RELAT R, P279
   BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244
   BOSKEY AL, 1991, CALCIFIED TISSUE INT, V49, P193, DOI 10.1007/BF02556117
   Boudeville P, 1999, J MATER SCI-MATER M, V10, P99, DOI 10.1023/A:1008921104080
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crompton KE, 2005, BIOPHYS CHEM, V117, P47, DOI 10.1016/j.bpc.2005.03.009
   DALAS E, 1991, LANGMUIR, V7, P1822, DOI 10.1021/la00056a040
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Don TM, 2006, CARBOHYD POLYM, V63, P331, DOI 10.1016/j.carbpol.2005.08.023
   DUNG P, 1994, CARBOHYD POLYM, V24, P209
   Foger F, 2006, BIOMATERIALS, V27, P4250, DOI 10.1016/j.biomaterials.2006.03.033
   Genta I, 1998, CARBOHYD POLYM, V36, P81, DOI 10.1016/S0144-8617(98)00022-8
   GHANEM A, 2001, J CONTROL RELEASE, V71, P127
   GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Hadgraft J, 2000, INT J PHARM, V200, P243, DOI 10.1016/S0378-5173(00)00402-6
   HAMODRAKAS SJ, 1982, BIOCHIM BIOPHYS ACTA, V700, P42, DOI 10.1016/0167-4838(82)90289-8
   HAMPDRAKES SJ, 1982, BIOCHIM BIOPHYS ACTA, V703, P216
   HATO K, 1995, J AM CERAM SOC, V78, P1049
   HENCH LL, 1993, ADV SERIES CERAMICS, V1, P365
   HENDRICKSON HS, 1967, ANAL CHEM, V39, P998, DOI 10.1021/ac60252a022
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   ISHIKAWA K, 1995, BIOMATERIALS, V16, P527, DOI 10.1016/0142-9612(95)91125-I
   Jayakumar R, 2006, MATER SCI FORUM, V514-516, P1015, DOI 10.4028/www.scientific.net/MSF.514-516.1015
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   JAYAKUMAR R, 2006, IN PRESS J BIOACT CO
   JAYAKUMAR R, 2006, IN PRESS DRUG DELIVE
   Jung BO, 1999, J APPL POLYM SCI, V72, P1713, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1713::AID-APP7>3.0.CO;2-T
   KAIFU K, 1981, POLYM J, V13, P241, DOI 10.1295/polymj.13.241
   Kast CE, 2001, BIOMATERIALS, V22, P2345, DOI 10.1016/S0142-9612(00)00421-X
   KENT JN, 1983, J ORAL MAXIL SURG, V41, P629, DOI 10.1016/0278-2391(83)90016-2
   KOBAYASHI S, 1987, NEUROSURGERY, V21, P751, DOI 10.1227/00006123-198711000-00032
   KOKUBO T, 1993, INTRO BIOCERAMICS, P81
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Lebouc F, 2005, POLYMER, V46, P319, DOI 10.1016/j.polymer.2004.11.017
   LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026
   LI ST, 1977, CALC TISS RES, V22, P275, DOI 10.1007/BF02010366
   LUKASIEWICZ A, 1963, TETRAHEDRON, V19, P1789, DOI 10.1016/S0040-4020(01)99253-1
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   MASS WA, 1998, POLYM INT, V47, P89
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Miwa A, 1998, PHARMACEUT RES, V15, P1844, DOI 10.1023/A:1011901921995
   MOEDRITZ.K, 1966, J ORG CHEM, V31, P1603, DOI 10.1021/jo01343a067
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P409, DOI 10.1007/BF00120283
   MUNTING E, 1993, J MATER SCI-MATER M, V4, P337, DOI 10.1007/BF00122290
   Muzzarelli R. A.A., 1973, NATURAL CHELATING PO, P83
   MUZZARELLI RAA, 1986, INT J BIOL MACROMOL, V8, P137, DOI 10.1016/0141-8130(86)90014-0
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P99, DOI 10.1016/0144-8617(93)90084-H
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   MUZZARELLI RAA, 1994, INT J BIOL MACROMOL, V16, P177, DOI 10.1016/0141-8130(94)90048-5
   Ng LT, 2005, CARBOHYD POLYM, V60, P523, DOI 10.1016/j.carbpol.2005.03.009
   NISHI N, 1987, INT J BIOL MACROMOL, V9, P109, DOI 10.1016/0141-8130(87)90035-3
   NISHI N, 1982, POLYM J, V14, P919, DOI 10.1295/polymj.14.919
   NISHI N, 1984, INT J BIOL MACROMOL, V6, P53, DOI 10.1016/0141-8130(84)90049-7
   NISHI N, 1986, INT J BIOL MACROMOL, V8, P311, DOI 10.1016/0141-8130(86)90046-2
   NISHI N, 1979, POLYM J, V11, P27, DOI 10.1295/polymj.11.27
   OKADA K., 1997, BIOCERAMICS, V10, P329
   Okamoto Y, 2002, CARBOHYD POLYM, V49, P249, DOI 10.1016/S0144-8617(01)00316-2
   Park JH, 2006, BIOMATERIALS, V27, P119, DOI 10.1016/j.biomaterials.2005.05.028
   PATRICK F, 1998, BIOMATERIALS, V19, P971
   PINE SH, 1971, J ORG CHEM, V36, P829, DOI 10.1021/jo00805a022
   Prabaharan M, 2006, MATER SCI FORUM, V514-516, P1010, DOI 10.4028/www.scientific.net/MSF.514-516.1010
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Prabaharan M, 2005, MACROMOL BIOSCI, V5, P965, DOI 10.1002/mabi.200500087
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Ramos V. M., 2002, INT J POLYM MATER, V51, P711
   Ramos VM, 2003, CARBOHYD POLYM, V51, P425, DOI 10.1016/S0144-8617(02)00211-4
   Ramos VM, 2003, CARBOHYD POLYM, V52, P39, DOI 10.1016/S0144-8617(02)00264-3
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   Ripamonti U, 1996, MRS BULL, V21, P36
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Sabnis S, 2000, INT J BIOL MACROMOL, V27, P181, DOI 10.1016/S0141-8130(00)00118-5
   SAKAGUCHI T, 1981, AGR BIOL CHEM TOKYO, V45, P2191, DOI 10.1080/00021369.1981.10864862
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   SCHNURCH AB, 2000, INT J PHARM, V194, P113
   SCHWARZENBACH G, 1949, HELV CHIM ACTA, V32, P1175, DOI 10.1002/hlca.19490320403
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   SHI C, 2006, J SUR RES, P185
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   Shu X, 2000, INT J PHARM, V201, P51, DOI 10.1016/S0378-5173(00)00403-8
   Sludden J, 2000, J PHARM PHARMACOL, V52, P377, DOI 10.1211/0022357001774110
   Smetana K, 1996, BIOMATERIALS, V17, P1563, DOI 10.1016/0142-9612(95)00345-2
   SOMORIN O, 1979, POLYM J, V11, P391, DOI 10.1295/polymj.11.391
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9
   Tokura S, 2001, BIOMACROMOLECULES, V2, P417, DOI 10.1021/bm0001345
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   URAGAMI T, 1983, MAKROMOL CHEM-RAPID, V4, P99
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Verma A. J., 2004, CARBOHYD POLYM, V55, P77
   Wang XH, 2003, J BIOACT COMPAT POL, V18, P135, DOI 10.1177/088391103033857
   Wang XH, 2002, BIOMATERIALS, V23, P4591, DOI 10.1016/S0142-9612(02)00205-3
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   WESTERBACK S, 1965, J AM CHEM SOC, V87, P2567, DOI 10.1021/ja01090a008
   Win PP, 2005, POLYM INT, V54, P533, DOI 10.1002/pi.1705
   Win PP, 2003, CARBOHYD POLYM, V53, P305, DOI 10.1016/S0144-8617(03)00068-7
   WOLFE SA, 1981, PLAST RECONSTR SURG, V68, P429, DOI 10.1097/00006534-198109000-00037
   YALPANI M, 1992, CARBOHYD POLYM, V19, P35, DOI 10.1016/0144-8617(92)90052-R
   Yamada M, 2004, ANGEW CHEM INT EDIT, V43, P3688, DOI 10.1002/anie.200353176
   Yao FL, 2003, POLYMER, V44, P6435, DOI 10.1016/S0032-3861(03)000676-1
   Yin YJ, 2004, MACROMOL BIOSCI, V4, P971, DOI 10.1002/mabi.200400063
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
   Yokogawa Y, 2001, J SOL-GEL SCI TECHN, V21, P105, DOI 10.1023/A:1011222003264
   YOSHIMME Y, 1996, BIOMATERIALS, V23, P2241
   YOSHIOKA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1901, DOI 10.1271/bbb.59.1901
   Zhu Y, 2003, J BIOACT COMPAT POL, V18, P375, DOI 10.1177/088391103039020
   Zikakis JP, 1984, CHITIN CHITOSAN RELA, pXVII
NR 133
TC 21
Z9 21
U1 1
U2 24
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD JUL 7
PY 2006
AR 035
PG 16
WC Polymer Science
SC Polymer Science
GA 063JH
UT WOS:000239014000001
DA 2018-10-20
ER

PT J
AU Abdelmoez, W
   Yoshida, H
AF Abdelmoez, Wael
   Yoshida, Hiroyuki
TI Synthesis of a novel protein-based plastic using sub-critical water
   technology
SO AICHE JOURNAL
LA English
DT Article
DE biodegradable polymers; BSA; protein-based plastics; sub-critical water;
   batch reactors
ID BOVINE SERUM-ALBUMIN; SUPERCRITICAL WATER; ORGANIC-ACIDS; HIGH-PRESSURE;
   AMINO-ACIDS; BIOMEDICAL APPLICATIONS; CROSS-LINKING; FISH MEAT;
   HYDROLYSIS; HEAT
AB This article reports the synthesis and characterization of a novel biodegradable plastic synthesized from the serum albumin of bovine blood (BSA) by using the sub-critical water technology in batch reactors. The optimum synthesis conditions were found to be in the range of 250-275 degrees C for a reaction time of 1 min using 160 g/L BSA as an initial concentration. After a reaction time of only 0.5 min, all water-soluble BSA molecules were completely transformed into water-insoluble solids without hydrolysis or decomposition. A variety of techniques have been used to study the nature of the formed solids. The obtained results reveled that such solids showed many plastic properties and could be processed to produce a biodegradable plastic. The produced solids were recovered, dried, and thermally processed to produce a plastic BSA (PBSA). In this way, it was possible to obtain a material with a variety of mechanical properties that might allow for its application in both the biomedical as well as the traditional biodegradable plastic fields. The average values of the yield strength and modulus of elasticity of the processed samples synthesized at 250 degrees C for 1-min reaction time were 31.2 and 780 MPa, respectively. The biodegradability was confirmed by measuring the methane gas production and weight losses during an anaerobic fermentation of the processed plastic samples. (c) 2006 American Institute of Chemical Engineers.
C1 Osaka Prefecture Univ, Ctr Excellence Project, Dept Chem Engn, Osaka 5998531, Japan.
RP Yoshida, H (reprint author), Osaka Prefecture Univ, Ctr Excellence Project, Dept Chem Engn, Osaka 5998531, Japan.
EM yoshida@chenteng.osakafu-u.ac.jp
CR Abdelmoez W, 2005, P EL MIN INT C SAF C, pE3
   ADRIANO KP, 1994, J APPL BIOMATER, V5, P133
   Daimon H, 2001, J CHEM ENG JPN, V34, P1091, DOI 10.1252/jcej.34.1091
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   DESHPANDE GV, 1984, FUEL, V63, P956, DOI 10.1016/0016-2361(84)90318-1
   Fang J, 2003, FOOD AGR ENV, V1, P82
   FERRY JD, 1948, ADV PROTEIN CHEM, V4, P1, DOI 10.1016/S0065-3233(08)60004-2
   Fox P. F., 1989, DEV DAIRY CHEM, P1
   Funtenberger S., 1995, Lebensmittel-Wissenschaft and Technologie, V28, P410, DOI 10.1016/0023-6438(95)90025-X
   Galazka VB, 1996, FOOD CHEM, V57, P393, DOI 10.1016/0308-8146(95)00239-1
   HAYAKAWA I, 1992, J FOOD SCI, V57, P288, DOI 10.1111/j.1365-2621.1992.tb05478.x
   HAYASHI R, 1992, COLLOQ INSE, V224, P185
   Hermansson A., 1979, FOOD TEXTURE RHEOLOG, P265
   HERMANSSON AM, 1979, ACS SYM SER, V92, P81
   KITABATAKE N, 1989, J FOOD SCI, V54, P1632, DOI 10.1111/j.1365-2621.1989.tb05176.x
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   KUZNETSOV AN, 1975, BIOCHIM BIOPHYS ACTA, V379, P139, DOI 10.1016/0005-2795(75)90015-X
   LEHNINGER AL, 1993, PRINCIPLE BIOCH
   LIN VJC, 1976, BIOPOLYMERS, V15, P203, DOI 10.1002/bip.1976.360150114
   Ma C. Y., 1991, Advances in Food and Nutrition Research, V35, P317, DOI 10.1016/S1043-4526(08)60067-4
   Mason T. J., 1998, ULTRASOUND FOOD PROC
   Messens W, 1997, TRENDS FOOD SCI TECH, V8, P107, DOI 10.1016/S0924-2244(97)01015-7
   NAKAMURA T, 1986, AGR BIOL CHEM TOKYO, V50, P2429, DOI 10.1080/00021369.1986.10867783
   OAKES J, 1976, J CHEM SOC FARAD T 1, V72, P228, DOI 10.1039/f19767200228
   Park HM, 2004, BIOMACROMOLECULES, V5, P2281, DOI 10.1021/bm049690f
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   SCHILLING CH, 1995, J MATER RES, V10, P2197, DOI 10.1557/JMR.1995.2197
   Tavakoli O, 2005, ENVIRON SCI TECHNOL, V39, P2357, DOI 10.1021/es030713s
   Van Camp J., 1996, Lebensmittel-Wissenschaft and Technologie, V29, P49
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   WETZEL R, 1980, EUR J BIOCHEM, V104, P469, DOI 10.1111/j.1432-1033.1980.tb04449.x
   Yoshida H, 2004, J CHEM ENG JPN, V37, P253, DOI 10.1252/jcej.37.253
   Yoshida H, 2003, J CHEM ENG JPN, V36, P441, DOI 10.1252/jcej.36.441
   Yoshida H, 1999, BIOTECHNOL PROGR, V15, P1090, DOI 10.1021/bp9900920
   YOSHIDA H, 2000, P JOINT 6 INT S HYDR, P122
   YOSHIDA H, 2004, P 10 AS PAC CONF CHE, pA272
NR 36
TC 14
Z9 14
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0001-1541
J9 AICHE J
JI AICHE J.
PD JUL
PY 2006
VL 52
IS 7
BP 2607
EP 2617
DI 10.1002/aic.10849
PG 11
WC Engineering, Chemical
SC Engineering
GA 055ZN
UT WOS:000238490200029
DA 2018-10-20
ER

PT J
AU Demir, SS
AF Demir, Semahat S.
TI Interactive cell modeling web-resource, iCell, as a simulation-based
   teaching and learning tool to supplement electrophysiology education
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE simulation data; computational models; single cell membrane models;
   membrane transport; learning styles
ID MATHEMATICAL-MODEL; ATRIAL CELL; REPOLARIZATION
AB An interactive cell modeling web site, iCell (http://ssd1.bme.memphis.edu/icell/), that integrates research and education, was developed to present and to disseminate JAVA-coded models of cellular activities, and to supplement physiology education. iCell can be used to supplement the text-book material as a simulation-based teaching and learning tool. Specifically, iCell allows the students to supplement their learning experiences of the text-book cellular physiology material by running simulations in an interactive environment. The site consists of JAVA-coded models of various cardiac cells and neurons, and provides simulation data of their bioelectric transport activities at cellular level. Each JAVA-coded model allows the user to go through menu options to change model parameters, run and view simulation results. The site also has a glossary section for the scientific terms. iCell has been used as a teaching and learning tool for seven graduate courses at the Joint Biomedical Engineering Program of University of Memphis and University of Tennessee. This modeling tool was also used as a collaboration site among our physiology colleagues interested in simulations of cell membrane activities. Scientists from the fields of biosciences, engineering, life sciences and medical sciences in 17 countries have tested and utilized iCell as a simulation-based teaching, learning and collaboration environment. iCell provides us with an interactive, platform-independent, and user-friendly teaching and learning resource, and also a collaboration environment for electrophysiology to be shared over the Internet. The usage of simulations for teaching and learning will continue advancing simulation-based engineering and sciences for research and development.
C1 Univ Memphis, Joint Grad Program Biomed Engn, Memphis, TN 38152 USA.
   Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38152 USA.
   Natl Sci Fdn, Biomed Engn & Res Aid Persons Disabil Program, Arlington, VA 22230 USA.
RP Demir, SS (reprint author), Univ Memphis, Joint Grad Program Biomed Engn, 330 Engn Technol Bldg,Univ Memphis Campus, Memphis, TN 38152 USA.
EM sdemir@memphis.edu
CR Alberts B., 1998, ESSENTIAL CELL BIOL
   Demir SS, 1997, BIOPHYS J, V72, P579, DOI 10.1016/S0006-3495(97)78697-1
   DEMIR SS, 1994, AM J PHYSIOL, V266, pC832
   Dunn R., 2000, PRACTICAL APPROACHES
   DWYER TM, 1997, ELECTROCHEM ELECTROP, V273, P2
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764
   Huang C, 2003, COMPUT MED IMAG GRAP, V27, P157, DOI 10.1016/S0895-6111(02)00089-7
   Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054
   Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666
   LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501
   NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849
   Nygren A, 1998, CIRC RES, V82, P63
   Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7
   RASMUSSON RL, 1990, AM J PHYSIOL, V259, pH370
   Riemer TL, 1998, AM J PHYSIOL-HEART C, V275, pH431, DOI 10.1152/ajpheart.1998.275.2.H431
   Sarasin L. C., 1998, LEARNING STYLE PERSP
   Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571
NR 17
TC 7
Z9 7
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2006
VL 34
IS 7
BP 1077
EP 1087
DI 10.1007/s10439-006-9138-0
PG 11
WC Engineering, Biomedical
SC Engineering
GA 064JS
UT WOS:000239085800001
PM 16794875
DA 2018-10-20
ER

PT J
AU Miller, LM
   Dumas, P
AF Miller, Lisa M.
   Dumas, Paul
TI Chemical imaging of biological tissue with synchrotron infrared light
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Review
DE synchrotron; infrared; microspectroscopy; imaging; biology; biomedical
ID IN-SITU CHARACTERIZATION; SCRAPIE-INFECTED CELLS; MOLECULAR CHEMISTRY;
   BIOMEDICAL APPLICATIONS; MINERAL-COMPOSITION; CYNOMOLGUS MONKEYS;
   PROTEIN-STRUCTURE; IR SPECTROSCOPY; EDGE RADIATION; PRION PROTEIN
AB Fourier transform infrared micro-spectroscopy (FTIRM) and imaging (FTIRI) have become valuable techniques for examining the chemical makeup of biological materials by probing their vibrational motions on a microscopic scale. Synchrotron infrared (S-IR) light is an ideal source for FTIRM and FTIRI due to the combination of its high brightness (i.e., flux density), also called brilliance, and broadband nature. Through a 10-mu m pinhole, the brightness of a synchrotron source is 100-1000 times higher than a conventional thermal (globar) source. Accordingly, the improvement in spatial resolution and in spectral quality to the diffraction limit has led to a plethora of applications that is just being realized. In this review, we describe the development of synchrotron-based FTIRM, illustrate its advantages in many applications to biological systems, and propose some potential future directions for the technique. (c) 2006 Elsevier B.V. All rights reserved.
C1 Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA.
   SOLEIL Synchrotron, Orme Merisiers, F-91192 Gif Sur Yvette, France.
RP Miller, LM (reprint author), Brookhaven Natl Lab, Natl Synchrotron Light Source, Bldg 725 D,75, Upton, NY 11973 USA.
EM lmiller@bnl.gov
FU NIGMS NIH HHS [GM66873]
CR Aparicio S, 2002, CALCIFIED TISSUE INT, V70, P422, DOI 10.1007/s00223-001-1016-z
   Bantignies JL, 2000, J COSMET SCI, V51, P73
   Beney L, 2004, APPL MICROBIOL BIOT, V65, P457, DOI 10.1007/s00253-004-1574-x
   Bertrand L, 2003, J SYNCHROTRON RADIAT, V10, P387, DOI 10.1107/S0909049503015334
   Bosch RA, 1999, NUCL INSTRUM METH A, V431, P320, DOI 10.1016/S0168-9002(99)00267-3
   Bosch RA, 2000, NUCL INSTRUM METH A, V454, P497, DOI 10.1016/S0168-9002(00)00476-9
   Bosch RA, 2002, REV SCI INSTRUM, V73, P1423, DOI 10.1063/1.1435813
   Bosch RA, 2002, NUCL INSTRUM METH A, V492, P284, DOI 10.1016/S0168-9002(02)01233-0
   Briki F, 2000, CELL MOL BIOL, V46, P1005
   Busa B, 2005, CALCIFIED TISSUE INT, V77, P386, DOI 10.1007/s00223-005-0148-y
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   CARR GL, 1995, REV SCI INSTRUM, V66, P1643, DOI 10.1063/1.1145870
   CARR GL, 1995, REV SCI INSTRUM, V66, P1490, DOI 10.1063/1.1145951
   Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965
   Carr GL, 1997, P SOC PHOTO-OPT INS, V3153, P51
   Carr GL, 1999, VIB SPECTROSC, V19, P53, DOI 10.1016/S0924-2031(98)00048-4
   CARR GL, 2006, SPECTROCHEMICAL ANAL, P56
   Carrier D, 1997, EUR J SOL STATE INOR, V34, P733
   Chan KLA, 2005, APPL SPECTROSC, V59, P149, DOI 10.1366/0003702053085070
   Choo LP, 1996, BIOPHYS J, V71, P1672, DOI 10.1016/S0006-3495(96)79411-0
   Diem M, 2004, INFRARED PHYS TECHN, V45, P331, DOI 10.1016/j.infrared.2004.01.013
   DIEM M, 2002, BIOPOLYMERS, V67, P4
   Dokken KM, 2005, SPECTROSCOPY, V20, P14
   Dumas P, 2003, VIB SPECTROSC, V32, P3, DOI 10.1016/S0924-2031(03)00043-2
   Dumas P, 2003, J BIOL PHYS, V29, P201, DOI 10.1023/A:1024448910761
   DUNCAN WD, 1983, APPL OPTICS, V22, P2914, DOI 10.1364/AO.22.002914
   Fried D, 2002, LASER SURG MED, V31, P186, DOI 10.1002/lsm.10085
   Gallant M, 2006, J BIOL CHEM, V281, P5, DOI 10.1074/jbc.C500244200
   Globus TR, 2002, J APPL PHYS, V91, P6105, DOI 10.1063/1.1466878
   Gough KM, 2003, ANAL BIOCHEM, V316, P232, DOI 10.1016/S0003-2697(03)00039-3
   HANFLAND M, 1992, PHYS REV LETT, V69, P1129, DOI 10.1103/PhysRevLett.69.1129
   Heraud P, 2005, FEMS MICROBIOL LETT, V249, P219, DOI 10.1016/j.femsle.2005.06.021
   Holman HN, 2000, BIOPOLYMERS, V57, P329
   Holman HYN, 2000, ENVIRON SCI TECHNOL, V34, P2513, DOI 10.1021/es991430w
   Holman HYN, 2003, J BIOL PHYS, V29, P275, DOI 10.1023/A:1024465414395
   Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X
   Huang RY, 2003, BONE, V33, P514, DOI 10.1016/S8756-3282(03)00233-3
   Huang RY, 2002, BONE, V30, P492, DOI 10.1016/S8756-3282(01)00691-3
   Huffman SW, 2002, APPL SPECTROSC, V56, P965, DOI 10.1366/000370202760249684
   Humecki H., 1995, PRACTICAL APPL INFRA
   Jackson M, 2000, ENCY ANAL CHEM
   Jamin N, 2003, BIOPOLYMERS, V72, P366, DOI 10.1002/bip.10435
   Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837
   Kalasinsky KS, 1998, CELL MOL BIOL, V44, P81
   Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1
   Kneipp J, 2004, BIOPOLYMERS, V74, P163, DOI 10.1002/bip.20064
   Kneipp J, 2003, BBA-MOL BASIS DIS, V1639, P152, DOI 10.1016/j.bbadis.2003.08.005
   Kreisler AJ, 2000, SUPERCOND SCI TECH, V13, P1235, DOI 10.1088/0953-2048/13/8/321
   Lasch P, 2002, VIB SPECTROSC, V28, P147, DOI 10.1016/S0924-2031(01)00153-9
   LEWIS EN, 1995, ANAL CHEM, V67, P3377, DOI 10.1021/ac00115a003
   Marinkovic NS, 2002, J SYNCHROTRON RADIAT, V9, P189, DOI 10.1107/S0909049502008543
   MARINKOVIC NS, 2000, REV SCI INSTRUM
   Martin MC, 2001, APPL SPECTROSC, V55, P111, DOI 10.1366/0003702011951551
   Mathis YL, 2003, J BIOL PHYS, V29, P313, DOI 10.1023/A:1024429801191
   MESSERSCHMIDT RG, 1995, PRACTICAL GUIDE INFR, P3
   Miller LM, 2004, BONE, V35, P498, DOI 10.1016/j.bone.2004.03.034
   Miller LM, 2000, CELL MOL BIOL, V46, P1035
   Miller LM, 2001, BBA-GEN SUBJECTS, V1527, P11, DOI 10.1016/S0304-4165(01)00093-9
   Miller LM, 2002, REV SCI INSTRUM, V73, P1357, DOI 10.1063/1.1435824
   Miller LM, 2005, VIB SPECTROSC, V38, P237, DOI 10.1016/j.vibspec.2005.03.010
   Miller LM, 2003, J BIOL PHYS, V29, P219, DOI 10.1023/A:1024401027599
   MILLER LM, 2006, IN PRESS J STRUCT BI
   Nucara A, 2003, REV SCI INSTRUM, V74, P3934, DOI 10.1063/1.1602959
   Park SY, 1999, COLLOID SURFACE B, V15, P325, DOI 10.1016/S0927-7765(99)00098-3
   Raab TK, 2001, PLANTA, V213, P881, DOI 10.1007/s004250100554
   REFFNER JA, 1995, REV SCI INSTRUM, V66, P1298, DOI 10.1063/1.1145958
   Schade U, 2000, NUCL INSTRUM METH A, V455, P476, DOI 10.1016/S0168-9002(00)00507-6
   SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1
   Szczerbowska-Boruchowska M, 2005, X-RAY SPECTROM, V34, P514, DOI 10.1002/xrs.866
   TAGUE T, 2000, MICROSC TODAY, V2
   Tobin MJ, 2004, FARADAY DISCUSS, V126, P27, DOI 10.1039/b306689d
   UGAWA A, 1992, REV SCI INSTRUM, V63, P1551, DOI 10.1063/1.1143017
   Wang Q, 2005, VIB SPECTROSC, V38, P61, DOI 10.1016/j.vibspec.2005.02.023
   Wang Q, 2005, VIB SPECTROSC, V38, P217, DOI 10.1016/j.vibspec.2005.02.011
   Wetzel DL, 1999, SCIENCE, V285, P1224, DOI 10.1126/science.285.5431.1224
   Wetzel DL, 2003, VIB SPECTROSC, V31, P109, DOI 10.1016/S0924-2031(02)00100-5
   Wetzel DL, 1998, CELL MOL BIOL, V44, P15
   Wetzel DL, 1998, CELL MOL BIOL, V44, P145
   WILLIAMS GP, 1992, REV SCI INSTRUM, V63, P1535, DOI 10.1063/1.1143014
   Xie AH, 1999, BIOPOLYMERS, V49, P591, DOI 10.1002/(SICI)1097-0282(199906)49:7<591::AID-BIP5>3.0.CO;2-Q
   Yee N, 2004, ENVIRON SCI TECHNOL, V38, P775, DOI 10.1021/es0346680
   Yu P, 2005, J AGR FOOD CHEM, V53, P9297, DOI 10.1021/jf051748+
   Yu P, 2005, J STRUCT BIOL, V150, P81, DOI 10.1016/j.jsb.2005.01.005
   Yu PQ, 2004, J AGR FOOD CHEM, V52, P7345, DOI 10.1021/jf049291b
NR 84
TC 229
Z9 231
U1 5
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD JUL
PY 2006
VL 1758
IS 7
BP 846
EP 857
DI 10.1016/j.bbamem.2006.04.010
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 084ZE
UT WOS:000240572100004
PM 16781664
OA Bronze
DA 2018-10-20
ER

PT J
AU Mendelsohn, R
   Flach, CR
   Moore, DJ
AF Mendelsohn, Richard
   Flach, Carol R.
   Moore, David J.
TI Determination of molecular conformation and permeation in skin via IR
   spectroscopy, microscopy, and imaging
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Review
DE stratum comeum; IR microscopy and imaging; lipid phase behavior;
   liposome permeation
ID STRATUM-CORNEUM; INFRARED-SPECTROSCOPY; IN-VIVO; PENETRATION; MIXTURES;
   RAMAN; VESICLES; BARRIER; INVIVO; MODEL
AB Skin tissue, in addition to its specific use in dermal research, provides an excellent model for developing the techniques of vibrational microscopy and imaging for biomedical applications. In addition to permitting characterization of various regions of skin, the relative paucity of major biological constituents in the stratum corneum (the outermost layer of skin), permits us to image, with microscopic resolution, conformational alterations and concentration variations in both the lipid and protein components. Thus we are able to monitor the effects of exogenous materials such as models for drug delivery agents (liposomes) and permeation enhancers (DMSO) on stratum corneum lipid organization and protein structure. In addition, we are able to monitor protein conformational changes in single corneocytes. The current article demonstrates these procedures, ranging from direct univariate measures of lipid chain conformational disorder, to factor analysis which permits us to image conformational differences between liposomes that have permeated through the stratum corneum from those which have remained on the surface in a reservoir outside the skin. (c) 2006 Elsevier B.V. All rights reserved.
C1 Rutgers State Univ, Dept Chem, Newark Coll, Newark, NJ 07102 USA.
   Int Special Prod, Wayne, NJ 07470 USA.
RP Mendelsohn, R (reprint author), Rutgers State Univ, Dept Chem, Newark Coll, 73 Warren St, Newark, NJ 07102 USA.
EM mendelso@andromeda.rutgers.edu
FU NIGMS NIH HHS [GM-29864]
CR BLANK IH, 1984, J INVEST DERMATOL, V82, P188, DOI 10.1111/1523-1747.ep12259835
   BOMMANNAN D, 1990, J INVEST DERMATOL, V95, P403, DOI 10.1111/1523-1747.ep12555503
   Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028
   FORSLIND B, 1994, ACTA DERM-VENEREOL, V74, P1
   Honeywell-Nguyen PL, 2002, BBA-GEN SUBJECTS, V1573, P130
   Lafleur M, 1998, CAN J CHEM, V76, P1501, DOI 10.1139/cjc-76-11-1501
   LINDEMANN U, 2002, SKIN PHARMACOL, V16, P228
   MAK VHW, 1990, PHARMACEUT RES, V7, P835, DOI 10.1023/A:1015960815578
   Mendelsohn R, 2003, J BIOMED OPT, V8, P185, DOI 10.1117/1.1560645
   Moore DJ, 2006, J PHYS CHEM B, V110, P2378, DOI 10.1021/jp054875h
   Naik A, 1995, J CONTROL RELEASE, V37, P299, DOI 10.1016/0168-3659(95)00088-7
   ONGPIPATTANAKUL B, 1994, BBA-BIOMEMBRANES, V1190, P115, DOI 10.1016/0005-2736(94)90040-X
   Potard G, 2000, SKIN PHARMACOL APPL, V13, P336, DOI 10.1159/000029941
   RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620
   SNYDER RG, 1994, J PHYS CHEM-US, V98, P674, DOI 10.1021/j100053a049
   SNYDER RG, 1995, J PHYS CHEM-US, V99, P8432, DOI 10.1021/j100020a082
   URBAN MW, 1996, DC0841233489 ACS
   Xiao CH, 2005, VIB SPECTROSC, V38, P151, DOI 10.1016/j.vibspec.2005.02.017
   Xiao CH, 2004, APPL SPECTROSC, V58, P382, DOI 10.1366/000370204773580202
   Xiao CH, 2005, J INVEST DERMATOL, V124, P622, DOI 10.1111/j.0022-202X.2004.23608.x
   Zhang GJ, 2006, J INVEST DERMATOL, V126, P1088, DOI 10.1038/sj.jid.5700225
NR 21
TC 107
Z9 108
U1 1
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD JUL
PY 2006
VL 1758
IS 7
BP 923
EP 933
DI 10.1016/j.bbamem.2006.04.009
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 084ZE
UT WOS:000240572100013
PM 16730643
OA Bronze
DA 2018-10-20
ER

PT J
AU Sahiner, N
   Godbey, WT
   McPherson, GL
   John, VT
AF Sahiner, N
   Godbey, WT
   McPherson, GL
   John, VT
TI Microgel, nanogel and hydrogel-hydrogel semi-IPN composites for
   biomedical applications: synthesis and characterization
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE nanogel; nanocomposite; hydrogels; polymeric biomaterials; pH-sensitive
   nanohydrogel
ID SWELLING BEHAVIOR; DRUG-DELIVERY; MICROEMULSION; CROSS; PROBE; GENE
AB Quaternary ammonium salt hydrogels from a cationic monomer, (3-acrylamidopropyl)-trimethylammonium chloride (APTMACl), in a variety sizes such as bulk, micro- and nano- has been prepared. The synthesis of micro- and nanogels were carried out in the microenvironment of water-in-oil microemulsions using two types of surfactants, namely, L-alpha- phosphatidylcholine (lecithin) and dioctyl sulfosuccinate sodium salt (AOT). Additionally, hydrogel-hydrogel composite semi-interpenetrating polymer networks (semi-IPN) was synthesized by dispersing previously prepared micro/nanogel into neutral monomers such as acrylamide (AAm) or 2-hydroxylethyl methcarylate (HEMA) before network formation. Hydrogel swelling and pH response behaviors have been investigated for bulk gels. Morphology, structure, and size of nano-, micro- and bulk materials were explored utilizing transmission electron microcopy (TEM), scanning electron microscopy (SEM) and atomic force microscopy (AFM). It was confirmed with gel electrophoresis that completely charged nanogel form a strong complex with DNA.
C1 Tulane Univ, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA.
   Tulane Univ, Dept Chem, New Orleans, LA 70118 USA.
RP Sahiner, N (reprint author), Univ Delaware, 201 DuPont Hall, Newark, DE 19716 USA.
EM sahiner@udel.edu
RI John, Vijay/G-3747-2010; Godbey, W/H-9407-2012
OI John, Vijay/0000-0001-5426-7585; Sahiner, Nurettin/0000-0003-0120-530X
CR ANDREAS R, 1999, POLYMER, V40, P3545
   Bouillot P, 2000, COLLOID POLYM SCI, V278, P74, DOI 10.1007/s003960050012
   Braun O, 2001, POLYMER, V42, P8499, DOI 10.1016/S0032-3861(01)00445-1
   DAOJI G, 2001, J AM CHEM SOC, V123, P7511
   DEIGNACIO M, 2000, PHARM RES, V17, P817
   DONALD V, 1999, FUNDAMENTALS BIOCH, P219
   Eljarrat-Binstock E, 2004, J BIOMAT SCI-POLYM E, V15, P397, DOI 10.1163/156856204323005271
   Essler F, 2001, COLLOID POLYM SCI, V279, P405, DOI 10.1007/s003960000458
   Fenart L, 1999, J PHARMACOL EXP THER, V291, P1017
   Fumiyoshi I., 2003, LANGMUIR, V19, P2568
   Giammona G, 2000, COLLOID POLYM SCI, V278, P69, DOI 10.1007/s003960050011
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   ISAMU K, 2004, J COLLOID INTERF SCI, V175, P450
   JANUSZ MR, 1999, NUCL INSTRUM METH B, V151, P56
   JAROSLAV B, 2000, MACROMOLECULES, V33, P5353
   JASON EM, 2004, CHEM MATER, V16, P5574
   Jing Z., 2000, MACROMOLECULES, V33, P102
   JUN C, 1999, J BIOMED MATER RES, V44, P53
   Karlsson JO, 1997, POLYMER, V38, P4727, DOI 10.1016/S0032-3861(96)01075-0
   Karlsson JO, 1998, POLYMER, V39, P3589, DOI 10.1016/S0032-3861(97)10353-6
   KOERT NJB, 2002, NAT MED, V8, P81
   MARIA JV, 2004, BIOCHIM BIOPHYS ACTA, V1663, P135
   MARIETA N, 2001, J PHARM SCI, V90, P681
   McAllister K, 2002, J AM CHEM SOC, V124, P15198, DOI 10.1021/ja027759q
   NICHOLAS AB, 2004, J BIOMAT SCI-POLYM E, V15, P125
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Rosso F, 2003, MAT SCI ENG C-BIO S, V23, P371, DOI 10.1016/S0928-4931(02)00290-4
   SANJEEB KS, 1998, J COLLOID INTERF SCI, V206, P361
   Saraydin D, 1995, POLYM ADVAN TECHNOL, V6, P719, DOI 10.1002/pat.1995.220061201
   SERGEY K, 2002, MACROMOLECULES, V35, P1911
   Soppimath KS, 2002, DRUG DEV IND PHARM, V28, P957, DOI 10.1081/DDC-120006428
   STEFAAN CDS, 2000, PHARM RES, V17, P113
   VLADIMIR GS, 2002, J AM CHEM SOC, V124, P11324
   YOSHIHITO O, 1998, ADV MATER, V10, P827
   Zhao B, 2001, LANGMUIR, V17, P4758, DOI 10.1021/la001709m
   Zrinyi M, 2000, COLLOID POLYM SCI, V278, P98, DOI 10.1007/s003960050017
NR 36
TC 118
Z9 118
U1 4
U2 126
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD JUL
PY 2006
VL 284
IS 10
BP 1121
EP 1129
DI 10.1007/s00396-006-1489-4
PG 9
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 059NW
UT WOS:000238740500005
DA 2018-10-20
ER

PT J
AU Jang, HS
   Ryu, KE
   Ahn, WS
   Chun, HJ
   Dal Park, H
   Park, KD
   Kim, YH
AF Jang, Hong Seok
   Ryu, Kyu Eun
   Ahn, Woong Shick
   Chun, Heung Jae
   Dal Park, Hyung
   Park, Ki Don
   Kim, Young Ha
TI Complement activation by sulfonated poly(ethylene glycol)-acrylate
   copolymers through alternative pathway
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE biomaterials; poly(ethylene glycol); acrylate; copolymerization;
   sulfonation complement activation; alternative pathway
ID PLASMA-PROTEIN ADSORPTION; NEGATIVE CILIA CONCEPT; BLOOD COMPATIBILITY;
   POLYURETHANE SURFACE; PLATELET-ADHESION; MEMBRANE; PEO
AB Previously, novel poly(ethylene glycol) (PEG) and sulfonated PEG acrylate (PEG-SO(3)A/OA) copolymers were prepared as coating and/or blending materials for biomedical applications. Surfaces modified with copolymers exhibited increased anti-coagulation properties and decreased plasma adsorption level due to increased hydrophilic properties and reorientation characteristics of PEG/PEG-SO(3)A chains in water phase. As continuation study, anti-complement effects of PEG-SO3/OA copolymers were investigated in vitro. and compared with those of low-density polyethylene (LDPE) and PEG/OA. C3 activation by PEG-SO3/OA samples was lower than that by PEG/OA samples, which was attributed to decreased surface nucleophile level of samples. PEG-SO3/OA samples increased inhibition of Bb production. resulting in decreased C5 activation. Owing to reduced activations of C3 and C5, PEG-SO3/OA samples markedly decreased SC5b-9 levels in plasma. (C) 2006 Elsevier B.V. All rights reserved.
C1 Catholic Univ, Coll Med, Inst Cell & Tissue Engn, Seoul 137701, South Korea.
   Catholic Univ, Coll Med, Uijeongbu St Marys Hosp, Dept Therapeut Radiol, Uijongbu 480130, South Korea.
   Catholic Univ, Coll Med, Dept Biomed Sci, Seoul 137701, South Korea.
   Catholic Univ, Coll Med, Kangnam St Marys Hosp, Dept Obstet & Gynecol, Seoul 137701, South Korea.
   Govt Complex Daejeon, Korean Intellectual Property Off, Chem & Biotechnol Exam Bur, Taejon 302701, South Korea.
   Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
   Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju 500712, South Korea.
RP Chun, HJ (reprint author), Catholic Univ, Coll Med, Inst Cell & Tissue Engn, Seoul 137701, South Korea.
EM chunhj@catholic.ac.kr
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   BERGER M, 1994, J MATER SCI-MATER M, V5, P622, DOI 10.1007/BF00120343
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Dal Park H, 2002, J BIOMED MATER RES, V60, P186
   Dey RK, 2003, BIOMATERIALS, V24, P2985, DOI 10.1016/S0142-9612(03)00122-4
   Fushimi F, 1998, ARTIF ORGANS, V22, P821, DOI 10.1046/j.1525-1594.1998.06046.x
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HALL R, 1984, MED LAB HAEMATOLOGY, pCH3
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   JOHNSON RJ, 1996, IMMUNOLOGY COMPLEMEN, P173
   Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O
   KIDANE A, 2000, COLLOID SURFACE B, V18, P325
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Kopp R, 2002, ASAIO J, V48, P598, DOI 10.1097/01.MAT.0000033639.23941.7E
   Lee HJ, 2000, COLLOID SURFACE B, V18, P355, DOI 10.1016/S0927-7765(99)00161-7
   Lin WC, 2005, COLLOID SURFACE B, V44, P82, DOI 10.1016/j.colsurfb.2005.05.015
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Ryu KE, 2003, MACROMOL RES, V11, P451, DOI 10.1007/BF03218975
   Ryu KE, 2004, MACROMOL RES, V12, P46, DOI 10.1007/BF03218994
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   Yuan J, 2004, COLLOID SURFACE B, V39, P87, DOI 10.1016/j.colsurfb.2004.08.019
NR 25
TC 11
Z9 12
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2006
VL 50
IS 2
BP 141
EP 146
DI 10.1016/j.colsurfb.2006.03.024
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 065MG
UT WOS:000239163400008
PM 16797170
DA 2018-10-20
ER

PT J
AU Simmons, D
   Shaw, J
   McKenzie, A
   Eaton, S
   Cameron, AJ
   Zimmet, P
AF Simmons, D
   Shaw, J
   McKenzie, A
   Eaton, S
   Cameron, AJ
   Zimmet, P
TI Is grand multiparity associated with an increased risk of dysglycaemia?
SO DIABETOLOGIA
LA English
DT Article
DE diabetes; hysterectomy; menopause; oral contraceptive pill; parity
ID DEPENDENT DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; INDIAN WOMEN;
   LIFE-STYLE; PARITY; NIDDM; PREVALENCE; OBESITY
AB Aims/hypothesis: We sought to determine the risk of diabetes and IGT/IFG with grand multiparity. Subjects, materials and methods: Women, aged >= N25 years, from the Australian Diabetes, Obesity and Lifestyle Study and the Crossroads Undiagnosed Disease Study (a rural study in Victoria, Australia), participated in a household census (response 67 and 70%, respectively), subsequently attending a biomedical examination that included an oral glucose tolerance test (58% [6198] and 69% [819]). Results: After adjusting for age, obesity and socio-economic status, diabetes, but not IGT/IFG, was less common among women with a parity of 1 to 2 (odds ratio [OR]=0.64 [0.48-0.84]) and 3 to 4 (OR=0.72 [0.53-0.96]) than in grand multiparous women. This relationship was unrelated to past hysterectomy, use of the oral contraceptive pill or menopausal status. Conclusions/interpretation: Grand multiparity is associated with an increased risk of diabetes but not of IGT/IFG. We postulate that parity accelerates transition from IGT/IFG to diabetes, more than it does transition from normal glucose tolerance to IGT/IFG.
C1 Univ Auckland, Waikato Clin Sch, Waikato Hosp, Hamilton, New Zealand.
   Univ Melbourne, Dept Rural Hlth, Shepparton, Vic, Australia.
   Int Diabet Inst, Melbourne, Vic, Australia.
   Northumbria Healthcare NHS Trust, N Shields, England.
RP Simmons, D (reprint author), Univ Auckland, Waikato Clin Sch, Waikato Hosp, Private Bag 3200,Pembroke St, Hamilton, New Zealand.
EM simmonsd@waikatodhb.govt.nz
RI Shaw, Jonathan/E-7388-2010
OI Shaw, Jonathan/0000-0002-6187-2203; Cameron, Adrian/0000-0002-0568-5497;
   Simmons, David/0000-0003-0560-0761
CR ALDERMAN BW, 1993, DIABETES CARE, V16, P1557, DOI 10.2337/diacare.16.12.1557
   BOYKO EJ, 1990, DIABETES CARE, V13, P848, DOI 10.2337/diacare.13.8.848
   CHARLES MA, 1994, AM J MED, V97, P250, DOI 10.1016/0002-9343(94)90008-6
   ChasanTaber L, 1997, DIABETES CARE, V20, P330, DOI 10.2337/diacare.20.3.330
   COLLINS VR, 1991, DIABETES CARE, V14, P975, DOI 10.2337/diacare.14.11.975
   Cowan LD, 1997, J WOMENS HEALTH, V6, P441, DOI 10.1089/jwh.1997.6.441
   Diamanti-Kandarakis E, 2003, J CLIN ENDOCR METAB, V88, P1927, DOI 10.1210/jc.2002-021528
   Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829
   Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6
   Hanley AJG, 2002, DIABETES CARE, V25, P690, DOI 10.2337/diacare.25.4.690
   KRITZSILVERSTEIN D, 1989, NEW ENGL J MED, V321, P1214, DOI 10.1056/NEJM198911023211802
   MANSON JE, 1992, AM J MED, V93, P13, DOI 10.1016/0002-9343(92)90674-Z
   Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x
   OSULLIVAN JB, 1966, PUBLICATION NAT C 11, V1000
   Peters RK, 1996, LANCET, V347, P227, DOI 10.1016/S0140-6736(96)90405-5
   RIMM EB, 1992, DIABETOLOGIA, V35, P967, DOI 10.1007/BF00401427
   SIMMONS D, 1992, DIABETIC MED, V9, P706, DOI 10.1111/j.1464-5491.1992.tb01877.x
   SIMMONS D, 2005, INT J OBESITY LOND, P703
   Unwin N, 2002, DIABETIC MED, V19, P708
   *WHO, 1999, DEF DIAGN CLASS DI 1
   World Health Organization, 1998, OB PREV MAN GLOB EP
NR 21
TC 23
Z9 23
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD JUL
PY 2006
VL 49
IS 7
BP 1522
EP 1527
DI 10.1007/s00125-006-0276-6
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 049OO
UT WOS:000238026100009
PM 16752170
OA Bronze
DA 2018-10-20
ER

PT J
AU Haubner, R
AF Haubner, Roland
TI alpha(v)beta(3)-integrin imaging: a new approach to characterise
   angiogenesis?
SO EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
LA English
DT Article
DE angiogenesis; radiolabelled RGD peptides; integrin alpha(v)beta(3);
   tracer techniques; molecular imaging
ID CYCLIC RGD PEPTIDE; CANCER ALPHA(V)-INTEGRIN EXPRESSION; TUMOR
   ANGIOGENESIS; ALPHA-V-BETA-3 EXPRESSION; INTEGRIN EXPRESSION;
   CELL-ADHESION; MOUSE MODEL; IN-VITRO; MICROPET; PET
AB Overview: The field of angiogenesis research is one of the most rapidly growing biomedical disciplines. Great efforts are being made to develop anti-angiogenesis drugs for treatment of cancer as well as non-oncological diseases. Thus, imaging techniques allowing non-invasive monitoring of corresponding molecular processes will be of great interest. One target structure involved in the angiogenic process is the integrin alpha(v)beta(3), which mediates the migration of activated endothelial cells during vessel formation.
   Materials and methods: A variety of radiolabelled RGD peptides have been introduced for monitoring of alpha(v)beta(3) expression using nuclear medicine tracer techniques.
   Objectives: This review discusses tracer development and highlights some strategies for tracer optimisation. It summarises the preclinical and clinical data and discusses the potential of this class of tracer to characterise angiogenesis.
C1 Med Univ Innsbruck, Univ Klin Nukl Med, A-6020 Innsbruck, Austria.
RP Haubner, R (reprint author), Med Univ Innsbruck, Univ Klin Nukl Med, Anichstr 35, A-6020 Innsbruck, Austria.
EM Roland.Haubner@uibk.ac.at
CR Assa-Munt N, 2001, BIOCHEMISTRY-US, V40, P2373, DOI 10.1021/bi002101f
   AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D
   Beer AJ, 2006, J NUCL MED, V47, P763
   Beer AJ, 2005, J NUCL MED, V46, P1333
   BEER AJ, 2006, IN PRESS CLIN CANC R
   Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808
   Bishop GG, 2001, CIRCULATION, V103, P1906
   Bock M, 2000, J NUCL MED, V41, p41P
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Chavakis E, 2002, DIABETOLOGIA, V45, P262, DOI 10.1007/s00125-001-0727-z
   Chen XY, 2004, MOL IMAGING, V3, P96, DOI 10.1162/1535350041464892
   Chen XY, 2004, J NUCL MED, V45, P1776
   Chen XY, 2004, EUR J NUCL MED MOL I, V31, P1081, DOI 10.1007/s00259-003-1452-2
   Chen XY, 2004, BIOCONJUGATE CHEM, V15, P41, DOI 10.1021/bc0300403
   Chen XY, 2004, NUCL MED BIOL, V31, P11, DOI 10.1016/S0969-8051(03)00128-8
   Chen XY, 2004, MOL IMAGING BIOL, V6, P350, DOI 10.1016/j.mibio.2004.06.004
   Creamer D., 2002, Angiogenesis, V5, P231, DOI 10.1023/A:1024515517623
   ELICEIRI BP, 2000, CANCER J SCI AM, V6, P245
   Ellis LM, 2002, ONCOLOGY-NY, V16, P14
   FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811
   Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263
   Gasparini G, 1995, Cancer J Sci Am, V1, P131
   Hagedorn M, 2000, CRIT REV ONCOL HEMAT, V34, P89, DOI 10.1016/S1040-8428(00)00056-1
   Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Haubner R, 2001, CANCER RES, V61, P1781
   Haubner R, 2004, NUKLEARMED-NUCL MED, V43, P26
   Haubner R, 2004, BIOCONJUGATE CHEM, V15, P61, DOI 10.1021/bc034170n
   Haubner R, 2002, J NUCL MED, V43, p89P
   Haubner R, 1999, J NUCL MED, V40, P1061
   Haubner R, 2001, J NUCL MED, V42, P326
   Haubner R, 2004, CURR PHARM DESIGN, V10, P1439, DOI 10.2174/1381612043384745
   HAUBNER R, 2005, PLOS MED, V2, P29
   Haubner R., 1997, ANGEW CHEM INT EDIT, V3, p[36, 1374]
   Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918
   Janssen M, 2002, CANCER BIOTHER RADIO, V17, P641, DOI 10.1089/108497802320970244
   Janssen ML, 2002, CANCER RES, V62, P6146
   Kuwano M, 2001, INTERNAL MED, V40, P565, DOI 10.2169/internalmedicine.40.565
   Longo R., 2002, Angiogenesis, V5, P237, DOI 10.1023/A:1024532022166
   Matter A, 2001, DRUG DISCOV TODAY, V6, P1005, DOI 10.1016/S1359-6446(01)01939-0
   Mitjans F, 2000, INT J CANCER, V87, P716, DOI 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.3.CO;2-I
   MYOKEN Y, 1991, P NATL ACAD SCI USA, V88, P5818
   Ogawa M, 2003, NUCL MED BIOL, V30, P1, DOI 10.1016/S0969-8051(02)00387-6
   Patel SR, 2001, CANCER, V92, P1347, DOI 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO;2-0
   Pichler BJ, 2005, J NUCL MED, V46, P184
   Pichler BJ, 2002, J NUCL MED, V43, p122P
   Poethko T, 2004, RADIOCHIM ACTA, V92, P317, DOI 10.1524/ract.92.4.317.35591
   Poethko T, 2004, J NUCL MED, V45, P892
   Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003
   Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Smith Jeffrey W, 2003, Curr Opin Investig Drugs, V4, P741
   Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756
   Su Z, 2002, BIOCONJUGATE CHEM, V13, P561, DOI 10.1021/bc0155566
   Su ZF, 2003, NUCL MED BIOL, V30, P141, DOI 10.1016/S0969-8051(02)00390-6
   Thumshirn G, 2003, CHEM-EUR J, V9, P2717, DOI 10.1002/chem.200204304
   van Hagen PM, 2000, INT J CANCER, V90, P186, DOI 10.1002/1097-0215(20000820)90:4<186::AID-IJC2>3.0.CO;2-P
   Wang W, 2005, CANCER BIOTHER RADIO, V20, P547, DOI 10.1089/cbr.2005.20.547
   Wu Y, 2005, J NUCL MED, V46, P1707
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Zhang XZ, 2006, J NUCL MED, V47, P113
NR 62
TC 70
Z9 72
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1619-7070
J9 EUR J NUCL MED MOL I
JI Eur. J. Nucl. Med. Mol. Imaging
PD JUL
PY 2006
VL 33
SU 13
BP S54
EP S63
DI 10.1007/s00259-006-0136-0
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 058DK
UT WOS:000238644800009
PM 16791598
DA 2018-10-20
ER

PT J
AU Denkbas, EB
   Ottenbrite, RM
AF Denkbas, EB
   Ottenbrite, RM
TI Perspectives on: Chitosan drug delivery systems based on their
   geometries
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Review
DE chitosan; microsphere; nanoparticle; membrane; sponge; rod; drug
   delivery; drug carrier; chitosan hydrogel
ID WOUND DRESSING MATERIAL; IN-VITRO RELEASE; COMPOSITE SCAFFOLDS;
   IONOTROPIC GELATION; DNA NANOPARTICLES; PROTEIN DELIVERY; CROSS-LINKING;
   MICROSPHERES; BEADS; CARRIERS
AB Chitosan is a natural polymer that has many physicochemical (polycationic, reactive OH and NH2 groups) and biological (bioactive, biocompatible, biodegradable) properties. These unique properties make chitosan an excellent material for the development of new biomedical applications. One of the most well known biomedical chitosan applications is in drug delivery systems. Chitosans have been used in the design of many different types of drug carriers for various administration routes such as oral, bucal, nasal, transdermal, parenteral, vaginal, cervical, intrauterine and rectal. Chitosan can be engineered into different shapes and geometries such as nanoparticles, microspheres, membranes, sponges and rods. This paper is a perspective on the preparation of the chitosan drug delivery systems based on different structural geometries. In this respect, special preparation techniques are used to prepare chitosan drug carriers by altering such parameters as crosslinker concentration, chitosan molecular weight, drug/polymer ratio and processing conditions all of which affect the morphology of chitosan drug carriers and release rate of the loaded drug.
C1 Hacettepe Univ, Dept Chem, Div Biochem, TR-06800 Ankara, Turkey.
   Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA.
RP Denkbas, EB (reprint author), Hacettepe Univ, Dept Chem, Div Biochem, TR-06800 Ankara, Turkey.
EM denkbas@hacettepe.edu.tr
CR ALLAN G, 1972, P S MANM POL PAP MAK
   AMIJI MM, 1996, PHARM RES, V13, P588
   Avadi MR, 2003, J BIOACT COMPAT POL, V18, P469, DOI 10.1177/0883911503040432
   Balassa LL, 1978, P 1 INT C CHIT CHIT
   Blanco MD, 2000, INT J PHARM, V202, P29, DOI 10.1016/S0378-5173(00)00408-7
   BODMEIER R, 1989, DRUG DEV IND PHARM, V15, P1475, DOI 10.3109/03639048909062758
   Bonina P, 2004, J BIOACT COMPAT POL, V19, P197, DOI 10.1177/0883911504044455
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P103
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225
   Chandy T, 1996, BIOMATERIALS, V17, P61, DOI 10.1016/0142-9612(96)80756-3
   CHEIN YW, 1992, NOVEL DRUG DELIVERY, P381
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Cui K, 2004, J BIOACT COMPAT POL, V19, P17, DOI 10.1177/0883911504042121
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   Denkbas EB, 2000, J APPL POLYM SCI, V76, P1637, DOI 10.1002/(SICI)1097-4628(20000613)76:11<1637::AID-APP4>3.0.CO;2-Q
   Denkbas EB, 2004, J BIOMATER APPL, V18, P291, DOI 10.1177/0885328204041510
   Denkbas EB, 2003, J BIOACT COMPAT POL, V18, P177, DOI 10.1177/088391103035388
   Denkbas EB, 1999, J MICROENCAPSUL, V16, P741
   Denkbas EB, 2002, J APPL POLYM SCI, V86, P3035, DOI 10.1002/app.11318
   DODANE V, 1998, PSTT, V1, P6
   Dureja H, 2001, INT J PHARM, V213, P193, DOI 10.1016/S0378-5173(00)00666-9
   Ehrenfreund-Kleinman T, 2003, J BIOACT COMPAT POL, V18, P323, DOI 10.1177/088391103038234
   EROGLU M, INT J PHARM, V235, P51
   Fernandez-Urrusuno R, 1999, PHARMACEUT RES, V16, P1576, DOI 10.1023/A:1018908705446
   Genta I, 1998, CARBOHYD POLYM, V36, P81, DOI 10.1016/S0144-8617(98)00022-8
   Genta I, 1997, INT J PHARM, V152, P237, DOI 10.1016/S0378-5173(97)00096-3
   Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X
   Hata H, 2000, BIOMATERIALS, V21, P1779, DOI 10.1016/S0142-9612(00)00069-7
   HAYASHI T, 1991, J APPL POLYM SCI, V42, P85, DOI 10.1002/app.1991.070420110
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   HIRANO S, 1994, ULLMANS ENCY IND CHE, P231
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   HWANG C, 1986, CHITIN NATURE TECHNO, P389
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Kenawy ER, 2005, J BIOACT COMPAT POL, V20, P95, DOI 10.1177/0883911505049655
   Khalaf SA, 2004, INT J AGRIC BIOL, V6, P1033
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   KINEZLESTERZER CA, 1983, MAKROMOL CHEM, V183, P1353
   Ko JA, 2002, INT J PHARM, V249, P165, DOI 10.1016/S0378-5173(02)00487-8
   Le Y, 1997, INDIAN J FIBRE TEXT, V22, P337
   Lim LY, 1997, DRUG DEV IND PHARM, V23, P981, DOI 10.3109/03639049709149150
   Liu WG, 2002, J CONTROL RELEASE, V83, P1
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   MALETTE WG, 1983, ANN THORAC SURG, V36, P55, DOI 10.1016/S0003-4975(10)60649-2
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Mark H. F., 1985, ENCY POLYM SCI ENG, V1, P20
   MARKEY ML, 1989, CHITIN CHITOSAN, P713
   MECLEAN S, 1998, EUR J PHARM SCI, V6, P153
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mi FL, 2001, J APPL POLYM SCI, V81, P1700, DOI 10.1002/app.1602.abs
   MITANI T, 1995, J ENVIRON SCI HEAL A, V30, P669, DOI 10.1080/10934529509376224
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   Muzzarelli RAA, 1999, CHITIN CHITINASES
   NAGYVARY JJ, 1979, NUTR REP INT, V20, P677
   OSHIMA Y, 1987, EUR J PLAST SURG, V10, P66
   Oungbho K, 1997, INT J PHARM, V156, P229, DOI 10.1016/S0378-5173(97)00201-9
   OZTURK E, 2006, IN PRESS INT J ARTIF
   Pan Y, 2002, INT J PHARM, V249, P139, DOI 10.1016/S0378-5173(02)00486-6
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1
   Roy K, 1999, NAT MED, V5, P387
   SANDFORD PA, 1988, P 4 INT C CHIT CHIT, P51
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   Senkoylu A, 2001, J BIOACT COMPAT POL, V16, P136, DOI 10.1106/3EH5-2R73-RC4V-Y9L7
   SHAHABEDDIN L, 1991, J MATER SCI-MATER M, V2, P222, DOI 10.1007/BF00703375
   Shi XY, 2002, BIOMATERIALS, V23, P4469, DOI 10.1016/S0142-9612(02)00165-5
   Shi YC, 1996, J CHROMATOGR A, V742, P107, DOI 10.1016/0021-9673(96)00260-9
   SHIRAISHI S, 1993, J CONTROL RELEASE, V25, P217, DOI 10.1016/0168-3659(93)90080-O
   Shu X, 2000, INT J PHARM, V201, P51, DOI 10.1016/S0378-5173(00)00403-8
   Shu XZ, 2001, J MICROENCAPSUL, V18, P237
   Stoilova O, 2001, J BIOACT COMPAT POL, V16, P379, DOI 10.1106/79TU-6C9K-EP62-N051
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Tan TW, 2003, J BIOACT COMPAT POL, V18, P207, DOI 10.1177/088391103035384
   Tucci MG, 2001, J BIOACT COMPAT POL, V16, P145, DOI 10.1106/NYTK-W829-UWC1-PMLW
   Vandenberg GW, 2001, J CONTROL RELEASE, V77, P297, DOI 10.1016/S0168-3659(01)00517-X
   Vasudev SC, 1997, BIOMATERIALS, V18, P375, DOI 10.1016/S0142-9612(96)00131-7
   Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang XH, 2003, J BIOACT COMPAT POL, V18, P135, DOI 10.1177/088391103033857
   Xin-Yuan S., 2004, J BIOACT COMPAT POLY, V19, P467
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YAO KD, 1995, J MACROMOL SCI R M C, VC35, P155, DOI 10.1080/15321799508014592
   Yongmei X Y D, 2003, INT J PHARMACEUT, V250, P215
   Zeng XF, 1998, J MEMBRANE SCI, V148, P195, DOI 10.1016/S0376-7388(98)00183-5
   Zhang M, 2003, J BIOACT COMPAT POL, V18, P391, DOI 10.1177/088391103039019
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zhou SB, 2001, J CONTROL RELEASE, V75, P27, DOI 10.1016/S0168-3659(01)00379-0
NR 102
TC 91
Z9 92
U1 1
U2 72
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2006
VL 21
IS 4
BP 351
EP 368
DI 10.1177/0883911506066930
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 059UZ
UT WOS:000238759000006
DA 2018-10-20
ER

PT J
AU Kannan, RY
   Salacinski, HJ
   Vara, DS
   Odlyha, M
   Seifalian, AM
AF Kannan, Ruben Y.
   Salacinski, Henryk J.
   Vara, Dina S.
   Odlyha, Marianne
   Seifalian, Alexander M.
TI Review paper: Principles and applications of surface analytical
   techniques at the vascular interface
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Review
DE polymer; vascular interface; electron spectroscopy; microcalorimetry;
   X-ray surface analytical techniques; ATR-Fourier transform infrared and
   Raman spectroscopy; electron probe; ion probe techniques
ID ION MASS-SPECTROMETRY; ENHANCED RAMAN-SCATTERING; ENDOTHELIAL-CELL
   GROWTH; ATOMIC-FORCE MICROSCOPY; AIR-WATER-INTERFACE; HUMAN
   SERUM-ALBUMIN; POLYMER SURFACES; IN-VITRO; SEGMENTED POLYURETHANE;
   BIOMATERIAL SURFACES
AB Surface properties have been found to be one of the key parameters which cause degradation and of thrombogenicity in all polymers used in biomedical devices, thus signifying the importance and the necessity for quantitative and accurate characterization of the polymer surface itself as used in the construction of the device. The characterization techniques employed generally involve thermal and spectroscopic measurements, in which class the electrochemical investigations and scanning probe microscopies can also be included. Current hypotheses on the correlations that exist between surface parameters and hemocompatibility and degradation of polymers are examined herein, but concentrating on the field of clinically utilized polymeric materials as used within medical devices themselves. Furthermore, this review provides a brief but complete synopsis of these techniques and other emerging ones, which have proven useful in the analysis of the surface properties of polymeric materials as used in the construction of cardiovascular devices. Statements and examples are given as to how specific information can be acquired from these differing methodologies and how it aids in the design and development of new polymers for usage in biomedical device construction.
C1 UCL, Acad Div Surg & Intervent Sci, BTEC, London, England.
   Univ London, Dept Chem Mat, Birkbeck Coll, London, England.
   Royal Free Hampstead NHS Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, Acad Div Surg & Intervent Sci, BTEC, Mortimer St, London, England.
EM a.seifalian@medsch.ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Amato I, 1997, SCIENCE, V276, P1982, DOI 10.1126/science.276.5321.1982
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   Aziz CA, 1996, J BIOMED MATER RES, V32, P193, DOI 10.1002/(SICI)1097-4636(199610)32:2<193::AID-JBM7>3.0.CO;2-O
   BAIER RE, 1971, FED PROC, V30, P1523
   Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Barbucci R, 2002, BIOMOL ENG, V19, P161, DOI 10.1016/S1389-0344(02)00022-9
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Blandamer MJ, 2003, CHEM SOC REV, V32, P264, DOI 10.1039/b207308k
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   Burns NL, 1998, BIOMATERIALS, V19, P423, DOI 10.1016/S0142-9612(97)00225-1
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chen Z, 1999, J BIOMAT SCI-POLYM E, V10, P901
   Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Dal Ponte DB, 2002, J ENDOVASC THER, V9, P333, DOI 10.1583/1545-1550(2002)009<0333:AAHAWA>2.0.CO;2
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Drude P, 1889, ANN PHYS CHEM, V272, P865
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Ghanbari-Siahkali A, 2003, APPL SPECTROSC, V57, P1482, DOI 10.1366/000370203322640116
   Gillen G, 1998, RAPID COMMUN MASS SP, V12, P1303, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1303::AID-RCM330>3.0.CO;2-7
   Goessl A, 2001, J BIOMAT SCI-POLYM E, V12, P721, DOI 10.1163/156856201750411620
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P465, DOI 10.1002/jbm.820150403
   GRANERO L, 1993, EUR J PHARM SCI, V1, P3, DOI 10.1016/0928-0987(93)90012-Y
   GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054
   GROBE GL, 1987, J BIOMED MATER RES, V21, P211, DOI 10.1002/jbm.820210206
   Grundke K, 1996, PROG COLL POL SCI S, V101, P58
   GUIDOIN P, 1994, ASIAO J, V40, pM870
   GUIDOIN R, 1993, BIOMATERIALS, V14, P694, DOI 10.1016/0142-9612(93)90068-D
   Hanlon E.B., 2000, PHYS MED BIOL, V45, P1
   Harzallah B, 1998, INT J BIOL MACROMOL, V23, P73, DOI 10.1016/S0141-8130(98)00035-X
   HODGKIN JH, 1990, BIOMATERIALS, V11, P9, DOI 10.1016/0142-9612(90)90044-Q
   Houlne MP, 2002, ANAL CHEM, V74, P4311, DOI 10.1021/ac020325t
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Iwasaki Y, 2003, J BIOMED MATER RES A, V65A, P164, DOI 10.1002/jbm.a.10459
   Jansson E, 2001, BIOMATERIALS, V22, P1803, DOI 10.1016/S0142-9612(00)00359-8
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Ji J, 2001, BIOMATERIALS, V22, P3015, DOI 10.1016/S0142-9612(01)00048-5
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   KANNAN RY, IN PRESS PLAST RECON
   Kellner R., 1998, ANAL CHEM
   KHATTAB MA, 1995, J DRUG TARGET, V3, P39, DOI 10.3109/10611869509015931
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kinumi T, 2000, J MASS SPECTROM, V35, P417, DOI 10.1002/(SICI)1096-9888(200003)35:3<417::AID-JMS952>3.0.CO;2-#
   Kirby BJ, 2003, LAB CHIP, V3, P5, DOI 10.1039/b21062ln
   LEE G, 1989, SCIENCE, V244, P475, DOI 10.1126/science.2470146
   Lee GJ, 2002, TETRAHEDRON-ASYMMETR, V13, P9, DOI 10.1016/S0957-4166(02)00044-7
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee KY, 1997, IEEE ELECTR DEVICE L, V18, P4, DOI 10.1109/55.553058
   Lee LT, 1999, J PHYS CHEM B, V103, P7489, DOI 10.1021/jp991032f
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P487, DOI 10.1002/jbm.b.10044
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Li YL, 2003, BIOTECHNOL BIOENG, V84, P305, DOI 10.1002/bit.10757
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   LU JR, 1995, J PHYS CHEM-US, V99, P8233, DOI 10.1021/j100020a055
   Lyman DJ, 2001, J BIOMED MATER RES, V58, P221, DOI 10.1002/1097-4636(2001)58:3<221::AID-JBM1011>3.3.CO;2-M
   Magoshi T, 2002, BIOMACROMOLECULES, V3, P976, DOI 10.1021/bm0200377
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McAnally GD, 2003, APPL SPECTROSC, V57, P44, DOI 10.1366/000370203321165197
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Murray-Wijelath J, 2004, J BIOMED MATER RES B, V70B, P223, DOI 10.1002/jbm.b.30044
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Notingher I, 2003, APPL SPECTROSC, V57, P1494, DOI 10.1366/000370203322640134
   OKOSHI T, 1993, J THORAC CARDIOV SUR, V105, P791
   Oleinikov VA, 1998, BIOORG KHIM+, V24, P412
   Olivieri MP, 1999, J BIOMED MATER RES, V46, P355, DOI 10.1002/(SICI)1097-4636(19990905)46:3<355::AID-JBM7>3.0.CO;2-O
   PASIC M, 1994, ANN THORAC SURG, V58, P677, DOI 10.1016/0003-4975(94)90726-9
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Polzonetti G, 2000, BIOMATERIALS, V21, P1531, DOI 10.1016/S0142-9612(00)00025-9
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   RATNER BD, 1993, CLIN MATER, V13, P71, DOI 10.1016/0267-6605(93)90093-M
   Renke-Gluszko M, 2004, BIOMATERIALS, V25, P5191, DOI 10.1016/j.biomaterials.2003.12.021
   Riepe G, 1997, EUR J VASC ENDOVASC, V13, P540, DOI 10.1016/S1078-5884(97)80062-7
   Riviere J.C., 1990, SURFACE ANAL TECHNIQ
   RYU GH, 1995, J BIOMED MATER RES, V29, P403, DOI 10.1002/jbm.820290315
   Saito N, 1997, BIOMATERIALS, V18, P1195, DOI 10.1016/S0142-9612(97)00046-X
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sanchez-Cortes S, 2002, BIOMACROMOLECULES, V3, P655, DOI 10.1021/bm015640o
   Sawyer P N, 1968, Ann N Y Acad Sci, V146, P49, DOI 10.1111/j.1749-6632.1968.tb20270.x
   SEEGER JM, 1995, J VASC SURG, V22, P327, DOI 10.1016/S0741-5214(95)70148-6
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   Soldani G, 2002, J MICROSC-OXFORD, V206, P139, DOI 10.1046/j.1365-2818.2002.01021.x
   SUNNER J, 1995, ANAL CHEM, V67, P4335, DOI 10.1021/ac00119a021
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tanyanyiwa J, 2002, ELECTROPHORESIS, V23, P3659, DOI 10.1002/1522-2683(200211)23:21<3659::AID-ELPS3659>3.0.CO;2-M
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   UCHIDA N, 1993, J BIOMED MATER RES, V27, P1269, DOI 10.1002/jbm.820271007
   Vasilets VN, 1997, BIOMATERIALS, V18, P1139, DOI 10.1016/S0142-9612(97)00045-8
   von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129
   VONVON RA, 1996, ANAL BIOANAL CHEM, V355, P543
   Vyorykka J, 2003, APPL SPECTROSC, V57, P1123, DOI 10.1366/00037020360695982
   Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Wetzels GMR, 1999, BIOMATERIALS, V20, P1879, DOI 10.1016/S0142-9612(99)00067-8
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Wu ZY, 2002, ELECTROPHORESIS, V23, P782, DOI 10.1002/1522-2683(200203)23:5<782::AID-ELPS782>3.0.CO;2-K
   Wulf M, 1999, J COLLOID INTERF SCI, V210, P172, DOI 10.1006/jcis.1998.5942
   Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g
   Xu YD, 2003, ANAL CHEM, V75, P185, DOI 10.1021/ac025907p
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
   Zheng JW, 2000, SPECTROSC SPECT ANAL, V20, P814
NR 117
TC 17
Z9 19
U1 4
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2006
VL 21
IS 1
BP 5
EP 32
DI 10.1177/0885328206065728
PG 28
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056QU
UT WOS:000238541000001
PM 16684795
DA 2018-10-20
ER

PT J
AU Silva, RA
   Silva, IP
   Rondot, B
AF Silva, RA
   Silva, IP
   Rondot, B
TI Effect of surface treatments on anodic oxide film growth and
   electrochemical properties of tantalum used for biomedical applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE AFM; anodic films; coronary stents; polarization; tantalum
ID SHAPE-MEMORY ALLOY; CORROSION BEHAVIOR; STAINLESS-STEEL; STENT;
   ANGIOPLASTY; ELECTRODES; RESISTANCE; LAYERS
AB Self-expandable nitinol (nickel-titanium) alloys and 316L stainless steel are the most commonly used materials in the production of coronary stents. However, tantalum (Ta) has already been used to make stents for endovascular surgery and may constitute an alternative to other materials because of its better electrochemical performance, namely its higher corrosion resistance, as well as its radio-opacity. The characterization of wet polished, chemically polished, wet polished anodized, and chemically polished anodized Ta electrodes has been performed in a 0.15M NaCl solution (simulated body fluid) using U-corr = f(t) measurements, anodic polarizations, capacity measurements, anodic oxidations, and atomic force microscopy (AFM) imaging. Anodic polarization curves have shown that the abnormal current density peak with a maximum value around 1.65V (critical applied potential, U-c) disappeared for the anodized electrodes indicating a probable relationship between the surface states and the film growth. These results are confirmed by capacity measurements. The behavior of wet polished and chemically polished electrodes during anodic oxidations seemingly indicated that for these particular treatments the film growth is different. The AFM images and roughness measurements have shown that chemical polishing produced smoother electrodes, a fact probably related to the differences in film growth.
C1 ISEP, CIEA, Inst Super Engn, P-4200072 Oporto, Portugal.
   INEB, Inst Biomed Engn, P-4150180 Oporto, Portugal.
   CNRS, CECM, F-94407 Vitry Sur Seine, France.
RP Silva, RA (reprint author), ISEP, CIEA, Inst Super Engn, Rua Dr Antonio Bernardino Almeida,431, P-4200072 Oporto, Portugal.
EM ras@isep.ipp.pt
OI Silva, Rui Alberto Goncalves/0000-0003-1359-1500
CR Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Cheng Y, 2004, SURF COAT TECH, V186, P346, DOI 10.1016/j.surfcoat.2004.01.012
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   GOY JJ, 1995, CATHETER CARDIO DIAG, V34, P128, DOI 10.1002/ccd.1810340410
   HAMASAKI N, 1995, CATHETER CARDIOV DIA, V42, P166
   HAMM CW, 1995, AM HEART J, V129, P423, DOI 10.1016/0002-8703(95)90262-7
   JONHSON PF, 1997, J BIOMED MATER RES, V11, P637
   KERREC O, 1995, ELECTROCHIM ACTA, V40, P719, DOI 10.1016/0013-4686(94)00330-4
   LEWERENZ HJ, 1992, ELECTROCHIM ACTA, V37, P847, DOI 10.1016/0013-4686(92)85037-L
   LOHRENGEL MM, 1994, ELECTROCHIM ACTA, V39, P1265, DOI 10.1016/0013-4686(94)E0046-3
   MACAGNO V, 1984, J ELECTROANAL CHEM, V180, P157, DOI 10.1016/0368-1874(84)83577-7
   Macionczyk F, 2001, SURF COAT TECH, V142, P1084, DOI 10.1016/S0257-8972(01)01096-9
   PARK JB, 1994, BIOMATERIALS SCI ENG, P217
   PIPPEN CMJ, 1997, J MATER SCI-MATER M, V8, P781
   Rieger J, 2004, CARDIOVASC INTER RAD, V27, P339, DOI 10.1007/s00270-003-2686-x
   SCHABALOVSKAYA S, 2003, J BIOMED MATER RES B, V66, P331
   SCHULTZE JW, 1986, ELECTROCHIM ACTA, V31, P355, DOI 10.1016/0013-4686(86)80090-1
   SEAH MP, 1988, NUCL INSTRUM METH B, V30, P128, DOI 10.1016/0168-583X(88)90109-7
   Shih CC, 2000, J BIOMED MATER RES, V52, P323
   Shih CC, 2003, J BIOMED MATER RES A, V67A, P1320, DOI 10.1002/jbm.a.20013
   Silva RA, 2002, J MATER SCI-MATER M, V13, P495, DOI 10.1023/A:1014779008598
   SILVA RA, 1998, P 14 EUR C BIOM HAG, P37
   STACKPOOL GJ, 1995, P COMB ORTH RES SOC, P45
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Strecker EPK, 2001, CARDIOVASC INTER RAD, V24, P168, DOI 10.1007/s002700002526
   Tan L, 2002, J MATER SCI-MATER M, V13, P501, DOI 10.1023/A:1014735225436
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Young L., 1961, ANODIC OXIDE FILMS
NR 30
TC 11
Z9 12
U1 0
U2 22
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2006
VL 21
IS 1
BP 93
EP 103
DI 10.1177/0885328206056378
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056QU
UT WOS:000238541000005
PM 16443631
DA 2018-10-20
ER

PT J
AU Williams, SK
   Kleinert, LB
   Hagen, KM
   Clapper, DL
AF Williams, SK
   Kleinert, LB
   Hagen, KM
   Clapper, DL
TI Covalent modification of porous implants using extracellular matrix
   proteins to accelerate neovascularization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE laminin 1; extracellular matrix; ePTFE; angiogenesis; neovascularization
ID FIBROBLAST-GROWTH-FACTOR; POLYTETRAFLUOROETHYLENE GRAFTS;
   ADIPOSE-TISSUE; ANGIOGENESIS; POROSITY; CELLS; EPTFE; DIFFERENTIATION;
   COMPONENTS; ADHESION
AB Healing associated with many polymeric biomedical implants commonly involves the formation of an avascular fibrous capsule. The lack of either formation or persistence of blood vessels in formed fibrous capsules, as well as a lack of new blood vessels within porous polymeric implants, often results in poor performance of the implant. The current study evaluated the use of extracellular matrix protein modification of a commonly used biomedical implant material, expanded polytetrafluoroethylene (ePTFE), as a mechanism to increase the neovascularization both within these porous implants and in tissue that forms in the peri-implant area. Discs of ePTFE were covalently modified with different extracellular matrix proteins including collagen type IV, fibronectin, and laminin type I. Discs were implanted into the adipose tissue of adult rats, and following a 5-week implant phase, histologic analysis of peri-implant tissue angiogenesis and implant neovascularization was performed. Striking differences were observed in angiogenic and neovascularization responses to matrix-modified ePTFE when compared with control, untreated ePTFE. Fibronectin treatment resulted in an extensive inflammatory response but, relative to the degree of inflammation, limited evidence of tissue angiogenesis or polymer neovascularization. Collagen type IV treatment groups exhibited a significant increase in angiogenesis in the peri-implant tissue with minimal evidence of implant neovascularization. In contrast to all other implant modifications, laminin type 1-treated ePTFE samples stimulated an extensive peri-implant tissue angiogenic response and a coordinate neovascularization of the porous interstices of the biomaterial. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA.
EM skwill@u.arizona.edu
FU NHLBI NIH HHS [HL 063875]
CR AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   Bando H, 2000, ADV EXP MED BIOL, V476, P267
   Berney T, 1999, CELL TRANSPLANT, V8, P577, DOI 10.1177/096368979900800602
   Black AF, 1998, FASEB J, V12, P1331
   Boswell CA, 1999, J BIOMED MATER RES, V48, P591, DOI 10.1002/(SICI)1097-4636(1999)48:5<591::AID-JBM1>3.0.CO;2-9
   Chaplain MAJ, 1996, INVAS METAST, V16, P222
   CHENG YF, 1989, J CELL PHYSIOL, V139, P275, DOI 10.1002/jcp.1041390209
   CLAPPER DL, 1994, T SOC BIOMATER, V17, P345
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Grant D S, 1997, EXS, V79, P317
   Hoying JB, 1996, J CELL PHYSIOL, V168, P294, DOI 10.1002/(SICI)1097-4652(199608)168:2<294::AID-JCP8>3.0.CO;2-K
   Kanda S, 1999, EXP CELL RES, V248, P203, DOI 10.1006/excr.1999.4400
   KOHLER TR, 1992, SURGERY, V112, P901
   Ling SH, 1999, HYPERTENSION, V34, P1141, DOI 10.1161/01.HYP.34.5.1141
   Lugassy C, 1999, J CUTAN PATHOL, V26, P78, DOI 10.1111/j.1600-0560.1999.tb01806.x
   MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153
   Rongish BJ, 1996, J MOL CELL CARDIOL, V28, P2203, DOI 10.1006/jmcc.1996.0212
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
NR 21
TC 10
Z9 11
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 59
EP 65
DI 10.1002/jbm.a.30659
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900008
PM 16602088
DA 2018-10-20
ER

PT J
AU Zhang, M
   King, R
   Hanes, M
   James, SP
AF Zhang, Min
   King, Richard
   Hanes, Mark
   James, Susan P.
TI A novel ultra high molecular weight polyethylene-hyaluronan
   microcomposite for use in total joint replacements. I. Synthesis and
   physical/chemical characterization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronan; polyethylene; microcomposite; surface modification; total
   joint replacements
ID SURFACE MODIFICATION; SILYLATION; COATINGS; UHMWPE; ASSAY
AB A novel microcomposite between ultra high molecular weight polyethylene (UHMWPE) and hyaluronan (HA) was developed to create a hydrophilic and lubricious UHMWPE surface for total joint replacement and other biomedical load-bearing applications. Preforms with interconnected micropores were used as the UHMWPE starting material to form a microcomposite with HA, rather than starting with fully dense, bulk UHMWPE. HA was silylated first to increase its hydrophobicity and compatibility with UHMWPE. The silylated groups were removed through hydrolysis prior to final compression molding. A uniform and enzymatic degradation resistant HA film layer was produced on the microcomposite surface, which quickly hydrated in water, forming a lubricious surface film that was fully wetted by water drops during contact angle measurements. Presence of HA film on the composite surface was also demonstrated through X-ray photoelectron spectroscopy analysis and Toluidine Blue 0 dye assay. The mechanical and tribological properties evaluation of the novel microcomposites are presented in Part II. (c) 2006 Wiley Periodicals, Inc.
C1 Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
   DePuy Orthopaed Inc, Warsaw, IN USA.
RP James, SP (reprint author), Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
EM sjames@lamar.colostate.edu
CR BAILEY FE, 1981, ACS SYM SER, V172, P127
   Balazs E. A., 1985, US Patent, Patent No. 4500676
   BEAUREGARD GP, 1999, THESIS COLORADO STAT
   Beavers E. M., 1992, US Patent, Patent No. 5148311
   Beavers E. M., 1987, US America Patent, Patent No. 4663233
   BOLLET AJ, 1963, J BIOL CHEM, V238, P3522
   Chen JS, 2000, NUCL INSTRUM METH B, V169, P26, DOI 10.1016/S0168-583X(00)00011-2
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   DELPECH B, 1987, J IMMUNOL METHODS, V104, P223, DOI 10.1016/0022-1759(87)90508-4
   Dong H, 2000, J MATER SCI LETT, V19, P1147, DOI 10.1023/A:1006755008958
   Dowson D., 1966, P I MECH ENG, V181, P45, DOI DOI 10.1243/PIME_CONF_1966_181_206_02
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   FRASER JRE, 1989, CIBA F SYMP, V143, P41
   GONDA J, 1991, COLLECT CZECH CHEM C, V56, P685, DOI 10.1135/cccc19910685
   Halpern G., 1990, US Patent, Patent No. 4959074
   Halpern G., 1989, US Patent, Patent No. 4801475
   HARMON RE, 1973, CARBOHYD RES, V31, P407, DOI 10.1016/S0008-6215(00)86207-2
   HEPBURN C, 1992, POLYURETHANE ELASTOM, P312
   HOEKSTRA D, 1999, HYALURONAN MODIFIED, P51
   Johnston JB, 2000, J BIOMED MATER RES, V53, P188, DOI 10.1002/(SICI)1097-4636(2000)53:2<188::AID-JBM9>3.3.CO;2-X
   Kawate K, 1999, JOINT ARTHROPLASTY, P87
   KING R, 2005, 51 ANN M ORTH RES SO, V30, P1682
   Klapperich CM, 1999, MATER RES SOC SYMP P, V550, P331
   LOWRY KM, 1994, J BIOMED MATER RES, V28, P861, DOI 10.1002/jbm.820280804
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Muratoglu OK, 1999, BIOMATERIALS, V20, P1463, DOI 10.1016/S0142-9612(99)00039-3
   PIERCE AE, 1968, SILYLATION ORGANIC C, P1
   RODRIGUEZ F, 1996, PRINCIPLES POLYM SYS, P225
   Shi W, 2003, SURF ENG, V19, P279, DOI [10.1179/026708403225006221, 10.1016/026708403225006221]
   SMITH B, 1998, INFRARED SPECTRAL IN, P158
   *US PHARM NAT FORM, 1990, OFF MON US PHARM NAT, P644
   Widmer MR, 2001, TRIBOL LETT, V10, P111, DOI 10.1023/A:1009074228662
   Zhang M, 2005, POLYMER, V46, P3639, DOI 10.1016/j.polymer.2005.03.022
   Zollfrank C, 2001, WOOD SCI TECHNOL, V35, P183, DOI 10.1007/s002260000071
NR 34
TC 14
Z9 15
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 86
EP 96
DI 10.1002/jbm.a.30701
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900011
PM 16602125
DA 2018-10-20
ER

PT J
AU Boccaccini, AR
   Blaker, JJ
   Maquet, V
   Chung, W
   Jerome, R
   Nazhat, SN
AF Boccaccini, Aldo R.
   Blaker, Jonny J.
   Maquet, Veronique
   Chung, Wendy
   Jerome, Robert
   Nazhat, Showan N.
TI Poly(D,L-lactide) (PDLLA) foams with TiO(2) nanoparticles and
   PDLLA/TiO(2)-Bioglass (R) foam composites for tissue engineering
   scaffolds
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT Conference on Syntactic and Composite Foams
CY AUG 01-05, 2004
CL Banff, CANADA
SP ECI
ID IN-VITRO CHARACTERIZATION; MECHANICAL-PROPERTIES; BIOMEDICAL MATERIALS;
   POLYMER SCAFFOLDS; POLYLACTIDE FOAMS; BONE; OSTEOBLAST; REGENERATION;
   BIOGLASS(R); FABRICATION
AB Porous poly(D,L-lactide) PDLLA foams containing 0, 5 and 20 wt% of TiO(2) nanoparticles were fabricated and characterised. The addition of Bioglassg particles was also studied in a composite containing 5 wt% of Bioglass(R) particles and 20 wt% of TiO(2) nanoparticles. The microstructure of the four different foam types was characterised using scanning electron microscopy (SEM) and their mechanical properties assessed by quasi-static compression testing. The in vitro behaviour of the foams was studied in simulated body fluid (SBF) at three different time points: 3, 21 and 28 days. The degradation of the samples was characterised quantitatively by measuring the water absorption and weight loss as a function of immersion time in SBE The bioactivity of the foams was characterised by observing hydroxyapatite (HA) formation after 21 days of immersion in SBF using SEM and confirmed with X-ray diffraction (XRD) analysis. It was found that the amount of HA was dependent on the distribution of TiO(2) nanoparticles and on the presence of Bioglassg in the foam samples. (c) 2006 Springer Science + Business Media, Inc.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2B9, England.
   Univ London Imperial Coll Sci & Technol, Ctr Tissue Engn & Regenerat Med, London SW7 2B9, England.
   Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
   UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2B9, England.
EM a.boccaccini@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013
OI Blaker, Jonny/0000-0003-1112-8619
CR Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2005, COMPOS PART A-APPL S, V36, P721, DOI 10.1016/j.compositesa.2004.11.002
   Boccaccini AR, 2005, MAT SCI ENG C-BIO S, V25, P23, DOI 10.1016/j.msec.2004.03.002
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   GIBSON LJ, 1988, CELLULAR SOLIDS STRU, P120
   Gutwein LG, 2002, J NANOPART RES, V4, P231, DOI 10.1023/A:1019920105207
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HILYARD NC, 1982, MECH CELLULAR PLASTI, P73
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius AA, 2001, J BIOMED MATER RES, V57, P126, DOI 10.1002/1097-4636(200110)57:1<126::AID-JBM1151>3.0.CO;2-M
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2001, SCRIPTA MATER, V44, P1639, DOI 10.1016/S1359-6462(01)00873-9
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 35
TC 40
Z9 41
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JUL
PY 2006
VL 41
IS 13
BP 3999
EP 4008
DI 10.1007/s10853-006-7575-7
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 067DQ
UT WOS:000239282300006
DA 2018-10-20
ER

PT J
AU Sencadas, V
   Gregorio, R
   Lanceros-Mendez, S
AF Sencadas, V.
   Gregorio Filho, R.
   Lanceros-Mendez, S.
TI Processing and characterization of a novel nonporous poly(vinilidene
   fluoride) films in the beta phase
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE films and coatings; scanning electron microscopy; microstructure;
   porosity; FTIR measurements; polymers and organics; processing;
   calorimetry
ID POLY(VINYLIDENE FLUORIDE); CRYSTALLINE PHASE; PVDF FILMS; TEMPERATURE;
   ORIENTATION; FTIR
AB Poly(vinylidene fluoride) (PVDF) has remarkable properties leading to electro-optics, electro-mechanical and biomedical applications. In particular, its piezo- and pyroelectric properties provide possibilities for many technological applications. The semicrystalline nature of PVDF, combined with the occurrence of at least four crystalline phases implies a complicated physical microstructure. The most frequently described and important phase is the P phase. The piezo- and pyroelectric properties mainly depend on this phase, so increasing the P phase content has always been a great concern. It is possible to obtain films in the 0 phase by solution but this material presents a high porosity leading to an opaque appearance and a decrease of the mechanical and electrical properties. In this work, porous films in the beta phase were obtained directly from the solution at 60 degrees C. After applying pressure perpendicular to the surface of the film at elevated temperature, the pores in the original sample are eliminated. The changes on the morphology and crystallinity associated to the pressure treatment were also studied. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Minho, Dept Fis, P-4710058 Braga, Portugal.
   Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Lanceros-Mendez, S (reprint author), Univ Minho, Dept Fis, Campus de Gualtar, P-4710058 Braga, Portugal.
EM lanceros@fisica.uminho.pt
RI Sencadas, Vitor/A-3932-2008; lanceros-mendez, senentxu/A-1730-2011
OI Sencadas, Vitor/0000-0003-1986-1348; lanceros-mendez,
   senentxu/0000-0001-6791-7620
CR Bormashenko Y, 2004, POLYM TEST, V23, P791, DOI 10.1016/j.polymertesting.2004.04.001
   EBELE G, 1996, IEEE T DIELECT EL IN, V3, P624
   FURUKAWA T, 1989, PHASE TRANSIT, V18, P143, DOI 10.1080/01411598908206863
   GREGORIO R, 1994, J POLYM SCI POL PHYS, V32, P859
   Gregorio R, 1999, J MATER SCI, V34, P4489
   Lanceros-Mendez S., 2002, Ferroelectrics, V273, P15, DOI 10.1080/00150190211756
   Lanceros-Mendez S, 2001, J MACROMOL SCI PHYS, VB40, P517, DOI 10.1081/MB-100106174
   LANCEROSMENDEZ S, Patent No. 103318
   Lovinger A. J., 1982, DEV CRYSTALLINE POLY
   LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115
   LUONGO JP, 1972, J POLYM SCI A2, V10, P1119, DOI 10.1002/pol.1972.160100613
   MATSUSHIGE K, 1980, POLYMER, V21, P1391, DOI 10.1016/0032-3861(80)90138-X
   NAEGELE D, 1978, APPL PHYS LETT, V33, P132, DOI 10.1063/1.90281
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   Sencadas V, 2004, THERMOCHIM ACTA, V424, P201, DOI 10.1016/j.tca.2004.06.006
   SENCADAS V, 2005, P ISE12 SEPT SALV BA
   SESSLER GM, 1987, TOPICS APP PHYS ELEC
NR 17
TC 123
Z9 125
U1 1
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD JUL 1
PY 2006
VL 352
IS 21-22
BP 2226
EP 2229
DI 10.1016/j.jnoncrysol.2006.02.052
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 060JZ
UT WOS:000238799800025
DA 2018-10-20
ER

PT J
AU Kobayashi, E
   Mochizuki, H
   Doi, H
   Yoneyama, T
   Hanawa, T
AF Kobayashi, Equo
   Mochizuki, Hiroto
   Doi, Hisashi
   Yoneyama, Takayuki
   Hanawa, Takao
TI Fatigue life prediction of biomedical titanium alloys under
   tensile/torsional stress
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 1st Asian Thermal Spray Conference (ATSC 2005)
CY NOV, 2005
CL Nagoya, JAPAN
DE titanium alloy; titanium-6Aluminum-7Niobium alloy; biomedical materials;
   fatigue life; fractograph; combined stress; tensile; torsional; Basquin
   plot
ID TI-6AL-7NB ALLOY; CASTINGS
AB In order to contribute for designing the implant devices with appropriate mechanical properties, fatigue properties of biomedical Ti-6Al-7Nb alloy, were evaluated through the tensile/torsional fatigue test. Fatigue properties for the tensile/torsional fatigue, the tensile fatigue, and the torsional fatigue were compared directly using equivalent stress defined by von Mises' yield condition. In the S-N plots, there were two regions showing different gradients in data and they are corresponded to the boundary of the low cycle fatigue and the high cycle fatigue. By the approximation with Basquin relation of the S-N data, elastic strain, sigma(a), and elastic shear strain, tau(a), showed good linearity to the fatigue life. Fatigue coefficients and fatigue exponents of Basquin relation obtained by the least square method might be useful to examine fatigue life of these alloys under tensile stress, torsional stress and tensile/torsional stress.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Kobayashi, E (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
OI Doi, Hisashi/0000-0003-0833-4809
CR Akahori T, 1998, J JPN I MET, V62, P952, DOI 10.2320/jinstmet1952.62.10_952
   Fash J. W., 1985, ASTM STP, P497
   Hoshide T, 1995, MATER SCI RES INT, V1, P169
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P567, DOI 10.1023/A:1008909408948
   Kobayashi E, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P115
   Kobayashi E, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P121
   KOBAYASHI E, 2000, 6 WORLD BIOM C SOC B, P925
   Sonsino C. M., 1985, ASTM STP, V853, P586
   SRIMANEEONG V, UNPUB DENT MAT J
   Srimaneepong V, 2004, DENT MATER J, V23, P497, DOI 10.4012/dmj.23.497
   Yamamoto T, 2005, J BIOMED MATER RES B, V73B, P301, DOI 10.1002/jbm.b.30215
   ZARDIACKAS LD, 1991, J BIOMED MATER RES, V25, P281, DOI 10.1002/jbm.820250302
NR 12
TC 1
Z9 1
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2006
VL 47
IS 7
BP 1826
EP 1831
DI 10.2320/matertrans.47.1826
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 082GP
UT WOS:000240375000037
OA Bronze
DA 2018-10-20
ER

PT J
AU Grewal, GS
   Bharara, M
   Cobb, JE
   Dubey, VN
   Claremont, DJ
AF Grewal, G. S.
   Bharara, M.
   Cobb, J. E.
   Dubey, V. N.
   Claremont, D. J.
TI A novel approach to thermochromic liquid crystal calibration using
   neural networks
SO MEASUREMENT SCIENCE AND TECHNOLOGY
LA English
DT Article
DE liquid crystal thermography; hue; neural networks; calibration
ID CONVECTIVE HEAT-TRANSFER; THERMOGRAPHY; TEMPERATURE; ANGLE
AB Liquid crystal thermography (LCT) is a common surface temperature measurement technique. Typically, the colour response is calibrated against temperature by building an analytical relation between the temperature and the hue of the colour. A suitable polynomial fit is then used to describe this relation after removing the discontinuity in the hue. The variability of hue at each calibration point determines the temperature resolution. However, this technique does not take into consideration the variability in R, G and B intensities used to determine the hue, leading to uncertainty in the measured temperature. This paper describes a novel technique using neural networks to calibrate thermochromic liquid crystal (TLC) material and compensate for high variability in RGB intensities along with other sources of noise in the data. A TLC-based temperature measurement system and calibration results are presented. In our measurements, the lighting intensity (8-bit mean intensity of black surface +/- standard deviation) is changed from a minimum of 16.65 +/- 2.30 to a maximum of 31.41 +/- 3.85. The neural networks were trained on the steady-state TLC calibration system. The results indicate that the neural networks can cope with the variation in lighting by merging the shifted hue curves into a single curve determined by the regression analysis of the test data. Performance characteristics studied on various network configurations relevant to the analysis are described. This approach may be useful in developing liquid crystal thermography for various biomedical applications.
C1 Bournemouth Univ, Sch Design Engn & Comp, Acad Biomed Engn Res Grp, Poole BH12 5BB, Dorset, England.
RP Grewal, GS (reprint author), Bournemouth Univ, Sch Design Engn & Comp, Acad Biomed Engn Res Grp, Poole BH12 5BB, Dorset, England.
CR ANDERSON M, 1999, THERMOCHROMIC LIQUID
   Anderson MR, 2004, J HEAT TRANS-T ASME, V126, P339, DOI 10.1115/1.1738425
   BAKRANIA S, 2002, TRANSIENT TECHNIQUE
   Behle M, 1996, APPL SCI RES, V56, P113, DOI 10.1007/BF02249377
   Bharath R., 1994, NEURAL NETWORK COMPU
   Bishop C.M., 1995, NEURAL NETWORKS PATT
   CAMCI C, 1992, J TURBOMACH, V114, P765, DOI 10.1115/1.2928030
   Chan TL, 2001, INT J HEAT MASS TRAN, V44, P2209, DOI 10.1016/S0017-9310(00)00267-2
   Hay JL, 1996, EXP THERM FLUID SCI, V12, P1, DOI 10.1016/0894-1777(95)00013-5
   Hay JL, 1998, EXP THERM FLUID SCI, V18, P251, DOI 10.1016/S0894-1777(98)10026-2
   Jambunathan K, 1996, INT J HEAT MASS TRAN, V39, P2329, DOI 10.1016/0017-9310(95)00332-0
   Kimura I, 1993, J FLOW VISUALIZATION, V1, P261
   Matsuda H., 2000, J FLOW VISUALIZATION, P103
   1991, HDB THERMOCHROMIC LI
NR 14
TC 7
Z9 7
U1 0
U2 5
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-0233
EI 1361-6501
J9 MEAS SCI TECHNOL
JI Meas. Sci. Technol.
PD JUL
PY 2006
VL 17
IS 7
BP 1918
EP 1924
DI 10.1088/0957-0233/17/7/033
PG 7
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 058DT
UT WOS:000238645900035
DA 2018-10-20
ER

PT J
AU Kushchevskaya, NF
AF Kushchevskaya, N. F.
TI Nanodimensional ferromagnetic powders fabricated by a thermochemical
   method. Possible approaches for biomedical applications of the powders
SO POWDER METALLURGY AND METAL CERAMICS
LA English
DT Article
DE ferromagnetic substance; medicine; biology; nanodimensional powder
AB Thermochemical methods of fabricating nanodimensional composite powders of ferromagnetic substances are developed. Ferromagnetic substances are the single magnets that possess a controlled set of physical, physico-chemical, and biomedical properties, which are also realized simultaneously. A physico-chemical principle for the fabrication of colloid-chemical systems as a foundation for nanostructural materials based on nanodimensional ferromagnetic substances is proposed. The ranges of application of such systems, i.e., biology and medicine, are established.
C1 Natl Acad Sci Ukraine, Inst Colloid Chem & Chem Water, UA-252143 Kiev, Ukraine.
RP Kushchevskaya, NF (reprint author), Natl Acad Sci Ukraine, Inst Colloid Chem & Chem Water, Zabolotny St 154, UA-252143 Kiev, Ukraine.
CR BARABOY VA, 1998, EXPER ONCOLOGY, V18, P413
   ESTRELALOPIS VR, 2000, ALGOLOGIYA, V10, P131
   Gvozdyak R. I., 1996, MIKROBIOL ZH, V58, P45
   Kushchevs'ka NF, 2002, METALLOFIZ NOV TEKH+, V24, P1537
   Kushchevskaya N. F., 1997, Biopolimery i Kletka, V13, P14
   KUSHCHEVSKAYA NF, 1997, NOVYE TEKHNOLOGII KH, P163
   KUSHCHEVSKAYA NF, 2003, THESIS KIEV
   KUSHCHEVSKAYA NF, 1997, POROSHKOV METALL, P116
   KUSHCHEVSKAYA NF, 1997, VRACHEBNOE DELO, P15
   Shvets T. M., 1998, Mikrobiolohichnyi Zhurnal, V60, P90
   SHVETS TM, 1997, VRACHEBNOE DELO, P73
   SHVETS TM, 1997, VRACHEBNOE DELO, P92
   SHVETS TMN, 2003, POROSHKOV METALL, P1
NR 13
TC 1
Z9 1
U1 0
U2 0
PU CONSULTANTS BUREAU/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-1302
J9 POWDER METALL MET C+
JI Powder Metall. Met. Ceram.
PD JUL-AUG
PY 2006
VL 45
IS 7-8
BP 395
EP 399
DI 10.1007/s11106-006-0095-9
PG 5
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 117OI
UT WOS:000242882200017
DA 2018-10-20
ER

PT J
AU Rinaudo, M
AF Rinaudo, Marguerite
TI Chitin and chitosan: Properties and applications
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE chitin structure; chitosan structure; chitosan derivatives;
   biomaterials; chitosan-based materials; cosmetics
ID ALGINATE-OLIGOCHITOSAN MICROCAPSULES; THALASSIOSIRA FLUVIATILIS HUSTEDT;
   CONTROLLED CHEMICAL-MODIFICATIONS; RESOLUTION ELECTRON-MICROSCOPY;
   MOLECULAR-WEIGHT MANIPULATION; PARTIALLY DEACETYLATED CHITIN; FIELD
   NMR-SPECTROSCOPY; SODIUM DODECYL-SULFATE; X-RAY-DIFFRACTION; SOLID-STATE
   NMR
AB Chitin is the second most important natural polymer in the world. The main sources exploited are two marine crustaceans, shrimp and crabs. Our objective is to appraise the state of the art concerning this polysaccharide: its morphology in the native solid state, methods of identification and characterization and chemical modifications, as well as the difficulties in utilizing and processing it for selected applications. We note the important work of P. Austin, S. Tokura and S. Hirano, who have contributed to the applications development of chitin, especially in fiber form. Then, we discuss chitosan, the most important derivative of chitin, outlining the best techniques to characterize it and the main problems encountered in its utilization. Chitosan, which is soluble in acidic aqueous media, is used in many applications (food, cosmetics, biomedical and pharmaceutical applications). We briefly describe the chemical modifications of chitosan-an area in which a variety of syntheses have been proposed tentatively, but are not yet developed on an industrial scale. This review emphasizes recent papers on the high value-added applications of these materials in medicine and cosmetics. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Grenoble 1, CERMAV, CNRS, F-38041 Grenoble 9, France.
RP Rinaudo, M (reprint author), Univ Grenoble 1, CERMAV, CNRS, BP53, F-38041 Grenoble 9, France.
EM marguerite.rinaudo@cermav.cnrs.fr
CR Abou-Aiad THM, 2006, POLYMER, V47, P379, DOI 10.1016/j.polymer.2005.02.122
   AIBA S, 1991, INT J BIOL MACROMOL, V13, P40, DOI 10.1016/0141-8130(91)90008-I
   AIBA S, 1985, INT J BIOL MACROMOL, V7, P120, DOI 10.1016/0141-8130(85)90042-X
   ALLAN GG, 1995, CARBOHYD RES, V277, P273, DOI 10.1016/0008-6215(95)00208-B
   ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   Andrew C. A. Wan, 1998, Biomaterials, V19, P1309
   ANNACHHATRE AP, 1996, CHITIN CHITOSAN ENV, P169
   ANTHONSEN MW, 1993, CARBOHYD POLYM, V22, P193, DOI 10.1016/0144-8617(93)90140-Y
   Arguelles-Monal W, 2003, ACS SYM SER, V833, P102
   Arguelles-Monal W, 2000, POLYMER, V41, P2373, DOI 10.1016/S0032-3861(99)00396-1
   ARGUELLESMONAL W, 1988, MAKROMOL CHEM-RAPID, V9, P693
   ATKINS E, 1985, J BIOSCIENCE, V8, P375, DOI 10.1007/BF02703990
   ATKINS EDT, 1979, INT J BIOL MACROMOL, V1, P29, DOI 10.1016/0141-8130(79)90006-0
   Austin P. R, 1975, US patent, Patent No. [3879377, 3,879,377]
   Austin P.R., 1984, CHITIN CHITOSAN RELA, P227
   AUSTIN PR, 1977, Patent No. 4029727
   Austin PR, 1975, US patent, Patent No. [3892731, 3,892,731]
   Auzely R, 2003, MACROMOL BIOSCI, V3, P562, DOI 10.1002/mabi.200300018
   Auzely-Velty R, 2002, MACROMOLECULES, V35, P7955, DOI 10.1021/ma020661o
   Auzely-Velty R, 2001, MACROMOLECULES, V34, P3574, DOI 10.1021/ma001873g
   Babak V, 1999, COLLOID SURFACE A, V147, P139, DOI 10.1016/S0927-7757(98)00752-3
   BABAK V, 2001, P 28 INT S CONTR REL, V2, P940
   Babak VG, 2000, POLYM BULL, V45, P77, DOI 10.1007/s002890070059
   Babak VG, 2000, MENDELEEV COMMUN, P94
   Babak VG, 1997, MENDELEEV COMMUN, P149
   BABAK VG, 2002, CHITOSAN PHARM CHEM, P277
   Baran ET, 2004, J MATER SCI-MATER M, V15, P759, DOI 10.1023/B:JMSM.0000032815.86972.5e
   Bartkowiak A, 1999, CHEM MATER, V11, P2486, DOI 10.1021/cm9910456
   Bartkowiak A, 2000, CHEM MATER, V12, P206, DOI 10.1021/cm991128m
   BARTKOWIAK AW, 1994, CHITIN WORLD, P119
   BARTNICKIGARCIA S, 1994, ARCH BIOCHEM BIOPHYS, V310, P6, DOI 10.1006/abbi.1994.1133
   BAXTER A, 1992, INT J BIOL MACROMOL, V14, P166, DOI 10.1016/S0141-8130(05)80007-8
   Berth G, 2002, BIOMACROMOLECULES, V3, P579, DOI 10.1021/bm0200130
   Berth G, 2002, CARBOHYD POLYM, V47, P39, DOI 10.1016/S0144-8617(00)00343-X
   Bhatia SC, 2000, BIOMACROMOLECULES, V1, P413, DOI 10.1021/bm0002959
   BLACKWEL.J, 1969, BIOPOLYMERS, V7, P281, DOI 10.1002/bip.1969.360070302
   BLACKWELL J, 1965, J MAR BIOL ASSOC UK, V45, P659, DOI 10.1017/S0025315400016489
   Blackwell J., 1973, BIOPOLYMERS, P474
   Brine C., 1992, ADV CHITIN CHITOSAN
   Brugnerotto J, 2001, MACROMOL SYMP, V168, P1, DOI 10.1002/1521-3900(200103)168:1<1::AID-MASY1>3.0.CO;2-W
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Brugnerotto J, 2001, POLYMER, V42, P9921, DOI 10.1016/S0032-3861(01)00557-2
   Buhler E, 2000, MACROMOLECULES, V33, P2098, DOI 10.1021/ma991309+
   Buhler E, 2000, INT J POLYM ANAL CH, V6, P155, DOI 10.1080/10236660008034656
   Capozza R. C., 1976, US Patent, Patent No. 3988411
   Capozza RC, 1976, US Patent, Patent No. [3989535, 3,989,535]
   CARTIER N, 1990, INT J BIOL MACROMOL, V12, P289, DOI 10.1016/0141-8130(90)90015-3
   CHANZY H, 1998, ADV CHITIN SCI, P11
   Charlot A, 2003, J PHYS CHEM B, V107, P8248, DOI 10.1021/jp022580n
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHIESSI E, 1993, INT J BIOL MACROMOL, V15, P145, DOI 10.1016/0141-8130(93)90017-G
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j
   Chow KS, 2002, CARBOHYD POLYM, V47, P357, DOI 10.1016/S0144-8617(01)00190-4
   ChretiennotDinet MJ, 1997, J PHYCOL, V33, P666, DOI 10.1111/j.0022-3646.1997.00666.x
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   DARMON SE, 1950, DISCUSS FARADAY SOC, P251, DOI 10.1039/df9500900251
   DATTA PK, 1984, PREP BIOCHEM, V14, P373, DOI 10.1080/10826068408070642
   Desai KGH, 2005, J MICROENCAPSUL, V22, P179, DOI 10.1080/02652040400026533
   Desbrieres J, 1997, MACROMOL SYMP, V113, P135, DOI 10.1002/masy.19971130113
   Desbrieres J, 1997, POLYM BULL, V39, P209, DOI 10.1007/s002890050140
   Desbrieres J, 1996, INT J BIOL MACROMOL, V19, P21, DOI 10.1016/0141-8130(96)01095-1
   DESBRIERES J, 1999, ACS SYM SER, V737, P199
   DOARES SH, 1995, P NATL ACAD SCI USA, V92, P4095, DOI 10.1073/pnas.92.10.4095
   DOMARD A, 1987, INT J BIOL MACROMOL, V9, P98, DOI 10.1016/0141-8130(87)90033-X
   DOMARD A, 1986, INT J BIOL MACROMOL, V8, P105, DOI 10.1016/0141-8130(86)90007-3
   DOMARD A, 1983, INT J BIOL MACROMOL, V5, P49, DOI 10.1016/0141-8130(83)90078-8
   DOMARD A, 1987, INT J BIOL MACROMOL, V9, P233, DOI 10.1016/0141-8130(87)90058-4
   DOMARD A, 1989, J APPL POLYM SCI, V38, P1799, DOI 10.1002/app.1989.070381002
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   DWELTZ NE, 1968, CAN J CHEMISTRY, V46, P1513, DOI 10.1139/v68-248
   Einbu A, 2004, BIOMACROMOLECULES, V5, P2048, DOI 10.1021/bm049710d
   El Zein A. R., 2002, CHITOSAN PHARM CHEM, P365
   Eli WJ, 1999, J CHEM THERMODYN, V31, P1283, DOI 10.1006/jcht.1999.0539
   *EUR CHIT SOC, 1998, ADV CHIT SCI, V2
   *EUR CHIT SOC, 2005, ADV CHIT SCI, V8
   *EUR CHIT SOC, 2003, ADV CHIT SCI, V6
   *EUR CHIT SOC, 2003, ADV CHIT SCI, V5
   *EUR CHIT SOC, 2004, ADV CHIT SCI, V7
   *EUR CHIT SOC, 2000, ADV CHIT SCI, V4
   *EUR CHIT SOC, 1996, ADV CHIT SCI, V1
   *EUR CHIT SOC, 1999, ADV CHIT SCI, V3
   FALK M, 1966, CAN J CHEMISTRY, V44, P2269, DOI 10.1139/v66-342
   FOCHER B, 1992, CARBOHYD POLYM, V17, P97, DOI 10.1016/0144-8617(92)90101-U
   GAGNAIRE D, 1982, MAKROMOL CHEM, V183, P593
   GAILL F, 1992, J STRUCT BIOL, V109, P116, DOI 10.1016/1047-8477(92)90043-A
   GALAT A, 1979, ACTA BIOCHIM POL, V26, P303
   GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804
   GOMEZGUILLEN M, 1992, CARBOHYD RES, V233, P255, DOI 10.1016/S0008-6215(00)90939-X
   Gonell H. W., 1926, Zs phys Chem Berlin, V152, P18
   Goycoolea FM, 2000, DEV FOOD SCI, V41, P265
   GOYCOOLEA FM, 2006, IN PRESS POLYM B
   HALL LD, 1980, J CHEM SOC CHEM COMM, P1153, DOI 10.1039/c39800001153
   HALL LD, 1984, Patent No. 4424346
   Hamman J. H., 2002, CHITOSAN PHARM CHEM, P41
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HASEGAWA M, 1994, POLYMER, V35, P983, DOI 10.1016/0032-3861(94)90942-3
   Helbert W, 1998, CELLULOSE, V5, P113, DOI 10.1023/A:1009272814665
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   HERTH W, 1977, J CELL BIOL, V73, P311, DOI 10.1083/jcb.73.2.311
   Herth W., 1986, P107
   Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y
   Hirano S, 1999, J BIOTECHNOL, V70, P373, DOI 10.1016/S0168-1656(99)00090-5
   Hirano S, 1998, BIOMATERIALS, V19, P293, DOI 10.1016/S0142-9612(97)00216-0
   HIRANO S, 1989, INT J BIOL MACROMOL, V11, P253, DOI 10.1016/0141-8130(89)90078-0
   HIRANO S, 1992, CARBOHYD RES, V225, P175, DOI 10.1016/0008-6215(92)80052-3
   Hirano S, 2001, MACROMOL SYMP, V168, P21, DOI 10.1002/1521-3900(200103)168:1<21::AID-MASY21>3.0.CO;2-D
   HIRANO S, 1990, CARBOHYDR RES, V20
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   HOLME KR, 1992, CARBOHYD RES, V225, P291, DOI 10.1016/S0008-6215(00)90502-0
   HOLME KR, 1991, MACROMOLECULES, V24, P3828, DOI 10.1021/ma00013a014
   HOSOKAWA J, 1990, IND ENG CHEM RES, V29, P800, DOI 10.1021/ie00101a015
   Hudson S. M., 2003, EPST, V1, P569
   HUDSON SM, 1998, ADV CHITIN SCI, V2, P590
   HUDSON SM, 1999, ADV CHITIN SCI, V3, P80
   Illum L., 2005, POLYSACCHARIDES STRU, P643
   Ito M., 1998, APPL CHITIN CHITOSAN, V4, P142
   Iwamoto R., 1982, CHITIN CHITOSAN, P82
   KANKE M, 1989, CHEM PHARM BULL, V37, P523
   KARNIKI SZ, 1994, CHITIN WORLD
   Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748
   Khan WM, 2002, PHOTOSYNTHETICA, V40, P621, DOI 10.1023/A:1024320606812
   Ko MJ, 1997, POLYM J, V29, P997, DOI 10.1295/polymj.29.997
   KOBAYASHI Y, 1982, P INT C 2D JPN SOC C, P244
   KOHGO O, 1992, ADVANCES IN CHITIN AND CHITOSAN, P526
   Kono H, 2004, BIOPOLYMERS, V75, P255, DOI 10.1002/bip.20124
   KOSYAKOV VN, 2002, J NUCL SCI TECHNOL S, V3, P508
   Kotze A. F., 2002, CHITOSAN PHARM CHEM, P31
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Kriz Z, 2003, ORG BIOMOL CHEM, V1, P2590, DOI 10.1039/b302935m
   Kubota N, 1997, POLYM J, V29, P123, DOI 10.1295/polymj.29.123
   KUBOTA N, 1998, POLYSACCHARIDES STRU, P595
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   KURITA K, 1990, MACROMOLECULES, V23, P2865, DOI 10.1021/ma00213a008
   KURITA K, 1979, J APPL POLYM SCI, V23, P511, DOI 10.1002/app.1979.070230221
   KURITA K, 1993, J POLYM SCI POL CHEM, V31, P2393, DOI 10.1002/pola.1993.080310923
   KURITA K, 1989, CHITIN CHITOSAN, P365
   LEDUNG P, 1994, CARBOHYD POLYM, V24, P209, DOI 10.1016/0144-8617(94)90132-5
   Lee KY, 1997, J APPL POLYM SCI, V63, P425, DOI 10.1002/(SICI)1097-4628(19970124)63:4<425::AID-APP3>3.0.CO;2-T
   Lee S.-T., 1998, ADV CHITIN SCI, V3, P475
   LEE VF, 1974, THESIS U WASHINGTON
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liu WG, 2003, BIOCONJUGATE CHEM, V14, P782, DOI 10.1021/bc020051g
   Liu WG, 2003, J BIOMAT SCI-POLYM E, V14, P851, DOI 10.1163/156856203768366567
   LOTMAR W, 1950, EXPERIENTIA, V6, P58, DOI 10.1007/BF02174818
   MAGHAMI GG, 1988, MAKROMOL CHEM, V189, P195
   MATHUR NK, 1990, J CHEM EDUC, V67, P938, DOI 10.1021/ed067p938
   Mazeau K, 2004, FOOD HYDROCOLLOID, V18, P885, DOI 10.1016/j.foodhyd.2004.04.004
   Mazeau K, 2000, J CARBOHYD CHEM, V19, P1269, DOI 10.1080/07328300008544150
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   MITANI T, 1991, AGR BIOL CHEM TOKYO, V55, P2419, DOI 10.1080/00021369.1991.10870942
   Miwa A, 1998, PHARMACEUT RES, V15, P1844, DOI 10.1023/A:1011901921995
   MIYA M, 1980, INT J BIOL MACROMOL, V2, P323, DOI 10.1016/0141-8130(80)90056-2
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Morimoto M, 2002, TRENDS GLYCOSCI GLYC, V14, P205, DOI 10.4052/tigg.14.205
   Mucha M, 1999, MACROMOL SYMP, V144, P391, DOI 10.1002/masy.19991440137
   Muzzarelli R., 1986, CHITIN NATURE TECHNO
   Muzzarelli R. A. A., 1982, CARBOHYD POLYM, V2, P145
   Muzzarelli R.A.A., 1973, NATURAL CHELATING PO
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   Muzzarelli RAA, 2000, CARBOHYD POLYM, V43, P263, DOI 10.1016/S0144-8617(00)00170-3
   Muzzarelli RAA, 1999, CARBOHYD POLYM, V39, P361, DOI 10.1016/S0144-8617(99)00027-2
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   MUZZARELLI RAA, 1978, P 1 INT C CHIT CHIT
   MUZZARELLI RAA, 1985, ENCY POLYM SCI ENG, V3, P430
   MUZZARELLI RAA, 2002, CHITOSAN PHARM CHEM
   MUZZARELLI RAA, 2001, CHITIN ENZYMOLOGY
   MUZZARELLI RAA, 1985, POLYSACCHARIDES, V3, P417
   Muzzarelli RAA, 1989, CHITIN CHITOSAN, P87
   Naggi A. M., 1986, CHITIN NATURE TECHNO, P371
   NIETO JM, 1992, CARBOHYD POLYM, V18, P221, DOI 10.1016/0144-8617(92)90067-Z
   Noishiki Y, 2005, BIOMACROMOLECULES, V6, P2362, DOI 10.1021/bm0500446
   Noishiki Y, 2004, MACROMOLECULES, V37, P6839, DOI 10.1021/ma0489265
   Noishiki Y, 2003, BIOMACROMOLECULES, V4, P944, DOI 10.1021/bm034024k
   Nonaka K, 2002, J COLLOID INTERF SCI, V246, P288, DOI 10.1006/jcis.2001.8091
   ODIJK T, 1979, BIOPOLYMERS, V18, P3111, DOI 10.1002/bip.1979.360181215
   OGAWA K, 1992, BIOSCI BIOTECH BIOCH, V56, P858, DOI 10.1271/bbb.56.858
   OGAWA K, 1993, CHEM MATER, V5, P726, DOI 10.1021/cm00029a026
   OGAWA K, 1991, AGR BIOL CHEM TOKYO, V55, P2375, DOI 10.1080/00021369.1991.10870939
   OGAWA K, 1984, ADV CHITIN CHITOSAN, P327
   OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9
   Olteanu M, 2003, PROG COLL POL SCI S, V122, P87
   OUCHI T, 1992, POLYM PREP AM CHEM S, V33, P537
   Ouchi T., 1999, ACS SYM SER, P15
   Park IK, 2001, J APPL POLYM SCI, V80, P2624, DOI 10.1002/app.1374
   PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109
   PELLETIER A, 1990, BIOTECHNOL BIOENG, V36, P310, DOI 10.1002/bit.260360313
   Peniche C, 2001, MACROMOL SYMP, V168, P103, DOI 10.1002/1521-3900(200103)168:1<103::AID-MASY103>3.0.CO;2-K
   PENICHECOVAS C, 1992, J APPL POLYM SCI, V46, P1147, DOI 10.1002/app.1992.070460703
   PENICHECOVAS C, 1988, CARBOHYD POLYM, V9, P249, DOI 10.1016/0144-8617(88)90043-4
   Persson J. E., 1990, INT J BIOL MACROMOL, V13, P221
   Philippova OE, 2001, BIOMACROMOLECULES, V2, P483, DOI 10.1021/bm005649a
   Pielka S, 2003, FIBRES TEXT EAST EUR, V11, P79
   Poirier M, 2002, CARBOHYD POLYM, V50, P363, DOI 10.1016/S0144-8617(02)00040-1
   Pospieszny H., 1994, CHITIN WORLD, P246
   Prado AGS, 2004, COLLOID SURFACE B, V35, P23, DOI 10.1016/j.colsutfb.2004.02.003
   Ramos VM, 2003, CARBOHYD POLYM, V51, P425, DOI 10.1016/S0144-8617(02)00211-4
   Ramos VM, 2003, CARBOHYD POLYM, V52, P39, DOI 10.1016/S0144-8617(02)00264-3
   RATHKE TD, 1994, J MACROMOL SCI R M C, VC34, P375, DOI 10.1080/15321799408014163
   RAYMOND L, 1993, CARBOHYD RES, V246, P331, DOI 10.1016/0008-6215(93)84044-7
   REED W, 1984, ACS SYM SER, V548, P297
   Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o
   REN LD, 1993, CARBOHYD POLYM, V21, P23, DOI 10.1016/0144-8617(93)90113-I
   REVOL JF, 1986, BIOPOLYMERS, V25, P1599, DOI 10.1002/bip.360250902
   Rhazi M, 2002, EUR POLYM J, V38, P1523, DOI 10.1016/S0014-3057(02)00026-5
   Rhazi M, 2002, POLYMER, V43, P1267, DOI 10.1016/S0032-3861(01)00685-1
   Rinaudo M, 1999, INT J POLYM ANAL CH, V5, P267, DOI 10.1080/10236669908009742
   Rinaudo M, 2005, BIOMACROMOLECULES, V6, P2396, DOI 10.1021/bm0580025
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   RINAUDO M, 1992, INT J BIOL MACROMOL, V14, P122, DOI 10.1016/S0141-8130(05)80001-7
   RINAUDO M, 1992, ADVANCES IN CHITIN AND CHITOSAN, P516
   RINAUDO M., 1989, CHITIN CHITOSAN SOUR, P71
   Rinaudo M., 2000, NATURAL POLYM AGROFI, P15
   Roberts G, 1992, CHITIN CHEM
   ROBERTS GAF, 1982, INT J BIOL MACROMOL, V4, P374, DOI 10.1016/0141-8130(82)90074-5
   Roberts GAF, 2001, J BIOTECHNOL, V89, P297, DOI 10.1016/S0168-1656(01)00316-9
   Rossle M, 2003, BIOMACROMOLECULES, V4, P981, DOI 10.1021/bm0340218
   Roy S. K., 1998, US Patent, Patent No. 5770712
   Rudall K.M., 1976, P21
   RUDALL K. M., 1963, ADVAN INSECT PHYSIOL, V1, P257, DOI 10.1016/S0065-2806(08)60177-0
   RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x
   RUDALL KM, 1969, J POLYM SCI, V28, P83, DOI DOI 10.1002/POLC.5070280110
   RUIZ M, 2002, CHITOSAN PHARM CHEM, P341
   RUIZHERRERA J, 1975, P NATL ACAD SCI USA, V72, P2706, DOI 10.1073/pnas.72.7.2706
   RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1
   Rusu-Balaita L, 2003, POLYM BULL, V50, P91, DOI 10.1007/s00289-003-0144-1
   SAITO H, 1987, MACROMOLECULES, V20, P2424, DOI 10.1021/ma00176a017
   SAITO H, 1981, CHEM LETT, P1479, DOI 10.1246/cl.1981.1479
   Saito Y, 1997, MACROMOLECULES, V30, P3867, DOI 10.1021/ma961787+
   Saito Y, 2000, INT J BIOL MACROMOL, V28, P81, DOI 10.1016/S0141-8130(00)00147-1
   SAITO Y, 1995, J STRUCT BIOL, V114, P218, DOI 10.1006/jsbi.1995.1021
   Saito Y, 1998, ADV CHITIN SCI, P507
   SAKAIRI N, 1999, ACS SYM SER, V737, P68
   Sakamoto J, 2000, MACROMOLECULES, V33, P4155, DOI 10.1021/ma000230y
   SANNAN T, 1976, MAKROMOL CHEM, V177, P3589
   SANNAN T, 1975, MAKROMOL CHEM, V176, P1191, DOI DOI 10.1002/MACP.1975.021760426
   Sashiwa H, 2003, BIOMACROMOLECULES, V4, P1250, DOI 10.1021/bm030022o
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Songkroah C, 2004, PROCESS BIOCHEM, V39, P1553, DOI 10.1016/S0032-9592(03)00284-X
   STEVENS WF, 1996, P 2 AS PAC S
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Suzuki K, 2000, POLYM J, V32, P334, DOI 10.1295/polymj.32.334
   TAMURA H, 2003, ADV CHITIN SCI, V7, P84
   TANNER SF, 1990, MACROMOLECULES, V23, P3576, DOI 10.1021/ma00217a008
   TERBOJEVICH M, 1991, CARBOHYD RES, V209, P251, DOI 10.1016/0008-6215(91)80161-F
   TERBOJEVICH M, 1989, MAKROMOL CHEM, V190, P2847
   TERBOJEVICH M, 1988, CARBOHYD RES, V180, P73, DOI 10.1016/0008-6215(88)80065-X
   Thanou M., 2005, POLYSACCHARIDES STRU, P661
   Thongngam M, 2005, LANGMUIR, V21, P79, DOI 10.1021/la048711o
   Thongngam M, 2004, J AGR FOOD CHEM, V52, P987, DOI 10.1021/jf034429w
   Toffey A, 1999, J APPL POLYM SCI, V73, P1879, DOI 10.1002/(SICI)1097-4628(19990906)73:10<1879::AID-APP7>3.0.CO;2-3
   Toffey A, 1996, J APPL POLYM SCI, V60, P75, DOI 10.1002/(SICI)1097-4628(19960404)60:1<75::AID-APP9>3.0.CO;2-S
   TOKURA S, 1992, ADVANCES IN CHITIN AND CHITOSAN, P87
   TOKURA S, 1994, J MACROMOL SCI PURE, VA31, P1701, DOI 10.1080/10601329408545878
   TOKURA S, 1982, P INT C 2D JPN SOC C, P244
   Varum K. M., 2005, POLYSACCHARIDES STRU, P625
   VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   Vasiliu S, 2005, EUR POLYM J, V41, P923, DOI 10.1016/j.eurpolymj.2004.11.017
   Venter JP, 2006, INT J PHARM, V313, P36, DOI 10.1016/j.ijpharm.2006.01.016
   VINCENDON M, 1992, ADVANCES IN CHITIN AND CHITOSAN, P556
   VINCENDON M, 1985, MAKROMOL CHEM, V186, P1787
   Vincendon M., 1994, CHITIN WORLD, P91
   WANG A, 1997, ZHONGGUO HAIYANG YAO, V16, P14
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   WANG W, 1991, MAKROMOL CHEM-RAPID, V12, P559
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   WEI YC, 1992, J POLYM SCI POL CHEM, V30, P2187, DOI 10.1002/pola.1992.080301013
   Welsh ER, 2003, BIOMACROMOLECULES, V4, P1357, DOI 10.1021/bm034111c
   WOJCIK G, 2003, Patent No. 6508958
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   YAMAGUCHI R, 1978, AGR BIOL CHEM TOKYO, V42, P1981, DOI 10.1080/00021369.1978.10863296
   YAMAKAWA H, 1974, MACROMOLECULES, V7, P128, DOI 10.1021/ma60037a024
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   YOSHINO H, 1992, ADVANCES IN CHITIN AND CHITOSAN, P565
   Yusof NLBM, 2003, J BIOMED MATER RES A, V66A, P224, DOI 10.1002/jbm.a.10545
   ZHANG M, 1994, FOOD HYDROCOLLOIDS S, P65
   Zhang YJ, 2005, BIOMACROMOLECULES, V6, P2365, DOI 10.1021/bm050058b
   ZIKAKIS JP, 2004, CHITIN CHITOSAN RELA
NR 284
TC 2987
Z9 3134
U1 135
U2 2269
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JUL
PY 2006
VL 31
IS 7
BP 603
EP 632
DI 10.1016/j.progpolymsci.2006.06.001
PG 30
WC Polymer Science
SC Polymer Science
GA 123GP
UT WOS:000243284700001
DA 2018-10-20
ER

PT J
AU Granja, PL
   De Jeso, B
   Bareille, R
   Rouais, F
   Baquey, C
   Barbosa, MA
AF Granja, Pedro L.
   De Jeso, Bernard
   Bareille, Reine
   Rouais, Francois
   Baquey, Charles
   Barbosa, Mario A.
TI Cellulose phosphates as biomaterials. In vitro biocompatibility studies
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE cellulose phosphates; phosphorylation; regenerated cellulose hydrogels;
   biomaterials; in vitro; biocompatibility; human bone marrow stromal
   cells; cytotoxicity; cell attachment; proliferation;
   immunohistochemistry
ID CALCIUM-PHOSPHATE; CELL-ADHESION; CYTOSKELETAL ORGANIZATION; WETTABILITY
   GRADIENT; OXIDIZED CELLULOSE; PROTEIN ADSORPTION; SURFACE-CHEMISTRY;
   GROWTH; MINERALIZATION; OSTEOBLASTS
AB Grafting of phosphate groups has been investigated as a means to render biomedical polymers able to induce the formation of an apatite layer. In the present investigation, regenerated cellulose hydrogels were surface modified by phosphorylation using a previously reported method. The in vitro biocompatibility of materials with varying phosphate contents was evaluated in cultured human bone marrow stromal cells (HBMSC), in terms of cytotoxicity, cell attachment, proliferation and immunohistochemistry. Negatively charged cellulose phosphates were neutralized in the form of the calcium salt before contact with cells. Cellulose phosphates were not cytotoxic, independently of the phosphate content. Unmodified regenerated cellulose hydrogels showed good rates of HBMSC attachment and proliferation. On the contrary, negatively charged, highly hydrophilic, phosphorylated surfaces showed poor HBMSC attachment and proliferation, as well as poor alkaline phosphatase-specific activity and expression of osteocalcin and type I collagen. Differences found are discussed in terms of surface chemical functionality, hydrophilicity and charge. (C) 2005 Elsevier B.V. All rights reserved.
C1 INEB, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, Oporto, Portugal.
   Univ Bordeaux 1, LCSV, Inst Pin, F-33405 Talence, France.
   Univ Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
RP Granja, PL (reprint author), INEB, Lab Biomat, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM pgranja@ineb.up.pt
RI Granja, Pedro/B-1685-2008
OI Granja, Pedro/0000-0003-2761-4929; Barbosa, Mario/0000-0003-3568-7482
CR *AFNOR, 1994, 309935 AFNORNF EN
   Albrektsson T., 1998, HDB BIOMATERIAL PROP, P500
   ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   ANWAR M, 1987, INDIAN J TEXT RES, V12, P24
   BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x
   Chauveaux D., 1990, CLIN MAT, V5, P251
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397
   Dias GJ, 2003, J MATER SCI-MATER M, V14, P739, DOI 10.1023/A:1025076002948
   Dumitriu S, 1996, POLYSACCHARIDES MED, P705
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   FRANZ G, 1986, ADV POLYM SCI, V76, P1
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GALGUT PN, 1990, BIOMATERIALS, V11, P561, DOI 10.1016/0142-9612(90)90078-5
   Granja P.L., 1999, FRONTIERS BIOMEDICAL, V2, P195
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Granja PL, 2001, J APPL POLYM SCI, V82, P3354, DOI 10.1002/app.2194
   Granja PL, 2001, J APPL POLYM SCI, V82, P3341
   Habbaba MM, 1997, J CHEM TECHNOL BIOT, V69, P405, DOI 10.1002/(SICI)1097-4660(199708)69:4<405::AID-JCTB729>3.0.CO;2-G
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hoffmann AS, 2004, BIOMATERIALS SCI INT, P107
   Hon DN-S, 1996, POLYSACCHARIDES MED, P87
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   HOSSEINI MM, 2000, BONE ENG, P295
   IKADA Y, 1989, CELLULOSE STRUCTURAL, P447
   International Standardization Organization, 1992, 109935 ISO
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.0.CO;2-2
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim SS, 1998, J BIOMED MATER RES, V40, P401, DOI 10.1002/(SICI)1097-4636(19980605)40:3<401::AID-JBM9>3.0.CO;2-J
   Lamba NMK, 1998, FRONTIERS TISSUE ENG, P121
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Li SH, 1997, J MATER SCI-MATER M, V8, P543, DOI 10.1023/A:1018546730925
   Linde A., 1992, CALCIFICATION BIOL S, P269
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Mizusawa Y, 1996, J PAEDIATR CHILD H, V32, P350, DOI 10.1111/j.1440-1754.1996.tb02569.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P658, DOI 10.1007/BF00123448
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   PADILHA PM, 1997, TALANTA, V41, P317
   POMMIER JC, 1987, Patent No. [0256906, 256906]
   POMMIER JC, 1986, Patent No. 8610331
   POMMIER JC, 1990, Patent No. 4904258
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X
   Skoog T, 1967, Scand J Plast Reconstr Surg, V1, P113
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   Uysal A, 2003, PLAST RECONSTR SURG, V112, P540, DOI 10.1097/01.PRS.0000070967.06488.63
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   VANDENBOS T, 1994, J BONE MINER RES, V9, P1205
   VEIS A, 1977, CALCIUM BINDING PROT, P408
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   VOGLER EA, 1993, SURFACTANT SCI SERIE, V49, P183
   VONRECUM AF, 1999, HDB BIOMATERIALS EVA, P227
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Yamamoto M, 1997, J BIOMED MATER RES, V37, P29, DOI 10.1002/(SICI)1097-4636(199710)37:1<29::AID-JBM4>3.0.CO;2-L
NR 64
TC 28
Z9 32
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD JUL
PY 2006
VL 66
IS 7
BP 728
EP 739
DI 10.1016/j.reactfunctpolym.2005.10.027
PG 12
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 065BK
UT WOS:000239134200005
DA 2018-10-20
ER

PT J
AU McMillin, CR
AF McMillin, Carl R.
TI Biomedical applications of rubbers and elastomers
SO RUBBER CHEMISTRY AND TECHNOLOGY
LA English
DT Review
ID POLYCARBONATE-BASED POLYURETHANES; LONG-TERM; THERMOPLASTIC ELASTOMERS;
   METHYLENE DIANILINE; BIODEGRADABLE POLYURETHANE; ENVIRONMENTAL
   CONTAMINANT; CARDIOVASCULAR STENTS; DEGRADATION-PRODUCTS; MEDICAL
   PRODUCTS; DISC REPLACEMENT
AB This paper discusses recent topics in the biomedical applications of rubbers and elastomers. It focuses on the current problems obtaining materials for implants from manufacturers due to concern about potential liability by raw materials manufacturers. The many problems and opportunities for development of polyurethane and silicone implants are discussed along with a review of a few other rubbers and elastomers used for implants. Some of the many other rubbers and elastomers available in medical grades and used in non-implant biomedical applications are presented.
RP McMillin, CR (reprint author), 6099 Warblers Roost, Brecksville, OH 44141 USA.
EM carl@syntheticbodyparts.com
CR Abraham GA, 2001, BIOMATERIALS, V22, P1971, DOI 10.1016/S0142-9612(00)00381-1
   Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38
   [Anonymous], 2000, SAFETY SILICONE BREA
   ARKLES B, 1983, BIOCOMPATIBLE POLYM, P749
   Asgian CM, 1989, T 15 ANN M SOC BIOM, P17
   Babu R, 2004, ASAIO J, V50, P479, DOI 10.1097/01.MAT.0000136511.99220.88
   Blanco J, 2005, Sleep Breath, V9, P20, DOI 10.1007/s11325-005-0003-4
   Burke A, 2004, ADV EXP MED BIOL, V553, P83
   Choi SH, 2002, J BIOMAT SCI-POLYM E, V13, P1163, DOI 10.1163/156856202320813864
   Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Crabtree JH, 2003, ASAIO J, V49, P290, DOI 10.1097/01.MAT.0000065467.87011.3B
   Cunningham BL, 2000, PLAST RECONSTR SURG, V105, P2143, DOI 10.1097/00006534-200005000-00037
   Cunningham BW, 2002, EUR SPINE J, V11, pS115, DOI 10.1007/s00586-002-0481-z
   ENKER P, 1993, SPINE, V18, P1061, DOI 10.1097/00007632-199306150-00017
   Fleurette J, 1992, Med Device Technol, V3, P52
   Ford Mary, 2004, J Hand Ther, V17, P64, DOI 10.1197/j.jht.2003.10.009
   Fraser Robert D, 2004, Spine J, V4, p245S, DOI 10.1016/j.spinee.2004.07.020
   Frick EM, 2003, BIOMACROMOLECULES, V4, P216, DOI 10.1021/bm025628b
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   Goma K, 2002, POLYM DEGRAD STABIL, V75, P113
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Haugen H, 2005, J BIOMED MATER RES B, V73B, P229, DOI 10.1002/jbm.b.30237
   Hentschel T, 1999, INFECTION, V27, pS43, DOI 10.1007/BF02561617
   Hildenbrand SL, 2005, PERFUSION-UK, V20, P351, DOI 10.1191/0267659105pf836oa
   HUMBLE MC, 2005, ONCOGENE, V56, P8217
   Hutchinson DT, 1997, J BIOMED MATER RES, V37, P94, DOI 10.1002/(SICI)1097-4636(199710)37:1<94::AID-JBM11>3.0.CO;2-Q
   Jefic Dijana, 2005, Nephrol News Issues, V19, P44
   Jones KP, 2004, ANN OCCUP HYG, V48, P455, DOI 10.1093/annhyg/mch038
   Kennan JJ, 1997, J BIOMED MATER RES, V36, P487
   Khorasani MT, 2006, J BIOMED MATER RES B, V76B, P41, DOI 10.1002/jbm.b.30363
   Kiat-amnuay S, 2006, J PROSTHET DENT, V95, P249, DOI 10.1016/j.prosdent.2005.12.006
   Kicheva YI, 2004, J MATER SCI-MATER M, V15, P909, DOI 10.1023/B:JMSM.0000036279.97458.8e
   Kimata H, 2005, PUBLIC HEALTH, V119, P1145, DOI 10.1016/j.puhe.2005.03.014
   Kondyurin AV, 2004, J BIOMAT SCI-POLYM E, V15, P145, DOI 10.1163/156856204322793548
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002
   LAMBERT M, 2006, J BIOMED MAT RES B
   LEE CK, 1991, SPINE S, V16, P253
   Legendre D, 2003, ARTIF ORGANS, V27, P457, DOI 10.1046/j.1525-1594.2003.07238.x
   Levitt Adam B, 2004, Cardiovasc Radiat Med, V5, P34, DOI 10.1016/j.carrad.2004.03.002
   Lewandowski TA, 2005, HUM EXP TOXICOL, V24, P655, DOI 10.1191/0960327105ht587oa
   Linti C, 2002, INT J ARTIF ORGANS, V25, P994
   Liu CB, 2005, J BIOMED MATER RES A, V75A, P465, DOI 10.1002/jbm.a.30453
   Loff S, 2004, J PEDIATR GASTR NUTR, V39, P341, DOI 10.1097/00005176-200410000-00008
   Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326
   Martin DJ, 2000, BIOMATERIALS, V21, P1021, DOI 10.1016/S0142-9612(99)00271-9
   Mazumder MM, 2003, J BIOMAT SCI-POLYM E, V14, P1351, DOI 10.1163/156856203322599699
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   McBane JE, 2005, J BIOMED MATER RES A, V74A, P1, DOI 10.1002/jbm.a.30311
   McMillin C R, 1987, J Biomater Appl, V2, P3, DOI 10.1177/088532828700200101
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   MCMILLIN CR, 1988, TECHN S AKR RUBB GRO, P63
   MCMILLIN CR, 1991, HIGH PERFORMANCE BIO, P37
   MONTERO J, 2003, EYE CONTACT LENS, V29, pS57
   MONTERO J, 2003, EYE CONTACT LENS, V29, pS192
   Montero Jesus, 2003, Eye Contact Lens, V29, pS54
   Mulcahy JJ, 2004, J SEX MED, V1, P98, DOI 10.1111/j.1743-6109.2004.10115.x
   Muller-Hulsbeck S, 2002, INVEST RADIOL, V37, P314, DOI 10.1097/00004424-200206000-00002
   MUZZARELLI RAA, 1994, J BIOMAT SCI-POLYM E, V6, P541
   Nakayama Y, 2005, INT J ARTIF ORGANS, V28, P600
   Ogawa R, 2002, J BIOMED MATER RES, V62, P214, DOI 10.1002/jbm.10339
   Okamura M, 2006, TOXICOLOGY, V217, P129, DOI 10.1016/j.tox.2005.09.021
   PASTOR MCD, 2006, ALLERGOL IMMUNOPATH, V34, P17
   POL H, 1995, DEVICE TECHNOL, V6, P18
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Radley Huw, 2003, Med Device Technol, V14, P38
   Rhee JY, 2005, J VASC SURG, V42, P321, DOI 10.1016/j.jvs.2005.04.043
   Rosenberg C, 2002, J ENVIRON MONITOR, V4, P711, DOI 10.1039/b206340a
   SANDS AT, 1995, P NATL ACAD SCI USA, V92, P8517, DOI 10.1073/pnas.92.18.8517
   SCOTT G, 1988, FREE RADICAL RES COM, V5, P141, DOI 10.3109/10715768809066923
   Sendijarevic V, 2004, ENVIRON SCI TECHNOL, V38, P1066, DOI 10.1021/es035072f
   Severyns K, 2000, Med Device Technol, V11, P28
   SHINTANI H, 1995, J BIOMATER APPL, V10, P23, DOI 10.1177/088532829501000102
   SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008
   Silva P, 2005, J MATER SCI-MATER M, V16, P663, DOI 10.1007/s10856-005-2538-0
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   Sipkens K, 2000, Med Device Technol, V11, P8
   SIPKENS K, 2000, MED DEVICE TECHNOL, V11, P12
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stone M, 1998, CLIN ANAT, V11, P191, DOI 10.1002/(SICI)1098-2353(1998)11:3<191::AID-CA7>3.0.CO;2-W
   Takigawa S, 2004, J HAND SURG-AM, V29A, P785, DOI 10.1016/j.jhsa.2004.03.008
   Tang YW, 2003, BIOMATERIALS, V24, P2805, DOI 10.1016/S0142-9612(03)00081-4
   Taylor JE, 2005, BIOMATERIALS, V26, P6467, DOI 10.1016/j.biomaterials.2005.04.009
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Trigwell S, 2006, J BIOMED MATER RES B, V76B, P241, DOI 10.1002/jbm.b.30359
   van Minnen B, 2006, J BIOMED MATER RES A, V76A, P377, DOI 10.1002/jbm.a.30531
   VANDENKERCKHOVE E, 2001, BURNS, V3, P205
   Verma S, 2005, NEW ENGL J MED, V353, P730, DOI 10.1056/NEJMcibr052030
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6
   Wang J, 2002, ANN PLAS SURG, V48, P617, DOI 10.1097/00000637-200206000-00009
   Weiss Susan, 2004, J Hand Ther, V17, P401, DOI 10.1197/j.jht.2004.07.002
   Wilson G J, 1995, ASAIO J, V41, pM728, DOI 10.1097/00002480-199507000-00109
   Woo Denise K, 2004, Dermatitis, V15, P206, DOI 10.2310/6620.2004.04031
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Yoon J, 2002, YONSEI MED J, V43, P242, DOI 10.3349/ymj.2002.43.2.242
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang JY, 2003, TISSUE ENG, V9, P1143, DOI 10.1089/10763270360728053
   ZIMMERS KB, 1992, 11 S BIOM ENG C MEMP, P74
   2000, BIOMATERIALS AVAILAB
   2002, ADV DRUG DELIVERY DR, V54
   1993, POLYM SOLVES HEART P
NR 103
TC 10
Z9 10
U1 4
U2 50
PU AMER CHEMICAL SOC INC
PI AKRON
PA RUBBER DIV UNIV AKRON PO BOX 499, AKRON, OH 44309-0499 USA
SN 0035-9475
J9 RUBBER CHEM TECHNOL
JI Rubber Chem. Technol.
PD JUL-AUG
PY 2006
VL 79
IS 3
BP 500
EP 519
DI 10.5254/1.3547948
PG 20
WC Polymer Science
SC Polymer Science
GA 214IZ
UT WOS:000249732500006
DA 2018-10-20
ER

PT J
AU Bruns, N
   Tiller, JC
AF Bruns, Nico
   Tiller, Joerg C.
TI Nanophasic amphiphilic conetworks with a fluorophilic phase
SO MACROMOLECULES
LA English
DT Article
ID UV-CURABLE SYSTEMS; POLYMER NETWORKS; PERFLUOROPOLYETHER STRUCTURES;
   COPOLYMER HYDROGELS; CELL-ADHESION; COATINGS; SURFACE; SEPARATION;
   INSULIN; GLUCOSE
AB Amphiphilic conetworks, generally considered as hydrophilic/ hydrophobic materials, are recently gaining great interest due to their wide range of possible applications in catalysis, sensors, and biomedical applications. However, little is known about conetworks with highly fluorinated phases. Here, we describe two readily available methods that allow the synthesis of nanophase separated hydrophobic/fluorophilic and hydrophilic/ fluorophilic conetworks. The first kind was achieved by the novel "hot plate technique", which allows to homogenize a mixture of the perfluoro-tagged 1H, 1H, 2H, 2H-hexadecylfluorodecyl acrylate and a dimethacrylate terminated poly( dimethylsiloxane). Upon photopolymerization, nanophase separated conetworks in all compositions were obtained. Further, hydrophilic/ fluorophilic conetworks could be accessed by applying the precursor approach for the synthesis of amphiphilic conetworks. To this end, 2-hydroxyethyl acrylate was modified with a perfluoro-tagged silane, mixed with dimethacrylate-terminated perfluoropolyether, photopolymerized, and subsequently deprotected. The amphiphilic behavior as well as the nanophase morphology of all conetworks was proven with swelling experiments, AFM, TEM, and DSC measurements. Preliminary results show the great affinity of the hydrophilic/ fluorophilic conetworks to the catalytically important enzyme lipase, indicating their potential as phase transfer matrix for biotransformations in perfluorinated solvents and supercritical fluids.
C1 Univ Freiburg, Freiburg Mat Res Ctr, D-79104 Freiburg, Germany.
   Univ Freiburg, Inst Macromol Chem, Dept Chem, D-79104 Freiburg, Germany.
RP Tiller, JC (reprint author), Univ Freiburg, Freiburg Mat Res Ctr, Stefan Meier Str 21, D-79104 Freiburg, Germany.
EM joerg.tiller@fmf.uni-freiburg.de
RI Bruns, Nico/C-6485-2009; Tiller, Joerg/S-2010-2016
OI Bruns, Nico/0000-0001-6199-9995; 
CR Barakat I, 1999, J POLYM SCI POL CHEM, V37, P2401, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2401::AID-POLA14>3.0.CO;2-9
   BLEZER R, 1995, POLYM BULL, V34, P101, DOI 10.1007/BF00294894
   Bongiovanni R, 1998, MACROMOL CHEM PHYS, V199, P1099
   Bongiovanni R, 2004, J FLUORINE CHEM, V125, P345, DOI 10.1016/j.jfluchem.2003.07.017
   Bongiovanni R, 2000, J APPL POLYM SCI, V75, P651
   Bromberg L, 2002, LANGMUIR, V18, P4944, DOI 10.1021/la011868l
   Bruns N, 2005, MACROMOLECULES, V38, P2431, DOI 10.1021/ma047302w
   Bruns N, 2005, NANO LETT, V5, P45, DOI 10.1021/nl048413b
   CHEN D, 1988, J MACROMOL SCI CHEM, VA25, P389, DOI 10.1080/00222338808053376
   Consolati G, 2001, POLYMER, V42, P9723, DOI 10.1016/S0032-3861(01)00515-8
   de Wolf E, 1999, CHEM SOC REV, V28, P37, DOI 10.1039/a805644g
   ELIAS HG, 2001, MAKROMOLEKULE, V2
   FRIENDS GD, 1995, MACROMOL SYMP, V98, P619, DOI 10.1002/masy.19950980153
   Game P, 2002, MACROMOLECULES, V35, P917, DOI 10.1021/ma001988k
   Gan DJ, 2003, J POLYM SCI POL CHEM, V41, P3531, DOI 10.1002/pola.10968
   Gudipati CS, 2005, LANGMUIR, V21, P3044, DOI 10.1021/la048015o
   Guiseppi-Elie A, 2002, ADV MATER, V14, P743, DOI 10.1002/1521-4095(20020517)14:10<743::AID-ADMA743>3.0.CO;2-H
   Hadjichristidis N., 2002, BLOCK COPOLYMERS SYN
   Haigh R, 2002, BIOMATERIALS, V23, P3509, DOI 10.1016/S0142-9612(02)00081-9
   Haigh R, 2000, BIOMATERIALS, V21, P735, DOI 10.1016/S0142-9612(99)00245-8
   HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72
   Ivan B, 2005, MACROMOL SYMP, V227, P265, DOI 10.1002/masy.200550926
   IVAN B, 1991, ACS S SER, V469, P203
   IVAN B, 1991, ACS SYM SER, V469, P194
   Johnson G, 1999, J BIOMAT SCI-POLYM E, V10, P217, DOI 10.1163/156856299X00144
   Kennedy JP, 2001, MACROMOL SYMP, V172, P57
   Kennedy JP, 2003, ACS SYM SER, V833, P290
   KESZLER B, 1993, J CONTROL RELEASE, V25, P115, DOI 10.1016/0168-3659(93)90100-J
   KESZLER B, 1984, J MACROMOL SCI CHEM, V21, P327
   Morin AM, 2000, J FLUORESC, V10, P7, DOI 10.1023/A:1009475210933
   MUNSON MSB, 1964, J PHYS CHEM-US, V68, P796, DOI 10.1021/j100786a015
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Patrickios CS, 2003, CURR OPIN COLLOID IN, V8, P76, DOI 10.1016/S1359-0294(03)00005-0
   Podual K, 2000, POLYMER, V41, P3975, DOI 10.1016/S0032-3861(99)00620-5
   Priola A, 1997, MACROMOL CHEM PHYS, V198, P1893, DOI 10.1002/macp.1997.021980618
   Savin G, 2005, MACROMOLECULES, V38, P7536, DOI 10.1021/ma0509715
   Scherble J, 2002, MACROMOL CHEM PHYSIC, V203, P1866, DOI 10.1002/1521-3935(200208)203:12<1866::AID-MACP1866>3.0.CO;2-G
   Scherble J, 2001, J POLYM SCI POL PHYS, V39, P1429, DOI 10.1002/polb.1114
   SCHERBLE J, 2002, THESIS A LUDWIGS U F
   Schmid RD, 1998, ANGEW CHEM INT EDIT, V37, P1609
   Shamlou S, 1997, J BIOMED MATER RES, V35, P157, DOI 10.1002/(SICI)1097-4636(199705)35:2<157::AID-JBM3>3.0.CO;2-M
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P448, DOI 10.1002/jbm.a.10077
   Tanahashi K, 2002, BIOMACROMOLECULES, V3, P1030, DOI 10.1021/bm0200433
   Turri S, 2000, SURF INTERFACE ANAL, V29, P873, DOI 10.1002/1096-9918(200012)29:12<873::AID-SIA941>3.0.CO;2-C
   WEBER M, 1988, POLYMER, V29, P1071, DOI 10.1016/0032-3861(88)90017-1
NR 45
TC 43
Z9 43
U1 1
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD JUN 27
PY 2006
VL 39
IS 13
BP 4386
EP 4394
DI 10.1021/ma052592h
PG 9
WC Polymer Science
SC Polymer Science
GA 054NZ
UT WOS:000238385900021
DA 2018-10-20
ER

PT J
AU Foo, CWP
   Patwardhan, SV
   Belton, DJ
   Kitchel, B
   Anastasiades, D
   Huang, J
   Naik, RR
   Perry, CC
   Kaplan, DL
AF Foo, CWP
   Patwardhan, SV
   Belton, DJ
   Kitchel, B
   Anastasiades, D
   Huang, J
   Naik, RR
   Perry, CC
   Kaplan, DL
TI Novel nanocomposites from spider silk-silica fusion (chimeric) proteins
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterials; nanostructures; silaffin; biomineralization; ceramics
ID BIOACTIVE COMPOSITE-MATERIALS; BOMBYX-MORI SILK; POLY(ETHYLENE OXIDE);
   FIBROIN; SCAFFOLDS; FILMS; SILICIFICATION; MORPHOGENESIS; EXPRESSION;
   CRYSTALS
AB Silica skeletal architectures in diatoms are characterized by remarkable morphological and nanostructural details. Silk proteins from spiders and silkworms form strong and intricate self-assembling fibrous biomaterials in nature. We combined the features of silk with biosilica through the design, synthesis, and characterization of a novel family of chimeric proteins for subsequent use in model materials forming reactions. The domains from the major ampullate spidroin 1 (MaSp1) protein of Nephila clavipes spider dragline silk provide control over structural and morphological details because it can be self-assembled through diverse processing methods including film casting and fiber electrospinning. Biosilica nanostructures in diatoms are formed in aqueous ambient conditions at neutral pH and low temperatures. The R5 peptide derived from the silaffin protein of Cylindrotheca fusiformis induces and regulates silica precipitation in the chimeric protein designs under similar ambient conditions. Whereas mineralization reactions performed in the presence of R5 peptide alone form silica particles with a size distribution of 0.5-10 mu m in diameter, reactions performed in the presence of the new fusion proteins generate nanocomposite materials containing silica particles with a narrower size distribution of 0.5-2 mu m in diameter. Furthermore, we demonstrate that composite morphology and structure could be regulated by controlling processing conditions to produce films and fibers. These results suggest that the chimeric protein provides new options for processing and control over silica particle sizes, important benefits for biomedical and specialty materials, particularly in light of the all aqueous processing and the nanocomposite features of these new materials.
C1 Nottingham Trent Univ, Sch Biomed & Nat Sci, Interdisciplinary Biomed Res Ctr, Biomol & Mat Interface Res Grp, Nottingham NG11 8NS, England.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol & Chem Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
RP Kaplan, DL (reprint author), Nottingham Trent Univ, Sch Biomed & Nat Sci, Interdisciplinary Biomed Res Ctr, Biomol & Mat Interface Res Grp, Clifton Lane, Nottingham NG11 8NS, England.
EM david.kaplan@tufts.edu
RI Patwardhan, Siddharth/B-5037-2009
OI Patwardhan, Siddharth/0000-0002-4958-8840; Perry, Professor
   Carole/0000-0003-1517-468X
FU NIBIB NIH HHS [EB 003210, EB 000252, R01 EB003210, R01 EB000252]
CR Albarran B, 2005, PROTEIN ENG DES SEL, V18, P147, DOI 10.1093/protein/gzi014
   Asai T, 2005, BIOMOL ENG, V21, P145, DOI 10.1016/j.bioeng.2004.10.001
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Belton D, 2005, CHEM COMMUN, P3475, DOI 10.1039/b504310g
   Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Boskey A L, 1998, J Cell Biochem Suppl, V30-31, P83
   Brott LL, 2001, NATURE, V413, P291, DOI 10.1038/35095031
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cunniff P. M., 1994, SILK POLYM, V544, P234
   DUBROVSKY T, 1996, THIN SOLID FILMS, V285, P698
   Frey W, 2003, ADV MATER, V15, P248, DOI 10.1002/adma.200390058
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Icke C, 2002, MOL PHARMACOL, V62, P203, DOI 10.1124/mol.62.2.203
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Knecht MR, 2003, CHEM COMMUN, P3038, DOI 10.1039/b309074d
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   MULLER WEG, 2003, SILICON BIOMINERALIZ
   Naik RR, 2003, CHEM COMMUN, P238, DOI 10.1039/b210635c
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   Park E, 1998, J DRUG TARGET, V6, P53, DOI 10.3109/10611869808997881
   Paternolli C, 2002, MAT SCI ENG C-BIO S, V22, P155, DOI 10.1016/S0928-4931(02)00164-9
   Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c
   PATWARDHAN SV, 2003, THESIS U CINCINNATI
   Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Simpson T.L, 1981, SILICON SILICEOUS ST
   Sleytr UB, 2003, IEEE ENG MED BIOL, V22, P140, DOI 10.1109/MEMB.2003.1213637
   Slocik JM, 2005, J MATER CHEM, V15, P749, DOI 10.1039/b413074j
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k
   VORONKOV MG, 1997, SILICON LIFE
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   WHITLOCK PW, 2005, THESIS U CINCINNATI
   Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   WONG PF, 2004, TRENDS BIOTECHNOL, V22, P577
   WONG PFC, 2006, APPL PHYS A, V82, P223
   Yan SZ, 2001, J BIOL CHEM, V276, P8500, DOI 10.1074/jbc.M010361200
NR 47
TC 114
Z9 117
U1 3
U2 74
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 20
PY 2006
VL 103
IS 25
BP 9428
EP 9433
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 058JD
UT WOS:000238660400011
PM 16769898
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Mandl, S
   Fleischer, A
   Manova, D
   Rauschenbach, B
AF Mandl, S
   Fleischer, A
   Manova, D
   Rauschenbach, B
TI Wear behaviour of NiTi shape memory alloy after oxygen-PIII treatment
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Protective Coatings and Thin Films held at the E-MRS Spring
   Meeting
CY MAY   31, 2004-JUN 03, 2005
CL Strasbourg, FRANCE
SP E-MRS
DE PIII; NiTi; rutile; wear; biocompatibility
ID IMMERSION ION-IMPLANTATION; TITANIUM; DIFFUSION
AB Super-elastic Nitinol (NiTi alloys) is predestined for major biomedical applications as its mechanical properties are more closely matched to those of living bones than titanium alloys. Using suitable surface modifications, it is possible to form pure titania (rutile) surface layers, thus prohibiting the outdiffusion of toxic nickel cations. The wear behaviour and the lifetime of such surface layers, produced by oxygen plasma immersion ion implantation (PIII) at 25 W and 250-550 degrees C sample temperature, are measured and compared to that of untreated NiTi. Ballon-disc tests with intermittent impact loading revealed a specific wear volume of the treated samples comparable to that of the base material, slightly lower and higher depending on the process conditions. An increased fatigue lifetime was found for lower temperatures and higher oxygen fluences, indicating that the layer thickness is not the decisive factor. Instead, internal stress relaxation and atomic rearrangement are proposed as the dominant mechanism. (c) 2005 Elsevier B.V All rights reserved.
C1 Leibniz Inst Oberflachenmodifizierung, Leipzig, Germany.
RP Mandl, S (reprint author), Leibniz Inst Oberflachenmodifizierung, Leipzig, Germany.
EM stephan.maendl@iom-leipzig.de
CR ASSMANN W, 1994, NUCL INSTRUM METH B, V89, P131, DOI 10.1016/0168-583X(94)95159-4
   Chudoba T, 2002, SURF COAT TECH, V154, P140, DOI 10.1016/S0257-8972(02)00016-6
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   ELAGLI K, 1994, P 20 ANN M SOC BIOM, P262
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   FLEISCHER A, 2005, THESIS U APPL SCI KO
   Fujisawa N, 2003, WEAR, V254, P111, DOI 10.1016/S0043-1648(02)00307-1
   Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221, P163
   KITZING M, 2005, THESIS U LEIPZIG
   Mandl S, 2005, SURF COAT TECH, V196, P293, DOI 10.1016/j.surfcoat.2004.08.170
   Mandl S, 2001, SURF COAT TECH, V142, P1046, DOI 10.1016/S0257-8972(01)01066-0
   Mandl S, 2000, SURF COAT TECH, V125, P84, DOI 10.1016/S0257-8972(99)00559-9
   MANDL S, 2002, GENET ANAL-BIOMOL E, V19, P131
   Manova D, 2003, J VAC SCI TECHNOL A, V21, P643, DOI 10.1116/1.1566785
   Manova D, 2001, PLASMA SOURCES SCI T, V10, P423, DOI 10.1088/0963-0252/10/3/305
   Melton K. N, 1990, ENG ASPECTS SHAPE ME, P21
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   Scherge M, 2003, WEAR, V255, P395, DOI 10.1016/S0043-1648(03)00273-4
   SCHLIEPHAKE H, 1993, INT J ORAL MAX SURG, V22, P20, DOI 10.1016/S0901-5027(05)80350-9
   Thorwarth G, 2001, SURF COAT TECH, V136, P236, DOI 10.1016/S0257-8972(00)01021-5
   WOJCIAKSTOTARD B, 1996, CELL RES, V226, P426
   ZIEGLER JF, 1986, STOPPING RANGE IONS
NR 24
TC 13
Z9 14
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 20
PY 2006
VL 200
IS 22-23
BP 6225
EP 6229
DI 10.1016/j.surfcoat.2005.11.070
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 046WR
UT WOS:000237842300013
DA 2018-10-20
ER

PT J
AU Anselme, K
   Bigerelle, M
AF Anselme, K
   Bigerelle, M
TI Effect of a gold-palladium coating on the long-term adhesion of human
   osteoblasts on biocompatible metallic materials
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Protective Coatings and Thin Films held at the E-MRS Spring
   Meeting
CY MAY   31, 2004-JUN 03, 2005
CL Strasbourg, FRANCE
SP E-MRS
DE titanium; stainless steel; coating; cell adhesion; surface topography;
   surface chemistry; osteoblast; human
ID CELL-ADHESION; BONE-CELLS; SURFACES; TI; TOPOGRAPHY; ROUGHNESS;
   CORROSION; ALLOYS; BETA
AB Our ambition for several years is to study the in vitro interface between human bone cells and biomedical metals in order to improve dental and orthopaedic implant's surface. The long-term adhesion of human osteoblasts cultured on pure titanium, titanium alloy and stainless steel substrates presenting 4 different surface morphologies and 2 different roughness amplitudes (obtained by sand-blasting, acid-etching, electro-erosion and polishing) was quantified from 24 h to 21 days. The half part of the samples was sputter-coated with gold-palladium. The coating by a nanometric gold-palladium layer influenced differently the long-term adhesion of human osteoblasts as a function of the composition of the substrate. This influence was either positive, neutral or negative but was significantly demonstrated only three times. In all the three cases, the coating improved the long-term adhesion of ostcoblasts. Consequently, it appears that a gold-palladium coating could be a good way to improve cell adhesion, and perhaps tissue adhesion, on metallic surfaces with low biocompatibility like polished stainless steel substrates or acid-etched pure titanium substrates. (c) 2005 Elsevier B.V. All rights reserved.
C1 CNRS, UPR 9069, ICSI, F-68057 Mulhouse, France.
   CNRS, UTC, Lab Roberval, FRE 2833,Ctr Rech Royallieu, F-60205 Compiegne, France.
RP Anselme, K (reprint author), CNRS, UPR 9069, ICSI, 15,Rue Jean Starcky,BP2488, F-68057 Mulhouse, France.
EM Karine.Anselme@uha.fr
OI Anselme, Karine/0000-0002-6669-205X; Maxence,
   Bigerelle/0000-0002-4144-245X
CR Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   BARANOWSKI T J JR, 1983, Journal of Orthopaedic Research, V1, P120, DOI 10.1002/jor.1100010202
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   BOYAN BD, 2001, ANN REV MATER RES, V31, P371
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   ITO A, 1995, J BIOMED MATER RES, V29, P893, DOI 10.1002/jbm.820290715
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Locci P, 1996, J PERIODONTOL, V67, P1260, DOI 10.1902/jop.1996.67.12.1260
   Schmuki P, 2005, CORROS SCI, V47, P1239, DOI 10.1016/j.corsci.2004.05.023
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   TIFFANYCASTIGLIONI E, 1993, NEUROTOXICOLOGY, V14, P513
   Wang Q, 1998, CLIN ORTHOP RELAT R, P259
NR 16
TC 20
Z9 22
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 20
PY 2006
VL 200
IS 22-23
BP 6325
EP 6330
DI 10.1016/j.surfcoat.2005.11.001
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 046WR
UT WOS:000237842300032
DA 2018-10-20
ER

PT J
AU Amaral, M
   Salgueiredo, E
   Oliveira, FJ
   Fernandes, AJS
   Costa, FM
   Silva, RF
AF Amaral, M
   Salgueiredo, E
   Oliveira, FJ
   Fernandes, AJS
   Costa, FM
   Silva, RF
TI NCD by HFCVD on a Si3N4-bioglass composite for biomechanical
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Protective Coatings and Thin Films held at the E-MRS Spring
   Meeting
CY MAY   31, 2004-JUN 03, 2005
CL Strasbourg, FRANCE
SP E-MRS
DE NCD; Si3N4-bioglass composite; biomedical applications
ID CHEMICAL-VAPOR-DEPOSITION; SILICON-NITRIDE; THIN-FILMS; NANODIAMOND;
   CERAMICS; SYSTEM; CVD
AB A biocompatible Si3N4-bioglass composite was coated with nanocrystalline diamond (NCD) by the hot filament chemical vapour deposition technique (HFCVD) using a H-2/Ar/CH4 gas mixture. The advantages of the biocomposite are combined with a hard, smooth and low friction coating, making it a potential material for biotribological applications. Very low intrinsic surface roughness in the range 5 to 15 nm was determined by AFM and crystallite sizes of 1 to 30 nm were measured by TEM. The substrate temperature, Ar/H-2 ratio, starting roughness and cooling rate after deposition are key factors in determining the uniformity and adhesion of the NCD film to the biocomposite. To avoid blistering and guarantee high adhesion levels, depositions must be conducted below the bioglass crystallization temperature (637 degrees C). The highest growth rate (1 mu m h(-1)) was reached with a Ar/H-2 = 0-1 ratio. Brale indentation tests with 200 N showed that flat lapped substrates give a better adhesion relatively to smoother ones pre-polished in soft cloths. Slow cooling rates after deposition (2 degrees C min(-1)) prevented film delamination under this applied load. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Aveiro, CICECO, Glass & Ceram Engn Dept, Aveiro, Portugal.
   Univ Aveiro, Dept Phys, Aveiro, Portugal.
RP Amaral, M (reprint author), Univ Aveiro, CICECO, Glass & Ceram Engn Dept, Aveiro, Portugal.
EM msamaral@cv.ua.pt
RI Universidade Aveiro, Departamento Fisica/E-4128-2013; Amaral,
   Margarida/B-7393-2008; Silva, Rui/B-8208-2008; Costa,
   Florinda/J-4345-2013; Oliveira, Filipe/H-2618-2013
OI Amaral, Margarida/0000-0003-4966-2614; Silva, Rui/0000-0002-2584-1792;
   Costa, Florinda/0000-0001-8729-714X; Oliveira,
   Filipe/0000-0001-7956-6565
CR Amaral M, 2005, THIN SOLID FILMS, V482, P232, DOI 10.1016/j.tsf.2004.11.140
   Amaral M, 2004, DIAM RELAT MATER, V13, P643, DOI 10.1016/j.diamond.2003.10.045
   Amaral M, 2002, BIOMATERIALS, V23, P4897, DOI 10.1016/S0142-9612(02)00249-1
   Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   Belmonte M, 2005, DIAM RELAT MATER, V14, P54, DOI 10.1016/j.diamond.2004.06.032
   Belmonte M, 2003, J AM CERAM SOC, V86, P749, DOI 10.1111/j.1151-2916.2003.tb03369.x
   Chow L, 2000, THIN SOLID FILMS, V368, P193, DOI 10.1016/S0040-6090(00)00763-X
   Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405
   Fries MD, 2004, DIAM RELAT MATER, V13, P1740, DOI 10.1016/j.diamond.2004.02.014
   Gupta S, 2002, J MATER RES, V17, P1820, DOI 10.1557/JMR.2002.0270
   Liao MY, 2002, J CRYST GROWTH, V236, P85, DOI 10.1016/S0022-0248(01)02160-1
   Lin T, 2000, APPL PHYS LETT, V77, P2692, DOI 10.1063/1.1320039
   Mitura S, 1999, CHAOS SOLITON FRACT, V10, P2165, DOI 10.1016/S0960-0779(98)00251-3
   PAPO MJ, 2004, J MATER SCI-MATER M, V15, P7
   Zhang YF, 2001, DIAM RELAT MATER, V10, P1523, DOI 10.1016/S0925-9635(01)00383-1
NR 16
TC 4
Z9 4
U1 0
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 20
PY 2006
VL 200
IS 22-23
BP 6409
EP 6413
DI 10.1016/j.surfcoat.2005.11.089
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 046WR
UT WOS:000237842300048
DA 2018-10-20
ER

PT J
AU Zhao, SP
   Ma, D
   Zhang, LM
AF Zhao, San-Ping
   Ma, Dong
   Zhang, Li-Ming
TI New semi-interpenetrating network hydrogels: Synthesis, characterization
   and properties
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE drug controlled release; hydroxypropyl guar gum; mechanical properties;
   photopolymerizable macromers; semi-IPN hydrogels; swelling behavior
ID TISSUE ENGINEERING APPLICATIONS; POLY(ETHYLENE GLYCOL); BIODEGRADABLE
   HYDROGELS; DIACRYLATE MACROMERS; CONTROLLED-RELEASE; POLYMER NETWORKS;
   BETA-CHITIN; ACID); POLYACRYLAMIDE; COPOLYMERS
AB Amphiphilic hydrogels composed of aliphatic polyesters and poly(ethylene glycol) have potential applications in drug delivery, tissue engineering and other biomedical devices due to their advantageous biological properties, biocompatibility and biodegradability. However, they also exhibit some shortcomings in terms of their reactivity, swelling and mechanical properties. To address these limitations new semi-interpenetrating network. (semi-IPN) hydrogels based on poly(ethylene glycol)-co-poly(epsilon-caprolactone) (PEG-PCL) diacrylate macromer and hydroxypropyl guar gum (HPGG) were prepared by,a low intensity ultraviolet (UV) light irradiation method, and characterized by FT-IR, DSC and WAXD analysis: Their properties were evaluated by investigating the swelling kinetics, dynamic mechanical theology and the release behavior for bovine serum albumin (BSA). It was found that I the introduction of the semi-IPN structure and HPGG decreased the crystallinity of PEG segments in the hydrogel, and improved the swelling and mechanical properties of the hydrogel, as well as lowered the release percentage of BSA from the hydrogel. Such hydrogel materials may have more advantages as a potentially interesting platform for the design of medical devices.
C1 Zhongshan Univ, Sch Chem & Chem Engn, Guangzhou 510275, Peoples R China.
   Zhongshan Univ, Key Lab Polymer Composite & Funct Mat, Minist Educ, Guangzhou 510275, Peoples R China.
RP Zhang, LM (reprint author), Zhongshan Univ, Sch Chem & Chem Engn, Guangzhou 510275, Peoples R China.
EM ceszhlm@mail.sysu.edu.cn
RI Zhang, Li-Ming/K-7012-2013
CR AHMAD MB, 1994, POLYMER, V35, P1997, DOI 10.1016/0032-3861(94)90995-4
   Chiellini F, 2003, MACROMOL SYMP, V197, P369, DOI 10.1002/masy.200350732
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   DEO PP, 2005, Patent No. 2005175641
   Guan YL, 1996, J APPL POLYM SCI, V61, P393
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hartstein I, 2005, CURR MED RES OPIN, V21, P255, DOI 10.1185/030079905X26252
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hubbell JA, 1995, U.S.A Patent Application, Patent No. 5410016
   JEVNE A, 1986, Patent No. 4593053
   Kayaman N, 1999, MACROMOL CHEM PHYSIC, V200, P231, DOI 10.1002/(SICI)1521-3935(19990101)200:1<231::AID-MACP231>3.0.CO;2-#
   Kayaman-Apohan N, 2001, MACROMOL CHEM PHYSIC, V202, P1182, DOI 10.1002/1521-3935(20010401)202:7<1182::AID-MACP1182>3.0.CO;2-R
   Kelner A, 2005, J CONTROL RELEASE, V101, P13, DOI 10.1016/j.jconrel.2004.09.010
   KIM SS, 1995, POLYMER, V36, P4497, DOI 10.1016/0032-3861(95)96859-7
   Krusic MK, 2004, MACROMOL CHEM PHYSIC, V205, P2214, DOI 10.1002/macp.200400210
   Lee J, 2003, ARCH PHARM RES, V26, P880, DOI 10.1007/BF02980036
   Lee YM, 1997, POLYMER, V38, P2415, DOI 10.1016/S0032-3861(96)00789-6
   Matsusaki M, 2005, BIOMACROMOLECULES, V6, P3351, DOI 10.1021/bm050369m
   Nivasu VM, 2004, POLYM ADVAN TECHNOL, V15, P128, DOI 10.1002/pat.415
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Rigter PL, 1987, J CONTROL RELEASE, V5, P37
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SCHOTT H, 1992, J PHARM SCI, V81, P467, DOI 10.1002/jps.2600810516
   Stile RA, 2002, BIOMACROMOLECULES, V3, P591, DOI 10.1021/bm0101466
   Williamson SL, 1998, MACROMOLECULES, V31, P8134, DOI 10.1021/ma980718n
   Xia YQ, 2005, BIOMACROMOLECULES, V6, P2601, DOI 10.1021/bm050324l
   YASUHIKO T, 1998, PURE APPL CHEM, V70, P1277
   Zainuddin J. J., 2002, J BIOMAT SCI-POLYM E, V13, P1007
   Zhang JT, 2004, MACROMOL BIOSCI, V4, P575, DOI 10.1002/mabi.200400003
   Zhang LM, 2005, J BIOACT COMPAT POL, V20, P297, DOI 10.1177/0883911505053882
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 33
TC 34
Z9 35
U1 2
U2 33
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN 16
PY 2006
VL 6
IS 6
BP 445
EP 451
DI 10.1002/mabi.200600011
PG 7
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 059GQ
UT WOS:000238721700007
PM 16761276
DA 2018-10-20
ER

PT J
AU White, A
   Burns, D
   Christensen, TW
AF White, A
   Burns, D
   Christensen, TW
TI Effective terminal sterilization using supercritical carbon dioxide
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE supercritical fluid; carbon dioxide; spore inactivation; peracetic acid
ID MOLECULAR-WEIGHT POLYETHYLENE; FLUID EXTRACTION; ETHYLENE-OXIDE;
   GAMMA-IRRADIATION; BONE ALLOGRAFTS; INACTIVATION; CO2; INFECTIONS;
   PRESSURE; PROTEINS
AB Gentle alternatives to existing sterilization methods are called for by rapid advances in biomedical technologies. Supercritical fluid technologies have found applications in a wide range of areas and have been explored for use in the inactivation of medical contaminants. In particular, supercritical CO2 is appealing for sterilization due to the ease at which the supercritical state is attained, the non-reactive nature, and the ability to readily penetrate substrates. However, rapid inactivation of bacterial endospores has proven a barrier to the use of this technology for effective terminal sterilization. We report the development of a supercritical CO2 based sterilization process capable of achieving rapid inactivation of bacterial endospores while in terminal packaging. Moreover, this process is gentle; as the morphology, ultrastructure, and protein profiles of inactivated microbes are maintained. These properties of the sterilization process suit it for possible use on a wide range of biomedical products including: materials derived from animal tissues, protein based therapies, and other sensitive medical products requiring gentle terminal sterilization. (c) 2006 Elsevier B.V. All rights reserved.
C1 NovaSterilis Inc, Lansing, NY 14882 USA.
RP Christensen, TW (reprint author), NovaSterilis Inc, Lansing, NY 14882 USA.
EM tim@cnymail.com
CR *AAI, 1995, STERILIZATION MED DE
   Akkus O, 2001, J ORTHOP RES, V19, P927, DOI 10.1016/S0736-0266(01)00004-3
   BERUBE R, 1991, METHODS TESTING SAN, P1058
   BLOCK SS, 2001, DISINFECTION STERILA
   *CDC, 2001, MMWR-MORBID MORTAL W, V50, P1081
   CDC, 2001, MMWR-MORBID MORTAL W, V50, P1035
   CLAPP PA, 1994, FREE RADICAL RES, V21, P147, DOI 10.3109/10715769409056566
   CONRAD EU, 1995, J BONE JOINT SURG AM, V77A, P214, DOI 10.2106/00004623-199502000-00007
   Crawford C, 2005, CLIN INFECT DIS, V41, P195, DOI 10.1086/430911
   Digas G, 2003, ACTA ORTHOP SCAND, V74, P531, DOI 10.1080/00016470310017910
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   Duffy P, 2000, J REPROD FERTIL, V118, P9, DOI 10.1530/reprod/118.1.9
   Fages J, 1998, ASAIO J, V44, P289
   Fages J, 1998, ASAIO J, V44, P278
   FAGES J, 1994, BIOMATERIALS, V15, P650, DOI 10.1016/0142-9612(94)90162-7
   FDA, 1993, GUID PREM NOT 510 K
   FERREIRA SD, 2001, CLIN ORTHOP RELAT R, V388, P233
   FLORACK EIM, 1990, INT ARCH OCC ENV HEA, V62, P273, DOI 10.1007/BF00640833
   Ge YQ, 2002, J AGR FOOD CHEM, V50, P685, DOI 10.1021/jf010615v
   Goldman M, 1997, J BIOMED MATER RES, V37, P43, DOI 10.1002/(SICI)1097-4636(199710)37:1<43::AID-JBM6>3.0.CO;2-J
   GOODMAN JL, 2004, N ENGL J MED
   Hong SI, 1999, J FOOD SCI, V64, P728, DOI 10.1111/j.1365-2621.1999.tb15120.x
   ISENSCHMID A, 1995, J BIOTECHNOL, V39, P229, DOI 10.1016/0168-1656(95)00018-L
   *ISO, 2000, ISO14937
   Kainer MA, 2004, NEW ENGL J MED, V350, P2564, DOI 10.1056/NEJMoa023222
   Klapperich C, 2000, J BIOMED MATER RES, V53, P73, DOI 10.1002/(SICI)1097-4636(2000)53:1<73::AID-JBM10>3.0.CO;2-A
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   OSTERMANGOLKAR S, 1988, SCAND J WORK ENV HEA, V14, P372, DOI 10.5271/sjweh.1906
   RASMUSSEN TJ, 1994, ARTHROSCOPY, V10, P188, DOI 10.1016/S0749-8063(05)80092-1
   Shimoda M, 2001, J APPL MICROBIOL, V91, P306, DOI 10.1046/j.1365-2672.2001.01386.x
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Spilimbergo S, 2003, BIOTECHNOL BIOENG, V84, P627, DOI 10.1002/bit.10783
   VANDERVELDE EG, 1992, J CHROMATOGR, V626, P135, DOI 10.1016/0021-9673(92)85337-S
   WILLIE BM, 2004, J BIOMED MATER RES, V1, P477
NR 36
TC 96
Z9 100
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JUN 10
PY 2006
VL 123
IS 4
BP 504
EP 515
DI 10.1016/j.jbiotec.2005.12.033
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 050QH
UT WOS:000238102500011
PM 16497403
DA 2018-10-20
ER

PT J
AU Lee, JW
   Serna, F
   Nickels, J
   Schmidt, CE
AF Lee, JW
   Serna, F
   Nickels, J
   Schmidt, CE
TI Carboxylic acid-functionalized conductive polypyrrole as a bioactive
   platform for cell adhesion
SO BIOMACROMOLECULES
LA English
DT Article
ID OSTEOBLAST ADHESION; ELECTRIC-FIELDS; POLYMER; FILMS; RGD; BIOMATERIALS;
   ATTACHMENT; PYRROLE; PEPTIDE; SURFACE
AB Electroactive polymers such as polypyrrole (PPy) are highly attractive for a number of biomedical applications, including their use as coatings for electrodes or neural probes and as scaffolds to induce tissue regeneration. Surface modification of these materials with biological moieties is desired to enhance the biomaterial-tissue interface and to promote desired tissue responses. Here, we present the synthesis and physicochemical characterization of poly(1-(2-carboxyethyl) pyrrole) (PPyCOOH), a PPy derivative that contains a chemical group that can be easily modified with biological moieties at the N-position of the polymer backbone. FTIR, XPS, and fluorescence microscopy were used to demonstrate the successful incorporation of carboxylic acid (-COOH) functionality into PPy materials, and a four-point probe analysis was used to demonstrate electrical conductivity in the semiconductor range. Human umbilical vascular endothelial cells (HUVECs) cultured on PPyCOOH films surface-modified with the cell-adhesive Arg-Gly-Asp (RGD) motif demonstrated improved attachment and spreading. Thus, PPyCOOH could be useful in developing PPy composites that contain a variety of biological molecules as bioactive conducting platforms for specific biomedical purposes.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Texas Mat Inst, Austin, TX 78712 USA.
RP Lee, JW (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
EM jwoonlee@mail.cm.utexas.edu; schmidt@che.utexas.edu
RI Nickels, Jonathan/I-1913-2012; Schmidt, Christine/P-1613-2016
OI Nickels, Jonathan/0000-0001-8351-7846; 
FU NIBIB NIH HHS [R01EB004529, R01 EB004529-04, R01 EB004529]
CR Azioune A, 2005, ELECTROCHIM ACTA, V50, P1661, DOI 10.1016/j.electacta.2004.10.014
   Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Brahim S, 2005, ELECTROANAL, V17, P556, DOI 10.1002/elan.200403109
   Chen SJ, 2000, J MATER SCI LETT, V19, P2157, DOI 10.1023/A:1026799415199
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Goldman R, 1996, BIOELECTROMAGNETICS, V17, P450, DOI 10.1002/(SICI)1521-186X(1996)17:6<450::AID-BEM4>3.0.CO;2-2
   KIANI MS, 1992, SYNTHETIC MET, V46, P293, DOI 10.1016/0379-6779(92)90355-M
   KIESS HG, 1992, CONJUGATED CONDUCTIN
   MAEDA S, 1995, MACROMOLECULES, V28, P2905, DOI 10.1021/ma00112a042
   Otero TF, 1997, BIOELECTROCH BIOENER, V42, P117, DOI 10.1016/S0302-4598(96)05112-4
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   POLITIS MJ, 1989, NEUROSURGERY, V25, P71, DOI 10.1227/00006123-198907000-00012
   Pruneanu S, 1997, MATER CHEM PHYS, V48, P240, DOI 10.1016/S0254-0584(96)01894-9
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Ruangchuay L, 2004, REACT FUNCT POLYM, V61, P11, DOI 10.1016/j.reactfunctpolym.2004.03.004
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Skotheim T.A, 1998, HDB CONDUCTING POLYM
   Spadaro JA, 1997, BIOELECTROMAGNETICS, V18, P193, DOI 10.1002/(SICI)1521-186X(1997)18:3<193::AID-BEM1>3.0.CO;2-Y
   TAKEI J, 1993, ARCH ORTHOP TRAUMA S, V112
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 30
TC 130
Z9 133
U1 7
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2006
VL 7
IS 6
BP 1692
EP 1695
DI 10.1021/bm060220q
PG 4
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 051SH
UT WOS:000238180600002
PM 16768385
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, SF
   Lu, LC
   Yaszemski, MJ
AF Wang, SF
   Lu, LC
   Yaszemski, MJ
TI Bone-tissue-engineering material poly(propylene fumarate): Correlation
   between molecular weight, chain dimensions, and physical properties
SO BIOMACROMOLECULES
LA English
DT Article
ID GLASS-TRANSITION TEMPERATURE; UNSATURATED POLYESTER RESINS;
   QUANTITATIVE-EVALUATION; SEGMENTAL RELAXATION; MELT VISCOSITY; POLYMER
   MELTS; ENTANGLEMENT; DEPENDENCE; POLYSTYRENE; STYRENE
AB Poly(propylene fumarate) (PPF) is an important biodegradable and cross-linkable polymer designed for bone-tissue-engineering applications. For the first time we report the extensive characterization of this biomaterial including molecular weight dependences of physical properties such as glass transition temperature T-g, thermal degradation temperature T-d, density rho, melt viscosity eta(0), hydrodynamic radius R-H, and intrinsic viscosity [eta]. The temperature dependence of eta(0) changes progressively with molecular weight, whereas it can be unified when the temperature is normalized to T-g. The plateau modulus G(N)(0) and entanglement molecular weight M-e have been obtained from the rheological master curves. A variety of chain microstructure parameters such as the Mark-Houwink-Sakurada constants K and alpha, characteristic ratio C-infinity, unperturbed chain dimension r(0)(2)/ M, packing length p, Kuhn length b, and tube diameter a have been deduced. Further correlation between the microstructure and macroscopic physical properties has been discussed in light of recent progress in polymer dynamics to supply a better understanding about this unsaturated polyester to advance its biomedical uses. The molecular weight dependence of T-g for six polymer species including PPF has been summarized to support that M-e is irrelevant for the finite length effect on the glass transition, whereas surprisingly these polymers can be divided into two groups when their normalized T-g is plotted simply against M-w to indicate the deciding roles of inherent chain properties such as chain fragility, intermolecular cooperativity, and chain end mobility.
C1 Mayo Clin, Coll Med, Dept Orthoped Surg, Tissue Engn & Polymer Biomat Lab,Dept Physiol & B, Rochester, MN 55905 USA.
RP Yaszemski, MJ (reprint author), Mayo Clin, Coll Med, Dept Orthoped Surg, Tissue Engn & Polymer Biomat Lab,Dept Physiol & B, 200 1st St SW, Rochester, MN 55905 USA.
EM yaszemski.michael@mayo.edu
FU NIAMS NIH HHS [R01 AR045871, R01 AR045871-06, R01 AR045871-07, R01
   AR45871]; NIBIB NIH HHS [R01 EB003060-03, R01 EB003060, R01 EB003060-04]
CR BELLENGER V, 1992, J APPL POLYM SCI, V44, P643, DOI 10.1002/app.1992.070440411
   BOYER RF, 1974, MACROMOLECULES, V7, P142, DOI 10.1021/ma60037a030
   CLARSON SJ, 1985, POLYMER, V26, P930, DOI 10.1016/0032-3861(85)90140-5
   COLBY RH, 1987, MACROMOLECULES, V20, P2226, DOI 10.1021/ma00175a030
   COOKE MN, 2002, J BIOMED MATER RES B, V64, P65
   COWIE JMG, 1975, EUR POLYM J, V11, P297
   Domb AJ, 1996, BIOMATERIALS, V17, P411, DOI 10.1016/0142-9612(96)89657-8
   Dudowicz J, 2005, J PHYS CHEM B, V109, P21285, DOI 10.1021/jp0523266
   Edwards S. F., 1988, THEORY POLYM DYNAMIC
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fetters LJ, 1999, MACROMOLECULES, V32, P6847, DOI 10.1021/ma990620o
   FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001
   Fetters LJ, 1999, J POLYM SCI POL PHYS, V37, P1023, DOI 10.1002/(SICI)1099-0488(19990515)37:10<1023::AID-POLB7>3.0.CO;2-T
   FOX TG, 1955, J POLYM SCI, V15, P371, DOI 10.1002/pol.1955.120158006
   FRADET A, 1982, MAKROMOL CHEM, V183, P319
   Fradet A., 1989, COMPREHENSIVE POLYM, V5, P331
   GREENBERG AR, 1984, POLYMER, V25, P927, DOI 10.1016/0032-3861(84)90075-2
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Huang YJ, 1998, POLYMER, V39, P6631, DOI 10.1016/S0032-3861(98)00164-5
   JUDAS D, 1984, MAKROMOL CHEM, V185, P2583
   Kharas GB, 1997, J APPL POLYM SCI, V66, P1123
   KUSY RP, 1984, POLYMER, V25, P600, DOI 10.1016/0032-3861(84)90026-0
   KUSY RP, 1987, J POLYM SCI POL LETT, V25, P435
   Lide D.R., 2002, HDB CHEM PHYS
   LIU G, 1994, J APPL POLYM SCI, V51, P1991, DOI 10.1002/app.1994.070511202
   Majeste JC, 1998, RHEOL ACTA, V37, P486, DOI 10.1007/s003970050135
   Minagawa M, 2002, MACROMOL CHEM PHYSIC, V203, P2475, DOI 10.1002/macp.200290030
   Miwa Y, 2005, MACROMOLECULES, V38, P832, DOI 10.1021/ma048287y
   NGAI KL, 1993, MACROMOLECULES, V26, P6824, DOI 10.1021/ma00077a019
   ORDELT Z, 1963, MAKROMOLEKUL CHEM, V63, P153
   PACI M, 1982, MAKROMOL CHEM, V183, P377
   PETER SJ, 1997, HDB BIODEGRADABLE PO
   PIRAS A, 1988, THESIS U P M CURIE P
   PODZIMEK S, 1994, J APPL POLYM SCI, V53, P1351
   Rizos AK, 1998, MACROMOLECULES, V31, P6217, DOI 10.1021/ma980613k
   Roland CM, 2003, J CHEM PHYS, V119, P1838, DOI 10.1063/1.1581850
   ROLAND CM, 1992, MACROMOLECULES, V25, P5765, DOI 10.1021/ma00047a030
   Roland CM, 1996, MACROMOLECULES, V29, P5747, DOI 10.1021/ma960045d
   Rubinstein M., 2003, POLYM PHYS
   Santangelo PG, 1998, MACROMOLECULES, V31, P4581, DOI 10.1021/ma971823k
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Van Krevelen D.W., 1990, PROPERTIES POLYM
   WANG F, 1993, MACROMOLECULES, V26, P3826, DOI 10.1021/ma00067a017
   Wang SF, 2005, MACROMOLECULES, V38, P7358, DOI 10.1021/ma050884c
   Wang SF, 2004, MACROMOLECULES, V37, P1641, DOI 10.1021/ma034835g
   Wang SF, 2003, MACROMOLECULES, V36, P5355, DOI 10.1021/ma0210426
   WU S, 1989, J POLYM SCI POL PHYS, V27, P723, DOI 10.1002/polb.1989.090270401
   WU SH, 1992, POLYMER, V33, P509, DOI 10.1016/0032-3861(92)90727-E
   Yang YS, 1997, J APPL POLYM SCI, V64, P133, DOI 10.1002/(SICI)1097-4628(19970404)64:1<133::AID-APP12>3.0.CO;2-5
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
NR 51
TC 92
Z9 94
U1 5
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2006
VL 7
IS 6
BP 1976
EP 1982
DI 10.1021/bm060096a
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 051SH
UT WOS:000238180600039
PM 16768422
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rezwan, K
   Chen, QZ
   Blaker, JJ
   Boccaccini, AR
AF Rezwan, K
   Chen, QZ
   Blaker, JJ
   Boccaccini, AR
TI Biodegradable and bioactive porous polymer/inorganic composite scaffolds
   for bone tissue engineering
SO BIOMATERIALS
LA English
DT Review
DE scaffolds; bioactivity; bone tissue engineering; composites; porosity;
   biodegradability
ID SIMULATED BODY-FLUID; IN-VITRO CHARACTERIZATION; BIOGLASS(R)-FILLED
   POLYLACTIDE FOAMS; POLYMER/BIOACTIVE GLASS COMPOSITES; CALCIUM-PHOSPHATE
   FORMATION; GROWTH-FACTOR DELIVERY; OSTEOBLAST-LIKE CELLS;
   MECHANICAL-PROPERTIES; HARD-TISSUE; BIOMEDICAL APPLICATIONS
AB Biodegradable polymers and bioactive ceramics are being combined in a variety of composite materials for tissue engineering scaffolds. Materials and fabrication routes for three-dimensional (3D) scaffolds with interconnected high porosities suitable for bone tissue engineering are reviewed. Different polymer and ceramic compositions applied and their impact on biodegradability and bioactivity of the scaffolds are discussed, including in vitro and in vivo assessments. The mechanical properties of today's available porous scaffolds are analyzed in detail, revealing insufficient elastic stiffness and compressive strength compared to human bone. Further challenges in scaffold fabrication for tissue engineering such as biomolecules incorporation, surface functionalization and 3D scaffold characterization are discussed, giving possible solution strategies. Stern cell incorporation into scaffolds as a future trend is addressed shortly, highlighting the immense potential for creating next-generation synthetic/living composite biomaterials that feature high adaptivencss to the biological environment. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci & Technol, Ctr Tissue Engn & Regenerat Med, London SW7 2AZ, England.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
EM a.boccaccini@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013; Rezwan, Kurosch/K-9451-2013
OI Rezwan, Kurosch/0000-0002-7318-1119; Blaker, Jonny/0000-0003-1112-8619
CR Aho AJ, 2004, J MATER SCI-MATER M, V15, P1165, DOI 10.1023/B:JMSM.0000046401.50406.9b
   Aksay IA, 1998, CURR OPIN SOLID ST M, V3, P219, DOI 10.1016/S1359-0286(98)80093-4
   Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.3.CO;2-#
   ANDREW SD, 2001, J MATER SCI-MATER M, V12, P673
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ANTONIOU G, 2000, ELECTRON J BIOTECHN, P3
   Azevedo HS, 2005, MAT SCI ENG C-BIO S, V25, P169, DOI 10.1016/j.msec.2005.01.007
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   Blacher S, 2005, ACTA BIOMATER, V1, P565, DOI 10.1016/j.actbio.2005.06.003
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Boccaccini AR, 2005, MAT SCI ENG C-BIO S, V25, P23, DOI 10.1016/j.msec.2004.03.002
   Boccaccini AR, 2003, J BIOMED MATER RES B, V67B, P618, DOI 10.1002/jbm.b.10047
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Boccaccini AR, 2002, CURR OPIN SOLID ST M, V6, P251, DOI 10.1016/S1359-0286(02)00080-3
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   BOCCACCINI AR, IN PRESS J MAT SCI
   BROWN S, 2001, BIOCERAMICS, V14, P213
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   CHEN QZ, IN PRESS J BIOMED A
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   Darling AL, 2004, J BIOMED MATER RES B, V70B, P311, DOI 10.1002/jbm.b.30050
   Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Day RM, 2004, J MATER SCI-MATER M, V15, P729, DOI 10.1023/B:JMSM.0000030216.73274.86
   de Guevara-Fernandez SL, 2003, BIOMATERIALS, V24, P4037, DOI 10.1016/S0142-9612(03)00279-5
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Di Silvio L, 1999, J MATER SCI-MATER M, V10, P653
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   Gabelnick HL, 1983, ADV HUMAN FERTILITY, V2, P149
   GATTI AM, 1994, BIOMATERIALS, V15, P208, DOI 10.1016/0142-9612(94)90069-8
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gutwein LG, 2002, J NANOPART RES, V4, P231, DOI 10.1023/A:1019920105207
   Hammerle CHF, 1997, CLIN ORAL IMPLAN RES, V8, P198, DOI 10.1034/j.1600-0501.1997.080306.x
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Hench L.L., 1998, HDB BIOMATERIAL PROP, P355, DOI 10.1007/978-1-4615-5801-9_22
   Hench L.L., 1999, INTRO BIOCERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1999, BIOCERAMICS, P37
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Heule M, 2003, ADV MATER, V15, P1191, DOI 10.1002/adma.200304670
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IROH JO, 1999, POLYM DATA HDB, P361
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   Jaakkola T, 2004, BIOMATERIALS, V25, P575, DOI 10.1016/S0142-9612(03)00558-1
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   JARCHO M, 1977, J BIOENG, V1, P79
   Jiang G, 2005, BIOMATERIALS, V26, P2281, DOI 10.1016/j.biomaterials.2004.07.042
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   JONES JR, 2003, J BIOMED MATER RES, V68, P36
   Juhasz JA, 2004, BIOMATERIALS, V25, P949, DOI 10.1016/j.biomaterials.2003.07.005
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KASAGA T, 2001, BIOMATERIALS, V22, P9
   KAUFMANN EAB, 2004, TISSUE ENG, V6, P19
   KEAVENY TM, 1993, BONE GROWTH, P285
   Kellomaki M, 2000, J MATER SCI-MATER M, V11, P345, DOI 10.1023/A:1008977806693
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Khan YM, 2004, J BIOMED MATER RES A, V69A, P728, DOI 10.1002/jbm.a.30051
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   Kim HW, 2005, J MATER SCI-MATER M, V16, P189, DOI 10.1007/s10856-005-6679-y
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Klein C. P. A. T, 1990, HDB BIOACTIVE CERAMI, P3
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   Kohn J, 1996, BIOMATERIALS SCI INT, P64
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T., 1999, INTRO BIOCERAMICS, P75
   Korventausta J, 2003, BIOMATERIALS, V24, P5173, DOI 10.1016/S0142-9612(03)00425-3
   Kumudine C, 1999, POLYM DATA HDB, P70
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   LAURENCIN CT, 2002, METHODS TISSUE ENG, P705
   Lee LJ, 2005, COMPOS SCI TECHNOL, V65, P2344, DOI 10.1016/j.compscitech.2005.06.016
   Lee SB, 2005, BIOMATERIALS, V26, P1961, DOI 10.1016/j.biomaterials.2004.06.032
   LeGeros R. Z., 1999, INTRO BIOCERAMICS, P139
   LEGEROS RZ, 2002, BIOCERAMICS, V15, P3
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li HY, 2005, COMPOS SCI TECHNOL, V65, P2226, DOI 10.1016/j.compscitech.2005.04.051
   Li HY, 2005, J BIOMATER APPL, V20, P137, DOI 10.1177/0885328205049472
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Lobel KD, 1998, J BIOMED MATER RES, V39, P575, DOI 10.1002/(SICI)1097-4636(19980315)39:4<575::AID-JBM11>3.0.CO;2-6
   Lobel KD, 1996, J SOL-GEL SCI TECHN, V7, P69, DOI 10.1007/BF00401885
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Lu HH, 2005, BIOMATERIALS, V26, P6323, DOI 10.1016/j.biomaterials.2005.04.005
   LU LC, 1999, POLYM DATA HDB, P527
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   MAGILL JH, 1999, POLYM DATA HDB, P746
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Miyazaki T, 2001, J CERAM SOC JPN, V109, P929, DOI 10.2109/jcersj.109.1275_929
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Mrksich M, 2002, CURR OPIN CHEM BIOL, V6, P794, DOI 10.1016/S1367-5931(02)00362-9
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   Niiranen H, 2004, J BIOMED MATER RES A, V69A, P699, DOI 10.1002/jbm.a.30043
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   OLSENCLAIRE J, 2006, IN PRESS WERKSTOFFTE
   OONISHI H, 1995, 8 INT S CER MED TOK, P137
   Payne RG, 2002, METHODS TISSUE ENG, P649
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ramakrishna S, 2004, INTRO BIOCOMPOSITES, P36
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Rich J, 2002, BIOMATERIALS, V23, P2143, DOI 10.1016/S0142-9612(01)00345-3
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   SCHILLER C, 2000, FUNCTIONALLY GRADED, P97
   Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SEPULVEDA P, 2001, J BIOMED MATER RES, V59, P340
   Shastri VP, 2002, METHODS TISSUE ENG, P609
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, J BIOMED MATER RES A, V70A, P442, DOI 10.1002/jbm.a.30099
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Taddei P, 2005, J MOL STRUCT, V744, P135, DOI 10.1016/j.molstruc.2004.10.039
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Tirelli N., 2002, REV MOL BIOTECHNOL, V90, P3, DOI DOI 10.1016/S1389-0352(01)00057-5
   Uchida M, 2001, J AM CERAM SOC, V84, P2041
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Verma S, 2002, ARCH MICROBIOL, V179, P66, DOI 10.1007/s00203-002-0500-9
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Weng J, 2002, BIOMATERIALS, V23, P2623, DOI 10.1016/S0142-9612(01)00393-3
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   WILLIAMS RA, 1994, BIOSENS BIOELECTRON, V9, P159, DOI 10.1016/0956-5663(94)80108-8
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamamuro T., 1990, HDB BIOACTIVE CERAMI
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 193
TC 1993
Z9 2052
U1 103
U2 1515
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2006
VL 27
IS 18
BP 3413
EP 3431
DI 10.1016/j.biomaterials.2006.01.039
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 032OD
UT WOS:000236783000010
PM 16504284
DA 2018-10-20
ER

PT J
AU Pal, K
   Banthia, AK
   Majumdar, DK
AF Pal, Kunal
   Banthia, A. K.
   Majumdar, D. K.
TI Development of carboxymethyl cellulose acrylate for various biomedical
   applications
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID PH-SENSITIVE HYDROGELS; EQUILIBRIUM SWELLING BEHAVIOR; DEXTRAN
   HYDROGELS; DRUG-DELIVERY; METHACRYLATE; RELEASE
AB The purpose of this work is to prepare a pH-sensitive hydrogel membrane of sodium carboxymethyl cellulose acrylate for drug delivery and other biomedical applications. The hydrogel was made by esterification of sodium carboxymethyl cellulose (SCMC) and acryloyl chloride (ACl). The esterified product was characterized by FTIR spectroscopy and XRD. Swelling, hemocompatibility, water vapor transmission rate, contact angle and diffusional studies were also done. Biocompatibility of the membrane was established by quantification of cell growth of L929 cells and mice splenocytes. The FTIR spectrum of the hydrogel suggested the formation of ester bonds between the hydroxyl groups of sodium carboxymethyl cellulose and the carbonyl group of acryloyl chloride. Water vapor transmission rate, hemocompatibility, contact angle and swelling studies indicated that the hydrogel can be tried as a wound dressing material. The hydrogel showed pH-dependent swelling behavior arising from the acidic pendant group in the polymer network. The permeability of the hydrogel membrane produced, as shown by salicylic acid diffusion, increased in response to an increase in pH of the external medium. The hydrogel membrane was permeable to salicylic acid at pH 7.2 but not at pH 2.0 (0.01N HCl). The effect of changes of pH on the hydrogel's permeability was found to be reversible. The hydrogel membrane was found to be compatible with the L929 mice fibroblast cell line and mice splenocytes. The esterified product of SCMC and ACl swells on increase of pH indicating its possible use in a pH-sensitive drug delivery system and as a wound dressing material.
C1 Indian Inst Technol, Ctr Mat Sci, Kharagpur 721302, W Bengal, India.
   Delhi Inst Pharmaceut Sci & Res, New Delhi 110017, India.
RP Pal, K (reprint author), Indian Inst Technol, Ctr Mat Sci, Kharagpur 721302, W Bengal, India.
EM ajitbanthia2000@yahoo.co.in
CR *ASTM, E9600E1 ASTM
   BRANNONPEPPAS L, 1990, BIOMATERIALS, V11, P635, DOI 10.1016/0142-9612(90)90021-H
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Brondsted H, 1998, J CONTROL RELEASE, V53, P7, DOI 10.1016/S0168-3659(97)00233-2
   Chiu HC, 1999, J BIOMAT SCI-POLYM E, V10, P591, DOI 10.1163/156856299X00504
   Chiu HC, 2002, BIOMATERIALS, V23, P1103, DOI 10.1016/S0142-9612(01)00222-8
   Falamarzian M, 1998, DRUG DEV IND PHARM, V24, P667, DOI 10.3109/03639049809082369
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   HENCH LL, BIOMATERIALS INTERFA, P170
   HOVGAARD L, 1995, J CONTROL RELEASE, V36, P159, DOI 10.1016/0168-3659(95)00049-E
   Hu Y, 2001, J APPL POLYM SCI, V81, P1624, DOI 10.1002/app.1593.abs
   KATCHALSKY A, 1955, J POLYM SCI, V15, P69, DOI 10.1002/pol.1955.120157906
   Khare A.R., 1994, J BIOMAT SCI-POLYM E, V6, P6
   KHARE AR, 1993, J BIOMAT SCI-POLYM E, V4, P275, DOI 10.1163/156856293X00564
   KOU JH, 1988, PHARMACEUT RES, V5, P592, DOI 10.1023/A:1015998131160
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Markland P, 1999, J BIOMED MATER RES, V47, P595, DOI 10.1002/(SICI)1097-4636(19991215)47:4<595::AID-JBM17>3.3.CO;2-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PAL K, 2006, MAT MANUF PROCESS
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   YOUNG RJ, 2004, INTRO POLYM, P195
NR 23
TC 35
Z9 36
U1 3
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2006
VL 1
IS 2
BP 85
EP 91
DI 10.1088/1748-6041/1/2/006
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LD
UT WOS:000249596900008
PM 18460761
DA 2018-10-20
ER

PT J
AU Lee, KY
   Park, M
   Kim, HM
   Lim, YJ
   Chun, HJ
   Kim, H
   Moon, SH
AF Lee, K-Y
   Park, M.
   Kim, H-M
   Lim, Y-J
   Chun, H-J
   Kim, H.
   Moon, S-H
TI Ceramic bioactivity: progresses, challenges and perspectives
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID SIMULATED BODY-FLUID; APATITE-FORMING ABILITY; SODIUM-SILICATE GLASS;
   BONE BONDING ABILITY; BIOMIMETIC PROCESS; IN-VITRO;
   MECHANICAL-PROPERTIES; TITANIUM METAL; TEM-EDX; SURFACE
AB Bioactivity is a property of the ceramic surface which induces biological integration of living soft and hard tissues. The core mechanism of bioactivity is surface biomineralization of calcium phosphate nanocrystallites on ceramics with specific compositions and structures, inspiring acellular and cellular strategies for bio-interactive materials with new physical, chemical and biological functions. These include bioactive surface functionalizations on metallic, ceramic and polymeric substrata for biomedical materials with different mechanical properties, bioactive ceramic-polymer nanohybrids for soft tissue replacements and engineering, template-textured depositions of biomimetic nano-calcium phosphate for hybridization of bio-macromolecular and cellular functions, concerning which this paper reviews with in vivo and in vitro fundamentals and perspectives in tissue engineering.
C1 Yonsei Univ, Sch Adv Mat Sci & Engn, Seoul 120749, South Korea.
   Seoul Natl Univ, Sch Dent, Seoul 151, South Korea.
   Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea.
   Yonsei Univ, Coll Med, Seoul 120749, South Korea.
RP Lee, KY (reprint author), Yonsei Univ, Sch Adv Mat Sci & Engn, 134 Shinchon Dong, Seoul 120749, South Korea.
EM hmkim@yonsei.ac.kr
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Chen Q, 2001, J MATER SCI-MATER M, V12, P515, DOI 10.1023/A:1011267612849
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   FILGUEIRAS MR, 1993, J BIOMED MATER RES, V27, P445, DOI 10.1002/jbm.820270405
   Fujibayashi S, 2003, BIOMATERIALS, V24, P3445, DOI 10.1016/S0142-9612(03)00221-7
   Gamble J. E., 1967, CHEM ANATOMY PHYSL P
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1998, J BIOMED MATER RES, V15, P11
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kamitakahara M, 2001, J SOL-GEL SCI TECHN, V21, P75, DOI 10.1023/A:1011261617377
   KAMITAKAHARA M, 2001, BIOCERAMICS, V14, P633
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   Kim HM, 2000, J MATER SCI-MATER M, V11, P421, DOI 10.1023/A:1008935924847
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HM, 2001, BIOMATERIALS, V22, P2489, DOI 10.1016/S0142-9612(00)00437-3
   Kim HM, 1996, B CHEM SOC JPN, V69, P2387, DOI 10.1246/bcsj.69.2387
   KITSUGI T, 1990, J BIOMED MATER RES, V24, P259, DOI 10.1002/jbm.820240211
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1991, J CERAM SOC JPN, V99, P965
   KOKUBO T, 1989, BIOCERAMICS, V1, P157
   LANZA RP, 1996, PRINCIPLE TISSUE ENG
   LEONOR IB, 2003, 29 ANN M SOC BIOM RE, P387
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Lin H, 1996, J CERAM SOC JPN, V104, P291, DOI 10.2109/jcersj.104.291
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   LOTY C, 2003, CONNECT TISSUE RES, V43, P524
   Masanori K., 2001, BIOMATERIALS, V22, P1705
   Miyata N., 2001, BIOCERAMICS, V14, P117
   Miyazaki T, 2001, J CERAM SOC JPN, V109, P929, DOI 10.2109/jcersj.109.1275_929
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Nagano M, 1996, J BIOMED MATER RES, V31, P487, DOI 10.1002/(SICI)1097-4636(199608)31:4<487::AID-JBM8>3.3.CO;2-M
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTUSKI C, 1991, J BIOMED MATER RES, V25, P1363
   Oyane A, 1999, J BIOMED MATER RES, V47, P367, DOI 10.1002/(SICI)1097-4636(19991205)47:3<367::AID-JBM11>3.0.CO;2-A
   Oyane A, 1999, BIOMATERIALS, V20, P79, DOI 10.1016/S0142-9612(98)00146-X
   Ozawa N, 2002, J BIOMED MATER RES, V62, P579, DOI 10.1002/jbm.10281
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Takadama H, 2001, CHEM MATER, V13, P1108, DOI 10.1021/cm0008718
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Uchida M, 2001, J AM CERAM SOC, V84, P2041
   YAN WQ, 1997, J BIOMED MATER RES, V37, P265
NR 63
TC 45
Z9 47
U1 2
U2 30
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2006
VL 1
IS 2
BP R31
EP R37
DI 10.1088/1748-6041/1/2/R01
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LD
UT WOS:000249596900001
PM 18460754
DA 2018-10-20
ER

PT J
AU Rajan, A
   Abraham, TE
AF Rajan, Akhila
   Abraham, T. Emilia
TI Enzymatic modification of cassava starch by bacterial lipase
SO BIOPROCESS AND BIOSYSTEMS ENGINEERING
LA English
DT Article
DE cassava starch; esterification; degree of substitution; recovered
   coconut oil; lipase; starch ester
ID FATTY-ACID ESTERS; BLENDS; POLYETHYLENE; DEGRADATION; PLASTICS; AMYLOSE;
   POTATO
AB Enzymatic modification of starch using long chain fatty acid makes it thermoplastic suitable for a myriad of industrial applications. An industrial lipase preparation produced by Burkholderia cepacia (lipase PS) was used for modification of cassava starch with two acyl donors, lauric acid and palmitic acid. Reactions performed with palmitic acid by liquid-state and microwave esterification gave a degree of substitution (DS) of 62.08% (DS 1.45) and 42.06% (DS 0.98), respectively. Thermogravimetric analysis showed that onset of decomposition is at a higher temperature (above 600 degrees C) for modified starch than the unmodified starch (280 degrees C). Modified starch showed reduction in alpha-amylase digestibility compared to native starch (76.5-18%). Swelling power lowered for modified starch as esterification renders starch more hydrophobic, making it suitable for biomedical applications as materials for bone fixation and replacements, carriers for controlled release of drugs and bioactive agents. Thus enzymatic esterification is ecoffiendly.
C1 CSIR, Reg Res Lab, Polymer Sect, Chem Sci Div, Trivandrum 695019, Kerala, India.
RP Abraham, TE (reprint author), CSIR, Reg Res Lab, Polymer Sect, Chem Sci Div, Trivandrum 695019, Kerala, India.
EM emiliatea@yahoo.com
RI TVM, NIIST/E-5132-2012
OI TVM, NIIST/0000-0002-5814-466X; Rajan, Akhila/0000-0002-9624-4696;
   Rajan, Dr.Akhila/0000-0003-3913-6688
CR Aburto J, 1999, J APPL POLYM SCI, V74, P1440, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1440::AID-APP17>3.0.CO;2-V
   Aburto J, 1997, CARBOHYD POLYM, V34, P101, DOI 10.1016/S0144-8617(97)00053-2
   CADDICK S, 1995, TETRAHEDRON, V51, P10403, DOI 10.1016/0040-4020(95)00662-R
   DOANE WM, 1992, STARCH-STARKE, V44, P293, DOI 10.1002/star.19920440805
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fang JM, 2002, CARBOHYD POLYM, V47, P245, DOI 10.1016/S0144-8617(01)00187-4
   GOHEEN SM, 1991, J APPL POLYM SCI, V42, P2691, DOI 10.1002/app.1991.070421007
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Kacurakova M, 1998, J SCI FOOD AGR, V77, P38, DOI 10.1002/(SICI)1097-0010(199805)77:1<38::AID-JSFA999>3.0.CO;2-5
   Kacurakova M, 2001, CARBOHYD POLYM, V44, P291, DOI 10.1016/S0144-8617(00)00245-9
   Lewandowicz G, 1997, CARBOHYD POLYM, V34, P213, DOI 10.1016/S0144-8617(97)00091-X
   LOUPY A, 1994, SYNTHETIC COMMUN, V24, P159, DOI 10.1080/00397919408013814
   Mack E.J., 1987, HYDROGELS MED PHARM, P65
   Malac M, 2001, NANOTECHNOLOGY, V12, P11, DOI 10.1088/0957-4484/12/1/303
   Marcazzan M, 1999, J BIOCHEM BIOPH METH, V38, P191, DOI 10.1016/S0165-022X(98)00044-X
   MILADINOV VD, 1999, IND ENG CHEM RES, V10, P3892
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Noomrio MH, 1990, P NATL CHEM C, VII, P139
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Roper H., 1996, CARBOHYDRATES EUROPE, V15, P22
   SAGAR AD, 1995, J APPL POLYM SCI, V58, P1647, DOI 10.1002/app.1995.070580927
   SCHOCH TJ, 1964, METHODS CARBOHYDRATE, V4, P106
   SHOGREN RL, 1993, STARCH-STARKE, V45, P276, DOI 10.1002/star.19930450806
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   SOWMYA S, 1994, SYNTHETIC COMMUN, V24, P2097, DOI 10.1080/00397919408010221
   Thiebaud S, 1997, J APPL POLYM SCI, V65, P705
   XUA YX, 2005, IND CROP PROD, V21, P361
NR 27
TC 36
Z9 44
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1615-7591
J9 BIOPROC BIOSYST ENG
JI Bioprocess. Biosyst. Eng.
PD JUN
PY 2006
VL 29
IS 1
BP 65
EP 71
DI 10.1007/s00449-006-0060-5
PG 7
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 067DK
UT WOS:000239281700008
PM 16736230
DA 2018-10-20
ER

PT J
AU Boulanger, J
   El Akel, A
   Charette, A
   Liu, FS
AF Boulanger, J
   El Akel, A
   Charette, A
   Liu, FS
TI Direct imaging of turbid media using long-time back-scattered photons, a
   numerical study
SO INTERNATIONAL JOURNAL OF THERMAL SCIENCES
LA English
DT Article
DE direct imaging; back-scattered photons; near infrared radiation; optical
   tomography; biomedical optics; discrete ordinates method; transient
   radiation
ID INFRARED LASER SPECTROSCOPY; OPTICAL-PROPERTIES; 2-DIMENSIONAL
   ENCLOSURES; RADIATIVE-TRANSFER; SCATTERING; REFLECTANCE; MEDICINE;
   TISSUE
AB Direct imaging is a convenient way to obtain information on the interior of a semi-transparent turbid material by non-invasive probing using laser beams. The major difficulty is linked to scattering which scrambles the directional information coming from the laser beam. It is found in this paper that the long-term multiple-scattered reflected photons may provide structural information on the inside of a material, which offers an interesting alternative to using information only from un-scattered or least-scattered photons as obtained from current direct imaging set-ups for thin media.
   Based on some observations on a non-homogeneous three layered 1-D slab irradiated by a laser pulse, a direct probing methodology making use of the long-term back-scattered photons is illustrated to recover inclusions positions in a turbid 2-D medium. First, the numerical model is presented. Second, an extended parametrical study is conducted on 1-D homogeneous and non-homogeneous slabs with different laser pulse durations. It is found that the reflected asymptotic logarithmic slope carries information about the presence of the inclusion and that short laser pulses are not necessary since only the decaying parts of the remanent optical signature is important. Longer laser pulses allow a higher level of energy injection and signal to noise ratio. Third, those observations are used for the probing of a 2-D non-homogeneous phantom. (C) 2005 Elsevier SAS. All rights reserved.
C1 Natl Res Council Canada, Inst Technol Procedes Chim & Environm, Ottawa, ON K1A 0R6, Canada.
   Univ Quebec, Dept Appl Sci, Grp Rech Ingn Procedes & Syst, Chicoutimi, PQ G7H 2B1, Canada.
RP Charette, A (reprint author), Natl Res Council Canada, Inst Technol Procedes Chim & Environm, 1200 Chemin Montreal, Ottawa, ON K1A 0R6, Canada.
EM andre_charette@uqac.ca
CR Arridge S. R., 1999, INVERSE PROBL, V15, P41, DOI DOI 10.1088/0266-5611/15/2/022
   Arridge SR, 1997, PHYS MED BIOL, V42, P841, DOI 10.1088/0031-9155/42/5/008
   AYRANCI I, 2003, P EUR 73 COMP THERM
   Boulanger J, 2005, J QUANT SPECTROSC RA, V91, P297, DOI 10.1016/j.jqsrt.2004.05.062
   Boulanger J, 2005, J QUANT SPECTROSC RA, V91, P189, DOI 10.1016/j.jqsrt.2004.05.057
   BREWSTER MQ, 1995, INT J HEAT MASS TRAN, V38, P2569, DOI 10.1016/0017-9310(95)00013-Y
   CHANCE B, 1997, PHILOS T ROY SOC L B, V352
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8
   DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008
   Franceschini MA, 2000, OPT EXPRESS, V6, P49, DOI 10.1364/OE.6.000049
   Hebden JC, 1997, PHYS MED BIOL, V42, P825, DOI 10.1088/0031-9155/42/5/007
   HEBDEN JC, 1993, APPL OPTICS, V32, P372, DOI 10.1364/AO.32.000372
   Hielscher AH, 1996, APPL OPTICS, V35, P719, DOI 10.1364/AO.35.000719
   MADSEN SJ, 1992, APPL OPTICS, V31, P3509, DOI 10.1364/AO.31.003509
   MAHON R, 1993, APPL OPTICS, V32, P7425, DOI 10.1364/AO.32.007425
   MODEST MF, 1993, RADIATIVE HEAT TRANS
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   Quaresima V, 2002, BRAIN RES BULL, V59, P235, DOI 10.1016/S0361-9230(02)00871-7
   Ramankutty MA, 1997, J QUANT SPECTROSC RA, V57, P107, DOI 10.1016/S0022-4073(96)00090-8
   Sakami M, 2002, J QUANT SPECTROSC RA, V73, P169, DOI 10.1016/S0022-4073(01)00216-3
   Sakami M, 2000, J QUANT SPECTROSC RA, V64, P275, DOI 10.1016/S0022-4073(99)00100-4
   Sakami M, 2001, J HEAT TRANS-T ASME, V123, P892, DOI 10.1115/1.1375812
   SAKAMI M, 2000, ASME HTD, V366, P135
   STONE JM, 1992, J COMPUT PHYS, V100, P402, DOI 10.1016/0021-9991(92)90246-U
   Vesely F. J., 2001, COMPUTATIONAL PHYS I
   Wan SK, 2004, J QUANT SPECTROSC RA, V84, P493, DOI 10.1016/S0022-4073(03)00266-8
   WANG L, 1993, APPL OPTICS, V32, P5043, DOI 10.1364/AO.32.005043
   Wray A. A., 1990, MINIMAL STORAGE TIME
   1989, APPL OPT, V28
   1993, APPL OPT, V32
   1991, APPL OPT, V30
NR 32
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1290-0729
J9 INT J THERM SCI
JI Int. J. Therm. Sci.
PD JUN
PY 2006
VL 45
IS 6
BP 537
EP 552
DI 10.1016/j.ijthermalsci.2005.09.007
PG 16
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA 037PG
UT WOS:000237158600001
OA Green Published
DA 2018-10-20
ER

PT J
AU de Carlos, A
   Borrajo, JP
   Serra, J
   Gonzalez, P
   Leon, B
AF de Carlos, A
   Borrajo, JP
   Serra, J
   Gonzalez, P
   Leon, B
TI Behaviour of MG-63 osteoblast-like cells on wood-based biomorphic SiC
   ceramics coated with bioactive glass
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PULSED-LASER DEPOSITION; SILICATE-GLASSES; THIN-FILMS; COATINGS;
   HYDROXYAPATITE; HYDROXYLAPATITE; PROLIFERATION; INVITRO
AB The aim of this study was to test the in vitro cytotoxicity of wood-based biomorphic Silicon Carbide (SiC) ceramics coated with bioactive glass, using MG-63 human osteoblast-like cells, with a view to their application in bone implantology. To better understand the scope of this study, it should be taken into account that biomorphic SiC ceramics have only recently been developed and this innovative product has important properties such as interconnected porosity, high strength and toughness, and easy shaping.
   In the solvent extraction test, all the extracts had almost no effect on cellular activity even at 100% concentration, and cells incubated in the bioactive glass-coated SiC ceramics extracts showed a proliferation rate similar to that of the Thermanox control. There were no significant differences when the cellular attachment response of the cells on the wood-based biomorphic SiC ceramics, uncoated or coated with bioactive glass, was compared to the one exhibited by reference materials like Ti6Al4V and bulk bioactive glass. This fact looks very promising for biomedical applications.
C1 Univ Vigo, Dept Fis Aplicada, Vigo 36200, Spain.
   Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36200, Spain.
RP Borrajo, JP (reprint author), Univ Vigo, Dept Fis Aplicada, Vigo 36200, Spain.
EM jpb@uvigo.es
RI de Carlos, Alejandro/L-5819-2014; New Materials Group, FA3/D-6799-2014
OI de Carlos, Alejandro/0000-0003-0138-4918; New Materials Group,
   FA3/0000-0003-4286-2015; Serra, Julia/0000-0001-6187-4025; GONZALEZ,
   PIO/0000-0002-7353-712X
CR Amaral M, 2002, BIOMATERIALS, V23, P4897, DOI 10.1016/S0142-9612(02)00249-1
   Borrajo JP, 2004, KEY ENG MAT, V254-2, P23, DOI 10.4028/www.scientific.net/KEM.254-256.23
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   Cune MS, 1996, CLIN ORAL IMPLAN RES, V7, P345, DOI 10.1034/j.1600-0501.1996.070407.x
   D'Alessio L, 2001, APPL SURF SCI, V183, P10, DOI 10.1016/S0169-4332(01)00466-4
   D'Alessio L, 1999, APPL SURF SCI, V138, P527, DOI 10.1016/S0169-4332(98)00610-2
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   Ferraz MP, 2000, BIOMATERIALS, V21, P813, DOI 10.1016/S0142-9612(99)00249-5
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   Gonzalez P, 2002, VACUUM, V67, P647, DOI 10.1016/S0042-207X(02)00256-7
   Grant P, 2004, J ARTHROPLASTY, V19, P274, DOI 10.1016/S0883-5403(03)00402-9
   Kim HM, 2001, KEY ENG MATER, V192-195, P47, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.47
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Lee GY, 2005, KEY ENG MATER, V284-286, P1069, DOI 10.4028/www.scientific.net/KEM.284-286.1069
   Liste S, 2004, THIN SOLID FILMS, V453, P224, DOI 10.1016/j.tsf.2003.11.258
   Liste S, 2004, THIN SOLID FILMS, V453, P219, DOI 10.1016/j.tsf.2003.11.123
   Lusquinos F, 2003, J BIOMED MATER RES A, V64A, P630, DOI 10.1002/jbm.a.10440
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   Mayor B, 1998, THIN SOLID FILMS, V317, P363, DOI 10.1016/S0040-6090(97)00625-1
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Porter AE, 2004, BIOMATERIALS, V25, P5199, DOI 10.1016/j.biomaterials.2003.12.018
   Price N, 1997, J BIOMED MATER RES, V37, P394, DOI 10.1002/(SICI)1097-4636(19971205)37:3<394::AID-JBM10>3.0.CO;2-C
   Serra J, 2004, APPL PHYS A-MATER, V79, P983, DOI 10.1007/s00339-004-2610-5
   Serra J, 2002, J MATER SCI-MATER M, V13, P1221, DOI 10.1023/A:1021174912802
   SERRA J, 2001, KEY ENG MATER, V192, P635
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P340
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zeng HT, 2000, J BIOMED MATER RES, V50, P248, DOI 10.1002/(SICI)1097-4636(200005)50:2<248::AID-JBM20>3.3.CO;2-9
NR 34
TC 30
Z9 31
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2006
VL 17
IS 6
BP 523
EP 529
DI 10.1007/s10856-006-8935-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 042BY
UT WOS:000237503300006
PM 16691350
DA 2018-10-20
ER

PT J
AU Roh, DH
   Kang, SY
   Kim, JY
   Kwon, YB
   Kweon, HY
   Lee, KG
   Park, YH
   Baek, RM
   Heo, CY
   Choe, J
   Lee, JH
AF Roh, DH
   Kang, SY
   Kim, JY
   Kwon, YB
   Kweon, HY
   Lee, KG
   Park, YH
   Baek, RM
   Heo, CY
   Choe, J
   Lee, JH
TI Wound healing effect of silk fibroin/alginate-blended sponge in full
   thickness skin defect of rat
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CELL NUCLEAR ANTIGEN; IN-VITRO; FIBROIN; PROLIFERATION; ATTACHMENT;
   EXPRESSION; CALCIUM; GROWTH
AB Silk fibroin (SF) and alginate (AA) have been proved to be invaluable natural materials in the field of biomedical engineering. This study was designed to compare the wound healing effect of SF, AA and SF/AA-blended sponge (SF/AA) with clinically used Nu Gauze(TM) (CONT) in a rat full thickness wound model. Two circular skin wounds on the back of rat were covered with either of CONT, SF, AA or SF/AA. On the postoperative days of 3, 7, 10 and 14, residual wound area was calculated, and skin wound tissues were biopsied to measure the area of regenerated epithelium and collagen deposition as well as the number of proliferating cell nuclear antigen (PCNA)-immunoreactive cells. Half healing time (HT50) of SF/AA was dramatically reduced as compared with that of SF, AA or CONT. Furthermore, SF/AA significantly increased the size of re-epithelialization and the number of PCNA positive cells, whereas the effect of SF/AA on collagen deposition was not significantly different as compared with that of SF or AA. These results demonstrate that the wound healing effect of SF/AA is the best among other treatments including SF and AA, and this synergic effect is mediated by re-epithelialization via rapid proliferation of epithelial cell.
C1 Seoul Natl Univ, Coll Vet Med, Dept Vet Physiol, Seoul 151742, South Korea.
   Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151742, South Korea.
   Chonbuk Natl Univ Med Sch, Inst Med Sci, Dept Pharmacol, Chonju 561180, South Korea.
   Natl Inst Agr Sci & Technol, Dept Agr Biol, Suwon 441100, South Korea.
   Seoul Natl Univ, Coll Agr & Life Sci, Sch Biol Resources & Mat Engn, Seoul 151742, South Korea.
   Seoul Natl Univ, Bundang Hosp, Dept Plast Surg, Songnam 463707, South Korea.
   Inje Univ Sanggye Paik Hosp, Dept Plast Surg, Seoul 139707, South Korea.
RP Lee, JH (reprint author), Seoul Natl Univ, Coll Vet Med, Dept Vet Physiol, Seoul 151742, South Korea.
EM JHL1101@snu.ac.kr
RI Baek, Rong-Min/J-5505-2012; Heo, Chan Yeong/J-5719-2012
CR ATTWOOD AI, 1989, BRIT J PLAST SURG, V42, P373, DOI 10.1016/0007-1226(89)90001-5
   BLAIR SD, 1988, BRIT J SURG, V75, P969, DOI 10.1002/bjs.1800751010
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Cross SE, 1999, J INVEST DERMATOL, V112, P36, DOI 10.1046/j.1523-1747.1999.00473.x
   FRANK FI, 1992, ARCH PATHOL LAB MED, V116, P1142
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403
   HERGOTT GJ, 1991, EXP CELL RES, V195, P307, DOI 10.1016/0014-4827(91)90378-8
   Kim JS, 1997, AM J PHYSIOL-LUNG C, V273, pL1235, DOI 10.1152/ajplung.1997.273.6.L1235
   Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x
   Lee KG, 2004, J APPL POLYM SCI, V93, P2174, DOI 10.1002/app.20714
   Liu MX, 1999, CELL TISSUE RES, V297, P423, DOI 10.1007/s004410051369
   Madibally SV, 2003, J SURG RES, V109, P92, DOI 10.1006/jsre.2003.6564
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   O'Donoghue J M, 1997, Acta Chir Plast, V39, P53
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
NR 20
TC 93
Z9 99
U1 1
U2 43
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2006
VL 17
IS 6
BP 547
EP 552
DI 10.1007/s10856-006-8938-y
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 042BY
UT WOS:000237503300009
PM 16691353
DA 2018-10-20
ER

PT J
AU Satomi, T
   Ueno, K
   Fujita, Y
   Kobayashi, H
   Tanaka, J
   Mitamura, Y
   Tateishi, T
   Otsuka, H
AF Satomi, Tomomi
   Ueno, Koji
   Fujita, Yohei
   Kobayashi, Hisatoshi
   Tanaka, Junzo
   Mitamura, Yoshinori
   Tateishi, Tetsuya
   Otsuka, Hidenori
TI Synthesis of polypyridine-graft-PEG copolymer for protein repellent and
   stable interface
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE poly (ethylene glycol); pyridine unit; protein repellent surface
ID POLY(ETHYLENE OXIDE); CHAIN-LENGTH; ADSORPTION; SURFACE; GOLD;
   MONOLAYERS; DENSITY; COADSORPTION; TEMPERATURE; PYRIDINE
AB Polypyridine grafted with poly(ethylene glycol) (Py-g-PEG) have been synthesized. Radical copolymerization of methyl-terminated PEG macromonomer with 4-pyridylmethyl methacrylate homogeneously proceeded and the obtained copolymer spontaneously adsorbs from aqueous solution onto gold surfaces, where the pyridine parts act as the multipoint anchor to the surface and the PEG parts provide the strong steric repulsion between the chains. As a result, the highly protein repellent and stable surface was constructed through multipoint pyridine attachment as compared with singlepoint pyridine attachment. Py-g-PEGs thus synthesized are promising material to functionalize metal and semiconductor material and to self-assemble into micelle in biotechnological and biomedical field.
C1 Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan.
   Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050044, Japan.
   Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 060, Japan.
RP Otsuka, H (reprint author), Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.
RI kobayashi, hisatoshi/H-2720-2011
OI kobayashi, hisatoshi/0000-0001-9487-0725
CR Bain C.D., 1989, J AM CHEM SOC, V111, P312
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Bilic A, 2002, J PHYS CHEM B, V106, P6740, DOI 10.1021/jp020590i
   GLASS JE, 1996, HYDROPHILIC POLYM PE
   HARRIS JM, 1992, POLY ETHYLENE GLYCOL
   Leventis N, 2001, J PHYS CHEM B, V105, P3663, DOI 10.1021/jp0107199
   LI YZ, 1992, J AM CHEM SOC, V114, P2428, DOI 10.1021/ja00033a018
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   Skaff H, 2003, CHEM COMMUN, P52, DOI 10.1039/b208718a
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   TTOUGHTON EB, 1988, LANGMUIR, V4, P365
   Uchida K, 2005, ANAL CHEM, V77, P1075, DOI 10.1021/ac0486140
   Wu DY, 2002, J PHYS CHEM A, V106, P9042, DOI 10.1021/jp025970i
NR 20
TC 7
Z9 7
U1 1
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2006
VL 6
IS 6
BP 1792
EP 1796
DI 10.1166/jnn.2006.234
PG 5
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 061MF
UT WOS:000238875900038
PM 17025085
DA 2018-10-20
ER

PT J
AU Putlayev, V
   Veresov, A
   Pulkin, M
   Soin, A
   Kuznetsov, V
AF Putlayev, V.
   Veresov, A.
   Pulkin, M.
   Soin, A.
   Kuznetsov, V.
TI Silicon-substituted hydroxyapatite ceramics (Si-HAp): densification and
   grain growth through the prism of sintering theories
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE bioceramics; aliovalent doping; silicon; sintering; segregation
ID CALCIUM PHOSPHATES; MICROSTRUCTURE; HYDROXYLAPATITE; BIOMATERIALS;
   BIOCERAMICS; CALCINATION; IMPLANTS
AB Ceramics based on calcium phosphates is known to be a prospective material for biomedical applications. Noticeable attention is paid to hydroxyapatite Ca10(PO4)(6)(OH)(2) (HAp) due to its affinity to a bone mineral. It was recognized recently that Si-doped HAp is a highly promising material in sense of bioactivity improvement. In the frame of distinct research activity structured around this subject, some special problems are to be solved: (1) solubility of Si in the bulk of HAp lattice (and its limit) vs. segregation of Si to free surfaces and grain boundaries, (2) rationalization of Si effect on sintering of HAp ceramics, (3) charge compensation over aliovalent doping of HAp with Si and its interplay with thermal stability of HAp phase.
   The work was focused on a fabrication of Si-HAp with Ca-10(PO4)(6-x)(SiO4)(x)(OH)(2-x) (x=0.1) nominal composition and evaluation the effect of Si on sintering of HAp ceramics. The limit of Si solubility in HAp lattice was estimated to be not higher than x=0.1 in the formula above (at 1000 degrees C; according to XRD and SEM/ EDX). The essence of the silicon influence consists in significant suppression of grain growth during the initial stage of sintering. Silicon doping reduces grain boundary mobility (increasing activation energy of lattice diffusion) along with the increase of pore mobility (in fact, increasing grain boundary diffusion). We believe that the effect of Si on sintering behaviour can be treated in terms of its segregation to grain boundaries, the phenomenon arising from a lattice instability of Si-HAp due to the charge compensation in the course of aliovalent doping.
C1 Moscow MV Lomonosov State Univ, Dept Chem, Div Inorgan Chem, Moscow 119899, Russia.
   Moscow MV Lomonosov State Univ, Dept Mat Sci, Moscow 119899, Russia.
   Moscow MV Lomonosov State Univ, Inst Mech, Moscow 119899, Russia.
RP Putlayev, V (reprint author), Moscow MV Lomonosov State Univ, Dept Chem, Div Inorgan Chem, Moscow 119899, Russia.
EM putl@inorg.chem.msu.ru
CR Arcos D, 2004, SOLID STATE SCI, V6, P987, DOI 10.1016/j.solidstatesciences.2004.05.001
   Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Balas F, 2003, J BIOMED MATER RES A, V66A, P364, DOI 10.1002/jbm.a.10579
   Barralet JE, 2000, J MATER SCI-MATER M, V11, P719, DOI 10.1023/A:1008975812793
   Bernache-Assollant D, 2003, J EUR CERAM SOC, V23, P229, DOI 10.1016/S0955-2219(02)00186-3
   Best S. M., 1996, International Patent Appl, Patent No. [PCT/GB 97/02325, 9702325]
   BROOK RJ, 1969, J AM CERAM SOC, V52, P56, DOI 10.1111/j.1151-2916.1969.tb12664.x
   CARLISLE EM, 1981, CALCIFIED TISSUE INT, V33, P27, DOI 10.1007/BF02409409
   CARLISLE EM, 1970, SCIENCE, V167, P179
   Fanovich MA, 1998, J MATER SCI-MATER M, V9, P53, DOI 10.1023/A:1008834712212
   Fateeva LV, 2001, REFRACT IND CERAM+, V42, P3, DOI 10.1023/A:1011395014951
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Gross KA, 2004, BIOMATERIALS, V25, P1375, DOI 10.1016/S0142-9612(03)00565-9
   Harmer M, 1984, ADV CERAM, V10, P679
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Langstaff S, 1999, BIOMATERIALS, V20, P1727, DOI 10.1016/S0142-9612(99)00086-1
   LAZORYAK BI, 1988, KRISTALLOGRAFIYA+, V33, P1113
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leventouri T, 2003, BIOMATERIALS, V24, P4205, DOI 10.1016/S0142-9612(03)00333-8
   Pan YM, 2002, REV MINERAL GEOCHEM, V48, P13, DOI 10.2138/rmg.2002.48.2
   Patel N, 2001, J MATER SCI-MATER M, V12, P181, DOI 10.1023/A:1008986430940
   PLOKHIKH NV, 2004, MENDELEEV COMMUN JUL, P178, DOI DOI 10.1070/MC2004v014n04ABEH001975
   Porter AE, 2004, J BIOMED MATER RES A, V68A, P133, DOI 10.1002/jbm.a.20064
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   YAN MF, 1981, MATER SCI ENG, V48, P53, DOI 10.1016/0025-5416(81)90066-5
NR 29
TC 14
Z9 17
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD JUN
PY 2006
VL 37
IS 6
BP 416
EP 421
DI 10.1002/mawe.200600007
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 061FH
UT WOS:000238856100002
DA 2018-10-20
ER

PT J
AU Dewidar, MM
   Yoon, HC
   Lim, JK
AF Dewidar, Montasser Marasy
   Yoon, Ho-Chel
   Lim, Jae Kyoo
TI Mechanical properties of metals for biomedical applications using powder
   metallurgy process: A review
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Review
DE powder metallurgy; mechanical properties; 316L stainless steel;
   Co-Cr-Mo; Ti-6Al4V
ID CO-CR-MO; AUSTENITIC STAINLESS-STEELS; TOTAL HIP-ARTHROPLASTY; IN-VITRO
   CORROSION; ARGON-FILLED PORES; TITANIUM-ALLOYS; ON-METAL; ORTHOPEDIC
   IMPLANTS; MICROSTRUCTURAL EVOLUTION; SUPERPLASTIC EXPANSION
AB The uses of biomaterials have been revolutionizing the biomedical field in deployment as implants for humans. During the past five decades, many implant materials made of metals have been put into practical use. Powder metallurgy techniques have been used to produce controlled porous structures, such as porous coatings applied for dental and orthopedic surgical implants, which allow bony tissue ingrowth within the implant surface, thereby improving fixation. This paper examines various important metals using powder metallurgy technology to produce elements of a total hip replacement. These alloys are 316L stainless steel alloy, Co-Cr-Mo alloy, and Ti-6AI-4V alloy. Also, this paper examines current information on the mechanical properties. Mechanical properties are discussed as a function of type of materials and process of fabrication. This article addresses the engineering aspects concerning the advantages and disadvantages of each type of material.
C1 Chonbuk Natl Univ, Fac Mech & Aerosp Syst Engn, Automobile Hi Technol Res Inst, Jeonju 561756, Jeonbuk, South Korea.
   High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
   Chonbuk Natl Univ, Dept Mech Design, Jeonju 561756, South Korea.
RP Lim, JK (reprint author), Chonbuk Natl Univ, Fac Mech & Aerosp Syst Engn, Automobile Hi Technol Res Inst, Jeonju 561756, Jeonbuk, South Korea.
EM jklim@chonbuk.ac.kr
CR ABKOWITS S, 1986, J MET, V36, P273
   AHMED T, 1995, P 8 WORLD TIT C BIRM, P183
   Amigo V, 2003, J MATER PROCESS TECH, V141, P117, DOI 10.1016/S0924-0136(03)00243-7
   ANDREN HO, 2000, INT J REFRACT MET H, V18, P273
   ANTONIO AM, 2005, COMPOS SCI TECHNOL, V65, P1749
   *ASM INT, 1984, MET HDB ASM INT, V7
   BARDOS DI, 1979, BIOMAT MED DEV ARTIF, V1, P73
   Baszkiewicz J, 1998, J MATER SCI, V33, P4561, DOI 10.1023/A:1004420806048
   Bautista A, 2005, MATER CORROS, V56, P98, DOI 10.1002/maco.200403818
   BECHTOL CO, 1959, METALS ENG BONE JOIN, P55
   Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   BECKER BS, 1995, POWDER METALL, V38, P201, DOI 10.1179/pom.1995.38.3.201
   Becker BS, 2000, INT J MATER PROD TEC, V15, P149, DOI 10.1504/IJMPT.2000.001244
   BECKER BS, 1997, POWDER METALL, V40, P305
   Binet C, 2005, J MATER PROCESS TECH, V164, P1160, DOI 10.1016/j.jmatprotec.2005.02.128
   BLACK J, 1992, BIOL PERFORMANCE MAT
   BOROWY KH, 1995, TITANIUM 84 SCI TECH, V2, P1381
   BOYERM R, 1994, MAT PROPERTIES HDB T, P286
   BRONZINO DJ, 1999, BIOMEDICAL ENG HDB, P1
   BRUNETTE DM, 2002, TITANIUM MED, P2
   Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6
   CHARLEY J, 1970, CLIN ORTHOP RELAT R, V72, P18
   CHARNLEY J, 1961, LANCET, V1, P1129
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Chen FS, 2003, SURF COAT TECH, V173, P9, DOI 10.1016/S0257-8972(02)00842-3
   CHIAVERINI V, 1992, ADV POWDER METALLURG, V5, P359
   CHUNG HH, 2003, J MATER PROCESS TECH, V138, P231
   CLARKE C, 1992, ASTM, P7
   Delo DP, 1999, ACTA MATER, V47, P2841, DOI 10.1016/S1359-6454(99)00132-9
   Demulsant X, 1996, MAT SCI ENG A-STRUCT, V219, P202, DOI 10.1016/S0921-5093(96)10426-3
   Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724
   DOBBS HS, 1983, J MATER SCI, V18, P391, DOI 10.1007/BF00560627
   Dong ZL, 2003, BIOMATERIALS, V24, P97, DOI 10.1016/S0142-9612(02)00267-3
   Dorr LD, 2000, J BONE JOINT SURG AM, V82A, P789, DOI 10.2106/00004623-200006000-00005
   Dowson D, 1995, WEAR, V190, P171, DOI 10.1016/0043-1648(96)80015-9
   DOWSON D, 1992, ASM HDB, V18, P656
   DOWSON G, 1990, POWDER METALLURGY PR, P183
   Durgalakshmi D, 2003, J MATER PROCESS TECH, V132, P293, DOI 10.1016/S0924-0136(02)00945-7
   DUWEZ P, 1949, T AM I MIN MET ENG, V185, P571
   EMURA S, 1996, TITANIUM 95 SCI TECH, P2714
   ERIC W, 2001, J ARTHROPLASTY, V16, P2
   Escobedo J, 1996, MATER DESIGN, V17, P79, DOI 10.1016/S0261-3069(96)00036-2
   EYLON D, 1995, ASM METALS HDB, V2, P77
   FROES FH, 2002, P TMS S HIGH PERF ME, P192
   FROES FH, 1989, P L WORLD C TIT, P1161
   Fujita T, 1996, MAT SCI ENG A-STRUCT, V213, P148, DOI 10.1016/0921-5093(96)10232-X
   German R. M., 1998, POWDER METALLURGY IR
   GERMAN RM, 1984, METAL POWDER IND, P219
   Godfrey TMT, 2000, MAT SCI ENG A-STRUCT, V282, P240, DOI 10.1016/S0921-5093(99)00699-1
   GRECO RS, 1994, IMPLANTATION BIOL HO, P173
   Griffin LV, 1999, J BIOMECH, V32, P105, DOI 10.1016/S0021-9290(98)00151-1
   HARRIS K, 1999, P 24 BICTA C INV CAS, P1
   HEINZ L, 1996, J PROSTHET DENT, V75, P515
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   Hoshide T, 1995, MATER SCI RES INT, V1, P169
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   ITAMURA MT, 1993, ASME FED, V173, P57
   Ivasishin O. M., 2004, Strength of Materials, V36, P225, DOI 10.1023/B:STOM.0000035756.11562.c3
   Ivasishin OM, 2000, KEY ENG MAT, V188, P55, DOI 10.4028/www.scientific.net/KEM.188.55
   Ji CH, 2001, MAT SCI ENG A-STRUCT, V311, P74, DOI 10.1016/S0921-5093(01)00942-X
   JOHN AH, 2005, BIOMATERIALS, V26, P5890
   JONES PR, 1992, J BIOMED ENG, V14, P379, DOI 10.1016/0141-5425(92)90082-V
   JOON BP, 1992, BIOMATERIALS INTRO
   JOVANOVIAE MT, 2004, MAT DESIGN, V27, P192
   KAGER IJ, 2000, BIOPHYS J, V79, P1737
   KALPANA S. K., 2004, COLLOID SURFACE B, V39, P133
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Koseski RP, 2005, MAT SCI ENG A-STRUCT, V390, P171, DOI 10.1016/j.msea.2004.08.002
   KOVACS P, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2705
   LAMPMAN S, 1995, ASM METALS HDB, V2, P592
   LE MDH, 2004, NEUROSURG FOCUS, V17, P1
   Lei MK, 2001, BIOMATERIALS, V22, P641, DOI 10.1016/S0142-9612(00)00226-X
   LESZEK W, 2001, MATER CHARACT, V46, P221
   Li XD, 2005, J BIOMED MATER RES B, V72B, P353, DOI 10.1002/jbm.b.30168
   Li YM, 2003, J MATER PROCESS TECH, V137, P65, DOI 10.1016/S0924-0136(02)01067-1
   Liu CT, 1996, INTERMETALLICS, V4, P429, DOI 10.1016/0966-9795(96)00047-7
   Lombardi AV, 2001, J ARTHROPLASTY, V16, P122, DOI 10.1054/arth.2001.29307
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MACDONALD SJ, 2003, CLIN ORTHOP RELAT R, V406, P282
   MASAYUK K, 2004, J BIOMED MATER RES B, V68, P88
   MASUO H, 2003, MAT SCI ENG A-STRUCT, V352, P85
   MASUO HA, 1991, ISIJ INT, V31, P922
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   MITSUO N, 1991, ISIJ INT, V31, P848
   MOLINARI A, 1997, METAL POWDER REPORT, V52, P285
   Molins C., 1992, ADV POWDER METALLURG, V5, P345
   Murray NGD, 2004, ACTA MATER, V52, P2279, DOI 10.1016/j.actamat.2004.01.019
   Murray NGD, 2004, ACTA MATER, V52, P2269, DOI 10.1016/j.actamat.2004.01.039
   NORMAN TL, 1995, J BIOMECH, V28, P309, DOI 10.1016/0021-9290(94)00069-G
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Ono Y, 2003, CRYOGENICS, V43, P483, DOI 10.1016/S0011-2275(03)00125-5
   Otero E, 1998, CORROS SCI, V40, P1421, DOI 10.1016/S0010-938X(98)00047-X
   OTERO E, 1995, MATER CHARACT, V35, P145, DOI 10.1016/1044-5803(95)00099-2
   Paszenda Z, 1998, J MATER PROCESS TECH, V78, P143, DOI 10.1016/S0924-0136(97)00476-7
   Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1
   Pawlikowski M, 2003, COMPUT STRUCT, V81, P887, DOI 10.1016/S0045-7949(02)00428-5
   PETER WL, 1998, ASM HDB POWDER METAL, V7
   PETERS M, 1981, SCI TECHNOL, V22, P1777
   PHAM QT, 1996, MAT DESIGN, V17, P79
   Pieczonka T, 1997, J MATER PROCESS TECH, V64, P327, DOI 10.1016/S0924-0136(96)02583-6
   Pina C, 1998, J MATER SCI-MATER M, V9, P93, DOI 10.1023/A:1008899031776
   PROTEK AG, 1994, METASUL TECHNICAL BR, P154
   RATCHESON RA, 1995, P ORTH RES SOC ANN M, P23
   Rei M, 2002, MATER LETT, V52, P360, DOI 10.1016/S0167-577X(01)00422-0
   Revell PA, 1998, BIOMATERIALS, V19, P1579, DOI 10.1016/S0142-9612(97)00118-X
   Rieker C, 2002, Hip Int, V12, P73, DOI 10.5301/HIP.2008.3859
   Saito T, 1998, MAT SCI ENG A-STRUCT, V243, P273, DOI 10.1016/S0921-5093(97)00813-7
   SAITO T, 1993, P 3 JAP INT SAMPE S, P1810
   Saldivar AJ, 2001, SCRIPTA MATER, V45, P427, DOI 10.1016/S1359-6462(01)01037-5
   SCHEY JA, 1996, CLIN ORTHOP S, V329, P115
   Sieber HP, 1999, J BONE JOINT SURG BR, V81B, P46, DOI 10.1302/0301-620X.81B1.9047
   Simmons JW, 1996, MAT SCI ENG A-STRUCT, V207, P159, DOI 10.1016/0921-5093(95)09991-3
   SMITH E, 2005, ARTHROPLASTY ARTHRIT
   Stefansson N, 2003, METALL MATER TRANS A, V34, P691, DOI 10.1007/s11661-003-0103-3
   Steinemann S., 1980, EVALUATION BIOMATERI
   STEINEMANN SG, 1985, TITANIUM SCI TECHNOL, V2, P1373
   STREICHER RM, 1994, T 20 ANN M SOC BIOM, P323
   SUMAN D, 1999, MATER DESIGN, V20, P115
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   THOMAS PS, 1996, J ARTHROPLASTY, V11, P322
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   UPADHYAYA GS, 2000, SINTERING METALS CER, P344
   VINICIUS ARH, 2001, J MATER PROCESS TECH, V118, P212
   WAGNER M, 2000, CLIN ORTHOP RELAT R, V379, P123
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X
   Wang A, 1999, WEAR, V225, P708, DOI 10.1016/S0043-1648(98)00384-6
   Wang A, 2001, WEAR, V250, P212, DOI 10.1016/S0043-1648(01)00643-3
   Wasnik DN, 2003, SCRIPTA MATER, V49, P135, DOI 10.1016/S1359-6462(03)00220-3
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLIAMS DF, 1986, P CONS C EUR SOC BIO, P45
   WILLIAMS DF, 1987, P CONS C EUR SOC BIO, P236
   Wise DL, 1995, ENCY HDB BIOMATERIAL
   WOOD RA, 1972, TITANIUM ALLOYS HDB, P33
   Xue WC, 2004, SURF COAT TECH, V185, P340, DOI 10.1016/j.surfcoat.2003.12.018
   YULE JA, 1994, ATOMIZATION METALS P, P177
   Zioupos P, 1996, J BIOMECH, V29, P989, DOI 10.1016/0021-9290(96)00001-2
NR 139
TC 41
Z9 42
U1 4
U2 56
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1598-9623
EI 2005-4149
J9 MET MATER INT
JI Met. Mater.-Int.
PD JUN
PY 2006
VL 12
IS 3
BP 193
EP 206
DI 10.1007/BF03027531
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 058IX
UT WOS:000238659800001
DA 2018-10-20
ER

PT J
AU Langer, R
AF Langer, R
TI Biomaterials for drug delivery and tissue engineering
SO MRS BULLETIN
LA English
DT Article
DE biological; biomedical; microstructure; tissue
ID SHAPE-MEMORY POLYMERS; CONTROLLED-RELEASE; MACROMOLECULES
AB The following article is an edited transcript based on the Von Hippel Award presentation by Robert Langer of the Massachusetts Institute of Technology on November 30, 2005, at the Materials Research Society Fall Meeting in Boston. Langer was honored with MRS's highest award for his "pioneering accomplishments in the science and application of biomaterials in drug delivery and tissue engineering, particularly in inventing the use of materials for protein and DNA delivery, and for his achievements in interdisciplinary research which have generated new medical products, created new fields of biornaterials science, and inspired research programs throughout the world."
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, E25-342,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
CR LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Langer R, 1998, NATURE, V392, P5
   Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Santini JT, 1999, NATURE, V397, P335
   SEFTON MV, 1984, J PHARM SCI, V73, P1859, DOI 10.1002/jps.2600731258
NR 7
TC 16
Z9 16
U1 3
U2 43
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD JUN
PY 2006
VL 31
IS 6
BP 477
EP 485
DI 10.1557/mrs2006.122
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 053ZP
UT WOS:000238345300019
DA 2018-10-20
ER

PT J
AU Ho, D
   Chang, S
   Montemagno, CD
AF Ho, Dean
   Chang, Stacy
   Montemagno, Carlo D.
TI Fabrication of biofunctional nanomaterials via Escherichia coli OmpF
   protein air/water interface insertion/integration with copolymeric
   amphiphiles
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
AB Fabrication of next-generation biologically active materials will involve the integration of proteins with synthetic membrane materials toward a wide spectrum of applications in nanoscale medicine, including high-throughput drug testing, energy conversion for powering medical devices, and biocloaking films for mimicry of cellular membrane surfaces toward the enhancement of implant biocompatibility. We have used ABA triblock copolymer membranes (PMOXA-PDMS-PMOXA) of varied thicknesses as platform materials for Langmuir film-based functionalization with the OmpF pore protein from Escherichia coli by fabricating monolayers of copolymer amphiphile-protein complexes on the air/water interface. Here we demonstrate that the ability for protein insertion at the air/water interface during device fabrication is dependent upon the initial surface coverage with the copolymer as well as copolymer thickness. Methacrylate-terminated block copolymer structures that were 4 nm (4METH) and 8 nm (8METH) in length were used as the protein reconstitution matrix, whereas a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipid (similar to 4 nm thickness) was used as a comparison to demonstrate the effects of copolymer length on protein integration capabilities. Wilhemy surface pressure measurements (mN/m) revealed a greater protein insertion in the 4METH and POPC structures compared with the 8METH structure, indicating that shorter copolymer chains possess enhanced biomimicry of natural lipid-based membranes. In addition, comparisons between the isothermal characteristics of the 4METH, 8METH, and POPC membranes reveal that phase transitions of the 4METH resemble a blend of the 8METH and POPC materials, indicating that the 4METH chain may possess hybrid properties of both copolymers and lipids. Furthermore, we have shown that following the deposition of the amphiphilic materials on the air/water interface, the OmpF can be deposited directly on top of the amphiphiles (surface addition), thus effectively further enhancing protein insertion because of the buoying effects of the membranes. These characteristics of Langmuir-Blodgett-based fabrication of copolymer-biomolecule hybrids represent a synthesis strategy for next-generation biomedical materials. (c) 2006 Elsevier Inc. All rights reserved.
RP Ho, D (reprint author), Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, 7523 Boelter Hall,420 Westwood Pl, Los Angeles, CA 90095 USA.
EM deanh@seas.ucla.edu
CR Aranda-Espinoza H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208301
   BOGOMOLNI RA, 1976, BIOCHIM BIOPHYS ACTA, V440, P68, DOI 10.1016/0005-2728(76)90114-6
   COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher BM, 2002, J PHYS CHEM B, V106, P2848, DOI 10.1021/jp011958z
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Ghannam MM, 1999, BIOPHYS CHEM, V80, P31, DOI 10.1016/S0301-4622(99)00058-7
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a
   Ho D, 2004, NANOTECHNOLOGY, V15, P1084, DOI 10.1088/0957-4484/15/038
   Ho D, 2004, IEEE T NANOTECHNOL, V3, P256, DOI [10.1109/TNANO.2004.828530, 10.1109/tnano.2004.828530]
   HO D, 2003, IEEE T NANOTECHNOL, V2, P379
   HO D, 2005, BIONANOINFORMATION F, V1, P1
   Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   Nardin C., 2002, REV MOL BIOTECHNOL, V90, P17
   Pata V, 2003, BIOPHYS J, V85, P2111, DOI 10.1016/S0006-3495(03)74639-6
   Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k
   Pitard B, 1996, EUR J BIOCHEM, V235, P779, DOI 10.1111/j.1432-1033.1996.t01-1-00779.x
   Rathman JF, 2005, FARADAY DISCUSS, V129, P193, DOI 10.1039/b410919h
   Robertson KM, 2002, FEBS LETT, V528, P53, DOI 10.1016/S0014-5793(02)03173-3
   STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5
NR 23
TC 15
Z9 15
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JUN
PY 2006
VL 2
IS 2
BP 103
EP 112
DI 10.1016/j.nano.2005.12.004
PG 10
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 069WP
UT WOS:000239480200007
PM 17292122
DA 2018-10-20
ER

PT J
AU Vyas, SM
   Turanek, J
   Knotigova, P
   Kasna, A
   Kvardova, V
   Koganti, V
   Rankin, SE
   Knutson, BL
   Lehmler, HJ
AF Vyas, Sandhya M.
   Turanek, Jaroslav
   Knoetigova, Pavlina
   Kasna, Andrea
   Kvardova, Veronika
   Koganti, Venkat
   Rankin, Stephen E.
   Knutson, Barbara L.
   Lehmler, Hans-Joachim
TI Synthesis and biocompatibility evaluation of partially fluorinated
   pyridinium bromides
SO NEW JOURNAL OF CHEMISTRY
LA English
DT Article
ID LONG-CHAIN ALKANETHIOLS; KOENIGS-KNORR REACTION; AIR-WATER-INTERFACE;
   BIOMEDICAL APPLICATIONS; SURFACTANTS; SILICA; BEHAVIOR; ESTERS;
   HYDROCARBON; TOXICITY
AB Although cationic surfactants are of general interest for a variety of consumer and biomedical applications, only a limited number of partially fluorinated, single-tailed, cationic surfactants have been synthesized. To study the potential usefulness of fluorinated cationic surfactants for these applications we synthesized a series of partially fluorinated pyridinium bromide surfactants. Three 10-perfluoroalkyldecyl pyridinium surfactants were synthesized by coupling a perfluoroalkyl iodide with 9-decene-1-yl acetate using an AIBN mediated radical reaction. The resulting 9-iodo-10-perfluoroalkyldec-1-yl acetates were deiodinated using HI-Zn-EtOH and hydrolyzed using KOH-EtOH to yield the corresponding 10-perfluoroalkyldecanol. The partially fluorinated alcohol was converted into the bromide using Br-2-PPh3. Alkylation of excess pyridine with the bromides gave the desired 10-perfluoroalkyldecyl pyridinium bromides in good yields. Three 10-perfluoroalkylundecyl surfactants were synthesized using a similar approach with 10-undecenoic acid methyl ester as starting material. Based on an initial in vitro toxicity assessment, the toxicity of the partially fluorinated pyridinium surfactants was slightly lower or comparable to benzalkonium chloride, a typically cationic surfactant (with IC(50)s of tested compounds ranging from 5 to 15 mu M). An increase in the length and/or the degree of fluorination of the hydrophobic tail correlated with a mild decrease of cytotoxicity and haemolytic activity. Partially fluorinated pyridinium surfactants may, therefore, be useful for biomedical applications such as components for novel gene and drug delivery systems.
C1 Univ Iowa, Dept Environm & Occupat Hlth, Iowa City, IA 52242 USA.
   Vet Res Inst, Dept Immunol, Brno 62133, Czech Republic.
   Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40536 USA.
RP Lehmler, HJ (reprint author), Univ Iowa, Dept Environm & Occupat Hlth, Iowa City, IA 52242 USA.
EM hans-joachim-lehmler@uiowa.edu
RI Rankin, Stephen/A-3265-2013
OI Rankin, Stephen/0000-0002-8615-7564; Lehmler,
   Hans-Joachim/0000-0001-9163-927X
CR ASAKAWA T, 1995, LANGMUIR, V11, P478, DOI 10.1021/la00002a019
   BANK U, 1991, Allergie und Immunologie (Leipzig), V37, P119
   BRACE NO, 1982, J FLUORINE CHEM, V20, P313, DOI 10.1016/S0022-1139(00)82223-X
   BRACE NO, 1962, J CHEM SOC, P4491
   Bramer T, 2003, PHARMACEUT RES, V20, P1661, DOI 10.1023/A:1026103805283
   DROBECK HP, 1994, SURF SCI SER, V53, P61
   Ghosh K, 2005, LANGMUIR, V21, P6145, DOI 10.1021/la050311t
   Graupe M, 1999, J FLUORINE CHEM, V93, P107, DOI 10.1016/S0022-1139(98)00284-X
   GREINER J, 1988, TETRAHEDRON LETT, V29, P2193, DOI 10.1016/S0040-4039(00)86708-8
   Guillod F, 1995, CHEM PHYS LIPIDS, V78, P149, DOI 10.1016/0009-3084(95)02492-2
   IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7
   Kissa E, 2001, FLUORINATED SURFACTA, V97
   KRAFFT MP, 1990, NEW J CHEM, V14, P869
   KRAFFT MP, 1991, EUR J MED CHEM, V26, P545, DOI 10.1016/0223-5234(91)90151-C
   Kuo JHS, 2005, COLLOID SURFACE B, V41, P189, DOI 10.1016/j.colsurfb.2004.12.008
   LASIC DD, 1997, LIPOSOMES GENE DELIV
   Lehmler HJ, 2002, J FLUORINE CHEM, V117, P17, DOI 10.1016/S0022-1139(02)00169-0
   Lehmler HJ, 2001, J FLUORINE CHEM, V107, P141, DOI 10.1016/S0022-1139(00)00384-5
   Lehmler HJ, 1999, CHEMTECH, V29, P7
   MILIUS A, 1991, NEW J CHEM, V15, P337
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murphy KE, 2003, J AM CHEM SOC, V125, P4690, DOI 10.1021/ja0300618
   Naud C, 2000, J FLUORINE CHEM, V104, P173, DOI 10.1016/S0022-1139(00)00215-3
   NIVET JB, 1991, EUR J MED CHEM, V26, P953, DOI 10.1016/0223-5234(91)90138-D
   NIVET JB, 1992, EUR J MED CHEM, V27, P891, DOI 10.1016/0223-5234(92)90020-2
   Osei-Prempeh G, 2005, MICROPOR MESOPOR MAT, V85, P16, DOI 10.1016/j.micromeso.2005.06.014
   Pitten FA, 2001, ARZNEIMITTEL-FORSCH, V51, P588
   Rankin SE, 2004, MICROPOR MESOPOR MAT, V73, P197, DOI 10.1016/j.micromeso.2004.05.013
   Ravi S, 2001, J INDIAN I SCI, V81, P299
   Riess JG, 2002, J FLUORINE CHEM, V114, P119, DOI 10.1016/S0022-1139(02)00017-9
   RIESS JG, 1991, ADV MATER, V3, P249, DOI 10.1002/adma.19910030507
   Sadtler VM, 1998, NEW J CHEM, V22, P609, DOI 10.1039/a708757h
   Tan B, 2005, NANOTECHNOLOGY, V16, pS502, DOI 10.1088/0957-4484/16/7/026
   Tan B, 2005, CHEM MATER, V17, P916, DOI 10.1021/cm048991t
   Tan B, 2004, LANGMUIR, V20, P6981, DOI 10.1021/la049474s
   Tondre C, 2001, ADV COLLOID INTERFAC, V93, P115, DOI 10.1016/S0001-8686(00)00081-6
   Turanek J, 2004, ANTI-CANCER DRUG, V15, P537, DOI 10.1097/01.cad.0000127147.57796.e5
   ZARIF L, 1989, J FLUORINE CHEM, V44, P73, DOI 10.1016/S0022-1139(00)84372-9
   ZARIF L, 1990, J MED CHEM, V33, P1262, DOI 10.1021/jm00166a028
NR 39
TC 30
Z9 30
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1144-0546
J9 NEW J CHEM
JI New J. Chem.
PD JUN
PY 2006
VL 30
IS 6
BP 944
EP 951
DI 10.1039/b516039a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 056RS
UT WOS:000238543400027
DA 2018-10-20
ER

PT J
AU Carmen, A
   Arquimedes, K
   Rosestela, P
   Gema, G
   Nohemy, D
   Jeanette, G
   Yanixia, S
AF Carmen, A
   Arquimedes, K
   Rosestela, P
   Gema, G
   Nohemy, D
   Jeanette, G
   Yanixia, S
TI HDPE/HA composites obtained in solution: Effect of the gamma radiation
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article
DE HDPE/HA composites; radiation; mechanical behavior; thermal behavior;
   thermodegradative behavior
ID HYDROXYAPATITE-REINFORCED POLYETHYLENE; TENSILE; FTIR
AB Radiation is employed to sterilize composite materials used in the biomedical field. Due to the changes induced by radiation onto polymeric materials, it is important to study variations in their melt flow index (MFI), as well as in their mechanical and thermal properties. In this work, those previous parameters were determined in composites obtained via solution of a high-density polyethylene (HDPE) in decalin, with different amounts of hydroxyapatite (HA), varying from 10 to 30 parts per hundred after being exposed to gamma radiation at absorbed doses between 25 and 100 kGy. After the irradiation, the MFI of HDPE dissolved in decalin and precipitated afterwards and without filler increased from 6 to 24 g/10 min at the highest absorbed doses. This behavior was also observed in composites with 10 pph of HA, being the increase less pronounced, specifically in the range between 50 and 100 kGy. Composites with 20 and 30 pph of HA showed a maximum MFI value at 50 kGy, which decreased at higher doses. This implies that the filler begin to exert an influence because it does not melt at the test temperature and consequently, it does not flow. It was observed that Young's modulus increased with HA addition due to rigidity of the ceramic filler. Radiation did not significantly affect this tensile property. On the other hand, the tensile strength did not show significant variations at the different doses but the filler content did affect this property improving it. Finally, elongation at break showed a drastic decrease with filler addition. When the thermal behavior was studied it was noticed that crystallization and melting temperatures remained unchanged. Instead, crystallinity degree slightly increased in the composites, and a little decrease was obtained when they were irradiated. (c) 2006 Elsevier B.V. All rights reserved.
C1 Venezuelan Inst Sci Res, Polymer Lab, Chem Ctr, IVIC, Caracas 1020 A, Venezuela.
   Venezuelan Inst Sci Res, Mat Lab, IVIC, Technol Ctr, Caracas 1020 A, Venezuela.
   Cent Univ Venezuela, Fac Ingn, Escuela Ingn Quim, Caracas, Venezuela.
   Univ Simon Bolivar, Dept Mecan, Caracas, Venezuela.
RP Carmen, A (reprint author), Venezuelan Inst Sci Res, Polymer Lab, Chem Ctr, IVIC, POB 21827, Caracas 1020 A, Venezuela.
EM calbano@ivic.ve; akaram@quimica.ivic.ve
CR Albano C, 2003, POLYM BULL, V51, P135, DOI 10.1007/s00289-003-0206-4
   ALBANO C, 2004, ANTEC 2004 P CHIC, P3371
   ARROYO M, 1988, REV PLASTICOS MODERN, V383, P705
   Bandrup J., 1966, POLYM HDB
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   DOLE M, 1973, RADIAT CHEM MACROMOL, V2, P282
   GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495
   Joseph R, 2002, POLYM ENG SCI, V42, P326, DOI 10.1002/pen.10951
   KUNORI T, 1980, J MACROMOL SCI PHYS, VB18, P135, DOI 10.1080/00222348008241376
   LIU Q, 1997, J BIOMATER RES, P40
   MAITI SN, 1992, J APPL POLYM SCI, V44, P353, DOI 10.1002/app.1992.070440219
   MCALLUM JP, 1970, EUR POLYM J, P1033
   Muller AJ, 1997, POLYM BULL, V39, P465, DOI 10.1007/s002890050174
   Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512
   NICOLAIS L, 1971, POLYM ENG SCI, V11, P194, DOI 10.1002/pen.760110305
   NIELSEN LE, 1966, J APPL POLYM SCI, V10, P97, DOI 10.1002/app.1966.070100107
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   SILVA P, IN PRESS REV MEX FIS
   Smallwood HM, 1944, J APPL PHYS, V15, P758, DOI 10.1063/1.1707385
   Sousa RA, 2002, J APPL POLYM SCI, V86, P2873, DOI 10.1002/app.11301
   SPADAVECCHIA U, 2001, P 6 CIASEM C INT MIC
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   WANG M, 1994, BRIT CERAM T, V93, P91
NR 23
TC 10
Z9 12
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUN
PY 2006
VL 247
IS 2
BP 331
EP 341
DI 10.1016/j.nimb.2006.03.004
PG 11
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 051SW
UT WOS:000238182200026
DA 2018-10-20
ER

PT J
AU Stasiek, J
   Stasiek, A
   Jewartowski, M
   Collins, MW
AF Stasiek, J
   Stasiek, A
   Jewartowski, M
   Collins, MW
TI Liquid crystal thermography and true-colour digital image processing
SO OPTICS AND LASER TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Colour and Design Conference
CY NOV 21-22, 2003
CL London, ENGLAND
SP Linnean Soc London, Inst Mech Engineers
DE liquid crystal thermography; image processing; biomedicine
AB in the last decade thermochromic liquid crystals (TLC) and true-colour digital image processing have been successfully used in non-intrusive technical, industrial and biomedical studies and applications. Thin coatings of TLCs at surfaces are utilized to obtain detailed temperature distributions and heat transfer rates for steady or transient processes. Liquid crystals also can be used to make visible the temperature and velocity fields in liquids by the simple expedient of directly mixing the liquid crystal material into the liquid (water, glycerol, glycol, and silicone oils) in very small quantities to use as thermal and hydrodynamic tracers. In biomedical situations e.g., skin diseases, breast cancer, blood circulation and other medical application, TLC and image processing are Successfully used as an additional non-invasive diagnostic method especially useful for screening large groups of potential patients. The history of this technique is reviewed, principal methods and tools are described and some examples are also presented. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Gdansk Tech Univ, PL-80952 Gdansk, Poland.
   Brunel Univ, Thermofluids Grp, Inst Mech Engineers, London, England.
   Brunel Univ, Sch Engn & Design, London, England.
RP Stasiek, J (reprint author), Gdansk Tech Univ, Narutowicza 11-12, PL-80952 Gdansk, Poland.
EM jstasick@pg.gda.pl
OI Jewartowski, Marcin/0000-0003-2455-8837; Stasiek,
   Jan/0000-0003-0475-6246
CR AKINO N, 1990, FLOW VISUALIZATION, V5, P87
   ASHFORTHFROST S, 1992, P 1 IMECHE SEM OPT M, P121
   Baughn J. W., 1991, P 32 HEAT TRANSF FLU, P15
   DATA TRANSLATION Ltd, 1991, IM PROC HDB
   HILLER WJ, 1993, INT J HEAT MASS TRAN, V36, P3251, DOI 10.1016/0017-9310(93)90008-T
   Jones T., 1992, P 1 IMECHE SEM OPT M, P51
   Jung A, 1998, THERMOGRAPHIC METHOD
   KLOSOWICZ S, 1992, MOL CRYST LIQ CRYST, V215, P253, DOI 10.1080/10587259208038532
   Kowalewski TA, 1999, INT J COMPUT FLUID D, V11, P193, DOI 10.1080/10618569908940874
   KOWALEWSKI TA, 1998, 8 INT S FLOW VIS SOR
   Leiner W., 1996, P 3 I MECH E SEM OPT, P1
   Moffat R J, 1991, P 9 INT HEAT TRANSF, V1, P308
   MOFFAT RJ, 1988, EXP THERM FLUID SCI, V1, P3, DOI 10.1016/0894-1777(88)90043-X
   PARSLEY M, 1988, FLUCOME 88 SHEFF U U, P216
   Reinitzer R., 1888, MONATSH CHEM, V9, P421
   Stasiek J, 1997, HEAT MASS TRANSFER, V33, P27, DOI 10.1007/s002310050158
   Stasiek J, 1996, ATLAS VISUALIZATION, V2
   STASIEK J, 1999, EUROMECH 406 C
   STASIEK JA, 2002, OPTO ELECT REV, V10
   Zmija J, 1989, CHOLESTERIC LIQUID C
NR 20
TC 39
Z9 41
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0030-3992
J9 OPT LASER TECHNOL
JI Opt. Laser Technol.
PD JUN-SEP
PY 2006
VL 38
IS 4-6
BP 243
EP 256
DI 10.1016/j.optlastec.2005.06.028
PG 14
WC Optics; Physics, Applied
SC Optics; Physics
GA 029DS
UT WOS:000236539300006
DA 2018-10-20
ER

PT J
AU Neumann, A
   Unkel, C
   Werry, C
   Herborn, CU
   Maier, HR
   Ragoss, C
   Jahnke, K
AF Neumann, A
   Unkel, C
   Werry, C
   Herborn, CU
   Maier, HR
   Ragoss, C
   Jahnke, K
TI Prototype of a silicon nitride ceramic-based miniplate osteofixation
   system for the midface
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article; Proceedings Paper
CT 107th Annual Meeting of the
   American-Academy-of-Otolaryngology-Head-and-Neck-Surgery
CY SEP 21-24, 2003
CL ORLANDO, FL
SP Amer Acad Otolaryngol Head & Neck Surg
ID IN-VITRO; TOXICITY; SURGERY; TISSUE; CELLS
AB OBJECTIVE: The favorable properties of silicon nitride (Si3N4) ceramics, such as high mean strength level and fracture toughness, suggest biomedical use as an implant material. Minor reservations about the biocompatibility of Si3N4 ceramics were cleared up by previous in vitro and in vivo investigations.
   STUDY DESIGN AND SETTING: A Si3N4 prototype mini-fixation system was manufactured and implanted for osteosynthesis of artificial frontal bone defects in 3 minipigs. After 3 months, histological sections, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans were obtained. Finite element modeling (FEM) was used to simulate stresses and strains on Si3N4 miniplates and screws to calculate survival probabilities.
   RESULTS: Si3N4 miniplates and screws showed satisfying intraoperative workability. There was no implant loss, displacement, or fracture. Bone healing was complete in all animals. The formation of new bone was observed in direct contact to the implants. The implants showed no artifacts on CT and MRI scanning. FEM simulation confirmed the mechanical reliability of the screws, whereas simulated plate geometries regarding pullout forces at maximum load showed limited safety in a bending situation.
   CONCLUSIONS: Si3N4 ceramics show a good biocompatibility outcome both in vitro and in vivo. In ENT surgery, this ceramic may serve as a biomaterial for osteosynthesis (eg, of the midface including reconstruction the floor of the orbit and the skull base). To our knowledge, this is the first introduction of a ceramic-based miniplate-osteofixation system. Advantages compared with titanium are no risk of implantation to bone with mucosal attachment, no need for explantation, and no interference with radiologic imaging. Disadvantages include the impossibility of individual bending of the miniplates. (c) 2006 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
C1 Univ Essen Gesamthsch, Dept Otorhinolaryngol, Essen, Germany.
   Dept Otorhinolaryngol, Essen, Germany.
   Dept Radiol, Essen, Germany.
   Inst Ceram Components Mech Engn, Aachen, Germany.
RP Neumann, A (reprint author), Univ Essen Gesamthsch, Dept Otorhinolaryngol, Essen, Germany.
EM andreas.neumann@uni-essen.de
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   JAHNKE K, 1979, ARCH OTO-RHINO-LARYN, V223, P373, DOI 10.1007/BF01109587
   JAHNKE K, 1985, NEW DIMENSIONS OTORH, V2, P185
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Marti A, 2000, Injury, V31 Suppl 4, P33
   Neumann A, 2004, MATERIALWISS WERKST, V35, P569, DOI 10.1002/mawe.200400778
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   NEUMANN A, 2004, LARYNGO RHINO OTOL, V83, P734
   NORTHUP SJ, 1988, HDB BIOMATERIALS EVA, P209
   PLESTER D, 1981, AM J OTOL, V3, P104
   RICHERSON DW, 1989, MATER SCI FORUM, V47, P282
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   Ruan S, 1999, Zhonghua Kou Qiang Yi Xue Za Zhi, V34, P223
   SOHRABI A, 1998, BIOCERAMICS, V11, P309
   STEINHART H, 1995, HNO, V43, P211
   Svensson I, 1997, AM J IND MED, V31, P335, DOI 10.1002/(SICI)1097-0274(199703)31:3<335::AID-AJIM10>3.0.CO;2-1
   Wilsnack R E, 1973, Biomater Med Devices Artif Organs, V1, P543
NR 21
TC 17
Z9 17
U1 1
U2 7
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD JUN
PY 2006
VL 134
IS 6
BP 923
EP 930
DI 10.1016/j.otohns.2006.01.022
PG 8
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 052KF
UT WOS:000238231900006
PM 16730531
DA 2018-10-20
ER

PT J
AU Allcock, HR
   Steely, LB
   Singh, A
AF Allcock, HR
   Steely, LB
   Singh, A
TI Hydrophobic and superhydrophobic surfaces from polyphosphazenes
SO POLYMER INTERNATIONAL
LA English
DT Review
DE superhydrophobic; hydrophobic; hydrophilic; polyphosphazene; phosphazene
ID BLOCK-COPOLYMERS; POLYMERS; FILMS;
   POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>; POLY(ORGANOPHOSPHAZENES);
   CYCLOTRIPHOSPHAZENES; ROUGHNESS; FIBERS
AB Hydrophobic polymers play a crucial role in many biomedical and commercial applications. Hydrophobic polyphosphazenes offer opportunities for the tuning of surface properties that are not found for many conventional hydrophobic materials. Thus, changes in the side groups linked to the polyphosphazene skeleton allow the surface character to be changed from highly hydrophilic to hydrophobic. The hydrophobic side groups range from fluoroalkoxy groups to aryloxy and organosificon units. Moreover, the polymer architectures can be varied from single-substituent species to mixed substituent polymers or to block or comb copolymer structures. Superhydrophobicity, with contact angles to water as high as 159 degrees, has been achieved by electrospinning a fluoroalkoxy derivative to nanofiber mats. (c) 2006 Society of Chemical Industry.
C1 Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
RP Allcock, HR (reprint author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.
EM hra@chem.psu.edu
CR Acatay K, 2004, ANGEW CHEM INT EDIT, V43, P5210, DOI 10.1002/anie.200461092
   Allcock H.R., 2003, CHEM APPL POLYPHOSPH
   ALLCOCK HR, 1990, MACROMOLECULES, V23, P1626, DOI 10.1021/ma00208a011
   Allcock HR, 2004, MACROMOLECULES, V37, P5824, DOI 10.1021/ma040049f
   Allcock HR, 1996, MACROMOLECULES, V29, P7740, DOI 10.1021/ma960876j
   Allcock HR, 1996, CHEM MATER, V8, P2730, DOI 10.1021/cm9602050
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   Allcock HR, 1998, APPL ORGANOMET CHEM, V12, P659, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<659::AID-AOC773>3.0.CO;2-2
   ALLCOCK HR, 1991, CHEM MATER, V3, P450, DOI 10.1021/cm00015a018
   Allcock HR, 2001, MACROMOLECULES, V34, P6858, DOI 10.1021/ma010088g
   ALLCOCK HR, 1995, CHEM MATER, V7, P1469, DOI 10.1021/cm00056a011
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1502, DOI 10.1021/ma00160a002
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   Bertolucci M, 2004, MACROMOLECULES, V37, P3666, DOI 10.1021/ma035934x
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   Chang Y, 2001, MACROMOLECULES, V34, P269, DOI 10.1021/ma992036l
   Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   GAO YJ, 1995, CHINA VEGETABLES, V1, P38
   Gleria M, 2004, J FLUORINE CHEM, V125, P329, DOI 10.1016/j.jfluchem.2003.07.015
   JAEGER R, 1995, MACROMOLECULES, V28, P539, DOI 10.1021/ma00106a019
   Kolich C. H., 1990, US Pat, Patent No. 4945139
   Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924
   Lee KB, 2001, CURR APPL PHYS, V1, P379, DOI 10.1016/S1567-1739(01)00039-6
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Ma ML, 2005, LANGMUIR, V21, P5549, DOI 10.1021/la047064y
   Mark J. E., 2005, INORGANIC POLYM
   Miwa M, 2000, LANGMUIR, V16, P5754, DOI [10.1021/la991660o, 10.1021/1a991660o]
   Nakajima A, 2000, LANGMUIR, V16, P7044, DOI 10.1021/la000155k
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t
   PENTON HR, 1988, ACS SYM SER, V360, P277
   PENTON HR, 1986, Patent No. 205349
   PENTON HR, 1996, Patent No. 743524
   PETERSON ES, 1993, SEPAR SCI TECHNOL, V28, P271, DOI 10.1080/01496399308019490
   RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055
   Simonutti R, 1996, MACROMOLECULES, V29, P4958, DOI 10.1021/ma9514939
   SINGH A, 2005, LANGMUIR ASAP
   SINGLER RE, 1992, SYNTHETIC LUBRIFICAN, P215
   Sun H, 1997, J AM CHEM SOC, V119, P3611, DOI 10.1021/ja963077p
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Waltman RJ, 1997, CHEM MATER, V9, P2185, DOI 10.1021/cm9703132
   Wisian-Neilson P, 2002, INORG CHEM, V41, P4775, DOI 10.1021/ic025760k
NR 44
TC 55
Z9 58
U1 5
U2 56
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUN
PY 2006
VL 55
IS 6
BP 621
EP 625
DI 10.1002/pi.2030
PG 5
WC Polymer Science
SC Polymer Science
GA 042RZ
UT WOS:000237548400006
DA 2018-10-20
ER

PT J
AU Naraindas, H
AF Naraindas, H
TI Of spineless babies and folic acid: Evidence and efficacy in biomedicine
   and ayurvedic medicine
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE India; evidence; efficacy; science; medicine; alternate; ayurveda
ID ILLNESS; CULTURE
AB The basic premise of the paper is that Western medicine's co-opting of specific technologies and materials from other (indigenous) medical traditions, stripped of the original theories underlying their use, has problematic consequences for the practitioners and patients of both source and recipient traditions. The paper begins by illustrating the historical continuity of this process by way of an example from India's colonial era. The fact that specific practices or materials are regarded as biomedically useful because they 'work' (are efficacious) does not mean that the 'traditional' theories underlying them are seen as correct. The knowledge contained in these traditions is not counted as legitimate, as the emphasis in biomedicine (the legitimate canon) on an identifiable concrete location in the body for the source of health problems creates difficulties-both for patients when their problems are not provided with a cause that matches their subjective awareness, and for the practitioners of other traditions whose patients have been exposed to biomedicine. The paper goes on to demonstrate, using case examples from extended ethnographic fieldwork in southern India, how this is played out in a setting in which an educated Indian patient population accepts this form of knowledge as legitimate but espouses ayurvedic therapy. Notions of 'evidence' are shown to be central to the interplay between biomedical and other medical traditions, since objective tests and measures in biomedicine are accepted as the only legitimate 'evidence' of cure, but these do not necessarily accord either with the premises of these other traditions or with patients' subjective perceptions of well-being. Returning to an acceptance and practice of other traditions, consequently, requires nothing less than a fundamental cognitive shift in the grounds for what constitutes 'evidence.' (c) 2005 Elsevier Ltd. All rights reserved.
C1 Jawaharlal Nehru Univ, Sch Social Sci, CSSS, New Delhi 110067, Delhi, India.
RP Naraindas, H (reprint author), Jawaharlal Nehru Univ, Sch Social Sci, CSSS, New Meharauli Rd, New Delhi 110067, Delhi, India.
EM harish-naraindas@uiowa.edu
CR AINSLIE W, 1913, MAT MED HINDOOSTAN A
   ATKINSON P, 1995, MED TALK MED WORK LI
   BANERJEE M, IN PRESS PLURALISM P
   BANERJEE M, 1995, THESIS U DELHI DELHI
   BYNUM WF, 1987, MED FRINGE MED ORTHO
   Canguilhem G, 1991, NORMAL PATHOLOGICAL
   CARAKA, 1983, CARAKA SAMHITA, V2
   CARAKA, 1976, CHAUKAMBA SANSKRIT S
   DAS V, 2002, ISERDD DELH
   Fissell Mary, 1991, BRIT MED AGE REFORM, P92
   Foucault Michel, 1973, BIRTH CLIN ARCHAEOLO
   GERSON EM, 1976, SOC SCI MED, V10, P219, DOI 10.1016/0037-7856(76)90002-0
   JEWSON ND, 1976, SOCIOLOGY, V10, P225, DOI 10.1177/003803857601000202
   KASL SV, 1966, ARCH ENVIRON HEALTH, V12, P246, DOI 10.1080/00039896.1966.10664365
   KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251
   MECHANIC D, 1969, POVERTY HLTH SOCIOLO, P191
   Naraindas H, 1996, CONTRIB INDIAN SOC, V30, P1, DOI 10.1177/006996679603000101
   OSHAUGHNESSY WB, 1839, PREPARATIONS INDIAN
   OSHAUGHNESSY WB, 1941, BENGAL DISPENSATORY
   Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3
   Scheid V, 2001, INNOVATION CHINESE M, P370
   SUCHMAN E, 1963, SOCIOLOGY FIELD PUBL
   TABOR DC, 1981, SOCIAL SCI MED B, V15
   Wujastyk Dominik, 2001, ROOTS AYURVEDA
   YOUNG A, 1981, SOCIAL SCI MED B, V15, P376
   ZIMMERMAN F, 1987, JUNGLE AROMA MEATS
   ZOLA IK, 1966, AM SOCIOL REV, V31, P615, DOI 10.2307/2091854
NR 27
TC 18
Z9 18
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUN
PY 2006
VL 62
IS 11
BP 2658
EP 2669
DI 10.1016/j.socscimed.2005.11.043
PG 12
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 047HL
UT WOS:000237870300005
PM 16414165
DA 2018-10-20
ER

PT J
AU Zhao, L
   Xu, L
   Mitomo, H
   Yoshii, F
AF Zhao, L
   Xu, L
   Mitomo, H
   Yoshii, F
TI Synthesis of pH-sensitive PVP/CM-chitosan hydrogels with improved
   surface property by irradiation
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE poly(N-vinylpyrrolidone); carboxymethylchitosan; hydrogels; irradiation;
   pH-sensitive; bovine serum albumin; adsorption
ID COMPOSITE MF MEMBRANE; KAPPA-CARRAGEENAN; RADIATION; ADSORPTION; CHITIN
AB In order to develop a nontoxicity, biocompatibility, pH-sensitive hydrogel system with potential ability to immobilize and absorb proteins, the hydrogel membranes of poly(N-vinylpyrrolidone) (PVP) and carboxymethylated chitosan (CM-chitosan) blend were prepared with electron beam (EB) irradiation at room temperature. The FTIR spectroscopic, mechanical property, swelling behavior, and surface property of the hydrogel membrane were measured. The capacity of these gel membranes to adsorb bovine serum albumin (BSA) was investigated with varying content of CM-chitosan by static adsorption experiment at pH 7.4. The mechanical and swelling properties were improved obviously after adding CM-chitosan into PVP hydrogels. The changes of contact angles of water, glycerin and octane drops on the blend membranes surface with increasing CM-chitosan content indicated that the CM-chitosan molecules were more hydrophilic than PVP molecules, and cause a larger polar component of surface free energy. The incorporation of CM-chitosan introduced the protein adsorptive property into blend system. From these preliminary evaluations, it is possible to conclude that these materials have potential for applications in the biomedical field. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Gunma Univ, Dept Biol & Chem Engn, Kiryu, Gumma 3768515, Japan.
   Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1520033, Japan.
   Japan Atom Energy Res Inst, Takasaki Radiat Chem Res Estab, Takasaki, Gumma 3701292, Japan.
RP Zhao, L (reprint author), Nisshin Elect Co Ltd, R&D Labs, Adv Mat Res Ctr, Ukyo Ku, 47,Umezu Takase Cho, Kyoto 6158686, Japan.
EM Zhao_Long@nissin.co.jp
RI Xu, Ling/B-1044-2012
CR Abad LV, 2003, RADIAT PHYS CHEM, V68, P901, DOI 10.1016/S0969-806X(03)00164-6
   ALTEMEIER WA, 1954, AMA ARCH SURG, V69, P309, DOI 10.1001/archsurg.1954.01270030037004
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P9, DOI 10.1016/0142-9612(86)90081-5
   Crescenzi V, 1997, POLYM GELS NETW, V5, P225, DOI 10.1016/S0966-7822(96)00051-2
   Dumitriu S., 1996, POLYSACCHARIDES MED
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   Gombotz W.R., 1986, HYDROGELS MED PHARM, P95
   HOFFMAN AS, 1981, RADIAT PHYS CHEM, V18, P323, DOI 10.1016/0146-5724(81)90085-6
   Hong Y, 1998, J BIOMED MATER RES, V39, P650, DOI 10.1002/(SICI)1097-4636(19980315)39:4<650::AID-JBM21>3.0.CO;2-9
   HU DSG, 1996, J APPL POLYM SCI, V59, P1
   HUGLIN MB, 1986, J APPL POLYM SCI, V31, P457, DOI 10.1002/app.1986.070310213
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KAETSU S, 1981, RADIAT PHYS CHEM, V18, P342
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Nho YC, 2002, J APPL POLYM SCI, V85, P1787, DOI 10.1002/app.10812
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   SAIKI I, 1992, CHITIN DERIVATIVES L, P20
   TOKURA S, 1990, CARBOHYD POLYM, V13, P273, DOI 10.1016/0144-8617(90)90059-2
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   Zhai ML, 2000, RADIAT PHYS CHEM, V57, P459
   Zhao L, 2003, CARBOHYD POLYM, V53, P439, DOI 10.1016/S0144-8617(03)00103-6
   Zhao L, 2003, CARBOHYD POLYM, V51, P169, DOI 10.1016/S0144-8617(02)00210-2
   Zhao ZP, 2003, J MEMBRANE SCI, V217, P151, DOI 10.1016/S0376-7388(03)00105-4
   Zhao ZP, 2002, DESALINATION, V144, P35, DOI 10.1016/S0011-9164(02)00285-0
NR 29
TC 70
Z9 73
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 30
PY 2006
VL 64
IS 3
BP 473
EP 480
DI 10.1016/j.carbpol.2005.12.014
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 052PO
UT WOS:000238245800011
DA 2018-10-20
ER

PT J
AU Smith, AM
   Banwell, EF
   Edwards, WR
   Pandya, MJ
   Woolfson, DN
AF Smith, Andrew M.
   Banwell, Eleanor F.
   Edwards, Wayne R.
   Pandya, Maya J.
   Woolfson, Derek N.
TI Engineering increased stability into self-assembled protein fibers
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID HELICAL COILED-COILS; GCN4 LEUCINE-ZIPPER; PEPTIDE-AMPHIPHILE
   NANOFIBERS; SCAFFOLDS; FABRICATION; PARALLEL; DESIGN; BIOMATERIALS;
   ANTIPARALLEL; HETERODIMER
AB Two stages in the rational redesign of a peptide-based, self-assembling fiber (SAF) are described. The SAF system comprises two peptides designed to form an offset a-helical coiled-coil heterodimer. The "sticky-ends" are complementary and promote longitudinal assembly. Alone, the two peptides are unstructured, but co-assemble upon mixing to form a-helical fibrils, which bundle to form fibers 40-50 nm wide and tens of micrometers long. Assembly is controllable and occurs at pH 7 in water, making SAFs a potential scaffold for 3D cell culture. The purposes of the redesigns were 1) to investigate the fiber-thickening process, and 2) to increase fiber stability for potential biological and biomedical applications. First, mutations were made to the original peptide designs to increase fibril-fibril interactions and so produce thicker and more-stable fibers. The second iteration aimed to increase the primary peptide-peptide interactions by increasing the overlap in the offset dimer and so promote the initial step in fiber formation. As judged by circular dichroism spectroscopy and transmission electron microscopy, both iterations; improved fiber assembly and stability: the critical peptide concentration for assembly improved from 60 lam to 4 gm; the midpoint of thermal unfolding increased from 22 degrees C to 65 degrees C; and the salt tolerance improved from 75 mm to greater than 230 mm KCl. These improvements bring closer applications of the SAF system under physiological conditions, for example as a biocompatible material for 3D cell culture. In addition, ordered surface features were observed in the second- and third-generation fibers compared with the original design. This indicates improved internal order in the redesigned fibers. In turn, this suggests a molecular mechanism for the improved stability and sheds light on the fiber-assembly process.
C1 Univ Sussex, Sch Life Sci, Dept Biochem, Brighton BN1 9QG, E Sussex, England.
RP Woolfson, DN (reprint author), Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
EM d.n.woolfson@bristol.ac.uk
RI Smith, Andrew/C-8945-2009; Banwell, Eleanor/B-1171-2009
OI Smith, Andrew/0000-0002-1538-9712; 
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Kajava AV, 2004, J PEPT SCI, V10, P291, DOI 10.1002/psc.520
   Kojima S, 1997, P JPN ACAD B-PHYS, V73, P7, DOI 10.2183/pjab.73.7
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8
   MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0
   MCLACHLAN AD, 1982, J MOL BIOL, V162, P693, DOI 10.1016/0022-2836(82)90396-5
   MENG JJ, 1994, J BIOL CHEM, V269, P18679
   Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h
   MONERA OD, 1994, BIOCHEMISTRY-US, V33, P3862, DOI 10.1021/bi00179a010
   MONERA OD, 1993, J BIOL CHEM, V268, P19218
   NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001
   Offer G, 2002, J STRUCT BIOL, V137, P41, DOI 10.1006/jsbi.2002.4448
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3
   OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X
   PARRY DAD, 1999, GUIDEBOOK CYTOSKELET
   Persidis A, 1999, NAT BIOTECHNOL, V17, P508, DOI 10.1038/8700
   PHILLIPS GN, 1986, J MOL BIOL, V192, P128, DOI 10.1016/0022-2836(86)90469-9
   Pollard T. D., 2002, CELL BIOL
   Powers ET, 2002, ANGEW CHEM INT EDIT, V41, P127, DOI 10.1002/1521-3773(20020104)41:1<127::AID-ANIE127>3.0.CO;2-F
   Ryadnov MG, 2005, J AM CHEM SOC, V127, P12407, DOI 10.1021/ja052972i
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045
   Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SMITH AM, 2003, THESIS U SUSSEX UK
   Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   THOMPSON KS, 1993, BIOCHEMISTRY-US, V32, P5491, DOI 10.1021/bi00072a001
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365
   Zimenkov Y, 2004, TETRAHEDRON, V60, P7237, DOI 10.1016/j.tet.2004.06.068
NR 58
TC 61
Z9 64
U1 4
U2 29
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAY 19
PY 2006
VL 16
IS 8
BP 1022
EP 1030
DI 10.1002/adfm.200500568
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 050FO
UT WOS:000238073100003
DA 2018-10-20
ER

PT J
AU Taniyasu, Y
   Kasu, M
   Makimoto, T
AF Taniyasu, Y
   Kasu, M
   Makimoto, T
TI An aluminium nitride light-emitting diode with a wavelength of 210
   nanometres
SO NATURE
LA English
DT Article
ID SI-DOPED ALN; PHOTOLUMINESCENCE; SEMICONDUCTORS; CONDUCTION; EMISSION;
   GROWTH; GAN
AB Compact high-efficiency ultraviolet solid-state light sources(1) such as light-emitting diodes (LEDs) and laser diodes - are of considerable technological interest as alternatives to large, toxic, low-efficiency gas lasers and mercury lamps. Microelectronic fabrication technologies and the environmental sciences both require light sources with shorter emission wavelengths: the former for improved resolution in photolithography and the latter for sensors that can detect minute hazardous particles. In addition, ultraviolet solid-state light sources are also attracting attention for potential applications in high-density optical data storage, biomedical research, water and air purification, and sterilization. Wide-bandgap materials, such as diamond(2) and III - V nitride semiconductors (GaN, AlGaN and AlN; refs 3 - 10), are potential materials for ultraviolet LEDs and laser diodes, but suffer from difficulties in controlling electrical conduction. Here we report the successful control of both n-type and p-type doping in aluminium nitride ( AlN), which has a very wide direct bandgap(11) of 6 eV. This doping strategy allows us to develop an AlN PIN (p-type/intrinsic/n-type) homojunction LED with an emission wavelength of 210 nm, which is the shortest reported to date for any kind of LED. The emission is attributed to an exciton transition, and represents an important step towards achieving exciton-related light-emitting devices as well as replacing gas light sources with solid-state light sources.
C1 NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan.
RP Taniyasu, Y (reprint author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.
EM taniyasu@will.brl.ntt.co.jp
RI Kasu, Makoto/N-4118-2018
OI Kasu, Makoto/0000-0002-0881-9454
CR Adivarahan V, 2004, APPL PHYS LETT, V85, P2175, DOI 10.1063/1.1796525
   Akasaki I, 1997, JPN J APPL PHYS 1, V36, P5393, DOI 10.1143/JJAP.36.5393
   Amano H, 2004, PHYS STATUS SOLIDI A, V201, P2679, DOI 10.1002/pssa.200405044
   Edgar J. H., 1994, PROPERTIES GROUP 3 N
   Han J, 1998, APPL PHYS LETT, V73, P1688, DOI 10.1063/1.122246
   Hirayama H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1899760
   Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258
   Kuokstis E, 2002, APPL PHYS LETT, V81, P2755, DOI 10.1063/1.1510586
   Li J, 2003, APPL PHYS LETT, V83, P5163, DOI 10.1063/1.1633965
   Mireles F, 1998, PHYS REV B, V58, P3879, DOI 10.1103/PhysRevB.58.3879
   NAKAMURA S, 1992, JPN J APPL PHYS 2, V31, pL139, DOI 10.1143/JJAP.31.L139
   NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL1332, DOI 10.1143/JJAP.34.L1332
   Nam KB, 2003, APPL PHYS LETT, V83, P878, DOI 10.1063/1.1594833
   Ng HM, 1998, APPL PHYS LETT, V73, P821, DOI 10.1063/1.122012
   Nishida T, 1999, PHYS STATUS SOLIDI A, V176, P45, DOI 10.1002/(SICI)1521-396X(199911)176:1<45::AID-PSSA45>3.0.CO;2-0
   Pankove J. I., 1971, Journal of Luminescence, V4, P63, DOI 10.1016/0022-2313(71)90009-3
   Ponce FA, 1997, NATURE, V386, P351, DOI 10.1038/386351a0
   Rojo JC, 2001, J CRYST GROWTH, V231, P317
   Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712
   SZE SM, 1981, PHYS SEMICONDUCTOR D, P63
   Taniyasu Y, 2003, PHYS STATUS SOLIDI A, V200, P40, DOI 10.1002/pssa.200303409
   Taniyasu Y, 2004, APPL PHYS LETT, V85, P4672, DOI 10.1063/1.1824181
   Taniyasu Y, 2002, APPL PHYS LETT, V81, P1255, DOI 10.1063/1.1499738
NR 23
TC 1051
Z9 1080
U1 28
U2 553
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 18
PY 2006
VL 441
IS 7091
BP 325
EP 328
DI 10.1038/nature04760
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 043IB
UT WOS:000237593200042
PM 16710416
DA 2018-10-20
ER

PT J
AU Huo, QS
   Liu, J
   Wang, LQ
   Jiang, YB
   Lambert, TN
   Fang, E
AF Huo, QS
   Liu, J
   Wang, LQ
   Jiang, YB
   Lambert, TN
   Fang, E
TI A new class of silica cross-linked micellar core-shell nanoparticles
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID DRUG-DELIVERY DEVICES; BLOCK-COPOLYMERS; CONTROLLED-RELEASE; MESOPOROUS
   SILICA; PLURONIC MICELLES; AQUEOUS-SOLUTION; FLUORESCENCE; SURFACTANT;
   SYSTEMS; DESIGN
AB Micellar nanoparticles made of surfactants and polymers have attracted wide attention in the materials and biomedical community for controlled drug delivery, molecular imaging, and sensing; however, their long-term stability remains a topic of intense study. Here we report a new class of robust, ultrafine silica core-shell nanoparticles formed from silica cross-linked, individual block copolymer micelles. Compared with pure polymeric micelles, the main advantage of the new core-shell nanoparticles is that they have significantly improved stability and do not break down during dilution. We also studied the drug loading and release properties of the silica cross-linked micellar particles, and we found that the new core-shell nanoparticles have a slower release rate which allows the entrapped molecules to be slowly released over a much longer period of time under the same experimental conditions. A range of functional groups can be easily incorporated through co-condensation with the silica matrix. The potential to deliver hydrophobic agents into cancer cells has been demonstrated. Because of their unique structures and properties, these novel core-shell nanoparticles could potentially provide a new nanomedicine platform for imaging, detection, and treatment, as well as novel colloidal particles and building blocks for mutlifunctional materials.
C1 Univ New Mexico, Pacific NW Natl Lab, Richland, WA 99352 USA.
   Univ New Mexico, Albuquerque, NM 87131 USA.
   Sandia Natl Labs, Albuquerque, NM 87185 USA.
RP Liu, J (reprint author), Univ New Mexico, Pacific NW Natl Lab, Richland, WA 99352 USA.
EM jun.liu@pnl.gov
CR ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
   Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Asefa T, 1999, NATURE, V402, P867
   Babonneau F, 2004, J SOL-GEL SCI TECHN, V31, P219, DOI 10.1023/B:JSST.0000047991.73840.8b
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.3.CO;2-I
   Chu B., 1996, SURF SCI SERIES, V60, P67
   COUVREUR P, 1993, ADV DRUG DELIVER REV, V10, P141, DOI 10.1016/0169-409X(93)90046-7
   Desai PR, 2001, COLLOID SURFACE A, V178, P57, DOI 10.1016/S0927-7757(00)00493-3
   Ding JF, 1998, J PHYS CHEM B, V102, P6107, DOI 10.1021/jp9805510
   DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437
   Engelhardt G., 1987, HIGH RESOLUTION SOLI
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207
   GUACHER G, 2005, J CONTROL RELEASE, V109, P169
   HAM JS, 1953, J CHEM PHYS, V21, P756, DOI 10.1063/1.1699014
   Kabanov AV, 1996, MACROMOLECULES, V29, P6797, DOI 10.1021/ma960120k
   KABANOV AV, 1992, BIOCHEM INT, V26, P1035
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   KABANOV AV, 1989, FEBS LETT, V258, P343, DOI 10.1016/0014-5793(89)81689-8
   KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004
   Klinkner AM, 1997, J HISTOCHEM CYTOCHEM, V45, P743, DOI 10.1177/002215549704500513
   Lam YM, 1999, PHYS CHEM CHEM PHYS, V1, P3331, DOI 10.1039/a902369k
   Lasic DD, 1996, NATURE, V380, P561, DOI 10.1038/380561a0
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Li W, 2005, COLLOID J+, V67, P159, DOI 10.1007/s10595-005-0075-7
   Murthy KS, 2001, CHEM COMMUN, P773
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   Pedroso MAS, 2000, COLLOID POLYM SCI, V278, P1180, DOI 10.1007/s003960000380
   PROCHAZKA A, 1979, Z MAKROMOL CHEM, V180, P2521
   Rapoport N, 1999, COLLOID SURFACE B, V16, P93, DOI 10.1016/S0927-7765(99)00063-6
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   Sharma PK, 2004, INT J PHARM, V278, P361, DOI 10.1016/j.ijpharm.2004.03.029
   Soo PL, 2005, MOL PHARMACEUT, V2, P519, DOI 10.1021/mp050049h
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Thurmond KB, 1999, COLLOID SURFACE B, V16, P45, DOI 10.1016/S0927-7765(99)00060-0
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   WASHINGTON C, 1989, INT J PHARM, V56, P71, DOI 10.1016/0378-5173(89)90062-8
   WASHINGTON C, 1990, INT J PHARM, V58, P1, DOI 10.1016/0378-5173(90)90280-H
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Wu ZJ, 2005, J CONTROL RELEASE, V104, P497, DOI 10.1016/j.jconrel.2005.02.023
   Yang PD, 1998, NATURE, V396, P152
   Yokoyama M, 1998, BIORELATED POLYM GEL, P193
   Yokoyama Y, 1996, J Cardiol, V27, P121
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 44
TC 212
Z9 217
U1 3
U2 176
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 17
PY 2006
VL 128
IS 19
BP 6447
EP 6453
DI 10.1021/ja060367p
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 043HF
UT WOS:000237590400048
PM 16683810
DA 2018-10-20
ER

PT J
AU Tsai, BH
   Lin, CH
   Lin, JC
AF Tsai, BH
   Lin, CH
   Lin, JC
TI Synthesis and property evaluations of photocrosslinkable chitosan
   derivative and its photocopolymerization with poly(ethylene glycol)
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; poly(ethylene glycol); photocopolymerization; crosslinking;
   water affinity
ID CHEMICAL-MODIFICATIONS; NMR CHARACTERIZATION; CROSS-LINKING; HYDROGEL;
   DIACRYLATE; NETWORK; POLYSACCHARIDE; PHTHALOYLATION; ADHESIVE
AB Photocrosslinkable polymers are clean and convenient materials for the biomedical uses. Chitosan which owns excellent biocompatible and antimicrobial properties, is one of the choices while it is introduced with photosensitive functional groups. In this Study, chitosan was N-phthaloylated to react with acryloyl chloride in the organic solvent homogeneously and the result has been verified by the Solubility test. Fourier transformed infrared spectrometry and nuclear magnetic resonance spectrometer analysis indicated that the modification with the attachment of the photosensitive functional group, the acryloyl group, onto chitosan and poly(ethylene glycol) (PEG) was feasible. The differential scanning calorimetry analysis further indicated that the melting points of the N-phathaloylated chitosan were decreased as compared with the untreated chitosan control. Then photocrosslinkable chitosan derivative (CH-PAA) was photocopolymerized with PEG diacrylate (PEGA) under UV irradiation. The adhesion strength characterization and swelling capacity evaluation for this photocopolymer have shown obvious raises of the adhesiveness and water-adsorption abilities as compared with the photopolymer of CH-PAA. (c) 2006 Wiley Periodicals, Inc.
C1 Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan.
EM jclin@mail.ncku.edu.tw
RI Lin, Jui-Che/C-8230-2012
OI Lin, Jui-Che/0000-0003-4436-655X
CR Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   De Angelis AA, 1998, MACROMOLECULES, V31, P1595, DOI 10.1021/ma971619x
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   DUST JM, 1990, MACROMOLECULES, V23, P3742, DOI 10.1021/ma00218a005
   Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jameela SR, 2002, J APPL POLYM SCI, V86, P1873, DOI 10.1002/app.11112
   Kim SH, 1999, CARBOHYD POLYM, V40, P183, DOI 10.1016/S0144-8617(99)00053-3
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Lee SJ, 2000, CARBOHYD POLYM, V41, P197, DOI 10.1016/S0144-8617(99)00088-0
   Liu L, 2004, CARBOHYD POLYM, V57, P97, DOI 10.1016/j.carbpol.2004.04.009
   Mao C, 2004, MAT SCI ENG C-BIO S, V24, P479, DOI 10.1016/j.msec.2003.09.168
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SILVERSTEIN RM, 1998, SPECTROMETRIC IDENTI, P84
   SILVERSTEIN RM, 1998, SPECTROMETRIC IDENTI, P228
   Smeds KA, 1999, J MACROMOL SCI PURE, VA36, P981, DOI 10.1081/MA-100101577
   Wang JW, 2003, J MATER SCI-MATER M, V14, P1079, DOI 10.1023/B:JMSM.0000004005.52762.ea
   Wang T, 2001, SEED SCI RES, V11, P93, DOI 10.1079/SSR200063
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Zhang J, 2003, J APPL POLYM SCI, V90, P1851, DOI 10.1002/app.12844
NR 25
TC 9
Z9 10
U1 1
U2 23
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 5
PY 2006
VL 100
IS 3
BP 1794
EP 1801
DI 10.1002/app.23074
PG 8
WC Polymer Science
SC Polymer Science
GA 023TY
UT WOS:000236150300014
DA 2018-10-20
ER

PT J
AU Gutierrez, MC
   Jobbagy, M
   Rapun, N
   Ferrer, ML
   del Monte, F
AF Gutierrez, MC
   Jobbagy, M
   Rapun, N
   Ferrer, ML
   del Monte, F
TI A biocompatible bottom-up route for the preparation of hierarchical
   biohybrid materials
SO ADVANCED MATERIALS
LA English
DT Article
ID PIG-LIVER ESTERASE; MESOPOROUS MATERIALS; FUNCTIONAL EXPRESSION;
   POLY(VINYL ALCOHOL); NANOPARTICLES; SILICA; MEMBRANES; LIQUID; SOL;
   TEMPLATE
AB Ice-segregation-induced self-assembly is a versatile and biocompatible process that facilitates the preparation of hierarchical biohybrid materials exhibiting a very sophisticated structure with up to six levels of space organization: the ternary structure of esterase, the PVA domains surrounding esterase, the silica cages entrapping the PVA domains, and the macroporous structure resulting from ice segregation (see figure). The resulting materials are attractive for biomedical and sensor applications.
C1 CSIC, Spanish Res Council, Inst Mat Sci Madrid, E-28049 Madrid, Spain.
RP Ferrer, ML (reprint author), CSIC, Spanish Res Council, Inst Mat Sci Madrid, E-28049 Madrid, Spain.
EM mferrer@icmm.csic.es
RI del Monte, Francisco/A-5643-2011; Gutierrez, Maria/B-5386-2013; Ferrer,
   Maria Luisa/C-5463-2011
OI del Monte, Francisco/0000-0002-2868-0023; Gutierrez,
   Maria/0000-0001-8612-7974; Ferrer, Maria Luisa/0000-0003-2284-8259;
   Jobbagy, Matias/0000-0002-6860-341X
CR Bencharit S, 2002, NAT STRUCT BIOL, V9, P337, DOI 10.1038/nsb790
   Bencharit S, 2003, CHEM BIOL, V10, P341, DOI 10.1016/S1074-5521(03)00071-1
   Caruso RA, 2002, ADV FUNCT MATER, V12, P307, DOI 10.1002/1616-3028(20020418)12:4<307::AID-ADFM307>3.0.CO;2-9
   Chen FE, 2005, ADV SYNTH CATAL, V347, P549, DOI 10.1002/adsc.200404311
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Ferrer ML, 2002, CHEM MATER, V14, P3619, DOI 10.1021/cm025562r
   Goltner CG, 1997, ADV MATER, V9, P431, DOI 10.1002/adma.19970090516
   Groenewolt M, 2005, ADV MATER, V17, P1158, DOI 10.1002/adma.200401549
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lange S, 2001, CHEMBIOCHEM, V2, P576, DOI 10.1002/1439-7633(20010803)2:7/8<576::AID-CBIC576>3.3.CO;2-P
   Lawn B.R., 1993, FRACTURE BRITTLE SOL
   Ma D, 2004, ADV MATER, V16, P1838, DOI 10.1002/adma.200400351
   MCANN JT, 2006, J AM CHEM SOC, V128, P1436
   Mukai SR, 2004, CHEM COMMUN, P874, DOI 10.1039/b316597c
   Musidlowska-Persson A, 2003, PROTEIN ENG, V16, P1139, DOI 10.1093/protein/gzg120
   NIZNANSKY D, 1995, J NON-CRYST SOLIDS, V180, P191, DOI 10.1016/0022-3093(94)00484-6
   Reetz MT, 1996, BIOTECHNOL BIOENG, V49, P527, DOI 10.1002/(SICI)1097-0290(19960305)49:5<527::AID-BIT5>3.0.CO;2-L
   Rhodes KH, 2000, CHEM MATER, V12, P2832, DOI 10.1021/cm000438y
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Sen T, 2003, ANGEW CHEM INT EDIT, V42, P4649, DOI 10.1002/anie.200351479
   Soler-illia GJD, 2002, CHEM REV, V102, P4093, DOI 10.1021/cr0200062
   Sukumaran J, 2005, ENZYME MICROB TECH, V37, P254, DOI 10.1016/j.enzmictec.2005.03.014
   TOONE EJ, 1990, J AM CHEM SOC, V112, P4946, DOI 10.1021/ja00168a047
   Uragami T, 2002, MACROMOLECULES, V35, P9156, DOI 10.1021/ma020850u
   Villaescusa LA, 2005, J PHYS CHEM B, V109, P19643, DOI 10.1021/jp053511m
   Wang DY, 2001, CHEM MATER, V13, P364, DOI 10.1021/cm001184j
   Yu AM, 2005, CHEM MATER, V17, P171, DOI 10.1021/cm048659h
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
   Zhang JG, 2004, J AM CHEM SOC, V126, P7908, DOI 10.1021/ja031523k
   Zhou Y, 2003, ADV MATER, V15, P1452, DOI 10.1002/adma.200305265
NR 31
TC 82
Z9 83
U1 2
U2 48
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD MAY 2
PY 2006
VL 18
IS 9
BP 1137
EP +
DI 10.1002/adma.200502550
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 043YX
UT WOS:000237640200004
DA 2018-10-20
ER

PT J
AU Andrianov, AK
   Marin, A
AF Andrianov, AK
   Marin, A
TI Degradation of polyaminophosphazenes: Effects of hydrolytic environment
   and polymer processing
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED-RELEASE; POLYPHOSPHAZENES; ESTER)PHOSPHAZENES>; DELIVERY
AB Polyphosphazenes with amino acid ester side groups show potential as hydrolytically degradable materials for biomedical applications. This study focuses on practical aspects of their use as biodegradable materials, such as effects of the hydrolytic environment and sample processing. Poly[di(ethyl glycinato)phosphazene], PEGP, and poly[ di(ethyl alaninato) phosphazene], PEAP, were prepared by macromolecular substitution reaction, ensuring the absence of the residual chlorine atoms to avoid their influence on the hydrolysis. The kinetics of polymer degradation was studied by simultaneously measuring polymer mass loss, molecular weight decrease, and the release of phosphates and ammonia. The effect of pH, buffer composition, temperature, casting solvents, and film thickness were investigated.
C1 Parallel Solut Inc, Cambridge, MA 02138 USA.
RP Andrianov, AK (reprint author), Parallel Solut Inc, 763D Concord Ave, Cambridge, MA 02138 USA.
EM aandrianov@parallelsolutionsinc.com
RI Andrianov, Alexander/Q-1205-2017
OI Andrianov, Alexander/0000-0001-6186-6156
CR Allcock H.R., 2003, CHEM APPL POLYPHOSPH
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P563, DOI 10.1016/0142-9612(94)90205-4
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P1071, DOI 10.1021/ma00083a001
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Andrianov AK, 2006, BIOMACROMOLECULES, V7, P394, DOI 10.1021/bm050790a
   Andrianov AK, 2005, MACROMOLECULES, V38, P7972, DOI 10.1021/ma0509309
   Andrianov AK, 2004, BIOMACROMOLECULES, V5, P1999, DOI 10.1021/bm049745d
   Andrianov AK, 2004, MACROMOLECULES, V37, P414, DOI 10.1021/ma0355655
   ANDRIANOV AK, 1993, J CONTROL RELEASE, V27, P69, DOI 10.1016/0168-3659(93)90058-D
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   Cui YJ, 2004, BIOMATERIALS, V25, P451, DOI 10.1016/S0142-9612(03)00532-5
   Edlund U, 2003, ADV DRUG DELIVER REV, V55, P585, DOI 10.1016/S0169-409X(03)00036-X
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Heller J, 2004, BIOMACROMOLECULES, V5, P1625, DOI 10.1021/bm040049n
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LEONARD RH, 1963, CLIN CHEM, V9, P417
   Luten J, 2003, J CONTROL RELEASE, V89, P483, DOI 10.1016/S0168-3659(03)00127-5
   Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [10.1016/S0003-2670(00)88444-5, DOI 10.1016/S0003-2670(00)88444-5]
   Nair LS, 2006, J BIOMED MATER RES A, V76A, P206, DOI 10.1002/jbm.a.30532
   RUIZ EM, 1993, BIOMATERIALS, V14, P491, DOI 10.1016/0142-9612(93)90235-T
   Veronese FM, 1999, BIOMATERIALS, V20, P91, DOI 10.1016/S0142-9612(97)00104-X
NR 23
TC 34
Z9 35
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2006
VL 7
IS 5
BP 1581
EP 1586
DI 10.1021/bm050959k
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 043IE
UT WOS:000237593600027
PM 16677042
DA 2018-10-20
ER

PT J
AU Knackstedt, MA
   Arns, CH
   Senden, TJ
   Gross, K
AF Knackstedt, MA
   Arns, CH
   Senden, TJ
   Gross, K
TI Structure and properties of clinical coralline implants measured via 3D
   imaging and analysis
SO BIOMATERIALS
LA English
DT Article
DE microtomography; scaffolds; pore morphology; diffusivity; fluid
   dynamics; elasticity
ID MICRO-COMPUTED-TOMOGRAPHY; LINEAR ELASTIC PROPERTIES; BONE-GRAFT
   SUBSTITUTE; MICROTOMOGRAPHIC IMAGES; POROUS HYDROXYAPATITE; RESORPTION;
   AUGMENTATION; SIMULATION; SANDSTONE; SCAFFOLDS
AB The development and design of advanced porous materials for biomedical applications requires a thorough understanding of how material structure impacts on mechanical and transport properties. This paper illustrates a 3D imaging and analysis study of two clinically proven coral bone graft samples (Porites and Goniopora). Images are obtained from X-ray micro-computed tomography (micro-CT) at a resolution of 16.8 mu m. A visual comparison of the two images shows very different structure; Porites has a homogeneous structure and consistent pore size while Goniopora has a bimodal pore size and a strongly disordered structure. A number of 3D structural characteristics are measured directly on the images including pore volume-to-surface-area, pore and solid size distributions, chord length measurements and tortuosity. Computational results made directly on the digitized tomographic images are presented for the permeability, diffusivity and elastic modulus of the coral samples. The results allow one to quantify differences between the two samples. 3D digital analysis can provide a more thorough assessment of biomaterial structure including the pore wall thickness, local flow, mechanical properties and diffusion pathways. We discuss the implications of these results to the development of optimal scaffold design for tissue ingrowth. (c) 2005 Published by Elsevier Ltd.
C1 Australian Natl Univ, Dept Appl Math, RSPhysSE, Canberra, ACT 0200, Australia.
   Univ Melbourne, Dept Mech & Mfg Engn, Parkville, Vic 3052, Australia.
RP Knackstedt, MA (reprint author), Australian Natl Univ, Dept Appl Math, RSPhysSE, Canberra, ACT 0200, Australia.
EM mark.knackstedt@anu.edu.au
RI Senden, Tim/A-7319-2008; Arns, Christoph/A-5036-2009; Gross,
   Karlis/G-2793-2010
OI Senden, Tim/0000-0001-6808-7219; Arns, Christoph/0000-0003-1721-3996; 
CR Arns CH, 2004, J PETROL SCI ENG, V45, P41, DOI 10.1016/j.petrol.2004.05.001
   Arns CH, 2002, GEOPHYSICS, V67, P1396, DOI 10.1190/1.1512785
   Arns CH, 2001, GEOPHYS RES LETT, V28, P3361, DOI 10.1029/2001GL012987
   ARNS CH, 2001, PHYS REV E, V63
   Auzerais FM, 1996, GEOPHYS RES LETT, V23, P705, DOI 10.1029/96GL00776
   BIERI H, 1984, COMPUT VISION GRAPH, V28, P166, DOI 10.1016/S0734-189X(84)80019-5
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   CARTMELL S, J BIOMED MAT RES, V69, P97
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Coles ME, 1998, SPE RESERV EVAL ENG, V1, P288, DOI 10.2118/50985-PA
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   Dagli AS, 1997, EUR ARCH OTO-RHINO-L, V254, P274, DOI 10.1007/BF02905986
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   DULLIEN FAL, 1992, POROUS MEDIA FLUID T
   Elsinger E C, 1996, J Foot Ankle Surg, V35, P396
   FERREOL B, 1995, TRANSPORT POROUS MED, V20, P3, DOI 10.1007/BF00616923
   Fricain JC, 1996, J PERIODONTAL RES, V31, P463, DOI 10.1111/j.1600-0765.1996.tb01410.x
   GARBOCZI EJ, 1995, J MECH PHYS SOLIDS, V43, P1349, DOI 10.1016/0022-5096(95)00050-S
   GARBOCZI EJ, 1998, 6269 NIST, pCH2
   GEORGE B, 1989, NEUROCHIRURGIE, V35, P145
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   Hilpert M, 2001, ADV WATER RESOUR, V24, P243, DOI 10.1016/S0309-1708(00)00056-7
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Jones AC, 2004, J MATER SCI-MATER M, V15, P529, DOI 10.1023/B:JMSM.0000021133.48661.62
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   KIECHEL SF, 1977, SURG GYNECOL OBSTET, V144, P58
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Layoun W, 2003, AESTHET PLAST SURG, V27, P269, DOI 10.1007/s00266-003-2129-8
   Martys N. S., 1999, SPIE, V309, P205
   Martys NS, 1996, PHYS REV E, V53, P743, DOI 10.1103/PhysRevE.53.743
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   MAVKO G, 1998, ROCK PHSY HDB
   MCNAB A, 1995, AUST NZ J OPHTHALMOL, V23, P117, DOI 10.1111/j.1442-9071.1995.tb00139.x
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   OKARINEN KS, 2003, DENTAL TRAUMATOL, V19, P19
   Qian YH, 1998, EUROPHYS LETT, V42, P359, DOI 10.1209/epl/i1998-00255-3
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055
   SAKELLARIOU A, 2004, P SOC PHOTO-OPT INS, V5535, P166
   Sheppard AP, 2004, PHYSICA A, V339, P145, DOI 10.1016/j.physa.2004.03.057
   Shors C, 1993, INTRO BIOCERAMICS, P181
   TENCER AF, 1990, HDB BIOACTIVE CERAMI, V2, P209
   THOVERT JF, 2001, PHYS REV E, V63, P61307
   VELICH N, 2004, J CRANIOFAC SURG, V151, P38
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
   Wolfe SW, 1999, J HAND SURG-AM, V24A, P816, DOI 10.1053/jhsu.1999.0816
   ZDEBLICK TA, 1994, SPINE, V19, P2348, DOI 10.1097/00007632-199410150-00017
NR 50
TC 43
Z9 49
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2006
VL 27
IS 13
BP 2776
EP 2786
DI 10.1016/j.biomaterials.2005.12.016
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 019UQ
UT WOS:000235862600015
PM 16423388
DA 2018-10-20
ER

PT J
AU Arias, FJ
   Reboto, V
   Martin, S
   Lopez, I
   Rodriguez-Cabello, JC
AF Arias, F. Javier
   Reboto, Virginia
   Martin, Susana
   Lopez, Isabel
   Rodriguez-Cabello, J. Carlos
TI Tailored recombinant elastin-like polymers for advanced biomedical and
   nano(bio)technological applications
SO BIOTECHNOLOGY LETTERS
LA English
DT Article; Proceedings Paper
CT 4th Conference on Textile Quality and Biotechnology
CY FEB 20-23, 2005
CL Gran Canaria, SPAIN
SP European Union COST Act 847
DE elastin-like polymers; genetic engineering; nanobiotechnology;
   protein-based polymers; smart polymers; tissue engineering
ID EXTRACELLULAR-MATRIX PROTEINS; CELL; ADHESION; DESIGN; BIOMATERIALS;
   SEQUENCES; BEHAVIOR; DOMAINS
AB The genetic engineering of protein-based polymers is a method that enables, in an easy way, the design of complex and highly functional macromolecules. As examples of this approach, different molecular designs are presented, with increasing degree of complexity, showing how the controlled increase in their complexity yields (multi)functional materials with more selected and sophisticated properties. The simplest designs show interesting properties already, but the adequate introduction of given chemical functions along the polymer chain provides an opportunity to expand the range of properties to enhanced smart behavior and self-assembly. Finally, examples are given where those molecular designs further incorporate selected bioactivities in order to develop materials for the most cutting edge applications in biomedicine and nano(bio)technology.
C1 Univ Valladolid, ETSII, Dept Fis Mat Condensada, BIOFORGE Res Grp, E-47011 Valladolid, Spain.
RP Rodriguez-Cabello, JC (reprint author), Univ Valladolid, ETSII, Dept Fis Mat Condensada, BIOFORGE Res Grp, Paseo Cauce S-N, E-47011 Valladolid, Spain.
EM cabello@bioforge.uva.es
RI Arias, Francisco Javier/A-2640-2012; Rodriguez-Cabello, Jose
   Carlos/G-6555-2017
OI Arias, Francisco Javier/0000-0001-8584-3768; Rodriguez-Cabello, Jose
   Carlos/0000-0002-3438-858X
CR Alix Alain J. P., 2001, Journal de la Societe de Biologie, V195, P181
   Alonso M, 2001, MACROMOLECULES, V34, P8072, DOI 10.1021/ma010455o
   Alonso M, 2000, MACROMOLECULES, V33, P9480, DOI 10.1021/ma001348h
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Flamia R, 2004, BIOMACROMOLECULES, V5, P1511, DOI 10.1021/bm049930r
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Girotti A, 2004, MACROMOLECULES, V37, P3396, DOI 10.1021/ma035603k
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Martino M, 2002, MACROMOL BIOSCI, V2, P319, DOI 10.1002/1616-5195(200209)2:7<319::AID-MABI319>3.0.CO;2-L
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Nicol A., 1994, BIOTECHNOLOGY BIOACT
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Reguera J, 2004, J AM CHEM SOC, V126, P13212, DOI 10.1021/ja047417f
   Richman GP, 2005, J CONTROL RELEASE, V101, P3, DOI 10.1016/j.jconrel.2004.07.034
   Rodriguez-Cabello JC, 2002, ADV MATER, V14, P1151, DOI 10.1002/1521-4095(20020816)14:16<1151::AID-ADMA1151>3.0.CO;2-Y
   Rodriguez-Cabello JC, 2005, PROG POLYM SCI, V30, P1119, DOI 10.1016/j.progpolymsci.2005.07.004
   Rodriguez-Cabello JC, 2000, BIOPOLYMERS, V54, P282, DOI 10.1002/1097-0282(20001005)54:4<282::AID-BIP50>3.0.CO;2-F
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Urry D. W., 1990, POLYM MAT SCI ENG, V63, P329
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 2005, SUSTAINS LIFE CONSIL
   Urry DW, 1993, BIOTECHNOLOGICAL POL, P82
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
NR 28
TC 40
Z9 40
U1 2
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2006
VL 28
IS 10
BP 687
EP 695
DI 10.1007/s10529-006-9045-3
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 056BT
UT WOS:000238496700003
PM 16791722
DA 2018-10-20
ER

PT J
AU Grubek-Jaworska, H
   Nejman, P
   Czuminska, K
   Przybylowski, T
   Huczko, A
   Lange, H
   Bystrzejewski, M
   Baranowski, P
   Chazan, R
AF Grubek-Jaworska, H
   Nejman, P
   Czuminska, K
   Przybylowski, T
   Huczko, A
   Lange, H
   Bystrzejewski, M
   Baranowski, P
   Chazan, R
TI Preliminary results on the pathogenic effects of intratracheal exposure
   to one-dimensional nanocarbons
SO CARBON
LA English
DT Article
DE carbon nanotubes; chemical vapor deposition; electron microscopy;
   bioactivity
ID CARBON NANOTUBE MATERIAL; PULMONARY TOXICITY; NANOTECHNOLOGY
AB Because of the unique structural, mechanical, and electrical properties, 1-D (one-dimensional) carbon nanotubes and nanofibers have been studied For possible use in many fields from Molecular electronics to biomedical applications for several years. The 1-D carbon nanomaterials are produced presently on large scale. The inhalation of ultrafine nanocarbons can cause inflammatory lung response. The pathogenicity of 1-D carbon nanostructure remains, however, unclear.
   We examined in vivo the effects of intratracheal instillation of 1-D carbon nanomaterials (NanoLab nanotubes, Pyrograf and Showa Denko nanofibers) vs. control (pure suspension fluid) on lung tissue in guinea pig model.
   Three months intratracheal exposure to 1-D nanocarbons caused organizing pneumonitis (Bronchiolitis obliterans organizing pneumonia) with focal non-specific desquamative interstitial prieumonia-like ("DIP-like") reaction without fibrosis or with mild peribronchiolar fibrosis in all experimental animals but not in controls. Infiltration of inflammatory cells and increase of IL-8 concentration in BAL-fluid depended on the nanomaterial used. The protein concentration in BAL-fluids in experimental animals did not differ significantly in comparison to the control group, although exudate to alveoli was observed in all the experimental groups histopathologically.
   Our results indicate that exposure on intratracheally introduced carbon nanotubes/nanofibers may induce measurable pulmonary pathology. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Warsaw Univ, Dept Chem, PL-02093 Warsaw, Poland.
   Med Univ Warsaw, Dept Pneumol, PL-02091 Warsaw, Poland.
   Agr Univ Warsaw, Fac Vet Med, PL-02787 Warsaw, Poland.
RP Huczko, A (reprint author), Warsaw Univ, Dept Chem, PL-02093 Warsaw, Poland.
EM ahuczko@chenl.uw.edu.pl
RI Nejman-Gryz, Patrycja/M-4345-2018
OI Nejman-Gryz, Patrycja/0000-0002-2101-5397; Huczko,
   Andrzej/0000-0003-3688-1121
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Cai H, 2003, ANAL BIOANAL CHEM, V375, P287, DOI 10.1007/s00216-002-1652-9
   COLBERT DT, 2001, PERSPECTIVES FULLERE, P3
   Dreher KL, 2004, TOXICOL SCI, V77, P3, DOI 10.1093/toxsci/kfh041
   Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502
   Kamp DW, 1999, THORAX, V54, P638, DOI 10.1136/thx.54.7.638
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   LIPPMANN M, 1994, ANN OCCUP HYG, V38, P459, DOI 10.1093/annhyg/38.4.459
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   Oberdorster G, 2002, INHAL TOXICOL, V14, P29, DOI 10.1080/089583701753338622
   Oberdorster G, 2000, INT ARCH OCC ENV HEA, V73, pS60, DOI 10.1007/PL00014628
   REICH S, 1999, CARBON NANOTUBES, P3
   Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848
   Service RF, 2003, SCIENCE, V300, P243
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Upadhyay D, 2003, EXP BIOL MED, V228, P650
   URNAU L, 1996, ASSOCIATES CARRY RES, P6
   Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a
   Wong SS, 1998, NATURE, V394, P52
   WRIGHT JL, 1986, EXP LUNG RES, V11, P307, DOI 10.3109/01902148609062832
NR 22
TC 37
Z9 42
U1 3
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
J9 CARBON
JI Carbon
PD MAY
PY 2006
VL 44
IS 6
BP 1057
EP 1063
DI 10.1016/j.carbon.2005.12.011
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 031DH
UT WOS:000236683800005
DA 2018-10-20
ER

PT J
AU Li, KM
   Rivory, LP
   Clarke, SJ
AF Li, Kong M.
   Rivory, Laurent P.
   Clarke, Stephen J.
TI Solid-phase extraction (SPE) techniques for sample preparation in
   clinical and pharmaceutical analysis: A brief overview
SO CURRENT PHARMACEUTICAL ANALYSIS
LA English
DT Review
ID TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHIC DETERMINATION;
   RESTRICTED-ACCESS MATERIAL; SULFOACYLATED POLY(STYRENE-DIVINYLBENZENE)
   COPOLYMERS; INHIBITOR ATAZANAVIR BMS-232632; MOLECULARLY IMPRINTED
   POLYMERS; PEDIATRIC PLASMA SAMPLES; LC-MS-MS; GAS-CHROMATOGRAPHY;
   QUANTITATIVE-DETERMINATION
AB Quantitation of low concentration of drugs, metabolites and endogenous compounds in plasma has always been a difficulty and challenge task for analytical chemists in biomedical and pharmaceutical analysis. It often requires extracting and concentrating the analytes in the samples for quantitative analysis. Extraction from the plasma matrix potentially enables the simultaneous removal of endogenous interfering substances and the enrichment of the analytes. However, extraction procedures are frequently, the most time consuming steps of the analytical process. Lack of robustness of the extraction procedure is a common problem leading to the invalidation of entire analytic runs. Solid-Phase Extraction (SPE) is a powerful sample preparation technique currently available for rapid clean-up and enrichment of sample analytes preceding chromatographic analysis. Compared to traditional liquid-liquid extraction (LLE), SPE provides major advantages in terms of simplicity, high throughput, robustness, and in most cases, greater cost effectiveness. A wide range of SPE resin chemistries is now available for various applications. The sampling format has also extended from simple packed disposable syringes to cartridges, disks, SPE pipette tips, 96-well and 384-well microplates. Therefore, SPE sample preparation techniques provide improved assay standardisation and hence better reproducibility. The objective of this article was to review literatures regarding SPE extraction theory, extraction modes and its application in clinical and pharmaceutical analysis. Updated information about the most important features of the SPE materials and the future trends in SPE sample preparation are also discussed.
C1 Univ Sydney, Inst Biomed Res, Sch Med Sci, Fac Med,Dept Pharmacol, Sydney, NSW 2006, Australia.
   Johnson & Johnson Res Pty Ltd, Strawberry Hills, NSW 2012, Australia.
   Concord Hosp, Dept Med, Concord, NSW 2137, Australia.
RP Li, KM (reprint author), Univ Sydney, Inst Biomed Res, Sch Med Sci, Fac Med,Dept Pharmacol, Sydney, NSW 2006, Australia.
EM kmli@mail.usyd.edu.au
OI Rivory, Laurent/0000-0002-1734-7882
CR AbuRuz S, 2003, J CHROMATOGR B, V798, P193, DOI 10.1016/j.chromb.2003.09.044
   Andersson LI, 2000, ANALYST, V125, P1515, DOI 10.1039/b005386o
   ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019
   Beike J, 2004, INT J LEGAL MED, V118, P289, DOI 10.1007/s00414-004-0463-2
   Bereczki A, 2001, J CHROMATOGR A, V930, P31, DOI 10.1016/S0021-9673(01)01190-6
   Berggren C, 2000, J CHROMATOGR A, V889, P105, DOI 10.1016/S0021-9673(00)00424-6
   Boone CM, 2001, FORENSIC SCI INT, V121, P89, DOI 10.1016/S0379-0738(01)00457-1
   Calderoli S, 2003, J PHARMACEUT BIOMED, V32, P601, DOI 10.1016/S0731-7085(03)00167-5
   Chassaing C, 2004, J CHROMATOGR B, V804, P71, DOI 10.1016/j.jchromb.2003.12.011
   CHEN J, 1995, ANAL CHEM, V67, P2530, DOI 10.1021/ac00111a006
   Chiap P, 2002, J CHROMATOGR A, V975, P145, DOI 10.1016/S0021-9673(02)01334-1
   Cooper GAA, 1998, J ANAL TOXICOL, V22, P389, DOI 10.1093/jat/22.5.389
   Dumasia MC, 2003, XENOBIOTICA, V33, P1013, DOI 10.1080/00498250310001602766
   Fan Y, 2005, TALANTA, V65, P111, DOI 10.1016/j.talanta.2004.05.040
   Fan Y, 2004, ANALYST, V129, P1065, DOI 10.1039/b410785c
   Fang J, 2004, J CHROMATOGR B, V809, P9, DOI 10.1016/j.jchromb.2004.05.029
   Fernandez M, 2003, J CHROMATOGR B, V791, P357, DOI 10.1016/S1570-0232(03)00252-6
   Fontanals N, 2004, J CHROMATOGR A, V1030, P63, DOI 10.1016/j.chroma.2003.10.076
   Fontanals N, 2004, J CHROMATOGR A, V1035, P281, DOI 10.1016/j.chroma.2004.02.049
   Fu I, 2004, J PHARMACEUT BIOMED, V35, P837, DOI 10.1016/j.jpba.2004.02.016
   Fucci N, 2003, FORENSIC SCI INT, V134, P40, DOI 10.1016/S0379-0738(03)00098-7
   Gentili S, 2004, J CHROMATOGR B, V801, P289, DOI 10.1016/j.jchromb.2003.11.034
   Guermouche S, 2004, J CHROMATOGR SCI, V42, P250, DOI 10.1093/chromsci/42.5.250
   Hare LG, 2004, J CHROMATOGR B, V806, P263, DOI 10.1016/j.jchromb.2004.04.007
   He H, 2005, J CHROMATOGR B, V814, P385, DOI 10.1016/j.jchromb.2004.10.048
   Hendrickson HP, 2005, J MASS SPECTROM, V40, P19, DOI 10.1002/jms.766
   Hennion MC, 1999, J CHROMATOGR A, V856, P3, DOI 10.1016/S0021-9673(99)00832-8
   Huang ZP, 2003, J CHROMATOGR B, V792, P241, DOI 10.1016/S1570-0232(03)00269-1
   HUIZING MT, 1995, J CHROMATOGR B, V664, P373, DOI 10.1016/0378-4347(94)00477-M
   Huq S, 2005, J CHROMATOGR A, V1073, P355, DOI 10.1016/j.chroma.2004.10.052
   Iwai M, 2004, J CHROMATOGR B, V806, P65, DOI 10.1016/j.jchromb.2004.03.016
   Jemal M, 2003, J CHROMATOGR B, V795, P273, DOI 10.1016/S1570-0232(03)00589-0
   Jemal M, 1999, J CHROMATOGR B, V732, P501, DOI 10.1016/S0378-4347(99)00323-0
   Jenkins KM, 2004, J ANAL TOXICOL, V28, P50, DOI 10.1093/jat/28.1.50
   Kataoka H, 1999, J CHROMATOGR B, V731, P353, DOI 10.1016/S0378-4347(99)00237-6
   Kataoka H, 2000, J ANAL TOXICOL, V24, P257, DOI 10.1093/jat/24.4.257
   Kim HY, 2004, J PHARMACEUT BIOMED, V34, P661, DOI 10.1016/j.jpba.2003.11.003
   Klingenberg A, 2002, J CHROMATOGR A, V946, P91, DOI 10.1016/S0021-9673(01)01538-2
   Lachenmeier DW, 2003, RAPID COMMUN MASS SP, V17, P472, DOI 10.1002/rcm.945
   Leon-Gonzalez ME, 2000, J CHROMATOGR A, V902, P3, DOI 10.1016/S0021-9673(00)00942-0
   Li KM, 2004, J CHROMATOGR B, V804, P319, DOI 10.1016/j.jchromb.2004.01.034
   Li KM, 2003, ANAL CHIM ACTA, V486, P51, DOI 10.1016/S0003-2670(03)00463-X
   Lindenblatt H, 1998, J CHROMATOGR B, V709, P255, DOI 10.1016/S0378-4347(98)00067-X
   Majors RE, 2002, LC GC N AM, V20, P1098
   Mandrioli R, 2003, J CHROMATOGR B, V783, P253, DOI 10.1016/S1570-0232(02)00664-5
   Masque N, 1997, ANALYST, V122, P425, DOI 10.1039/a607504e
   Masque N, 1997, J CHROMATOGR A, V771, P55, DOI 10.1016/S0021-9673(97)00125-8
   Mazuel C, 2003, J PHARMACEUT BIOMED, V33, P1093, DOI 10.1016/S0731-7085(03)00434-5
   Millership JS, 2001, J PHARMACEUT BIOMED, V25, P871, DOI 10.1016/S0731-7085(01)00367-3
   Muller C, 2002, J CHROMATOGR B, V773, P47, DOI 10.1016/S1570-0232(02)00142-3
   Mullett WM, 2002, J CHROMATOGR A, V963, P325, DOI 10.1016/S0021-9673(02)00216-9
   Mullett WM, 1999, J PHARMACEUT BIOMED, V21, P835, DOI 10.1016/S0731-7085(99)00220-4
   Padua AAF, 2004, J CHROMATOGR B, V809, P211, DOI 10.1016/j.jchromb.2004.06.021
   Peters FT, 2003, J MASS SPECTROM, V38, P659, DOI 10.1002/jms.483
   Pirogov AV, 2003, ANAL BIOANAL CHEM, V376, P745, DOI 10.1007/s00216-003-1953-7
   Pocurull E, 1996, J CHROMATOGR A, V755, P67, DOI 10.1016/S0021-9673(96)00574-2
   Qi S, 2005, J CHROMATOGR B, V814, P105, DOI 10.1016/j.jchromb.2004.10.009
   Rbeida O, 2004, J CHROMATOGR A, V1030, P95, DOI 10.1016/j.chroma.2003.11.031
   Rbeida O, 2003, J PHARMACEUT BIOMED, V32, P829, DOI 10.1016/S0731-7085(03)00186-9
   Saleh MI, 2000, ANALYST, V125, P1569, DOI 10.1039/b000010h
   Schuster A, 2003, J CHROMATOGR B, V788, P377, DOI 10.1016/S1570-0232(03)00063-1
   SELLERGREN B, 1994, ANAL CHEM, V66, P1578, DOI 10.1021/ac00081a036
   Shi G, 2003, J PHARMACEUT BIOMED, V31, P937, DOI 10.1016/S0731-7085(02)00675-1
   Smeds A, 2003, J CHROMATOGR B, V793, P297, DOI 10.1016/S1570-0232(03)00330-1
   Snow NH, 2000, J CHROMATOGR A, V885, P445, DOI 10.1016/S0021-9673(00)00192-8
   Svennberg H, 2003, J CHROMATOGR B, V787, P231, DOI 10.1016/S1570-0232(02)00317-3
   Telepchak M. J., 2004, FORENSIC CLIN APPL S
   Theodoridis G, 2002, J CHROMATOGR A, V948, P163, DOI 10.1016/S0021-9673(01)01457-1
   Theodoridis G, 2000, J CHROMATOGR B, V745, P49, DOI 10.1016/S0378-4347(00)00203-6
   Toennes SW, 2004, J PHARMACEUT BIOMED, V35, P169, DOI 10.1016/j.jpba.2004.01.013
   Tong XCS, 2004, J PHARMACEUT BIOMED, V35, P867, DOI 10.1016/j.jpba.2004.02.017
   Ulrich S, 2000, J CHROMATOGR A, V902, P167, DOI 10.1016/S0021-9673(00)00934-1
   Wachs T, 2003, ANAL CHEM, V75, P1769, DOI 10.1021/ac020501y
   Walles M, 2002, ANAL BIOANAL CHEM, V374, P1179, DOI 10.1007/s00216-002-1614-2
   Wang AQ, 2002, RAPID COMMUN MASS SP, V16, P975, DOI 10.1002/rcm.669
   Whittington D, 2003, J CHROMATOGR B, V796, P95, DOI 10.1016/j.jchromb.2003.08.007
   Wissiack R, 2000, J CHROMATOGR A, V896, P159, DOI 10.1016/S0021-9673(00)00730-5
   Wu JC, 2000, ANALYST, V125, P2216, DOI 10.1039/b006211l
   Xia YQ, 2003, J CHROMATOGR B, V788, P317, DOI 10.1016/S1570-0232(03)00036-9
   Yang LY, 2004, J CHROMATOGR B, V809, P75, DOI 10.1016/j.jchromb.2004.06.032
   Yang LY, 2003, J CHROMATOGR B, V792, P229, DOI 10.1016/S1570-0232(03)00267-8
   Yawney J, 2002, J ANAL TOXICOL, V26, P325, DOI 10.1093/jat/26.6.325
   Zhang J, 2004, J CHROMATOGR B, V806, P167, DOI 10.1016/j.jchromb.2004.03.056
   Zoutendam PH, 2003, J PHARMACEUT BIOMED, V33, P1073, DOI 10.1016/S0731-7085(03)00362-5
NR 84
TC 30
Z9 32
U1 4
U2 71
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4129
EI 1875-676X
J9 CURR PHARM ANAL
JI Curr. Pharm. Anal.
PD MAY
PY 2006
VL 2
IS 2
BP 95
EP 102
DI 10.2174/157341206776819346
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 106JW
UT WOS:000242097800001
DA 2018-10-20
ER

PT J
AU Chiellini, F
AF Chiellini, F
TI Perspectives on: In vitro evaluation of biomedical polymers
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE biomedical polymers; biocompatibility; in vitro testing; cytotoxicity;
   cell biology; in vitro assays; biomaterial assays; polymeric
   biomaterials
ID ANTIINFLAMMATORY CYTOKINE; BIOCOMPATIBILITY; TOXICITY; BIOMATERIALS;
   INDUCTION; CULTURES; ENERGY; FORCE; MODEL
AB Recently polymeric materials have gained tremendous attention in a wide variety of applications spanning from electronics to environmental and biomedical fields. In this paper, current in vitro methods for polymers biocompatibility assessment are reviewed in combination with new concepts and techniques that appear promising for the development and improvement of in vitro methods with the purpose of reducing animal experimentation. The utilization of medical devices, for example, has always been subordinate to the assessment of their biocompatibility. This aspect, as well as the methods for evaluating biocompatibility have changed over the years as a result of new developments in cell biology that have revolutionized in vitro techniques for assaying polymeric materials for bioapplications.
C1 Univ Pisa, UdR INSTM Consortium Dept Chem & Ind Chem, I-56126 Pisa, Italy.
RP Chiellini, F (reprint author), Univ Pisa, UdR INSTM Consortium Dept Chem & Ind Chem, I-56126 Pisa, Italy.
EM federica@dcci.unipi.it
RI Chiellini, Federica/F-3233-2010
OI Chiellini, Federica/0000-0003-4680-9975
CR Albert D. E., 2002, MED DEVICE TECHNOL, V24, P50
   Albert David E, 2004, Med Device Technol, V15, P15
   Allen Matthew, 1994, Clinical Materials, V16, P189, DOI 10.1016/0267-6605(94)90116-3
   [Anonymous], 109931 ISO
   ASTM, 1983, STAND PRACT DIR CONT
   Barbucci R, 2003, J MATER SCI-MATER M, V14, P721, DOI 10.1023/A:1024919917969
   Bhogal N, 2005, TRENDS BIOTECHNOL, V23, P299, DOI 10.1016/j.tibtech.2005.04.006
   BRENDLERSCHWAAB SY, 1994, TOXICOL IN VITRO, V8, P1285, DOI 10.1016/0887-2333(94)90122-8
   Bruner LH, 1996, TOXICOL IN VITRO, V10, P479, DOI 10.1016/0887-2333(96)00028-8
   Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd.961
   Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248
   Coecke S, 1999, ATLA-ALTERN LAB ANIM, V27, P579
   DEKKER A, 1994, CELL MATER, V4, P101
   Epstein NJ, 2005, ACTA ORTHOP, V76, P412, DOI 10.1080/17453670510041321
   Ferruti P, 2005, BIOMACROMOLECULES, V6, P2229, DOI 10.1021/bm050210+
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   HARMAND MF, 1997, BIOCOMPATIBILITY A 1, P121
   Ingles D, 2003, Med Device Technol, V14, P18
   *ISO, 1994, 10993 ISO
   *ISO, 1992, BIOL COMP MED DEV 5
   Isomaki P, 1996, ARTHRITIS RHEUM, V39, P386, DOI 10.1002/art.1780390306
   IWAMOTO M, 2005, FEBS LETT, V25, P6921
   Jaffe M, 2003, THERMOCHIM ACTA, V396, P141, DOI 10.1016/S0040-6031(02)00524-5
   JOHNSON HJ, 1983, J BIOMED MATER RES, V17, P571, DOI 10.1002/jbm.820170403
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kirkpatrick C J, 1998, Med Device Technol, V9, P22
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Manso M, 2002, BIOMOL ENG, V19, P239, DOI 10.1016/S1389-0344(02)00030-8
   MIOSSEC P, 1995, CLIN EXP RHEUMATOL, V13, P13
   Owen G Rh, 2005, Eur Cell Mater, V9, P85
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Ruggiero C, 2005, CELL BIOCHEM BIOPHYS, V43, P407, DOI 10.1385/CBB:43:3:407
   Signori F, 2005, POLYMER, V46, P9642, DOI 10.1016/j.polymer.2005.07.071
   Silva GA, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P339
   *US FDA DEP HLTH H, G951 US FDA DEP HLTH
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Ward RK, 1998, TOXICOL IN VITRO, V12, P163, DOI 10.1016/S0887-2333(97)00098-2
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Wilk Sr, 2003, OPT PHOTONICS NEWS, V14, P18
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
NR 45
TC 22
Z9 23
U1 0
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2006
VL 21
IS 3
BP 257
EP 271
DI 10.1177/0883911506064672
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 038CR
UT WOS:000237196500006
DA 2018-10-20
ER

PT J
AU Fernandez, JG
   Mills, CA
   Rodriguez, R
   Gomila, G
   Samitier, J
AF Fernandez, JG
   Mills, CA
   Rodriguez, R
   Gomila, G
   Samitier, J
TI All-polymer microfluidic particle size sorter for biomedical
   applications
SO PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT International Conference on Trends in Nanotechnology
CY AUG 29-SEP 02, 2005
CL Oviedo, SPAIN
ID SENSOR
AB The design and method for the production of an all-polymer microfluidic particle sorter, for use in biomedical applications, is described. The sorter is made from biocompatible materials with properties, such as high optical transparency, that make it useful in a biological laboratory. The method of sorting is designed to be gentle on biological species, using a method of guiding the particles towards the filter, and has been successfully used to separate latex beads depending on their diameters. Preliminary qualitative experiments have been able to separate beads of 45 and 90 mu m in diameter from a mixture of the two. These dimensions are on the same scale as those of some eukaryotic cells. (c) 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
C1 CREBEC, Lab Nanobioengn, Barcelona 08028, Spain.
RP Fernandez, JG (reprint author), CREBEC, Lab Nanobioengn, Barcelona Sci Pk,Joseph Samitier 1-5, Barcelona 08028, Spain.
EM jgfernandez@pcb.ub.es
RI Mills, Christopher/C-5535-2009; Gomila, Gabriel/E-1467-2017
OI Mills, Christopher/0000-0002-2906-4978; Gomila,
   Gabriel/0000-0002-1949-1757
CR Belgrader P, 2000, BIOSENS BIOELECTRON, V14, P849, DOI 10.1016/S0956-5663(99)00060-3
   Ben-Dov N, 1999, BBA-MOL CELL RES, V1448, P372, DOI 10.1016/S0167-4889(98)00147-5
   Bessueille F, 2005, BIOSENS BIOELECTRON, V21, P908, DOI 10.1016/j.bios.2005.02.007
   Buchholz BA, 2001, ANAL CHEM, V73, P157, DOI 10.1021/ac001023z
   Cavaliere T., 2004, NEWBORN INFANT NURSI, V4, P231
   Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Figeys D, 1998, ANAL CHEM, V70, P3728, DOI 10.1021/ac980320p
   Glasgow IK, 2001, IEEE T BIO-MED ENG, V48, P570, DOI 10.1109/10.918596
   Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p
   Holmes AS, 1998, J MICROELECTROMECH S, V7, P416, DOI 10.1109/84.735350
   Kamholz AE, 1999, ANAL CHEM, V71, P5340, DOI 10.1021/ac990504j
   Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346
   Weigl BH, 1997, SENSOR ACTUAT B-CHEM, V39, P452, DOI 10.1016/S0925-4005(96)02120-X
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 15
TC 4
Z9 4
U1 2
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0031-8965
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Mat.
PD MAY
PY 2006
VL 203
IS 6
BP 1476
EP 1480
DI 10.1002/pssa.200566111
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 046WN
UT WOS:000237841900075
DA 2018-10-20
ER

PT J
AU Starr, TB
   Matanoski, G
   Anders, MW
   Andersen, ME
AF Starr, TB
   Matanoski, G
   Anders, MW
   Andersen, ME
TI Workshop overview: Reassessment of the cancer risk of dichloromethane in
   humans
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE dichloromethane; cancer; PBPK; epidemiology; risk assessment
ID METHYLENE-CHLORIDE; SALMONELLA-TYPHIMURIUM; CARBON-MONOXIDE;
   DNA-ADDUCTS; FILM BASE; METABOLISM; MORTALITY; DIHALOMETHANES; EXPOSURE;
   FORMALDEHYDE
AB The U.S. Environmental Protection Agency (U.S. EPA) classifies dichloromethane (DCM) as a "probable human carcinogen," based upon its risk assessment conducted in the late 1980s (http://www.epa.gov/iris/subst/0070.htm). Since that time, cancer risk-assessment practices have evolved, leading to improved scientifically based methods for estimating risk and for illuminating as well as reducing residual uncertainties. A new physiologically based pharmacokinetic (PBPK) model has been developed, using data from human volunteers exposed to low DCM levels, that provides new information on the human to human variability in DCM metabolism and elimination (L. M. Sweeney et al., 2004, Toxicol. Lett. 154, 201-216). This information, along with data from other published human studies, has been used to develop a new cancer risk estimation model utilizing probabilistic methodology similar to that employed recently by U.S. EPA for other chemicals (ENVIRON Health Sciences Institute, 2005, Development of population cancer risk estimates for environmental exposure to dichloromethane using a physiologically based pharmacokinetic model. Final Report to Eastman Kodak Company). This article summarizes the deliberations of a scientific peer-review panel convened on 3 and 4 May 2005 at the CIIT Centers for Health Research in Research Triangle Park, North Carolina, to review the "state of the science" for DCM and to critically evaluate the new information for its utility in assessing potential human cancer risks from DCM exposure. The panel (Melvin E Andersen, CIIT Centers for Health Research, Research Triangle Park, NC 27709; A. John Bailer, Miami University, Scripps Gerontology Center, Oxford, OH 45056; Kenneth S. Crump, ENVIRON Health Sciences Institute, Ruston, LA 71270; Clifford R. Elcombe, University of Dundee, Biomedical Research Centre, Dundee DD1 9SY, United Kingdom; Linda S. Erdreich, Exponent, 420 Lexington Avenue, Suite 1740, New York, NY 10170; Jeffery W. Fisher, University of Georgia, Department of Environmental Health Science, Athens, GA 30602; David Gaylor, Gaylor and Associates, LLC, Eureka Springs, AR 72631; F Peter Guengerich, Vanderbilt University, Department of Biochemistry, Nashville, TN 37232; Kenneth Mundt, ENVIRON Health Sciences Institute, Amherst, MA 01004; Lorenz R Rhomberg, Gradient Corporation, Cambridge, MA 021138; Charles Timchalk, Pacific Northwest National Laboratory, Richland, WA 99352), chaired by M.E.A., was composed of experts in xenobiotic metabolism and carcinogenic mechanisms, PBPK modeling, epidemiology, biostatistics, and quantitative risk assessment. Observers included representatives from U.S. EPA, CIIT, and Eastman Kodak Company (Kodak), as well as several consultants to Kodak. The workshop was organized and sponsored by Kodak, which employs DCM as a solvent in the production of imaging materials. Overall, the panel concluded that the new models for DCM risk assessment were scientifically and technically sound and represented an advance over those employed in past assessments.
C1 TBS Associates, Raleigh, NC 27615 USA.
   Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21202 USA.
   Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.
   CIIT Ctr Hlth Res, Res Triangle Pk, NC 27709 USA.
RP Starr, TB (reprint author), TBS Associates, 7500 Rainwater Rd, Raleigh, NC 27615 USA.
EM tbstarr@mindspring.com
OI Andersen, Melvin/0000-0002-3894-4811
CR AHMED AE, 1978, BIOCHEM PHARMACOL, V27, P2021, DOI 10.1016/0006-2952(78)90061-8
   ANDERS MW, 1977, J ENVIRON PATHOL TOX, V1, P117
   ANDERSEN ME, 1991, TOXICOL APPL PHARM, V108, P14, DOI 10.1016/0041-008X(91)90264-F
   ANDERSEN ME, 1987, TOXICOL APPL PHARM, V14, P243
   ASTRAND I, 1975, Scandinavian Journal of Work Environment and Health, V1, P78
   BLOCKI FA, 1994, J BIOL CHEM, V269, P8826
   Bois FY, 2000, ENVIRON HEALTH PERSP, V108, P307, DOI 10.1289/ehp.00108s2307
   CANTOR KP, 1995, J OCCUP ENVIRON MED, V37, P336, DOI 10.1097/00043764-199503000-00011
   CASANOVA M, 1992, TOXICOL APPL PHARM, V114, P162, DOI 10.1016/0041-008X(92)90109-6
   CLEWELL HJ, 1993, ANAL METABOLISM METH
   DIVINCENZO GD, 1981, TOXICOL APPL PHARM, V59, P130, DOI 10.1016/0041-008X(81)90460-9
   El-Masri HA, 1999, TOXICOL APPL PHARM, V158, P221, DOI 10.1006/taap.1999.8715
   ENGSTROM J, 1977, SCAND J WORK ENV HEA, V3, P215, DOI 10.5271/sjweh.2771
   *ENVIRON HLTH SCI, 2005, DEV POP CANC RISK ES
   *EPA, 1991, INT RISK INF SYST DI
   GARGAS ML, 1986, TOXICOL APPL PHARM, V82, P211, DOI 10.1016/0041-008X(86)90196-1
   Gibbs GW, 1996, J OCCUP ENVIRON MED, V38, P693, DOI 10.1097/00043764-199607000-00012
   GIBBS GW, 1992, MORTALITY WORKERS EM
   GRAVES RJ, 1994, MUTAT RES, V320, P235, DOI 10.1016/0165-1218(94)90050-7
   GREEN T, 1983, MUTAT RES, V118, P277, DOI 10.1016/0165-1218(83)90211-2
   Haber LT, 2002, REGUL TOXICOL PHARM, V35, P177, DOI 10.1006/rtph.2001.1517
   Hearne FT, 1999, J OCCUP ENVIRON MED, V41, P1154, DOI 10.1097/00043764-199912000-00022
   HEARNE FT, 1987, J OCCUP ENVIRON MED, V29, P217
   HEINEMAN EF, 1994, AM J IND MED, V26, P155, DOI 10.1002/ajim.4700260203
   Jonsson F, 2001, TOXICOL SCI, V59, P209, DOI 10.1093/toxsci/59.2.209
   Jonsson F, 2001, TOXICOL APPL PHARM, V174, P99, DOI 10.1006/taap.2001.9206
   Kayser MF, 2001, J BACTERIOL, V183, P5209, DOI 10.1128/JB.183.17.5209-5212.2001
   Kim SK, 1996, J APPL TOXICOL, V16, P437, DOI 10.1002/(SICI)1099-1263(199609)16:5<437::AID-JAT371>3.0.CO;2-2
   KUBIC VL, 1975, DRUG METAB DISPOS, V3, P104
   LANES SF, 1993, SCAND J WORK ENV HEA, V19, P426, DOI 10.5271/sjweh.1451
   Marsch GA, 2001, CHEM RES TOXICOL, V14, P600, DOI 10.1021/tx010006h
   *NTP, 1986, NIH PUBL, P208
   OSHA, 1997, FED REG, V62, P1493
   REITZ RH, 1988, TOXICOL LETT, V43, P97, DOI 10.1016/0378-4274(88)90023-9
   Sarangapani R, 2002, INHAL TOXICOL, V14, P789, DOI 10.1080/08958370290084647
   STEWART RD, 1972, ARCH ENVIRON HEALTH, V25, P342, DOI 10.1080/00039896.1972.10666184
   Sweeney LM, 2004, TOXICOL LETT, V154, P201, DOI 10.1016/j.toxlet.2004.08.002
   THIER R, 1993, P NATL ACAD SCI USA, V90, P8576, DOI 10.1073/pnas.90.18.8576
   Tomenson JA, 1997, OCCUP ENVIRON MED, V54, P470, DOI 10.1136/oem.54.7.470
NR 39
TC 15
Z9 15
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
J9 TOXICOL SCI
JI Toxicol. Sci.
PD MAY
PY 2006
VL 91
IS 1
BP 20
EP 28
DI 10.1093/toxsci/kfj145
PG 9
WC Toxicology
SC Toxicology
GA 032WX
UT WOS:000236808200004
PM 16507920
OA Bronze
DA 2018-10-20
ER

PT J
AU Lee, CIP
   Leong, SH
   Png, AEH
   Choo, KW
   Syn, C
   Lim, DTH
   Law, HY
   Kon, OL
AF Lee, Cheryl I. P.
   Leong, Siew Hong
   Png, Adrian E. H.
   Choo, Keng Wah
   Syn, Christopher
   Lim, Dennis T. H.
   Law, Hai Yang
   Kon, Oi Lian
TI An isothermal method for whole genome amplification of fresh and
   degraded DNA for comparative genomic hybridization, genotyping and
   mutation detection
SO DNA RESEARCH
LA English
DT Article
DE whole genome amplification; isothermal; comparative genomic
   hybridization; genotyping; mutations
ID DISPLACEMENT AMPLIFICATION; SAMPLES; PRIMER; DEGRADATION; CELL; PCR
AB Molecular genotyping has important biomedical and forensic applications. However, limiting amounts human biological material often yield genomic DNA (gDNA) in insufficient quantity and of poor quality for a reliable analysis. This motivated the development of an efficient whole genome amplification method with quantitatively unbiased representation usable on fresh and degraded gDNA. Amplification of fresh frozen, formalin-fixed paraffin-embedded (FFPE) and DNase-degraded DNA using degenerate oligonucleotide-primed PCR or primer extension amplification using a short primer sequence bioinformatically optimized for coverage of the human genome was compared with amplification using current primers by chromosome-based and BAC-array comparative genomic hybridization (CGH), genotyping at short tandem repeats (STRs) and single base mutation detection. Compared with current primers, genome amplification using the bioinformatically optimized primer was significantly less biased on CGH in self-self hybridizations, and replicated tumour genome copy number aberrations, even from FFPE tissue. STR genotyping could be performed on degraded gDNA amplified using our technique but failed with multiple displacement amplification. Of the IS different single base mutations 16 (89.5%) were correctly identified by sequencing gDNA amplified from clinical samples using our technique. This simple and efficient isothermal method should be helpful for genetic research and clinical and forensic applications.
C1 KK Womens & Childrens Hosp, Dept Paediat Med, Singapore 229899, Singapore.
   Natl Canc Ctr, Div Med Sci, Singapore 169610, Singapore.
   Nanyang Polytech, Bioinformat Grp, Singapore 569830, Singapore.
   Ctr Forens Sci, Singapore 169078, Singapore.
   Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore.
RP Kon, OL (reprint author), KK Womens & Childrens Hosp, Dept Paediat Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.
EM dmskol@nccs.com.sg
CR Bertram L, 2005, J MED GENET, V42, P857, DOI 10.1136/jmg.2004.024596
   Budowle B, 1999, J FORENSIC SCI, V44, P1277
   Budowle B, 2001, FORENSIC SCI COMMUN, V3
   Chung DT, 2004, J FORENSIC SCI, V49, P733
   Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902
   Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494
   Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203
   Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557
   MACKEY J, 1993, ANAL BIOCHEM, V212, P428, DOI 10.1006/abio.1993.1351
   Moretti TR, 2001, J FORENSIC SCI, V46, P647
   Tay ST, 2003, CANCER RES, V63, P3309
   TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K
   Wang G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh070
   Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404
   Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350
   ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847
NR 18
TC 12
Z9 16
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1340-2838
J9 DNA RES
JI DNA Res.
PD APR 30
PY 2006
VL 13
IS 2
BP 77
EP 88
DI 10.1093/dnares/dsi029
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 219WU
UT WOS:000250119700004
PM 16766515
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Krause, D
   Thomas, B
   Leinenbach, C
   Eifler, D
   Minay, EJ
   Boccaccini, AR
AF Krause, D
   Thomas, B
   Leinenbach, C
   Eifler, D
   Minay, EJ
   Boccaccini, AR
TI The electrophoretic deposition of Bioglass (R) particles on stainless
   steel and Nitinol substrates
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE electrophoretic deposition; Bioglass (R) coating; stainless steel;
   nickel-titanium alloy; shape memory alloy; biomedical materials
ID SHAPE-MEMORY ALLOYS; HYDROXYAPATITE COATINGS; BIOMEDICAL APPLICATIONS;
   TITANIUM; CERAMICS; CRYSTALLIZATION; TEMPERATURE; PARAMETERS; KINETICS
AB 45S5 Bioglass (R) coatings have been produced on stainless steel (type 304) plates by electrophoretic deposition (EPD). Aqueous suspensions of Bioglass (R) powder (mean particle size < 3 mu m) were used. In addition, shape memory nickel-titanium wires were also coated with Bioglass (R) using an optimised EPD procedure. EPD led to the fort-nation of thick (up to 30 mu m) and uniform coatings covering tile substrates very homogeneously No microcracks were formed during tile drying stage. For all substrates, best results were achieved with suspensions of distilled water containing 20 wt.% Bioglass (R), an applied voltage of 5 V and a deposition time of 5 min. For the stainless steel plates, sintering at 950 degrees C led to a complete covering of the plates with a continuous Bioglass (R) layer, assisted by viscous flow of the glass. Sintering of the Bioglass (R)-coated wires at temperatures > 800 degrees C led to a diffusion of nickel and titanium into the Bioglass (R) coating which was confirmed by EDX analysis. The results demonstrate that the EPD technique is a very useful method to produce uniform and reproducible Bioglass (R) coatings on metallic planar substrates and wires for biomedical applications. The technique presented here should be considered as a convenient alternative for bioactive coatings in comparison to other methods such as sol-gel coating and plasma-based deposition techniques. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ Kaiserslautern, Inst Mat Sci & Engn, D-867663 Kaiserslautern, Germany.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
EM a.boccaccini@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013; Leinenbach, Christian/I-6276-2013
OI Leinenbach, Christian/0000-0003-0435-495X
CR Bibby JK, 2004, GLASS TECHNOL, V45, P80
   BIBBY JK, 2003, BIOCERAMICS, V15, P279
   Boccaccini AR, 2002, CURR OPIN SOLID ST M, V6, P251, DOI 10.1016/S1359-0286(02)00080-3
   Bogdanski D, 2004, MAT SCI ENG A-STRUCT, V378, P527, DOI 10.1016/j.msea.2003.11.071
   Choi J, 2003, BIOMATERIALS, V24, P3689, DOI 10.1016/S0142-9612(03)00241-2
   Chu CL, 1996, MAT SCI ENG A-STRUCT, V216, P193, DOI 10.1016/0921-5093(96)10409-3
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Hamagami J, 2004, SOLID STATE IONICS, V172, P331, DOI 10.1016/j.ssi.2004.02.046
   HEAVENS SN, 1990, ADV CERAMIC PROCESSI, P255
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL., 1993, INTRO BIOCERAMICS, P239
   HENCH LL, 2003, ENCY MAT SCI TECHNOL, P563
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Lipscomb I. P., 1996, APPL SHAPE MEMORY AL
   Ma J, 2003, J MATER SCI-MATER M, V14, P797, DOI 10.1023/A:1025092506583
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   Miyazaki S., 1999, SHAPE MEMORY MAT, V12, P267
   Mondragon-Cortez P, 2004, MATER LETT, V58, P1336, DOI 10.1016/j.matlet.2003.09.024
   Moreno R, 2002, ELEC SOC S, V2002, P94
   MORGAN NB, 2003, MAT SCI ENG A-STRUCT, V378, P16
   OZAWA N, 2003, BIOCERAMICS, V15, P67
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Rizkalla AS, 1996, J BIOMED MATER RES, V32, P119, DOI 10.1002/(SICI)1097-4636(199609)32:1<119::AID-JBM14>3.0.CO;2-H
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Silver FH., 1994, BIOMATERIALS MED DEV
   Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Tabellion J, 2004, J MATER SCI, V39, P803, DOI 10.1023/B:JMSC.0000012907.52051.fb
   Van der Biest OO, 1999, ANNU REV MATER SCI, V29, P327, DOI 10.1146/annurev.matsci.29.1.327
   VANHUMBEECK J, 1999, SHAPE MEMORY MAT, P149
   VANHUMBEECK J, 1998, METALS BIOMATERIALS, P73
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wang R, 2003, J BIOMED MATER RES A, V67A, P270, DOI 10.1002/jbm.a.10114
   Wang ZG, 2004, PHYSICA B, V353, P9, DOI 10.1016/j.physb.2004.08.021
   Yeung KWK, 2004, MAT SCI ENG A-STRUCT, V383, P213, DOI 10.1061/j.msea.2004.05.063
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 40
TC 51
Z9 51
U1 1
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 27
PY 2006
VL 200
IS 16-17
BP 4835
EP 4845
DI 10.1016/j.surfcoat.2005.04.029
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 029UQ
UT WOS:000236590300024
DA 2018-10-20
ER

PT J
AU Helmke, BP
   Minerick, AR
AF Helmke, BP
   Minerick, AR
TI Designing a nano-interface in a microfluidic chip to probe living cells:
   Challenges and perspectives
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Proceedings Paper
CT Conference on Designing Nanostructures at the Interface Between
   Biomedical and Physical Systems
CY NOV 19-21, 2004
CL Natl Acad Sci & Engn, Arnold & Mabel Beckman Ctr, Irvine, CA
HO Natl Acad Sci & Engn, Arnold & Mabel Beckman Ctr
ID RED-BLOOD-CELLS; ENDOTHELIAL-CELLS; SHEAR-STRESS; DIELECTROPHORESIS;
   SEPARATION; MICROARRAYS; SYSTEMS; FIELD; MANIPULATION; FLOW
AB Nanotechnology-based materials are beginning to emerge as promising platforms for biomedical analysis, but measurement and control at the cell-chip interface remain challenging. This idea served as the basis for discussion in a focus group at the recent National Academies Keck Futures Initiative. In this Perspective, we first outline recent advances and limitations in measuring nanoscale mechanical, biochemical, and electrical interactions at the interface between biomaterials and living cells. Second, we present emerging experimental and conceptual platforms for probing living cells with nanotechnology-based tools in a microfluidic chip. Finally, we explore future directions and critical needs for engineering the cell-chip interface to create an integrated system capable of highresolution analysis and control of cellular physiology.
C1 Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   Mississippi State Univ, Dave C Swalm Sch Chem Engn, Mississippi State, MS 39762 USA.
RP Helmke, BP (reprint author), Univ Virginia, Dept Biomed Engn, POB 800759, Charlottesville, VA 22908 USA.
EM helmke@virginia.edu
RI Minerick, Adrienne/D-9957-2011
OI Minerick, Adrienne/0000-0002-2382-7831
CR Andersson H, 2004, CURR OPIN BIOTECH, V15, P44, DOI 10.1016/j.copbio.2004.01.004
   Arai F, 2001, ELECTROPHORESIS, V22, P283, DOI 10.1002/1522-2683(200101)22:2<283::AID-ELPS283>3.0.CO;2-C
   Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163
   BECKER FF, 1994, J PHYS D APPL PHYS, V27, P2659, DOI 10.1088/0022-3727/27/12/030
   Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916
   Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855
   Chen CS, 2000, METH MOL B, V139, P209
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5
   Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532
   Cummings EB, 2003, ANAL CHEM, V75, P4724, DOI 10.1021/ac0340612
   Durr M, 2003, ELECTROPHORESIS, V24, P722, DOI 10.1002/elps.200390087
   Gascoyne P, 2002, LAB CHIP, V2, P70, DOI 10.1039/b110090c
   Gawron AJ, 2001, EUR J PHARM SCI, V14, P1, DOI 10.1016/S0928-0987(01)00153-1
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896
   Green NG, 2000, J PHYS D APPL PHYS, V33, P632, DOI 10.1088/0022-3727/33/6/308
   Greish YE, 2005, J MATER SCI-MATER M, V16, P613, DOI 10.1007/s10856-005-2531-7
   Haab BB, 2003, PROTEOMICS, V3, P2116, DOI 10.1002/pmic.200300595
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Helmke BP, 2003, BIOPHYS J, V84, P2691, DOI 10.1016/S0006-3495(03)75074-7
   Jin LJ, 2001, BIOTECHNIQUES, V31, P1332, DOI 10.2144/01316md01
   JONES TB, 1979, J ELECTROSTAT, V6, P207, DOI 10.1016/0304-3886(79)90092-5
   Jordan B, 2002, P NATL ACAD SCI USA, V99, P2942, DOI 10.1073/pnas.261710699
   Kadaksham ATJ, 2004, ELECTROPHORESIS, V25, P3625, DOI 10.1002/elps.200406092
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Kricka LJ, 2001, CLIN CHIM ACTA, V307, P219, DOI 10.1016/S0009-8981(01)00451-X
   Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728
   Lapizco-Encinas BH, 2004, ELECTROPHORESIS, V25, P1695, DOI 10.1002/elps.200405899
   Lapizco-Encinas BH, 2004, ANAL CHEM, V76, P1571, DOI 10.1021/ac034804j
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARKX GH, 1995, BIOTECHNOL BIOENG, V45, P337, DOI 10.1002/bit.260450408
   Martinsen O., 2002, ENCY SURFACE COLLOID
   McKnight TE, 2004, J PHYS CHEM B, V108, P7115, DOI 10.1021/jp037987m
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Minerick AR, 2003, ELECTROPHORESIS, V24, P3703, DOI 10.1002/elps.200305644
   Minerick AR, 2002, ELECTROPHORESIS, V23, P2165, DOI 10.1002/1522-2683(200207)23:14<2165::AID-ELPS2165>3.0.CO;2-#
   MOGNASCHI ER, 1983, J PHYS D APPL PHYS, V16, P1533, DOI 10.1088/0022-3727/16/8/020
   Muller T, 1996, BIOTECHNOL TECH, V10, P221, DOI 10.1007/BF00184018
   Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0
   Nagel T, 1999, ARTERIOSCL THROM VAS, V19, P1825, DOI 10.1161/01.ATV.19.8.1825
   Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101
   Pethig R, 1996, CRIT REV BIOTECHNOL, V16, P331, DOI 10.3109/07388559609147425
   Pethig R, 2003, IEEE ENG MED BIOL, V22, P43, DOI 10.1109/MEMB.2003.1266046
   POHL HA, 1978, DIELECTROPHORESIS
   Ratanachoo K, 2002, BBA-BIOMEMBRANES, V1564, P449, DOI 10.1016/S0005-2736(02)00494-7
   Rathore A., 2004, ELECTROKINETIC PHENO
   Reichle C, 2001, ELECTROPHORESIS, V22, P272, DOI 10.1002/1522-2683(200101)22:2<272::AID-ELPS272>3.0.CO;2-K
   Schnelle T, 1999, J ELECTROSTAT, V46, P13, DOI 10.1016/S0304-3886(98)00055-2
   Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692
   Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166
   Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688
   Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q
   Voldman J, 2001, BIOPHYS J, V80, P531, DOI 10.1016/S0006-3495(01)76035-3
   Walt DR, 2005, SCIENCE, V308, P217, DOI 10.1126/science.1108161
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang SC, 2004, IND ENG CHEM RES, V43, P2902, DOI 10.1021/ie030689r
   Wang XB, 2000, ANAL CHEM, V72, P832, DOI 10.1021/ac990922o
   WASHIZU M, 1990, J ELECTROSTAT, V25, P109, DOI 10.1016/0304-3886(90)90040-3
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   WU YK, 1994, BIOPHYS J, V66, P114, DOI 10.1016/S0006-3495(94)80762-3
   Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7
   Zhao B, 2002, ANAL CHEM, V74, P4259, DOI 10.1021/ac020269w
   Zheng LF, 2004, LANGMUIR, V20, P8612, DOI 10.1021/la049687h
NR 67
TC 36
Z9 39
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 25
PY 2006
VL 103
IS 17
BP 6419
EP 6424
DI 10.1073/pnas.0507304103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 037MM
UT WOS:000237151000003
PM 16618928
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Persson, PV
   Casas, J
   Iversen, T
   Cordova, A
AF Persson, PV
   Casas, J
   Iversen, T
   Cordova, A
TI Direct organocatalytic chemoselective synthesis of a dendrimer-like star
   polyester
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; LIPASE-CATALYZED FORMATION;
   EPSILON-CAPROLACTONE; LIVING POLYMERIZATION;
   2,2-BIS(HYDROXYMETHYL)PROPIONIC ACID; ORGANIC CATALYSTS;
   MOLECULAR-OXYGEN; MANNICH REACTION; POLY(EPSILON-CAPROLACTONE); POLYMERS
AB We have developed a direct organocatalytic synthesis of a dendrimer-like star polyester. The synthesis was based on lactic acid-catalyzed bulk ring-opening polymerization (ROP) of c-caprolactone (epsilon-CL) with the hexahydroxy-functional dendrimer 2,2-bis(hydroxymethyl)propanoic acid as the initiator. The polymerization was highly chemoselective, and the catalyst was readily recovered by precipitation of the polyester products. The reaction was performed without solvent and without the need of an inert atmosphere. In addition, the ROPs are operationally simple, inexpensive, and environmentally benign. Organic acid catalysis provides a new entry for the synthesis of Valuable dendritic materials as well as polyesters for biomedical applications.
C1 STFI Packforsk AB, SE-11486 Stockholm, Sweden.
   Stockholm Univ, Arrhenius Lab, Dept Organ Chem, SE-10691 Stockholm, Sweden.
RP Iversen, T (reprint author), STFI Packforsk AB, POB 5604, SE-11486 Stockholm, Sweden.
EM tommy.iversen@stfi.se; acordova@organ.su.se
RI Cordova, Armando/B-8885-2011
OI Cordova, Armando/0000-0001-9620-8698
CR Bogevig A, 2004, ANGEW CHEM INT EDIT, V43, P1109, DOI 10.1002/anie.200353018
   BUSSON P, 1913, J AM CHEM SOC, V35, P9070
   Casas J, 2004, ADV SYNTH CATAL, V346, P1087, DOI 10.1002/adsc.200404082
   Chiellini E, 1996, ADV MATER, V8, P305, DOI 10.1002/adma.19960080406
   Connor EF, 2002, J AM CHEM SOC, V124, P914, DOI 10.1021/ja0173324
   Cordova A, 1998, POLYMER, V39, P6519, DOI 10.1016/S0032-3861(98)00068-8
   Cordova A, 2004, J AM CHEM SOC, V126, P8914, DOI 10.1021/ja047930t
   Cordova A, 2004, CHEM-EUR J, V10, P1987, DOI 10.1002/chem.200305646
   Cordova A, 2004, ACCOUNTS CHEM RES, V37, P102, DOI 10.1021/ar030231l
   Cordova A, 2003, SYNLETT, P1651, DOI 10.1055/s-2003-41423
   Cordova A, 2001, BIOMACROMOLECULES, V2, P1347, DOI 10.1021/bm0101015
   Cordova A, 1998, J AM CHEM SOC, V120, P13521, DOI 10.1021/ja982252u
   Cordova A, 2001, J AM CHEM SOC, V123, P8248, DOI 10.1021/ja001819f
   Cordova A, 1998, MACROMOLECULES, V31, P1040, DOI 10.1021/ma971297x
   Cordova A, 1999, POLYMER, V40, P6709, DOI 10.1016/S0032-3861(99)00017-8
   Coulembier O, 2005, ANGEW CHEM INT EDIT, V44, P4964, DOI 10.1002/anie.200500723
   Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D
   Dalko PI, 2004, ANGEW CHEM INT EDIT, V43, P5138, DOI 10.1002/anie.200400650
   DOVE AP, 2005, J AM CHEM SOC, V127, P1398
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   DUTHALER RO, 2003, ANGEW CHEM INT EDIT, V442, P975
   FRECHET JMJ, 1994, SCIENCE, V263, P1710, DOI 10.1126/science.8134834
   Fujisato T, 1996, MACROMOL SYMP, V103, P73
   GILLIES ER, 2002, J AM CHEM SOC, P14137
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Gustavsson MT, 2004, BIOMACROMOLECULES, V5, P106, DOI 10.1021/bm034244y
   Hafren J, 2005, MACROMOL RAPID COMM, V26, P82, DOI 10.1002/marc.200400470
   Hecht S, 1999, J AM CHEM SOC, V121, P9239, DOI 10.1021/ja9922882
   Ibrahem I, 2004, ANGEW CHEM INT EDIT, V43, P6528, DOI 10.1002/anie.200460678
   Ihre H, 2001, J AM CHEM SOC, V123, P5908, DOI 10.1021/ja010524e
   Ihre H, 1998, MACROMOLECULES, V31, P4061, DOI 10.1021/ma9718762
   Ihre H, 1996, J AM CHEM SOC, V118, P6388, DOI 10.1021/ja954171t
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   Kubisa P, 1999, PROG POLYM SCI, V24, P1409, DOI 10.1016/S0079-6700(99)00028-3
   Liu JY, 2004, MACROMOLECULES, V37, P2674, DOI 10.1021/ma0348066
   Malkoch M, 2002, MACROMOLECULES, V35, P8307, DOI 10.1021/ma0205360
   Momiyama N, 2005, J AM CHEM SOC, V127, P1080, DOI 10.1021/ja0444637
   Nederberg F, 2001, ANGEW CHEM INT EDIT, V40, P2712, DOI 10.1002/1521-3773(20010716)40:14<2712::AID-ANIE2712>3.0.CO;2-Z
   Newkome G.R., 2001, DENDRIMERS DENDRONS
   OKEEFE BJ, 2001, J CHEM SOC DA, V15, P2215
   Ovitt TM, 1999, J AM CHEM SOC, V121, P4072, DOI 10.1021/ja990088k
   Persson PV, 2004, MACROMOLECULES, V37, P5889, DOI 10.1021/ma049562j
   Pihko PM, 2004, ANGEW CHEM INT EDIT, V43, P2062, DOI 10.1002/anie.200301732
   Sanda F, 2002, MACROMOLECULES, V35, P680, DOI 10.1021/ma011341f
   Shibasaki Y, 2000, MACROMOLECULES, V33, P4316, DOI 10.1021/ma992138b
   Slomkowski S, 1996, MACROMOL SYMP, V103, P213
   Sunden H, 2004, ANGEW CHEM INT EDIT, V43, P6532, DOI 10.1002/anie.200460295
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Trollsas M, 1997, MACROMOLECULES, V30, P8508, DOI 10.1021/ma970798f
   Trollsas M, 1998, J AM CHEM SOC, V120, P4644, DOI 10.1021/ja973678w
   VION JM, 1986, MACROMOLECULES, V19, P1828, DOI 10.1021/ma00161a009
   Wahlberg J, 2003, BIOMACROMOLECULES, V4, P1068, DOI 10.1021/bm0340725
   Wilson BC, 2004, MACROMOLECULES, V37, P9709, DOI 10.1021/ma048239d
NR 53
TC 27
Z9 28
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD APR 18
PY 2006
VL 39
IS 8
BP 2819
EP 2822
DI 10.1021/ma0521710
PG 4
WC Polymer Science
SC Polymer Science
GA 035JE
UT WOS:000236996200017
DA 2018-10-20
ER

PT J
AU Sarazin, P
   Virgilio, N
   Favis, BD
AF Sarazin, P
   Virgilio, N
   Favis, BD
TI Influence of the porous morphology on the in vitro degradation and
   mechanical properties of poly(L-lactide) disks
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polylactide; macroporous; co-continuity; blends; melt mixing
ID BIODEGRADABLE POLYMERS; CELL TRANSPLANTATION; INTERNAL-FIXATION; BONE;
   BIOCOMPATIBILITY; SCAFFOLDS
AB Poly(L-lactide) (PLLA) materials having an interconnected porosity are proposed as an alternative to nonporous biornaterials. Such materials allow for the potential of modulating the degradation behavior and the mechanical properties. In this article, the preparation of porous PLLA disks or cylinders with 50 and 65% void volume is presented. It is demonstrated that both a symmetric and asymmetric porosity can be generated within the disk itself. In addition, open- and closed-cell structures can also be prepared. The accelerated hi vitro degradation on symmetric open-cell porous PLLA disks and on the nonporous control indicate a similar behavior in terms of melting temperature and inherent viscosity of the remaining pieces of the specimens, but the crystallinity and the mass of the remaining fragments are much smaller for the porous specimens. The mechanical properties under compression are determined for open and closed-cell porous cylinders, porous tubes, and for the nonporous PLLA. The results highlight the excellent mechanical integrity of the prepared porous structures and demonstrate that such materials could have potential for use as biomedical implants. (c) 2006 Wiley Periodicals, Inc.
C1 Ecole Polytech, Dept Chem Engn, CREPEC, Montreal, PQ H3C 3A7, Canada.
RP Favis, BD (reprint author), Ecole Polytech, Dept Chem Engn, CREPEC, Montreal, PQ H3C 3A7, Canada.
EM basil.favis@polymtl.ca
CR Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   FAVIS BD, UNPUB MICROPOROUS AR
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   *ISO, 1997, 13781 ISO
   Laitinen O, 2002, J BIOMED MATER RES, V61, P33, DOI 10.1002/jbm.10115
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Peters MC, 1997, MATER SCI FORUM, V250, P43, DOI 10.4028/www.scientific.net/MSF.250.43
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Sarazin P, 2003, BIOMACROMOLECULES, V4, P1669, DOI 10.1021/bm030034+
   Tsuji H, 2004, POLYM DEGRAD STABIL, V84, P515, DOI 10.1016/j.polymdegradstab.2004.01.010
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
NR 16
TC 6
Z9 6
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2006
VL 100
IS 2
BP 1039
EP 1047
DI 10.1002/app.23185
PG 9
WC Polymer Science
SC Polymer Science
GA 015MV
UT WOS:000235556400024
DA 2018-10-20
ER

PT J
AU Min, BM
   Jeong, L
   Lee, KY
   Park, WH
AF Min, BM
   Jeong, L
   Lee, KY
   Park, WH
TI Regenerated silk fibroin nanofibers: Water vapor-induced structural
   changes and their effects on the behavior of normal human cells
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE beta-sheet conformation; cell behavior; nanofiber; silk fibroin;
   structural changes
ID BOMBYX-MORI SILK; NORMAL HUMAN KERATINOCYTES; OSTEOBLAST IN-VITRO;
   SOLID-STATE; CONFORMATION TRANSITION; POLY(D,L-LACTIC ACID);
   NMR-SPECTROSCOPY; FILMS; DIFFERENTIATION; METHANOL
AB Nanofibrous non-woven matrices were prepared by electrospinning a regenerated silk fibroin (SF) solution, and the structural changes of SF nanofibers treated with water vapor were investigated using time-resolved IR and C-13 CP/ MAS NMR spectroscopy. Conformational transitions of SF from random coil to beta-sheet structures were induced by water vapor treatment and were strongly dependent on the treatment time and temperature. Water vapor treatment provided a useful means of stabilizing the SF nanofiber matrices, resulting in the formation of matrices with a decreased solubility in water and increased mechanical strength. The adhesion and spreading of both normal human keratinocytes and fibroblasts onto the SF nanofiber matrices were also investigated, and the water vapor-treated SF nanofiber matrices showed good cellular compatibility, in comparison with traditional methanol-treated ones. This approach to controlling the conformational changes of SF nanofibers by water vapor treatment may be useful in the design and tailoring of novel materials for biomedical applications, including wound dressings and scaffolds for tissue engineering.
C1 Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.
   Chungnam Natl Univ, Coll Engn, Dept Text Engn, Taejon 305764, South Korea.
   Seoul Natl Univ, Coll Dent, Dept Oral Biochem & Craniomaxillofacial Reconstru, Dent Res Inst, Seoul 110749, South Korea.
   Seoul Natl Univ, BK21 HLS, Coll Dent, Seoul 110749, South Korea.
RP Lee, KY (reprint author), Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.
EM leeky@hanyang.ac.kr; parkwh@cnu.ac.kr
RI Min, Byung-Moo/F-2854-2012
OI Lee, Kuen Yong/0000-0002-5759-5952; Park, Won Ho/0000-0003-1768-830X
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   ASAKURA T, 1992, J POLYM SCI POL PHYS, V30, P693, DOI 10.1002/polb.1992.090300706
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen X, 2002, BIOCHEMISTRY-US, V41, P14944, DOI 10.1021/bi026550m
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Fujii K, 2000, J JPN SOC FOOD SCI, V47, P363
   GUO M, 1991, EXP CELL RES, V195, P315, DOI 10.1016/0014-4827(91)90379-9
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN D, 1994, ACS S SERIES, V544
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   KIM JP, 1992, J CELL PHYSIOL, V151, P443, DOI 10.1002/jcp.1041510303
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200
   Oh JE, 2002, CELL COMMUN ADHES, V9, P173, DOI 10.1080/154190602901116410
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   Park BS, 2005, J BIOMED MATER RES A, V74A, P640, DOI 10.1002/jbm.a.30326
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   Peng XN, 2004, ACTA CHIM SINICA, V62, P2127
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   SanchezMateos P, 1996, SEMIN CANCER BIOL, V7, P99, DOI 10.1006/scbi.1996.0015
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 40
TC 102
Z9 112
U1 1
U2 50
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 12
PY 2006
VL 6
IS 4
BP 285
EP 292
DI 10.1002/mabi.200500246
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 035JC
UT WOS:000236996000003
PM 16572474
DA 2018-10-20
ER

PT J
AU Suzuki, D
   Kawaguchi, H
AF Suzuki, D
   Kawaguchi, H
TI Hybrid microgels with reversibly changeable multiple brilliant color
SO LANGMUIR
LA English
DT Article
ID CORE-SHELL PARTICLES; OPTICAL-PROPERTIES; MACROSCOPIC MATERIALS; GOLD
   NANOPARTICLES; SEMICONDUCTOR; MICROSPHERES; NANOCRYSTALS; MULTILAYERS;
   TEMPLATE; HYDROGEL
AB We report reversibly color changeable hybrid microgels that tune multiple brilliant colors due to interparticle interactions of SPR using several structured nanoparticles. The interparticle interactions were brought out using the thermosensitive swelling/deswelling property of microgel. We employ N-isopropylacrylamide (NIPAM) and glycidyl methacrylate (GMA) copolymerized microgels (NG microgels) as templates for in Situ synthesis of Au nanoparticles. The seed Au nanoparticles could be stably grown by Successive reduction of Au and Ag in the microgels. Interestingly, the hybrid microgels were able to exhibit multiple brilliant colors by attaching Au/Ag multiple core/shell bimetallic nanoparticles in the microgels, and the color change reversibility of each hybrid microgel was accomplished by adjusting the nanoparticles' sizes. Obtained microgels shown in this study will find important applications such as in biomedical and electronic devices.
C1 Keio Univ, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Kawaguchi, H (reprint author), Keio Univ, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
EM haruma@applc.keio.ac.jp
CR Boal AK, 2000, NATURE, V404, P746
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Fernandez-Nieves A, 2000, MACROMOLECULES, V33, P2114, DOI 10.1021/ma991520l
   Gittins DI, 1999, ADV MATER, V11, P737, DOI 10.1002/(SICI)1521-4095(199906)11:9<737::AID-ADMA737>3.0.CO;2-1
   Gong YJ, 2005, CHEM MATER, V17, P2648, DOI 10.1021/cm047932c
   Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808
   Kuang M, 2005, ADV MATER, V17, P267, DOI 10.1002/adma.200400818
   Liang ZJ, 2003, CHEM MATER, V15, P3176, DOI 10.1021/cm031014h
   Liz-Marzan LM, 2006, LANGMUIR, V22, P32, DOI 10.1021/la0513353
   Lu LH, 2002, CHEM COMMUN, P144, DOI 10.1039/b108473a
   Maye MM, 2002, J AM CHEM SOC, V124, P4958, DOI 10.1021/ja025724k
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Musick MD, 1997, CHEM MATER, V9, P1499, DOI 10.1021/cm970087w
   Rodriguez-Gonzalez B, 2005, J MATER CHEM, V15, P1755, DOI 10.1039/b500556f
   Shenton W, 1999, ADV MATER, V11, P449, DOI 10.1002/(SICI)1521-4095(199904)11:6<449::AID-ADMA449>3.0.CO;2-A
   Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L
   Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003
   Suzuki D, 2005, LANGMUIR, V21, P12016, DOI 10.1021/la0516882
   Suzuki D, 2005, LANGMUIR, V21, P8175, DOI 10.1021/la0504356
   Tsuji S, 2004, LANGMUIR, V20, P2449, DOI 10.1021/la030333k
   Ung T, 1998, LANGMUIR, V14, P3740, DOI 10.1021/la980047m
   Virtanen J, 2001, J POLYM SCI POL CHEM, V39, P3716, DOI 10.1002/pola.10017
   Wang ZL, 1998, ADV MATER, V10, P13, DOI 10.1002/(SICI)1521-4095(199801)10:1<13::AID-ADMA13>3.0.CO;2-W
   Zhang JG, 2004, J AM CHEM SOC, V126, P7908, DOI 10.1021/ja031523k
NR 24
TC 103
Z9 109
U1 9
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 11
PY 2006
VL 22
IS 8
BP 3818
EP 3822
DI 10.1021/la052999f
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 032AG
UT WOS:000236745700056
PM 16584261
DA 2018-10-20
ER

PT J
AU McCubbin, PJ
   Forbes, E
   Gow, MM
   Gorham, SD
AF McCubbin, PJ
   Forbes, E
   Gow, MM
   Gorham, SD
TI Covalent attachment of quaternary ammonium compounds to a polyethylene
   surface via a hydrolyzable ester linkage: Basis for a controlled-release
   system of antiseptics from an inert surface
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biological applications of polymers; graft copolymers; polyethylene
   (PE); surfaces
ID GRAFT-POLYMERIZATION; ANTIBACTERIAL ACTIVITY; FUNCTIONAL-GROUPS;
   PREVENTION; CATHETERS; INFECTION; POLYMERS; COLONIZATION; COPOLYMERS;
   ACRYLAMIDE
AB The colonization of medical devices such as catheters, topical wound dressings, and surgical implants by micro-organisms is an ongoing problem, particularly as many strains of bacteria are becoming resistant to antibiotics. Such a problem may be addressed by a material surface that is able to provide a slow release of a disinfectant during its period of usage. To achieve this objective, a novel material was prepared in which a quaternary ammonium salt was covalently bound onto a polyethylene backbone via a hydrolyzable ester linkage, which provided a slow release of the disinfecting agent. A low-density polyethylene film was treated with glow discharge followed by the graft polymerization of acrylic acid. A tertiary amine function was introduced onto the film by the esterification of the carboxylic acid groups, via an acid chloride intermediate, with 4-hydroxy-N-methyl piperidine. The tertiary amine on the piperidine was then quaternized with a series of alkyl bromides of various chain lengths. The quaternary ammonium salt was released slowly by the hydrolysis of the ester bond over a 4-h period. To test the efficacy of the quaternary ammonium function itself, soluble compounds were prepared as follows. 4-Hydroxy-N-methyl piperidine was esterified with acetic anhydride and a corresponding series of quaternary ammonium salts prepared again by a reaction with alkyl bromides of various chain lengths. A preliminary microbiological survey of the materials included an investigation of the effect of the chain length as well as the efficacy of the soluble quaternary salts themselves. As expected, only the longer alkyl chains provided quaternary ammonium salts with bactericidal properties, chain lengths of less than 10 carbon atoms proving ineffective. Both the polymer-bound and soluble long-chain quaternary ammonium salts were effective against suspensions of Staphylococcus aureus and Escherichia coli. The results therefore indicate that such a system may well be useful in the development of biomedical materials such as surgical implants or dressings in which a slow release of a disinfectant or other physiologically active agent such as an anti-inflammatory drug may be required. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Paisley, Dept Chem & Chem Engn, Paisley PA1 2BE, Renfrew, Scotland.
   Univ Paisley, Dept Biol Sci, Paisley PA1 2BE, Renfrew, Scotland.
RP Gorham, SD (reprint author), Univ Paisley, Dept Chem & Chem Engn, Paisley PA1 2BE, Renfrew, Scotland.
EM chem.ceng@paisley.ac.uk
CR AUJUSTA S, 1994, J APPL POLYM SCI, V53, P1149
   BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   Baudrion F, 1998, J APPL POLYM SCI, V70, P2657, DOI 10.1002/(SICI)1097-4628(19981226)70:13<2657::AID-APP11>3.0.CO;2-X
   Denyer SP, 1998, INT BIODETER BIODEGR, V41, P261, DOI 10.1016/S0964-8305(98)00023-7
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HSUI GH, 1993, J POLYM SCI A, V31, P3327
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   IWATA H, 1988, J POLYM SCI POL CHEM, V26, P3309, DOI 10.1002/pola.1988.080261216
   JANSEN B, 1990, ZBL BAKT-INT J MED M, V272, P401, DOI 10.1016/S0934-8840(11)80040-X
   Jansson R. E., 1992, US Patent, Patent No. [5,104,649, 5104649]
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   KASHIDA A, 1991, BIOMATERIALS, V12, P786
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LEVY RS, 1970, A EINSTEIN MED CTR, V18, P67
   MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9
   MAKI DG, 1981, AM J MED, V70, P739, DOI 10.1016/0002-9343(81)90605-7
   MAKI GD, 1994, 31 INT C ANT AG CHEM
   NESTER EW, 1995, MICROBIOLOGY HUMAN P, P91
   NORDIN N, 1993, J APPL POLYM SCI, V50, P663
   RAAD II, 1992, CLIN INFECT DIS, V15, P197, DOI 10.1093/clinids/15.2.197
   RAHN O, 1947, ANNU REV MICROBIOL, V1, P173, DOI 10.1146/annurev.mi.01.100147.001133
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   SCHWARTZ C, 1990, J CLIN ONCOL, V8, P1591, DOI 10.1200/JCO.1990.8.9.1591
   SENUMA M, 1989, J APPL POLYM SCI, V37, P2837, DOI 10.1002/app.1989.070371005
   SENUMA M, 1993, ANGEW MAKROMOL CHEM, V204, P119, DOI 10.1002/apmc.1993.052040111
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   VAARA M, 1992, MICROBIOL REV, V56, P395
NR 30
TC 13
Z9 14
U1 2
U2 19
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 5
PY 2006
VL 100
IS 1
BP 538
EP 545
DI 10.1002/app.23296
PG 8
WC Polymer Science
SC Polymer Science
GA 015MS
UT WOS:000235556100066
DA 2018-10-20
ER

PT J
AU Zhang, YZ
   Venugopal, J
   Huang, ZM
   Lim, CT
   Ramakrishna, S
AF Zhang, YZ
   Venugopal, J
   Huang, ZM
   Lim, CT
   Ramakrishna, S
TI Crosslinking of the electrospun gelatin nanofibers
SO POLYMER
LA English
DT Article
DE gelatin; electrospinning; crosslinking
ID LINKED GELATIN; MECHANICAL-PROPERTIES; THERMAL-PROPERTIES; COLLAGEN;
   GLUTARALDEHYDE; FIBERS; BIOPROSTHESES; MICROSPHERES; PROSTHESES;
   MEMBRANES
AB Gelatin (Gt) nanofibers have been prepared by using an electrospinning process in a previous study. In order to improve their water-resistant ability and thermomechnical performance for potential biomedical applications, in this article. the electrospun gelatin nanofibers were crosslinked with saturated glutaraldehyde (GTA) vapor at room temperature. An exposure of this nanofibrous material in the GTA vapor for 3 days generated a crosslinking extent sufficient to preserve the fibrous morphology tested by soaking in 37 degrees C warm water. On the other hand, the crosslinking also led to improved thermostability, and substantial enhancement in mechanical properties. The denaturation temperature corresponding to the helix to coil transition of the air-dried samples increased by about 11 degrees C and the tensile strength and modulus were nearly 10 times higher than those of the as-electrospun gelatin fibers. Furthermore, cytotoxicity was evaluated based on a cell proliferation study by culturing human dermal fibroblasts (HDFs) on the crosslinked gelatin fibrous scaffolds for 1, 3, 5 and 7 days. It was found cell expansion took place and almost linearly increased during the course of whole period of the cell culture. The initial inhibition of cell expansion on the crosslinked gelatin fibrous substrate suggested some cytotoxic effect of the residual GTA on the cells. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
RP Zhang, YZ (reprint author), Natl Univ Singapore, Div Bioengn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM biezyz@nus.edu.sg
RI Zhang, Yanzhong/A-9865-2008; Lim, Chwee Teck/B-3307-2011
OI Zhang, Yanzhong/0000-0002-2663-1279; Lim, Chwee
   Teck/0000-0003-4019-9782; Jayarama Reddy, Venugopal/0000-0001-5867-8007
CR AKIN H, 1995, J APPL POLYM SCI, V58, P95, DOI 10.1002/app.1995.070580110
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   BIGI A, 1987, INT J BIOL MACROMOL, V9, P363, DOI 10.1016/0141-8130(87)90010-9
   BOTTOMS E, 1966, NATURE, V211, P97, DOI 10.1038/211097a0
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Cortesi R, 1998, BIOMATERIALS, V19, P1641, DOI 10.1016/S0142-9612(98)00034-9
   FUJIMORI E, 1965, BIOPOLYMERS, V3, P115, DOI 10.1002/bip.360030202
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   GUIDOIN R, 1987, BIOMATERIALS, V8, P433, DOI 10.1016/0142-9612(87)90079-2
   HARLAND RS, 1989, COLLOID POLYM SCI, V267, P218, DOI 10.1007/BF01410578
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kim JS, 2000, POLYM J, V32, P616, DOI 10.1295/polymj.32.616
   Lee KH, 2003, J POLYM SCI POL PHYS, V41, P1256, DOI 10.1002/polb.10482
   Li JK, 1998, J MICROENCAPSUL, V15, P163, DOI 10.3109/02652049809006846
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Nagura M, 2002, POLYM J, V34, P761, DOI 10.1295/polymj.34.761
   Olde Damink L. H. H., 1995, J MATER SCI-MATER M, V6, P460, DOI [DOI 10.1007/BF00123371, 10.1007/BF00123371]
   PEZRON I, 1991, POLYMER, V32, P3201, DOI 10.1016/0032-3861(91)90143-7
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   ROSSMURPHY SB, 1992, POLYMER, V33, P2622, DOI 10.1016/0032-3861(92)91146-S
   RUIJGROK JM, 1994, J MATER SCI-MATER M, V5, P80, DOI 10.1007/BF00121695
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   VEIS A, 1963, J BIOL CHEM, V238, P2003
   Ward A. G., 1977, SCI TECHNOLOGY GELAT
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 33
TC 345
Z9 354
U1 3
U2 157
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR 5
PY 2006
VL 47
IS 8
BP 2911
EP 2917
DI 10.1016/j.polymer.2006.02.046
PG 7
WC Polymer Science
SC Polymer Science
GA 033AG
UT WOS:000236817700037
DA 2018-10-20
ER

PT J
AU Ma, DL
   Guan, JW
   Normandin, F
   Denommee, S
   Enright, G
   Veres, T
   Simard, B
AF Ma, DL
   Guan, JW
   Normandin, F
   Denommee, S
   Enright, G
   Veres, T
   Simard, B
TI Multifunctional nano-architecture for biomedical applications
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID DOPED SILICA NANOPARTICLES; CORE-SHELL NANOPARTICLES; BIOCONJUGATED
   NANOPARTICLES; MAGNETIC NANOPARTICLES; DNA; NANOCRYSTALS; BIOMOLECULES;
   SENSITIVITY; MICROARRAYS
AB A multifunctional architecture for biomedical applications has been developed by deliberately combining the useful functions of superparamagnetism, luminescence, and surface functionality into one material. Good control of the core-shell architecture has been achieved by employing a sol-gel synthesis. Superparamagnetic iron oxide nanoparticles are first coated with silica to isolate the magnetic core from the surrounding. Subsequently, the dye molecules are doped inside a second silica shell to improve photostability and allow for versatile surface functionalities. The architecture has been characterized by transmission electron microscopy, UV-vis absorption and emission spectroscopy, energy-dispersive X-ray spectroscopy, X-ray diffraction, and magnetometry. The hybrid nanoparticles exhibit improved superparamagnetic behavior over the as-received nanoparticles with a significant decrease in the blocking temperature. The architecture shows emission properties similar to those of the free dye molecules, suggesting that the first silica shell successfully prevents luminescence quenching by minimizing dyemagnetic core interactions.
C1 Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada.
   Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
RP Simard, B (reprint author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.
EM benoit.simard@nrc-cnrc.gc.ca
OI Ma, Dongling/0000-0001-8558-3150
CR Bao P, 2002, ANAL CHEM, V74, P1792, DOI 10.1021/ac0111964
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b
   Farrell D, 2003, J PHYS CHEM B, V107, P11022, DOI 10.1021/jp0351831
   Frenkel J, 1930, NATURE, V126, P274, DOI 10.1038/126274a0
   Grasset F, 2002, LANGMUIR, V18, P8209, DOI 10.1021/la020322b
   He YP, 2005, J PHYS D APPL PHYS, V38, P1342, DOI 10.1088/0022-3727/38/9/003
   Lee Y, 2005, ADV FUNCT MATER, V15, P503, DOI 10.1002/adfm.200400187
   Lu Y, 2002, NANO LETT, V2, P183, DOI 10.1021/nl015681q
   MA D, UNPUB NANOTECHNOLOGY
   Ma D., UNPUB
   Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p
   Mine E, 2003, J COLLOID INTERF SCI, V264, P385, DOI 10.1016/S0021-9797(03)00422-3
   Ngo AT, 1999, EUR PHYS J B, V9, P583, DOI 10.1007/s100510050801
   Park JI, 2004, J AM CHEM SOC, V126, P9072, DOI 10.1021/ja049649k
   Santra S, 2001, ANAL CHEM, V73, P4988, DOI 10.1021/ac010406+
   Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590
   Sappey R, 1997, PHYS REV B, V56, P14551, DOI 10.1103/PhysRevB.56.14551
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Sun SH, 1999, J APPL PHYS, V85, P4325, DOI 10.1063/1.370357
   Tapec R, 2002, J NANOSCI NANOTECHNO, V2, P405, DOI 10.1166/jnn.2002.114
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   TRONC E, 1995, HYPERFINE INTERACT, V95, P129, DOI 10.1007/BF02146310
   Vestal CR, 2004, INT J NANOTECHNOL, V1, P240, DOI 10.1504/IJNT.2004.003727
   Vestal CR, 2004, J PHYS CHEM B, V108, P18222, DOI 10.1021/jp0464526
   Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.040486101
   Zhao XJ, 2003, ANAL CHEM, V75, P3476, DOI 10.1021/ac034330o
   Zhao XJ, 2003, J AM CHEM SOC, V125, P11474, DOI 10.1021/ja0358854
   Zhou XC, 2004, ANAL CHEM, V76, P5302, DOI 10.1021/ac049472c
NR 29
TC 139
Z9 140
U1 1
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD APR 4
PY 2006
VL 18
IS 7
BP 1920
EP 1927
DI 10.1021/cm052067x
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 028PC
UT WOS:000236499300029
DA 2018-10-20
ER

PT J
AU Lee, H
   Hong, SH
   Yang, KY
   Choi, KW
AF Lee, H
   Hong, SH
   Yang, KY
   Choi, KW
TI Fabrication of 100 nm metal lines on flexible plastic substrate using
   ultraviolet curing nanoimprint lithography
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID NANO-IMPRINTING LITHOGRAPHY; WAFER
AB Since polymer is flexible, lightweight, reliable and transparent and its material properties can easily be modified, it is a suitable substrate material for organic electronic devices, biomedical devices, and especially for flexible displays. To build a nano-device on a polymer substrate, nano to microsized patterning must be done. However, conventional photolithography cannot be used to fabricate patterns on flexible polymer substrate, due to the focusing and substrate handling issue associated with flexibility of polymer substrate and potential interaction between polymer and developer or other organic solvents used in photolithography. Degradation of polymer substrate during resist baking process over 120 degrees C can be another problem. In this study, 100 nm sized resist patterns were made on flexible polyethylene-terephthalate (PET) film using newly developed monomer based UV curing imprinting lithography. Compared to conventional imprint lithography, UV curing imprint lithography uses monomer based liquid phase resin and thus patterns can be fabricated without residual layer at room temperature and at much lower pressure (< 3-5 atm) with UV illumination. No degradation of PET film was observed due to the imprint process and, as a result, 100 nm sized Ti-Au metal patterns were successfully formed on PET film using UV curing imprint lithography and lift-off process.
C1 Korea Univ, Dept Mat Sci & Engn, Seoul 136701, South Korea.
   Korea Inst Nucl Safety, Taejon 305338, South Korea.
RP Lee, H (reprint author), Korea Univ, Dept Mat Sci & Engn, 1,5Ka, Seoul 136701, South Korea.
EM heonlee@korea.ac.kr
CR Chou SY, 1997, MICROELECTRON ENG, V35, P237, DOI 10.1016/S0167-9317(96)00097-4
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Colburn M, 1999, P SOC PHOTO-OPT INS, V3676, P379, DOI 10.1117/12.351155
   Gao JX, 2004, CHEM MATER, V16, P956, DOI 10.1021/cm0342849
   Hashimoto J, 2004, JPN J APPL PHYS 1, V43, P3419, DOI 10.1143/JJAP.43.3419
   Jung GY, 2004, APPL PHYS A-MATER, V78, P1169, DOI 10.1007/s00339-003-2393-0
   Lee H, 2005, MICROELECTRON ENG, V77, P42, DOI 10.1016/j.mee.2004.08.008
   Lee H, 2005, MICROELECTRON ENG, V77, P168, DOI 10.1016/j.mee.2004.10.004
   Liao WC, 2004, MICROELECTRON ENG, V75, P145, DOI 10.1016/j.mee.2004.03.084
   McAlpine MC, 2003, NANO LETT, V3, P443, DOI 10.1021/nl034031e
   Tan H, 1998, J VAC SCI TECHNOL B, V16, P3926, DOI 10.1116/1.590438
NR 11
TC 49
Z9 50
U1 2
U2 17
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD APR 3
PY 2006
VL 88
IS 14
AR 143112
DI 10.1063/1.2193653
PG 3
WC Physics, Applied
SC Physics
GA 030CX
UT WOS:000236612000086
DA 2018-10-20
ER

PT J
AU De la Fuente, JM
   Penades, S
AF De la Fuente, JM
   Penades, S
TI Glyconanoparticles: Types, synthesis and applications in glycoscience,
   biomedicine and material science
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE glyconanoparticle; quantum dot; magnetic nanoparticle; carbohydrate
   interaction; multivalence; glycobiology
ID CARBOHYDRATE-CARBOHYDRATE INTERACTION; ENCAPSULATED GOLD NANOPARTICLES;
   SPONGE MICROCIONA-PROLIFERA; SEMICONDUCTOR QUANTUM DOTS; SURFACE-PLASMON
   RESONANCE; MEDIATED SELF-RECOGNITION; EMBRYONAL CARCINOMA-CELLS;
   MAGNETIC NANOPARTICLES; NANOSTRUCTURED MATERIALS; MULTIVALENT
   INTERACTIONS
AB Nanoparticles are the subject of numerous papers and reports and are full of promises for electronic, optical, magnetic and biomedical applications. Although metallic nanoparticles have been functionalized with peptides, proteins and DNA during the last 20 years, carbohydrates have not been used with this purpose until 2001. Since the first synthesis of gold nanoparticles functionalized with carbohydrates (glyconanoparticles) was reported, the number of published articles has considerably increased. This article reviews progress in the development of nanoparticles functionalized with biological relevant oligosaccharides. The glyconanoparticles constitute a good bio-mimetic model of carbohydrate presentation at the cell surface, and maybe, excellent tools for Glycobiology, Biomedicine and Material Science investigations. (c) 2005 Elsevier B.V. All rights reserved.
C1 CSIC, Inst Invest Quim, Grp Carbohidratos, Seville 41092, Spain.
RP Penades, S (reprint author), CSIC, Inst Invest Quim, Grp Carbohidratos, Amer Vespucio 49, Seville 41092, Spain.
EM lafuente@iiq.csic.es; penades@iiq.csic.es
OI de la Fuente, Jesus M/0000-0003-1081-8482
CR Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   ALIVISATOS AP, 2000, PURE APPL CHEM, V72, P3
   Andre S, 1999, GLYCOBIOLOGY, V9, P1253, DOI 10.1093/glycob/9.11.1253
   Andre S, 2001, CHEMBIOCHEM, V2, P822, DOI 10.1002/1439-7633(20011105)2:11<822::AID-CBIC822>3.0.CO;2-W
   Arranz-Plaza E, 2002, J AM CHEM SOC, V124, P13035, DOI 10.1021/ja020536f
   Aslan K, 2004, J FLUORESC, V14, P391, DOI 10.1023/B:JOFL.0000031820.17358.28
   Aslan K, 2004, ANAL BIOCHEM, V330, P145, DOI 10.1016/j.ab.2004.03.032
   Barrientos AG, 2003, CHEM-EUR J, V9, P1909, DOI 10.1002/chem.200204544
   BENOIT H, 1999, CARBOHYD RES, V315, P48
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046
   Brousseau LC, 1998, J AM CHEM SOC, V120, P7645, DOI 10.1021/ja981262s
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655
   BURKAT W, 1986, J BIOL CHEM, V261, P2853
   Cairo CW, 2002, J AM CHEM SOC, V124, P1615, DOI 10.1021/ja016727k
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chen YF, 2003, NANO LETT, V3, P581, DOI 10.1021/n1034086g
   Chen YJ, 2005, CHEMBIOCHEM, V6, P1169, DOI 10.1002/cbic.200500023
   Choi SK, 1997, J AM CHEM SOC, V119, P4103, DOI 10.1021/ja963519x
   CHOI SK, 2004, SYNTHETIC MULTIVARIA
   Cliffel DE, 2000, LANGMUIR, V16, P9699, DOI 10.1021/la000922f
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   Collier CP, 1997, SCIENCE, V277, P1978, DOI 10.1126/science.277.5334.1978
   Coulthard I, 1998, CAN J CHEM, V76, P1707, DOI 10.1139/cjc-76-11-1707
   Crespo P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.087204
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   de La Fuente J. M., 2001, ANGEW CHEM INT EDIT, V40, P2257, DOI DOI 10.1002/1521-3773(20010618)40:12
   de la Fuente JDM, 2005, TETRAHEDRON-ASYMMETR, V16, P387, DOI 10.1016/j.tetasy.2004.12.002
   de la Fuente JM, 2004, GLYCOCONJUGATE J, V21, P149, DOI 10.1023/B:GLYC.0000044846.80014.cb
   de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+
   de la Fuente JM, 2005, CHEMBIOCHEM, V6, P989, DOI 10.1002/cbic.200500071
   de la Fuente JM, 2005, J AM CHEM SOC, V127, P6192, DOI 10.1021/ja0431354
   de Paz JL, 2005, TETRAHEDRON-ASYMMETR, V16, P149, DOI 10.1016/j.tetasy.2004.11.066
   de Souza AC, 2004, EUR J ORG CHEM, P4323, DOI 10.1002/ejoc.200400255
   de Souza AC, 2005, CHEMBIOCHEM, V6, P828, DOI 10.1002/cbic.200400380
   DELAFUENTE JM, UNPUB
   Drechsler U, 2004, CHEM-EUR J, V10, P5570, DOI 10.1002/chem.200306076
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b
   EGGENS I, 1989, J BIOL CHEM, V264, P9476
   Fan EK, 2000, J AM CHEM SOC, V122, P2663, DOI 10.1021/ja993388a
   FELDHERR CM, 1992, P NATL ACAD SCI USA, V89, P11002, DOI 10.1073/pnas.89.22.11002
   Fendler JH, 1996, CHEM MATER, V8, P1616, DOI 10.1021/cm960116n
   Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045
   Gerion D, 2002, J AM CHEM SOC, V124, P7070, DOI 10.1021/ja017822w
   GLEITER H, 1992, ADV MATER, V4, P474, DOI 10.1002/adma.19920040704
   Goldman ER, 2002, J AM CHEM SOC, V124, P6378, DOI 10.1021/ja0125570
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   HAKOMORI S, 1991, PURE APPL CHEM, V63, P473, DOI 10.1351/pac199163040473
   Halkes KM, 2005, EUR J ORG CHEM, P3650, DOI 10.1002/ejoc.200500256
   Hanaki K, 2003, BIOCHEM BIOPH RES CO, V302, P496, DOI 10.1016/S0006-291X(03)00211-0
   Hernaiz MJ, 2002, ANGEW CHEM INT EDIT, V41, P1554, DOI 10.1002/1521-3773(20020503)41:9<1554::AID-ANIE1554>3.0.CO;2-3
   Hogemann D, 2002, BIOCONJUGATE CHEM, V13, P116, DOI 10.1021/bc015549h
   Horan N, 1999, P NATL ACAD SCI USA, V96, P11782, DOI 10.1073/pnas.96.21.11782
   Houseman BT, 2002, TOP CURR CHEM, V218, P1
   Hu J, 2001, J AM CHEM SOC, V123, P1464, DOI 10.1021/ja003180l
   Huang HZ, 2004, COLLOID SURFACE B, V39, P31, DOI 10.1016/j.colsurfb.2004.08.014
   Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jule E, 2003, BIOCONJUGATE CHEM, V14, P177, DOI 10.1021/bc025598+
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   Kim TH, 2004, BIOMATERIALS, V25, P3783, DOI 10.1016/j.biomaterials.2003.10.063
   KINGERYWOOD JE, 1992, J AM CHEM SOC, V114, P7303, DOI 10.1021/ja00044a057
   Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095
   KOJIMA N, 1994, GLYCOCONJUGATE J, V11, P238, DOI 10.1007/BF00731224
   KOJIMA N, 1989, J BIOL CHEM, V264, P20159
   LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001
   Letsinger RL, 2000, BIOCONJUGATE CHEM, V11, P289, DOI 10.1021/bc990152n
   Lin CC, 2002, J AM CHEM SOC, V124, P3508, DOI 10.1021/ja0200903
   Lin CC, 2003, CHEM COMMUN, P2920, DOI 10.1039/b308995a
   Liu JQ, 2001, BIOMACROMOLECULES, V2, P362, DOI 10.1021/bm015515c
   Lopez-Cartes C, 2005, J PHYS CHEM B, V109, P8761, DOI 10.1021/jp050184+
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   MAHTAB R, 1995, J AM CHEM SOC, V117, P9099, DOI 10.1021/ja00140a040
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   Marinakos SM, 2001, J PHYS CHEM B, V105, P8872, DOI 10.1021/jp010820d
   Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y
   MAXWELL DJ, 2002, J AM CHEM SOC, V124, P9609
   MISEVIC GN, 1993, J BIOL CHEM, V268, P4922
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q
   Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545
   Nelson A, 2004, J AM CHEM SOC, V126, P11914, DOI 10.1021/ja0491073
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Nolting B, 2003, LANGMUIR, V19, P6465, DOI 10.1021/la034414s
   OTSUJI E, 1995, INT J ONCOL, V6, P319
   Otsuka H, 2001, J AM CHEM SOC, V123, P8226, DOI 10.1021/ja010437m
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   PENADES S, Patent No. 2004108165
   Perez JM, 2004, CHEMBIOCHEM, V5, P261, DOI 10.1002/cbic.200300730
   Polak J.M., 1984, IMMUNOLABELING ELECT
   Potapova I, 2003, J AM CHEM SOC, V125, P320, DOI 10.1021/ja028641c
   Qi LF, 2005, BIOORG MED CHEM LETT, V15, P1397, DOI 10.1016/j.bmcl.2005.01.010
   QUIN D, 1999, ADV MATER, V11, P1433
   Robinson A, 2005, CHEMBIOCHEM, V6, P1899, DOI 10.1002/cbic.200500112
   Rojas TC, 2002, ADV MATER, V14, P585, DOI 10.1002/1521-4095(20020418)14:8<585::AID-ADMA585>3.0.CO;2-W
   Rojo J, 2004, CHEMBIOCHEM, V5, P291, DOI 10.1002/cbic.200300726
   Rosenthal SJ, 2002, J AM CHEM SOC, V124, P4586, DOI 10.1021/ja003486s
   Roy R., 2002, REV MOL BIOTECH, V90, P291
   Sapra S, 2001, CHEM COMMUN, P2188, DOI 10.1039/b106420g
   Schellenberger EA, 2004, CHEMBIOCHEM, V5, P275, DOI 10.1002/cbic.200300713
   Song Y, 1998, J BIOL CHEM, V273, P2517, DOI 10.1074/jbc.273.5.2517
   SPILLMAN D, 2000, CARBOHYDRATE CARBOHY, P1061
   SPILLMANN D, 1993, J BIOL CHEM, V268, P13378
   SPILLMANN D, 1995, J BIOL CHEM, V270, P5089, DOI 10.1074/jbc.270.10.5089
   Spreitzer G, 2000, CHEM COMMUN, P209, DOI 10.1039/a907178d
   STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340
   Sun XL, 2004, CHEMBIOCHEM, V5, P1593, DOI 10.1002/cbic.200400137
   Sutherland AJ, 2002, CURR OPIN SOLID ST M, V6, P365, DOI 10.1016/S1359-0286(02)00081-5
   Svarovsky SA, 2005, TETRAHEDRON-ASYMMETR, V16, P587, DOI 10.1016/j.tetasy.2004.12.003
   Takae S, 2005, BIOMACROMOLECULES, V6, P818, DOI 10.1021/bm049427e
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Templeton AC, 1999, LANGMUIR, V15, P66, DOI 10.1021/la9808420
   Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w
   Thoma G, 2002, ANGEW CHEM INT EDIT, V41, P3195, DOI 10.1002/1521-3773(20020902)41:17<3195::AID-ANIE3195>3.0.CO;2-X
   Tkachenko AG, 2003, J AM CHEM SOC, V125, P4700, DOI 10.1021/ja0296935
   Tsai CS, 2005, CHEM COMMUN, P4273, DOI 10.1039/b507237a
   TURNBULL WB, 2002, REV MOL BIOTECHNOL, V90, P231
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Vernon SD, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-12
   Wang J, 2005, SMALL, V1, P1036, DOI 10.1002/smll.200500214
   Watson KJ, 1999, J AM CHEM SOC, V121, P462, DOI 10.1021/ja983173l
   WEIGEL PH, 1979, J BIOL CHEM, V254, P830
   West JL, 2000, CURR OPIN BIOTECH, V11, P215, DOI 10.1016/S0958-1669(00)00082-3
   Westenhoff S, 2002, J AM CHEM SOC, V124, P2448, DOI 10.1021/ja0173728
   Winter JO, 2001, ADV MATER, V13, P1673, DOI 10.1002/1521-4095(200111)13:22<1673::AID-ADMA1673>3.0.CO;2-6
   Woller EK, 2003, J AM CHEM SOC, V125, P8820, DOI 10.1021/ja0352496
   WORMALD MR, 1991, BIOCHEM BIOPH RES CO, V180, P1214, DOI 10.1016/S0006-291X(05)81325-7
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Yu S, 2002, P NATL ACAD SCI USA, V99, P2854, DOI 10.1073/pnas.052707599
   Zhang J, 2004, ANAL BIOCHEM, V332, P253, DOI 10.1016/j.ab.2004.05.051
NR 134
TC 194
Z9 195
U1 2
U2 82
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD APR
PY 2006
VL 1760
IS 4
BP 636
EP 651
DI 10.1016/j.bbagen.2005.12.001
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 040JH
UT WOS:000237374300012
PM 16529864
DA 2018-10-20
ER

PT J
AU Shangguan, YY
   Wang, YW
   Wu, Q
   Chen, GQ
AF Shangguan, YY
   Wang, YW
   Wu, Q
   Chen, GQ
TI The mechanical properties and in vitro biodegradation and
   biocompatibility of UV-treated
   poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)
SO BIOMATERIALS
LA English
DT Article
DE UV radiation; biodegradation; PHBHHx; PHB; mechanical property
ID HEART-VALVES; MICROBIAL POLYHYDROXYALKANOATES; BONE-MARROW; TISSUE;
   SCAFFOLDS; IRRADIATION; COLLAGEN; POLYHYDROXYBUTYRATE; PROLIFERATION;
   AFFINITY
AB Strong mechanical properties and controllable biodegradability, together with biocompatibility, are the important requirement for the development of medical implant materials. In this study, an ultraviolet (UV) radiation method was developed to achieve controlled degradation for bacterial biopolyester poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) which has a low biodegradation rate that limits its application for many implant applications required quick degradation. When UV radiation was applied directly to PHBHHx powder, significant molecular weight (Mw) losses were observed with the powder, Mw reduction depended on the UV radiation time. At the same time, a broad PHBHHx Mw distribution was the result of inhomogeneous radiation. Interestingly, this inhomogeneous radiation helped maintain the mechanical properties of films made of the UV-radiated powder. In comparison, the PHBHHx films subjected to direct UV radiation became very brittle although their degradation was faster than that of the PHBHHx powders subjected to direct UV radiation. After 15 weeks of degradation in simulated body fluid (SBF), films prepared from 8 and 16 It UV-treated PHBHHx powders maintained 92% and 87% of their original weights, respectively, while the untreated PHBHHx films lost only 1 % of its weight. Significant increases in growth of fibroblast L929 were observed on films prepared from UV-radiated powders. This improved biocompatibility could be attributed to increasing hydrophilic functional groups generated by increasing polar groups C-O and C=O. In general, UV-treated PHBHHx powder had a broad Mw distribution, which contributed to fast degradation due to dissolution of low Mw polymer fragments, and strong mechanical property due to high Mw polymer chains. Combined with its improved biocompatibility, PHBHHx is one more step close to become a biomedical implant material. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
   Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
RP Chen, GQ (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
EM chengq@mail.tsinghua.edu.cn
CR Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Doi Y., 2002, BIOPOLYMERS
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Fischbach C, 2001, SURF SCI, V491, P333, DOI 10.1016/S0039-6028(01)01297-3
   Gijsman P, 1996, POLYM DEGRAD STABIL, V53, P45, DOI 10.1016/0141-3910(96)00027-4
   Kaczmarek H, 2005, POLYM DEGRAD STABIL, V88, P189, DOI 10.1016/j.polymdegradstab.2004.04.017
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   Kunze C, 2002, J MATER SCI-MATER M, V13, P1051, DOI 10.1023/A:1020392606225
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   OPTIZ F, 2004, CARDIOVASC RES, V63, P719
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   SIMON FW, 1999, INT J BIOL MACROMOL, V25, P111
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Sodian R, 2000, CIRCULATION, V102, P22
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   Wang YW, 2005, BIOMACROMOLECULES, V6, P566, DOI 10.1021/bm049342d
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   WANG YW, 2004, BIOMATERIALS, V26, P899
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zhao K, 2002, J MATER SCI-MATER M, V13, P849, DOI 10.1023/A:1016596228316
   Zheng Z, 2003, J BIOMAT SCI-POLYM E, V14, P615, DOI 10.1163/156856203322274888
NR 39
TC 52
Z9 58
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2006
VL 27
IS 11
BP 2349
EP 2357
DI 10.1016/j.biomaterials.2005.11.024
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016PF
UT WOS:000235631500003
PM 16325905
DA 2018-10-20
ER

PT J
AU Bettinger, CJ
   Orrick, B
   Misra, A
   Langer, R
   Borenstein, JT
AF Bettinger, CJ
   Orrick, B
   Misra, A
   Langer, R
   Borenstein, JT
TI Micro fabrication of poly (glycerol-sebacate) for contact guidance
   applications
SO BIOMATERIALS
LA English
DT Article
DE microstructure; biodegradation; biocompatibility; nanotopography
ID MICROGROOVED POLYSTYRENE; EPITHELIAL-CELLS; TOPOGRAPHY; FIBROBLASTS;
   SUBSTRATA; POLY(DIMETHYLSILOXANE); NANOTOPOGRAPHY; ORGANIZATION;
   MORPHOLOGY; SURFACES
AB Controlling cell orientation and morphology through topographical patterning is a phenomenon that is applicable to a wide variety of medical applications such as implants and tissue engineering scaffolds. Previous work in this field, termed contact guidance, has demonstrated the application of this cellular response on a wide variety of material substrates such as silicon, quartz, glass, and poly(dimethyl siloxane) typically using ridge-groove geometries with sharp feature edges. One limitation of these studies in terms of biomedical applications is the choice of material. Therefore, demonstrating contact guidance and topography in a biodegradable material platform is a promising strategy for controlling cellular arrangements in tissue engineering scaffolds. This study investigates several strategies to advance contact guidance strategies and technology to more practical applications. Flexible biodegradable substrates with rounded features were fabricated by replica-molding poly(glycerol-sebacate) on sucrose-coated microfabricated silicon. Bovine aortic endothelial cells were cultured on substrates with microstructures between 2 and 5 mu m in wavelength and with constant feature depth of 0.45 mu m. Cells cultured on substrates with smaller pitches exhibited a substantially higher frequency of cell alignment and smaller circularity index. This work documents the first known use of using a flexible, biodegradable substrate with rounded features for use in contact guidance applications. The replica-molding technique described here is a general process that can be used to fabricate topographically patterned substrates with rounded features for many biomaterials. Furthermore, these results may lead to further elucidation of the mechanism of cell alignment and contact guidance on microfabricated substrates. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Charles Stark Draper Lab Inc, MEMS Technol Grp, Cambridge, MA 02139 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Borenstein, JT (reprint author), Charles Stark Draper Lab Inc, MEMS Technol Grp, 555 Technol Sq, Cambridge, MA 02139 USA.
EM jborenstein@draper.com
RI Bettinger, Christopher/A-3895-2009
FU NIDCR NIH HHS [DE013023]; NHLBI NIH HHS [HL060435]
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   Braber E. T. d., 1996, BIOMATERIALS, V17, P2037
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Jiang XY, 2002, LANGMUIR, V18, P3273, DOI 10.1021/la011668+
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   LEATRESE DH, 1998, J BIOMED MATER RES, V42, P396
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   SVITKINA TM, 1995, J CELL SCI, V108, P735
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WEBB A, 1995, J CELL SCI, V108, P2747
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
NR 31
TC 152
Z9 156
U1 5
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2006
VL 27
IS 12
BP 2558
EP 2565
DI 10.1016/j.biomaterials.2005.11.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 017VT
UT WOS:000235722100006
PM 16386300
DA 2018-10-20
ER

PT J
AU Chung, PH
   Perevedentseva, E
   Tu, JS
   Chang, CC
   Cheng, CL
AF Chung, P. -H.
   Perevedentseva, E.
   Tu, J. -S.
   Chang, C. C.
   Cheng, C. -L.
TI Spectroscopic study of bio-functionalized nanodiamonds
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, and Nitrides
CY SEP 11-16, 2005
CL Toulouse, FRANCE
DE nanodiamonds; biomedical applications; sensors; surface characterization
ID DIAMOND SURFACES; QUANTUM DOTS; IN-VIVO; INFRARED-SPECTROSCOPY; DNA;
   IMMOBILIZATION; NANOPARTICLES; NANOCRYSTALS; DESORPTION; PEPTIDES
AB Nano-scale materials with attached biomolecules on the surface can be used as bioprobes in cell and tissue analysis. The conjugation of these nanoparticles with biomolecules is one of the key steps in the development of bioprobes. In this work nanometer-sized diamonds (5 and 100 nm) are functionalized and conjugated with protein lysozyme via physical adsorption. The process of creating functional groups on the nanodiamond surface is studied using Fourier Transform Infrared-spectroscopy (FTIR). The conjugation of nanodiamonds with biontolecules and nanodiamond-biomolecule interaction are analyzed with UV/VIS and FTIR spectroscopy. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Dong Hwa Univ, Dept Phys, Shoufeng 974, Hualien, Taiwan.
   Russian Acad Sci, PN Lebedev Phys Inst, Moscow 117901, Russia.
   Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.
RP Cheng, CL (reprint author), Natl Dong Hwa Univ, Dept Phys, 1 Sec 2 Da Hsueh Rd, Shoufeng 974, Hualien, Taiwan.
EM clcheng@mail.ndhu.edu.tw
RI Perevedentseva, Elena/M-9925-2015
OI Chang, Chia-Ching/0000-0002-3444-0894
CR Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   ANDO T, 1993, J CHEM SOC FARADAY T, V89, P749, DOI 10.1039/ft9938900749
   ANDO T, 1993, J CHEM SOC FARADAY T, V89, P3635, DOI 10.1039/ft9938903635
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Cao YC, 2003, J AM CHEM SOC, V125, P14676, DOI 10.1021/ja0366235
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268
   Coradin T, 2003, J MATER CHEM, V13, P705, DOI 10.1039/b210514d
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Forbes ZG, 2003, IEEE T MAGN, V39, P3372, DOI 10.1109/TMAG.2003.816260
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gu HR, 2005, J PHYS CHEM B, V109, P13611, DOI 10.1021/jp050625p
   Huang LCL, 2004, LANGMUIR, V20, P5879, DOI 10.1021/la0495736
   Huang T, 2003, ENZYME MICROB TECH, V33, P958, DOI 10.1016/j.enzmictec.2003.07.005
   Jones AP, 2000, ASTRON ASTROPHYS, V355, P1191
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   Knickerbocker T, 2003, LANGMUIR, V19, P1938, DOI 10.1021/la026279
   KOSSOVSKY N, 1995, BIOCONJUGATE CHEM, V6, P507, DOI 10.1021/bc00035a001
   Laikhtman A, 2003, J CHEM PHYS, V119, P1794, DOI 10.1063/1.1580097
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Mathieu HJ, 2001, SURF INTERFACE ANAL, V32, P3, DOI 10.1002/sia.995
   Poh WC, 2004, LANGMUIR, V20, P5484, DOI 10.1021/la0490947
   Puzyr' AP, 2004, PHYS SOLID STATE+, V46, P761, DOI 10.1134/1.1711469
   Salata OV, 2004, J NANOBIOTECHNOL, V2, P1, DOI DOI 10.1186/1477-3155-2-3
   Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375
   Tsubota T, 2002, PHYS CHEM CHEM PHYS, V4, P806, DOI 10.1039/b107349b
   Ushizawa K, 2002, CHEM PHYS LETT, V351, P105, DOI 10.1016/S0009-2614(01)01362-8
   Whaley SR, 2000, NATURE, V405, P665
   YANG W, 2002, NAT MATTERS, V1, P263
NR 29
TC 142
Z9 144
U1 2
U2 46
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2006
VL 15
IS 4-8
SI SI
BP 622
EP 625
DI 10.1016/j.diamond.2005.11.019
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 065JU
UT WOS:000239157000034
DA 2018-10-20
ER

PT J
AU Kwok, SCH
   Ha, PCT
   McKenzie, DR
   Bilek, MMM
   Chu, PK
AF Kwok, S. C. H.
   Ha, P. C. T.
   McKenzie, D. R.
   Bilek, M. M. M.
   Chu, Paul K.
TI Biocompatibility of calcium and phosphorus doped diamond-like carbon
   thin films synthesized by plasma immersion ion implantation and
   deposition
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 16th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, and Nitrides
CY SEP 11-16, 2005
CL Toulouse, FRANCE
DE diamond-like carbon; doping; blood compatibility; plasma immersion ion
   implantation and deposition
ID C-H FILMS; DLC COATINGS; IN-VITRO; ACTIVATION; HEMOCOMPATIBILITY;
   ADSORPTION; PLATELETS; TITANIUM
AB Diamond-like carbon has superior mechanical and chemical properties and has been widely studied as coatings in the optics, magnetic media, semiconductor and biomedical industry. In order to enhance the properties and performance of the materials, elemental doping and multi-layer deposition have been proposed. In cardiovascular biomedical applications such as artificial heart valves, low-temperature isotropic pyrolytic carbon (LTIC) is the most widely used material, but its blood compatibility is still not adequate. Diamond-like carbon (DLC) is a potential substitute due to its good biocompatibility and mechanical properties. In addition, the blood compatibility may be further enhanced by introducing some biologically friendly elements. In this work, calcium and phosphorus doped DLC films were fabricated by plasma immersion ion implantation and deposition (PIII and D). The structure and biological properties were assessed using X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), contact angle measurement, and platelet adhesion test. Reduced platelet adhesion was obtained from the calcium or phosphorus doped DLC compared to LTIC, suggesting that doping DLC with calcium or phosphorus enhances its surface blood compatibility. (c) 2005 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
   Univ Sydney, Sch Phys, Appl & Plasma Phys Grp, Sydney, NSW, Australia.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; McKenzie, David/0000-0002-2476-1301;
   Bilek, Marcela/0000-0003-3363-2664
CR Babonneau D, 2000, J APPL PHYS, V87, P3432, DOI 10.1063/1.372363
   Chu PK, 2004, J VAC SCI TECHNOL B, V22, P289, DOI 10.1116/1.1632920
   CHU PK, 2004, NUCL SCI TECH, V15, P123
   Dorner-Reisel A, 2002, THIN SOLID FILMS, V420, P263, DOI 10.1016/S0040-6090(02)00745-9
   ELAM JH, 1992, BIOMATERIALS, V13, P3, DOI 10.1016/0142-9612(92)90086-4
   Fortunato W, 2005, THIN SOLID FILMS, V476, P246, DOI 10.1016/j.tsf.2004.09.027
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hauert R, 1999, SURF COAT TECH, V120, P291, DOI 10.1016/S0257-8972(99)00499-5
   JEONG W, 2000, THIN SOLID FILMS, V374, P103
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Krishnan LK, 2002, BIOMOL ENG, V19, P251, DOI 10.1016/S1389-0344(02)00029-1
   Kwok SCH, 2004, J BIOMED MATER RES A, V70A, P107, DOI 10.1002/jbm.a.30070
   KWOK SCH, 2004, DIAM RELAT MATER, V14, P78
   Liu TY, 2005, BIOMATERIALS, V26, P1437, DOI 10.1016/j.biomaterials.2004.04.039
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Panwar OS, 2004, DIAM RELAT MATER, V13, P513, DOI 10.1016/j.diamond.2003.12.011
   Podgornik B, 2005, THIN SOLID FILMS, V476, P92, DOI 10.1016/j.tsf.2004.09.028
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   VANOSS CJ, 1988, J CHEM REV, V88, P92
   Waidmann S, 1999, CARBON, V37, P823, DOI 10.1016/S0008-6223(98)00278-4
   Yang P, 2004, SURF COAT TECH, V177, P747, DOI 10.1016/j.surfcoat.2003.08.016
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 23
TC 34
Z9 44
U1 0
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2006
VL 15
IS 4-8
SI SI
BP 893
EP 897
DI 10.1016/j.diamond.2005.10.062
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 065JU
UT WOS:000239157000090
DA 2018-10-20
ER

PT J
AU Gao, Y
   Kong, L
   Zhang, L
   Gong, YD
   Chen, GQ
   Zhao, NM
   Zhang, XF
AF Gao, Y
   Kong, L
   Zhang, L
   Gong, YD
   Chen, GQ
   Zhao, NM
   Zhang, XF
TI Improvement of mechanical properties of poly(DL-lactide) films by
   blending of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE poly(3-hydroxybutyrate-co-3-hydroxyhexanoate); poly(DL-lactide); blends;
   mechanical property
ID ISOLATION INFRARED-SPECTROSCOPY; SURFACE FREE-ENERGY; DOT-O
   INTERACTIONS; THERMAL-BEHAVIOR; IN-VITRO; HYDROGEN;
   POLYHYDROXYALKANOATES; BIOCOMPATIBILITY; FIBRONECTIN; SCAFFOLDS
AB Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) and poly(DL-lactide) (PDLLA) were blended at different ratios in an attempt to form a biomaterial with suitable properties for nerve regeneration. FT-IR and X-ray analysis showed that the blending of the PDLLA component did not alter the helical structure of PHBHHx, but did lead to a reduction of crystallinity. Differential scanning calorimetry (DSC) analysis indicated that the two polymers were immiscible in the melted state. The mechanical properties of certain composite films were more desirable than those of unblended PDLLA films. Blends consisting of PDLLA and PHBHHx at ratios of 2:1 and 1:2 exhibited a lower elastic modulus and a higher elongation at break compared to unblended PDLLA. ELISA results indicated that the amount of fibronectin adsorbed on composite films was much higher than the amount adsorbed on PDLLA film. The results of this study demonstrate the feasibility of using PDLLA/PHBHHx blended materials for biomedical applications. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Technol, Beijing 100084, Peoples R China.
RP Zhang, XF (reprint author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Technol, Beijing 100084, Peoples R China.
EM zxf-dbs@mail.tsinghua.edu.cn
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Andreopoulos AG, 1999, J MATER SCI-MATER M, V10, P29, DOI 10.1023/A:1008887910068
   Blatchford MA, 2002, J AM CHEM SOC, V124, P14818, DOI 10.1021/ja027337g
   Boldeskul IE, 1997, J MOL STRUCT, V437, P167, DOI 10.1016/S0022-2860(97)00137-3
   CARBONETTO S, 1983, J NEUROSCI, V3, P2324
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   CORNIBERT J, 1972, J MOL BIOL, V71, P735
   DAVIS PA, 1992, J MATER SCI-MATER M, V3, P359, DOI 10.1007/BF00705368
   Delanoye SN, 2002, J AM CHEM SOC, V124, P11854, DOI 10.1021/ja027610e
   Deng XM, 2001, EUR POLYM J, V37, P211, DOI 10.1016/S0014-3057(00)00090-2
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   Gu YL, 1999, J AM CHEM SOC, V121, P9411, DOI 10.1021/ja991795g
   GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Harada T, 2002, CHEM PHYS LETT, V362, P453, DOI 10.1016/S0009-2614(02)01139-9
   Hobza P, 2000, CHEM REV, V100, P4253, DOI 10.1021/cr990050q
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V37, P253, DOI 10.1016/0141-3910(92)90167-4
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIPINSKY ES, 1986, CHEM ENG PROG, V82, P26
   Matsuura H, 2003, J AM CHEM SOC, V125, P13910, DOI 10.1021/ja030538f
   Michalski MC, 1998, J COLLOID INTERF SCI, V208, P319, DOI 10.1006/jcis.1998.5814
   MILLARUELO AI, 1988, BRAIN RES, V466, P219
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   OLSSON J, 1995, COLLOID SURFACE B, V5, P161, DOI 10.1016/0927-7765(95)01212-2
   Padermshoke A, 2004, VIB SPECTROSC, V36, P241, DOI 10.1016/j.vibspec.2003.11.016
   Persin Z, 2004, TEXT RES J, V74, P55, DOI 10.1177/004051750407400110
   Sato H, 2004, MACROMOLECULES, V37, P7203, DOI 10.1021/ma049117o
   Sato H, 2004, MACROMOLECULES, V37, P3763, DOI 10.1021/ma049863t
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   van der Veken BJ, 2001, J AM CHEM SOC, V123, P12290, DOI 10.1021/ja010915t
   Verreck G, 2005, BIOMATERIALS, V26, P1307, DOI 10.1016/j.biomaterials.2004.04.040
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   [杨吟野 Yang Yinye], 2002, [生物医学工程学杂志, Journal of Biomedical Engineering], V19, P25
   YOKOUCHI M, 1973, POLYMER, V14, P267, DOI 10.1016/0032-3861(73)90087-6
   Yoshida H, 1997, J PHYS CHEM A, V101, P1731, DOI 10.1021/jp9624010
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 48
TC 58
Z9 66
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD APR
PY 2006
VL 42
IS 4
BP 764
EP 775
DI 10.1016/j.eurpolymj.2005.09.028
PG 12
WC Polymer Science
SC Polymer Science
GA 039ZT
UT WOS:000237348500005
DA 2018-10-20
ER

PT J
AU Petrini, P
   Arciola, CR
   Pezzali, I
   Bozzini, S
   Montanaro, L
   Tanzi, MC
   Speziale, P
   Visai, L
AF Petrini, P
   Arciola, CR
   Pezzali, I
   Bozzini, S
   Montanaro, L
   Tanzi, MC
   Speziale, P
   Visai, L
TI Antibacterial activity of zinc modified titanium oxide surface
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE titanium; anatase; rutile; zinc oxide; oral streptococcal strains;
   antibacterial activity; biofilm formation
ID IN-VITRO; BACTERIAL-COLONIZATION; IMPLANT MATERIALS; POWDER SLURRY;
   TIO2; WATER; DISINFECTION; ADHERENCE; ADHESION; MUTANS
AB Titanium-based implants are successfully used for various biomedical applications. However, in some cases, e.g. in dental implants, failures due to bacterial colonization are reported. Surface modification is a commonly proposed strategy to prevent infections. In this work, titanium oxide, naturally occurring on the surface of titanium, was modified by promoting the formation of a mixed titanium and zinc oxide, on the basis of the idea that zinc oxide on titanium surface may act as the zinc oxide used in pharmaceutical formulation for its lenitive and antibacterial effects. The present work shows that it is possible to form a mixed titanium and zinc oxide on titanium surfaces, as shown by Scanning Electron Microscopy and XPS analysis. To this end titanium was preactivated by UV on crystalline titanium oxide, both in the anatase form or in the co-presence of anatase and rutile. By performing antibacterial assays, we provide evidence of a significant reduction in the viability of five streptococcal oral strains on titanium oxide surfaces modified with zinc. In conclusion, this type of chemical modification of titanium oxide surfaces with zinc might be considered a new way to reduce the risk of bacterial colonization, increasing the lifetime of dental system applications.
C1 Univ Pavia, Dept Biochem, Med Sect, I-27100 Pavia, Italy.
   Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
   Politecn Milan, Dept Bioengn, Biomat Lab, I-20133 Milan, Italy.
RP Visai, L (reprint author), Univ Pavia, Dept Biochem, Med Sect, Via Taramelli 3B, I-27100 Pavia, Italy.
EM lvisai@unipv.it
RI Tanzi, Maria Cristina/I-4620-2013; Petrini, Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254
CR Berry C W, 1992, Implant Dent, V1, P59, DOI 10.1097/00008505-199200110-00006
   Blake DM, 1999, SEPAR PURIF METHOD, V28, P1, DOI 10.1080/03602549909351643
   Brunette D. M., 2001, TITANIUM MED, P231
   Chiesa R, 2003, J Appl Biomater Biomech, V1, P91
   Dominguez C, 1998, CATAL TODAY, V40, P85, DOI 10.1016/S0920-5861(97)00125-9
   Drake DR, 1999, INT J ORAL MAX IMPL, V14, P226
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   FUJIOKAHIRAI Y, 1987, J BIOMED MATER RES, V21, P913, DOI 10.1002/jbm.820210707
   Gatewood R R, 1993, Clin Oral Implants Res, V4, P53, DOI 10.1034/j.1600-0501.1993.040201.x
   Gopal J., 2003, TRENDS BIOMATER ARTI, V17, P13
   Grossner-Schreiber B, 2001, CLIN ORAL IMPLAN RES, V12, P543, DOI 10.1034/j.1600-0501.2001.120601.x
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   Herman GS, 2003, J PHYS CHEM B, V107, P2788, DOI 10.1021/jp0275544
   Imazato S, 1997, J DENT RES, V76, P768, DOI 10.1177/00220345970760030901
   LEONHARDT A, 1995, J DENT RES, V74, P1607, DOI 10.1177/00220345950740091701
   LEONHARDT A, 1995, CLIN ORAL IMPLAN RES, V4, P3
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   NAKAZATO G, 1989, International Journal of Oral and Maxillofacial Implants, V4, P321
   Pilliar RM, 2003, BIO-IMPLANT INTERFACE: IMPROVING BIOMATERIALS AND TISSUE REACTIONS, P43
   Qian D, 2004, J MATER SCI, V39, P5389, DOI 10.1023/B:JMSC.0000039251.24875.ee
   SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B
   Sandrini E, 2003, J Appl Biomater Biomech, V1, P33
   Sardin S, 2004, J ORAL REHABIL, V31, P140, DOI 10.1046/j.0305-182X.2003.01136.x
   Sawai J, 1998, J FERMENT BIOENG, V86, P521, DOI 10.1016/S0922-338X(98)80165-7
   SAWAI J, 1995, J CHEM ENG JPN, V28, P288, DOI 10.1252/jcej.28.288
   Sawai J, 2000, WORLD J MICROB BIOT, V16, P187, DOI 10.1023/A:1008916209784
   Sawai J., 1999, T MAT RES SOC JAPAN, V24, P667
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Sumita T, 2002, APPL SURF SCI, V200, P21, DOI 10.1016/S0169-4332(02)00614-1
   WEI C, 1994, ENVIRON SCI TECHNOL, V28, P934, DOI 10.1021/es00054a027
   William A.J., 1996, J AIR WASTE MANAGE, V46, P891
   Wolinsky L E, 1989, Int J Oral Maxillofac Implants, V4, P27
   Yamamoto O, 1998, J CERAM SOC JPN, V106, P1007, DOI 10.2109/jcersj.106.1007
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
NR 35
TC 75
Z9 77
U1 2
U2 24
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD APR
PY 2006
VL 29
IS 4
BP 434
EP 442
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 048SY
UT WOS:000237968000013
PM 16705613
DA 2018-10-20
ER

PT J
AU Legeay, G
   Poncin-Epaillard, F
   Arciola, CR
AF Legeay, G
   Poncin-Epaillard, F
   Arciola, CR
TI New surfaces with hydrophilic/hydrophobic characteristics in relation to
   (no)bioadhesion
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE surfaces; hydrophilic; hydrophobic; bioadhesion
ID MODIFIED INTRAOCULAR LENSES; STAPHYLOCOCCUS-EPIDERMIDIS; IN-VITRO;
   ADHESION; HEPARIN; CELLS
AB The possibility of biosurfaces with high or low adhesiveness for protein, bacteria or eukaryotic cells is discussed.
   At the interface surface object/biological milieu, biocompatibility, (no) bioadhesion and (no) biocontamination are shown to be correlated with physico-chemical surface characteristics. First consequence is the (no) possibility of biofilm formation.
   Substrates with low surface energy could interact only with hydrophobic biomolecules. On substrates with high surface energy, a water monolayer spontaneously formed. Modification of a surface by plasma techniques is a way for engineering biomaterials. Plasma techniques are dry processes and more suitable for biomedical applications. In the field of biomaterial medical devices, in hygienic prevention of nosocomial diseases, in food packaging, the use of substrates with a very hydrophilic character may help to prevent the proliferation of cells and bacteria. Such a technique is so efficient that antibiotic molecules are not necessary. Therefore, surface engineering is a tool for modifying and adapting materials to specific biological applications.
C1 Ctr Transfert Technol Mans, F-72000 Le Mans, France.
   Univ Maine, CNRS, Lab Polymeres Colloides & Interfaces, UMR 6120, F-72017 Le Mans, France.
   Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
RP Legeay, G (reprint author), Ctr Transfert Technol Mans, 20 Rue Thales Milet, F-72000 Le Mans, France.
EM glegeay@cttm-lemans.com
CR An YH, 2005, INT J ARTIF ORGANS, V28, P1126
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   ARCIOLA CR, 1993, J APPL BIOMATER, V4, P249, DOI 10.1002/jab.770040306
   BELLESSORT S, 2002, STRATEGIE PROTHETIQU, V2, P113
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   CADIEUX P, 2003, COLLOID SURFACE B, V28, P5
   Chavant P, 2002, APPL ENVIRON MICROB, V68, P728, DOI 10.1128/AEM.68.2.728-737.2002
   Chen G, 2003, J ADHES SCI TECHNOL, V17, P2131, DOI 10.1163/156856103772150742
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   EPAILLARD PF, 2005, Patent No. 0503322
   Faucheux N, 2004, BIOMATERIALS, V25, P2501, DOI 10.1016/j.biomaterials.2003.09.036
   Grasso JE, 1996, J AM DENT ASSOC, V127, P90, DOI 10.14219/jada.archive.1996.0036
   Henry M, 2003, LANGMUIR, V19, P6271, DOI 10.1021/la034081z
   Hindie A, 2005, BIOMOL ENG, V22, P205, DOI 10.1016/j.bioeng.2005.07.002
   HOSTETTLER F, 1997, Patent No. 5849368
   IKADA Y, 1984, ADV POLYM SCI, V57, P135
   Kessler L, 2003, J BIOMAT SCI-POLYM E, V14, P1135, DOI 10.1163/156856203769231619
   KOPIA G, 2001, Patent No. 0187372A1
   LEEDS HR, 1971, Patent No. 362079
   LEGEAY G, 2001, P CIP 2001 ANT, P10
   LEGEAY G, 2002, Patent No. 027036508
   LEGEAY G, 2001, Patent No. 1133972
   MAN N K, 1990, Artificial Organs, V14, P44
   MASAKAZU S, 1984, Patent No. 59164709
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   NAGEL MD, 2003, Patent No. 0313993
   Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725
   Poncin-Epaillard F, 2003, J BIOMAT SCI-POLYM E, V14, P1005, DOI 10.1163/156856203769231538
   PORTOLES M, 1993, J CATARACT REFR SURG, V19, P755, DOI 10.1016/S0886-3350(13)80345-8
   Suzer S, 1997, APPL SPECTROSC, V51, P1741, DOI 10.1366/0003702971939451
   Tenke P, 2004, INT J ANTIMICROB AG, V23, pS67, DOI 10.1016/j.ijantimicag.2003.12.007
   THANHTHUY LT, 2001, Patent No. 1070508A1
   WRIGHT C, 2003, Patent No. 0176915
NR 36
TC 43
Z9 44
U1 1
U2 15
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD APR
PY 2006
VL 29
IS 4
BP 453
EP 461
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 048SY
UT WOS:000237968000015
PM 16705615
DA 2018-10-20
ER

PT J
AU Douglas, VK
AF Douglas, Vasiliki K.
TI Childbirth among the Canadian Inuit: A review of the clinical and
   cultural literature
SO INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH
LA English
DT Review
DE birthing; Inuit; Canada; midwifery; evacuation; epidemiology
ID UMBILICAL-CORD BLOOD; POLYCHLORINATED-BIPHENYLS; EXPOSURE; QUEBEC;
   WOMEN; NUNAVIK; BIRTH; INFANTS; NORTH; SEAL
AB Background. This study reviews the historical, anthropological and biomedical literature on childbirth among Canadian Inuit resident in the Canadian Arctic. The modern period is characterised by increased tension as southern intervention replaced traditional birthing with a biomedical model and evacuation to metropolitan hospitals for birth. Inuit concern over the erosion of traditional culture has confronted biomedical concern over perinatal outcomes. Recently, community birthing centres have been established in Nunavik and Nunavut in order to integrate traditional birthing techniques with biomedical support.
   Objectives. To review the literature on Inuit childbirth in order to suggest avenues for future research.
   Study Design. Material for this review was gathered through combining library searches, database searches in ANTHROPOLOGYPlus, MEDLINE, CINAHL and Science-Direct, and a bibliographic search through the results.
   Results. Epidemiological studies of Inuit childbirth are outdated, inconclusive, or inseparable from non-Inuit data. Anthropological studies indicate that evacuation for childbirth has deleterious social and cultural effects and that there is considerable support for traditional communal birthing in combination with biomedical techniques and technology.
   Conclusions. Investigation of alternative solutions to maintaining acceptable perinatal outcomes among the Inuit seems desirable. Epidemiological and comparative qualitative studies of perinatal outcomes across the Arctic are needed to reconcile the cultural desirability of communal birthing with claims of its medical feasibility.
C1 Univ Alberta, Fac Nursing, Edmonton, AB, Canada.
RP Douglas, VK (reprint author), 5445 Old Summit Lake Rd, Prince George, BC V2K 5S5, Canada.
CR Arctic Monitoring Assessment Program, 2004, AMAP ASS 2002 PERS O
   Arctic Monitoring Assessment Programme, 2003, AMAP ASS 2002 HUM HL
   *AV CULT I, 1984, INT REP TRAD MED RES
   Ayotte P, 2003, ENVIRON HEALTH PERSP, V111, P1253, DOI 10.1289/ehp.6054
   BAIKIE M, 1990, NO PERSPECTIVES, V18, P21
   BASKETT TF, 1978, BRIT MED J, V2, P1001, DOI 10.1136/bmj.2.6143.1001
   Bjerregaard P, 1998, CIRCUMPOLAR INUIT HL
   BORRE K, 1991, MED ANTHROPOL Q, V5, P48, DOI 10.1525/maq.1991.5.1.02a00080
   BORRE K, 1994, ARCTIC ANTHROPOL, V31, P1
   Bouchard F, 1988, Arctic Med Res, V47 Suppl 1, P495
   BRETT B, 1976, CIRCUMPOLAR HLTH, P435
   BRIGGS J, 2001, INTERVIEWING INUIT E, V3
   Chamberlain M, 2000, MIDWIFERY, V16, P116, DOI 10.1054/midw.1999.0202
   Chamberlain M, 1998, Int J Circumpolar Health, V57 Suppl 1, P116
   CHATWOOD S, 1996, THESIS MCGILL U MONT
   Chatwood-Affleck S, 1998, Int J Circumpolar Health, V57 Suppl 1, P121
   Dallaire F, 2004, ENVIRON HEALTH PERSP, V112, P1359, DOI 10.1289/ehp.7255
   Dallaire F, 2003, ENVIRON HEALTH PERSP, V111, P1660, DOI 10.1289/ehp.6269
   DANGLURE BS, 1967, HOMME, V7, P92
   Daviss B A, 1996, Midwifery Today Childbirth Educ, P45
   Daviss B A, 1997, Midwifery Today Childbirth Educ, P45
   DAVISSPUTT BA, 1993, INT CONF MIDW 23 INT
   DAVISSPUTT BA, 1990, GOSSIP SPOKEN HIST W, P91
   Demissie K, 2000, PERINATAL HLTH INDIC
   Duffy Ronald Quinn, 1988, ROAD NUNAVUT PROGR E
   DUFOUR R, 1984, CAN J PUBLIC HEALTH, V75, P137
   DUFOUR R, 1984, RECHERCHES AMERINDIE, V14, P17
   Dufour Rose, 1988, FEMME ENFANTEMENT SA
   ELIAS B, 1995, STUDY SOCAL CULTURAL
   England J I, 1998, Int J Circumpolar Health, V57 Suppl 1, P113
   Finnemore B I, 1992, Arctic Med Res, V51, P117
   FLETCHER C, 1993, INUULITSIVIK MATERNI
   Furgal C., 1995, INUIT PERSPECTIVES E
   GAGNON J, 1989, NATIVE STUD REV, V5, P175
   GRIEG M, 1988, ARCTIC MED RES, V47, P485
   Grondin J., 1989, NATIVE STUD REV, V5, P17
   Guemple L., 1972, ALLIANCE ESKIMO SOC, P56
   HARVALD B, 1981, OBSTET EMERGENCIES C
   HOBART C, 1976, CIRCUMPOLAR HLTH, P452
   HOLUBOWSKY M, 1976, CIRCUMPOLAR HLTH, P441
   Houd S, 2004, Int J Circumpolar Health, V63 Suppl 2, P239
   *IN MAT, 2004, UNPUB STRAT PLAN DEV
   *IND AFF NO DEV, 2003, 2 IND AFF NO DEV
   Jasen P, 1997, SOC HIST MED, V10, P383, DOI 10.1093/shm/10.3.383
   Kaufert P, 1993, KNOWLEDGE POWER PRAC, P32
   KAUFERT P, 1991, ARCTIC MED RES S, P577
   Kaufert P A, 1988, Arctic Med Res, V47 Suppl 1, P481
   KAUFERT PA, 1990, MED ANTHROPOL Q, V4, P427, DOI 10.1525/maq.1990.4.4.02a00040
   KAUFERT PA, 1997, BIRTHS POWER SOCIAL, P325
   KOOTOO B, 2002, ETUDES INUIT STUDIES, V26, P175
   *LABR IN ASS, 2004, ANN REP 2003 2004
   LAROCHELLE G, 1976, FACETTES IDENTITE AM, P219
   Laugrand Frederic, 2000, REPRESENTING TUURNGA, VI
   LAVOIE J, 2003, ABORIGINAL AUTONOMY, P332
   LESSARD P, 1987, CAN MED ASSOC J, V137, P1017
   Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693
   Lucas M, 2004, LIPIDS, V39, P617, DOI 10.1007/s11745-004-1274-7
   Luo ZC, 2004, PAEDIATR PERINAT EP, V18, P40, DOI 10.1111/j.1365-3016.2003.00529.x
   MACAULAY A, 2002, THESIS U MANITOBA WI
   MCGRATH J, 2000, INUKTITUT, V88, P10
   Meyer F, 1991, EVALUATION PERINATAL
   Muckle G, 2001, ENVIRON HEALTH PERSP, V109, P957, DOI 10.2307/3454999
   Muckle G, 1998, CAN J PUBLIC HEALTH, V89, pS20
   Muggah Elizabeth, 2004, Int J Circumpolar Health, V63 Suppl 2, P242
   MURDOCK AI, 1979, CAN MED ASSOC J, V120, P291
   O'Neil J D, 1988, Arctic Med Res, V47 Suppl 1, P485
   ONeil JD, 1997, ARCTIC ANTHROPOL, V34, P29
   ONEIL JD, 1991, ARCTIC MED RES S, V5, P572
   OOSTEN J, 2001, INTERVIEWING INUIT E, V1
   *PAUKT, 1990, IK
   Qinuajuak L, 1996, Midwifery Today Childbirth Educ, P55
   Qinuajuak L, 1996, Midwifery Today Childbirth Educ, P56
   RAJSIGL D, 1984, THESIS YORK U DOWNSV
   ROBINSON E, 1991, ARCTIC MED RES S, P596
   SCHAEFER O, 1993, HLTH PROBLEMS HLTH C
   SCHAEFER O, 1976, FACETTES IDENTITE AM, P279
   SENNETT ES, 1991, ARCTIC MED RES S5, V5, P601
   Shephard RJ, 1996, HLTH CONSEQUENCES MO
   Sillett M, 1988, Arctic Med Res, V47 Suppl 1, P102
   Smith Derek G., 1993, ANTHR PUBLIC POLICY, P41
   SPADY D, 1991, 2 WORLDS REPORT NW T
   Stern P R, 1995, Arctic Med Res, V54, P21
   Stevenson M L, 1988, Arctic Med Res, V47 Suppl 1, P492
   Stonier J., 1990, CHILDBIRTH CANADIAN, P61
   Therrien M., 2001, INTERVIEWING INUIT E, V5
   Therrien Michele, 1995, RECHERCHES AMERINDIE, V25, P71
   Tookalak N, 1996, Midwifery Today Childbirth Educ, P54
   TOURIGNY A, 1991, EVALUATIO PERINATAL
   Tremblay M.-A., 2002, MAIN THEORETICAL ORI
   VOISEY E, 1990, CHILDBIRTH CANADIAN, P37
   WEBBER G, 1993, CAN FAM PHYSICIAN, V39, P781
NR 91
TC 22
Z9 22
U1 0
U2 3
PU INTERNATIONAL ASSOCIATION CIRCUMPOLAR HEALTH PUBLISHERS
PI OULU
PA AAPISTIE1, OULU, FIN-90220, FINLAND
SN 1239-9736
J9 INT J CIRCUMPOL HEAL
JI Int. J. Circumpolar Health
PD APR
PY 2006
VL 65
IS 2
BP 117
EP 132
DI 10.3402/ijch.v65i2.18087
PG 16
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 142MI
UT WOS:000244653600003
PM 16711464
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chen, M
   Hofestadt, R
AF Chen, M
   Hofestadt, R
TI A medical bioinformatics approach for metabolic disorders: Biomedical
   data prediction, modeling, and systematic analysis
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE metabolic disorders; medical bioinformatics; systems biology;
   integrative bioinformatics; urea cycle disorders; inborn errors;
   PathAligner
ID RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; PETRI NETS; NETWORKS;
   ASSOCIATION; PATHWAYS
AB During the past century, studies of metabolic disorders have focused research efforts to improve clinical diagnosis and management, to illuminate metabolic mechanisms, and to find effective treatments. The availability of human genome sequences and trallscriptomic, proteomic, and metabolomic data provides us with a challenging opportunity to develop computational approaches for systematic analysis of metabolic disorders. In this paper, we present a strategy of bioinformatics analysis to exploit the current data available both on genomic and metabolic levels and integrate these at novel levels of understanding of metabolic disorders. PathAligner is applied to predict biomedical data based on a given disorder. A case study on urea cycle disorders is demonstrated. A Petri net model is constructed to estimate the regulation both on genomic and metabolic levels. We also analyze the transcription factors, signaling pathways and associated disorders to interpret the occurrence and regulation of the urea cycle.
   Availability. PathAligner's metabolic disorder analyzer is available at http://bibiserv.techfak.uni-bielefeld.de/pathaligner/pathaligner_MDA.html. Supplementary materials are available at http://www.techflk.ulli-bielefeld.de/-mchen/metabolic-disorders. (c) 2005 Elsevier Inc. All rights reserved.
C1 Zhejiang Univ, Coll Life Sci, Grp Bioinformat, Hangzhou 310029, Peoples R China.
   Univ Bielefeld, Fac Technol, Dept Bioinformat Med Informat, D-33501 Bielefeld, Germany.
RP Chen, M (reprint author), Zhejiang Univ, Coll Life Sci, Grp Bioinformat, Hangzhou 310029, Peoples R China.
EM mchen@techfak.uni-bielefeld.de
CR Agrawal H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268702
   Atanassov K., 1995, P INT WORKSH BIOPR E
   BAHN A, 2002, BIOINFORMATICS, V18, P1486, DOI DOI 10.1093/BIOINFORMATICS/18.11.1486
   BATSHAW ML, 1982, NEW ENGL J MED, V306, P1387, DOI 10.1056/NEJM198206103062303
   Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836
   BUSTINCE H, 1997, P INT S BIOPR SYST 9, V6, P20
   Carlson E, 2003, ARTHRITIS RHEUM, V48, P1165, DOI 10.1002/art.11033
   Chen HM, 2004, SER REMOTE SENS, V3, P3, DOI 10.1142/9789812702630_0001
   Chen Ming, 2003, In Silico Biology, V3, P347
   CLARKE TR, 1996, CLIN GUIDE INHERITED
   Daskalov M., 1996, P 7 NAT C BIOM PHYS, P185
   Doi Atsushi, 2004, In Silico Biol, V4, P271
   Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853
   ERMEL C, 1996, P INT DES PROC TECHN, V1, P186
   Fox JJ, 2001, CHAOS, V11, P809, DOI 10.1063/1.1414882
   Genrich H., 2001, International Journal on Software Tools for Technology Transfer, V3, P394, DOI 10.1007/s100090100058
   GERHARD E, 1991, BIOMED TECH, V36, P66, DOI 10.1515/bmte.1991.36.4.66
   Glanze WD, 1986, MOSBYS MED NURSING D
   Gomez CM, 2001, NEUROLOGY, V56, P1618
   Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.jbiosystems.2004.03.003
   HOFESTADT R, 1998, SILICO BIOL, V1, P6
   Iwashige Kenichi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P19, DOI 10.2114/jpa.23.19
   Karev GP, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-18
   LEHNINGER AL, 1993, PRINCIPLES BIOCH, P12
   LEVY J, 1970, J CLIN INVEST, V49, P708, DOI 10.1172/JCI106283
   Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270
   Matsuno H., 2000, PAC S BIOC, V5, P338
   MORK P, 2001, J BIOMED INFORM S, V35, pS473
   Mounts WM, 1997, INT J BIOL MACROMOL, V20, P265, DOI 10.1016/S0141-8130(97)00026-3
   NEBOT A, 1994, THESIS U POLITECNICA
   NEWKIRK MM, 1993, MOL IMMUNOL, V30, P255, DOI 10.1016/0161-5890(93)90054-F
   Nissinen R, 2003, SCAND J RHEUMATOL, V32, P340, DOI 10.1080/03009740410004990
   OUCHI Y, 1998, MEDINFO, V9, P675
   PETERSON JL, 1981, PETRI NET THEORY MOD
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Reddy V., 1993, P 1 INT C INT SYST M, V1, P328
   SORSICH J, 1996, P 7 NAT C BIOM PHYS, P195
   Sujansky W, 2001, J BIOMED INFORM, V34, P285, DOI 10.1006/jbin.2001.1024
   Thomaseth K, 2001, SIMULAT PRACT THEORY, V9, P1, DOI 10.1016/S0928-4869(01)00038-6
   Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711
   Witte T, 2000, RHEUMATOL INT, V19, P107, DOI 10.1007/s002960050112
   Ye X, 2000, GENE THER, V7, P1761, DOI 10.1038/sj.gt.3301299
   Ye XH, 1996, J BIOL CHEM, V271, P3639
   Yonekura Y, 2003, NITRIC OXIDE-BIOL CH, V8, P164, DOI 10.1016/S1089-8603(03)00025-9
NR 44
TC 19
Z9 21
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
EI 1532-0480
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD APR
PY 2006
VL 39
IS 2
BP 147
EP 159
DI 10.1016/j.jbi.2005.05.005
PG 13
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA 027MQ
UT WOS:000236420100004
PM 16023895
OA Bronze
DA 2018-10-20
ER

PT J
AU Baroli, B
AF Baroli, B
TI Photopolymerization of biomaterials: issues and potentialities in drug
   delivery, tissue engineering, and cell encapsulation applications
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Conference on Applications of Immobilization/Bioencapsulation in
   Medicine, Pharmacy, Food Technology and Biotechnology
CY JUN 25-27, 2004
CL Belgrade, SERBIA MONTENEG
SP COST 840, Biochem Engn Soc, Univ Belgrade,Fac Agr, Univ Belgrade, Fac Technol, Assoc Chem Engineers
DE photopolymerization; drug delivery; tissue engineering; cell
   encapsulation
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; FORMING DEGRADABLE NETWORKS; VALVULAR
   INTERSTITIAL-CELLS; MESENCHYMAL STEM-CELLS; GAMMA-IRRADIATION; IN-VITRO;
   CONTROLLED-RELEASE; PHOTOCROSSLINKED POLYANHYDRIDES; CROSS-LINKING; PEG
   HYDROGELS
AB Photopolymerization is a widely explored technology that has recently been recognized to have also great potentialities in the biomedical field. This paper aims to provide a general overview of this technology by briefly describing materials and methods used to produce linear or crosslinked polymer networks for drug delivery, tissue engineering and cell encapsulation. In addition, potentialities and areas of investigation that are not fully explored but that could provide solutions for better control over the technology when applied to the biomedical field will be indicated as wen. (c) 2006 Society of Chemical Industry.
C1 Univ Cagliari, Fac Farm, Dipartimento Farmaco Chim Tecnol, I-09124 Cagliari, Italy.
RP Baroli, B (reprint author), Univ Cagliari, Fac Farm, Dipartimento Farmaco Chim Tecnol, I-09124 Cagliari, Italy.
EM bbaroli@unica.it
RI Baroli, Biancamaria/K-3392-2012
CR About I, 2005, DENT MATER, V21, P156, DOI 10.1016/j.dental.2004.02.011
   Affatato S, 2002, BIOMATERIALS, V23, P1439, DOI 10.1016/S0142-9612(01)00265-4
   Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   An YJ, 2000, J CONTROL RELEASE, V64, P205, DOI 10.1016/S0168-3659(99)00143-1
   Andrzejewska E, 2001, PROG POLYM SCI, V26, P605, DOI 10.1016/S0079-6700(01)00004-1
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, J DENT RES, V75, P1607, DOI 10.1177/00220345960750081301
   Baroli B, 2003, J PHARM SCI, V92, P1186, DOI 10.1002/jps.10378
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Bland MH, 1996, BIOMATERIALS, V17, P1109, DOI 10.1016/0142-9612(96)85912-6
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Burdick JA, 2003, BIOMATERIALS, V24, P1613, DOI 10.1016/S0142-9612(02)00538-0
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burdick JA, 2001, J BIOMAT SCI-POLYM E, V12, P1253, DOI 10.1163/156856201753395789
   Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Burkoth AK, 2000, J BIOMED MATER RES, V51, P352
   Calis S, 2002, FARMACO, V57, P55, DOI 10.1016/S0014-827X(01)01171-5
   Chan-Park MB, 2004, MACROMOL BIOSCI, V4, P665, DOI 10.1002/mabi.200300139
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Declercq HA, 2005, BIOMACROMOLECULES, V6, P1608, DOI 10.1021/bm050031s
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Desmangles AI, 2001, BIOTECHNOL BIOENG, V72, P634, DOI 10.1002/1097-0290(20010320)72:6<634::AID-BIT1029>3.3.CO;2-A
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Esen C, 1996, J COLLOID INTERF SCI, V179, P276, DOI 10.1006/jcis.1996.0214
   Faisant N, 2003, EUR J PHARM BIOPHARM, V56, P271, DOI 10.1016/S0939-6411(03)00104-8
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Fouassier JP, 2003, PROG ORG COAT, V47, P16, DOI 10.1016/S0300-9440(03)00011-0
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   Gobin AS, 2003, J BIOMED MATER RES A, V67A, P255, DOI 10.1002/jbm.a.10110
   Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775
   Goodner MD, 2002, CHEM ENG SCI, V57, P887, DOI 10.1016/S0009-2509(01)00287-1
   Grotzinger C, 2003, POLYMER, V44, P3671, DOI 10.1016/S0032-3861(03)00286-6
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   HELSETH DL, 1989, ORAL SURG ORAL MED O, V68, P223, DOI 10.1016/0030-4220(89)90197-7
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   Hubbell JA, 1996, J CONTROL RELEASE, V39, P305, DOI 10.1016/0168-3659(95)00162-X
   Hutchison JB, 2004, LAB CHIP, V4, P658, DOI 10.1039/b405985a
   Ishizu K, 2004, J COLLOID INTERF SCI, V272, P76, DOI 10.1016/j.jcis.2003.12.037
   Itoga K, 2004, J BIOMED MATER RES A, V69A, P391, DOI 10.1002/jbm.a.30010
   Jakubiak J, 2003, POLYMER, V44, P5219, DOI 10.1016/S0032-3861(03)00568-8
   Kawata S, 2003, APPL SURF SCI, V208, P153, DOI 10.1016/S0169-4332(02)01358-2
   Kim BS, 2000, J POLYM SCI POL CHEM, V38, P1277, DOI 10.1002/(SICI)1099-0518(20000415)38:8<1277::AID-POLA11>3.0.CO;2-S
   Kim SH, 2000, J BIOMATER APPL, V15, P23, DOI 10.1106/ML30-FMLG-1HRU-7C4B
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Kizilel S, 2004, LANGMUIR, V20, P8652, DOI 10.1021/la0496744
   Knezevic A, 2002, J ORAL REHABIL, V29, P782, DOI 10.1046/j.1365-2842.2002.00897.x
   LAURENCIN CT, 1990, CLIN LAB MED, V10, P549
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Liew LA, 2002, SENSOR ACTUAT A-PHYS, V95, P120, DOI 10.1016/S0924-4247(01)00723-3
   Lovell LG, 2001, DENT MATER, V17, P504, DOI 10.1016/S0109-5641(01)00010-0
   Lu MZ, 2000, J MICROENCAPSUL, V17, P245
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   MAFFEZZOLI A, 1994, BIOMATERIALS, V15, P1221, DOI 10.1016/0142-9612(94)90273-9
   Maggi L, 2004, INT J PHARM, V269, P343, DOI 10.1016/j.ijpharm.2003.09.027
   Magoshi T, 2002, BIOMACROMOLECULES, V3, P976, DOI 10.1021/bm0200377
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Masters KSB, 2005, J BIOMAT SCI-POLYM E, V16, P659, DOI 10.1163/1568562053783722
   Masters KSB, 2002, WOUND REPAIR REGEN, V10, P286, DOI 10.1046/j.1524-475X.2002.10503.x
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Meniga A, 1997, BIOMATERIALS, V18, P1349, DOI 10.1016/S0142-9612(97)00047-1
   Missirlis D, 2005, LANGMUIR, V21, P2605, DOI 10.1021/la047367s
   Miyamoto K, 2004, J BIOMED MATER RES A, V70A, P550, DOI 10.1002/jbm.a.30112
   Nakayama Y, 1999, BIOMATERIALS, V20, P963, DOI 10.1016/S0142-9612(98)00252-X
   Narayanan V, 1997, TRENDS POLYM SCI, V5, P415
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   ODIAN G, 1991, PRINCIPLES POLYM
   Ohan MP, 2003, J BIOMED MATER RES A, V67A, P1188, DOI 10.1002/jbm.a.20018
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Poshusta AK, 2003, J BIOMED MATER RES A, V64A, P62, DOI 10.1002/jbm.a.10274
   Poshusta AK, 2001, CELLS TISSUES ORGANS, V169, P272, DOI 10.1159/000047891
   Price GJ, 1997, EUR POLYM J, V33, P599, DOI 10.1016/S0014-3057(96)00239-X
   Quek CH, 2004, BIOMATERIALS, V25, P3531, DOI 10.1016/j.biomaterials.2003.09.112
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quick DJ, 2004, J CONTROL RELEASE, V97, P333, DOI 10.1016/j.jconrel.2004.03.001
   QUICK DJ, 2004, PHARM RES, V20, P773
   Rich J, 2002, J BIOMED MATER RES, V63, P346, DOI 10.1002/jbm.10232
   Ries MD, 2001, J BONE JOINT SURG AM, V83A, P116, DOI 10.2106/00004623-200100022-00009
   Rockwood CA, 2002, J SHOULDER ELB SURG, V11, P191, DOI 10.1067/mse.2002.121480
   ROZEMA FR, 1991, J APPL BIOMATER, V2, P23, DOI 10.1002/jab.770020104
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Schoenmakers RG, 2004, J CONTROL RELEASE, V95, P291, DOI 10.1016/j.jconrel.2003.12.009
   Simms HM, 2005, LAB CHIP, V5, P151, DOI 10.1039/b412589d
   Swanson T, 2004, AM J ORTHOD DENTOFAC, V125, P337, DOI 10.1016/j.ajodo.2003.04.011
   Tarle Z, 2002, J ORAL REHABIL, V29, P662, DOI 10.1046/j.1365-2842.2002.00866.x
   Teomim D, 2001, BIOMACROMOLECULES, V2, P1015, DOI 10.1021/bm010078n
   *USP, 2000, US PHARM, V24
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Watkins AW, 2003, J BIOMAT SCI-POLYM E, V14, P267, DOI 10.1163/156856203763572716
   Weyenberg W, 2004, EUR J PHARM SCI, V23, P77, DOI 10.1016/j.ejps.2004.05.010
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yaman A, 2001, Curr Opin Drug Discov Devel, V4, P760
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yokoyama S, 2003, THIN SOLID FILMS, V438, P452, DOI 10.1016/S0040-6090(03)00804-6
   Young JS, 2000, BIOMATERIALS, V21, P1181, DOI 10.1016/S0142-9612(00)00018-1
NR 119
TC 76
Z9 79
U1 2
U2 19
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD APR
PY 2006
VL 81
IS 4
BP 491
EP 499
DI 10.1002/jctb.1468
PG 9
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 034QU
UT WOS:000236946500003
OA Bronze
DA 2018-10-20
ER

PT J
AU Kapp, MB
AF Kapp, MB
TI Ethical and legal issues in research involving human subjects: do you
   want a piece of me?
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Review
ID STORED BIOLOGICAL SAMPLES; LEFTOVER BODY MATERIAL; INFORMED-CONSENT;
   SCIENTIFIC PURPOSES; CLINICAL-RESEARCH; TISSUE SAMPLES; NO CONSENT;
   BIOBANKS; BANKING
AB The conduct of biomedical research involving the participation of human beings implicates a variety of ethical concerns pertaining to such values as dignity, bodily integrity, autonomy, and privacy. These ethical concerns have been translated into a complex regulatory apparatus in the USA, containing specific legal provisions concerning such matters as participant safety, informed consent, and confidentiality. A topic of particular interest for pathologists is the handling of human tissue specimens that may be used for present, or stored for future, research purposes. This article examines the ethical and legal ramifications of obtaining and storing tissue samples for research purposes, with special attention to the issues of informed consent and confidentiality.
C1 So Illinois Univ, Sch Law, Carbondale, IL 62901 USA.
RP Kapp, MB (reprint author), So Illinois Univ, Sch Law, 1150 Douglas Dr, Carbondale, IL 62901 USA.
EM kapp@siu.edu
CR Allen Michael D, 2004, IRB, V26, P9, DOI 10.2307/3563947
   Annas GJ, 2002, NEW ENGL J MED, V346, P216, DOI 10.1056/NEJM200201173460320
   Ashburn TT, 2000, ARCH INTERN MED, V160, P3377, DOI 10.1001/archinte.160.22.3377
   Burton JL, 2001, J CLIN PATHOL, V54, P820, DOI 10.1136/jcp.54.11.820
   Chen DT, 2005, ARCH INTERN MED, V165, P652, DOI 10.1001/archinte.165.6.652
   Clayton Ellen Wright, 2004, IRB, V26, P14, DOI 10.2307/3564099
   CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786
   Clayton EW, 2005, J LAW MED ETHICS, V33, P15, DOI 10.1111/j.1748-720X.2005.tb00206.x
   Cohen J, 2006, LEA COMMUN SER, P3
   *COHEN JJ, 2005, COMMUNICATION   1103
   COLEMAN CARL H., 2005, ETHICS REGULATION RE, P3
   EVANS BJ, IN PRESS J LEGAL MED
   Faden RR, 1986, HIST THEORY INFORMED, P114
   Gibbs JN, 2004, FOOD DRUG LAW J, V59, P265
   Goodson ML, 2004, J CLIN PATHOL, V57, P135, DOI 10.1136/jcp.2003.9886
   GREELEY HT, 1999, WAKE FOREST L REV, V34, P740
   Hakimian R, 2004, JAMA-J AM MED ASSOC, V292, P2500, DOI 10.1001/jama.292.20.2500
   Hoeyer K, 2005, ARCH INTERN MED, V165, P97, DOI 10.1001/archinte.165.1.97
   JONSEN AR, 1998, BIRTH BIOETHICS, P125
   KETTISLINDBLAD A, 2005, EUR J PUBLIC HL 1005
   KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806
   Maschke KJ, 2004, THEOR MED BIOETH, V25, P143, DOI 10.1023/B:META.0000033773.44765.7c
   Morente MM, 2005, HEMATOL ONCOL, V23, P54, DOI 10.1002/hon.749
   Morreim EH, 2004, J LAW MED ETHICS, V32, P474, DOI 10.1111/j.1748-720X.2004.tb00160.x
   *NAT BIOETH ADV CO, 1999, RES INV HUM BIOL MA
   OHNISHI AA, 2002, BMJ MED ETHICS, V3, P1
   Sade RM, 2002, ARCH INTERN MED, V162, P1439, DOI 10.1001/archinte.162.13.1439
   Sankar P, 2004, MED ANTHROPOL Q, V18, P429, DOI 10.1525/maq.2004.18.4.429
   Savulescu J, 2002, BRIT MED J, V325, P649
   U.S. Department of Health and Human Services & National Institutes of Health, 2004, RES REP DAT HIPAA PR
   *US DEP HHS, 2004, GUID RES INV COD PR
   van Diest PJ, 2002, BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648
   VEATCH RM, 1987, PATIENT PARTNER THEO, P16
   Wendler D, 2002, ARCH INTERN MED, V162, P1457, DOI 10.1001/archinte.162.13.1457
   Winickoff DE, 2001, J BIOLAW BUS, V4, P11
   2006, FED REG         0109, V71, P1429
NR 36
TC 24
Z9 25
U1 0
U2 9
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 1472-4146
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD APR
PY 2006
VL 59
IS 4
BP 335
EP 339
DI 10.1136/jcp.2005.030957
PG 5
WC Pathology
SC Pathology
GA 025ZD
UT WOS:000236305400001
PM 16567467
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Polini, R
   Kumashiro, S
   Jackson, MJ
   Amar, M
   Ahmed, W
   Sein, H
AF Polini, R
   Kumashiro, S
   Jackson, MJ
   Amar, M
   Ahmed, W
   Sein, H
TI A study of diamond synthesis by hot filament chemical vapor deposition
   on Nc coatings
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT 4th International Surface Engineering Congress and Exposition
CY AUG 01-03, 2005
CL St Paul, MN
DE chemical vapor deposition (CVD); diamond; nc; superhard coatings;
   TiN/Si3N4
ID GAS-PHASE; NUCLEATION; GROWTH; TOOLS
AB Deposition of diamond films onto various substrates can result in significant technological advantages in terms of functionality and improved life and performance of components. Diamond is hard, wear resistant, chemically inert, and biocompatible. It is considered to be the ideal material for surfaces of cutting tools and biomedical components. However, it is well known that diamond deposition onto technologically important substrates, such as co-cemented carbides and steels, is problematic due to carbon interaction with the substrate, low nucleation densities, and poor adhesion. Several papers previously published in the relevant literature have reported the application of interlayer materials such as metal nitrides and carbides to provide bonding between diamond and hostile substrates. In this study, the chemical vapor deposition (CVD) of polycrystalline diamond on TiN/SiNx nc (nc) interlayers deposited at relatively low temperatures has been investigated for the first time. The nc layers were deposited at 70 or 400 degrees C on Si substrates using a dual ion beam deposition system. The results showed that a preliminary seeding pretreatment with diamond suspension was necessary to achieve large diamond nucleation densities and that diamond nucleation was larger on nc films than on bare sc-Si subjected to the same pretreatment and CVD process parameters. TiN/SiNx layers synthesized at 70 or 400 degrees C underwent different nanostructure modifications during diamond CVD. The data also showed that TiN/SiNx films obtained at 400 degrees C are preferable in so far as their use as interlayers between hostile substrates and CVD diamond is concerned.
C1 Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
   Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
RP Polini, R (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM jacksomj@purdue.edu
RI Polini, Riccardo/D-2289-2017
OI Polini, Riccardo/0000-0002-6551-0883; Ahmed, Waqar/0000-0003-4152-5172
CR CHEN X, 1993, J APPL PHYS, V74, P4168, DOI 10.1063/1.354420
   Colligon JS, 2004, PHILOS T ROY SOC A, V362, P103, DOI 10.1098/rsta.2003.1303
   Davis R. F., 1993, DIAMOND FILMS COATIN
   Endler I, 1996, DIAM RELAT MATER, V5, P299, DOI 10.1016/0925-9635(95)00352-5
   FAN WD, 1994, J MATER RES, V9, P2850, DOI 10.1557/JMR.1994.2850
   Faure C, 1999, DIAM RELAT MATER, V8, P830, DOI 10.1016/S0925-9635(98)00363-X
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   IIJIMA S, 1991, J MATER RES, V6, P1491, DOI 10.1557/JMR.1991.1491
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   *JCPDS, 1989, 85879 JCPDS INT CTR
   *JCPDS, 1989, 381420 JCPDS INT CTR
   Jentsch HG, 2000, ADV ENG MATER, V2, P369, DOI 10.1002/1527-2648(200006)2:6<369::AID-ADEM369>3.0.CO;2-8
   LI SZ, 1992, PLASMA CHEM PLASMA P, V12, P287
   Liu H. M., 1995, DIAMOND CHEM VAPOR D
   MITSUDA Y, 1993, DIAM RELAT MATER, V2, P333, DOI 10.1016/0925-9635(93)90077-F
   MOLINARI E, 1992, APPL PHYS LETT, V61, P1287, DOI 10.1063/1.107567
   MOLINARI E, 1992, J MATER RES, V7, P1778, DOI 10.1557/JMR.1992.1778
   Nesladek M, 1995, THIN SOLID FILMS, V270, P184, DOI 10.1016/0040-6090(95)06914-3
   Rebouta L, 2000, SURF COAT TECH, V133, P234, DOI 10.1016/S0257-8972(00)00934-8
   Schwarz S, 2003, DIAM RELAT MATER, V12, P701, DOI 10.1016/S0925-9635(03)00061-X
   Silva S, 1999, DIAM RELAT MATER, V8, P1913, DOI 10.1016/S0925-9635(99)00156-9
   Veprek S, 2000, SURF COAT TECH, V133, P152, DOI 10.1016/S0257-8972(00)00957-9
NR 22
TC 1
Z9 1
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9495
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD APR
PY 2006
VL 15
IS 2
BP 218
EP 222
DI 10.1361/105994906X95913
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 029KO
UT WOS:000236561400015
DA 2018-10-20
ER

PT J
AU Sudheer, SK
   Pillai, VPM
   Nayar, VU
   Pothiawala, Y
   Kothwala, D
AF Sudheer, S. K.
   Pillai, V. P. Mahadevan
   Nayar, V. U.
   Pothiawala, Yavar
   Kothwala, Devesh
TI Micromachining of 316LVM stainless steel tubes using periodic
   acousto-optic modulation of pulsed Nd : YAG lasers for cardiovascular
   stent applications
SO JOURNAL OF MICROLITHOGRAPHY MICROFABRICATION AND MICROSYSTEMS
LA English
DT Article
DE pulsed Nd : YAG laser; micromachining; cardiovascular stent;
   acousto-optic modulator; Bragg diffraction; piercing routine;
   heat-affected zone
ID FOLLOW-UP; RESTENOSIS; ARTERY
AB Optoelectronic techniques can be used in laser applications in biomedical instrumentation to achieve better flexibility and control of the available optical power. These techniques enable the processing and manufacturing of biomedical implants like cardiovascular stents and micrometallic components with reduced heat-affected zone (HAZ) and extremely precise edge cutting. The present investigations deal with the study of laser piercing routines and further profile cutting of thin stainless steel sheet tubes for biomedical implant manufacturing. The process is performed using an acousto-optic (AO) modulator-based pulsed Nd:YAG laser. The AO modulator used in the experiments is a Bragg diffraction device. During the piercing of holes, the focused laser power is gradually increased from a low value and finally reaches the maximum as the beam goes deeper into the material. The most suitable value of dwell time is found to be 50 ms. A nine step staircase modulating voltage with a maximum ac component of 800 mV is used, and the laser power is 4 W in TEM00 operation. The acousto-optic modulator-based pulsed Nd:YAG laser is capable of cutting extremely complex geometries of stents on 316LVM tubing. Laser cutting results in a kerf width of 20.5 +/- 0.5 mu m. Precise strut dimensions of 115 +/- 15 mu m for subsidiary strut, 150 +/- 15 mu m for main strut, and 150 +/- 15 mu m for the link are also obtained. With the piercing routine, extremely fine holes with reduced heat-affected zones are produced, and this quality is reflected during consequent machining of required profiles for implants. (C) 2006 Society of Photo-Optical Instrumentation Engineers.
C1 Sahajanand Technol, Laser Res & Dev Div, Surat 394230, Gujarat, India.
   Univ Kerala, Dept Optoelect, Thiruvananthapuram 695581, Kerala, India.
   Sahajanand Med Technol, Div Res & Dev, Surat 395003, Gujarat, India.
RP Sudheer, SK (reprint author), Sahajanand Technol, Laser Res & Dev Div, Plots 33,34,35,Surat Special Econ Zone, Surat 394230, Gujarat, India.
EM sudheer@sahajanand.co.in
CR Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   BEYER E, 1985, LASER OPTOELEKTR SEP
   BEYER R, 1997, J INTRAVASC CARDIOL, V9, P363
   BRUNSKI JB, 1996, BIOMATERIALS SCI INT
   COMPTE P, 1984, CONT BIOMATERIALS, P66
   DOTTER CT, 1983, RADIOLOGY, V147, P259, DOI 10.1148/radiology.147.1.6828741
   DOTTER CT, 1969, INVEST RADIOL, V4, P329, DOI 10.1097/00004424-196909000-00008
   ILAVARASAN PM, 1995, P 5 INT FAIM C
   KLEIN WR, 1967, IEEE T SON ULTRASON, VSU14, P123, DOI 10.1109/T-SU.1967.29423
   KOECHNER W, 1996, SOLIDSTATE LASER ENG
   LAU KW, 2004, SINGAPORE MED J
   LEE CS, 1985, PARAMETRIC STUDIES P
   LIPSCOMP IP, 1996, APPL SHAPE MEMORY AL
   MAASS D, 1984, RADIOLOGY, V152, P659, DOI 10.1148/radiology.152.3.6463245
   MAASS D, 1983, PROGR ARTIF ORG, V1, P979
   MAY A, 2002, MED DEVICE TECHN JAN
   PALMAZ JC, 1985, RADIOLOGY, V156, P63
   PARK JB, 1992, BIOMATERIALS INTRO
   REMINE WH, 1954, AMA ARCH SURG, V69, P255, DOI 10.1001/archsurg.1954.01270020121014
   ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995
   ROGERS CD, 2004, MEDREV, V5, pS9
   Roguin A, 1999, CORONARY ARTERY DIS, V10, P421, DOI 10.1097/00019501-199909000-00012
   ROUSSEAU H, 1987, RADIOLOGY, V164, P709, DOI 10.1148/radiology.164.3.3303120
   SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   Steinemann S. G., 1996, Injury, V27, pSC16
   Wang K., 1997, ACTA BIOMEDICA LOVAN, V162, P89
   WRIGHT KC, 1985, RADIOLOGY, V156, P69, DOI 10.1148/radiology.156.1.4001423
   ZHAO H, 2002, ELECTROCHEMICAL POLI
NR 29
TC 6
Z9 6
U1 0
U2 3
PU SPIE-INT SOCIETY OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1537-1646
J9 J MICROLITH MICROFAB
JI J. Microlithogr. Microfabr. Microsyst.
PD APR-JUN
PY 2006
VL 5
IS 2
AR 023010
DI 10.1117/1.2201038
PG 9
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Optics
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Optics
GA 070CE
UT WOS:000239497100017
DA 2018-10-20
ER

PT J
AU Ho, D
   Garcia, D
   Ho, CM
AF Ho, D
   Garcia, D
   Ho, CM
TI Nanomanufacturing and characterization modalities for
   bio-nano-informatics systems
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE bionanotechnology; nanomanufacturing; characterization; materials;
   medicine; protein; DNA; RNA; atomic force microscopy
ID TRIBLOCK COPOLYMER MEMBRANES; TEMPLATE-DIRECTED SYNTHESES;
   POROUS-SILICON; POLYNUCLEOTIDE MOLECULES; TUNNELING MICROSCOPE; PHOTONIC
   CRYSTALS; PURPLE MEMBRANE; DNA-MOLECULES; SMART DUST; DISCRIMINATION
AB In the next decade or two, the feature size of microelectronic devices will continue to decrease and is eventually expected to reach fabrication and material limits. With the field of microelectronics rapidly approaching the end of its roadmap, the National Nanotechnology Initiative (NNI) was created for the purpose of creating new technologies and to maintain the momentum of continuous scientific and technological progress. Primarily, the fields of nanoscience and nanotechnology aim to synthesize, characterize, apply, and control macro functional molecules and consist of three areas. First, the area of bio-nanotechnologies concerns that of biological molecules such as DNA, the molecule that serves as the blueprint of all living organisms. Harnessing the intrinsic functionality of these nano-sized biological molecules, i.e., DNA/RNA and proteins, will yield enormous potential for a wide array of applications (biomedical, energy, sensing, etc.) Second, diminishing electronic device feature sizes has spurred the development of new techniques for nanoelectronics and has emerged as a critical area of research. Third, these macro functional molecules possess rich potential for various new nanomaterials that have applications in bio-nano and nanoelectronics industries. Given the range of devices and applications that may be generated and addressed, respectively, through the fruition of these areas, development of novel and advanced core characterization and nanomanufacturing technologies will serve as a requisite strategy toward the realization of the potential underlying nanotechnological development. As such, this review will address how these novel technologies will be used to achieve a true coalescence of nanoscience and nanotechnology. This, in turn, will ultimately benefit the human condition by using the building blocks and fundamental findings of nanoscience to develop systems based on the fusion of biology, nanotechnology, and informatics, with embedded intelligence and emergent behavior.
C1 Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, CMISE, Los Angeles, CA 90095 USA.
   CALTECH, Dept Elect Engn, Div Engn & Appl Sci, Pasadena, CA 91125 USA.
RP Ho, D (reprint author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA.
RI Ho, Dean/B-7618-2009; Ho, Chih-ming/I-6537-2012
OI Ho, Chih-Ming/0000-0001-7369-5446
CR Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5
   Amabilino DB, 1995, CHEM REV, V95, P2725, DOI 10.1021/cr00040a005
   AMABILINO DB, 1994, TRENDS POLYM SCI, V2, P146
   ANELLI PL, 1991, J AM CHEM SOC, V113, P5131, DOI 10.1021/ja00013a096
   Anelli PL, 1997, CHEM-EUR J, V3, P1113, DOI 10.1002/chem.19970030719
   ASHTON PR, 1992, J CHEM SOC CHEM COMM, P1124, DOI 10.1039/c39920001124
   Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X
   Bates M, 2003, BIOPHYS J, V84, P2366, DOI 10.1016/S0006-3495(03)75042-5
   BECKER RS, 1987, NATURE, V325, P419, DOI 10.1038/325419a0
   Belohradsky M, 1997, COLLECT CZECH CHEM C, V62, P527, DOI 10.1135/cccc19970527
   Belohradsky M, 1996, COLLECT CZECH CHEM C, V61, P1, DOI 10.1135/cccc19960001
   BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   Boukherroub R, 2002, J ELECTROCHEM SOC, V149, pH59, DOI 10.1149/1.1432679
   Breault GA, 1999, TETRAHEDRON, V55, P5265, DOI 10.1016/S0040-4020(99)00282-3
   Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269
   Carr DW, 1999, APPL PHYS LETT, V75, P920, DOI 10.1063/1.124554
   Carr DW, 1998, J VAC SCI TECHNOL B, V16, P3821, DOI 10.1116/1.590416
   CHAMBRON JC, 1993, TOP CURR CHEM, V165, P131
   Chang JP, 2000, J APPL PHYS, V87, P4449, DOI 10.1063/1.373090
   CHAO Y, 2004, SOL STAT SENS ACT MI, P176
   Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j
   Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391
   Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702
   Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f
   DIETRICHBUCHECK.CO, 1991, BIOORGANIC CHEM FRON, V2, P195
   DIETRICHBUCHECKER CO, 1987, CHEM REV, V87, P795, DOI 10.1021/cr00080a007
   Doi M., 1987, THEORY POLYM DYNAMIC
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   FAN LS, 1988, TECH DIGEST INT ELEC, P666
   Fang N, 2003, APPL PHYS LETT, V82, P161, DOI 10.1063/1.1536712
   Flynn CE, 2003, ACTA MATER, V51, P5867, DOI 10.1016/j.actamat.2003.08.031
   FOSTER JS, 1988, NATURE, V331, P324, DOI 10.1038/331324a0
   FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933
   GIBSON HW, 1993, ADV MATER, V5, P11, DOI 10.1002/adma.19930050103
   Gibson HW, 1996, LARGE RING MOLECULES, P191
   GIBSON HW, 1994, PROG POLYM SCI, V19, P843, DOI 10.1016/0079-6700(94)90034-5
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Ho CM, 1998, ANNU REV FLUID MECH, V30, P579, DOI 10.1146/annurev.fluid.30.1.579
   Ho CM, 2001, PROC IEEE MICR ELECT, P375, DOI 10.1109/MEMSYS.2001.906556
   Ho D, 2005, NANOTECHNOLOGY, V16, P3120, DOI 10.1088/0957-4484/16/12/066
   Ho D, 2004, NANOTECHNOLOGY, V15, P1084, DOI 10.1088/0957-4484/15/038
   Ho D, 2004, IEEE T NANOTECHNOL, V3, P256, DOI [10.1109/TNANO.2004.828530, 10.1109/tnano.2004.828530]
   HO D, 2004, P ELECTROCHEM SOC, P206
   Ho S, 2003, PROG AEROSP SCI, V39, P635, DOI 10.1016/j.paerosci.2003.04.001
   Hong FT, 1999, PROG SURF SCI, V62, P1, DOI 10.1016/S0079-6816(99)00014-3
   Huang H, 2002, J VLSI SIG PROC SYST, V30, P55, DOI 10.1023/A:1014090623991
   Huang TJ, 2004, APPL PHYS LETT, V85, P5391, DOI 10.1063/1.1826222
   Huang TJ, 2004, NANO LETT, V4, P2065, DOI 10.1021/nl035099x
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   KASIANOWICZ JJ, 1995, BIOPHYS J, V69, P94, DOI 10.1016/S0006-3495(95)79879-4
   KAY BK, 1996, PHAGE DISPLAY PEPTID
   Kim HH, 2003, J ELECTROCHEM SOC, V150, pA209, DOI 10.1149/1.1534095
   LARSON RG, 1989, MACROMOLECULES, V22, P3004, DOI 10.1021/ma00197a022
   LEE H, 2003, IEEE P NANOTECHNOLOG, V2, P733
   LEIGH DA, 2000, ANGEW CHEM, V112, P358
   Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037
   Link JR, 2003, P NATL ACAD SCI USA, V100, P10607, DOI 10.1073/pnas.1233824100
   Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100
   MARCUS RB, 1990, APPL PHYS LETT, V56, P236, DOI 10.1063/1.102841
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079
   Meller A, 2003, J PHYS-CONDENS MAT, V15, pR581, DOI 10.1088/0953-8984/15/17/202
   Meller A, 2001, PHYS REV LETT, V86, P3435, DOI 10.1103/PhysRevLett.86.3435
   Nardin C, 2000, LANGMUIR, V16, P7708, DOI 10.1021/la000204t
   Nardin C, 2000, CHEM COMMUN, P1433, DOI 10.1039/b004280n
   Nardin C, 2001, EUR PHYS J E, V4, P403, DOI 10.1007/s101890170095
   Nardin C., 2002, REV MOL BIOTECHNOL, V90, P17
   Nielsen MB, 2000, CHEM SOC REV, V29, P153, DOI 10.1039/a803992e
   Pendry J, 2001, PHYS WORLD, V14, P47
   Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1
   RACKER E, 1974, J BIOL CHEM, V249, P662
   Raymo FM, 1999, CHEM REV, V99, P1643, DOI 10.1021/cr970081q
   Raymo FM, 1996, TRENDS POLYM SCI, V4, P208
   RAYMO FM, 1998, CHEMTRACTS, V11, P491
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   ROGERS D, 1950, NEUTROPHIL CRAWLING
   Saleh OA, 2003, NANO LETT, V3, P37, DOI 10.1021/nl0255202
   Sauer M, 2001, CHEM COMMUN, P55, DOI 10.1039/b007118h
   Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101
   Schill G., 1971, CATENANES ROTAXANES
   Schmedake TA, 2002, ADV MATER, V14, P1270, DOI 10.1002/1521-4095(20020916)14:18<1270::AID-ADMA1270>3.0.CO;2-R
   Seel C, 2000, CHEM-EUR J, V6, P21, DOI 10.1002/(SICI)1521-3765(20000103)6:1<21::AID-CHEM21>3.0.CO;2-L
   Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298
   Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847
   Shenton W, 1999, ADV MATER, V11, P253, DOI 10.1002/(SICI)1521-4095(199903)11:3<253::AID-ADMA253>3.3.CO;2-Z
   Siwy Z, 2002, EUROPHYS LETT, V60, P349, DOI 10.1209/epl/i2002-00271-3
   Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184
   Sone J, 1999, NANOTECHNOLOGY, V10, P135, DOI 10.1088/0957-4484/10/2/306
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555
   SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0
   SPUDICH JL, 1983, BIOPHYS J, V43, P243, DOI 10.1016/S0006-3495(83)84345-8
   Stewart MP, 1998, ANGEW CHEM INT EDIT, V37, P3257, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3257::AID-ANIE3257>3.0.CO;2-1
   STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5
   STOECKENIUS W, 1974, Journal of Supramolecular Structure, V2, P769, DOI 10.1002/jss.400020519
   Stoenescu R, 2004, MACROMOL BIOSCI, V4, P930, DOI 10.1002/mabi.200400065
   Stoenescu R, 2002, CHEM COMMUN, P3016, DOI 10.1039/b209352a
   Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941
   Taubert A, 2004, CURR OPIN CHEM BIOL, V8, P598, DOI 10.1016/j.cbpa.2004.09.008
   Tseng HR, 2004, CHEMPHYSCHEM, V5, P111, DOI 10.1002/cphc.200300992
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699
   VINCENT G, 1994, APPL PHYS LETT, V64, P2367, DOI 10.1063/1.111982
   WALBA DM, 1985, TETRAHEDRON, V41, P3161, DOI 10.1016/S0040-4020(01)96671-2
   WANG J, 2002, EMBO REP, V15, P15
   Wang TH, 2005, J AM CHEM SOC, V127, P5354, DOI 10.1021/ja0426421
   WANG TH, 2000, P INT C MATH ENG TEC
   WANG TH, 2001, IEEE 14 INT C MICR E, P431
   WIKSTROM M, 1992, J BIOL CHEM, V267, P10266
   Winterhalter M, 2001, TALANTA, V55, P965, DOI 10.1016/S0039-9140(01)00494-5
   Wong PK, 2003, J FLUID MECH, V497, P55, DOI 10.1017/S002211200300658X
   WONG PK, 2005, THESIS U CALIFORNIA
   Woodruff D. P., 1994, MODERN TECHNIQUES SU
   Xi JZ, 2005, ADV FUNCT MATER, V15, P1233, DOI 10.1002/adfm.200400619
   Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025
   ZASAZINSKI JA, 1994, SCIENCE, V263, P1344
NR 117
TC 15
Z9 16
U1 3
U2 19
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD APR
PY 2006
VL 6
IS 4
BP 875
EP 891
DI 10.1166/jnn.2006.173
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 036KE
UT WOS:000237069200001
PM 16736745
DA 2018-10-20
ER

PT J
AU Tucek, J
   Zboril, R
   Petridis, D
AF Tucek, J
   Zboril, R
   Petridis, D
TI Maghemite nanoparticles by view of Mossbauer spectroscopy
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE maghemite; gamma-Fe2O3; spinel; in-field Mossbauer spectroscopy;
   superparamagnetism; interparticle interactions
ID FINE-PARTICLE SYSTEMS; IRON-OXIDE NANOPARTICLES; GLASS COLLECTIVE STATE;
   RAY-POWDER DIFFRACTION; MAGNETIC-PROPERTIES; GAMMA-FE2O3 NANOPARTICLES;
   INTERPARTICLE INTERACTIONS; FERRIMAGNETIC PARTICLES; NANOSIZED
   MAGHEMITE; SUPERPARAMAGNETIC GAMMA-FE2O3
AB A Fe-57 Mossbauer spectrometry applied in a broad range of temperatures and external magnetic fields is presented as a powerful investigating tool for the structural and magnetic characterization of maghemite (gamma-Fe2O3) nanoparticles, which presently constitute a modern advanced material used in various fields of scientific, technological, and biomedical interest. Reflections of structural and magnetic properties in the hyperfine parameters of Mossbauer spectra of nanomaghemite samples prepared by different routes with varying particle size distribution, particle morphology, and degree of interparticle interactions (isolated nanoparticles, powders, nanocomposites, films) are reviewed. Some crucial points concerning the description of the magnetic regime of strongly interacting maghemite nanoparticles are also briefly discussed with respect to their Mossbauer spectra.
C1 Palacky Univ, Dept Phys Chem, Olomouc 71146, Czech Republic.
   Palacky Univ, Dept Expt Phys, Olomouc 71146, Czech Republic.
   NCSR Demokritos, Inst Mat Sci, Athens 15310, Greece.
RP Zboril, R (reprint author), Palacky Univ, Dept Phys Chem, Svobody 26, Olomouc 71146, Czech Republic.
RI Zboril, Radek/F-5153-2015
OI Zboril, Radek/0000-0002-3147-2196; Tucek, Jiri/0000-0003-2037-4950
CR Adnan J, 1999, PHYS EARTH PLANET IN, V110, P43, DOI 10.1016/S0031-9201(98)00128-9
   ARMSTRONG RJ, 1966, PHYS LETT, V23, P414, DOI 10.1016/0031-9163(66)91069-9
   Bate G, 1975, MAGNETIC OXIDE, P703
   BATLLE X, 1993, J APPL PHYS, V74, P3333, DOI 10.1063/1.354558
   Batlle X, 1996, J MAGN MAGN MATER, V157, P191, DOI 10.1016/0304-8853(95)01019-X
   Belin T, 2002, J SOLID STATE CHEM, V163, P459, DOI 10.1006/jssc.2001.9426
   Berkov DV, 2001, J MAGN MAGN MATER, V226, P1936, DOI 10.1016/S0304-8853(00)01293-2
   Berkov DV, 1998, J MAGN MAGN MATER, V186, P199, DOI 10.1016/S0304-8853(98)00078-X
   Berry FJ, 2000, HYPERFINE INTERACT, V126, P269, DOI 10.1023/A:1012639216406
   Blundell S., 2001, MAGNETISM CONDENSED
   BOMATIMIGUEL O, 2002, IEEE T MAGN, V38, P2616
   Bourlinos A, 2001, ADV MATER, V13, P289, DOI 10.1002/1521-4095(200102)13:4<289::AID-ADMA289>3.0.CO;2-U
   Bourlinos AB, 2003, MICROPOR MESOPOR MAT, V58, P155, DOI 10.1016/S1387-1811(02)00613-3
   Caizer C, 2003, MAT SCI ENG B-SOLID, V97, P129, DOI 10.1016/S0921-5107(02)00403-8
   Cannas C, 2002, J MATER CHEM, V12, P3141, DOI 10.1039/b204292d
   Chaneac C, 1995, NANOSTRUCT MATER, V6, P715, DOI 10.1016/0965-9773(95)00158-1
   Chantrell RW, 1996, J MAGN MAGN MATER, V157, P250, DOI 10.1016/0304-8853(95)01039-4
   CHANTRELL RW, 1985, J MAGN MAGN MATER, V53, P199, DOI 10.1016/0304-8853(85)90150-7
   COEY JMD, 1971, PHYS REV LETT, V27, P1140, DOI 10.1103/PhysRevLett.27.1140
   da Costa GM, 1998, HYPERFINE INTERACT, V117, P207, DOI 10.1023/A:1012691209853
   DEBAKKER PMA, 1991, PHYS CHEM MINER, V18, P131, DOI 10.1007/BF00216606
   Depeyrot J., 2000, J MAGN MAGN MATER, V252, P375
   Diakonov II, 1998, EUR J MINERAL, V10, P17
   Dinesen AR, 2001, J THERM ANAL CALORIM, V64, P1303, DOI 10.1023/A:1011582004634
   Dormann J L, 1998, J MAGN MAGN MATER, V183, P255
   Dormann JL, 1999, J MAGN MAGN MATER, V203, P23, DOI 10.1016/S0304-8853(99)00180-8
   Dormann JL, 1999, J MAGN MAGN MATER, V202, P251, DOI 10.1016/S0304-8853(98)00627-1
   Dormann JL, 1999, NANOSTRUCT MATER, V12, P757, DOI 10.1016/S0965-9773(99)00231-7
   Dormann JL, 1996, PHYS REV B, V53, P14291, DOI 10.1103/PhysRevB.53.14291
   DORMANN JL, 1988, J PHYS C SOLID STATE, V21, P2015, DOI 10.1088/0022-3719/21/10/019
   Dormann JL, 1997, ADV CHEM PHYS, V98, P283, DOI 10.1002/9780470141571.ch4
   Dormann JL, 1998, J MAGN MAGN MATER, V187, pL139, DOI 10.1016/S0304-8853(98)00135-8
   Dronskowski R, 2001, ADV FUNCT MATER, V11, P27, DOI 10.1002/1616-3028(200102)11:1<27::AID-ADFM27>3.0.CO;2-X
   Ennas G, 1999, J MATER RES, V14, P1570, DOI 10.1557/JMR.1999.0210
   Ensling J, 1998, HYPERFINE INTERACT, V111, P143, DOI 10.1023/A:1012624827290
   Ezzir A, 1999, J MAGN MAGN MATER, V196, P37, DOI 10.1016/S0304-8853(98)00653-2
   Fabris JD, 1997, HYPERFINE INTERACT, V110, P23, DOI 10.1023/A:1012619331408
   Fiorani D, 2002, PHYSICA B, V320, P122, DOI 10.1016/S0921-4526(02)00659-2
   GODINHO M, 1995, J MAGN MAGN MATER, V140, P369, DOI 10.1016/0304-8853(94)01503-1
   Greneche JM, 2003, HYPERFINE INTERACT, V148, P79, DOI 10.1023/B:HYPE.0000003767.27069.54
   Greneche JM, 2003, NATO SCI SER II-MATH, V94, P83
   Grimm S, 1997, J MATER SCI, V32, P1083, DOI 10.1023/A:1018598927041
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   HANSEN MF, 1998, J MAGN MAGN MATER, V184, pL262
   Hayashi M, 1997, J MAGN MAGN MATER, V171, P170, DOI 10.1016/S0304-8853(97)00056-5
   HENDRIKSEN PV, 1994, J PHYS-CONDENS MAT, V6, P3091, DOI 10.1088/0953-8984/6/16/014
   Herrero E, 1997, SOLID STATE IONICS, V101, P213
   HUANG CY, 1985, J MAGN MAGN MATER, V51, P1, DOI 10.1016/0304-8853(85)90002-2
   Iglesias O, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144401
   Iglesias O, 2004, PHYS STATUS SOLIDI A, V201, P3329, DOI 10.1002/pssa.200405486
   Iglesias O, 2004, PHYSICA B, V343, P286, DOI 10.1016/j.physb.2003.08.019
   Iglesias O, 2002, COMP MATER SCI, V25, P577, DOI 10.1016/S0927-0256(02)00337-3
   Iglesias O, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.184416
   ISHII Y, 1980, IEEE T MAGN, V16, P1114, DOI 10.1109/TMAG.1980.1060660
   Itoh H, 2003, J COLLOID INTERF SCI, V265, P283, DOI 10.1016/S0021-9797(03)00511-3
   Janot R, 2002, J ALLOY COMPD, V333, P302, DOI 10.1016/S0925-8388(01)01737-6
   JARJAYES O, 1994, J MAGN MAGN MATER, V138, P115, DOI 10.1016/0304-8853(94)90407-3
   Jeong JR, 2004, PHYS STATUS SOLIDI B, V241, P1593, DOI 10.1002/pssb.200304549
   Jonsson PE, 2001, EUROPHYS LETT, V55, P418, DOI 10.1209/epl/i2001-00430-0
   Jung JS, 2004, J MAGN MAGN MATER, V272, pE1157, DOI 10.1016/j.jmmm.2003.12.700
   Kachkachi H, 2000, EUR PHYS J B, V14, P681, DOI 10.1007/s100510051079
   Kechrakos D, 2003, J MAGN MAGN MATER, V262, P107, DOI 10.1016/S0304-8853(03)00029-5
   Keller R, 1996, J MAGN MAGN MATER, V162, P85, DOI 10.1016/0304-8853(96)00082-0
   Khaleel AA, 2004, CHEM-EUR J, V10, P925, DOI 10.1002/chem.200305135
   Kodama RH, 1999, J MAGN MAGN MATER, V200, P359, DOI 10.1016/S0304-8853(99)00347-9
   Kodama RH, 1997, PHYS REV LETT, V79, P1393, DOI 10.1103/PhysRevLett.79.1393
   KODAMA RH, 1999, PHYS REV B, V59, P13584
   LIN SY, 1996, J MAGN MAGN MATER, V159, P405
   LINDEROTH S, 1994, J APPL PHYS, V75, P6583, DOI 10.1063/1.356902
   Liu T, 1999, NANOSTRUCT MATER, V11, P487, DOI 10.1016/S0965-9773(99)00333-5
   LOPEZ A, 1995, J MAGN MAGN MATER, V140, P383, DOI 10.1016/0304-8853(94)00793-4
   MACIAS M, 1988, THERMOCHIM ACTA, V133, P106
   MADDOCK AG, 1998, MOSSBAUER SPECTROSCO
   Malaescu I, 2000, J MAGN MAGN MATER, V218, P91, DOI 10.1016/S0304-8853(00)00334-6
   Mazo-Zuluaga J, 2003, HYPERFINE INTERACT, V148, P153, DOI 10.1023/B:HYPE.0000003776.84005.89
   MCCLELLAND E, 1993, GEOPHYS J INT, V112, P517, DOI 10.1111/j.1365-246X.1993.tb01185.x
   MCMICHAEL RD, 1992, J MAGN MAGN MATER, V111, P29, DOI 10.1016/0304-8853(92)91049-Y
   MORALES MP, 1994, J SOLID STATE CHEM, V108, P158, DOI 10.1006/jssc.1994.1024
   Morales MP, 1999, CHEM MATER, V11, P3058, DOI 10.1021/cm991018f
   Morales MP, 1998, J MAGN MAGN MATER, V183, P232, DOI 10.1016/S0304-8853(97)01061-5
   Morales MP, 1997, J PHYS-CONDENS MAT, V9, P5461, DOI 10.1088/0953-8984/9/25/013
   Morales MP, 1999, J MAGN MAGN MATER, V203, P146, DOI 10.1016/S0304-8853(99)00278-4
   Moreno EM, 2002, LANGMUIR, V18, P4972, DOI 10.1021/la020037s
   MORRISH AH, 1983, J MAGN MAGN MATER, V35, P105, DOI 10.1016/0304-8853(83)90468-7
   MORRISH AH, 1980, J MAGN MAGN MATER, V15-8, P1089, DOI 10.1016/0304-8853(80)90899-9
   MORRISH AH, 1976, J PHYS C SOLID STATE, V37, P6
   MORUP S, 1976, APPL PHYS, V11, P63, DOI 10.1007/BF00895017
   Morup S, 2003, J MAGN MAGN MATER, V266, P110, DOI 10.1016/S0304-8853(03)00462-1
   MORUP S, 1995, PHYS REV B, V52, P287, DOI 10.1103/PhysRevB.52.287
   MORUP S, 1983, J MAGN MAGN MATER, V37, P39, DOI 10.1016/0304-8853(83)90350-5
   MORUP S, 1995, J MAGN MAGN MATER, V140, P409, DOI 10.1016/0304-8853(94)00963-5
   MORUP S, 1994, PHYS REV LETT, V72, P3278, DOI 10.1103/PhysRevLett.72.3278
   Mukadam MD, 2004, J MAGN MAGN MATER, V272, P1401, DOI 10.1016/j.jmmm.2003.12.139
   Narasimhan BRV, 2002, MATER LETT, V52, P295, DOI 10.1016/S0167-577X(01)00409-8
   NASRAZADANI S, 1993, CORROS SCI, V34, P1355, DOI 10.1016/0010-938X(93)90092-U
   Ngo AT, 1999, EUR PHYS J B, V9, P583, DOI 10.1007/s100510050801
   NOMIZU T, 2001, ANAL SCI, V17, pI177
   NORRIS RV, 1985, J GEOPHYS REV, V90, P3126
   Oh SJ, 1998, HYPERFINE INTERACT, V112, P59, DOI 10.1023/A:1011076308501
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   PANKHURST QA, 1991, PHYS REV LETT, V67, P248, DOI 10.1103/PhysRevLett.67.248
   PARKER FT, 1993, PHYS REV B, V47, P7885, DOI 10.1103/PhysRevB.47.7885
   Pascal C, 1999, CHEM MATER, V11, P141, DOI 10.1021/cm980742f
   POLLARD RJ, 1990, J PHYS-CONDENS MAT, V2, P983, DOI 10.1088/0953-8984/2/4/017
   PRENE P, 1993, IEEE T MAGN, V29, P2658, DOI 10.1109/20.280834
   Prodan D, 1999, J MAGN MAGN MATER, V203, P63, DOI 10.1016/S0304-8853(99)00189-4
   Randrianantoandro N, 2001, MATER LETT, V47, P150, DOI 10.1016/S0167-577X(00)00227-5
   Safarik I, 2002, MONATSH CHEM, V133, P737, DOI 10.1007/s007060200047
   Schimanke G, 2000, SOLID STATE IONICS, V136, P1235, DOI 10.1016/S0167-2738(00)00593-2
   Serna CJ, 2001, SOLID STATE COMMUN, V118, P437, DOI 10.1016/S0038-1098(01)00150-8
   Shafi KVPM, 2002, CHEM MATER, V14, P1778, DOI 10.1021/cm011535
   SHMAKOV AN, 1995, J APPL CRYSTALLOGR, V28, P141, DOI 10.1107/S0021889894010113
   Sohn BH, 1998, J MAGN MAGN MATER, V182, P216, DOI 10.1016/S0304-8853(97)00675-6
   Somogyvari Z, 2002, APPL PHYS A-MATER, V74, pS1077, DOI 10.1007/s003390101192
   Spiers KM, 2004, KEY ENG MAT, V254-2, P213, DOI 10.4028/www.scientific.net/KEM.254-256.213
   Tao SW, 1999, SENSOR ACTUAT B-CHEM, V61, P33, DOI 10.1016/S0925-4005(99)00276-2
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Tejada J, 1996, CHEM MATER, V8, P1784, DOI 10.1021/cm9602003
   Teng XW, 2003, NANO LETT, V3, P261, DOI 10.1021/nl025918y
   Tepper T, 2004, IEEE T MAGN, V40, P1685, DOI 10.1109/TMAG.2004.827215
   Tofail SAM, 2002, J MAGN MAGN MATER, V242, P588, DOI 10.1016/S0304-8853(01)01112-X
   Tronc E, 1995, NANOSTRUCT MATER, V6, P945, DOI 10.1016/0965-9773(95)00216-2
   Tronc E, 2003, J MAGN MAGN MATER, V262, P6, DOI 10.1016/S0304-8853(03)00011-8
   Tronc E, 2000, J MAGN MAGN MATER, V221, P63, DOI 10.1016/S0304-8853(00)00369-3
   Tronc E, 1998, HYPERFINE INTERACT, V112, P97, DOI 10.1023/A:1011092712136
   Tronc E, 1998, J SOLID STATE CHEM, V139, P93, DOI 10.1006/jssc.1998.7817
   Tueros MJ, 2003, HYPERFINE INTERACT, V148, P103, DOI 10.1023/B:HYPE.0000003770.22742.e7
   van Lierop J, 2000, PHYS REV LETT, V85, P3021, DOI 10.1103/PhysRevLett.85.3021
   Veintemillas-Verdaguer S, 1998, MATER LETT, V35, P227, DOI 10.1016/S0167-577X(97)00251-6
   Vestal CR, 2004, J PHYS CHEM B, V108, P18222, DOI 10.1021/jp0464526
   Vollath D, 1995, NANOSTRUCT MATER, V6, P941, DOI 10.1016/0965-9773(95)00215-4
   Vollath D, 1997, J MATER RES, V12, P2175, DOI 10.1557/JMR.1997.0291
   VOOGT FC, 1995, SURF SCI, V331, P1508, DOI 10.1016/0039-6028(95)00347-9
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Ye XS, 1998, J PHYS D APPL PHYS, V31, P2739, DOI 10.1088/0022-3727/31/20/006
   Zayat MZ, 2003, ADV MATER, V15, P1809, DOI 10.1002/adma.200305436
   Zboril R, 2003, NATO SCI SER II-MATH, V94, P21
   Zboril R, 2002, CHEM MATER, V14, P969, DOI 10.1021/cm0111074
   Zboril R, 2002, HYPERFINE INTERACT, V139, P597, DOI 10.1023/A:1021226929237
   Zhang L, 1997, J APPL PHYS, V81, P6892, DOI 10.1063/1.365233
   Zysler RD, 2000, J MAGN MAGN MATER, V221, P37, DOI 10.1016/S0304-8853(00)00368-1
NR 142
TC 87
Z9 87
U1 12
U2 97
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD APR
PY 2006
VL 6
IS 4
BP 926
EP 947
DI 10.1166/jnn.2006.183
PG 22
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 036KE
UT WOS:000237069200004
PM 16736748
DA 2018-10-20
ER

PT J
AU Volceanov, A
   Volceanov, E
   Stoleriu, S
AF Volceanov, A
   Volceanov, E
   Stoleriu, S
TI Hydroxiapatite-zirconia composites for biomedical applications
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on New Research Trends in Materials Science
   (ARM-4)
CY SEP 04-06, 2005
CL Constantsa, ROMANIA
DE hydroxiapatite; zirconia; biomaterial
AB Hydroxiapatite with stabilised or unstabilised zirconia ceramics were synthesised by solid state-reaction of oxide powders. Their sinterability as well as phase analysis were studied by X-ray diffraction analysis. The microstructure of sintered materials was investigated by scanning electron microscopy (SEM) and EDAX. The ceramic and some mechanical properties were investigated using a comparative approach. An interaction mechanism between zirconia and its polymorphs with calcium phosphates existing or formed after sintering is discussed.
C1 Univ Politech Bucharest, Bucharest, Romania.
   ICEM SA, Met Res Inst, Bucharest, Romania.
RP Volceanov, A (reprint author), Univ Politech Bucharest, Bucharest, Romania.
EM avolceanov@gmail.com
RI VOLCEANOV, Adrian/C-5005-2011
OI VOLCEANOV, Adrian/0000-0002-7668-861X; STOLERIU,
   Stefania/0000-0003-3553-2034
CR ABDELFATTAH WI, 1998, NEW BIOMEDICAL MAT B
   AOKI H, 1991, SCI MED APPL HIDROXY
   BEHERI HH, 1995, PREPARATION CHARACTE
   BONFIELD W, 1995, P 4 EUR CER, V8
   HENCH LL, 1992, BIOMATERIALS INTERFA
   HENCH LL, 1998, BIOACTIVE MAT POTENT
   PARK JB, 1987, BIOMATERIALS SCI ENG
   Pramatarova L, 2005, J OPTOELECTRON ADV M, V7, P469
   TOWNLEY CO, 1995, BIOCERAMICS MAT APPL
   YAMASKITA K, 1986, J AM CERAM SOC
NR 10
TC 8
Z9 8
U1 1
U2 3
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD APR
PY 2006
VL 8
IS 2
BP 585
EP 588
PG 4
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 035KX
UT WOS:000237001000039
DA 2018-10-20
ER

PT J
AU Ferruti, P
   Ranucci, E
   Bianchi, S
   Falciola, L
   Mussini, PR
   Ross, M
AF Ferruti, P
   Ranucci, E
   Bianchi, S
   Falciola, L
   Mussini, PR
   Ross, M
TI Novel polyamidoamine-based hydrogel with an innovative molecular
   architecture as a Co2+-, Ni2+-, and Cu2+-sorbing material:
   Cyclovoltammetry and extended X-ray absorption fine structure studies
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE electrochemistry; extended X-ray absorption fine structure (EXAFS)
   spectroscopy; hydrogels; metal-polymer complexes; polyamidoamines
ID POLY(AMIDOXIME) CHELATING RESIN; ION-EXCHANGE RESINS; METAL-IONS;
   APPLIED MACROINORGANICS; BIOMEDICAL APPLICATIONS; ENDOSOMOLYTIC
   POLYMERS; COMPLEX-FORMATION; MACRO-INORGANICS; AMINE) STRUCTURE;
   POLY(AMIDO-AMINE)S
AB An amphoteric polyamidoamine (PAA)-based hydrogel, named INT-PAA1, with a novel molecular architecture was prepared and studied as a Co2+-, Ni2+-, and Cu2+-sorbing material. This hydrogel was obtained by the synthesis of a PAA in the presence of a second presynthesized PAA carrying many primary amino groups as side substituents, which acted as a macromolecular crosslinking agent. Therefore, it had an intersegmented structure. INT-PAA1 exhibited a remarkable sorption capacity and sorption rate for Co2+, Ni2+, and Cu2+ that were advantageously in situ monitored by cyclic voltammetry. An extended X-ray absorption fine structure spectroscopy characterization of the Co2+/INT-PAA1 complex was also performed. The very fast and quantitative metal-ion uptake, made apparent by an intense coloring of the hydrogel, showed remarkable potential for environmental applications such as heavy-metal detection, recovery, and elimination. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Milan, Dept Organ & Ind Chem, I-20133 Milan, Italy.
   Univ Milan, Interdisciplinary Ctr Nanostruct Interfaces & Mat, I-20133 Milan, Italy.
   Univ Milan, Dept Phys Chem & Electrochem, I-20133 Milan, Italy.
   Univ Milan, Interdisciplinary Ctr Nanostruct Interfaces & Mat, I-20133 Milan, Italy.
RP Ferruti, P (reprint author), Univ Milan, Dept Organ & Ind Chem, Via Venezian 21, I-20133 Milan, Italy.
EM paolo.ferruti@unimi.it
RI Mussini, Patrizia/F-6852-2015; Ranucci, Elisabetta/J-3899-2015;
   Falciola, Luigi/Q-2256-2016
OI Mussini, Patrizia/0000-0003-4063-1563; Ranucci,
   Elisabetta/0000-0002-6402-2650; Falciola, Luigi/0000-0002-2031-239X;
   Ferruti, Paolo/0000-0002-5404-440X
CR Barbucci R, 2000, J INORG BIOCHEM, V81, P229, DOI 10.1016/S0162-0134(00)00127-6
   BARBUCCI R, 1983, POLYM COMMUN, V24, P26
   BARBUCCI R, 1979, POLYMER, V20, P1298, DOI 10.1016/0032-3861(79)90159-9
   Barbucci R, 2001, POLYM ADVAN TECHNOL, V12, P271, DOI 10.1002/pat.141
   BARBUCCI R, 1982, POLYMER, V23, P148, DOI 10.1016/0032-3861(82)90031-3
   BARBUCCI R, 1981, J POLYM SCI PS, V69, P49
   Chiron N, 2003, WATER RES, V37, P3079, DOI 10.1016/S0043-1354(03)00156-8
   DANGELO P, 2002, PHYS REV B, V66, DOI UNSP 064209-1-064209-7
   DENAMOR DA, 1995, PURE APPL CHEM, V67, P1053
   Ferruti P, 2000, MACROMOLECULES, V33, P7793, DOI 10.1021/ma000378h
   Ferruti P, 2005, MACROMOL BIOSCI, V5, P613, DOI 10.1002/mabi.200500020
   Ferruti P, 2002, MACROMOL RAPID COMM, V23, P332, DOI 10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   Ferruti P, 1999, MACROMOL CHEM PHYS, V200, P1644
   FERRUTI P, 1981, J CHEM SOC DALTON, P539, DOI 10.1039/dt9810000539
   FERRUTI P, 1982, J APPL POLYM SCI, V27, P2239, DOI 10.1002/app.1982.070270633
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   Filipponi A., 2000, TASK Quarterly, V4, P575
   GILEADI E, 1964, MOD ASPECT ELECTROC, V3, P371
   Gotoh T, 2004, CHEMOSPHERE, V55, P135, DOI 10.1016/j.chemosphere.2003.11.016
   Ho YS, 2003, WATER RES, V37, P2323, DOI 10.1016/S0043-1354(03)00002-2
   Lutfor MR, 2000, EUR POLYM J, V36, P2105, DOI 10.1016/S0014-3057(99)00286-4
   Malgesini B, 2003, MACROMOL BIOSCI, V3, P59, DOI 10.1002/mabi.200390009
   MARTELL AE, 1996, METAL COMPLEXES AQUE, P89
   PESAVENTO M, 1983, J APPL POLYM SCI, V28, P3361, DOI 10.1002/app.1983.070281105
   Richardson S, 1999, J DRUG TARGET, V6, P391, DOI 10.3109/10611869908996846
   vanBerkel PM, 1997, REACT FUNCT POLYM, V32, P139, DOI 10.1016/S1381-5148(96)00077-6
   Zohuriaan-Mehr MJ, 2004, REACT FUNCT POLYM, V61, P23, DOI 10.1016/j.reactfunctpolym.2004.03.006
NR 28
TC 12
Z9 12
U1 1
U2 20
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD APR 1
PY 2006
VL 44
IS 7
BP 2316
EP 2327
DI 10.1002/pola.21349
PG 12
WC Polymer Science
SC Polymer Science
GA 024LZ
UT WOS:000236197800016
DA 2018-10-20
ER

PT J
AU Horiuchi, Y
   Inamura, T
   Kim, HY
   Miyazaki, S
   Wakashima, K
   Hosoda, H
AF Horiuchi, Yosuke
   Inamura, Tomonari
   Kim, Hee Young
   Miyazaki, Syuichi
   Wakashima, Kenji
   Hosoda, Hideki
TI X-ray diffraction analysis of Ti-18 mol % Nb based shape memory alloys
   containing 3d transition metal elements
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE phase constitution; shape memory alloys; X-ray diffraction analysis;
   lattice parameter; texture
ID MECHANICAL-PROPERTIES; MARTENSITIC TRANSFORMATIONS; BIOMEDICAL ALLOYS;
   BEHAVIOR
AB The effect of 3d-transition-metal alloying on the phase constitution of Ti-18 mol%Nb based shape memory alloys was investigated by Xray diffraction analysis (XRD) at room temperature. The baseline binary Ti-18 mol%Nb alloy (called Binary) and ternary Ti-18 mol%Nb-3 mol%X alloys (X = V, Cr, Mn, Fe, Co and Ni, called 3X) were fabricated by Ar arc-melting method, followed by homogenization at 1273 K for 3.6 ks. These alloys were cold-rolled with 30% and 98% reduction in thickness. Some specimens from 98% cold rolled material were solution treated at 1273 K for 1.8 ks and quenched in water. It was found that the phase present in the solution-treated and quenched Binary and 3V was alpha" martensite phase and that of the other alloys was beta phase. No other phase or ordering was confirmed in these baseline and 3X alloys. The lattice parameter of beta phase showed a good correlation with the Goldschmidt atom radius of the ternary alloying metals. It was confirmed that (1) almost same type of deformation texture was formed in beta phase materials regardless of the alloying metals but that (2) the development of recrystallization texture was suggested to be different depending on the alloying metals.
C1 Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
   Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Horiuchi, Y (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
EM horiuchi@ken.pi.titech.ac.jp
RI Inamura, Tomonari/E-5712-2014; Kim, Hee Young/F-6065-2011; Miyazaki,
   Shuichi/A-3113-2012
OI Kim, Hee Young/0000-0003-1981-6678; Miyazaki,
   Shuichi/0000-0003-3849-4176
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   Collings E. W., 1994, MAT PROPERTIES HDB T, P5
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   DUWEZ P, 1953, T AM SOC METAL, V45, P934
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   FUKUI Y, 2003, T MRS J, V28, P623
   Hosoda H, 2005, MATER SCI FORUM, V475-479, P2329, DOI 10.4028/www.scientific.net/MSF.475-479.2329
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Hosoda N., 2001, JAPAN I METALS, V2, P1623
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   KIMURA H, 1985, J JPN SOC DENT MAT D, V4, P377
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda K., 2003, T MRS J, V28, P631
   LEI CY, 1993, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MARTENSITIC TRANSFORMATIONS (ICOMAT-92), P539
   MIURA H, 2003, J CRYST SOC JPN, V45, P145
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   NITTA K, P INT S STRUCT BIOM, P25
   Ohmatsu Y., 2001, JAPAN I METALS, V2, P1627
   Sasano H., 1990, P INT C TIT ICOMAT 8, P1667
   SUGIMOTO T, 1988, P 6 WORLD C TIT, P1069
NR 26
TC 8
Z9 8
U1 1
U2 14
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2006
VL 47
IS 4
BP 1209
EP 1213
DI 10.2320/matertrans.47.1209
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 068CZ
UT WOS:000239351000041
OA Bronze
DA 2018-10-20
ER

PT J
AU Ding, T
   Liu, QY
   Shi, R
   Tian, M
   Yang, H
   Zhang, LQ
AF Ding, T
   Liu, QY
   Shi, R
   Tian, M
   Yang, H
   Zhang, LQ
TI Synthesis, characterization and in vitro degradation study of a novel
   and rapidly degradable elastomer
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE poly(PEG-co-CA) (PEC); elastomer; in vitro degradation; synthesis
ID CROSS-LINKED POLYETHERS; DRUG-DELIVERY SYSTEMS; CITRIC-ACID;
   POLY(LACTIDE-CO-GLYCOLIDE) PLGA; BIODEGRADABLE ELASTOMERS; COPOLYMERS;
   POLY(EPSILON-CAPROLACTONE); POLY(L-LACTIDE); BIOMATERIALS; POLYESTERS
AB Biodegradable elastomers represent a useful class of biornaterials. In this paper, a novel biodegradable clastomer, poly(PEG-co-CA) (PEC), was synthesized by condensation of poly(ethylene glycol) (PEG) and citric acid (CA) under atmospheric pressure without any catalyst. We first synthesized a pre-polymer by carrying out a controlled condensation reaction between PEG and citric acid, and then post-polymerised and simultaneously cross-linked the pre-polymer in the mould at 120 degrees C. The pre-polymer was characterized by FT-IR, H-1 NMR, C-13 NMR, GPC and DSC. A series of polymers were prepared at different post-polymerisation time and different monomer ratios. Measurements on the mechanical properties of PEC testified that the new polymers are elastomers with low hardness and big elongation, and hydrolytic degradation of the polymer films in a buffer of pH 7.4 at 37 degrees C showed that PEC had excellent degradability (all the films show the weight losses more than 60% after 96 h incubation). The different post-polymerisation time and monomer ratio had strong influence on the degradation rates and mechanical performances. The material is expected to be useful for controlled drug delivery and other biomedical applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
   Henan Univ, Coll Chem & Chem Engn, Kaifeng 475001, Peoples R China.
RP Zhang, LQ (reprint author), Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
EM zhangliqunghp@yahoo.com
RI zhang, liqun/S-7337-2016
OI zhang, liqun/0000-0003-0291-4351
CR AMALIA PS, 2002, J APPL POLYM SCI, V85, P2929
   Amsden B, 2004, BIOMACROMOLECULES, V5, P1399, DOI 10.1021/bm034538j
   Ayhan F, 2003, J BIOMED MATER RES B, V64B, P13, DOI 10.1002/jbm.b.10411
   Barroso-Bujans F, 2003, J APPL POLYM SCI, V88, P302, DOI 10.1002/app.11664
   Bogdanov B, 1998, POLYMER, V39, P1631, DOI 10.1016/S0032-3861(97)00444-8
   Brian G. A., 2004, BIOMACROMOLECULES, V5, P2479
   CRAWFORD RD, 1995, BIOCHEM MOL MED, V54, P1, DOI 10.1006/bmme.1995.1001
   DAHIYAT BI, 1995, REACT POLYM, V25, P101, DOI 10.1016/0923-1137(95)91297-P
   Deng XM, 2002, EUR POLYM J, V38, P1435, DOI 10.1016/S0014-3057(02)00017-4
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P213
   GROOT JH, 1998, POLYM B, V41, P299
   HELEN HL, 2003, J BIOMED MATER RES A, V64, P465
   HINRICHS WLJ, 1992, BIOMATERIALS, V13, P585, DOI 10.1016/0142-9612(92)90026-K
   Hu YQ, 2004, POLYM DEGRAD STABIL, V85, P705, DOI 10.1016/j.polymdegradstab.2003.12.010
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   LANGER R, 2000, AICHE J, V46, P1288
   LIU Q, IN PRESS J APPL POLY
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Nagata M, 2004, POLYMER, V45, P87, DOI 10.1016/j.polymer.2003.11.003
   Nagata M, 2003, J POLYM SCI POL CHEM, V41, P2930, DOI 10.1002/pola.10884
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Pol BJM, 1996, J BIOMED MATER RES, V32, P321
   Pol BJM, 1996, J BIOMED MATER RES, V32, P307
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   Sivalingam G, 2004, POLYM DEGRAD STABIL, V84, P393, DOI 10.1016/j.polymdegradstab.2003.12.008
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Tsuji H, 2003, POLYM DEGRAD STABIL, V81, P501, DOI 10.1016/S0141-3910(03)00150-2
   WADA R, 1991, PHARMACEUT RES, V8, P1292, DOI 10.1023/A:1015860030772
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yao FL, 2004, EUR POLYM J, V40, P1895, DOI 10.1016/j.eurpolymj.2004.04.017
   Yao FL, 2003, J POLYM SCI POL CHEM, V41, P2073, DOI 10.1002/pola.10756
NR 36
TC 39
Z9 43
U1 5
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD APR
PY 2006
VL 91
IS 4
BP 733
EP 739
DI 10.1016/j.polymdegradstab.2005.06.007
PG 7
WC Polymer Science
SC Polymer Science
GA 007DM
UT WOS:000234948300013
DA 2018-10-20
ER

PT J
AU Kenawy, ER
   Abdel-Hay, FI
   Abou El-Magd, A
   Mahmoud, Y
AF Kenawy, ER
   Abdel-Hay, FI
   Abou El-Magd, A
   Mahmoud, Y
TI Biologically active polymers: VII. Synthesis and antimicrobial activity
   of some crosslinked copolymers with quaternary ammonium and phosphonium
   groups
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE bioactive polymers; antimicrobial polymers; biocide, biomedical
   polymers; quaternary ammonium groups; quaternary phosphonium groups;
   biological applications of polymers; crosslinked copolymers; water
   treatment
ID ANTIBACTERIAL ACTIVITY; POLY(ETHYLENE-CO-VINYL ALCOHOL); METHACRYLATE
   POLYMERS; BIOCIDES; DERIVATIVES; WATER; POLYURETHANES
AB Microbial infection remains one of the most serious complications associated with the use of indwelling medical devices. Antimicrobial agents are those materials capable of killing pathogenic microorganisms. In general, they are low molecular weight compounds. However, most of these molecules are toxic to the environment and their application is short lived. If these materials attached to polymers, it would be ideal solution to overcome problems associated with low molecular weight material.
   Our recent studies were focused on the development of antimicrobial polymers to attain high value products. ln a continuation to our effort in this field, we report here the synthesis of crosslinked copolymers based on copolymerization of vinylbenzyl chloride (VBC) either with 2-chloroethyl vinyl ether (CEVE), or methylmethacrylate (MMA) using the divinylbenzene as crosslinker (DVB). The crosslinked copolymers were further modified by quaternization with triphenylphosphine and triethylamine. The antimicrobial activity of the modified copolymers was tested against various microorganisms (Staphylococcus aureus, Escherichia coli, Bacillus subtilis, Aspergillusflavits, Fusarium oxysporion and Candida albicans). In general, the copolymers showed good antimicrobial activity against the tested microorganisms. (c) 2005 Elsevier B.V. All rights reserved.
C1 Tanta Univ, Fac Sci, Dept Chem, Polymer Res Grp, Tanta, Egypt.
   Tanta Univ, Fac Sci, Dept Bot, Mycol Res Lab, Tanta, Egypt.
RP Kenawy, ER (reprint author), Tanta Univ, Fac Sci, Dept Chem, Polymer Res Grp, Tanta, Egypt.
EM ekenawy@yahoo.com
RI ABOUELMAGD, Ahmed/A-2952-2012
OI Mahmoud, Yehia/0000-0002-7009-0115; Kenawy,
   El-Refaie/0000-0002-0194-843X
CR Appendini P, 2001, J APPL POLYM SCI, V81, P609, DOI 10.1002/app.1476
   Dizman B, 2004, J APPL POLYM SCI, V94, P635, DOI 10.1002/app.20872
   Eknoian MW, 1999, POLYMER, V40, P1367, DOI 10.1016/S0032-3861(98)00383-8
   Grapski JA, 2001, BIOMATERIALS, V22, P2239, DOI 10.1016/S0142-9612(00)00412-9
   HAZZIZALASKAR J, 1993, J APPL POLYM SCI, V50, P651, DOI 10.1002/app.1993.070500410
   Kawabata N, 1998, REACT FUNCT POLYM, V37, P213, DOI 10.1016/S1381-5148(97)00133-8
   Kelly HM, 2004, INT J PHARM, V274, P167, DOI 10.1016/j.ijpharm.2004.01.019
   Kenawy ER, 2002, J POLYM SCI POL CHEM, V40, P2384, DOI 10.1002/pola.10325
   Kenawy ER, 2005, J BIOACT COMPAT POL, V20, P95, DOI 10.1177/0883911505049655
   Kenawy ER, 2003, MACROMOL BIOSCI, V3, P107, DOI 10.1002/mabi.200390016
   Kenawy ER, 2002, MACROMOL BIOSCI, V2, P261, DOI 10.1002/1616-5195(200208)2:6<261::AID-MABI261>3.0.CO;2-2
   Kenawy ER, 2001, J APPL POLYM SCI, V82, P1364, DOI 10.1002/app.1973
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   Lin J, 2001, POLYMER, V42, P7903, DOI 10.1016/S0032-3861(01)00272-5
   Mahmoud Y. A. G., 2001, ARAB J BIOTECH, V4, P15
   Nurkeeva ZS, 2004, EUR J PHARM BIOPHARM, V57, P245, DOI 10.1016/s0939-6411(03)00149-8
   Park ES, 2004, J APPL POLYM SCI, V93, P765, DOI 10.1002/app.20534
   Park ES, 2001, J APPL POLYM SCI, V80, P728, DOI 10.1002/1097-4628(20010502)80:5<728::AID-APP1149>3.3.CO;2-Z
   Park ES, 2001, INT BIODETER BIODEGR, V47, P209, DOI 10.1016/S0964-8305(01)00058-0
   Park JS, 1998, J APPL POLYM SCI, V69, P2213, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2213::AID-APP13>3.0.CO;2-#
   Patel MB, 2003, J APPL POLYM SCI, V89, P895, DOI 10.1002/app.11970
   Piozzi A, 2004, INT J PHARM, V280, P173, DOI 10.1016/j.ijpharm.2004.05.017
   PRIDHAM TG, 1956, PHYTOPATHOLOGY, V46, P275
   Salmaso S, 2004, INT J PHARM, V287, P163, DOI 10.1016/j.ijpharm.2004.09.003
   Samuel U., 2004, INT J ANTIMICROB AG, V23, P75
   Shi ZL, 2005, BIOMATERIALS, V26, P501, DOI 10.1016/j.biomaterials.2004.02.060
   Sun YY, 2001, J APPL POLYM SCI, V81, P617, DOI 10.1002/app.1477
   Sun YY, 2001, J APPL POLYM SCI, V80, P2460, DOI 10.1002/app.1353
   Sun YY, 2001, J POLYM SCI POL CHEM, V39, P3348, DOI 10.1002/pola.1317
   Sun YY, 2001, J POLYM SCI POL CHEM, V39, P3073, DOI 10.1002/pola.1288
   Tyagi M, 2000, J APPL POLYM SCI, V76, P1109, DOI 10.1002/(SICI)1097-4628(20000516)76:7<1109::AID-APP15>3.0.CO;2-#
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
NR 33
TC 93
Z9 100
U1 4
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD APR
PY 2006
VL 66
IS 4
BP 419
EP 429
DI 10.1016/j.reactfunctpolym.2005.09.002
PG 11
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 030MJ
UT WOS:000236638400005
DA 2018-10-20
ER

PT J
AU Garnier, S
   Laschewsky, A
   Storsberg, J
AF Garnier, S.
   Laschewsky, A.
   Storsberg, J.
TI Polymeric surfactants: Novel agents with exceptional properties
SO TENSIDE SURFACTANTS DETERGENTS
LA English
DT Review
DE block copolymer; polymer surfactant; tailor-made properties;
   nanotechnology
ID AMPHIPHILIC BLOCK-COPOLYMERS; FRAGMENTATION CHAIN-TRANSFER; TRANSFER
   RADICAL POLYMERIZATION; CROSS-LINKED MICELLES; ABC TRIBLOCK COPOLYMERS;
   SUPERCRITICAL CARBON-DIOXIDE; TRANSFER RAFT POLYMERIZATION;
   AQUEOUS-SOLUTION PROPERTIES; OXIDE)-POLY(PROPYLENE OXIDE)-POLY(ETHYLENE
   OXIDE); RESPONSIVE PARTICULATE EMULSIFIERS
AB This article presents recent progress in the field of polymeric surfactants made of permanently amphiphilic block copolymers or of stimulus-sensitive ones. We highlight key points in the design of amphiphilic macromolecules, to yield polymer surfactants with tailor-made properties, as well as recently developed and still challenging application fields for this new class of surfactants. The efficiency boosting of amphiphilic block copolymers as co-surfactants in microemulsions is discussed, as are surface modification by polymer surfactants, and stabilization of dispersions. Moreover, the use of block copolymers in nanosciences is presented, for instance as a tool for nanomaterial fabrication, or for biomedical and cosmetic applications in bio-nanotechnology. Finally, self-assembly and applications of some newly developed "exotic" amphiphilic block copolymer structures as new surface-active materials will be highlighted.
C1 Fraunhofer Inst Angew Polymerforsch, D-14476 Potsdam, Germany.
   Univ Potsdam, D-14414 Potsdam, Germany.
RP Laschewsky, A (reprint author), Fraunhofer Inst Angew Polymerforsch, Geiselberg 69, D-14476 Potsdam, Germany.
EM Laschewsky@iap.fhg.de
OI Laschewsky, Andre/0000-0003-2443-886X
CR Abe M, 1999, CURR OPIN COLLOID IN, V4, P354, DOI 10.1016/S1359-0294(99)90017-1
   Albertin L, 2004, MACROMOLECULES, V37, P7530, DOI 10.1021/ma049129+
   Alexandridis P, 1997, CURR OPIN COLLOID IN, V2, P478, DOI 10.1016/S1359-0294(97)80095-7
   Amalvy JI, 2004, LANGMUIR, V20, P4345, DOI 10.1021/la035921c
   Andre X, 2005, MACROMOL RAPID COMM, V26, P558, DOI 10.1002/marc.200400510
   [Anonymous], 1986, Pat, Patent No. [4581429, 4581429 USA]
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Antonietti M, 1996, MACROMOLECULES, V29, P3800, DOI 10.1021/ma951446g
   Antoun S, 2001, POLYMER, V42, P3641, DOI 10.1016/S0032-3861(00)00746-1
   Arotcarena M, 2002, J AM CHEM SOC, V124, P3787, DOI 10.1021/ja012167d
   ASTAFIEVA I, 1995, MACROMOLECULES, V28, P7127, DOI 10.1021/ma00125a015
   ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034
   BADER H, 1984, ANGEW MAKROMOL CHEM, V123, P457, DOI 10.1002/apmc.1984.051230121
   Banez MVD, 2000, MACROMOLECULES, V33, P451
   BARRON MJ, 1974, J POLYM SCI POL CHEM, V12, P1269, DOI 10.1002/pol.1974.170120613
   Batt-Coutrot D, 2003, EUR POLYM J, V39, P2243, DOI 10.1016/S0014-3057(03)00179-4
   Baussard JF, 2004, POLYMER, V45, P3615, DOI 10.1016/j.polymer.2004.03.081
   Bertin PA, 2004, MACROMOLECULES, V37, P8364, DOI 10.1021/ma035741+
   Bian K, 2005, MACROMOLECULES, V38, P695, DOI 10.1021/ma0485383
   Bockstaller MR, 2005, ADV MATER, V17, P1331, DOI 10.1002/adma.200500167
   Bohorquez M, 1999, J COLLOID INTERF SCI, V216, P34, DOI 10.1006/jcis.1999.6273
   Bohrisch J, 1997, MACROMOL RAPID COMM, V18, P975, DOI 10.1002/marc.1997.030181104
   Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   Brannan AK, 2004, MACROMOLECULES, V37, P8816, DOI 10.1021/ma048858m
   Breulmann M, 2000, MACROMOL CHEM PHYSIC, V201, P204, DOI 10.1002/(SICI)1521-3935(20000201)201:2<204::AID-MACP204>3.0.CO;2-1
   Bronich TK, 2005, J AM CHEM SOC, V127, P8236, DOI 10.1021/ja043042m
   Bronstein LH, 1999, LANGMUIR, V15, P6256, DOI 10.1021/la990146f
   Bronstein LM, 1998, MACROMOL CHEM PHYSIC, V199, P1357, DOI 10.1002/macp.1998.021990713
   Bulychev NA, 2004, MACROMOL CHEM PHYSIC, V205, P2457, DOI 10.1002/macp.200400203
   Burguiere C, 1999, MACROMOLECULES, V32, P3883, DOI 10.1021/ma982037y
   Burguiere C, 2003, POLYMER, V44, P509, DOI 10.1016/S0032-3861(02)00811-X
   Busse K, 2002, MACROMOLECULES, V35, P178, DOI 10.1021/ma0116809
   Butun V, 2000, MACROMOLECULES, V33, P1, DOI 10.1021/ma9914669
   Butun V, 1998, J AM CHEM SOC, V120, P12135, DOI 10.1021/ja981932u
   Butun V, 2001, MACROMOLECULES, V34, P1503, DOI 10.1021/ma0018392
   Byelov D, 2004, LANGMUIR, V20, P10433, DOI 10.1021/la049317t
   Byelov D, 2004, PHYSICA B, V350, pE931, DOI 10.1016/j.physb.2004.03.240
   Cai YL, 2004, MACROMOLECULES, V37, P9728, DOI 10.1021/ma0487756
   Cameron NS, 1999, CAN J CHEM, V77, P1311, DOI 10.1139/v99-141
   Cammas-Marion S, 2000, MACROMOL CHEM PHYSIC, V201, P355, DOI 10.1002/(SICI)1521-3935(20000201)201:3<355::AID-MACP355>3.0.CO;2-9
   Canelas DA, 1997, MACROMOLECULES, V30, P5673, DOI 10.1021/ma970579u
   CAO T, 1991, MACROMOLECULES, V24, P6300, DOI 10.1021/ma00023a036
   Castelletto V, 2003, MACROMOLECULES, V36, P1694, DOI 10.1021/ma021396x
   Chang Y, 2002, BIOMACROMOLECULES, V3, P1364, DOI 10.1021/bm0200087b
   Charleux B, 2005, MACROMOLECULES, V38, P5485, DOI 10.1021/ma050087e
   Checot F, 2005, LANGMUIR, V21, P4308, DOI 10.1021/la0468500
   Chen CW, 1999, LANGMUIR, V15, P7998, DOI 10.1021/la9817462
   Chen M, 2004, MACROMOLECULES, V37, P5479, DOI 10.1021/ma049037k
   Chen XL, 1999, LANGMUIR, V15, P8007, DOI 10.1021/la9810253
   Chen XR, 2004, MACROMOL BIOSCI, V5, P157, DOI 10.1002/mabi.200400150
   Chen XR, 2005, COLLOID POLYM SCI, V283, P452, DOI 10.1007/s00396-004-1203-3
   Chen XR, 2004, MACROMOL RAPID COMM, V25, P1575, DOI 10.1002/marc.200400232
   Chen YM, 2001, MACROMOL CHEM PHYSIC, V202, P3273, DOI 10.1002/1521-3935(20011101)202:17<3273::AID-MACP3273>3.0.CO;2-8
   Cheng CX, 2005, MACROMOLECULES, V38, P3044, DOI 10.1021/ma040196t
   Chiu JJ, 2005, J AM CHEM SOC, V127, P5036, DOI 10.1021/ja050376i
   Choucair A, 2004, LANGMUIR, V20, P3894, DOI 10.1021/la035924p
   Colfen H, 2001, MACROMOL RAPID COMM, V22, P219, DOI 10.1002/1521-3927(20010201)22:4<219::AID-MARC219>3.0.CO;2-G
   Convertine AJ, 2005, MACROMOL RAPID COMM, V26, P791, DOI 10.1002/marc.200500042
   Creutz S, 1998, MACROMOLECULES, V31, P681, DOI 10.1021/ma970987y
   Crothers M, 2002, LANGMUIR, V18, P8685, DOI 10.1021/la026086m
   Cui L, 2003, MACROMOLECULES, V36, P8246, DOI 10.1021/ma0351524
   Cunningham MF, 2002, PROG POLYM SCI, V27, P1039, DOI 10.1016/S0079-6700(02)00008-4
   Dai S, 2004, LANGMUIR, V20, P1597, DOI 10.1021/la035837x
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   de Laat AWM, 1998, COLLOID POLYM SCI, V276, P176, DOI 10.1007/s003960050226
   Desai PR, 2002, COLLOID SURFACE A, V197, P19, DOI 10.1016/S0927-7757(01)00801-9
   Donovan MS, 2003, J POLYM SCI POL CHEM, V41, P1262, DOI 10.1002/pola.10658
   Donovan MS, 2002, MACROMOLECULES, V35, P4570, DOI 10.1021/ma020191l
   Donovan MS, 1999, POLY PREPR, V40, P281
   DORGAN JR, 1993, MACROMOLECULES, V26, P5321, DOI 10.1021/ma00072a008
   Edrington AC, 2001, ADV MATER, V13, P421, DOI 10.1002/1521-4095(200103)13:6<421::AID-ADMA421>3.0.CO;2-#
   Endo H, 2002, APPL PHYS A-MATER, V74, pS392, DOI 10.1007/s003390201550
   Endo H, 2001, J CHEM PHYS, V115, P580, DOI 10.1063/1.1377881
   Endo H, 2000, PHYS REV LETT, V85, P102, DOI 10.1103/PhysRevLett.85.102
   Feng XS, 2002, MACROMOLECULES, V35, P4888, DOI 10.1021/ma020004j
   Fischer A, 2001, POLYMER, V42, P1441, DOI 10.1016/S0032-3861(00)00493-6
   Forster S, 1996, J CHEM PHYS, V104, P9956
   Forster S, 1997, BER BUNSEN PHYS CHEM, V101, P1671, DOI 10.1002/bbpc.19971011124
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   FRASER C, 1995, MACROMOLECULES, V28, P7248, DOI 10.1021/ma00125a030
   Frielinghaus H, 2004, PHYSICA B, V350, P186, DOI [10.1016/j.physb.2004.04.023, 10.1016/j.physb.2004.04.04.023]
   Fujii S, 2005, ADV MATER, V17, P1014, DOI 10.1002/adma.200401641
   Fujii S, 2005, J AM CHEM SOC, V127, P7304, DOI 10.1021/ja050049a
   Fukushima S, 2005, J AM CHEM SOC, V127, P2810, DOI 10.1021/ja0440506
   Fustin CA, 2005, EUR PHYS J E, V16, P291, DOI 10.1140/epje/i2004-10086-0
   Gabaston LI, 1999, POLYMER, V40, P4505, DOI 10.1016/S0032-3861(98)00689-2
   Gaillard N, 2003, J POLYM SCI POL CHEM, V41, P684, DOI 10.1002/pola.10606
   Garcia CBW, 2003, J AM CHEM SOC, V125, P13310, DOI 10.1021/ja037116q
   Garnier S, 2005, MACROMOLECULES, V38, P7580, DOI 10.1021/ma0506785
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Gillies ER, 2005, BIOCONJUGATE CHEM, V16, P361, DOI 10.1021/bc049851c
   Gohy J.F., 2002, E-POLYMERS, V021, P1
   Gohy JF, 2003, POLYM INT, V52, P1611, DOI 10.1002/pi.1348
   Gohy JF, 2002, MACROMOLECULES, V35, P7427, DOI 10.1021/ma0204812
   Gohy JF, 2002, MACROMOLECULES, V35, P4560, DOI 10.1021/ma012042t
   Gohy JF, 2001, MACROMOLECULES, V34, P7435, DOI 10.1021/ma010535s
   Gompper G, 2001, J PHYS-CONDENS MAT, V13, P9055, DOI 10.1088/0953-8984/13/41/302
   Gosa KL, 2002, COLLOID SURFACE A, V197, P257, DOI 10.1016/S0927-7757(01)00902-5
   Goto A, 2004, PROG POLYM SCI, V29, P329, DOI 10.1016/j.progpolymsci.2004.01.002
   Gotz H, 2002, J POLYM SCI POL CHEM, V40, P3379, DOI 10.1002/pola.10428
   Granville AM, 2005, MACROMOLECULES, V38, P3263, DOI 10.1021/ma048620y
   Gref R, 1998, COLLOID SURFACE A, V143, P413, DOI 10.1016/S0927-7757(98)00524-X
   GUZONAS DA, 1992, MACROMOLECULES, V25, P2434, DOI 10.1021/ma00035a022
   Haag R., 2004, ANGEW CHEM, V116, P280
   Hales M, 2004, LANGMUIR, V20, P10809, DOI 10.1021/la0484016
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Hamley IW, 2004, MACROMOLECULES, V37, P5337, DOI 10.1021/ma049396f
   Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u
   HOEMER P, 1998, MACROMOL CHEM PHYS, V199, P343
   Hou SJ, 1999, MACROMOL RAPID COMM, V20, P440, DOI 10.1002/(SICI)1521-3927(19990801)20:8<440::AID-MARC440>3.0.CO;2-R
   Hou SJ, 2003, LANGMUIR, V19, P2485, DOI 10.1021/la020773w
   Hruby M, 2005, J APPL POLYM SCI, V95, P201, DOI 10.1002/app.21121
   Hua FJ, 2004, LANGMUIR, V20, P3954, DOI 10.1021/la036124h
   Huang W, 2005, J POLYM SCI POL CHEM, V43, P2038, DOI 10.1002/pola.20688
   Huang WL, 2002, MACROMOL CHEM PHYSIC, V203, P1715, DOI 10.1002/1521-3935(200207)203:10/11<1715::AID-MACP1715>3.0.CO;2-N
   Hussain H, 2003, MACROMOL CHEM PHYSIC, V204, P936, DOI 10.1002/macp.200390070
   Ishizu K, 2004, J APPL POLYM SCI, V91, P3233, DOI 10.1002/app.13493
   Ivanova R, 1999, COLLOID SURFACE A, V149, P23, DOI 10.1016/S0927-7757(98)00416-6
   Jada A, 1999, COLLOID SURFACE A, V149, P315, DOI 10.1016/S0927-7757(98)00521-4
   JADA A, 1993, COLLOID SURFACE A, V75, P203, DOI 10.1016/0927-7757(93)80431-D
   Jagur-Grodzinski J, 2001, REACT FUNCT POLYM, V49, P1, DOI 10.1016/S1381-5148(01)00059-1
   Jain NJ, 2000, COLLOID SURFACE A, V173, P85, DOI 10.1016/S0927-7757(99)00514-2
   Jain S, 2004, MACROMOLECULES, V37, P1511, DOI 10.1021/ma035467j
   Jakobs B, 1999, LANGMUIR, V15, P6707, DOI 10.1021/la9900876
   Jakobs B, 2000, TENSIDE SURFACT DET, V37, P357
   Jakubowski W, 2005, J POLYM SCI POL CHEM, V43, P1498, DOI 10.1002/pola.20629
   Jaramillo TF, 2003, J AM CHEM SOC, V125, P7148, DOI 10.1021/ja029800v
   Jiang GH, 2005, POLYMER, V46, P81, DOI 10.1016/j.polymer.2004.10.065
   Jiang JQ, 2005, J AM CHEM SOC, V127, P8290, DOI 10.1021/ja0521019
   Jiang Y, 2005, MACROMOLECULES, V38, P6710, DOI 10.1021/ma050424j
   JOHNER A, 1990, MACROMOLECULES, V23, P5299, DOI 10.1021/ma00228a001
   Jordan R, 2001, MACROMOLECULES, V34, P1606, DOI 10.1021/ma001615j
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0
   Karymov MA, 1996, LANGMUIR, V12, P4748, DOI 10.1021/la9604240
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kataoka K, 1999, MACROMOLECULES, V32, P6892, DOI 10.1021/ma990973n
   Katsampas I, 2005, MACROMOLECULES, V38, P1307, DOI 10.1021/ma048275c
   Kaya H, 2002, APPL PHYS A-MATER, V74, pS499, DOI 10.1007/s003390101113
   Kickelbick G, 2003, LANGMUIR, V19, P10073, DOI 10.1021/la035063k
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kim MS, 2004, J BIOMED MATER RES A, V70A, P154, DOI 10.1002/jbm.a.30049
   Kim SY, 2000, J CONTROL RELEASE, V65, P345, DOI 10.1016/S0168-3659(99)00207-2
   Kjoniksen AL, 2005, MACROMOLECULES, V38, P948, DOI 10.1021/ma048581q
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Konak C, 2002, POLYMER, V43, P3735
   Kotre T, 2004, MACROMOL SYMP, V217, P203, DOI 10.1002/masy.200451316
   Kotzev A, 2002, MACROMOLECULES, V35, P1091, DOI 10.1021/ma011047n
   KOTZEV A, 2001, CHEM PHYS, V202, P3257
   Kozlov MY, 2000, MACROMOLECULES, V33, P3305, DOI 10.1021/ma991634x
   Kubowicz S, 2005, ANGEW CHEM INT EDIT, V44, P5262, DOI 10.1002/anie.200500584
   Kujawa P, 2002, J PHYS CHEM B, V106, P5578, DOI 10.1021/jp0145053
   Kukula H, 2002, MACROMOLECULES, V35, P2538, DOI 10.1021/ma011606q
   Kumar A, 2001, J DISPER SCI TECHNOL, V22, P245, DOI 10.1081/DIS-100105211
   Lacroix-Desmazes P, 2004, J POLYM SCI POL CHEM, V42, P3537, DOI 10.1002/pola.20193
   Lai JI, 2005, J PHYS CHEM B, V109, P15, DOI 10.1021/jp0457702
   Laruelle G, 2004, MACROMOL RAPID COMM, V25, P1839, DOI 10.1002/marc.200400315
   Laschewsky A, 2003, TENSIDE SURFACT DET, V40, P246
   Lazzari M, 2003, ADV MATER, V15, P1583, DOI 10.1002/adma.200300382
   Lecommandoux SB, 2005, ADV MATER, V17, P712, DOI 10.1002/adma.200400599
   Lee AS, 2002, MACROMOLECULES, V35, P8540, DOI 10.1021/ma0114842
   Lee AS, 1999, MACROMOLECULES, V32, P4302, DOI 10.1021/ma981865o
   Lee S, 2004, MACROMOLECULES, V37, P8349, DOI 10.1021/ma049076w
   Lefay C, 2004, MACROMOL RAPID COMM, V25, P1215, DOI 10.1002/marc.200400117
   Lele BS, 2002, MACROMOLECULES, V35, P6714, DOI 10.1021/ma020433h
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Licciardi M, 2005, BIOMACROMOLECULES, V6, P1085, DOI 10.1021/bm049271i
   Lieske A, 1998, MACROMOL CHEM PHYSIC, V199, P255, DOI 10.1002/(SICI)1521-3935(19980201)199:2<255::AID-MACP255>3.3.CO;2-4
   Liu BL, 2005, MACROMOLECULES, V38, P2131, DOI 10.1021/ma048035x
   Liu FT, 2003, J AM CHEM SOC, V125, P15059, DOI 10.1021/ja038142r
   Liu GJ, 2002, MACROMOLECULES, V35, P9788, DOI 10.1021/ma021021b
   LIU S, 2001, ANGEW CHEM, V113, P2390
   Liu SY, 2002, ANGEW CHEM INT EDIT, V41, P1413, DOI 10.1002/1521-3773(20020415)41:8<1413::AID-ANIE1413>3.0.CO;2-K
   Liu SY, 2002, LANGMUIR, V18, P8350, DOI 10.1021/la020496t
   Liu SY, 2001, CURR OPIN COLLOID IN, V6, P249, DOI 10.1016/S1359-0294(01)00090-5
   Liu SY, 2002, MACROMOLECULES, V35, P6121, DOI 10.1021/ma020447n
   Logan JL, 2005, LANGMUIR, V21, P3424, DOI 10.1021/la0468242
   Loos K, 2005, MACROMOLECULES, V38, P873, DOI 10.1021/ma0345549
   Loykulnant S, 2001, MACROMOLECULES, V34, P8434, DOI 10.1021/ma0107861
   Lutz JF, 2005, MACROMOL CHEM PHYSIC, V206, P813, DOI 10.1002/macp.200500067
   Lysenko EA, 2004, J PHYS CHEM B, V108, P12352, DOI 10.1021/jp048777s
   Maeda Y, 2002, MACROMOLECULES, V35, P217, DOI 10.1021/ma011034+
   Mahajan S, 2004, MACROMOL RAPID COMM, V25, P1889, DOI 10.1002/marc.200400383
   Malmstrom EE, 1998, MACROMOL CHEM PHYSIC, V199, P923
   Manners I, 2001, SCIENCE, V294, P1664, DOI 10.1126/science.1066321
   Mao GP, 1997, MACROMOLECULES, V30, P2556, DOI 10.1021/ma9617835
   MARQUES C, 1988, MACROMOLECULES, V21, P1051, DOI 10.1021/ma00182a035
   MARTIC PA, 1994, J COLLOID INTERF SCI, V163, P517, DOI 10.1006/jcis.1994.1133
   Matsumoto K, 2004, MACROMOLECULES, V37, P2256, DOI 10.1021/ma021166i
   Matsumoto K, 2004, LANGMUIR, V20, P7270, DOI 10.1021/la049371+
   Matsuoka H, 2004, LANGMUIR, V20, P7412, DOI 10.1021/la0492153
   Mayer ABR, 1997, COLLOID POLYM SCI, V275, P333, DOI 10.1007/s003960050090
   McHugh MA, 2002, MACROMOLECULES, V35, P6479, DOI 10.1021/ma012169i
   Melnichenko YB, 1999, MACROMOLECULES, V32, P5344, DOI 10.1021/ma990640q
   Mertoglu M, 2005, POLYMER, V46, P7726, DOI 10.1016/j.polymer.2005.03.101
   Mertoglu M, 2005, MACROMOLECULES, V38, P3601, DOI 10.1021/ma048268o
   MIANO F, 1992, COLLOID SURFACE, V68, P9, DOI 10.1016/0166-6622(92)80143-P
   Mori T, 2004, LANGMUIR, V20, P313, DOI 10.1021/la0356194
   Mossmer S, 2000, MACROMOLECULES, V33, P4791, DOI 10.1021/ma992006i
   MUNCH MR, 1988, MACROMOLECULES, V21, P1366, DOI 10.1021/ma00183a031
   MUNCH MR, 1990, MACROMOLECULES, V23, P2313, DOI 10.1021/ma00210a030
   Murthy KS, 2001, CHEM COMMUN, P773
   NAGARAJAN R, 1989, MACROMOLECULES, V22, P4312, DOI 10.1021/ma00201a029
   Napoli A, 2004, LANGMUIR, V20, P3487, DOI 10.1021/la0357054
   Napoli A, 2002, LANGMUIR, V18, P8324, DOI 10.1021/la025897n
   Narrainen AP, 2002, J POLYM SCI POL CHEM, V40, P439, DOI 10.1002/pola.10122
   Neiser MW, 2004, ANGEW CHEM INT EDIT, V43, P3192, DOI 10.1002/anie.200353259
   Neugebauer D, 2003, MACROMOLECULES, V36, P2598, DOI 10.1021/ma025883o
   Nicol E, 2005, POLYMER, V46, P2020, DOI 10.1016/j.polymer.2005.01.044
   Nicolas J, 2004, MACROMOLECULES, V37, P4453, DOI 10.1021/ma049800a
   Nikova AT, 2004, MACROMOLECULES, V37, P2215, DOI 10.1021/ma035638k
   Niu HJ, 2005, LANGMUIR, V21, P4205, DOI 10.1021/la046883f
   Ohno K, 2002, MACROMOLECULES, V35, P8989, DOI 10.1021/ma0209491
   Pai TSC, 2004, POLYMER, V45, P4383, DOI 10.1016/j.polymer.2004.04.041
   Pandit N, 2000, J COLLOID INTERF SCI, V222, P213, DOI 10.1006/jcis.1999.6628
   Park EK, 2005, BIOMATERIALS, V26, P1053, DOI 10.1016/j.biomaterials.2004.04.008
   PARSONAGE E, 1991, MACROMOLECULES, V24, P1987, DOI 10.1021/ma00008a041
   Pedersen JS, 2003, COLLOID SURFACE A, V213, P175, DOI 10.1016/S0927-7757(02)00511-3
   Piirma I, 1992, POLYMERIC SURFACTANT
   Pilon LN, 2005, LANGMUIR, V21, P3808, DOI 10.1021/la047046g
   Pyun J, 2004, MACROMOL CHEM PHYSIC, V205, P411, DOI 10.1002/macp.200300070
   Qi K, 2004, J AM CHEM SOC, V126, P6599, DOI 10.1021/ja039647k
   Qi LM, 2001, NANO LETT, V1, P61, DOI 10.1021/nl0055052
   Rager T, 1997, MACROMOLECULES, V30, P4911, DOI 10.1021/ma961866l
   Ranger M, 2001, J POLYM SCI POL CHEM, V39, P3861, DOI 10.1002/pola.10029
   Raula J, 2003, LANGMUIR, V19, P3499, DOI 10.1021/la026872r
   Ravi P, 2005, POLYMER, V46, P137, DOI 10.1016/j.polymer.2004.11.009
   Ravi P, 2003, MACROMOLECULES, V36, P173, DOI 10.1021/ma021302j
   Rieger J, 2005, CHEM COMMUN, P274, DOI 10.1039/b411565a
   Rieger M. M., 1997, SURFACTANTS COSMETIC
   Riess G, 2004, MACROMOL RAPID COMM, V25, P401, DOI 10.1002/marc.200300048
   Riess G, 1999, COLLOID SURFACE A, V153, P99, DOI 10.1016/S0927-7757(98)00429-4
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Rojas OJ, 2002, LANGMUIR, V18, P8085, DOI 10.1021/la025989c
   Rossi S, 1997, REV I FR PETROL, V52, P199, DOI 10.2516/ogst:1997019
   Ruysschaert T, 2005, J AM CHEM SOC, V127, P6242, DOI 10.1021/ja043600x
   Rzayev J, 2005, MACROMOLECULES, V38, P3, DOI 10.1021/ma047870b
   Sakai T, 2005, J PHYS CHEM B, V109, P7766, DOI 10.1021/jp046221z
   Sakai T, 2004, LANGMUIR, V20, P8426, DOI 10.1021/la049514s
   Samoshina Y, 2005, LANGMUIR, V21, P2855, DOI 10.1021/la047311y
   Sartori A, 2005, MACROMOLECULES, V38, P3432, DOI 10.1021/ma0489624
   Save M, 2005, MACROMOLECULES, V38, P280, DOI 10.1021/ma048487+
   Schaller C, 2002, MACROMOL SYMP, V179, P173, DOI 10.1002/1521-3900(200203)179:1<173::AID-MASY173>3.0.CO;2-O
   Schaller C, 2002, MACROMOL SYMP, V187, P695, DOI 10.1002/1521-3900(200209)187:1<695::AID-MASY695>3.0.CO;2-I
   Schmidt SC, 2002, J POLYM SCI POL PHYS, V40, P2364, DOI 10.1002/polb.10291
   Schrage S, 2003, MACROMOLECULES, V36, P1417, DOI 10.1021/ma0255940
   Schuch H, 2000, MACROMOLECULES, V33, P1734, DOI 10.1021/ma991491e
   Sfika V, 2004, MACROMOLECULES, V37, P9551, DOI 10.1021/ma048621q
   Sidorov SN, 1999, J COLLOID INTERF SCI, V212, P197, DOI 10.1006/jcis.1998.6035
   Sidorov SN, 2004, LANGMUIR, V20, P3543, DOI 10.1021/la0360658
   Sin SL, 2005, MACROMOLECULES, V38, P3943, DOI 10.1021/ma050097f
   Soni SS, 2003, J PHYS CHEM B, V107, P5382, DOI 10.1021/jp027444x
   Soo PL, 2004, J POLYM SCI POL PHYS, V42, P923, DOI 10.1002/polb.10739
   Sottmann T, 2002, CURR OPIN COLLOID IN, V7, P57, DOI 10.1016/S1359-0294(02)00003-1
   Stenzel MH, 2004, MACROMOL BIOSCI, V4, P445, DOI 10.1002/mabi.200300113
   Stepanek M, 1998, ACTA POLYM, V49, P96
   Stepanek M, 1998, ACTA POLYM, V49, P103
   Stolnik S, 1997, COLLOID SURFACE A, V122, P151, DOI 10.1016/S0927-7757(96)03826-5
   Storey RF, 2005, POLYMER, V46, P2141, DOI 10.1016/j.polymer.2004.12.041
   STORSBERG J, 2004, SOFW J, V14, P130
   Su YL, 2003, J COLLOID INTERF SCI, V264, P526, DOI 10.1016/S0021-9797(03)00472-7
   Sugihara S, 2004, J POLYM SCI POL CHEM, V42, P2601, DOI 10.1002/pola.20121
   Sugiyama M, 2001, J PHYS CHEM B, V105, P12448, DOI 10.1021/jp011959r
   Sumerlin BS, 2004, J POLYM SCI POL CHEM, V42, P1724, DOI 10.1002/pola.11069
   Sumerlin BS, 2003, MACROMOLECULES, V36, P5982, DOI 10.1021/ma034088n
   Szablan Z, 2004, J POLYM SCI POL CHEM, V42, P2432, DOI 10.1002/pola.20098
   Szajdzinska-Pietek E, 2004, POLYMER, V45, P4113, DOI 10.1016/j.polymer.2004.03.101
   Taboada P, 2005, LANGMUIR, V21, P5263, DOI 10.1021/la0503808
   Tachibana Y, 2003, CHEM COMMUN, P106, DOI 10.1039/b210181e
   Tan BH, 2005, POLYMER, V46, P1347, DOI 10.1016/j.polymer.2004.11.070
   Tauer K, 2005, POLYMER, V46, P1003, DOI 10.1016/j.polymer.2004.11.035
   Tauer K, 2002, MACROMOL CHEM PHYSIC, V203, P319, DOI 10.1002/1521-3935(20020101)203:2<319::AID-MACP319>3.0.CO;2-7
   Thompson RB, 2002, MACROMOLECULES, V35, P1060, DOI 10.1021/ma011563d
   Tian YQ, 2002, MACROMOLECULES, V35, P3739, DOI 10.1021/ma011859j
   Toomey R, 2005, MACROMOLECULES, V38, P5137, DOI 10.1021/ma048121x
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Uddin MH, 2003, MACROMOLECULES, V36, P1261, DOI 10.1021/ma0210978
   Vasilieva YA, 2004, MACROMOLECULES, V37, P2728, DOI 10.1021/ma035574d
   Vieira JB, 2005, LANGMUIR, V21, P4441, DOI 10.1021/la050040m
   Virtanen J, 2002, LANGMUIR, V18, P5360, DOI 10.1021/la0118208
   Voulgaris D, 2001, MACROMOL CHEM PHYSIC, V202, P3284, DOI 10.1002/1521-3935(20011101)202:17<3284::AID-MACP3284>3.0.CO;2-0
   Wang G, 2004, MACROMOLECULES, V37, P8911, DOI 10.1021/ma048416a
   Wang XS, 2005, MACROMOLECULES, V38, P1928, DOI 10.1021/ma049793q
   Wang XS, 2003, J AM CHEM SOC, V125, P12686, DOI 10.1021/ja037521h
   Weaver JVM, 2002, CHEM COMMUN, P2122, DOI 10.1039/b207251n
   Weaver JVM, 2004, ANGEW CHEM INT EDIT, V43, P1389, DOI 10.1002/anie.200352428
   Wendler U, 1998, MACROMOL RAPID COMM, V19, P185, DOI 10.1002/marc.1998.030190405
   Wesslen B, 1998, MACROMOL SYMP, V130, P403, DOI 10.1002/masy.19981300134
   Wohlrab S, 2001, J POLYM SCI POL CHEM, V39, P3797, DOI 10.1002/pola.10026
   Won YY, 2003, MACROMOLECULES, V36, P953, DOI 10.1021/ma021439+
   Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d
   Xiong XY, 2003, MACROMOLECULES, V36, P9979, DOI 10.1021/ma035292d
   Xu J, 2004, ANGEW CHEM INT EDIT, V43, P5491, DOI 10.1002/anie.200460906
   XU R, 1992, J APPL POLYM SCI APP, V51, P135
   Yamada K, 1999, MACROMOLECULES, V32, P3553, DOI 10.1021/ma9816315
   Yang J, 2004, MACROMOL BIOSCI, V4, P1092, DOI 10.1002/mabi.200400128
   Yang ZG, 2005, EUR POLYM J, V41, P267, DOI 10.1016/j.europolymj.2004.09.023
   Yao J, 2004, LANGMUIR, V20, P2157, DOI 10.1021/la0355343
   Yates MZ, 1999, MACROMOLECULES, V32, P1018, DOI 10.1021/ma981457k
   Yun JP, 2004, J MACROMOL SCI PURE, VA41, P613, DOI 10.1081/MA-120034194
   Yusa S, 2004, MACROMOLECULES, V37, P7507, DOI 10.1021/ma0492519
   Yusa SI, 2005, BIOMACROMOLECULES, V6, P663, DOI 10.1021/bm0495553
   Zhang X, 1999, MACROMOLECULES, V32, P1763, DOI 10.1021/ma981332f
   Zhang Y, 2004, COLLOID POLYM SCI, V282, P1323, DOI 10.1007/s00396-004-1068-5
   Zhao JX, 1997, MACROMOLECULES, V30, P7143, DOI 10.1021/ma970427z
   Zheng Y, 1999, J PHYS CHEM B, V103, P10331, DOI 10.1021/jp9923264
   Zhu MQ, 2001, CHEM COMMUN, P365, DOI 10.1039/b009815i
NR 307
TC 26
Z9 26
U1 2
U2 49
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0932-3414
J9 TENSIDE SURFACT DET
JI Tenside Surfactants Deterg.
PD APR-MAY
PY 2006
VL 43
IS 2
BP 88
EP 102
DI 10.3139/113.100290
PG 15
WC Chemistry, Applied; Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 053AS
UT WOS:000238276500003
DA 2018-10-20
ER

PT J
AU Dresser, R
AF Dresser, R
TI Private-sector research ethics: Marketing or good conflicts management?
   The 2005 John J. Conley lecture on medical ethics
SO THEORETICAL MEDICINE AND BIOETHICS
LA English
DT Article
DE business ethics; conflicts of interest; corporate responsibility;
   pharmaceutical companies; research ethics; scientific integrity
ID CLINICAL-TRIAL AGREEMENTS; OF-INTEREST
AB Pharmaceutical companies are major sponsors of biomedical research. Most scholars and policymakers focus their attention on government and academic oversight activities, however. In this article, I consider the role of pharmaceutical companies' internal ethics statements in guiding decisions about corporate research and development (R&D). I review materials from drug company websites and contributions from the business and medical ethics literature that address ethical responsibilities of businesses in general and pharmaceutical companies in particular. I discuss positive and negative uses of pharmaceutical companies' ethics materials and describe shortcomings in the companies' existing ethics programs. To guide employees and reassure outsiders, companies must add rigor, independence, and transparency to their R&D ethics programs.
C1 Washington Univ, Sch Med, Program Med & Humanities, St Louis, MO 63130 USA.
RP Dresser, R (reprint author), Washington Univ, Sch Med, Program Med & Humanities, 1 Brookings Dr,Box 1120, St Louis, MO 63130 USA.
EM dresser@wulaw.wustl.edu
CR ANGELL M, 2004, TRUTH DRUG COMPANIES
   Avorn J., 2004, POWERFUL MED BENEFIT
   Berenson Alex, 2005, N Y Times Web, pA32
   Brock D W, 2001, Dev World Bioeth, V1, P33, DOI 10.1111/1471-8847.00005
   COUZIN J, 2005, SCIENCE, V307, P89
   Croghan TW, 2004, HEALTH AFFAIR, V23, P23, DOI 10.1377/hlthaff.23.1.23
   De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225
   DEMAISTRE J, 1992, BARTLETTS FAMILIAR Q
   DHANDA R, 2002, GUIDING ICARUS MERGI
   Dresser R, 2005, HASTINGS CENT REP, V35, P10
   Dresser R, 2001, SCI OFFERS SALVATION
   DuVal G, 2004, J LAW MED ETHICS, V32, P613, DOI 10.1111/j.1748-720X.2004.tb01967.x
   Eaton ML, 2004, ETHICS BUSINESS BIOS
   Friedman M., 1970, NY TIMES MAGAZI 0913, V13, P32
   Goodpaster Kenneth, 2003, HARVARD BUS REV, P131
   HAHN H, 2005, NY TIMES        0531, pA18
   Levinsky NG, 2002, NEW ENGL J MED, V347, P759, DOI 10.1056/NEJMsb020853
   Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115
   Olsen NJ, 2005, NEW ENGL J MED, V352, P2578, DOI 10.1056/NEJMp058105
   PAINE LS, 2003, VALUE SHIFT CO MUST
   Porter M., 2003, HARVARD BUS REV, P27
   PSATY B, 2004, JAMA-J AM MED ASSOC, V292, P2629
   Relmen Arnold S., 2002, NEW REPUBLIC, P27
   Spencer E. M., 2000, ORG ETHICS HLTH CARE
   Steinbrook R, 2005, NEW ENGL J MED, V352, P2160, DOI 10.1056/NEJMp048353
   Strom BL, 2004, JAMA-J AM MED ASSOC, V292, P2643, DOI 10.1001/jama.292.21.2643
   Thompson Dennis F., 2005, RESTORING RESPONSIBI
NR 27
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1386-7415
J9 THEOR MED BIOETH
JI Theor. Med. Bioeth.
PD APR
PY 2006
VL 27
IS 2
BP 115
EP 139
DI 10.1007/s11017-005-5289-5
PG 25
WC Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Social Issues; Biomedical Social
   Sciences
GA 042WX
UT WOS:000237562400001
PM 16699963
DA 2018-10-20
ER

PT J
AU Chen, JT
   Xu, Z
   Gu, QS
   Chen, WL
   Cai, WY
   Jiang, LX
   Zhang, XY
AF Chen, JT
   Xu, Z
   Gu, QS
   Chen, WL
   Cai, WY
   Jiang, LX
   Zhang, XY
TI Characterization of type I bovine tendon collagen as biomedical
   materials using MALDI tandem time-of-flight mass spectrometry
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT 8th Annual Meeting of the Tissue-Engineering-Society-International
   (TESI)
CY OCT 22-25, 2005
CL Shanghai, PEOPLES R CHINA
SP Tissue Engn Soc Int
C1 Tongji Univ, Dept Mat Sci & Engn, Microelect Mat Inst, Shanghai 200092, Peoples R China.
   Shanghai Qisheng Biol Preparat Co Ltd, Shanghai 201106, Peoples R China.
EM JT.chen@hotmail.com
NR 0
TC 0
Z9 0
U1 1
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2006
VL 12
IS 4
MA 267
BP 1075
EP 1075
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 041YV
UT WOS:000237494400299
DA 2018-10-20
ER

PT J
AU Jeong, L
   Lee, KY
   Liu, JW
   Park, WH
AF Jeong, L
   Lee, KY
   Liu, JW
   Park, WH
TI Time-resolved structural investigation of regenerated silk fibroin
   nanofibers treated with solvent vapor
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE silk fibroin; electrospun nanofiber; structural change; solvent vapor
ID BOMBYX-MORI SILK; IN-VITRO; SOLID-STATE; NMR-SPECTROSCOPY; FILMS;
   CONFORMATION; SCAFFOLDS; METHANOL; CULTURE; CELLS
AB Nonwoven matrices of silk fibroin (SF) nanofibers were prepared by electrospinning a regenerated SF solution, followed by treatment with solvent vapor including water, methanol, ethanol, and propanol. Structural changes of solvent vapor-treated SF nanofibers were investigated in a time-resolved manner using IR spectroscopy. Conformational transitions of SF nanofibers from random coil to P-sheet forms were dependent on the type of solvent vapor used, and their transition rates were strongly influenced by treatment temperatures. Consistent with previous findings, methanol vapor treatment provided a fast and effective means by which to alter the secondary structure of SF nanofibers. However, treatment with water vapor, as compared to treatment with alcohol vapor, was also useful for inducing structural changes in SF nanofibers. As demonstrated in the present study, our approach of controlling secondary structure formation of proteins by solvent vapor treatment and monitoring real-time conformational changes may be useful for the design and tailoring of materials for biomedical applications. (c) 2006 Elsevier B.V. All rights reserved.
C1 Hanyang Univ, Coll Engn, Dept Bioenerget, Seoul 133791, South Korea.
   Chungnam Natl Univ, Coll Engn, Dept Text Engn, Taejon 305764, South Korea.
   Chungnam Natl Univ, Dept Polymer Sci & Engn, Taejon 305764, South Korea.
RP Lee, KY (reprint author), Hanyang Univ, Coll Engn, Dept Bioenerget, Seoul 133791, South Korea.
EM leeky@hanyang.ac.kr; parkwh@cnu.ac.kr
OI Lee, Kuen Yong/0000-0002-5759-5952; Park, Won Ho/0000-0003-1768-830X
CR Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Chen G, 2004, J MATER SCI-MATER M, V15, P671, DOI 10.1023/B:JMSM.0000030208.89523.2a
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Dal Pra I, 2003, TISSUE ENG, V9, P1113, DOI 10.1089/10763270360728026
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   KAPLAN D, 1994, ACS S SERIES, V544
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   Peng XN, 2004, ACTA CHIM SINICA, V62, P2127
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Takeshita H, 2000, MACROMOL MATER ENG, V283, P126
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 36
TC 67
Z9 71
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR 30
PY 2006
VL 38
IS 2
BP 140
EP 144
DI 10.1016/j.ijbiomac.2006.02.009
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 040TC
UT WOS:000237402300010
PM 16545448
DA 2018-10-20
ER

PT J
AU Fuertes, AB
   Tartaj, P
AF Fuertes, AB
   Tartaj, P
TI A facile route for the preparation of superparamagnetic porous carbons
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MAGNETIC NANOPARTICLES; GAMMA-FE2O3 NANOPARTICLES; BIOMEDICAL
   APPLICATIONS; MESOPOROUS SILICA; COMPOSITES; SURFACE; NANOCRYSTALS;
   ADSORPTION; PARTICLES; SPHERES
AB We present here a novel and simple synthetic strategy for fabricating superparamagnetic nanomagnets randomly dispersed in porous carbons. The method can be basically considered as a pyrolysis performed inside the restricted volume formed by the pores of an activated carbon. Such magnetic porous materials exhibit large surface areas (up to 1600 m(2) g(-1)), high pore volumes (up to 1.0 cm(3) g(-1)), and a porosity made up of accessible pores. An additional advantage of this method is its versatility, which allows composites with tunable magnetic properties to be obtained. In this way, it is possible to obtain superparamagnetic composites that can be easily manipulated by an external magnetic field.
C1 CSIC, Inst Nacl Carbon, E-33080 Oviedo, Spain.
   CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
RP Fuertes, AB (reprint author), CSIC, Inst Nacl Carbon, Apartado 73, E-33080 Oviedo, Spain.
EM abefu@incar.csic.es; ptartaj@icmm.csic.es
RI Fuertes, Antonio B/H-6905-2015; Tartaj, Pedro/B-8983-2008
OI Fuertes, Antonio B/0000-0002-5931-1669; Tartaj,
   Pedro/0000-0001-7323-1545
CR BANSAL RC, 1988, ACTIVE CARBON, pCH6
   Berry CC, 2005, J MATER CHEM, V15, P543, DOI 10.1039/b409715g
   Bourlinos AB, 2001, J PHYS CHEM B, V105, P7432, DOI 10.1021/jp010286+
   Choi M, 2005, J AM CHEM SOC, V127, P1924, DOI 10.1021/ja044907z
   Choi M, 2003, NAT MATER, V2, P473, DOI 10.1038/nmat923
   Cornell R. M., 1996, IRON OXIDES STRUCTUR
   Cullity B. D., 1972, INTRO MAGNETIC MAT
   DACOATA GM, 1994, J SOLID STATE CHEM, V113, P405, DOI 10.1006/jssc.1994.1388
   ELHILO M, J MAGN MAGN MAT
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Jeong UY, 2005, J AM CHEM SOC, V127, P1098, DOI 10.1021/ja043847u
   Kruk M, 1997, LANGMUIR, V13, P6267, DOI 10.1021/la970776m
   Lee J, 2005, ANGEW CHEM INT EDIT, V44, P7427, DOI 10.1002/anie.200502995
   Lee J, 2005, CARBON, V43, P2536, DOI 10.1016/j.carbon.2005.05.005
   Lee Y, 2005, ADV FUNCT MATER, V15, P503, DOI 10.1002/adfm.200400187
   Li Z, 2005, ADV MATER, V17, P1001, DOI 10.1002/adma.200401545
   Lu AH, 2004, ANGEW CHEM INT EDIT, V43, P4303, DOI 10.1002/anie.200454222
   Martinez B, 1998, PHYS REV LETT, V80, P181, DOI 10.1103/PhysRevLett.80.181
   MILLER JD, 2004, Patent No. 20040147397
   Morales MP, 1999, CHEM MATER, V11, P3058, DOI 10.1021/cm991018f
   MORUP S, 1995, PHYS REV B, V52, P287, DOI 10.1103/PhysRevB.52.287
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Nunez L, 1999, J MAGN MAGN MATER, V194, P102, DOI 10.1016/S0304-8853(98)00571-X
   Oliveira LCA, 2002, CARBON, V40, P2177, DOI 10.1016/S0008-6223(02)00076-3
   Oxtoby DW, 1998, ACCOUNTS CHEM RES, V31, P91, DOI 10.1021/ar9702278
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Radovic L R, 2001, CHEM PHYS CARBON, V27
   RADOVIC LR, 1997, CHEM PHYS CARBON, V25, pCH3
   Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702
   Ring TA, 2001, ADV COLLOID INTERFAC, V91, P473, DOI 10.1016/S0001-8686(00)00073-7
   Rudge SR, 2000, BIOMATERIALS, V21, P1411, DOI 10.1016/S0142-9612(00)00006-5
   Safarik I, 2004, BIOMAGN RES TECHNOL, V2, P7, DOI DOI 10.1186/1477-044X-2-7
   Skumryev V, 2003, NATURE, V423, P850, DOI 10.1038/nature01687
   Tartaj P, 2004, ADV MATER, V16, P529, DOI 10.1002/adma.200305814
   Tartaj P, 2003, J AM CHEM SOC, V125, P15754, DOI 10.1021/ja0380594
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
   Tian BZ, 2003, ADV MATER, V15, P1370, DOI 10.1002/adma.200305211
   Viau G, 1996, J MATER CHEM, V6, P1047, DOI 10.1039/jm9960601047
   Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P1375, DOI 10.1002/anie.200390352
NR 40
TC 77
Z9 78
U1 3
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAR 21
PY 2006
VL 18
IS 6
BP 1675
EP 1679
DI 10.1021/cm052695e
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 025LG
UT WOS:000236267000044
DA 2018-10-20
ER

PT J
AU De Castro, M
   Orive, G
   Gascon, AR
   Hernandez, RM
   Pedraz, JL
AF De Castro, M
   Orive, G
   Gascon, AR
   Hernandez, RM
   Pedraz, JL
TI Evaluation of human serum albumin as a substitute of foetal bovine serum
   for cell culture
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE encapsulation; human serum albumin; foetal bovine serum; C2C12 cells;
   BHK cells; culture medium
ID ALGINATE BEADS; MICROCAPSULES; THERAPY; MICROENCAPSULATION; BIOPOLYMERS;
   TECHNOLOGY; CHALLENGES; DELIVERY
AB Cell microencapsulation requires clinically approved materials for their use in pharmaceutical and/or biomedical applications. The overwhelming majority of the literature has used the classical alginate-poly-L-lysine-alginate (APA) capsules for cell immobilization. Although alginate is granted with the medical approval, some of the remaining components such as foetal bovine serum (FBS), an essential ingredient of cell culture media, are not in accordance with the guidelines affirmed by the American Society for Testing and Materials (ASTM) and Food and Drug Administration (FDA). In this paper, human serum albumin (HSA), a medically approved substance, was evaluated as a potential substitute of FBS. The effect of different percentages of FBS and HSA was studied on the proliferation rate, viability and protein production of two different cell lines (C2C12 and baby hamster kidney (BHK) cells), maintained in culture and immobilized in APA microcapsules. Results show that substitution of FBS by HSA reduced the functionality of both non-encapsulated and encapsulated BHK cells. However, immobilized C2C12 cells presented the highest level of viability and a reduction in protein production of 25% when 1% HSA was used. It can be concluded that HSA might be a possible substitute of FBS in order to maintain or transport encapsulated C2C12 cells for short periods of time before implantation. (C) 2005 Elsevier B.V. All rights reserved.
C1 Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
RP Pedraz, JL (reprint author), Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
EM knppemuj@vc.ehu.es
RI Hernandez, Rosa Maria/S-6332-2017
OI Hernandez, Rosa Maria/0000-0002-3947-409X; PEDRAZ MUNOZ, JOSE
   LUIS/0000-0002-3938-2267
CR Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Chang TMS, 2004, ARTIF ORGANS, V28, P265, DOI 10.1111/j.1525-1594.2004.47343.x
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Cirone P, 2004, HUM GENE THER, V15, P945, DOI 10.1089/hum.2004.15.945
   *COMM PROP MED PRO, 2003, NOT GUID US BOV SER
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Ha JS, 2003, BBA-MOL CELL RES, V1640, P119, DOI 10.1016/S0167-4889(03)00027-2
   Hortelano G, 1999, HUM GENE THER, V10, P1281, DOI 10.1089/10430349950017969
   Joly A, 1997, TRANSPLANTATION, V63, P795, DOI 10.1097/00007890-199703270-00002
   Levy MC, 1996, J MICROENCAPSUL, V13, P169, DOI 10.3109/02652049609052905
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)0073-7
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Schneider S, 2003, J MICROENCAPSUL, V20, P627, DOI 10.1080/0265204031000140796
   Shinya E, 1999, BIOMED PHARMACOTHER, V53, P471, DOI 10.1016/S0753-3322(00)88106-8
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
NR 17
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD MAR 9
PY 2006
VL 310
IS 1-2
BP 8
EP 14
DI 10.1016/j.ijpharm.2005.10.028
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 025YA
UT WOS:000236302300002
PM 16434155
DA 2018-10-20
ER

PT J
AU Engstrom, JUA
   Lindgren, LJ
   Helgee, B
AF Engstrom, JUA
   Lindgren, LJ
   Helgee, B
TI Synthesis of novel monomers and copolymers from 1-vinylpyrrolidin-2-one:
   Attractive materials for drug delivery systems?
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE copolymerization; drug delivery systems; functionalization of polymers;
   polyvinylpyrrolidone
ID REACTIVITY RATIOS; PHOTOPOLYMERIZATIONS; POLYMERS; PVP
AB Polyvinylpyrrolidone (PVP) is a synthetic, nontoxic, water-soluble polymer commonly used in a wide range of applications including several pharmaceutical applications. One example of an important application is the controlled release and delivery of therapeutic agents into sites of inflammation or tumours. However, PVP lacks reactive groups, which limits the possibility of adding new functions to the polymer in order to modify its physical and chemical properties. Furthermore, large differences in radical reactivity between 1-vinylpyrrolidin-2-one (NVP) and most other monomers lead to compositional drift during copolymerization. This complicates the introduction of reactive groups into the polymer using this method. Monomers that are derivatives of NVP itself are expected to show smaller differences in radical reactivity and therefore provide a way of preparing PVP with adjustable properties. Here we present the synthesis of five NVP-based monomers and their use in the preparation of functional PVP with adjustable properties in terms of solubility, loading of functional groups, and molar mass. The results show the possibility of tailoring PVP for different biomedical applications e.g. drug delivery systems.
   [GRAPHICS]
   Copolymers from 1-vinylpyrrolidin-2-one.
C1 Chalmers Univ Technol, Dept Chem & Biol Engn Polymer Technol, SE-41296 Gothenburg, Sweden.
RP Helgee, B (reprint author), Chalmers Univ Technol, Dept Chem & Biol Engn Polymer Technol, SE-41296 Gothenburg, Sweden.
EM Bertil.Helgee@chem.chalmers.se
CR AZORLOSA JL, 1968, WATER SOLUBLE RESINS, P131
   BARABAS ES, 1969, Patent No. 3468831
   Barabas ES, 1989, ENCY POLYM SCI ENG, P198
   BARABAS ES, 1969, Patent No. 3467613
   Bencini M, 2005, MACROMOLECULES, V38, P8211, DOI 10.1021/ma050422z
   Brunius CF, 2002, J POLYM SCI POL CHEM, V40, P3652, DOI 10.1002/pola.10468
   Brunius CF, 2001, MACROMOL RAPID COMM, V22, P1474, DOI 10.1002/1521-3927(20011201)22:18<1474::AID-MARC1474>3.0.CO;2-7
   BUEHLER V, 1984, ACTA PHARM TECHNOL, V30, P317
   D'Souza AJM, 2004, J CONTROL RELEASE, V94, P91, DOI 10.1016/j.jconrel.2003.09.014
   GREENLEY RZ, 1980, J MACROMOL SCI CHEM, VA14, P445, DOI 10.1080/00222338008081032
   GROSSER F, 1966, Patent No. 3244657
   HAAF F, 1985, POLYM J, V17, P143, DOI 10.1295/polymj.17.143
   Horak D, 2000, J POLYM SCI POL CHEM, V38, P653, DOI 10.1002/(SICI)1099-0518(20000201)38:3<653::AID-POLA29>3.0.CO;2-P
   JATZKEWITZ H, 1955, Z NATURFORSCH PT B, V10, P27
   Kaneda Y, 2004, BIOMATERIALS, V25, P3259, DOI 10.1016/j.biomaterials.2003.10.003
   MERIJAN A, 1970, Patent No. 3494907
   Tsunoda S, 2000, J CONTROL RELEASE, V68, P335, DOI 10.1016/S0168-3659(00)00249-2
   White LA, 2002, J POLYM SCI POL CHEM, V40, P694, DOI 10.1002/pola.10142
   White LA, 1999, POLYMER, V40, P6597, DOI 10.1016/S0032-3861(99)00189-5
NR 19
TC 16
Z9 16
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD MAR 3
PY 2006
VL 207
IS 5
BP 536
EP 544
DI 10.1002/macp.200500479
PG 9
WC Polymer Science
SC Polymer Science
GA 026XB
UT WOS:000236375300008
DA 2018-10-20
ER

PT J
AU Diaz, A
   Lopez, T
   Manjarrez, J
   Basaldella, E
   Martinez-Blanes, JM
   Odriozola, JA
AF Diaz, A
   Lopez, T
   Manjarrez, J
   Basaldella, E
   Martinez-Blanes, JM
   Odriozola, JA
TI Growth of hydroxyapatite in a biocompatible mesoporous ordered silica
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nanostructured materials; mesoporous silica; biocompatibility;
   hydroxyapatite
ID BRAIN BIOCOMPATIBILITY; IN-VITRO; BONE; BIOACTIVITY; PHOSPHATE; GLASSES;
   SURFACE; NMR
AB A novel biomaterial (HA-SBA-15) has been developed based on the growth of calcium phosphate hydroxyapatite (HA) nanoparticles within an organized silica structure (SBA-15). Characterization of the material was carried out using a combination of X-ray diffraction, X-ray fluorescence, transmission electron microscopy, N-2 adsorption-desorption isotherms and nuclear magnetic resonance. Transmission electron microscopy observations and N-2 porosimetry revealed the crystallization of hydroxyapatite nanoparticles inside the mesopore cavities of the silica structure. Specific surface areas of 760 m(2) g(-1) and 260 m(2) g(-1) were measured for the SBA-15 and the HA-SBA-15 material, respectively. The hydroxyl groups present in the silica nanostructure surface have brought about cationic defects in the silicium sites, mainly with those of tetrahedral symmetry, and promoted the formation of siloxanes. Si-29 MAS-NMR analysis shows a significant reduction of the silanol groups concentration with HA growing within the base (SBA-15) material. Studies and brain tissue biocompatibility tests were carried out. Histopathological studies on the SBA-15 implant material showed no changes to the tissue nearby. The results confirmed the synthesis of a silica-based composite containing HA nanoparticles with the potential for biomedical applications. (c) 2005 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Univ Sevilla, CSIC, Ctr Invest Cientificas Isla Cartuja, Dept Quim Inorgan, Seville 41092, Spain.
   Univ Sevilla, CSIC, Ctr Invest Cientificas Isla Cartuja, Inst Ciencia Mat, Seville 41092, Spain.
   Univ Autonoma Metropolitana Iztapalapa, Mexico City 09340, DF, Mexico.
   Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Mexico City 14269, DF, Mexico.
   Natl Univ La Plata, CINDECA, CIC, RA-1900 La Plata, Argentina.
RP Diaz, A (reprint author), Univ Sevilla, CSIC, Ctr Invest Cientificas Isla Cartuja, Dept Quim Inorgan, Avda Amer Vespucio 49, Seville 41092, Spain.
EM aranzazu@icmse.csic.es
RI Diaz-Cuenca, Aranzazu/M-3019-2013; Odriozola, Jose Antonio/N-2777-2013
OI Diaz-Cuenca, Aranzazu/0000-0002-5790-4452; Odriozola, Jose
   Antonio/0000-0002-8283-0459
CR Barroug A, 2004, J ORTHOPAED RES, V22, P703, DOI 10.1016/j.orthres.2003.10.016
   Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006
   BRINKER CJ, 1988, J NON-CRYST SOLIDS, V100, P31, DOI 10.1016/0022-3093(88)90005-1
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hench L.L., 2002, FUTURE STRATEGIES TI, P3
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HUMBERT B, 1995, J NON-CRYST SOLIDS, V191, P29, DOI 10.1016/0022-3093(95)00311-8
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j
   Landmesser H, 1997, SOLID STATE IONICS, V101, P271, DOI 10.1016/S0167-2738(97)84042-8
   Lopeze T, 2005, OPT MATER, V27, P1270, DOI 10.1016/j.optmat.2004.11.023
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035
   RAMDAS S, 1984, NATURE, V308, P521, DOI 10.1038/308521a0
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   van Grieken R, 2003, LANGMUIR, V19, P3966, DOI 10.1021/la026970c
   Veziers J, 2001, J NEUROSURG, V95, P489, DOI 10.3171/jns.2001.95.3.0489
   Yu SH, 2004, J MATER CHEM, V14, P2124, DOI 10.1039/b401420k
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 25
TC 57
Z9 59
U1 1
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2006
VL 2
IS 2
BP 173
EP 179
DI 10.1016/j.actbio.2005.12.006
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 018TM
UT WOS:000235787700005
PM 16701875
DA 2018-10-20
ER

PT J
AU Kim, JJ
   Zhang, Z
   Park, JC
   Ng, SK
AF Kim, JJ
   Zhang, Z
   Park, JC
   Ng, SK
TI BioContrasts: extracting and exploiting protein-protein contrastive
   relations from biomedical literature
SO BIOINFORMATICS
LA English
DT Article
ID DATABASE; UPDATE
AB Motivation: Contrasts are useful conceptual vehicles for learning processes and exploratory research of the unknown. For example, contrastive information between proteins can reveal what similarities, divergences and relations there are of the two proteins, leading to invaluable insights for better understanding about the proteins. Such contrastive information are found to be reported in the biomedical literature. However, there have been no reported attempts in current biomedical text mining work that systematically extract and present such useful contrastive information from the literature for exploitation.
   Results: Our BioContrasts system extracts protein-protein contrastive information from MEDLINE abstracts and presents the information to biologists in a web-application for exploitation. Contrastive information are identified in the text abstracts with contrastive negation patterns such as 'A but not B'. A total of 799 169 pairs of contrastive expressions were successfully extracted from 2.5 million MEDLINE abstracts. Using grounding of contrastive protein names to Swiss-Prot entries, we were able to produce 41 471 pieces of contrasts between Swiss-Prot protein entries. These contrastive pieces of information are then presented via a user-friendly interactive web portal that can be exploited for applications such as the refinement of biological pathways.
   Availability: BioContrasts can be accessed at http://biocontrasts.i2r.a-star.edu.sg. It is also mirrored at http://biocontrasts.biopathway.org
   Supplementary information: Supplementary materials are available at Bioinformatics online.
   Contact: skng@i2r.a-star.edu.sg; park@cs.kaist.ac.kr.
C1 Inst Infocomm Res, Knowledge Discovery Dept, Singapore 119613, Singapore.
   Korea Adv Inst Sci & Technol, Div Comp Sci, Taejon 305701, South Korea.
   Korea Adv Inst Sci & Technol, AITrc, Taejon 305701, South Korea.
RP Ng, SK (reprint author), Inst Infocomm Res, Knowledge Discovery Dept, 21 Heng Mui Keng Terrace, Singapore 119613, Singapore.
EM park@cs.kaist.ac.kr; skng@i2r.a-star.edu.sg
RI Kim, Jung-jae/A-3738-2011
CR Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Brill E, 1995, COMPUT LINGUIST, V21, P543
   COHEN KB, 2004, ARTIFICIAL INTELLIGE
   Fellbaum C., WORDNET ELECT LEXICA
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Kim J., 2004, P WORKSH REF RES ITS, P79
   KIM JJ, 2006, IN PRESS ACM T AS LA
   Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a
   Krauthammer M, 2004, J BIOMED INFORM, V37, P512, DOI 10.1016/j.jbi.2004.08.004
   LI XL, 2005, P 1 INT WORKSH DAT M
   PRINCE ELLEN F, 1992, DISCOURSE DESCRIPTIO, P295, DOI DOI 10.1075/PBNS.16.12PRI
   Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086
   Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104
   Smith L, 2004, BIOINFORMATICS, V20, P2320, DOI 10.1093/bioinformatics/bth227
   Umbach C., 2004, J SEMANT, V21, P155
NR 18
TC 13
Z9 15
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD MAR 1
PY 2006
VL 22
IS 5
BP 597
EP 605
DI 10.1093/bioinformatics/btk016
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 016EV
UT WOS:000235604400012
PM 16368768
OA Bronze
DA 2018-10-20
ER

PT J
AU Reynolds, MM
   Hrabie, JA
   Oh, BK
   Politis, JK
   Citro, ML
   Keefer, LK
   Meyerhoff, ME
AF Reynolds, MM
   Hrabie, JA
   Oh, BK
   Politis, JK
   Citro, ML
   Keefer, LK
   Meyerhoff, ME
TI Nitric oxide releasing polyurethanes with covalently linked
   diazeniumdiolated secondary amines
SO BIOMACROMOLECULES
LA English
DT Article
ID IMPROVED BLOOD COMPATIBILITY; SEGMENTED POLYURETHANES; BIOMEDICAL
   APPLICATION; CHEMICAL SENSORS; POLYMERIC FILMS; THROMBORESISTANT;
   GRAFTS; DESIGN; PLASMA
AB Two novel strategies for synthesizing stable polyurethanes (PUs) capable of generating bioactive nitric oxide (NO) are described. The methods rely on covalently attaching diazeniumdiolate (N2O2-) groups onto secondary amine nitrogens at various positions within the polymer chain such that, when in contact with water or physiological fluids, only the two molecules of NO available from each diazeniumdiolate moiety are released into the surrounding medium, with potential byproducts remaining covalently bound to the matrix. Extensive analysis of the NO, products released from the polymers was employed to develop appropriate strategies to better stabilize the diazeniumdiolate-based polymer structures. In one approach, diazeniumdiolate groups are attached to secondary amino nitrogens of alkane diamines inserted within the diol chain extender of a PU material. Oxidative loss of NO was minimized by blending the polymer with a biocompatible, relatively normucleophilic salt before exposing solutions of the polymer to NO during the diazeniumdiolation step. Fluxes of molecular NO from such materials during immersion in physiological buffer reached levels as high as 19 pmol center dot cm(-2)center dot s(-1) with a total recovery of 21 nmol of NO/mg of PU. A second general synthetic strategy involved omega-haloalkylating the urethane nitrogens and then displacing the halide from the resulting polymer with a nucleophilic polyamine to form a PU with pendent amino groups suitable for diazenitundiolation. Commercially available Pellethane 2363-80AE that was bromobutylated and then reacted with diethylenetriamine and further exposed to gaseous NO proved stable in solid form for several months, but released NO with a total recovery of 17 nmol/mg upon immersion in physiological buffer. This material showed an initial NO flux of 14 pmol center dot cm(-2)center dot s(-1) when immersed in pH 7.4 buffer at 37 degrees C, with gradually decreasing but still observable fluxes for up to 6 days.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   SAIC Frederick Inc, Basic Res Program, Natl Canc Inst, Frederick, MD 21702 USA.
   NCI, Chem Sect, Lab Comparat Carcinogenesis, Frederick, MD 21702 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
RI Keefer, Larry/N-3247-2014
OI Keefer, Larry/0000-0001-7489-9555
FU NCI NIH HHS [N01-CO-12400]; Intramural NIH HHS; NIBIB NIH HHS
   [EB-000783]
CR Alferiev IS, 2002, BIOMATERIALS, V23, P4753, DOI 10.1016/S0142-9612(02)00224-7
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   BATCHELOR MM, 2001, PREPR P AM CHEM SOC, V84, P594
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   Davies KM, 2001, J AM CHEM SOC, V123, P5473, DOI 10.1021/ja002899q
   DRAGO RS, 1961, J AM CHEM SOC, V83, P1819, DOI 10.1021/ja01469a012
   DURST S, 1974, RADIOLOGY, V113, P599, DOI 10.1148/113.3.599
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Hans D, 1993, Eur J Med, V2, P157
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y
   Korematsu A, 1999, J MATER CHEM, V9, P647, DOI 10.1039/a806279j
   LYMAN DJ, 1977, INT J POLYM MATER, V5, P211, DOI 10.1080/00914037708075207
   LYMAN DJ, 1978, J BIOMED MATER RES, V12, P337, DOI 10.1002/jbm.820120307
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Mowery KA, 1999, ELECTROANAL, V11, P681, DOI 10.1002/(SICI)1521-4109(199907)11:10/11<681::AID-ELAN681>3.3.CO;2-R
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SHIBUTA R, 1986, J BIOMED MATER RES, V20, P971, DOI 10.1002/jbm.820200712
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Szycher M, 1999, SZYCHERS HDB POLYURE
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   Verma S, 2005, NEW ENGL J MED, V353, P730, DOI 10.1056/NEJMcibr052030
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 32
TC 60
Z9 61
U1 1
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2006
VL 7
IS 3
BP 987
EP 994
DI 10.1021/bm060028o
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 023OP
UT WOS:000236136400048
PM 16529441
DA 2018-10-20
ER

PT J
AU Kannan, RY
   Salacinski, HJ
   Odlyha, M
   Butler, PE
   Seifalian, AM
AF Kannan, RY
   Salacinski, HJ
   Odlyha, M
   Butler, PE
   Seifalian, AM
TI The degradative resistance of polyhedral oligomeric silsesquioxane
   nanocore integrated polyurethanes: An in vitro study
SO BIOMATERIALS
LA English
DT Article
DE polymer; degradative; medical devices; tissue engineering; bypass graft
ID POLY(ETHERURETHANE UREA); VASCULAR GRAFTS; BIODEGRADATION; BEHAVIOR;
   VIVO; POLY(CARBONATE-UREA)URETHANE; POLY(DIMETHYLSILOXANE);
   BIOSTABILITY; POLYMERS; URETHANE
AB Polymer biostability is one of the critical parameters by which these materials are selected for use as biomedical devices. This is the major rationale for the use of polymers which are highly crystalline and stiff namely expanded polytetrafluoroethylene (ePTFE) and Dacron in particular, as arterial bypass grafts. While this is immaterial in high-flow states, it becomes critically important at lower flows with a greater need for more compliant vessels. Polyurethanes being one of the most compliant polymers known are as such, the natural choice to build Such constructs. However, concerns regarding their resistance to degradation have limited their use as vascular prostheses and in order to augment their strength, herein a novel polyhedral oligomeric silsesquioxane integrated poly(carbonate-urea)urethane (POSS-PCU) nanocomposite was synthesised by our group. In the following series of experiments, the POSS-PCU nanocomposite samples were exposed to accelerated degradative solutions, in an 'in-house' established model in vitro for tip to 70 days before being subjected to infra-red spectroscopy, scanning electron microscopy, stress-strain studies and differential scanning calorimetry. Our results demonstrate that these silsesquioxane nanocores shield the soft segment(s) of the polyurethane, responsible for its compliance and elasticity from all forms of degradation, principally oxidation and hydrolysis. These nanocomposites hence provide an optimal method by which these polymers may be strengthened whilst maintaining their elasticity.. making them ideal as vascular prostheses particularly at low flow states. (C) 2005 Elsevier Ltd. All rights reserved.
C1 UCL, BTEC, Acad Div Surg & Intervent Sci, London NW3 2PF, England.
   Univ London, Birkbeck Coll, Dept Chem Mat, London, England.
   Royal Free Hosp Hampstead NHS Trust, Dept Plast & Reconstruct Surg, London NW3 2QG, England.
RP Seifalian, AM (reprint author), UCL, BTEC, Acad Div Surg & Intervent Sci, Rowland Hill, London NW3 2PF, England.
EM A.Seifalian@UCL.AC.UK
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322; Butler,
   Peter/0000-0001-7419-1493
FU Engineering and Physical Sciences Research Council [EP/C519353/1]
CR Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1996, CHEM BIOCH DEGRADATI, P243
   Eberhart A, 1999, J BIOMED MATER RES, V48, P546, DOI 10.1002/(SICI)1097-4636(1999)48:4<546::AID-JBM22>3.0.CO;2-V
   Edwards A, 1998, J BIOMATER APPL, V13, P23, DOI 10.1177/088532829801300102
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gunatillake P. A., 2001, BIOMEDICAL APPL POLY, P160
   Hsu SH, 2000, ARTIF ORGANS, V24, P119, DOI 10.1046/j.1525-1594.2000.06338.x
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   KANNAN RY, 2005, IN PRESS PLAST RECON
   KANNAN RY, 2005, IN PRESS CELL BIOCH
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Merkel TC, 2002, SCIENCE, V296, P519, DOI 10.1126/science.1069580
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   NOVAK BM, 1993, ADV MATER, V5, P422, DOI 10.1002/adma.19930050603
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   Salacinski HJ, 2002, BIOMATERIALS, V23, P2231, DOI 10.1016/S0142-9612(01)00356-8
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   SHIBAYAMA M, 1991, MACROMOLECULES, V24, P6254, DOI 10.1021/ma00023a031
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Turi E.A., 1981, THERMAL CHARACTERIZA
   Vara DS, 2005, BIOMATERIALS, V26, P3987, DOI 10.1016/j.biomaterials.2004.10.015
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   WU YK, 1994, J BIOMED MATER RES, V28, P515, DOI 10.1002/jbm.820280414
   Zhang Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195504
NR 38
TC 133
Z9 136
U1 1
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2006
VL 27
IS 9
BP 1971
EP 1979
DI 10.1016/j.biomaterials.2005.10.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 007IO
UT WOS:000234962500036
PM 16253324
DA 2018-10-20
ER

PT J
AU Hu, ZY
   Zhou, DM
   Greenberg, R
   Thundat, T
AF Hu, ZY
   Zhou, DM
   Greenberg, R
   Thundat, T
TI Nanopowder molding method for creating implantable high-aspect-ratio
   electrodes on thin flexible substrates
SO BIOMATERIALS
LA English
DT Article
DE neural prosthesis; nanoparticle; micromachining; biocompatibility;
   micropatterning; electrodes
ID MICRO POWDER-METALLURGY; ELECTRICAL-STIMULATION; NANOPARTICLES;
   PROSTHESIS; COATINGS; PACKING; RETINA; FILMS; ARRAY
AB Metal nanopartieles and a nanopowder molding process were used to fabricate 2D and 3D patternable structures having a height-to-width ratio of up to 10:1. By means of this process, an entire neural stimulation circuit, including stimulating electrode, connection trace, and contact pad, can be fused into one continuous, integrated structure where different sections can have different heights, widths, and shapes. The technique is suitable for mass production, and the fabricated electrode is robust and very flexible. More importantly for biomedical applications, the entire fabricated structure can be packed at room temperature onto a biocompatible flexible substrate, such as polydimethylsiloxane, parylene, and polyimide as well as other temperature-sensitive or vacuum-sensitive materials. The electrodes and wires have about the same electrical resistivities as bulk materials and desirable electrochemical properties, including low impedance. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.
   Second Sight Med Prod Inc, Sylmar, CA 91342 USA.
   Univ So Calif, Dept Mat Sci, Los Angeles, CA 90089 USA.
RP Hu, ZY (reprint author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.
EM huzn@ornl.gov
RI Hu, Zhiyu/J-7742-2013
OI Thundat, Thomas/0000-0003-1721-1181
CR Ayon AA, 1999, J ELECTROCHEM SOC, V146, P339, DOI 10.1149/1.1391611
   Bard A. J., 1980, ELECTROCHEMICAL METH, P1
   Bell TE, 1998, SENSOR ACTUAT A-PHYS, V66, P63, DOI 10.1016/S0924-4247(97)01717-2
   BORKOVEC M, 1994, FRACTALS, V3, P521
   de Haro C, 2002, BIOMATERIALS, V23, P4515, DOI 10.1016/S0142-9612(02)00195-3
   Dodds PS, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.016117
   Dodds PS, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056108
   FINNEY JL, 1970, PROC R SOC LON SER-A, V319, P479, DOI 10.1098/rspa.1970.0189
   Gardner M, 1966, PACKING SPHERES NEW, P82
   Gross M, 2002, SENSOR ACTUAT A-PHYS, V96, P105, DOI 10.1016/S0924-4247(01)00768-3
   HILBERT D, 1999, GEOMETRY IMAGINATION, P45
   Hu ZY, 2005, ENERG FUEL, V19, P855, DOI 10.1021/ef0496754
   Huang CQ, 2001, ANN BIOMED ENG, V29, P791, DOI 10.1114/1.1397793
   Humayun MS, 1999, VISION RES, V39, P2569, DOI 10.1016/S0042-6989(99)00052-8
   JAEGER HM, 1992, SCIENCE, V255, P1523, DOI 10.1126/science.255.5051.1523
   Madou M.J, 1997, FUNDAMENTALS MICROFA, P1
   Margalit E, 2002, SURV OPHTHALMOL, V47, P335, DOI 10.1016/S0039-6257(02)00311-9
   MARRESE CA, 1987, ANAL CHEM, V59, P217, DOI 10.1021/ac00128a049
   Meyer JU, 2002, SENSOR ACTUAT A-PHYS, V97-8, P1, DOI 10.1016/S0924-4247(01)00807-X
   MORTIMER JT, 1980, ANN BIOMED ENG, V8, P235, DOI 10.1007/BF02364479
   Piotter V, 2003, SADHANA-ACAD P ENG S, V28, P299, DOI 10.1007/BF02717139
   ROBBLEE LS, 1990, NEURAL PROSTHESES FU, P25
   Rogers C.A., 1958, P LOND MATH SOC, V3, P609, DOI 10.1112/plms/s3-8.4.609
   Rogers C.A, 1964, PACKING COVERING
   Rota A, 2002, MICROSYST TECHNOL, V8, P323, DOI 10.1007/s00542-002-0157-y
   Rota A, 2002, MICROSYST TECHNOL, V7, P225, DOI 10.1007/s005420100101
   Seo JM, 2004, MAT SCI ENG C-BIO S, V24, P185, DOI 10.1016/j.msec.2003.09.019
   Shibata T, 2002, J AM CHEM SOC, V124, P11989, DOI 10.1021/ja026764r
   Slavcheva E, 2004, J ELECTROCHEM SOC, V151, pE226, DOI 10.1149/1.1747881
   Steinhaus H., 1999, MATH SNAPSHOTS, P202
   Vinci RP, 1996, ANNU REV MATER SCI, V26, P431, DOI 10.1146/annurev.ms.26.080196.002243
   Wautelet M, 2003, J PHYS-CONDENS MAT, V15, P3651, DOI 10.1088/0953-8984/15/21/313
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   WELLS D, 1991, PENGUIN DICT CURIOUS, P237
   WELLS D, 1986, PENGUIN DICT CUROUS, P29
   Wu AKC, 2000, NUMER HEAT TR A-APPL, V37, P631
NR 36
TC 15
Z9 16
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2006
VL 27
IS 9
BP 2009
EP 2017
DI 10.1016/j.biomaterials.2005.10.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 007IO
UT WOS:000234962500040
PM 16310844
DA 2018-10-20
ER

PT J
AU Du, C
   Moradian-Oldak, J
AF Du, Chang
   Moradian-Oldak, Janet
TI Tooth regeneration: challenges and opportunities for biomedical material
   research
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID CALCIUM-PHOSPHATE COATINGS; DYNAMIC LIGHT-SCATTERING; APATITE
   CRYSTAL-GROWTH; EPITHELIAL ROOT SHEATH; ENAMEL MATRIX PROTEINS; GENE
   SPLICE PRODUCTS; STEM-CELLS; AMELOGENESIS IMPERFECTA; IN-VIVO;
   RECOMBINANT AMELOGENIN
AB Tooth regeneration presents many challenges to researchers in the fields of biology, medicine and material science. This review considers the opportunities for biomedical material research to contribute to this multidisciplinary endeavor. We present short summaries and an overview on the collective knowledge of tooth developmental biology, advances in stem-cell research, and progress in the understanding of the tooth biomineralization principles as they provide the foundation for developing strategies for reparative and regenerative medicine. We emphasize that various biomaterials developed via biomimetic strategies have great potential for tooth tissue engineering and regeneration applications. The current practices in tooth tissue engineering approaches and applications of biomimetic carriers or scaffolds are also discussed.
C1 Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA.
RP Du, C (reprint author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.
RI Du, Chang/H-4200-2012
OI Du, Chang/0000-0002-6460-0764
CR AMAND TRS, 2000, DEV BIOL, V15, P323
   Barrere F, 2003, J BIOMED MATER RES A, V64A, P378, DOI 10.1002/jbm.a.10291
   Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204
   Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001
   Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534
   Bouropoulos N, 2004, J DENT RES, V83, P278, DOI 10.1177/154405910408300402
   Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278
   Butler WT, 2002, CONNECT TISSUE RES, V43, P301, DOI 10.1080/03008200290000682
   Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287
   Chai Y, 2000, DEVELOPMENT, V127, P1671
   Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7
   DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   DIEKWISCH T, 1993, DEVELOPMENT, V117, P471
   Du C, 2005, J DENT RES, V84, P1070, DOI 10.1177/154405910508401120
   Du C, 2005, SCIENCE, V309, P2166
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703
   EASTOE JE, 1960, NATURE, V187, P411, DOI 10.1038/187411b0
   EASTOE JE, 1971, COMPREHENSIVE BIOCH, V25, P785
   Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636
   FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077
   Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200
   Grigoriou M, 1998, DEVELOPMENT, V125, P2063
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Habelitz S, 2004, J DENT RES, V83, P698, DOI 10.1177/154405910408300908
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x
   Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105
   Hardcastle Z, 1998, DEVELOPMENT, V125, P2803
   Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P693, DOI 10.1111/j.1600-051X.1997.tb00251.x
   Hu JCC, 2003, CRIT REV ORAL BIOL M, V14, P387, DOI 10.1177/154411130301400602
   Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j
   Iijima M, 2002, J DENT RES, V81, P69, DOI 10.1177/154405910208100115
   Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6
   Kawana F, 2001, ANAT REC, V264, P438, DOI 10.1002/ar.10016
   KOKUBO T, 1989, BIOCERAMICS, V2, P235
   KRAMER I R H, 1951, Br Dent J, V91, P1
   Krebsbach PH, 1996, J BIOL CHEM, V271, P4431
   LagerstromFermer M, 1995, CONNECT TISSUE RES, V32, P241, DOI 10.3109/03008209509013729
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lin CR, 1999, NATURE, V401, P279
   Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   LIU Y, 2004, ANN BIOMED ENG, V32, P1
   LIU Y, 2003, BIOCERAMICS, V16, P619
   Liu YL, 2004, TISSUE ENG, V10, P101, DOI 10.1089/107632704322791745
   Lu MF, 1999, NATURE, V401, P276
   LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155
   Lyngstadaas SP, 1998, ANAT RECORD, V250, P268, DOI 10.1002/(SICI)1097-0185(199803)250:3<268::AID-AR2>3.0.CO;2-X
   Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6
   Masuya H, 2005, HUM MOL GENET, V14, P575, DOI 10.1093/hmg/ddi054
   Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779
   MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Mooney DJ, 1996, BIOTECHNOL PROGR, V12, P865, DOI 10.1021/bp960073f
   Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008
   Moradian-Oldak J, 1998, BIOPOLYMERS, V46, P225, DOI 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R
   Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8
   MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006
   MORADIANOLDAK J, 2006, IN PRESS
   MORADIANOLDAK J, 2006, EUR J ORAL SCI, V114, P1
   MORADIANOLDAK J, 2006, IN PRESS CELLS TISSU
   Murray PE, 2004, STEM CELLS DEV, V13, P255, DOI 10.1089/154732804323099181
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5
   Ohazama A, 2004, J DENT RES, V83, P518, DOI 10.1177/154405910408300702
   Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200
   Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6
   Peters H, 1998, EUR J ORAL SCI, V106, P38, DOI 10.1111/j.1600-0722.1998.tb02151.x
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   REITH EJ, 1961, J BIOPHYS BIOCHEM CY, V9, P825, DOI 10.1083/jcb.9.4.825
   ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2
   ROBINSON C, 1981, CALCIFIED TISSUE INT, V33, P513, DOI 10.1007/BF02409483
   Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Ruch JV, 1998, BIOCHEM CELL BIOL, V76, P923, DOI 10.1139/bcb-76-6-923
   Sarkar L, 2000, P NATL ACAD SCI USA, V97, P4520, DOI 10.1073/pnas.97.9.4520
   Schwarz Frank, 2004, Clin Oral Investig, V8, P165
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   SKOBE Z, 1977, ANAT RECORD, V187, P329, DOI 10.1002/ar.1091870305
   Slavkin H C, 1975, J DENT RES, V53, P157
   SLAVKIN HC, 1989, J PERIODONTAL RES, V24, P28, DOI 10.1111/j.1600-0765.1989.tb00854.x
   SMALES FC, 1975, NATURE, V258, P772, DOI 10.1038/258772a0
   SMITH C, 1998, CRIT REV ORAL BIOL M, V9, P129
   SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3
   Stigter M, 2002, BIOMATERIALS, V23, P4143, DOI 10.1016/S0142-9612(02)00157-6
   Thesleff I, 2003, MED PRIN PRACT, V12, P43, DOI 10.1159/000069840
   Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9
   THOMAS HF, 1989, ARCH ORAL BIOL, V34, P27, DOI 10.1016/0003-9969(89)90043-5
   Tompkins K, 2006, BONE, V38, P172, DOI 10.1016/j.bone.2005.08.013
   Tompkins K, 2005, J BONE MINER RES, V20, P341, DOI 10.1359/JBMR.041107
   TRAVIS DF, 1964, J CELL BIOL, V23, P447, DOI 10.1083/jcb.23.3.447
   Tucker AS, 1999, J DENT RES, V78, P826, DOI 10.1177/00220345990780040201
   Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136
   Uchida M, 2004, ADV MATER, V16, P1071, DOI 10.1002/adma.200400152
   Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002
   Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440
   Veis A, 2003, REV MINERAL GEOCHEM, V54, P249, DOI 10.2113/0540249
   Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003
   Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200
   Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502
   WARSHAWSKY H, 1989, ANAT REC, V224, P242, DOI 10.1002/ar.1092240214
   WATSON ML, 1960, J BIOPHYS BIOCHEM CY, V7, P489, DOI 10.1083/jcb.7.3.489
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096
   WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173
   Wen HB, 1999, BIOMATERIALS, V20, P1717, DOI 10.1016/S0142-9612(99)00085-X
   Wen HB, 2003, J BIOMED MATER RES A, V64A, P483, DOI 10.1002/jbm.a.10401
   Wen HB, 2000, J DENT RES, V79, P1902, DOI 10.1177/00220345000790111501
   Yamamoto H, 2003, J ELECTRON MICROSC, V52, P559, DOI 10.1093/jmicro/52.6.559
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
   Zeichner-David M, 2001, MATRIX BIOL, V20, P307, DOI 10.1016/S0945-053X(01)00155-X
   ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299
NR 128
TC 12
Z9 13
U1 4
U2 30
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD MAR
PY 2006
VL 1
IS 1
BP R10
EP R17
DI 10.1088/1748-6041/1/1/R02
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212GM
UT WOS:000249582000004
PM 18458377
DA 2018-10-20
ER

PT J
AU Cui, FZ
   Lee, IS
   Spector, M
AF Cui, Fu-Zhai
   Lee, In-Seop
   Spector, Myron
TI Welcome to biomedical materials
SO BIOMEDICAL MATERIALS
LA English
DT Editorial Material
C1 Tsing Hua Univ, Beijing 100084, Peoples R China.
   Yonsei Univ, Seoul 120749, South Korea.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Cui, FZ (reprint author), Tsing Hua Univ, Beijing 100084, Peoples R China.
NR 0
TC 0
Z9 0
U1 1
U2 6
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD MAR
PY 2006
VL 1
IS 1
DI 10.1088/1748-6041/1/1/E01
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212GM
UT WOS:000249582000001
OA Bronze
DA 2018-10-20
ER

PT J
AU Kitzmiller, J
   Beversdorf, D
   Hansford, D
AF Kitzmiller, J
   Beversdorf, D
   Hansford, D
TI Fabrication and testing of microelectrodes for small-field cortical
   surface recordings
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE surface microelectrodes; cortical column potential measurement; platinum
   lift-off
ID NEOCORTEX
AB A microfabrication approach to produce a microelectrode array that is suitable for use with human patients has been developed. The device is comprised of materials that are consistent with those of clinically used macroelectrodes (platinum electrode contacts suspended within a biomedical grade polydimethylsiloxane, PDMS). Photolithography, metal deposition, wire bonding, and PDMS encapsulation were used to fabricate the device. Cytotoxicity testing with both mammalian and human cortical cells suggests that the device is suitable for use with human patients and implementation of the device in animal studies revealed that reliable evoked potentials could be acquired with the designed spatial resolution.
C1 Ohio State Univ, Columbus, OH 43210 USA.
RP Hansford, D (reprint author), Ohio State Univ, Columbus, OH 43210 USA.
EM hansford.4@osu.edu
RI Hansford, Derek/B-5306-2012; Beversdorf, David/M-2786-2016
OI Beversdorf, David/0000-0002-0298-0634
FU NINDS NIH HHS [K23 NS043222]
CR BECHTEREVA N, 2000, INT J PSYCOPHYSIOLOG, V37
   Black J, 1999, BIOL PERFORMANCE MAT
   Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3
   Eckhorn R, 2001, OPHTHALMOLOGE, V98, P369, DOI 10.1007/s003470170143
   Heppelmann B, 2001, EXP BRAIN RES, V141, P501, DOI 10.1007/s002210100888
   KARAMANL.AN, 1972, BRAIN RES, V44, P127, DOI 10.1016/0006-8993(72)90370-8
   KITZMILLER J, 2004, DESIGN ENG EVALUATIO
   MAGHRIBI M, 2002, P 2 ANN INT IEEE EMB, P80
   MISULIS KE, 1994, SPELMANNS EVOKED POT
   Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701
   Oya H, 2002, J NEUROSCI, V22, P9502
   Schwartz TH, 2000, J COGNITIVE NEUROSCI, V12, P803, DOI 10.1162/089892900562615
   WAREN DJ, 2001, NEUROSCIENCE, V105, P19
   WILLIAMSON PD, 1993, ANN NEUROL, V34, P781, DOI 10.1002/ana.410340605
NR 14
TC 15
Z9 15
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD MAR
PY 2006
VL 8
IS 1
BP 81
EP 85
DI 10.1007/s10544-006-6386-6
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 014OH
UT WOS:000235489000011
PM 16491335
DA 2018-10-20
ER

PT J
AU Rickert, D
   Lendlein, A
   Peters, I
   Moses, MA
   Franke, RP
AF Rickert, D
   Lendlein, A
   Peters, I
   Moses, MA
   Franke, RP
TI Biocompatibility testing of novel multifunctional polymeric biomaterials
   for tissue engineering applications in head and neck surgery: an
   overview
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE polymeric biodegradable materials; biocompatibility testing; tissue
   engineering; head and neck surgery
ID BIOMEDICAL APPLICATIONS; OLIGO(EPSILON-CAPROLACTONE) SEGMENTS;
   STERILIZATION; CYTOTOXICITY; CHALLENGES; IMPLANTS; SYSTEM; MATRIX;
   CELLS; PCR
AB Biomaterial research and tissue engineering are rapidly growing scientific fields that need an interdisciplinary approach where clinicians should be included from the onset. Biocompatibility testing in vitro and in vivo comprise the agarose-overlay test, the MTT test, direct cell seeding tests and the chorioallantoic membrane test for angiogenic effects, among others. Molecular biology techniques such as real-time polymerase chain reaction and microarray technology facilitate the investigation of tissue integration into biomaterials on a cellular and molecular level. The physicochemical characterization of biomaterials is conducted using such methods as X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM). Excellent biocompatibility and biofunctionality were demonstrated for a series of recently developed multifunctional biodegradable, polymeric biomaterials both in vitro and in vivo. Novel, multifunctional polymeric biomaterials offer a highly specific adjustment to the physiological, anatomical and surgical requirements and can thereby facilitate new therapeutic options in head and neck surgery.
C1 Univ Ulm, Dept Otolaryngol Head & Neck Surg, D-89075 Ulm, Germany.
   Univ Ulm, Dept Biomath, Cent Inst Biomed Engn, Ulm, Germany.
   Forschungszentrum Karlsruhe, Inst Biol Interface, Karlsruhe, Germany.
   GKSS Forschungszentrum Geestacht GmbH, Inst Chem, Teltow, Germany.
   Harvard Univ, Sch Med, Childrens Hosp, Dept Surg, Boston, MA USA.
   Harvard Univ, Sch Med, Childrens Hosp, Vasc Biol Program, Boston, MA USA.
RP Rickert, D (reprint author), Univ Ulm, Dept Otolaryngol Head & Neck Surg, Prittwitzstr 43, D-89075 Ulm, Germany.
EM Dorothee.Rickert@medizin.uni-ulm.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR *ASTM, 1992, F813883 ASTM
   BRUNE D, 1997, SURFACE CHARACTERIZA
   Chehade M, 1997, AUST NZ J OPHTHALMOL, V25, P255, DOI 10.1111/j.1442-9071.1997.tb01512.x
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   Germain L, 2000, MED BIOL ENG COMPUT, V38, P232, DOI 10.1007/BF02344782
   Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995
   Goldstein JA, 2001, CLIN PLAST SURG, V28, P653
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   GRUEN TA, 1984, J BIOMED MATER RES, V18, P577, DOI 10.1002/jbm.820180511
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KUCHARZ E, 1991, COLLAGENS BIOCH PATH
   L'Heureux N, 1998, FASEB J, V12, P47
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Lee WPA, 2002, J AM COLL SURGEONS, V194, P324, DOI 10.1016/S1072-7515(01)01181-4
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Lloyd Andrew W, 2002, Med Device Technol, V13, P18
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   Melton L, 1999, LANCET, V354, P1272, DOI 10.1016/S0140-6736(05)76049-9
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Ravanti L, 2000, INT J MOL MED, V6, P391
   RAWE J, 2000, TIME EUROPE, P155
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2002, BIOMED TECH, V47, P285, DOI 10.1515/bmte.2002.47.11.285
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   SMITH MD, 1992, INT J ARTIF ORGANS, V15, P191
   Stocum David L., 1998, Wound Repair and Regeneration, V6, P276, DOI 10.1046/j.1524-475X.1998.60404.x
   THUROFF JW, 1983, UROLOGY, V21, P155, DOI 10.1016/0090-4295(83)90012-2
   VACANTI JP, 1999, LANCET S1, V354, P132
   Vogel G, 1999, SCIENCE, V286, P2238, DOI 10.1126/science.286.5448.2238
   WHITBY DJ, 1991, DEVELOPMENT, V112, P651
   Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5
NR 39
TC 40
Z9 43
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0937-4477
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD MAR
PY 2006
VL 263
IS 3
BP 215
EP 222
DI 10.1007/s00405-005-0950-1
PG 8
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 044EU
UT WOS:000237656000005
PM 16437250
DA 2018-10-20
ER

PT J
AU de Montgolfier, S
   Moutel, G
   Duchange, N
   Callies, I
   Sharara, L
   Beaumont, C
   Feingold, J
   Herve, C
AF de Montgolfier, S
   Moutel, G
   Duchange, N
   Callies, I
   Sharara, L
   Beaumont, C
   Feingold, J
   Herve, C
TI Evaluation of biobank constitution and use: multicentre analysis in
   France and propositions for formalising the activities of Research
   Ethics Committees
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE biobank; Research Ethics Committee; biomedical research; informed
   consent; human biological resources; genetic databases
ID DNA BANKING; INFORMED-CONSENT
AB Biobanks are collections of biological material and related files gathered and stored for clinical or research purposes. Here, we investigated the questions raised during the evaluation of biobanks by biomedical Research Ethics Committees (RECs), particularly in the context of genetic research. We sent a questionnaire to all RECs in France to survey their concerns and the ethical criteria used when evaluating research involving the storage of biological samples. Most of the RECs think that they should be consulted to evaluate the constitution of biobanks. The proportion of RECs of this opinion depended on whether the biobank is being constituted in the absence of an associated research project (initially created for clinical purposes or for undefined research) (14/28), whether the biobank is being constituted for research use (21/28) or whether an existing research biobank is being re-used (19/28). Views diverged concerning the way ethics principles are applied, showing that REC evaluations of biobanks might be formalised at each of the following steps: constitution, use and re-use. In this paper, we suggest concrete elements that could be integrated into the application of the new French law concerning the protection of the human beings participating in research as well as into international recommendations. (c) 2005 Elsevier SAS. All rights reserved.
C1 Fac Med Paris 5, Lab Eth Med & Med Legale, F-75006 Paris, France.
   Fac Med Paris 5, IIREB, F-75006 Paris, France.
RP Moutel, G (reprint author), Fac Med Paris 5, Lab Eth Med & Med Legale, 45 Rue St Peres, F-75006 Paris, France.
EM moutel@necker.fr
RI Duchange, Nathalie/G-1137-2010; MOUTEL, Gregoire/N-8777-2015
OI Duchange, Nathalie/0000-0001-7898-6023; Moutel,
   Gregoire/0000-0002-5585-106X
CR [Anonymous], 2003, INT DECL HUM GEN DAT
   [Anonymous], 1995, OFFICIAL J L, V281, P31
   Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315
   CALLIES I, 2004, DROIT DEONTOLOGIE SO, V4, P148
   Cambon-Thomsen A, 2003, REV EPIDEMIOL SANTE, V51, P99
   CAZEDEMONTGOLFI.S, 2002, THESIS PARIS 5
   *CCNE, 1998, OP 60 REEX LAW BIOET
   *CCNE, 2003, OP 77 ETH ISS RAIS C
   CHARRU A, 1996, CAHIER CHARGES BANQU
   de Montgolfier S, 2002, PHARMACOGENETICS, V12, P667, DOI 10.1097/00008571-200212000-00001
   Deschenes M, 2001, CLIN GENET, V59, P221, DOI 10.1034/j.1399-0004.2001.590403.x
   European Society of Human Genetics, 2003, Eur J Hum Genet, V11 Suppl 2, pS8
   Godard B, 2003, EUR J HUM GENET, V11, pS88, DOI 10.1038/sj.ejhg.5201114
   Hirtzlin I, 2003, EUR J HUM GENET, V11, P475, DOI 10.1038/sj.ejhg.5201007
   KNOPPERS BM, 2001, COMMUNITY GENET, V3, P212
   Le Roux N, 2003, REV MED INTERNE, V24, P803, DOI 10.1016/j.revmed.2003.09.006
   LOUISOT P, 1994, DICT PERMANENT BIOET, P9692
   MCEWEN JE, 1995, AM J HUM GENET, V56, P1477
   Merz JF, 1999, SCIENCE, V283, P1647, DOI 10.1126/science.283.5408.1647
   MORIN AL, 2001, DROIT EC, V89, P40
   Moutel G, 2004, PHARMACOGENETICS, V14, P195, DOI 10.1097/01.fpc.0000114714.42625.9e
   Moutel G, 1998, LANCET, V351, P1121, DOI 10.1016/S0140-6736(97)07394-7
   2004, J OFFICIEL, P14063
   1994, J OFFICIEL, V26, P10747
   2004, J OFFICIEL, V11, P14277
   2004, J OFFICIEL, P14140
   2002, J OFFICIEL 2002, P4118
NR 27
TC 8
Z9 9
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD MAR-APR
PY 2006
VL 49
IS 2
BP 159
EP 167
DI 10.1016/j.ejmg.2004.12.002
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 034CU
UT WOS:000236903200007
PM 16530713
DA 2018-10-20
ER

PT J
AU Choi, HM
AF Choi, HM
TI Interaction of antibiotic with PAN and cationic-dyeable PET fibers in
   development of infection resistant biomedical material
SO FIBERS AND POLYMERS
LA English
DT Article
DE doxycycline; cationic-dyeable poly(ethylene terephthalate);
   poly(acrylonitrile); infection resistant materials; hydrolysis
ID POLYACRYLONITRILE; POLYESTER; MEMBRANES; POLYMER
AB Interaction of a representative antibiotic, doxycycline (Doxy), with commercial poly(acrylonitrile) (PAN) and cationic-dyeable poly(ethylene terephthalate) (PET) fiber was studied in development of infection resistant biomedical materials. Regular PET was also employed for a comparison purpose. Their interactions were investigated at different treatment temperatures, times, and pHs. Fibers were also hydrolyzed by 1% NaOH for 1 or 2 hours at 85 degrees C and 100 degrees C to study effect of hydrolysis on antibiotic sorption. Infection-resistant characteristics of the substrates were evaluated by zone of inhibition (ZOI) test. Results revealed that a significant chemical change occurred in PAN and cationic-dyeable PET due to hydrolysis. Additional functional groups obtained by hydrolysis not only enhanced sorption of the antibiotics but also provided greater ZOI values, indicating substantial improvement in sustained infection resistance properties.
C1 Soongsil Univ, Dept Text Engn, Seoul 156743, South Korea.
RP Choi, HM (reprint author), Soongsil Univ, Dept Text Engn, Seoul 156743, South Korea.
EM hchoi@ssu.ac.kr
CR Banning TP, 2002, INT J PHARM, V235, P219, DOI 10.1016/S0378-5173(01)00988-7
   Benavides S, 2002, ANN PHARMACOTHER, V36, P334
   Bide M, 2003, AATCC REV, V3, P24
   BURKINSHAW SM, 1990, CHEM APPL DYES, P365
   Choi HM, 2004, TEXT RES J, V74, P333, DOI 10.1177/004051750407400409
   Choi HM, 2004, J APPL POLYM SCI, V92, P3343, DOI 10.1002/app.20332
   CHRISTINA AG, 1987, SCIENCE, V237, P1588
   DABROVSKA L, 1978, J BIOMED MATER RES, V12, P591, DOI 10.1002/jbm.820120503
   Evans-Strickfaden T T, 1996, PDA J Pharm Sci Technol, V50, P154
   GLASBY JS, 1992, ENCY ANTIBIOTICS, P243
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   Groth T, 2002, J BIOMED MATER RES, V61, P290, DOI 10.1002/jbm.10191
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Ishikiriyama K, 1995, THERMOCHIM ACTA, V267, P169, DOI 10.1016/0040-6031(95)02476-X
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   Rao BR, 1996, TEXT CHEM COLOR, V28, P17
   Seifert B, 2002, ARTIF ORGANS, V26, P189, DOI 10.1046/j.1525-1594.2002.06876.x
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
NR 18
TC 3
Z9 3
U1 0
U2 5
PU KOREAN FIBER SOCIETY
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CENTER #501 635-4 YEOGSAM-DONG, KANGNAM-GU,
   SEOUL 135-703, SOUTH KOREA
SN 1229-9197
J9 FIBER POLYM
JI Fiber. Polym.
PD MAR
PY 2006
VL 7
IS 1
BP 1
EP 7
DI 10.1007/BF02933594
PG 7
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 027NH
UT WOS:000236421800001
DA 2018-10-20
ER

PT J
AU Putlyaev, VI
   Safronova, TV
AF Putlyaev, V. I.
   Safronova, T. V.
TI A new generation of calcium phosphate biomaterials: The role of phase
   and chemical compositions
SO GLASS AND CERAMICS
LA English
DT Article
AB Calcium phosphate materials arc increasingly applied in the treatment and replacement of bone tissues. The effect of their phase and chemical (ionic) composition on biomedical properties (bioresistivity and bioresorption) of such materials is considered. The principles of the formation of bioceramic microstructure, as well as possible directions for chemical modification of calcium phosphates using biocompatible anions and cations, are discussed.
C1 Moscow MV Lomonosov State Univ, Moscow, Russia.
RP Putlyaev, VI (reprint author), Moscow MV Lomonosov State Univ, Moscow, Russia.
RI Safronova, Tatiana/D-7285-2012
OI Safronova, Tatiana/0000-0002-9799-5029
CR Barinov S.M., 2005, BIOCERAMICS BASED CA
   BARINOV T, 1998, INORGANIC PHOSPHATE
   BELETSKII BI, 2000, STEKLO KERAM, P35
   Georgiou G, 2001, BIOMATERIALS, V22, P2811, DOI 10.1016/S0142-9612(01)00025-4
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kanazawa T., 1998, INORGANIC PHOSPHATE
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Meshkov G V, 1996, Stomatologiia (Mosk), V75, P35
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   SARKISOV PD, 1993, STEKLO KERAM, P5
   Suchanek W, 1997, BIOMATERIALS, V18, P923, DOI 10.1016/S0142-9612(97)00019-7
   Tas AC, 2004, J AM CERAM SOC, V87, P2195, DOI 10.1111/j.1151-2916.2004.tb07490.x
   TRETYAKOV YD, 2004, INORGANIC CHEM, V2
NR 13
TC 23
Z9 24
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0361-7610
EI 1573-8515
J9 GLASS CERAM+
JI Glass Ceram.
PD MAR-APR
PY 2006
VL 63
IS 3-4
BP 99
EP 102
DI 10.1007/s10717-006-0049-1
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 079WU
UT WOS:000240209400010
DA 2018-10-20
ER

PT J
AU Fusco, S
   Borzacchiello, A
   Netti, PA
AF Fusco, S
   Borzacchiello, A
   Netti, PA
TI Perspectives on: PEO-PPO-PEO triblock copolymers and their biomedical
   applications
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE PEO-PPO-PEO; pluronics; thermo-reversible gel; block copolymers;
   micellization; drug delivery; biomedical applications
ID PLURONIC P-105 MICELLES; P85 BLOCK-COPOLYMER; AQUEOUS-SOLUTIONS;
   THERMOREVERSIBLE GELATION; PERCUTANEOUS-ABSORPTION; ASSOCIATING
   POLYMERS; DRUG-DELIVERY; RELEASE; GELS; CELLS
AB Thermo-reversible polymeric gels represent an interesting class of materials that can be tailored for a wide range of applications. The triblock poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) based systems, PEO-PPO-PEO, show thermoreversible gelation around body temperature and, therefore, are particularly suitable for biomedical applications such as drug delivery, gene therapy and tissue engineering. The PEO-PPO-PEO triblock copolymers have amphiphilic characteristics and self-assemble into micelles to form a variety of close packed structures. By varying the block composition (PEO/PPO ratio) and the molecular weight, it is possible to tailor the final properties of these systems to meet the specific application needs. In this report the thermodynamic basis of micellization of PEO-PPO-PEO systems is described. The factors influencing the micelles formation are discussed along with the methods used to investigate the micellization process and morphology as well as with the main applications of these systems in biomedical fields.
C1 Univ Naples Federico II, Interdisciplinary Res Ctr Biomed Mat, I-80125 Naples, Italy.
   CNR, Inst Composite & Biomed Mat, I-80125 Naples, Italy.
RP Netti, PA (reprint author), Univ Naples Federico II, Interdisciplinary Res Ctr Biomed Mat, Piazzale Tecchio 80, I-80125 Naples, Italy.
EM nettipa@unina.it
OI NETTI, PAOLO/0000-0002-2435-7181
CR Alakhov VY, 1996, BIOCONJUGATE CHEM, V7, P209, DOI 10.1021/bc950093n
   ALAKHOV VY, 1994, Patent No. 9408564
   ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   ALEXANDRIDIS P, 1995, J AM OIL CHEM SOC, V72, P824
   ANNABLE T, 1993, J RHEOL, V37, P695, DOI 10.1122/1.550391
   Astafieva I, 1996, FEBS LETT, V389, P278, DOI 10.1016/0014-5793(96)00607-2
   Attwood D, 1983, SURFACTANTS SYSTEMS
   Batrakova E, 1999, PHARM RES-DORDR, V16, P1373, DOI 10.1023/A:1018942823676
   Bochot A, 1998, INT J PHARM, V162, P119, DOI 10.1016/S0378-5173(97)00419-5
   Bromberg L, 1998, IND ENG CHEM RES, V37, P4267, DOI 10.1021/ie980358s
   BROWN W, 1991, J PHYS CHEM-US, V95, P1850, DOI 10.1021/j100157a064
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Cho CW, 2001, CANCER LETT, V162, P75, DOI 10.1016/S0304-3835(00)00629-7
   Cho CW, 2000, BIOTECHNOL APPL BIOC, V32, P21, DOI 10.1042/BA20000022
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Coppola L, 2000, COLLOID POLYM SCI, V278, P434, DOI 10.1007/s003960050536
   GANG W, 2002, J CONTROL RELEASE, V83, P65
   GEBHART CL, 2003, J BIOACT COMP POLYM, V15, P147
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   GUZMAN M, 1992, INT J PHARM, V80, P119, DOI 10.1016/0378-5173(92)90269-8
   Ho AK, 2001, LANGMUIR, V17, P3538, DOI 10.1021/la001301p
   Hunter R. J., 1987, FDN COLLOIDAL SCI, V1
   Husseini GA, 2000, J CONTROL RELEASE, V69, P43, DOI 10.1016/S0168-3659(00)00278-9
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   JEONG B, 2001, CHEM COMMUN, V16, P1516
   KABANOV AV, 1992, BIOCHEM INT, V26, P1035
   KABANOV AV, 1995, MACROMOLECULES, V28, P2303, DOI 10.1021/ma00111a026
   KABANOV AV, 1992, J CONTROL RELEASE, V22, P141, DOI 10.1016/0168-3659(92)90199-2
   Katakam M, 1997, J CONTROL RELEASE, V49, P21, DOI 10.1016/S0168-3659(97)01648-9
   Kurisawa M, 2000, J CONTROL RELEASE, V68, P1, DOI 10.1016/S0168-3659(00)00246-7
   Lee BJ, 1997, INT J PHARM, V159, P105, DOI 10.1016/S0378-5173(97)00276-7
   MALMSTEN M, 1992, MACROMOLECULES, V25, P5440, DOI 10.1021/ma00046a049
   MCCORMICK CL, 2000, STIMULIRESPONSIVE WA
   Mingvanish W, 1999, J PHYS CHEM B, V103, P11269, DOI 10.1021/jp992547+
   MIYAZAKI S, 1984, CHEM PHARM BULL, V32, P4205
   MIYAZAKI S, 1995, J PHARM PHARMACOL, V47, P455, DOI 10.1111/j.2042-7158.1995.tb05829.x
   MORIKAWA K, 1987, CANCER RES, V47, P37
   Mortensen K, 1995, MACROMOLECULES, V28, P8829, DOI 10.1021/ma00130a016
   MORTENSEN K, 1996, J PHYS-CONDENS MAT, V8, P103
   Munshi N, 1997, CANCER LETT, V118, P13, DOI 10.1016/S0304-3835(97)00218-8
   PRUDHOMME RK, 1996, LANGMUIR, V12, P1651
   Pruitt JD, 2000, MACROMOLECULES, V33, P9306, DOI 10.1021/ma0008544
   Rapoport N, 2004, INT J PHARMACEUT, V277, P155, DOI 10.1016/j.ijpharm.2003.09.048
   Rapoport N, 1999, COLLOID SURFACE B, V16, P93, DOI 10.1016/S0927-7765(99)00063-6
   Rapoport NY, 1999, J CONTROL RELEASE, V58, P153, DOI 10.1016/S0168-3659(98)00149-7
   Shalaby S. W., 1991, ACS S SERIES, V467
   SLEPNEV VI, 1992, BIOCHEM INT, V26, P587
   WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016
   Wu CH, 1997, MACROMOLECULES, V30, P4574, DOI 10.1021/ma9701088
   YEKTA A, 1995, MACROMOLECULES, V28, P956, DOI 10.1021/ma00108a025
   Yoshioka H, 1998, POLYM ADVAN TECHNOL, V9, P155
   YU GE, 1992, J CHEM SOC FARADAY T, V88, P2537, DOI 10.1039/ft9928802537
NR 56
TC 101
Z9 103
U1 2
U2 40
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2006
VL 21
IS 2
BP 149
EP 164
DI 10.1177/0883911506063207
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 014MI
UT WOS:000235483900005
DA 2018-10-20
ER

PT J
AU Ito, H
   Steplewski, A
   Alabyeva, T
   Fertala, A
AF Ito, H
   Steplewski, A
   Alabyeva, T
   Fertala, A
TI Testing the utility of rationally engineered recombinant collagen-like
   proteins for applications in tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE recombinant collagen; cartilage; tissue engineering; chondrocytes
ID DISCOIDIN DOMAIN RECEPTOR; HUMAN PROCOLLAGEN-II; TRIPLE-HELIX;
   ANNEXIN-V; ARTICULAR-CARTILAGE; D-PERIOD; CHONDROCYTES; EXPRESSION;
   BINDING; MATRIX
AB Collagens are attractive proteins as materials for tissue engineering. Over the last decade, significant progress has been made in developing technologies for large-scale production of native-like human recombinant collagens. Yet, the rational design of customized collagen-like proteins for smart biomaterials to enhance the quality of engineered tissues has not been explored. We mapped the D4 domain of human collagen II as most critical for supporting migration of chondrocytes and used this information to genetically engineer a collagen-like protein consisting of tandem repeats of the D4 domain (mD4 collagen). This novel collagen has been utilized to fabricate a scaffold for support of chondrocytes. We determined superior qualities of cartilaginous constructs created by chondrocytes cultured in scaffolds containing the mD4 collagen in comparison to those formed by chondrocytes cultured in bare scaffolds or those coated with wild-type collagen II. Our results are a first attempt to rationally engineer collagen-like proteins with characteristics tailored for specific needs of cartilage engineering and provide a basis for rational engineering of similar proteins for a variety of biomedical applications. (C) 2005 Wiley Periodicals, Inc.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.
RP Fertala, A (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.
EM andrzej.fertala@jefferson.edu
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Arnold WV, 1997, MATRIX BIOL, V16, P105, DOI 10.1016/S0945-053X(97)90039-1
   Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822
   Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Chang C, 2003, OSTEOARTHR CARTILAGE, V11, P603, DOI 10.1016/S1063-4584(03)00087-6
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fertala A, 2001, J BIOMED MATER RES, V57, P48, DOI 10.1002/1097-4636(200110)57:1<48::AID-JBM1140>3.0.CO;2-S
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   Gosiewska A, 2001, TISSUE ENG, V7, P267, DOI 10.1089/10763270152044134
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   HOLMVALL K, 1995, EXP CELL RES, V221, P496, DOI 10.1006/excr.1995.1401
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   KIRSCH T, 1992, FEBS LETT, V310, P143, DOI 10.1016/0014-5793(92)81316-E
   KUTTAN R, 1980, BIOCHEM INT, V1, P455
   Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089
   Majsterek I, 2003, PROTEIN SCI, V12, P2063, DOI 10.1110/ps.0385103
   Mollenhauer J, 1999, J HISTOCHEM CYTOCHEM, V47, P209, DOI 10.1177/002215549904700209
   Myllyharju J, 2000, METH MOL B, V139, P39
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Pulkkinen L, 1998, AM J PATHOL, V152, P157
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Shimizu M, 1997, CELL STRUCT FUNCT, V22, P309, DOI 10.1247/csf.22.309
   Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0
   Sieron AL, 2002, CYTOKINE, V18, P214, DOI 10.1006/cyto.2002.1035
   SIERON AL, 1993, J BIOL CHEM, V268, P21232
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Spain TL, 1998, TISSUE ENG, V4, P343, DOI 10.1089/ten.1998.4.343
   Steplewski A, 2004, J MOL BIOL, V338, P989, DOI 10.1016/j.jmb.2004.03.037
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122
   Vernon RB, 2002, IN VITRO CELL DEV-AN, V38, P97
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   vonderMark K, 1997, CELL MOL LIFE SCI, V53, P539, DOI 10.1007/s000180050069
   Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200
NR 42
TC 27
Z9 32
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2006
VL 76A
IS 3
BP 551
EP 560
DI 10.1002/jbm.a.30551
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013AY
UT WOS:000235383200013
PM 16278869
DA 2018-10-20
ER

PT J
AU Milner, KR
   Snyder, AJ
   Siedlecki, CA
AF Milner, KR
   Snyder, AJ
   Siedlecki, CA
TI Sub-micron texturing for reducing platelet adhesion to polyurethane
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE platelet adhesion; polyurethane; texture; microfabrication
ID VON-WILLEBRAND-FACTOR; SHEAR-STRESS; STAPHYLOCOCCUS-EPIDERMIDIS;
   BIOMEDICAL APPLICATIONS; SEGMENTED POLYURETHANE; VONWILLEBRAND-FACTOR;
   FIBRINOGEN; FLOW; ACTIVATION; MEMBRANE
AB Platelet adhesion is a key event in thrombus development on blood-contacting medical devices. It has been demonstrated that changes to the chemistry of a material surface can reduce platelet adhesion. In this work, it is hypothesized that sub-micron surface textures may also reduce adhesion via a decrease in the surface area of material with which platelets can make contact, and hence a decreased probability of interaction with adhesive ligands. A polyether(urethane urea) was textured with two different sizes of sub-micron pillars using a replication molding technique that did not alter the material surface chemistry. Adhesion of platelets was assessed in a physiologically relevant shear stress range of 0-67 dyn/cm(2) using a rotating disk system. Platelets were immunofluorescently labeled and adhesion was compared on smooth and textured samples. Platelet adhesion was greatest at low shear stress ranging from 0 to 5 dyn/cm(2), and sub-micron textures were observed to reduce platelet adhesion in this range. Additionally, non-adherent platelets did not demonstrate large-scale activation after exposure to textured samples. We conclude that surface textures with sub-platelet dimensions may reduce platelet adhesion from plasma to polyether(urethane urea) at low shear stress. (C) 2005 Wiley Periodicals, Inc.
C1 Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU NHLBI NIH HHS [1R21HL080979]
CR BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   BEUMER S, 1994, BLOOD, V84, P3724
   Bonnefoy A, 2000, BIOPHYS J, V78, P2834, DOI 10.1016/S0006-3495(00)76826-3
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   COTTONARO CN, 1981, ASAIO T, V27, P391
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   DAILY JW, 1960, J BASIC ENG, V3, P217
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   FABRIZIUSHOMAN DJ, 1992, THROMB HAEMOSTASIS, V68, P194
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GROUSE LH, 1990, AM J PATHOL, V136, P399
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   Kroll MH, 1996, BLOOD, V88, P1525
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LEVICH VG, 1962, PHYSICOCHEMICAL HYDR
   Liu Q, 2000, J BIOMATER APPL, V14, P349, DOI 10.1106/R01N-DT0C-UU1C-2GM8
   MILNER KR, 2004, MAT RES SOC S P, V820
   NAGAI H, 1993, THROMB RES, V71, P467, DOI 10.1016/0049-3848(93)90120-D
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   RUGGERI ZM, 1993, FASEB J, V7, P308
   RYU GH, 1995, J BIOMED MATER RES, V29, P403, DOI 10.1002/jbm.820290315
   Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6
   Shattil SJ, 1998, BLOOD, V91, P2645
   SHEPPECK RA, 1991, BLOOD, V78, P673
   STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   TURITTO VT, 1972, ASAIO T, V18, P348
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WEISS HJ, 1986, J CLIN INVEST, V78, P1072, DOI 10.1172/JCI112663
   Xia YN, 1997, ADV MATER, V9, P147, DOI 10.1002/adma.19970090211
   Zaidi TN, 1996, BLOOD, V88, P2967
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 39
TC 47
Z9 48
U1 4
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2006
VL 76A
IS 3
BP 561
EP 570
DI 10.1002/jbm.a.30554
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013AY
UT WOS:000235383200014
PM 16278867
DA 2018-10-20
ER

PT J
AU Nimmagadda, A
   Thurston, K
   Nollert, MU
   McFetridge, PSF
AF Nimmagadda, A
   Thurston, K
   Nollert, MU
   McFetridge, PSF
TI Chemical modification of SWNT alters in vitro cell-SWNT interactions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE SWNT; surface modification; cell interactions; compatibility; in vitro
ID WALLED CARBON NANOTUBES; FUNCTIONALIZATION; CYTOTOXICITY; GROWTH
AB Single-walled carbon nanotubes (SWNT) have been the focus of considerable attention as a material with extraordinary mechanical and electrical properties. SWNT have been proposed in a number of biomedical applications, including neural, bone, and dental tissue engineering. In these applications, it is clear that surrounding tissues will come into surface contact with SWNT composites, and compatibility between SWNT and host cells must be addressed. This investigation describes the gross physical and chemical effects of different SWNT preparations on in vitro cell viability and metabolic activity. Three different SWNT preparations were analyzed: as purchased (AP-NT), purified (PUR-NT), and functionalized with glucosamine (GA-NT), over concentrations of 0.001-1.0% (wt/vol). With the exception of the lowest SWNT concentrations, increasing concentrations of SWNT resulted in a decrease of cell viability, which was dependent on SWNT preparation. The metabolic activity of 3T3 cells was also dependent on SWNT preparation and concentration. These investigations have shown that these SWNT preparations have significant effects on in vitro cellular function that cannot be attributed to one factor alone, but are more likely the result of several unfavorable interactions. Effects, such as destabilizing the cell membrane, soluble toxic contaminants, and limitations in mass transfer as the SWNT coalesce into sheets, may all play a role in these interactions. Using comprehensive purification processes and modifying the NT-surface chemistry to introduce functional groups or reduce hydrophobicity or both, these interactions can be significantly improved. (C) 2005 Wiley Periodicals, Inc.
C1 Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA.
   Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA.
RP McFetridge, PSF (reprint author), Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA.
EM pmcfetridge@ou.edu
RI Mcfetridge, Peter/A-2802-2010
CR BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0
   Byth HA, 2001, PHYTOCHEM ANALYSIS, V12, P340, DOI 10.1002/pca.595
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Erlanger BF, 2001, NANO LETT, V1, P465, DOI 10.1021/nl015570r
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Lin Y, 2004, J MATER CHEM, V14, P527, DOI 10.1039/b314481j
   Matarredona O, 2003, J PHYS CHEM B, V107, P13357, DOI 10.1021/jp0365099
   MATSUI H, 1983, J CELL SCI, V59, P133
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Pompeo F, 2002, NANO LETT, V2, P369, DOI 10.1021/nl015680y
   ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023
   Saito R., 1998, PHYS PROPERTIES CARB
   SANDER TJ, 1997, NATURE, V386, P474
   SCHULER E, 2003, DISC NAN PERSP ENTW
   SEIFALIAN AM, 1999, TISSUE ENG VASCULAR, P621
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
NR 32
TC 112
Z9 114
U1 0
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2006
VL 76A
IS 3
BP 614
EP 625
DI 10.1002/jbm.a.30577
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013AY
UT WOS:000235383200020
PM 16315191
DA 2018-10-20
ER

PT J
AU Fiorito, S
   Serafino, A
   Andreola, F
   Togna, A
   Togna, G
AF Fiorito, S
   Serafino, A
   Andreola, F
   Togna, A
   Togna, G
TI Toxicity and biocompatibility of carbon nanoparticles
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE C-60 fullerenes; carbon nanotubes; toxicity; biocompatibility
ID NITRIC-OXIDE SYNTHASE; PULMONARY TOXICITY; SKIN IRRITATION; NULL RISK;
   NANOTUBES; C-60; CELLS; CYTOTOXICITY; FULLERENES; ADHESION
AB A review is presented of the literature data concerning the effects induced by carbon nanoparticles on the biological environment and the importance of these effects in human and animal health. The discovery in 1985 of fullerenes, a novel carbon allotrope with a polygonal structure made up solely by 60 carbon atoms, and in 1991 of carbon nanotubes, thin carbon filaments (1-3 mu m in length and 1-3 nm in diameter) with extraordinary mechanical properties, opened a wide field of activity in carbon research. During the last few years, practical applications of fullerenes as biological as well as pharmacological agents have been investigated. Various fullerene-based compounds were tested for biological activity, including antiviral, antioxidant, and chemiotactic activities. Nanotubes consist of carbon atoms arranged spirally to form concentric cylinders, that are perfect crystals and thinner than graphite whiskers. They are stronger than steel but very flexible and lightweight and transfer heat better than any other known material. These characteristics make them suitable for various potential applications such as super strong cables and tips for scanning probe microscopes, as well as biomedical devices for drug delivery, medical diagnostic, and therapeutic applications. The effects induced by these nanostructures on rat lung tissues, as well as on human skin and human macrophage and keratinocyte cells are presented.
C1 Univ Roma La Sapienza, CNR, Dept Expt Med & Pathol, Rome, Italy.
   Univ Montpellier 2, CNRS, Lab Colloids Glasses & Nanomat, Montpellier, France.
   CNR, Inst Neurobiol & Mol Med, Rome, Italy.
   Univ Roma La Sapienza, Dept Pharmacol & Human Physiol, Rome, Italy.
RP Fiorito, S (reprint author), Univ Roma La Sapienza, CNR, Dept Expt Med & Pathol, Rome, Italy.
OI Fiorito, Silvana/0000-0001-9006-5702; SERAFINO,
   ANNALUCIA/0000-0002-1142-4752
CR Baierl T, 1996, EXP TOXICOL PATHOL, V48, P508, DOI 10.1016/S0940-2993(96)80068-6
   Borm PJA, 2004, J NANOSCI NANOTECHNO, V4, P521, DOI 10.1166/jnn.2004.081
   Chen BX, 1998, P NATL ACAD SCI USA, V95, P10809, DOI 10.1073/pnas.95.18.10809
   DAXIANG C, 2005, TOXICOL LETT, V155, P73
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   FIORITO S, 2005, ISAB2 MONTR, P67
   FIORITO S, IN PRESS CARBON
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   Huczko A, 1999, FULLERENE SCI TECHN, V7, P935, DOI 10.1080/10641229909351390
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P247, DOI 10.1081/FST-100102972
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P251, DOI 10.1081/FST-100102973
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009
   Moussa F, 1997, FULLERENE SCI TECHN, V5, P503, DOI 10.1080/15363839708015904
   MOUSSA F, 1995, FULLERENE SCI TECHN, V3, P333, DOI 10.1080/153638X9508543788
   Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Rancan F, 2002, J PHOTOCH PHOTOBIO B, V67, P157, DOI 10.1016/S1011-1344(02)00320-2
   Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006
   Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Wolff DJ, 2001, BIOCHEMISTRY-US, V40, P37, DOI 10.1021/bi0019444
   Wolff DJ, 2000, ARCH BIOCHEM BIOPHYS, V378, P216, DOI 10.1006/abbi.2000.1843
   YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8
   Zhan GD, 2003, NAT MATER, V2, P38, DOI 10.1038/nmat793
NR 32
TC 94
Z9 106
U1 1
U2 45
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD MAR
PY 2006
VL 6
IS 3
BP 591
EP 599
DI 10.1166/jnn.2006.125
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 020VR
UT WOS:000235941500002
PM 16573109
DA 2018-10-20
ER

PT J
AU Rahman, M
   Wang, ZG
   Wong, YS
AF Rahman, M
   Wang, ZG
   Wong, YS
TI A review on high-speed machining of titanium alloys
SO JSME INTERNATIONAL JOURNAL SERIES C-MECHANICAL SYSTEMS MACHINE ELEMENTS
   AND MANUFACTURING
LA English
DT Article; Proceedings Paper
CT International Conference on Leading Edge Manufacturing in the 21st
   Century
CY OCT 19-22, 2005
CL Nagoya, JAPAN
DE high-speed machining; titanium alloys; cutting force model; tool wear
ID BINDERLESS CBN TOOLS; TI-6AL-4V ALLOY; TEMPERATURE; PERFORMANCE; WEAR
AB Titanium alloys have been widely used in the aerospace, biomedical and automotive industries because of their good strength-to-weight ratio and superior corrosion resistance. However, it is very difficult to machine them due to their poor machin-ability. When machining titanium alloys with conventional tools, the tool wear rate progresses rapidly, and it is generally difficult to achieve a cutting speed of over 60 m/min. Other types of tool materials, including ceramic, diamond, and cubic boron nitride (CBN), are highly reactive with titanium alloys at higher temperature. However, binder-less CBN (BCBN) tools, which do not have any hinder, sintering agent or catalyst, have a remarkably longer tool life than conventional CBN inserts even at high cutting speeds. In order to get deeper understanding of high speed machining (HSM) of titanium alloys, the generation of mathematical models is essential. The models are also needed to predict the machining parameters for HSM. This paper aims to give an overview of recent developments in machining and HSM of titanium alloys, geometrical modeling of HSM, and cutting force models for HSM of titanium alloys.
C1 Natl Univ Singapore, Dept Mech Engn, Singapore 119260, Singapore.
RP Rahman, M (reprint author), Natl Univ Singapore, Dept Mech Engn, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM mpemusta@nus.edu.sg
RI Rahman, Mustafizur/G-1998-2012
CR Bhaumik SK, 1995, MATER DESIGN, V16, P221, DOI 10.1016/0261-3069(95)00044-5
   Ezugwu EO, 2005, INT J MACH TOOL MANU, V45, P1009, DOI 10.1016/j.ijmachtools.2004.11.027
   Ezugwu EO, 2005, TRIBOL T, V48, P18, DOI 10.1080/05698190590890290
   Ezugwu EO, 1997, J MATER PROCESS TECH, V68, P262, DOI 10.1016/S0924-0136(96)00030-1
   Hirosaki K, 2004, JSME INT J C-MECH SY, V47, P14, DOI 10.1299/jsmec.47.14
   Hua J, 2005, J ENG MATER-T ASME, V127, P136, DOI 10.1115/1.1839192
   KING RI, 1984, WINT ANN M ASME NEW, P1
   Kitagawa T, 1997, WEAR, V202, P142, DOI 10.1016/S0043-1648(96)07255-9
   KONIG W, 1993, IND DIAMOND REV, V53, P85
   KULJANIC E, 1998, ANN CIRP, V47, P61, DOI DOI 10.1016/S0007-8506(07)62785-1
   Lei ST, 2002, INT J MACH TOOL MANU, V42, P653, DOI 10.1016/S0890-6955(02)00012-3
   Li L, 2004, KEY ENG MAT, V259-2, P804, DOI 10.4028/www.scientific.net/KEM.259-260.804
   Molinari A, 2002, INT J PLASTICITY, V18, P443, DOI 10.1016/S0749-6419(01)00003-1
   Muller A, 2004, J MECH DESIGN, V126, P488, DOI 10.1115/1.1737377
   Nabhani F, 2001, ROBOT CIM-INT MANUF, V17, P99, DOI 10.1016/S0736-5845(00)00042-9
   Sandstrom DR, 1998, MACH SCI TECHNOL, V2, P343, DOI 10.1080/10940349808945675
   *SANDV TRYCK, 2001, SANDV HARD MAT CEM C, P4
   SCHULZ H, 2004, P INT C HIGH SPEED M, P1
   Siekmann HJ, 1955, MACHINE TITANIUM, P78
   *SUM EL IND, 2000, PERF CUTT TOOLS
   Sumiya H, 2000, J MATER SCI, V35, P1181, DOI 10.1023/A:1004780218732
   Wang Z. G., 2005, 8 CIRP INT WORKSH MO
   Wang ZG, 2005, WEAR, V258, P752, DOI 10.1016/j.wear.2004.09.066
   Wang ZG, 2005, INT J MACH TOOL MANU, V45, P105, DOI 10.1016/j.ijmachtools.2004.06.021
   WANG ZG, 2005, CIRP ANN-MANUF TECHN, P71
   ZAREENA AR, 2002, THESIS NATL U SINGAP
   Zoya ZA, 2000, J MATER PROCESS TECH, V100, P80, DOI 10.1016/S0924-0136(99)00464-1
NR 27
TC 106
Z9 109
U1 3
U2 79
PU JAPAN SOC MECHANICAL ENGINEERS
PI TOKYO
PA SHINANOMACHI-RENGAKAN BLDG., SHINANOMACHI 35, SHINJUKU-KU, TOKYO,
   160-0016, JAPAN
SN 1344-7653
J9 JSME INT J C-MECH SY
JI JSME Int. J. Ser. C-Mech. Syst. Mach. Elem. Manuf.
PD MAR
PY 2006
VL 49
IS 1
BP 11
EP 20
DI 10.1299/jsmec.49.11
PG 10
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 037TA
UT WOS:000237168800003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kim, HY
   Ohmatsu, Y
   Kim, JI
   Inamura, T
   Hosoda, H
   Miyazaki, S
AF Kim, Hee Young
   Ohmatsu, Yoshinori
   Kim, Jae Il
   Inamura, Tomonari
   Hosoda, Hideki
   Miyazaki, Shuichi
TI Effect of Nb addition on shape memory behavior of Ti-Mo-Ga alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MECHANICAL-PROPERTIES; INDUCED MARTENSITE; BIOMEDICAL ALLOYS;
   TITANIUM-ALLOYS; SUPERELASTICITY; DEFORMATION
AB Effect of Nb addition on mechanical properties and shape memory behavior of Ti-Mo-Ga alloys was investigated by cyclic loading-unloading tensile tests, tensile tests at various temperatures and Vickers hardness tests. The martensitic transformation start temperature (Ms) decreased by 20 K with 1 at% increase of Nb content in the Ti-6Mo-3Ga(at%) alloy. The shape memory effect was observed in the Ti-6Mo3Ga(at%) alloy. The superelastic strain increased with increasing Nb content. The increase of the yield stress during the cyclic deformation decreased the strain recovery rate in the Ti-6Mo-3Ga(at%) alloy. Aging at intermediate temperatures resulted in increase in hardness of the Ti6Mo-3Ga-(0-4)Nb(at%) alloys. The increase in hardness decreased significantly with increasing Nb content because the addition of Nb was effective to suppress the omega phase hardening. The yield stress decreased and the strain recovery rate increased with increasing number of cycle in the Ti-6Mo-3Ga-4Nb(at%) alloy.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Dong A Univ, Pusan 604714, South Korea.
   Tokyo Inst Technol, Precis & Intelligent Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011; Inamura,
   Tomonari/E-5712-2014
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678; 
CR Baker C., 1971, Metal Science Journal, V5, P92
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   FROES FH, 1980, METALL TRANS A, V11, P21, DOI 10.1007/BF02700435
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   LANGMAYR F, 1994, PHYS REV B, V49, P11759, DOI 10.1103/PhysRevB.49.11759
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   MIYAZAKI S, 1986, METALL TRANS A, V17, P115, DOI 10.1007/BF02644447
   MIYAZAKI S, 1990, ENG ASPECTS SHAPE ME, P452
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
NR 20
TC 13
Z9 14
U1 0
U2 20
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2006
VL 47
IS 3
BP 518
EP 522
DI 10.2320/matertrans.47.518
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 046CS
UT WOS:000237789600016
OA Bronze
DA 2018-10-20
ER

PT J
AU Gilmour, JA
AF Gilmour, Jean A.
TI Hybrid space: constituting the hospital as a home space for patients
SO NURSING INQUIRY
LA English
DT Article
DE hospital; hybrid space; nurse-patient relationship; spatial
   vulnerability; therapeutic landscape
ID CARE; INVOLVEMENT; GEOGRAPHY; DEMENTIA
AB A growing body of nursing writing is engaged in reviewing the material and relational world of nursing using geographical concepts. This paper draws upon research undertaken in hospital settings where nurses constituted the hospital as a home space for patients. Nurses' practices created an equitable and patient-centred use of physical space in the hospital ward, along with the intimate, extended and personal relationships associated by patients with a caring and homely environment. It is suggested that this constitution of space resonates with the geographic notion of the therapeutic landscape and can be read as a challenge to more conventional uses of hospital spaces shaped by biomedical concerns. The implications of merging the distinctly different spaces and places of home and hospital are also explored using the concepts of hybridity and spatial vulnerability. The complex hybrid nursing creation of home space within hospital places works against the grain of usual understandings of hospitals as specialised illness spaces that are the domain of the health professional inhabitants. While there are limitations and dangers in the representation, this constitution of space is an expression of core nursing values privileging patient-nurse relationships and supports the maintenance of identity and personal expression.
C1 Massey Univ, Wellington, New Zealand.
RP Gilmour, JA (reprint author), Massey Univ, POB 756, Wellington, New Zealand.
EM j.a.gilmour@massey.ac.nz
CR Andrews Gavin J, 2003, Nurs Philos, V4, P231, DOI 10.1046/j.1466-769X.2003.00140.x
   Andrews Gavin J, 2002, Nurs Inq, V9, P221, DOI 10.1046/j.1440-1800.2002.00157.x
   Benner P, 1989, PRIMACY CARING STRES
   Brown L, 2004, SOC SCI MED, V58, P427, DOI 10.1016/S0277-9536(03)00163-1
   Burden B, 1998, J ADV NURS, V27, P15, DOI 10.1046/j.1365-2648.1998.00494.x
   DUNCAN J, 2000, HUMAN GEOGRAPHY, P582
   Foucault M, 1972, ARCHAEOLOGY KNOWLEDG
   Foucault Michel, 1995, DISCIPLINE PUNISH BI
   GESLER WM, 1992, SOC SCI MED, V34, P735, DOI 10.1016/0277-9536(92)90360-3
   Gilmour JA, 2002, J ADV NURS, V39, P546, DOI 10.1046/j.1365-2648.2002.02323.x
   GILMOUR JA, 2001, THESIS MASSEY U PALM
   Goffman E., 1968, ASYLUMS ESSAYS SOCIA
   GREGORY DG, 2000, HUMAN GEOGRAPHY, P767
   Haggstrom T, 1996, J ADV NURS, V24, P431, DOI 10.1046/j.1365-2648.1996.d01-625.x
   Halford S, 2003, J ADV NURS, V42, P201, DOI 10.1046/j.1365-2648.2003.02601.x
   Harding Sandra, 1991, WHOSE SCI WHOSE KNOW
   Kontos PC, 1998, J AGING STUD, V12, P167, DOI 10.1016/S0890-4065(98)90013-5
   LIASCHENKO J, 1994, ADV NURS SCI, V17, P16, DOI 10.1097/00012272-199412000-00005
   Liaschenko J., 1997, SCHOLARLY INQUIRY NU, V11, P45
   MAES S, ONS NEWS, V18, P3
   Malone RE, 2003, SOC SCI MED, V56, P2317, DOI 10.1016/S0277-9536(02)00230-7
   Martsolf D. S., 2002, ORTHOPAEDIC NURSING, V21, P61
   MAY C, 1991, J ADV NURS, V16, P552, DOI 10.1111/j.1365-2648.1991.tb01690.x
   MORSE JM, 1991, J ADV NURS, V16, P455, DOI 10.1111/j.1365-2648.1991.tb03436.x
   Peter Elizabeth, 2002, Nurs Inq, V9, P65, DOI 10.1046/j.1440-1800.2002.00138.x
   Porteous J. Douglas, 2001, DOMICIDE GLOBAL DEST
   Purkis M E, 1996, Nurs Inq, V3, P101, DOI 10.1111/j.1440-1800.1996.tb00020.x
   Rose G., 2000, HUMAN GEOGRAPHY, P364
   Rundqvist EM, 1999, J ADV NURS, V29, P800, DOI 10.1046/j.1365-2648.1999.00955.x
   Savage J, 1997, Nurs Inq, V4, P237, DOI 10.1111/j.1440-1800.1997.tb00109.x
   Sheets V R, 2001, Dimens Crit Care Nurs, V20, P36, DOI 10.1097/00003465-200109000-00010
   Simpson John, 1989, OXFORD ENGLISH DICT
   Sixsmith A. J., 1990, WELFARE AGEING EXPER, P172
   Spain Daphne, 1992, GENDERED SPACES
   Taylor B, 1994, BEING HUMAN ORDINARI
   TURNER BS, 1997, FOUCAULT HLTH MED, pR8
   Young HM, 1998, J AGING STUD, V12, P149, DOI 10.1016/S0890-4065(98)90012-3
   Young R., 1995, COLONIAL DESIRE HYBR
NR 38
TC 28
Z9 29
U1 1
U2 6
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1320-7881
J9 NURS INQ
JI Nurs. Inq.
PD MAR
PY 2006
VL 13
IS 1
BP 16
EP 22
DI 10.1111/j.1440-1800.2006.00276.x
PG 7
WC Nursing
SC Nursing
GA 094HU
UT WOS:000241231300004
PM 16494663
DA 2018-10-20
ER

PT J
AU Lu, DY
   Aksimentiev, A
   Shih, AY
   Cruz-Chu, E
   Freddolino, PL
   Arkhipov, A
   Schulten, K
AF Lu, DY
   Aksimentiev, A
   Shih, AY
   Cruz-Chu, E
   Freddolino, PL
   Arkhipov, A
   Schulten, K
TI The role of molecular modeling in bionanotechnology
SO PHYSICAL BIOLOGY
LA English
DT Article
ID APOLIPOPROTEIN-A-I; NANOSCALE LIPID-BILAYERS; HIGH-DENSITY-LIPOPROTEIN;
   CARBON NANOTUBE MEMBRANES; NANOMETER-DIAMETER PORE; DNA HAIRPIN
   MOLECULES; SOLID-STATE NANOPORE; DYNAMICS SIMULATIONS; POLYNUCLEOTIDE
   MOLECULES; ELECTROLYTIC TRANSPORT
AB Molecular modeling is advocated here as a key methodology for research and development in bionanotechnology. Molecular modeling provides nanoscale images at atomic and even electronic resolution, predicts the nanoscale interaction of unfamiliar combinations of biological and inorganic materials, and evaluates strategies for redesigning biopolymers for nanotechnological uses. The methodology is illustrated in this paper through reviewing three case studies. The first one involves the use of single-walled carbon nanotubes as biomedical sensors where a computationally efficient, yet accurate, description of the influence of biomolecules on nanotube electronic properties through nanotube-biomolecule interactions was developed; this development furnishes the ability to test nanotube electronic properties in realistic biological environments. The second case study involves the use of nanopores manufactured into electronic nanodevices based on silicon compounds for single molecule electrical recording, in particular, for DNA sequencing. Here, modeling combining classical molecular dynamics, material science and device physics, described the interaction of biopolymers, e.g., DNA, with silicon nitrate and silicon oxide pores, furnished accurate dynamic images of pore translocation processes, and predicted signals. The third case study involves the development of nanoscale lipid bilayers for the study of embedded membrane proteins and cholesterol. Molecular modeling tested scaffold proteins, redesigned apolipoproteins found in mammalian plasma that hold the discoidal membranes in the proper shape, and predicted the assembly as well as final structure of the nanodiscs. In entirely new technological areas such as bionanotechnology, qualitative concepts, pictures and suggestions are sorely needed; these three case studies document that molecular modeling can serve a critical role in this respect, even though it may still fall short on quantitative precision.
C1 Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.
RP Lu, DY (reprint author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.
EM kschulte@ks.uiuc.edu
RI Aksimentiev, Aleksei/A-3581-2010; Freddolino, Peter/C-2288-2008;
   Schulten, Klaus/D-5561-2009; Lu, Deyu/O-4418-2016
OI Lu, Deyu/0000-0003-4351-6085; Cruz-Chu, Eduardo/0000-0001-5797-9238;
   Aksimentiev, Aleksei/0000-0002-6042-8442
FU NIGMS NIH HHS [R01 GM067887, R01 GM067887-03, 1 R01 GM067887]; NHGRI NIH
   HHS [R01-HG003713, R01 HG003713]; NCRR NIH HHS [P41 RR005969, P41
   RR005969-16, 5-P41-RR05969]
CR Akenson M., 1999, BIOPHYS J, V77, P3227
   Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727
   Aksimentiev A, 2004, BIOPHYS J, V87, P2086, DOI 10.1529/biophysj.104.042960
   Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8
   Allen R, 2003, J PHYS-CONDENS MAT, V15, pS297, DOI 10.1088/0953-8984/15/1/340
   Ashkenasy N, 2005, ANGEW CHEM INT EDIT, V44, P1401, DOI 10.1002/anie.200462114
   Ayton G, 2002, BIOPHYS J, V83, P3357, DOI 10.1016/S0006-3495(02)75336-8
   Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003
   Bakaev VA, 1999, J CHEM PHYS, V111, P9803, DOI 10.1063/1.480317
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503
   Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k
   Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599
   BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   BOGUSKI MS, 1986, J LIPID RES, V27, P1011
   BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8
   Chang H, 2004, NANO LETT, V4, P1551, DOI 10.1021/nl049267c
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   CICERO G, 2005, COMMUNICATION
   Civjan N.R., 2003, BIOTECHNIQUES, V35, P562
   Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02
   CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Crozier PS, 2001, BIOPHYS J, V81, P3077, DOI 10.1016/S0006-3495(01)75946-2
   CRUZCHU ER, UNPUB
   D'Souza AS, 2002, J AM CERAM SOC, V85, P1499, DOI 10.1111/j.1151-2916.2002.tb00303.x
   Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad
   Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g
   Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574
   Duan H, 2004, ARCH BIOCHEM BIOPHYS, V424, P141, DOI 10.1016/j.abb.2004.02.010
   FEUSTON BP, 1989, J CHEM PHYS, V91, P564, DOI 10.1063/1.457440
   Fologea D, 2005, NANO LETT, V5, P1905, DOI 10.1021/nl051199m
   Gracheva ME, 2006, NANOTECHNOLOGY, V17, P622, DOI 10.1088/0957-4484/17/3/002
   Heng JB, 2006, BIOPHYS J, V90, P1098, DOI 10.1529/biophysj.105.070672
   Heng JB, 2005, BELL LABS TECH J, V10, P5, DOI 10.1002/bltj.20102
   Heng JB, 2005, NANO LETT, V5, P1883, DOI 10.1021/nl0510816
   Heng JB, 2004, BIOPHYS J, V87, P2905, DOI 10.1529/biophysj.104.041814
   Ho C, 2005, P NATL ACAD SCI USA, V102, P10445, DOI 10.1073/pnas.0500796102
   Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   JONAS A, 1989, J BIOL CHEM, V264, P4818
   Joseph S, 2003, NANO LETT, V3, P1399, DOI 10.1021/nl0346326
   Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503
   LAMB RN, 1982, J CHEM SOC FARAD T 1, V78, P61, DOI 10.1039/f19827800061
   Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965
   Lin MF, 1997, PHYS REV B, V56, P4996, DOI 10.1103/PhysRevB.56.4996
   Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101
   Lu DY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.246801
   Lu DY, 2005, J PHYS CHEM B, V109, P11461, DOI 10.1021/jp050420g
   Lu DY, 2004, NANO LETT, V4, P2383, DOI 10.1021/nl0485511
   Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g
   Mashl RJ, 2003, NANO LETT, V3, P589, DOI 10.1021/nl0340226
   Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079
   NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3
   Noon WH, 2002, CHEM PHYS LETT, V355, P445, DOI 10.1016/S0009-2614(02)00209-9
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X
   RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070
   RICK SW, 1994, J CHEM PHYS, V101, P6141, DOI 10.1063/1.468398
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512
   Saito R., 1998, PHYS PROPERTIES CARB
   SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8
   Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755
   Service RF, 2004, SCIENCE, V304, P674
   Shaw AW, 2004, FEBS LETT, V556, P260, DOI 10.1016/S0014-5793(03)01400-5
   Shelley JC, 2001, J PHYS CHEM B, V105, P9785, DOI 10.1021/jp011637n
   Shih AY, 2005, BIOPHYS J, V88, P548, DOI 10.1529/biophysj.104.046896
   SHIH AY, 2005, IN PRESS J PHYS CH B
   Sligar SG, 2003, BIOCHEM BIOPH RES CO, V312, P115, DOI 10.1016/j.bbrc.2003.09.188
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   SPRIK M, 1988, J CHEM PHYS, V89, P7556, DOI 10.1063/1.455722
   Staii C, 2005, NANO LETT, V5, P1774, DOI 10.1021/nl051261f
   Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903
   Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
   Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696
   Vercoutere WA, 2003, NUCLEIC ACIDS RES, V31, P1311, DOI 10.1093/nar/gkg218
   Wei CY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.235901
   WENDEL JA, 1992, J CHEM PHYS, V97, P5048, DOI 10.1063/1.463859
   Werder T, 2003, J PHYS CHEM B, V107, P1345, DOI 10.1021/jp0268112
   Yeh IC, 2004, P NATL ACAD SCI USA, V101, P12177, DOI 10.1073/pnas.0402699101
   Zhu FQ, 2003, BIOPHYS J, V85, P236, DOI 10.1016/S0006-3495(03)74469-5
   Zhuravlev LT, 2000, COLLOID SURFACE A, V173, P1, DOI 10.1016/S0927-7757(00)00556-2
NR 88
TC 47
Z9 48
U1 0
U2 26
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1478-3967
J9 PHYS BIOL
JI Phys. Biol.
PD MAR
PY 2006
VL 3
IS 1
BP S40
EP S53
DI 10.1088/1478-3975/3/1/S05
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 029DZ
UT WOS:000236540400006
PM 16582464
OA Green Accepted
DA 2018-10-20
ER

PT J
AU He, HY
   Li, L
   Lee, LJ
AF He, HY
   Li, L
   Lee, LJ
TI Photopolymerization and structure formation of methacrylic acid based
   hydrogels in water/ethanol mixture
SO POLYMER
LA English
DT Article
DE photopolymerization of hydrogels; water/ethanol composition; viscosity
   change
ID CROSS-LINKING COPOLYMERIZATION; GLYCOL DIMETHACRYLATE EGDMA;
   METHYL-METHACRYLATE; MICROGEL FORMATION; CONTROLLED-RELEASE; NETWORK
   STRUCTURE; POLYMERIZATION; SOLVENT; CYCLIZATION; MONOMERS
AB Hydrogels are a desired material for biomedical and pharmaceutical applications. To better control the synthesized hydrogels for various applications, it is necessary to have a thorough understanding of hydrogel structure and reaction mechanism. In this Study, pH-sensitive hydrogel networks consisting of methacrylic acid (MAA) crosslinked with tri(ethylene glycol) dimethacrylate (TEGDMA) were synthesized by free-radical photopolymerization in the water/ethanol mixture. Reaction rate was measured using Photo-differential scanning calorimetry (PhotoDSC) with a modified sample pan designed for handling volatile reagents. A photo-rheometer and a dynamic light scattering (DLS) goniometer were used to follow the changes in viscosity and molecule size of the resin system during photopolymerization. It was found that the rate of polymerization increased and more compact and less swelling gels would form with a higher water fraction in 50 wt% solvent/reactant mixture. This is because the weaker interactions between the MAA and the solvent give a higher opportunity for propagation and a higher reaction rate. And the hydrophobic TEGDMA and initiator tend to form aggregates in the higher water solution, contributing to the inhomogeneous microgel formation. This mechanism is conformed by viscosity measurement, DLS analysis, scanning electron microscopy (SEM) observation, and kinetics analysis. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
RP Lee, LJ (reprint author), Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
EM leelj@chbmeng.ohio-state.edu
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ANSETH KS, 1994, POLYMER, V35, P3243, DOI 10.1016/0032-3861(94)90129-5
   CHIU YY, 1995, J POLYM SCI POL CHEM, V33, P257, DOI 10.1002/pola.1995.080330208
   COOK WD, 1993, J POLYM SCI POL CHEM, V31, P1053, DOI 10.1002/pola.1993.080310428
   CRUMP S, 2001, COMPOSITES 2001 CONV, P3
   DUSEK K, 1980, POLYMER, V21, P750, DOI 10.1016/0032-3861(80)90290-6
   Elliott JE, 2002, J PHYS CHEM B, V106, P2843, DOI 10.1021/jp012845i
   Elliott JE, 2001, CHEM ENG SCI, V56, P3173, DOI 10.1016/S0009-2509(00)00547-9
   HASSAN CM, 1999, J AM CHEM SOC, P54
   HENRICIOLIVE G, 1965, Z PHYS CHEM NEUE FOL, V47, P286, DOI 10.1524/zpch.1965.47.5_6.286
   Hong PD, 1998, POLYMER, V39, P5809, DOI 10.1016/S0032-3861(98)00031-7
   HORIE K, 1975, J POLYM SCI POL CHEM, V13, P445, DOI 10.1002/pol.1975.170130217
   HSU CP, 1993, POLYMER, V34, P4516, DOI 10.1016/0032-3861(93)90158-7
   Jakubiak J, 2000, J POLYM SCI POL CHEM, V38, P876, DOI 10.1002/(SICI)1099-0518(20000301)38:5<876::AID-POLA12>3.3.CO;2-E
   Kwok AY, 2003, POLYMER, V44, P6195, DOI 10.1016/S0032-3861(03)00671-2
   Lai YC, 1997, ACS SYM SER, V673, P35
   Li L, 2005, POLYMER, V46, P11540, DOI 10.1016/j.polymer.2005.10.051
   Lowman AM, 1997, MACROMOLECULES, V30, P4959, DOI 10.1021/ma970399k
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   PEPPAS NA, 1991, J BIOACT COMPAT POL, V6, P241, DOI 10.1177/088391159100600303
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Sun XD, 1997, IND ENG CHEM RES, V36, P1343, DOI 10.1021/ie960682s
   Ward JH, 2001, J CONTROL RELEASE, V71, P183, DOI 10.1016/S0168-3659(01)00213-9
NR 24
TC 20
Z9 23
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD FEB 22
PY 2006
VL 47
IS 5
BP 1612
EP 1619
DI 10.1016/j.polymer.2006.01.014
PG 8
WC Polymer Science
SC Polymer Science
GA 018EL
UT WOS:000235746700018
DA 2018-10-20
ER

PT J
AU Iijima, M
   Nagasaki, Y
AF Iijima, M
   Nagasaki, Y
TI Synthesis of poly[N-isopropylacrylamide-g-poly(ethylene glycol)] with a
   reactive group at the poly(ethylene glycol) end and its thermosensitive
   self-assembling character
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Review
DE graft polymers; nanoparticles; poly(ethylene glycol);
   poly(N-isopropylacrylamide); self-assembled nanoparticles;
   stimuli-sensitive polymers; temperature-sensitive polymers
ID BLOCK-COPOLYMER MICELLES; POLYION COMPLEX MICELLES; G-PEO COPOLYMER;
   POLYMERIC MICELLES; GRAFT-COPOLYMERS; AQUEOUS-SOLUTIONS;
   LIGHT-SCATTERING; DRUG-DELIVERY; N-ISOPROPYLACRYLAMIDE; ASSOCIATION
   BEHAVIOR
AB Poly[N-isopropylacrylamide-g-poly(ethylene glycol)]s with a reactive group at the poly(ethylene glycol) (PEG) end were synthesized by the radical copolymerization of N-isopropylacrylamide with a PEG macromonomer having an acetal group at one end and a methacryloyl group at the other chain end. The temperature dependence of the aqueous solutions of the obtained graft copolymers was estimated by light scattering measurements. The intensity of the light scattering from aqueous polymer solutions increased with increasing temperature. In particular, at temperatures above 40 degrees C, the intensity abruptly increased, indicating a phase separation of the graft copolymer due to the lower critical solution temperature (LCST) of the poly(N-isopropylacrylamide) segment. No turbidity was observed even above the LCST, and this suggested a nanoscale self-assembling structure of the graft copolymer. The dynamic light scattering measurements confirmed that the size of the aggregate was in the range of several tens of nanometers. The acetal group at the end of the PEG graft chain was easily converted to the aldehyde group by an acid treatment, which was analyzed by H-1 NMR. Such a temperature-induced nanosphere possessing reactive PEG tethered chains on the surface is promising for new nanobased biomedical materials. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tsukuba, Ibaraki 3058453, Japan.
   Okayama Natl Coll Technol, Dept Mat Chem & Bioengn, Oyama, Tochigi 3230806, Japan.
RP Nagasaki, Y (reprint author), Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058453, Japan.
EM nagasaki@nagalabo.jp
CR Akiyama Y, 2000, MACROMOLECULES, V33, P5841, DOI 10.1021/ma000167c
   Akiyama Y, 2000, BIOCONJUGATE CHEM, V11, P947, DOI 10.1021/bc000034w
   BADER H, 1984, ANGEW MAKROMOL CHEM, V123, P457, DOI 10.1002/apmc.1984.051230121
   Bae Y., 2003, ANGEW CHEM, V115, P4788
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   Berlinova IV, 2001, POLYMER, V42, P5963, DOI 10.1016/S0032-3861(01)00080-5
   BOUCHER EA, 1976, J POLYM SCI POL PHYS, V14, P2241, DOI 10.1002/pol.1976.180141209
   Cammas S, 1997, J CONTROL RELEASE, V48, P157, DOI 10.1016/S0168-3659(97)00040-0
   CAMMAS S, 1995, BIOCONJUGATE CHEM, V6, P226, DOI 10.1021/bc00032a011
   Cammas S, 1996, MACROMOLECULES, V29, P3227, DOI 10.1021/ma951025z
   CAMMAS S, 1995, MACROMOL CHEM PHYSIC, V196, P1899, DOI 10.1002/macp.1995.021960609
   Chen HW, 2005, MACROMOLECULES, V38, P8045, DOI 10.1021/ma050994j
   Chen HW, 2005, MACROMOLECULES, V38, P4403, DOI 10.1021/ma050222n
   Chiu HC, 1998, POLYMER, V39, P1609, DOI 10.1016/S0032-3861(97)00436-9
   Chu BJ, 2002, J CHROMATOGR A, V966, P1, DOI 10.1016/S0021-9673(02)00702-1
   Chung JE, 2000, J CONTROL RELEASE, V65, P93, DOI 10.1016/S0168-3659(99)00242-4
   Da J, 2004, J POLYM SCI POL CHEM, V42, P360, DOI 10.1002/pola.10796
   Emoto K, 2000, J AM CHEM SOC, V122, P2653, DOI 10.1021/ja993821g
   Emoto K, 2000, COLLOID SURFACE B, V18, P337, DOI 10.1016/S0927-7765(99)00159-9
   EMOTO K, 2001, J CONGESTIVE FAILURE, V1, P271
   GAO ZS, 1994, MACROMOLECULES, V27, P7923, DOI 10.1021/ma00104a058
   Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054
   Han SK, 2003, COLLOID SURFACE A, V214, P49, DOI 10.1016/S0927-7757(02)00389-8
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Harris JM, 1997, ACS S SERIES, V680
   Hasan E, 2002, MACROMOL SYMP, V177, P125, DOI 10.1002/1521-3900(200201)177:1<125::AID-MASY125>3.0.CO;2-3
   Hayashi H, 2004, MACROMOLECULES, V37, P5389, DOI 10.1021/ma049199g
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HOFFMAN AS, 1995, MACROMOL SYMP, V98, P645, DOI 10.1002/masy.19950980156
   Huang W, 2005, J POLYM SCI POL CHEM, V43, P2038, DOI 10.1002/pola.20688
   Iijima M, 1999, MACROMOLECULES, V32, P1140, DOI 10.1021/ma9815962
   Ishii T, 2005, POLYM J, V37, P221, DOI 10.1295/polymj.37.221
   Ito K, 1998, PROG POLYM SCI, V23, P581, DOI 10.1016/S0079-6700(97)00049-X
   Jones MC, 2003, BIOCONJUGATE CHEM, V14, P774, DOI 10.1021/bc020041f
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kataoka K, 1999, MACROMOLECULES, V32, P6892, DOI 10.1021/ma990973n
   Kohori F, 1998, J CONTROL RELEASE, V55, P87, DOI 10.1016/S0168-3659(98)00023-6
   Kohori F, 2002, J CONTROL RELEASE, V78, P155, DOI 10.1016/S0168-3659(01)00492-8
   Kono K, 2002, J CONTROL RELEASE, V80, P321, DOI 10.1016/S0168-3659(02)00018-4
   KWON G, 1994, J CONTROL RELEASE, V29, P17, DOI 10.1016/0168-3659(94)90118-X
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   La SB, 1996, J PHARM SCI, V85, P85, DOI 10.1021/js950204r
   Lee KK, 1998, POLYM BULL, V40, P455, DOI 10.1007/s002890050276
   Leobandung W, 2002, J CONTROL RELEASE, V80, P357, DOI 10.1016/S0168-3659(02)00028-7
   Liang DH, 1999, MACROMOLECULES, V32, P6326, DOI 10.1021/ma9901792
   Lin HH, 2001, MACROMOLECULES, V34, P3710, DOI 10.1021/ma001852m
   MAEDA H, 1989, CRIT REV THER DRUG, V6, P193
   Maeda Y, 2001, MACROMOL RAPID COMM, V22, P1390, DOI 10.1002/1521-3927(20011101)22:17<1390::AID-MARC1390>3.0.CO;2-Z
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Matsuya T, 2003, ANAL CHEM, V75, P6124, DOI 10.1021/ac034346e
   Mori T, 2005, J POLYM SCI POL CHEM, V43, P1007, DOI 10.1002/pola.20563
   Mori T, 2004, J POLYM SCI POL CHEM, V42, P2651, DOI 10.1002/pola.20123
   Morihara Y, 2005, J POLYM SCI POL CHEM, V43, P6048, DOI 10.1002/pola.21097
   NAGASAKA A, 1955, B I CHEM RES KYOTO U, V33, P85
   Nagasaki Y, 2001, BIOMACROMOLECULES, V2, P1067, DOI 10.1021/bm015574q
   NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P702, DOI 10.1021/bc00036a007
   NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P231, DOI 10.1021/bc00032a012
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Nagasaki Y, 1997, MACROMOLECULES, V30, P6489, DOI 10.1021/ma9705026
   Nakamura T, 1998, BIOCONJUGATE CHEM, V9, P300, DOI 10.1021/bc970179b
   Oishi M, 2003, BIOMACROMOLECULES, V4, P1426, DOI 10.1021/bm034164u
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   PARK TG, 1994, J APPL POLYM SCI, V52, P85, DOI 10.1002/app.1994.070520110
   PERRIN DD, 1980, PURIFICATION LAB CHE
   Qiu XP, 1997, MACROMOLECULES, V30, P7921, DOI 10.1021/ma970894g
   RAE YH, 2000, J CONTROL RELEASE, V64, P3
   RINGSDORF H, 1991, MACROMOLECULES, V24, P1678, DOI 10.1021/ma00007a034
   Robinson DN, 2002, MACROMOLECULES, V35, P3668, DOI 10.1021/ma011525u
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040
   Song MJ, 2004, J POLYM SCI POL CHEM, V42, P772, DOI 10.1002/pola.10851
   Sugihara S, 2004, J POLYM SCI POL CHEM, V42, P2601, DOI 10.1002/pola.20121
   Topouza D, 2004, J POLYM SCI POL CHEM, V42, P6230, DOI 10.1002/pola.20479
   Topp MDC, 1997, MACROMOLECULES, V30, P8518, DOI 10.1021/ma9710803
   Topp MDC, 2000, MACROMOLECULES, V33, P4986, DOI 10.1021/ma9917500
   VELICHKOVA RS, 1995, PROG POLYM SCI, V20, P819, DOI 10.1016/0079-6700(95)00004-Y
   Virtanen J, 2000, MACROMOLECULES, V33, P336, DOI 10.1021/ma990978k
   Virtanen J, 2000, MACROMOLECULES, V33, P5970, DOI 10.1021/ma9918093
   Virtanen J, 2002, MACROMOLECULES, V35, P4763, DOI 10.1021/ma0122391
   Wang Y, 2004, J POLYM SCI POL CHEM, V42, P2093, DOI 10.1002/pola.20046
   Wesslen B, 1998, MACROMOL SYMP, V130, P403, DOI 10.1002/masy.19981300134
   WU C, 1995, MACROMOLECULES, V28, P8381, DOI 10.1021/ma00128a056
   XU RL, 1991, MACROMOLECULES, V24, P87, DOI 10.1021/ma00001a014
   Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5
   Yamamoto Y, 1999, COLLOID SURFACE B, V16, P135, DOI 10.1016/S0927-7765(99)00065-X
   Yasugi K, 1999, MACROMOLECULES, V32, P8024, DOI 10.1021/ma991066l
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOKOYAMA M, 1992, BIOCONJUGATE CHEM, V3, P295, DOI 10.1021/bc00016a007
   YOKOYAMA M, 1993, DRUG DELIV, V1, P11
   ZALIPSKY S, 1994, REACT POLYM, V22, P243, DOI 10.1016/0923-1137(94)90122-8
   Zhang J, 2005, MACROMOLECULES, V38, P1936, DOI 10.1021/ma0490193
   Zhang LF, 1997, MACROMOLECULES, V30, P1001, DOI 10.1021/ma961413g
   Zhu PW, 1999, MACROMOLECULES, V32, P2068, DOI 10.1021/ma9814705
NR 95
TC 28
Z9 28
U1 1
U2 27
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD FEB 15
PY 2006
VL 44
IS 4
BP 1457
EP 1469
DI 10.1002/pola.21264
PG 13
WC Polymer Science
SC Polymer Science
GA 009JI
UT WOS:000235107500011
DA 2018-10-20
ER

PT J
AU Bunzli, JCG
AF Bunzli, JCG
TI Lanthanide-containing luminescent molecular edifices
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article; Proceedings Paper
CT Rare Earths 2004 Conference
CY NOV 07-12, 2004
CL Nara, JAPAN
SP Rare Earth Soc Japan, ICFE 05, Org Comm, Japan Soc Promot Sci, Commemorat Org Japan World Exposit 70, Nara Convent Bur, Iwatani Naoji Fdn, Murata Sci Fdn, Izumi Sci & Technol Fdn, Kao Fdn Arts & Sci, Nippon Sheet Glass Fdn Mat Sci & Engn, Fdn Promot Mat Sci & Technol Japan, Asahi Glass Fdn
DE lanthanide; luminescence; macrocycle; self-assembly; helicate;
   bimetallic; liquid crystal; ionic liquid
ID CONTAINING LIQUID-CRYSTALS; PHOSPHINOYL PENDANT ARMS; CONTAINING
   METALLOMESOGENS; FUNCTIONAL ASSEMBLIES; MAGNETIC-PROPERTIES; HIGHLY
   LUMINESCENT; PHASE-TRANSITIONS; COMPLEXES; IONS; COORDINATION
AB The first part of this short review focuses oil the insertion of luminescent lanthanide ions into molecular compounds. The main requirements for the development of highly luminescent chelates with potential applications in biomedical analysis and time-resolved luminescent microscopy are presented. We then describe the design of adequate macrocyclic receptors with potential applications ill nuclear waste management and in the design of liquid crystalline materials. In the latter case, the luminescent properties of the lanthanide, ions can be taken advantage of for the determination of the transition temperature. Finally, we turn to self-assembly processes, which allow a fine-tuning of the coordination sphere and, consequently, of the electronic, and associated, properties of the lanthanide ions. Heteropairs of lanthanide ions may be specifically recognized, which leads to the design of bifunctional (bicolour) probes. Moreover, the properties of one metal ion call be controlled by the presence of the other metal ion (either 4f or 3d) when both are inserted into polymetallic edifices. (c) 2005 Elsevier B.V. All rights reserved.
C1 Ecole Polytech Fed Lausanne, Lab Lanthanide Supramol Chem, CH-1015 Lausanne, Switzerland.
RP Bunzli, JCG (reprint author), Ecole Polytech Fed Lausanne, Lab Lanthanide Supramol Chem, CH-1015 Lausanne, Switzerland.
EM Jean-claude.bunzli@epfl.ch
RI Bunzli, Jean-Claude/C-7303-2008
OI Bunzli, Jean-Claude/0000-0003-0140-3402
CR Andre N, 2004, INORG CHEM, V43, P515, DOI 10.1021/ic0351996
   Asfari Z, 2001, CALIXARENES
   Atwood JL, 2001, COORDIN CHEM REV, V222, P3, DOI 10.1016/S0010-8545(01)00345-9
   Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g
   BELARBI Z, 1989, J PHYS CHEM-US, V93, P8105, DOI 10.1021/j100361a026
   Binnemans K, 2002, CHEM REV, V102, P2303, DOI 10.1021/cr010287y
   Binnemans K, 2002, J MATER CHEM, V12, P3374, DOI 10.1039/b206810a
   Binnemans K, 2001, CHEMPHYSCHEM, V2, P680, DOI 10.1002/1439-7641(20011119)2:11<680::AID-CPHC680>3.0.CO;2-#
   BUNZLI JCG, 1981, INORG CHIM A-LETT, V53, pL219, DOI 10.1016/S0020-1693(00)84801-X
   Bunzli JCG, 2004, MET IONS BIOL SYST, V42, P39
   Bunzli JCG, 2002, CHEM REV, V102, P1897, DOI 10.1021/cr010299j
   Bunzli JCG, 2000, J ALLOY COMPD, V303, P66, DOI 10.1016/S0925-8388(00)00609-5
   BUNZLI JCG, 1984, COORDIN CHEM REV, V60, P191, DOI 10.1016/0010-8545(84)85066-3
   BUNZLI JCG, 2005, SPECTROSCOPIC PROPER, pCH11
   BUNZLI JCG, 1989, LANTHANIDE PROBES LI, V219, pCH7
   BUNZLI JCG, 1987, HDB PHYSICS CHEM RAR, V9, pCH60
   BUNZLI JCG, 2001, ENCY MAT SCI TECHNOL, V10, P4465
   Cantuel M, 2002, J CHEM SOC DALTON, P1929, DOI 10.1039/b200011c
   Corkery RW, 1999, J LUMIN, V82, P1, DOI 10.1016/S0022-2313(99)00026-5
   de Sa GF, 2000, COORDIN CHEM REV, V196, P165, DOI 10.1016/S0010-8545(99)00054-5
   Elhabiri M, 2004, NEW J CHEM, V28, P1096, DOI 10.1039/b405934d
   Elhabiri M, 2004, EUR J INORG CHEM, P51, DOI 10.1002/ejic.200300549
   Elhabiri M, 1999, J AM CHEM SOC, V121, P10747, DOI 10.1021/ja991854q
   Elhabiri M, 1998, CHEM COMMUN, P2347, DOI 10.1039/a806730i
   Fatin-Rouge N, 2000, J AM CHEM SOC, V122, P10810, DOI 10.1021/ja001089b
   Faulkner S, 2004, DALTON T, P1405, DOI 10.1039/b401302f
   FERRAND AC, 2004, THESIS SWISS FEDERAL
   Gorller-Walrand C, 1998, HANDB PHYSI, V25, P101, DOI 10.1016/S0168-1273(98)25006-9
   Guillet E, 2004, CHEM MATER, V16, P4063, DOI 10.1021/cm049296o
   Gunnlaugsson T, 2004, TETRAHEDRON, V60, P105, DOI 10.1016/j.tet.2003.10.086
   GUNZLI JCG, 2000, CALIXARENES SEPARATI, V757, P179
   GUTSCHE CD, 1983, TETRAHEDRON, V39, P409, DOI 10.1016/S0040-4020(01)88541-0
   Hebbink GA, 2003, J PHYS CHEM A, V107, P2483, DOI 10.1021/jp0260090
   Imbert D, 2003, J AM CHEM SOC, V125, P15698, DOI 10.1021/ja0386501
   JENSEN TB, THESIS SWISS FEDERAL
   KASUGA K, 1980, J AM CHEM SOC, V102, P4835, DOI 10.1021/ja00534a047
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   KOMIYAMA M, 2004, HDB PHYS CHEM RARE E, V34, pCH222
   Le Saulnier L, 1999, J CHEM SOC DALTON, P3919, DOI 10.1039/a907693j
   Lehn J.-M, 1995, SUPRAMOLECULAR CHEM
   Liu S, 2004, CHEM SOC REV, V33, P445, DOI 10.1039/b309961j
   Liu WS, 2004, J AM CHEM SOC, V126, P2280, DOI 10.1021/ja036635q
   Martin N, 1998, INORG CHEM, V37, P577, DOI 10.1021/ic971401r
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   Ozawa L, 2003, CHEM REV, V103, P3835, DOI 10.1021/cr0203490
   Parker D, 2000, COORDIN CHEM REV, V205, P109, DOI 10.1016/S0010-8545(00)00241-1
   PIECHOCKI C, 1985, CHEM PHYS LETT, V122, P124, DOI 10.1016/0009-2614(85)85490-7
   Piguet C, 1999, CHEM SOC REV, V28, P347, DOI 10.1039/a804240c
   PIGUET C, 1993, J AM CHEM SOC, V115, P8197, DOI 10.1021/ja00071a032
   Qi MH, 2003, J PHYS CHEM B, V107, P7640, DOI 10.1021/jp034128p
   Ramirez F. D. M., 2001, DALTON T, P3205
   Ramirez FD, 2002, J CHEM SOC DALTON, P4505, DOI 10.1039/b206238k
   Ramirez FDM, 2004, EUR J INORG CHEM, P2348, DOI 10.1002/ejic.200300824
   RAMIREZ FDM, 2005, UNPUB
   Sastri V. R, 2003, MODERN ASPECTS RARE
   SATO N, 1993, J CHEM SOC PERK T 2, P621, DOI 10.1039/p29930000621
   Silva FRGE, 2002, J PHYS CHEM A, V106, P1670, DOI 10.1021/jp012884u
   Stang PJ, 1997, ACCOUNTS CHEM RES, V30, P502, DOI 10.1021/ar9602011
   Suarez S, 2004, CHEM MATER, V16, P3257, DOI [10.1021/cm049754t, 10.1021/cm.049754t]
   Suarez S, 2003, CHEM COMMUN, P1226, DOI 10.1039/b302438e
   SUAREZ S, 2005, UNPUB
   Van Deun R, 2003, J MATER CHEM, V13, P1520, DOI 10.1039/b305158g
   Videva V, 2004, EUR J INORG CHEM, P2173, DOI 10.1002/ejic.200300858
   WANG XY, 1992, INORG CHEM, V31, P1095, DOI 10.1021/ic00032a034
   Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684
   Werts MHV, 2002, PHYS CHEM CHEM PHYS, V4, P1542, DOI 10.1039/b107770h
   Werts MHV, 2000, ANGEW CHEM INT EDIT, V39, P4542, DOI 10.1002/1521-3773(20001215)39:24<4542::AID-ANIE4542>3.3.CO;2-3
   YU LJ, 1977, APPL PHYS LETT, V31, P719, DOI 10.1063/1.89528
   Zucchi G, 2002, INORG CHEM, V41, P2459, DOI 10.1021/ic011121i
NR 69
TC 32
Z9 32
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD FEB 9
PY 2006
VL 408
BP 934
EP 944
DI 10.1016/j.jallcom.2004.11.098
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 013YG
UT WOS:000235445300215
DA 2018-10-20
ER

PT J
AU Hammer, DA
   Waugh, RE
AF Hammer, DA
   Waugh, RE
TI Teaching cellular engineering
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT 3rd Annual Biomedical Imaging Research Opportunities Workshop
CY MAR 11-12, 2005
CL Bethesda, MD
SP Acad Radiol Res, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Biomed Engn Soc, Radiol Soc N Amer
DE cellular engineering; education; curriculum
AB Cellular engineering is one of the fastest growing subdisciplines in the field of Biomedical Engineering. It involves the application of engineering analysis to understand and control cellular behavior, with the ultimate objective of developing novel therapeutic or diagnostic approaches for the clinic or harnessing cellular function for commercial applications. Well-educated students in this area need strong foundational knowledge in engineering science, chemistry, and cell and molecular biology. In undergraduate curricula, the challenge is to include essential engineering skills plus appropriate levels of training in chemistry and biology while satisfying accreditation-mandated breadth in engineering training. At the graduate level, educators must accommodate students with diverse backgrounds and provide them with both a state-of-the-art understanding of the life sciences and the most advanced engineering skills. Engineering curricular content should include mechanics and materials, physical chemistry, transport phenomena, and control theory. Training from faculty with appointments and research programs in the life sciences is generally recommended, and additional life science content should also be integrated within the engineering curriculum. A capstone course in cellular engineering that includes opportunities for students to have hands-on experiences with state-of-the-art laboratory techniques is highly recommended.
C1 Univ Rochester, Med Ctr, Dept Biomed Engn, Rochester, NY 14642 USA.
   Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Waugh, RE (reprint author), Univ Rochester, Med Ctr, Dept Biomed Engn, Box 639,601 Elmwood Ave, Rochester, NY 14642 USA.
EM waugh@bme.rochester.edu
CR Alberts B, 2002, MOL BIOL CELL
   Lauffenburger D., 1993, RECEPTORS
   Nelson P, 2004, BIOL PHYS ENERGY INF
NR 3
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2006
VL 34
IS 2
BP 253
EP 256
DI 10.1007/s10439-005-9019-y
PG 4
WC Engineering, Biomedical
SC Engineering
GA 028QG
UT WOS:000236502300011
PM 16450196
DA 2018-10-20
ER

PT J
AU Perner, P
   Janichen, S
   Perner, H
AF Perner, P
   Janichen, S
   Perner, H
TI Case-based object recognition for airborne fungi recognition
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 2nd Workshop on Casebased Reasoning in the Health Sciences held at the
   ECCBR-04 Workshop
CY 2004
CL Madrid, SPAIN
DE case-based object recognition; similarity measure; acquisition of form
   models; shape alignment; clustering; fungi spore; recognition;
   biotechnological application
ID MODEL; IMAGES; SNAKES; AFFINE
AB Objective: Model-based object recognition is a well-known task in Computer Vision. Usually, one object that can be generalized by a model. should be detected in an image based on this model. Biomedical. applications have the special quality that one object can have a great variation in appearance. Therefore the appearance of this object cannot be generalized by one model. A set of cases of the appearance of this object (sometimes 50 cases or more) is necessary to detect this object in an image. The recognition method is rather case-based object recognition than model-based object recognition. Case-based object recognition is a challenging task.
   Methods and material: It puts special requirements to the similarity measure and needs a matching algorithm that can work fast in a large number of cases. It also needs a case acquisition procedure that can capture the great variation in appearance of an object and generalize these data into a case description. In this paper we describe the chosen case representation, the similarity measure and the matching as well. as the case acquisition procedure. We evaluate our method based on a Large enough set of digital images containing biological objects such as fungi spores.
   Results: We can show that the similarity measure is superior to detect the objects in the images. The developed method for case acquisition and learning of generalized cases allows us to learn interactively a sufficient number of cases that are further stored into our case base. Finally, we give results on the performance of the system by calculating the recognition rate.
   Conclusion: These result show that we have developed a novel similarity measure for object detection in digital grey-level images and a novel procedure for case acquisition and learning that allows us to learn a sufficiently large enough case base and to generalize over a group of cases. (c) 2005 Elsevier B.V. All rights reserved.
C1 IBaI, Inst Comp Vis & Appl Comp Sci, D-04107 Leipzig, Germany.
RP Perner, P (reprint author), IBaI, Inst Comp Vis & Appl Comp Sci, Kornerstr 10, D-04107 Leipzig, Germany.
EM ibaiperner@aol.com
RI Rohlf, F/A-8710-2008
OI Perner, Petra/0000-0003-3355-1397
CR Alt H., 1996, HDB COMPUTATIONAL GE, P121
   Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558
   Bookstein F L, 1997, Med Image Anal, V1, P225, DOI 10.1016/S1361-8415(97)85012-8
   Bookstein FL, 1986, STAT SCI, V1, P181, DOI DOI 10.1214/SS/1177013696
   BRESENHAM JE, 1965, IBM SYST J, V4, P25, DOI 10.1147/sj.41.0025
   BROWN LG, 1992, ACM COMPUT SURV, V24, P325, DOI DOI 10.1145/146370.146374
   BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851
   CHEN Q, 2003, P 2 IEEE INT WORKSH, P77
   Cheng DC, 2002, COMPUT METH PROG BIO, V67, P27, DOI 10.1016/S0169-2607(00)00149-8
   Cootes TF, 1999, IMAGE VISION COMPUT, V17, P567, DOI 10.1016/S0262-8856(98)00175-9
   Dryden IL, 1998, STAT SHAPE ANAL
   Feldmar J, 1996, INT J COMPUT VISION, V18, P99, DOI 10.1007/BF00054998
   GRIMSON WEL, 1991, IEEE T PATTERN ANAL, V13, P1201, DOI 10.1109/34.106994
   HAENSELMANN T, 2000, P SPIE HUM VIS EL IM, V7, P387
   Hill A, 2000, IEEE T PATTERN ANAL, V22, P241, DOI 10.1109/34.841756
   HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073
   JAIN AK, 1988, ALGORITHMS CLUSTERIN
   JURIE F, 1998, P EUR C COMP VIS, P642
   KASS M, 1987, INT J COMPUT VISION, V1, P321
   Katartzis A., 2001, P IEEE INT GEOSC REM, P2832
   Kendall D. G., 1989, STAT SCI, V4, P87, DOI DOI 10.1214/SS/1177012582
   LAMDAN Y, 1990, IEEE T ROBOTIC AUTOM, V6, P578, DOI 10.1109/70.62047
   Latecki LJ, 2000, IEEE T PATTERN ANAL, V22, P1185, DOI 10.1109/34.879802
   Leibe B, 2004, P ECCV WORKSH STAT L, P17
   Lele S, 2001, INVARIANT APPROACH S
   Mokhtarian F., 1996, P INT WORKSH IM DAT, P35
   MORTENSEN EN, 1995, P 22 ANN C COMP GRAP, P191, DOI DOI 10.1145/218380.218442
   Olson CF, 1997, IEEE T IMAGE PROCESS, V6, P103, DOI 10.1109/83.552100
   Perner P, 2002, DATA MINING MULTIMED
   Rangarajan A., 1997, P 15 INT C INF PROC, P29
   SCLAROFF S, 1995, IEEE T PATTERN ANAL, V17, P545, DOI 10.1109/34.387502
   Shahrokni A, 2002, COMP ANIM CONF PROC, P65, DOI 10.1109/CA.2002.1017508
   VELTKAMP RC, 2001, SHAPE MODEL INT, P1880
   WALL K, 1984, COMPUT VISION GRAPH, V28, P220, DOI 10.1016/S0734-189X(84)80023-7
NR 34
TC 17
Z9 17
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
EI 1873-2860
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD FEB
PY 2006
VL 36
IS 2
BP 137
EP 157
DI 10.1016/j.artmed.2005.04.002
PG 21
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 023GF
UT WOS:000236113700003
PM 16207527
DA 2018-10-20
ER

PT J
AU Bichindaritz, I
AF Bichindaritz, I
TI Memoire: A framework for semantic interoperability of case-based
   reasoning systems in biology and medicine
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 2nd Workshop on Casebased Reasoning in the Health Sciences held at the
   ECCBR-04 Workshop
CY 2004
CL Madrid, SPAIN
DE case-based reasoning; semantic Web; medical informatics; artificial
   intelligence in medicine; psychiatry; hypertension; oncology
AB Objective: Memoire is a framework for sharing and distributing case bases and case-based reasoning (CBR) systems in biology and medicine.
   Methods and material: This paper first introduces the semantic Web approach to build a better Web where search engines, knowledge sources and servers, applications and services can live, work, and learn in cooperation. This semantic approach is particularly well. suited for biomedical domains because significant ontologies have been developed there and constitute a sound basis for the standardization effort required for the semantic Web. Case-based reasoning systems in biomedicine have also benefited from these biomedical ontologies and models.
   Results: This article demonstrates for three such systems how a semantics infused approach in CBR gives better, more accurate results in CBR. From this previous work on a semantic approach in CBR in biomedicine, the Memoire framework has evolved.
   Conclusion: Memoire proposes a unified OWL-based representation language for cases and case-based ontologies in biomedicine, where a Web Ontology Language (OWL) is a language to represent ontologies on the Web. Memoire provides a set of toots for building case-based reasoning systems compliant with its language. Memoire is extensible and can be adapted to different types of biomedical application domains, tasks, and environments. Memoire wilt permit bridging the gap within the multiple case-based reasoning systems dedicated to a single domain, and make available to agents and Web services the case-based competency of the CBR systems adopting its interchange language. The approach could be extended to other application domains of CBR. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Washington, Tacoma, WA 98402 USA.
RP Bichindaritz, I (reprint author), Univ Washington, 1900 Commerce St, Tacoma, WA 98402 USA.
EM ibichind@u.washington.edu
FU AHRQ HHS [R01HS09407]
CR American Psychiatric Association, 1987, DIAGN STAT MAN MENT
   BERNERSLEE T, 2001, SCI AM           MAY
   Bichindaritz I., 1992, Technique et Science Informatiques, V11, P69
   Bichindaritz I, 1998, LECT NOTES ARTIF INT, V1488, P334
   BICHINDARITZ I, 1995, LECT NOTES ARTIF INT, V1010, P391
   BOUAUD J, 1994, P ICCS 94 WORKSH KNO, P1
   BUTTLER D, 2002, SIGMOD REC, V31, P590
   CRUZ IF, 2001, 1 SEM WEB WORK S, P1
   FININ T, 2002, SPECIAL ISSUE SEMANT, V31, P340
   GOBLE C, 2002, SIGMOD REC, V31, P650
   GRUTTER R, 2001, 1 SEM WEB WORK S, P5870
   Hendler J., 2002, J I ELECT ENG JPN, V122, P676, DOI 10.1541/ieejjournal.122.676
   SKODOL AE, 1987, ANNOTATED BIBLIO DSM
   Staab S, 2003, COMP FUNCT GENOM, V4, P98, DOI 10.1002/cfg.240
   TUTTLE MS, 2001, 1 SEM WEB WORK S, P50
NR 15
TC 37
Z9 38
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD FEB
PY 2006
VL 36
IS 2
BP 177
EP 192
DI 10.1016/j.artmed.2005.10.009
PG 16
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 023GF
UT WOS:000236113700005
PM 16459063
DA 2018-10-20
ER

PT J
AU Maeda, T
   Kanda, T
   Yonekura, Y
   Yamamoto, K
   Aoyagi, T
AF Maeda, T
   Kanda, T
   Yonekura, Y
   Yamamoto, K
   Aoyagi, T
TI Hydroxylated poly(N-isopropylacrylamide) as functional thermoresponsive
   materials
SO BIOMACROMOLECULES
LA English
DT Article
ID N-ISOPROPYLACRYLAMIDE; PHASE-TRANSITION; TEMPERATURE SENSITIVITY;
   AQUEOUS-SOLUTIONS; CLOUD POINT; POLYMER; HYDROGELS; WATER; COPOLYMERS;
   SURFACES
AB In this study, we developed a poly(N-isopropylacrylamide)-based thermoresponsive polymeric material with a high content of hydroxyl groups. We newly designed the functional monomer, N-(2-hydroxyisopropyl)acrylan-lide (HIPAAm), considering maintaining the continuous and repeated structure of the isopropylamide group after copolymerization and the monomer reactivity ratios. The thermoresponsive polymer was derived by conventional radical copolymerization of HIPAAm with N-isopropylacrylamide (NIPAAm) in high yield. Estimation of monomer reactivity ratios, r(1) and r(2), supported the almost random sequence of the comonomers. The obtained copolymers showed a very sensitive phase transition and/or separation in response to temperature in aqueous media although they have many hydrophilic parts, and their thermoresponsive behavior was not affected by the pH. Furthermore, the cloud points of these copolymers closely depended on the HIPAAm content and could be easily controlled by adding salts. HIPAAm is expected to regulate the phase transition and/or separation temperature of the NIPAAm-based copolymers while maintaining their desirable sensitive thermoresponse. Differential scanning calorimetric analysis showed that dehydration of the polymer chains occurring in phase transition became incomplete with increasing HIPAAm content. Moreover, it was found that poly(NIPAAm-co-HIPAAm) having a high content of the HIPAAm unit showed liquid-liquid phase separation involving coacervation. The sizes of the coacervate droplets were relatively monodisperse and very minimal. Poly(NIPAAm-co-HIPAAm) is valuable for use in biomedical fields such as bioseparation.
C1 Kagoshima Univ, Dept Nanostruct & Adv Mat, Grad Sch Sci & Engn, Kagoshima 8900065, Japan.
RP Aoyagi, T (reprint author), Kagoshima Univ, Dept Nanostruct & Adv Mat, Grad Sch Sci & Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.
EM aoyagi@eng.kagoshima-u.ac.jp
CR Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Aoki T, 2001, MACROMOLECULES, V34, P3118, DOI 10.1021/ma001866s
   Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Ebara M, 2004, SURF SCI, V570, P134, DOI 10.1016/j.susc.2004.06.183
   Ebara M, 2001, J POLYM SCI POL CHEM, V39, P335, DOI 10.1002/1099-0518(20010201)39:3<335::AID-POLA1000>3.0.CO;2-H
   Eeckman F, 2004, INT J PHARM, V273, P109, DOI 10.1016/j.ijpharm.2003.12.013
   FEIL H, 1992, MACROMOLECULES, V25, P5528, DOI 10.1021/ma00046a063
   FLORIN E, 1984, J CHEM SOC FARAD T 1, V80, P2889, DOI 10.1039/f19848002889
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   KJELLANDER R, 1981, J CHEM SOC FARAD T 1, V77, P2053, DOI 10.1039/f19817702053
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   KUBOTA K, 1990, J PHYS CHEM-US, V94, P5154, DOI 10.1021/j100375a070
   MARCHETTI M, 1990, MACROMOLECULES, V23, P1760, DOI 10.1021/ma00208a034
   Materna K, 2004, J COLLOID INTERF SCI, V269, P466, DOI 10.1016/jjcis.2003.08.002
   Matsumoto A, 2004, MACROMOLECULES, V37, P1502, DOI 10.1021/ma035382i
   Miyazaki H, 1996, POLYMER, V37, P681, DOI 10.1016/0032-3861(96)83156-9
   PRIEST JH, 1987, ACS SYM SER, V350, P255
   Shild H. G., 1992, PROG POLYM SCI, V17, P163
   SHILD HG, 1990, J PHYS CHEM-US, V94, P4352
   Sugihara S, 2004, MACROMOLECULES, V37, P1711, DOI 10.1021/ma034730d
   Xue W, 2000, POLYMER, V41, P7575, DOI 10.1016/S0032-3861(00)00171-3
   Yakushiji T, 1998, LANGMUIR, V14, P4657, DOI 10.1021/la980090+
   Yamamoto K, 2003, MACROMOL CHEM PHYS, V204, P1027, DOI 10.1002/macp.200390073
   Yin XC, 2005, MACROMOLECULES, V38, P2109, DOI 10.1021/ma048853p
   Yoshida T, 2003, J POLYM SCI POL CHEM, V41, P779, DOI 10.1002/pola.10595
NR 28
TC 68
Z9 70
U1 1
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2006
VL 7
IS 2
BP 545
EP 549
DI 10.1021/bm050829b
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 015FZ
UT WOS:000235538600021
PM 16471928
DA 2018-10-20
ER

PT J
AU Yang, X
   Parker, D
   Whitehead, L
   Ryder, NS
   Weidmann, B
   Stabile-Harris, M
   Kizer, D
   McKinnon, M
   Smellie, A
   Powers, D
AF Yang, X
   Parker, D
   Whitehead, L
   Ryder, NS
   Weidmann, B
   Stabile-Harris, M
   Kizer, D
   McKinnon, M
   Smellie, A
   Powers, D
TI A collaborative hit-to-lead investigation leveraging medicinal chemistry
   expertise with high throughput library design, synthesis and
   purification capabilities
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
DE high throughput screening; parallel synthesis; hit-to-lead; resource
   management; laboratory automation; library design; antiinfectives
AB High throughput screening (FITS) campaigns, where laboratory automation is used to expose biological targets to large numbers of materials from corporate compound collections, have become commonplace within the lead generation phase of pharmaceutical discovery [1]. Advances in genomics and related fields have afforded a wealth or targets such that screening facilities at larger organizations routinely execute over 100 hit-finding campaigns per year [2]. Often, 10(5) or 10(6) molecules will be tested within a campaign/cycle to locate a large number of actives requiring follow-up investigation. Due to resource constraints at every organization, traditional chemistry methods for validating flits and developing structure activity relationships (SAR) become untenable when challenged with hundreds of hits in multiple chemical families per target. To compound the issue, comparison and prioritization of hits versus multiple screens, or physical chemical property criteria, is made more complex by the informatics issues associated with handling large data sets. This article describes a collaborative research project designed to simultaneously leverage the medicinal chemistry and drug development expertise of the Novartis Institutes for Biomedical Research Inc. (NIBRI) and ArQule Inc.'s high throughput library design, synthesis and purification capabilities. The work processes developed by the team to efficiently design, prepare, purify, assess and prioritize multiple chemical classes that were identified during high throughput screening, cheminformatics and molecular modeling activities will be detailed.
C1 ArQule Inc, Div Chem Technol, Woburn, MA 01801 USA.
   Novartis Inst Biomed Res Inc, Infect Dis, Cambridge, MA 02139 USA.
RP Powers, D (reprint author), ArQule Inc, Div Chem Technol, 19 Presidential Way, Woburn, MA 01801 USA.
EM dpowers@arqule.com
OI Whitehead, Lewis/0000-0002-6125-0893
NR 0
TC 4
Z9 4
U1 0
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD FEB
PY 2006
VL 9
IS 2
BP 123
EP 130
DI 10.2174/138620706775541891
PG 8
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 014GY
UT WOS:000235468800007
PM 16475970
DA 2018-10-20
ER

PT J
AU Halpern, JM
   Xie, ST
   Sutton, GP
   Higashikubo, BT
   Chestek, CA
   Lu, H
   Chiel, HJ
   Martin, HB
AF Halpern, JM
   Xie, ST
   Sutton, GP
   Higashikubo, BT
   Chestek, CA
   Lu, H
   Chiel, HJ
   Martin, HB
TI Diamond electrodes for neurodynamic studies in Aplysia californica
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Applied Diamond Conference/NanoCarbon
CY MAY 15-19, 2005
CL Argonne Natl Lab, Chicago, IL
HO Argonne Natl Lab
DE hot filament CVD; diamond film; sensors; biomedical applications
ID SEROTONIN; MOVEMENTS; NEURON; FILMS
AB As part of an ongoing effort to demonstrate that diamond is a versatile electrode material for biological applications, we present our progress in the development of diamond electrodes for the study of neurodynamics in an animal model, Aplysia californica. Diamond provides a unique opportunity to integrate neural stimulation and sensing in the same implantable device. Data from several parallel studies are presented: in vitro measurement of serotonin concentration, measurement of electrical activity, and neural stimulation. Using diamond microelectrodes, changes of the Aplysia californica's feeding patterns are being studied as a function of concentration of serotonin, which can act as a neuromodulator of feeding behavior. (c) 2005 Elsevier B.V. All rights reserved.
C1 Case Western Reserve Univ, Dept Chem Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Mech Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Elect Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.
RP Martin, HB (reprint author), Case Western Reserve Univ, Dept Chem Engn, AW Smith Bldg,Room 131,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM hbm@cwru.edu
OI Halpern, Jeffrey/0000-0003-0814-1986
CR HIGASHIKUBO BT, 2005, RES SHOW CASE
   Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309
   IWAKI M, 1983, NUCL INSTRUM METHODS, V209, P1129, DOI 10.1016/0167-5087(83)90930-4
   Jian W, 2004, LANGMUIR, V20, P11450, DOI 10.1021/la048740z
   MARTIN H, 1995, 3 INT C WASH DC NIST, P91
   Martin HB, 1996, J ELECTROCHEM SOC, V143, pL133, DOI 10.1149/1.1836901
   MARTIN HB, 2002, AICHE P P172 SENS TE, P168
   MARTIN HB, 2005, ELECTROCHEMISTRY DIA, P26
   MEULEMANS A, 1987, BRAIN RES, V414, P158, DOI 10.1016/0006-8993(87)91339-4
   Miao H, 2003, ANAL BIOANAL CHEM, V377, P1007, DOI 10.1007/s00216-003-2191-8
   MORTON DW, 1993, J COMP PHYSIOL A, V173, P519
   Notsu H, 2001, ELECTROCHEM SOLID ST, V4, pH1, DOI 10.1149/1.1346556
   PLESKOV YV, 1999, RUSS CHEM REV, V68, P381, DOI DOI 10.1070/RC1999V068N05ABEH000494
   Popa E, 1999, ELECTROCHEM SOLID ST, V2, P49, DOI 10.1149/1.1390730
   Rao TN, 2000, J ELECTROANAL CHEM, V491, P175, DOI 10.1016/S0022-0728(00)00208-4
   Sarada BV, 2000, ANAL CHEM, V72, P1632, DOI 10.1021/ac9908748
   Strother T, 2002, LANGMUIR, V18, P968, DOI 10.1021/la0112561
   Swain GM, 1998, MRS BULL, V23, P56, DOI 10.1557/S0883769400029389
   Tenne R, 1998, ISRAEL J CHEM, V38, P57
   Tsunozaki K, 2002, CHEM LETT, P502, DOI 10.1246/cl.2002.502
   WEISS KR, 1981, ADV PHYSL SCI, V23, P305
   XIE S, 2004, ELECTROCHEM SOC FALL, P1808
   Yano T, 1998, J ELECTROCHEM SOC, V145, P1870, DOI 10.1149/1.1838569
NR 23
TC 43
Z9 45
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
EI 1879-0062
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD FEB-MAR
PY 2006
VL 15
IS 2-3
BP 183
EP 187
DI 10.1016/j.diamond.2005.06.039
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 027UE
UT WOS:000236440300002
DA 2018-10-20
ER

PT J
AU Xie, ST
   Shafer, G
   Wilson, CG
   Martin, HB
AF Xie, ST
   Shafer, G
   Wilson, CG
   Martin, HB
TI In vitro adenosine detection with a diamond-based sensor
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Applied Diamond Conference/NanoCarbon
CY MAY 15-19, 2005
CL Argonne Natl Lab, Chicago, IL
HO Argonne Natl Lab
DE hot filament CVD; diamond film; sensors; biomedical applications
ID SCAN CYCLIC VOLTAMMETRY; RESPIRATORY RHYTHM; PACEMAKER; COMPLEX
AB Diamond-based electrodes promise major advantages over present electrode technologies used in biomedical research. To demonstrate these advantages, boron-doped diamond microelectrodes were developed for in vitro detection of adenosine, an important neuromodulator in the central nervous system. Diamond was selectively deposited as part of a unique fabrication strategy to obtain non-planar, needle-like diamond microelectrodes. Preliminary flow injection analysis showed quantified adenosine down to 10 nM, a lower level than the estimated basal adenosine level in vivo, and lower than what is achieved on other electrode materials. As an example of in vitro application, the diamond probe was used to investigate the role of adenosine in respiratory rhythmogenesis (i.e., the modulation of one's breathing rate). (c) 2005 Elsevier B.V. All rights reserved.
C1 Case Western Reserve Univ, Dept Chem Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.
RP Martin, HB (reprint author), Case Western Reserve Univ, Dept Chem Engn, AW Smith Bldg,Room 131,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM hbm@cwru.edu
CR ARANDA JV, 1976, NEW ENGL J MED, V295, P413, DOI 10.1056/NEJM197608192950803
   Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31
   ELNOUR KA, 2001, ELECTROANAL, V12, P805
   JACKSON BP, 1995, ANAL CHEM, V67, P1115, DOI 10.1021/ac00102a015
   Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540
   Martin HB, 1996, J ELECTROCHEM SOC, V143, P133
   Michael D, 1998, ANAL CHEM, V70, p586A, DOI 10.1021/ac9819640
   Michael DJ, 1999, ANAL CHEM, V71, P3941, DOI 10.1021/ac990491+
   Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385
   SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005
   Wilson CG, 2004, RESP PHYSIOL NEUROBI, V141, P201, DOI 10.1016/j.resp.2004.04.012
NR 11
TC 45
Z9 45
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD FEB-MAR
PY 2006
VL 15
IS 2-3
BP 225
EP 228
DI 10.1016/j.diamond.2005.08.018
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 027UE
UT WOS:000236440300011
DA 2018-10-20
ER

PT J
AU Zhu, XW
   Aslarn, DM
AF Zhu, XW
   Aslarn, DM
TI CVD diamond thin film technology for MEMS packaging
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Applied Diamond Conference/NanoCarbon
CY MAY 15-19, 2005
CL Argonne Natl Lab, Chicago, IL
HO Argonne Natl Lab
DE diamond; thin film package; integrated; MEMS
ID WIRELESS INTEGRATED MICROSYSTEMS; FLIP-CHIP; FABRICATION; RELIABILITY;
   OXYGEN
AB Due to its extreme hardness, chemical and mechanical stability, large band gap and highest thermal conductivity, poly-crystalline diamond (poly-C) is expected to be an excellent packaging material for biomedical and environmental MEMS devices. A poly-C thin film packaging technology has been developed to explore the application of this novel material on post-MEMS encapsulation packaging process. To study the poly-C thin film packaging a testchip was fabricated using PECVD deposited oxide as a sacrificial material. Large access ports were opened along the package edge to release thin film package using oxide etch. Then, additional poly-C growth was used to seal the access ports. In the test package, boron doped poly-C was also studied as the material for electrical feedthroughs that can be embedded into the undoped electrically insulating poly-C package. This poly-C thin film packaging process and the all-diamond packaging concept has been developed for the first time. (c) 2005 Elsevier B.V. All rights reserved.
C1 Michigan State Univ, E Lansing, MI 48824 USA.
RP Zhu, XW (reprint author), Michigan State Univ, 2120 Engn Bldg, E Lansing, MI 48824 USA.
EM zhuxiang@egr.msu.edu
CR ASLAM M, 1995, P 8 INT C SOL STAT S, P222
   Bjorkman H, 1999, SENSOR ACTUAT A-PHYS, V73, P24, DOI 10.1016/S0924-4247(98)00250-7
   Choi HW, 2005, J VAC SCI TECHNOL B, V23, P130, DOI 10.1116/1.1843826
   EFREMOW NN, 1985, J VAC SCI TECHNOL B, V3, P416, DOI 10.1116/1.583276
   GIESLER J, 1994, IEEE T COMPON PACK B, V17, P256, DOI 10.1109/96.311771
   GROT SA, 1992, APPL PHYS LETT, V61, P2326, DOI 10.1063/1.108232
   Guillaudeu S, 2003, DIAM RELAT MATER, V12, P65, DOI 10.1016/S0925-9635(02)00286-8
   IKEDA K, 1990, SENSOR ACTUAT A-PHYS, V21, P146, DOI 10.1016/0924-4247(90)85028-3
   Kloeser J, 1996, IEEE T COMPON PACK A, V19, P24, DOI 10.1109/95.486558
   Kohn E, 1999, DIAM RELAT MATER, V8, P934, DOI 10.1016/S0925-9635(98)00294-5
   LIN L, 2000, J MAT PROCESS MANUFA, V8, P347
   Lin LW, 1998, J MICROELECTROMECH S, V7, P286, DOI 10.1109/84.709645
   Lin LW, 2000, IEEE TRANS ADV PACK, V23, P608, DOI 10.1109/6040.883749
   MOORES KA, 2001, FUTURE CIRCUITS INT, V7, P45
   SANDHU GS, 1989, APPL PHYS LETT, V55, P437, DOI 10.1063/1.101890
   Snidero E, 2003, J APPL PHYS, V93, P2700, DOI 10.1063/1.1539922
   SURYANARAYANA D, 1993, IEEE T COMPON HYBR, V16, P858, DOI 10.1109/33.273685
   Zhang WJ, 1999, J VAC SCI TECHNOL A, V17, P763, DOI 10.1116/1.581646
   Zhu XW, 2004, J MICROELECTROMECH S, V13, P396, DOI 10.1109/JMEMS.2004.828739
   Zhu XW, 2003, PROC IEEE MICR ELECT, P658
   Ziaie B, 1996, J MICROELECTROMECH S, V5, P166, DOI 10.1109/84.536623
NR 21
TC 24
Z9 25
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD FEB-MAR
PY 2006
VL 15
IS 2-3
BP 254
EP 258
DI 10.1016/j.diamond.2005.08.009
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 027UE
UT WOS:000236440300017
DA 2018-10-20
ER

PT J
AU Hardman, R
AF Hardman, R
TI A toxicologic review of quantum dots: Toxicity depends on
   physicochemical and environmental factors
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Review
DE environment; human health; nanomaterials; nanosized particles;
   nanotechnology; nanotoxicology; quantum dots; toxicology
ID CADMIUM INDUCES APOPTOSIS; IN-VIVO; BIOLOGICAL DETECTION; SELENIUM
   TOXICITY; CDSE NANOCRYSTALS; LIVE CELLS; LONG-TERM; NANOTECHNOLOGY;
   NANOTOXICOLOGY; CYTOTOXICITY
AB As a growing applied science, nanotechnology has considerable global socioeconomic value, and the benefits afforded by nanoscale materials and processes are expected to have significant impacts on almost all industries and all areas of society. A diverse array of engineered nanoscale products and processes have emerged [e.g., carbon nanotubes, fiallerene derivatives, and quantum dots (QDs)], with widespread applications in fields such as medicine, plastics, energy, electronics, and aerospace. With the nanotechnology economy estimated to be valued at $1 trillion by 2012, the prevalence of these materials in society will be increasing, as will the likelihood of exposures. Importantly, the vastness and novelty of the nanotechnology frontier leave many areas unexplored, or underexplored, such as the potential adverse human health effects resulting from exposure to novel nanomaterials. It is within this context that the need for understanding the potentially harmful side effects of these materials becomes clear. The reviewed literature suggests several key points: Not all QDs are alike; engineered QDs cannot be considered a uniform group of substances. QD absorption, distribution, metabolism, excretion, and toxicity depend on multiple factors derived from both inherent physicochemical properties and environmental conditions; QD size, charge, concentration, outer coating bioactivity (capping material and functional groups), and oxidative, photolytic, and mechanical stability have each been implicated as determining factors in QD toxicity. Although they offer potentially invaluable societal benefits such as drug targeting and in vivo biomedical imaging, QDs may also pose risks to human health and the environment under certain conditions.
C1 Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.
RP Hardman, R (reprint author), Duke Univ, Nicholas Sch Environm & Earth Sci, LSRC A333, Durham, NC 27708 USA.
EM ron.hardman@duke.edu
RI Hardman, Ron/A-5788-2008
CR Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Aldana J, 2001, J AM CHEM SOC, V123, P8844, DOI 10.1021/ja016424q
   Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Beaurepaire E, 2004, NANO LETT, V4, P2079, DOI 10.1021/nl049105g
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q
   Colton HM, 2004, TOXICOL SCI, V80, P183, DOI 10.1093/toxsci/kfh144
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Fan TWM, 2002, AQUAT TOXICOL, V57, P65, DOI 10.1016/S0166-445X(01)00261-2
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019
   Hanaki K, 2003, BIOCHEM BIOPH RES CO, V302, P496, DOI 10.1016/S0006-291X(03)00211-0
   Henson MC, 2004, EXP BIOL MED, V229, P383
   Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562
   Hood E, 2004, ENVIRON HEALTH PERSP, V112, pA740, DOI 10.1289/ehp.112-a740
   Hoshino A, 2004, BIOCHEM BIOPH RES CO, V314, P46, DOI 10.1016/j.bbrc.2003.11.185
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Kim S, 2003, J AM CHEM SOC, V125, P11466, DOI 10.1021/ja0361749
   Kloepfer JA, 2003, APPL ENVIRON MICROB, V69, P4205, DOI 10.1128/AEM.69.7.4205-4213.2003
   Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   Lovric J, 2005, J MOL MED, V83, P377, DOI 10.1007/s00109-004-0629-x
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   *NAT SCI FDN, 2004, NAN SCI ENG PROGR SO
   *NAT TOX PROGR, 2005, TOX EV NAN MAT FACT
   NORDAN M, 2004, NANOTECH REPORT 2004
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Parak WJ, 2002, ADV MATER, V14, P882, DOI 10.1002/1521-4095(20020618)14:12<882::AID-ADMA882>3.0.CO;2-Y
   Poliandri AHB, 2003, TOXICOL APPL PHARM, V190, P17, DOI 10.1016/S0041-008X(03)00191-1
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Rudge SR, 2000, BIOMATERIALS, V21, P1411, DOI 10.1016/S0142-9612(00)00006-5
   Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751
   Scherer F, 2001, GENE THER, V9, P102
   Service RF, 2004, SCIENCE, V304, P1732, DOI 10.1126/science.304.5678.1732
   Shiohara A, 2004, MICROBIOL IMMUNOL, V48, P669, DOI 10.1111/j.1348-0421.2004.tb03478.x
   Spallholz JE, 2002, AQUAT TOXICOL, V57, P27, DOI 10.1016/S0166-445X(01)00268-5
   *US EPA, 2003, RES PLANN WORKSH REP
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Wu YW, 2004, PHYSICA E, V25, P242, DOI 10.1016/j.physe.2004.06.023
   YU S, 2005, J MATER CHEM, V14, P2781
NR 49
TC 1263
Z9 1339
U1 22
U2 701
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD FEB
PY 2006
VL 114
IS 2
BP 165
EP 172
DI 10.1289/ehp.8284
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 010VP
UT WOS:000235226300032
PM 16451849
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tack, F
   Bakker, A
   Maes, S
   Dekeyser, N
   Bruining, M
   Elissen-Roman, C
   Janicot, M
   Brewster, M
   Janssen, HM
   De Waal, BFM
   Fransen, PM
   Lou, X
   Meijer, EW
AF Tack, F
   Bakker, A
   Maes, S
   Dekeyser, N
   Bruining, M
   Elissen-Roman, C
   Janicot, M
   Brewster, M
   Janssen, HM
   De Waal, BFM
   Fransen, PM
   Lou, X
   Meijer, EW
TI Modified poly(propylene imine) dendrimers as effective transfection
   agents for catalytic DNA enzymes (DNAzymes)
SO JOURNAL OF DRUG TARGETING
LA English
DT Article
DE poly(propylene imine) dendrimers; DNA enzymes; gene transfection agents;
   cellular toxicity
ID STARBURST POLYAMIDOAMINE DENDRIMERS; GENE DELIVERY; IN-VITRO; ANTISENSE
   OLIGONUCLEOTIDES; PAMAM DENDRIMERS; DRUG-DELIVERY; PLASMID DNA;
   BIOMEDICAL APPLICATIONS; AMPHIPHILIC DENDRIMERS; EFFICIENT TRANSFER
AB The major bottleneck in gene therapy remains the issue of delivery. In this work, various modified poly(propylene imine) (PPI) dendrimers are introduced as gene transfection agents. Commercially available PPI-dendrimers have been modified (i) at the exterior primary amines with acetyl groups or glycol gallate (PEG-like) groups, and (ii) at the interior tertiary amines with methyl iodide (MeI) or MeCl to produce multiple quaternized cationic sites in the core of the dendrimer. The prepared materials have been tested with respect to their binding capabilities to DNA, their toxicity in cell cultures, their in vitro transfection efficiency and their in vivo delivery possibilities. In all cases, a 33-mer oligonucleotide (DNAzyme) was used. Polyacrylamide gel electrophoresis (PAGE) studies have demonstrated strong but reversible binding, where the quarternized and higher generation dendrimer species have shown more potent binding. Typically, for the modified fourth PPI-dendrimers, binding is observed at a concentration of about 4 mu M DNA and a dendrimer-DNA charge ratio of around 2:1-1:1. All the tested PPI-dendrimers display a low cellular toxicity, especially when higher serum contents are used in the culture medium. For example, most of the prepared fourth generation PPI-dendrimers are not or hardly toxic up to at least 20 mu M in 20% serum. An in vitro characterization has revealed a high dendrimer-mediated intracellular uptake of the DNAzyme: all the tested fourth generation PPI-dendrimers display transfection efficiencies close to or exceeding 80%, even when the concentration of serum in the medium is increased from 10 to 40%. Finally, the potential of using modified PPI-dendrimers for in vivo gene therapy experiments is demonstrated. Injecting a G4-PEG(MeI)-ssDNA complex intravenously into Nude mice has resulted in a high nuclear uptake as confirmed by co-localization studies.
C1 Johnson & Johnson Pharmaceut Res & Dev, Oncol Discovery Res & Early Dev, B-2340 Beerse, Belgium.
   Erasmus Univ, Dept Expt Surg Oncol, Rotterdam, Netherlands.
   Johnson & Johnson Pharmaceut Res & Dev, ChemPharm Dept, B-2340 Beerse, Belgium.
   SyMO Chem BV, Eindhoven, Netherlands.
RP Janicot, M (reprint author), Johnson & Johnson Pharmaceut Res & Dev, Oncol Discovery Res & Early Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium.
EM mjanicot@prdbe.jnj.com
RI lou, xianwen/B-6847-2011; Meijer, E.W./K-7632-2013
OI Meijer, E.W./0000-0003-4126-7492; bakker, annette/0000-0001-8420-7831
CR BAKKER A, 2001, G I T IMAGING MICROS, P52
   Bielinska A, 1996, NUCLEIC ACIDS RES, V24, P2176, DOI 10.1093/nar/24.11.2176
   Bielinska AU, 1999, BIOCONJUGATE CHEM, V10, P843, DOI 10.1021/bc990036k
   Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y
   Bragonzi A, 1999, GENE THER, V6, P1995, DOI 10.1038/sj.gt.3301039
   Cheng HH, 2000, GENETICA, V108, P53, DOI 10.1023/A:1004047902652
   Choi JS, 2000, J AM CHEM SOC, V122, P474, DOI 10.1021/ja9931473
   DEBRABANDERVANDENBERG EMM, 1993, ANGEW CHEM INT EDIT, V32, P1308, DOI 10.1002/anie.199313081
   DeLong R, 1997, J PHARM SCI, V86, P762, DOI 10.1021/js960409f
   DUNCAN R, 1996, P INT S CONTR REL BI, V23, P105
   ELSSENROMAN C, 1997, PMSE, V77, P145
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   Hollins AJ, 2004, PHARM RES, V21, P458, DOI 10.1023/B:PHAM.0000019300.04836.51
   Hong SP, 2004, BIOCONJUGATE CHEM, V15, P774, DOI 10.1021/bc049962b
   Joester D, 2003, ANGEW CHEM INT EDIT, V42, P1486, DOI 10.1002/anie.200250284
   Kabanov VA, 2000, MACROMOLECULES, V33, P9587, DOI 10.1021/ma000674u
   Kihara F, 2003, BIOCONJUGATE CHEM, V14, P342, DOI 10.1021/bc025613a
   Kreider JL, 2001, J POLYM SCI POL CHEM, V39, P821, DOI 10.1002/1099-0518(20010315)39:6<821::AID-POLA1055>3.0.CO;2-F
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Kuo JHS, 2005, J PHARM PHARMACOL, V57, P489, DOI 10.1211/0022357055803
   Lee JH, 2003, BIOCONJUGATE CHEM, V14, P1214, DOI 10.1021/bc034095g
   Lim YB, 2002, BIOCONJUGATE CHEM, V13, P1181, DOI 10.1021/bc025581r
   Liu MJ, 1999, PHARM SCI TECHNOL TO, V2, P393, DOI 10.1016/S1461-5347(99)00203-5
   Liu MJ, 1999, J POLYM SCI POL CHEM, V37, P3492, DOI 10.1002/(SICI)1099-0518(19990901)37:17<3492::AID-POLA7>3.3.CO;2-S
   Loup C, 1999, CHEM-EUR J, V5, P3644, DOI 10.1002/(SICI)1521-3765(19991203)5:12<3644::AID-CHEM3644>3.0.CO;2-I
   Luo D, 2002, MACROMOLECULES, V35, P3456, DOI 10.1021/ma0106346
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   OHASKI M, 2002, BIOCONJUGATE CHEM, V13, P510
   Omidi Y, 2005, J DRUG TARGET, V13, P431, DOI 10.1080/10611860500418881
   Ottaviani MF, 2000, MACROMOLECULES, V33, P7842, DOI 10.1021/ma000877i
   Pan YJ, 1999, MACROMOLECULES, V32, P5468, DOI 10.1021/ma990675q
   Pan YJ, 2000, MACROMOLECULES, V33, P3731, DOI 10.1021/ma9919864
   Patri AK, 2002, CURR OPIN CHEM BIOL, V6, P466, DOI 10.1016/S1367-5931(02)00347-2
   Qin LH, 1998, HUM GENE THER, V9, P553, DOI 10.1089/hum.1998.9.4-553
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   SCHATZLEIN AG, 2005, J CONTROL RELEASE, V3101, P247
   SCHLUTER DA, 1999, SYNTHESIS POLY MAT S, pCH12
   Shah DS, 2000, INT J PHARM, V208, P41, DOI 10.1016/S0378-5173(00)00534-2
   Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P4447, DOI 10.1093/nar/25.22.4447
   Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P
   Tan YD, 2001, MOL THER, V3, P673, DOI 10.1006/mthe.2001.0311
   Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Thomas TP, 2004, BIOMACROMOLECULES, V5, P2269, DOI 10.1021/bm049704h
   WORNER C, 1993, ANGEW CHEM INT EDIT, V32, P1306, DOI 10.1002/anie.199313061
   Wu JY, 2005, CHEM COMMUN, P313, DOI 10.1039/b414241a
   Yoo H, 1999, PHARMACEUT RES, V16, P1799, DOI 10.1023/A:1018926605871
   Zinselmeyer BH, 2002, PHARMACEUT RES, V19, P960, DOI 10.1023/A:1016458104359
NR 49
TC 57
Z9 66
U1 1
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1061-186X
J9 J DRUG TARGET
JI J. Drug Target.
PD FEB
PY 2006
VL 14
IS 2
BP 69
EP 86
DI 10.1080/10611860600635665
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 031XW
UT WOS:000236739500003
PM 16608734
DA 2018-10-20
ER

PT J
AU Robertson, SW
   Gong, XY
   Ritchie, RO
AF Robertson, SW
   Gong, XY
   Ritchie, RO
TI Effect of product form and heat treatment on the crystallographic
   texture of austenitic Nitinol
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID SHAPE-MEMORY ALLOYS; POLYCRYSTALLINE NITI; STRAIN; TENSION; MODEL
AB The superelastic material Nitinol, a nearly equiatomic alloy of nickel and titanium, is rapidly becoming one of the most important metallic implant materials in the biomedical industry, especially for the fabrication of endovascular stents. The manufacture of these stents, and countless other Nitinol products, originates from various forms of raw material such as tube, sheet or rod. However, depending upon which product form is used, the crystallographic texture in Nitinol can be significantly different, which can lead to marked changes in its mechanical properties. In this paper, we present a study to show the characteristic texture in various Nitinol product forms (tube, sheet, and rod), before and after annealing heat treatments, with specific quantification of the major texture components. We further present predictions of the mechanical response based upon such texture, and provide experimental verification with uniaxial tensile tests. Results show that the form of the starting material has a profound influence on characteristic texture and predicted mechanical response. Furthermore, annealing heat treatments, rather than reducing the texture, are found to increase the strength of this texture. (c) 2006 Springer Science + Business Media, Inc.
C1 Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
   Nitinol Devices & Components, Fremont, CA 94539 USA.
RP Ritchie, RO (reprint author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
EM roritchie@lbl.gov
RI Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR Frick CP, 2004, METALL MATER TRANS A, V35A, P2013, DOI 10.1007/s11661-004-0150-4
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   Gao S, 2003, MAT SCI ENG A-STRUCT, V362, P107, DOI 10.1016/S0921-5093(03)00585-9
   Hornbogen E, 2002, Z METALLKD, V93, P3, DOI 10.3139/146.020003
   Inoue H, 1996, ACTA MATER, V44, P4825, DOI 10.1016/S1359-6454(96)00120-6
   KITAMURA K, 1997, P INT C SHAP MEM SUP, P47
   Kocks U. F., 1998, TEXTURE ANISOTROPY, P195
   LI DY, 1990, ACTA METALL MATER, V38, P19, DOI 10.1016/0956-7151(90)90130-9
   MATTHIES S, 1982, PHYS STATUS SOLIDI B, V112, pK111, DOI 10.1002/pssb.2221120254
   McNaney JM, 2003, MECH MATER, V35, P969, DOI 10.1016/S0167-6636(02)00310-1
   MONASEVICH LA, 1979, MET SCI HEAT TREAT+, V21, P735, DOI 10.1007/BF00708647
   MULDER JH, 1993, Z METALLKD, V84, P501
   ONO N, 1989, MATER T JIM, V30, P756, DOI 10.2320/matertrans1989.30.756
   ONO N, 1988, T JPN I MET, V29, P267, DOI 10.2320/matertrans1960.29.267
   ROBERTSON SW, 2004, IN PRESS P SHAP MEM
   Shu YC, 1998, ACTA MATER, V46, P5457, DOI 10.1016/S1359-6454(98)00184-0
   Sitepu H, 2002, APPL PHYS A-MATER, V74, pS1676, DOI 10.1007/s003390201934
   Vaidyanathan R, 2001, METALL MATER TRANS A, V32, P777
   Wenk HR, 1998, J APPL CRYSTALLOGR, V31, P262, DOI 10.1107/S002188989700811X
   Yuan WQ, 1999, MAT SCI ENG A-STRUCT, V271, P439, DOI 10.1016/S0921-5093(99)00311-1
NR 20
TC 23
Z9 23
U1 1
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD FEB
PY 2006
VL 41
IS 3
BP 621
EP 630
DI 10.1007/s10853-006-6478-y
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 030BW
UT WOS:000236609300005
DA 2018-10-20
ER

PT J
AU Krishnan, KM
   Pakhomov, AB
   Bao, Y
   Blomqvist, P
   Chun, Y
   Gonzales, M
   Griffin, K
   Ji, X
   Roberts, BK
AF Krishnan, KM
   Pakhomov, AB
   Bao, Y
   Blomqvist, P
   Chun, Y
   Gonzales, M
   Griffin, K
   Ji, X
   Roberts, BK
TI Nanomagnetism and spin electronics: materials, microstructure and novel
   properties
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID BIASED MNPD/FE BILAYERS; MOLECULAR-BEAM EPITAXY; DOPED TIO2 ANATASE;
   ROOM-TEMPERATURE; MAGNETIZATION REVERSAL; COBALT NANOCRYSTALS; EXCHANGE
   BIAS; THIN-FILMS; BIOMEDICAL APPLICATIONS; HYSTERESIS LOOPS
AB We present an overview of the critical issues of current interest in magnetic and magnetoelectronic materials. A broad demonstration of the successful blend of materials synthesis, microstructural evolution and control, new physics and novel applications that is central to research in this field is presented. The critical role of size, especially at the nanometer length scale, dimensionality, as it pertains to thin films and interfaces, and the overall microstructure, in determining a range of fundamental properties and potential applications, is emphasized. Even though the article is broad in scope, examples are drawn mainly from our recent work in magnetic nanoparticles and core-shell structures, exchange, proximity and interface effects in thin film heterostructures, and dilute magnetic dielectrics, a new class of materials for spin electronics applications. (c) 2006 Springer Science + Business Media, Inc.
C1 Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
RP Krishnan, KM (reprint author), Univ Washington, Dept Mat Sci & Engn, Box 352120, Seattle, WA 98195 USA.
EM kannanmk@u.washington.edu
CR BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472
   BAO Y, 2000, J APPL PHYS, V97
   Bao YP, 2005, J MAGN MAGN MATER, V293, P15, DOI 10.1016/j.jmmm.2005.01.037
   Bao YP, 2005, J PHYS CHEM B, V109, P7220, DOI 10.1021/jp044363n
   Bao YP, 2003, J MAGN MAGN MATER, V266, pL245, DOI 10.1016/S0304-8853(03)00649-8
   BEAN CP, 1955, J APPL PHYS, V26, P1381, DOI 10.1063/1.1721912
   Berger A, 1996, PHYS REV LETT, V76, P519, DOI 10.1103/PhysRevLett.76.519
   Bland J. A. C., 1994, ULTRATHIN MAGNETIC S
   Bland J A C, 1994, ULTRATHIN MAGNETIC S, V1
   Blomqvist P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.107203
   Blomqvist P, 2004, J APPL PHYS, V96, P6523, DOI 10.1063/1.1806257
   Blomqvist P, 2004, J APPL PHYS, V95, P8487, DOI 10.1063/1.1751230
   Blomqvist P, 2004, J APPL PHYS, V95, P8019, DOI 10.1063/1.1713023
   Brezovich I. A, 1988, MED PHYSICS MONOGRAP, V16, P82
   Brus L, 1998, J PHYS CHEM SOLIDS, V59, P459, DOI 10.1016/S0022-3697(97)00201-1
   Canedy CL, 1997, J APPL PHYS, V81, P5367, DOI 10.1063/1.364599
   Chambers SA, 2001, APPL PHYS LETT, V79, P3467, DOI 10.1063/1.1420434
   Chambers SA, 2003, MRS BULL, V28, P729, DOI 10.1557/mrs2003.214
   Chambers SA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.100401
   Chambers SA, 2002, THIN SOLID FILMS, V418, P197, DOI 10.1016/S0040-6090(02)00709-5
   Cheng N, 2001, J APPL PHYS, V89, P6597, DOI 10.1063/1.1360677
   Cheng N, 2000, J APPL PHYS, V87, P6647, DOI 10.1063/1.372798
   CHO NH, 1992, J APPL PHYS, V72, P5799, DOI 10.1063/1.351934
   Cho SJ, 2004, J APPL PHYS, V95, P6804, DOI 10.1063/1.1676033
   Chun YS, 2004, J APPL PHYS, V95, P6858, DOI 10.1063/1.1689909
   Coey JMD, 2004, APPL PHYS LETT, V84, P1332, DOI 10.1063/1.1650041
   COEY JMD, 1996, RARE EARTH ION PERMA
   Connolly J, 2001, J MAGN MAGN MATER, V225, P156, DOI 10.1016/S0304-8853(00)01245-2
   Crew DC, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.184418
   Denbeaux G, 2001, IEEE T MAGN, V37, P2764, DOI 10.1109/20.951300
   Donahue M. J., 1999, OOMMF USERS GUIDE VE
   DRAAISMA HJG, 1987, J MAGN MAGN MATER, V66, P351, DOI 10.1016/0304-8853(87)90169-7
   Ejsing L, 2004, APPL PHYS LETT, V84, P4729, DOI 10.1063/1.1759380
   FALICOV LM, 1990, J MATER RES, V5, P1299, DOI 10.1557/JMR.1990.1299
   FANNIN PC, 1988, J MAGN MAGN MATER, V72, P95, DOI 10.1016/0304-8853(88)90276-4
   Fitzsimmons MR, 2000, PHYS REV LETT, V84, P3986, DOI 10.1103/PhysRevLett.84.3986
   FREI EH, 1957, PHYS REV, V106, P446, DOI 10.1103/PhysRev.106.446
   Gierlings M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.092407
   Girt E, 2001, SCRIPTA MATER, V44, P1431, DOI 10.1016/S1359-6462(01)00936-8
   Gonzales M, 2005, J MAGN MAGN MATER, V293, P265, DOI 10.1016/j.jmmm.2005.02.020
   Griffin KA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1853311
   Griffin KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157204
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   HADJIPANAYIS G, 2001, MAGNETIC RECORDING 2
   Han GC, 2004, J MAGN MAGN MATER, V268, P159, DOI 10.1016/S0304-8853(03)00492-X
   Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537
   HERTZER G, 1989, IEEE T MAGN, V25, P3327
   Himpsel FJ, 1998, ADV PHYS, V47, P511, DOI 10.1080/000187398243519
   Ijiri Y, 1998, PHYS REV LETT, V80, P608, DOI 10.1103/PhysRevLett.80.608
   Jonker BT, 2003, MRS BULL, V28, P740, DOI 10.1557/mrs2003.216
   Jordan A., 1997, SCI CLIN APPL MAGNET
   Kim JY, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.017401
   KITTEL C, 1949, REV MOD PHYS, V21, P541, DOI 10.1103/RevModPhys.21.541
   KNELLER EF, 1991, IEEE T MAGN, V27, P3588, DOI 10.1109/20.102931
   Koon NC, 1997, PHYS REV LETT, V78, P4865, DOI 10.1103/PhysRevLett.78.4865
   KOOY C, 1950, PHILIPS RES REP, V15, P7
   Kortright JB, 1999, J MAGN MAGN MATER, V207, P7, DOI 10.1016/S0304-8853(99)00485-0
   KRISHNAN KM, 2001, NATO ASI MAGNETIC RE, P251
   KRONMULLER H, 1966, MODERN PROBLEMS META, V2
   Kusinski GJ, 2001, APPL PHYS LETT, V79, P2211, DOI 10.1063/1.1407301
   Kuwabara S, 2001, JPN J APPL PHYS 2, V40, pL724, DOI 10.1143/JJAP.40.L724
   LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001
   Landau L., 1935, Physikalische Zeitschrift der Sowjetunion, V8, P153
   Leighton C, 2000, PHYS REV LETT, V84, P3466, DOI 10.1103/PhysRevLett.84.3466
   Leighton C, 2001, PHYS REV LETT, V86, P4394, DOI 10.1103/PhysRevLett.86.4394
   Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117
   Lubensky TC, 1997, SOLID STATE COMMUN, V102, P187, DOI 10.1016/S0038-1098(96)00718-1
   Lyon JL, 2004, NANO LETT, V4, P719, DOI 10.1021/nl035253f
   MALOZEMOFF AP, 1988, PHYS REV B, V37, P7673, DOI 10.1103/PhysRevB.37.7673
   Matsumoto Y, 2001, SCIENCE, V291, P854, DOI 10.1126/science.1056186
   MOODERA JS, 1995, PHYS REV LETT, V74, P3273, DOI 10.1103/PhysRevLett.74.3273
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Morrish A. H., 1965, PHYS PRINCIPLES MAGN
   NAJI P, 2001, 2001 IEEE INT SOL ST, P437
   NEEL L, 1954, J PHYS-PARIS, V15, P225, DOI 10.1051/jphysrad:01954001504022500
   Nikitenko VI, 2000, PHYS REV LETT, V84, P765, DOI 10.1103/PhysRevLett.84.765
   Nikitenko VI, 1998, PHYS REV B, V57, pR8111, DOI 10.1103/PhysRevB.57.R8111
   Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2
   Ogale SB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.077205
   Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509
   *PAC NW NAT LAB, RBS MEAS COURT V SHU
   Pakhomov AB, 2005, J APPL PHYS, V97, DOI 10.1063/1.1855195
   Pakhomov AB, 2004, J APPL PHYS, V95, P7393, DOI 10.1063/1.1669224
   Pakhomov AB, 2003, APPL PHYS LETT, V83, P4357, DOI 10.1063/1.1629369
   PAL L, 1968, J APPL PHYS, V39, P538, DOI 10.1063/1.2163510
   Park MS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161201
   PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359
   Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553
   QIAN JP, 1990, J VAC SCI TECHNOL A, V8, P4117, DOI 10.1116/1.576453
   Reed ML, 2001, APPL PHYS LETT, V79, P3473, DOI 10.1063/1.1419231
   REIMER L, 1997, TRANSMISSION ELECT M
   Rife JC, 2003, SENSOR ACTUAT A-PHYS, V107, P209, DOI 10.1016/S0924-4247(03)00380-7
   Roberts BK, 2005, J APPL PHYS, V97, DOI 10.1063/1.1847914
   ROSENCWAIG A, 1971, PHYS REV LETT, V26, P779, DOI 10.1103/PhysRevLett.26.779
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Santamaria J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.190601
   Schmidt G, 2001, PHYSICA E, V10, P484, DOI 10.1016/S1386-9477(01)00142-4
   Scholl A, 2002, REV SCI INSTRUM, V73, P1362, DOI 10.1063/1.1445485
   Schulthess TC, 1998, PHYS REV LETT, V81, P4516, DOI 10.1103/PhysRevLett.81.4516
   SHENG P, 1992, PHILOS MAG B, V65, P357, DOI 10.1080/13642819208207638
   Shinde SR, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115211
   SLONCZEWSKI JC, 1995, J MAGN MAGN MATER, V150, P13, DOI 10.1016/0304-8853(95)00081-X
   SPERIOSU VS, 1991, PHYS REV B, V44, P5358, DOI 10.1103/PhysRevB.44.5358
   Stamps RL, 2000, J PHYS D APPL PHYS, V33, pR247, DOI 10.1088/0022-3727/33/23/201
   STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007
   Tartaj P, 2004, ENCY NANOSCIENCE NAN, V6, P823
   te Velthuis SGE, 2000, J APPL PHYS, V87, P5046, DOI 10.1063/1.373243
   Theodoropoulou N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107203
   Ueda K, 2001, APPL PHYS LETT, V79, P988, DOI 10.1063/1.1384478
   Varela M, 2001, PHYS REV LETT, V86, P5156, DOI 10.1103/PhysRevLett.86.5156
   VARELA M, UNPUB
   Welp U, 2003, J APPL PHYS, V93, P7726, DOI 10.1063/1.1540152
   Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389
   Wu SY, 2003, APPL PHYS LETT, V82, P3047, DOI 10.1063/1.1570521
   Yang SG, 2002, APPL PHYS LETT, V81, P2418, DOI 10.1063/1.1509475
   Ziese M., 2001, SPIN ELECT
NR 116
TC 115
Z9 116
U1 3
U2 64
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD FEB
PY 2006
VL 41
IS 3
BP 793
EP 815
DI 10.1007/s10853-006-6564-1
PG 23
WC Materials Science, Multidisciplinary
SC Materials Science
GA 030BW
UT WOS:000236609300019
DA 2018-10-20
ER

PT J
AU Huang, HX
   Yang, KK
   Wang, YZ
   Wang, XL
   Jun, L
AF Huang, HX
   Yang, KK
   Wang, YZ
   Wang, XL
   Jun, L
TI Synthesis, characterization, and thermal properties of a novel
   pentaerythritol-initiated star-shaped poly(p-dioxanone)
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE biodegradable; poly(p-dioxanone); ring-opening polymerization; star
   polymers
ID STANNOUS OCTOATE; TIN(II) OCTOATE; POLYMERIZATION; COPOLYMERS; POLYMERS;
   LACTIDE; POLYLACTIDE; MECHANISM
AB A novel star-shaped poly(p-dioxanone) was synthesized by the ring-opening polymerization of p-dioxanone initiated by pentaerythritol with stannous octoate as a catalyst in bulk. The effect of the molar ratio of the monomer to the initiator on the polymerization was studied. The polymers were characterized with H-1 NMR and C-13 NMR spectroscopy. The thermal properties of the polymers were investigated with differential scanning calorimetry and thermogravimetric analysis. The novel star-shaped poly(p-dioxanone) has a potential use in biomedical materials. (c) 2005 Wiley Periodicals, Inc.
C1 Sichuan Univ, Coll Chem, Ctr Degradable & flame Retardant Polymer Mat, Chengdu 610064, Peoples R China.
   Natl Univ Singapore, Div Bioengn, Fac Engn, Singapore 117576, Singapore.
RP Wang, YZ (reprint author), Sichuan Univ, Coll Chem, Ctr Degradable & flame Retardant Polymer Mat, Chengdu 610064, Peoples R China.
EM yzwang@mail.sc.cninfo.net
RI Wang, Yu-Zhong/E-3633-2013; Yang, Ke-Ke/G-6131-2018; Li, Jun/B-5308-2008
OI Wang, Yu-Zhong/0000-0001-7535-7635; Yang, Ke-Ke/0000-0002-7019-6059; Li,
   Jun/0000-0003-2982-7960
CR Arvanitoyannis I, 1996, POLYMER, V37, P651, DOI 10.1016/0032-3861(96)83152-1
   ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   BENNET SL, 2004, Patent No. 0058164
   Choi YK, 1996, P INT S CONTR REL BI, V23, P349
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   Doddi N, 1977, US, Patent No. [4, 032, 988, 4032988]
   KIM SH, 1993, MAKROMOL CHEM, V194, P3229
   KIM SH, 1992, MAKROMOL CHEM, V193, P1623
   Knischka R, 2000, MACROMOLECULES, V33, P315, DOI 10.1021/ma991192p
   Korhonen H, 2001, POLYMER, V42, P7541, DOI 10.1016/S0032-3861(01)00150-1
   Kowalski A, 2000, MACROMOLECULES, V33, P689, DOI 10.1021/ma9906940
   Kowalski A, 1998, MACROMOL RAPID COMM, V19, P567, DOI 10.1002/(SICI)1521-3927(19981101)19:11<567::AID-MARC567>3.3.CO;2-K
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P702, DOI 10.1021/ma991181w
   Lang MD, 2002, J POLYM SCI POL CHEM, V40, P1127, DOI 10.1002/pola.10171
   Lipinsky ES, 1997, United States patent, Patent No. [US 5, 767, 222, 5767222]
   Maglio G, 2004, MACROMOL RAPID COMM, V25, P1139, DOI 10.1002/marc.200400113
   Naraghi KS, 1999, MACROMOL RAPID COMM, V20, P122, DOI 10.1002/(SICI)1521-3927(19990301)20:3<122::AID-MARC122>3.0.CO;2-M
   Nguyen C, 2000, MACROMOLECULES, V33, P4281, DOI 10.1021/ma991407v
   Voit B, 2000, J POLYM SCI POL CHEM, V38, P2505, DOI 10.1002/1099-0518(20000715)38:14<2505::AID-POLA10>3.0.CO;2-8
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
NR 20
TC 18
Z9 18
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD FEB 1
PY 2006
VL 44
IS 3
BP 1245
EP 1251
DI 10.1002/pola.21240
PG 7
WC Polymer Science
SC Polymer Science
GA 004VN
UT WOS:000234780700019
DA 2018-10-20
ER

PT J
AU Lee, H
   Hong, S
   Yang, K
   Choi, K
AF Lee, H
   Hong, S
   Yang, K
   Choi, K
TI Fabrication of nano-sized resist patterns on flexible plastic film using
   thermal curing nano-imprint lithography
SO MICROELECTRONIC ENGINEERING
LA English
DT Article
DE flexible substrate; transparent polymer film; PET
   (polyethylene-terephthalate) film; hot embossing nano-imprinting
   lithography; monomer based imprinting lithography; benzyl-methacrylate
   monomer; thermal initiator; polymerization
ID NANOIMPRINT LITHOGRAPHY; IMMERSION LITHOGRAPHY; WAFER
AB Due to polymer's excellent flexibility, transparency, reliability and light weight, it is a good candidate material for substrate of devices including organic electronic devices, biomedical devices, and flexible displays (LCD and OLED). In order to build such devices on polymer, nano- to micron-sized patterning must be accomplished. Since polymer materials reacts with organic solvents or developer solutions which are inevitably used in photolithography and cannot bear high temperature (similar to 140 degrees C process for photoresist baking, conventional photolithography cannot be used to polymer substrate. In this research, monomer based thermal curing imprinting lithography was used to make as small as 100 nm dense line and space patterns on flexible PET (polyethylene-terephthalate) film. Compared to hot embossing lithography, monomer based thermal curing imprint lithography uses monomer based imprint resin which consists of base monomer and thermal initiator. Since it is liquid phase at room temperature and polymerization can be initiated at 85 degrees C, which is much lower than glass temperature of polymer resin, the pattern transfer can be done at much lower temperature and pressure. Hence, patterns as small as 100 nm were successfully fabricated on flexible PET film substrate by monomer based thermal curing imprinting lithography at 85 degrees C and 5 atm without any noticeable degradation of PET substrate. (c) 2005 Elsevier B.V. All rights reserved.
C1 Korea Univ, Dept Mat Sci & Engn, Seoul 136701, South Korea.
   Korea Inst Nucl Safety, Taejon, South Korea.
RP Lee, H (reprint author), Korea Univ, Dept Mat Sci & Engn, Anam Dong 5Ga-1, Seoul 136701, South Korea.
EM heonlee@korea.ac.kr
CR Arnold WH, 2004, J MICROLITH MICROFAB, V3, P8, DOI 10.1117/1.1640619
   Chou SY, 1997, MICROELECTRON ENG, V35, P237, DOI 10.1016/S0167-9317(96)00097-4
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   CHOU SY, 1997, J VAC SCI TECHNOL B, V16, P3922
   Colburn M, 1999, P SOC PHOTO-OPT INS, V3676, P379, DOI 10.1117/12.351155
   Gao JX, 2004, CHEM MATER, V16, P956, DOI 10.1021/cm0342849
   Jung GY, 2004, APPL PHYS A-MATER, V78, P1169, DOI 10.1007/s00339-003-2393-0
   Lee H, 2005, MICROELECTRON ENG, V77, P42, DOI 10.1016/j.mee.2004.08.008
   Lee H, 2005, MICROELECTRON ENG, V77, P168, DOI 10.1016/j.mee.2004.10.004
   Lee H, 2004, JPN J APPL PHYS 1, V43, P8369, DOI 10.1143/JJAP.43.8369
   Liao WC, 2004, MICROELECTRON ENG, V75, P145, DOI 10.1016/j.mee.2004.03.084
   McAlpine MC, 2003, NANO LETT, V3, P443, DOI 10.1021/nl034031e
   Owa S, 2004, J MICROLITH MICROFAB, V3, P97, DOI 10.1117/1.1637593
   Silverman PJ, 2005, J MICROLITH MICROFAB, V4, DOI 10.1117/1.1862647
NR 14
TC 53
Z9 53
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
EI 1873-5568
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD FEB
PY 2006
VL 83
IS 2
BP 323
EP 327
DI 10.1016/j.mee.2005.09.006
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 018MT
UT WOS:000235769200019
DA 2018-10-20
ER

PT J
AU Stroock, AD
   Cabodi, M
AF Stroock, AD
   Cabodi, M
TI Microfluidic biomaterials
SO MRS BULLETIN
LA English
DT Article
DE biological; biomedical; fluidics; microscale; soft lithography; tissue
ID VACUUM-ASSISTED CLOSURE; HYDROGELS; MICROFABRICATION; SYSTEMS; WOUNDS;
   GELS
AB Biomedical applications-prostheses, tissue engineering, drug delivery, and wound healing-demand increasingly sophisticated characteristics from the materials that come into contact with living systems in the laboratory and the clinic. With the development of microfluidics, there is an opportunity to create active biomaterials based on embedded microfluidic structures. These structures allow for control of the concentrations of soluble chemicals and hydrodynamic stresses within the material and at its interfaces, and thus allow one to tailor the environment experienced by the living tissue. In this article, we review initial efforts to develop these microfluidic biomaterials and present considerations regarding the required characteristics of the materials and of the microfluiclic-mediated mass transfer. As specific examples, we present work toward microfluidic control of mass transfer in scaffolds for tissue engineering and in wound dressings.
CR Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   CABODI M, 2005, ASME SUMM BIOENG C V
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Fournier R. L., 1998, BASIC TRANSPORT PHEN
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104
   Lambert KV, 2005, EUR J VASC ENDOVASC, V29, P219, DOI 10.1016/j.ejvs.2004.12.017
   Langer R., 2000, PRINCIPLES TISSUE EN
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748
   McDonald JC, 2002, ANAL CHEM, V74, P1537, DOI 10.1021/ac010938q
   MORYKWAS MJ, 1993, FASEB J, V7, pA138
   Pins GD, 2000, FASEB J, V14, P593
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saxena V, 2004, PLAST RECONSTR SURG, V114, P1086, DOI 10.1097/01.prs.0000135330.51408.97
   Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h
   Therriault D, 2005, ADV MATER, V17, P395, DOI 10.1002/adma.200400481
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   WEISZ PB, 1973, SCIENCE, V179, P433, DOI 10.1126/science.179.4072.433
NR 27
TC 20
Z9 21
U1 0
U2 10
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD FEB
PY 2006
VL 31
IS 2
BP 114
EP 119
DI 10.1557/mrs2006.25
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 014JB
UT WOS:000235474800023
DA 2018-10-20
ER

PT J
AU Pauzauskie, PJ
   Radenovic, A
   Trepagnier, E
   Shroff, H
   Yang, PD
   Liphardt, J
AF Pauzauskie, PJ
   Radenovic, A
   Trepagnier, E
   Shroff, H
   Yang, PD
   Liphardt, J
TI Optical trapping and integration of semiconductor nanowire assemblies in
   water
SO NATURE MATERIALS
LA English
DT Article
ID PARTICLES; MANIPULATION; ALIGNMENT; NANOTUBES; TWEEZERS; OBJECTS; FORCE;
   BEAM
AB Semiconductor nanowires have received much attention owing to their potential use as building blocks of miniaturized electrical(1), nanofluidic(2) and optical devices(3). Although chemical nanowire synthesis procedures have matured and now yield nanowires with specific compositions(4) and growth directions(5), the use of these materials in scientific, biomedical and microelectronic applications is greatly restricted owing to a lack of methods to assemble nanowires into complex heterostructures with high spatial and angular precision. Here we show that an infrared single-beam optical trap can be used to individually trap, transfer and assemble high-aspect-ratio semiconductor nanowires into arbitrary structures in a fluid environment. Nanowires with diameters as small as 20 nm and aspect ratios of more than 100 can be trapped and transported in three dimensions, enabling the construction of nanowire architectures that may function as active photonic devices. Moreover, nanowire structures can now be assembled in physiological environments, offering new forms of chemical, mechanical and optical stimulation of living cells.
C1 Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA.
RP Liphardt, J (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.
EM p_yang@berkeley.edu; liphardt@physics.berkeley.edu
RI Pauzauskie, Peter/A-1316-2014; Liphardt, Jan/A-5906-2012; Radenovic,
   Aleksandra/C-5350-2011; Shroff, Hari/E-7247-2016
OI Shroff, Hari/0000-0003-3613-8215; Liphardt, Jan/0000-0003-2835-5025
CR ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   Chen M, 2003, APPL PHYS LETT, V82, P3310, DOI 10.1063/1.1569429
   Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566
   Gauthier RC, 1997, J OPT SOC AM B, V14, P3323, DOI 10.1364/JOSAB.14.003323
   Gauthier RC, 1999, APPL OPTICS, V38, P4861, DOI 10.1364/AO.38.004861
   GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0
   Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935
   Johnson JC, 2003, J PHYS CHEM B, V107, P8816, DOI 10.1021/jp034482n
   Karnik R, 2005, NANO LETT, V5, P943, DOI 10.1021/nl050493b
   Korda P, 2002, REV SCI INSTRUM, V73, P1956, DOI 10.1063/1.1455136
   Kress H, 2004, APPL PHYS LETT, V84, P4271, DOI 10.1063/1.1737056
   Kuykendall T, 2004, NAT MATER, V3, P524, DOI 10.1038/nmat1177
   Law M, 2004, ANNU REV MATER RES, V34, P83, DOI 10.1146/annurev.matsci.34.040203.112300
   Messer B, 2000, J AM CHEM SOC, V122, P10232, DOI 10.1021/ja002553f
   Nugent-Glandorf L, 2004, OPT LETT, V29, P2611, DOI 10.1364/OL.29.002611
   Rubinsztein-Dunlop H, 1998, ADV QUANTUM CHEM, V30, P469, DOI 10.1016/S0065-3276(08)60523-7
   SATO S, 1994, OPT LETT, V19, P1807, DOI 10.1364/OL.19.001807
   Shelton WA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036204
   Sirbuly DJ, 2005, P NATL ACAD SCI USA, V102, P7800, DOI 10.1073/pnas.0408641102
   Sirbuly DJ, 2005, J PHYS CHEM B, V109, P15190, DOI 10.1021/jp051813i
   Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272
   SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930
   Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X
   Wang WU, 2005, P NATL ACAD SCI USA, V102, P3208, DOI 10.1073/pnas.0406368102
   Wu YY, 2001, ADV MATER, V13, P520, DOI 10.1002/1521-4095(200104)13:7<520::AID-ADMA520>3.0.CO;2-W
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Yang PD, 2003, NATURE, V425, P243, DOI 10.1038/425243a
   Yu T, 2004, NANOTECHNOLOGY, V15, P1732, DOI [10.1088/0957-4484/15/12/005, 10.1088/0957-4484.15.12.005]
NR 29
TC 271
Z9 277
U1 5
U2 111
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD FEB
PY 2006
VL 5
IS 2
BP 97
EP 101
DI 10.1038/nmat1563
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 008SC
UT WOS:000235060000015
PM 16429143
OA Green Published
DA 2018-10-20
ER

PT J
AU Shen, W
   Zhang, KC
   Kornfield, JA
   Tirrell, DA
AF Shen, W
   Zhang, KC
   Kornfield, JA
   Tirrell, DA
TI Tuning the erosion rate of artificial protein hydrogels through control
   of network topology
SO NATURE MATERIALS
LA English
DT Article
ID DE-NOVO DESIGN; HELICAL COILED-COILS; DRUG-DELIVERY; ETHOXYLATED
   URETHANES; POLY(ETHYLENE OXIDE); STABILITY; POLYMERS; MODEL;
   SPECIFICITY; RHEOLOGY
AB Erosion behaviour governs the use of physical hydrogels in biomedical applications ranging from controlled release to cell encapsulation. Genetically engineered protein hydrogels offer unique means of controlling the erosion rate by engineering their amino acid sequences and network topology. Here, we show that the erosion rate of such materials can be tuned by harnessing selective molecular recognition, discrete aggregation number and orientational discrimination of coiled-coil protein domains. Hydrogels formed from a triblock artificial protein bearing dissimilar helical coiled-coil end domains ( P and A) erode more than one hundredfold slower than hydrogels formed from those bearing the same end domains ( either P or A). The reduced erosion rate is a consequence of the fact that looped chains are suppressed because P and A tend not to associate with each other. Thus, the erosion rate can be tuned over several orders of magnitude in artificial protein hydrogels, opening the door to diverse biomedical applications.
C1 CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Kornfield, JA (reprint author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
EM weishen@its.caltech.edu; jak@cheme.caltech.edu; tirrell@caltech.edu
CR Anderson BC, 2001, J CONTROL RELEASE, V70, P157, DOI 10.1016/S0168-3659(00)00341-2
   ANNABLE T, 1993, J RHEOL, V37, P695, DOI 10.1122/1.550391
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Francois J, 2003, LANGMUIR, V19, P10011, DOI 10.1021/la0208833
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070
   Hodges RS, 1996, BIOCHEM CELL BIOL, V74, P133, DOI 10.1139/o96-015
   Huglin M. B., 1972, LIGHT SCATTERING POL
   KACZMARSKI JP, 1993, MACROMOLECULES, V26, P5149, DOI 10.1021/ma00071a026
   KENNEDY SB, 2001, THESIS U MASSACHUSET
   Kim BS, 2000, J POLYM SCI POL CHEM, V38, P1277, DOI 10.1002/(SICI)1099-0518(20000415)38:8<1277::AID-POLA11>3.0.CO;2-S
   Kohn WD, 1998, TRENDS BIOTECHNOL, V16, P379, DOI 10.1016/S0167-7799(98)01212-8
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200
   LUNDBERG DJ, 1994, LANGMUIR, V10, P3027, DOI 10.1021/la00021a028
   Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761
   Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PETKA WA, 1997, THESIS U MASSACHUSET
   Pham QT, 1999, MACROMOLECULES, V32, P2996, DOI 10.1021/ma982007v
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Shen W, 2005, THESIS CALTECH PASAD
   Tae G, 2001, MACROMOLECULES, V34, P6409, DOI 10.1021/ma0107511
   Tam KC, 1998, MACROMOLECULES, V31, P4149, DOI 10.1021/ma980148r
   Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3
NR 29
TC 183
Z9 188
U1 1
U2 47
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD FEB
PY 2006
VL 5
IS 2
BP 153
EP 158
DI 10.1038/nmat1573
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 008SC
UT WOS:000235060000026
PM 16444261
OA Green Published
DA 2018-10-20
ER

PT J
AU Choi, HS
   Yui, N
AF Choi, HS
   Yui, N
TI Design of rapidly assembling supramolecular systems responsive to
   synchronized stimuli
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE biomedical applications; cooperative host-guest interactions;
   cyclodextrin-conjugated poly(epsilon-lysine); fast responsiveness;
   intermolecular ionic interactions; stimuli-sensitive hydrogels;
   supramolecular assembly
ID CYCLODEXTRIN-CONJUGATED POLY(EPSILON-LYSINE); BETA-CYCLODEXTRIN;
   INCLUSION COMPLEXES; ALPHA-CYCLODEXTRIN; POLY(ETHYLENE GLYCOL);
   POLYPSEUDOROTAXANE FORMATION; TRIBLOCK COPOLYMERS; POLYMER SURFACTANT;
   SIDE-GROUPS; PH
AB This review treats several aspects of supramolecular self-assembling systems based on rapidly responsive hydrogels from polymeric hosts and low molecular weight guests. A series of cyclodextrin-conjugated poly(epsilon-lysine)s (CDPLs) have been designed as host molecules and their complexation behavior has been investigated with various functional guest moieties containing hydrophobic and anionic groups at their termini. Systematic studies on the inclusion complexation provide evidence that dual cooperative interactions, i.e. specific host-guest and intermolecular ionic interactions, play a dominant role in the fast aggregation process; the induction time for supramolecular aggregation between beta-CDPL and 3-trimethylsilylpropionic acid (TPA) was found to be very short (within 100 ms). This rapidly assembling system shows a clear dependence on pH and temperature, which significantly affect the dramatic aggregation into the supramolecular structure. Comparison of the geometries of beta-CDPL and TPA analogs reveals that the smaller radius and bond length of carbon as compared to silicon give smaller host cross-sectional areas and allow penetration closer to the smaller rim of beta-CD (H-5); therefore, the binding constants are larger than those of trimethylsilyl groups. The length and penetration depth of the guest molecules strongly affect the supramolecular aggregation with beta-CDPL, the guests acting as noncovalent crosslinkers through intermolecular ionic interactions. This rapid and delicate supramolecular self-assembling system is promising as a stimuli-responsive material and should find a broad range of applications because the functionality is variable and switchable in response to simultaneous multiple stimuli. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.
   Japan Adv Inst Sci & Technol, COE Program Century 21, Nomi, Ishikawa 9231292, Japan.
RP Yui, N (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.
EM yui@jaist.ac.jp
RI Choi, Hak Soo/C-9954-2011
CR Alvarez-Parrilla E, 2001, J PHYS CHEM B, V105, P5994, DOI 10.1021/jp003310c
   Amiel C, 1996, J INCLUS PHENOM MOL, V25, P61, DOI 10.1007/BF01041537
   Amiel C, 1999, ADV COLLOID INTERFAC, V79, P105, DOI 10.1016/S0001-8686(98)00070-0
   Ashton PR, 1998, J AM CHEM SOC, V120, P11190, DOI 10.1021/ja981889a
   Auzely-Velty R, 2001, MACROMOLECULES, V34, P3574, DOI 10.1021/ma001873g
   BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030
   Bermudez V, 2000, NATURE, V406, P608, DOI 10.1038/35020531
   CATENA GC, 1989, ANAL CHEM, V61, P905, DOI 10.1021/ac00183a024
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Choi HS, 2005, BIOMACROMOLECULES, V6, P1200, DOI 10.1021/bm0400729
   Choi HS, 2004, MACROMOLECULES, V37, P10036, DOI 10.1021/ma0487610
   Choi HS, 2004, CHEMPHYSCHEM, V5, P1431, DOI 10.1002/cphc.200400172
   Choi HS, 2004, MACROMOLECULES, V37, P6705, DOI 10.1021/ma049215+
   Choi HS, 2004, J PHYS CHEM B, V108, P7646, DOI 10.1021/jp037388f
   Choi HS, 2003, MACROMOLECULES, V36, P5342, DOI 10.1021/ma034259o
   Choi HS, 2003, J AM CHEM SOC, V125, P6350, DOI 10.1021/ja034149x
   Choi HS, 2002, MACROMOL BIOSCI, V2, P298, DOI 10.1002/1616-5195(200208)2:6<298::AID-MABI298>3.0.CO;2-#
   Choi HS, 2003, MACROMOLECULES, V36, P9313, DOI 10.1021/ma035200k
   DERATANI A, 1995, MACROMOL CHEM PHYSIC, V196, P343, DOI 10.1002/macp.1995.021960124
   DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027
   GODDARD ED, 1986, COLLOID SURFACE, V19, P255, DOI 10.1016/0166-6622(86)80340-7
   HARADA A, 1976, MACROMOLECULES, V9, P705, DOI 10.1021/ma60053a004
   HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   HARADA A, 1994, NATURE, V370, P126, DOI 10.1038/370126a0
   HASKARD CA, 1996, J PHYS CHEM-US, V100, P18445
   Hernandez JV, 2004, SCIENCE, V306, P1532, DOI 10.1126/science.1103949
   Hollas M, 1998, J PHYS CHEM B, V102, P2947, DOI 10.1021/jp9800719
   HUANG X, 1989, BIOTECHNOL BIOENG, V34, P102, DOI 10.1002/bit.260340113
   Huh KM, 2002, MACROMOL RAPID COMM, V23, P179, DOI 10.1002/1521-3927(20020201)23:3<179::AID-MARC179>3.0.CO;2-U
   HWANG TL, 1992, J AM CHEM SOC, V114, P3157, DOI 10.1021/ja00034a083
   Iliopoulos I, 1998, CURR OPIN COLLOID IN, V3, P493, DOI 10.1016/S1359-0294(98)80023-X
   Jiao H, 2002, MACROMOLECULES, V35, P1980, DOI 10.1021/ma0118163
   JOBE DJ, 1988, J PHYS CHEM-US, V92, P3582, DOI 10.1021/j100323a051
   KONDO H, 1976, J BIOCHEM-TOKYO, V79, P393, DOI 10.1093/oxfordjournals.jbchem.a131082
   KUSHWAHA DRS, 1980, BIOPOLYMERS, V19, P219, DOI 10.1002/bip.1980.360190202
   Lee SC, 2004, MACROMOLECULES, V37, P7464, DOI 10.1021/ma048666r
   LEHN JM, 1988, ANGEW CHEM INT EDIT, V27, P89, DOI 10.1002/anie.198800891
   Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758
   Li J, 2001, MACROMOLECULES, V34, P8829, DOI 10.1021/ma011129b
   Li J, 2003, J AM CHEM SOC, V125, P1788, DOI 10.1021/ja026623p
   Lo Nostro P, 2002, J PHYS CHEM B, V106, P2166, DOI 10.1021/jp0129151
   MWAKIBETE H, 1995, LANGMUIR, V11, P57, DOI 10.1021/la00001a013
   Narita T, 1999, J PHYS CHEM B, V103, P6262, DOI 10.1021/jp990358l
   OGATA N, 1976, POLYM LETT EDIT, V14, P459
   Ooya T, 1999, J CONTROL RELEASE, V58, P251, DOI 10.1016/S0168-3659(98)00163-1
   OOYA T, 1995, MACROMOL RAPID COMM, V16, P259, DOI 10.1002/marc.1995.030160405
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PICULELL L, 1992, ADV COLLOID INTERFAC, V41, P149, DOI 10.1016/0001-8686(92)80011-L
   Saito M, 2001, J CHEM PHYS, V114, P1, DOI 10.1063/1.1334599
   SELISKAR CJ, 1971, J AM CHEM SOC, V93, P5414, DOI 10.1021/ja00750a017
   Weickenmeier M, 1997, MACROMOL RAPID COMM, V18, P1117, DOI 10.1002/marc.1997.030181216
   WENZ G, 1994, ANGEW CHEM INT EDIT, V33, P803, DOI 10.1002/anie.199408031
   WENZ G, 1992, ANGEW CHEM INT EDIT, V31, P197, DOI 10.1002/anie.199201971
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   YOSHIDA N, 1990, J PHYS CHEM-US, V94, P4246, DOI 10.1021/j100373a068
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YUI N, 2004, REFLEXIVE POLYM HYDR, P85
NR 59
TC 44
Z9 45
U1 6
U2 50
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD FEB
PY 2006
VL 31
IS 2
BP 121
EP 144
DI 10.1016/j.progpolymsci.2005.09.002
PG 24
WC Polymer Science
SC Polymer Science
GA 030JG
UT WOS:000236630100001
DA 2018-10-20
ER

PT J
AU Zheng, JH
   Kaufmann, P
   Feng, Y
   Zhang, PX
   Zhou, L
AF Zheng, JH
   Kaufmann, P
   Feng, Y
   Zhang, PX
   Zhou, L
TI Titanium materials for biomedical applications
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT Xi An International Titanium Conference (XITC05)
CY OCT 16-19, 2005
CL Xi an, PEOPLES R CHINA
SP NW Inst Nonferrous Metal Res, Nonferrous Metals Soc China, Asian Off Aerospace Res & Dev
DE Ti biomaterials; biomedical applications; market and market drivers
AB This paper presents the recent development and the status of Titanium materials for biomedical applications. In recent years, Ti and Ti alloy are widely used in this field. It is reported that the global market of Ti materials in medical applications reaches over 1000 tons per year and the robust growth is expected in orthopedic implant and trauma market in the future.
C1 DKSH Switzerland Ltd, CH-8034 Zurich, Switzerland.
   Western Supercond Technol Co Ltd, Xian 710021, Peoples R China.
RP Zheng, JH (reprint author), DKSH Switzerland Ltd, Wiesenstr 8,POB 888, CH-8034 Zurich, Switzerland.
CR *IMPL BAS DENT REC, 2005, WORLDW IMPL BON GRAF
   *INT TIT ASS, 2005, TIT NEWSL J, V6
   LUTJERING G, 1994, SCI TECHNOLOGY C, P95
   LUTJERING G, 2004, TI 2003 SCI TECHNOL, P3165
   NIINOMI M, 2003, SCI TECHNOLOGY ADV M, P445
   Silver F.H., 1999, BIOMATERIALS SCI BIO, P87
   SPARROW N, 2005, MARKET WATCH ORTHOPA, V5
   von Walterskirchen M., 2004, US MARKET MED DEVICE
NR 8
TC 1
Z9 1
U1 0
U2 0
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD FEB
PY 2006
VL 35
SU 1
BP 139
EP 142
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 041FY
UT WOS:000237440700033
DA 2018-10-20
ER

PT J
AU Yu, ZT
   Zhou, L
   Niu, JL
   Cai, YR
   Luo, LJ
   Huang, FQ
AF Yu, ZT
   Zhou, L
   Niu, JL
   Cai, YR
   Luo, LJ
   Huang, FQ
TI beta type titanium alloys used in surgical implant materials
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT Xi An International Titanium Conference (XITC05)
CY OCT 16-19, 2005
CL Xi an, PEOPLES R CHINA
SP NW Inst Nonferrous Metal Res, Nonferrous Metals Soc China, Asian Off Aerospace Res & Dev
DE biomaterial; beta type titanium alloys; surgical implant materials
ID MECHANICAL-PROPERTIES; DESIGN
AB Titanium and its titanium alloys are becoming more and more promising biomedical materials with their lower density and lower modulus, high ratio of strength vs. density, fine corrosion resistance and workability, especially its fine biocompatibility. The paper summarized the category, characteristic, R & D, and application of biomedical titanium and its titanium alloys, and the alloy designing, melting, processing, heat treatment and microstructure, surface modification etc. of beta type titanium alloys were introduced. Finally, the future developing direction on biomedical implant materials is also discussed.
C1 NW Inst Nonferrous Met Res, Xian 710016, Peoples R China.
RP Yu, ZT (reprint author), NW Inst Nonferrous Met Res, Xian 710016, Peoples R China.
CR Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Chu Chenglin, 1998, MAT SCI TECHNOLOGY, V6, P40
   FENG YF, 2001, RARE METALS, V25, P349
   [葛建华 Ge Jianhua], 2003, [化工新型材料, New Chemical Materials], V31, P34
   HUANG YL, 2002, J MAT ENG, V11, P35
   JUDY RW, 1986, RARE METAL MAT ENG, V6, P50
   Jun Chen, 2002, ACTA METALLURGICA SI, V38, P108
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   LI ZC, 1998, RARE METAL MAT ENG, V27, P56
   Liang FH, 2003, RARE METAL MAT ENG, V32, P241
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   [宁聪琴 Ning Congqin], 2002, [材料科学与工艺, Material Science and Technology], V10, P100
   OKAZAKI Y, 1995, J JPN I MET, V59, P1078, DOI 10.2320/jinstmet1952.59.10_1078
   Ren Yibin, 2002, MAT REV, V16, P12
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   WANG JY, 1987, P 6 CHIN TI C, P187
   YU ZT, Patent No. 031531393
   YU ZT, Patent No. 031531385
   YU ZT, 2005, MATER SCI FORUM, V475, P2349
   Zhang YP, 2000, CHINESE PHYS LETT, V17, P206, DOI 10.1088/0256-307X/17/3/018
NR 24
TC 2
Z9 3
U1 0
U2 0
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD FEB
PY 2006
VL 35
SU 1
BP 261
EP 265
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 041FY
UT WOS:000237440700064
DA 2018-10-20
ER

PT J
AU Dong, Q
   Chen, CZ
   Wang, DG
   Ji, QM
AF Dong, Qing
   Chen, Chuanzhong
   Wang, Diangang
   Ji, Qianmao
TI Research status about surface modification of biomedical Ti and its
   alloys by micro-arc oxidation
SO SURFACE REVIEW AND LETTERS
LA English
DT Article
DE micro-arc oxidation; biomaterial; microstructure; property
ID TOTAL HIP-ARTHROPLASTY; TREATED TITANIUM; OXIDIZED TITANIUM; BONE
   RESPONSE; IN-VITRO; COATINGS; IMPLANTS; FILMS; MICROSTRUCTURE;
   HYDROXYAPATITE
AB Ti and its alloys are considered to be very promising in biological material field. But their biological activity and corrosion resistance in body fluid still need to be improved. As a novel technique for surface treatment, Micro-arc oxidation (MAO) is attracting interest from those who want to improve their implant properties through surface modification. This paper reviewed the application of MAO on biomedical Ti-alloys. The structure characteristic such as surface and cross-section micrographs, phase components, and element distribution were analyzed. The mechanical and biological properties of MAO films were further discussed on this basis. The effects of current density, voltage, and electrolyte on the structure and properties of the films were summarized.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shandong Informat Technol Coll, Shandong 261041, Weifang, Peoples R China.
RP Chen, CZ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
EM czchen@sdu.edu.cn
OI Wang, Diangang/0000-0003-4980-116X
CR Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buly R L, 1992, J Arthroplasty, V7, P315, DOI 10.1016/0883-5403(92)90056-V
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Han Y, 2004, J BIOMED MATER RES A, V71A, P608, DOI 10.1002/jbm.a.30177
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Han Y, 2002, MATER LETT, V56, P744, DOI 10.1016/S0167-577X(02)00606-7
   Hsieh MF, 2002, MATER CHEM PHYS, V74, P245, DOI 10.1016/S0254-0584(01)00474-6
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Ichikawa T, 2000, INT J ORAL MAX IMPL, V15, P231
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 2000, J BIOMED MATER RES, V52, P553, DOI 10.1002/1097-4636(20001205)52:3<553::AID-JBM14>3.0.CO;2-X
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   Nie X, 2000, SURF COAT TECH, V133, P331, DOI 10.1016/S0257-8972(00)00953-1
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   PAJUNEN M, 1992, Z METALLKD, V83, P17
   Piveteau LD, 1999, J MATER SCI-MATER M, V10, P161, DOI 10.1023/A:1008985423644
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sul YT, 2002, CLIN ORAL IMPLAN RES, V13, P252, DOI 10.1034/j.1600-0501.2002.130304.x
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Sundararajan G, 2003, SURF COAT TECH, V167, P269, DOI 10.1016/S0257-8972(02)00918-0
   TANG G, 2004, KUEI SUAN JEN HSUEH, V32, P127
   [唐光昕 Tang Guangxin], 2004, [材料研究学报, Chinese Journal of Materials Research], V18, P435
   Tang GX, 2004, MATER LETT, V58, P1857, DOI 10.1016/j.matlet.2003.11.016
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Wang YM, 2004, RARE METAL MAT ENG, V33, P502
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Xue WB, 2002, MATER LETT, V56, P737, DOI 10.1016/S0167-577X(02)00605-5
   Xue WB, 2002, MATER LETT, V52, P435, DOI 10.1016/S0167-577X(01)00440-2
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Yang GL, 2002, J ALLOY COMPD, V345, P196
   ZHANG Y, 2004, KUEI SUAN JEN HSUEH, V32, P122
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
NR 42
TC 14
Z9 15
U1 1
U2 23
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD FEB
PY 2006
VL 13
IS 1
BP 35
EP 43
DI 10.1142/S0218625X06007792
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 068YI
UT WOS:000239410500006
DA 2018-10-20
ER

PT J
AU Trau, D
   Jiang, J
   Sucher, NJ
AF Trau, D
   Jiang, J
   Sucher, NJ
TI Preservation of the biofunctionality of DNA and protein during
   microfabrication
SO LANGMUIR
LA English
DT Article
ID TOTAL ANALYSIS SYSTEMS; MICROARRAY TECHNOLOGY; NANOWIRES; MEDICINE;
   BIOLOGY; NANOSTRUCTURES; NANOTECHNOLOGY; DEVICES; CHIP
AB Microfabrication processes, especially in silicon, are not compatible with biomolecules. Silicon and metal-based materials having crystalline structures are manipulated under harsh conditions with acids, bases, and organic solvents at high temperature. In comparison, organic biomolecules such as DNA and proteins have complex, three-dimensional structures and are sensitive to denaturation, oxidation, hydrolysis, and thermal destruction. Here, we report on the integration of DNA and the biotin-binding protein NeutrAvidin into microfabrication processes by using a novel approach based on a gold passivation mask. Our data show that this passivation method preserves similar to 84% of the biofunctionality of DNA and similar to 30% of that of NeutrAvidin under harsh process conditions. This novel technology enables the integration of DNA, proteins, and potentially other biological molecules into mass scalable microfabrication processes for biomedical devices, biochips, biosensors, and microelectromechanical systems with biomolecules (BioMEMS).
C1 Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
   Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Biotechnol Res Inst, Kowloon, Hong Kong, Peoples R China.
RP Trau, D (reprint author), Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
EM bietrau@nus.edu.sg; nikolaus.sucher@childrens.harvard.edu
RI Trau, Dieter/B-1633-2008
OI Trau, Dieter/0000-0001-6706-9123; Sucher, Nikolaus/0000-0001-6233-1612
CR ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651
   Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528
   Bratthauer G L, 1999, Methods Mol Biol, V115, P203
   Carles M, 2001, FRESEN J ANAL CHEM, V371, P190, DOI 10.1007/s002160100964
   Cheung MKL, 2003, LANGMUIR, V19, P5846, DOI 10.1021/la027039x
   Flounders AW, 1997, BIOSENS BIOELECTRON, V12, P447, DOI 10.1016/S0956-5663(96)00064-4
   Goldsmith ZG, 2004, INT J MOL MED, V13, P483
   Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b
   Harris JR, 1999, IEEE ANN HIST COMPUT, V21, P49, DOI 10.1109/85.801532
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247
   Lenigk R, 2001, LANGMUIR, V17, P2497, DOI 10.1021/la001355z
   Li Z, 2004, NANO LETT, V4, P245, DOI 10.1021/nl034958e
   Liu MZ, 2002, NANO LETT, V2, P863, DOI 10.1021/nl025626x
   Maruccio G, 2003, NANO LETT, V3, P479, DOI 10.1021/nl034046c
   Monson CF, 2003, NANO LETT, V3, P359, DOI 10.1021/nl034016+
   Niemeyer CM, 2002, SCIENCE, V297, P62, DOI 10.1126/science.1073843
   Niemeyer CM, 2002, ANGEW CHEM INT EDIT, V41, P3779, DOI 10.1002/1521-3773(20021018)41:20<3779::AID-ANIE3779>3.0.CO;2-F
   Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298
   Seeman NC, 1998, ANNU REV BIOPH BIOM, V27, P225, DOI 10.1146/annurev.biophys.27.1.225
   Trau D, 2002, ANAL CHEM, V74, P3168, DOI 10.1021/ac020053u
   Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   Voldman J, 2003, NAT MATER, V2, P433, DOI 10.1038/nmat936
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1
   Willner Itamar, 2002, J Biotechnol, V82, P325, DOI 10.1016/S1389-0352(01)00050-2
NR 30
TC 11
Z9 11
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 31
PY 2006
VL 22
IS 3
BP 877
EP 881
DI 10.1021/la052182m
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 008VF
UT WOS:000235068100008
PM 16430241
DA 2018-10-20
ER

PT J
AU Schneider, A
   Francius, G
   Obeid, R
   Schwinte, P
   Hemmerle, J
   Frisch, B
   Schaaf, P
   Voegel, JC
   Senger, B
   Picart, C
AF Schneider, A
   Francius, G
   Obeid, R
   Schwinte, P
   Hemmerle, J
   Frisch, B
   Schaaf, P
   Voegel, JC
   Senger, B
   Picart, C
TI Polyelectrolyte multilayers with a tunable Young's modulus: Influence of
   film stiffness on cell adhesion
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SMOOTH-MUSCLE-CELLS; SUCCINIMIDE DERIVATIVES;
   QUANTITATIVE-ANALYSIS; SUBSTRATE MECHANICS; EXPONENTIAL-GROWTH; IR
   SPECTROMETRY; IN-VITRO; SURFACE; SOFT
AB Mechanical properties of model and natural gels have recently been demonstrated to play an important role in various cellular processes such as adhesion, proliferation, and differentiation, besides events triggered by chemical ligands. Understanding the biomaterial/cell interface is particularly important in many tissue engineering applications and in implant surgery. One of the final goals would be to control cellular processes precisely at the biomaterial surface and to guide tissue regeneration. In this work, we investigate the substrate mechanical effect on cell adhesion for thin polyelectrolyte multilayer (PEM) films, which can be easily deposited on any type of material. The films were cross linked by means of a water-soluble carbodiimide (EDC), and the film elastic modulus was determined using the AFM nanoindentation technique with a colloidal probe. The Young's modulus could be varied over 2 orders of magnitude (from 3 to 400 kPa) for wet poly((L)-lysine)/hyaluronan (PLL/HA) films by changing the EDC concentration. The chemical changes upon cross linking were characterized by means of Fourier transform infrared spectroscopy (FTIR). We demonstrated that the adhesion and spreading of human chondrosarcoma cells directly depend on the Young's modulus. These data indicate that, besides the chemical properties of the polyelectrolytes, the substrate mechanics of PEM films is an important parameter influencing cell adhesion and that PEM offer a new way to prepare thin films of tunable mechanical properties with large potential biomedical applications including drug release.
C1 Univ Strasbourg 1, INSERM, U595, Fac Chirurg Dentaire, F-67085 Strasbourg, France.
   Univ Freiburg, Inst Mol Med & Zellforsch, Sekt Biophys, D-79104 Freiburg, Germany.
   Univ Strasbourg 1, CNRS, UMR 7514, Chim Bioorgan Lab,Fac Pharm, F-67401 Illkirch Graffenstaden, France.
   Univ Strasbourg 1, Inst Charles Sadron, CNRS, F-67083 Strasbourg, France.
RP Picart, C (reprint author), Univ Strasbourg 1, INSERM, U595, Fac Chirurg Dentaire, 11 Rue Humann, F-67085 Strasbourg, France.
EM catherine.picart@univ-montp2.fr
RI SCHAAF, Pierre/J-2751-2016; Francius, Gregory/A-4246-2015
OI SCHAAF, Pierre/0000-0001-7423-5492; Francius,
   Gregory/0000-0001-8533-9449; PICART, Catherine/0000-0002-4854-6366;
   PICART, Catherine/0000-0003-0130-1000; Frisch,
   Benoit/0000-0002-8378-2508
CR Aylin F, 2003, ORG BIOMOL CHEM, V1, P2290, DOI 10.1039/b211936f
   Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   BHUSHAN B, 2001, WEAR 2, V250, P1105
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   BOTT R, 2000, AUST J CHEM, P53
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Dubreuil F, 2003, EUR PHYS J E, V12, P215, DOI 10.1140/epje/i2003-10056-0
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   ENGLER A, 2005, SURF SCI, V570, P253
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FRANCIUS G, 2005, IN PRESS MICROSC RES
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Haxaire K, 2003, BIOPOLYMERS, V72, P149, DOI 10.1002/bip.10342
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Koktysh DS, 2002, ADV FUNCT MATER, V12, P255, DOI 10.1002/1616-3028(20020418)12:4<255::AID-ADFM255>3.0.CO;2-1
   Konuklar FA, 2002, J PHYS CHEM A, V106, P11205, DOI 10.1021/jp0261531
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   PICART C, 2005, ADV FUNCT MAT    NOV, P1771
   PISTORIUS AMA, 1993, INT J PEPT PROT RES, V42, P570
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   RICHERT L, 2005, IN PRESS CELL BIOCH
   Richert L., 2004, LANGMUIR, V1, P284
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Rutland MW, 2004, J ADHES SCI TECHNOL, V18, P1199, DOI 10.1163/1568561041581324
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Schreyeck G, 1999, LANGMUIR, V15, P8212, DOI 10.1021/la990229w
   Shen G, 2004, NUCLEIC ACIDS RES, V32, P5973, DOI 10.1093/nar/gkh932
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   TIMKOVICH R, 1977, ANAL BIOCHEM, V79, P135, DOI 10.1016/0003-2697(77)90387-6
   VOGLER EA, 1987, J BIOMED MATER RES, V21, P1197, DOI 10.1002/jbm.820211004
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Xiao SJ, 2004, J PHYS CHEM B, V108, P16508, DOI 10.1021/jp0477262s
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 60
TC 211
Z9 211
U1 6
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 31
PY 2006
VL 22
IS 3
BP 1193
EP 1200
DI 10.1021/la0521802
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 008VF
UT WOS:000235068100050
PM 16430283
DA 2018-10-20
ER

PT J
AU Prasad, S
   Quijano, J
AF Prasad, S
   Quijano, J
TI Development of nanostructured biomedical micro-drug testing device based
   on in situ cellular activity monitoring
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE nanoporous cell based devices; in vitro test platforms; porous alumina
   substrates; neuron patterning; neuron electrophysiology
ID POROUS ALUMINA; ANODIC ALUMINA; NEURONS; CELLS; DIFFUSION; MEMBRANES;
   SILICON; FABRICATION; KINETICS; CULTURE
AB Integration of micro and nanofabrication techniques with biotechnology has resulted in the development of in vitro analytical and diagnostic tools for biomedical applications. The focus of such technology has primarily been on therapeutic and sensing applications. The long-term integration of cells with inorganic materials provides the basis for novel sensing platforms. This paper describes the creation of, nanoporous, biocompatible, alumina membranes as a platform for incorporation into a cell based device targeted for in situ recording of cellular electrical activity variations due to the changes associated with the surrounding microenvironments more specifically due to the effect of therapeutic drugs. Studies described herein focus on the interaction of nanoporous alumina substrates embedded in silicon, patterned with cells of interest. The cells that have been used to develop the in vitro test platform are primary hippocampal neurons. Demonstrated here, is the fidelity of such a system in terms of determination of cell viability, proliferation, and functionality. The response of the cells to the "drug" molecules is electro-optically characterized in an in situ manner. The capability of such, micro fabricated nanoporous membranes as in vitro drug testing platforms, is first theoretically estimated using two dimensional finite element modeling of the diffusion of the molecules of interest through the nanoporous substrate using CFDRC (TM). It is then experimentally established, using glucose and immunoglobulin G (IgG). (c) 2005 Elsevier B.V. All rights reserved.
C1 Portland State Univ, Biome Microdevices & Nanotechnol Lab, Dept Elect & Comp Engn, Portland, OR 97201 USA.
RP Prasad, S (reprint author), Portland State Univ, Biome Microdevices & Nanotechnol Lab, Dept Elect & Comp Engn, 160-11,FAB,1900 SW 4th Ave, Portland, OR 97201 USA.
EM sprasad@pdx.edu
OI Prasad, Shalini/0000-0002-2404-3801
CR Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471
   Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje
   Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100
   Bai Q, 2001, IEEE T BIO-MED ENG, V48, P911, DOI 10.1109/10.936367
   BUCHHALTER JR, 1991, BRAIN RES BULL, V26, P333, DOI 10.1016/0361-9230(91)90003-3
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DESAI TA, 1999, J BIOMED MICRODEVICE, V1, P131
   Fromherz P, 2002, CHEMPHYSCHEM, V3, P276, DOI 10.1002/1439-7641(20020315)3:3<276::AID-CPHC276>3.0.CO;2-A
   Gramlich G, 2004, J AM CHEM SOC, V126, P5482, DOI 10.1021/ja039845b
   HAMABE W, 2005, J PHARMACOL EXP THER, V312, P214
   Harris AL, 2001, Q REV BIOPHYS, V34, P325
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Jessensky O, 1998, APPL PHYS LETT, V72, P1173, DOI 10.1063/1.121004
   Kokonou M, 2005, NANOTECHNOLOGY, V16, P103, DOI 10.1088/0957-4484/16/1/021
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   Livescu A, 2003, J CELL MOL MED, V7, P73, DOI 10.1111/j.1582-4934.2003.tb00205.x
   Madou M. J., 2002, FUNDAMENTALS MICROFA
   Maher MP, 1999, J NEUROSCI METH, V87, P45, DOI 10.1016/S0165-0270(98)00156-3
   Masuda H, 2004, ELECTROCHEMISTRY, V72, P389
   Masuda H, 1997, J ELECTROCHEM SOC, V144, pL127, DOI 10.1149/1.1837634
   Masuda H, 1996, JPN J APPL PHYS 2, V35, pL126, DOI 10.1143/JJAP.35.L126
   Merli PG, 2003, ULTRAMICROSCOPY, V94, P89, DOI 10.1016/S0304-3991(02)00217-6
   NEWMAN J, 1966, J ELECTROCHEM SOC, V113, P501, DOI 10.1149/1.2424003
   NEWMAN LJ, 1966, GENETICS, V53, P55
   Nicholson C, 2000, PROG BRAIN RES, V125, P129
   PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0
   PATERMARAKIS G, 1993, ELECTROCHIM ACTA, V38, P2351, DOI 10.1016/0013-4686(93)80119-K
   Polla DL, 2000, ANNU REV BIOMED ENG, V2, P551, DOI 10.1146/annurev.bioeng.2.1.551
   Prasad S, 2004, ELECTROPHORESIS, V25, P3746, DOI 10.1002/elps.200406066
   Prasad S, 2004, BIOSENS BIOELECTRON, V19, P1599, DOI 10.1016/j.bios.2003.12.013
   PRASAD S, 2003, J BIOMED MICRODEVICE, V5, P125
   REGEHR WG, 1988, IEEE T BIO-MED ENG, V35, P1023, DOI 10.1109/10.8687
   RIGBY WR, 1990, T I MET FINISH, V68, P95, DOI 10.1080/00202967.1990.11870875
   Romer W, 2004, BIOPHYS J, V86, P955
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   Saitoh R, 2004, PHARM RES, V21, P749, DOI 10.1023/B:PHAM.0000026423.48583.e2
   Sernee MF, 2003, EUR J BIOCHEM, V270, P495, DOI 10.1046/j.1432-1033.2003.03405.x
   Shulz DE, 1997, EUR J NEUROSCI, V9, P396, DOI 10.1111/j.1460-9568.1997.tb01409.x
   Swan EEL, 2005, J BIOMED MATER RES A, V72A, P288, DOI 10.1002/jbm.a.30223
   SZE M, 1994, SEMICONDUCTOR SENSOR
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wheatley DN, 1998, BIOSYSTEMS, V45, P151, DOI 10.1016/S0303-2647(97)00073-7
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
   Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698
   Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
NR 47
TC 28
Z9 28
U1 2
U2 13
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JAN 15
PY 2006
VL 21
IS 7
BP 1219
EP 1229
DI 10.1016/j.bios.2005.05.005
PG 11
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 002XC
UT WOS:000234644400029
PM 15990287
DA 2018-10-20
ER

PT J
AU Colombo, P
AF Colombo, P
TI Conventional and novel processing methods for cellular ceramics
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article; Proceedings Paper
CT Royal-Society Discussion Meeting on Engineered Foams and Porous
   Materials
CY NOV, 2005
CL London, ENGLAND
SP Royal Soc
DE cellular; ceramic; foam; honeycomb; fibre; rod
ID RETICULATED POROUS CERAMICS; MICROCELLULAR CERAMICS; STARCH
   CONSOLIDATION; HOLLOW SPHERES; FOAMS; WOOD; MICROSTRUCTURE;
   INFILTRATION; COMPOSITES; BEHAVIOR
AB Cellular ceramics are a class of highly porous materials that covers a wide range of structures, such as foams, honeycombs, interconnected rods, interconnected fibres, interconnected hollow spheres. Recently, there has been a surge of activity in this field, because these innovative materials have started to be used as components in special and advanced engineering applications. These include filtering liquids and particles in gas streams, porous burners, biomedical devices, lightweight load-bearing structures, etc. Improvements in conventional processing methods and the development of innovative fabrication approaches are required because of the increasing specific demands on properties and morphology (cell size, size distribution and interconnection) for these materials, which strictly depend on the application considered. This paper will cover the main fabrication methods for cellular ceramics, focusing primarily on foams, offering some insight into novel fabrication processes and recent developments.
C1 Univ Bologna, Dipartimento Chim Applicata & Sci Mat, I-40136 Bologna, Italy.
   Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
RP Colombo, P (reprint author), Univ Bologna, Dipartimento Chim Applicata & Sci Mat, Viale Risorgimento 2, I-40136 Bologna, Italy.
EM paolo.colombo@mail.ing.unibo.it
CR Adler J., 1999, Patent, Patent No. [EP 0907621, 0907621]
   Bardhan P, 1997, CURR OPIN SOLID ST M, V2, P577, DOI 10.1016/S1359-0286(97)80048-4
   BORRELLI NF, 2001, Patent No. 626038,
   BUCKLEY JD, 1981, AM CERAM SOC BULL, V60, P1196
   Celades C.R., 1990, European Patent, Patent No. 0369098
   Cichocki FR, 1998, J AM CERAM SOC, V81, P1661
   Cochran JK, 1998, CURR OPIN SOLID ST M, V3, P474, DOI 10.1016/S1359-0286(98)80010-7
   Colombo P, 2004, J AM CERAM SOC, V87, P152, DOI 10.1111/j.1551-2916.2004.00152.x
   Colombo P, 2002, MATER RES INNOV, V6, P260, DOI 10.1007/s10019-002-0209-z
   CROOKE PR, 1982, Patent No. 2097777
   DANNOUX TLA, 2004, Patent No. 6755131
   de Sousa FCG, 2005, ADV APPL CERAM, V104, P30, DOI 10.1179/174367605225011025
   Dhara S, 2003, J AM CERAM SOC, V86, P1645, DOI 10.1111/j.1151-2916.2003.tb03534.x
   FITZGERALD TJ, 1995, J MATER SCI, V30, P1037, DOI 10.1007/BF01178442
   FUJIU T, 1990, J AM CERAM SOC, V73, P85, DOI 10.1111/j.1151-2916.1990.tb05095.x
   Garrn I, 2004, J EUR CERAM SOC, V24, P579, DOI 10.1016/S0955-2219(03)00259-0
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Grader GS, 1999, J MATER RES, V14, P1485, DOI 10.1557/JMR.1999.0199
   Green DJ, 2003, MRS BULL, V28, P296, DOI 10.1557/mrs2003.84
   GREEN DJ, 1985, J AM CERAM SOC, V68, P403, DOI 10.1111/j.1151-2916.1985.tb10153.x
   Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3
   Herzog A, 2004, J AM CERAM SOC, V87, P784, DOI 10.1111/j.1551-2916.2004.00784.x
   HORNSBY PR, 2004, Patent No. 20040084795
   Innocentini MDM, 1998, J AM CERAM SOC, V81, P3349, DOI 10.1111/j.1151-2916.1998.tb02782.x
   Jayasinghe SN, 2002, J POROUS MAT, V9, P265, DOI 10.1023/A:1021648812377
   KAR G, 2003, Patent No. 6548142
   Kato Y., 1986, GB Pat., Patent No. [2 168 337 (A), 2168337]
   KATSUKI H, 1992, J MATER SCI, V27, P6067, DOI 10.1007/BF01133751
   Kim YW, 2003, J AM CERAM SOC, V86, P2231, DOI 10.1111/j.1151-2916.2003.tb03641.x
   Klett J., 1999, J COMPOSITES MANUFAC, V15, P1
   KOMARNENI S, 1995, MATER RES SOC SYMP P, V371, P285
   LACHMAN IM, 1981, AM CERAM SOC BULL, V60, P202
   Lemos AF, 2000, MAT SCI ENG C-BIO S, V11, P35, DOI 10.1016/S0928-4931(00)00134-X
   Lewis JA, 2002, CURR OPIN SOLID ST M, V6, P245, DOI 10.1016/S1359-0286(02)00031-1
   Li SH, 2003, J AM CERAM SOC, V86, P65, DOI 10.1111/j.1151-2916.2003.tb03279.x
   Lopes RA, 1996, MAT SCI ENG A-STRUCT, V209, P149, DOI 10.1016/0921-5093(95)10146-2
   Luyten J, 2005, ADV APPL CERAM, V104, P4, DOI 10.1179/174367605225010990
   Lyckfeldt O, 1998, J EUR CERAM SOC, V18, P131, DOI 10.1016/S0955-2219(97)00101-5
   Mattern A, 2004, J EUR CERAM SOC, V24, P3399, DOI [10.1016/j.jeurceramsoc.2003.10.030, 10.1016/j.jeurceromsoc.2003.10.030]
   Nangrejo MR, 2000, J EUR CERAM SOC, V20, P1777, DOI 10.1016/S0955-2219(00)00046-7
   Ortana A., 2004, European Patent, Patent No. [1, 382,590 A2, 1382590]
   Peng HX, 2000, J EUR CERAM SOC, V20, P807, DOI 10.1016/S0955-2219(99)00229-0
   PFAFF E, 1997, Patent No. 19605149
   Pu XP, 2004, J AM CERAM SOC, V87, P1392, DOI 10.1111/j.1151-2916.2004.tb07745.x
   Scheffler M, 2005, CELLULAR CERAMICS: STRUCTURE, MANUFACTURING, PROPERTIES AND APPLICATIONS, P1, DOI 10.1002/3527606696
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   SHERMAN AJ, 1991, AM CERAM SOC BULL, V70, P1025
   Sieber H, 2001, CERAM ENG SCI PROC, V22, P225
   Singh M, 2004, J EUR CERAM SOC, V24, P209, DOI 10.1016/S0955-2219(03)00244-9
   Stuecker JN, 2003, J MATER PROCESS TECH, V142, P318, DOI 10.1016/S0924-0136(03)00586-7
   Tang FQ, 2004, J EUR CERAM SOC, V24, P341, DOI 10.1016/S0955-2219(03)00223-1
   Thijs I., 2003, J AM CERAM SOC, V87, P170
   VANVOORHEES EJ, 1991, J AM CERAM SOC, V74, P2747
   Vogli E, 2002, J EUR CERAM SOC, V22, P2663, DOI 10.1016/S0955-2219(02)00131-0
   Weaire D, 2001, PHYS FOAMS
   Zampieri A, 2004, ADV MATER, V16, P819, DOI 10.1002/adma.200306304
   Zeschky J, 2003, COMPOS SCI TECHNOL, V63, P2361, DOI 10.1016/S0266-3538(03)00269-0
   Zhu XW, 2001, J AM CERAM SOC, V84, P1654
   Zollfrank C, 2004, J EUR CERAM SOC, V24, P495, DOI 10.1016/S0955-2219(03)00200-0
NR 61
TC 262
Z9 266
U1 6
U2 93
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
EI 1471-2962
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD JAN 15
PY 2006
VL 364
IS 1838
BP 109
EP 124
DI 10.1098/rsta.2005.1683
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 002FN
UT WOS:000234597000007
PM 18272455
DA 2018-10-20
ER

PT J
AU Jones, JR
   Lee, PD
   Hench, LL
AF Jones, JR
   Lee, PD
   Hench, LL
TI Hierarchical porous materials for tissue engineering
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article; Proceedings Paper
CT Royal-Society Discussion Meeting on Engineered Foams and Porous
   Materials
CY NOV, 2005
CL London, ENGLAND
SP Royal Soc
DE bioactive glass; scaffold; tissue engineering; X-ray microtomography;
   mineralization
ID X-RAY MICROTOMOGRAPHY; BIOMEDICAL MATERIALS; FOAM SCAFFOLDS; GLASSES;
   CELL; HYDROXYAPATITE; BIOCERAMICS; OSTEOBLASTS; DISSOLUTION; STRATEGY
AB Biological organisms have evolved to produce hierarchical three-dimensional structures with dimensions ranging from nanometres to metres. Replicating these complex living hierarchical structures for the purpose of repair or replacement of degenerating tissues is one of the great challenges of chemistry, physics, biology and materials science. This paper describes how the use of hierarchical porous materials in tissue engineering applications has the potential to shift treatments from tissue replacement to tissue regeneration. The criteria that a porous material must fulfil to be considered ideal for bone tissue engineering applications are listed. Bioactive glass foam scaffolds have the potential to fulfil all the criteria, as they have a hierarchical porous structure similar to that of trabecular bone, they can bond to bone and soft tissue and they release silicon and calcium ions that have been found to up-regulate seven families of genes in osteogenic cells. Their hierarchical structure can be tailored for the required rate of tissue bonding, resorption and delivery of dissolution products. This paper describes how the structure and properties of the scaffolds are being optimized with respect to cell response and that tissue culture techniques must be optimized to enable growth of new bone in vitro.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Jones, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, S Kensington Campus, London SW7 2AZ, England.
EM julian.r.jones@imperial.ac.uk
RI Jones, Julian/B-1007-2012; Lee, Peter/R-2323-2016
OI Jones, Julian/0000-0002-2647-8024; Lee, Peter/0000-0002-3898-8881
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   ANGUY Y, 1995, ADV WATER RESOUR, V17, P337
   Atwood RC, 2004, SCRIPTA MATER, V51, P1029, DOI 10.1016/j.scriptamat.2004.08.014
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   DAVIES JE, 2000, BONE ENG
   Fetner A E, 1994, Compendium, V15, P935
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Jones JR, 2004, KEY ENG MAT, V254-2, P981, DOI 10.4028/www.scientific.net/KEM.254-256.981
   Jones JR, 2004, J BIOMED MATER RES B, V68B, P36, DOI 10.1002/jbm.b.10071
   Jones JR, 2003, J MATER SCI, V38, P3783, DOI 10.1023/A:1025988301542
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin ZJ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.224107
   MacKenzie K. J. D., 2002, MULTINUCLEAR SOLID S
   Mangan AP, 1999, IEEE T VIS COMPUT GR, V5, P308, DOI 10.1109/2945.817348
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Okii N, 2001, NEUROL MED-CHIR, V41, P100, DOI 10.2176/nmc.41.100
   Papathanasiou TD, 1997, POLYM COMPOSITE, V18, P242, DOI 10.1002/pc.10279
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   ROSEN MJ, 1989, SURFACTANTS INTERFAC
   Sahimi M., 1995, FLOWS POROUS MEDIA F
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P14, DOI 10.1016/S0022-3093(02)01882-3
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Skipper LJ, 2004, J BIOMED MATER RES A, V70A, P354, DOI 10.1002/jbm.a.30093
   Stock SR, 1999, INT MATER REV, V44, P141, DOI 10.1179/095066099101528261
   Takezawa T, 2003, BIOMATERIALS, V24, P2267, DOI 10.1016/S0142-9612(03)00038-3
   Wilson J., 1995, BIOCERAMICS, V8, P239
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   XYNOS ID, 2000, CALCIFIED TISSUE INT, V45, P67321
   Xynos ID, 2000, J BIOMED MATER RES, V155, P151
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 39
TC 123
Z9 127
U1 3
U2 38
PU ROYAL SOCIETY
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T ROY SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD JAN 15
PY 2006
VL 364
IS 1838
BP 263
EP 281
DI 10.1098/rsta.2005.1689
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 002FN
UT WOS:000234597000018
PM 18272465
DA 2018-10-20
ER

PT B
AU Cheng, XY
   Li, Y
   Tao, XM
   Tsang, HYJ
   Leung, MY
   Xue, P
   Cheng, XX
   Yuen, CWM
AF Cheng, Xiaoyin
   Li, Yang
   Tao, Xiaoming
   Tsang, Hing Yee J.
   Leung, Mei Yi
   Xue, Pu
   Cheng, Xiaoxiang
   Yuen, C. W. M.
GP IEEE
TI Polypyrrole-coated fabric strain sensor with high sensitivity and good
   stability
SO 2006 1ST IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND
   MOLECULAR SYSTEMS, VOLS 1-3
LA English
DT Proceedings Paper
CT IEEE International Conference of Nano/Micro Engineered and Molecular
   Systems
CY JAN 18-21, 2006
CL Zhuhai, PEOPLES R CHINA
SP IEEE
DE fabric strain sensor; polypyrrole; stability
AB The sensitivity and stability are mainly factors to hold back the practical applications of Polypyrrole coated fabrics. In this paper, a flexible fabric strain sensor with high sensitivity, good stability and large deformation is reported. It is fabricated by depositing a nano-layer (200nm to 300nm) of polypyrrole on the fabric substrate at low temperature. Thickness and morphology of the conducting thin film on the surface of the fibers were examined by scanning probe microscopy (SPM) and scanning electron microscopy (SENP. The measurement of the conductivity change with strain shows the fabrics so prepared exhibits a high strain sensitivity of similar to 160 for a deformation as large as 50%, while its good stability is indicated by a small loss of conductivity after the thermal and humidity aging tests, and supported by the slight change in conductivity and sensitivity over a storage of eighteen months. The flexible strain sensor is expected to be a promising "soft" smart material with good sensing properties in the preparation of smart garment, wearable hardware and biomedical applications.
C1 [Cheng, Xiaoyin; Tao, Xiaoming; Tsang, Hing Yee J.; Leung, Mei Yi; Xue, Pu; Cheng, Xiaoxiang; Yuen, C. W. M.] Hong Kong Polytech Univ, ITC, Nanotechnol Ctr, Hong Kong, Hong Kong, Peoples R China.
   [Li, Yang] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou, Zhejiang, Peoples R China.
RP Cheng, XY (reprint author), Hong Kong Polytech Univ, ITC, Nanotechnol Ctr, Hong Kong, Hong Kong, Peoples R China.
EM tcxyc@inet.polyu.edu.hk
RI Tao, XiaoMing/A-9992-2010
OI Tao, XiaoMing/0000-0002-2406-0695
FU Innovative Technology Fund, The SAR Government of Hong Kong [ZPOD
   (ITS/071/02)]
FX This project was funded by the Innovative Technology Fund, The SAR
   Government of Hong Kong (Project code. (ZPOD (ITS/071/02)).
CR Jiang XP, 2002, J BIOMED MATER RES, V62, P507, DOI 10.1002/jbm.10240
   Oh KW, 2003, J APPL POLYM SCI, V88, P1225, DOI 10.1002/app.11783
   Rossi DD, 1999, MAT SCI ENG C-BIO S, V7, P31
   Scilingo EP, 2003, IEEE SENS J, V3, P460, DOI 10.1109/JSEN.2003.815771
   Wallace G G, 2003, CONDUCTIVE ELECTROAC
NR 5
TC 0
Z9 0
U1 0
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0139-0
PY 2006
BP 1245
EP +
DI 10.1109/NEMS.2006.334708
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGM58
UT WOS:000248485802050
DA 2018-10-20
ER

PT B
AU Goenaga, MA
   Juan, EJ
AF Goenaga, Miguel A.
   Juan, Eduardo J.
GP IEEE
TI Modeling impermeable membranes as acoustic filters for biomedical
   aplications
SO 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15
LA English
DT Proceedings Paper
CT 28th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 30-SEP 03, 2006
CL New York, NY
SP IEEE Engn Med & Biol Soc
DE transmission coefficient; membrane; impermeable; sound propagation
AB The main purpose of this research project was to explore a mathematical expression that could be used by medical device designers to appropriately select impermeable membranes to isolate acoustic transducers from water, dust, car-wax or other foreign material. The sound transmission properties of various types of impermeable membranes were analytically evaluated and compared to experimental measurements. Computer simulations were also performed to estimate the effects of three key membrane parameters: thickness (h), density (p) and sound speed (c), on the membrane's overall acoustic response. Results indicated that membrane thickness and density affect sound transmission the most. Membrane sound speed had minimal effect on sound transmission.
C1 [Goenaga, Miguel A.; Juan, Eduardo J.] Univ Puerto Rico, Dept Elect & Comp Engn, Mayaguez, PR 00681 USA.
RP Goenaga, MA (reprint author), Univ Puerto Rico, Dept Elect & Comp Engn, Mayaguez, PR 00681 USA.
EM ejuan@4ccc.uprm.cdu
CR BERGER R, 2000, Patent No. 6164409
   Blackstock David T., 2000, FUNDAMENTALS PHYS AC
   GUNNERSEN F, 2004, Patent No. 6795562
   Juan EJ, 2002, IEEE T BIO-MED ENG, V49, P584, DOI 10.1109/TBME.2002.1001973
   KINSLER LE, 1982, FUNDAMENTALS ACOUSTI
   MARSHALL I, 1991, CLIN PHYS PHYSIOL M, V12, P131, DOI 10.1088/0143-0815/12/2/002
   URGATE D, 2003, P 25 ANN INT C IEEE
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0032-4
PY 2006
BP 2394
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BGI19
UT WOS:000247284702179
DA 2018-10-20
ER

PT B
AU Kuncova-Kallio, J
   Kallio, PJ
AF Kuncova-Kallio, Johana
   Kallio, Pasi J.
GP IEEE
TI PDMS and its suitability for analytical microfluidic devices
SO 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15
LA English
DT Proceedings Paper
CT 28th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 30-SEP 03, 2006
CL New York, NY
SP IEEE Engn Med & Biol Soc
ID PROTEIN ADSORPTION; POLY(DIMETHYLSILOXANE); SYSTEM; ELECTROPHORESIS;
   FABRICATION; MICROVALVE; MICROPUMP; IMMUNOASSAY; ADHESION; CHANNELS
AB Poly(dimethylsiloxane) also known as PDMS is used in a wide range of biomedical applications. These range from implants through catheters to soft contact lenses. Therefore, it is understandable that PDMS has been extensively tested for these purposes.
   In past years, the microfluidics has moved from predominantly silicon and glass structures towards polymers due to their ease of manufacturing and moderate cost. PDMS has gained a lot of attention in various analytical applications. However, the testing of its suitability for such applications has not been as thorough as in the biomedical applications, perhaps relying on the experiments from that field.
   Microfluidic PDAIS structures are more and more popular in various analytical devices. Such devices consume less reagents and can work with lower sample volumes. On the other hand, the surface-to-sample-volume ratio becomes larger. That increases the influence of material properties on the actual measurement. Some of the challenges include adsorption, diffusion, surface rougness, permeability and elasticity of PDAIS, which are discussed in this paper.
C1 [Kuncova-Kallio, Johana; Kallio, Pasi J.] Tampere Univ Technol, Inst Automat & Control, Micro & Nanosyst Res Grp, PO Box 692, FIN-33101 Tampere, Finland.
RP Kuncova-Kallio, J (reprint author), Tampere Univ Technol, Inst Automat & Control, Micro & Nanosyst Res Grp, PO Box 692, FIN-33101 Tampere, Finland.
EM johana.kuncova-kallio@tut.fi
RI Kallio, Pasi/G-4260-2014
OI Kallio, Pasi/0000-0002-2890-6782
FU graduate school of the Tampere University of Technology; Finnish
   Cultural Foundation
FX This work was supported in part by the graduate school of the Tampere
   University of Technology and in part by the Finnish Cultural Foundation.
CR BHATTACHARYA S, 2005, J MICROELECTROMECHAN, V14
   Boscaini E, 2004, INT J MASS SPECTROM, V239, P179, DOI 10.1016/j.ijms.2004.08.011
   Boxshall K, 2006, SURF INTERFACE ANAL, V38, P198, DOI 10.1002/sia.2274
   Butler JE, 1997, J MOL RECOGNIT, V10, P36, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<36::AID-JMR353>3.0.CO;2-G
   Chang WJ, 2003, BIOMED MICRODEVICES, V5, P281, DOI 10.1023/A:1027301628547
   Croce G, 2004, SUPERLATTICE MICROST, V35, P601, DOI 10.1016/j.spmi.2003.09.014
   *DOW COM CORP, 2006, SYLG 184 MAT PROP
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919
   ELZAIM HS, 2001, POLYM BIOMATERIALS, P79
   Eteshola E, 2001, SENSOR ACTUAT B-CHEM, V72, P129, DOI 10.1016/S0925-4005(00)00640-7
   Gao YL, 2005, ANAL CHIM ACTA, V543, P109, DOI 10.1016/j.aca.2005.04.032
   GLIERE A, 2006, IN PRESS SENSORS A A
   Go JS, 2004, SENSOR ACTUAT A-PHYS, V114, P438, DOI 10.1016/j.sna.2003.12.028
   Jeong OC, 2005, SENSOR ACTUAT A-PHYS, V123-24, P453, DOI 10.1016/j.sna.2005.01.035
   Kang JH, 2005, SENSOR ACTUAT B-CHEM, V107, P980, DOI 10.1016/j.snb.2004.12.052
   Kim JH, 2005, SENSOR ACTUAT A-PHYS, V120, P365, DOI 10.1016/j.sna.2004.12.024
   Kim JY, 2005, SENSOR ACTUAT A-PHYS, V119, P593, DOI 10.1016/j.sna.2004.09.023
   Kim MS, 2005, SENSOR ACTUAT B-CHEM, V107, P818, DOI 10.1016/j.snb.2004.12.069
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   MARK JE, 2005, INORGANIC POLYM, P4
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Monahan J, 2002, ELECTROPHORESIS, V23, P2347, DOI 10.1002/1522-2683(200207)23:14<2347::AID-ELPS2347>3.0.CO;2-G
   Moorcroft M. J., 2005, NUCL ACIDS RES, V33
   OEVIRK G, 2000, ELECTROPHORESIS, V21, P107
   Olah A, 2005, EUR POLYM J, V41, P2803, DOI 10.1016/j.eurpolymj.2005.06.008
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   Prakash AR, 2006, SENSOR ACTUAT B-CHEM, V113, P398, DOI 10.1016/j.snb.2005.03.049
   Takao H, 2005, SENSOR ACTUAT A-PHYS, V119, P468, DOI 10.1016/j.sna.2004.10.023
   Wang CH, 2005, BIOSENS BIOELECTRON, V21, P419, DOI 10.1016/j.bios.2004.11.004
   Xiang Q, 2006, BIOSENS BIOELECTRON, V21, P2006, DOI 10.1016/j.bios.2005.09.019
   Yoo JC, 2006, MICROELECTRON ENG, V83, P1684, DOI 10.1016/j.mee.2006.01.202
NR 33
TC 0
Z9 0
U1 1
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0032-4
PY 2006
BP 2688
EP +
PG 3
WC Engineering, Biomedical
SC Engineering
GA BGI19
UT WOS:000247284703041
DA 2018-10-20
ER

PT B
AU Suaning, GJ
   Lavoie, P
   Forrester, J
   Armitage, T
   Lovell, NH
AF Suaning, G. J.
   Lavoie, P.
   Forrester, J.
   Armitage, T.
   Lovell, N. H.
GP IEEE
TI Microelectronic retinal prosthesis: III. A new method for fabrication of
   high-density hermetic feedthroughs
SO 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15
LA English
DT Proceedings Paper
CT 28th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 30-SEP 03, 2006
CL New York, NY
SP IEEE Engn Med & Biol Soc
DE hermetic feedthrough; implant; vision prosthesis
ID METAL
AB Therapeutic, electronic medical implants used in auditory, visual, functional, and behavioral neuroprosthesis often are required to maintain their function for the remaining lifetime of the implantee. This requirement presents a substantial engineering obstacle that has previously limited the practical tipper quantity of electrodes, or other signal carrying channels such devices may possess. Hermetic encapsulation of any implanted electronics and the tendency of this encapsulation to leak is a well-known problem for biomedical engineers. Each "hard-wired" signal required by, or elicited from, the implant must pass through the encapsulation without breaching hermecticity. The present paper describes a method of fabrication of hermetic feedthoughs (leak < 2 x 10(-9) std cc He/s) comprising materials with superior biological compatibility characteristics and able to accommodate relatively high numbers of signal carrying channels relative to existing methods, while allowing this to occur within small areas.
C1 [Suaning, G. J.; Lavoie, P.; Forrester, J.; Armitage, T.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia.
   [Suaning, G. J.; Lovell, N. H.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Suaning, GJ (reprint author), Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia.
CR ALLEN RV, 1983, J MATER SCI, V18, P2835, DOI 10.1007/BF00547601
   *ASTM, 2003, STAND TEST METH HERM
   Backous DD, 2002, OTOL NEUROTOL, V23, P463, DOI 10.1097/00129492-200207000-00012
   BLACK MM, 1982, PHYS TECHNOL, V13, P50, DOI 10.1088/0305-4624/13/2/302
   DEBRUIN HJ, 1978, NATURE, V272, P712, DOI 10.1038/272712a0
   DEBRUIN HJ, 1972, J MATER SCI, V7, P909, DOI 10.1007/BF00550438
   Jiang GQ, 2005, J BIOMED MATER RES B, V72B, P316, DOI 10.1002/jbm.b.30161
   Klomp JT, 1970, SCI CERAM, V5, P501
   Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020
   Schuettler M, 2005, J NEURAL ENG, V2, pS121, DOI 10.1088/1741-2560/2/1/013
NR 10
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0032-4
PY 2006
BP 5253
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BGI19
UT WOS:000247284706038
DA 2018-10-20
ER

PT B
AU Tran, TH
   Kwon, JH
   Lee, KS
   Lee, JW
   Ju, BK
AF Tran, Thu-Hong
   Kwon, Jae-Hong
   Lee, Kyong-Soo
   Lee, Jin-Woo
   Ju, Byeong-Kwon
GP IEEE
TI pH sensor using carbon nanotubes as sensing material
SO 2006 FIRST INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND ELECTRONICS
LA English
DT Proceedings Paper
CT 1st International Conference on Communications and Electronics (ICCE
   2006)
CY OCT 10-11, 2006
CL Hanoi Univ Technol, Hanoi, VIETNAM
SP IEEE
HO Hanoi Univ Technol
DE sensor; hydroxyl ions; single wall carbon nanotube (SWCNT)
ID CELLS
AB Carbon nanotube (CNT) integrated with biological functionalities is expected to be one of the most promising field in future biomedical applications. CNT material with prominent properties along with application of micro fabrication technology make possible enormous application potential sensors with high resolution, more accurate, higher sensitivity and micrometer size. One of these applications, introduced in this paper, is pH sensors using CNT as sensing material. Monitoring and evaluating the pH of the solution in a bioprocess is one of the key steps in the success of bioreactor operation. Our proposal based on the changes significantly in electrical property of CNT under different pH environment. This paper describes a method for designing a simple and fast response pH sensor employing single wall carbon nanotube (SWCNT) using a spray. The conductance and the typical amperometric respond of SWCNT at room temperature at different hydroxyl ion concentrations were successfully demonstrated.
C1 [Tran, Thu-Hong; Kwon, Jae-Hong; Lee, Kyong-Soo; Lee, Jin-Woo; Ju, Byeong-Kwon] Korea Univ, Coll Engn, Display & NanoSyst Lab, 5Ka 1, Seoul 136701, South Korea.
   [Ju, Byeong-Kwon] Korea Univ, Dept Phys, Seoul 136701, South Korea.
RP Tran, TH (reprint author), Korea Univ, Coll Engn, Display & NanoSyst Lab, 5Ka 1, Seoul 136701, South Korea.
EM bkju@korea.ac.kr
RI Lee, Kyongsoo/G-3354-2012
OI Lee, Kyongsoo/0000-0003-2809-6107
FU Institute for Information Technology Advancement in the Ministry of
   Information and Communications
FX The project is funded by the Leading Edge R&D Program of the Institute
   for Information Technology Advancement in the Ministry of Information
   and Communications. Korea University assisted in meeting publication
   costs of this article.
CR Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bezryadin A, 1998, PHYS REV LETT, V80, P4036, DOI 10.1103/PhysRevLett.80.4036
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Franklin NR, 2002, APPL PHYS LETT, V81, P913, DOI 10.1063/1.1497710
   Fu Q, 2005, J PHYS CHEM B, V109, P13406, DOI 10.1021/jp0525686
   Guillorn MA, 2002, APPL PHYS LETT, V81, P2860, DOI 10.1063/1.1512955
   JOSEPH W, 2004, ELECTROANAL, V17, P7
   Landi BJ, 2005, PROG PHOTOVOLTAICS, V13, P165, DOI 10.1002/pip.604
   Pan H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245425
   Sinnott SB, 2001, CRIT REV SOLID STATE, V26, P145, DOI 10.1080/20014091104189
   SMART SK, 2005, IN PRESS CARBON
   Tans SJ, 1998, NATURE, V393, P49
   WANG J, 2005, ELECTROANALYSIS
   Watson KA, 2005, POLYMER, V46, P2076, DOI 10.1016/j.polymer.2004.12.057
   Zhao W, 2002, J AM CHEM SOC, V124, P12418, DOI 10.1021/ja027861n
   Zheng Ming, 2004, J Am Chem Soc, V126, P15490, DOI 10.1021/ja0457967
   1991, SUMIO NATURE, V354, P56
NR 17
TC 1
Z9 1
U1 1
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0568-8
PY 2006
BP 490
EP +
DI 10.1109/CCE.2006.350876
PG 2
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BGH53
UT WOS:000246996300092
DA 2018-10-20
ER

PT S
AU Lee, BS
   He, JJ
   Wu, WJ
   Shih, WP
AF Lee, Bor-Shun
   He, Jyun-Jhang
   Wu, Wen-Jong
   Shih, Wen-Pin
GP IEEE
TI MEMS power receiver using piezoelectric cantilever beams and
   interdigitated electrodes
SO 2006 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN, AND CYBERNETICS,
   VOLS 1-6, PROCEEDINGS
SE IEEE International Conference on Systems Man and Cybernetics Conference
   Proceedings
LA English
DT Proceedings Paper
CT IEEE International Conference on Systems, Man and Cybernetics
CY OCT 08-11, 2006
CL Taipei, TAIWAN
SP IEEE Syst, Man & Cybernet Soc, Minist Educ, Natl Sci Council, Natl Taipei Univ Technol, Natl Chiao Tung Univ
AB Over the years, there has been a growing interest in the field of power transmission technologies for low-power electronic devices, such as wireless sensor networks and biomedical sensor applications. Among all possible energy sources, the mechanical vibrations have been considered as a potential choice for power transmission in a wide variety of applications. This paper presents the development of a piezoelectric MEMS transducer which has the ability to receive mechanical energy of ambient vibrations from an external generator and transform it into electrical energy that can be used in energy storage applications. The piezoelectric MEMS transducer comprises of a beam structure based on the silicon wafer and a pair of interdigitated electrodes placed in between the lead zirconate titanate (Pb(Zr,Ti)O-3, PZT) material and the beam structure. This transducer transforms mechanical strain energy into electrical charge with the d(33) mode of PZT. An optional proof mass can be built at the tip of the beam to adjust the structure resonant frequency of the transducer for most adaptable frequency matching to the various vibration generators. A theoretical model is also presented to investigate the relations between the charge generation ability and the design parameters of the transducer. To optimize the fabrication, a customized PZT deposition chamber which could deposit PZT thin film up to tens micron in minutes was used to deposit the piezoelectric layer on the beam structure.
C1 [Lee, Bor-Shun; He, Jyun-Jhang] Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 106, Taiwan.
   [Shih, Wen-Pin] Natl Taiwan Univ, Dept Mech Engn, Taipei 106, Taiwan.
RP Lee, BS (reprint author), Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 106, Taiwan.
EM wpshih@ntu.edu.tw
RI Wu, Wen-Jong/C-4246-2013
OI Wu, Wen-Jong/0000-0003-0223-249X
FU Technology Development Program for Academic; Ministry of Economics
   Affairs, Taiwan
FX This work was supported by the Technology Development Program for
   Academic by Ministry of Economics Affairs, Taiwan.
CR AMIRTHARAJAH R, 1999, THESIS I TECHNOLOGY
   FENNER RT, 1986, ENG ELASTICITY, P179
   *IEEE, 1978, 176 IEEE STAND
   JEON YB, 2003, CIRP SEM MICR NAN TE
   Roundy S., 2003, IEEE INT S LOW POW E
   Roundy S., 2003, ENERGY SCAVENGING WI
   Sodano H. A., 2004, Shock and Vibration Digest, V36, P197, DOI 10.1177/0583102404043275
   Williams CB, 1996, SENSOR ACTUAT A-PHYS, V52, P8, DOI 10.1016/0924-4247(96)80118-X
NR 8
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1062-922X
BN 978-1-4244-0099-7
J9 IEEE SYS MAN CYBERN
PY 2006
BP 3227
EP +
DI 10.1109/ICSMC.2006.384614
PG 2
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Computer Science, Cybernetics
SC Automation & Control Systems; Computer Science
GA BGK85
UT WOS:000248078503091
DA 2018-10-20
ER

PT S
AU Stieglitz, T
AF Stieglitz, Thomas
GP IEEE
TI Biomedical microimplants for sensory and motor neuroprostheses
SO 2006 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-11,
   PROCEEDINGS
SE IEEE International Symposium on Circuits and Systems
LA English
DT Proceedings Paper
CT IEEE International Symposium on Circuits and Systems
CY MAY 21-24, 2006
CL Kos, GREECE
SP IEEE
ID FUTURE PERSPECTIVES; PROSTHESIS; STIMULATION; ELECTRODES; IMPLANTS;
   PATIENT
AB Neuroprostheses are devices that directly interface a technical implant with the human nervous system to restore sensory or motor function or to modulate the central nervous system properties after traumatization or severe diseases. respectively. Nowadays, cochlea implants help the deaf to hear and bladder stimulators control the micturition in spinal cord injuried subjects. Deep brain stimulation of patients with Parkinson's disease suppresses tremor and electrical stimulation of the spinal cord modulates the hyperactive bladder. Research is done in various fields for several challenging applications to make the blind see and the lame walk with the help of neural prostheses. Microsystem technology offers tremendous opportunities in this field due to its inherently high degree of minaturization. Flexible and light-weighted multichannel devices to interface the nervous system have been developed. Materials like polyimide and parylene C were combined with medical grade silicone rubbers to assemble flexible microimplants with recording and stimulation circuitry, telemetric signal and energy transmission. Some examples will be discussed in this paper to give an overview of possibilities and limitations of this technological approach.
C1 Univ Freiburg, IMTEK, Dept Microsyst Engn, Lab Biomed Microtechnol, D-79110 Freiburg, Germany.
RP Stieglitz, T (reprint author), Univ Freiburg, IMTEK, Dept Microsyst Engn, Lab Biomed Microtechnol, Georges-Koehler Allee 102, D-79110 Freiburg, Germany.
EM stieglitz@imtek.de
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
CR Alteheld N, 2004, BIOMED TECH, V49, P99, DOI 10.1515/BMT.2004.020
   FEDERSPIL P, 2004, BIOMED TECH, V49, P76
   JUDSON JP, 1968, J AMER MED ASSOC, V203, P1033, DOI 10.1001/jama.203.12.1033
   Kuchta J, 2004, BIOMED TECH, V49, P83, DOI 10.1515/BMT.2004.017
   Lago N, 2005, BIOMATERIALS, V26, P2021, DOI 10.1016/j.biomaterials.2004.06.025
   LIBERSON W T, 1961, Arch Phys Med Rehabil, V42, P101
   Meyer JU, 2001, IEEE TRANS ADV PACK, V24, P366, DOI 10.1109/6040.938305
   Navarro X, 1998, J PERIPHER NERV SYST, V3, P91
   Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9
   Rijkhoff NJM, 2004, CHILD NERV SYST, V20, P75, DOI 10.1007/s00381-003-0859-1
   Rupp R, 2004, BIOMED TECH, V49, P93, DOI 10.1515/BMT.2004.019
   SAUERWEIN DS, 2003, EUR UROL, V2, P565
   Stieglitz T, 2004, P ANN INT IEEE EMBS, V26, P4178
   Stieglitz T, 2005, IEEE ENG MED BIOL, V24, P58, DOI 10.1109/MEMB.2005.1511501
   STIEGLITZ T, 2003, P 8 ANN INT C INT FU, P69
   Stieglitz T, 2000, BIOMED MICRODEVICES, V2, P283, DOI 10.1023/A:1009955222114
   Veraart C, 2004, EXPERT REV MED DEVIC, V1, P139, DOI 10.1586/17434440.1.1.139
   Walter P, 2005, INVEST OPHTH VIS SCI, V46, P1780, DOI 10.1167/iovs.04-0924
NR 18
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0271-4302
BN 978-0-7803-9389-9
J9 IEEE INT SYMP CIRC S
PY 2006
BP 2189
EP 2192
DI 10.1109/ISCAS.2006.1693053
PG 4
WC Computer Science, Hardware & Architecture; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BFY13
UT WOS:000245413502154
DA 2018-10-20
ER

PT B
AU Dargahi, J
   Najarian, S
   Changizi, MA
AF Dargahi, Javad
   Najarian, Siamak
   Changizi, Mohammad Amin
BE Lavoie, M
   AlHaddad, K
   Lagace, PJ
TI A novel tactile probe with applications in biomedical robotics
SO 2006 IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, VOLS 1-7
LA English
DT Proceedings Paper
CT IEEE International Symposium on Industrial Electronics
CY JUL 09-13, 2006
CL Montreal, CANADA
SP IEEE Ind Elect Soc, ABB Canada, Ecol Technol Superieure
ID ENDOSCOPIC GRASPER; SENSOR
AB In this research, sensitivity of a novel tactile probe was investigated experimentally and theoretically. These probes are made from three different parts, a rigid Plexiglas as support and two different compressible materials. As the sensing elements, two piezoelectric films of PVDF are incorporated into the probe and the combination of the resulting output voltages is related to the object softness. Depending on the softness of the sensed objects, there is a distinct difference between the output voltages. Harder objects tend to manifest waveforms with higher peaks and with steeper rises at the start of the tests. We made use of these important features and conducted a number of tests in order to analyze the sensitivity of the designed probe. A mathematical model based on the properties of various elements in the tactile probe is developed, which could reasonably predict the general performance of the system. The effects of different parameters such as, softness of the two compressible sections of the probe, their thickness, and their corresponding area ratios are tested experimentally. Using the developed model, the experimental results are predicted with good accuracy and the discrepancy is found to be within the acceptable range. This prototype has applications in determining the softness of biological tissues/objects both in routine clinical examinations and during surgeries.
C1 [Dargahi, Javad; Changizi, Mohammad Amin] Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada.
   [Najarian, Siamak] Amirkabir Univ Technol, Dept Biomech, Tehran, Iran.
RP Dargahi, J (reprint author), Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada.
EM Mo_Chang@Encs.concordia.ca
CR BARCOHEN Y, 2000, P INT C SMART SYST R
   Brouwer I, 2001, ST HEAL T, V81, P69
   CORDOVA CJC, 2004, ELASTODYNAMICS HYSTE
   Dargahi A, 2005, IND ROBOT, V32, P268, DOI 10.1108/01439910510593965
   Dargahi J, 2000, J MICROELECTROMECH S, V9, P329, DOI 10.1109/84.870059
   Dargahi J, 2004, INT J MED ROBOT COMP, V1, P23, DOI 10.1581/mrcas.2004.010109
   Dargahi J, 2005, SENSOR MATER, V17, P7
   Dargahi J., 2004, Sensor Review, V24, P284, DOI 10.1108/02602280410545416
   Dargahi J, 2005, CAN J ELECT COMPUT E, V30, P225, DOI 10.1109/CJECE.2005.1541755
   Dargahi J., 2004, Sensor Review, V24, P74, DOI 10.1108/02602280410515851
   Dargahi J, 2004, SENSOR MATER, V16, P25
   Dargahi J, 2003, CAN J ELECT COMPUT E, V28, P155, DOI 10.1109/CJECE.2003.1425102
   Dargahi J, 2000, SENSOR ACTUAT A-PHYS, V80, P23, DOI 10.1016/S0924-4247(99)00295-2
   Dargahi J, 2002, J MECH DESIGN, V124, P576, DOI 10.1115/1.1471531
   Dargahi J, 1998, SENSOR ACTUAT A-PHYS, V71, P89, DOI 10.1016/S0924-4247(98)00159-9
   DARGAHI J, 1993, THESIS GLASGOW CALED
   Eringen A. C., 1975, ELASTODYNAMICS
   FISCH A, 2003, BIOL INSPIRED INTELL, pCH4
   Hibbeler RC, 2002, MECH MAT
   HOWE RD, 1994, P IEEE ENG MED BIOL, V14, P318, DOI DOI 10.1109/51.391770
   KAELIN CM, 2005, LIVING BREAST CANC
   Lee MH, 2000, INT J ROBOT RES, V19, P636, DOI 10.1177/027836490001900702
   Lee MH, 1999, MECHATRONICS, V9, P1, DOI 10.1016/S0957-4158(98)00045-2
   Murayama Y, 2004, J BIOMECH, V37, P67, DOI 10.1016/S0021-9290(03)00242-2
   NODA K, 2006, IN PRESS SENSORS A A
   Odon A., 2003, MEAS SCI REV, V3, P111
   Takashima K, 2005, SENSOR ACTUAT A-PHYS, V119, P372, DOI 10.1016/j.sna.2004.10.015
NR 27
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0496-4
PY 2006
BP 3345
EP +
PG 2
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BFS70
UT WOS:000244382906064
DA 2018-10-20
ER

PT S
AU Brand, S
   Klaua, R
   Dietrich, G
   Schultz, M
AF Brand, Sebastian
   Klaua, Robert
   Dietrich, Georg
   Schultz, Michael
GP IEEE
TI Ultrasonic Detection and quantitative analysis of microscopic bubbles
   and particles in solution: enhanced by attenuation compensation
SO 2006 IEEE ULTRASONICS SYMPOSIUM, VOLS 1-5, PROCEEDINGS
SE Ultrasonics Symposium
LA English
DT Proceedings Paper
CT IEEE Ultrasonics Symposium
CY OCT 03-06, 2006
CL Vancouver, CANADA
SP IEEE
DE ultrasound; bubble detection; patient safety; artherial filter;
   extracorporal circuit
AB In many technical and medical applications microscopic bubbles and particles play an important role. For a non-invasive and quantitative estimation of the particle characteristics acoustic properties along the path of sound propagation are of major concern. When applying clamp-on probes that can be used with a variety of tubes the compensation of the acoustic attenuation is crucial for reliable parameter estimation. In addition, the acoustic properties of the tube material vary as a function of environmental conditions. An ultrasonic probe that enabled an automated and real-time compensation for attenuation properties was under investigation. The set up employs ultrasound in pulsed wave Doppler mode to provide a higher sensitivity for moving objects. Experiments on different tubes (wall-thickness and material) were performed. Glass beads with Gaussian distributed diameters between 300 mu m and 400 mu m were used as bubble-phantoms. The means and standard deviations of the particle sizes were estimated from the compensated and uncompensated signals. Size estimates were in the range between 100 and 700 mu m with a standard deviation of up to 100% when using uncompensated signals. Standard deviations of the estimates applying the compensation algorithm were 50% with mean values of approximately 380 mu m. The described method for attenuation compensation was implemented in the bubble counter system BCC200 (GAMPT mbH, Zappendorf, Germany). It enables a precise monitoring of the occurrence of microscopic bubbles and solid particles for the application in open heart surgery and will increase the patient safety. With its performance the BCC200 can also be employed for the development of arterial filters and oxygenators in biomedical applications and for quality control in industrial applications.
C1 [Brand, Sebastian] Univ Halle Wittenberg, Q BAM Grp, Dept Orthopaed, Halle, Germany.
   [Klaua, Robert; Dietrich, Georg; Schultz, Michael] GAMPTmbH, Dept Med Res, Zappendorf, Germany.
RP Brand, S (reprint author), Univ Halle Wittenberg, Q BAM Grp, Dept Orthopaed, Halle, Germany.
EM Sebastian.Brand@medizin.uni-halle.de; info@gampt.de
CR Chang PH, 1996, ULTRASOUND MED BIOL, V22, P1205, DOI 10.1016/S0301-5629(96)00146-9
   DEVIN C, 1959, J ACOUST SOC AM, V31, P1654, DOI 10.1121/1.1907675
   JENDERKA KV, 2002, SENS 2002 P IEEE, V1, P528
   JENDERKA KV, 1998, P 1998 IEEE ULTR S, V2, P1819
   MEDWIN H, 1977, ULTRASONICS, V15, P7, DOI 10.1016/0041-624X(77)90005-1
   SHUNG KK, 1976, IEEE T BIO-MED ENG, V23, P460, DOI 10.1109/TBME.1976.324604
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 978-1-4244-0201-4
J9 ULTRASON
PY 2006
BP 1840
EP +
DI 10.1109/ULTSYM.2006.470
PG 2
WC Acoustics; Engineering, Electrical & Electronic; Physics, Applied
SC Acoustics; Engineering; Physics
GA BIK54
UT WOS:000260407801072
DA 2018-10-20
ER

PT S
AU Doraiswami, R
AF Doraiswami, Ravi
GP IEEE
TI Nano nickel-tin interconnects and electrodes for next generation 15
   micron pitch embedded bio fluidic sensors in FR4 substrates
SO 56th Electronic Components & Technology Conference 2006, Vol 1 and 2,
   Proceedings
SE ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE
LA English
DT Proceedings Paper
CT 56th Electronic Components and Technology Conference
CY 2006
CL San Diego, CA
SP Elect Components, Assembilies & Mat Assoc, Elect Ind Alliance, IEEE Components, Packaging & Mfg Technol Soc, IEEE
AB Lead free solder bumping requirements have challenged researchers to develop new technologies to achieve fine pitch interconnects. ITRS has predicts that by 2017 the industry will require 70 micron pitch area array lead free interconnects for flip chips. This paper describes bumping, assembly and reliability evaluation of a new nano composite 15 micron pitch interconnect technology.
   Nanoparticles are the most common building blocks in several applications of Nanotechnology. Beside, the enormous increase of their surface area, the high surface to volume ratio of the nano particles results in extraordinary high reactivity, and unusual physical properties (optical, magnetic, etc.). Several types of nanostructures (nano particles, nano-wires and nano-rods) can be fabricated. Dispersed nano particles are used in several important applications, e.g., catalysis, biomedical applications, nano coatings and nanocomposites. Nanostructured materials, prepared by consolidating nanoparticles with a very high density of grain boundary, have been shown to lead to dramatically improved mechanical and physical properties. Lead free interconnect reliability has been a concern due tin pest (whiskers), intermetalics and high temperature reflow problems.
   This problem becomes even more pronounced when the pitch of the flip chip reduces to 100 microns or lesser. This paper proposes a novel nano metal composite for fine pitch lead free interconnect as an alternative to solder for fine pitch flip chip interconnect [1-2]. This paper describes design, process, fabrication and reliability test for composite interconnects fabricated using Ni nano particles distributed in a tin core. A wafer level process is developed for flip chip having 15 micron pitch composite nano structured interconnect. The composition and intermetallics formed at the chip-to- interconnect-interface are evaluated when sent through 4 reflow cycles. Composition of the intermetalics is evaluated to study the distribution Ni3Sn4, Cu6Sn5 and Cu3Sn. Shear test on the interconnects provide bump adhesion strength and fatigue resistance information. The failure mode associated with shear test is also presented. The chip is thermally cycled in a oven from -55 degrees C to 125 degrees C and after every 100 cycles is evaluated for defects using X-Ray and Sonoscan techniques. A crossection is made and the composition at interface is also evaluated for intermetalic diffusion. The paper provides optimized data for next generation nano composite interconnect for fine pitch flip chip to achieve high reliability. The paper also describes a process to fabricate substrates with nano lines and embedded fluidic channels.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Doraiswami, R (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
CR Aggarwal AO, 2004, 9TH INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, 2004 PROCEEDINGS, P69, DOI 10.1109/ISAPM.2004.1287991
   BAKIR MS, 2002, P 52 EL COMP TECHN C, P1087
   BROWNN W, 1999, ADV ELECT PACKAGING
   Colburn M, 1999, P SOC PHOTO-OPT INS, V3676, P379, DOI 10.1117/12.351155
   COLBURN M, 2000, 2000 SPIE 25 INT S M, V3, P311
   GUPTA P, 2003, P 5O EL COMP TECHN C, P34
   MA L, 2002, P EL COMP TECHN C, P1359
   MANCINI DP, 2003, SPIE MICR C FEB, P200
   RANK, 2004, SPIE MICR C FEB, P112
   Tummala RR, 2001, FUNDAMENTALS MICROSY
   ZHU Q, 2002, P C THERM PHEN EL SY, P833
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0569-5503
BN 1-4244-0151-8
J9 ELEC COMP C
PY 2006
SI 2006
BP 1323
EP 1325
DI 10.1109/ECTC.2006.1645826
PG 3
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEP36
UT WOS:000238566601035
DA 2018-10-20
ER

PT B
AU Lin, H
   Dan, WH
   Dan, NH
   Ye, YC
   Guan, LB
   Mi, ZJ
AF Lin Hai
   Dan Weihua
   Dan Nianhua
   Ye Yichun
   Guan Linbo
   Mi Zhenjian
GP Sichuan Univ
TI Preparation and characterization of collagen powder
SO 7th Asian International Conference of Leather Science and Technology
   Sect 1 and 2
LA English
DT Proceedings Paper
CT 7th Asian International Conference of Leather Science and Technology
CY OCT 15-18, 2006
CL Chengdu, PEOPLES R CHINA
SP China Leather Ind Assoc, Japanese Assoc Leather Technol, Korea Inst Footwear & Leather Technol, Sichuan Leather Assoc, China Leather & Footwear Ind Res Inst, Shandong Coll Light Ind, Tanners Council Japan, Hokkaido Univ, Tokyo Univ Agr & Technol
DE collagen powder; preparation; characterization; biomaterial; porcine
   skin
AB Possessed with particular structure, collagen has low antigencity associated with high biocompatibility and constitutes one of the major raw materials for biomaterial applications, which is being much more important in biomedical realm. Collagen powder was prepared from porcine skin with the optimized techniques acquired. The results of determination focused on collagen's components, structure and integrative performances, inculding Hydroxyproline Content Test, Amino Acid Analysis, Protein Content, Circular Dichroism (CD), FTIR, DSC, Isoelectric Point (PI) and SEM, indicated that collagen powder was pure, conformed to the characters of Type I Collagen and was preserved the natural triple helix in a great degree, which was indispensable as biomaterials.
C1 Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Sichuan, Peoples R China.
RP Dan, NH (reprint author), Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Sichuan, Peoples R China.
CR BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   *CHINA PHARM COMM, 2000, CHIN PHARM
   DAN WH, 2004, BIOMEDICAL ENG CLIN, V8, P45
   DAN WH, LEATHER CHEM, V21, P24
   DAN WH, 2004, BIOMEDICAL ENG CLIN, V8, P52
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   LEE CH, 2001, INT J PHARM, V222, P1
   LIN H, 2006, CHINESE LEATHER, V35, P26
   LIN H, 2006, CHINESE LEATHER, V35, P19
   LU ZX, 1987, CIRCULAR DICHROISM I
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Sivakumar P, 2000, COMP BIOCHEM PHYS B, V125, P555, DOI 10.1016/S0305-0491(00)00167-X
   TAN W, 2000, P 22 ANN INT C IEEE, V2, P1509
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Uskokovic V, 2003, MATER SCI FORUM, V413, P269
   WANG Ji-hua, 2004, CHEMISTRY, V7, P482
   Xie MX, 2003, CHEM J CHINESE U, V24, P226
NR 17
TC 0
Z9 0
U1 0
U2 9
PU CHINESE LEATHER INDUSTRY ASSOC
PI CHENGDU
PA C/O KEY LABORATORY OF LEATHER CHEM & ENG MINISTRY EDUCATION, SICHUAN
   UNIV, CHENGDU, 610065, PEOPLES R CHINA
PY 2006
BP 1099
EP 1106
PG 8
WC Engineering, Manufacturing; Materials Science, Textiles
SC Engineering; Materials Science
GA BFS71
UT WOS:000244383100147
DA 2018-10-20
ER

PT S
AU Yamashita, T
   Ohishi, Y
AF Yamashita, Tatsuya
   Ohishi, Yasutake
BE Dutta, AK
   Ohishi, Y
   Dutta, NK
   Moerk, J
TI Spectroscopic properties of Tb3+-Yb3+ codoped toorosilicate glasses for
   green lasers and amplifiers
SO ACTIVE AND PASSIVE OPTICAL COMPONENTS FOR COMMUNICATIONS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Active and Passive Optical Components for Communication VI
CY OCT 03-04, 2006
CL Boston, MA
SP SPIE
DE laser material; fiber laser; optical amplifier; up-conversion;
   cooperative energy transfer
ID RARE-EARTH IONS; UP-CONVERSION; FIBER LASERS; LUMINESCENCE; INTENSITIES;
   ABSORPTION; CRYSTAL
AB Visible fiber lasers and amplifiers have potential applications in the fields of optical data storage, spectroscopy, biomedical, and optical local area networks. A spectroscopic analysis has been performed on a borosilicate glass, codoped with Tb3+ and Yb3+, to assess this material as a green laser and amplifier medium. The rare-earth ion concentration effect on thermal, absorption, and emission properties of the glasses were investigated using differential scanning calorimetry, UV/VIS/NIR absorption, and luminescence measurements, respectively. These materials were found to have good glass-forming ability, and show a high thermal stability, indicating the potential to facilitate low-loss fiber fabrication. Judd-Oflet analysis was performed for Tb3+ doped in the borosilicate glasses. The radiative lifetime of the D-5(4) level was found to be 2.6 ms, and was almost constant in 0.5-15 wt.% concentration range. The peak cross section for stimulated emission by the D-5(4)-> F-7(5) transition was found to be 0.8x10(-21) cm(2) at lambda = 542 nm. In the Tb3+-Yb3+- codoped glasses, the green emission resulting from the cooperative energy transfer between doped ions was observed under infrared excitation (lambda(ex) = 0.98 mu m). This upconversion emission increased with doping ion concentration. These results suggested that the Tb3+-Yb3+-codoped borosilicate glass is a promising candidate for an all-solid-state upconversion green laser and amplifier.
C1 [Yamashita, Tatsuya; Ohishi, Yasutake] Toyota Technol Inst, Tempaku Ku, 2-12-1 Hisakata, Nagoya, Aichi 4688511, Japan.
   [Yamashita, Tatsuya] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.
RP Yamashita, T (reprint author), Toyota Technol Inst, Tempaku Ku, 2-12-1 Hisakata, Nagoya, Aichi 4688511, Japan.
FU "High-Tech Research Center" project for private Universities from
   Ministry of Education, Culture, Sports, Science and Technology (MEXT)
FX This work is partly supported by the High-Tech Research Center project
   for private Universities: matching found subsidy from Ministry of
   Education, Culture, Sports, Science and Technology (MEXT), 2002-2006.
CR ALLAIN JY, 1992, ELECTRON LETT, V28, P111, DOI 10.1049/el:19920068
   Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g
   BJORKLUND S, 1967, APPL PHYS LETT, V10, P160, DOI 10.1063/1.1754892
   CAIRD JA, 1981, J CHEM PHYS, V74, P805, DOI 10.1063/1.441182
   Carnall W. T., 1977, ENERGY LEVEL STRUCTU
   DELOACH LD, 1993, IEEE J QUANTUM ELECT, V29, P1179, DOI 10.1109/3.214504
   FUNK DS, 1995, IEEE J SEL TOP QUANT, V1, P784, DOI 10.1109/2944.473660
   JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750
   Kam CH, 2003, PHYSICA B, V337, P237, DOI 10.1016/S0921-4526(03)00409-5
   Noginov MA, 1996, J OPT SOC AM B, V13, P735, DOI 10.1364/JOSAB.13.000735
   OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366
   OHISHI Y, 1994, IEICE T COMMUN, VE77B, P421
   OSTERMAYER FW, 1970, PHYS REV B-SOLID ST, V1, P4208, DOI 10.1103/PhysRevB.1.4208
   Paschotta R, 1997, J OPT SOC AM B, V14, P1213, DOI 10.1364/JOSAB.14.001213
   WHITLEY TJ, 1991, ELECTRON LETT, V27, P1785, DOI 10.1049/el:19911110
   YAMADA Y, 1991, P SOC PHOTO-OPT INS, V1581, P304
   YAMASHITA T, 2006, IN PRESS P ECOC 2006
NR 17
TC 11
Z9 11
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6487-2
J9 PROC SPIE
PY 2006
VL 6389
AR 638912
DI 10.1117/12.685507
PG 11
WC Optics; Telecommunications
SC Optics; Telecommunications
GA BFI52
UT WOS:000242037000032
DA 2018-10-20
ER

PT S
AU Antunes, RA
   Wiggers, WS
   Terada, M
   Vendhausen, PAP
   Costa, I
AF Antunes, Renato A.
   Wiggers, Wagner S.
   Terada, Maysa
   Vendhausen, Paulo A. P.
   Costa, Isolda
BE Salgado, L
   Filho, FA
TI The corrosion behaviour of TiN-coated powder injection molded AISI 316L
   steel
SO ADVANCED POWDER TECHNOLOGY V
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Latin American Conference on Powder Technology
CY OCT 26-29, 2005
CL Salvador, BRAZIL
SP Abbott, Basf, Brats, Bruker, Citra, Cofap, Combustol Metalpo, Dorst, Durit, Eckagranules, Engefor, GIG, Hoganas Brasil, Inco, Mahle Miba, Magneti Marelli, Metaldyne `, Mextra, QMP, Qualisinter, SCM, Shimadzu, Zoz
DE corrosion; powder injection moulding; AISI 316L; TiN
ID STAINLESS-STEEL; RESISTANCE; GAS
AB The use of AISI 316L stainless steels for biomedical applications as implants is widespread due to a combination of low cost and easy formability. However, wrought 316L steel is prone to localized corrosion. Coating deposition is commonly used to overcome this problem. Ceramic hard coatings, like titanium nitride, are used to improve both corrosion and wear resistance of stainless steels. Powder injection moulding (PIM) is an attractive method to manufacture complex, near net-shape components. Stainless steels obtained from this route have shown mechanical and corrosion properties similar to wrought materials. The literature on the use of PIM 316L steel, either coated or not, as implants is still very scarce. The aim of the present work was to study the corrosion behaviour of PIM 316L in two conditions: TiN-coated and bare. Electrochemical investigations were performed using EIS and potentiodynamic polarization techniques.
C1 [Antunes, Renato A.; Terada, Maysa; Costa, Isolda] CNEN SP, IPEN, CCTM, Av Prof Lineu Prestes 2242,Cidade Univ, BR-05508900 Sao Paulo, Brazil.
   [Wiggers, Wagner S.; Vendhausen, Paulo A. P.] UFSC, Engn Mat, Florac, France.
RP Antunes, RA (reprint author), CNEN SP, IPEN, CCTM, Av Prof Lineu Prestes 2242,Cidade Univ, BR-05508900 Sao Paulo, Brazil.
EM icosta@ipen.br
RI Costa, Isolda/E-8506-2012; Antunes, Renato/K-4738-2015; Terada,
   Maysa/D-3277-2012
OI Costa, Isolda/0000-0002-4987-3334; Antunes, Renato/0000-0003-1540-6495;
   Terada, Maysa/0000-0002-2011-5759
FU CNPq; CAPES
FX Authors are grateful to CNPq and CAPES for the financial support to this
   work. Lupatech S/A and Brasimet S/A are acknowledged for providing the
   PIM 316L stainless steel specimens and the TiN coating deposition,
   respectively.
CR CAI LX, 1995, INT J POWDER METALL, V31, P257
   Fathi MH, 2003, DENT MATER, V19, P188, DOI 10.1016/S0109-5641(02)00029-5
   Hubler R, 2001, SURF COAT TECH, V142, P1078, DOI 10.1016/S0257-8972(01)01321-4
   Koseski RP, 2005, MAT SCI ENG A-STRUCT, V390, P171, DOI 10.1016/j.msea.2004.08.002
   Liu C, 2003, SURF COAT TECH, V163, P597, DOI 10.1016/S0257-8972(02)00630-8
   NYLUND A, 1995, INT J POWDER METALL, V31, P365
   OTERO E, 1995, MATER CHARACT, V35, P145, DOI 10.1016/1044-5803(95)00099-2
   PEREIRA ML, 1995, J MATER SCI-MATER M, P523
   SHARON A, 1994, POWDER METALL, V37, P67, DOI 10.1179/pom.1994.37.1.67
   SOBRAL AVC, 2001, SCIENCE, P1019
NR 10
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2006
VL 530-531
BP 105
EP +
DI 10.4028/www.scientific.net/MSF.530-531.105
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFT13
UT WOS:000244481100017
DA 2018-10-20
ER

PT S
AU Rigo, ECS
   Bottino, MC
   Carraro, BD
   Taddei, EB
   Henriques, VAR
   Silva, CRM
   Bressiani, AHA
   Bressiani, JC
AF Rigo, E. C. S.
   Bottino, M. C.
   Carraro, B. D.
   Taddei, E. B.
   Henriques, V. A. R.
   Silva, C. R. M.
   Bressiani, A. H. A.
   Bressiani, J. C.
BE Salgado, L
   Filho, FA
TI Biomimetic coatings on Ti-based alloys obtained by powder metallurgy for
   biomedical applications
SO ADVANCED POWDER TECHNOLOGY V
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Latin American Conference on Powder Technology
CY OCT 26-29, 2005
CL Salvador, BRAZIL
SP Abbott, Basf, Brats, Bruker, Citra, Cofap, Combustol Metalpo, Dorst, Durit, Eckagranules, Engefor, GIG, Hoganas Brasil, Inco, Mahle Miba, Magneti Marelli, Metaldyne `, Mextra, QMP, Qualisinter, SCM, Shimadzu, Zoz
DE powder metallurgy; titanium alloys; biomimetic method; hydroxyapatite;
   sodium silicate
ID CHEMICALLY TREATED TITANIUM; MECHANICAL-PROPERTIES; TI-13NB-13ZR ALLOY;
   DENTAL IMPLANTS; BIOCOMPATIBILITY; MICROSTRUCTURE; PHOSPHATE; ELEMENTS;
   GROWTH
AB Comparing to hydroxyapatite (HA), which forms a strong chemical bond with the bony tissues, metallic materials are not able to bond with bone. For this reason, a great variety of complex coating methods, such as pulse-laser deposition, ion-beam assisted deposition and plasma-spray has been used to form a HA layer onto metallic surfaces. This study evaluated the performance of the biomimetic technique on apatite-based coating formation on two Ti-alloys. Ti-13Nb-13Zr and Ti-35Nb-7Zr-5Ta were obtained via powder metallurgy. The Ti-based alloys were biomimetically coated using a technique which was modified from the conventional ones using a sodium silicate solution as the nucleant agent. Both alloys presented similar behavior in the evaluated conditions which means the formation of a homogeneous and well defined HA coating. These results show that these new non-toxic Ti-alloys seem to be very promising for biomedical applications.
C1 Univ Sao Francisco, PPG Engn & Ciencia Mat, Rua Alexandre R Barbosa 45, BR-13251900 Itatiba, SP, Brazil.
RP Rigo, ECS (reprint author), Univ Sao Francisco, PPG Engn & Ciencia Mat, Rua Alexandre R Barbosa 45, BR-13251900 Itatiba, SP, Brazil.
EM eliana.rigo@saofrancisco.edu.br
RI Rigo, Eliana/H-4926-2012; Henriques, Vinicius/G-2465-2012; Bressiani,
   Jose/I-1426-2012; da Silva, Cosme/J-1394-2018; Bressiani,
   Ana/I-1402-2012
OI Rigo, Eliana/0000-0003-3368-5707; da Silva, Cosme/0000-0001-6301-6446;
   Bottino, Marco C./0000-0001-8740-2464
FU FAPESP; CAPES
FX The authors gratefully thank the financial support provided by FAPESP
   and CAPES.
CR Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Berthon G, 2002, COORDIN CHEM REV, V228, P319, DOI 10.1016/S0010-8545(02)00021-8
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   HENCH LL, 1991, CERAMIC GLASSES GLAS
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Kokubo T, 1999, COMPOS PART A-APPL S, V30, P405, DOI 10.1016/S1359-835X(98)00127-4
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kutty MG, 2004, J MATER SCI-MATER M, V15, P145, DOI 10.1023/B:JMSM.0000011815.50383.bd
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lemons Jack E, 2004, J Oral Implantol, V30, P318, DOI 10.1563/0712.1
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Stoch A, 1999, J MOL STRUCT, V511, P287, DOI 10.1016/S0022-2860(99)00170-2
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
NR 22
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2006
VL 530-531
BP 599
EP +
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFT13
UT WOS:000244481100097
DA 2018-10-20
ER

PT S
AU Hanawa, T
AF Hanawa, T
BE Umakoshi, Y
   Fujimoto, S
TI Recent development of new alloys for biomedical use
SO ADVANCED STRUCTURAL AND FUNCTIONAL MATERIALS DESIGN, PROCEEDINGS
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Advanced Structural and Functional Materials
   Design
CY NOV 10-12, 2004
CL Osaka, JAPAN
SP 21st Century COE Program, Osaka Univ
DE alloy; biomaterial; titanium; stainless steel; shape memory alloy;
   surface modification; surface morphology
ID NITROGEN ABSORPTION TREATMENT; AUSTENITIC STAINLESS-STEEL;
   MECHANICAL-PROPERTIES; CORROSION BEHAVIOR; AMORPHOUS-ALLOYS
AB Metallic materials are widely used in medicine not only for orthopedic implants but also for cardiovascular devices and other purposes. New alloys for biomedical use are developed all over the world continuously to decrease corrosion, toxicity and fracture during implantation and increase interfacial and dynamical tissue compatibility. Most of efforts are made to develop titanium alloys, especially in P-type alloys whose Young's modulus is as low as cortical bone. Nickel-free alloy is also necessary to prevent nickel allergy: nickel-free austenitic stainless steels and shape memory alloys are developed. To increase biocompatibility, the controls of surface morphology and surface treatment or modification are necessary.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Chiyoda Ku, Tokyo 1010062, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
CR Baker C., 1971, Metal Science Journal, V5, P92
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Gebeau RC, 2001, ADV MATER PROCESS, V159, P46
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Hiromoto S, 2001, CORROS SCI, V43, P1767, DOI 10.1016/S0010-938X(00)00168-2
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   *JAP STAINL STEEL, 1995, SUT BINR, P491
   KATADA Y, 2001, J MAT PROCESS TECHNO, V117
   KATADA Y, 2000, CUR ADV MAT P, V13, P116
   KOLLEROV MY, 1995, TITANIUM 95 SCI TECH, P2571
   Kuroda D, 2003, MATER TRANS, V44, P1363, DOI 10.2320/matertrans.44.1363
   Kuroda D, 2003, MATER TRANS, V44, P414, DOI 10.2320/matertrans.44.414
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MATSUSHITA T, 1999, MAT JAPAN, V38, P239
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   SASANO H, 1988, P 6 WORLD C TIT, P1667
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
NR 23
TC 18
Z9 18
U1 2
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-996-2
J9 MATER SCI FORUM
PY 2006
VL 512
BP 243
EP 248
DI 10.4028/www.scientific.net/MSF.512.243
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BEH28
UT WOS:000237250000042
DA 2018-10-20
ER

PT B
AU Subramanian, K
   Hwang, JJ
AF Subramanian, K.
   Hwang, Jihong
BE Gao, H
   Wang, J
   Jin, Z
   Guo, DM
TI Surface finishing processes and technologies: State-of-the art and
   emerging needs, in the global economy
SO ADVANCES IN ABRASIVE MACHINING AND SURFACING TECHNOLOGIES, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Surface Finishing Technology and Surface
   Engineering (ICSFT2006)
CY SEP 25-27, 2006
CL Dalian, PEOPLES R CHINA
SP Chinese Comm Surface Finishing Technol, Dalian Univ Technol, Univ New S Wales, Minist Educ, Key Lab Precis & Non Tradit Maching Technol, Natl Nat Sci Fdn China, Chinese Prod Engn Inst, Mech Engn Inst Liaoning Province, Dalian Assoc Sci & Technol, Dalian Yincheng Polishing Equipment Co Ltd, Dalian Longzheng Polishing Manufacture Co Ltd, Shenyang Mike Mat Maching Equipment Co Ltd
DE surface finishing; abrasive finishing processes; system approach; value
   chain
AB Engineering components are generally rigid objects defined by their shape, material properties as well as their surfaces. Each of these elements of an object plays a critical role in terms of its ability to meet the desired functional need or end result. Achieving such end results together with a judicious combination of the process economics are the keys to success in any industrial application.
   Growing range of applications in automotive, aerospace, bearings, cutting tools, biomedical, electronics, ceramics and other industries require processing a wide range of engineered materials. The functionality of these components as well as the productivity of these processes are constantly being challenged to meet the growing needs of Global Economy. In addition to that, many naturally available materials such as lumber, stone, etc. are machined and finished, in, response to the furniture and construction boom, worldwide.
   There are many competing processes available for the generation of surfaces in engineering components. Some are old, others new. But, each process relies on unique combination of process mechanisms or microscopic interactions, to generate the desired surfaces. Understanding such mechanisms leads to possibilities to propose and develop new finishing solutions and systems.
   In this over-view talk, we will survey the wide range of finishing processes, their applicability for engineering materials and components from a diversity of industries. This survey will be followed by the identification of governing mechanisms in selected processes, which have resulted in innovation of new process concepts. The talk will conclude with identification of a list of emerging needs and opportunities and methodologies to take advantage of such opportunities.
C1 [Subramanian, K.; Hwang, Jihong] St Gobain Co, Higgins Grinding Technol Ctr, 1 New Bond St,Mail Stop 413-201, Worcester, MA 01606 USA.
RP Subramanian, K (reprint author), St Gobain Co, Higgins Grinding Technol Ctr, 1 New Bond St,Mail Stop 413-201, Worcester, MA 01606 USA.
EM K.Subramanian@saint-gobain.com
CR HITCHINER M, 2002, IMTS 2002 MAN C CHIC
   KOMANDURI R, 1997, ANN CIRP, V46
   KOPAC J, 2006, IN PRESS J MAT PROCE
   SUBRAMANIAN K, 1994, ASM HDB, V5
   SUBRAMANIAN K, 2000, SYSTEM APPROACH STRA
   SUBRAMANIAN K, 1999, MEASUREMENT ANAL GRI
   TONSHOFF HK, 1998, ANN CIRP, V47
   WEBSTER J, 2004, ANN CIRP, V53
NR 8
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS DESIGN MANUFACTURING
PI RIVERWOOD
PA 26 WEEMALA AVE, RIVERWOOD, NSW NSW 2210, AUSTRALIA
BN 978-0-9580692-7-4
PY 2006
BP 1
EP +
PG 2
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BGD23
UT WOS:000246140100001
DA 2018-10-20
ER

PT S
AU Flack, WW
   Nguyen, HA
   Shaw, M
   Do Canto, M
AF Flack, Warren W.
   Nguyen, Ha-Ai
   Shaw, Mark
   Do Canto, Manny
BE Lin, Q
TI Highly re-entrant profiles in a thick photosensitive material for
   Nanotechnology applications
SO ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XXIII, PTS 1 AND 2
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Advances in Resist Technology and Processing XXIII
CY FEB 20-22, 2006
CL San Jose, CA
SP SPIE
DE re-entrant profiles; sidewall angle; ink-jet print head; MEMS; thick
   photoresist
AB The requirements for highly specialized photosensitive materials for nanotechnology and Micro-ElectroMechanical Systems (MEMS) applications are being driven by the rapid growth of consumer products incorporating these devices. These high volume consumer devices including accelerometers for air-bag sensors, biomedical sensors, optical switches and ink jet print heads. These applications all require ultra-thick photosensitive materials with highly controllable lithographic properties.
   For ink-jet print head applications, the lithography requirements include the formation of high aspect ratio structures with a negative (re-entrant) profile for nozzle formation. In order to form the required nozzle geometry for high resolution ink-jet printers, photosensitive materials need to be capable of providing up to 10 degree negative profiles at a film thickness of up to 25 microns. For consistent print dot size it is necessary to maintain excellent control and repeatability of the sidewall angle of the nozzle. Since this material remains on the substrate as a permanent part of the ink-jet print head, the mechanical and adhesive properties of the material are as important as the lithographic properties.
   This paper investigates modifications to an existing MicroChem epoxy-based SU8-4000 thick photoresist to generate highly re-entrant sidewall angles for next-generation high resolution ink-jet nozzle formation. Multiple versions of SU8-4000 with different levels of dye tuned for the exposure wavelength are exposed using a IX lithography system optimized for thick photoresist processing. This stepper uses a combination of low numerical aperture, broadband exposure and large focus offsets for optimal processing of thick photosensitive materials. Basic photoresist characterization techniques in conjunction with cross sectional SEM analysis are used to establish lithographic capabilities for nozzle formation.
C1 [Flack, Warren W.; Nguyen, Ha-Ai] Ultratech Inc, San Jose, CA 95134 USA.
   [Shaw, Mark; Do Canto, Manny] MicroChem Corp, Newton, MA 02464 USA.
RP Flack, WW (reprint author), Ultratech Inc, San Jose, CA 95134 USA.
CR Box G. E. P., 1978, STAT EXPT
   BRUNNER T, 1991, ADV RESIST TECHNOLOG, V1466, P297
   CHUNG S, 2000, SPIE, V4192, P44
   FLACK W, 1998, ADV RESIST TECHNOLOG, V333
   FLACK W, 1998, MAT DEVICE CHARACTER, V3512
   FLACK W, 1999, SPIE, V3678, P474
   FLORES G, 1993, SPIE, V1927
   Levinson H. J., 2001, PRINCIPLES LITHOGRAP
   MARTIN B, 1994, SPIE, V2196, P486
   *SAS INC, 2005, JMP 5 REF MAN
NR 10
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6196-2
J9 PROC SPIE
PY 2006
VL 6153
BP U1662
EP U1671
AR 61534I
DI 10.1117/12.655721
PG 10
WC Engineering, Manufacturing; Engineering, Electrical & Electronic
SC Engineering
GA BEM64
UT WOS:000238175500151
DA 2018-10-20
ER

PT J
AU Eder, C
   Falkner, E
   Nehrer, S
   Losert, UM
   Schoffl, H
AF Eder, C
   Falkner, E
   Nehrer, S
   Losert, UM
   Schoffl, H
TI Introducing the concept of the 3Rs into tissue engineering research
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article
DE tissue engineering; the 3Rs; serumfree cell culture; antibiotic free
   cell culture; HET-CAM
ID FETAL BOVINE SERUM; FREE CELL; IN-VITRO; CULTURE
AB Tissue engineering, defined as using a combination of cultured cells and biodegradable scaffolds to repair tissue damaged by injury or disease, represents a booming sector of biomedical research. Animal experimentation is routinely performed prior to clinical trials. The presented study tries to translate the aspect of the 3Rs to tissue engineering research: Cell culture protocols were adapted to antibiotic free and serum free conditions. Biomaterials (Bio-Gide (R) and a collagen sponge prototype) were pre-tested using the HET-CAM assay. CAM-testing suggested a protocol change for application of the Bio-Gide (R) scaffold and demonstrated unsuitable material properties of the collagen sponge. Application of 3R compliant protocols for tissue engineering research led to increased cell proliferation, higher synthesis of extracellular matrix molecules, reduced dedifferentiation and more information about the biomaterials at an early experimental stage. Tissue engineering research can therefore profit from the increased efforts to validate in vitro alternatives and supplements to animal testing.
C1 Biomed Soc Promot Biomed & Med Technol Res Upper, A-4021 Linz, Austria.
   Med Univ Vienna, Core Unit Biomed Res, Vienna, Austria.
   Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria.
   Zet Ctr Alternat & Complementary Methods Anim Tes, Linz, Austria.
RP Eder, C (reprint author), Biomed Soc Promot Biomed & Med Technol Res Upper, POB 210, A-4021 Linz, Austria.
EM claudia.eder@biomed.or.at
CR Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Brown LD, 2002, IN VITRO CELL DEV-AN, V38, P411
   Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6
   Chua K H, 2005, Eur Cell Mater, V9, P58
   Eder C, 2005, ANIM WELFARE, V14, P297
   *EUR COMM HLTH CON, 2001, OP STAT ART TISS ENG
   Falkner E, 2004, ATLA-ALTERN LAB ANIM, V32, P573
   FALKNER E, 2003, REPLACEMENT SERA CEL
   Froud S J, 1999, Dev Biol Stand, V99, P157
   Gauchia R, 1996, CONTACT DERMATITIS, V35, P374, DOI 10.1111/j.1600-0536.1996.tb02429.x
   Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275
   Jennings A, 1999, Dev Biol Stand, V99, P51
   Jochems CEA, 2002, ATLA-ALTERN LAB ANIM, V30, P219
   JUX C, 2003, J INTERVENTIONAL CAR, V6, P149
   Kalweit S, 1987, Mol Toxicol, V1, P597
   Kappeler A, 1996, BIOLOGICALS, V24, P131, DOI 10.1006/biol.1996.0017
   KUHLMAN I, 1993, ALTEX-ALTERN TIEREXP, V10, P27
   Louhimies S, 2002, ATLA-ALTERN LAB ANIM, V30, P217
   Mackensen A, 2000, CANCER IMMUNOL IMMUN, V49, P152, DOI 10.1007/s002620050614
   Merten O W, 1999, Dev Biol Stand, V99, P167
   MORGAN TJ, 2005, ARTHRITIS RES THE S1, V7, P58
   NDIRITU CG, 1977, J AM VET MED ASSOC, V171, P335
   RHANGAN SR, 1979, ADV VIRUS RES, V24, P1
   Romeis B., 1989, MIKROSKOPISCHE TECHN
   Russel W, 1959, PRINCIPLES HUMANE EX
   Shah G, 1999, Dev Biol Stand, V99, P17
   Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.y,the.2004.02.012
   Spielmann H, 1995, Methods Mol Biol, V43, P199
   TSCHUONG L, 2002, HUM GENE THER, V13, P1605
   Tumia NS, 2004, AM J SPORT MED, V32, P915, DOI 10.1177/0363546503261710
   van der Noordaa J, 1999, Dev Biol Stand, V99, P45
   van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009
   VANTIENHOVEN EAE, 2001, PRECLINICAL SAFETY A
   Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306
NR 34
TC 6
Z9 7
U1 0
U2 2
PU SPEKTRUM AKADEMISCHER VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 2006
VL 23
IS 1
BP 17
EP 23
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 017IT
UT WOS:000235688000003
PM 16477344
DA 2018-10-20
ER

PT J
AU Chan, KLA
   Kazarian, SG
AF Chan, KLA
   Kazarian, SG
TI Detection of trace materials with fourier transform infrared
   spectroscopy using a multi-channel detector
SO ANALYST
LA English
DT Article
ID PHARMACEUTICAL FORMULATIONS; SPATIAL-RESOLUTION; DRUG-RELEASE;
   DISSOLUTION
AB FTIR spectroscopy is one of the most powerful methods for material characterization. However, the sensitivity of this analytical tool is often very limited especially for materials with weak infrared absorption or when spectral bands of the targeted trace material overlap with the spectral bands of major components. Fortunately, for heterogeneous samples, there is an opportunity to improve the sensitivity of detection by using an imaging approach. This paper explores the opportunity of enhancing the sensitivity of FTIR spectroscopy to detect trace amounts of materials using the FTIR imaging approach based on a focal plane array (FPA) detector. Model sample tablets of ibuprofen in hydroxypropyl methylcellulose ( HPMC) have been used to exemplify the detection limits of FTIR spectroscopy using: (a) a conventional mercury cadmium telluride (MCT) detector and (b) a FPA detector. The sensitivity level was compared and it has been found that for this particular set of samples, the lowest concentration of ibuprofen in HPMC that can be detected using attenuated total reflection (ATR) measuring mode with the single element MCT detector was 0.35 wt% while using the FPA detector, the presence of drug has been detected in a sample that contains as low as 0.075 wt% of drug. The application of using this enhanced sensitivity offered by the multi-channel detector to probe trace amounts of drug particles left on the surface of a finger after handling a small amount of the drug has also been demonstrated. These results have broad implications for forensic, biomedical and pharmaceutical research.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England.
RP Kazarian, SG (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England.
RI Kazarian, Sergei/C-1259-2013
OI Kazarian, Sergei/0000-0003-1768-9134
FU Engineering and Physical Sciences Research Council [EP/C532678/1]
CR Artyushkova K, 2001, J VAC SCI TECHNOL A, V19, P2791, DOI 10.1116/1.1405512
   Burka E. M., 2000, US Patent, Patent No. [6,141,100, 6141100]
   Chan KLA, 2005, J COMB CHEM, V7, P185, DOI 10.1021/cc049840q
   Chan KLA, 2003, ANAL CHEM, V75, P2140, DOI 10.1021/ac026456b
   Chan KLA, 2003, APPL SPECTROSC, V57, P381, DOI 10.1366/00037020360625907
   Chan KLA, 2005, APPL SPECTROSC, V59, P149, DOI 10.1366/0003702053085070
   CHAN KLA, 2005, IN PRESS CHEM ENG RE
   GRIFFITHS PR, 1986, FOURIER TRANSFORM IN
   Kazarian SG, 2003, MACROMOLECULES, V36, P9866, DOI 10.1021/ma035210l
   Kazarian SG, 2004, MACROMOLECULES, V37, P579, DOI 10.1021/ma035420y
   Koenig JL, 1998, MICROSCOPIC IMAGING
   Miller-Chou BA, 2002, MACROMOLECULES, V35, P440, DOI 10.1021/ma0115038
   Roggo Y, 2005, ANAL CHIM ACTA, V535, P79, DOI 10.1016/j.aca.2004.12.037
   Snively CM, 1999, APPL SPECTROSC, V53, P170, DOI 10.1366/0003702991946497
   Snively CM, 1998, MACROMOLECULES, V31, P3753, DOI 10.1021/ma971511h
   Sommer AJ, 2001, APPL SPECTROSC, V55, P252, DOI 10.1366/0003702011951803
   van der Weerd J, 2004, J CONTROL RELEASE, V98, P295, DOI 10.1016/j.jconrel.2004.05.007
   van der Weerd J, 2004, VIB SPECTROSC, V35, P9, DOI 10.1016/j.vibspec.2003.11.004
NR 18
TC 62
Z9 62
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
J9 ANALYST
JI Analyst
PY 2006
VL 131
IS 1
BP 126
EP 131
DI 10.1039/b511243e
PG 6
WC Chemistry, Analytical
SC Chemistry
GA 995JG
UT WOS:000234096000018
PM 16365673
DA 2018-10-20
ER

PT J
AU Gavalas, VG
   Berrocal, MJ
   Bachas, LG
AF Gavalas, VG
   Berrocal, MJ
   Bachas, LG
TI Enhancing the blood compatibility of ion-selective electrodes
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE ion-selective electrodes; biocompatibility; hemocompatibility;
   blood-membrane interactions
ID NITRIC-OXIDE RELEASE; CARBOXYLATED POLY(VINYL CHLORIDE); MICROFABRICATED
   ARRAY SENSORS; PLASTICIZER-FREE POLYMER; CELL-BASED BIOSENSOR; PROTEIN
   ADSORPTION; CHEMICAL SENSORS; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE;
   POTENTIOMETRIC PROPERTIES; POLYURETHANE MEMBRANES
AB In vivo monitoring of various analytes is important for many bioanalytical and biomedical applications. The crucial challenge in this type of applications is the interaction of the sensor with the host environment, which is qualitatively described by the term biocompatibility. This review discusses recent advances in methods and materials used for the improvement of the biocompatibility of ion-selective electrodes especially as It relates to their interaction with blood components.
C1 Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.
   Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA.
RP Bachas, LG (reprint author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.
EM bachas@uky.edu
RI Bachas, Leonidas/G-2479-2015
OI Bachas, Leonidas/0000-0002-3308-6264
CR Aldenhoff YBJ, 1997, BIOCONJUGATE CHEM, V8, P296, DOI 10.1021/bc970020z
   Aldenhoff YBJ, 2001, J BIOMED MATER RES, V54, P224, DOI 10.1002/1097-4636(200102)54:2<224::AID-JBM9>3.0.CO;2-E
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Ambrose TM, 1996, ELECTROANAL, V8, P1095, DOI 10.1002/elan.1140081204
   ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   ANDERSON K, 2003, P ANN M ADHES SOC M, V26, P448
   Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Badr IHA, 2005, TALANTA, V65, P261, DOI 10.1016/j.talanta.2004.06.018
   Bakker E, 1999, ANAL CHIM ACTA, V393, P11, DOI 10.1016/S0003-2670(99)00056-2
   Bakker E, 1997, CHEM REV, V97, P3083, DOI 10.1021/cr940394a
   Berrocal MJ, 2002, ANAL CHEM, V74, P3644, DOI 10.1021/ac025604v
   Berrocal MJ, 2001, ANAL CHEM, V73, P5328, DOI 10.1021/ac010375i
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRATOV A, 1995, ANAL CHEM, V67, P3589, DOI 10.1021/ac00115a032
   Brooks K A, 1996, Anal Chem, V68, P1439, DOI 10.1021/ac950915+
   Buhlmann P, 1998, CHEM REV, V98, P1593, DOI 10.1021/cr970113+
   CHA GS, 1991, ANAL CHEM, V63, P1666, DOI 10.1021/ac00017a003
   CHA MJ, 1995, ANAL CHIM ACTA, V315, P311, DOI 10.1016/0003-2670(95)00337-Y
   COSOFRET VV, 1994, ANAL CHEM, V66, P3592, DOI 10.1021/ac00093a010
   COSOFRET VV, 1994, ANALYST, V119, P2283, DOI 10.1039/an9941902283
   COSOFRET VV, 1993, ELECTROANAL, V5, P725, DOI 10.1002/elan.1140050904
   Cosofret VV, 1996, TALANTA, V43, P143, DOI 10.1016/0039-9140(95)01724-0
   DAVIES ML, 1991, SELECT ELECTR REV, V13, P159
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   Deo S K, 2003, ANAL CHEM, V75, p206A
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   ESPADASTORRE C, 1995, ANAL CHEM, V67, P3108, DOI 10.1021/ac00114a003
   Fibbioli M, 2002, CHEM MATER, V14, P1721, DOI 10.1021/cm0109589
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   GEUN SC, 1989, TALANTA, V36, P271
   Hall MW, 2002, J BIOMED MATER RES, V59, P528, DOI 10.1002/jbm.1266
   HAYWARD JA, 1986, BIOMATERIALS, V7, P126, DOI 10.1016/0142-9612(86)90069-4
   Heng LY, 1996, ANAL CHIM ACTA, V324, P47, DOI 10.1016/0003-2670(96)00019-0
   Heng LY, 2004, TALANTA, V63, P73, DOI 10.1016/j.talanta.2003.12.051
   Heng LY, 2000, ANAL CHEM, V72, P42, DOI 10.1021/ac9904765
   Hogg G, 1996, ANAL CHIM ACTA, V335, P103, DOI 10.1016/S0003-2670(96)00284-X
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J POLYM SCI POL CHEM, V30, P929, DOI 10.1002/pola.1992.080300524
   Ishihara K, 2004, BIOMATERIALS, V25, P1115, DOI 10.1016/S0142-9612(03)00624-0
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   Jain R, 2004, J BIOMED MATER RES A, V68A, P296, DOI 10.1002/jbm.a.20045
   Ji J, 2002, J MATER SCI-MATER M, V13, P677, DOI 10.1023/A:1015789726455
   Keefer LK, 2003, NAT MATER, V2, P357, DOI 10.1038/nmat913
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   KLEE D, 2000, ADV POLYM SCI, V149, P1
   KLINKMANN H, 1987, UREMIA THERAPY
   Kost GJ, 1999, CHEST, V115, P1140, DOI 10.1378/chest.115.4.1140
   Levitchev S, 1998, FRESEN J ANAL CHEM, V361, P252, DOI 10.1007/s002160050874
   LEWENSTAM A, 1991, ELECTROANAL, V3, P727, DOI 10.1002/elan.1140030802
   LIN YS, 1992, BIOMATERIALS, V13, P497
   LINDNER E, 1995, ELECTROANAL, V7, P864, DOI 10.1002/elan.1140070913
   LIU D, 1993, ANAL CHIM ACTA, V274, P37, DOI 10.1016/0003-2670(93)80602-H
   Malinowska E, 2001, ANAL CHIM ACTA, V432, P67, DOI 10.1016/S0003-2670(00)01348-9
   MARXER MM, 2005, ANAL CHEM, V77, P848
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   May KML, 2005, ANAL BIOANAL CHEM, V382, P1010, DOI 10.1007/s00216-005-3224-2
   May KML, 2004, ANAL CHEM, V76, P4156, DOI 10.1021/ac049810+
   MEYERHOFF ME, 1993, TRAC-TREND ANAL CHEM, V12, P257, DOI 10.1016/0165-9936(93)87065-6
   Michalska AJ, 2004, ANAL CHEM, V76, P2031, DOI 10.1021/ac0353132
   Monge S, 2003, J APPL POLYM SCI, V87, P1794, DOI 10.1002/app.11608
   Mowery KA, 1999, ELECTROANAL, V11, P681, DOI 10.1002/(SICI)1521-4109(199907)11:10/11<681::AID-ELAN681>3.3.CO;2-R
   MURPHY SM, 1992, BIOMATERIALS, V13, P979, DOI 10.1016/0142-9612(92)90148-H
   Murthy JN, 1997, CLIN BIOCHEM, V30, P385, DOI 10.1016/S0009-9120(97)00046-5
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2431, DOI 10.1016/S0142-9612(03)00113-3
   OH BK, 2003, J AM CHEM SOC, V123, P9552
   Olsson P, 2000, J BIOMAT SCI-POLYM E, V11, P1261, DOI 10.1163/156856200744192
   Phaneuf MD, 1998, ARTIF ORGANS, V22, P657, DOI 10.1046/j.1525-1594.1998.05091.x
   Piao MH, 2003, SENSORS, V3, P192, DOI 10.3390/s30600192
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Poplawski ME, 1997, ANAL CHIM ACTA, V355, P249, DOI 10.1016/S0003-2670(97)00482-0
   PUNGOR E, 1979, ANAL CHIM ACTA, V109, P279, DOI 10.1016/S0003-2670(01)84258-6
   Puntener M, 2002, ELECTROANAL, V14, P1329, DOI 10.1002/1521-4109(200211)14:19/20<1329::AID-ELAN1329>3.0.CO;2-V
   Qin Y, 2003, ANAL CHEM, V75, P3038, DOI 10.1021/ac0263059
   Qin Y, 2002, ELECTROANAL, V14, P1375, DOI 10.1002/1521-4109(200211)14:19/20<1375::AID-ELAN1375>3.0.CO;2-8
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RATNER BD, 1996, SURFACE MODIFICATION, P1
   Robbins ME, 2003, J AM CHEM SOC, V125, P6068, DOI 10.1021/ja034019o
   Rumenjak V, 2003, CLIN CHIM ACTA, V335, P75, DOI 10.1016/S0009-8981(03)00278-X
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   Shin JH, 1996, ANAL CHEM, V68, P221, DOI 10.1021/ac9506037
   Shin JH, 2004, ANAL CHEM, V76, P4543, DOI 10.1021/ac049776z
   Simon MA, 1996, J BIOMED MATER RES, V30, P313, DOI 10.1002/jbm.820300302
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200
   Tsujimura Y, 1996, ANALYST, V121, P1705, DOI 10.1039/an9962101705
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Yajima S, 2002, ANAL CHIM ACTA, V463, P31, DOI 10.1016/S0003-2670(02)00341-0
   Young CC, 1997, J CHEM EDUC, V74, P177, DOI 10.1021/ed074p177
   YU J, 1991, BIOMATERIALS, V12, P119, DOI 10.1016/0142-9612(91)90188-G
   Yun SY, 1997, ANAL CHEM, V69, P868, DOI 10.1021/ac9605455
NR 103
TC 20
Z9 20
U1 0
U2 35
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JAN
PY 2006
VL 384
IS 1
BP 65
EP 72
DI 10.1007/s00216-005-0039-0
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 007NM
UT WOS:000234976400017
PM 16132141
DA 2018-10-20
ER

PT J
AU Lee, LJ
AF Lee, LJ
TI Polymer nanoengineering for biomedical applications
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE polymeric materials; nano-fabrication; medical device
ID GLASS-TRANSITION TEMPERATURE; ASPECT-RATIO STRUCTURES; NANOIMPRINT
   LITHOGRAPHY; NANOFLUIDIC CHANNELS; POLYANILINE NANOFIBERS; IMPRINT
   LITHOGRAPHY; DRUG-DELIVERY; MICROLAYER COEXTRUSION;
   MECHANICAL-PROPERTIES; MICROFLUIDIC SYSTEMS
AB Polymeric materials possess many attractive properties such as high toughness and recyclability. Some possess excellent biocompatibility, are biodegradable, and can provide various biofunctionalities. Proper combination of functional polymers and biomolecules can offer tailored properties for various biomedical applications. This overview article covers three major sections: Applications of Polymeric Structures and Devices, Nanoscale Polymer Fabrication Technologies, and Conclusions and Future Directions.
C1 Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
RP Lee, LJ (reprint author), Ohio State Univ, Dept Chem & Biomol Engn, 140 W 19th Ave, Columbus, OH 43210 USA.
EM leelj@chbmeng.ohio-state.edu
CR AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364
   Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   BAER E, 1987, SCIENCE, V235, P1015, DOI 10.1126/science.3823866
   Becker H, 1999, P SOC PHOTO-OPT INS, V3877, P74, DOI 10.1117/12.359323
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Becker H, 2000, SENSOR ACTUAT A-PHYS, V83, P130, DOI 10.1016/S0924-4247(00)00296-X
   BECKER H, 1999, IEEE, P228
   Bognitzki M, 2000, ADV MATER, V12, P637, DOI 10.1002/(SICI)1521-4095(200005)12:9<637::AID-ADMA637>3.0.CO;2-W
   Boiko YM, 1998, MACROMOLECULES, V31, P6620, DOI 10.1021/ma9610368
   Boiko YM, 1997, MACROMOLECULES, V30, P3708, DOI 10.1021/ma960002x
   BOWLING GL, 2001, FIB SOC SPRING 2001, V1
   Brott LL, 2001, NATURE, V413, P291, DOI 10.1038/35095031
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Cao H, 2002, APPL PHYS LETT, V81, P174, DOI 10.1063/1.1489102
   Cao H, 2002, APPL PHYS LETT, V81, P3058, DOI 10.1063/1.1515115
   Casey BG, 1999, MICROELECTRON ENG, V46, P125, DOI 10.1016/S0167-9317(99)00031-3
   Casey BG, 1997, MICROELECTRON ENG, V35, P393, DOI 10.1016/S0167-9317(96)00208-0
   Chiou NR, 2005, ADV MATER, V17, P1679, DOI 10.1002/adma.200401000
   Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11
   Chou SY, 2002, NATURE, V417, P835, DOI 10.1038/nature00792
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Chou SY, 1997, J VAC SCI TECHNOL B, V15, P2897, DOI 10.1116/1.589752
   Chou SY, 2001, MRS BULL, V26, P512, DOI 10.1557/mrs2001.122
   Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605
   CIRINO GA, 2002, P ELECTROCHEM SOC, V8, P188
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Conlisk AT, 2002, ANAL CHEM, V74, P2139, DOI 10.1021/ac011198o
   Czaplewski DA, 2003, APPL PHYS LETT, V83, P4836, DOI 10.1063/1.1633008
   D'Amore A, 2000, KUNSTST-PLAST EUR, V90, P52
   Dam TH, 1999, REV SCI INSTRUM, V70, P3982, DOI 10.1063/1.1150024
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Desai TA, 1999, BIOMED MICRODEVICES, V2, P11, DOI 10.1023/A:1009903215959
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   DOSHI J, 2001, NONWOVENS WORLD  AUG, P64
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919
   EHRFELD W, 1995, RADIAT PHYS CHEM, V45, P349, DOI 10.1016/0969-806X(93)E0007-R
   Epstein AJ, 1992, US Patent, Patent No. 5135696
   Fages J, 1998, ASAIO J, V44, P289
   FANG DZX, 2001, J TEXTILE APPAREL TE, V1
   Fleischer R., 1975, NUCL TRACKS SOLIDS P
   Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Gad-el-Hak M, 1999, J FLUID ENG-T ASME, V121, P5, DOI 10.1115/1.2822013
   GADEGAARD N, 2000, CONDENS MATTER PHYS, P66
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guo LJ, 2004, NANO LETT, V4, P69, DOI 10.1021/nl034877i
   HAGMANN P, 1989, INT POLYM PROC, V4, P188, DOI 10.3139/217.890188
   HAN X, 2004, ANN TECH C SOC PLAST, P1723
   HANEMANN T, 1998, POLY PREPR, V39, P657
   Harnett CK, 2001, J VAC SCI TECHNOL B, V19, P2842, DOI 10.1116/1.1409383
   HEALEY BG, 1995, SCIENCE, V269, P1078, DOI 10.1126/science.7652555
   Heckele M, 1998, MICROSYST TECHNOL, V4, P122, DOI 10.1007/s005420050112
   Heidari B, 2000, J VAC SCI TECHNOL B, V18, P3557, DOI 10.1116/1.1326923
   Hirai Y, 2002, J VAC SCI TECHNOL B, V20, P2867, DOI 10.1116/1.1515305
   HSU DT, 1999, ELECTROCHEM SOC P, V99, P53
   Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y
   Huang JX, 2004, J AM CHEM SOC, V126, P851, DOI 10.1021/ja0371754
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   IKADA Y, 2003, TSUK INT C CTR TSUK
   Jaszewski RW, 1999, APPL SURF SCI, V143, P301, DOI 10.1016/S0169-4332(99)00014-8
   Jaszewski RW, 1998, MICROELECTRON ENG, V42, P575, DOI 10.1016/S0167-9317(98)00135-X
   Jaszewski RW, 1997, MICROELECTRON ENG, V35, P381, DOI 10.1016/S0167-9317(96)00203-1
   KATAPHINAN W, 2001, J TEXTILE APPAREL TE, V1
   KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Kim JS, 1999, POLYM COMPOSITE, V20, P124, DOI 10.1002/pc.10340
   Kim KJ, 1997, J MEMBRANE SCI, V123, P303, DOI 10.1016/S0376-7388(96)00232-3
   KING KR, 2002, MRS SPRING S
   KOEPPEL S, 1999, KUNSTSTOFFESYNTHETIC, P11
   KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003
   Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P909, DOI 10.1002/pol.1981.180190601
   LEE GB, 2000, SPIE, V112, P4117
   Lee LJ, 2001, BIOMED MICRODEVICES, V3, P339, DOI 10.1023/A:1012469017354
   Li GC, 2004, MACROMOLECULES, V37, P2683, DOI 10.1021/ma035891k
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WL, 2003, NANOTECHNOLOGY, V14, P578, DOI 10.1088/0957-4484/14/6/302
   Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311
   LIN L, 1996, P 7 INT S, P67
   Locascio LE, 1999, J CHROMATOGR A, V857, P275, DOI 10.1016/S0021-9673(99)00774-8
   Madou M. J., 2002, FUNDAMENTALS MICROFA
   Madou MJ, 2001, BIOMED MICRODEVICES, V3, P245, DOI 10.1023/A:1011419515576
   MARTIN CR, 1995, ACCOUNTS CHEM RES, V28, P61, DOI 10.1021/ar00050a002
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MOONEY DJ, 1999, GROWING NEW ORGANS
   Mueller C, 2000, J APPL POLYM SCI, V78, P816, DOI 10.1002/1097-4628(20001024)78:4<816::AID-APP150>3.0.CO;2-D
   Mueller CD, 1997, POLYM ENG SCI, V37, P355, DOI 10.1002/pen.11678
   Nakamura M, 2001, BIOTECHNOL PROGR, V17, P1145, DOI 10.1021/bp010109q
   Norris ID, 2000, SYNTHETIC MET, V114, P109, DOI 10.1016/S0379-6779(00)00217-4
   PAN LW, 1999, CYLINDRICAL PLASTIC, P217
   Panchagnula R, 1998, INT J PHARM, V172, P1, DOI 10.1016/S0378-5173(98)00188-4
   PANGARIBUAN T, 1992, JPN J APPL PHYS 2, V31, pL1302, DOI 10.1143/JJAP.31.L1302
   Pantano P, 1996, CHEM MATER, V8, P2832, DOI 10.1021/cm9603314
   Pantano P, 1997, REV SCI INSTRUM, V68, P1357, DOI 10.1063/1.1147941
   Powell HM, 2003, LANGMUIR, V19, P9071, DOI 10.1021/la0349368
   Qin D, 1998, TOP CURR CHEM, V194, P1
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   RODE M, 1999, IEEE J MICROELECTROM, V8
   Rudoy VM, 2002, COLLOID J+, V64, P746, DOI 10.1023/A:1021558424276
   Ruprecht R, 1995, P SOC PHOTO-OPT INS, V2639, P146, DOI 10.1117/12.221272
   SCHERR EM, 1991, SYNTHETIC MET, V41, P735, DOI 10.1016/0379-6779(91)91173-8
   Schift H, 1999, MICROELECTRON ENG, V46, P121, DOI 10.1016/S0167-9317(99)00030-1
   Schift H, 2000, MICROELECTRON ENG, V53, P171, DOI 10.1016/S0167-9317(00)00289-6
   SMITH D, 2001, ELECTROSPUN SKIN MAS, P14
   SMITH D, 2001, ELECTROSPUN FIBERS A, P44
   Sproule TL, 2004, J SUPERCRIT FLUID, V28, P241, DOI 10.1016/S0896-8446(03)00044-5
   Stjernstrom M, 1998, J MICROMECH MICROENG, V8, P33, DOI 10.1088/0960-1317/8/1/006
   Tan H, 1998, J VAC SCI TECHNOL B, V16, P3926, DOI 10.1116/1.590438
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Teichroeb JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016104
   Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126
   Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z
   TSAI PP, 2001, J TEXTILE APPAREL TE, V1
   Turner SW, 1998, J VAC SCI TECHNOL B, V16, P3835, DOI 10.1116/1.590419
   Vacanti JP, 1999, LANCET, V354, pSI32
   Wang J, 1999, APPL PHYS LETT, V75, P2767, DOI 10.1063/1.125143
   WANG S, 2004, UNPUB ADV MAT
   Xia YN, 1997, ADV MATER, V9, P147, DOI 10.1002/adma.19970090211
   Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   Xie FC, 2002, MACROMOLECULES, V35, P1491, DOI 10.1021/ma011689a
   Xing R, 2003, J VAC SCI TECHNOL B, V21, P1318, DOI 10.1116/1.1585066
   Yang Y, 2004, ADV MATER, V16, P560, DOI 10.1002/adma.200306159
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   ZENG C, 2004, POL PROC SOC AM REG
   Zhang LJ, 2002, NANOTECHNOLOGY, V13, P750, DOI 10.1088/0957-4484/13/6/311
   Zhang XM, 2000, J POLYM SCI POL PHYS, V38, P654, DOI 10.1002/(SICI)1099-0488(20000301)38:5<654::AID-POLB2>3.0.CO;2-Z
   ZHANG Y, 2001, HIGH SURFACE AREA CH, V222
   ZIEGLER D, 2001, J TEXTILE APPAREL TE, V1
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 142
TC 51
Z9 51
U1 3
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JAN
PY 2006
VL 34
IS 1
BP 75
EP 88
DI 10.1007/s10439-005-9011-6
PG 14
WC Engineering, Biomedical
SC Engineering
GA 026PO
UT WOS:000236354800008
PM 16541328
DA 2018-10-20
ER

PT J
AU Balboni, I
   Chan, SM
   Kattah, M
   Tenenbaum, JD
   Butte, AJ
   Utz, PJ
AF Balboni, Imelda
   Chan, Steven M.
   Kattah, Michael
   Tenenbaum, Jessica D.
   Butte, Atul J.
   Utz, Paul J.
TI Multiplexed protein array platforms for analysis of autoimmune diseases
SO ANNUAL REVIEW OF IMMUNOLOGY
SE Annual Review of Immunology
LA English
DT Review; Book Chapter
DE autoimmunity; proteomics; autoantibodies; cytokines; signaling
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; MICROARRAY SUPPORT MATERIALS;
   GLUTAMIC-ACID DECARBOXYLASE; CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS;
   RHEUMATOID-ARTHRITIS; MASS-SPECTROMETRY; ANTIBODY MICROARRAY;
   HIGH-THROUGHPUT; HUMAN CYTOKINES
AB Several proteomics platforms have emerged in the past decade that show great promise for filling in the many gaps that remain from earlier studies of the genome and from the sequencing of the human genome itself This review describes applications of proteomics technologies to the study of autoimmune diseases. We focus largely on biased technology platforms that are capable of analyzing a large panel of known analytes, as opposed to techniques such as two dimensional gel electrophoresis (2DIGE) or mass spectroscopy that represent unbiased approaches (as reviewed in 1). At present, the main analytes that can be systematically studied in autoimmunity include autoantibodies, cytokines and chemokines, components of signaling pathways, and cell-surface receptors. We review the most commonly used platforms for such studies, citing important discoveries and limitations that exist. We conclude by reviewing advances in biomedical informatics that will eventually allow the human pro-teome to be deciphered.
C1 Stanford Univ, Sch Med, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.
   Stanford Univ, Sch Med, Stanford Med Informat, Dept Med, Stanford, CA 94305 USA.
   Stanford Univ, Sch Med, Div Rheumatol, Dept Pediat, Stanford, CA 94305 USA.
   Stanford Univ, Sch Med, Div Endocrinol, Dept Pediat, Stanford, CA 94305 USA.
RP Balboni, I (reprint author), Stanford Univ, Sch Med, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.
EM pjutz@stanford.edu
OI Kattah, Michael/0000-0002-6067-6585
FU NLM NIH HHS [K22LM008261, K22 LM008261-03, K22 LM008261]; NHLBI NIH HHS
   [N01-HV-28183]; NIGMS NIH HHS [R01 GM079719, R01 GM079719-01]; NIAID NIH
   HHS [AI0151614, AI40093, AI50865, AI50854]; NIAMS NIH HHS [AR49328];
   NIDDK NIH HHS [R01DK062948, T32DK063702, DK61934, P30 DK56339]
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761
   Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6
   Angenendt P, 2002, ANAL BIOCHEM, V309, P253, DOI 10.1016/S0003-2697(02)00257-9
   APPEL RD, 1991, ELECTROPHORESIS, V12, P722, DOI 10.1002/elps.1150121006
   Appel RD, 1997, ELECTROPHORESIS, V18, P2735, DOI 10.1002/elps.1150181507
   Arbuckle MR, 1999, SCAND J IMMUNOL, V50, P447
   Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933
   Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100
   Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562
   Belov L, 2003, PROTEOMICS, V3, P2147, DOI 10.1002/pmic.200300599
   Belov L, 2001, CANCER RES, V61, P4483
   Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064
   Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2
   Bruni R, 2005, J PEPT SCI, V11, P225, DOI 10.1002/psc.595
   Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139
   Chan-Hui PY, 2004, CLIN IMMUNOL, V111, P162, DOI 10.1016/j.clim.2003.12.015
   Copeland S, 2004, J IMMUNOL METHODS, V284, P99, DOI 10.1016/j.jim.2003.10.011
   Craft J, 1997, ARTHRITIS RHEUM, V40, P1374, DOI 10.1002/art.1780400803
   de Vegvar HEN, 2003, J VIROL, V77, P11125, DOI 10.1128/JVI.77.20.11125-11138.2003
   Demir E, 2002, BIOINFORMATICS, V18, P996, DOI 10.1093/bioinformatics/18.7.996
   Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7
   Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624
   Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007
   Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726
   Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802
   Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727
   Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473
   Geho D, 2005, BIOCONJUGATE CHEM, V16, P559, DOI 10.1021/bc0479113
   Gevaert K, 2000, ELECTROPHORESIS, V21, P1145, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1145::AID-ELPS1145>3.0.CO;2-Z
   Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598
   Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101
   Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797
   Haab BB, 2001, GENOME BIOL, V2
   Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906
   Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926
   Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461
   Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje
   Huang Ruo-Pan, 2004, Methods Mol Biol, V264, P215
   Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015
   Hueber W, 2005, ARTHRITIS RHEUM, V52, P2645, DOI 10.1002/art.21269
   Hueber W, 2002, ARTHRITIS RES, V4, P290, DOI 10.1186/ar426
   Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233
   Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028
   Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x
   James JA, 1996, J IMMUNOL, V156, P4018
   James JA, 1998, IMMUNOL REV, V164, P185, DOI 10.1111/j.1600-065X.1998.tb01220.x
   JAMES JA, 1994, CLIN EXP IMMUNOL, V98, P419
   JAMESON AK, 1995, SOLID STATE NUCL MAG, V4, P1, DOI 10.1016/0926-2040(94)00028-B
   Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.0.CO;2-O
   Joos TO, 2000, ELECTROPHORESIS, V21, P2641, DOI 10.1002/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.0.CO;2-5
   Kader HA, 2005, AM J GASTROENTEROL, V100, P414, DOI 10.1111/j.1572-0241.2005.40819.x
   KANTER J, 2006, IN PRESS NAT MED
   KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0
   Keech CL, 1996, J IMMUNOL, V157, P3694
   Kirou KA, 2005, ARTHRITIS RHEUM, V52, P1491, DOI 10.1002/art.21031
   LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0
   Lin T, 1998, ANAL CHEM, V70, P5162, DOI 10.1021/ac980823v
   Lueking A, 2005, MOL CELL PROTEOMICS, V4, P1382, DOI 10.1074/mcp.T500004-MCP200
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 2000, SCIENCE, V289, P1760
   Magnano MD, 2004, CLIN EXP RHEUMATOL, V22, pS134
   Marengo E, 2005, PROTEOMICS, V5, P654, DOI 10.1002/pmic.200401015
   MCCARRON RM, 1990, J NEUROIMMUNOL, V29, P73, DOI 10.1016/0165-5728(90)90149-H
   McInnes IB, 2004, CURR OPIN PHARMACOL, V4, P392, DOI 10.1016/j.coph.2004.04.003
   Mezzasoma L, 2002, CLIN CHEM, V48, P121
   Moody MD, 2001, BIOTECHNIQUES, V31, P186, DOI 10.2144/01311dd03
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Nagorsen D, 2004, CYTOKINE, V25, P31, DOI 10.1016/j.cyto.2003.08.012
   Naserke HE, 1998, J IMMUNOL, V161, P6963
   Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100
   Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290
   Nishimoto N, 2004, ARTHRITIS RHEUM, V50, P1761, DOI 10.1002/art.20303
   Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100
   Nishizuka S, 2003, CANCER RES, V63, P5243
   Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3
   Oda Y, 2003, ANAL CHEM, V75, P2159, DOI 10.1021/ac026196y
   Orchard S, 2004, PROTEOMICS, V4, P490, DOI 10.1002/pmic.200300694
   Orth T, 1998, SCAND J RHEUMATOL, V27, P461
   Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265
   Perez OD, 2002, NAT BIOTECHNOL, V20, P155
   Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509
   Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891
   Pietropaolo M, 2001, CURR DIRECT AUTOIMMU, V4, P252
   Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101
   Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639
   Revel M, 2003, PHARMACOL THERAPEUT, V100, P49, DOI 10.1016/S0163-7258(03)00085-8
   Rhyne PW, 2003, BIOTECHNIQUES, V35, P624, DOI 10.2144/03353pf01
   Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859
   Robinson WH, 2002, ARTHRITIS RHEUM, V46, P885, DOI 10.1002/art.10129
   Robinson WH, 2002, CLIN IMMUNOL, V103, P7, DOI 10.1006/clim.2002.5185
   Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295
   Routsias JG, 2004, CLIN CHIM ACTA, V340, P1, DOI 10.1016/j.cccn.2003.10.011
   Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Sanchez JC, 2001, PROTEOMICS, V1, P136
   Scheu S, 2001, BASIC APPL ECOL, V2, P3, DOI 10.1078/1439-1791-00031
   Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370
   Schweinsberg J, 2002, RANDOM STRUCT ALGOR, V20, P59, DOI 10.1002/rsa.10000
   Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197
   Scofield RH, 1996, ARTHRITIS RHEUM, V39, P1664, DOI 10.1002/art.1780391008
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao WP, 2003, J BIOMED BIOTECHNOL, P299, DOI 10.1155/S1110724303209268
   Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200
   Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065
   Sohnlein P, 2000, DIABETOLOGIA, V43, P210, DOI 10.1007/s001250050031
   Sreekumar A, 2001, CANCER RES, V61, P7585
   Stafford HA, 1998, CLIN EXP RHEUMATOL, V16, P119
   Steinman L, 1996, P NATL ACAD SCI USA, V93, P2253, DOI 10.1073/pnas.93.6.2253
   Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1
   Stone JD, 2005, P NATL ACAD SCI USA, V102, P3744, DOI 10.1073/pnas.0407019102
   STULTS JT, 1990, METHOD BIOCHEM ANAL, V34, P145
   Szodoray P, 2004, SCAND J IMMUNOL, V59, P592, DOI 10.1111/j.0300-9475.2004.01432.x
   Taka H, 2000, J BIOCHEM-TOKYO, V127, P723, DOI 10.1093/oxfordjournals.jbchem.a022663
   Tam SW, 2002, J IMMUNOL METHODS, V261, P157, DOI 10.1016/S0022-1759(01)00572-5
   Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139
   Targoni OS, 2001, J IMMUNOL, V166, P4757, DOI 10.4049/jimmunol.166.7.4757
   Taylor CF, 2003, NAT BIOTECHNOL, V21, P247, DOI 10.1038/nbt0303-247
   TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0
   TOPFER F, 1995, P NATL ACAD SCI USA, V92, P875, DOI 10.1073/pnas.92.3.875
   Utz PJ, 2005, IMMUNOL REV, V204, P264, DOI 10.1111/j.0105-2896.2005.00251.x
   Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926
   Vilcek J, 2004, TRENDS PHARMACOL SCI, V25, P201, DOI 10.1016/j.tips.2004.02.011
   VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2
   Wang CC, 2002, J PROTEOME RES, V1, P337, DOI 10.1021/pr0255203
   Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275
   Warren SJP, 2003, J INVEST DERMATOL, V120, P104, DOI 10.1046/j.1523-1747.2003.12017.x
   Wulfkuhle JD, 2003, PROTEOMICS, V3, P2085, DOI 10.1002/pmic.200300591
   Zha HB, 2004, LAB INVEST, V84, P235, DOI 10.1038/labinvest.3700051
   Zhou X, 2004, J TURBUL, V5, DOI 10.1088/1468-5248/5/1/028
NR 134
TC 81
Z9 85
U1 1
U2 20
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0732-0582
EI 1545-3278
J9 ANNU REV IMMUNOL
JI Annu. Rev. Immunol.
PY 2006
VL 24
BP 391
EP 418
DI 10.1146/annurev.immunol.24.021605.090709
PG 28
WC Immunology
SC Immunology
GA 043ES
UT WOS:000237583300013
PM 16551254
DA 2018-10-20
ER

PT S
AU Burger, C
   Hsiao, BS
   Chu, B
AF Burger, Christian
   Hsiao, Benjamin S.
   Chu, Benjamin
TI Nanofibrous materials and their applications
SO ANNUAL REVIEW OF MATERIALS RESEARCH
SE Annual Review of Materials Research
LA English
DT Review; Book Chapter
DE electrospinning; electroblowing; nanofibers; nonwoven membranes; tissue
   engineering; ultrafiltration
ID TISSUE-ENGINEERING SCAFFOLDS; UNIAXIALLY ALIGNED ARRAYS; ELECTRICALLY
   FORCED JETS; ELECTROSPUN NANOFIBERS; POLYMER NANOFIBERS; NONWOVEN MATS;
   LIQUID JETS; BENDING INSTABILITY; HOLLOW NANOFIBERS; CARBON NANOFIBERS
AB Nanostructured fibrous materials have been made more readily available in large part owing to recent advances in electrospinning and related technologies, including the use of electrostatic or gas-blowing forces as well as a combination of both forces. The nonwoven structure has unique features, including interconnected pores and a very large surface-to-volume ratio, which enable such nanofibrous scaffolds to have many biomedical and industrial applications. The chemical composition of electrospun membranes can be adjusted through the use of different polymers, polymer blends, or nanocomposites made of organic or inorganic materials. In addition to the control of material composition, the processing flexibility in maneuvering physical parameters and structures, such as fiber diameter, mesh size, porosity, texture, and pattern formation, offers the capability to design electrospun scaffolds that can meet the demands of numerous practical applications. This review provides a selective description of the fabrication of nanofibrous membranes and applications with specific examples in anti-adhesion in surgery and ultrafiltration in water treatment.
C1 SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
RP Burger, C (reprint author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
EM cburger@sunysb.edu; bhsiao@notes.cc.sunysb.edu; bchu@notes.cc.sunysb.edu
CR Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Baykal A, 2000, EUR J SURG, V166, P490
   Bergshoef MM, 1999, ADV MATER, V11, P1362, DOI 10.1002/(SICI)1521-4095(199911)11:16<1362::AID-ADMA1362>3.0.CO;2-X
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Blasinska A, 2004, FIBRES TEXT EAST EUR, V12, P51
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Cai KY, 2002, J BIOMED MATER RES, V62, P283, DOI 10.1002/jbm.10067
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Cha DI, 2005, J APPL POLYM SCI, V96, P460, DOI 10.1002/app.21467
   Chen GP, 2004, TISSUE ENG, V10, P323, DOI 10.1089/107632704323061681
   Chiu JB, 2005, J BIOMED NANOTECHNOL, V1, P115, DOI 10.1166/jbn.2005.018
   Chu B., 2005, Patent Appl., Patent No. [10/936568, 10936568]
   CHU B, 2004, Patent No. 0292888
   Chun I, 1999, J ADV MATER-COVINA, V31, P36
   Chung GS, 2005, J APPL POLYM SCI, V97, P165, DOI 10.1002/app.21742
   Dalton PD, 2005, POLYMER, V46, P611, DOI 10.1016/j.polymer.2004.11.075
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191
   Ding B, 2004, SENSOR ACTUAT B-CHEM, V101, P373, DOI 10.1016/j.snb.2004.04.008
   Ding B, 2004, POLYMER, V45, P1895, DOI 10.1016/j.polymer.2004.01.026
   Ding B, 2002, FIBER POLYM, V3, P73, DOI 10.1007/BF02875403
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Fabbricante A., 1997, U.S. Pat., Patent No. [5,679,379, 5679379]
   Fang DF, 2003, ABSTR PAP AM CHEM S, V226, pU424
   Fang X, 1997, J MACROMOL SCI PHYS, VB36, P169, DOI 10.1080/00222349708220422
   Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004
   FENN JB, 1990, MASS SPECTROM REV, V9, P37, DOI 10.1002/mas.1280090103
   FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315
   Fong H, 2002, POLYMER, V43, P775, DOI 10.1016/S0032-3861(01)00665-6
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Fong H, 1999, J POLYM SCI POL PHYS, V37, P3488, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3488::AID-POLB9>3.0.CO;2-M
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Ge JJ, 2004, J AM CHEM SOC, V126, P15754, DOI 10.1021/ja048648p
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Hohman MM, 2001, PHYS FLUIDS, V13, P2221, DOI 10.1063/1.1384013
   Hou HQ, 2005, CHEM MATER, V17, P967, DOI 10.1021/cm0484955
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hutmacher DW, 2002, DRUGS TODAY, V38, P113, DOI 10.1358/dot.2002.38.2.820107
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Jiang HL, 2004, J BIOMAT SCI-POLYM E, V15, P279, DOI 10.1163/156856204322977184
   Kenawy ER, 2002, MACROMOL BIOSCI, V2, P261, DOI 10.1002/1616-5195(200208)2:6<261::AID-MABI261>3.0.CO;2-2
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kim C, 2003, APPL PHYS LETT, V83, P1216, DOI 10.1063/1.1599963
   Kim C, 2004, ELECTROCHIM ACTA, V50, P883, DOI 10.1016/j.electacta.2004.02.072
   Kim C, 2004, ELECTROCHIM ACTA, V50, P877, DOI 10.1016/j.electacta.2004.02.071
   Kim C, 2004, ELECTROCHEM SOLID ST, V7, pA397, DOI 10.1149/1.1801631
   Kim CW, 2005, J POLYM SCI POL PHYS, V43, P1673, DOI 10.1002/polb.20475
   Kim JR, 2004, ELECTROCHIM ACTA, V50, P69, DOI 10.1016/j.electacta.2004.07.014
   Kim JS, 1999, POLYM COMPOSITE, V20, P124, DOI 10.1002/pc.10340
   Kim JS, 2000, POLYM J, V32, P616, DOI 10.1295/polymj.32.616
   Kim JS, 1999, POLYM ENG SCI, V39, P849, DOI 10.1002/pen.11473
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Krishnappa RVN, 2003, J MATER SCI, V38, P2357, DOI 10.1023/A:1023984514389
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P909, DOI 10.1002/pol.1981.180190601
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P921, DOI 10.1002/pol.1981.180190602
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P933, DOI 10.1002/pol.1981.180190603
   Larsen G, 2003, J AM CHEM SOC, V125, P1154, DOI 10.1021/ja028983i
   Lee KH, 2003, POLYMER, V44, P4029, DOI 10.1016/S0032-3861(03)00345-8
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Lee KH, 2002, J POLYM SCI POL PHYS, V40, P2259, DOI 10.1002/polb.10293
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   Li D, 2004, NANO LETT, V4, P933, DOI 10.1021/nl049590f
   Li D, 2005, SMALL, V1, P83, DOI 10.1002/smll.200400056
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liu HQ, 2002, J POLYM SCI POL PHYS, V40, P2119, DOI 10.1002/polb.10261
   Liu HQ, 2004, NANO LETT, V4, P671, DOI 10.1021/nl049826f
   Liu TB, 2003, PROG POLYM SCI, V28, P5, DOI 10.1016/S0079-6700(02)00077-1
   Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MacDiarmid AG, 2001, SYNTHETIC MET, V119, P27, DOI 10.1016/S0379-6779(00)00597-X
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McCann JT, 2005, J MATER CHEM, V15, P735, DOI 10.1039/b415094e
   McKee MG, 2006, SCIENCE, V311, P353, DOI 10.1126/science.1119790
   Megelski S, 2002, MACROMOLECULES, V35, P8456, DOI 10.1021/ma020444a
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Norris ID, 2000, SYNTHETIC MET, V114, P109, DOI 10.1016/S0379-6779(00)00217-4
   Pawlowski KJ, 2003, POLYMER, V44, P1309, DOI 10.1016/S0032-3861(02)00859-5
   RANGKUPAN R, 2003, J MET MAT MINERALS, V12, P81
   Ray NF, 1994, J AM COLL SURGEONS, V186, P1
   Rayleigh L., 1882, PHILOS MAG, V14, P184, DOI [DOI 10.1080/14786448208628425, 10.1080/14786448208628425]
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   Sanders JE, 2005, BIOMATERIALS, V26, P813, DOI 10.1016/j.biomaterials.2004.03.030
   Schreuder-Gibson H, 2002, J ADV MATER-COVINA, V34, P44
   Shawon J, 2004, J MATER SCI, V39, P4605, DOI 10.1023/B:JMSC.0000034155.93428.ea
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Shin YM, 2001, APPL PHYS LETT, V78, P1149, DOI 10.1063/1.1345798
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Smit E, 2005, POLYMER, V46, P2419, DOI 10.1016/j.polymer.2005.02.002
   SRINIVASAN G, 1995, POLYM INT, V36, P195, DOI 10.1002/pi.1995.210360210
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI DOI 10.1002/RCM.1290020802
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Theron SA, 2005, POLYMER, V46, P2889, DOI 10.1016/j.polymer.2005.01.054
   Tomer V, 2005, SOL ENERG MAT SOL C, V85, P477, DOI 10.1016/j.solmat.2004.04.019
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Wan YQ, 2003, BIOMATERIALS, V24, P2195, DOI 10.1016/S0142-9612(03)00107-8
   Wang XF, 2005, POLYMER, V46, P4853, DOI 10.1016/j.polymer.2005.03.058
   Wang XY, 2004, NANO LETT, V4, P331, DOI 10.1021/nl034885z
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1375, DOI 10.1021/bm025652p
   Wu LL, 2005, J MEMBRANE SCI, V250, P167, DOI 10.1016/j.memsci.2004.10.024
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yuan XY, 2004, POLYM INT, V53, P1704, DOI 10.1002/pi.1538
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang G, 2005, MAT SCI ENG B-SOLID, V116, P353, DOI 10.1016/j.mseb.2004.05.050
   Zhang YJ, 2005, MATER CHEM PHYS, V91, P217, DOI 10.1016/j.matchemphys.2004.11.020
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao ZZ, 2005, J APPL POLYM SCI, V97, P466, DOI 10.1002/app.21762
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
   Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/0l.sla.0000143302.48223.7e
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   2000, Patent No. 6114017
NR 134
TC 426
Z9 427
U1 17
U2 323
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1531-7331
BN 978-0-8243-1736-2
J9 ANNU REV MATER RES
JI Ann. Rev. Mater. Res.
PY 2006
VL 36
BP 333
EP 368
DI 10.1146/annurev.matsci.36.011205.123537
PG 36
WC Materials Science, Multidisciplinary
SC Materials Science
GA 074JC
UT WOS:000239807500012
DA 2018-10-20
ER

PT J
AU Finne-Wistrand, A
   Albertsson, AC
AF Finne-Wistrand, Anna
   Albertsson, Ann-Christine
TI The use of polymer design in resorbable colloids
SO ANNUAL REVIEW OF MATERIALS RESEARCH
SE Annual Review of Materials Research
LA English
DT Review; Book Chapter
DE resorbable polymers; architecture; properties; biomedical applications
ID RING-OPENING POLYMERIZATION; DRUG-DELIVERY SYSTEMS; IN-VITRO
   DEGRADATION; DOUBLE-WALLED MICROSPHERES; BIODEGRADABLE MICROSPHERES;
   CONTROLLED-RELEASE; SURFACE MODIFICATION; BLOCK-COPOLYMERS;
   POLY(ETHYLENE GLYCOL); TRIBLOCK COPOLYMERS
AB During the past decade, researchers in the field of polymer chemistry have developed a wide range of very powerful procedures for constructing ever-more-sophisticated polymers. These methods subsequently have been used in suitable systems to solve specific medical problems. This is complicated, and many key factors such as mechanical properties, biocompatibility, biodegradation, stability, and degradation profile must be considered. Colloid particle systems can be used to solve many biomedical- and pharmaceutical-related problems, and it is expected that nanotechnology can be used to develop these materials, devices, and systems even further. For example, an injectible scaffold system with a defined release and degradation profile has huge potential for the repair and regeneration of damaged tissues. This short, nonexhaustive review presents examples of polymer architecture in resorbable particles that have been compared and tested in biomedical applications. We also discuss the design of polymers for core-shell structures.
C1 Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, S-10044 Stockholm, Sweden.
RP Finne-Wistrand, A (reprint author), Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, S-10044 Stockholm, Sweden.
EM annaf@polymer.kth.se; aila@polymer.kth.se
RI Xu, Qingguo/C-1962-2014; Albertsson, Ann-Christine/Q-6107-2016
OI Xu, Qingguo/0000-0003-3191-0771; Albertsson,
   Ann-Christine/0000-0001-8696-9143
CR Al-Azemi TF, 1999, MACROMOLECULES, V32, P6536, DOI 10.1021/ma990639r
   ALBERTSSON AC, 1992, MAKROMOL CHEM-M SYMP, V53, P221, DOI 10.1002/masy.19920530121
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Arimura H, 2003, MACROMOL BIOSCI, V3, P18, DOI 10.1002/mabi.200390001
   Atkins TW, 1998, J MICROENCAPSUL, V15, P31, DOI 10.3109/02652049809006833
   Barbato F, 2001, BIOMATERIALS, V22, P1371, DOI 10.1016/S0142-9612(00)00291-X
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Bezemer JM, 2000, J CONTROL RELEASE, V66, P307, DOI 10.1016/S0168-3659(99)00287-4
   Bittner B, 1999, J CONTROL RELEASE, V60, P297, DOI 10.1016/S0168-3659(99)00085-1
   Breitenbach A, 2002, POLYM ADVAN TECHNOL, V13, P938, DOI 10.1002/pat.233
   Breitenbach A, 2000, J CONTROL RELEASE, V64, P167, DOI 10.1016/S0168-3659(99)00134-0
   Breitenbach A, 2000, J CONTROL RELEASE, V63, P53, DOI 10.1016/S0168-3659(99)00173-X
   Cadee JA, 2001, J BIOMED MATER RES, V56, P600, DOI 10.1002/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I
   Carelli V, 1999, INT J PHARM, V179, P73, DOI 10.1016/S0378-5173(98)00387-1
   CHOI YK, 1996, POLYM PREPRINTS, V37, P109
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   Chung JT, 2005, INT J PHARM, V288, P51, DOI 10.1016/j.ijpharm.2004.09.011
   Conti B, 1997, EUR J PHARM SCI, V5, P287, DOI 10.1016/S0928-0987(97)00023-7
   COOMBES AGA, 1994, BIOMATERIALS, V15, P673, DOI 10.1016/0142-9612(94)90165-1
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013
   Dong CM, 2005, J CONTROL RELEASE, V107, P53, DOI 10.1016/j.jconrel.2005.05.024
   DONG CM, 2005, POLYM PREPR ACS DIV, V46, P272
   Edlund U, 2000, J BIOACT COMPAT POL, V15, P214, DOI 10.1106/ME8A-MUBN-4LFH-P6XQ
   Edlund U, 1999, J POLYM SCI POL CHEM, V37, P1877, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1877::AID-POLA17>3.0.CO;2-4
   Edlund U, 2005, J AM CHEM SOC, V127, P8865, DOI 10.1021/ja052073u
   Feng YK, 1999, MACROMOL CHEM PHYSIC, V200, P1506, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1506::AID-MACP1506>3.0.CO;2-T
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Gallardo A, 1998, J CONTROL RELEASE, V55, P171, DOI 10.1016/S0168-3659(98)00047-9
   Garcia JT, 1999, J MICROENCAPSUL, V16, P83, DOI 10.1080/026520499289338
   Gaur U, 2000, INT J PHARM, V202, P1, DOI 10.1016/S0378-5173(99)00447-0
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Guan HL, 2005, BIOMACROMOLECULES, V6, P1954, DOI 10.1021/bm0492069
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Gupta KC, 2001, J MATER SCI-MATER M, V12, P753, DOI 10.1023/A:1017976014534
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Han SK, 2005, SCI TECHNOL ADV MAT, V6, P468, DOI 10.1016/j.stam.2005.03.017
   Hanes J, 1998, BIOMATERIALS, V19, P163, DOI 10.1016/S0142-9612(97)00221-4
   HELLER J, 1987, Journal of Controlled Release, V5, P173, DOI 10.1016/0168-3659(87)90008-3
   Hemsley AR, 2000, PHILOS T ROY SOC A, V358, P547, DOI 10.1098/rsta.2000.0545
   Hruby M, 2005, J APPL POLYM SCI, V95, P201, DOI 10.1002/app.21121
   Hu YQ, 2003, J BIOMAT SCI-POLYM E, V14, P1363, DOI 10.1163/156856203322599707
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong YI, 2003, J APPL POLYM SCI, V89, P1116, DOI 10.1002/app.12297
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   John G, 2000, MAT SCI ENG C-BIO S, V13, P91, DOI 10.1016/S0928-4931(00)00181-8
   Jule E, 2004, REFLEXIVE POLYMERS AND HYDROGELS, P355
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Keegan ME, 2004, MACROMOLECULES, V37, P9779, DOI 10.1021/ma049470u
   Khang G, 2003, MACROMOL RES, V11, P207, DOI 10.1007/BF03218355
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   Kumbar SG, 2003, J APPL POLYM SCI, V89, P2940, DOI 10.1002/app.12386
   Kurkuri MD, 2004, J CONTROL RELEASE, V96, P9, DOI 10.1016/j.jconrel.2003.12.025
   Langer R, 1998, NATURE, V392, P5
   Leach KJP, 1998, BIOMATERIALS, V19, P1981
   Lee JB, 2004, MACROMOL BIOSCI, V4, P957, DOI 10.1002/mabi.200400073
   Lee TH, 2002, J CONTROL RELEASE, V83, P437, DOI 10.1016/S0168-3659(02)00235-3
   Li YX, 1998, POLYMER, V39, P3087, DOI 10.1016/S0032-3861(97)10048-9
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Liu SQ, 2003, BIOMACROMOLECULES, V4, P1784, DOI 10.1021/bm034189t
   Lu LB, 2005, J POLYM SCI POL CHEM, V43, P2468, DOI 10.1002/pola.20719
   Lucke A, 2002, J CONTROL RELEASE, V80, P157, DOI 10.1016/S0168-3659(02)00020-2
   Luo Y, 2001, EXPERT OPIN THER PAT, V11, P1395
   MATHISEN T, 1989, MACROMOLECULES, V22, P3838, DOI 10.1021/ma00200a003
   Mi FL, 2000, CARBOHYD POLYM, V41, P389, DOI 10.1016/S0144-8617(99)00104-6
   Missirlis D, 2005, LANGMUIR, V21, P2605, DOI 10.1021/la047367s
   Muller M, 2003, J BIOMED MATER RES A, V66A, P55, DOI 10.1002/jbm.a.10502
   Muvaffak A, 2004, J MICROENCAPSUL, V21, P293, DOI 10.1080/02652040310001637848
   Neradovic D, 2001, MACROMOLECULES, V34, P7589, DOI 10.1021/ma011198q
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Ouchi T, 2004, J POLYM SCI POL CHEM, V42, P453, DOI 10.1002/pola.10848
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
   PAPISOV MI, 1995, ADV DRUG DELIVER REV, V16, P127, DOI 10.1016/0169-409X(95)00021-X
   Peracchia MT, 1997, J CONTROL RELEASE, V46, P223, DOI 10.1016/S0168-3659(96)01597-0
   Pettit DK, 1997, PHARMACEUT RES, V14, P1422, DOI 10.1023/A:1012176823155
   Pfeifer BA, 2005, BIOMATERIALS, V26, P117, DOI 10.1016/j.biomaterials.2004.02.015
   Pistel KF, 1999, J CONTROL RELEASE, V59, P309, DOI 10.1016/S0168-3659(99)00008-5
   Pollauf EJ, 2005, INT J PHARM, V301, P294, DOI 10.1016/j.ijpharm.2005.06.004
   Qi K, 2004, J AM CHEM SOC, V126, P6599, DOI 10.1021/ja039647k
   Raman C, 2005, J CONTROL RELEASE, V103, P149, DOI 10.1016/j.conrel.2004.11.012
   Rijcken CJF, 2005, BIOMACROMOLECULES, V6, P2343, DOI 10.1021/bm0502720
   Ruan G, 2003, BIOMATERIALS, V24, P5037, DOI 10.1016/S0142-9612(03)00419-8
   Ryner M, 2001, MACROMOL SYMP, V175, P11, DOI 10.1002/1521-3900(200110)175:1<11::AID-MASY11>3.0.CO;2-F
   Sahli N, 2005, MACROMOL CHEM PHYSIC, V206, P1257, DOI 10.1002/macp.200500045
   SANCHEZ A, 1993, INT J PHARM, V99, P263, DOI 10.1016/0378-5173(93)90369-Q
   Scholes P. D., 1997, CONTROLLED DRUG DELI, P73
   SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040
   Shen YQ, 1999, MACROMOLECULES, V32, P3891, DOI 10.1021/ma990029r
   Shuai XT, 2004, BIOCONJUGATE CHEM, V15, P441, DOI 10.1021/bc034113u
   Soga O, 2004, LANGMUIR, V20, P9388, DOI 10.1021/la048354h
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STURESSON C, 1993, INT J PHARM, V89, P235, DOI 10.1016/0378-5173(93)90249-F
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   Tian L, 2004, MACROMOLECULES, V37, P538, DOI 10.1021/ma030411a
   Topp MDC, 1997, MACROMOLECULES, V30, P8518, DOI 10.1021/ma9710803
   Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2
   Van Tomme SR, 2005, BIOMATERIALS, V26, P2129, DOI 10.1016/j.biomaterials.2004.05.035
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Venkataprasad N, 1999, VACCINE, V17, P1814, DOI 10.1016/S0264-410X(98)00372-7
   Wang W, 2000, LANGMUIR, V16, P7859, DOI 10.1021/la000633r
   XIONG CD, 1995, J APPL POLYM SCI, V55, P865, DOI 10.1002/app.1995.070550604
   Yamamoto H, 2005, J CONTROL RELEASE, V102, P373, DOI 10.1016/j.jconrel.2004.10.010
   Yang YY, 2003, J CONTROL RELEASE, V88, P201, DOI 10.1016/S0168-3659(02)00491-1
   Ydens I, 2005, E-POLYMERS
   Yoncheva K, 2000, PHARMAZIE, V55, P148
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Zeng FQ, 2005, BIOMACROMOLECULES, V6, P2140, DOI 10.1021/bm050124+
   Zeng Y, 2005, J BIOMAT SCI-POLYM E, V16, P371, DOI 10.1163/1568562053654121
   Zhang L, 2005, J BIOMAT SCI-POLYM E, V16, P1095, DOI 10.1163/1568562054798527
   Zhang Q, 2000, J AM CHEM SOC, V122, P3642, DOI 10.1021/ja993941o
   Zhou SB, 2001, J CONTROL RELEASE, V75, P27, DOI 10.1016/S0168-3659(01)00379-0
NR 118
TC 13
Z9 13
U1 1
U2 13
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1531-7331
J9 ANNU REV MATER RES
JI Ann. Rev. Mater. Res.
PY 2006
VL 36
BP 369
EP 395
DI 10.1146/annurev.matsci.36.032905.091005
PG 27
WC Materials Science, Multidisciplinary
SC Materials Science
GA 074JC
UT WOS:000239807500013
DA 2018-10-20
ER

PT J
AU Donnelly, M
   Bittner, T
   Rosse, C
AF Donnelly, M
   Bittner, T
   Rosse, C
TI A formal theory for spatial representation and reasoning in biomedical
   ontologies
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article
DE ontology knowledge; representation; anatomy; mereology; spatial
   reasoning
ID ANATOMY
AB Objective The objective of this paper is to demonstrate how a formal spatial theory can be used as an important tool for disambiguating the spatial information embodied in biomedical ontologies and for enhancing their automatic reasoning capabilities. Method and materials This paper presents a format theory of parthood and location relations among individuals, called Basic Inclusion Theory (BIT). Since biomedical ontologies are comprised of assertions about classes of individuals (rather than assertions about individuals), we define parthood and location relations among classes in the extended theory Basic Inclusion Theory for Classes (BIT + Cl). We then demonstrate the usefulness of this format theory for making the logical structure of spatial information more precise in two ontologies concerned with human anatomy: the Foundational Model of Anatomy (FMA) and GALEN.
   Results We find that in both the FMA and GALEN, class-level spatial relations with different logical properties are not always explicitly distinguished. As a result, the spatial information included in these biomedical ontologies is often ambiguous and the possibilities for implementing consistent automatic reasoning within or across ontologies are limited.
   Conclusion Precise format characterizations of at[ spatial relations assumed by a biomedical ontology are necessary to ensure that the information embodied in the ontology can be fully and coherently utilized in a computational environment. This paper can be seen as an important beginning step toward achieving this goat, but much more work along these tines is required. (c) 2005 Elsevier B.V. All rights reserved.
C1 SUNY Buffalo, Dept Philosophy, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA.
   SUNY Buffalo, Dept Geog, Buffalo, NY 14261 USA.
   Univ Washington, Dept Biol Struct, Struct Informat Grp, Seattle, WA 98195 USA.
RP Donnelly, M (reprint author), SUNY Buffalo, Dept Philosophy, New York State Ctr Excellence Bioinformat & Life, 135 Pk Hall, Buffalo, NY 14260 USA.
EM md63@buffalo.edu
RI Bittner, Thomas/B-4543-2010; Smith, Barry/A-9525-2011
OI Bittner, Thomas/0000-0003-4204-1532; Smith, Barry/0000-0003-1384-116X
CR Asher N, 1995, P 14 INT JOINT C ART, P846
   Beck Rainer, 2003, AMIA Annu Symp Proc, P71
   BITTNER T, 2004, P 16 EUR C ART INT, P283
   Bittner T., 2004, P INT C FORM ONT INF, P37
   Casati R., 1999, PARTS PLACES STRUCTU
   Cohn AG, 1997, GEOINFORMATICA, V1, P1
   Donnelly M, 2004, ARTIF INTELL, V160, P145, DOI 10.1016/j.artint.2004.06.003
   DONNELLY M, 2004, P 11 WORLD C MED INF, P351
   Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401
   Ginsberg Matthew L., 1987, READINGS NONMONOTONI
   Mejino JLV, 2004, KR MED P, P48
   Noy NF, 2004, DATA KNOWL ENG, V48, P335, DOI 10.1016/j.datak.2003.06.002
   Price C., 2000, BJHC&IM-British Journal of Healthcare Computing & Information Management, V17, P27
   Rector A, 1994, P 12 INT C EUR FED M, P229
   Rector AL, 1996, ST HEAL T, V34, P174
   ROGERS J, 2000, AMIA 2000 P ANN S AM, P714
   Rogers J.E, 2001, P MEDINFO 2001, P256
   Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007
   SCHULZ S, 2001, P FOIS 01, P210
   SCHULZ S, 2004, P 16 EUR C ART INT A, P283
   Simons Peter, 1987, PARTS STUDY ONTOLOGY
   Smith B, 1996, DATA KNOWL ENG, V20, P287, DOI 10.1016/S0169-023X(96)00015-8
   Smith B., 2004, P 11 WORLD C MED INF, P444
NR 23
TC 24
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD JAN
PY 2006
VL 36
IS 1
BP 1
EP 27
DI 10.1016/j.artmed.2005.07.004
PG 27
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 011BG
UT WOS:000235242000001
PM 16249077
DA 2018-10-20
ER

PT J
AU Yahia, LH
   Manceur, A
   Chaffraix, P
AF Yahia, LH
   Manceur, A
   Chaffraix, P
TI Bioperformance of shape memory alloy single crystals
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE shape memory alloys; magnetic shape memory; single crystal;
   bioperformance; biocompatibility; corrosion; fatigue; nickel-titanium;
   copper-based alloys
ID NI-MN-GA; FIELD-INDUCED STRAIN; TENSION-COMPRESSION ASYMMETRY;
   MARTENSITE START TEMPERATURES; TRANSFORMATION STRESS LEVELS;
   ELECTROCHEMICAL CORROSION; POLYCRYSTALLINE NITI; IN-VITRO; BEHAVIOR;
   FATIGUE
AB Shape memory alloys (SMA) represent a large family of alloys that show unique characteristics. They have been exploited in several fields for diverse applications. For the last 20 years, these alloys and more particularly Ni-Ti alloys have revolutionized the field of metallic biomaterials. Applications in the biomedical area are multiple and these materials improve significantly the quality of the diagnostics, treatments and surgeries. To our knowledge, most devices are made of SMAs in the polycrystalline form. Nevertheless, the single crystal form shows several promising advantages especially concerning its mechanical performances. In this paper we describe the advantages, advances and limits of using different SMA single crystals for biomedical applications, including biocompatibility and corrosion resistance. We also discuss the low response time of classical thermal SMAs as well as the new advances in research on magnetic SMA single crystals.
C1 Ecole Polytech, Biomech & Biomat Res Ctr, Dept Mech Engn, Stn Ctr Ville,Grp Res Biomech & Biomat, Montreal, PQ H3C 3A7, Canada.
RP Yahia, LH (reprint author), Ecole Polytech, Biomech & Biomat Res Ctr, Dept Mech Engn, Stn Ctr Ville,Grp Res Biomech & Biomat, POB 6079, Montreal, PQ H3C 3A7, Canada.
EM yahia@grbb.polymtl.ca
CR *A2IM, TECHN
   Abdullah N, 2002, INT J NONLINEAR MECH, V37, P1263, DOI 10.1016/S0020-7462(02)00018-5
   *ALKOR, ALKOR COMM BROCH
   *AMT, AMT COMM BROCH
   [Anonymous], MERCK MANUAL DIAGNOS
   ARAB AA, 1988, ACTA METALL MATER, V36, P2627, DOI 10.1016/0001-6160(88)90207-6
   ARBUZOVA LA, 1964, PHYS MET METALLOGR, V17, P68
   BARBOSA MA, 1991, BIOMATERIALS DEGRADA, P227
   Benatti OFM, 2000, J PROSTHET DENT, V84, P360, DOI 10.1067/mpr.2000.109377
   BUCHHEIT TE, 1994, METALL MATER TRANS A, V25, P2383, DOI 10.1007/BF02648858
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   Cingolani E, 1999, MAT SCI ENG A-STRUCT, V273, P595, DOI 10.1016/S0921-5093(99)00436-0
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   Cizek P., 1989, Metallic Materials, V27, P52
   Dang Van K, 1999, HIGH CYCLE METAL FAT, P57
   DELAEY L, 1978, 28 INCRA U CATH LEUV, P91
   DUERIG W, 1990, ENG ASPECTS SHAPE ME, P369
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   Gall K, 1999, J ENG MATER-T ASME, V121, P28, DOI 10.1115/1.2815995
   Gall K, 1999, J ENG MATER-T ASME, V121, P19, DOI 10.1115/1.2815993
   Gall K, 1999, ACTA MATER, V47, P1203, DOI 10.1016/S1359-6454(98)00432-7
   Gall K, 2001, MAT SCI ENG A-STRUCT, V317, P85, DOI 10.1016/S0921-5093(01)01183-2
   GANS E, CHARACTERIZAITON NI
   GAO X, SMA SINGLE CRYSTAL E
   GERSTNER E, 2002, NATURE           OCT
   Glavatska N, 2002, SCRIPTA MATER, V46, P605, DOI 10.1016/S1359-6462(02)00019-2
   GRIFFIN CD, 1983, J BIOMED MATER RES, V17, P489, DOI 10.1002/jbm.820170308
   GUENIN G, 1977, SCRIPTA METALL MATER, V11, P1071, DOI 10.1016/0036-9748(77)90310-6
   HAUTCOEUR A, 1994, ETUDE COMP COMPORTEM, P1
   HAUTCOEUR A, 1991, MONOCRISTAUX ELABORA, P1
   HAUTCOEUR A, 1994, THERMOMECHANICAL BEH, P1
   Hildebrand H.F., 1998, METALS BIOMATERIALS, P265
   Hornbogen E., 1989, Praktische Metallographie, V26, P279
   Huang W, 2002, MATER DESIGN, V23, P11, DOI 10.1016/S0261-3069(01)00039-5
   Ikuta K., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P2156, DOI 10.1109/ROBOT.1990.126323
   KHACHIN VN, 1978, PHYS MET METALLOGR, V46, P49
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   KURDYUMOV GV, 1949, DOKL AKAD NAUK SSSR+, V66, P211
   KWARCIAK J, 1987, J MATER SCI, V22, P2341, DOI 10.1007/BF01082113
   LIKHACHEV AA, 1999, QUANTITATIVE MODEL L
   Liu TZ, 1997, FREE RADICAL BIO MED, V23, P155, DOI 10.1016/S0891-5849(96)00553-9
   Liu X. W., 2002, Materials Science Forum, V394-395, P565
   MANCEUR A, 2003, UNPUB CORROSION SCI
   Marcusson JA, 1996, CONTACT DERMATITIS, V34, P320, DOI 10.1111/j.1600-0536.1996.tb02215.x
   Matsumoto M, 2002, J MAGN MAGN MATER, V239, P521, DOI 10.1016/S0304-8853(01)00635-7
   MATSUMOTO O, 1987, ACTA METALL MATER, V35, P2137, DOI 10.1016/0001-6160(87)90042-3
   McKelvey AL, 1999, J BIOMED MATER RES, V47, P301, DOI 10.1002/(SICI)1097-4636(19991205)47:3<301::AID-JBM3>3.0.CO;2-H
   MERLUZZI VJ, 1989, RES COMMUN CHEM PATH, V66, P425
   MIYAZAKI S, 1988, ACTA METALL MATER, V36, P181, DOI 10.1016/0001-6160(88)90037-5
   MIYAZAKI S, 1981, T JPN I MET, V22, P244, DOI 10.2320/matertrans1960.22.244
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1984, SCRIPTA METALL MATER, V18, P883, DOI 10.1016/0036-9748(84)90254-0
   MIYAZAKI S, 1990, ENG ASPECTS SHAPE ME, P369
   Murray SJ, 2000, APPL PHYS LETT, V77, P886, DOI 10.1063/1.1306635
   NILSSONJATKO JE, 1980, 8 INT VACUUM C, V2, P527
   Novak V, 1999, MAT SCI ENG A-STRUCT, V273, P280, DOI 10.1016/S0921-5093(99)00355-X
   O'Handley RC, 1998, J APPL PHYS, V83, P3263, DOI 10.1063/1.367094
   Ogasawara Y, 2002, BIOL TRACE ELEM RES, V86, P269, DOI 10.1385/BTER:86:3:269
   OKADA M, 1999, J EXP MED, V189
   Orgeas L, 1995, J PHYS IV, V5, P605, DOI 10.1051/jp4/199558605
   Otsuka K., 2002, MRS B
   Overholser RW, 1999, SCRIPTA MATER, V40, P1095, DOI 10.1016/S1359-6462(99)00080-9
   RAYMOND WR, 1995, HDB METAL LIGAND INT, V2, P1253
   RHYANEN J, 1999, THESIS OULU U
   Saburi T, 1981, P INT C SOL SOL PHAS, P1455
   SAKAMOTO H, 1983, T JPN I MET, V24, P665, DOI 10.2320/matertrans1960.24.665
   SAKAMOTO H, 1981, T JPN I MET, V22, P579, DOI 10.2320/matertrans1960.22.579
   Sax N. I., 1989, DANGEROUS PROPERTIES
   Schmalz G, 1998, BIOMATERIALS, V19, P1689, DOI 10.1016/S0142-9612(98)00075-1
   Sehitoglu H, 2000, ACTA MATER, V48, P3311, DOI 10.1016/S1359-6454(00)00153-1
   Sehitoglu H, 2001, MAT SCI ENG A-STRUCT, V314, P67, DOI 10.1016/S0921-5093(00)01924-9
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Sharma P, 2000, J APPL TOXICOL, V20, P313, DOI 10.1002/1099-1263(200007/08)20:4<313::AID-JAT660>3.0.CO;2-J
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Sozinov A, 2002, APPL PHYS LETT, V80, P1746, DOI 10.1063/1.1458075
   SUZUKI Y, 1989, MRS P, P557
   TADAKI T, 1988, ANNU REV MATER SCI, V18, P25
   TAUTZENBERGER P, 1989, MARTENSITIC TRANSFOR, P213
   THEIRRY B, 2000, J BIOMED MATER RES, V51, P586
   Turenne S, 2000, CAN METALL QUART, V39, P217
   Ullakko K, 1996, J MATER ENG PERFORM, V5, P405, DOI 10.1007/BF02649344
   Ullakko K, 2001, SCRIPTA MATER, V44, P475, DOI 10.1016/S1359-6462(00)00610-2
   Ullakko K, 1996, APPL PHYS LETT, V69, P1966, DOI 10.1063/1.117637
   Van Humbeeck J., 1998, SHAPE MEMORY MAT, P149
   VANHUMBECK J, 1997, J PHYS 4, V7
   VANHUMBEECK J, 1991, ENDEAVOUR, V15, P148, DOI 10.1016/0160-9327(91)90119-V
   VANHUMBEECK J, 1989, MARTENSITIC TRANSFOR, P15
   VENUGOPAL B, 1978, METAL TOXICITY MAMMA, V2, P78
   VIAHHI IE, 1997, P 2 INT C SHAP MEM S, P263
   VIVET A, P 4 EUR MEC C EMMC4
   WASILEWSKI RJ, 1971, METALL TRANS, V2, P2973, DOI 10.1007/BF02814943
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Yawny A, 2000, MAT SCI ENG A-STRUCT, V290, P108, DOI 10.1016/S0921-5093(00)00925-4
   ZHANG XY, VARIANT SELECTION CR, P1
NR 94
TC 8
Z9 12
U1 0
U2 8
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 2
BP 101
EP 118
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 012LQ
UT WOS:000235341100003
PM 16477119
DA 2018-10-20
ER

PT J
AU Wiersma, S
   Dolan, F
   Taylor, D
AF Wiersma, S
   Dolan, F
   Taylor, D
TI Fatigue and fracture in materials used for micro-scale biomedical
   components
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE strength; ductility; fatigue; stainless steel; stents; stress
   concentrations
AB Some biomedical components involve the use of materials in microscopic quantities, i.e. in section sizes which are of the same order of magnitude as microstructural features in the material, such as grains. The mechanical behaviour of the material may be different when used in these quantities, compared to its behaviour in macroscopic amounts. An example of a microscopic component is the cardiovascular stent. To ensure the integrity of the stent during deployment and subsequent use, the designer must be able to simulate possible failure modes, i.e. monotonic fracture and fatigue, and the effect of stress concentrations. We carried out tests on specimens of 316L stainless steel, with and without stress concentrations. We found a significant size effect, in which the behaviour of these microscopic specimens was different from that of larger, macroscopic specimens. Microscopic specimens had lower tensile strengths and higher ductility. Under cyclic loading, the material's behaviour at large numbers of cycles was independent of specimen size, but the microscopic specimens were inferior at smaller numbers of cycles to failure. Fatigue limits for the notched specimens could be predicted using an existing theory (the Theory of Critical Distances) but parameter values were different at the macro- and micro-scale. Thus, data from conventional, macroscopic specimens cannot be used to predict the behaviour of this material when used for microscopic components. Mechanical working and annealing strongly affected the tensile strength and ductility, but had no significant effect on fatigue behaviour.
C1 Trinity Coll Dublin, Trinity Ctr Bioengn, Dept Mech Engn, Dublin 2, Ireland.
   Medtron AVE, Galway, Ireland.
RP Taylor, D (reprint author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dept Mech Engn, Dublin 2, Ireland.
EM dtaylor@tcd.ie
CR Bazant Z.P., 2004, MATER STRUCT, V37, P1
   BLOM AF, 1986, BEHAV SHORT FATIGUE, P37
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   Taylor D, 1999, INT J FATIGUE, V21, P413, DOI 10.1016/S0142-1123(99)00007-9
   Taylor D, 2000, FATIGUE FRACT ENG M, V23, P387
NR 5
TC 26
Z9 26
U1 0
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2006
VL 16
IS 2
BP 137
EP 146
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 012LQ
UT WOS:000235341100006
PM 16477122
DA 2018-10-20
ER

PT S
AU Lewis, K
   Boonyang, U
   Evans, L
   Siripaisarnpipat, S
   Ben-Nissan, B
AF Lewis, K
   Boonyang, U
   Evans, L
   Siripaisarnpipat, S
   Ben-Nissan, B
BE Nakamura, T
   Yamashita, K
   Neo, M
TI A comparative study of Thai and Australian crocodile bone for use as a
   potential biomaterial
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; crocodile; biomaterial; bone; bonegraft; bioceramic
ID PHOSPHATE; APATITES; FTIR
AB This study aims to characterize the structure and properties of crocodile bone to assess the potential for use in biomedical applications. Crocodile bone samples obtained from Thailand (Crocodylus siamensis) and Australia (Crocodylus porosus), being the tail and the tibia respectively, were treated to remove organic material and the inner spongy (trabecular) material. The dense cortical bone was used for comparative instrumental analyses. Specific comparisons were made against bovine cortical bone and pure synthetic hydroxyapatite. The material was then analyzed using simultaneous differential thermal analysis/thermogravimetric analysis (DTA/TGA), Fourier-Transform infrared spectroscopy (FTIR), and X-ray diffraction analysis (XRD). Imaging of full bone samples was also conducted using an environmental scanning electron microscopy (ESEM). The SEM provided valuable information through the imaging of samples, showing a marked increase in bone porosity for crocodile material when compared to bovine samples. The crystallinity and/or crystallite size of carbonated hydroxyapatite has been found to be lower than synthetic apatite, with the tibia being the least crystalline of the bone types studied. The crystallinity index (CI) is used as a measure of crystallite size and internal strain. The strain is affected by substitutions in the structure and these results provide a starting point for comparison of the resulting mechanical properties. There is a need for any biomaterial chosen for bone replacement to allow adequate osteointegration. Thus the study this far shows that crocodile bone is a very promising source of carbonated apatite for biomedical applications.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Broadway, NSW 2007, Australia.
   Kasetsart Univ, Dept Chem, Bangkok 10903, Thailand.
RP Lewis, K (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, POB 123, Broadway, NSW 2007, Australia.
EM Kanthi.C.Lewis@its.edu.au; g4784020@ku.ac.th; Louise.Evans@uts.edu.au;
   fscits@ku.ac.th; Besim.Ben-Nissan@uts.edu.au
CR APFELBAUM F, 1992, J INORG BIOCHEM, V45, P277, DOI 10.1016/0162-0134(92)84016-G
   Ben-Nissan B, 1995, ENCY HDB BIOMATERIAL, V1, P191
   *DAT JOINT COMM PO, 1995, 90432 DAT JOINT COMM
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   MUCALO MR, 2004, CROAT CHEM ACTA, V3, P509
   Overgaard S, 1999, J BONE JOINT SURG BR, V81B, P725, DOI 10.1302/0301-620X.81B4.9282
   Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/s002239900161
   PERSON A, 1995, J ARCHAEOL SCI, V22, P211, DOI 10.1006/jasc.1995.0023
   Seebacher F, 2003, AUST J ZOOL, V51, P15, DOI 10.1071/ZO02036
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
NR 10
TC 3
Z9 3
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 15
EP 18
DI 10.4028/www.scientific.net/KEM.309-311.15
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500004
DA 2018-10-20
ER

PT S
AU Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
AF Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
BE Nakamura, T
   Yamashita, K
   Neo, M
TI A histological study of human derived tooth-hydroxyapatite (THA)
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; grafting; bone graft; osteoconduction
ID BOVINE CANCELLOUS BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS
AB Different types of bone-graft substitutes have been developed and are in the market worldwide to eliminate the drawbacks of autogenous grafting. They vary in composition, strength, osteoinductive and osteoconductive properties, mechanism and rates by which they are resorbed and remodelled. Tooth derived hydroxyapatite (THA) is a novel biomaterial. This study was performed to determine the histological properties of THA on animals. A commercial coralline HA (CHA, Proosteon 200, Interpore Cross, USA) was used as control material. 20 sheeps were used and divided into 2 groups. Human THA (Group A) and CHA (Group B) materials were implanted to the tibiae of 10 sheeps for each group. The histological examinations of surrounding bone response were done 12 weeks after implantation. There was no significant difference histologically between group A and B. All materials were found to be surrounded by new bone tissue. THA was found to be as efficient as the standard CHA on histological basis. In addition, economical production of THA should be taken into consideration. Therefore, THA may be a viable alternative on bone grafting provided that clinical trials will be completed.
C1 Marmara Univ, Dept Ind Engn, Sch Engn, TR-34722 Istanbul, Turkey.
   Pasabahce State Hosp, Dept Pathol, Istanbul, Turkey.
   Istanbul Univ, Sch Vet Med, Dept Surg, Istanbul, Turkey.
   Baltalimani Bone Dis Educ & Res Hosp, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Dept Ind Engn, Sch Engn, TR-34722 Istanbul, Turkey.
EM foktar@eng.marmara.edu.tr; hsayrak@turknokta.net; serhatozsoy@yahoo.com;
   heybelin@yahoo.com
CR Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   Guizzardi S, 2000, J BIOMED MATER RES, V53, P227, DOI 10.1002/(SICI)1097-4636(2000)53:3<227::AID-JBM7>3.3.CO;2-5
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Ohbayashi Y, 2000, BIOMATERIALS, V21, P501, DOI 10.1016/S0142-9612(99)00208-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1997, P NAT BIOM ENG S BIY, P54
   PONGKAO D, 1999, P 12 INT S CER MED, V12, P357
   VARGAS G, 1997, P 10 INT S CER MED, V10, P565
   VEHOF WM, 2000, BIOMATER, V21, P2001
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
NR 14
TC 7
Z9 8
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 27
EP 30
DI 10.4028/www.scientific.net/KEM.309-311.27
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500007
DA 2018-10-20
ER

PT S
AU Lopez, HY
   Cortes, DA
   Escobedo, S
   Mantovani, D
AF Lopez, HY
   Cortes, DA
   Escobedo, S
   Mantovani, D
BE Nakamura, T
   Yamashita, K
   Neo, M
TI In vitro bioactivity assessment of metallic magnesium
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE magnesium; bioactivity; SBF; magnesium degradation; apatite layer
ID CORROSION BEHAVIOR
AB In the aim to decrease the degradation rate of magnesium in simulated body fluid, pure magnesium was treated by two different routes, i) by soaking specimens in an HF aqueous solution at 30 degrees C for 30 min and ii) by heating specimens at 345 degrees C for 15 min. The treated samples were immersed in simulated body fluid (SBF) at 37 degrees C for different periods of time. Samples with no treatment were also immersed in SBF. The magnesium released into the SBF, the weight loss of the specimens and the pH of SBF increased with time of immersion in all the cases. The heat treated samples showed a lower degradation rate and lower pH values. A substantial decrease of magnesium concentration in the SBF corresponding to the heat treated samples was also observed. However, the degradation rate of the heat treated samples remains being extremely high. On the other hand, a bonelike apatite layer was observed after only 3 days of immersion in SBF in all the cases. The thickness of this layer increased with time of immersion. Further research needs to be performed to decrease the degradation rate. However, these results indicate that magnesium is a highly potential bioactive material for biomedical applications.
C1 CINVESTAV, Unidad Saltillo, Saltillo 25000, Coahuila, Mexico.
   Inst Tecnol Saltillo, Saltillo 25280, Coahuila, Mexico.
   Univ Laval, Unite Bioingn & Biotechnol, Hop Francois Assise, Ste Foy, PQ G1K 7P4, Canada.
RP Lopez, HY (reprint author), CINVESTAV, Unidad Saltillo, Carr Saltillo Monterrey Km 13-5 AP 663, Saltillo 25000, Coahuila, Mexico.
EM dora.cortes@cinvestav.edu.mx; sesc@fenix.its.mx;
   Diego.Mantovani@gmn.ulaval.ca
OI Cortes-Hernandez, Dora Alicia/0000-0001-7822-1493; Mantovani,
   Diego/0000-0001-9672-895X
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   HENCH L, 1993, INTRO BIOCERAMICS
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Levesque J, 2003, MATER SCI FORUM, V426-4, P521, DOI 10.4028/www.scientific.net/MSF.426-432.521
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   MIYAJI F, 1998, BIOCERAMICS, V8, P323
   MIYAZAKI T, 1997, BIOCERAMICS, V10, P11
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 10
TC 30
Z9 33
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 453
EP 456
DI 10.4028/www.scientific.net/KEM.309-311.453
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500111
DA 2018-10-20
ER

PT S
AU Aizawa, M
   Patel, N
   Porter, AE
   Best, SM
   Bonfield, W
AF Aizawa, M
   Patel, N
   Porter, AE
   Best, SM
   Bonfield, W
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Syntheses of silicon-containing apatite fibres by a homogeneous
   precipitation method and their characterization
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hydroxyapatite; apatite fibre; silicon-containing apatite; homogeneous
   precipitation method
ID HYDROXYAPATITE
AB Silicon-containing apatite (Si-HAp) fibres were successfully synthesized by a homogeneous precipitation method. The resulting Si-HAp fibres were composed of carbonate-containing apatite fibres with preferred orientation in the c-axis. The Si contents in the Si-HAp fibres could be controlled by the Si concentration of the starting solutions. TEM observation indicated that the Si-HAp fibres were of single crystal. The Si-HAp fibres have potential as novel materials for high-performance biomedical devices.
C1 Meiji Univ, Sch Sci & Technol, Dept Ind Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.
   Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Aizawa, M (reprint author), Meiji Univ, Sch Sci & Technol, Dept Ind Chem, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.
EM mamorua@isc.meiji.ac.jp; ez8046@yahoo.co.uk; aep30@cam.ac.uk;
   smb51@cam.ac.uk; wb210@cam.ac.uk
CR Aizawa M, 2000, J CERAM SOC JPN, V108, P249, DOI 10.2109/jcersj.108.1255_249
   Aizawa M., 2004, PHOSPHORUS RES B, V17, P268
   AIZAWA M, 2004, BIOMATERIALS, V26, P3427
   Gibson I, 1999, BIOCERAMICS, V12, P191
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Porter AE, 2004, J BIOMED MATER RES A, V68A, P133, DOI 10.1002/jbm.a.20064
NR 6
TC 7
Z9 9
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 1129
EP 1132
DI 10.4028/www.scientific.net/KEM.309-311.1129
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500275
DA 2018-10-20
ER

PT S
AU Pezzotti, G
   Clarke, IC
   Jobe, C
   Donaldson, T
   Yamamoto, K
   Tateiwa, T
AF Pezzotti, G
   Clarke, IC
   Jobe, C
   Donaldson, T
   Yamamoto, K
   Tateiwa, T
BE Nakamura, T
   Yamashita, K
   Neo, M
TI Confocal Raman spectroscopic analysis of ceramic hip joints
SO BIOCERAMICS 18, PTS 1 AND 2
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 18th International Symposium on Ceramics in Medicine
CY DEC 05-08, 2005
CL Kyoto, JAPAN
SP Int Soc Ceram Med
DE hip joint; ceramics; Raman spectroscopy; residual stress; phase
   transformation
ID WEAR
AB A survey of confocal Raman/fluorescence microprobe spectroscopic techniques is presented with emphasis placed on surface analysis of artificial hip joints. Suitable instrumental configurations are first explained in some details in order to describe the versatility of the spectroscopic microprobes to biomedical materials analyses. Then, these notions, which represent the foundation for structural and mechanical analyses of joint surfaces, are applied to selected cases of paramount importance in hip arthroplasty.
C1 Kyoto Inst Technol, Ceram Phys Lab, Kyoto 606, Japan.
   Kyoto Inst Technol, Res Inst Nanosci, Kyoto 606, Japan.
   Orthopaed Res Ctr, Dept Orthopaed, Loma Linda, CA USA.
   Tokyo Med Univ, Dept Orthoped Surg, Tokyo, Japan.
   Japan Med Mat Co, Osaka, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Kyoto 606, Japan.
EM pezzotti@kit.ac.jp
CR DOWSON D, 1982, WEAR, V75, P313, DOI 10.1016/0043-1648(82)90156-9
   Pezzotti G, 2004, J BIOMED OPT, V9, P372, DOI 10.1117/1.1647547
   Shishido T, 2003, J BIOMED MATER RES B, V67B, P638, DOI 10.1002/jbm.b.10048
NR 3
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-992-X
J9 KEY ENG MAT
PY 2006
VL 309-311
BP 1211
EP 1214
DI 10.4028/www.scientific.net/KEM.309-311.1211
PN 1-2
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BED87
UT WOS:000236902500295
DA 2018-10-20
ER

PT J
AU Ren, KF
   Ji, J
   Shen, JC
AF Ren, KF
   Ji, J
   Shen, JC
TI Tunable DNA release from cross-linked ultrathin DNA/PLL multilayered
   films
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID BY-LAYER ADSORPTION; CANCER GENE-THERAPY; THIN-FILMS; POLYELECTROLYTE
   FILMS; IONIC-STRENGTH; DELIVERY; NANOPARTICLES; ANGIOGENESIS;
   DEPOSITION; BUILDUP
AB A novel ultrathin enzymatically degradable multilayered film using DNA as building blocks was fabricated by the layer-by-layer (LbL) technique. The UV-vis spectrometry and AFM experiments showed that the buildup of DNA and poly-L-lysine (PLL) was a kind of "exponentially growing films". The dye adsorption experiment suggested that the DNA molecules in the multilayered films were effectively protected by PLL. The films were further cross-linked by glutaraldehyde (GA). The cross-linking density of the films was modulated through the simple controlling of the time of the GA incubation process. An in vitro enzymatic degradation was carried out to investigate the DNA release profiles. The UV-vis spectrometry and fluorescence measurements indicated that the DNA release profiles were accordingly changed with the cross-linking density of the films. The nanoscale, easily processed enzymatically biodegradable PLL/DNA film with the ability to precisely control DNA release profiles may serve as a novel DNA delivery system, which may have great potential for gene therapy applications in implantable materials and biomedical devices.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM jijian@zju.edu.cn
RI Ren, Ke-feng/I-3593-2012; Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771; Ji, Jian/0000-0001-9870-4038
CR Curiel DT, 2000, CANCER GENE THER, V7, P1197, DOI 10.1038/sj.cgt.7700222
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Douglas MP, 1998, MUTAT RES-FUND MOL M, V401, P77, DOI 10.1016/S0027-5107(97)00314-X
   DUTTON MD, 1995, ANAL BIOCHEM, V230, P353, DOI 10.1006/abio.1995.1488
   Ekblom P, 1996, CURR OPIN CELL BIOL, V8, P599, DOI 10.1016/S0955-0674(96)80099-8
   El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Feldheim DL, 1996, J AM CHEM SOC, V118, P7640, DOI 10.1021/ja9612007
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   Isner JM, 1996, HUM GENE THER, V7, P959, DOI 10.1089/hum.1996.7.8-959
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Jin W, 2001, J AM CHEM SOC, V123, P8121, DOI 10.1021/ja015807l
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Lang J, 1999, J PHYS CHEM B, V103, P11393, DOI 10.1021/jp9915073
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x
   MEAGER A, 1999, GENE THERAPY TECHNOL
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Palasis M, 2000, HUM GENE THER, V11, P237, DOI 10.1089/10430340050015987
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   PORUMB H, 1978, PROG BIOPHYS MOL BIO, V34, P175
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Rabbani SA, 1998, IN VIVO, V12, P135
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   REN K, 2006, IN PRESS BIOMATERIAL
   Ren KF, 2004, CHEM J CHINESE U, V25, P1576
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rigoberto A, 2003, LANGMUIR, V19, P654
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shi XY, 2002, J PHYS CHEM B, V106, P1173, DOI 10.1021/jp0132634
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Steitz R, 2000, COLLOID SURFACE A, V163, P63, DOI 10.1016/S0927-7757(99)00431-8
   Sukhorukov GB, 1996, THIN SOLID FILMS, V284, P220, DOI 10.1016/S0040-6090(95)08309-X
   Tan QG, 2003, BIOMATERIALS, V24, P4699, DOI 10.1016/S0142-9612(03)00363-6
   THIERRY B, 2004, 7 WORLD BIOM C, P1820
   Vijayanathan V, 2002, BIOCHEMISTRY-US, V41, P14085, DOI 10.1021/bi0203987
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Yoo D, 1997, SYNTHETIC MET, V85, P1425, DOI 10.1016/S0379-6779(97)80304-9
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zhu HG, 2004, BIOMACROMOLECULES, V5, P1933, DOI 10.1021/bm049753u
NR 47
TC 73
Z9 79
U1 2
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JAN-FEB
PY 2006
VL 17
IS 1
BP 77
EP 83
DI 10.1021/bc050264g
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 006NZ
UT WOS:000234905500011
PM 16417254
DA 2018-10-20
ER

PT J
AU Ramachandran, S
   Yu, YB
AF Ramachandran, Sivakumar
   Yu, Yihua Bruce
TI Peptide-based viscoelastic matrices for drug delivery and tissue repair
SO BIODRUGS
LA English
DT Article
ID SELF-ASSEMBLING PEPTIDE; COMPLEMENTARY OLIGOPEPTIDE; REVERSIBLE
   HYDROGELS; DESIGNED PEPTIDE; SYSTEMATIC VARIATION; BIOLOGICAL-MATERIALS;
   NANOFIBERS; SCAFFOLDS; PROTEINS; DIFFERENTIATION
AB Molecular self-assembly has paved the way to create novel, supramolecular, functional biomaterials. Peptide-based biomaterials are gaining interest as a result of their programability, biodegradability, and bioresorbability. Further, unlike polymeric materials,. peptides can be made monodisperse with precise control over sequence, chain length, and stereochemistry. Peptide-based viscoelastic matrices have been designed and characterized for various biomedical applications, such as tissue engineering scaffolds or drug delivery vehicles. The 'holy grail' in designing an ideal tissue engineering scaffold lies in mimicking the cues of the tissue's natural extracellular matrix (ECM). Some of the key elements of ECM that are incorporated into these peptide scaffolds include cell-adhesive and protease-sensitive sequences for enhanced cell-cell and cell-biomaterial interactions. Peptide-based viscoelastic matrices can also be engineered with drug carrying protease-sensitive sequences for controlled and site-specific drug delivery. Molecular-level engineering of simple oligopeptide modules can be used to control the position and density of the bio-mimetic functionalities in the supramolecular structures, which demonstrates the power of the 'bottom-up' approach in self-assembly.
C1 Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Yu, YB (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM bruce.yu@utah.edu
FU NIBIB NIH HHS [EB 004416]
CR Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   BERG JM, 2002, BIOCHEMISTRY-US, P58
   Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dobson CM, 2001, PHILOS T ROY SOC B, V356, P133, DOI 10.1098/rstb.2000.0758
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Fisher A. B., 2001, AM J PHYSIOL-LUNG C, V281, P529
   Ghandehari H, 1998, PHARMACEUT RES, V15, P813, DOI 10.1023/A:1011999810298
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Hartgerink JD, 2004, CURR OPIN CHEM BIOL, V8, P604, DOI 10.1016/j.cbpa.2004.10.001
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hwang WM, 2003, J CHEM PHYS, V118, P389, DOI 10.1063/1.1524618
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Moss JA, 2006, BIOMACROMOLECULES, V7, P1011, DOI 10.1021/bm051001s
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Tang AJ, 2000, BIOCONJUGATE CHEM, V11, P363, DOI 10.1021/bc990133d
   Tauro JR, 2005, MOL PHARMACEUT, V2, P435, DOI 10.1021/mp050028n
   Tovar JD, 2005, J AM CHEM SOC, V127, P7337, DOI 10.1021/ja043764d
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   Yu B.Y, 2005, CHEM MATER, V17, P6583
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 62
TC 21
Z9 21
U1 0
U2 12
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 1173-8804
J9 BIODRUGS
JI Biodrugs
PY 2006
VL 20
IS 5
BP 263
EP 269
DI 10.2165/00063030-200620050-00001
PG 7
WC Oncology; Immunology; Pharmacology & Pharmacy
SC Oncology; Immunology; Pharmacology & Pharmacy
GA 105CD
UT WOS:000242006000001
PM 17025372
DA 2018-10-20
ER

PT J
AU Ho, D
   Fung, AO
   Montemagno, CD
AF Ho, D
   Fung, AO
   Montemagno, CD
TI Engineering novel diagnostic modalities and implantable cytomimetic
   nanomaterials for next-generation medicine
SO BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
LA English
DT Article
DE point of care; saliva diagnostics; lab on a chip; cytomimicry;
   implantable materials; therapeutics
ID TRIBLOCK COPOLYMER MEMBRANES; POLYMER NANOCONTAINER; HUMAN SALIVA; CELL;
   PROTEIN; SEPARATION; SYSTEM
AB The advent of 21st century medicine mill be based on a comprehensive approach to achieving the highly sensitive and specific detection of diseases, as well as the development of novel materials and devices based on biotic-abiotic interfacing as interventional modalities. Novel technologies that enable early identification of physiological changes will serve as a gateway tool for the proper treatment of these disorders. Toward the realization of these technologies, microfabrication and nanofabrication methods have been applied to biomedical systems that allow scientists to interact with cellular and molecular systems on their native size scales. Future enabling systems will build on the foundation composed of such devices. With respect to the envisioned fruition of biofunctional nanomaterials and systems, foundational studies of biological systems and molecules, as well as their interfacing with biocompatible materials, have produced a domain of components that can be integrated and engineered toward eventual cytomimetic materials for transplantation. In addition, the potential underscoring of their future applications in nanoscale medicine is based on the ability to engineer and design intelligent membrane/protein self-assembling and organization phenomena that are typically found in nature into these artificial composite systems. These devices will provide a powerful suite of solutions with broad applicabilities in nanomedicine, for example, (1) the use of concomitant protein functionality toward energy production and the powering of medical implants and (2) replacement of damaged cells (e.g., heart and neuron) with implantable biologically intelligent engineered materials. This work mill examine key advances in the areas of diagnostics and synthetic biology that have led to visionary contributions to next-generation medicine. Furthermore, we present 2 devices that will contribute to the realization of compelling biosensing and biofunctional material technologies. These systems include advanced diagnostic platforms for whole-cell detection, as well as copolymeric materials that have been functionalized by the coupled activity of their embedded membrane proteins. They are envisioned to successfully bridge the gap between foundational scientific progress and the realization of rapid point-of-care disease assessment and biofunctional devices with higher-order behavior. (C) 2006 American Society for Blood and Marrow Transplantation.
C1 Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Ho, D (reprint author), Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Dept Bioengn, 7523 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.
EM deanh@seas.ucia.edu; cdm@seas.ucla.edu
RI Ho, Dean/B-7618-2009
CR BOGOMOLNI RA, 1976, BIOCHIM BIOPHYS ACTA, V440, P68, DOI 10.1016/0005-2728(76)90114-6
   Broz P, 2005, J CONTROL RELEASE, V102, P475, DOI 10.1016/j.jconrel.2004.10.014
   Christodoulides N, 2005, LAB CHIP, V5, P261, DOI 10.1039/b414194f
   Figeys D, 2000, ANAL CHEM, V72, p330A, DOI 10.1021/ac002800y
   FUNG AO, 2005, IN PRESS P IEEE EMBS
   Gascoyne PRC, 2004, P IEEE, V92, P22, DOI 10.1109/JPROC.2003.820535
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Ho D, 2004, NANOTECHNOLOGY, V15, P1084, DOI 10.1088/0957-4484/15/038
   Ho D, 2004, IEEE T NANOTECHNOL, V3, P256, DOI [10.1109/TNANO.2004.828530, 10.1109/tnano.2004.828530]
   Kim Y, 2005, NANOTECHNOLOGY, V16, pS484, DOI 10.1088/0957-4484/16/7/024
   Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/0897715042664867
   Li Y, 2005, Adv Dent Res, V18, P3
   MANDEL ID, 1993, J AM DENT ASSOC, V124, P85, DOI 10.14219/jada.archive.1993.0007
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   Miller S M, 1994, Clin Lab Sci, V7, P39
   Nardin C, 2000, LANGMUIR, V16, P7708, DOI 10.1021/la000204t
   Park J, 2005, LAB CHIP, V5, P1264, DOI 10.1039/b506803g
   Pitard B, 1996, EUR J BIOCHEM, V235, P779, DOI 10.1111/j.1432-1033.1996.t01-1-00779.x
   Severs NJ, 2000, BIOESSAYS, V22, P188, DOI 10.1002/(SICI)1521-1878(200002)22:2<188::AID-BIES10>3.0.CO;2-T
   Shelby JP, 2003, P NATL ACAD SCI USA, V100, P14618, DOI 10.1073/pnas.2433968100
   Shi W, 1998, HYBRIDOMA, V17, P365, DOI 10.1089/hyb.1998.17.365
   Vankrunkelsven S, 2004, ELECTROPHORESIS, V25, P1714, DOI 10.1002/elps.200405900
   WIKSTROM M, 1992, J BIOL CHEM, V267, P10266
   Yang CY, 2005, LAB CHIP, V5, P1017, DOI 10.1039/b504737d
   ZHANG L, 1995, SCIENCE, V268, P727
NR 25
TC 5
Z9 5
U1 0
U2 11
PU CARDEN JENNINGS PUBL CO LTD
PI CHARLOTTESVILLE
PA BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903 USA
SN 1083-8791
J9 BIOL BLOOD MARROW TR
JI Biol. Blood Marrow Transplant.
PD JAN
PY 2006
VL 12
IS 1
SU 1
BP 92
EP 99
DI 10.1016/j.bbmt.2005.09.013
PG 8
WC Hematology; Immunology; Transplantation
SC Hematology; Immunology; Transplantation
GA 010FB
UT WOS:000235171200017
PM 16399592
OA Other Gold
DA 2018-10-20
ER

PT S
AU Steiner, G
   Maitz, M
   Tunc, S
   Salzer, R
AF Steiner, Gerald
   Maitz, Manfred
   Tunc, Sibel
   Salzer, Reiner
BE MahadevanJansen, A
   Petrich, WH
TI Blood compatibility of artificial blood vessels probed by infrared
   spectroscopic imaging
SO BIOMEDICAL VIBRATIONAL SPECTROSCOPY III: ADVANCES IN RESEARCH AND
   INDUSTRY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biomedical Vibrational Spectroscopy III
CY JAN 21-24, 2006
CL San Jose, CA
SP SPIE
DE protein adsorption; protein conformations; fibrinogen; FTIR
   spectroscopic imaging
ID SECONDARY STRUCTURE; PROTEIN ADSORPTION; FORCE MICROSCOPY; FIBRINOGEN;
   SURFACES; IGG; FTIR
AB The determination of protein structure and function plays an important role in biomedical and biochemical research. Common techniques that. give full structural information do not permit in-vivo measurements. Infrared spectroscopy has a sufficient sensitivity to examine the structure of proteins solution under in-situ conditions and even on surfaces. However, measurements at few spots on the surface are not suitable to find out the blood compatibility of the protein layer, because the changes in conformation occur often in small domains. Here we report on the investigations of adsorbed fibrinogen with FTIR imaging. FTIR imaging permits an identification of coagulation spots in the micrometer range and the identification of coagulation spots on the implant material.
C1 [Steiner, Gerald; Salzer, Reiner] Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
   [Maitz, Manfred] Southwest Jiaotong Univ, Emeishan, Peoples R China.
   [Tunc, Sibel] Akdeniz Univ, Antalya, Turkey.
RP Steiner, G (reprint author), Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
EM gerald.steiner@chemie.tu-dresden.de
RI Tunc, Sibel/C-1651-2016
OI Maitz, Manfred/0000-0002-0671-048X
FU DAAD (German Academic Exchange Service); Rossendorf Research Center
FX The support of DAAD (German Academic Exchange Service) and the
   Rossendorf Research Center to Sibel Tunc is gratefully acknowledged. The
   authors gratefully acknowledge Prof. Luis Vazguez from the Instituto de
   Ciencia de Materiales de Madrid (CSIC) for the assistance with the AFM
   investigations.
CR Buijs J, 1996, LANGMUIR, V12, P1605, DOI 10.1021/la950665s
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   SARVER RW, 1991, ANAL BIOCHEM, V194, P89, DOI 10.1016/0003-2697(91)90155-M
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
NR 13
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6135-0
J9 PROC SPIE
PY 2006
VL 6093
AR 609302
DI 10.1117/12.644907
PG 8
WC Engineering, Biomedical; Instruments & Instrumentation; Spectroscopy
SC Engineering; Instruments & Instrumentation; Spectroscopy
GA BEL10
UT WOS:000237678500002
DA 2018-10-20
ER

PT S
AU Fujioka, K
   Khumpuang, S
   Horede, M
   Sugiyama, S
AF Fujioka, K
   Khumpuang, S
   Horede, M
   Sugiyama, S
BE Nicolau, DV
TI Novel Pressure-gradient driven component for blood extraction
SO BIOMEMS AND NANOTECHNOLOGY II
SE Progress in Biomedical Optics and Imaging
LA English
DT Proceedings Paper
CT Conference on BioMEMS and Nanotechnology II
CY DEC 12-14, 2005
CL Brisbane, AUSTRALIA
SP SPIE, Queensland Univ Technol, USAF Off Sci Res Asian Off Aerosp Res & Dev, Def Sci & Technol Org, Bandwidth Foundry
DE blood extraction; disposable; microneedle; x-ray lithography
ID MICRONEEDLE ARRAY
AB Portable blood analysis devices are usually appreciable for applications in blood diagnostic system. We have designed and fabricated a low-cost and simple deal blood extraction device for a biomedical analysis. The device mainly composes of blood extraction tool and a functional bio-chemical analyzing element. In this work, we report the fabrication and pressure-gradient testing results of the blood extraction tool which consists of painless microneedle array and pressure-gradient tank. Microneedle array was fabricated by X-ray lithography using PCT (Plane-pattern to Cross-section Transfer) technique. The idea of our extraction device was simple but capability which is just to hold a sufficient pressure gradient between the tank and blood vessel. The device can draw the volume of blood up to 237 mu l. The device was made of low-cost and disposable materials since it is expected to be used for single blood analysis system. In this work, we introduce design, fabrication and mechanism of the pressure gradient driven component including the extraction test results. The fabrication method of microneedle used in our system is also described.
C1 Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.
RP Fujioka, K (reprint author), Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.
RI Khumpuang, Sommawan/L-2094-2018
OI Khumpuang, Sommawan/0000-0003-4686-9353
CR BLEY P, 1994, FED J S1, V5, P34
   Cabuz C, 2001, PROC IEEE MICR ELECT, P519, DOI 10.1109/MEMSYS.2001.906593
   EHRFELD W, 1995, RADIAT PHYS CHEM, V45, P349, DOI 10.1016/0969-806X(93)E0007-R
   GUO IS, 2003, INT S MICR HUM SCI, P45
   Khumpuang S, 2003, PROC SPIE, V5275, P231, DOI 10.1117/12.522939
   KHUMPUANG S, 2005, P 22 SENS S, P25
   Kim K, 2004, J MICROMECH MICROENG, V14, P597, DOI 10.1088/0960-1317/14/4/021
   Rinderknecht D, 2005, J MICROMECH MICROENG, V15, P861, DOI 10.1088/0960-1317/15/4/026
   Schabmueller CGJ, 2002, J MICROMECH MICROENG, V12, P420, DOI 10.1088/0960-1317/12/4/313
   Schmalz O, 1996, ANGEW MAKROMOL CHEM, V239, P93, DOI 10.1002/apmc.1996.052390109
   Song WH, 2005, J MICROMECH MICROENG, V15, P1425, DOI 10.1088/0960-1317/15/8/007
   SUGIYAMA S, 2001, P TRANSDUCERS 01, P1574
NR 12
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1605-7422
BN 0-8194-6067-2
J9 PRO BIOMED OPT IMAG
PY 2006
VL 6036
AR 60361H
DI 10.1117/12.638563
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BEB08
UT WOS:000236540300036
DA 2018-10-20
ER

PT S
AU Nakanishi, N
   Yamamoto, H
   Tsuchiya, K
   Uetsuji, Y
   Nakamachi, E
AF Nakanishi, N
   Yamamoto, H
   Tsuchiya, K
   Uetsuji, Y
   Nakamachi, E
BE Nicolau, DV
TI Development of wearable medical device for bio-MEMS
SO BIOMEMS AND NANOTECHNOLOGY II
SE Progress in Biomedical Optics and Imaging
LA English
DT Proceedings Paper
CT Conference on BioMEMS and Nanotechnology II
CY DEC 12-14, 2005
CL Brisbane, AUSTRALIA
SP SPIE, Queensland Univ Technol, USAF Off Sci Res Asian Off Aerosp Res & Dev, Def Sci & Technol Org, Bandwidth Foundry
DE bio-MEMS; wearable medical device; blood sugar level control; micropump
   controlled by electrolysis; microneedle; glucose sensor; inslin
ID FIELD-EFFECT TRANSISTOR
AB Biomedical Micro Electro Mechanical Systems (Bio-MEMS) have been applied to the development of a variety of health care related products including health Monitoring Systems (HMS) and Drug Delivery Systems (DDS). We focus on research to develop the new type compact medical device used for blood sugar control. The new type compact medical device comprises (1) a micropump system to extract blood using a pressure change occurred by electrolysis, (2) a platinum (Pt) electrode as a blood sugar sensor immobilized Glucose Oxidase (GOx) and attached to the gate electrode of Metal-Oxide-Semiconductor Field Effect Transistor (MOSFET) to detect the amount of glucose in extracted blood, and (3) a micropump system to inject insulin using a pressure change occurred by electrolysis. GOx was immobilized on a self assemble spacer combined with a Pt electrode by the cross-link method using BSA as an additional bonding material. The device can extract blood in a few microliter through a painless microneedle with the micropump, which used the pressure change occurred by electrolysis. The liquid extraction ability of the micropump system through a microneedle, which is 3.8 mm in length and 100 pm in internal diameter, was measured. The wearable medical device with using the micropump controlled by electrolysis could extract human blood at the speed of 0.15 mu l/sec. If the wearable medical device extracts human blood for 6 seconds, it is enough human blood volume to measure a glucose level, compared to the amount of commercial based glucose level monitor. The electrode embedded in the blood extraction device chamber could detect electrons generated by the hydrolysis of hydrogen peroxide produced by the reaction between GOx and glucose in extracted blood of a few microliter, using the constant electric current measurement system of the MOSFET type hybrid glucose sensor. The output voltage for the glucose diluted in the chamber was increased lineally with increase of the glucose concentration. The compact medical device with the air bubble that occurred by electrolysis could inject insulin at the speed of 6.15 mu l/sec.
C1 Osaka Inst Technol, Grad Sch, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.
   ASTM Res Inst Kyoto, Shimogyo Ku, Kyoto 6008813, Japan.
   Tokai Univ, Dept Precis Eng, Hiratsuka, Kanagawa 2591292, Japan.
   Osaka Inst Technol, Fac Mech Eng, Asahi Ku, Osaka 5358585, Japan.
RP Nakanishi, N (reprint author), Osaka Inst Technol, Grad Sch, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.
OI Tsuchiya, Kazuyoshi/0000-0002-7098-4477
FU Japan Science and Technology Agency; Kyoto City Collaboration of
   Regional Entities
FX This study is a result on development of wristwatch type medical device
   supported by Japan Science and Technology Agency and Kyoto City
   Collaboration of Regional Entities for the Advancement of Technological
   Excellence.
CR CARAS S, 1980, ANAL CHEM, V52, P1935, DOI 10.1021/ac50062a035
   CARAS S D, 1985, Analytical Chemistry, V57, P1920
   JONES JC, 1978, SCI AM, V238, P138, DOI 10.1038/scientificamerican0678-138
   Martin FJ, 2001, BIOMED MICRODEVICES, V3, P97, DOI 10.1023/A:1011442024658
   Oki A, 2003, JPN J APPL PHYS 1, V42, P3722, DOI 10.1143/JJAP.42.3722
   SHULGA AA, 1992, SENSOR ACTUAT B-CHEM, V10, P41, DOI 10.1016/0925-4005(92)80009-M
   TSUCHIYA K, 2005, T JPN SOC MECH ENG-C, V71, P603
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
NR 8
TC 1
Z9 1
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1605-7422
BN 0-8194-6067-2
J9 PRO BIOMED OPT IMAG
PY 2006
VL 6036
AR 60390P
DI 10.1117/12.638162
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BEB08
UT WOS:000236540300019
DA 2018-10-20
ER

PT B
AU Henry, D
   Lenghaus, K
   Wilson, KA
   Hirsch-Kuchma, M
   Jenkins, J
   Sundaram, S
   Hickman, JJ
AF Henry, David
   Lenghaus, Keith
   Wilson, Kerry A.
   Hirsch-Kuchma, Melissa
   Jenkins, Jerry
   Sundaram, Shankar
   Hickman, James J.
BE Renugopalakrishnan, V
   Lewis, RV
TI Submonolayer measurements of adsorbed proteins in microfluidic channels
SO BIONANOTECHNOLOGY: PROTEINS TO NANODEVICES
LA English
DT Proceedings Paper
CT 47th Annual Meeting of the Biophysical-Society
CY MAR 01-05, 2003
CL SAN ANTONIO, TX
SP Biophys Soc, Axon Instruments, ALA Sci Instruments
DE microfluidics; protein adsorption; CFD; XPS; simulation; flow
ID ION MASS-SPECTROMETRY; ENHANCED RAMAN-SPECTROSCOPY; OPTICAL-EMISSION
   SPECTROSCOPY; SINGLE-MOLECULE DETECTION; COLLOIDAL SILVER; TOF-SIMS;
   ADSORPTION; SURFACES; XPS; FILMS
AB Microelectromechanical systems (MEMS), and soon nanoelectromechanical systems (NEMS), are projected to have a major impact in systems for toxin detection, proteomics and biomedical applications. This chapter describes experimental systems that were developed in our labs, as well as those being developed elsewhere, that are being used to understand protein deposition at sub-monolayer coverages in these devices. Modeling tools, used in conjunction with experimental results, can also be utilized for predicting the interactions of proteins with these microsystems, under static and flow conditions, with the goal of creating biocompatible MEMS devices that can be easily integrated with biologically based assay systems. The long-term combination and integration of biological and electronic components requires a thorough understanding of surface/biomolecule interactions in these devices. The use of surface modification techniques has allowed the tailoring of the interface between biological/nonbiological materials, independent of the bulk composition of the nonbiological material, to enable reproducible experimental design. Our results to date have indicated we can measure protein adsorption down to less that 1% of a monolayer and that static results are very different than those observed under flow conditions, and this has been supported by the modeling results. Thus, data obtained under static conditions cannot be used as a predictor for behavior under flow conditions, which should be the predominant situation in most biological assay systems.
C1 [Lenghaus, Keith; Wilson, Kerry A.; Hirsch-Kuchma, Melissa; Hickman, James J.] Univ Cent Florida, 12424 Res Pkwy,Suite 400, Orlando, FL 32826 USA.
   [Henry, David; Lenghaus, Keith; Wilson, Kerry A.; Hickman, James J.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   [Jenkins, Jerry; Sundaram, Shankar] CFD Res Corp, Huntsville, AL 35805 USA.
RP Henry, D (reprint author), Univ Cent Florida, 12424 Res Pkwy,Suite 400, Orlando, FL 32826 USA.
FU MTO Office at DARPA [F 30602-01-2-6541]; NSF [ECS-0003227]
FX We would like to acknowledge the MTO Office at DARPA, grant number F
   30602-01-2-6541, and NSF, grant number ECS-0003227, for funding this
   project. The initial experiments for this chapter were performed at
   Clemson University as indicated by the dual affiliations for K. Wilson,
   K. Lenghaus, and J. Hickman.
CR BRIGGS MP, 1992, PRACTICAL SURFACE AN
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Butler J. E., 1993, Molecular Immunology, V30, P1165, DOI 10.1016/0161-5890(93)90135-X
   Butler JE, 1997, IMMUNOL INVEST, V26, P39, DOI 10.3109/08820139709048914
   BUTLER JE, 1981, METHOD ENZYMOL, P482
   Cao YC, 2003, J AM CHEM SOC, V125, P14676, DOI 10.1021/ja0366235
   CHAKRABORTY A, 2004, P SIMBIOSYS PI M PAL
   Chi QJ, 2000, J AM CHEM SOC, V122, P4047, DOI 10.1021/ja993174t
   Coen MC, 2001, J COLLOID INTERF SCI, V233, P180, DOI 10.1006/jcis.2000.7240
   Connatser RM, 2004, J SEP SCI, V27, P1545, DOI 10.1002/jssc.200401886
   Delfino I, 2005, BIOPHYS CHEM, V113, P41, DOI 10.1016/j.bpc.2004.07.006
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Dodero G, 2000, COLLOID SURFACE A, V175, P121, DOI 10.1016/S0927-7757(00)00521-5
   Dufrene YF, 1999, APPL SURF SCI, V144-45, P638, DOI 10.1016/S0169-4332(98)00881-2
   Glidle A, 2003, ANAL CHEM, V75, P2559, DOI 10.1021/ac0261653
   GOTTLIEB M, 1987, ANAL BIOCHEM, V165, P33, DOI 10.1016/0003-2697(87)90197-7
   GREGG SD, 1967, ADSORPTION SURFACE A
   Griesser HJ, 2004, BIOMATERIALS, V25, P4861, DOI 10.1016/j.biomaterials.2004.01.049
   HAMES BD, 1990, GEL ELECTROPHORESIS
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Jenkins J, 2004, ANAL BIOCHEM, V331, P207, DOI 10.1016/j.ab.2004.03072
   Jin FX, 2003, ANAL CHEM, V75, P4801, DOI 10.1021/ac034109b
   Jin FX, 2004, J ANAL ATOM SPECTROM, V19, P1199, DOI 10.1039/b401397b
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Koo TW, 2005, OPT LETT, V30, P1024, DOI 10.1364/OL.30.001024
   Lasseter TL, 2004, J AM CHEM SOC, V126, P10220, DOI 10.1021/ja047642x
   Lenghaus K, 2003, LANGMUIR, V19, P5971, DOI 10.1021/la034294o
   Lenghaus K, 2002, CARBON, V40, P743, DOI 10.1016/S0008-6223(01)00194-4
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Pacholski ML, 1999, CHEM REV, V99, P2977, DOI 10.1021/cr980137w
   Perry Robert, 1997, PERRYS CHEM ENG HDB
   Petoral RM, 2002, COLLOID SURFACE B, V25, P335, DOI 10.1016/S0927-7765(01)00331-9
   Podstawka E, 2004, APPL SPECTROSC, V58, P1147, DOI 10.1366/0003702042336073
   Podstawka E, 2004, APPL SPECTROSC, V58, P570, DOI 10.1366/000370204774103408
   Podstawka E, 2004, APPL SPECTROSC, V58, P581, DOI 10.1366/000370204774103417
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   ROOT DD, 1993, ANAL BIOCHEM, V209, P354, DOI 10.1006/abio.1993.1134
   RUDZINSKI W, 1997, EQUILIBRIA DYNAMICS, V104
   Sane SU, 1999, ANAL BIOCHEM, V269, P255, DOI 10.1006/abio.1999.4034
   Schnyder B, 2002, SURF INTERFACE ANAL, V34, P40, DOI 10.1002/sia.1248
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sousa SR, 2004, LANGMUIR, V20, P9745, DOI 10.1021/la049158d
   Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   TOVBIN YK, 1997, EQUILIBRIA DYNAMICS, V104
   Valladares DL, 1998, CARBON, V36, P1491, DOI 10.1016/S0008-6223(98)00141-9
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Wagner MS, 2002, ANAL CHEM, V74, P1824, DOI 10.1021/ac0111311
   Wagner MS, 2002, J BIOMAT SCI-POLYM E, V13, P407, DOI 10.1163/156856202320253938
   Wagner MS, 2005, ANAL CHEM, V77, P911, DOI 10.1021/ac048945c
NR 51
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-4219-1
PY 2006
BP 257
EP 274
DI 10.1007/978-1-4020-4375-8_13
PG 18
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Science & Technology - Other Topics
GA BFB13
UT WOS:000240620800013
DA 2018-10-20
ER

PT S
AU Engel, A
   Ottermann, C
   Resch-Genger, U
   Hoffmann, K
   Schweizer, S
   Selling, J
   Spaeth, JM
   Rupertus, V
AF Engel, A.
   Ottermann, C.
   Resch-Genger, U.
   Hoffmann, K.
   Schweizer, S.
   Selling, J.
   Spaeth, J. M.
   Rupertus, V.
BE Grzymala, R
   Haeberle, O
TI Glass based fluorescence reference materials used for optical and
   biophotonic applications
SO BIOPHOTONICS AND NEW THERAPY FRONTIERS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biophotonics and New Therapy Frontiers
CY APR 03-05, 2006
CL Strasbourg, FRANCE
SP Conseil Gen Bas Rhin, Commun Urbaine Strasbourg, Reg Alsace, Alsace Dev Agcy, CNOP, COST, EU Framework Programme, ESF, DGaO, European Opt Soc, ePIXnet, FlexDis, ISIS, NEMO, OLLA, OPERA, PHOREMOST, Photon Cluster, RhenaPhoton Alsace, SIOF, SPIE Europe
DE fluorescence; reference material; glass; glass ceramics; biophotonic;
   multiplexing
AB Fluorescence techniques are known for their high sensitivity and are widely used as analytical tools and detection methods for product and process control, material sciences, environmental and biotechnical analysis, molecular genetics, cell biology, medical diagnostics, and drug screening.
   For routine measurements by fluorescence techniques the existence of an improved quality assurance is one of the basic needs. According to DIN/ISO 17025 certified standards are used for fluorescence diagnostics having the drawback of giving relative values only.
   Typical requirements onto fluorescence reference materials or standards deal with the verification of the instrument performance as well as the improvement of the data comparability. Especially for biomedical applications fluorescence labels are used for the detection of proteins. In particular these labels consist of nano crystalline materials like US and CdSe. The field of Non-Cadmium containing materials is under investigation.
   In order to evaluate whether glass based materials can be used as standards it is necessary to calculate absolute values like absorption/excitation cross sections or relative quantum yields. This can be done using different quantities of dopands in glass, glass ceramics or crystals. The investigated materials are based on different types of glass - silicate, phosphate and boron glass - which play a dominant role for the absorption and emission mechanism. Additional to the so-called elementary fluorescence properties induced by raw earth elements the formation of defects lead to higher cross sections additionally.
   The main investigations deal with wavelength accuracy and lifetime of doped glasses, glass ceramics and crystalline samples. Moreover intensity patterns, homogeneity aspects and photo stability will be discussed.
C1 [Engel, A.; Ottermann, C.; Rupertus, V.] Schott AG, Hattenbergstr 10, D-55014 Mainz, Germany.
   [Resch-Genger, U.; Hoffmann, K.] Fed Inst Mat Res & Test, D-12489 Berlin, Germany.
   [Schweizer, S.; Selling, J.; Spaeth, J. M.] Univ Paderborn, Dept Phys, D-33098 Paderborn, Germany.
RP Engel, A (reprint author), Schott AG, Hattenbergstr 10, D-55014 Mainz, Germany.
RI Resch-Genger, Ute/B-8369-2009; Schweizer, Stefan/H-3518-2011
OI Resch-Genger, Ute/0000-0002-0944-1115; 
CR EHRT D, 2001, P INT C GLASS ED SCO, V1, P84
   ENGEL A, 2005, SPIE, P5856
   ENGEL A, 2001, HIGH QUALITY CAF2 US, P177
   GEFFKEN W, 1962, GLASTECHN BERICHTE, V35, P27
   HAYDEN J, 2004, COMMUNICATION
   *JOGIS, 031975 JOGIS
   LAKOWISC, 1999, PRINCIPLE FLUORESCEN
   RAVI BG, 1992, INT J MOD PHYS B, V6, P2809, DOI 10.1142/S0217979292002255
   REISFELD, 1972, J RES NATL INST STAN, pA76
   RESCH U, 2005, J FLUORESC, P74
   SPAETH, 1999, APPL PHYS LETT, V75, P228
   Stroud J. S., 1971, J AM CERAM SOC, V54, P8
   2005, 36 TI SCHOTT TECHN I
NR 13
TC 1
Z9 1
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6247-0
J9 PROC SPIE
PY 2006
VL 6191
AR 619110
DI 10.1117/12.663627
PG 10
WC Biophysics; Optics
SC Biophysics; Optics
GA BEL84
UT WOS:000238042700035
DA 2018-10-20
ER

PT S
AU Pierrat, R
   Ben Braham, N
   Scheffold, F
   Carminati, R
AF Pierrat, R.
   Ben Braham, N.
   Scheffold, F.
   Carminati, R.
BE Grzymala, R
   Haeberle, O
TI Diffusing-wave spectroscopy beyond the diffusive regime: The influence
   of short light paths and anisotropic scattering
SO BIOPHOTONICS AND NEW THERAPY FRONTIERS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biophotonics and New Therapy Frontiers
CY APR 03-05, 2006
CL Strasbourg, FRANCE
SP Conseil Gen Bas Rhin, Commun Urbaine Strasbourg, Reg Alsace, Alsace Dev Agcy, CNOP, COST, EU Framework Programme, ESF, DGaO, European Opt Soc, ePIXnet, FlexDis, ISIS, NEMO, OLLA, OPERA, PHOREMOST, Photon Cluster, RhenaPhoton Alsace, SIOF, SPIE Europe
DE diffusing wave spectroscopy; turbid media; multiple scattering; light
   fluctuations; Brownian motion
ID RADIATIVE-TRANSFER; RANDOM-MEDIA; TRANSITION; TRANSPORT
AB We study the fluctuations of light multiply scattered by particles under Brownian motion in a fluid. We focus on the behavior of the time correlation function of the field in the non-diffusive regime, in both transmission and reflection. In transmission through optically thin systems, an extended Diffusing-Wave Spectroscopy (DWS) model based on the Radiative Transfer Equation (RTE) is described, which predicts substantial deviations from the standard DWS theory. For backscattered light, experiments using unpolarized light show a clear dependence on the anisotropy factor g. This behavior is not described by the standard DWS theory. A good agreement with the data is obtained using the RTE model, and an approximate model in which the path-length distribution of the standard DWS is corrected by a prefactor which depends on the level of anisotropy. These results should have broad applications in diffuse-light biomedical imaging, and in the field of soft-materials and biomaterials analysis.
C1 [Pierrat, R.; Carminati, R.] Ecole Cent Paris, Lab EM2C, CNRS, F-92295 Chatenay Malabry, France.
   [Ben Braham, N.; Scheffold, F.] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.
RP Carminati, R (reprint author), Ecole Cent Paris, Lab EM2C, CNRS, F-92295 Chatenay Malabry, France.
EM remi.carminati@cep.fr
RI Carminati, Remi/H-6882-2014
OI Scheffold, Frank/0000-0002-0567-5811
FU EU Integrated Project Molecular Imaging [LSHG-CT-2003-503259];
   TopNano21/KTI [5971.2]
FX This work was supported by the EU Integrated Project Molecular Imaging
   under contract LSHG-CT-2003-503259. Financial support by TopNano21/KTI
   (project no. 5971.2) is gratefully acknowledged.
CR BENBRAHAM N, 2006, UNPUB
   BERNE PJ, 1976, DYNAMIC LIGHT SCATTE
   Bizheva KK, 1998, PHYS REV E, V58, P7664, DOI 10.1103/PhysRevE.58.7664
   Brown W., 1993, DYNAMIC LIGHT SCATTE
   Carminati R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213903
   CHANDRASEKHAR S, 1960, RADIAT TRANSFER
   DURIAN DJ, 1995, PHYS REV E, V51, P3350, DOI 10.1103/PhysRevE.51.3350
   Elaloufi R, 2004, J OPT SOC AM A, V21, P1430, DOI 10.1364/JOSAA.21.001430
   Elaloufi R, 2002, J OPT A-PURE APPL OP, V4, pS103, DOI 10.1088/1464-4258/4/5/355
   GAYEN SK, 1996, OPT PHOTONICS NEWS, V7, P17
   Ishimaru A., 1997, WAVE PROPAGATION SCA
   KAPLAN PD, 1993, APPL OPTICS, V32, P3828, DOI 10.1364/AO.32.003828
   Lemieux PA, 1998, PHYS REV E, V57, P4498, DOI 10.1103/PhysRevE.57.4498
   MACKINTOSH FC, 1989, PHYS REV B, V40, P2383, DOI 10.1103/PhysRevB.40.2383
   MARET G, 1987, Z PHYS B CON MAT, V65, P409, DOI 10.1007/BF01303762
   Periasamy A., 2001, METHODS CELLULAR IMA
   PINE DJ, 1988, PHYS REV LETT, V60, P1134, DOI 10.1103/PhysRevLett.60.1134
   PINE DJ, 1990, J PHYS FRANCE, V51, P2110
   Popescu G, 2001, APPL OPTICS, V40, P4215, DOI 10.1364/AO.40.004215
   Rojas-Ochoa LF, 2004, J OPT SOC AM A, V21, P1799, DOI 10.1364/JOSAA.21.001799
   Scheffold F, 2003, SOFT MATER, V1, P139, DOI 10.1081/SMTS-120022461
   Sebbah P., 2001, WAVES IMAGING COMPLE
   THOMAS GE, 1999, RADIAT TRANSFER ATMO
   Wax A, 2001, APPL OPTICS, V40, P4222, DOI 10.1364/AO.40.004222
   YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445
NR 25
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6247-0
J9 PROC SPIE
PY 2006
VL 6191
AR 619116
DI 10.1117/12.660912
PG 7
WC Biophysics; Optics
SC Biophysics; Optics
GA BEL84
UT WOS:000238042700039
DA 2018-10-20
ER

PT J
AU Goessler, UR
   Riedel, K
   Hormann, K
   Riedel, F
AF Goessler, Ulrich Reinhart
   Riedel, Katrin
   Hoermann, Karl
   Riedel, Frank
TI Perspectives of gene therapy in stem cell tissue engineering
SO CELLS TISSUES ORGANS
LA English
DT Review
DE gene therapy; vectors; mesenchymal stem cells; cartilage; chondrocytes;
   tissue engineering; extracellular matrix; plastic and reconstructive
   surgery
ID MARROW STROMAL CELLS; BONE MORPHOGENETIC PROTEINS; DIFFERENTIATION
   IN-VITRO; ARTICULAR-CARTILAGE; GROWTH-FACTOR; MOLECULAR SIGNATURE;
   THICKNESS DEFECTS; FUTURE-PROSPECTS; PROGENITOR CELLS; VIRAL VECTORS
AB Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain or improve tissue function. It is hoped that forming tissue de novo will overcome many problems in plastic surgery associated with such areas as wound healing and the immunogenicity of transplanted tissue that lead to dysfunctional repair. Gene therapy is the science of the transfer of genetic material into individuals for therapeutic purposes by altering cellular function or structure at the molecular level. Recently, tissue engineering has been used in conjunction with gene therapy as a hybrid approach. This combination of stem-cell-based tissue engineering with gene therapy has the potential to provide regenerative tissue cells within an environment of optimal regulatory protein expression and would have many benefits in various areas such as the transplantation of skin, cartilage or bone. The aim of this review is to outline tissue engineering and possible applications of gene therapy in the field of biomedical engineering as well as basic principles of gene therapy, vectors and gene delivery. Copyright (c) 2006 S. Karger AG, Basel
C1 Heidelberg Univ, Fac Clin Med, Dept Otolaryngol Head & Neck Surg, Mannheim, Germany.
   Heidelberg Univ, Dept Hand Plast & Reconstruct Surg, Burn Ctr, BG Trauma Ctr, Ludwigshafen, Germany.
RP Goessler, UR (reprint author), Univ Mannheim, HNO Klin Mannheim, Theodor Kutzer Ufer, DE-68135 Mannheim, Germany.
EM ugoessler@web.de
CR Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488
   Arai F, 2005, TRENDS CARDIOVAS MED, V15, P75, DOI 10.1016/j.tcm.2005.03.002
   Arai F, 2005, INT J HEMATOL, V82, P371, DOI 10.1532//IJH97.05100
   Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314
   Bonadio J, 2000, ADV DRUG DELIVER REV, V44, P185, DOI 10.1016/S0169-409X(00)00094-6
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bonadio J, 2002, ANN NY ACAD SCI, V961, P58, DOI 10.1111/j.1749-6632.2002.tb03048.x
   Brandenberger Ralph, 2004, BMC Dev Biol, V4, P10, DOI 10.1186/1471-213X-4-10
   Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CHENG L, 1993, P NATL ACAD SCI USA, V90, P4455, DOI 10.1073/pnas.90.10.4455
   Christenson L, 1997, TISSUE ENG, V3, P71, DOI 10.1089/ten.1997.3.71
   COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7
   Corti S, 2005, HISTOL HISTOPATHOL, V20, P977, DOI 10.14670/HH-20.977
   CRYSTAL RG, 1995, SCIENCE, V270, P404, DOI 10.1126/science.270.5235.404
   Dani C, 1997, J CELL SCI, V110, P1279
   DANOS O, 1992, BONE MARROW TRANSPL, V9, P131
   Day CS, 1999, TISSUE ENG, V5, P119, DOI 10.1089/ten.1999.5.119
   Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527
   EVANS CH, 1995, J BONE JOINT SURG AM, V77A, P1103, DOI 10.2106/00004623-199507000-00021
   Garry DJ, 2003, CURR OPIN NEPHROL HY, V12, P447, DOI 10.1097/01.mnh.0000079694.89474.b2
   Goessler UR, 2005, INT J MOL MED, V15, P899
   Goessler UR, 2004, INT J MOL MED, V13, P505
   GOFF SP, 1987, BIOCHIM BIOPHYS ACTA, V907, P93, DOI 10.1016/0304-419X(87)90001-1
   GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317
   HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515
   Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2
   KODAMA S, 2005, SCI AGING KNOWLEDGE, pPE2
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kraus KH, 2006, VET SURG, V35, P232, DOI 10.1111/j.1532-950X.2006.00142.x
   Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755
   Krisky DM, 1998, GENE THER, V5, P1593, DOI 10.1038/sj.gt.3300766
   Kristensen DM, 2005, APMIS, V113, P756, DOI 10.1111/j.1600-0463.2005.apm_391.x
   Kroger H, 1997, CALCIFIED TISSUE INT, V61, P33, DOI 10.1007/s002239900289
   Krougliak V, 1995, HUM GENE THER, V6, P1575, DOI 10.1089/hum.1995.6.12-1575
   Lakshmipathy U, 2005, BLOOD REV, V19, P29, DOI 10.1016/j.blre.2004.03.001
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118
   Lemischka IR, 2003, NATURE, V425, P778, DOI 10.1038/425778a
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Luyten FP, 1995, ACTA ORTHOP SCAND, V66, P51, DOI 10.3109/17453679509157647
   Maeda S, 2002, J CELL PHYSIOL, V193, P73, DOI 10.1002/jcp.10151
   Mandalam Ramkumar K, 2002, Mil Med, V167, P78
   Marshall E, 2000, SCIENCE, V287, P953, DOI 10.1126/science.287.5455.953
   Marshall E, 2002, SCIENCE, V298, P34, DOI 10.1126/science.298.5591.34
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Minsk AG, 1998, TISSUE ENG, V4, P445, DOI 10.1089/ten.1998.4.445
   Mitchell CA, 1996, GROWTH FACTORS, V13, P37, DOI 10.3109/08977199609034565
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530
   Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7
   O'Driscoll SW, 1999, CLIN ORTHOP RELAT R, pS186, DOI 10.1097/00003086-199910001-00020
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Oligino TJ, 2000, CLIN ORTHOP RELAT R, pS17
   Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967
   Polak J, 2005, GENE THER, V12, P1725, DOI 10.1038/sj.gt.3302651
   Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037
   Ramoshebi Lentsha N, 2002, Expert Rev Mol Med, V4, P1
   Robbins PD, 1998, PHARMACOL THERAPEUT, V80, P35, DOI 10.1016/S0163-7258(98)00020-5
   ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Salyapongse AN, 1999, CLIN PLAST SURG, V26, P663
   Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPINDLER KP, 1995, J ORTHOP RES, V13, P201, DOI 10.1002/jor.1100130208
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559
   Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630
   Trippel S B, 1997, Instr Course Lect, V46, P473
   Vats A, 2002, CLIN OTOLARYNGOL, V27, P227, DOI 10.1046/j.1365-2273.2002.00579.x
   VERFAILLIE CM, 2002, STEM CELLS HYPE REAL, P369
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Warren SM, 2002, J NEUROSURG, V97, P481, DOI 10.3171/spi.2002.97.4.0481
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   WILES MV, 1991, DEVELOPMENT, V111, P259
   WONG M, 1995, DEV BIOL, V167, P130, DOI 10.1006/dbio.1995.1012
   WONG MY, 1993, IN VITRO CELL DEV-AN, V29A, P917
   Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098
NR 86
TC 29
Z9 35
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2006
VL 183
IS 4
BP 169
EP 179
DI 10.1159/000096508
PG 11
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 113SI
UT WOS:000242617200001
PM 17159343
DA 2018-10-20
ER

PT S
AU Wan, WK
   Hutter, JL
   Millon, L
   Guhados, G
AF Wan, W. K.
   Hutter, J. L.
   Millon, L.
   Guhados, G.
BE Oksman, K
   Sain, M
TI Bacterial cellulose and its nanocomposites for biomedical applications
SO CELLULOSE NANOCOMPOSITES: PROCESSING, CHARACTERIZATION, AND PROPERTIES
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT 229th National Meeting of the American-Chemical-Society
CY MAR 13-17, 2005
CL San Diego, CA
SP Amer Chem Soc
ID XYLINUM SUBSP SUCROFERMENTANS; ATOMIC-FORCE MICROSCOPY;
   ACETOBACTER-XYLINUM; MECHANICAL-PROPERTIES; STATIC CULTURE; HYDROGELS;
   STRAINS; ACID; BIOSYNTHESIS; CANTILEVERS
AB Bacterial cellulose is a natural nanomaterial produced by strains of the bacterium Acetobacter xylinum in static, shaken and agitated cultures. With fiber dimension of -30 nm and being very hydrophilic, it is ideally suited for a broad range of biomedical applications. The bacterial cellulose fiber has a high degree of crystallinity. Using atomic force microscopy for direct nanomechanical measurement, we have determined that these fibers are very strong and when used in combination with other biocompatible materials, produce nanocomposites suitable for use in medical device applications. In particular, nanocomposites consisting of bacterial cellulose and poly(vinyl alcohol) have been investigated. A broad range of mechanical properties control was demonstrated. Materials with properties closely mimic that of cardiovascular tissues were prepared. These materials are potential candidates as synthetic replacements of natural cardiovascular tissues. (c) 2006 American Chemical Society.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Phys & Astron, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
CR BENBASSAT A, 1992, Patent No. 5114849
   BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400
   Brown AJ, 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   BUNGAY HR, 1999, Patent No. 5955926
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   BYROM D, 1990, Patent No. 4929550
   BYROM D, 1991, MICROBIAL CELLULOSE
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   COLVIN JR, 1963, J CELL BIOL, V17, P105, DOI 10.1083/jcb.17.1.105
   COOK KE, 1980, CURR MICROBIOL, V3, P203, DOI 10.1007/BF02602449
   DUDMAN WF, 1960, J GEN MICROBIOL, V22, P25, DOI 10.1099/00221287-22-1-25
   Eichhorn SJ, 2001, CELLULOSE, V8, P197, DOI 10.1023/A:1013181804540
   EPPAS NA, 2000, ADV POLYM SCI, V8, P37
   FONTANA JD, 1990, J APPL BIOCH BIOTECH, V25, P253
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   GORDON MJ, 1999, THESIS U ONTARIO
   GROMETELHANAN Z, 1963, J BACTERIOL, V85, P284
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   HAYASH K, 2001, BIOMECHANICAL TECHNI, V2
   HESTRIN S, 1947, NATURE, V159, P64, DOI 10.1038/159064a0
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   HORII F, 1982, POLYM B, V8, P162
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Ishida T, 2003, BIOTECHNOL BIOENG, V83, P474, DOI 10.1002/bit.10690
   Johnson DC, 1989, US Patent, Patent No. [4,863,565, 4863565]
   Joseph G, 2003, J CHEM TECHNOL BIOT, V78, P964, DOI 10.1002/jctb.869
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kojima Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1585, DOI 10.1271/bbb.61.1585
   Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091
   KRIEGER J, 1990, CHEM ENG NEWS   0302, V68, P37
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Leeson-Dietrich J, 1995, J Heart Valve Dis, V4, P88
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   MARXFIGINI M, 1974, BIOCHIM BIOPHYS ACTA, V338, P382, DOI 10.1016/0304-4165(74)90299-2
   MARXFIGINI M, 1982, CELLULOSE OTHER NATU
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   MAYNE ASD, 1989, J THORAC CARDIOV SUR, V98, P170
   MOOYOUNG M, 1969, BIOTECHNOL BIOENG, V11, P393
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   MUHLETHALER K, 1949, BIOCHIM BIOPHYS ACTA, V3, P527, DOI 10.1016/0006-3002(49)90126-2
   Naritomi T, 1998, J FERMENT BIOENG, V85, P89, DOI 10.1016/S0922-338X(97)80360-1
   OHAD I, 1962, J CELL BIOL, V12, P31, DOI 10.1083/jcb.12.1.31
   Ougiya H, 1998, BIOSCI BIOTECH BIOCH, V62, P1714, DOI 10.1271/bbb.62.1714
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   Sakairi N, 1998, CARBOHYD POLYM, V35, P233, DOI 10.1016/S0144-8617(97)00135-5
   Salvetat JP, 1999, PHYS REV LETT, V82, P944, DOI 10.1103/PhysRevLett.82.944
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   SCHRAMM M, 1957, BIOCHEM J, V67, P669, DOI 10.1042/bj0670669
   Seto A, 1997, BIOSCI BIOTECH BIOCH, V61, P735, DOI 10.1271/bbb.61.735
   SHIBAZAKI H, 1993, J APPL POLYM SCI, V50, P965, DOI 10.1002/app.1993.070500605
   Son HJ, 2001, BIOTECHNOL APPL BIOC, V33, P1, DOI 10.1042/BA20000065
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tahara N, 1997, BIOSCI BIOTECH BIOCH, V61, P1862, DOI 10.1271/bbb.61.1862
   Timoshenko S. P., 1997, MECH MAT
   TONOUCHI N, 1995, BIOSCI BIOTECH BIOCH, V59, P805, DOI 10.1271/bbb.59.805
   TOYOSAKI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1498, DOI 10.1271/bbb.59.1498
   TOYOSAKI H, 1995, J GEN APPL MICROBIOL, V41, P307, DOI 10.2323/jgam.41.307
   Tsuchida T, 1997, PURE APPL CHEM, V69, P2453, DOI 10.1351/pac199769112453
   Verschuren PG, 2000, J BIOSCI BIOENG, V89, P414, DOI 10.1016/S1389-1723(00)89089-1
   WALTERS DA, 1996, REV SCI INSTRUM, V67, P3580
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Watanabe K, 1998, BIOSCI BIOTECH BIOCH, V62, P1290, DOI 10.1271/bbb.62.1290
   WATANABE K, 1995, BIOSCI BIOTECH BIOCH, V59, P65, DOI 10.1271/bbb.59.65
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
   WILLIAMS WS, 1989, APPL ENVIRON MICROB, V55, P2448
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   YAGI H, 1975, IND ENG CHEM PROC DD, V14, P488, DOI 10.1021/i260056a024
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   YOSHINO K, 1991, SYNTHETIC MET, V41, P1593
   ZABRISKIE DW, 1999, TRADERS GUIDE FERMEN
NR 77
TC 40
Z9 40
U1 0
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3980-0
J9 ACS SYM SER
PY 2006
VL 938
BP 221
EP 241
PG 21
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA BEW12
UT WOS:000239747600015
DA 2018-10-20
ER

PT J
AU Kuzielova, E
   Hruba, J
   Palou, M
   Smrckova, E
AF Kuzielova, Eva
   Hruba, Jana
   Palou, Martin
   Smrckova, Eva
TI Influence of P2O5 upon the crystallization of lithium disilicate and
   fluoroapatite in bio-glass ceramics
SO CERAMICS-SILIKATY
LA English
DT Article
DE fluoroapatite; lithium disilicate; bio-glass ceramics
ID SILICATE-GLASSES; ELECTRON-MICROSCOPY; CRYSTAL NUCLEATION; KINETICS;
   GROWTH; FLUORIDE
AB Referred work is a preliminary investigation of the lithium disilicate (LS2) and the fluoroapatite (FA) crystallization in bio-glass ceramics. Composite glass-ceramics with various content of P2O5 in oxide system SiO2-Li2O-CaO-CaF2-P2O5 were prepared by heat treatment of glass at different temperatures. Two crystalline phases lithium disilicate (LS2) and fluorapatite (FA) were developed in the samples depending on P2O5 content and temperature. The increase of temperature as well as the content of P2O5 promote the crystallization of FA. XRD measurements supplemented by DTA results showed that LS2 crystallization at lower temperature is inhibited because of the present of amorphous FA. On the contrary, crystalline phase of FA promoted the crystallization of LS2. Phase separation of the samples is well observed in scanning electronic micrograph. The Vickers hardness values of prepared bio-glass ceramics are higher than the average hardness of biological tooth and these materials could be applied as mechanically loaded biomedical implants.
C1 Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Bratislava 81237, Slovakia.
RP Kuzielova, E (reprint author), Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Radlinskeho 9, Bratislava 81237, Slovakia.
EM eva.kuzielova@stuba.sk
CR BARKER MF, 1988, PHYS CHEM GLASSES, V29, P240
   CHEN A, 1988, J NON-CRYST SOLIDS, V100, P353, DOI 10.1016/0022-3093(88)90045-2
   Clifford A, 1996, J NON-CRYST SOLIDS, V196, P346, DOI 10.1016/0022-3093(95)00611-7
   HEADLEY TJ, 1984, J AM CERAM SOC, V67, P620, DOI 10.1111/j.1151-2916.1984.tb19606.x
   HENCH LL, 1971, PHYS CHEM GLASSES, V12, P58
   JAMES PF, 1971, J MATER SCI, V6, P1345, DOI 10.1007/BF00549678
   JAMES PF, 1974, PHYS CHEM GLASSES, V15, P95
   JAMES PF, 1985, J NON-CRYST SOLIDS, V73, P517, DOI 10.1016/0022-3093(85)90372-2
   James PF, 1997, J NON-CRYST SOLIDS, V219, P17, DOI 10.1016/S0022-3093(97)00247-0
   JAMES PF, 1974, PHILOS MAG, V30, P789, DOI 10.1080/14786437408207235
   Kim HW, 2004, J AM CERAM SOC, V87, P1939
   Kim HW, 2004, BIOMATERIALS, V25, P2919, DOI 10.1016/j.biomaterials.2003.09.074
   KINSER DL, 1968, J AM CERAM SOC, V51, P445, DOI 10.1111/j.1151-2916.1968.tb11916.x
   Misra DN, 1999, J COLLOID INTERF SCI, V220, P387, DOI 10.1006/jcis.1999.6537
   Mojumdar SC, 2004, J THERM ANAL CALORIM, V78, P73, DOI 10.1023/B:JTAN.0000042155.26913.79
   ROWLANDS EG, 1979, PHYS CHEM GLASSES, V20, P19
   Soares PC, 2003, J NON-CRYST SOLIDS, V331, P217, DOI 10.1016/j.jnoncrysol.2003.08.075
NR 17
TC 11
Z9 11
U1 0
U2 7
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2006
VL 50
IS 3
BP 159
EP 162
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 104FT
UT WOS:000241943000006
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Roosjen, A
   Norde, W
   van der Mei, HC
   Busscher, HJ
AF Roosjen, Astrid
   Norde, Willem
   van der Mei, Henny C.
   Busscher, Henk J.
BE Grundke, K
   Stamm, M
   Adler, HJ
TI The use of positively charged or low surface free energy coatings versus
   polymer brushes in controlling biofilm formation
SO Characterization of Polymer Surfaces and Thin FIlms
SE PROGRESS IN COLLOID AND POLYMER SCIENCE
LA English
DT Proceedings Paper
CT 10th Dresden Polymer Meeting
CY APR 10-13, 2005
CL Dresden, GERMANY
DE biofilm; biomaterial centered infection; microbial adhesion; polymer
   brushes; surface free energy
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLY(ETHYLENE OXIDE) BRUSHES;
   SELF-ASSEMBLED MONOLAYERS; BACTERIAL ADHESION; POLYETHYLENE-GLYCOL;
   PROTEIN ADSORPTION; POLYSTYRENE SURFACES; BIOMEDICAL POLYMERS; MICROBIAL
   ADHESION; PARALLEL-PLATE
AB Biofilm formation on biomaterials implant surfaces and subsequent infectious complications are a frequent reason for failure of many biomedical devices, such as total hip arthroplasties, vascular catheters and urinary catheters. The development of a biofilm is initiated by the formation of a conditioning film of adsorbed macromolecules, such as proteins, followed by adhesion of microorganisms, where after they grow and anchor through secretion of extracellular polymeric substances. Adhesion of microorganisms is influenced by the physico-chemical properties of the biomaterial surface. Positively charged materials stimulate bacterial adhesion, but prevent growth of adhering bacteria. The use of low surface free energy materials did not always reduce in vitro adhesion of bacteria, but has been found beneficial in in vivo applications where fluctuating shear forces prevail, like on intra-oral devices and urine catheters. Polymer brushes have shown a very high reduction in in vitro adhesion of a great variety of microorganisms. However, for clinical application, the long term stability of polymer brushes is still a limiting factor. Further effort is therefore required to enhance the stability of polymer brushes on biomaterial implant surfaces to facilitate clinical use of these promising coatings.
C1 Univ Groningen, Med Ctr, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Wageningen & Res Ctr, Lab Phys Chem & Colloid Sci, NL-67036 HB Wageningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Med Ctr, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Bakker DP, 2003, COLLOID SURFACE B, V32, P179, DOI 10.1016/S0927-7765(03)00159-0
   BHATT MV, 1983, SYNTHESIS-STUTTGART, P249, DOI 10.1055/s-1983-30301
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   BUSSCHER HJ, 1990, MICROBIAL CELL SURFA, P335
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DEXTER SC, 1975, APPL MICROBIOL, V30, P298
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Dufrene YF, 1996, MICROBIOL-SGM, V142, P855, DOI 10.1099/00221287-142-4-855
   ESCHER A, 1990, BIOFILMS, P445
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Han S, 1997, POLYMER, V38, P317, DOI 10.1016/S0032-3861(97)88175-X
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Harris J. M., 1992, POLYETHYLENE GLYCOL, P283
   HARRIS JM, 1992, POLYETHYLENEGLYCOL
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Holland NB, 1998, NATURE, V392, P799
   HONG HG, 1994, LANGMUIR, V10, P153, DOI 10.1021/la00013a023
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KI DP, 1998, BIOMATERIALS, V19, P851
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   LEE J, 1989, J COLLOID INTERF SCI, V131, P252, DOI 10.1016/0021-9797(89)90166-5
   Lee- Smith J, 2001, J ORTHOPAEDIC NURSIN, V5, P37
   LYKLEMA J, 1989, COLLOID SURFACE, V39, P175, DOI 10.1016/0166-6622(89)80186-6
   Maas JH, 2003, THIN SOLID FILMS, V426, P135, DOI 10.1016/S0040-6090(03)00033-6
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Nomura S, 1997, J BIOMED MATER RES, V38, P35
   NORDE W, 2003, COLLOID INTERFACES L, P47
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   PAULSSON M, 1994, J BIOMED MATER RES, V28, P311, DOI 10.1002/jbm.820280305
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   QUIRYNEN M, 1994, J PERIODONTOL, V65, P162, DOI 10.1902/jop.1994.65.2.162
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   RIEKERINK MBO, 2001, THESIS STRUCTURAL CH, P65
   Rolla G., 1991, BIOFOULING, V3, P175
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   RYLE AP, 1965, NATURE, V206, P1256, DOI 10.1038/2061256a0
   SHARMA PK, 2002, COLLOID INTERFACE SC, V98, P341
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Thomas R.R., 1999, FLUOROPOLYMERS, P47
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Tsibouklis J, 2003, ADV MATER, V15, P647, DOI 10.1002/adma.200301638
   Van Oss C. J., 1991, BIOFOULING, V4, P25
   Vrolijk N.H., 1990, Biofouling, V2, P39
   WEERKAMP AH, 1989, MICROBIAL ECOLOGY HL, V2, P11
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 77
TC 46
Z9 46
U1 0
U2 19
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-255X
BN 3-540-31241-2
J9 PROG COLL POL SCI S
PY 2006
VL 132
BP 138
EP 144
DI 10.1007/2882_026
PG 7
WC Materials Science, Characterization & Testing; Polymer Science
SC Materials Science; Polymer Science
GA BEL71
UT WOS:000238029200018
OA Green Published
DA 2018-10-20
ER

PT J
AU Bottrill, M
   Nicholas, LK
   Long, NJ
AF Bottrill, Melanie
   Nicholas, Lilian Kwok
   Long, Nicholas J.
TI Lanthanides in magnetic resonance imaging
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
DE `
ID MRI CONTRAST AGENTS; SOLID-STATE CHARACTERIZATION; CROSS-LINKED
   NANOPARTICLES; UNUSUALLY LARGE RELAXIVITY; MODIFIED GDDTPA COMPLEXES;
   OPTIMAL WATER EXCHANGE; HUMAN SERUM-ALBUMIN; EU-II COMPLEXES; HIGH-FIELD
   MRI; QUANTUM DOTS
AB Magnetic Resonance Imaging is perhaps the most important and prominent technique in diagnostic clinical medicine and biomedical research. Its success and development as an imaging technique has been aided by the characteristics of contrast agents that enhance signal intensities and improve specificity. Gadolinium(III) remains the dominant starting material for contrast agent design but other lanthanide ions (and other oxidation states i.e. + 2) are also being increasingly investigated as alternatives to gadolinium( III) within laboratory conditions. This critical review provides a concise summary of the MRI-active gadolinium( III) complexes to date their pros and cons, an outline of contrast agents based on other lanthanide ions ( e. g. europium, dysprosium), and directs the reader to newer, more speculative areas of lanthanide-containing contrast agent design.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
RP Bottrill, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, Exhibit Rd, London SW7 2AZ, England.
EM n.long@imperial.ac.uk
RI Long, Nicholas/U-6160-2017
OI Long, Nicholas/0000-0002-8298-938X
CR ADZAMLI IK, 1991, MAGNET RESON MED, V17, P141, DOI 10.1002/mrm.1910170118
   ADZAMLI IK, 1991, INVEST RADIOL, V26, P143, DOI 10.1097/00004424-199102000-00009
   Aime S, 2005, ADV INORG CHEM, V57, P173, DOI 10.1016/S0898-8838(05)57004-1
   Aime S, 2005, ANGEW CHEM INT EDIT, V44, P1813, DOI 10.1002/anie.200462566
   AIME S, 1994, INORG CHEM, V33, P4696, DOI 10.1021/ic00099a020
   Aime S, 1998, ANGEW CHEM INT EDIT, V37, P2673, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2673::AID-ANIE2673>3.0.CO;2-#
   Aime S, 1998, CHEM SOC REV, V27, P19, DOI 10.1039/a827019z
   AIME S, 1999, ACCOUNTS CHEM RES, V32, P914
   AIME S, 2002, MAGN RESON MED, P47
   Balkus Jr KJ, 1992, U.S. Patent, Patent No. 5122363
   Becker ML, 2004, BIOCONJUGATE CHEM, V15, P710, DOI 10.1021/bc049945m
   BLOCH F, 1946, PHYS REV, V69, P127, DOI 10.1103/PhysRev.69.127
   Bolskar RD, 2003, J AM CHEM SOC, V125, P5471, DOI 10.1021/ja03400984
   Bombieri G, 2002, J ALLOY COMPD, V344, P9, DOI 10.1016/S0925-8388(02)00296-7
   Botta M, 2000, EUR J INORG CHEM, P399
   BRESINSKA I, 1994, J PHYS CHEM-US, V98, P12989, DOI 10.1021/j100100a029
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Bulte JWM, 1998, INVEST RADIOL, V33, P841, DOI 10.1097/00004424-199811000-00008
   Burai L, 2002, CHEM COMMUN, P2366, DOI 10.1039/b206709a
   Burai L, 2000, CHEM-EUR J, V6, P3761, DOI 10.1002/1521-3765(20001016)6:20<3761::AID-CHEM3761>3.0.CO;2-6
   Burai L, 2003, CHEM-EUR J, V9, P1394, DOI 10.1002/chem.200390159
   CACHERIS WP, 1990, MAGN RESON IMAGING, V8, P467, DOI 10.1016/0730-725X(90)90055-7
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Caravan P, 2002, J AM CHEM SOC, V124, P3152, DOI 10.1021/ja017168k
   Chan KWY, 2004, J INORG BIOCHEM, V98, P677, DOI 10.1016/j.jinorgbio.2004.02.008
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   CHANG CA, 1993, INORG CHEM, V32, P3501, DOI 10.1021/ic00068a020
   Cohen SM, 2000, INORG CHEM, V39, P5747, DOI 10.1021/ic000563b
   Corson DT, 2000, BIOCONJUGATE CHEM, V11, P292, DOI 10.1021/bc990125x
   Cox J., 2003, CHEM BR          SEP, P21
   Crich SG, 2004, MAGNET RESON MED, V51, P938, DOI 10.1002/mrm.20072
   Csajbok E, 2005, CHEM-EUR J, V11, P4799, DOI 10.1002/chem.200500039
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   ELST LV, 2002, ACAD RADIOL S, V9, pS297
   Fatin-Rouge N, 2000, J AM CHEM SOC, V122, P10810, DOI 10.1021/ja001089b
   Fatin-Rouge N, 2004, J ALLOY COMPD, V374, P298, DOI 10.1016/j.jallcom.2003.11.125
   Feng JH, 2003, BIOORGAN MED CHEM, V11, P3359, DOI 10.1016/S0968-0896(03)00263-3
   FISHER M, 1999, ANGEW CHEM INT EDIT, V38, P885
   FLEISCH H, 2000, BISPHOSHONATES BONE
   FREED JH, 1978, J CHEM PHYS, V68, P4034, DOI 10.1063/1.436302
   Frias JC, 2004, J AM CHEM SOC, V126, P16316, DOI 10.1021/ja044911a
   Fulton DA, 2006, CHEM COMMUN, P1064, DOI 10.1039/b517997a
   Fulton DA, 2005, CHEM COMMUN, P474, DOI 10.1039/b413536a
   Gamarra LF, 2005, J MAGN MAGN MATER, V289, P439, DOI 10.1016/j.jmmm.2004.11.123
   GERALDES CFGC, 1989, INORG CHEM, V28, P3336, DOI 10.1021/ic00316a018
   Gibby WA, 2004, INVEST RADIOL, V39, P138, DOI 10.1097/01.rli.0000112789.57341.01
   Green M, 1999, CHEM COMMUN, P2235, DOI 10.1039/a904202d
   Hamblin J, 2005, CHEM COMMUN, P657, DOI 10.1039/b415464a
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Jacques V, 2002, TOP CURR CHEM, V221, P123
   Kellar KE, 1998, INVEST RADIOL, V33, P835, DOI 10.1097/00004424-199811000-00007
   Kim DK, 2003, CHEM MATER, V15, P4343, DOI 10.1021/cm031104m
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   KOWALEWSKI J, 1985, PROG NUCL MAGN RESON, P17
   Kubicek V, 2005, J AM CHEM SOC, V127, P16477, DOI 10.1021/ja054905u
   Lanza GM, 1998, ACAD RADIOL, V5, pS173, DOI 10.1016/S1076-6332(98)80097-4
   Lanza GM, 2004, J NUCL CARDIOL, V11, P733, DOI 10.1016/j.nuclcard.2004.002
   LAUFFER RB, 1991, MAGNET RESON MED, V22, P339, DOI 10.1002/mrm.1910220237
   LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003
   LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0
   LAZAR I, 1991, INORG CHEM, V30, P5016, DOI 10.1021/ic00026a030
   Lee J, 2005, J AM CHEM SOC, V127, P13164, DOI 10.1021/ja051294x
   Lowe MP, 2002, AUST J CHEM, V55, P551, DOI 10.1071/CH02172
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Mikawa M, 2001, BIOCONJUGATE CHEM, V12, P510, DOI 10.1021/bc000136m
   Mulder WJM, 2006, NANO LETT, V6, P1, DOI 10.1021/nl051935m
   MURPHY KS, 2003, J MATER CHEM, V13, P2785
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   Nicolle GM, 2002, J BIOL INORG CHEM, V7, P757, DOI 10.1007/s00775-002-0353-3
   Nicolle GM, 2002, CHEM-EUR J, V8, P1040, DOI 10.1002/1521-3765(20020301)8:5<1040::AID-CHEM1040>3.0.CO;2-D
   Pan D, 2003, CHEM COMMUN, P2400, DOI 10.1039/b307878g
   Parker D, 2002, CHEM REV, V102, P1977, DOI 10.1021/cr010452+
   Parmelee DJ, 1997, INVEST RADIOL, V32, P741, DOI 10.1097/00004424-199712000-00004
   Pierre VC, 2005, J AM CHEM SOC, V127, P504, DOI 10.1021/ja045263y
   Platas-Iglesias C, 2002, CHEM-EUR J, V8, P5121, DOI 10.1002/1521-3765(20021115)8:22<5121::AID-CHEM5121>3.0.CO;2-W
   PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37
   REISS P, 2002, NANO LETT, P2
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   RINCK PA, 1993, MAGNETIC RESONANCE M
   Rudovsky J, 2005, CHEM-EUR J, V11, P2373, DOI 10.1002/chem.200400367
   Rudovsky J, 2005, ORG BIOMOL CHEM, V3, P112, DOI 10.1039/b410103k
   Schiffelers R. M., 2004, NUCLEIC ACIDS RES, V32, P149
   Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   SHERRY AD, 1988, MAGNET RESON MED, V8, P180, DOI 10.1002/mrm.1910080208
   SHERRY AD, 1987, INORG CHIM ACTA, V139, P137
   Sherry AD, 1997, J ALLOY COMPD, V249, P153
   Shikata F, 2002, EUR J PHARM BIOPHARM, V53, P57, DOI 10.1016/S0939-6411(01)00198-9
   Shinohara H, 2000, REP PROG PHYS, V63, P843, DOI 10.1088/0034-4885/63/6/201
   Smith AM, 2004, PHOTOCHEM PHOTOBIOL, V80, P377, DOI 10.1562/2004-06-21-IR-209.1
   STARYNOWICZ P, 1995, POLYHEDRON, V14, P3573, DOI 10.1016/0277-5387(95)00174-Q
   Steckel JS, 2004, ANGEW CHEM INT EDIT, V43, P2154, DOI 10.1002/anie.200453728
   STEZOWSKI JJ, 1984, ISRAEL J CHEM, V24, P323
   Sutherland AJ, 2002, CURR OPIN SOLID ST M, V6, P365, DOI 10.1016/S1359-0286(02)00081-5
   Tan WB, 2005, ADV MATER, V17, P2375, DOI 10.1002/adma.200401650
   Terreno E, 2004, INVEST RADIOL, V39, P235, DOI 10.1097/01.rli.0000116607.26372.d0
   Toth E, 2005, J AM CHEM SOC, V127, P799, DOI 10.1021/ja044688h
   Toth E, 2002, TOP CURR CHEM, V221, P61
   Toth E, 2001, COORDIN CHEM REV, V216, P363, DOI 10.1016/S0010-8545(01)00312-5
   Toth E, 1996, CHEM-EUR J, V2, P1607, DOI 10.1002/chem.19960021220
   Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p
   Turner JL, 2005, ADV FUNCT MATER, V15, P1248, DOI 10.1002/adfm.200500005
   Tweedle MF, 1999, TOP BIOL INORG CHEM, V2, P1
   TWEEDLE MF, 1995, INVEST RADIOL, V99, P2293
   Vander Elst L, 2002, MAGN RESON MED, V47, P1121, DOI 10.1002/mrm.10163
   VANDERELST L, 2000, P INT SOC MAG RESON, V8, P2057
   VYMAZAL J, 1993, JMRI-J MAGN RESON IM, V3, P637, DOI 10.1002/jmri.1880030413
   Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956
   Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7
   Weisman GR, 1996, J ORG CHEM, V61, P5186, DOI 10.1021/jo9606665
   Weissleder R, 1992, REV MAGN RESON MED, V4, P1
   Winter P, 2005, J MAGN MAGN MATER, V293, P540, DOI 10.1016/j.jmmm.2005.01.062
   Winter PM, 2003, MAGNET RESON MED, V50, P411, DOI 10.1002/mrm.10532
   Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95
   WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113
   Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P
   Zhang SR, 2003, ACCOUNTS CHEM RES, V36, P783, DOI 10.1021/ar020228m
   Zhang SR, 2001, J AM CHEM SOC, V123, P1517, DOI 10.1021/ja005820q
   Zhang SR, 1997, FULLERENE SCI TECHN, V5, P1635, DOI 10.1080/15363839708013345
   Zheng Q, 2005, J AM CHEM SOC, V127, P16178, DOI 10.1021/ja054593v
   Zuo CS, 2004, RADIOLOGY, V232, P160, DOI 10.1148/radiol.2321030876
NR 124
TC 337
Z9 338
U1 6
U2 188
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2006
VL 35
IS 6
BP 557
EP 571
DI 10.1039/b516376p
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA 047UH
UT WOS:000237903700007
PM 16729149
DA 2018-10-20
ER

PT J
AU Wang, YP
   Bennett, C
   Pan, T
AF Wang, YP
   Bennett, C
   Pan, T
TI Endoscopic mucosal resection for early gastric cancer
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID ASPIRATION MUCOSECTOMY; STRIP BIOPSY; LESIONS; TUMORS; ESOPHAGEAL;
   EFFICACY; STOMACH; DEVICE
AB Background The treatment of early gastric cancer (EGC) using an endoscopy, namely, endoscopic mucosal resection (EMR), has been adopted for about 20 years, but the effectiveness and the safety of the modality are still controversial. The quality of these trials has not been assessed systematically.
   Objectives The purpose of this review was to compare the effectiveness and the safety of EMR with gastrectomy for the treatment of EGC.
   Search strategy Searches were conducted on the Cochrane Central Register of Controlled Trials - CENTRAL (which includes the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group Trials Register) on The Cochrane Library (Issue 1 2005) MEDLINE (1966 to March 2005) and EMBASE (1980 to March 2005), CINAHL (1985-March 2005) and CBM (Chinese BioMedical Database 1982-2002). Reference lists from trials selected by electronic searching were handsearched to identify further relevant trials. Published abstracts from conference proceedings from the United European Gastroenterology Week (published in Gut) and Digestive Disease Week (published in Gastroenterology) were handsearched. Members of the Cochrane UGPD Group, and experts in the field were contacted and asked to provide details of outstanding clinical trials and any relevant unpublished materials.
   Selection criteria All randomised controlled trials of EGC patients involving a treatment arm of EMR and a comparison arm of gastrectomy were to be included, but no RCTs were found.
   Data collection and analysis Three reviewers (YP Wang, C Bennett and T Pan) independently assessed the eligibility of potential trials and extracted the data.
   Main results There are no included randomised control trials for the systematic review. Available evidence from non-randomised controlled trials is discussed in the main text of this review.
   Author's conclusions There is a lack of randomised controlled trials in which EMR is compared with gastrectomy for EGC. There is a need for well designed randomised controlled trials to determine the effects of EMR compared to gastrectomy.
C1 Sichuan Univ, W China Hosp, Chengdu 610041, Peoples R China.
RP Wang, YP (reprint author), Sichuan Univ, W China Hosp, S Renmin Rd, Chengdu 610041, Peoples R China.
CR Ahmad NA, 2002, GASTROINTEST ENDOSC, V55, P390, DOI 10.1067/mge.2002.121881
   BARREDA B, 1998, REV GASTROENTEROLOGI, V18, P214
   CHONAN A, 1998, DIGEST ENDOSC, V10, P31
   Eguchi T., 2003, DIGEST ENDOSC, V15, P113, DOI DOI 10.1016/J.GIE.2005.08.026
   FUJISAKI J, 1997, PROGR DIGEST ENDOSC, V50, P70
   Fukase K, 1994, DIGEST ENDOSC, V6, P241, DOI [10.1111/j.1443-1661.1994.tb00373.x, DOI 10.1111/J.1443-1661.1994.TB00373.X]
   Giovannini M, 1999, ENDOSCOPY, V31, P698
   Hamada T, 1996, Nihon Rinsho, V54, P1292
   Hamada T, 2001, Nihon Geka Gakkai Zasshi, V102, P745
   HIKI Y, 1995, WORLD J SURG, V19, P517, DOI 10.1007/BF00294712
   Hiki Y, 1996, Nihon Geka Gakkai Zasshi, V97, P273
   Inoue H, 2002, J GASTROEN HEPATOL, V17, P382, DOI 10.1046/j.1440-1746.2002.02732.x
   Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]
   Kajiyama T, 1996, GASTROINTEST ENDOSC, V44, P404, DOI 10.1016/S0016-5107(96)70089-5
   Kashuba E, 1999, J HUMAN VIROL, V2, P33
   Katsube T, 2002, HEPATO-GASTROENTEROL, V49, P1510
   Kim HS, 2000, YONSEI MED J, V41, P577, DOI 10.3349/ymj.2000.41.5.577
   Kojima T, 1998, GASTROINTEST ENDOSC, V48, P550, DOI 10.1016/S0016-5107(98)70108-7
   Kondo H, 2001, Ann Ital Chir, V72, P27
   Llorens P, 2000, REV MED CHILE, V128, P969
   Matsushita M, 1997, GASTROINTEST ENDOSC, V45, P512, DOI 10.1016/S0016-5107(97)70183-4
   MISUMI A, 1991, JPN J GASTROENTEROL, V24, P2610
   Miyata M, 2000, ENDOSCOPY, V32, P773, DOI 10.1055/s-2000-7712
   Mizumoto S, 1992, Nihon Geka Gakkai Zasshi, V93, P1071
   Nelson DB, 2000, GASTROINTEST ENDOSC, V52, P860, DOI 10.1016/S0016-5107(00)70224-0
   NISHIDA T, 1996, NIPPON ROMEN IGAKKA, V30, P376
   Noda M, 1997, ENDOSCOPY, V29, P361, DOI 10.1055/s-2007-1004216
   O'Mahony S, 2001, GUT, V48, P151, DOI 10.1136/gut.48.2.151
   OIZUMI H, 1991, Stomach and Intestine (Tokyo), V26, P289
   Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225
   Ponchon T, 2001, J CLIN GASTROENTEROL, V32, P6, DOI 10.1097/00004836-200101000-00004
   Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251
   Suzuki Y, 1999, GASTROINTEST ENDOSC, V49, P192, DOI 10.1016/S0016-5107(99)70485-2
   Tada M, 2000, J GASTROEN HEPATOL, V15, pD98
   TAKEKOSHI T, 1994, ENDOSCOPY, V26, P352, DOI 10.1055/s-2007-1008990
   Takekoshi T, 1988, Gan To Kagaku Ryoho, V15, P1449
   Takeshita K, 1997, HEPATO-GASTROENTEROL, V44, P1602
   Takeshita K, 1997, GUT, V40, P123, DOI 10.1136/gut.40.1.123
   Tanabe S, 1999, GASTROINTEST ENDOSC, V50, P819, DOI 10.1016/S0016-5107(99)70165-3
   Tanabe S, 2002, GASTROINTEST ENDOSC, V56, P708, DOI 10.1067/mge.2002.129085
   TANI M, 1997, PROGR DIGEST ENDOSC, V50, P74
   Wehrmann T, 2001, Z GASTROENTEROL, V39, P919, DOI 10.1055/s-2001-18538
   Yamao T., 1996, CANCER, V77, P597
   Yoshikane H, 2001, ENDOSCOPY, V33, P795, DOI 10.1055/s-2001-16515
   Zhou L, 1995, Zhonghua Nei Ke Za Zhi, V34, P443
NR 45
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2006
IS 1
AR CD..45276.pub2
DI 10.1002/14651858.CD004276.pub2
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 007OE
UT WOS:000234978200033
OA Bronze
DA 2018-10-20
ER

PT B
AU Korhonen, A
   Krymolowski, Y
   Collier, N
AF Korhonen, Anna
   Krymolowski, Yuval
   Collier, Nigel
GP COLING
TI Automatic Classification of Verbs in Biomedical Texts
SO COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE
LA English
DT Proceedings Paper
CT 21st International Conference on Computational Linguistics/44th Annual
   Meeting of the Association for Computational Linguistics
CY JUL 17-21, 2006
CL Sydney, AUSTRALIA
SP Assoc Computat Linguist
AB Lexical classes, when tailored to the application and domain in question, can provide an effective means to deal with a number of natural language processing (NI-P) tasks. While manual construction of such classes is difficult, recent research shows that it is possible to automatically induce verb classes from cross-domain corpora with promising accuracy. We report a novel experiment where similar technology is applied to the important, challenging domain of biomedicine. We show that the resulting classification, acquired from a corpus of biomedical journal articles, is highly accurate and strongly domain-specific. It can be used to aid BIO-NLP directly or as useful material for investigating the syntax and semantics of verbs in biomedical texts.
C1 [Korhonen, Anna] Univ Cambridge, Comp Lab, Cambridge CB3 0GD, England.
RP Korhonen, A (reprint author), Univ Cambridge, Comp Lab, 15 JJ Thomson Ave, Cambridge CB3 0GD, England.
EM alk23@cl.cam.ac.uk; yuvalkr@cs.technion.ac.il; collier@nii.ac.jp
CR BREW C, 2002, C EMP METH NAT LANG
   BRISCOE EJ, 2002, 3 INT C LANG RES EV, P1499
   BRISCOE EJ, 1997, 5 ACL C APPL NAT LAN, P356
   Dimitrov AG, 2001, NETWORK-COMP NEURAL, V12, P441, DOI 10.1088/0954-898X/12/4/303
   Dorr B. J., 1997, Machine Translation, V12, P271, DOI 10.1023/A:1007965530302
   Friedman C, 2002, J BIOMED INFORM, V35, P222, DOI 10.1016/S1532-0464(03)00012-1
   Hatzivassiloglou V, 2002, INT J MED INFORM, V67, P19, DOI 10.1016/S1386-5056(02)00054-0
   Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553
   HOFFMAN T, 2001, MACH LEARN, V42, P177
   Jackendoff Ray, 1990, SEMANTIC STRUCTURES
   Korhonen A., 2003, P 41 ANN M ASS COMP, P64
   KORHONEN A, 2002, THESIS U CAMBRIDGE U
   LEASE M, 2005, 2 INT JOINT C NAT LA, P58
   Leech G., 1992, LANGUAGE RES, V28, P1
   Levin B, 1993, ENGLISH VERB CLASSES
   Merlo P, 2001, COMPUT LINGUIST, V27, P373, DOI 10.1162/089120101317066122
   Miller G., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235
   Prescher D., 2000, 18 INT C COMP LING S, P649
   Spasic I, 2005, BIOINFORMATICS, V21, P2748, DOI 10.1093/bioinformatics/bti338
   TISHBY N, 1999, P 37 ANN ALL C COMM, P368
   VLACHOS A, 2006, PAC S BIOC
NR 21
TC 2
Z9 2
U1 0
U2 2
PU ASSOC COMPUTATIONAL LINGUISTICS-ACL
PI STROUDSBURG
PA 209 N EIGHTH STREET, STROUDSBURG, PA 18360 USA
BN 978-1-932432-65-7
PY 2006
BP 345
EP 352
PG 8
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
SC Computer Science
GA BNG36
UT WOS:000274500200044
DA 2018-10-20
ER

PT S
AU Kim, DH
   Okamoto, K
   Goldner, LS
   Hwang, J
AF Kim, Dal-Hyun
   Okamoto, Kenji
   Goldner, Loni S.
   Hwang, Jeeseong
BE Osinski, M
   Yamamoto, K
   Jovin, TM
TI Characterization of single functionalized quantum dots using combined
   atomic force and confocal fluorescence microscopy
SO COLLOIDAL QUANTUM DOTS FOR BIOMEDICAL APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Colloidal Quantum Dots for Biomedical Applications
CY JAN 22-24, 2006
CL San Jose, CA
SP SPIE
DE single nanocrystal; confocal microscope; atomic force microscope;
   quantum dot
ID IN-VIVO; NANOCRYSTALS; BLINKING; AFM
AB Fluorescent nanocrystals (quantum dots or QDs) have a number of unique properties that overcome the limitations of conventional organic dyes. However, the optical properties of QDs have been observed to be strongly dependent upon their local chemical environment including novel surface coatings, which have been developed to render QDs water soluble and conjugation ready leading to their use as fluorescent tags and optical sensors for a variety of biological and biomedical applications. The quantitative utility of QDs in complex biological systems requires that their optical properties be well understood and interrelated with their chemical functionalization on the surface and their interactions with surface-conjugated materials. In this report, quantitative measurement of adhesion forces between a hydrophilic or a hydrophobic AFM probe and an amine-functionalized single QD or a hydrophilic substrate were obtained to demonstrate the utility of the atomic force microscopy (AFM) as a tool to probe surface functionalities of single functionalized QDs. We also present procedures to combine AFM and confocal fluorescence microscopy in an effort to simultaneously probe optical characteristics and physical/chemical properties of single or clustered functionalized QDs at the nanoscale.
C1 Natl Inst Stand & Technol, Phys Lab, Opt Technol Div, 100 Bur Dr,Mail Stop 8443, Gaithersburg, MD 20899 USA.
RP Kim, DH (reprint author), Natl Inst Stand & Technol, Phys Lab, Opt Technol Div, 100 Bur Dr,Mail Stop 8443, Gaithersburg, MD 20899 USA.
EM jch@nist.gov
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Eske LD, 1999, COLLOID SURFACE A, V154, P33, DOI 10.1016/S0927-7757(98)00907-8
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Gradinaru CC, 2004, ULTRAMICROSCOPY, V99, P235, DOI 10.1016/j.ultramic.2003.12.009
   Green J.-B. D., 2003, MATER TODAY, V6, P22
   HEINZ WF, 1999, NANOTECHNOLOGY, V17, P143
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   ISRELACHVILI JN, 1992, INTERMOLECULAR SURFA, P332
   Kassies R, 2005, J MICROSC-OXFORD, V217, P109, DOI 10.1111/j.0022-2720.2005.01428.x
   Koberling F, 2001, ADV MATER, V13, P672, DOI 10.1002/1521-4095(200105)13:9<672::AID-ADMA672>3.0.CO;2-W
   Kolodny LA, 2001, ANAL CHEM, V73, P1959, DOI 10.1021/ac001472z
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Rankl M, 2003, COLLOID SURFACE B, V30, P177, DOI 10.1016/S0927-7765(03)00085-7
   Yao J, 2005, P NATL ACAD SCI USA, V102, P14284, DOI 10.1073/pnas.0506523102
NR 14
TC 0
Z9 0
U1 1
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6138-5
J9 PROC SPIE
PY 2006
VL 6096
AR 60960G
DI 10.1117/12.661784
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BEL14
UT WOS:000237689800007
DA 2018-10-20
ER

PT S
AU Arnold, CL
   Ertmer, W
   Lubatschowski, H
AF Arnold, C. L.
   Ertmer, W.
   Lubatschowski, H.
BE Neev, J
   Nolte, S
   Heisterkamp, A
   Schaffer, CB
TI Simulation of ultrashort pulse induced plasma generation and interaction
   within the bulk of transparent Kerr media
SO COMMERCIAL AND BIOMEDICAL APPLICATIONS OF ULTRAFAST LASERS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
CY JAN 22-25, 2006
CL San Jose, CA
SP Del Mar Ventures, Spectra-Phys, High Q Laser, Time-Bandwidth Product, Femtolasers, SPIE
DE ultrashort laser pulses; optical breakdown; nonlinear pulse propagation;
   ophthalmology
ID INTRASTROMAL REFRACTIVE SURGERY; LASER-PULSES; OPTICAL-BREAKDOWN;
   PROPAGATION; DIELECTRICS; DAMAGE; BEAMS
AB Recently ultrashort laser pulses became most important for micro structuring and biomedical applications such as refractive surgery. Ultrashort laser pulses tightly focused to a small spot easily provide intensity sufficient to induce nonlinear ionization. A plasma is generated and heated in the focus resulting in optical breakdown. The energy deposited in the plasma and the mechanical effects subsequent to optical breakdown are utilized by modern applications of ultrashort laser pulses to induce controlled highly reproducible material alteration.
   A model including both nonlinear pulse propagation and plasma generation is introduced to numerically investigate the interaction of ultrashort laser pulses with the self-induced plasma in the vicinity of the focus. The numerical code is based on a (3+1)-dimensional nonlinear Schrodinger equation describing the pulse propagation. A multi rate equation model recently published by B. Rethfeld is used to simultaneously calculate the generation of free electrons. It is the first numerically simple approach to describe nonlinear ionization that allows a non static energy distribution of free electrons in the conduction band. The code is applicable to any transparent Kerr medium, whose linear and nonlinear optical parameters are known. Numerical calculations based oil this model are used to understand the dependence between the size, the geometry and the free electron density of ultrashort laser pulse induced optical breakdown plasmas in various focusing geometries. The code enables to use arbitrary initial conditions for the laser field in the focus. More realistic focusing scenarios than the simple assumption of focused gaussian beams can be taken into account. Nonlinear side effects, such as streak formation occurring in addition to optical breakdown during ultrashort pulse refractive eye surgeries can be numerically investigated.
C1 [Arnold, C. L.; Lubatschowski, H.] Laser Zentrum Hannover EV, D-30419 Hannover, Germany.
   [Ertmer, W.] Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany.
RP Arnold, CL (reprint author), Laser Zentrum Hannover EV, D-30419 Hannover, Germany.
EM C.Arnold@lzh.de
RI Arnold, Cord/B-9365-2014
CR Arnold CL, 2005, P SOC PHOTO-OPT INS, V5714, P126, DOI 10.1117/12.588903
   Arnold CL, 2005, APPL PHYS B-LASERS O, V80, P247, DOI 10.1007/s00340-004-1701-5
   BLOEMBERGEN N, 1974, IEEE J QUANTUM ELECT, V10, P555
   DEMICHELIS C, 1969, IEEE J QUANTUM ELECT, VQE 5, P188, DOI 10.1109/JQE.1969.1075758
   DUCK FA, 1995, PHYS PROPERTIES TISS
   Engelberg YM, 2004, J OPT SOC AM A, V21, P2135, DOI 10.1364/JOSAA.21.002135
   Feng Q, 1997, IEEE J QUANTUM ELECT, V33, P127, DOI 10.1109/3.552252
   Heisterkamp A, 2003, GRAEF ARCH CLIN EXP, V241, P511, DOI 10.1007/s00417-003-0683-z
   Heisterkamp A, 2002, P SOC PHOTO-OPT INS, V4611, P136, DOI 10.1117/12.470587
   Heisterkamp A, 2002, APPL PHYS B-LASERS O, V74, P419, DOI 10.1007/s003400200825
   Horvath ZL, 2003, OPT COMMUN, V222, P51, DOI 10.1016/S0030-4018(03)01562-1
   Kaiser A, 2000, PHYS REV B, V61, P11437, DOI 10.1103/PhysRevB.61.11437
   KELDYSH LV, 1960, SOV PHYS JETP-USSR, V10, P509
   KELDYSH LV, 1965, SOV PHYS JETP, V20, P5
   KENNEDY PK, 1995, IEEE J QUANTUM ELECT, V31, P2241, DOI 10.1109/3.477753
   Liu W, 2003, APPL PHYS B-LASERS O, V76, P215, DOI 10.1007/s00340-002-1087-1
   LIU X, 1997, OSA TECHNICAL DIGEST, V11, P169
   Lubatschowski H, 2000, GRAEF ARCH CLIN EXP, V238, P33, DOI 10.1007/s004170050006
   Martinez-Corral M, 2002, OPT EXPRESS, V10, P98, DOI 10.1364/OE.10.000098
   Rethfeld B, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187401
   ROTHENBERG JE, 1992, OPT LETT, V17, P583, DOI 10.1364/OL.17.000583
   Sales TRM, 1997, J OPT SOC AM A, V14, P1637, DOI 10.1364/JOSAA.14.001637
   Schaffer CB, 2001, OPT LETT, V26, P93, DOI 10.1364/OL.26.000093
   Siegman A., 1986, LASERS
   STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248
   Sudrie L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.186601
   Sudrie L, 2001, OPT COMMUN, V191, P333, DOI 10.1016/S0030-4018(01)01152-X
   The International Association for the Properties of Water and Steam, 1997, REL REFR IND ORD WAT
   Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6
   WILLIAMS F, 1976, J CHEM PHYS, V64
   Zickler L, 2003, P SOC PHOTO-OPT INS, V4978, P194, DOI 10.1117/12.478582
NR 31
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6150-4
J9 PROC SPIE
PY 2006
VL 6108
AR 610808
DI 10.1117/12.645637
PG 12
WC Biochemical Research Methods; Optics
SC Biochemistry & Molecular Biology; Optics
GA BEF45
UT WOS:000237087800004
DA 2018-10-20
ER

PT S
AU Wiesauer, K
   Pircher, M
   Goetzinger, E
   Hitzenberger, CK
   Engelke, R
   Ahrens, G
   Pfeiffer, K
   Ostrzinski, U
   Gruetzner, G
   Oster, R
   Stifter, D
AF Wiesauer, Karin
   Pircher, Michael
   Goetzinger, Erich
   Hitzenberger, Christoph K.
   Engelke, Rainer
   Ahrens, Gisela
   Pfeiffer, Karl
   Ostrzinski, Ute
   Gruetzner, Gabi
   Oster, Reinhold
   Stifter, David
BE Neev, J
   Nolte, S
   Heisterkamp, A
   Schaffer, CB
TI Ultra-high resolution, polarization sensitive transversal optical
   coherence tomography for structural analysis and strain mapping
SO COMMERCIAL AND BIOMEDICAL APPLICATIONS OF ULTRAFAST LASERS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
CY JAN 22-25, 2006
CL San Jose, CA
SP Del Mar Ventures, Spectra-Phys, High Q Laser, Time-Bandwidth Product, Femtolasers, SPIE
DE optical coherence tomography; OCT; polarization sensitive; transversal
   scanning; ultra-high resolution; femtosecond laser; non-destructive
   testing; material investigations
ID QUANTIFICATION; BIREFRINGENCE
AB Optical coherence tomography (OCT) is a contactless and non-invasive technique nearly exclusively applied for biomedical imaging of tissues. Besides the internal structure, additionally strains within the sample can be mapped when OCT is performed in a polarization sensitive (PS) way. In this work, we demonstrate the benefits of PS-OCT imaging for non-biological applications. We have developed the OCT technique beyond the state-of-the-art: based on transversal ultra-high resolution (UHR-)OCT, where an axial resolution below 2 pm within materials is obtained using a femtosecond laser as light source, we have modified the setup for polarization sensitive measurements (transversal UHR-PS-OCT). We perform structural analysis and strain mapping for different types of samples: for a highly strained elastomer specimen we demonstrate the necessity of UHR-imaging. Furthermore, we investigate epoxy waveguide structures, photoresist Moulds for the fabrication of micro-electromechanical parts (MEMS), and the glass-fibre composite outer shell of helicopter rotor blades where cracks are present. For these examples, transversal scanning UHR-PS-OCT is shown to provide important information about the structural properties and the strain distribution within the samples.
C1 [Wiesauer, Karin; Stifter, David] Upper Austrian Res GmbH, Hafenstr 47-51, A-4020 Linz, Austria.
   [Pircher, Michael; Goetzinger, Erich; Hitzenberger, Christoph K.] Med Univ Vienna, Ctr Biomed Engn & Phys, A-1090 Vienna, Austria.
   [Engelke, Rainer; Ahrens, Gisela; Pfeiffer, Karl; Ostrzinski, Ute; Gruetzner, Gabi] Micro Resist Technol GmbH, D-12555 Berlin, Germany.
   [Oster, Reinhold] Eurocopter Deutschland GmbH, D-81663 Munich, Germany.
RP Wiesauer, K (reprint author), Upper Austrian Res GmbH, Hafenstr 47-51, A-4020 Linz, Austria.
EM karin.wiesauer@uar.at
RI Wiesauer, Karin/D-3751-2013; Stifter, David/B-5767-2016
OI Michael, Pircher/0000-0001-9285-7527
FU Austrian Science Fund FWF [P16585-N08, L126-N08]; European Commission
   (FP6 CRAFT Project) [COOP-CT-2003-507825]
FX This work has been supported by the Austrian Science Fund FWF (Projects:
   P16585-N08 and L126-N08) and the European Commission (FP6 CRAFT Project:
   COOP-CT-2003-507825).
CR Baumgartner A, 2000, CARIES RES, V34, P59, DOI 10.1159/000016571
   Bouma BE, 2002, HDB OPTICAL COHERENC
   Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119
   Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221
   Dubois A, 2002, APPL OPTICS, V41, P805, DOI 10.1364/AO.41.000805
   Duncan MD, 1998, OPT EXPRESS, V2, P540, DOI 10.1364/OE.2.000540
   Dunkers JP, 1999, COMPOS PART A-APPL S, V30, P139, DOI 10.1016/S1359-835X(98)00084-0
   FERCHER AF, 1995, OPT COMMUN, V117, P43, DOI 10.1016/0030-4018(95)00119-S
   Gotzinger E, 2004, J BIOMED OPT, V9, P94, DOI 10.1117/1.1629308
   HEE MR, 1992, J OPT SOC AM B, V9, P903, DOI 10.1364/JOSAB.9.000903
   Hitzenberger CK, 2003, OPT EXPRESS, V11, P2753, DOI 10.1364/OE.11.002753
   Hitzenberger CK, 2001, OPT EXPRESS, V9, P780, DOI 10.1364/OE.9.000780
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   PIRCHER M, 2004, J PHYS MED BIOL, V49, P1257
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   Saxer CE, 2000, OPT LETT, V25, P1355, DOI 10.1364/OL.25.001355
   Stifter D, 2003, APPL PHYS A-MATER, V76, P947, DOI 10.1007/s00339-002-2065-5
   SWANSON EA, 1992, OPT LETT, V17, P151, DOI 10.1364/OL.17.000151
   Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43
   Wiesauer K, 2005, ACTA MATER, V53, P2785, DOI 10.1016/j.actamat.2005.02.034
   Wiesauer K, 2005, OPT EXPRESS, V13, P1015, DOI 10.1364/OPEX.13.001015
   Yang ML, 2004, ARCHAEOMETRY, V46, P171, DOI 10.1111/j.1475-4754.2004.00151.x
NR 22
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6150-4
J9 PROC SPIE
PY 2006
VL 6108
AR 61080K
DI 10.1117/12.643769
PG 8
WC Biochemical Research Methods; Optics
SC Biochemistry & Molecular Biology; Optics
GA BEF45
UT WOS:000237087800014
DA 2018-10-20
ER

PT J
AU Lam, MWY
   Baranoski, GVG
AF Lam, Michael W. Y.
   Baranoski, Gladimir V. G.
TI A predictive light transport model for the human iris
SO COMPUTER GRAPHICS FORUM
LA English
DT Article; Proceedings Paper
CT 27th Annual Conference of the Eurographics-Association
CY SEP 04-08, 2006
CL Vienna, AUSTRIA
SP Eurograph Assoc, Austrian Acad Sci, Vienna Univ Technol
ID HUMAN OCULAR FUNDUS; HUMAN-EYE; SPECTRAL REFLECTANCE; IRIDIAL
   PIGMENTATION; MICROSCOPIC FINDINGS; BROWN EYES; HUMAN BLUE; COLOR;
   MELANOCYTES; TISSUES
AB Recently, light interactions with organic matter have become the object of detailed investigations by image synthesis researchers. Besides allowing these materials to be rendered in a more intuitive manner these efforts aim to extend the scope of computer graphics applications to areas such as applied optics and biomedical imaging. There are, however organic materials that still lack predictive simulation solutions. Among these, the ocular tissues, especially those forming the human iris, pose the most challenging modeling problems which are often associated with data scarcity. In this paper we describe the first biophysically-based light transport model for the human iris ever presented in the scientific literature. The proposed model algorithmically simulates the light scattering and absorption processes occurring within the iridal tissues, and computes the spectral radiometric responses of these tissues. Its design is based on the current scientific understanding of the iridal morphological and optical characteristics, and it is controlled by parameters directly related to these biophysical attributes. The accuracy and predictability of the spectral results provided by the model are evaluated through comparisons with actual measured iridal data, and its integration into rendering frameworks is illustrated through the generation of images depicting iridal chromatic variations.
C1 Univ Waterloo, Sch Comp Sci, Nat Phenomena Simulat Grp, Waterloo, ON N2L 3G1, Canada.
RP Lam, MWY (reprint author), Univ Waterloo, Sch Comp Sci, Nat Phenomena Simulat Grp, Waterloo, ON N2L 3G1, Canada.
RI Baranoski, Gladimir/A-1944-2008
CR BEEMS EM, 1990, EXP EYE RES, V50, P393, DOI 10.1016/0014-4835(90)90140-P
   Bergamin O, 1998, GRAEF ARCH CLIN EXP, V236, P567, DOI 10.1007/s004170050122
   Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954
   BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776
   Bueno JM, 2002, APPL OPTICS, V41, P116, DOI 10.1364/AO.41.000116
   Daugman J, 2001, P ROY SOC B-BIOL SCI, V268, P1737, DOI 10.1098/rspb.2001.1696
   Deering MF, 2005, ACM T GRAPHIC, V24, P649, DOI 10.1145/1073204.1073243
   DELORI FC, 1991, INVEST OPHTH VIS SCI, V32, P1144
   DELORI FC, 1989, APPL OPTICS, V28, P1061, DOI 10.1364/AO.28.001061
   Duck F., 1990, PHYS PROPERTIES TISS
   Eagle R C Jr, 1988, Trans Am Ophthalmol Soc, V86, P581
   EDLEHAUSER H, 1979, PHYSL HUMAN EYE VISU, P68
   FLEWELLING R, 2000, BIOMEDICAL ENG HDB, P1
   Forrester JV, 2002, EYE BASIC SCI PRACTI
   FUKSHANSKY L, 1987, J QUANT SPECTROSC RA, V38, P389, DOI 10.1016/0022-4073(87)90033-1
   Geng LJ, 1999, EXP EYE RES, V69, P539, DOI 10.1006/exer.1999.0735
   HALSTEAD MA, 1996, SIGGRAPH, P335
   HAMMER M, 1995, PHYS MED BIOL, V40, P963, DOI 10.1088/0031-9155/40/6/001
   Hammer M, 2002, PHYS MED BIOL, V47, P179, DOI 10.1088/0031-9155/47/2/301
   IMAI F, 2000, PRELIMINARY EXPT SPE
   Imesch PD, 1997, SURV OPHTHALMOL, V41, pS117, DOI 10.1016/S0039-6257(97)80018-5
   Imesch PD, 1996, ARCH OPHTHALMOL-CHIC, V114, P443, DOI 10.1001/archopht.1996.01100130439015
   Jacques S., 2001, OPTICAL ABSORPTION M
   Jacques S. L., 1996, OSA TOPS ADV OPTICAL, V2, P364
   KHLEBTSOV NG, 2002, HDB OPTICAL BIOMEDIC, P31
   LAM M, 2006, THESIS U WATERLOO CA
   Lefohn A, 2003, IEEE COMPUT GRAPH, V23, P70, DOI 10.1109/MCG.2003.1242384
   MENON IA, 1992, J OCUL PHARMACOL, V8, P35, DOI 10.1089/jop.1992.8.35
   MENON IA, 1987, BRIT J OPHTHALMOL, V71, P549, DOI 10.1136/bjo.71.7.549
   NOLTE J, 1979, PHYSL HUMAN EYE VISU, P217
   Prahl S., 1988, THESIS U TEXAS AUSTI
   Preece SJ, 2002, PHYS MED BIOL, V47, P2863, DOI 10.1088/0031-9155/47/16/303
   Prota G, 1998, EXP EYE RES, V67, P293, DOI 10.1006/exer.1998.0518
   Purgathofer W, 2003, COMPUT GRAPH FORUM, V22, pXIX, DOI 10.1111/1467-8659.00668
   Regan S., 1997, Investigative Ophthalmology and Visual Science, V38, pS810
   SAGAR MA, 1994, SIGGRAPH 94, P205
   SHIRLEY P, 1990, THSEIS U ILLINOIS
   SNELL RS, 1989, CLIN ANATOMY EYE
   Stiles W. S., 1982, COLOR SCI CONCEPTS M
   Strutt JW, 1871, PHILOS MAG, V41, P447, DOI DOI 10.1080/14786447108640507
   Takamoto T, 2001, CURR EYE RES, V22, P412, DOI 10.1076/ceyr.22.6.412.5490
   TSUCHIDA M, 1987, CHEM PHYS LIPIDS, V44, P297, DOI 10.1016/0009-3084(87)90055-7
   TUCHIN V, 2000, TISSUE OPTICS LIGHTS, V38
   UNANDER J, 2000, PROJECT IRIS IMAGE R
   van de Hulst H C, 1980, MULTIPLE LIGHT SCATT, V1
   VANDENBERG TJTP, 1994, VISION RES, V34, P1453, DOI 10.1016/0042-6989(94)90146-5
   VANNORREN D, 1986, VISION RES, V26, P313, DOI 10.1016/0042-6989(86)90028-3
   VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311
   Wang HQ, 2005, IEEE I CONF COMP VIS, P1691
   Wecker L, 2005, 3 INT C COMP GRAPH I, P121
   Wildes RP, 1997, P IEEE, V85, P1348, DOI 10.1109/5.628669
   Wilkerson CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P437, DOI 10.1001/archopht.1996.01100130433014
   Wistrand PJ, 1997, SURV OPHTHALMOL, V41, pS129, DOI 10.1016/S0039-6257(97)80020-3
   WYATT H, 1970, BRIT J OPHTHALMOL, V54, P177, DOI 10.1136/bjo.54.3.177
   Zscheile FP, 1942, PLANT PHYSIOL, V17, P331, DOI 10.1104/pp.17.3.331
NR 55
TC 13
Z9 13
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0167-7055
J9 COMPUT GRAPH FORUM
JI Comput. Graph. Forum
PY 2006
VL 25
IS 3
BP 359
EP 368
PG 10
WC Computer Science, Software Engineering
SC Computer Science
GA 087IT
UT WOS:000240736800015
DA 2018-10-20
ER

PT J
AU Karbowiak, T
   Debeaufort, F
   Voilley, A
AF Karbowiak, T
   Debeaufort, F
   Voilley, A
TI Importance of surface tension characterization for food, pharmaceutical
   and packaging products: a review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE surface tension; contact angle; wettability; packaging; food; polymer;
   coating
ID CONTACT-ANGLE INTERPRETATION; FREE-ENERGY CALCULATION; THIN-LAYER
   WICKING; INTERFACIAL-TENSION; SOLID-SURFACES; FLOTATION SEPARATION;
   OXYGEN-PLASMA; EDIBLE FILMS; WATER; LIQUIDS
AB This article reviews the various theoretical approaches that have been developed for determination of the surface tension of solids, and the applications to food industrial products. The surface tension of a solid is a characteristic of surface properties and interfacial interactions such as adsorption, wetting or adhesion. The knowledge of surface tension is thus of great interest for every domain involved in understanding these mechanisms, which recover a lot of industrial investigations. Indeed, it is the case for the packaging industry, the food materials science, the biomedical applications and the pharmaceutical products, cleaning, adhesive technology, painting, coating and more generally all fields in relation with wettability of their systems. There is however no direct method for measurements of surface tension of solids, except the contact angle measurements combined with an appropriate theoretical approach are indirect methods for estimation of surface tension of solids. Moreover since the publication by Young (1805) who developed the basis of the theory of contact angle some two hundred years ago, measurements and interpretations are still discussed in scientific literature, pointing out the need to better understand the fundamental mechanisms of solid-liquid interfacial interactions. Applications of surface tension characterization in the field of food materials science are detailed, especially for packaging and coating applications, which recover different actual orientations in order to improve process and quality.
C1 Univ Bourgogne 1, Dept Bioengn, IMSAPS, ENSBANA, F-21000 Dijon, France.
   Bourgogne Technol, CRITT2ABI, F-21000 Dijon, France.
   IUT Genie Biol, F-21078 Dijon, France.
RP Debeaufort, F (reprint author), Univ Bourgogne 1, Dept Bioengn, IMSAPS, ENSBANA, Esplanade Erasme, F-21000 Dijon, France.
EM frederic.debeaufort@u-bourgogne.fr
RI karbowiak, thomas/Q-2151-2018
OI karbowiak, thomas/0000-0002-4229-3003
CR Adachi S., 1995, NIPPON SHOKUHIN KAGA, V42, P137
   ALTURAIF H, 2004, PROGR ORGANIC COATIN, V39, P62
   Bangham DH, 1937, T FARADAY SOC, V33, P1459, DOI 10.1039/tf9373301459
   BARTHWAL SK, 2003, CONTACT ANGLE WETTAB, V3, P117
   Bateni A, 2003, COLLOID SURFACE A, V219, P215, DOI 10.1016/S0927-7757(03)00053-0
   Bernardin JD, 1997, INT J HEAT MASS TRAN, V40, P1017, DOI 10.1016/0017-9310(96)00184-6
   Bialopiotrowicz T, 2001, EUR POLYM J, V37, P1047, DOI 10.1016/S0014-3057(00)00190-7
   BOULANGEPERTMAN.N, 2003, CONTACT ANGLE WETABI, V3, P501
   BOURGES C, 1993, CR ACAD SCI II, V316, P311
   Briandet R, 2001, COLLOID SURFACE B, V21, P299, DOI 10.1016/S0927-7765(00)00213-7
   Brook MA, 1997, COLLOID SURFACE B, V9, P285, DOI 10.1016/S0927-7765(97)00036-2
   Buckton G., 1993, CONTACT ANGLE WETTAB, P437
   CARVALHO AJF, 2004, IND CROP PROD, V21, P331
   CASSIE ABD, 1948, DISCUSS FARADAY SOC, V3, P11, DOI 10.1039/df9480300011
   Chaudhury MK, 1996, MAT SCI ENG R, V16, P97, DOI 10.1016/0927-796X(95)00185-9
   CHEN P, 1998, DROPS BUBBLES INTERF, P61
   CHENG P, 1990, COLLOID SURFACE, V43, P151, DOI 10.1016/0166-6622(90)80286-D
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cioffi MOH, 2003, MATER CHARACT, V50, P209, DOI 10.1016/S1044-5803(03)00094-9
   Combe EC, 2004, DENT MATER, V20, P262, DOI 10.1016/S0109-5641(03)00102-7
   Crafton EF, 2004, INT J HEAT MASS TRAN, V47, P1187, DOI 10.1016/j.ijheatmasstransfer.2003.09.006
   De Bruyn K, 2003, SURF COAT TECH, V163, P710, DOI 10.1016/S0257-8972(02)00684-9
   de Ruijter M, 1998, COLLOID SURFACE A, V144, P235, DOI 10.1016/S0927-7757(98)00659-1
   Debeaufort F, 1998, CRIT REV FOOD SCI, V38, P299, DOI 10.1080/10408699891274219
   Decker EL, 1999, COLLOID SURFACE A, V156, P177, DOI 10.1016/S0927-7757(99)00069-2
   Della Volpe C, 2004, J COLLOID INTERF SCI, V271, P434, DOI 10.1016/j.jcis.2003.09.049
   Drelich J, 1997, POL J CHEM, V71, P525
   Drelich J, 1999, SEP PURIF TECHNOL, V15, P9, DOI 10.1016/S1383-5866(98)00047-1
   DRESNER S, 1971, UNITS MEASUREMENTS, P168
   Dupre A., 1869, THEORIE MECANIQUE CH, P369
   ELLIOTT GEP, 1964, RECENT PROGR SURFACE, V2, P110
   Etzler F.M., 2003, CONTACT ANGLE WETTAB, V3, P219
   Etzler FM, 2003, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 3, P219
   Extrand CW, 2002, J COLLOID INTERF SCI, V248, P136, DOI 10.1006/jcis.2001.8172
   Fowkes F.M., 1987, J ADHES SCI TECHNOL, V1, P7, DOI DOI 10.1163/156856187X00049
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   FOWKES FM, 1980, J COLLOID INTERF SCI, V78, P200, DOI 10.1016/0021-9797(80)90508-1
   FOX HW, 1950, J COLL SCI IMP U TOK, V5, P514, DOI 10.1016/0095-8522(50)90044-4
   Gattin R, 2002, INT BIODETER BIODEGR, V50, P25, DOI 10.1016/S0964-8305(02)00039-2
   GAYDOS J, 1987, J COLLOID INTERF SCI, V120, P76, DOI 10.1016/0021-9797(87)90324-9
   GINL M, 2001, COLLOID SURF A, V181, P279
   GIRIFALCO LA, 1957, J PHYS CHEM-US, V61, P904, DOI 10.1021/j150553a013
   GOOD RJ, 1977, J COLLOID INTERF SCI, V59, P398, DOI 10.1016/0021-9797(77)90034-0
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   Goodman Roger, 1992, MODERN APPROACHES WE, P1
   GREGG SJ, 1965, SURFACE CHEM SOLIDS, P199
   HOLLANDER A, 1995, J COLLOID INTERF SCI, V169, P493, DOI 10.1006/jcis.1995.1060
   JAMES SG, 1993, J POLYM SCI POL PHYS, V31, P221, DOI 10.1002/polb.1993.090310211
   JANCZUK B, 1989, J COLLOID INTERF SCI, V127, P55
   Jasper J. J., 1972, J PHYS CHEM REF DATA, V1, P841
   Jayasekara R, 2004, POLYM TEST, V23, P17, DOI 10.1016/S0142-9418(03)00049-7
   Kalogianni EP, 2004, COLLOID SURFACE B, V35, P159, DOI 10.1016/j.colsurfb.2004.03.008
   Kiss E, 1999, COLLOID SURFACE B, V15, P181, DOI 10.1016/S0927-7757(99)00009-6
   KO YC, 1981, J COLLOID INTERF SCI, V82, P25, DOI 10.1016/0021-9797(81)90120-X
   Krochta JM, 1997, FOOD TECHNOL-CHICAGO, V51, P61
   KRUSS, 1997, DROP SHAPE ANAL MANU
   Kwok D., 2003, CONTACT ANGLE WETTAB, V3, P117
   Kwok DY, 2000, COLLOID SURFACE A, V161, P31, DOI 10.1016/S0927-7757(99)00323-4
   Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6
   Kwok DY, 1996, COLLOID SURFACE A, V116, P63, DOI 10.1016/0927-7757(96)03590-X
   Kwok DY, 2000, J COLLOID INTERF SCI, V225, P323, DOI 10.1006/jcis.2000.6749
   Kwok DY, 2000, COLLOID SURFACE A, V161, P49, DOI 10.1016/S0927-7757(99)00324-6
   LAHOOTI S, 1996, APPL SURFACE THERMOD, P441
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   LAM CNC, 2001, HDB APPL SURFACE COL
   Lee L.-H., 1993, CONTACT ANGLE WETTAB, P45
   LI D, 1990, J COLLOID INTERF SCI, V137, P304, DOI 10.1016/0021-9797(90)90067-X
   Loget Francois, 2002, REV HIST MATH, V8, P207
   Luner PE, 2001, COLLOID SURFACE A, V181, P31, DOI 10.1016/S0927-7757(00)00805-0
   Luner PE, 1996, INT J PHARM, V128, P29, DOI 10.1016/0378-5173(95)04208-3
   LUNER PE, 2002, CONTACT ANGLE WETTAB, V2, P299
   Marmur A, 1996, COLLOID SURFACE A, V116, P55, DOI 10.1016/0927-7757(96)03585-6
   Matsunaga M, 2000, POLYM DEGRAD STABIL, V70, P325, DOI 10.1016/S0141-3910(00)00105-1
   Michalski MC, 1997, CRIT REV FOOD SCI, V37, P591, DOI 10.1080/10408399709527791
   Mirabedini SM, 2004, INT J ADHES ADHES, V24, P163, DOI 10.1016/j.ijadhadh.2003.09.004
   Moosheimer U, 1999, SURF COAT TECH, V116, P812, DOI 10.1016/S0257-8972(99)00137-1
   Muszynski L., 2003, CONTACT ANGLE WETTAB, V3, P463
   NEUMANN AW, 1974, J COLLOID INTERF SCI, V49, P291, DOI 10.1016/0021-9797(74)90365-8
   Norris DA, 1999, J CONTROL RELEASE, V59, P173, DOI 10.1016/S0168-3659(98)00191-6
   Oh E, 1999, INT J PHARM, V188, P203, DOI 10.1016/S0378-5173(99)00224-0
   Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pepin X, 1999, PHARM SCI TECHNOL TO, V2, P111, DOI 10.1016/S1461-5347(99)00129-7
   Peroval C, 2004, J MEMBRANE SCI, V233, P129, DOI 10.1016/j.memsci.2004.01.009
   Perry RH, 1984, PERRYS CHEM ENG HDB
   Peschel S, 2003, SCI HORTIC-AMSTERDAM, V97, P265, DOI 10.1016/S0304-4238(02)00207-8
   Phan D, 2002, J AGR FOOD CHEM, V50, P2423, DOI 10.1021/jf010898r
   PHAN TD, 2002, J AGR FOOD CHEM, V50, P266
   Ponter AB, 2002, CONTACT ANGLE WETTAB, V2, P331
   Roman-Gutierrez A, 2003, POWDER TECHNOL, V129, P37, DOI 10.1016/S0032-5910(02)00154-7
   ROTENBERG Y, 1983, J COLLOID INTERF SCI, V93, P169, DOI 10.1016/0021-9797(83)90396-X
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   SCHONHORN H, 1966, J PHYS CHEM-US, V70, P4086, DOI 10.1021/j100884a511
   SCHRADER ME, 2002, CONTACT ANGLE WETTAB, V3, P67
   Sedev RV, 1996, J COLLOID INTERF SCI, V180, P36, DOI 10.1006/jcis.1996.0271
   Shen HT, 2002, RESOUR CONSERV RECY, V35, P229, DOI 10.1016/S0921-3449(02)00003-4
   Shen W, 2000, COLLOID SURFACE A, V173, P117, DOI 10.1016/S0927-7757(00)00454-4
   Siboni S, 2004, J COLLOID INTERF SCI, V271, P454, DOI 10.1016/j.jcis.2003.09.050
   Singh BP, 1998, FILTR SEPARAT, V35, P525, DOI 10.1016/S0015-1882(98)80027-X
   Tsuchiya Y, 1998, PROG ORG COAT, V34, P100, DOI 10.1016/S0300-9440(97)00117-3
   van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X
   VANOSS CJ, 1992, LANGMUIR, V8, P2877, DOI 10.1021/la00048a006
   VANOSS CJ, 1995, CLAY CLAY MINER, V43, P474, DOI 10.1346/CCMN.1995.0430411
   VANOSS CJ, 1992, J ADHES SCI TECHNOL, V6, P413, DOI 10.1163/156856192X00755
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   WONG DWS, 1992, J AGR FOOD CHEM, V40, P540, DOI 10.1021/jf00016a002
   WU S, 1973, J ADHESION, V5, P39, DOI 10.1080/00218467308078437
   Wu S., 1971, J POLYM SCI C, V34, P19, DOI DOI 10.1002/POLC.5070340105
   YASUDA T, 1994, LANGMUIR, V10, P2435, DOI 10.1021/la00019a068
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 116
TC 54
Z9 55
U1 2
U2 52
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1040-8398
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PY 2006
VL 46
IS 5
BP 391
EP 407
DI 10.1080/10408390591000884
PG 17
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 057RO
UT WOS:000238613100003
PM 16891211
DA 2018-10-20
ER

PT J
AU Kazakov, S
   Levon, K
AF Kazakov, Sergey
   Levon, Kalle
TI Liposome-nanogel structures for future pharmaceutical applications
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article; Proceedings Paper
CT 2nd Nanomedicine and Drug Delivery Symposium
CY AUG, 2004
CL Brooklyn, NY
DE liposomes; nanogels; supramolecular assembly; lipobeads; drug delivery
   systems
ID METH-A-SARCOMA; LONG-CIRCULATING LIPOSOMES; DYNAMIC LIGHT-SCATTERING;
   OCULAR DELIVERY SYSTEMS; PHASE-TRANSITION; DRUG-DELIVERY; PEPTIDE
   LIGANDS; CYCLOSPORINE-A; ENCAPSULATED GANCICLOVIR; INTRAVITREAL
   INJECTION
AB Nanoparticles have been extensively studied as drug delivery systems. In this review, we focus on a relatively new type of nanoparticles - lipobeads - a liposome-hydrogel assembly as a novel drug delivery system. An appropriate assemblage of spherical hydrogel particles and liposomes combines the properties of both classes of materials and may find a variety of biomedical applications. The bi-compartmental Structure of lipobeads is a natural configuration. Thus, the technology of their preparation can be a key step of designing more stable and effective vaccines. Biocompatibility and stability, ability to deliver a broad range of bioactive molecules, environmental responsiveness of both inner nanogel core and external lipid bilayer, and individual specificity of both compartments make the liposome-nanogel design a versatile drug delivery system relevant for all known drug administration routes and suitable for different diseases with possibility of efficient targeting to different organs. New findings on reversible and irreversible aggregation of lipobeads can lead to novel combined drug delivery systems regarding lipobeads as multipurpose containers. The research on hydrogelliposome submicrometer structures has just begun and fundamental studies on interactions between hydrogels and liposomes are in demand.
C1 Polytech Univ, Polymer Res Inst, Brooklyn, NY 11201 USA.
   Pace Univ, Dept Chem & Phys Sci, Pleasantville, NY 10570 USA.
RP Levon, K (reprint author), Polytech Univ, Polymer Res Inst, 6 Metrotech Ctr, Brooklyn, NY 11201 USA.
EM klevon@poly.edu
RI Levon, Kalle/H-7990-2016
OI Levon, Kalle/0000-0001-6833-6254
CR Adams LB, 1999, ANTIMICROB AGENTS CH, V43, P1638, DOI 10.1128/AAC.43.7.1638
   AFZELIUS P, 1989, BIOCHIM BIOPHYS ACTA, V979, P231, DOI 10.1016/0005-2736(89)90439-2
   Allen TM, 1998, DRUGS, V56, P747, DOI 10.2165/00003495-199856050-00001
   Buck S, 2004, BIOMACROMOLECULES, V5, P2230, DOI 10.1021/bm049751+
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Cabanes A, 1998, INT J ONCOL, V12, P1035
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Calvo P, 1996, J PHARM SCI, V85, P530, DOI 10.1021/js950474+
   Calvo P, 1996, PHARMACEUT RES, V13, P311, DOI 10.1023/A:1016015803611
   Clemons KV, 1998, ANTIMICROB AGENTS CH, V42, P899, DOI 10.1128/AAC.42.4.899
   Cortesi R, 1999, AM J HEMATOL, V62, P33, DOI 10.1002/(SICI)1096-8652(199909)62:1<33::AID-AJH6>3.0.CO;2-M
   DAVID S, 1984, MICROSPHERES DRUG TH
   De Miguel I, 2000, PHARMACEUT RES, V17, P817, DOI 10.1023/A:1007504124603
   De SK, 2002, J MICROELECTROMECH S, V11, P544, DOI 10.1109/JMEMS.2002.803281
   DEMIGUEL I, 1995, BBA-BIOMEMBRANES, V1237, P49, DOI 10.1016/0005-2736(95)00079-I
   DOI K, 1994, BIOL PHARM BULL, V17, P1414
   Duzgunes N, 1999, MOL MEMBR BIOL, V16, P111, DOI 10.1080/096876899294832
   EGGENS I, 1989, J BIOL CHEM, V264, P9476
   Eichenbaum GM, 1999, MACROMOLECULES, V32, P4867, DOI 10.1021/ma981945s
   Eichenbaum GM, 1998, MACROMOLECULES, V31, P5084, DOI 10.1021/ma970897t
   Eichenbaum GM, 1999, MACROMOLECULES, V32, P8996, DOI 10.1021/ma9908393
   Embree L, 1998, CANCER CHEMOTH PHARM, V41, P347, DOI 10.1007/s002800050750
   ENDE MTA, 1997, PROTEIN DELIVERY PHY, P139
   ERMAN B, 1986, MACROMOLECULES, V19, P2342, DOI 10.1021/ma00163a003
   Fenart L, 1999, J PHARMACOL EXP THER, V291, P1017
   Fresta M, 1999, J PHARM PHARMACOL, V51, P565, DOI 10.1211/0022357991772664
   Gabizon A, 1998, J CONTROL RELEASE, V53, P275, DOI 10.1016/S0168-3659(97)00261-7
   GEHRKE SH, 1989, CHEM ENG SCI, V44, P559, DOI 10.1016/0009-2509(89)85032-8
   Green PG, 1996, J CONTROL RELEASE, V41, P33, DOI 10.1016/0168-3659(96)01354-5
   GREGORIADIS G, 1992, LIPOSOME TECHNOLOGY
   Gulati M, 1998, J MICROENCAPSUL, V15, P137, DOI 10.3109/02652049809006844
   HELFFERI.F, 1965, J PHYS CHEM-US, V69, P1178, DOI 10.1021/j100888a015
   HIROKAWA Y, 1985, MACROMOLECULES, V18, P2782, DOI 10.1021/ma00154a075
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308
   ILAVSKY M, 1982, MACROMOLECULES, V15, P782, DOI 10.1021/ma00231a019
   Ito S, 1999, LANGMUIR, V15, P4289, DOI 10.1021/la9811867
   JANAS VF, 1980, MACROMOLECULES, V13, P977, DOI 10.1021/ma60076a042
   Ji J, 2001, ANAL CHEM, V73, P3521, DOI 10.1021/ac010344n
   JI T, 2003, POLYM PREPRINT, V44, P483
   Johnson EM, 1998, ANTIMICROB AGENTS CH, V42, P1412, DOI 10.1128/AAC.42.6.1412
   Kazakov S, 2004, CHEM COMMUN, P430, DOI 10.1039/b312389h
   Kazakov S, 2002, MACROMOLECULES, V35, P1911, DOI 10.1021/ma011644+
   Kazakov S, 2003, LANGMUIR, V19, P8086, DOI 10.1021/la030066i
   Kazakov S, 2002, P SOC PHOTO-OPT INS, V4695, P42, DOI 10.1117/12.475202
   KAZAKOV S, 2004, P 32 ACM NERM, P96
   KAZAKOV S, 2003, POLYM PREPRINT, V44, P16
   Kazakov S, 2002, POLYM PREPRINT, V43, P381
   KAZAKOV S, 2002, Patent No. 20030305842
   Kazakov SV, 2002, INT J THERMOPHYS, V23, P161, DOI 10.1023/A:1013957127723
   Khuller GK, 2004, CURR PHARM DESIGN, V10, P3263, DOI 10.2174/1381612043383250
   Kimura T, 1998, ARTIF CELL BLOOD SUB, V26, P455, DOI 10.3109/10731199809117466
   Kiser PF, 1998, NATURE, V394, P459
   Kiser PF, 2000, J CONTROL RELEASE, V68, P9, DOI 10.1016/S0168-3659(00)00236-4
   Knight V, 1999, CANCER CHEMOTH PHARM, V44, P177, DOI 10.1007/s002800050965
   Knurr J, 2003, APPL ENVIRON MICROB, V69, P6841, DOI 10.1128/AEM.69.11.6841-6847.2003
   Kreuter J., 1994, COLLOIDAL DRUG DELIV
   Krishna R, 1997, CANCER RES, V57, P5246
   Lamproglou I, 1998, INT J RADIAT ONCOL, V42, P179, DOI 10.1016/S0360-3016(98)00202-8
   LASIC DD, 1993, LIPOSOMES PHYS APPL
   Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5
   LeBourlais C, 1996, J MICROENCAPSUL, V13, P473
   LeBourlais CA, 1997, J MICROENCAPSUL, V14, P457, DOI 10.3109/02652049709033830
   Legendre JY, 1997, BIOCONJUGATE CHEM, V8, P57, DOI 10.1021/bc960076d
   Leitzke S, 1998, ANTIMICROB AGENTS CH, V42, P459
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   Lundberg BB, 1998, ANTI-CANCER DRUG DES, V13, P453
   Ma AH, 2004, ANAL CHEM, V76, P569, DOI 10.1021/ac.034940o
   Major M, 1997, BBA-BIOMEMBRANES, V1327, P32, DOI 10.1016/S0005-2736(97)00041-2
   Markland P, 1999, J BIOMED MATER RES, V47, P595, DOI 10.1002/(SICI)1097-4636(19991215)47:4<595::AID-JBM17>3.3.CO;2-9
   MARTIN FJ, 1981, BIOCHEMISTRY-US, V20, P4229, DOI 10.1021/bi00517a043
   MARTIN FJ, 1982, J BIOL CHEM, V257, P286
   MAYER LD, 1990, BIOCHIM BIOPHYS ACTA, V1025, P143, DOI 10.1016/0005-2736(90)90091-2
   McNamara KP, 2001, ANAL CHEM, V73, P3240, DOI 10.1021/ac0102314
   Medina OP, 2004, CURR PHARM DESIGN, V10, P2981, DOI 10.2174/1381612043383467
   MEISNER D, 1995, ADV DRUG DELIVER REV, V16, P75, DOI 10.1016/0169-409X(95)00016-Z
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Moriya H, 1997, PHARMACEUT RES, V14, P1621, DOI 10.1023/A:1012142704924
   Ng CC, 2004, BIOPHYS J, V87, P323, DOI 10.1529/biophysj.103.030627
   Ng CC, 2001, MACROMOLECULES, V34, P5759, DOI 10.1021/ma0100899
   Ogawa K, 2003, LANGMUIR, V19, P3178, DOI 10.1021/la0267185
   Ogawa Y, 2001, LANGMUIR, V17, P2670, DOI 10.1021/la001577x
   Ohta Y, 1997, J OCUL PHARMACOL TH, V13, P537, DOI 10.1089/jop.1997.13.537
   OKU N, 1994, INT J CANCER, V58, P415, DOI 10.1002/ijc.2910580318
   OSIRO M, 1993, LIPOSOMES
   Oussoren C, 1999, INT J PHARM, V180, P261, DOI 10.1016/S0378-5173(99)00016-2
   Park K., 1997, CONTROLLED DRUG DELI
   PARK TG, 1993, MACROMOLECULES, V26, P5045, DOI 10.1021/ma00071a010
   Patton JN, 2005, BIOMACROMOLECULES, V6, P414, DOI 10.1021/bm049432i
   Patton JN, 2005, BIOMACROMOLECULES, V6, P2204, DOI 10.1021/bm050144b
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   Peppas N. A., 1987, HYDROGELS MED PHARM
   PerezSoler R, 1997, CLIN CANCER RES, V3, P373
   PEYMAN GA, 1987, RETINA-J RET VIT DIS, V7, P227, DOI 10.1097/00006982-198707040-00005
   Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v
   PLEYER U, 1994, CURR EYE RES, V13, P177, DOI 10.3109/02713689408995775
   Plunkett KN, 2003, MACROMOLECULES, V36, P3960, DOI 10.1021/ma025874f
   Qiu XP, 1997, MACROMOLECULES, V30, P6090, DOI 10.1021/ma970484s
   RICKA J, 1984, MACROMOLECULES, V17, P2916, DOI 10.1021/ma00142a081
   RINGSDORF H, 1991, ANGEW CHEM INT EDIT, V30, P315, DOI 10.1002/anie.199103151
   Rogers JA, 1998, CRIT REV THER DRUG, V15, P421
   Rolland A, 1993, PHARM PARTICULATE CA
   Sadzuka Y, 1998, CANCER LETT, V127, P99, DOI 10.1016/S0304-3835(98)00031-7
   SCHAEFFER HE, 1982, INVEST OPHTH VIS SCI, V22, P220
   Scialli AR, 1997, TERATOLOGY, V56, P305, DOI 10.1002/(SICI)1096-9926(199711)56:5<305::AID-TERA3>3.0.CO;2-W
   Shibayama M, 1996, J CHEM PHYS, V105, P4358, DOI 10.1063/1.472252
   Shibayama M, 1996, MACROMOLECULES, V29, P6966, DOI 10.1021/ma960866i
   Shoji Y, 2004, CURR PHARM DESIGN, V10, P785, DOI 10.2174/1381612043453009
   SIEGEL RA, 1988, MACRMOMOLECULES, V21, P3251
   Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   Suzuki H, 1999, LANGMUIR, V15, P4283, DOI 10.1021/la981187z
   Symon Z, 1999, CANCER, V86, P72, DOI 10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   Tokudome Y, 1996, BBA-BIOMEMBRANES, V1279, P70, DOI 10.1016/0005-2736(95)00242-1
   Trafny EA, 1999, J MICROENCAPSUL, V16, P419
   Turnbough CL, 2003, J MICROBIOL METH, V53, P263, DOI 10.1016/S0167-7012(03)00030-7
   Valero V, 1999, J CLIN ONCOL, V17, P1425, DOI 10.1200/JCO.1999.17.5.1425
   van der Veen AH, 1998, INT J CANCER, V77, P901
   van Slooten ML, 1999, INT J PHARM, V183, P33, DOI 10.1016/S0378-5173(99)00039-3
   Verdonck LF, 1998, LEUKEMIA RES, V22, P249, DOI 10.1016/S0145-2126(97)00160-4
   von Hoegen P, 2001, ADV DRUG DELIVER REV, V51, P113, DOI 10.1016/S0169-409X(01)00175-2
   Waalkes MV, 1998, ANTI-CANCER DRUG DES, V13, P291
   WATTS A, 1978, BIOCHEMISTRY-US, V17, P1792, DOI 10.1021/bi00602a034
   Williams DD, 2003, APPL ENVIRON MICROB, V69, P6288, DOI 10.1128/AEM.69.10.6288-6293.2003
   Wong JP, 1999, VACCINE, V17, P1788, DOI 10.1016/S0264-410X(98)00439-3
   Woodle MC, 1998, LONG CIRCULATING LIP
   Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1737, DOI 10.1128/AAC.43.7.1737
   Yagi N, 1999, CHEM COMMUN, P1687, DOI 10.1039/a905322k
   Zignani M, 2000, BBA-BIOMEMBRANES, V1463, P383, DOI 10.1016/S0005-2736(99)00234-5
   Zou YY, 1995, CLIN CANCER RES, V1, P1369
   Zucchetti M, 1999, CANCER CHEMOTH PHARM, V44, P173, DOI 10.1007/s002800050964
NR 134
TC 35
Z9 36
U1 0
U2 27
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2006
VL 12
IS 36
BP 4713
EP 4728
DI 10.2174/138161206779026281
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 121HS
UT WOS:000243149300005
PM 17168774
DA 2018-10-20
ER

PT J
AU Kacmar, J
   Carlson, R
   Balogh, SJ
   Srienc, F
AF Kacmar, J
   Carlson, R
   Balogh, SJ
   Srienc, F
TI Staining and quantification of poly-3-hydroxybutyrate in Saccharomyces
   cerevisiae and Cupriavidus necator cell populations using automated flow
   cytometry
SO CYTOMETRY PART A
LA English
DT Article
DE Nile red; BODIPY 493/503; automated bioreactor monitoring;
   polyhydroxyalkanoates; Ralstonia eutropha
ID ALCALIGENES-EUTROPHUS H16; POLY-BETA-HYDROXYBUTYRATE; BACTERIAL
   POLYHYDROXYALKANOATES; ACIDS
AB Background: Poly [(R)-3-hydroxybutyric acid] (PHB) is a prokaryote storage material for carbon and energy that accumulates in cells under unbalanced growth conditions. Because this class of biopolymers has plastic-like properties, it has attracted considerable interest for biomedical applications and as a biodegradable commodity plastic. Current flow cytometric techniques to quantify intracellular PHB are based on Nile red. Here, an improved cytometric technique for cellular PHB quantification utilizing BODIPY 493/503 staining was developed. This technique was then automated using an automated flow cytometry System.
   Materials: Using flow cytometry, the fluorescence of Sac-charomyces cerevisiae and Cupriavidus necator with varying PHB content after staining with BODIPY 493/503 and Nile red was compared, and automated staining techniques were developed for both cultures.
   Results: BODIPY 493/503 staining had less background staining, higher sensitivity and specificity to PHB, and higher saturation values than did Nile red staining. The developed automated staining procedure was capable of analyzing the PHB content of a bioreactor sample even 25 min and measured the average PHB content With accuracy comparable to offline GC analysis.
   Conclusion: BODIPY 493/503 produced an overall better staining for PHB than did Nile red. When combined with the automated system, this technique provides a new method for the online monitoring and control of bio-reactors. (c) 2005 International Society for Analytical Cytology.
C1 Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.
   Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
RP Srienc, F (reprint author), Univ Minnesota, Inst Biotechnol, 240 Gortner Lab,1479 Gortner Ave, St Paul, MN 55108 USA.
EM srienc@umn.edu
CR Abu-Absi NR, 2003, CYTOM PART A, V51A, P87, DOI 10.1002/cyto.a.10016
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Carlson R, 2002, BIOTECHNOL BIOENG, V79, P121, DOI 10.1002/bit.10305
   DEGELAU A, 1995, APPL MICROBIOL BIOT, V42, P653
   DOI Y, 1986, MACROMOLECULES, V19, P2860, DOI 10.1021/ma00165a033
   GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207
   Gorenflo V, 1999, APPL MICROBIOL BIOT, V51, P765, DOI 10.1007/s002530051460
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Mittendorf V, 1998, P NATL ACAD SCI USA, V95, P13397, DOI 10.1073/pnas.95.23.13397
   MULLER S, 1995, APPL MICROBIOL BIOT, V43, P93
   RAMSAY BA, 1990, APPL ENVIRON MICROB, V56, P2093
   RIIS V, 1988, J CHROMATOGR, V445, P285, DOI 10.1016/S0021-9673(01)84535-0
   SRIENC F, 1984, BIOTECHNOL BIOENG, V26, P982, DOI 10.1002/bit.260260824
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0
   Vidal-Mas J, 2001, ANTON LEEUW INT J G, V80, P57, DOI 10.1023/A:1012208225286
NR 16
TC 29
Z9 31
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4922
J9 CYTOM PART A
JI Cytom. Part A
PD JAN
PY 2006
VL 69A
IS 1
BP 27
EP 35
DI 10.1002/cyto.a.20197
PG 9
WC Biochemical Research Methods; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 999IT
UT WOS:000234383700004
PM 16342115
OA Bronze
DA 2018-10-20
ER

PT S
AU Safronova, TV
   Putlayev, VI
   Belyakov, AV
   Shekhirev, MA
AF Safronova, Tatiana V.
   Putlayev, Valery I.
   Belyakov, Alexey V.
   Shekhirev, Mikhail A.
BE Chipara, M
   Puglisi, O
   Skomski, R
   Jones, FR
   Hsiao, BS
TI Sintering of HAP precipitated from solutions containing ammonium nitrate
   and PVA
SO DEGRADATION PROCESSES IN NANOSTRUCTURED MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Degradation Processes in Nanostructured Materials held at
   the 2005 MRS Fall Meeting
CY NOV 28-DEC 01, 2005
CL Boston, MA
ID CALCIUM-PHOSPHATE APATITES
AB Bioceramics based on hydroxyapatite (HAP) is known to be a prospective material for biomedical applications, However, sintering of HAP is still understudied in sense of reasonable selection of controlling parameters. In particular, the role of impurities and co-products of powder fabrication is still questionable. The data concerning the role of ammonium nitrate coming to precipitated HAP from the mother liquor, its effect on powder compaction and subsequent sintering, are not available.
   Nanosized powders of HAP were fabricated via conventional wet-precipitation technique by dropwise adding of Ca(NO3)(2) solution (0.25-1.67 M) to the stock solution of (NH4)(2)HPO4 (0.15-1.00 M) with pre-adjusted pH at 60 C in presence of polyvinyl alcohol (PVA). PVA was added to the stock solution in order (i) to block crystal growth during synthesis, (ii) to improve stability of Hap suspension to sedimentation, (iii) to regulate an aggregation of HA nanoparticles during synthesis and in the stage of drying.
   NH4NO3 - a by-product of the precipitation reaction, presented in as-precipitated powder in amount of 30%, was evaluated as an additive affecting a compaction of the powder and the initial stage of a sintering. The powder samples were tested by XRD, FTIR, light-scattering, TEM and SEM/EDX to get particle sizes, morphology and chemical composition, dilatometry. Ceramics were sintered at 700-1250 C and evaluated with SEM/EDX and density measurements.
   Addition of PVA to the stock solution in the course of HAP precipitation is a promising technique to control an aggregation of HAP nanoparticles in the stages of drying and sintering. PVA acting as a surfactant in the solution and as a binder in dry powder can keep highly reactive small HAP particles within large agglomerates providing better molding of the powder and controllable densification of ceramics. The effect of PVA on microstructure of the HAP powder and their sintering behaviour is discussed in terms of self-organisation concept and synergetics.
C1 [Safronova, Tatiana V.; Putlayev, Valery I.] Moscow MV Lomonosov State Univ, Dept Chem, Leniskie Gory 1, Moscow 119992, Russia.
   [Shekhirev, Mikhail A.] Moscow MV Lomonosov State Univ, Dept Mat Sci, Moscow 119992, Russia.
   [Belyakov, Alexey V.] Mendeleev Chem Technol Univ Russia, Dept Chem Thecnol Silicates, Moscow 125047, Russia.
RP Safronova, TV (reprint author), Moscow MV Lomonosov State Univ, Dept Chem, Leniskie Gory 1, Moscow 119992, Russia.
RI Safronova, Tatiana/D-7285-2012
OI Safronova, Tatiana/0000-0002-9799-5029
FU RFBR [05-03-32768]; programm 'Universities of Russia' [UR 06.02.556];
   MSU [26]
FX This work was partially supported by RFBR (grant #05-03-32768), the
   programm 'Universities of Russia'(UR 06.02.556), interdisciplinary grant
   of MSU #26, SEC 'Synthesis'. The assistance of N.Lyskov and R.Muydinov
   in TGA-experiments and dilatometry is deeply appreciated.
CR AMID Z, 1987, LANGMUIR, V3, P1063
   BALKEVICH VL, 1985, STEKLO KERAM, P25
   Belyakov AB, 2000, GLASS CERAM+, V57, P345, DOI 10.1023/A:1007146505135
   Belyakov AV, 2003, GLASS CERAM+, V60, P274, DOI 10.1023/B:GLAC.0000008226.99474.18
   BELYAKOV AV, 2002, CRACK MICROSTRUCTURE, P497
   BELYAKOV AV, 2003, METHODS PREPARATION
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   OMBRETTA M, 2004, ANNU REV MATER RES, V34, P41
   PRIGOGINE I, 1997, END CERTITUDE
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Si S, 2004, CHEM MATER, V16, P3489, DOI 10.1021/cm049205n
   YING JY, 2000, Patent No. 6013591
NR 13
TC 3
Z9 3
U1 0
U2 3
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-841-1
J9 MATER RES SOC SYMP P
PY 2006
VL 887
BP 237
EP +
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BEG71
UT WOS:000237235700027
DA 2018-10-20
ER

PT S
AU Yurke, B
   Lin, DC
   Langrana, NA
AF Yurke, B
   Lin, DC
   Langrana, NA
BE Carbone, A
   Pierce, NA
TI Use of DNA nanodevices in modulating the mechanical properties of
   polyacrylamide gels
SO DNA COMPUTING
SE LECTURE NOTES IN COMPUTER SCIENCE
LA English
DT Article; Proceedings Paper
CT 11th International Workshop on DNA Commputing (DNA 11)
CY JUN 06-09, 2005
CL London, CANADA
SP Fields Inst Res Math Sci, MITACS, Biomar Inc, Univ Western Ontario, Univ Western Ontario, Fac Sci
ID CROSS-LINKED GELS; SPHERICAL INCLUSIONS; DEVICE; HYBRIDIZATION;
   HYDROGEL; MACHINE
AB Here we show that bulk materials can be given new properties through the incorporation of DNA-based nanodevices. In particular, by employing simple nanodevices as crosslinks in polyacrylamide gels we have made the mechanical properties of these gels responsive to the presence of particular DNA strands. Two examples will be focused on here. One consists of a polymer system that can be switched between a sol and a gel state though the application of DNA strands that either form crosslinks or remove crosslinks. The other consists of a hydrogel whose crosslinks incorporate a motor domain. The stiffness of this hydrogel can be altered through the application of fuel strands, which stiffen and lengthen the crosslinks, or through the application of removal strands which remove the fuel strands form the motor domain. Such DNA-responsive gels may find applications in biomedical technology ranging from drug delivery to tissue engineering.
C1 Bell Labs, Murray Hill, NJ 07974 USA.
   Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA.
RP Yurke, B (reprint author), Bell Labs, 600 Mt Ave, Murray Hill, NJ 07974 USA.
EM yurke@lucent.com; dclin@eden.rutgers.edu; langrana@rutgers.edu
CR Alberti P, 2003, P NATL ACAD SCI USA, V100, P1569, DOI 10.1073/pnas.0335459100
   DITTMER WU, 2004, ANGEW CHEM INT EDIT, V43, P3549
   Feng LP, 2003, ANGEW CHEM INT EDIT, V42, P4342, DOI 10.1002/anie.200351818
   Li JWJ, 2002, NANO LETT, V2, P315, DOI 10.1021/n1015713+
   Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299
   Lin DC, 2005, J BIOMECH ENG-T ASME, V127, P571, DOI 10.1115/1.1933981
   Lin DC, 2005, J APPL PHYS, V97, DOI 10.1063/1.1847698
   Lin DC, 2005, J MATER RES, V20, P1456, DOI 10.1557/JMR.2005.0186
   Lin DC, 2004, J BIOMECH ENG-T ASME, V126, P104, DOI 10.1115/1.1645529
   Mao CD, 1999, NATURE, V397, P144
   Nagahara S, 1996, POLYM GELS NETW, V4, P111, DOI 10.1016/0966-7822(96)00001-9
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Semler EJ, 2001, BIOTECHNOL BIOENG, V75, P510, DOI 10.1002/bit.10113
   Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q
   Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j
   Simmel FC, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041913
   Simmel FC, 2002, APPL PHYS LETT, V80, P883, DOI 10.1063/1.1447008
   Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102
   Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a
   Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524
   Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651
NR 21
TC 11
Z9 11
U1 0
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
BN 3-540-34161-7
J9 LECT NOTES COMPUT SC
PY 2006
VL 3892
BP 417
EP 426
PG 10
WC Biochemistry & Molecular Biology; Computer Science, Theory & Methods
SC Biochemistry & Molecular Biology; Computer Science
GA BEM11
UT WOS:000238093800033
DA 2018-10-20
ER

PT J
AU Singh, P
   Gonzalez, MJ
   Manchester, M
AF Singh, Pratik
   Gonzalez, Maria J.
   Manchester, Marianne
TI Viruses and their uses in nanotechnology
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Review
DE virus; VLP; nanoparticles; nanotechnology Al47823 vertical bar CA112075
   vertical bar NOI-CO27181
ID COWPEA MOSAIC-VIRUS; MHC CLASS-I; RECEPTOR-MEDIATED ENDOCYTOSIS;
   TARGETED GENE DELIVERY; POLYOMAVIRUS JC VIRUS; T-CELL RESPONSES;
   BACTERIOPHAGE-MS2 COAT PROTEIN; SUPRAMOLECULAR BUILDING-BLOCKS;
   ANTIGEN-PRESENTING CELLS; CHLOROTIC MOTTLE VIRUS
AB The use of materials derived from natural sources in materials science has allowed the harnessing of complex structures resulting from eons of evolutionary fine-tuning. A better understanding of the structure and function of viruses has revealed a collection of natural molecular assemblies and containers with a variety of shapes, sizes, stabilities, dynamic properties, and chemical reactivities. Viruses are increasingly being used in materials science, engineering, and nanotechnology as tools and building blocks for electronics, chemistry, and biomedical science. Here we discuss different types of viruses presently in use, their physical properties, and their potential uses in a variety of nanotechnology applications.
C1 Scripps Res Inst, Ctr Integrat Mol Biosci, Dept Cell Biol, La Jolla, CA 92037 USA.
RP Manchester, M (reprint author), Scripps Res Inst, Ctr Integrat Mol Biosci, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM marim@scripps.edu
OI Manchester, Marianne/0000-0002-7143-5744
CR Abbing A, 2004, J BIOL CHEM, V279, P27410, DOI 10.1074/jbc.M313612200
   Ahlquist P, 1992, Curr Opin Genet Dev, V2, P71, DOI 10.1016/S0959-437X(05)80325-9
   Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257
   Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998
   Arap Wadih, 1998, Current Opinion in Oncology, V10, P560, DOI 10.1097/00001622-199811000-00014
   Arora PS, 2004, CHEM BIOL, V11, P418, DOI 10.1016/j.chembiol.2004.04.003
   Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003
   Atkinson SF, 2001, J BIOL CHEM, V276, P27930, DOI 10.1074/jbc.M102825200
   Azios NG, 2001, ONCOGENE, V20, P5199, DOI 10.1038/sj.onc.1204555
   Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236
   Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299
   Becker A, 2000, PHOTOCHEM PHOTOBIOL, V72, P234, DOI 10.1562/0031-8655(2000)072<0234:MCAFOI>2.0.CO;2
   Beijerinck M. W, 1898, VERHANDELINGEN KONIN, V6, P3
   Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
   BENGARY H, 2002, MOL THER, V6, P287
   Bierne H, 2002, J CELL SCI, V115, P3357
   Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017
   Bousarghin L, 2003, J GEN VIROL, V84, P157, DOI 10.1099/vir.0.18789-0
   BRACIALE TJ, 1987, IMMUNOL REV, V98, P95, DOI 10.1111/j.1600-065X.1987.tb00521.x
   BRIDGES KR, 1985, J CLIN INVEST, V76, P913, DOI 10.1172/JCI112089
   Brown WL, 2002, INTERVIROLOGY, V45, P371, DOI 10.1159/000067930
   Brumfield S, 2004, J GEN VIROL, V85, P1049, DOI 10.1099/vir.0.19688-0
   Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893
   Cargile BJ, 2001, ANAL CHEM, V73, P1277, DOI 10.1021/ac0007251
   Chatterji A, 2005, NANO LETT, V5, P597, DOI 10.1021/nl048007s
   Chatterji A, 2004, BIOCONJUGATE CHEM, V15, P807, DOI 10.1021/bc0402888
   Chatterji A, 2004, CHEM BIOL, V11, P855, DOI 10.1016/j.chembiol.2004.04.011
   Chen LM, 2004, CHEM BIOL, V11, P1081, DOI 10.1016/j.chembiol.2004.05.019
   CHEN Z, 1990, SEMIN VIROL, V1, P453
   Choi Y, 2005, CELL CYCLE, V4, P669, DOI 10.4161/cc.4.5.1684
   Christ M, 2000, HUM GENE THER, V11, P415, DOI 10.1089/10430340050015888
   Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041
   Combita AL, 2001, FEMS MICROBIOL LETT, V204, P183, DOI 10.1111/j.1574-6968.2001.tb10883.x
   Cotter MJ, 2005, FRONT BIOSCI, V10, P1098, DOI 10.2741/1603
   CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378
   Da Silva DM, 2001, INT IMMUNOL, V13, P633, DOI 10.1093/intimm/13.5.633
   Dalsgaard K, 1997, NAT BIOTECHNOL, V15, P248, DOI 10.1038/nbt0397-248
   Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5
   DESSENS JT, 1993, J GEN VIROL, V74, P889, DOI 10.1099/0022-1317-74-5-889
   Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211
   Douglas T, 2003, SCIENCE, V299, P1192, DOI 10.1126/science.1081791
   Drobni P, 2004, ANTIVIR RES, V64, P63, DOI 10.1016/j.antiviral.2004.05.005
   Ellerby HM, 1999, NAT MED, V5, P1032
   ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85
   Engler H, 2004, VIROLOGY, V328, P52, DOI 10.1016/j.virol.2004.06.043
   Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d
   FORSTOVA J, POLYOMA VIRUS PSEUDO
   Gabizon A, 2004, ADV DRUG DELIVER REV, V56, P1177, DOI 10.1016/j.addr.2004.01.011
   Gabizon A, 1999, BIOCONJUGATE CHEM, V10, P289, DOI 10.1021/bc9801124
   Giblin MF, 2005, IN VIVO, V19, P9
   Gleiter S, 2003, BIOL CHEM, V384, P247, DOI 10.1515/BC.2003.028
   Goldmann C, 1999, J VIROL, V73, P4465
   Goldmann C, 2000, J VIROL METHODS, V90, P85, DOI 10.1016/S0166-0934(00)00226-3
   Goren D, 2000, CLIN CANCER RES, V6, P1949
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295
   Gunther C, 2001, FASEB J, V15, P1646, DOI 10.1096/fj.00-0645fje
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47
   Henning P, 2005, GENE THER, V12, P211, DOI 10.1038/sj.gt.3302408
   Higginbotham JN, 2002, HUM GENE THER, V13, P129, DOI 10.1089/10430340152712683
   Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495
   Hooker JM, 2004, J AM CHEM SOC, V126, P3718, DOI 10.1021/ja031790q
   HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0
   Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4
   INOUE T, 1993, J CELL PHYSIOL, V156, P212, DOI 10.1002/jcp.1041560128
   Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101
   Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1
   Kawabata H, 1998, Tech Hand Up Extrem Surg, V2, P72, DOI 10.1097/00130911-199803000-00010
   Kawakami Y, 2004, CANCER SCI, V95, P784, DOI 10.1111/j.1349-7006.2004.tb02182.x
   Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102
   Klem MT, 2003, J AM CHEM SOC, V125, P10806, DOI 10.1021/ja0363718
   KNIPE DM, 1996, FIELDS VIROLOGY, P273
   Komagome R, 2002, J VIROL, V76, P12992, DOI 10.1128/JVI.76.24.12992-13000.2002
   Koo M, 1999, P NATL ACAD SCI USA, V96, P7774, DOI 10.1073/pnas.96.14.7774
   KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629
   Kratz F, 1998, J PHARM SCI, V87, P338, DOI 10.1021/js970246a
   Kratz F, 2000, J DRUG TARGET, V8, P305, DOI 10.3109/10611860008997908
   Lam KS, 1997, ANTI-CANCER DRUG DES, V12, P145
   Landon LA, 2003, J CELL BIOCHEM, V90, P509, DOI 10.1002/jcb.10634
   LEAMON CP, 1993, J BIOL CHEM, V268, P24847
   LEE RJ, 1994, J BIOL CHEM, V269, P3198
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Lenz P, 2003, CLIN IMMUNOL, V106, P231, DOI 10.1016/S1521-6616(02)00039-6
   Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346
   LEVINE A, 2001, FUNDAMENTAL VIROLOGY, P3
   Li HY, 2002, TRENDS PHARMACOL SCI, V23, P206, DOI 10.1016/S0165-6147(02)01989-2
   Lin TW, 1999, VIROLOGY, V265, P20, DOI 10.1006/viro.1999.0038
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Lu YJ, 2005, INT J CANCER, V116, P710, DOI 10.1002/ijc.21126
   Lu YJ, 2004, ADV DRUG DELIVER REV, V56, P1161, DOI 10.1016/j.addr.2004.01.009
   Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740
   Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100
   MARVIN DA, 1994, J MOL BIOL, V235, P260, DOI 10.1016/S0022-2836(05)80032-4
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   MCINTOSH PD, 1999, FOREST PRACTICES NEW, V1, P17
   Medintz IL, 2005, LANGMUIR, V21, P5501, DOI 10.1021/la0468287
   Merle E, 1999, J CELL BIOCHEM, V74, P628, DOI 10.1002/(SICI)1097-4644(19990915)74:4<628::AID-JCB12>3.3.CO;2-9
   Modelska A, 1998, P NATL ACAD SCI USA, V95, P2481, DOI 10.1073/pnas.95.5.2481
   MONTROSS L, 1991, J VIROL, V65, P4991
   Mori T, 2004, CURR PHARM DESIGN, V10, P2335, DOI 10.2174/1381612043383944
   Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930
   Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242
   Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157
   Nettelbeck DM, 2004, INT J CANCER, V108, P136, DOI 10.1002/ijc.11563
   Oyewumi MO, 2004, J CONTROL RELEASE, V95, P613, DOI 10.1016/j.jconrel.2004.01.002
   Peabody DS, 2003, J NANOBIOTECHNOL, V1, P5, DOI DOI 10.1186/1477-3155-1-5
   Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003
   Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539
   Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000
   PICKETT GG, 1993, NUCLEIC ACIDS RES, V21, P4621, DOI 10.1093/nar/21.19.4621
   Porta C, 2003, VIROLOGY, V310, P50, DOI 10.1016/S0042-6822(03)00140-5
   Portney NG, 2005, LANGMUIR, V21, P2098, DOI 10.1021/la047525f
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Qu QM, 2004, J BIOL CHEM, V279, P27735, DOI 10.1074/jbc.M310827200
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017
   Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+
   Reid T, 2002, CANCER GENE THER, V9, P979, DOI 10.1038/sj.cgt.7700539
   Rein DT, 2004, INT J CANCER, V111, P698, DOI 10.1002/ijc.20295
   Rennermalm A, 2001, VACCINE, V19, P3376, DOI 10.1016/S0264-410X(01)00080-9
   Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101
   Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198
   Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001
   RIECKMANN P, 1994, J VIROL, V68, P217
   Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0
   Ross JF, 1999, CANCER-AM CANCER SOC, V85, P348, DOI 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4
   ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Ruedl C, 2002, EUR J IMMUNOL, V32, P818, DOI 10.1002/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U
   Ruoslahti E, 2002, CANCER CELL, V2, P97, DOI 10.1016/S1535-6108(02)00100-9
   Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036
   SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1
   SANDO S, 2003, NUCL ACIDS RES S, V3, P289
   Sato Y, 2000, FASEB J, V14, P2108, DOI 10.1096/fj.99-1052com
   Schiedner G, 2003, HUM GENE THER, V14, P1631, DOI 10.1089/104303403322542275
   SCHIEDNER G, 2002, HIGH CAPACITY GUTLES, P429
   Schlick TL, 2005, J AM CHEM SOC, V127, P3718, DOI 10.1021/ja046239n
   Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511
   Schneemann A, 2003, ADV PROTEIN CHEM, V64, P1
   Sen Gupta S, 2005, BIOCONJUGATE CHEM, V16, P1572, DOI 10.1021/bc050147l
   Shu D, 2003, J NANOSCI NANOTECHNO, V3, P295, DOI 10.1166/jnn.2003.160
   Signore A, 2001, EUR J NUCL MED, V28, P1555
   Singh M, 1999, CURR PHARM DESIGN, V5, P443
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Soll RM, 2001, EUR J BIOCHEM, V268, P2828, DOI 10.1046/j.1432-1327.2001.02161.x
   SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6
   Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X
   Stephenson SM, 2004, METHOD ENZYMOL, V387, P33
   Stolz B, 1999, ITAL J GASTROENTEROL, V31, pS224
   Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777
   Storni T, 2002, J IMMUNOL, V168, P2880, DOI 10.4049/jimmunol.168.6.2880
   Strable E, 2004, NANO LETT, V4, P1385, DOI 10.1021/nl0493850
   Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F
   VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0
   Wang A, 2004, LASER FOCUS WORLD, V40, P15
   Wang M, 2003, CANCER RES, V63, P6864
   Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e
   Wang Q, 2002, CHEM BIOL, V9, P805, DOI 10.1016/S1074-5521(02)00165-5
   Wang Q, 2002, CHEM BIOL, V9, P813, DOI 10.1016/S1074-5521(02)00166-7
   Weaver M, 2003, J NEURO-ONCOL, V65, P3, DOI 10.1023/A:1026246500788
   Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37
   Wu M, 1999, CANCER EPIDEM BIOMAR, V8, P775
   Xu L, 2002, HUM GENE THER, V13, P469, DOI 10.1089/10430340252792594
   Yamada T, 2003, NAT BIOTECHNOL, V21, P885, DOI 10.1038/nbt843
   Yamada Tadanori, 2004, Current Drug Targets - Infectious Disorders, V4, P163, DOI 10.2174/1568005043341037
   Yan MY, 2004, VIROLOGY, V324, P297, DOI 10.1016/j.virol.2004.03.045
   Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200
   Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3
   Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   ZHAO XX, 1995, VIROLOGY, V207, P486, DOI 10.1006/viro.1995.1108
NR 173
TC 106
Z9 111
U1 10
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4391
EI 1098-2299
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD JAN
PY 2006
VL 67
IS 1
BP 23
EP 41
DI 10.1002/ddr.20064
PG 19
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 044OG
UT WOS:000237681400004
DA 2018-10-20
ER

PT S
AU Sung, SY
   Kim, YJ
AF Sung, SY
   Kim, YJ
BE Kim, HS
   Li, YB
   Lee, SW
TI Investment casting of Ti alloys for biomedical application
SO ECO-MATERIALS PROCESSING & DESIGN VII
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Eco-Materials Processing and Design
CY JAN 08-11, 2006
CL Chengdu, PEOPLES R CHINA
SP Res Ctr Nano-Biomat, Sichuan Univ, Analyt & Testing Ctr, Natl Incubat Base Nano-Biomat Industrializat, Dept Sci & Technol, Sichuan Univ, S West Jiaotong Univ, Soc Nano-Technol, Korean Sci & Engn Fdn, Japan Soc Promot Sci, Hanyang Univ, Core Univ Program, Osaka Univ, Core Univ Program, Sichuan Guona Sci & Tech Co Ltd
DE alpha-case; titanium; interfacial reaction; mold materials
AB The aim of this study is to clarify the alpha-case formation mechanisms for the economic net-shape forming of Ti and Ti alloys. The a-case formation reaction between Ti and Al2O3 mold was examined in a plasma arc melting furnace. The reaction products were characterized by using an electron probe micro-analyzer and transmission electron microscopy. The a-case generation between Ti and Al(2)o(3) mold could not be explained by the conventional a-case formation mechanism, which is known to be formed by the interstitials, especially oxygen dissolved from mold materials. However, on the basis of our experimental results and thermodynamic consideration, it was confirmed that the alpha-case is formed not only by interstitial oxygen atoms but also by substitutional metal atoms dissolved from mold materials. Based on the alpha-case formation mechanism, alpha-case free net-shape forming of Ti and Ti alloys could be possible for biomedical applications.
C1 Sungkyunkwan Univ, Dept Adv Mat Engn, Suwon 440746, South Korea.
RP Sung, SY (reprint author), Sungkyunkwan Univ, Dept Adv Mat Engn, 300 Chunchun Dong, Suwon 440746, South Korea.
EM hurtler@skku.edu; yjk1122@skku.edu
CR Clemens H, 2000, ADV ENG MATER, V2, P551, DOI 10.1002/1527-2648(200009)2:9<551::AID-ADEM551>3.0.CO;2-U
   EYLON D, 1984, JOM, V38, P55
   KIM YJ, 2004, Patent No. 1020040069535
   Leyens C, 2003, TITANIUM TITANIUM AL
   POMPE W, 2000, MAT SCI ENG A-STRUCT, V362, P40
   Say WC, 2004, SURF COAT TECH, V176, P337, DOI 10.1016/S0257-8972(03)00747-3
   Stefanescu D. M., 1998, METAL HDB, V15
   ZHANG X, 1994, JOM, V48, P30
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-995-4
J9 MATER SCI FORUM
PY 2006
VL 510-511
BP 794
EP 797
DI 10.4028/www.scientific.net/MSF.510-511.794
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEF98
UT WOS:000237176000199
DA 2018-10-20
ER

PT S
AU Mayr, H
   Ordung, M
   Ziegler, G
AF Mayr, Helmar
   Ordung, Marc
   Ziegler, Guenter
BE Boccaccini, AR
   VanderBiest, O
   Clasen, R
TI EPD of a sub micron HA powder for biomedical applications
SO ELECTROPHORETIC DEPOSITON: FUNDAMENTALS AND APPLICATIONS II
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Electrophoretic Deposition
CY MAY 29-JUN 02, 2005
CL Castelvecchio Pascoli, ITALY
SP Engn Conf Int, Electrochem Soc, Amer Ceram Soc, European Ceram Soc, Inst Mat Minerals & Min, London, German Mat Soc
DE hydroxyapatite; electrophoretic deposition; sub micron powder; model
ID ELECTROPHORETIC DEPOSITION; HYDROXYAPATITE
AB Hydroxyapatite ceramics for biomedical applications are used in form of layers, granulates and bulk materials. A new method to produce layers or bulk materials is the electrophoretic deposition. To achieve layers with a thickness between 5 and 50 mu m the use of a fine powder with particle size in the sub micron range is essential. In this work we show that commercially available hydroxyapatite powders, which usually have a strong tendency to agglomerate, can be milled to particle sizes smaller than 500 rim. Using one of these powders and optimizing the parameters for the electrophoretic deposition thin, homogenous layers were produced.
C1 Friedrich Baur Res Inst Biomat, D-95447 Bayreuth, Germany.
RP Mayr, H (reprint author), Friedrich Baur Res Inst Biomat, Ludwig Thoma Str 36C, D-95447 Bayreuth, Germany.
EM helmar.mayr@fbi-biomaterialien.de; marc.ordung@fbi-biomaterialien.de;
   guenter.ziegler@fbi-biomaterialien.de
CR Boccaccini AR, 2001, CHEM-ING-TECH, V73, P443, DOI 10.1002/1522-2640(200105)73:5<443::AID-CITE443>3.3.CO;2-6
   Debye P, 1923, PHYS Z, V24, P305
   POPA A, 2005, IN PRES J EUROP CERA
   Wei M, 2005, J MATER SCI-MATER M, V16, P319, DOI 10.1007/s10856-005-0630-0
   Wei M, 2005, J MATER SCI-MATER M, V16, P101, DOI 10.1007/s10856-005-5995-6
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 7
TC 2
Z9 2
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2006
VL 314
BP 225
EP 230
DI 10.4028/www.scientific.net/KEM.314.225
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Materials Science
GA BEM47
UT WOS:000238128200036
DA 2018-10-20
ER

PT S
AU Stokes, DJ
   Morrissey, F
   Lich, BH
AF Stokes, D. J.
   Morrissey, F.
   Lich, B. H.
BE Brown, PD
   Baker, R
   Hamilton, B
TI A new approach to studying biological and soft materials using focused
   ion beam scanning electron microscopy (FIB SEM)
SO EMAG-NANO 2005: IMAGING, ANALYSIS AND FABRICATION ON THE NANOSCALE
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT EMAG/NANO Conference on Imaging, Analysis and Fabrication on the
   Nanoscale
CY AUG 31-SEP 02, 2005
CL Univ Leeds, Leeds, ENGLAND
SP Elect Microscopy & Anal Grp, Nanoscale Phys & Technol Grp
HO Univ Leeds
AB Over the last decade techniques such as confocal. light microscopy, in combination with fluorescent labelling, have helped biologists and life scientists to study biological architectures at tissue and cell level in great detail. Meanwhile, obtaining information at very small length scales is possible with the combination of sample preparation techniques and transmission electron microscopy (TEM) or scanning transmission electron microscopy (STEM). Scanning electron microscopy (SEM) is well known for the determination of surface characteristics and morphology. However, the desire to understand the three dimensional relationships of meso-scale hierarchies has led to the development of advanced microscopy techniques, to give a further complementary approach. A focused ion beam (FIB) can be used as a nano-scalpel and hence allows us to reveal internal microstructure in a site-specific manner. Whilst FIB instruments have been used to study and verify the three-dimensional architecture of man made materials, SEM and FIB technologies have now been brought together in a single instrument representing a powerful combination for the study of biological specimens and soft materials. We demonstrate the use of FIB SEM to study three-dimensional relationships for a range of length scales and materials, from small-scale cellular structures to the larger scale interactions between biomedical materials and tissues. FIB cutting of heterogeneous mixtures of hard and soft materials, resulting in a uniform cross-section, has proved to be of particular value since classical preparation methods tend to introduce artefacts. Furthermore, by appropriate selection, we can sequentially cross-section to create a series of,slices' at specific intervals. 3D reconstruction software can then be used to volume-render information from the 2D slices, enabling us to immediately see the spatial relationships between microstructural components.
C1 [Stokes, D. J.] Univ Cambridge, Cavendish Lab, Dept Phys, Madingley Rd, Cambridge CB3 0HE, England.
   [Morrissey, F.] FEI Co, Aztec Ctr Bristol, Bristol BS32 4TD, Avon, England.
   [Lich, B. H.] FEI Co, Eindhoven, Netherlands.
RP Stokes, DJ (reprint author), Univ Cambridge, Cavendish Lab, Dept Phys, Madingley Rd, Cambridge CB3 0HE, England.
EM djs49@phy.cam.ac.uk
CR MORRISSEY F, 2005, MICROSC MICROANAL S1, V11, P775
   STOKES DJ, UNPUB
NR 2
TC 29
Z9 29
U1 0
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2006
VL 26
BP 50
EP +
DI 10.1088/1742-6596/26/1/012
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BEM04
UT WOS:000238090200012
OA Bronze
DA 2018-10-20
ER

PT S
AU Toh, SL
   Teh, TKH
   Vallaya, S
   Goh, JCH
AF Toh, S. L.
   Teh, T. K. H.
   Vallaya, S.
   Goh, J. C. H.
BE Lee, SB
   Kim, YJ
TI Novel silk scaffolds for ligament tissue engineering applications
SO EXPERIMENTAL MECHANICS IN NANO AND BIOTECHNOLOGY, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Experimental Mechanics (ICEM 2006)/5th Asian
   Conference on Experimental Mechanics (ACEM5)
CY SEP 26-26, 2006
CL Cheju Isl, SOUTH KOREA
SP Korea Adv Inst Sci & Technol, Asian Comm Expt Mech
DE ligament reconstruction; tissue engineering; knitted silk scaffold;
   nanofibers
ID MARROW STROMAL CELLS; BIOMATERIALS; SUTURES
AB Scaffold technology is integral in advancing tissue engineering and one of the tissues of interest here is the tendon/ligament. Advancement in the tissue engineering of tendon/ligament has become very much a materials engineering problem than ever, with the selection of appropriate biomaterial and scaffold architecture. Such is the key to successful tendon/ligament tissue regeneration construct. Popular materials used in recent years include various poly (1-lactic) biomaterials and collagen. However, shortcomings of these materials, in terms of poor mechanical strength or short degradation period, are yet overcome. Bombyx mori silk, though used in biomedical sutures for decades due to its excellent mechanical properties, has been overlooked for applications in ligament tissue engineering, only until recently. This is largely due to previous misconceptions in its biocompatibility and biodegradability characteristics. This paper describes the use of a silk-based scaffold with knitted architecture and investigates its strengths as compared to previous PLGA-based knitted scaffolds. An electrospun nanofiber surface on knitted microfiber architecture is adopted and it is found to have better composite-material integrity, in vitro degradation resistance, and encourages cell adhesion and proliferation.
C1 [Toh, S. L.; Teh, T. K. H.; Goh, J. C. H.] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
   [Goh, J. C. H.] Natl Univ Singapore, Dept Orthopaed Surg, Singapore 117548, Singapore.
   [Toh, S. L.] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
   [Vallaya, S.] Mahasarakaham Univ, Bangkok, Thailand.
RP Toh, SL (reprint author), Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
EM bietohsl@nus.edu.sg; khteh@nus.edu.sg; svallaya@gmail.com;
   dosgohj@nus.edu.sg
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BELL E, 1995, TISSUE ENG, P63
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   LAURENCIN CT, 2005, LIGAMENT TISSUE ENG
   Miyasaka KC, 1991, AM J KNEE SURG, V4, P3
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   SILVER FH, 1991, J LONG-TERM EFF MED, P35
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
NR 12
TC 7
Z9 7
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-415-4
J9 KEY ENG MATER
PY 2006
VL 326-328
BP 727
EP +
DI 10.4028/www.scientific.net/KEM.326-328.727
PN 1-2
PG 2
WC Biotechnology & Applied Microbiology; Engineering, Mechanical;
   Nanoscience & Nanotechnology; Materials Science, Ceramics; Materials
   Science, Multidisciplinary; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics; Materials Science
GA BFO49
UT WOS:000243448200178
DA 2018-10-20
ER

PT S
AU Yesin, KB
   Vollmers, K
   Nelson, BJ
AF Yesin, KB
   Vollmers, K
   Nelson, BJ
BE Ang, MH
   Khatib, O
TI Actuation, sensing, and fabrication for in vivo magnetic microrobots
SO EXPERIMENTAL ROBOTICS IX
SE Springer Tracts in Advanced Robotics
LA English
DT Proceedings Paper
CT 9th International Symposium on Experimental Robotics (ISER)
CY JUN 18-21, 2004
CL Singapore, SINGAPORE
ID RHEOLOGY
AB This paper investigates some of the fundamental design issues related to untethered biomedical microrobots guided inside the human body through external magnetic fields. Immediate application areas for these microrobots include cardiovascular, intraocular and inner-ear diagnosis and surgery. Issues investigated include the effects of magnetic actuation forces and viscous drag forces faced by magnetic microrobots, fabrication of MEMS devices with integrated hard magnetic materials and position sensing of the microrobot for intraocular applications. A new active defocused tracking method is proposed for visually servoing the microrobot in 3D using only a single microscope view.
C1 Swiss Fed Inst Technol, Inst Robot & Intelligent Syst, Zurich, Switzerland.
RP Yesin, KB (reprint author), Swiss Fed Inst Technol, Inst Robot & Intelligent Syst, Zurich, Switzerland.
EM yesin@iris.mavt.ethz.ch; karl.vollmers@iris.mavt.ethz.ch;
   brad.nelson@iris.mavt.ethz.ch
RI Nelson, Bradley/B-7761-2013
OI Nelson, Bradley/0000-0001-9070-6987
CR ALLEGRO S, 1996, IEEE INT C IM PROC, V1, P677
   Amblard F, 1996, REV SCI INSTRUM, V67, P818, DOI 10.1063/1.1146816
   CHIRILLA TV, 1998, HDB BIOMATERIAL PROP
   DESPOPOULOS A, 1991, COLOR ATLAS PHYSL, P156
   Haber C, 2000, REV SCI INSTRUM, V71, P4561, DOI 10.1063/1.1326056
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   HOLLIGAN DL, 2003, IOP NANOTECHNOLOGY, V14, P661
   Jin J., 1999, ELECTROMAGNETIC ANAL
   LEE B, 1992, BIORHEOLOGY, V29, P521
   LEE B, 1992, THESIS U PENNSYLVANI
   MATHIEU J, 2003, IEEE CCECE C EL COMP, P835
   Nayar SK, 1996, IEEE T PATTERN ANAL, V18, P1186, DOI 10.1109/34.546256
   Sendoh M., 2000, P 2000 INT S MICR HU, P65
   VICCI L, 2001, TR01031 DEP COMP SCI
   Vikramaditya B, 1997, IEEE INT CONF ROBOT, P3172, DOI 10.1109/ROBOT.1997.606771
   VOLLMERS K, 2003, IEEE INT C MEMS MEMS, P60
   YESIN KB, 2004, IEEE INT C ROB AUT
   ZHOROWSKI M, 1997, SCI CLIN APPL MAGNET, P205
NR 18
TC 4
Z9 4
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1610-7438
BN 3-540-28816-3
J9 SPRINGER TRAC ADV RO
PY 2006
VL 21
BP 321
EP +
PG 2
WC Robotics
SC Robotics
GA BED74
UT WOS:000236887500031
DA 2018-10-20
ER

PT S
AU Lopez, CP
   Santoyo, FM
   Zamarripa, RG
   Mendez, CC
AF Lopez, CP
   Santoyo, FM
   Zamarripa, RG
   Mendez, CC
BE Rosas, E
   Cardoso, R
   Bermudez, JC
   BarbosaGarcia, O
TI Measurements of mechanical deformation using a full field optical
   interferometry and a fast camera
SO FIFTH SYMPOSIUM OPTICS IN INDUSTRY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 5th Symposium Optics in Industry
CY SEP 08-09, 2005
CL Santiago Queretaro, MEXICO
SP CENAM, Acad Mexicana Opt, SMF Div Opt, SPIE Mexico Chapter
DE ESPI interferometry; high speed camera
ID SPECKLE PATTERN INTERFEROMETRY
AB Full field optical interferometry known as ESPI (Electronic Speckle Pattern Interferometry), has been applied to dynamical deformations on solid and semisolid objects. Although microscopic (I to 30 micrometers), these deformations offer enough information to know even an early crack detection of the material. In industrial and biomedical environments however there is a lot of noise bigger than the signal we try to recovery, therefore is necessary to compensate mechanical or digitally or both. In this paper we will discuss the basic operating principle of the interferometer and analyze its performance. The technique use a continue wave laser for illuminating the tested object. The transient event is recorded by an ultra fast digital image camera. Data processing is completed with a help of a spatio-temporal algorithm. Some results are presented.
C1 Ctr Invest Opt AC, Loma Bosque 115, Leon 37150, Guanajuato, Mexico.
RP Lopez, CP (reprint author), Ctr Invest Opt AC, Loma Bosque 115, Leon 37150, Guanajuato, Mexico.
OI Mendoza-Santoyo, fernando/0000-0002-4596-3316
FU Consejo Nacional de Ciencia y Tecnologia [48177]
FX The authors thank the Consejo Nacional de Ciencia y Tecnologia for
   supporting this research under project 48177.
CR AGUANNO MV, 2004, 12 INT C EXPT MECH B
   COOKSON TJ, 1978, OPT LASER TECHNOL, V10, P119, DOI 10.1016/0030-3992(78)90057-9
   Fernandez A, 1997, APPL OPTICS, V36, P2058, DOI 10.1364/AO.36.002058
   Jones R., 1989, HOLOGRAPHIC SPECKLE
   Ma CC, 2001, EXP MECH, V41, P8, DOI 10.1007/BF02323099
   Moore AJ, 1999, APPL OPTICS, V38, P1159, DOI 10.1364/AO.38.001159
NR 6
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6078-8
J9 PROC SPIE
PY 2006
VL 6046
AR 60461W
DI 10.1117/12.674603
PG 5
WC Optics
SC Optics
GA BEB16
UT WOS:000236544400068
DA 2018-10-20
ER

PT S
AU Xu, XX
   Zheng, YF
AF Xu, X. X.
   Zheng, Y. F.
BE Aliabadi, MH
   Li, Q
   Li, L
   Buchholz, FG
TI Synthesis and characterization of magnetic nanoparticles and their
   reinforcement in polyurethane film
SO FRACTURE AND DAMAGE MECHANICS V, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th International Conference on Fracture and Damage Mechanics
CY SEP 13-15, 2006
CL Harbin, PEOPLES R CHINA
SP Harbin Engn Univ
DE magnetite nanoparticles; synthesis; PU composite films
AB Magnetic nanoparticles have attracted intensive attention for their wide applications as biomaterials and magnetic storage materials. Polyurethane is one of the most biocompatible polymers and has been used widely in vivo. In this paper, the magnetite nanoparticles were synthesized by chemical precipitation under different conditions. The as-prepared samples were characterized by X-ray diffraction and transmission electron microscopy, and their magnetic properties were evaluated on a vibrating sample magnetometer. Then the magnetite nanoparticles with different amounts were doped into polyurethane directly and composite films were made. Reinforced by the inorganic particles, PU composite films were also characterized by Fourier transform infrared spectra and mechanical tests., and the surface morphology of the composite film was observed by Atomic Force Microscope The results showed the composite material was reinforced by magnetic nanoparticles and also showed magnetic behavior. This kind of composite materials have the potential to be used as hyperthermia treatment in biomedical field, like coatings on cardiovascular stents.
C1 [Xu, X. X.; Zheng, Y. F.] Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
   [Zheng, Y. F.] Peking Univ, Engn Coll, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
RP Xu, XX (reprint author), Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
EM xuxiaoxue99731@163.com; yfzheng@pku.edu.cn
OI Zheng, Y.F./0000-0002-7402-9979
FU Harbin Science Research Foundation [6212.]
FX This work was supported by Harbin Science Research Foundation Project
   No. 6212.
CR Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   Predoi D, 2003, J OPTOELECTRON ADV M, V5, P211
   Qu SC, 1999, J COLLOID INTERF SCI, V215, P190, DOI 10.1006/jcis.1999.6185
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Tang ZG, 2000, COLLOID SURFACE B, V19, P19, DOI 10.1016/S0927-7765(00)00134-X
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   WOEDTKE T, 2003, BIOS BIOEL, V19, P269
   YOULING Y, 2004, COLLOID SURFACE B, V35, P1
NR 9
TC 4
Z9 5
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2006
VL 324-325
BP 659
EP +
DI 10.4028/www.scientific.net/KEM.324-325.659
PN 1-2
PG 2
WC Materials Science, Ceramics; Mechanics; Materials Science, Composites
SC Materials Science; Mechanics
GA BFN88
UT WOS:000243377000162
DA 2018-10-20
ER

PT J
AU Barlow-Stewart, K
   Yeo, SS
   Meiser, B
   Goldstein, D
   Tucker, K
   Eisenbruch, M
AF Barlow-Stewart, K
   Yeo, SS
   Meiser, B
   Goldstein, D
   Tucker, K
   Eisenbruch, M
TI Toward cultural competence in cancer genetic counseling and genetics
   education: Lessons learned from Chinese-Australians
SO GENETICS IN MEDICINE
LA English
DT Article
DE kinship; Chinese culture; family history; cultural competence; cancer
   genetics; genetic counseling; genetics education
ID FOLLOW-UP CARE; INHERITED PREDISPOSITION; OVARIAN-CANCER;
   RECOMMENDATIONS; BREAST; BRCA2; RISK; COMMUNICATION; INDIVIDUALS;
   MUTATIONS
AB Purpose: In societies such as Australia with a strong multicultural makeup, culturally determined attitudes to genetics, testing, and counseling may be, incompatible with current genetics service provision. Methods: An ethnographic investigation using purposive sampling to increase subject diversity was used to explore the range of beliefs about kinship and inheritance using Chinese-Australians as a case. Participants comprised a sample of 15 Chinese-Australians who had been recruited through several community-based organizations. Results: The level of acculturation does not correlate with holding beliefs about inheritance, kinship, and causes of hereditary cancer that are based on "Western" biomedical or traditional concepts. Mismatch between beliefs may exist within families that can impact participation in cancer genetic testing. Family history taking that underpins the surveillance, management, and referral to genetic counseling where there is a strong family history of breast, ovarian, or colorectal cancer can also be impacted unless recognition is made of the patrilineal concept of kinship prevalent in this Chinese-Australian community. Conclusion: This community-based study confirmed and validated views and beliefs on inheritance and kinship and inherited cancer attributed to senior family members by Chinese-Australians who attended cancer genetic counseling. Barriers to communication can occur where there may be incompatibility within the family between "Western" and traditional beliefs. The findings were used to develop strategies for culturally competent cancer genetic counseling with Australian-Chinese patients. These include nonjudgmental incorporation of their belief systems into the genetic counseling process and avoidance of stereotyping. They have also influenced the development of genetics education materials to optimize family history taking.
C1 Royal N Shore Hosp, Ctr Genet Educ, St Leonards, NSW 2065, Australia.
   Univ New S Wales, Ctr Culture & Hlth, Kensington, NSW 2033, Australia.
   Prince Wales Hosp, Dept Med Oncol, Randwick, NSW 2031, Australia.
   Univ New S Wales, Sch Psychiat, Kensington, NSW 2033, Australia.
   Univ New S Wales, Prince Wales Clin Sch, Kensington, NSW 2033, Australia.
   Univ Victoria, Inst Hlth & Divers, Victoria, BC V8W 2Y2, Canada.
RP Barlow-Stewart, K (reprint author), Royal N Shore Hosp, Ctr Genet Educ, Ctr Genet Educ Bldg 36, St Leonards, NSW 2065, Australia.
CR Atkin K, 2003, ETHNIC HEALTH, V8, P91, DOI 10.1080/1355785032000123159
   *AUSTR CANC NETW, 2002, FAM ASP BOW CANC GUI
   *AUSTR CANC NETW, 1999, GUID FAM ASP CANC
   BARLOWSTEWART K, 2003, IMPORTANCE FAMILY HL
   BARLOWSTEWART K, 2003, IMPORTANCE YOUR FAMI
   Baty BJ, 2003, AM J MED GENET A, V118A, P146, DOI 10.1002/ajmg.a.10150
   Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997
   Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915
   Chen WT, 2004, CANCER NURS, V27, P407
   Eisenbruch M, 2004, SOC SCI MED, V59, P235, DOI 10.1016/j.socscimed.2003.10.016
   EISENBRUCH M, 2004, UNESCO AS PAC REG TR, P1
   Eisinger F, 1998, ANN ONCOL, V9, P939, DOI 10.1023/A:1008389021382
   Forrest K, 2003, CLIN GENET, V64, P317, DOI 10.1034/j.1399-0004.2003.00142.x
   Genao I, 2003, AM J MED SCI, V326, P136, DOI 10.1097/00000441-200309000-00006
   Glanz K, 1999, CANCER EPIDEM BIOMAR, V8, P329
   Honda K, 2003, CLIN GENET, V64, P131, DOI 10.1034/j.1399-0004.2003.00112.x
   Leung K., 1996, HDB CHINESE PSYCHOL, P247
   Lewis Linwood J, 2002, J Genet Couns, V11, P193, DOI 10.1023/A:1015279123108
   Meiser B, 2001, J MED GENET, V38, P425, DOI 10.1136/jmg.38.7.425
   Miles MB, 1994, QUALITATIVE DATA ANA
   MING Z, 2001, MED CLASSIC YELLOW E
   *NAT BREAST CANC C, 2000, CURR BEST ADV FAM AS
   *NAT CTR CULT COMP, 2003, CULT COMP FACT SHEET
   PATTON MQ, 1990, QUALITATIVE EVALUATI
   Peters J. A., 2001, J GENET COUNS, V10, P133, DOI 10.1023/A:1009491714527
   Phillips KA, 2000, CLIN GENET, V57, P376, DOI 10.1034/j.1399-0004.2000.570508.x
   Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787
   Rissel C, 1998, Ethn Health, V3, P213
   Singer E, 2004, GENET TEST, V8, P31, DOI 10.1089/109065704323016012
   Spradley JP, 1979, ETHNOGRAPHIC INTERVI
   Thompson HS, 2002, CANCER EPIDEM BIOMAR, V11, P1579
   United States Department of Health & Human Services, 2004, US SURG GEN FAM HIST
   WALTER A, 1990, GETTING HEIR
   Wang Vivian, 1992, J Genet Couns, V1, P81, DOI 10.1007/BF00960087
   Wang VO, 2001, AM J MED GENET, V106, P208
   Weil J, 2001, CLIN GENET, V59, P143, DOI 10.1034/j.1399-0004.2001.590301.x
   Wonderling D, 2001, BRIT J CANCER, V85, P166, DOI 10.1054/bjoc.2001.1893
   Wong-Kim Evaon, 2003, Cancer Control, V10, P22
   Yeo SS, 2005, PSYCHO-ONCOLOGY, V14, P174, DOI 10.1002/pon.831
NR 39
TC 39
Z9 39
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 1098-3600
J9 GENET MED
JI Genet. Med.
PD JAN
PY 2006
VL 8
IS 1
BP 24
EP 32
DI 10.1097/01.gim.0000195884.86201.a0
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 005VA
UT WOS:000234850900004
PM 16418596
OA Bronze
DA 2018-10-20
ER

PT J
AU Albrecht, MA
   Evans, CW
   Raston, CL
AF Albrecht, MA
   Evans, CW
   Raston, CL
TI Green chemistry and the health implications of nanoparticles
SO GREEN CHEMISTRY
LA English
DT Review
ID WALL CARBON NANOTUBES; SEMICONDUCTOR QUANTUM DOTS; ULTRAFINE PARTICLES;
   INTRATRACHEAL INSTILLATION; BIOMEDICAL APPLICATIONS; GOLD NANOPARTICLES;
   PULMONARY TOXICITY; TITANIUM-DIOXIDE; OXIDATIVE STRESS; BORON-NITRIDE
AB Until recently the spectacular developments in nanotechnology have been with little regard to their potential effect on human health and the environment. There are no specific regulations on nanoparticles except existing regulations covering the same material in bulk form. Difficulties abound in devising such regulations, beyond self-imposed regulations by responsible companies, because of the likelihood of different properties exhibited by any one type of nanoparticle, which are tuneable by changing their size, shape and surface characteristics. Green chemistry metrics need to be incorporated into nanotechnologies at the source. This review scopes this issue in the context of potential health effects of nanoparticles, along with medical applications of nanoparticles including imaging, drug delivery, disinfection, and tissue repair. Nanoparticles can enter the human body through the lungs, the intestinal tract, and to a lesser extent the skin, and are likely to be a health issue, although the extent of effects on health are inconclusive. Nanoparticles can be modified to cross the brain blood barrier for medical applications, but this suggests other synthetic nanoparticles may unintentionally cross this barrier.
C1 Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley 6009, Australia.
RP Raston, CL (reprint author), Univ Western Australia, Sch Biomed Biomol & Chem Sci, M313, Crawley 6009, Australia.
EM clraston@chem.uwa.edu.au
RI Raston, Colin/G-1971-2012; Albrecht, Matthew/A-7474-2012
OI Albrecht, Matthew/0000-0002-6540-5979; Evans,
   Cameron/0000-0003-2312-9803
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Alyautdin RN, 1997, PHARMACEUT RES, V14, P325, DOI 10.1023/A:1012098005098
   Anastas P. T., 1998, GREEN CHEM THEORY PR
   Anastas PT, 2003, GREEN CHEM, V5, pG29, DOI 10.1039/b211620k
   [Anonymous], 2004, NEW SCI, V184, P17
   Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje
   Bogunia-Kubik K, 2002, BIOSYSTEMS, V65, P123, DOI 10.1016/S0303-2647(02)00010-2
   Carbon Nanotechnologies Incorporated, BUCK PROP US
   CHEN W, 2002, R829606 EPA
   CHOI CQ, 1995, SCI AM, P292
   CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966
   Churg A, 1998, AM J PHYSIOL-LUNG C, V274, pL81, DOI 10.1152/ajplung.1998.274.1.L81
   Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093
   Cousins BG, 2004, J MATER SCI-MATER M, V15, P355, DOI 10.1023/B:JMSM.0000021101.64938.b3
   Crichton M., 2002, PREY
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   DAVIES P, 2004, MANAGING RISKS NANOT
   *DEP PREM CAB, 2003, HOP FUT W AUSTR STAT
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   DIALLO MS, 2002, R829626 EPA
   Donaldson K, 2004, COMMUN ACM, V47, P113, DOI 10.1145/1029496.1029518
   Donaldson K, 2004, MUTAT RES-FUND MOL M, V553, P5, DOI 10.1016/j.mrfmmm.2004.06.011
   Donaldson K, 2002, J AEROSOL MED, V15, P213, DOI 10.1089/089426802320282338
   Donaldson K, 1996, TOXICOL LETT, V88, P293, DOI 10.1016/0378-4274(96)03752-6
   Dowling A, 2005, NEW SCI, V185, P19
   Dowling AP, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00628-5
   Dreher KL, 2004, TOXICOL SCI, V77, P3, DOI 10.1093/toxsci/kfh041
   DREXLER KE, 1986, ENGINES CREATION COM
   *ENV PROT AG NAT C, 2003, ENV TOOLS FUT TOD NA
   *ETC GROUP, 2004, NAN UNPR UNR
   *EUR COM, 2003, NAN QUAL SKIN BARR U
   European Commission, 2004, NAN PREL RISK AN BAS
   Eyles JE, 2003, J CONTROL RELEASE, V86, P25, DOI 10.1016/S0168-3659(02)00296-1
   Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X
   Fortner JD, 2005, ENVIRON SCI TECHNOL, V39, P4307, DOI 10.1021/es0498099n
   FREITAS RA, 2003, NANOMEDICINE A, V2
   Giles J, 2004, NATURE, V429, P591, DOI 10.1038/429591b
   Goho A., 2003, SCI NEWS, V164, P381
   GOHO A, 2005, SCI NEWS, V167, P266
   Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i
   GRAHAMROWE D, 2005, NEW SCI         0307
   *GREEN CHEM I ACS, 2005, GLOSS GREEN CHEM TER
   Green M, 2005, CHEM COMMUN, P121, DOI 10.1039/b413175d
   *GREENP UK, 2003, FUT TECHN TOD CHOIC
   Gupta AK, 2005, BIOMATERIALS, V26, P1565, DOI 10.1016/j.biomaterials.2004.05.022
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   Hargroves K. J, 2005, NATURAL ADVANTAGE NA
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hassan MHA, 2005, SCIENCE, V309, P65, DOI 10.1126/science.1111138
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hoet P.H, 2004, J NANOBIOTECHNOL, V2
   Hoet PHM, 2004, NAT BIOTECHNOL, V22, P19, DOI 10.1038/nbt0104-19
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Jia X, 2005, LIFE SCI, V76, P1989, DOI 10.1016/j.lfs.2004.09.026
   JOY B, 2000, WHY FUTURE DOESNT NE
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kazan-Allen L, 2005, LUNG CANCER-J IASLC, V49, pS3, DOI 10.1016/j.lungcan.2005.03.002
   Kertesz Z, 2005, NUCL INSTRUM METH B, V231, P280, DOI 10.1016/j.nimb.2005.01.071
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Kleiner K, 2003, NEW SCI, V177, P14
   Kloepfer JA, 2003, APPL ENVIRON MICROB, V69, P4205, DOI 10.1128/AEM.69.7.4205-4213.2003
   *KRAFT, 2005, ATOMWORKS
   Kreuter J, 2003, PHARMACEUT RES, V20, P409, DOI 10.1023/A:1022604120952
   Kuhn KP, 2003, CHEMOSPHERE, V53, P71, DOI 10.1016/S0045-6535(03)00362-X
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Liu SQ, 2004, COLLOID SURFACE B, V36, P155, DOI 10.1016/j.colsurfb.2004.03.020
   Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4333, DOI 10.1002/anie.200501089
   Lok C, 2004, TECHNOL REV, V107, P81
   Lucas EM, 1999, NANOSTRUCT MATER, V12, P179, DOI 10.1016/S0965-9773(99)00093-8
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   MARK D, 2004, P 1 INT S OCC HLTH I
   Masciangioli T, 2003, ENVIRON SCI TECHNOL, V37, p102A, DOI 10.1021/es0323998
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   Monti D, 2000, BIOCHEM BIOPH RES CO, V277, P711, DOI 10.1006/bbrc.2000.3715
   Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Murr LE, 2004, J MATER SCI-MATER M, V15, P237, DOI 10.1023/B:JMSM.0000015483.06136.68
   Nagaveni K, 2004, ENVIRON SCI TECHNOL, V38, P1600, DOI 10.1021/es034696i
   *NAN INV, 2005, TECHNOL REV, V108, P20
   *NUTR LTD, 2005, ISR LIF SCI IND
   O'Connor M, 2004, ANALYST, V129, P1176, DOI 10.1039/b412805b
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   *OILFRESH CORP, 2005, OILFRESH 1000 ANT CA
   Ozkar S, 2005, J AM CHEM SOC, V127, P4800, DOI 10.1021/ja0437813
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   PEASE R, 2005, BBC NEWS        0622
   Peters A, 2001, CIRCULATION, V103, P2810
   Phoenix C, 2004, NANOTECHNOLOGY, V15, P869, DOI 10.1088/0957-4484/15/8/001
   Poole Jr C. P., 2003, INTRO NANOTECHNOLOGY
   Rancan F, 2002, J PHOTOCH PHOTOBIO B, V67, P157, DOI 10.1016/S1011-1344(02)00320-2
   RAO SS, 2005, TELEMAT INFORM, V22, P361, DOI DOI 10.1016/J.TELE.2005.01.007
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Royal Society and Royal Academy of Engineers, 2004, NAN NAN OPP UNC
   Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c
   Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586
   Schulz J, 2002, ADV DRUG DELIVER REV, V54, pS157, DOI 10.1016/S0169-409X(02)00120-5
   Seaton A, 2005, LANCET, V365, P923, DOI 10.1016/S0140-6736(05)71061-8
   Sebastian PJ, 2005, SOL ENERG MAT SOL C, V88, P129, DOI 10.1016/j.solmat.2004.12.001
   Service RF, 2000, SCIENCE, V290, P1526, DOI 10.1126/science.290.5496.1526
   Service RF, 2003, SCIENCE, V300, P243
   Sharma S, 2004, BIOSENS BIOELECTRON, V20, P227, DOI 10.1016/j.bios.2004.01.034
   Shiohara A, 2004, MICROBIOL IMMUNOL, V48, P669, DOI 10.1111/j.1348-0421.2004.tb03478.x
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Somorjai GA, 2001, APPL CATAL A-GEN, V222, P3, DOI 10.1016/S0926-860X(01)00825-0
   Stix G, 2003, SCI AM, V288, P28, DOI 10.1038/scientificamerican0203-28
   STIX G, 2004, SCI AM, P290
   TALBOT S, 2005, EVIDENT TECHNOLOGIES, P1
   Tinkle SS, 2003, ENVIRON HEALTH PERSP, V111, P1202, DOI 10.1289/ehp.5999
   United Nations, 1987, OUR COMM FUT REP WOR
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Wang CB, 1997, ENVIRON SCI TECHNOL, V31, P2154, DOI 10.1021/es970039c
   Wang IC, 1999, J MED CHEM, V42, P4614, DOI 10.1021/jm990144s
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   WAYT WW, 1999, SCI AM, P281
   Yang XL, 2002, TOXICOL IN VITRO, V16, P41, DOI 10.1016/S0887-2333(01)00102-3
   Yu JC, 2005, ENVIRON SCI TECHNOL, V39, P1175, DOI 10.1021/es035374h
   Zhang QW, 2003, J OCCUP HEALTH, V45, P23, DOI 10.1539/joh.45.23
   Zhang WX, 1998, CATAL TODAY, V40, P387, DOI 10.1016/S0920-5861(98)00067-4
   Zhang Y, 1998, SCIENCE, V281, P973, DOI 10.1126/science.281.5379.973
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
   ZINK J, 2002, U S FLORIDA MAGAZINE
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   2003, NEW SCI, V178, P3
   2003, MAT TODAY, V6, P6
   2003, CHEM ENG NEWS   0811
NR 144
TC 267
Z9 273
U1 4
U2 89
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
EI 1463-9270
J9 GREEN CHEM
JI Green Chem.
PY 2006
VL 8
IS 5
BP 417
EP 432
DI 10.1039/b517131h
PG 16
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 039QR
UT WOS:000237321800007
DA 2018-10-20
ER

PT S
AU Niemeyer, TC
   Grandini, CR
   Schneider, SG
AF Niemeyer, T. C.
   Grandini, C. R.
   Schneider, S. G.
BE Igata, N
   Takeuchi, S
TI Low-frequency high-temperature internal friction in Ti-13Nb-13Zr alloy
SO HIGH DAMPING MATERIALS II
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on High Damping Materials
CY SEP 09-10, 2005
CL Kyoto, JAPAN
SP Japan Soc Promot Sci, Kajima Fdn, Ogasawara Fdn, Suzuki Fdn
DE Ti alloys; internal friction; high damping; anelasticity
ID METAL-MATRIX COMPOSITES; TITANIUM-ALLOYS; MICROSTRUCTURE; BEHAVIOR;
   ELEMENTS; MODULUS
AB Recent studies have been done to achieve biomedical alloys containing non-toxic elements and presenting low elastic moduli. It has been reported that Ti-Nb-Zr alloys rich in beta phase, especially Ti-13Nb-13Zr, have potential characteristics for substituting conventional materials such as Ti-6Al-4V, stainless steel and Co alloys. The aim of this work is to study the internal friction (IF) of Ti-13Nb-13Zr (TNZ) alloy due to the importance of the absorption impacts in orthopedic applications. The internal friction of this alloy produced by are melting was measured using an inverted torsion pendulum with the free decay method. The measurements were performed from 77 to 700 K with heating rate of I K/min, in a vacuum better than 10(-5) mBar. The results show a relaxation structure at high temperature strongly dependent on microstructure of the material. Qualitative discussions are presented for the experimental results, and the possibility of using the TNZ as a high damping material is briefly mentioned.
C1 UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
   FAENQUIL, Dept Mat Engn, BR-12600970 Lorena, SP, Brazil.
RP Niemeyer, TC (reprint author), UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
EM niemeyer@fc.unesp.br; betog@fc.unesp.br; sandra@demar.faenquil.br
RI Niemeyer, Terlize/A-7995-2013; Schneider, Sandra/E-6087-2015; Grandini,
   Carlos Roberto/A-3790-2008
OI Niemeyer, Terlize/0000-0002-8887-8226; Grandini, Carlos
   Roberto/0000-0002-3336-309X
CR Davidson J.A., 1992, US Patent, Patent No. [4.169.597, 4169597]
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   KE TS, 1947, PHYS REV, V71, P533, DOI 10.1103/PhysRev.71.533
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S., 1980, EVALUATION BIOMATERI
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   ZHANG J, 1994, ACTA METALL MATER, V42, P395, DOI 10.1016/0956-7151(94)90495-2
   ZHANG J, 1993, J MATER SCI, V28, P835, DOI 10.1007/BF01151266
NR 13
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8707 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-406-5
J9 KEY ENG MAT
PY 2006
VL 319
BP 103
EP 108
DI 10.4028/www.scientific.net/KEM.319.103
PG 6
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BFE07
UT WOS:000241411000016
DA 2018-10-20
ER

PT S
AU Klumel, G
   Gridish, Y
   Szafranek, I
   Karni, Y
AF Klumel, G
   Gridish, Y
   Szafranek, I
   Karni, Y
BE Zediker, MS
TI Reliable high power diode lasers: thermo-mechanical fatigue aspects
SO HIGH-POWER DIODE LASER TECHNOLOGY AND APPLICATIONS IV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on High-Power Diode Laser Technology and Applications IV
CY JAN 23-25, 2006
CL San Jose, CA
SP SPIE
DE diode laser; repetitive cw operation; solders; fatigue; reliability
ID BARS; RELIABILITY
AB High power water-cooled diode lasers are finding increasing demand in biomedical, cosmetic and industrial applications, where repetitive cw (continuous wave) and pulsed cw operation modes are required. When operating in such modes, the lasers experience numerous complete thermal cycles between "cold" heat sink temperature and the "hot" temperature typical of thermally equilibrated cw operation. It is clearly demonstrated that the main failure mechanism directly linked to repetitive cw operation is thermo-mechanical fatigue of the solder joints adjacent to the laser bars, especially when "soft" solders are used. Analyses of the bonding interfaces were carried out using scanning electron microscopy. It was observed that intermetallic compounds, formed already during the bonding process, lead to the solders fatigue both on the p- and n-side of the laser bar. Fatigue failure of solder joints in repetitive cw operation reduces useful lifetime of the stacks to hundreds hours, in comparison with more than 10,000 hours lifetime typically demonstrated in commonly adopted non-stop cw reliability testing programs. It is shown, that proper selection of package materials and solders, careful design of fatigue sensitive parts and bum-in screening in the bard pulse operation mode allow considerable increase of lifetime and reliability, without compromising the device efficiency, optical power density and compactness.
C1 SCD Semicond Devices, POB 2250, IL-31021 Haifa, Israel.
RP Klumel, G (reprint author), SCD Semicond Devices, POB 2250, IL-31021 Haifa, Israel.
CR Behringer M, 2005, P SOC PHOTO-OPT INS, V5711, P12, DOI 10.1117/12.592398
   ENGELMAIER W, 1983, IEEE T COMPON HYBR, V6, P232, DOI 10.1109/TCHMT.1983.1136183
   Gerhardt A, 2004, APPL PHYS LETT, V84, P3525, DOI 10.1063/1.1739516
   HU JM, 1993, MICROCIRCUITS ELECT, V16, P1
   *ISO, 2003, 17526 ISO
   JAEGGI D, 2005, EUROPHOTONICS    AUG, P26
   Jellison J. E., 1979, GOLD INDIUM INTERMET
   SCHMITT A, 2005, EUROPHOTONICS    JUN, P28
   Scholz C, 2003, P SOC PHOTO-OPT INS, V4973, P60, DOI 10.1117/12.478370
   Shigley JE, 1986, MECH ENG DESIGN
   Treusch G, 2005, P SOC PHOTO-OPT INS, V5711, P132, DOI 10.1117/12.598256
   Wolff D, 2005, P SOC PHOTO-OPT INS, V5711, P66, DOI 10.1117/12.582666
NR 12
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6146-6
J9 PROC SPIE
PY 2006
VL 6104
AR 610402
DI 10.1117/12.644435
PG 12
WC Optics
SC Optics
GA BEE63
UT WOS:000236976000002
DA 2018-10-20
ER

PT S
AU Fujii, Y
AF Fujii, Y
BE Bally, GV
   Luo, Q
TI Biomedical measurement using the levitation mass method - art. no.
   60261K
SO ICO20: Biomedical Optics
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 20th Congress of the International-Commission-for-Optics
CY AUG 21-26, 2005
CL Changchun, PEOPLES R CHINA
SP Int Commiss Opt, Chinese Opt Soc, Changchun Inst Opt, Fine Mech & Phys, CAS, AFOSR Asia Off, Chinese Acad Engn, Chinese Acad Sci & Technol, European Opt Soc, IEEE LEOS, Natl Nat Sci Fdn China, Opt Soc Japan, Opt Soc Korea, Opt Soc Russia, Siberian, Opt Soc Amer, SPIE
DE mechanical properties; kinetic properties; impulse response; dynamic
   response; inertial force; optical interferometer; pneumatic linear
   bearing
ID FORCE-MOMENT SENSOR; TRANSDUCERS; OSCILLATION
AB The mechanical response of a palm of a human hand against impact force is accurately determined by means of a practical method, a variation of the Levitation Mass Method. In the method, a mass that is levitated with a pneumatic linear bearing, and hence encounters negligible friction, is made to collide with a material under test. During the collision the Doppler frequency shift of a laser beam reflecting from the mass is accurately measured using an optical interferometer. The velocity, position, acceleration and inertial force of the mass are calculated from the measured time-varying Doppler shift. The method is characterized by the fact that preparation of the test specimen is very easy, the testing time is very short and the measurement accuracy is very high. The possibility of using the method for biomedical engineering is discussed.
C1 Gunma Univ, Dept Elect Engn, Kiryu, Gumma 3768515, Japan.
RP Fujii, Y (reprint author), Gunma Univ, Dept Elect Engn, Kiryu, Gumma 3768515, Japan.
CR Bruns T, 2002, MEASUREMENT, V32, P85, DOI 10.1016/S0263-2241(01)00048-3
   Fujii Y, 2004, REV SCI INSTRUM, V75, P119, DOI 10.1063/1.1634363
   Fujii Y, 2003, MEAS SCI TECHNOL, V14, P1741, DOI 10.1088/0957-0233/14/10/301
   Fujii Y, 2003, MEAS SCI TECHNOL, V14, P1259, DOI 10.1088/0957-0233/14/8/310
   Fujii Y, 2003, REV SCI INSTRUM, V74, P3137, DOI 10.1063/1.1574396
   Fujii Y, 2002, OPT LASER ENG, V38, P305, DOI 10.1016/S0143-8166(01)00151-8
   Fujii Y, 2001, REV SCI INSTRUM, V72, P3108, DOI 10.1063/1.1376657
   FUJII Y, UNPUB J BIOMECHANICS
   FUJII Y, IN PRES MECH SYSTEMS
   GUEDES RM, IN PRESS J BIOMECHAN
   Kumme R., 1998, Measurement, V23, P239, DOI 10.1016/S0263-2241(98)00027-X
   Park YK, 2002, MEAS SCI TECHNOL, V13, P654, DOI 10.1088/0957-0233/13/5/302
   Park YK, 2002, MEAS SCI TECHNOL, V13, P1311, DOI 10.1088/0957-0233/13/8/320
   TREBACZ H, IN PRESS J BIOMECHAN
NR 14
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6057-5
J9 P SOC PHOTO-OPT INS
PY 2006
VL 6026
BP K261
EP K261
AR 60261K
DI 10.1117/12.667682
PG 7
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BDU00
UT WOS:000235332500056
DA 2018-10-20
ER

PT J
AU Wagner, M
   Zamelczyk-Pajewska, M
   Landes, C
   Sudhoff, H
   Kosmider, J
   Richards, T
   Krause, UM
   Stark, R
   Groh, A
   Weichert, F
   Linder, R
AF Wagner, M
   Zamelczyk-Pajewska, M
   Landes, C
   Sudhoff, H
   Kosmider, J
   Richards, T
   Krause, UM
   Stark, R
   Groh, A
   Weichert, F
   Linder, R
TI Simulating soft data to make soft data applicable to simulation
SO IN VIVO
LA English
DT Article
DE crisp data; non-crisp data; mathematical modelling; systems biology;
   simulating soft data
ID T-CELL RESPONSE; LYMPHOCYTE-RESPONSE; CLASSIFICATION; MODEL; SELECTION;
   RECOGNITION; IMMUNOLOGY; GENERATION; STIMULI; MEMORY
AB Background: Biomedical processes are often influenced by measures considered "non-crisp", "soft" or "subjective". Despite the growing awareness of the importance of such measures, they are rarely considered in biomedical simulation. This study introduces an input generator for soft data (input generator SD) that makes soft data applicable to simulation.
   Materials and Methods: Machine learning approaches and standard regression techniques were applied to simulate odour intensity ratings.
   Results: The performance of all the applied methods was satisfactory and the results can be used to modify systems biological mathematical models.
   Conclusion: Soft data should no longer be discounted in systems biological simulations. Exemplarily, it can be demonstrated that the input generator SD produces results that are similar to those that the simulated system can generate. Machine learning and/or appropriate conventional mathematical approaches may be applied to simulate non-crisp processes that can be used to modify mathematical models of any granularity.
C1 Univ Saarland, Dept Pathol, D-6650 Homburg, Germany.
   Tech Univ Szczecin, Air Odour Qual Lab, Inst Chem Engn & Proc Environm Protect, PL-71065 Szczecin, Poland.
   Goethe Univ Frankfurt, D-6000 Frankfurt, Germany.
   Ruhr Univ Bochum, Sch Med, St Elizabeth Hosp, Dept Otorhinolaryngol Head & Neck Surg, D-4630 Bochum, Germany.
   Univ W Indies, Sci Lib, Kingston 7, Jamaica.
   Univ Saarland, Inst Educ, D-6600 Saarbrucken, Germany.
   Univ Saarland, Inst Appl Math, D-6600 Saarbrucken, Germany.
   Univ Dortmund, Dept Comp Sci 7, Dortmund, Germany.
   Med Univ Lubeck, Inst Med Informat, D-23538 Lubeck, Germany.
RP Wagner, M (reprint author), Univ Klinikum Saarlandes, Inst Allgemeine & Spezielle Pathol, D-66421 Homburg, Germany.
EM trouth@gmx.net
RI Fachbereich14, Dekanat/C-8553-2015
CR Adler R H, 2004, Ther Umsch, V61, P728, DOI 10.1024/0040-5930.61.12.728
   Bocharov G, 2001, IMMUNOL CELL BIOL, V79, P74, DOI 10.1046/j.1440-1711.2001.00985.x
   BOX GEP, 1979, ROBUSTNESS STAT, P201, DOI DOI 10.1016/B978-0-12-438150-6.50018-2
   Chang CC, 2002, NEURAL COMPUT, V14, P1959, DOI 10.1162/089976602760128081
   Chao DL, 2004, J THEOR BIOL, V228, P227, DOI 10.1016/j.jtbi.2003.12.011
   Davenport MP, 2002, J IMMUNOL, V168, P3309, DOI 10.4049/jimmunol.168.7.3309
   De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001
   Demissie S, 2000, INT J NEUROSCI, V103, P79, DOI 10.3109/00207450009003254
   El-Naqa I, 2004, IEEE T MED IMAGING, V23, P1233, DOI 10.1109/TMI.2004.834601
   GELSEMA ES, 1989, METHOD INFORM MED, V28, P63
   GHANTA VK, 1987, J NEUROSCI RES, V18, P10, DOI 10.1002/jnr.490180105
   GHANTA VK, 1995, PHARMACOL BIOCHEM BE, V50, P399, DOI 10.1016/0091-3057(94)00286-R
   Hausotter W, 1996, Versicherungsmedizin, V48, P57
   Heisele B, 2003, PATTERN RECOGN, V36, P2007, DOI 10.1016/S0031-3203(03)00062-1
   Hiramoto RN, 1997, INT J NEUROSCI, V92, P259, DOI 10.3109/00207459708986405
   HIRAMOTO RN, 1993, PHARMACOL BIOCHEM BE, V44, P275, DOI 10.1016/0091-3057(93)90462-3
   JAIN AK, 1978, PATTERN RECOGN, V10, P365, DOI 10.1016/0031-3203(78)90008-0
   KANAL L, 1971, PATTERN RECOGN, V3, P225, DOI 10.1016/0031-3203(71)90013-6
   Linder R, 2002, IN VIVO, V16, P37
   LINDER R, 2001, LECT NOTES COMPUTER, V2199, P168
   Liu Huiqing, 2002, Genome Inform, V13, P51
   Morse JM, 2004, QUAL HEALTH RES, V14, P591, DOI 10.1177/1049732304263678
   NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269
   Salmon-Divon M, 2005, MOL IMMUNOL, V42, P397, DOI 10.1016/j.molimm.2004.07.018
   Salmon-Divon M, 2003, B MATH BIOL, V65, P199, DOI 10.1016/S0092-8240(02)00093-9
   Salmon-Divon Mali, 2003, Clin Dev Immunol, V10, P183, DOI 10.1080/10446670310001642140
   SOLVASON HB, 1991, INT J NEUROSCI, V61, P277, DOI 10.3109/00207459108990746
   SOSA MMC, 1996, ACTA PEDIAT MEX, V17, P8
   van Baalen CA, 2002, EUR J IMMUNOL, V32, P2644, DOI 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R
   WAGNER M, 1998, REV MED HOSP GEN, V61, P195
   Wodarz D, 2003, IMMUNOL LETT, V86, P213, DOI 10.1016/S0165-2478(03)00023-3
   Yates A, 2001, Brief Bioinform, V2, P245, DOI 10.1093/bib/2.3.245
   ZELLER C, 1979, SCHWEIZ MED WSCHR, V109, P773
NR 33
TC 0
Z9 0
U1 0
U2 3
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
EI 1791-7549
J9 IN VIVO
JI In Vivo
PD JAN-FEB
PY 2006
VL 20
IS 1
BP 49
EP 54
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 003FG
UT WOS:000234666500009
PM 16433028
DA 2018-10-20
ER

PT J
AU Ponsonnet, L
   Treheux, D
   Lissac, M
   Jaffrezic, N
   Grosgogeat, B
AF Ponsonnet, L.
   Treheux, D.
   Lissac, M.
   Jaffrezic, N.
   Grosgogeat, B.
TI Review of in vitro studies on the biocompatibility of NiTi alloys
SO INTERNATIONAL JOURNAL OF APPLIED ELECTROMAGNETICS AND MECHANICS
LA English
DT Article
DE corrosion; biocompatibility; alloys (NiTi); orthodontic wires
ID NICKEL-TITANIUM ALLOY; SHAPE-MEMORY ALLOY; CORROSION BEHAVIOR;
   ORTHODONTIC APPLIANCES; SURFACE; WIRES; RESISTANCE; BIODEGRADATION;
   FIBROBLASTS; ROUGHNESS
AB Nickel-Titanium (NiTi) alloys exhibit special mechanical properties known as shape memory effect and superelasticity. The first effect relates to the fact that after deformation at low temperature, the material regains its original shape after heating. The second effect denotes an unusual flexibility of the material that is far greater than the flexibility of common metallic materials. These properties can be put to excellent use in various biomedical applications, such as orthodontic wires, orthopaedic implants for osteosynthesis, stents for various applications, bone substitution materials and experimental systems for scoliosis correction. The purpose of the present review is to analyze in vitro NiTi biocompatibility compared to other titanium alloys. The problem of Ni's possible toxicity is discussed. Corrosion properties in an oral environment are investigated. The effect of surface chemical composition and surface roughness on cell adhesion, morphology and proliferation is shown as an example. Sterilization is taken into account and its influence on roughness and mechanical properties, chemical composition, wettability and bacterial adhesion inhibition is evaluated. The conclusion is that NiTi is at least as biocompatible as conventional titanium due to the TiO2 oxide layer, and that only in special chemical conditions can Ni diffuse out of the NiTi material.
C1 Ecole Cent Lyon, CEGELY, UMR 5005, F-69134 Ecully, France.
   Ecole Cent Lyon, LTDS, UMR 5513, F-69134 Ecully, France.
   UFR Odontol, LEIBO, EA 637, F-69008 Lyon, France.
RP Ponsonnet, L (reprint author), Ecole Cent Lyon, CEGELY, UMR 5005, F-69134 Ecully, France.
EM laurence.ponsonnet@ec-lyon.fr
CR Al-Waheidi E M, 1995, Quintessence Int, V26, P385
   ASSAD M, 1994, ANN CHIRURG, V48, P8
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BERTRAND AL, IN PRESS EUR CELLS M
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   Es-Souni M, 2001, BIOMATERIALS, V22, P2153, DOI 10.1016/S0142-9612(00)00406-3
   Heintz C, 2001, J ENDOVASC THER, V8, P248, DOI 10.1583/1545-1550(2001)008<0248:CNWIEA>2.0.CO;2
   Hunt NP, 1999, ANGLE ORTHOD, V69, P433
   Iijima M, 2001, Dent Mater J, V20, P103
   KERUSUO H, 1996, AM J ORTHOD DENTOFAC, V109, P148
   Kim JJ, 1999, HUM REPROD, V14, P45, DOI 10.1093/humrep/14.suppl_2.45
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   Kusy RP, 2000, CLIN ORTHOD RES, V3, P230
   Loreille Jean-Paul, 2002, Orthod Fr, V73, P71
   MUSTER D, 2000, ACTUALITES BIOMATERI, V5, P33
   Oshida Y, 1990, MATER SCI FORUM, V56, P705
   PERNIER C, IN PRESS EUR J ORTHO, V26
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Rose E C, 1998, J Orofac Orthop, V59, P253, DOI 10.1007/BF01321792
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 2000, MINIM INVASIV THER, V9, P99, DOI 10.3109/13645700009063056
   SARKAR NK, 1983, J ORAL REHABIL, V10, P121, DOI 10.1111/j.1365-2842.1983.tb00106.x
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   SH L, 2001, AM J ORTHOD DENTOFAC, V120, P654
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Staffolani N, 1999, J DENT, V27, P449, DOI 10.1016/S0300-5712(98)00073-6
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   TRIGWELL S, 1997, P 2 INT C SHAP MEM S, P383
   Venugopalan R, 2000, MINIM INVASIV THER, V9, P67, DOI 10.3109/13645700009063052
   Wen XJ, 1997, BIO-MED MATER ENG, V7, P1
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Widu F, 1999, J MATER SCI-MATER M, V10, P275, DOI 10.1023/A:1008953412622
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
NR 40
TC 11
Z9 11
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1383-5416
J9 INT J APPL ELECTROM
JI Int. J. Appl. Electromagn. Mech.
PY 2006
VL 23
IS 3-4
BP 147
EP 151
PG 5
WC Engineering, Electrical & Electronic; Mechanics; Physics, Applied
SC Engineering; Mechanics; Physics
GA 085KF
UT WOS:000240602300002
DA 2018-10-20
ER

PT J
AU Johnson, AT
AF Johnson, AT
TI The making of a new discipline
SO INTERNATIONAL JOURNAL OF ENGINEERING EDUCATION
LA English
DT Article
DE biological engineering; agricultural engineering; new discipline
AB The transformation of agricultural engineering into biological engineering is a larger change than meets the eye. First of all, agricultural engineering is an applications discipline, and biological engineering is a science-based discipline. Thus, the emphasis of the education must change from its specific uses to a more general utilization of biological systems. Second, any discipline must have a core set of technical materials and methods. In agricultural engineering, these were largely supplied by the Ferguson Foundation series of textbooks that were used very widely. A new, agreement must be reached about how to supply these for biological engineering. Third, biological engineering is not likely to evolve only from agricultural engineering. chemical engineering, and to some extent biomedical engineering, also has designs on the discipline. Fourth, although the goal of biological engineering has been fairly clear since the early 1970's, the steps to reach the goal are not obvious to those who are trying to form the new discipline. The prospects for the new discipline of biological engineering (ire great, but much work remains to be done.
C1 Univ Maryland, College Pk, MD 20742 USA.
RP Johnson, AT (reprint author), Univ Maryland, College Pk, MD 20742 USA.
EM ajohnso2@umd.edu
CR ALOCILJA EC, 2002, PRINCIPLES BIOSYSTEM
   [Anonymous], 2004, COMMUNICATION
   ARTHUR RM, 1970, AGR ENG, P151
   *ASAE, 1990, UND BIOL ENG CURR VI
   *ASEE, 2004, ASEE PRISM, V13, P20
   BIRD RB, 1960, TRANSPORT PHENOMENA
   BRONZINO JD, 1995, BIOMEDICAL ENG HDB, pR5
   Cundiff J. S., 2003, DYNAMICS BIOL SYSTEM
   Datta A. K., 2002, BIOL BIOENVIRONMENTA
   Fung Y., 1990, BIOMECHANICS MOTION
   Fung Y. C., 1981, BIOMECHANICS MECH PR
   FUNG YC, 1984, BIODYNAMICS CIRCULAT
   GARRETT RE, 1992, 90384115734 CSRS USD
   Geankoplis C. J., 1993, TRANSPORT PROCESSES
   HALFORD B, 2003, ASEE PRISM, V13, P34
   HAYNIE DT, 2001, BIOL THERMODYNAMICS
   IRWIN RW, 1988, 12681 U GUELPH ONT A
   Johnson A. T., 2003, European Journal of Engineering Education, V28, P37, DOI 10.1080/030437903000092243
   Johnson A. T., 1999, BIOL PROCESS ENG
   JOHNSON AT, 2002, AIMBE NEWSLETTER APR, P9
   Johnson AT., 1995, J ENG EDUC, V84, P311
   JOHNSON AT, 2004, BIOL ENG
   KLINE J, 1976, BIOL FDN BIOMEDICAL
   Linsenmeier RA, 2003, IEEE ENG MED BIOL, V22, P32, DOI 10.1109/MEMB.2003.1237489
   LOEWER OJ, 2003, ENCY AGR FOOD BIOL
   *NC STAT U, BRIEF HIST BIOL AGR
   OGILVIE J, 2001, COMMUNICATION   0711
   PILKINGTON TC, 1989, IEEE ENG MED BIOL, V8, P9, DOI 10.1109/51.35573
   ROHRBACH RD, 2004, COMMUNICATION
   SIMRALL HC, 1968, AGR ENG, V49, P584
   TOZEREN A, 2004, NEW BIOL ENG COMPUTE
   TRUSKY GA, 2004, TRANSPORT PHENOMENA
   VERMA BP, 2003, ENCY AGR FOOD BIOL E
   *WHIT FDN, 1998, ED GOALS BIOM ENG CU
NR 34
TC 3
Z9 3
U1 0
U2 2
PU TEMPUS PUBLICATIONS
PI DUBLIN
PA DUBLIN INST TECHNOLOGY, BOLTON ST, DUBLIN, IRELAND
SN 0949-149X
J9 INT J ENG EDUC
JI Int. J. Eng. Educ
PY 2006
VL 22
IS 1
BP 3
EP 8
PG 6
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA 012RJ
UT WOS:000235356600003
DA 2018-10-20
ER

PT J
AU King, PH
   Collins, JC
AF King, Paul H.
   Collins, Jerry C.
TI Ethical and professional training of biomedical engineers
SO INTERNATIONAL JOURNAL OF ENGINEERING EDUCATION
LA English
DT Article
DE ethics; biomedical engineering; technology; design; syllabus
AB Where once ethical concerns in biomedical engineering coursework involved primarily the effects of technology on medicine and health care distribution, several factors currently affect the presentation of ethical material to biomedical engineers. These include the maturation of the field as an ABET (Accreditation Board for Engineering and Technology) accreditable discipline, with the commitment for instruction in ethics and increasing student and faculty concerns over ethical misconduct relating to the profession. This paper reviews ethics instruction at Vanderbilt University, relating past history and current societal expectations to the current expression of ethical concerns in design and design seminars and in a specific course in ethics.
C1 Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
RP King, PH (reprint author), Vanderbilt Univ, Dept Biomed Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM paul.h.king@vanderbilt.edu
OI King, Paul/0000-0003-3363-8425
CR Bransford JD, 1999, PEOPLE LEARN BRAIN M
   Collins NH, 2001, CYTOTHERAPY, V3, P1, DOI 10.1080/146532401753156331
   Herkert J. R., 2002, BRIDGE, V32, P8
   HERKERT JR, 2002, BRIDGE, V32, P9
   KING PH, 2003, DESIGN BIOMEDICAL DE
   LAFOLLETTE MC, 1992, STEALING PRINT FRAUD, P13208
   Lambrecht B., 2001, DINNER NEW GENE CAFE
   *NAT COMM PROT HUM, 1979, BELM REP ETH PRINC G
   NIETZSCHE F, 1994, GENEALOGY MORALITY, P86
   OINSENMEIER RA, 2003, IEEE EMB MAGAZIN JUL, P32
   Schwartz DL, 1999, INSTRUCTIONAL-DESIGN THEORIES AND MODELS, VOL II, P183
   STEWART WW, 1987, NATURE, V325, P207, DOI 10.1038/325207a0
   Winner L, 1990, BROAD NARROW INTERPR, P53, DOI [10.1007/978-94-009-0557-3_6, DOI 10.1007/978-94-009-0557-3_6]
NR 13
TC 4
Z9 4
U1 0
U2 6
PU TEMPUS PUBLICATIONS
PI DUBLIN
PA DUBLIN INST TECHNOLOGY, BOLTON ST, DUBLIN, IRELAND
SN 0949-149X
J9 INT J ENG EDUC
JI Int. J. Eng. Educ
PY 2006
VL 22
IS 6
BP 1173
EP 1181
PG 9
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA 118RN
UT WOS:000242959500009
DA 2018-10-20
ER

PT J
AU Zhou, SA
   Uesaka, M
AF Zhou, SA
   Uesaka, M
TI Bioelectrodynamics in living organisms
SO INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE
LA English
DT Review
DE bioelectricity; bioelectrodynamics; biomechanics; biology; biomedicine
ID TRANSCRANIAL MAGNETIC STIMULATION; MONOCHROMATIC X-RAYS;
   ELECTROMAGNETIC-FIELDS; SYNCHROTRON-RADIATION; DIELECTRIC-PROPERTIES;
   PHOTODYNAMIC THERAPY; ICTALURUS-NEBULOSUS; ELECTRICAL-ACTIVITY; TISSUE
   INTERACTIONS; BIOLOGICAL TISSUES
AB This article introduces an interdisciplinary subject of bioelectrodynamics in living organisms and its related research challenges and opportunities. Bioelectrodynamics in living organisms is aimed to reveal critical roles of electromagnetism and mechanics in biology, to correlate biophysical functions of living organisms with biochemical processes at the cellular level, and to introduce theoretical basis and methodology, such as modeling and simulations, for stimulating technical innovations and promoting technology development in biomedicine as well as for the study of human healthcare issues related to environments among others in our modern society. The article reviews some important issues in bioelectrodynamic modeling. This includes the modeling of living cells, blood, bones and soft tissues that may have unique properties, such as active control, regulation and remodeling capabilities that are completely different from those of conventionally man-made materials. Possible biological effects and potential biomedical usages of endogenous and exogenous electromagnetic fields and mechanical stresses in living organisms are also reviewed, which indicate promising future of biomedical imaging and therapeutic methods based on bioelectrodynamic techniques. The fact that living organisms may have well-organized structures, actively controlled actions and responses, extremely sensitivity in electromagnetic fields and mechanical actions, and amazing signal amplification functions may not only cause complexity and variety of the biological world, but also create opportunities for technical innovations in biomedicine to improve future quality of human life. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Tokyo, Nucl Prefess Sch, Grad Sch Engn, Tokai, Ibaraki 3191188, Japan.
RP Zhou, SA (reprint author), Univ Tokyo, Nucl Prefess Sch, Grad Sch Engn, 2-22 Shirane Shirakata, Tokai, Ibaraki 3191188, Japan.
EM shu-ang.zhou@telia.com
CR ADEY WR, 1980, P IEEE, V68, P119, DOI 10.1109/PROC.1980.11591
   ADEY WR, 1981, PHYSIOL REV, V61, P435
   ALBERTS B, 1994, MOL BIOL CELL
   ALBRECHTBUEHLER G, 1992, P NATL ACAD SCI USA, V89, P8288, DOI 10.1073/pnas.89.17.8288
   Ali SM, 2003, INT J ONCOL, V22, P1181
   ASTUMIAN RD, 1995, P NATL ACAD SCI USA, V92, P3740, DOI 10.1073/pnas.92.9.3740
   BARKER AT, 1985, LANCET, V1, P1106
   BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063
   BAULE G, 1963, AM HEART J, V66, P95, DOI 10.1016/0002-8703(63)90075-9
   BECKER R, 1985, BODY ELECT ELECTROMA
   Becker R O, 1967, Med Times, V95, P657
   BERG IM, 2002, BIOCHEMISTRY
   Blasberg RG, 2003, MOL CANCER THER, V2, P335
   BRENNER D, 1975, SCIENCE, V190, P480, DOI 10.1126/science.170683
   BURGER EH, 1998, ADV ORGAN BIOL A, V5, P107
   Burgher Julie M, 2002, Cardiovasc Radiat Med, V3, P163, DOI 10.1016/S1522-1865(03)00080-5
   Canatella PJ, 2004, BIOPHYS J, V86, P3260, DOI 10.1016/S0006-3495(04)74374-X
   Carroll F, 2003, J CELL BIOCHEM, V90, P502, DOI 10.1002/jcb.10632
   Carroll FE, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790583
   Chien S, 2003, PROG BIOPHYS MOL BIO, V83, P131, DOI 10.1016/s0079-6107(03)00053-1
   CHOY RVS, 1987, CLIN ECOL, V4, P93
   CHRISTENSEN PA, 1989, BRIT J ANAESTH, V62, P258, DOI 10.1093/bja/62.3.258
   COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664
   COHEN D, 1970, APPL PHYS LETT, V16, P278, DOI 10.1063/1.1653195
   COLE KS, 1949, ARCH SCI PHYSIOL, V3, P253
   Corry B, 2000, BIOPHYS J, V78, P2364, DOI 10.1016/S0006-3495(00)76781-6
   Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4
   Curra A, 2002, NEUROLOGY, V59, P1851, DOI 10.1212/01.WNL.0000038744.30298.D4
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0
   Dev SB, 2000, IEEE T PLASMA SCI, V28, P206, DOI 10.1109/27.842905
   Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071
   DUNDEE JW, 1989, J ROY SOC MED, V82, P268
   EINTHOVEN W, 1925, NOBEL LECT      1211
   Elleaume H, 2000, PHYS MED BIOL, V45, pL39, DOI 10.1088/0031-9155/45/9/102
   Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201
   Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002
   Frohlich H, 1983, COHERENT EXCITATIONS
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Fung Y., 1990, BIOMECHANICS MOTION
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   FURCHGOTT RF, 1998, NITRIC OXIDE SIGNALI
   Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002
   Geselowitz DB, 1999, P IEEE, V87, P1842, DOI 10.1109/5.790643
   GESELOWITZ DB, 1989, P IEEE, V77, P857, DOI 10.1109/5.29327
   GRATTA CD, 2001, REP PROG PHYS, V64, P1759
   GUZELSU N, 1990, J BIOMECH, V23, P673, DOI 10.1016/0021-9290(90)90167-2
   Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060
   JACOBS JA, 1987, GEOMAGNETISMN
   Janmey PA, 1998, PHYSIOL REV, V78, P763
   Jaspard F, 2003, PHYSIOL MEAS, V24, P137, DOI 10.1088/0967-3334/24/1/310
   JOHNS PC, 1987, PHYS MED BIOL, V32, P675, DOI 10.1088/0031-9155/32/6/002
   JOHNSON MW, 1980, J BIOMECH, V13, P437, DOI 10.1016/0021-9290(80)90037-8
   JUSTUS R, 1970, CALC TISS RES, V5, P222, DOI 10.1007/BF02017551
   Kettenmann H, 1997, TRENDS NEUROSCI, V20, P239, DOI 10.1016/S0166-2236(97)01063-1
   Kilts CD, 2003, J CLIN PSYCHIAT, V64, P31
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Konev S. V., 1967, FLUORESCENCE PHOSPHO
   KONEV SV, 1966, BIOPHYS-USSR, V11, P410
   LASTER BH, 1993, RADIAT RES, V133, P219, DOI 10.2307/3578359
   Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101
   Lavon A, 2004, DRUG DISCOV TODAY, V9, P670
   LEDGER PW, 1992, ADV DRUG DELIVER REV, V9, P289, DOI 10.1016/0169-409X(92)90027-N
   Lefaucheur JP, 2005, CLIN NEUROPHYSIOL, V116, P244, DOI 10.1016/j.clinph.2004.11.017
   Marino AA, 2003, BIOELECTROMAGNETICS, V24, P339, DOI 10.1002/bem.10098
   Markin VS, 2004, PHYS BIOL, V1, P110, DOI 10.1088/1478-3967/1/2/007
   MARMONT G, 1949, J CELL COMPAR PHYSL, V34, P351, DOI 10.1002/jcp.1030340303
   MATSUSHITA S, 1967, PHYS GEOMAGNETIC PHE
   McMakin C, 2004, J BODYWORK MOVEMENT, V8, P143
   Mitragotri S, 2000, PHARMACEUT RES, V17, P1354, DOI 10.1023/A:1007522114438
   Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077
   Moruzzi G, 1996, BRAIN RES BULL, V40, P69, DOI 10.1016/0361-9230(96)00036-6
   Moy G, 2000, BIOPHYS J, V78, P2349, DOI 10.1016/S0006-3495(00)76780-4
   OKINO M, 1987, JPN J CANCER RES, V78, P1319
   Oschman JL, 2005, J BODYW MOV THER, V9, P3, DOI 10.1016/S1360-8592(03)0009-5
   Pang LJ, 2001, J PHOTOCH PHOTOBIO B, V64, P21, DOI 10.1016/S1011-1344(01)00185-3
   PETERS RC, 1974, J COMP PHYSIOL, V92, P11, DOI 10.1007/BF00696523
   Peters RC, 2002, J PHYSIOLOGY-PARIS, V96, P397, DOI 10.1016/S0928-4257(03)00018-4
   Piccolino M, 1998, BRAIN RES BULL, V46, P381, DOI 10.1016/S0361-9230(98)00026-4
   PIKAL MJ, 1992, ADV DRUG DELIVER REV, V9, P201, DOI 10.1016/0169-409X(92)90024-K
   PILLA AA, 1987, MECHANISTIC APPROACH, P39
   PINSKY M, 1995, EMF BOOK WHAT YOU SH
   Popp F.-A., 1998, BIOPHOTONS, P238
   POPP FA, 1976, BIOPHOTONEN
   Pullan A, 2004, PROG BIOPHYS MOL BIO, V85, P523, DOI 10.1016/j.pbiomolbio.2004.02.003
   Repacholi MH, 1999, BIOELECTROMAGNETICS, V20, P133, DOI 10.1002/(SICI)1521-186X(1999)20:3<133::AID-BEM1>3.0.CO;2-O
   ROTH A, 1968, Z VERGL PHYSIOL, V61, P196, DOI 10.1007/BF00341115
   ROTH A, 1962, J COMP PHYSIOL, V79, P113
   Schirmacher A, 2000, BIOELECTROMAGNETICS, V21, P338, DOI 10.1002/1521-186X(200007)21:5<338::AID-BEM2>3.0.CO;2-Q
   Secomb TW, 2001, BIORHEOLOGY, V38, P305
   Smith C, 1989, ELECTROMAGNETIC MAN, DOI St Martin's Press
   Taton TA, 2001, NATURE, V412, P491, DOI 10.1038/35087687
   TENFORDE TS, 1987, HEALTH PHYS, V53, P585, DOI 10.1097/00004032-198712000-00002
   Thompson SP, 1910, P R SOC LOND B-CONTA, V82, P396, DOI 10.1098/rspb.1910.0032
   Torikoshi M, 2003, PHYS MED BIOL, V48, P673, DOI 10.1088/0031-9155/48/5/308
   UESAKA M, 2003, JOINT 6 ICFA ADV NOV
   VANWIJK R, 2001, J SCI EXPLOR, V15, P183
   VISSER KR, 1989, ANN BIOMED ENG, V17, P463, DOI 10.1007/BF02368066
   WALCOTT C, 1980, IEEE T MAGN, V16, P1008, DOI 10.1109/TMAG.1980.1060868
   Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239
   Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820
   Weaver JC, 1998, BIOPHYS J, V75, P2251, DOI 10.1016/S0006-3495(98)77669-6
   WEBB S, 1997, CONFORMAL RADIOTHERA
   Wheldon TE, 2000, PHYS MED BIOL, V45, pR77, DOI 10.1088/0031-9155/45/7/201
   WILSON BW, 1990, EXTREMELY LOW FREQUE
   Wiltschko R., 1995, MAGNETIC ORIENTATION
   Zhadin MN, 2001, BIOELECTROMAGNETICS, V22, P27, DOI 10.1002/1521-186X(200101)22:1<27::AID-BEM4>3.0.CO;2-2
   Zhong Z, 2000, NUCL INSTRUM METH A, V450, P556, DOI 10.1016/S0168-9002(00)00308-9
NR 108
TC 20
Z9 20
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7225
EI 1879-2197
J9 INT J ENG SCI
JI Int. J. Eng. Sci.
PD JAN
PY 2006
VL 44
IS 1-2
BP 67
EP 92
DI 10.1016/j.ijengsci.2005.11.001
PG 26
WC Engineering, Multidisciplinary
SC Engineering
GA 016PJ
UT WOS:000235631900007
DA 2018-10-20
ER

PT J
AU Weon, BM
   Je, JH
   Hwu, Y
   Margaritondo, G
AF Weon, Byung Mook
   Je, Jung Ho
   Hwu, Yeukuang
   Margaritondo, Giorgio
TI Phase contrast X-ray imaging
SO INTERNATIONAL JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE X-ray imaging; phase contrast; hard X-ray; unmonochromatic beam;
   microradiology; microtomography; nanoradiology
ID LOCALIZED ELECTROCHEMICAL DEPOSITION; ENHANCED SYNCHROTRON RADIOLOGY;
   COMPUTED-TOMOGRAPHY; DIFFRACTION; RADIATION; MICRORADIOGRAPHY;
   MICROTOMOGRAPHY; INTERFEROMETER; NANOPARTICLES; MAMMOGRAPHY
AB In the last decade X-ray imaging based on phase contrast greatly advanced thanks to the use of unmonochromatic synchrotron hard X-rays. The recent advances are going beyond microradiology and microtomography to reach nanometre scale. This paper reviews basic theory and selected applications to biomedical and materials sciences. The forthcoming improvements in phase contrast X-ray imaging will lead to even better imaging of many different phenomena at nanometre level.
C1 Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Biomed Imaging Ctr, I BIO Program, Pohang 790784, South Korea.
   Acad Sinica, Inst Phys, Taipei 11529, Taiwan.
   Ecole Polytech Fed Lausanne, Inst Phys Nanostruct, CH-1015 Lausanne, Switzerland.
RP Je, JH (reprint author), Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Biomed Imaging Ctr, I BIO Program, Pohang 790784, South Korea.
EM bmweon@postech.ac.kr; jhje@postech.ac.kr; phhwu@sinica.edu.tw;
   giorgio.margaritondo@epfl.ch
RI Weon, Byung Mook/D-1493-2011; Centre d'imagerie Biomedicale,
   CIBM/B-5740-2012; Margaritondo, Giorgio/B-1367-2008
OI Weon, Byung Mook/0000-0002-5224-5590; 
CR ALBERTS B, 2004, ESSENTIAL CELL BIOL, P85
   Arfelli F, 1998, PHYS MED BIOL, V43, P2845, DOI 10.1088/0031-9155/43/10/013
   Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286
   ARHATARI BD, 2004, REV SCI INSTRUM, V75, P5272
   Baik S, 2004, REV SCI INSTRUM, V75, P4355, DOI 10.1063/1.1807000
   BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212
   Borse PH, 2004, NANOTECHNOLOGY, V15, pS389, DOI 10.1088/0957-4484/15/6/013
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0
   Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309
   Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471
   HART M, 1971, REP PROG PHYS, V34, P435, DOI 10.1088/0034-4885/34/2/302
   Hwu Y, 2004, PHYS MED BIOL, V49, P501, DOI 10.1088/0031-9155/49/4/002
   Hwu Y, 2004, BIOPHYS J, V87, P4180, DOI 10.1529/biophysj.103.034991
   Hwu Y, 2002, J PHYS D APPL PHYS, V35, pR105, DOI 10.1088/0022-3727/35/13/201
   Hwu Y, 1999, J APPL PHYS, V86, P4613, DOI 10.1063/1.371411
   Hwu Y, 2001, NUCL INSTRUM METH A, V467, P1294, DOI 10.1016/S0168-9002(01)00643-X
   INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012
   KOGOSHIMA Y, 1999, JPN J APPL PHYS, V38, pL470
   Lee HJ, 2003, NUCL INSTRUM METH B, V199, P342, DOI 10.1016/S0168-583X(02)01561-6
   Margaritondo G, 1999, J APPL PHYS, V85, P3406, DOI 10.1063/1.369697
   Margaritondo G, 1998, PHYS WORLD, V11, P28
   Margaritondo G, 2002, ELEMENTS SYNCHROTRON
   Margaritondo G, 1988, INTRO SYNCHROTRON RA
   Meuli R, 2004, EUR RADIOL, V14, P1550, DOI 10.1007/s00330-004-2361-x
   MIAO J, 2002, PHYS REV LETT, V89, P88303
   Momose A, 2003, OPT EXPRESS, V11, P2303, DOI 10.1364/OE.11.002303
   Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473
   MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9
   Peele AG, 2004, REV SCI INSTRUM, V75, P3382, DOI 10.1063/1.1779612
   Pisano ED, 2000, RADIOLOGY, V214, P26, DOI 10.1148/radiology.214.1.r00ja5226
   Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194
   Raven C, 1996, APPL PHYS LETT, V69, P1826, DOI 10.1063/1.117446
   Rontgen WC, 1896, NATURE, V53, P274
   Schneider G, 2003, ANAL BIOANAL CHEM, V376, P558, DOI 10.1007/s00216-003-2007-x
   Seol SK, 2005, ADV FUNCT MATER, V15, P934, DOI 10.1002/adfm.200400514
   Seol SK, 2004, ELECTROCHEM SOLID ST, V7, pC95, DOI 10.1149/1.1775951
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   SNIGIREV A, 1995, ESRF NEWSLETTER, V24, P23
   Spanne P, 1999, PHYS MED BIOL, V44, P741, DOI 10.1088/0031-9155/44/3/016
   Stampanoni M, 2003, APPL PHYS LETT, V82, P2922, DOI 10.1063/1.1569428
   Takeda T, 2002, CIRCULATION, V105, P1708, DOI 10.1161/01.CIR.0000012752.35225.6C
   Tsai WL, 2003, NUCL INSTRUM METH B, V199, P457, DOI 10.1016/S0168-583X(02)01533-1
   Tsai WL, 2002, NATURE, V417, P139, DOI 10.1038/417139a
   Webb A., 2003, INTRO BIOMEDICAL IMA
   WEISSLEDER R, 2001, NAT REV, V2, P1
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
NR 47
TC 25
Z9 25
U1 0
U2 11
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA
PA WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 896, CH-1215
   GENEVA, SWITZERLAND
SN 1475-7435
J9 INT J NANOTECHNOL
JI Int. J. Nanotechnol.
PY 2006
VL 3
IS 2-3
BP 280
EP 297
DI 10.1504/IJNT.2006.009584
PG 18
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 075NS
UT WOS:000239892500008
DA 2018-10-20
ER

PT S
AU Sheeparamatti, BG
   Angadi, SA
   Sheeparamatti, RB
   Kadadevaramath, JS
AF Sheeparamatti, B. G.
   Angadi, S. A.
   Sheeparamatti, R. B.
   Kadadevaramath, J. S.
BA Tay, FEH
   Jianmin, M
   Bergstrom, J
   Iliescu, C
BF Tay, FEH
   Jianmin, M
   Bergstrom, J
   Iliescu, C
TI A Teaching - Learning Framework for MEMS Education
SO INTERNATIONAL MEMS CONFERENCE 2006
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT International MEMS Conference 2006
CY MAY 09-12, 2006
CL Singapore, SINGAPORE
SP Inst Bioengineering & NanoTechnol
DE Micro-electro-mechanical systems; MEMS education; modeling and
   simulation; reduced order modeling
AB Micro-Electro-Mechanical Systems (MEMS) technology has been identified as one of the most promising technologies in the 21(st) century. MEMS technology has opened up a wide array of unforeseen applications. Hence it is necessary to train the technocrats of tomorrow in this emerging field to meet the industrial/societal demands. The drive behind fostering of MEMS technology is the reduction in the cost, size, weight, and power consumption of the sensors, actuators, and associated electronics. MEMS is a multidisciplinary engineering and basic science area which includes electrical engineering, mechanical engineering, material science and biomedical engineering. Hence MEMS education needs a special approach to prepare the technocrats for a career in MEMS. The modern education methodology using computer based training systems (CBTS) with embedded modeling and simulation tools will help in this direction. The availability of computer based learning resources such as MATLAB, ANSYS/Multiphysics and rapid prototyping tools have contributed to proposition of an efficient teaching-learning framework for MEMS education presented in this paper. This paper proposes a conceptual framework for teaching/learning MEMS in the current technical education scenario.
C1 [Sheeparamatti, B. G.; Angadi, S. A.; Sheeparamatti, R. B.] Basaveshwar Engn Coll, Bagalkot 587102, India.
   [Kadadevaramath, J. S.] Karnatak Univ, Dharwad 580001, Karnataka, India.
RP Sheeparamatti, BG (reprint author), Basaveshwar Engn Coll, Bagalkot 587102, India.
EM sheepar@yahoo.com; vinay_angadi@yahoo.com;
   rajeshwari_sheepar@yahoo.co.in; Jagadish_sk59@rediff.com
OI Angadi, Shanmukhappa/0000-0001-9756-9786
CR FRECHETTE L, 2003, P 15 BIENN U GOV IND
   JAVALAGI CM, 2002, P ISTE 32 ANN CONV N
   JUDY JW, 2002, P INT C ENG ED MANCH
   Lin LW, 2001, IEEE T EDUC, V44, P61, DOI 10.1109/13.912711
   SHEEPARAMATTI BG, 2005, P INT C HUM MACH INT, P207
   2002, FUTURE MEMS NASA TEC
NR 6
TC 0
Z9 0
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2006
VL 34
BP 247
EP 252
DI 10.1088/1742-6596/34/1/041
PG 6
WC Automation & Control Systems; Nanoscience & Nanotechnology; Physics,
   Multidisciplinary
SC Automation & Control Systems; Science & Technology - Other Topics;
   Physics
GA BTE85
UT WOS:000286667100041
OA Bronze
DA 2018-10-20
ER

PT S
AU ul Haque, A
   Rokkam, M
   De Carlo, AR
   Wereley, ST
   Wells, HW
   McLamb, WT
   Roux, SJ
   Irazoqui, PP
   Porterfield, DM
AF ul Haque, A.
   Rokkam, M.
   De Carlo, A. R.
   Wereley, S. T.
   Wells, H. W.
   McLamb, W. T.
   Roux, S. J.
   Irazoqui, P. P.
   Porterfield, D. M.
BA Tay, FEH
   Jianmin, M
   Bergstrom, J
   Iliescu, C
BF Tay, FEH
   Jianmin, M
   Bergstrom, J
   Iliescu, C
TI Design, Fabrication and Characterization of an In Silico Cell Physiology
   lab for Bio Sensing Applications
SO INTERNATIONAL MEMS CONFERENCE 2006
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT International MEMS Conference 2006
CY MAY 09-12, 2006
CL Singapore, SINGAPORE
SP Inst Bioengineering & NanoTechnol
ID SELECTIVE ELECTRODE; CALCIUM; MICROFABRICATION; LITHOGRAPHY
AB In this paper, we report the design, fabrication and characterization of an in-silico cell physiology biochip for measuring Ca2+ ion concentrations and currents around single cells. This device has been designed around specific science objectives of measuring real time multidimensional calcium flux patterns around sixteen Ceratopteris richardii fern spores in microgravity flight experiments and ground studies. The sixteen microfluidic cell holding pores are 150 by 150 mu m each and have 4 Ag/AgCl electrodes leading into them. An SU-8 structural layer is used for insulation and packaging purposes. The in-silico cell physiology lab is wire bonded on to a custom PCB for easy interface with a state of the art data acquisition system. The electrodes are coated with a Ca2+ ion selective membrane based on ETH-5234 ionophore and operated against an Ag/AgCl reference electrode. Initial characterization results have shown Nernst slopes of 30mv/decade that were stable over a number of measurement cycles. While this work is focused on technology to enable basic research on the Ceratopteris richardii spores, we anticipate that this type of cell physiology lab-on-a-chip will be broadly applied in biomedical and pharmacological research by making minor modifications to the electrode material and the measurement technique. Future applications include detection of glucose, hormones such as plant auxin, as well as multiple analyte detection on the same chip.
C1 [ul Haque, A.; Rokkam, M.; De Carlo, A. R.; Wereley, S. T.; Wells, H. W.; McLamb, W. T.; Roux, S. J.; Irazoqui, P. P.; Porterfield, D. M.] Purdue Univ, Bindley Biosci Ctr, Physiol Sensing Facil, W Lafayette, IN 47907 USA.
RP ul Haque, A (reprint author), Purdue Univ, Bindley Biosci Ctr, Physiol Sensing Facil, W Lafayette, IN 47907 USA.
EM porterf@purdue.edu
FU National Aeronautics and Space Agency; Purdue University
FX The authors would like to thank Rameez Chatni and other members of the
   Laboratory of Integrated Bionanotechnology Applications (Purdue
   University) for their valuable advice and support on this project. They
   would also like to thank the staff of the BirckNanotechnology Center
   (Purdue University) and the NCF facility at UIC. The project was funded
   by the National Aeronautics and Space Agency, and Purdue University.
CR AMMANN D, 1986, PRINCIPLES DESIGN AP
   ANKER P, 1981, ANAL CHEM, V53, P1970, DOI 10.1021/ac00236a005
   Chatterjee A, 2000, PLANTA, V210, P607, DOI 10.1007/s004250050050
   Chien FSS, 1999, APPL PHYS LETT, V75, P2429, DOI 10.1063/1.125037
   Chronis N, 2004, PROC IEEE MICR ELECT, P17, DOI 10.1109/MEMS.2004.1290511
   Guenat OT, 2005, SENSOR ACTUAT B-CHEM, V105, P65, DOI 10.1016/j.snb.2004.02.037
   Konopka A, 2004, ANAL CHEM, V76, P6410, DOI 10.1021/ac0492158
   Lee CH, 2004, MICROELECTRON ENG, V73-4, P529, DOI 10.1016/j.mee.2004.03.030
   Liu J, 2004, MICROSYST TECHNOL, V10, P265, DOI 10.1007/s00542-002-0242-2
   *MICROCHEM, 2005, PHOT RES DEV REM OPT
   Porterfield DM, 2002, PLANT ROOTS HIDDEN H, V3rd, P333
   PURVES RD, 1981, MICROELECTRODES METH
   Suzuki H, 2000, ELECTROANAL, V12, P703, DOI 10.1002/1521-4109(200005)12:9<703::AID-ELAN703>3.0.CO;2-7
   Thong JTL, 1997, SENSOR ACTUAT A-PHYS, V63, P243, DOI 10.1016/S0924-4247(97)80511-0
   Uhlig A, 1997, ANAL CHEM, V69, P4032, DOI 10.1021/ac960957d
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 16
TC 2
Z9 2
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2006
VL 34
BP 740
EP 746
DI 10.1088/1742-6596/34/1/122
PG 7
WC Automation & Control Systems; Nanoscience & Nanotechnology; Physics,
   Multidisciplinary
SC Automation & Control Systems; Science & Technology - Other Topics;
   Physics
GA BTE85
UT WOS:000286667100122
OA Bronze
DA 2018-10-20
ER

PT J
AU Ljungqvist, A
   Martinez-Patino, MJ
   Martinez-Vidal, A
   Zagalaz, L
   Diaz, P
   Mateos, C
AF Ljungqvist, Arne
   Martinez-Patino, Maria Jose
   Martinez-Vidal, A.
   Zagalaz, Luisa
   Diaz, Pino
   Mateos, Covadonga
TI The history and current policies on gender testing in elite athletes
SO INTERNATIONAL SPORTMED JOURNAL
LA English
DT Review
DE gender identity; sex determination; gender verification; sex
   discrimination, sport
ID VERIFICATION; SEX; OLYMPICS; SPORTS; ESSAY
AB The purported rationale of sex verification tests in elite sports was to ensure women competed on equal terms by preventing male impostors masquerading as women from obtaining unfair gender-related advantages in women-only sports events. This review traces the developments and current policies on gender verification of elite women athletes since the inception of sex controls in the 1960s. In the advent of sex controls women athletes were forced to parade in the nude before a panel of gynaecologists and were subjected to traumatic and degrading visual genital inspections. Subsequently, screening of female athletes involved genetic-based laboratory testing which was initially based on a simple technique of evaluating a buccal smear for the presence of a Barr body, and more recently the determination of the presence of Y chromosomes or male-related genetic material using PCR amplification of chromosomal DNA extracted from nucleated cells.
   The publicity surrounding the notorious case of the Spanish national champion hurdler, Maria Patino, in the 1980s prompted calls for the elimination of sex controls in elite sports. Maria Patino, who was publicly humiliated when she failed her sex verification test due to androgen resistance, was stripped of her titles and disqualified from competing in women-only sport events, only to be reinstated 3 years later. By then, however, her career as a professional athlete was over. Maria Patino's case and those of other athletes who had been unjustly excluded from competitive sport prompted changes in the regulations regarding sex verification which brought them in line with the development of elite sport and biomedical science.
   Women athletes with rare sex-related genetic abnormalities, such as 5-alpha-steroid-reductase deficiency, complete or almost complete androgen insensitivity, and chromosomal mosaicism, have no unfair gender-related advantages and should not be disqualified from competing in elite sports events. Nor should they be stigmatised and their right to privacy should be guaranteed by sports organizations during the process of gender verification.
   The abandonment of compulsory sex verification tests of female athletes which was initiated by the International Association of Athletics Federations (IAAF) was later followed by most international sports federations, and in the end also by the International Olympic Committee (IOC), although initially only provisionally. The abandonment of sex verification tests brought an end to the traumatic, demeaning, and unjust regulations bringing them in line with advancements in sport, modern medicine, and science.
C1 Univ Vigo, Special Didact Dept, Fac Sci Educ & Sport, Grp Res Project HI6, Pontevedra, Spain.
   Int Olymp Comm, Med Commiss, Lausanne, Switzerland.
   Univ Jaen, Dept Phys Educ, Fac Phys Educ, Jaen, Spain.
   Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain.
   Univ Jaen, Human Evolut Res Project, Jaen, Spain.
RP Martinez-Patino, MJ (reprint author), Univ Vigo, Special Didact Dept, Fac Sci Educ & Sport, Grp Res Project HI6, Pontevedra, Spain.
EM Arne.Ljungqvist@rf.se; mjpatino@uvigo.es; aurora@uvigo.es;
   lzagalaz@ujaen.es; pinod@uvigo.es; cmateos@def.ulpgc.es
RI MARTINEZ-PATINO, MARIA JOSE/K-7359-2014
OI MARTINEZ-PATINO, MARIA JOSE/0000-0003-2721-9240
CR Carlson A, 2005, LANCET, V366, pS39, DOI 10.1016/S0140-6736(05)67842-7
   Carlson Alison, 1991, WOMENS SPORT FIT MAR, P24
   de la Chapelle A., 1986, NEW STUDIES ATHLETIC, V1, P49
   DELACHAPELLE A, 1986, JAMA-J AM MED ASSOC, V256, P1920, DOI 10.1001/jama.256.14.1920
   Elsas LJ, 2000, GENET MED, V2, P249, DOI 10.1097/00125817-200007000-00008
   Ferguson-Smith M A, 1991, Br J Sports Med, V25, P17
   FERGUSONSMITH MA, 1992, NATURE, V355, P10, DOI 10.1038/355010a0
   Genel M, 2005, LANCET, V366, pS41, DOI 10.1016/S0140-6736(05)67843-9
   HAY E, 1972, JAMA-J AM MED ASSOC, V4, P39
   International Olympic Committee, 2004, 3 WORLD C WOM SPORT
   LJUNGQVIST A, 1992, JAMA-J AM MED ASSOC, V267, P850, DOI 10.1001/jama.267.6.850
   LJUNGQVIST A, 2000, OLYMPIC ENCY, V3, P183
   LJUNGQVIST A, 2001, INT ENCY WOMEN SPORT, P447
   Martinez-Patino MJ, 2005, LANCET, V366, pS38, DOI 10.1016/S0140-6736(05)67841-5
   SIMPSON JL, 1986, JAMA-J AM MED ASSOC, V256, P1938
   Simpson JL, 2000, JAMA-J AM MED ASSOC, V284, P1568, DOI 10.1001/jama.284.12.1568
   SIMPSON JL, 1993, SPORTS MED, V16, P305, DOI 10.2165/00007256-199316050-00002
   1987, LANCET, V2, P1265
NR 18
TC 7
Z9 7
U1 0
U2 13
PU INTERNATIONAL FEDERATION OF SPORTS MEDICINE
PI NEWLANDS
PA UCT/MRC RES UNIT EXERC SCI SPORTS MED, U CAPETOWN, BOUNDARY ROAD,
   NEWLANDS, 7700, SOUTH AFRICA
SN 1528-3356
J9 INT SPORTMED J
JI Int. Sportmed. J.
PY 2006
VL 7
IS 3
BP 225
EP 230
PG 6
WC Sport Sciences
SC Sport Sciences
GA 113RC
UT WOS:000242614000006
DA 2018-10-20
ER

PT J
AU Elias, Y
   Fernandez, JM
   Mor, T
   Weinstein, Y
AF Elias, Yuval
   Fernandez, Jose M.
   Mor, Tal
   Weinstein, Yossi
TI Optimal algorithmic cooling of spins
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Article
ID NUCLEAR-MAGNETIC-RESONANCE; QUANTUM COMPUTATION; NMR-SPECTROSCOPY;
   PARAMAGNETIC MATERIALS; POLARIZATION TRANSFER; C-13 MRS; IN-VIVO;
   IMPLEMENTATION; METABOLISM; COMPUTERS
AB Algorithmic cooling (AC) is a recent spin-cooling approach that ernploys entropy compression methods in open systems. AC reduces the entropy of spins on suitable molecules beyond Shannon's bound on the degree of entropy compression by reversible manipulations. Remarkably, AC makes use of thermalization, a generally destructive facet of spin systems, as an integral part of the cooling scheme. AC is capable of cooling spins to very low temperatures and provides significant cooling for molecules containing as few as 5-7 spins. Application of AC to slightly larger molecules Could lead to breakthroughs in high-sensitivity NMR spectroscopy in the near future. Furthermore, AC may be germane to the development of scalable NMR quantum computers. We introduce here a new practicable algorithm, "PAC3'', and several new exhaustive cooling algorithms, Such as the Tribonacci and k-bonacci algorithms, In particular, we present the "all-bonacci" algorithm, which appears to reach the maximal degree of cooling obtainable by the optimal AC approach. AC is potentially beneficial for NMR-derived biomedical applications, which involve bio-molecules with isotope enrichments, such as C-13- and (IN)-I-15-labeled amino acids. We briefly Survey AC experiments, including a recent 3-spin experiment in which Shannon's bound was bypassed. The difficulties associated with cooling molecules hearing a greater number of spins are explained. Finally, the potential of selected cooling algorithms (practicable, exhaustive, and optimal algorithms) is illustrated with regard to a highly relevant bio-medical target-C-13-labeled glucose.
C1 Technion Israel Inst Technol, Dept Phys, IL-31096 Haifa, Israel.
   Technion Israel Inst Technol, Schulich Fac Chem, IL-31096 Haifa, Israel.
   Ecole Polytech, Dept Genie Informat, Montreal, PQ 6079, Canada.
   Technion Israel Inst Technol, Dept Comp Sci, IL-31096 Haifa, Israel.
RP Weinstein, Y (reprint author), Technion Israel Inst Technol, Dept Phys, IL-31096 Haifa, Israel.
EM yossiv@technion.ac.il
OI Fernandez, Jose M./0000-0001-9836-3595
CR ABRAMOVICH D, 1993, J MAGN RESON SER A, V105, P30, DOI 10.1006/jmra.1993.1245
   Anwar MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040501
   Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100
   BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457
   Baugh J, 2005, NATURE, V438, P470, DOI 10.1038/nature04272
   BERGER S, 2004, 200 MORE NMR EXPT PR, P302
   Boykin PO, 2002, P NATL ACAD SCI USA, V99, P3388, DOI 10.1073/pnas.241641898
   BRASSARD G, 2005, UNPUB P NATL ACAD SC
   Chang DE, 2001, CHEM PHYS LETT, V338, P337, DOI 10.1016/S0009-2614(01)00280-9
   Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634
   CORY DG, 1996, P 4 WORKSH PHYS COMP, P87
   COVER TM, 1991, ELEMENTS INFORM THEO, P88
   DiVincenzo DP, 1998, NATURE, V393, P113, DOI 10.1038/30094
   EMSLEY L, 1993, LECT PULSED NMR
   Farrar CT, 2001, J CHEM PHYS, V114, P4922, DOI 10.1063/1.1346640
   Fernandez JM, 2005, INT J QUANTUM INF, V3, P281, DOI 10.1142/S0219749905000888
   Fernandez JM, 2004, INT J QUANTUM INF, V2, P461, DOI 10.1142/S0219749904000419
   Fernandez JM, 2003, PROC SPIE, V5105, P185, DOI 10.1117/12.485841
   FERNANDEZ JM, 2003, THESIS U MONTREAL CA
   Freegarde T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.037904
   Garcia-Espinosa MA, 2004, NEUROCHEM INT, V45, P297, DOI 10.1016/j.neuint.2003.08.014
   Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350
   Ladd TD, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.017901
   MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058
   Oros AM, 2004, PHYS MED BIOL, V49, pR105, DOI 10.1088/0031-9155/49/20/R01
   Price MD, 2000, NEW J PHYS, V2, P101, DOI 10.1088/1367-2630/2/1/10
   Rodrigues TB, 2005, CONCEPT MAGN RESON A, V27A, P1, DOI 10.1002/cmr.a.20039
   Ross B, 2003, NMR BIOMED, V16, P358, DOI 10.1002/nbm.852
   Schulman L. J., 1999, Proceedings of the Thirty-First Annual ACM Symposium on Theory of Computing, P322, DOI 10.1145/301250.301332
   Schulman LJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.120501
   SCHULMAN LJ, 2007, SIAM J COMPUT, V36, P1729
   Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI 10.1137/S0097539795293172
   Slichter C. P., 1990, PRINCIPLES MAGNETIC
   SORENSEN OW, 1989, PROG NUCL MAG RES SP, V21, P503, DOI 10.1016/0079-6565(89)80006-8
   TWAMLEY, 2003, J PHYS REV A, V67, DOI UNSP 052318
   Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a
   VANZIJL PCM, 1995, MAGN RESON IMAGING, V13, P1213, DOI 10.1016/0730-725X(95)02034-Q
   WARREN WS, 1984, J CHEM PHYS, V81, P5437, DOI 10.1063/1.447644
   Warren WS, 1997, SCIENCE, V277, P1688, DOI 10.1126/science.277.5332.1688
   WEINSTEIN Y, 2003, THESIS TECHNION HAIF
NR 40
TC 11
Z9 11
U1 2
U2 5
PU SCIENCE FROM ISRAEL-DIVISION OF LASER PAGES PUBL LTD
PI JERUSALEM
PA PO BOX 35409, JERUSALEM 91352, ISRAEL
SN 0021-2148
J9 ISR J CHEM
JI Isr. J. Chem.
PY 2006
VL 46
IS 4
BP 371
EP 391
DI 10.1560/IJC_46_4_371
PG 21
WC Chemistry, Multidisciplinary
SC Chemistry
GA 238QL
UT WOS:000251462300004
DA 2018-10-20
ER

PT J
AU Bahadur, KCR
   Aryal, S
   Bhattarai, SR
   Bhattarai, N
   Kim, CH
   Kim, HY
AF Bahadur, KCR
   Aryal, S
   Bhattarai, SR
   Bhattarai, N
   Kim, CH
   Kim, HY
TI Stabilization of gold nanoparticles by hydrophobically-modified
   polycations
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polycation; gold nanoparticles; chitosan; self-assembly; biomaterial
ID CHITOSAN NANOCOMPOSITES; CHITIN; ACETYLATION; DERIVATIVES; MATRICES;
   SYSTEM; WATER; ACID
AB Surface-modified gold nanoparticles have pronounced benefits in the biomedical field due to their significant interaction with delivery materials. In the present study we used hydrophobically-modified polycations (i.e., N-acylated chitosan) to stabilize gold nanoparticles. Aliphatic hydrophobic groups, having carbon chains of different lengths, were first grafted onto the backbone of chitosan by N-acylation with fatty-acid chlorides in order to increase its hydrophobicity. Gold nanoparticles stabilized with native chitosan and N-acylated chitosan were prepared by the graft-onto approach. Chemical modification and its quantification were studied by Fourier-transform infrared (FT-IR) spectroscopy. Further, the stabilized gold nanoparticles were characterized by different physico-chemical techniques such as UV-Vis, FT-IR, TEM, TGA and DLS. Spectral studies of gold nanoparticles show the backbone and the side chain functional groups of chitosan were not cleaved during the conjugation process. TEM observations revealed that the modified chitosan gold nanoparticles were well dispersed and spherical in shape with average size around 10-12 nm in triply-distilled water at pH 7.4, whereas the native chitosan gold nanoparticles appeared as clusters with 9.9 nm as average diameter and were dispersed only in dilute HCl. The size of modified chitosan gold nanoparticles varied depending on the length of grafting molecules.
C1 Chonbuk Natl Univ, Dept Bio Nanosyst Engn, Chonju 561756, South Korea.
   Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   Chonbuk Natl Univ, Dept Text Engn, Chonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Bio Nanosyst Engn, Chonju 561756, South Korea.
EM khy@moak.chonbuk.ac.kr
RI Kim, Hak Yong/G-3826-2013; Aryal, Santosh/E-7310-2013
OI Kim, Hak Yong/0000-0002-4133-124X; KC, Remant/0000-0002-3554-7247;
   Aryal, Santosh/0000-0002-7807-6342
CR ARYAL S, 2006, IN PRESS SPECTROCH A
   ARYAL S, 2006, IN PRESS MAT CHEM PH
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Brewer SH, 2002, LANGMUIR, V18, P4460, DOI 10.1021/la025613z
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Chakrabarti R, 2003, J AM CHEM SOC, V125, P12531, DOI 10.1021/ja035399g
   Coche-Guerente L, 2005, ELECTROCHIM ACTA, V50, P2865, DOI 10.1016/j.electacta.2004.11.040
   Corbierre MK, 2001, J AM CHEM SOC, V123, P10411, DOI 10.1021/ja0166287
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HOFFMAN AJ, 1992, J PHYS CHEM-US, V96, P5546, DOI 10.1021/j100192a067
   Huang HZ, 2005, J COLLOID INTERF SCI, V282, P26, DOI 10.1016/j.jcis.2004.08.063
   Huang HZ, 2003, COLLOID SURFACE A, V226, P77, DOI 10.1016/S0927-7757(03)00382-0
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608
   Le Tien C, 2003, J CONTROL RELEASE, V93, P1, DOI 10.1016/S0168-3659(03)00327-4
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   MOORE GK, 1980, INT J BIOL MACROMOL, V2, P115, DOI 10.1016/0141-8130(80)90040-9
   OKAMOTO Y, 1993, J VET MED SCI, V55, P739, DOI 10.1292/jvms.55.739
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   Sashiwa H, 2002, BIOMACROMOLECULES, V3, P1126, DOI 10.1021/bm0200480
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Teranishi T, 1998, ADV MATER, V10, P596, DOI 10.1002/(SICI)1521-4095(199805)10:8<596::AID-ADMA596>3.0.CO;2-Y
   Tokura S, 1997, MACROMOL SYMP, V120, P1, DOI 10.1002/masy.19971200103
   Wyrwa D, 2002, NANO LETT, V2, P419, DOI 10.1021/nl0157086
   Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y
NR 32
TC 15
Z9 16
U1 2
U2 7
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 5
BP 579
EP 589
DI 10.1163/156856206776986279
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 053UH
UT WOS:000238330600006
PM 16800156
DA 2018-10-20
ER

PT J
AU Gretzer, C
   Emanuelsson, L
   Liljensten, E
   Thomsen, P
AF Gretzer, Christina
   Emanuelsson, Lena
   Liljensten, Elisabeth
   Thomsen, Peter
TI The inflammatory cell influx and cytokines changes during transition
   from acute inflammation to fibrous repair around implanted materials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biocompatibility; cytokine; poly(urethane urea); polystyrene; titanium;
   wound healing
ID KAPPA-B ACTIVATION; IN-VIVO; SOFT-TISSUE; BIOMEDICAL MATERIALS; HUMAN
   MONOCYTES; SURFACES; TITANIUM; VITRO; BIOCOMPATIBILITY; BIOMATERIALS
AB The inflammatory and fibrous responses in a subcutaneous rat model were evaluated around degradable polyurethane urea (PUUR; Artelon((R))), with titanium and tissue culture polystyrene (PS) discs having different surface chemical properties but similar surface topography. Cytokines, viability, cellular response, differentiation of cells and fibrous capsule formation and vascularization was investigated after 1, 7 and 21 days of implantation. The exudates retrieved from the pockets were analysed with respect to the total cell numbers, the proportions of cell types, the differentiation of monocytes/macrophages (ED1, ED2), the DNA content and the viability (LD, Trypan blue). Tumour necrosis factor alpha ((h)TNF-alpha) and interleukin-10 ((h)IL-10) were quantified by ELISA. The number of blood vessels, blood vessel luminal area, blood vessel distribution and the fibrous capsule thickness were analysed. The highest number of cells in the exudates around all implants was detected during the early phase of healing (1-7 days). The proportion of ED2-positive cells in the exudates increased from 2-8% at 1 day to 43-56% at 21 days. The levels of TNF-alpha were low with a decrease at 7 days. After 21 days high amounts of IL-10 in the exudates were detected, in particular around PUUR. This study shows that the transition from inflammation to repair (1-21 days) around PUUR, Ti and PS materials was characterized by a decrease in inflammatory cell influx, an increasing proportion of ED2-expressing macrophages, a biphasic TNF-alpha secretion, an increase of IL-10 and a fibrous capsule formation similar to all materials tested.
C1 Univ Gothenburg, Sahlgrenska Acad, Inst Surg Sci, SE-40530 Gothenburg, Sweden.
   Artimplant AB, Vastra Frolunda, Sweden.
RP Gretzer, C (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Surg Sci, SE-40530 Gothenburg, Sweden.
EM christina.gretzer@artimplant.se
OI Thomsen, Peter/0000-0003-3910-6665
CR AMON M, 1994, EYE, V8, P649, DOI 10.1038/eye.1994.161
   ANDERSON JM, 1981, FUNDAMENTAL ASPECTS, V11, P205
   Bezuidenhout D, 2002, ASAIO J, V48, P465, DOI 10.1097/01.MAT.0000026345.66193.59
   BRAND KG, 1988, CLIN PLAST SURG, V15, P533
   Butler K, 1999, Biomed Sci Instrum, V35, P267
   Butler K, 2001, PATHOL RES PRACT, V197, P29, DOI 10.1078/0344-0338-00005
   Bzowska M, 2002, EUR J IMMUNOL, V32, P2011, DOI 10.1002/1521-4141(200207)32:7<2011::AID-IMMU2011>3.0.CO;2-L
   EKENMAN I, 2001, INT SPORTS MED C DUB
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   GISSELFALT K, 2002, BIOMACROMOLECULES, V5, P951
   GISSELFALT K, 2006, IN PRESS BIOMACROMOL, V9
   Goreish HH, 2004, J BIOMED MATER RES A, V68A, P1, DOI 10.1002/jbm.a.10141
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Gretzer C, 2002, J MATER SCI-MATER M, V13, P735, DOI 10.1023/A:1016154504574
   Gretzer C, 2000, CYTOKINE, V12, P32, DOI 10.1006/cyto.1999.0523
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Karakecili AG, 2002, J BIOMAT SCI-POLYM E, V13, P185, DOI 10.1163/156856202317414366
   KUTAY S, 1990, BRIT POLYM J, V23, P267, DOI 10.1002/pi.4980230316
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   LILJENSTEN E, 2004, IN PRESS ANAL BIOANA
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Miki T, 1996, INT J ORAL MAX SURG, V25, P402, DOI 10.1016/S0901-5027(06)80042-1
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Nakaoka R, 2000, J BIOMED MATER RES, V49, P99, DOI 10.1002/(SICI)1097-4636(200001)49:1<99::AID-JBM12>3.3.CO;2-2
   NOJIRI C, 1995, ARTIF ORGANS, V19, P32, DOI 10.1111/j.1525-1594.1995.tb02241.x
   Parker JATC, 2003, TISSUE ENG, V9, P117, DOI 10.1089/107632703762687591
   Piskin E., 1994, J BIOMAT SCI-POLYM E, V6, P775
   Saad B, 1997, J MATER SCI-MATER M, V8, P497, DOI 10.1023/A:1018582311361
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   Suska F, 2001, J MATER SCI-MATER M, V12, P939, DOI 10.1023/A:1012844612753
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   THOMSEN P, 2000, BONE ENG, pCH10
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   VOSKERICIAN G, 2006, IN PRESS J BIOMED A
   WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558
NR 39
TC 89
Z9 90
U1 0
U2 17
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 6
BP 669
EP 687
DI 10.1163/156856206777346340
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 067VX
UT WOS:000239331800006
PM 16892728
DA 2018-10-20
ER

PT J
AU Gautrot, JE
   Zhu, XX
AF Gautrot, J. E.
   Zhu, X. X.
TI Biodegradable polymers based on bile acids and potential biomedical
   applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE bile acids; biodegradation; biocompatibility; drug delivery
ID SELF-ASSEMBLED NANOPARTICLES; MOLECULAR RECOGNITION CHEMISTRY; BEARING
   5-BETA-CHOLANIC ACID; CHOLIC-ACID; GLYCOL CHITOSAN; ARCHITECTURAL
   COMPONENT; TRANSDERMAL PHOTOPOLYMERIZATION; PHOSPHOLIPID MEMBRANE;
   LIPIDIC ASSOCIATIONS; MICELLAR SOLUTIONS
AB Bile acids are natural compounds that play an important biological role in the body. They are candidates of choice as building blocks of biocompatible and degradable polymers. Bile acids have been incorporated into biodegradable polymeric structures as pendant moieties on natural polymers, such as dextran and chitosan, and as the core component of the backbone of synthetic polymers and dendrimers. In the two latter cases, linkage of the repeating units relies on anhydride, ester or amide bonds. Owing to the rigidity of the steroidal polycyclic backbone and the amphiphilic properties of bile acids, materials based on these compounds can display interesting tunable properties. Therefore, biodegradable polymers based on bile acids are of particular interest to the fields of drug delivery, where their amphiphilic properties can be used to encapsulate drugs, and tissue engineering, where their rigid steroidal backbone make them good candidates for controlling the mechanical properties of the materials.
C1 Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada.
RP Zhu, XX (reprint author), Univ Montreal, Dept Chim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.
EM julian.zhu@umontreal.ca
RI Zhu, X. X./C-8991-2009; Gautrot, Julien/S-7920-2016
OI Zhu, X. X./0000-0003-0828-299X; Gautrot, Julien/0000-0002-1614-2578
CR AHLHEIM M, 1992, MAKROMOL CHEM, V193, P779
   AHLHEIM M, 1988, MAKROMOL CHEM-RAPID, V9, P299
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Balasubramanian R, 1999, CHEM COMMUN, P2353, DOI 10.1039/a907297g
   Balasubramanian R, 2001, J ORG CHEM, V66, P3035, DOI 10.1021/jo0013305
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Benrebouh A, 2001, POLYMER, V42, P4031, DOI 10.1016/S0032-3861(00)00837-5
   Benrebouh A, 2000, MACROMOL RAPID COMM, V21, P685, DOI 10.1002/1521-3927(20000601)21:10<685::AID-MARC685>3.0.CO;2-E
   Bhattarai KM, 1997, J ORG CHEM, V62, P8463, DOI 10.1021/jo971272w
   BONARLAW RP, 1993, TETRAHEDRON, V49, P9829, DOI 10.1016/S0040-4020(01)80185-X
   BONARLAW RP, 1993, TETRAHEDRON, V49, P9855
   BONARLAW RP, 1993, TETRAHEDRON, V49, P9845, DOI 10.1016/S0040-4020(01)80186-1
   BOURGES M, 1967, BIOCHIM BIOPHYS ACTA, V144, P189, DOI 10.1016/0005-2760(67)90149-X
   BOURGES M, 1967, BIOCHIM BIOPHYS ACTA, V137, P157, DOI 10.1016/0005-2760(67)90019-7
   BRAUN AG, 1982, P NATL ACAD SCI-BIOL, V79, P2056, DOI 10.1073/pnas.79.6.2056
   CAREY MC, 1970, AM J MED, V49, P590, DOI 10.1016/S0002-9343(70)80127-9
   CAREY MC, 1969, J COLLOID INTERF SCI, V31, P382, DOI 10.1016/0021-9797(69)90181-7
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chen WH, 2005, J AM CHEM SOC, V127, P12727, DOI 10.1021/ja053527q
   Cheng YA, 1996, J AM CHEM SOC, V118, P1813, DOI 10.1021/ja952976v
   Conix A, 1966, MACROMOL SYNTHESES, V2, P95
   Constantinidis I, 1999, BIOMATERIALS, V20, P2019, DOI 10.1016/S0142-9612(99)00104-0
   DENIKE JK, 1994, MACROMOL RAPID COMM, V15, P459, DOI 10.1002/marc.1994.030150603
   Diancourt F, 1996, J BIOACT COMPAT POL, V11, P203, DOI 10.1177/088391159601100303
   DOMB AJ, 1993, ADV POLYM SCI, V107, P93
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   Domb AJ, 1998, ACTA POLYM, V49, P526, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<526::AID-APOL526>3.0.CO;2-C
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   EVANS SM, 1995, J MOL STRUC-THEOCHEM, V334, P193, DOI 10.1016/0166-1280(94)04026-O
   Geurtsen W, 1998, J BIOMED MATER RES, V41, P474, DOI 10.1002/(SICI)1097-4636(19980905)41:3<474::AID-JBM18>3.0.CO;2-I
   Giri AK, 1997, MUTAT RES-REV MUTAT, V386, P25, DOI 10.1016/S1383-5742(96)00042-7
   Gouin S, 1998, LANGMUIR, V14, P4025, DOI 10.1021/la971155w
   Gouin S, 2000, MACROMOLECULES, V33, P5379, DOI 10.1021/ma991364i
   Gouin S, 1996, STEROIDS, V61, P664, DOI 10.1016/S0039-128X(96)00187-0
   Guo WX, 2004, POLYM DEGRAD STABIL, V84, P375, DOI 10.1016/j.polydegradstab.2003.10.012
   Hartmann MH, 1998, BIOPOLYMERS RENEWABL, P367
   Hill J. W., 1932, J AM CHEM SOC, V54, P1569
   HOFMANN AF, 1963, BIOCHIM BIOPHYS ACTA, V70, P306, DOI 10.1016/0006-3002(63)90754-6
   HOFMANN AF, 1963, BIOCHEM J, V89, P57, DOI 10.1042/bj0890057
   Hu XZ, 2005, STEROIDS, V70, P531, DOI 10.1016/j.steroids.2004.11.015
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IDA T, 1983, J ORG CHEM, V48, P1194
   Janout V, 1996, J AM CHEM SOC, V118, P1573, DOI 10.1021/ja953261v
   Janout V, 2005, J AM CHEM SOC, V127, P22, DOI 10.1021/ja044257z
   Janout V, 1997, J AM CHEM SOC, V119, P640, DOI 10.1021/ja962405i
   Janout V, 2000, J AM CHEM SOC, V122, P2671, DOI 10.1021/ja000007g
   Jing BW, 2004, J AM CHEM SOC, V126, P15930, DOI 10.1021/ja044400o
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Khatri CA, 2003, DENT MATER, V19, P584, DOI 10.1016/S0109-5641(02)00108-2
   Kim JB, 1999, POLYMER, V40, P7423, DOI 10.1016/S0032-3861(99)00388-2
   Kim JB, 2000, CHEM LETT, P414, DOI 10.1246/cl.2000.414
   Kim K, 2005, BIOMACROMOLECULES, V6, P1154, DOI 10.1021/bm049305m
   Krasko MY, 2003, POLYM ADVAN TECHNOL, V14, P832, DOI 10.1002/pat.403
   KWAN KH, 1978, J PHARM SCI, V67, P1711, DOI 10.1002/jps.2600671220
   Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   LAPPALAINEN KV, 1995, SPECTROCHIM ACTA A, V51, P1543, DOI 10.1016/0584-8539(95)01466-8
   LAURENCIN C, 1990, J BIOMED MATER RES, V24, P1463, DOI 10.1002/jbm.820241105
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee KY, 2000, COLLOID POLYM SCI, V278, P1216, DOI 10.1007/s003960000389
   Lee KY, 1998, MACROMOLECULES, V31, P378, DOI 10.1021/ma9711304
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   Luo LB, 2002, BIOCONJUGATE CHEM, V13, P1259, DOI 10.1021/bc025524y
   Matsusaki M, 2005, BIOMATERIALS, V26, P6263, DOI 10.1016/j.biomaterials.2005.03.044
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nakano K, 2001, POLYM J, V33, P172, DOI 10.1295/polymj.33.172
   Nichifor M, 1999, MACROMOLECULES, V32, P7078, DOI 10.1021/ma990408k
   Nichifor M, 2004, REACT FUNCT POLYM, V59, P141, DOI 10.1016/j.reactfunctpolym.2004.01.003
   Nichifor M, 1999, EUR POLYM J, V35, P2125, DOI 10.1016/S0014-3057(99)00013-0
   Noll O, 1996, MACROMOL RAPID COMM, V17, P553, DOI 10.1002/marc.1996.030170808
   Orienti I, 1996, J Pharm Belg, V51, P125
   Park JH, 2004, J CONTROL RELEASE, V95, P579, DOI 10.1016/j.jconrel.2003.12.020
   PATTINSON N, 1980, J CHROMATOGR, V187, P409, DOI 10.1016/S0021-9673(00)80473-2
   RADOMINSKAPYREK A, 1986, J LIPID RES, V27, P89
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shawaphun S, 1999, J AM CHEM SOC, V121, P5860, DOI 10.1021/ja9904641
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Silver F.H., 1999, BIOMATERIALS SCI BIO, P87
   SILVER FH, 1999, BIOMATERIALS SCI BIO, P27
   Slivniak R, 2005, MACROMOLECULES, V38, P5634, DOI 10.1021/ma050157h
   Slivniak R, 2005, MACROMOLECULES, V38, P5545, DOI 10.1021/ma0503918
   SMALL DM, 1969, NATURE, V221, P265, DOI 10.1038/221265a0
   SMALL DM, 1966, NATURE, V211, P816, DOI 10.1038/211816a0
   SMALL DM, 1966, BIOCHIM BIOPHYS ACTA, V125, P563, DOI 10.1016/0005-2760(66)90044-0
   Small DM, 1971, BILE ACIDS CHEM PHYS
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VADNERE M, 1980, J PHYS CHEM-US, V84, P1900, DOI 10.1021/j100452a007
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   Vijayakshmi N, 2005, ORG LETT, V7, P2727, DOI 10.1021/ol050809m
   Vijayaraghavan S, 2003, BIOCONJUGATE CHEM, V14, P667, DOI 10.1021/bc034007s
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   Wess G, 1996, ANGEW CHEM INT EDIT, V35, P2222, DOI 10.1002/anie.199622221
   Xu HB, 2001, POLYM BULL, V46, P435, DOI 10.1007/s002890170029
   Yoo HS, 2005, J CONTROL RELEASE, V103, P235, DOI 10.1016/j.jconrel.2004.11.033
   Zhang JB, 2003, J AM CHEM SOC, V125, P13984, DOI 10.1021/ja036390h
   Zhang YH, 1998, MACROMOL CHEM PHYSIC, V199, P1399, DOI 10.1002/macp.1998.021990718
   Zhang YH, 1996, MACROMOL CHEM PHYSIC, V197, P3473, DOI 10.1002/macp.1996.021971032
   Zhu XX, 2002, ACCOUNTS CHEM RES, V35, P539, DOI 10.1021/ar0101180
   Zhu XX, 1996, POLYMER, V37, P493, DOI 10.1016/0032-3861(96)82920-X
   Zuluaga F, 1999, POLYM BULL, V42, P41, DOI 10.1007/s002890050432
NR 101
TC 27
Z9 28
U1 1
U2 25
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 10
BP 1123
EP 1139
DI 10.1163/156856206778530713
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 113XS
UT WOS:000242631900004
DA 2018-10-20
ER

PT J
AU Hasirci, V
   Vrana, E
   Zorlutuna, P
   Ndreu, A
   Yilgor, P
   Basmanav, FB
   Aydin, E
AF Hasirci, V.
   Vrana, E.
   Zorlutuna, P.
   Ndreu, A.
   Yilgor, P.
   Basmanav, F. B.
   Aydin, E.
TI Nanobiomaterials: a review of the existing science and technology, and
   new approaches
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE nanobiomaterials; tissue engineering; drug delivery; composites;
   nanofibers
ID BLOCK COPOLYMERIC NANOSPHERES; TARGETED DRUG-DELIVERY; OSTEOBLAST-LIKE
   CELLS; IN-VITRO; POLYMERIC MICELLES; NANOPHASE CERAMICS;
   CONTROLLED-RELEASE; CONTACT GUIDANCE; GROWTH-FACTOR; NANOPARTICLES
AB Nanotechnology has made great strides forward in the creation of new surfaces, new materials and new forms which also find application in the biomedical field. Traditional biomedical applications started benefiting from the use nanotechnology in an array of areas, such as biosensors, tissue engineering, controlled release systems, intelligent systems and nanocomposites used in implant design. In this manuscript a review of developments in these areas will be provided along with some applications from our laboratories.
C1 Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   Middle E Tech Univ, Dept Biotechnol, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
RP Hasirci, V (reprint author), Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
EM vhasirci@metu.edu.tr
RI Aydin, Erkin/D-9422-2012; Vrana, Nihal/A-2029-2010; Zorlutuna,
   Pinar/A-7208-2015
OI Vrana, Nihal/0000-0002-5398-6710; Zorlutuna, Pinar/0000-0002-3122-7553
CR Ahn YC, 2006, CURR APPL PHYS, V6, P1030, DOI 10.1016/j.cap.2005.07.013
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Belkas JS, 2004, OPER TECH ORTHOP, V14, P190
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   BHATIA M, 2004, MED CHEM REV ONLINE, V1, P25
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Buchko CJ, 2001, BIOMATERIALS, V22, P1289, DOI 10.1016/S0142-9612(00)00281-7
   Chaw CS, 2004, BIOMATERIALS, V25, P4297, DOI 10.1016/j.biomaterials.2003.10.095
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHILKOTI A, 2000, ADV DRUG DEL REV, V54, P1093
   Choi DG, 2005, LANGMUIR, V21, P9390, DOI 10.1021/la0513205
   Chung JE, 2000, J CONTROL RELEASE, V65, P93, DOI 10.1016/S0168-3659(99)00242-4
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Courrier HM, 2002, CRIT REV THER DRUG, V19, P425, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Cui DX, 2003, BIOTECHNOL PROGR, V19, P683, DOI 10.1021/bp025791i
   Dai JD, 2004, INT J PHARM, V280, P229, DOI 10.1016/j.ijpharm.2004.05.006
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Dersch R, 2005, POLYM ADVAN TECHNOL, V16, P276, DOI 10.1002/pat.568
   Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Eccleston ME, 2000, J CONTROL RELEASE, V69, P297, DOI 10.1016/S0168-3659(00)00316-3
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Emery DFG, 1997, J BONE JOINT SURG BR, V79B, P240, DOI 10.1302/0301-620X.79B2.7165
   *ESA, 2003, NEWSLETTER, P166
   Fong H, 2004, POLYMER, V45, P2427, DOI 10.1016/j.polymer.2004.01.067
   Foss AC, 2004, EUR J PHARM BIOPHARM, V57, P163, DOI 10.1016/s0939-6411(03)00145-0
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   GRAHAM K., 2002, 15 ANN TECH C EXP AM, P1
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Hansma HG, 2004, CURR OPIN STRUC BIOL, V14, P380, DOI 10.1016/j.sbi.2004.05.005
   He LP, 2004, MAT SCI ENG A-STRUCT, V367, P51, DOI 10.1016/j.msea.2003.09.083
   HSIUE G, 2000, BIOMATERIALS, V23, P457
   Hu Y, 2005, POLYMER, V46, P12703, DOI 10.1016/j.polymer.2005.10.110
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   JAIN KK, 2005, DRUG DISOCVERY TODAY, V10, P21
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim IS, 2000, INT J PHARM, V211, P1, DOI 10.1016/S0378-5173(00)00592-5
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim SY, 2000, J CONTROL RELEASE, V65, P345, DOI 10.1016/S0168-3659(99)00207-2
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069
   Kyriakides TR, 2002, J CONTROL RELEASE, V78, P295, DOI 10.1016/S0168-3659(01)00504-1
   Lal M, 2000, CHEM MATER, V12, P2632, DOI 10.1021/cm000178k
   Lamprecht A, 2001, J PHARMACOL EXP THER, V299, P775
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lo CL, 2005, J CONTROL RELEASE, V104, P477, DOI 10.1016/j.jconrel.2005.03.004
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MAA Z, 2005, J MEMBRANE SCI, V265, P115
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   Martinez N, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-44
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Moller-Pedersen T, 2004, EXP EYE RES, V78, P553, DOI 10.1016/S0014-4835(03)00208-2
   Monsky WL, 1999, CANCER RES, V59, P4129
   Murthy N, 2003, J CONTROL RELEASE, V89, P365, DOI 10.1016/S0168-3659(03)00099-3
   Na K, 2004, J CONTROL RELEASE, V97, P513, DOI 10.1016/j.jconrel.2004.04.005
   NA K, 2003, J CONTROL RELEASE, V87, P32
   Nishiyama N, 2003, ADV EXP MED BIOL, V519, P155
   Olivier J. C., 2005, J AM SOC EXP NEUROTH, V2, P108
   Park EK, 2005, BIOMATERIALS, V26, P1053, DOI 10.1016/j.biomaterials.2004.04.008
   Pathak P, 2004, J AM CHEM SOC, V126, P10842, DOI 10.1021/ja046914t
   Patri AK, 2005, ADV DRUG DELIVER REV, V57, P2203, DOI 10.1016/j.addr.2005.09.014
   Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v
   PINCHUK L, 1994, Patent No. 5376117
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   Salvage JP, 2005, J CONTROL RELEASE, V104, P259, DOI 10.1016/j.jcornel.2005.02.003
   Sandler J, 2002, COMPOS PART A-APPL S, V33, P1033, DOI 10.1016/S1359-835X(02)00084-2
   Sawicka K, 2005, SENSOR ACTUAT B-CHEM, V108, P585, DOI 10.1016/j.snb.2004.12.013
   Schift H, 2002, MICROELECTRON ENG, V61-2, P423, DOI 10.1016/S0167-9317(02)00513-0
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shin YS, 2001, J CONTROL RELEASE, V73, P1, DOI 10.1016/S0168-3659(01)00247-4
   SIEGEL RA, 1993, ADV POLYM SCI, V109, P233
   Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9
   Teixeira AI, 2003, J VAC SCI TECHNOL B, V21, P683, DOI 10.1116/1.1545753
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Vihola H, 2002, EUR J PHARM SCI, V16, P69, DOI 10.1016/S0928-0987(02)00076-3
   Villen J, 2004, VACCINE, V22, P3523, DOI 10.1016/j.vaccine.2004.05.006
   Wakamatsu H, 2006, J MAGN MAGN MATER, V302, P327, DOI 10.1016/j.jmmm.2005.09.032
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Walsh WR, 2000, CLIN ORTHOP RELAT R, P258
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang CH, 2005, J CONTROL RELEASE, V108, P140, DOI 10.1016/j.jconrel.2005.07.017
   Wang J, 2005, J DRUG TARGET, V13, P73, DOI 10.1080/10611860400011935
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Webster TJ, 2003, AM CERAMIC SOC B, V82, P1
   Wei H, 2006, BIOMATERIALS, V27, P2028, DOI 10.1016/j.biomaterials.2005.09.028
   Whelan J, 2001, DRUG DISCOV TODAY, V6, P1183, DOI 10.1016/S1359-6446(01)02055-4
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   WU J, 2005, J CONTROL RELEASE, V1002, P361
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   XIAN Y, 2005, IN PRESS BIOSENSORS
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   YSHIMOTO H, 2003, BIOMATERIALS, V24, P2077
   Yuna YH, 2004, BIOMATERIALS, V25, P147
   Zhang QQ, 1996, ARTIF CELL BLOOD SUB, V24, P693, DOI 10.3109/10731199609118892
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 128
TC 47
Z9 50
U1 2
U2 47
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2006
VL 17
IS 11
BP 1241
EP 1268
DI 10.1163/156856206778667442
PG 28
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 113RL
UT WOS:000242614900004
PM 17176748
DA 2018-10-20
ER

PT J
AU Barbucci, R
   Leone, G
   Lamponi, S
AF Barbucci, R
   Leone, G
   Lamponi, S
TI Thixotrophy property of hydrogels to evaluate the cell growing on the
   inside of the material bulk (Amber effect)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polysaccharide hydrogel; tixotrophy; Amber effect; cell
ID CROSS-LINKING; CHITOSAN; BONE; PH; BIOMATERIALS; OSTEOBLASTS; BEHAVIOR;
   RELEASE; DESIGN; GROWTH
AB The realization of injectable hydrogels is one of the most challenging aims of biomedical research. Most injectable hydrogels are obtained by photopolymerization in situ. A hydrogel which is able to pass through a needle without losing its structure once crosslinked would be of great interest for several biomedical applications. In this work, hyaluronane and alginate-based 50% hydrogels were synthesized, their thixotrophic behavior was verified and their mechanical properties (G' and G") were determined before and after the passage through the needle. A morphological analysis by scanning electron microscopy (SEM) was also performed in order to evaluate the effect of the passage of the hydrogel through the needle on the morphological structure of the material. The thixotrophic property of these hydrogels is used to realize a cell-containing material that supports cell proliferation and growth permitting in vivo engineering of new tissues. In fact, thixotrophic hydrogel can be sucked together with cell suspension and in this way cells remain entrapped inside the hydrogel structure (Amber effect). A comparison of the cell growth using this technique with the classical seeding technique (cell seeding onto the hydrogel) was performed. A different behavior was found between hyaluronane and alginate-based hydrogels. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Siena, CRISMA, I-53100 Siena, Italy.
   Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, CRISMA, Via Aldo Moro 2, I-53100 Siena, Italy.
EM barbucci@unisi.it
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Barbucci R, 2000, MACROMOLECULES, V33, P7475, DOI 10.1021/ma0007029
   Barbucci R, 2003, MACROMOL SYMP, V204, P37, DOI 10.1002/masy.200351405
   Barbucci R, 2002, MACROMOL CHEM PHYSIC, V203, P1292, DOI 10.1002/1521-3935(200207)203:10/11<1292::AID-MACP1292>3.0.CO;2-I
   Barbucci R, 2000, J BIOMAT SCI-POLYM E, V11, P383, DOI 10.1163/156856200743779
   Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9
   Beattie MS, 1998, POLYMER, V39, P2597, DOI 10.1016/S0032-3861(97)00559-4
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chen F, 2003, BRIT J ORAL MAX SURG, V41, P240, DOI 10.1016/S0266-4356(03)00084-6
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Cohn D, 2003, BIOMATERIALS, V24, P3707, DOI 10.1016/S0142-9612(03)00245-X
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Virender K. S., 1981, ANAL BIOCHEM, V117, P147
NR 24
TC 17
Z9 18
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2006
VL 76B
IS 1
BP 33
EP 40
DI 10.1002/jbm.b.30390
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998FO
UT WOS:000234304200005
PM 16240431
DA 2018-10-20
ER

PT J
AU Waybright, TJ
   Van, QN
   Muschik, GM
   Conrads, TP
   Veenstra, TD
   Issaq, HJ
AF Waybright, Timothy J.
   Van, Que N.
   Muschik, Gary M.
   Conrads, Thomas P.
   Veenstra, Timothy D.
   Issaq, Haleem J.
TI LC-MS in metabonomics: Optimization of experimental conditions for the
   analysis of metabolites in human urine
SO JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
LA English
DT Article
DE metabonomics; metabolomics; urine; mass spectrometry; HPLC-MS
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; MULTIVARIATE STATISTICAL-ANALYSIS;
   CLINICALLY IMPORTANT METABOLITES; TANDEM MASS-SPECTROMETRY; RAT URINE;
   METABOLOMICS; NMR; SAMPLES; IDENTIFICATION; DIAGNOSIS
AB The analysis of metabolic pathways for dysfunction has been used for many years in the scientific and medical community to determine overall health. Metabonomics (metabolomics), the global profiling of metabolites, has experienced a rekindling of interest due, in part, to advances in analytical instrumentation for conducting measurements and informatics available for interpretation of the data acquired in this area of biomedical research. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) based approaches are two primary analytical methods of choice for conducting metabonomic measurements. To overcome the complexity and wide dynamic range of concentrations of metabolites present in biological samples, a common practice is to couple online an analytical separation, typically high performance liquid chromatography (HPLC), with the mass spectrometer. Hence, of critical importance are not only the MS acquisition parameters, but also optimization of those variables that impact the analytical HPLC separation as well. A systematic investigation of a number of variables related to HPLC, such as mobile phase composition and flow rate, gradient time, column dimensions, and packing material properties has been conducted. The results of this study show that 10 cm long x 1 mm inner diameter (i.d.), C-18 reversed-phase columns provide higher resolution than C-8 or C-4 columns for the analysis of urine samples. The results also show that longer columns and extended mobile phase gradients allowed detection of a greater number of metabolites. As expected, MS analysis of the same urine sample using positive and negative ionization modes resulted in detection of a different ensemble of metabolites. Though prior dilution of rat and mouse urine is a common practice in conducting HPLC-MS metabonomic analyses, our results suggest that a greater number of species may be observed using undiluted urine. The matrix ( composition) of urine collected from different individuals affected the reproducibility of retention times. The variability in metabolite retention times using internal standards, although improved, was not completely corrected.
C1 NCI, Lab Proteom & Analyt Technol, SAIC Frederick Inc, Frederick, MD 21702 USA.
RP Issaq, HJ (reprint author), NCI, Lab Proteom & Analyt Technol, SAIC Frederick Inc, POB B, Frederick, MD 21702 USA.
EM issaqh@mail.ncifcrf.gov
CR Boutilier K, 2005, ANAL CHIM ACTA, V534, P11, DOI 10.1016/j.aca.2004.04.047
   Brown SC, 2005, MASS SPECTROM REV, V24, P223, DOI 10.1002/mas.20011
   CARR HY, 1954, PHYS REV, V94, P638
   Crockford DJ, 2006, ANAL CHEM, V78, P363, DOI 10.1021/ac051444m
   Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021
   Fiehn O, 2003, EUR J BIOCHEM, V270, P579, DOI 10.1046/j.1432-1033.2003.03427.x
   Gamache PH, 2004, J AM SOC MASS SPECTR, V15, P1717, DOI 10.1016/j.jasms.2004.08.016
   Gonthier MP, 2003, J CHROMATOGR B, V789, P247, DOI 10.1016/S1570-0232(03)00073-4
   Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007
   Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390
   Hong JF, 1997, J CAPILLARY ELECTROP, V4, P65
   Hong Y, 2004, J AGR FOOD CHEM, V52, P6794, DOI 10.1021/jf040274w
   Hsu CT, 2006, SENSOR ACTUAT B-CHEM, V113, P22, DOI 10.1016/j.snb.2005.02.018
   Idborg-Bjorkman H, 2003, ANAL CHEM, V75, P4784, DOI 10.1021/ac0341618
   Jansen JJ, 2005, ANAL CHIM ACTA, V530, P173, DOI 10.1016/j.aca.2004.09.074
   KATAJAMAA M, 2005, BMC BIOINFORMATICS, V6
   KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6
   Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002
   Lenz EM, 2003, J PHARMACEUT BIOMED, V33, P1103, DOI 10.1016/S0731-7085(03)00410-2
   LINDON JC, 2003, ANAL CHEM, V75, pA385
   Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047
   Pham-Tuan H, 2003, J CHROMATOGR B, V789, P283, DOI 10.1016/S1570-0232(03)00077-1
   Plumb R, 2003, ANALYST, V128, P819, DOI 10.1039/b304296k
   Plumb RS, 2003, RAPID COMMUN MASS SP, V17, P2632, DOI 10.1002/rcm.1250
   Plumb RS, 2002, RAPID COMMUN MASS SP, V16, P1991, DOI 10.1002/rcm.813
   Rashed MS, 2001, J CHROMATOGR B, V758, P27, DOI 10.1016/S0378-4347(01)00100-1
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2
   Valafar F, 2002, ANN NY ACAD SCI, V980, P41, DOI 10.1111/j.1749-6632.2002.tb04888.x
   Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101
   Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151
   Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013
   Williams RE, 2005, TOXICOLOGY, V207, P179, DOI 10.1016/j.tox.2004.08.023
   Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r
   Yang J, 2004, J CHROMATOGR B, V813, P59, DOI 10.1016/j.jchromb.2004.09.032
NR 35
TC 16
Z9 18
U1 1
U2 36
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1082-6076
J9 J LIQ CHROMATOGR R T
JI J. Liq. Chromatogr. Relat. Technol.
PY 2006
VL 29
IS 17
BP 2475
EP 2497
DI 10.1080/10826070600914638
PG 23
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 081YA
UT WOS:000240352300001
DA 2018-10-20
ER

PT J
AU He, CL
   Huang, ZM
   Han, XJ
   Liu, L
   Zhang, HS
   Chen, LS
AF He, CL
   Huang, ZM
   Han, XJ
   Liu, L
   Zhang, HS
   Chen, LS
TI Coaxial electrospun poly(L-lactic acid) ultrafine fibers for sustained
   drug delivery
SO JOURNAL OF MACROMOLECULAR SCIENCE PART B-PHYSICS
LA English
DT Article; Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE drug delivery; coaxial electrospinning; core-shell; ultrafine fibers;
   poly(L-lactic acid); tetracycline hydrochloride
ID NANOFIBERS; RELEASE; POLYMER
AB A coaxial electrospinning technique to fabricate core-shell ultrafine fiber mats for drug delivery application is described in this paper. Poly (L-lactic acid) (PLLA) and tetracycline hydrochloride (TCH) were employed as the shell and core materials, respectively. To investigate the feasibility of the resulting fiber mats for use as drug release carriers, these electrospun fibers were characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), and tensile testing. In vitro drug release behavior was also examined by ultraviolet-visible (UV-VIS) spectroscopy. Results indicated that a reservoir-type drug release device can be conveniently obtained through encapsulating TCH in the PLLA ultrafine fiber. The size of the ultrafine fibers had a significant effect on their physical-chemical properties. Furthermore, a sustained TCH release from these fiber mats was also observed. Consequently, the electrospun ultrafine fiber mats containing drugs may be used as drug release carriers or made into biomedical devices such as sutures and wound dressings.
C1 Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
RP Huang, ZM (reprint author), Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
EM huangzm@mail.tongji.edu.cn
RI He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
CR Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Gibson R.F., 1994, PRINCIPLES COMPOSITE
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   HUANG ZM, 2006, J BIOMED MAT RES A
   IGNATIOUS F, 1988, Patent No. 02399
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jin FZ, 2002, MACROMOL RAPID COMM, V23, P909, DOI 10.1002/1521-3927(20021001)23:15<909::AID-MARC909>3.0.CO;2-8
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Li D, 2004, NANO LETT, V4, P933, DOI 10.1021/nl049590f
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   RAYMOND TB, 1998, SCIENCE, V281, P1161
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   SUN Z, 2003, ADV MATER, V22, P1929
   THERESA MA, 2004, SCIENCE, V303, P1818
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Yu JH, 2004, ADV MATER, V16, P1562, DOI 10.1002/adma.200306644
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhang YZ, 2004, CHEM MATER, V16, P3406, DOI 10.1021/cm049580f
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 22
TC 100
Z9 103
U1 4
U2 74
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0022-2348
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2006
VL 45
IS 4
BP 515
EP 524
DI 10.1080/00222340600769832
PG 10
WC Polymer Science
SC Polymer Science
GA 057SS
UT WOS:000238616100009
DA 2018-10-20
ER

PT J
AU Ulijn, RV
AF Ulijn, RV
TI Enzyme-responsive materials: a new class of smart biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; SUPRAMOLECULAR HYDROGEL; BIOMEDICAL
   APPLICATIONS; CROSS-LINKING; PEPTIDE; POLYMERS; BEADS; NANOLITHOGRAPHY;
   BIOFABRICATION; BIOCATALYSIS
AB Enzyme-responsive materials (ERMs) are a new class of smart materials that undergo macroscopic transitions when triggered by selective catalytic actions of enzymes. The use of enzymes as stimuli to trigger mechanical responses in materials opens up a number of possible applications in biology and medicine. Three different classes of ERMs are described, based on supramolecular assemblies, chemically crosslinked gels and (nanoparticle) surfaces. Potential applications in regenerative medicine, diagnostics, and drug delivery are discussed.
C1 Sch Mat & Manchester Interdisciplinary Bioctr, Manchester M1 7HS, Lancs, England.
RP Ulijn, RV (reprint author), Sch Mat & Manchester Interdisciplinary Bioctr, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM rein.ulijn@manchester.ac.uk
RI Ulijn, Rein/C-3998-2009
FU Engineering and Physical Sciences Research Council [GR/T09736/01]
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Amir RJ, 2005, ANGEW CHEM INT EDIT, V44, P4378, DOI 10.1002/anie.200500842
   Basso A, 2003, CHEM COMMUN, P1296, DOI 10.1039/b301680c
   Bosma AY, 2003, CHEM COMMUN, P2790, DOI 10.1039/b308078a
   Burke MD, 2005, J CONTROL RELEASE, V104, P141, DOI 10.1016/j.jconrel.2005.01.017
   Chen TH, 2003, BIOMACROMOLECULES, V4, P1558, DOI 10.1021/bm034145k
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Das G, 2002, SCIENCE, V298, P1600, DOI 10.1126/science.1077353
   de Groot FMH, 2001, CURR MED CHEM, V8, P1093
   Dos Santos S, 2005, J AM CHEM SOC, V127, P11888, DOI 10.1021/ja052083v
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Duncan R., 2003, BIOMEDICAL ASPECTS D, P193
   Eastoe J, 2005, SOFT MATTER, V1, P338, DOI 10.1039/b510877m
   Frey W, 2003, ADV MATER, V15, P248, DOI 10.1002/adma.200390058
   FREY W, 2004, BIOMATERIALS SCI INT, P107
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Guarise C, 2006, P NATL ACAD SCI USA, V103, P3978, DOI 10.1073/pnas.0509372103
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Halling PJ, 2005, CURR OPIN BIOTECH, V16, P385, DOI 10.1016/j.copbio.2005.08.006
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hyun J, 2004, J AM CHEM SOC, V126, P4770, DOI 10.1021/ja049956q
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kanaras AG, 2003, ANGEW CHEM INT EDIT, V42, P191, DOI 10.1002/anie.200390075
   KIM S, J BIOMED MAT RES A, V75, P73
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719
   Kumashiro Y, 2004, MACROMOL RAPID COMM, V25, P867, DOI 10.1002/marc.200300279
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LANGER R, NATURE, V428, P487
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lehn J.-M, 1995, SUPRAMOLECULAR CHEM
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Ooya T, 2001, BIOMACROMOLECULES, V2, P200, DOI 10.1021/bm005618f
   Plunkett KN, 2005, BIOMACROMOLECULES, V6, P632, DOI 10.1021/bm049349v
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reents R, 2001, ADV SYNTH CATAL, V343, P501, DOI 10.1002/1615-4169(200108)343:6/7<501::AID-ADSC501>3.0.CO;2-D
   Rehor A, 2005, J MATER CHEM, V15, P4006, DOI 10.1039/b510998a
   Riemenschneider L, 2005, NANO LETT, V5, P1643, DOI 10.1021/nl0484550
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Sofia SJ, 2002, J MACROMOL SCI PURE, VA39, P1151, DOI 10.1081/MA-120014843
   Sperinde JJ, 2000, MACROMOLECULES, V33, P5476, DOI 10.1021/ma000459d
   Sperinde JJ, 1997, MACROMOLECULES, V30, P5255, DOI 10.1021/ma970345a
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Tamaru S, 2005, CHEM-EUR J, V11, P7294, DOI 10.1002/chem.200500666
   Thornton PD, 2005, CHEM COMMUN, P5913, DOI 10.1039/b511005j
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Turner DC, 1996, LANGMUIR, V12, P4411, DOI 10.1021/la951520o
   Turner DC, 1997, LANGMUIR, V13, P4855, DOI 10.1021/la970324+
   Ulijn RV, 2003, CURR ORG CHEM, V7, P1333, DOI 10.2174/1385272033486422
   van Bommel KJC, 2005, ORG BIOMOL CHEM, V3, P2917, DOI 10.1039/b507157g
   Walker JP, 2005, ANAL CHEM, V77, P1596, DOI 10.1021/ac048562e
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wu LQ, 2004, TRENDS BIOTECHNOL, V22, P593, DOI 10.1016/j.tibtech.2004.09.008
   Yang ZM, 2004, CHEM COMMUN, P2424, DOI 10.1039/b408897b
   Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340
   Yeo WS, 2003, ANGEW CHEM INT EDIT, V42, P3121, DOI 10.1002/anie.200250862
   Yerushalmi R, 2005, J MATER CHEM, V15, P4480, DOI 10.1039/b505212b
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yui N., 2002, SUPRAMOLECULAR DESIG
   Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P1375, DOI 10.1002/anie.200390352
NR 66
TC 262
Z9 265
U1 12
U2 193
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2006
VL 16
IS 23
BP 2217
EP 2225
DI 10.1039/b601776m
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 050IY
UT WOS:000238082100001
DA 2018-10-20
ER

PT J
AU Wang, W
   Liu, XD
   Xie, YB
   Zhang, H
   Yu, WT
   Xiong, Y
   Xie, WY
   Ma, XJ
AF Wang, Wei
   Liu, Xiudong
   Xie, Yubing
   Zhang, Hua'an
   Yu, Weiting
   Xiong, Ying
   Xie, Weiyang
   Ma, Xiaojun
TI Microencapsulation using natural polysaccharides for drug delivery and
   cell implantation
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Review
ID ALGINATE GEL BEADS; N-ACETYLATED CHITOSANS; L-LYSINE MICROCAPSULES;
   IN-VITRO; ARTIFICIAL CELLS; ORAL DELIVERY; BIOCOMPATIBILITY EVALUATION;
   INTESTINAL DELIVERY; LACTOCOCCUS-LACTIS; CONTROLLED-RELEASE
AB Microencapsulation provides a simple and cost-effective way to enclose bioactive materials, such as drugs and cells, within a semi-permeable polymeric membrane for the purpose of protecting the bioactive materials and releasing the enclosed substances or their products in a controlled fashion. This article presents an overview of microencapsulation for biomedical applications, with focus on the progress accomplished in our laboratory. After a description of the materials chemistry and properties of natural polysaccharide-based microcapsules, applications of microencapsulation for drug delivery, cell culture and implantation are highlighted. In addition, the challenges and opportunities for chemists to assist the development of microencapsulation are discussed.
C1 Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China.
RP Ma, XJ (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, 457 Zhongshan Rd, Dalian 116023, Peoples R China.
EM maxj@dicp.ac.cn
CR Abalovich A, 2001, TRANSPLANT P, V33, P1977, DOI 10.1016/S0041-1345(01)01918-2
   AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bartkowiak A, 1999, ANN NY ACAD SCI, V875, P36, DOI 10.1111/j.1749-6632.1999.tb08492.x
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bienaime C, 2003, J BIOMED MATER RES A, V67A, P376, DOI 10.1002/jbm.a.10487
   Blanquet S, 2004, J BIOTECHNOL, V110, P37, DOI 10.1016/j.biotec.2004.01.012
   Blanquet S, 2001, TRENDS BIOTECHNOL, V19, P393, DOI 10.1016/S0167-7799(01)01739-5
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Buchser E, 1996, ANESTHESIOLOGY, V85, P1005, DOI 10.1097/00000542-199611000-00007
   BYSTRICKY S, 1990, CARBOHYD POLYM, V13, P283, DOI 10.1016/0144-8617(90)90060-6
   Chandy T, 1998, J APPL POLYM SCI, V70, P2143, DOI 10.1002/(SICI)1097-4628(19981212)70:11<2143::AID-APP7>3.0.CO;2-L
   Chang TMS, 2005, NAT REV DRUG DISCOV, V4, P221, DOI 10.1038/nrd1659
   Chang TMS, 2004, ARTIF ORGANS, V28, P265, DOI 10.1111/j.1525-1594.2004.47343.x
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chang TMS, 1998, ARTIF ORGANS, V22, P958, DOI 10.1046/j.1525-1594.1998.06243.x
   Cho YW, 2003, J PHARM PHARMACOL, V55, P721, DOI 10.1211/0022357021206
   de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   ELDRIDGE JH, 1991, MOL IMMUNOL, V28, P287, DOI 10.1016/0161-5890(91)90076-V
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   GIN H, 1990, BIOMATER ARTIF CELL, V18, P25, DOI 10.3109/10731199009117287
   Goldberg M, 2003, NAT REV DRUG DISCOV, V2, P289, DOI 10.1038/nrd1067
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Hari PR, 1996, J APPL POLYM SCI, V59, P1795
   He Y, 2000, CHEM J CHINESE U, V21, P278
   HENRY JB, 1991, CLIN DIAGNOSIS MANAG, P1371
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Isobe M, 1999, J BIOMED MATER RES, V45, P36, DOI 10.1002/(SICI)1097-4636(199904)45:1<36::AID-JBM5>3.0.CO;2-I
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   JANI P, 1990, J PHARM PHARMACOL, V42, P821, DOI 10.1111/j.2042-7158.1990.tb07033.x
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Kang IK, 2005, J MATER SCI-MATER M, V16, P533, DOI 10.1007/s10856-005-0529-9
   Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2004, BIOMATERIALS, V25, P2461, DOI 10.1016/j.biomaterials.2003.09.030
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   [李胜 Li Sheng], 2004, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V35, P657
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Liu Q, 2002, CHEM J CHINESE U, V23, P1417
   Liu XD, 2004, CARBOHYD POLYM, V56, P459, DOI 10.1016/j.carbpol.2004.03.011
   Liu XD, 2003, J APPL POLYM SCI, V87, P848, DOI 10.1002/app.11537
   Liu XD, 2000, CHINESE SCI BULL, V45, P2476
   Liu ZP, 2005, J CONTROL RELEASE, V102, P135, DOI 10.1016/j.jconrel.2004.06.022
   Ma J, 2006, J BIOTECHNOL, V125, P242, DOI 10.1016/j.jbiotec.2006.02.025
   MA XJ, 1994, ARTIF CELL BLOOD SUB, V22, P43, DOI 10.3109/10731199409117399
   MA XJ, 1995, CHIN J ORGAN TRANSPL, V16, P159
   Magyar JP, 2001, ANN NY ACAD SCI, V944, P135
   MORRIS W, 1994, VACCINE, V12, P5, DOI 10.1016/0264-410X(94)90003-5
   Murata Y, 2003, J BIOMAT SCI-POLYM E, V14, P581, DOI 10.1163/15685620360674263
   Murata Y, 2000, EUR J PHARM BIOPHARM, V50, P221, DOI 10.1016/S0939-6411(00)00110-7
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Orive G, 2003, CURR OPIN BIOTECH, V14, P659, DOI 10.1016/j.copbio.2003.10.007
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   Prakash S, 2000, INT J ARTIF ORGANS, V23, P429
   Qi WT, 2006, BIOTECHNOL BIOENG, V93, P887, DOI 10.1002/bit.20782
   Qi WT, 2006, J MEMBRANE SCI, V269, P126, DOI 10.1016/j.memsci.2005.06.027
   Ramadas M, 2000, J MICROENCAPSUL, V17, P405
   Ramdas M, 1999, J BIOMATER APPL, V13, P290, DOI 10.1177/088532829901300402
   Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471
   REES DA, 1981, PURE APPL CHEM, V53, P1, DOI 10.1351/pac198153010001
   Reibetanz U, 2006, MACROMOL BIOSCI, V6, P153, DOI 10.1002/mabi.200500163
   Ren DW, 2006, J MEMBRANE SCI, V280, P99, DOI 10.1016/j.memsci.2006.01.011
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   Sakai S, 2001, ANN NY ACAD SCI, V944, P277
   Shi MQ, 2005, CANCER BIOTHER RADIO, V20, P260, DOI 10.1089/cbr.2005.20.260
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SoonShiong P, 1996, J CONTROL RELEASE, V39, P399, DOI 10.1016/0168-3659(95)00151-4
   Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840
   Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strand BL, 2004, FOCUS BIOTECHNOL, V8A, P165
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   SUGAWARA S, 1994, PHARMACEUT RES, V11, P272, DOI 10.1023/A:1018963626248
   SUN L, 2005, CHIN J CLIN REHABIL, V9, P87
   SUTHERLAND RM, 1970, INT J RADIAT BIOL RE, V18, P491, DOI 10.1080/09553007014551401
   Tam SK, 2005, BIOMATERIALS, V26, P6950, DOI 10.1016/j.biomaterials.2005.05.007
   TEMEL A, 1991, ANN OPHTHALMOL, V23, P191
   Tse M, 1996, BIOTECHNOL BIOENG, V51, P271, DOI 10.1002/(SICI)1097-0290(19960805)51:3<271::AID-BIT3>3.3.CO;2-T
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Umamaheshwari RB, 2003, DRUG DELIV, V10, P151, DOI 10.1080/10717540390215555
   Vallbacka JJ, 2001, J CONTROL RELEASE, V72, P93, DOI 10.1016/S0168-3659(01)00265-6
   Vandenberg GW, 2001, J CONTROL RELEASE, V77, P297, DOI 10.1016/S0168-3659(01)00517-X
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Wang Q, 2006, HEPATOL RES, V35, P96, DOI 10.1016/j.hepres.2006.03.003
   Wang XL, 2006, BIOTECHNOL PROGR, V22, P791, DOI 10.1021/bp050386n
   Wei OY, 2004, J PHARM PHARM SCI, V7, P315
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4, P66
   Wolf R, 2005, BIOMATERIALS, V26, P6386, DOI 10.1016/j.biomaterials.2005.04.015
   XIAO X, 2004, CHIN J CLIN REHABIL, V8, P3953
   XIE Y, 1997, MEMBR SCI TECHNOL, V17, P15
   XIE YB, 1997, MEMBRANE SCI TECHNOL, V17, P51
   Xue WM, 2004, CHEM J CHINESE U, V25, P1342
   XUE WM, 2005, CHINESE SCI BULL, V20, P2463
   XUE WM, 2003, CHEM ONLINE, V66, pW12
   Xue YL, 2000, ARTIF CELL BLOOD SUB, V28, P337
   Yu WT, 2004, CHEM J CHINESE U, V25, P1381
   YUAN J, 1997, CHINESE WILD PLANT R, V16, P8
   Zhang H, 2005, KEY ENG MATER, V288-289, P499, DOI 10.4028/www.scientific.net/KEM.288-289.499
   Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491
   Zhang XL, 2005, BIOTECHNOL PROGR, V21, P1289, DOI 10.1021/bp050003l
   Zheng JH, 2006, J APPL POLYM SCI, V102, P2226, DOI 10.1002/app.24319
   Zhou Y, 2005, J BIOTECHNOL, V117, P99, DOI 10.1016/j.biotec.2004.11.004
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
   Zimmermann H, 2003, BIOMATERIALS, V24, P2083, DOI 10.1016/S0142-9612(02)00639-7
   付颖丽, 2002, [自然科学进展, Progress in Natural Science], V12, P845
   张晓慧, 2005, [解剖学杂志, Chinese Journal of Anatomy], V28, P234
NR 126
TC 112
Z9 125
U1 3
U2 54
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2006
VL 16
IS 32
BP 3252
EP 3267
DI 10.1039/b603595g
PG 16
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 071YJ
UT WOS:000239639500001
DA 2018-10-20
ER

PT J
AU Panhuis, MIH
AF Panhuis, Marc in het
TI Carbon nanotubes: enhancing the polymer building blocks for intelligent
   materials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Review
ID OPTICALLY-ACTIVE POLYANILINES; ELECTRICAL-PROPERTIES;
   MECHANICAL-PROPERTIES; ARTIFICIAL MUSCLES; CONJUGATED POLYMER; DOPED
   POLYANILINE; BIOMEDICAL APPLICATIONS; VIBRATIONAL PROPERTIES; ELECTRONIC
   TEXTILES; CHIRAL POLYANILINE
AB Electroactive polymers can be engineered at the molecular level to recognise external stimuli, they are conductive and they are capable of localised processing. These are properties which make them ideal building blocks for intelligent materials. This article investigates the suitability of carbon nanotubes for enhancing ( polymer) building blocks for intelligent materials.
C1 Univ Wollongong, Dept Chem, Wollongong, NSW 2522, Australia.
   Univ Wollongong, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
RP Panhuis, MIH (reprint author), Univ Wollongong, Dept Chem, Northfields Ave, Wollongong, NSW 2522, Australia.
EM marc@panhuis.org
RI in het Panhuis, Marc/D-2590-2012
OI in het Panhuis, Marc/0000-0002-3259-9295
CR Abell L, 1997, SYNTHETIC MET, V84, P803, DOI 10.1016/S0379-6779(96)04154-9
   AKAGI K, 1989, SYNTHETIC MET, V28, pD1, DOI 10.1016/0379-6779(89)90667-X
   Artukovic E, 2005, NANO LETT, V5, P757, DOI 10.1021/nl0505254o
   Bao ZN, 2002, MRS BULL, V27, P441, DOI 10.1557/mrs2002.142
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   BAUGHMAN RH, COMMUNICATION
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Boonchu C, 2003, SYNTHETIC MET, V135, P241, DOI 10.1016/S0379-6779(02)00671-9
   BOUMAN MM, 1995, ADV MATER, V7, P385, DOI 10.1002/adma.19950070408
   Bradley K, 2003, NANO LETT, V3, P1353, DOI 10.1021/nl0344864
   Burghard M, 2005, SURF SCI REP, V58, P1, DOI 10.1016/j.surfrep.2005.07.001
   CAI ZH, 1991, CHEM MATER, V3, P960, DOI 10.1021/cm00017a036
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Cochet M, 2001, CHEM COMMUN, P1450, DOI 10.1039/b104009j
   Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851
   Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a
   DELABOUGLISE D, 1990, SYNTHETIC MET, V39, P117, DOI 10.1016/0379-6779(90)90205-Y
   Dettlaff-Weglikowska U, 2005, J AM CHEM SOC, V127, P5125, DOI 10.1021/ja046685a
   Ding J, 2003, SYNTHETIC MET, V138, P391, DOI 10.1016/S0379-6779(02)00453-8
   DRESSELHAUS MS, 2001, CARBON NANOTUBES
   Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q
   Ericson LM, 2004, SCIENCE, V305, P1447, DOI 10.1126/science.1101398
   Feng W, 2003, CARBON, V41, P1551, DOI 10.1016/S0008-6223(03)00078-2
   Frackowiak E, 2006, J POWER SOURCES, V153, P413, DOI 10.1016/j.jpowsour.2005.05.030
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   Frehill F, 2002, J AM CHEM SOC, V124, P13694, DOI 10.1021/ja028119q
   Frizzell CJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245420
   Gao GH, 1998, NANOTECHNOLOGY, V9, P184, DOI 10.1088/0957-4484/9/3/007
   Gao M, 2003, SYNTHETIC MET, V137, P1393, DOI 10.1016/S0379-6779(02)01156-6
   Grossiord N, 2006, CHEM MATER, V18, P1089, DOI 10.1021/cm051881h
   Grossiord N, 2005, J MATER CHEM, V15, P2349, DOI 10.1039/b501805f
   Gupta R, 2005, NANOTECHNOLOGY, V16, P1707, DOI 10.1088/0957-4484/16/9/050
   Hara S, 2004, POLYM J, V36, P151, DOI 10.1295/polymj.36.151
   Huang JE, 2003, CARBON, V41, P2731, DOI 10.1016/S0008-6223(03)00359-2
   Huang JX, 2004, J AM CHEM SOC, V126, P851, DOI 10.1021/ja0371754
   Huang JX, 2006, CHEM COMMUN, P367, DOI 10.1039/b510956f
   Huang JX, 2003, ADV MATER, V15, P1158, DOI 10.1002/adma.200304835
   Hughes M, 2002, CHEM MATER, V14, P1610, DOI 10.1021/cm010744r
   Hughes M, 2005, ADV MATER, V17, P443, DOI 10.1002/adma.200401076
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   ITO M, 1988, POLYMER, V29, P1161, DOI 10.1016/0032-3861(88)90039-0
   Ivchenko EL, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155404
   Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797
   JIANG K, NATURE LONDON, V419, P801
   Kaempgen M, 2006, J ELECTROANAL CHEM, V586, P72, DOI 10.1016/j.jelechem.2005.09.009
   Kane-Maguire LAP, 1999, SYNTHETIC MET, V101, P817, DOI 10.1016/S0379-6779(98)01117-5
   Kane-Maguire LAP, 1999, SYNTHETIC MET, V106, P171, DOI 10.1016/S0379-6779(99)00139-3
   Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502
   KUHN HH, 1995, SYNTHETIC MET, V71, P2139, DOI 10.1016/0379-6779(94)03198-F
   Kumar S, 2002, MACROMOLECULES, V35, P9039, DOI 10.1021/ma0205055
   LACROIX JC, 1989, J ELECTROCHEM SOC, V136, P1308, DOI 10.1149/1.2096912
   Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978
   Langeveld-Voss BMW, 2000, J MOL STRUCT, V521, P285, DOI 10.1016/S0022-2860(99)00444-5
   Lee K, 2006, NATURE, V441, P65, DOI 10.1038/nature04705
   Lee SH, 2005, ADV FUNCT MATER, V15, P1495, DOI 10.1002/adfm.200400467
   LI YL, SCIENCE WASHINGTON, V304, P276
   Lin Y, 2004, J MATER CHEM, V14, P527, DOI 10.1039/b314481j
   Liu XL, 2005, ADV MATER, V17, P2727, DOI 10.1002/adma.200501211
   Long YZ, 2004, APPL PHYS LETT, V85, P1796, DOI 10.1063/1.1796370
   Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651
   Madden JDW, 2006, ADV MATER, V18, P870, DOI 10.1002/adma.200502136
   MAJIDI MR, 1994, POLYMER, V35, P3113, DOI 10.1016/0032-3861(94)90427-8
   Mann D, 2003, NANO LETT, V3, P1541, DOI 10.1021/nl034700o
   McCarthy B, 2002, J PHYS CHEM B, V106, P2210, DOI 10.1021/jp013745f
   Mcculloch I, 2006, NAT MATER, V5, P328, DOI 10.1038/nmat1612
   Mottaghitalab V, 2005, SYNTHETIC MET, V152, P77, DOI 10.1016/j.synthmet.2005.07.154
   Nalwa H.S., 1997, HDB ORGANIC CONDUCTI
   Norris ID, 2000, MACROMOLECULES, V33, P3237, DOI 10.1021/ma991339c
   Panhuis MIH, 2005, SMALL, V1, P820, DOI 10.1002/smll.200500001
   Panhuis MIH, 2003, CHEM BIOL, V10, P897, DOI 10.1016/j.chembiol.2003.10.005
   Panhuis MIH, 2005, J PHYS CHEM B, V109, P22725, DOI 10.1021/p053025z
   Panhuis MIH, 2004, J NANOSCI NANOTECHNO, V4, P976, DOI 10.1166/jnn.2004.148
   Panhuis MIH, 2003, J PHYS CHEM B, V107, P478, DOI 10.1021/jp026470s
   Persaud KC, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)00793-5
   Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x
   Pomfret SJ, 1998, ADV MATER, V10, P1351, DOI 10.1002/(SICI)1521-4095(199811)10:16<1351::AID-ADMA1351>3.0.CO;2-8
   Pornputtkul Y, 2005, CHEM COMMUN, P4539, DOI 10.1039/b508286m
   Poulin P, 2002, CARBON, V40, P1741, DOI 10.1016/S0008-6223(02)00042-8
   Qu LW, 2005, MACROMOLECULES, V38, P10328, DOI 10.1021/ma051762n
   Ramamurthy PC, 2004, SOLID STATE ELECTRON, V48, P2019, DOI [10.1016/j.sse.2004.05.051, 10.1016/j.ssc.2004.05.051]
   Reese C, 2004, MATER TODAY, V7, P20, DOI 10.1016/S1369-7021(04)00398-0
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Sainz R, 2005, ADV MATER, V17, P278, DOI 10.1002/adma.200400921
   Sainz R, 2005, NANOTECHNOLOGY, V16, pS150, DOI 10.1088/0957-4484/16/5/003
   SAINZ R, UNPUB
   Salvetat JP, 1999, PHYS REV LETT, V82, P944, DOI 10.1103/PhysRevLett.82.944
   Sandler JKW, 2003, POLYMER, V44, P5893, DOI 10.1016/S0032-3861(03)00539-1
   SATO M, 1986, SYNTHETIC MET, V14, P279, DOI 10.1016/0379-6779(86)90041-X
   Service RF, 2003, SCIENCE, V301, P909, DOI 10.1126/science.301.5635.909
   SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578
   Skotheim T.A, 1998, HDB CONDUCTING POLYM
   Small WR, 2006, J PHYS CHEM B, V110, P13029, DOI 10.1021/jp062365x
   Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113
   Smela E, 2005, SYNTHETIC MET, V151, P25, DOI 10.1016/j.synthmet.2005.03.009
   Snow ES, 2003, APPL PHYS LETT, V82, P2145, DOI 10.1063/1.1564291
   Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366
   Spinks GM, 2005, SYNTHETIC MET, V151, P85, DOI 10.1016/j.synthmet.2005.03.006
   Spinks GM, 2002, ADV MATER, V14, P1728, DOI 10.1002/1521-4095(20021203)14:23<1728::AID-ADMA1728>3.0.CO;2-8
   Strounina EV, 1999, SYNTHETIC MET, V106, P129, DOI 10.1016/S0379-6779(99)00121-6
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   Tahhan M, 2003, SMART MATER STRUCT, V12, P626, DOI 10.1088/0964-1726/12/4/313
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   TOKITO S, 1991, POLYMER, V32, P464, DOI 10.1016/0032-3861(91)90450-W
   Tombler TW, 2000, NATURE, V405, P769
   Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331
   Wallace G G, 2003, CONDUCTIVE ELECTROAC
   Wallace GG, 2002, ADV MATER, V14, P953, DOI 10.1002/1521-4095(20020705)14:13/14<953::AID-ADMA953>3.0.CO;2-T
   Wallace GG, 2002, J NANOSCI NANOTECHNO, V2, P441, DOI 10.1166/jnn.2002.142
   Wei ZX, 2003, ADV MATER, V15, P136, DOI 10.1002/adma.200390027
   White CT, 1998, NATURE, V393, P240, DOI 10.1038/30420
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   WU JX, UNPUB
   Wu TM, 2005, CARBON, V43, P734, DOI 10.1016/j.carbon.2004.10.043
   XIA YN, 1995, CHEM MATER, V7, P443, DOI 10.1021/cm00051a002
   Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941
   Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241
   YATES C, 1994, INSPEC MATTERS   MAR, P4
   Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
   Yu YJ, 2005, SYNTHETIC MET, V150, P271, DOI 10.1016/j.synthmet.2005.02.011
   Zengin H, 2002, ADV MATER, V14, P1480, DOI 10.1002/1521-4095(20021016)14:20<1480::AID-ADMA1480>3.0.CO;2-O
   Zhang H, 2006, J PHYS CHEM B, V110, P9095, DOI 10.1021/jp060193y
   Zhang J, 2005, CHIRALITY, V17, P404, DOI 10.1002/chir.20178
   Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311
   Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276
   Zhang XT, 2004, CARBON, V42, P1455, DOI 10.1016/j.carbon.2004.01.003
   ZHAO H, 1994, J MEMBRANE SCI, V87, P47, DOI 10.1016/0376-7388(93)E0053-G
NR 129
TC 48
Z9 48
U1 1
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2006
VL 16
IS 36
BP 3598
EP 3605
DI 10.1039/b606959b
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 083ZO
UT WOS:000240501100002
DA 2018-10-20
ER

PT J
AU Herschke, L
   Rottstegge, J
   Lieberwirth, I
   Wegner, G
AF Herschke, L
   Rottstegge, J
   Lieberwirth, I
   Wegner, G
TI Zinc phosphate as versatile material for potential biomedical
   applications Part 1
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Review
ID NUCLEAR-MAGNETIC-RESONANCE; CALCIUM PHOSPHATES; MECHANICAL-PROPERTIES;
   OCTACALCIUM PHOSPHATE; CRYSTAL-STRUCTURE; STRUCTURAL DATA; DENTAL
   CEMENTS; TRICALCIUM PHOSPHATE; SURFACE MODIFICATION; STANDARD ENTHALPIES
AB Synthetic alpha - and beta -Hopeite, two polymorphs of zinc phosphate tetrahydrates (ZPT) have been synthesized by hydrothermal crystallization from aqueous solution at 20 degrees C and 90 degrees C respectively. Aside from their subtitle crystallographic differences originating from a unique hydrogen bonding pattern, their thermodynamic interrelation has been thoroughfully investigated by means of X-Ray diffraction (XRD) and differential scanning calorimetry (DSC), combined with thermogravimetry (TGA-MS). Using a new heterogeneous step-reaction approach, the kinetics of dehydration of the two forms of ZPT was studied and their corresponding transition temperature determined. Low temperature DRIFT, FT-Raman and H-1, P-31 MAS-NMR reveal an oriented distortion of the zinc phosphate tetrahedra, due to a characteristic hydrogen bonding pattern and in accordance with the molecular tetrahedral linkage scheme of the phosphate groups. Biogenic Hydroxyapatite (HAP) and one of its metastable precursors, a calcium dihydrogen phosphate dihydrate (DCPD) or Brushite were also obtained and used to underline the resulting variations of chemical reactivity in zinc phosphates.
C1 Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Lieberwirth, I (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM lieberw@mpip-mainz.mpg.de
RI Lieberwirth, Ingo/Q-5862-2017; Mainz, EMZ-M/E-3619-2016
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   ALMAYDAMA HMA, 1992, THERMOCHIM ACTA, V196, P117, DOI 10.1016/0040-6031(92)85011-J
   ALMAYDAMA HMA, 1992, THERMOCHIM ACTA, V194, P117, DOI 10.1016/0040-6031(92)80010-T
   Arends J, 1987, J CRYST GROWTH, V84, P512
   Arias JL, 2003, APPL SURF SCI, V208, P57, DOI 10.1016/S0169-4332(02)01336-3
   ARNAUD Y, 1988, APPL SURF SCI, V32, P296, DOI 10.1016/0169-4332(88)90015-3
   ARNAUD Y, 1988, APPL SURF SCI, V32, P281, DOI 10.1016/0169-4332(88)90014-1
   Attar N, 2003, J PROSTHET DENT, V89, P127, DOI 10.1067/mpr.2003.20
   Baitalow F, 1998, J THERM ANAL CALORIM, V52, P5, DOI 10.1023/A:1010158918395
   Barrea RA, 2003, X-RAY SPECTROM, V32, P387, DOI 10.1002/xrs.657
   BAUMER A, 1985, B MINERAL, V108, P145
   BEHENCOURT A, 2003, PROG ORG COAT, V46, P280
   Beiro M, 2003, PROG ORG COAT, V46, P97, DOI 10.1016/S0300-9440(02)00216-3
   Berndt C. C., 1990, Materials Forum, V14, P161
   BERRY EE, 1967, SPECTROCHIM ACTA A, V23, P537
   BERRY RS, 1980, PHYS CHEM, P1147
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   Bigi A, 1997, J INORG BIOCHEM, V66, P259, DOI 10.1016/S0162-0134(96)00219-X
   BILLS PM, 1982, J ED MOD MAT SCI ENG, V4, P391
   BODIERHOULLE P, 1997, J DENT RES, V76, P895
   Bohlsen F, 2003, QUINTESSENCE INT, V34, P493
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   BROWN WE, 1987, CEMENTS RES PROGR, P351
   Cabanas MV, 2003, J MATER CHEM, V13, P1104, DOI 10.1039/b301435e
   CAMERON C, 1994, INT CERAM MONOGR, V1, P79
   CHAO GY, 1969, Z KRISTALLOGR KRIST, V130, P261, DOI 10.1524/zkri.1969.130.1-6.261
   CHAPMAN AC, 1965, SPECTROCHIM ACTA, V21, P633, DOI 10.1016/0371-1951(65)80019-4
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Cox J. D., 1989, CODATA KEY VALUES TH
   CRISP S, 1978, J DENT RES, V57, P254
   CUDENNEC Y, 1985, CR ACAD SCI II, V301, P93
   Czarnecka B, 2003, J MATER SCI-MATER M, V14, P601, DOI 10.1023/A:1024018923186
   D'Andrea SC, 2003, LANGMUIR, V19, P7904, DOI 10.1021/la027000s
   DICKINSON T, 2000, MAT RES SOC S, V617
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dorozhkin SV, 2002, PROG CRYST GROWTH CH, V44, P45, DOI 10.1016/S0960-8974(02)00004-9
   Dorozhkina EI, 2002, COLLOID SURFACE A, V210, P41, DOI 10.1016/S0927-7757(02)00217-0
   ERNST RRB, 1986, PRINCIPLES NUCL MAGN
   Filatova T. N., 1969, RUSS J INORG CHEM, V14, P424
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Freund F., 1977, J CHEM SOC DA, V6, P1136
   GERLACH A, 1993, BIOMATERIALS, V14, P770, DOI 10.1016/0142-9612(93)90042-Z
   Gibson I.R., 2000, J MATER SCI-MATER M, V12, P799, DOI DOI 10.1023/A:1008905613182
   Goller G, 2002, MATER LETT, V56, P142
   GORENSTEIN OG, 1984, PHOSPHORUS 31 NMR PR
   Grey NJA, 2001, J DENT RES, V80, P1152
   HAIDARA H, 1985, THESIS U MUHLHOUSE F
   HAUSSUHL S, 1993, CRYST RES TECHNOL, V28, P437, DOI 10.1002/crat.2170280402
   Hench L.L., 1993, ADV SERIES CERAMICS, V1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HERMANN B, 1977, Z MORPHOL ANTHROPOL, V68, P129
   Herschke L, 2004, CHEM-EUR J, V10, P2795, DOI 10.1002/chem.200305693
   Herzberg G., 1945, MOL SPECTRA MOL STRU
   HILL RJ, 1976, AM MINERAL, V61, P987
   Hina A, 2001, J CRYST GROWTH, V223, P213, DOI 10.1016/S0022-0248(00)01026-5
   Hiraishi N, 2003, INT ENDOD J, V36, P622, DOI 10.1046/j.1365-2591.2003.00700.x
   Isobe T, 2002, J PHYS CHEM B, V106, P5169, DOI 10.1021/jp0138936
   JINLONG N, 2002, J MATER SYNTH PROC, V9, P235
   Joshi VS, 2003, CRYST RES TECHNOL, V38, P817, DOI 10.1002/crat.200310100
   KANAZAWA T, 1985, INORGANIC PHOSPHATE
   KATNACK FL, 1958, J ELECTROCHEM SOC, V105, P125, DOI 10.1149/1.2428776
   Kenny S, 2001, J MATER SCI-MATER M, V12, P901, DOI 10.1023/A:1012828209119
   KNUUTTILA M, 1980, SCAND J DENT RES, V88, P513
   KOMRSKA J, 1969, SILIKATY, V13, P135
   KOTLOVA AG, 1976, INORG MATER, V11, P1247
   KUBOTA W, 1992, Journal of the Japanese Orthopaedic Association, V66, P110
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Lang J., 1987, B SOC SCI BRETAGNE, V53, P95
   LeGeros RZ, 1999, AM J DENT, V12, P65
   LUO P, 1996, Patent No. 5858318
   LUPIS CHP, 1983, CHEM THERMODYN, P87
   Lusvardi G, 2002, J MATER SCI-MATER M, V13, P91, DOI 10.1023/A:1013655123340
   Lutz HD, 1999, J MOL STRUCT, V511, P69, DOI 10.1016/S0022-2860(98)00630-9
   LUTZ HD, 1995, STRUCT BOND, V82, P85
   Lutz HD, 1998, TR APPL SPECT, V2, P59
   LUTZ HD, 1988, STRUCT BOND, V69, P97
   Lutz HD, 1997, J MOL STRUCT, V404, P63, DOI 10.1016/S0022-2860(96)09362-3
   Lutz HD, 1996, J ALLOY COMPD, V241, P1, DOI 10.1016/0925-8388(96)02311-0
   Malysheva AY, 2001, GLASS CERAM+, V58, P147, DOI 10.1023/A:1010976221563
   MARGERIT J, 1999, J MATER SCI-MATER M, V9, P449
   MIKENDA W, 1986, J MOL STRUCT, V147, P1, DOI 10.1016/0022-2860(86)87054-5
   Molera P, 2003, CORROS REV, V21, P349
   Morgan EF, 1997, J MATER SCI-MATER M, V8, P559, DOI 10.1023/A:1018550831834
   NAIR UB, 1995, J MATER SCI, V30, P2108, DOI 10.1007/BF00353042
   Nakamoto K., 1986, IR RAMAN SPECTRA INO
   Nicholson JW, 1999, J MATER SCI-MATER M, V10, P449, DOI 10.1023/A:1008991422909
   Nikonenko E. A., 1986, Russian Journal of Inorganic Chemistry, V31, P397
   NIKONENKO EA, 1985, RUSS J INORG CHEM, V30, P25
   Nriagu J. O., 1984, PHOSPHATE MINERALS
   NRIAGU JO, 1973, GEOCHIM COSMOCHIM AC, V37, P2357, DOI 10.1016/0016-7037(73)90284-6
   PARKER VB, 1971, NBS TECH NOTE, V270, P119
   Pawlig O, 1999, MATER RES BULL, V34, P1959, DOI 10.1016/S0025-5408(99)00206-8
   Pawlig O, 2001, SPECTROCHIM ACTA A, V57, P581, DOI 10.1016/S1386-1425(00)00410-8
   Pawlig O, 2000, CHEM MATER, V12, P1279, DOI 10.1021/cm991148o
   PERUSEVSKI V, 1988, J MOL STRUCT, V17, P349
   Rodriguez-Lorenzo LM, 2003, BIOMATERIALS, V24, P3777, DOI 10.1016/S0142-9612(03)00259-X
   ROLLAND C, 1991, CAN MINERAL, V29, P337
   SATO N, 1991, J MATER SCI LETT, V10, P115, DOI 10.1007/BF00721926
   SATO N, 1991, J MATER SCI, V26, P865
   SATO N, 1991, J MATER SCI, V26, P1383, DOI 10.1007/BF00544481
   Schutz D, 2003, EVOL ECOL RES, V5, P105
   SHYU LJ, 1983, J DENT RES, V62, P398, DOI 10.1177/00220345830620031901
   Socrates G., 1980, INFRARED CHARACTERIS
   STEPHENS JS, 1967, CAN J CHEMISTRY, V45, P2303, DOI 10.1139/v67-404
   STUTMAN JM, 1965, T NEW YORK ACAD SCI, V27, P669, DOI 10.1111/j.2164-0947.1965.tb02224.x
   SUGAMA T, 1995, J MATER SCI, V30, P809, DOI 10.1007/BF00356346
   Tamai M, 2003, J MATER SCI-MATER M, V14, P617, DOI 10.1023/A:1024075008165
   Terra J, 2002, PHILOS MAG A, V82, P2357, DOI 10.1080/01418610210131010
   Uo M, 2003, DENT MATER, V19, P487, DOI 10.1016/S0109-5641(02)00094-5
   VALDES JJP, 1997, J MATER SCI-MATER M, V5, P297
   VOLKOV AI, 1979, KHIM KHIM TEKHNOL MI, V14, P58
   VOLKOV AI, 1974, RUSS J PHYS CHEM, V48, P1701
   VOLKOV AL, 1974, RUSSIAN J PHYS CHE A, V48, P1697
   WAGMAN DD, 1969, NATL BUR STAND TECH, V270, P152
   WAGMAN DD, 1971, NATL BUR STAND TECH, V270, P49
   WAGMAN DD, 1968, NATL BUR STAND TECH, V270, P264
   WHITAKER A, 1973, J APPL CRYSTALLOGR, V6, P495, DOI 10.1107/S0021889873009325
   WILSON AD, 1970, J DENT RES, V49, P1049, DOI 10.1177/00220345700490050801
   WILSON AD, 1974, BRIT DENT J, V137, P313, DOI 10.1038/sj.bdj.4803314
   YAGLOV VN, 1978, KHIM KHIM TEKHNOL MI, V13, P7
   YAGLOV VN, 1974, DOKL AKAD NAUK B, V78, P624
   YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009
   YOUNG RA, 1980, P INT C PHOSP COMP, P73
NR 124
TC 39
Z9 41
U1 0
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2006
VL 17
IS 1
BP 81
EP 94
DI 10.1007/s10856-006-6332-4
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 999NN
UT WOS:000234396400010
PM 16389475
DA 2018-10-20
ER

PT J
AU Herschke, L
   Lieberwirth, I
   Wegner, G
AF Herschke, L
   Lieberwirth, I
   Wegner, G
TI Zinc phosphate as versatile material for potential biomedical
   applications Part II
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE; OCTACALCIUM PHOSPHATE; HYDROXYAPATITE CRYSTALS;
   TRICALCIUM PHOSPHATE; AQUEOUS-SOLUTIONS; DENTAL CEMENTS; DISSOLUTION;
   HOPEITE; SYSTEM; GROWTH
AB Surface chemical reactivity of two modifications of synthetic zinc phosphate tetrahydrate (alpha - and beta -form of Hopeite, alpha -,beta -ZPT) has been studied by selective chemical and e-beam etching in presence of diluted phosphoric acid and ammonia by Scanning Electron Microscopy (SEM) and microelectrophoresis (zeta potential measurements) in correlation with the corresponding bulk properties and crystal size distributions. The subtitle crystallographic differences between alpha -and beta -ZPT originating from a unique hydrogen bonding pattern, induce drastic variations of both surface potential and surface charge. Biogenic Hydroxyapatite (HAP) and one of its metastable precursors, a calcium dihydrogen phosphate dihydrate (DCPD) or Brushite were used to underline this resulting variation of chemical reactivity in zinc phosphates. In-situ monitoring of the transformation of Brushite in Hydroxyapatite is also reported.
C1 Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Lieberwirth, I (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM lieberw@mpip-mainz.mpg.de
RI Lieberwirth, Ingo/Q-5862-2017; Mainz, EMZ-M/E-3619-2016
CR AOKI H, 1991, SCI MED APPL HYDROXY, P46
   AOSAKA N, 1995, BIOCERAMICS, V8, P331
   BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Bigi A, 1999, J INORG BIOCHEM, V75, P145, DOI 10.1016/S0162-0134(99)00047-1
   BRACKETT WW, 1994, OPER DENT, V19, P106
   BROWN PW, 1992, J AM CERAM SOC, V75, P17, DOI 10.1111/j.1151-2916.1992.tb05435.x
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   CABRERA N, 1954, PHYS REV, V96, P1153, DOI 10.1103/PhysRev.96.1153
   Coleman AJ, 2001, QUINTESSENCE INT, V32, P811
   Czarnecka B, 2003, J MATER SCI-MATER M, V14, P601, DOI 10.1023/A:1024018923186
   D'Andrea SC, 2003, LANGMUIR, V19, P7904, DOI 10.1021/la027000s
   de Leeuw NH, 2002, PHYS CHEM CHEM PHYS, V4, P3865, DOI 10.1039/b203114k
   De Maeyer EAP, 2000, J BIOMED MATER RES, V52, P95, DOI 10.1002/1097-4636(200010)52:1<95::AID-JBM12>3.3.CO;2-O
   DELEEUW NH, 2001, CHEM COMMUN, V17, P1646
   DICKINSON JT, 2000, MAT RES SOC S, V617
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   Fleming GJP, 2003, DENT MATER, V19, P69, DOI 10.1016/S0109-5641(02)00006-4
   FRANK FC, 1951, ACTA CRYSTALLOGR, V4, P497, DOI 10.1107/S0365110X51001690
   Graham S, 1996, J CRYST GROWTH, V165, P106, DOI 10.1016/0022-0248(95)00994-9
   HANSEN NM, 1976, BIOCHIM BIOPHYS ACTA, V451, P549, DOI 10.1016/0304-4165(76)90150-1
   HARTEL RW, 1986, AICHE J, V32, P1136
   HERSCHKE L, IN PRESS J MAT SCI M
   HILL RJ, 1976, AM MINERAL, V61, P987
   Hina A, 2001, J CRYST GROWTH, V223, P213, DOI 10.1016/S0022-0248(00)01026-5
   Hunter R., 1986, FDN COLLOID SCI, V2
   Hunter R. J., 1986, FDN COLLOID SCI, VI-II
   Hunter RJ., 1981, ZETA POTENTIAL COLLO, P11, DOI DOI 10.1016/B978-0-12-361961-7.50006-7
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   IUPAC, 1979, SOLUBILITY DATA SERI, P250
   JOHNSON GW, 1950, J APPL PHYS, V21, P1057, DOI 10.1063/1.1699442
   JOHNSON GW, 1951, J APPL PHYS, V22, P797, DOI 10.1063/1.1700051
   KALENDOVA A, 2003, FARBE LACK, V109, P62
   Kanai H, 1996, PHOS RES B, V6, P293
   KENNEDY JH, 1977, J AM CERAM SOC, V60, P33, DOI 10.1111/j.1151-2916.1977.tb16088.x
   KOROLEV EN, 1993, PROBLEMY BEZOPASNOST, P3
   LEACH SA, 1960, ARCH ORAL BIOL, V3, P48, DOI 10.1016/0003-9969(60)90018-2
   LI JG, 1994, ACTA ODONTOL SCAND, V52, P209, DOI 10.3109/00016359409029048
   LI X, 1996, J APPL PHYS, V80, P2680
   Lopez-Macipe A, 1998, J COLLOID INTERF SCI, V200, P114, DOI 10.1006/jcis.1997.5343
   Ma J, 2003, J MATER SCI-MATER M, V14, P797, DOI 10.1023/A:1025092506583
   Matsumura Y, 1997, J CHEM SOC FARADAY T, V93, P4383, DOI 10.1039/a702320k
   MONMA H, 1981, J CHEM TECHNOL BIOT, V31, P15, DOI 10.1002/jctb.280310105
   MONMA H, 1978, YOGYO-KYOKAI-SHI, V86, P590
   MYERSON AS, 2002, HDB IND CRYSTALLIZAT, P101
   NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3
   NANCOLLAS GH, 1990, J DENT RES, V69, P1678, DOI 10.1177/00220345900690101001
   Nicholson JW, 1998, J MATER SCI-MATER M, V9, P549, DOI 10.1023/A:1008908523969
   NIELSEN AE, 1981, PURE APPL CHEM, V53, P2025, DOI 10.1351/pac198153112025
   Nishino T, 1996, J CERAM SOC JPN, V104, P729, DOI 10.2109/jcersj.104.729
   Nomoto R, 2001, DENT MATER, V17, P53, DOI 10.1016/S0109-5641(00)00058-0
   NRIAGU JO, 1973, GEOCHIM COSMOCHIM AC, V37, P2357, DOI 10.1016/0016-7037(73)90284-6
   OTHA K, 2003, KEY ENG MATER, V240, P517
   OTHA M, 1979, J CRYST GROWTH, V47, P135
   Otsuka M, 2000, J BIOMED MATER RES, V52, P819, DOI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.3.CO;2-F
   PEREZ L, 1984, J CRYST GROWTH, V66, P412, DOI 10.1016/0022-0248(84)90224-0
   Piemjai MM, 2001, INT J PROSTHODONT, V14, P412
   Piwowarezyk A, 2003, OPER DENT, V28, P535
   POSNER AS, 1984, CHEM STRUCTURE PRECI, P333
   Pretto M, 2003, J AM CERAM SOC, V86, P1534, DOI 10.1111/j.1151-2916.2003.tb03510.x
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   SAISON J, 1960, CR HEBD ACAD SCI, V250, P2374
   Sangwal K, 1996, PROG CRYST GROWTH CH, V32, P135, DOI 10.1016/0960-8974(96)00010-1
   Scudiero L, 1999, TRIBOL LETT, V6, P41, DOI 10.1023/A:1019134901387
   SERVAIS GE, 1971, J DENT RES, V50, P613, DOI 10.1177/00220345710500031601
   SOMASUNDARAN P, 1985, COLLOID SURFACE, V15, P309, DOI 10.1016/0166-6622(85)80081-0
   Sorensen JS, 2000, J CRYST GROWTH, V216, P399, DOI 10.1016/S0022-0248(00)00449-8
   Tang RK, 2003, J PHYS CHEM B, V107, P10653, DOI 10.1021/jp0346312
   Tang RK, 2001, J AM CHEM SOC, V123, P5437, DOI 10.1021/ja010064p
   THOMSON GP, 1948, P PHYS SOC LOND, V61, P403, DOI 10.1088/0959-5309/61/5/302
   TURNBULL D, 1952, IND ENG CHEM, V44, P1291
   Uo M, 2003, DENT MATER, V19, P487, DOI 10.1016/S0109-5641(02)00094-5
   VANDERMERWE JH, 1949, DISCUSS FARADAY SOC, P201, DOI 10.1039/df9490500201
   VanMiller EJ, 2003, AM J DENT, V16, P356
   VASUDEVAN TV, 1994, LANGMUIR, V10, P320, DOI 10.1021/la00013a047
   VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W
   VEZIE DL, 1995, POLYMER, V36, P1761, DOI 10.1016/0032-3861(95)90923-P
   Wilson A. D., 1993, ACID BASE CEMENTS TH
   WOLFE CW, 1940, AM MINERAL, V25, P795
   Yakubovich OV, 1999, ACTA CRYSTALLOGR C, V55, P151, DOI 10.1107/S0108270198011639
   Yamashita K, 1997, J AM CERAM SOC, V80, P1907
   ZHANG YN, 1992, MATER RES SOC SYMP P, V271, P465, DOI 10.1557/PROC-271-465
NR 82
TC 32
Z9 32
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2006
VL 17
IS 1
BP 95
EP 104
DI 10.1007/s10856-006-6333-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 999NN
UT WOS:000234396400011
PM 16389476
DA 2018-10-20
ER

PT J
AU Boccaccini, AR
   Roether, JA
   Thomas, BJC
   Shaffer, MSP
   Chavez, E
   Stoll, E
   Minay, EJ
AF Boccaccini, AR
   Roether, JA
   Thomas, BJC
   Shaffer, MSP
   Chavez, E
   Stoll, E
   Minay, EJ
TI The electrophoretic deposition of inorganic nanoscaled materials
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article; Proceedings Paper
CT 18th Fall Meeting of the Ceramic-Society-of-Japan
CY 2005
CL Kawasaki, JAPAN
SP Ceram Soc Japan
DE electrophoretic deposition; nanoparticles; carbon nanotubes; ceramic
   processing; sol-gel; composite materials; coatings; thick films; porous
   materials; functional coatings
ID CERAMIC-MATRIX COMPOSITES; WALLED CARBON NANOTUBES; ZNO NANOWIRE ARRAYS;
   SOL-GEL SUSPENSIONS; BATIO3 THIN-FILM; GOLD NANOPARTICLES;
   TITANIUM-DIOXIDE; FUEL-CELLS; ELECTROLYTIC DEPOSITION; METAL
   NANOPARTICLES
AB Electrophoretic deposition (EPD) is gaining increasing interest as a processing technique for production of novel inorganic nanostructured and nanoscale materials, including the use of nanoparticles, nanotubes, nanorods and related nanomaterials. Recent advances in the electrophoretic deposition of a great variety of ceramic and metallic nanoparticles, carbon nanotubes and other inorganic nanoscaled materials are discussed in this review. The purpose of the paper is to demonstrate the utility of an applied electric field to manipulate and control the deposition of electrically charged nanoscaled particles and other nanostructures on solid surfaces from liquid suspensions. A wide range of applications has been reviewed, demonstrating the high versatility and suitability of the EPD technique as a convenient nanotechnology processing tool. Nano-enamels and structural coatings, electrodes and films for fuel cells, capacitors, sensors and other microelectronic devices, fibre-reinforced and graded ceramic composites, nanostructured films and coatings for electronic, biomedical, optical, catalytic and electrochemical applications are some of the examples discussed. The combination of sol-gel methods and EPD for production of a variety of nanomaterials is also reviewed.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
   CIDETEC, Surface Finishing Dept, San Sebastian 20009, Spain.
   Tech Univ Ilmenau, Inst Mat Technol, D-98693 Ilmenau, Germany.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
EM a.boccaccini@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013; Shaffer, Milo/C-5977-2008
OI Shaffer, Milo/0000-0001-9384-9043
CR Affoune AM, 2001, LANGMUIR, V17, P547, DOI 10.1021/la001317f
   Ang LM, 1999, CHEM MATER, V11, P2115, DOI 10.1021/cm990078i
   Anne G, 2005, J AM CERAM SOC, V88, P2036, DOI 10.1111/j.1551-2916.2005.00387.x
   Bailey RC, 2000, ADV MATER, V12, P1930, DOI 10.1002/1521-4095(200012)12:24<1930::AID-ADMA1930>3.3.CO;2-6
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Belaroui K, 2002, KEY ENG MAT, V206-2, P519, DOI 10.4028/www.scientific.net/KEM.206-213.519
   Berber S, 2000, PHYS REV LETT, V84, P4613, DOI 10.1103/PhysRevLett.84.4613
   Berenguer-Murcia A, 2005, MICROPOR MESOPOR MAT, V78, P159, DOI 10.1016/j.micromeso.2004.10.005
   Bhatt KH, 2004, LANGMUIR, V20, P467, DOI 10.1021/la0349976
   Boccaccini AR, 2004, J MATER SCI, V39, P851, DOI 10.1023/B:JMSC.0000012914.47793.3e
   Boccaccini AR, 2004, J MATER SCI, V39, P769, DOI 10.1023/B:JMSC.0000012903.04936.d0
   Boccaccini AR, 2002, CURR OPIN SOLID ST M, V6, P251, DOI 10.1016/S1359-0286(02)00080-3
   Boccaccini AR, 2001, COMPOS PART A-APPL S, V32, P997, DOI 10.1016/S1359-835X(00)00168-8
   BOCCACCINI AR, 1995, JOM-J MIN MET MAT S, V47, P34
   Boccaccini AR, 2001, MATER LETT, V51, P225, DOI 10.1016/S0167-577X(01)00294-4
   Boccaccini AR, 1998, J MATER SCI, V33, P933, DOI 10.1023/A:1004351525920
   BOCCACCINI AR, 2004, CERAMIC T, V153, P77
   BOCCACCINI AR, UNPUB
   BOCCACCINI AR, 2002, P 1 INT C EL DEP BAN
   Cao Guozhong, 2004, NANOSTRUCTURES NANOM
   Cao GZ, 2004, J PHYS CHEM B, V108, P19921, DOI 10.1021/jp040492s
   Castro Y, 2005, J SOL-GEL SCI TECHN, V35, P51, DOI 10.1007/s10971-005-3214-z
   Castro Y, 2004, SURF COAT TECH, V182, P199, DOI 10.1016/j.surfcoat.2003.07.001
   Castro Y, 2002, ADV MATER, V14, P505, DOI 10.1002/1521-4095(20020404)14:7<505::AID-ADMA505>3.3.CO;2-W
   Chen F, 2005, KEY ENG MAT, V288-289, P183, DOI 10.4028/www.scientific.net/KEM.288-289.183
   Chen FL, 2001, J EUR CERAM SOC, V21, P127, DOI 10.1016/S0955-2219(00)00195-3
   Chou YI, 2005, IEEE ELECTR DEVICE L, V26, P62, DOI 10.1109/LED.2004.840736
   CLARK DE, 1988, CERAM ENG SCI P, V9, P1111
   Clasen R, 2002, ELEC SOC S, V2002, P279
   Colorado R, 2004, CHEM MATER, V16, P2691, DOI 10.1021/cm049710k
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Damjanovic T, 2005, J EUR CERAM SOC, V25, P577, DOI 10.1016/j.jeurceramsoc.2004.04.005
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   Du CS, 2005, J MATER CHEM, V15, P548, DOI 10.1039/b414682d
   Du CS, 2002, J MATER SCI LETT, V21, P565, DOI 10.1023/A:1015417206987
   Du CS, 2002, MATER LETT, V57, P434, DOI 10.1016/S0167-577X(02)00806-6
   Duan H, 2004, MATER RES BULL, V39, P1861, DOI 10.1016/j.materresbull.2004.06.012
   Esumi K, 1996, CARBON, V34, P279, DOI 10.1016/0008-6223(96)83349-5
   Fukada Y, 2004, J MATER SCI, V39, P787, DOI 10.1023/B:JMSC.0000012906.70457.df
   GALOR L, 1992, J ELECTROCHEM SOC, V139, P1078, DOI 10.1149/1.2069342
   Gao B, 2001, ADV MATER, V13, P1770, DOI 10.1002/1521-4095(200112)13:23<1770::AID-ADMA1770>3.0.CO;2-G
   Georgi C, 2003, MATERIALWISS WERKST, V34, P623, DOI 10.1002/mawe.200390125
   GHANI MSJ, 1994, IND CHEM, V14, P163
   GIERSIG M, 1993, LANGMUIR, V9, P3408, DOI 10.1021/la00036a014
   GIERSIG M, 1993, J PHYS CHEM-US, V97, P6334, DOI 10.1021/j100126a003
   Giersig M, 1999, J PHYS D APPL PHYS, V32, pL111, DOI 10.1088/0022-3727/32/22/101
   Girishkumar G, 2004, J PHYS CHEM B, V108, P19960, DOI 10.1021/jp046872v
   Girishkumar G, 2005, LANGMUIR, V21, P8487, DOI 10.1021/la051499j
   Gorelikov I, 2004, CHEM MATER, V16, P4122, DOI 10.1021/cm049446v
   Greil P, 2001, Z METALLKD, V92, P682
   Hasobe T, 2005, J AM CHEM SOC, V127, P1216, DOI 10.1021/ja047768u
   HIRASHIMA H, 1994, MATER RES SOC SYMP P, V346, P95
   Hosokura T, 2005, J SOL-GEL SCI TECHN, V33, P221, DOI 10.1007/s10971-005-5617-2
   Hu H, 2005, J PHYS CHEM B, V109, P11520, DOI 10.1021/jp050781w
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   ILLSTON TJ, 1993, 3 EUROCERAMICS, V1, P419
   Jang ES, 2005, ADV MATER, V17, P1742, DOI 10.1002/adma.200401221
   Jiang LQ, 2003, J COLLOID INTERF SCI, V260, P89, DOI 10.1016/S0021-9797(02)00176-5
   Jin YW, 2002, J APPL PHYS, V92, P1065, DOI 10.1063/1.1489067
   Kamada K, 2005, J MATER CHEM, V15, P3388, DOI 10.1039/b504364f
   Kamada K, 2004, ELECTROCHEM SOLID ST, V7, pB25, DOI 10.1149/1.1758932
   Kanamura K, 2004, SOLID STATE IONICS, V172, P303, DOI 10.1016/j.ssi.2004.01.039
   Kaneto K, 1999, SYNTHETIC MET, V103, P2543, DOI 10.1016/S0379-6779(98)00221-5
   Katagiri K, 1998, J AM CERAM SOC, V81, P2501
   Kawachi M, 2002, PHYSICA C, V372, P802, DOI 10.1016/S0921-4534(02)00911-5
   Kawachi M, 2001, PHYSICA C, V357, P1023, DOI 10.1016/S0921-4534(01)00512-3
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kaya C, 2005, SURF COAT TECH, V191, P303, DOI 10.1016/j.surfcoat.2004.03.042
   Kaya C, 2003, J EUR CERAM SOC, V23, P1655, DOI 10.1016/S0955-2219(02)00370-9
   Kaya C, 2002, J MATER SCI, V37, P4145, DOI 10.1023/A:1020087819697
   Kaya C, 2002, J MATER RES, V17, P3000, DOI 10.1557/JMR.2002.0435
   Kaya C, 1998, CERAM TRANS, V83, P399
   Ke C, 2001, CHEM COMMUN, P783, DOI 10.1039/b010197o
   Kim B, 2005, COLLOID SURFACE A, V256, P123, DOI 10.1016/j.colsurfa.2004.12.063
   KISHIDA K, 1994, NIPPON SERAM KYO GAK, V102, P336
   Kloepper KD, 2004, J PHYS CHEM B, V108, P2547, DOI 10.1021/jp035644i
   Krishnan A, 1998, PHYS REV B, V58, P14013, DOI 10.1103/PhysRevB.58.14013
   Kruger HG, 2004, J MATER SCI, V39, P839, DOI 10.1023/B:JMSC.0000012912.96350.d2
   Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534
   Lai LB, 2001, MATER RES BULL, V36, P1049, DOI 10.1016/S0025-5408(01)00591-8
   Laubersheimer J, 1998, J EUR CERAM SOC, V18, P255, DOI 10.1016/S0955-2219(97)00120-9
   LEE SH, 2005, IN PRESS COLL SURF B
   Lee SW, 2003, CHEM COMMUN, P780, DOI 10.1039/b300878a
   Li HX, 2000, J CRYST GROWTH, V212, P222, DOI 10.1016/S0022-0248(00)00023-3
   Li J, 2004, SCI TECHNOL ADV MAT, V5, P393, DOI 10.1016/j.stam.2004.02.002
   Li XH, 2003, J PHYS CHEM B, V107, P2453, DOI 10.1021/jp026887y
   Li YH, 2003, CARBON, V41, P1057, DOI 10.1016/S0008-6223(02)00440-2
   Liang P, 2005, SPECTROCHIM ACTA B, V60, P125, DOI 10.1016/j.sab.2004.11.010
   Limmer SJ, 2004, J MATER SCI, V39, P895, DOI 10.1023/B:JMSC.0000012919.21763.b2
   Limmer SJ, 2002, ADV FUNCT MATER, V12, P59, DOI 10.1002/1616-3028(20020101)12:1<59::AID-ADFM59>3.0.CO;2-B
   Limmer SJ, 2001, ADV MATER, V13, P1269, DOI 10.1002/1521-4095(200108)13:16<1269::AID-ADMA1269>3.0.CO;2-S
   Lin Y, 2004, APPL PHYS A-MATER, V78, P1197, DOI 10.1007/s00339-003-2192-7
   Liu HF, 2005, INTERMETALLICS, V13, P805, DOI 10.1016/j.intermet.2005.01.004
   Liu ZL, 2002, LANGMUIR, V18, P4054, DOI 10.1021/la0116903
   Luo TY, 2004, RARE METAL MAT ENG, V33, P885
   Ma J, 2002, J AM CERAM SOC, V85, P1735, DOI 10.1111/j.1151-2916.2002.tb00344.x
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Manocha LM, 2000, SCI ENG COMPOS MATER, V9, P219
   MARIJUAN JM, 2002, P 2002 EL SOC PENN, P175
   Matsuda A., 2004, HDB SOL GEL SCI TECH, V1, P309
   MATTHEWS D, 1994, AUST J CHEM, V47, P1869, DOI 10.1071/CH9941869
   McNally EA, 2005, MATER CHEM PHYS, V91, P391, DOI 10.1016/j.matchemphys.2004.11.045
   Moon JM, 2001, J PHYS CHEM B, V105, P5677, DOI 10.1021/jp0102365
   Moritz K, 2000, CFI-CERAM FORUM INT, V77, pE8
   Nguyen HQ, 2002, MATER CORROS, V53, P772, DOI 10.1002/1521-4176(200210)53:10<772::AID-MACO772>3.0.CO;2-#
   OBERLIN A, 1976, J CRYST GROWTH, V32, P335, DOI 10.1016/0022-0248(76)90115-9
   Oetzel C, 2004, CFI-CERAM FORUM INT, V81, pE35
   Ogata N, 2001, MATER LETT, V49, P7, DOI 10.1016/S0167-577X(00)00332-3
   Ozawa K, 2000, J SOL-GEL SCI TECHN, V19, P595, DOI 10.1023/A:1008713411632
   Ozturk K, 1999, SCRIPTA MATER, V41, P1191, DOI 10.1016/S1359-6462(99)00271-7
   Pang X, 2005, SURF COAT TECH, V195, P138, DOI 10.1016/j.surfcoat.2004.08.216
   PANG X, 2005, INT J NANOSCI, V4, P1
   PANG X, 2005, IN PRESS MAT CHEM PH
   Peiro AM, 2002, J MATER CHEM, V12, P2769, DOI 10.1039/b203922b
   Perez AT, 2001, EUROPHYS LETT, V55, P425, DOI 10.1209/epl/i2001-00431-5
   Randall CA, 2001, J CERAM SOC JPN, V109, pS2, DOI 10.2109/jcersj.109.S2
   Sakamoto R, 1998, J CERAM SOC JPN, V106, P1034, DOI 10.2109/jcersj.106.1034
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Sarkar P, 2000, J AM CERAM SOC, V83, P1399, DOI 10.1111/j.1151-2916.2000.tb01400.x
   Satishkumar BC, 1996, J PHYS D APPL PHYS, V29, P3173, DOI 10.1088/0022-3727/29/12/037
   Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4
   Shan W, 2004, MICROPOR MESOPOR MAT, V69, P35, DOI 10.1016/j.micromeso.2004.01.003
   Smeets K, 2002, KEY ENG MAT, V206-2, P2069, DOI 10.4028/www.scientific.net/KEM.206-213.2069
   Stoch A, 2005, J MOL STRUCT, V744, P627, DOI [10.1016/j.molstruc.2004.10.105, 10.1016/j.molstuc.2004.10.105]
   STOLL E, 2005, IN PRESS
   Su B, 2001, J EUR CERAM SOC, V21, P1539, DOI 10.1016/S0955-2219(01)00059-0
   Subramanian V, 2001, J PHYS CHEM B, V105, P11439, DOI 10.1021/jp011118k
   Sun J, 2004, CARBON, V42, P895, DOI 10.1016/j.carbon.2004.01.074
   Sun J, 2002, CHEM MATER, V14, P5169, DOI 10.1021/cm020736q
   Tabellion J, 2004, J MATER SCI, V39, P803, DOI 10.1023/B:JMSC.0000012907.52051.fb
   Takahashi K, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857087
   Takahashi K, 2005, J PHYS CHEM B, V109, P48, DOI 10.1021/jp044772j
   Tang FQ, 2003, MATER RES BULL, V38, P207, DOI 10.1016/S0025-5408(02)01029-2
   Tang FQ, 2002, MATER RES BULL, V37, P653, DOI 10.1016/S0025-5408(02)00693-1
   Teranishi T, 1999, J PHYS CHEM B, V103, P3818, DOI 10.1021/jp983478m
   Thomas BJC, 2005, J AM CERAM SOC, V88, P980, DOI 10.1111/j.1551-2916.2005.00155.x
   THOMAS BJC, 2005, IN PRESS KEY ENG MAT
   Uchikoshi T, 2004, CERAM INT, V30, P1975, DOI 10.1016/j.ceramint.2003.12.179
   Uchikoshi T, 2002, J CERAM SOC JPN, V110, P840, DOI 10.2109/jcersj.110.843
   Van der Biest OO, 1999, ANNU REV MATER SCI, V29, P327, DOI 10.1146/annurev.matsci.29.1.327
   van Tassel J, 2004, J MATER SCI, V39, P867, DOI 10.1023/B:JMSC.0000012916.92366.48
   VANTASSEL JJ, 2004, THESIS PENNSYLVANIA
   Verhoeckx GJ, 2002, ELEC SOC S, V2002, P118
   Wang CC, 2001, J CHIN INST CHEM ENG, V32, P289
   Wang YC, 2004, J APPL PHYS, V95, P1444, DOI 10.1063/1.1637710
   Wang YC, 2004, J AM CERAM SOC, V87, P84, DOI 10.1111/j.1551-2916.2004.00084.x
   Wang YC, 2002, J MATER CHEM, V12, P2439, DOI 10.1039/b111189m
   Wang ZJ, 2003, J MATER RES, V18, P151, DOI 10.1557/JMR.2003.0021
   Wei M, 2005, J MATER SCI-MATER M, V16, P319, DOI 10.1007/s10856-005-0630-0
   Wong EM, 1999, CHEM MATER, V11, P1959, DOI 10.1021/cm990264o
   Wu YJ, 2005, J EUR CERAM SOC, V25, P2041, DOI 10.1016/j.jeurceramsoc.2005.03.008
   Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243
   Yanagida S, 2005, MATER RES BULL, V40, P1335, DOI 10.1016/j.materresbull.2005.04.030
   Ye XR, 2005, J NANOSCI NANOTECHNO, V5, P964, DOI 10.1166/jnn.2005.133
   Yonezawa T, 1998, ADV MATER, V10, P414, DOI 10.1002/(SICI)1521-4095(199803)10:5<414::AID-ADMA414>3.3.CO;2-4
   Yoon JB, 2001, B KOR CHEM SOC, V22, P1111
   YOU CK, 2005, KEY ENG MATER, V17, P901
   Yui T, 2005, CHEM MATER, V17, P206, DOI 10.1021/cm0491882
   Yum JH, 2005, J PHOTOCH PHOTOBIO A, V173, P1, DOI 10.1016/j.jphotochem.2004.12.023
   Zhang YJ, 2003, CHEM PHYS LETT, V376, P493, DOI 10.1016/S0009-2614(03)01038-8
   ZHANG YN, 1992, MATER RES SOC SYMP P, V271, P465, DOI 10.1557/PROC-271-465
   ZHANG ZT, 1994, J AM CERAM SOC, V77, P1946, DOI 10.1111/j.1151-2916.1994.tb07075.x
   Zhao JL, 2005, KEY ENG MAT, V280-283, P243, DOI 10.4028/www.scientific.net/KEM.280-283.243
   Zhao LP, 2004, CARBON, V42, P423, DOI 10.1016/j.carbon.2003.10.024
   Zhao LP, 2003, COLLOID SURFACE A, V224, P127, DOI 10.1016/S0927-7757(03)00155-9
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
   ZHITOMIRSKY I, 2002, JOM              SEP, P31
   Zhou O, 2002, ACCOUNTS CHEM RES, V35, P1045, DOI 10.1021/ar010162f
NR 169
TC 98
Z9 99
U1 4
U2 76
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2006
VL 114
IS 1325
BP 1
EP 14
DI 10.2109/jcersj.114.1
PG 14
WC Materials Science, Ceramics
SC Materials Science
GA 018LI
UT WOS:000235765400002
OA Bronze
DA 2018-10-20
ER

PT J
AU Shih, CC
   Shih, CM
   Chou, KY
   Lin, SJ
   Su, YY
AF Shih, Chun-Che
   Shih, Chun-Ming
   Chou, Kuang-Yi
   Lin, Shing-Jong
   Su, Yea-Yang
TI Electrochemical behavior of MP35N implant alloy in simulated
   physiological media
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID 316L STAINLESS-STEEL; SURFACE OXIDE PROPERTIES; METAL-ION RELEASE;
   QUANTITATIVE-EVALUATION; BIOMEDICAL APPLICATIONS; CORROSION-RESISTANCE;
   PASSIVE FILM; STENTS; THROMBOGENICITY; ALLERGY
AB For years, MP35N alloy has been regarded as a very high corrosion-resistant material and has been widely used in various medical applications such as orthopedic implants, lead wire for pacemakers, and cardiovascular stents. Previous researchers of this alloy revealed corrosion pits or localized oxidation on the surface of this material after exposure to Ringer's solution. Therefore, a detailed examination of this multiphase alloy was designed to understand its electrochemical properties and to explore its corrosion behavior. Corrosion resistance of MP35N was investigated by open-circuit potential, anodic polarization, potentiostatic control, electrochemical impedance spectroscopy, and linear voltammetry techniques. Compositional studies of oxide film were examined by electron spectroscopy for chemical analysis. Surface morphologies of MP35N after electrochemical studies were characterized by scanning electron spectroscopy. Elemental distribution and chemical composition was identified by energy dispersive spectrum. Results indicate that chemical composition of the oxide film after passivation plays an important role in the determination of corrosion resistance of MP35N in Ringer's solution. A high concentration of hydroxyl and hydrate groups inside the passivated oxide film is beneficial to the corrosion resistance of this multiphase alloy. (c) 2006 The Electrochemical Society.
C1 Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Taipei 112, Taiwan.
   Taipei Vet Gen Hosp, Div Cardiovasc Surg, Taipei, Taiwan.
   Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.
   Taipei Med Univ, Sch Med, Taipei 110, Taiwan.
   Natl Taipei Coll Nursing, Ctr Gen Educ, Taipei 112, Taiwan.
RP Shih, CC (reprint author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.
EM ccshih@vghtpe.gov.tw
CR Altman PA, 1998, J BIOMED MATER RES, V43, P21, DOI 10.1002/(SICI)1097-4636(199821)43:1<21::AID-JBM3>3.0.CO;2-O
   ASAMI K, 1979, CORROS SCI, V19, P1007, DOI 10.1016/S0010-938X(79)80091-8
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   BOLZ A, 2000, BIOMATERIALS ENG DEV, V1, pCH13
   Breivik K, 1997, PACE, V20, P637, DOI 10.1111/j.1540-8159.1997.tb03882.x
   BROOKS AR, 1986, J ELECTROCHEM SOC, V133, P2459, DOI 10.1149/1.2108450
   Dasika UK, 2003, J THORAC CARDIOV SUR, V126, P2112, DOI 10.1016/S0022-5223(03)01376-X
   DEVINE TM, 1975, J BIOMED MATER RES, V9, P151, DOI 10.1002/jbm.820090205
   DEVINE TM, 1976, J ELECTROCHEM SOC, V123, P1433, DOI 10.1149/1.2132614
   ESCALAS F, 1975, J BIOMED MATER RES, V9, P303, DOI 10.1002/jbm.820090306
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hillen U, 2002, CONTACT DERMATITIS, V47, P353, DOI 10.1034/j.1600-0536.2002.470607.x
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Holton A, 2002, J CARDIOV MAGN RESON, V4, P423, DOI 10.1081/JCMR-120016381
   Keane FN, 2001, LANCET, V357, P1205, DOI 10.1016/S0140-6736(00)04350-6
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   LEMONS JE, 1976, J BIOMED MAT RES S, V7, P549
   MAGHER JM, 1997, MED ENG PHYS, V19, P668
   MCCAFFERTY E, 1995, CORROS SCI, V37, P481, DOI 10.1016/0010-938X(94)00150-5
   McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H
   Oiso N, 2004, CONTACT DERMATITIS, V51, P151, DOI 10.1111/j.0105-1873.2004.0426e.x
   OKAMOTO G, 1973, CORROS SCI, V13, P471, DOI 10.1016/0010-938X(73)90031-0
   RAGHEB T, 1991, ANN BIOMED ENG, V19, P151, DOI 10.1007/BF02368466
   *RICH MAN CO INC, 1980, TECHN PUBL RICH MAN, V3846
   RIONDINE S, 2001, ENV HLTH PERSPECT, V109, P239
   SAITO H, 1979, CORROS SCI, V19, P693, DOI 10.1016/S0010-938X(79)80141-9
   Sato N., 1998, ELECTROCHEMISTRY MET, P235
   Shih CC, 2003, THROMB RES, V111, P103, DOI 10.1016/j.thromres.2003.08.011
   Shih CC, 2004, EUR J CARDIO-THORAC, V25, P812, DOI 10.1016/j.ejcts.2003.11.043
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Shih CC, 2003, APPL SURF SCI, V219, P347, DOI 10.1016/S0169-4332(03)00706-2
   Shih CC, 2003, J BIOMED MATER RES A, V67A, P1320, DOI 10.1002/jbm.a.20013
   Shih CM, 2005, J CONTROL RELEASE, V102, P539, DOI 10.1016/j.jconrel.2004.10.031
   SU YY, 1997, P 2 INT C SHAP MEM S, P389
   Takazawa Kenji, 2003, J Artif Organs, V6, P71, DOI 10.1007/s100470300011
   TONCSANYI L, 1989, ELECTROCHIM ACTA, V34, P855
   TOUTOUZAS K, 2004, EUR HEART J, V3, P1
   Wang Y, 2003, MAGNET RESON MED, V49, P972, DOI 10.1002/mrm.10450
   YOUNKIN CN, 1974, J BIOMED MATER RES, V8, P219, DOI 10.1002/jbm.820080322
NR 41
TC 7
Z9 7
U1 2
U2 5
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2006
VL 153
IS 10
BP B403
EP B410
DI 10.1149/1.2221854
PG 8
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA 081IW
UT WOS:000240312000031
DA 2018-10-20
ER

PT J
AU Nagata, F
   Miyajima, T
   Yokogawa, Y
AF Nagata, F
   Miyajima, T
   Yokogawa, Y
TI A method to fabricate hydroxyapatite/poly (lactic acid) microspheres
   intended for biomedical application
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article; Proceedings Paper
CT International Symposium on Inorganic and Environmental Materials (ISIEM
   2004)
CY OCT 18-21, 2004
CL Eindhoven, NETHERLANDS
SP Philips, City Eindhoven, Technex bv, Corus Ceram Res Ctr, Fdn Cooperat Ceram Org, Dutch Soc Mat Sci
DE apatite; composite; biomedical applications; powders-chemical
   preparation; microsphere
ID REVERSE MICROEMULSIONS; CALCIUM-PHOSPHATE; MORPHOSYNTHESIS; FRAMEWORKS;
   FORM
AB The interaction between organic and inorganic materials enables one to fabricate inorganic/organic microsphere composites. In a novel microemulsion method, we have prepared surfactant-free poly(lactic acid) (PLA)/hydroxyapatite (HAp) microspheres by using the interfacial interaction between inorganic and organic materials, because surfactants are undesireble materials for biomedical applications due to their non-biodegradability. The studies that varied the ion concentrations in oil/water microemulsions revealed that HAp was nucleated at the end group PLA, COOH, and the array of the PLA end groups determined the crystal phase of the calcium phosphate as HAp under the low ion concentration condition. PLA induced the nucleation and precipitation of HAp at the oil/water interface, simultaneously, the precipitated HAp stabilized the microemulsion without surfactants. This novel process made surfactants unnecessary for organic/inorganic microsphere fabrications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Nagoya, Aichi 4638560, Japan.
RP Nagata, F (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.
EM f.nagata@aist.go.jp
RI Xu, Qingguo/C-1962-2014; nagata, fukue/M-8449-2018
OI Xu, Qingguo/0000-0003-3191-0771; nagata, fukue/0000-0002-5284-9626
CR Antonietti M, 1998, CHEM-EUR J, V4, P2493, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
   Collins AM, 2003, J MATER CHEM, V13, P1112, DOI 10.1039/b301183f
   Fowler CE, 2001, J MATER CHEM, V11, P1968, DOI 10.1039/b102675p
   Jafelicci M, 1999, J NON-CRYST SOLIDS, V247, P98, DOI 10.1016/S0022-3093(99)00040-X
   Li M, 2002, ADV FUNCT MATER, V12, P773, DOI 10.1002/adfm.200290006
   Mann S, 2000, ANGEW CHEM INT EDIT, V39, P3393
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Muthusamy E, 2002, ADV MATER, V14, P969, DOI 10.1002/1521-4095(20020705)14:13/14<969::AID-ADMA969>3.0.CO;2-1
   Nagata F, 2003, CHEM LETT, V32, P784, DOI 10.1246/cl.2003.784
   Sarikaya Y, 2002, J EUR CERAM SOC, V22, P305, DOI 10.1016/S0955-2219(01)00294-1
   Schacht S, 1996, SCIENCE, V273, P768, DOI 10.1126/science.273.5276.768
   Sims SD, 1998, ADV MATER, V10, P151, DOI 10.1002/(SICI)1521-4095(199801)10:2<151::AID-ADMA151>3.0.CO;2-U
   Sun QY, 2003, ADV MATER, V15, P1097, DOI 10.1002/adma.200304793
   VONBOMMEL KJC, 2003, ANGEW CHEM INT EDIT, V42, P980
   Walsh D, 1999, ADV MATER, V11, P324, DOI 10.1002/(SICI)1521-4095(199903)11:4<324::AID-ADMA324>3.0.CO;2-A
   WALSH D, 1994, SCIENCE, V264, P1576, DOI 10.1126/science.264.5165.1576
NR 16
TC 30
Z9 32
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PY 2006
VL 26
IS 4-5
BP 533
EP 535
DI 10.1016/j.jeurceramsoc.2005.06.006
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA 006PZ
UT WOS:000234910700029
DA 2018-10-20
ER

PT J
AU Haberko, K
   Bucko, MM
   Brzezinska-Miecznik, J
   Haberko, M
   Mozgawa, W
   Panz, T
   Pyda, A
   Zarebski, J
AF Haberko, K
   Bucko, MM
   Brzezinska-Miecznik, J
   Haberko, M
   Mozgawa, W
   Panz, T
   Pyda, A
   Zarebski, J
TI Natural hydroxyapatite - its behaviour during heat treatment
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article; Proceedings Paper
CT International Symposium on Inorganic and Environmental Materials (ISIEM
   2004)
CY OCT 18-21, 2004
CL Eindhoven, NETHERLANDS
SP Philips, City Eindhoven, Technex bv, Corus Ceram Res Ctr, Fdn Cooperat Ceram Org, Dutch Soc Mat Sci
DE calcination; biomedical applications; bone or gin hydroxyapatite
ID MECHANOCHEMICAL-HYDROTHERMAL SYNTHESIS; POROUS HYDROXYAPATITE; POWDERS;
   MAGNESIUM; PHOSPHATE
AB Natural origin hydroxyapatite (HAp) was extracted from animal bones by their treatment with hot NaOH solution. The remaining organic material oxidized in air atmosphere at moderate temperatures. In the material of this kind carbonate groups and small amounts of magnesium were found, usually not present in the synthetic HAp. Ca/P ratio in pig cortical bones was higher than that in the stoichiometric (synthetic) material. Fraction of carbonate groups decreased with temperature and CaO appeared at higher temperatures. but structure of hydroxyapatite became preserved even at 1000 degrees C, the highest temperature applied in this investigation. At temperatures > 700 degrees C crystallite growth became intensive, specific surface area of the powder decreased and compacts of such powder started to shrink. Biological test showed that CAL-72 (human osteosarcoma) cells growth depended on heat treatment temperature of the natural HAp substrate. (c) 2005 Elsevier Ltd. All rights reserved.
C1 AGH Univ Sci & Technol, Fac Mat & Ceram, PL-30059 Krakow, Poland.
   Jagiellonian Univ, Fac Biotechnol, Krakow, Poland.
RP Haberko, K (reprint author), AGH Univ Sci & Technol, Fac Mat & Ceram, Al Mickiewicza 30, PL-30059 Krakow, Poland.
EM haberko@uci.agh.edu.pl
CR AOKI H, 1991, SCI MED APPL HYDROXY
   Blazewicz M., 2004, EUROPEAN CELLS MAT, V7, P47
   BOBROWSKI A, 1986, CHEM ANAL-WARSAW, V31, P725
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Farmer V. C., 1974, INFRARED SPECTRA MIN, V4
   Haberko K., 2003, ENG BIOMATER, V6, P32
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   MROZ W, 2004, ANN TRANSPLANT, V9, P35
   STOCH A, 1972, CEMENT WAPNO GIPS, V6, P1
   Suchanek WL, 2004, BIOMATERIALS, V25, P4647, DOI [10.1016/j.biomaterials.2003.12.008, 10.1016/biomaterials.2003.12.008]
   Suchanek WL, 2004, J SOLID STATE CHEM, V177, P793, DOI 10.1016/j.jssc.2003.09.012
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Wilson RM, 1999, AM MINERAL, V84, P1406
   YOFE J, 1968, ANAL CHIM ACTA, V43, P346, DOI 10.1016/S0003-2670(00)89229-6
NR 15
TC 116
Z9 118
U1 2
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PY 2006
VL 26
IS 4-5
BP 537
EP 542
DI 10.1016/j.jeurceramsoc.2005.07.033
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 006PZ
UT WOS:000234910700030
DA 2018-10-20
ER

PT J
AU Bertinetti, L
   Tampieri, A
   Landi, E
   Martra, G
   Coluccia, S
AF Bertinetti, L
   Tampieri, A
   Landi, E
   Martra, G
   Coluccia, S
TI Punctual investigation of surface sites of HA and magnesium-HA
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE surfaces; apatite; magnesium; Spectroscopy; biomedical applications
ID CO; MGO; HYDROXYAPATITES; SPECTROSCOPY; MORPHOLOGY; REACTIVITY;
   APATITES; FTIR
AB IR spectroscopy of adsorbed CO is used for the first time to characterize surface cationic centres of pure and magnesium doped hydroxyapatite (HA and MHA, respectively). In air, water molecules saturate the coordination sphere of exposed surface cations by a strong coordinative interaction. At first, the materials were outgassed at 300 degrees C in order to remove water molecules adsorbed on the surface. Following this treatment, surface sites able to adsorb CO are produced. The vibrational frequency of adsorbed CO is sensitive to the features of the adsorbing sites. The IR spectra of CO adsorbed on HA revealed the presence of surface Ca(2+) ions differing for the degree of coordinative unsaturation and of P-OH groups. On MHA, CO was able to monitor the presence of surface Mg(2+) ions, the amount of which increased by aging the material in air. (c) 2005 Published by Elsevier Ltd.
C1 CNR, ISTEC, I-10100 Turin, Italy.
   Univ Turin, Dipartimento Chim, IFM, I-10100 Turin, Italy.
   Univ Turin, NIS Ctr Excellence, I-10100 Turin, Italy.
   CNR, ISTEC, I-38018 Faenza, Italy.
RP Bertinetti, L (reprint author), CNR, ISTEC, Str Cacce 37, I-10100 Turin, Italy.
EM l.bertinetti@to.istec.cnr.it
RI bertinetti, luca/G-1436-2013; Bertinetti, Luca/M-8242-2016
OI bertinetti, luca/0000-0002-4666-9610; Bertinetti,
   Luca/0000-0002-4666-9610; Martra, Gianmario/0000-0002-8012-5342; Landi,
   Elena/0000-0003-4495-129X
CR BIGI A, 1992, CALCIFIED TISSUE INT, V50, P439, DOI 10.1007/BF00296775
   COLUCCIA S, 1993, SPECTROCHIM ACTA A, V49, P1289, DOI 10.1016/0584-8539(93)80036-A
   HOLLINS P, 1979, SURF SCI, V89, P486, DOI 10.1016/0039-6028(79)90633-2
   Hollins P., 1980, Vibrational spectroscopy of adsorbates, P125
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   LEGEROS RZ, 1978, CALC TISS RES, V26, P111, DOI 10.1007/BF02013245
   LeGeros RZ, 1991, MONOGRAPHS ORAL SCI, V15, P82
   Marchese L, 1997, NATO ADV SCI I C-MAT, V498, P79
   Martra G, 2001, CATAL TODAY, V70, P121, DOI 10.1016/S0920-5861(01)00412-6
   MORTERRA C, 1988, J CHEM SOC FARAD T 1, V84, P1617, DOI 10.1039/f19888401617
   OKAZAKI M, 1991, BIOMATERIALS, V11, P831
   Pelmenschikov A, 2000, J PHYS CHEM B, V104, P11497, DOI 10.1021/jp002450j
   REY C, 1998, CALCIUM PHOSPHATES B, P217
   TAMPIERI A, 2003, P 8 ECERS C
   Yasukawa A, 1996, J MATER CHEM, V6, P1401, DOI 10.1039/jm9960601401
   YASUKAWA A, 2002, COLLOID SURF A, V204, P251
   ZECCHINA A, 1996, CATAL TODAY, V27, P323
NR 18
TC 32
Z9 33
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 2006
VL 26
IS 6
BP 987
EP 991
DI 10.1016/j.jeurceramsoc.2004.12.037
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 014SH
UT WOS:000235499700019
DA 2018-10-20
ER

PT J
AU Pavon, J
   Jimenez-Pique, E
   Anglada, M
   Lopez-Esteban, S
   Saiz, E
   Tomsia, AP
AF Pavon, J
   Jimenez-Pique, E
   Anglada, M
   Lopez-Esteban, S
   Saiz, E
   Tomsia, AP
TI Stress-corrosion cracking by indentation techniques of a glass coating
   on Ti6Al4V for biomedical applications
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE biomedical applications; glass fracture; corrosion; mechanical
   properties; indentation
ID BIOACTIVE GLASS; HERTZIAN INDENTATION; BRITTLE MATERIALS; IMPLANTS;
   FRACTURE; ALLOY
AB The fixation of bone replacement implants to the hosting tissue can be improved if the implants have a bioactive surface that can precipitate hydroxyapatite in vivo. Titanium alloys, despite their desirable mechanical and nontoxic properties, are not bioactive and do not bond directly to the bone. One of the ways to change a bioinert metallic surface such as a titanium alloy is to coat it with a bioactive material. This work presents the microstructural and stress-corrosion cracking characterization of two glass coatings on Ti6Al4V with different SiO2 contents (61% and 64%). These coatings belong to the SiO2-CaO-MgO-Na2O-K2O-P2O5 system and they were obtained by a simple enamelling technique. They will be used as the first layer of a bioactive multilayer system which will have an outer layer with a lower SiO2 content in order to ensure the surface bioactivity. Microstructural characterization performed by scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) shows that the coating porosity is clearly influenced by the firing time because of the longer extension of the reaction between Ti and SiO2. The X-ray diffraction (XRD) integration method shows that the amount of crystalline phase (2.4CaO 0.6Na(2)O P2O5) percentage is between 3 vol.% and 16 vol.%. After acid etching, a microstructure with clear boundaries is observed which is the result of the sintered glass particles separation. Stress-corrosion cracking was evaluated using Vickers and Hertzian (spherical) indentation, showing that both coatings are sensitive to subcritical crack growth, and that the coating with the lower silica content is more sensitive to stress-corrosion cracking. These two results are related with the larger residual stresses due to the thermal expansion mismatch. Finally, the stress-corrosion ring cracking behavior by Hertzian indentation is rationalized from the linear-elastic fracture mechanics framework. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Politecn Cataluna, ETSEIB, Dept Ciencia Mat & Engn Met, Barcelona 08028, Spain.
   Ernest Orlando Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Pavon, J (reprint author), Univ Politecn Cataluna, ETSEIB, Dept Ciencia Mat & Engn Met, Avda Diagonal 647, Barcelona 08028, Spain.
EM juan.jose.pavon-palacio@upc.es
OI ANGLADA, MARC/0000-0003-4955-3434; Jimenez-Pique,
   Emilio/0000-0002-6950-611X
CR *ASM COMM TIT TIT, 1980, MET HDB, V3, P372
   BARRY C, 1988, ADV CERAM MATER, V3, P127
   COOK SD, 1993, J BIOMED MATER RES, V27, P1501
   CULLITY BD, 1978, ELEMENTS XRAY DIFFRA, P315
   DOBBS HS, 1982, J MATER SCI, V17, P2340
   ENGLISH S, 1927, J AM CERAM SOC, V10, P122
   Fett T, 1999, ENG FRACT MECH, V64, P105, DOI 10.1016/S0013-7944(99)00060-0
   FRANK FC, 1967, PROC R SOC LON SER-A, V299, P291, DOI 10.1098/rspa.1967.0137
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Hall FP, 1930, J AM CERAM SOC, V13, P182, DOI 10.1111/j.1151-2916.1930.tb16561.x
   HASTINGS GW, 1989, BIOCERAMICS, V1, P355
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL., 1993, INTRO BIOCERAMICS, P239
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HUBER MT, 1940, ANN PHYS-LEIPZIG, V43, P153
   Jackson MJ, 1997, J MATER SCI LETT, V16, P1264, DOI 10.1023/A:1018566606548
   Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO;2-P
   KLUG G, 1995, QUANTITATIVE XRAY DI, P147
   Lacefield WR, 1993, INTRO BIOCERAMICS, P223
   Lawn BR, 2002, CURR OPIN SOLID ST M, V6, P229, DOI 10.1016/S1359-0286(02)00016-5
   Lawn BR, 1993, FRACTURE BRITTLE SOL, P249
   Lee TM, 1996, SURF COAT TECH, V79, P170, DOI 10.1016/0257-8972(95)02463-8
   Licht V, 2004, J EUR CERAM SOC, V24, P2907, DOI 10.1016/j.jeurceramsoc.2003.10.038
   Lopez-Esteban S, 2003, J EUR CERAM SOC, V23, P2921, DOI 10.1016/S0955-2219(03)00303-0
   Malzbender J, 2002, MAT SCI ENG R, V36, P47, DOI 10.1016/S0927-796X(01)00040-7
   Noyan I.C., 1987, RESIDUAL STRESS MEAS, P117
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   PAZO A, 1998, CERAMIC MICROSTRUCTU, P543
   Rhee YW, 2001, J AM CERAM SOC, V84, P1066, DOI 10.1111/j.1151-2916.2001.tb00791.x
   Roberts SG, 1999, J AM CERAM SOC, V82, P1809, DOI 10.1111/j.1151-2916.1999.tb02003.x
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Timoshenko S., 1951, THEORY ELASTICITY, P255
   TURNER PS, 1946, J RES NAT BUR STAND, V37, P239, DOI 10.6028/jres.037.015
   WARREN PD, 1995, J EUR CERAM SOC, V15, P201, DOI 10.1016/0955-2219(95)93941-U
   Whiters PJ, 2001, MAT SCI TECH, V17, P355, DOI [10.1179/026708301101509980, DOI 10.1179/026708301101509980]
   Winkelmann A, 1894, ANN PHYS CHEM, V51, P730
NR 36
TC 18
Z9 19
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 2006
VL 26
IS 7
BP 1159
EP 1169
DI 10.1016/j.jeurceramsoc.2005.01.045
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA 028VY
UT WOS:000236518100009
DA 2018-10-20
ER

PT J
AU Gregori, G
   Kleebe, HJ
   Mayr, H
   Ziegler, G
AF Gregori, G
   Kleebe, HJ
   Mayr, H
   Ziegler, G
TI EELS characterisation of beta-tricalcium phosphate and hydroxyapatite
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE apatite; tricalcium phosphate; electron microscopy; biomedical
   applications
ID RESOLUTION ELECTRON-MICROSCOPY; CALCIUM-PHOSPHATE; IRRADIATION DAMAGE;
   TEM; CERAMICS; APATITES; CRYSTALLINE; DIFFRACTION; CALCINATION;
   STABILITY
AB Hydroxyapatite (H A) and beta-tricalcium phosphate (beta-TCP) are of great interest due to their potential I application as bone-replacement materials. h; particular, composites made of a mixture of these Ca-phosphates revealed improved mechanical properties; however, the reason for this improvement is unknown. Future development and properties enhancement Of Such bioceramics is linked to the possibility to characterise their particular microstructure. In this context, the ability to quickly identify individual grains of HA and beta-TCP within these composites will allow acquiring information about the phase distributions and the phase-boundary microstructure. The aim of the present study is, therefore, to demonstrate that electron energy-loss spectroscopy (EELS) call be successfully employed to differentiate between individual grains of HA and beta-TCP in particular, the analysis of the near-edge structure of the oxygen K-ionisation edge allows detection of a characteristic signal at ca. 536eV that call be employed as all identification tool for HA. EELS investigations were performed first oil as-received and calcined (1000 degrees C) HA and beta-TCP powders and Subsequently on pure bulk HA and beta-TCP, samples sintered at 1250 degrees C. Finally, this method was Successfully applied to a HA/beta-TCP (50/50 wt.%) composite sintered at 1250 degrees C. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA.
   Univ Bayreuth, Friedrich Baur Res Inst Biomat, D-95447 Bayreuth, Germany.
   Colorado Sch Mines, Dept Met & Mat Engn, Golden, CO 80401 USA.
RP Gregori, G (reprint author), Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA.
EM giuliano@engineering.ucsb.edu
RI Kleebe, Hans-Joachim/C-5709-2016
CR Arnold S, 2001, J MICROSC-OXFORD, V202, P488, DOI 10.1046/j.1365-2818.2001.00831.x
   BOHNER M, 2001, EUR SPINE J, V10, P114
   Bonier J.M., 2001, KEY ENG MATER, V192-195, P119
   BRES EF, 1993, J CRYST GROWTH, V129, P149, DOI 10.1016/0022-0248(93)90444-2
   BRES EF, 1991, ULTRAMICROSCOPY, V35, P305, DOI 10.1016/0304-3991(91)90083-I
   CALDERIN L, 2003, PHYS REV B, V67, DOI UNSP 1341061
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Henning PA, 1999, ACTA CRYSTALLOGR B, V55, P170
   Kleebe HJ, 1997, J AM CERAM SOC, V80, P37, DOI 10.1111/j.1151-2916.1997.tb02788.x
   Leng Y, 2003, BIOMATERIALS, V24, P2125, DOI 10.1016/S0142-9612(03)00036-X
   Leng Y, 2002, J MATER SCI LETT, V21, P829, DOI 10.1023/A:1015722607608
   Liou SC, 2002, BIOMATERIALS, V23, P4541, DOI 10.1016/S0142-9612(02)00198-9
   Mathew M, 2001, J RES NATL INST STAN, V106, P1035, DOI 10.6028/jres.106.054
   Meldrum A, 1997, AM MINERAL, V82, P858
   NICOLOPOULOS S, 1995, J SOLID STATE CHEM, V116, P265, DOI 10.1006/jssc.1995.1212
   Rangavittal N, 2000, J BIOMED MATER RES, V51, P660, DOI 10.1002/1097-4636(20000915)51:4<660::AID-JBM14>3.0.CO;2-B
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   TAKADAMA H, 2001, KEY ENG MATER, V192, P51
NR 22
TC 26
Z9 26
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 2006
VL 26
IS 8
BP 1473
EP 1479
DI 10.1016/j.jeurceramsoc.2005.02.007
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 030QQ
UT WOS:000236649800021
DA 2018-10-20
ER

PT J
AU Pena, J
   Izquierdo-Barba, I
   Garcia, MA
   Vallet-Regi, M
AF Pena, J.
   Izquierdo-Barba, I.
   Garcia, M. A.
   Vallet-Regi, M.
TI Room temperature synthesis of chitosan/apatite powders and coatings
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE films; sol-gel processes; apatite; biomedical applications
ID CALCIUM-PHOSPHATE COATINGS; HYDROXYAPATITE COATINGS; IN-VITRO; COMPOSITE
   SCAFFOLDS; BIOMIMETIC METHOD; TITANIUM-ALLOY; CITRIC-ACID; CHITIN;
   MICROSPHERES; RELEASE
AB Bioactive chitosan/apatite powders and adherent coatings have been synthesized by a co-precipitation method and an alkaline transformation at room temperature. Powders with organic/inorganic ratios ranging from 42 to almost 90% can be prepared in substantial amounts. This method allows to coat Ti6A14V substrates yielding films with thicknesses of approximately 1 mu m that show an adhesion strength superior to 15 MPa. The coating procedure can be repeated to increase the thickness of the layer. The formation of apatite onto these materials after immersion in a simulated body fluid (SBF) indicates a potential bioactivity in vivo. The materials have been characterized by viscosimetry, XRD, FTIR, SEM, EDS and TG/ATD. The adhesion strength was determined by a pull-out test. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan, E-28040 Madrid, Spain.
   Univ Complutense Madrid, RENFE, CSIC, Inst Magnetismo Aplicado, Madrid 28230, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; pena, juan/E-5913-2018; Garcia, Miguel
   Angel/N-3043-2016; IZQUIERDO-BARBA, ISABEL/M-9921-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889; pena, juan/0000-0002-5992-908X;
   Garcia, Miguel Angel/0000-0001-9972-2182; IZQUIERDO-BARBA,
   ISABEL/0000-0002-4139-4646
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   ASTM (American Society for Testing and Materials) ASTM, 2001, ANN BOOK ASTM
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   DACULSI G, 2002, ITBM RBM, V23, P317
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Gu YW, 2003, BIOMATERIALS, V24, P1603, DOI 10.1016/S0142-9612(02)00573-2
   Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.0.CO;2-U
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HM, 2000, BIOMATERIALS, V21, P1129, DOI 10.1016/S0142-9612(99)00265-3
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kumar M, 1999, J BIOMED MATER RES, V45, P302, DOI 10.1002/(SICI)1097-4636(19990615)45:4<302::AID-JBM4>3.0.CO;2-A
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lewis G, 2000, BIO-MED MATER ENG, V10, P157
   Li F, 2002, SURF COAT TECH, V154, P88, DOI 10.1016/S0257-8972(01)01710-8
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Lin SJ, 2003, J BIOMED MATER RES A, V66A, P819, DOI 10.1002/jbm.a.10072
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Mao CB, 1999, J CRYST GROWTH, V206, P308, DOI 10.1016/S0022-0248(99)00315-2
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Muzarelli C, 2002, J INORG BIOCHEM, V92, P89
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Risbud M, 2001, J BIOMED MATER RES, V56, P120, DOI 10.1002/1097-4636(200107)56:1<120::AID-JBM1076>3.0.CO;2-W
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Stigter M, 2002, BIOMATERIALS, V23, P4143, DOI 10.1016/S0142-9612(02)00157-6
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sunny MC, 2002, J MATER SCI-MATER M, V13, P623, DOI 10.1023/A:1015709705074
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   Tachaboonyakiat W, 2002, J BIOMAT SCI-POLYM E, V13, P1021, DOI 10.1163/156856202760319162
   Tachaboonyakiat W, 2001, POLYM J, V33, P177, DOI 10.1295/polymj.33.177
   Van de Velde K, 2004, CARBOHYD POLYM, V58, P409, DOI 10.1016/j.carbpol.2004.08.004
   van der Houwen JAM, 2003, J CRYST GROWTH, V249, P572, DOI 10.1016/S0022-0248(02)02227-3
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   WENG W, 2002, MATER CHEM PHYS, V77, P578
   Weng WJ, 1999, J AM CERAM SOC, V82, P27
   XUA HHK, 2005, BIOMATERIALS, V26, P1337
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yamaguchi I, 2003, COLLOID SURFACE A, V214, P111, DOI 10.1016/S0927-7757(02)00365-5
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Yokogawa Y, 2001, J SOL-GEL SCI TECHN, V21, P105, DOI 10.1023/A:1011222003264
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Yoshida A, 2004, MATER TRANS, V45, P994, DOI 10.2320/matertrans.45.994
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhang Y, 2001, J NON-CRYST SOLIDS, V282, P159, DOI 10.1016/S0022-3093(01)00345-3
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 60
TC 26
Z9 27
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 2006
VL 26
IS 16
BP 3631
EP 3638
DI 10.1016/j.jeurceramsoc.2005.12.028
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 102VL
UT WOS:000241841300017
DA 2018-10-20
ER

PT J
AU Lemos, AF
   Rocha, JHG
   Quaresma, SSF
   Kannan, S
   Oktar, FN
   Agathopoulos, S
   Ferreira, JMF
AF Lemos, A. F.
   Rocha, J. H. G.
   Quaresma, S. S. F.
   Kannan, S.
   Oktar, F. N.
   Agathopoulos, S.
   Ferreira, J. M. F.
TI Hydroxyapatite nano-powders produced hydrothermally from nacreous
   material
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE nacre; powders-chemical preparation; microstructure-final; apatite;
   biomedical applications
ID OSTEOBLASTS MAINTAINED INVITRO; OYSTER-SHELL; PINCTADA-MAXIMA; SOLUBLE
   MATRIX; BONE-FORMATION; IN-VIVO; CARBONATE; CALCIUM; CORAL; TEMPERATURE
AB Nano-powders of pure AB-type carbonated hydroxyapatite (HA) sized of similar to 100 nm were successfully produced via hydrothermal transformation (HT) of milled oyster shell powders at 200 degrees C. Low production cost, worldwide availability and natural-biological origin of raw materials are important features of the investigated process. When fine shell powders were used, the transformation reaction from aragonite to hydroxyapatite was accomplished within about 24 h. Calcite, concentrated at the outer surface of the shells, was less prone to transform into hydroxyapatite under the investigated hydrothermal conditions, even after prolonged reaction time (72 h) or in highly concentrated phosphate solutions. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Aveiro, CICECO, Dept Ceram & Glass Eng, P-3810193 Aveiro, Portugal.
   Marmara Univ, Dept Ind Engn, TR-34710 Istanbul, Turkey.
RP Ferreira, JMF (reprint author), Univ Aveiro, CICECO, Dept Ceram & Glass Eng, P-3810193 Aveiro, Portugal.
EM jmf@cv.ua.pt
RI S, Kannan/Q-4342-2017
OI S, Kannan/0000-0003-2285-4907; Ferreira, Jose/0000-0002-7520-2809;
   Lemos, Alexandra/0000-0002-0065-7606
CR Ajakaiye A, 2003, ANIM FEED SCI TECH, V104, P209, DOI 10.1016/S0377-8401(02)00332-2
   Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
   Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   Choi CS, 2000, BIOMATERIALS, V21, P213, DOI 10.1016/S0142-9612(99)00120-9
   COULSON JM, 1974, TECNOLOGIA QUIMICA, P512
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704
   En-Nissan B, 2004, United States Patent, Patent No. [US2004/0091547 A1, 20040091547]
   FELKI HE, 1999, J ALLOY COMPD, V287, P114
   Feng QL, 2000, J CRYST GROWTH, V216, P459, DOI 10.1016/S0022-0248(00)00396-1
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Goller G, 2005, KEY ENG MAT, V284-286, P325
   JENNIFER L, 2000, J AM CERAM SOC, V83, P2341
   Jinawath S, 2002, MAT SCI ENG C-BIO S, V22, P35, DOI 10.1016/S0928-4931(02)00110-8
   Kwon HB, 2004, RESOUR CONSERV RECY, V41, P75, DOI 10.1016/j.resconrec.2003.08.005
   Lamghari M, 1999, BIOMATERIALS, V20, P2107, DOI 10.1016/S0142-9612(99)00113-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   Liao H, 1997, J MATER SCI-MATER M, V8, P823, DOI 10.1023/A:1018537318147
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Liou SC, 2003, BIOMATERIALS, V24, P3981, DOI 10.1016/S0142-9612(03)00303-X
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lowenstam HA, 1989, BIOMINERALIZATION
   Manoli F, 2000, J CRYST GROWTH, V217, P422, DOI 10.1016/S0022-0248(00)00515-7
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Rau JV, 2004, J BIOMED MATER RES B, V71B, P441, DOI 10.1002/jbm.b.30111
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Smith BL, 2000, J CRYST GROWTH, V211, P116, DOI 10.1016/S0022-0248(99)00820-9
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397
   Wolf G, 2001, J THERM ANAL CALORIM, V65, P687, DOI 10.1023/A:1011991124181
   Xu Y, 2001, MATER CHARACT, V47, P83, DOI 10.1016/S1044-5803(01)00154-1
   Yang J, 2003, J AM CERAM SOC, V86, P2055, DOI 10.1111/j.1151-2916.2003.tb03608.x
   Yang J, 2001, MAT SCI ENG C-BIO S, V15, P183, DOI 10.1016/S0928-4931(01)00274-0
   Yoon GL, 2003, WASTE MANAGE, V23, P825, DOI 10.1016/S0956-053X(02)00159-9
   Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g
NR 43
TC 72
Z9 76
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 2006
VL 26
IS 16
BP 3639
EP 3646
DI 10.1016/j.jeurceramsoc.2005.12.011
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 102VL
UT WOS:000241841300018
DA 2018-10-20
ER

PT J
AU Vojtech, D
   Cizova, H
   Volenec, K
AF Vojtech, D.
   Cizova, H.
   Volenec, K.
TI Investigation of magnesium-based alloys for biomedical applications
SO KOVOVE MATERIALY-METALLIC MATERIALS
LA English
DT Article
DE biomaterials; mechanical properties; microstructure; corrosion;
   magnesium
ID MG-AL ALLOYS; CORROSION BEHAVIOR; MECHANICAL-PROPERTIES; CA ALLOYS;
   AZ91; MICROSTRUCTURE
AB In this work, cast, as well as wrought, Mg-based alloys and pure Mg were investigated as promising materials for construction of biomedical degradable implants. Mg, AZ91, AM50 and MgCa5 alloys were studied. The alloys were prepared by various routes including casting into large sand or small metal moulds and hot extrusion. Microstructures and basic mechanical properties of the alloys were investigated. Chemical properties which are useful to predict the degradation rates of implants were determined by exposition tests in a model saliva solution. It was shown that the microstructures of the wrought materials contained recrystallized grains of alpha(Mg) phase and intermetallic phases. These microstructures were more uniform than those of the cast alloys which contained more or less continuous network of interdendritic phases around primary alpha(Mg). The presence of the network led to a reduction of strength of the cast alloys. Exposition tests showed that the cast AZ91Fe0.05 alloy corroded most rapidly in the model saliva. Its corrosion rate was sufficient for medical applications. The fine microstructure of this alloy resulted in a relatively uniform corrosion attack despite the high iron amount.
C1 Inst Chem Technol, Dept Met & Corros Engn, CR-16628 Prague 6, Czech Republic.
   ELLA CS, Hradec Kralove 50006, Czech Republic.
RP Vojtech, D (reprint author), Inst Chem Technol, Dept Met & Corros Engn, Technicka 5, CR-16628 Prague 6, Czech Republic.
EM Dalibor.Vojtech@vscht.cz
CR [Anonymous], 1992, ASM HDB, V13
   [Anonymous], 1990, ASM HDB, V2
   Aung NN, 2002, J APPL ELECTROCHEM, V32, P1397, DOI 10.1023/A:1022698916817
   Bonora PL, 2002, CORROS SCI, V44, P729, DOI 10.1016/S0010-938X(01)00101-9
   Chen RS, 2005, MATER SCI FORUM, V488-489, P275, DOI 10.4028/www.scientific.net/MSF.488-489.275
   Choi BH, 2005, MATER SCI FORUM, V475-479, P2477, DOI 10.4028/www.scientific.net/MSF.475-479.2477
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Duffo GS, 2004, CORROSION-US, V60, P594, DOI 10.5006/1.3287764
   Gale W. F., 2004, SMITHELLS METALS REF
   GEROLD B, 2004, Patent No. 2004098108
   GURMAN EM, 2000, J MAT SYNT P, V8, P133
   Hadzima B, 2003, KOVOVE MATER, V41, P257
   HAFERKAMP H, 2000, P 2 ISR INT C MAGN S, P159
   HAUSDORF G, 2002, Patent No. 2002004060
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   HEUBLEIN B, 2005, Patent No. 1552856
   Inoue H, 2002, CORROS SCI, V44, P603, DOI 10.1016/S0010-938X(01)00092-0
   Kainer K. U., 2003, MAGNESIUM ALLOYS TEC
   Khaselev O, 1998, CORROS SCI, V40, P1149, DOI 10.1016/S0010-938X(98)00019-5
   Kim JM, 2005, MATER SCI FORUM, V486-487, P424, DOI 10.4028/www.scientific.net/MSF.486-487.424
   Levesque J, 2003, MATER SCI FORUM, V426-4, P521, DOI 10.4028/www.scientific.net/MSF.426-432.521
   Liu MP, 2005, MATER SCI FORUM, V488-489, P763, DOI 10.4028/www.scientific.net/MSF.488-489.763
   Mathieu S, 2003, CORROS SCI, V45, P2741, DOI 10.1016/S0010-938X(03)00109-4
   Mathieu S, 2002, CORROS SCI, V44, P2737, DOI 10.1016/S0010-938X(02)00075-6
   Mathis K, 2005, KOVOVE MATER, V43, P238
   MEYERLINDENBERG A, 2002, Patent No. 02100452
   Neubert V, 2004, KOVOVE MATER, V42, P31
   PONCIN P, 2003, P MAT PROC MED DEV C, P266
   Song G., 1998, CORROS SCI, V39, P1769
   VOJTECH D, UNPUB
   Vojtech D, 2004, STENTS PRODUCTION BI
   Wang Y, 2004, MAT SCI ENG A-STRUCT, V366, P17, DOI 10.1016/j.msea.2003.08.055
   WINDHAGEN H, 2003, Patent No. 03055537
   Winzer N, 2005, ADV ENG MATER, V7, P659, DOI 10.1002/adem.200500071
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 35
TC 14
Z9 14
U1 0
U2 10
PU REDAKCIA KOVOVE MATERIALY
PI BRATISLAVA 38
PA UL RACIANSKA 75, PO BOX 95, 830 08 BRATISLAVA 38, SLOVAKIA
SN 0023-432X
J9 KOVOVE MATER
JI Kov. Mater.-Met. Mater.
PY 2006
VL 44
IS 4
BP 211
EP 223
PG 13
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 121LX
UT WOS:000243160200005
DA 2018-10-20
ER

PT J
AU Kim, J
   Choi, SY
   Kim, KM
   Lee, CH
   Park, HS
   Hwang, SS
   Hong, SM
   Kwak, S
   Yoo, HO
AF Kim, Jungahn
   Choi, Song-yee
   Kim, Kyung Min
   Lee, Cheol Han
   Park, Hyeong Soo
   Hwang, Seung Sang
   Hong, Soon Man
   Kwak, Soonjong
   Yoo, Hyun-Oh
TI Synthesis of PEO-based materials for biomedical applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 41st International Symposium on Macromolecules
CY JUL 16-21, 2006
CL Rio de Janeiro, BRAZIL
SP IUPAC, Brazilian Polymer Assoc
DE biomedical applications; ethylene oxide; living anionic polymerization;
   ring-opening
ID POLYMER ELECTROLYTES; GOLD NANOPARTICLES; DRUG-DELIVERY; GLYCOL;
   THERAPEUTICS; CHALLENGES
AB We have successfully carried out living anionic ring-opening polymerization of ethylene oxide in the mixture of benzene/dimethyl sulfoxide (DMSO) using authentic n-butyllithium with potassium tert-butoxide as the initiating system. The resulting poly(ethylene oxide) (PEO) used for biomedical applications could be readily modified by chain-end functionalizations. It was possible to control the molecular weight of PEO as well as to achieve quantitative chain-end functionalizations of PEO.
C1 Kyung Hee Univ, Dept Chem, Seoul, South Korea.
   Sogang Univ, Dept Chem Engn, Seoul 121742, South Korea.
   Korea Inst Sci & Technol, Polymer Hybrids Ctr, Seoul 130650, South Korea.
   Genic Co, Seoul, South Korea.
RP Kim, J (reprint author), Kyung Hee Univ, Dept Chem, Seoul, South Korea.
CR Alvarez MM, 1997, J PHYS CHEM B, V101, P3706, DOI 10.1021/jp962922n
   Bergen JM, 2006, MACROMOL BIOSCI, V6, P506, DOI 10.1002/mabi.200600075
   BURST M, 1994, J CHEM SOC CHEM COMM, P801
   Cheng TL, 2005, BIOCONJUGATE CHEM, V16, P1225, DOI 10.1021/bc050133f
   Croce F, 1999, J PHYS CHEM B, V103, P10632, DOI 10.1021/jp992307u
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   GILMAN H, 1964, J ORGANOMET CHEM, V2, P447, DOI 10.1016/S0022-328X(00)83259-3
   Glomm WR, 2005, J DISPER SCI TECHNOL, V26, P389, DOI 10.1081/DIS-200052457
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Hsieh H. L., 1996, ANIONIC POLYM PRINCI, P71
   KIM J, 2006, UNPUB MACROMOL RES
   Lutz JF, 2006, MACROMOLECULES, V39, P893, DOI 10.1021/ma0517042
   Martin JE, 2000, J PHYS CHEM B, V104, P9475, DOI 10.1021/jp001292t
   Morton M., 1975, RUBBER REV RUBBER CH, V48, P359
   Napoli A, 2001, MACROMOLECULES, V34, P8913, DOI 10.1021/ma0108057
   Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895
   Quirk R. P., 1993, RING OPENING POLYM M, P263
   Quirk R. P., 1992, COMPREHENSIVE POLY S, P82
   QUIRK RP, 1991, MAKROMOL CHEM-M SYMP, V42-3, P463, DOI 10.1002/masy.19910420138
   Satchi-Fainaro R, 2006, ADV POLYM SCI, V193, P1, DOI 10.1007/12_024
   Scrosati B., 2002, ADV LITHIUM ION BATT
   Sharpe M, 2002, DRUGS, V62, P2089, DOI 10.2165/00003495-200262140-00012
   Swierczynski D, 2001, CHEM MATER, V13, P1560, DOI 10.1021/cm001178n
   Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644
   Xiong HM, 2004, J MATER CHEM, V14, P2775, DOI 10.1039/b405179c
NR 25
TC 7
Z9 7
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2006
VL 245
BP 565
EP 570
DI 10.1002/masy.200651381
PG 6
WC Polymer Science
SC Polymer Science
GA 145FZ
UT WOS:000244852000082
DA 2018-10-20
ER

PT J
AU Nakabayashi, N
AF Nakabayashi, Nobuo
TI Preparation of biocompatible materials and their evaluation
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 41st International Symposium on Macromolecules
CY JUL 16-21, 2006
CL Rio de Janeiro, BRAZIL
SP IUPAC, Brazilian Polymer Assoc
DE biocompatible; blood compatible; fouling free; permeablemembrane;
   phospholipid polymer
ID 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE POLYMER; DIAMETER VASCULAR
   PROSTHESIS; CELLULOSE DIALYSIS MEMBRANE; PHOSPHOLIPID POLYMER; BLOOD
   COMPATIBILITY; PROTEIN ADSORPTION; IMPROVEMENT; SURFACE; POLYSULFONE
AB Biomedical application of polymers is an important topicin polymer society. Firstly, we have applied polymers developed for general usage. There has also been a need to prepare specially designed polymers to substitute or assist lost or diseased function of tissues and organs to improve quality of patients' lives. There was a big demand for non-thrombogenic materials to develop artificialheart. 2-Methacryloyloxyethyl phosphorylcholine (MPC) was prepared and functions of MPC copolymers were evaluated. MPC is a promising methacrylate to develop several advanced artificialorgans and therapeutic instruments requiring fouling-free, blood-compatibility, permeability, biocompatibility, etc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Nakabayashi, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
CR Brevig T, 2005, BIOMATERIALS, V26, P3039, DOI 10.1016/j.biomaterials.2004.09.006
   Foy JR, 1999, P I MECH ENG H, V213, P5, DOI 10.1243/0954411991534762
   Hasegawa T, 2002, J BIOMED MATER RES, V63, P333, DOI 10.1002/jbm.10210
   Ho SP, 2003, BIOMATERIALS, V24, P5121, DOI 10.1016/S0142-9612(03)00450-2
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6
   ISHIHARA K, 1994, ARTIF ORGANS, V18, P559, DOI 10.1111/j.1525-1594.1994.tb03379.x
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P271, DOI 10.1163/156856299X00342
   ISHIHARA K, 1992, BIOMATERIALS, V13, P235, DOI 10.1016/0142-9612(92)90190-Y
   ISHIHARA K, 2003, ARTIF ORGANS, V26, P1014
   ISHIHARA K, 1992, J BIOMED MATER RES, P26
   Iwasaki Y, 2002, BIOMATERIALS, V23, P3421, DOI 10.1016/S0142-9612(02)00044-3
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   Kanekura T, 2002, CLIN EXP DERMATOL, V27, P230, DOI 10.1046/j.1365-2230.2002.01005.x
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   Lewis AL, 2002, J BIOMED MATER RES, V63, P699, DOI 10.1002/jbm.10387
   MIYANO T, 1996, T 5 WORLD BIOM C, V2, P413
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2431, DOI 10.1016/S0142-9612(03)00113-3
   NISHIDA K, 1995, MED PROG TECHNOL, V21, P91
   Sakaki S, 1999, J BIOMED MATER RES, V47, P523, DOI 10.1002/(SICI)1097-4636(19991215)47:4<523::AID-JBM8>3.0.CO;2-J
   SAKAKI S, 2000, POLYM J, V33, P337
   Sakakida M., 1995, Japanese Journal of Artificial Organs, V24, P749
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Yoneyama T, 1998, J BIOMED MATER RES, V43, P15, DOI 10.1002/(SICI)1097-4636(199821)43:1<15::AID-JBM2>3.0.CO;2-P
   Yoneyama T, 2000, ARTIF ORGANS, V24, P23, DOI 10.1046/j.1525-1594.2000.06433.x
NR 27
TC 2
Z9 2
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2006
VL 245
BP 591
EP 598
DI 10.1002/masy.200651385
PG 8
WC Polymer Science
SC Polymer Science
GA 145FZ
UT WOS:000244852000086
DA 2018-10-20
ER

PT J
AU He, G
   Hagiwara, M
AF He, G
   Hagiwara, M
TI Ti alloy design strategy for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Ti alloys; biomaterials; nanostructure; Young's modulus; alloy design
ID NANOSTRUCTURED MATERIALS; ENHANCED PLASTICITY; MATERIALS SCIENCE;
   MICROSTRUCTURE; COMPOSITE; DUCTILITY
AB Based on the empirical rules for the composition design of bulk metallic glasses, a general composition formula for forming nano/ultrafine-structure is suggested. According to this formula a group of quinary Ti alloys have been developed. By controlling the solidification conditions an in situ formed bimodal microstructure consisting of micrometer-sized dendritic beta-Ti solid solution dispersed in a nano/ultrafine-structured matrix has been obtained in these quinary Ti alloys. The beta-Ti solid solution contributes to the ductility and the low Young's modulus, while the nano/ultrafine-structured matrix contributes to the high strength. The combination of high strength and low Young's modulus offers potential advantages in biomedical applications. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP He, G (reprint author), Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, 1954 Huashan Rd, Shanghai 200030, Peoples R China.
EM ghe@sjtu.edu.cn
CR Alexandrov IV, 1999, NANOSTRUCT MATER, V12, P709, DOI 10.1016/S0965-9773(99)00223-8
   Chen GL, 2001, MATER TRANS, V42, P1095, DOI 10.2320/matertrans.42.1095
   Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2
   He G, 2004, SOLID STATE COMMUN, V129, P711, DOI 10.1016/j.ssc.2003.12.026
   He G, 2002, J MATER RES, V17, P3015, DOI 10.1557/JMR.2002.0439
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Koch CC, 1999, MRS BULL, V24, P54, DOI 10.1557/S0883769400051551
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MASSALSKI TB, 1992, BINARY ALLOYS PHASE, V2, P2078
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Valiev R, 2002, NATURE, V419, P887, DOI 10.1038/419887a
   Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133
   Weertman JR, 1999, MRS BULL, V24, P44, DOI 10.1557/S088376940005154X
   Wu YJ, 2004, MAT SCI ENG A-STRUCT, V380, P349, DOI 10.1016/j.msea.2004.04.036
NR 17
TC 90
Z9 94
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2006
VL 26
IS 1
BP 14
EP 19
DI 10.1016/j.msec.2005.03.007
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 003IZ
UT WOS:000234676600003
DA 2018-10-20
ER

PT B
AU Hao, YL
   Li, SJ
   Yang, R
AF Hao, Y. L.
   Li, S. J.
   Yang, R.
BE Venugopalan, R
   Wu, M
TI Nanostructured beta-type titanium alloy for biomedical application
SO MEDICAL DEVICE MATERIALS III: PROCEEDINGS FROM THE MATERIALS & PROCESSES
   FOR MEDICAL DEVICES CONFERENCE 2005
LA English
DT Proceedings Paper
CT 3rd Materials and Processes for Medical Devices Conference
CY NOV 14-16, 2005
CL Boston, MA
SP ASM Int
ID SEVERE PLASTIC-DEFORMATION; MOLECULAR-DYNAMICS SIMULATION;
   NANOCRYSTALLINE COPPER; METALS; STRENGTH; BEHAVIOR; FE
AB To obtain fully dense nano-structured metallic materials, severe plastic deformation technique usually has to be used because normal deformation mechanisms, such as dislocation interaction, deformation twins and martensitic transformation, are ineffective in grain refinement. Recently we found localized, unstable plastic deformation in a beta-type Ti-Nb-Zr-Sn titanium alloy developed for biomedical application that is very effective in grain refinement but contributes little to strength. By taking advantage of this deformation mechanism, grain size less than 50 rim. can be easily achieved in conventionally cold-rolled sheet after only 90% thickness reduction. We call this alloy soft nanostructured metallic materials (NMMs) because the flow stress increases by only similar to 5.5% when coarse grains are refined to less than 50 nm, in contrast with several times increase for previously-reported NMMs. The reported titanium alloy with nano-size grains enables investigation of the intrinsic effect of nanostructured grains on properties related to biomedical applications. In this paper we examine the conditions under which such an unusual deformation mechanism can operate and report further strengthening of the nanostructured alloy by aging treatment. A technique to produce submicron porous surface of cold-rolled sheet after solution treatment is also reported.
C1 [Hao, Y. L.; Li, S. J.; Yang, R.] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
RP Hao, YL (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
FU NSFC [50471074, 30471754]; Chinese MoST [TG2000067105]
FX This work was supported by the NSFC (grants 50471074 and 30471754) and
   the Chinese MoST (grant TG2000067105).
CR Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   Hao YL, 2005, ACTA METALL SIN, V41, P1183
   HART EW, 1967, ACTA METALL MATER, V15, P351, DOI 10.1016/0001-6160(67)90211-8
   Hasnaoui A, 2003, SCIENCE, V300, P1550, DOI 10.1126/science.1084284
   Jia D, 2003, ACTA MATER, V51, P3495, DOI 10.1016/S1359-6454(03)00169-1
   Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032
   Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261
   Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463
   Murayama M, 2002, SCIENCE, V295, P2433, DOI 10.1126/science.1067430
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636
   Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328
   Sergueeva AV, 2003, MAT SCI ENG A-STRUCT, V339, P159, DOI 10.1016/S0921-5093(02)00122-3
   Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741
   Valiev R, 2004, NAT MATER, V3, P511, DOI 10.1038/nmat1180
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Valiev RZ, 2002, ANN CHIM-SCI MAT, V27, P3, DOI 10.1016/S0151-9107(02)80002-2
   Wei Q, 2004, ACTA MATER, V52, P1859, DOI 10.1016/j.actamat.2003.12.025
   Wolf D, 2005, ACTA MATER, V53, P1, DOI 10.1016/j.actamat.2004.08.045
   Yamakov V, 2004, NAT MATER, V3, P43, DOI 10.1038/nmat1035
NR 20
TC 0
Z9 0
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-845-8
PY 2006
BP 21
EP +
PG 2
WC Engineering, Biomedical; Metallurgy & Metallurgical Engineering;
   Materials Science, Biomaterials; Materials Science, Characterization &
   Testing
SC Engineering; Metallurgy & Metallurgical Engineering; Materials Science
GA BFY24
UT WOS:000245427500004
DA 2018-10-20
ER

PT J
AU Wang, G
   Wang, L
   Xiong, ZY
   Mao, B
   Li, TQ
AF Wang, G
   Wang, L
   Xiong, ZY
   Mao, B
   Li, TQ
TI Compound salvia pellet, a traditional Chinese medicine, for the
   treatment of chronic stable angina pectoris compared with nitrates: a
   meta-analysis
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE compound salvia pellet; stable angina pectoris; organic nitrates;
   meta-analysis randomized; controlled trials
ID RANDOMIZED-TRIALS; CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; QUALITY;
   GUIDELINES; MANAGEMENT; HEART; MECHANISMS; THERAPY; CONSORT
AB Background: Compound salvia pellet (CSP), consisting of active herbal ingredients extracted from Danshen (salvia miltiorrhiza), Sanqi (panax notoginseng), and Borneol (Cinnamomum camphora), is taken most frequently by patients with angina pectoris in China. To determine the efficacy and safety of CSP for the treatment of stable angina pectoris (SAP), a meta-analysis was undertaken.
   Material/Methods: An extensive search including MEDLINE, EMBASE, BA, Chinese Biomedical Database (CBM), and Chinese Cochrane Centre Controlled Trials Register from 1994 to 2004 was performed. Data were extracted independently from the included trials by two reviewers. Statistical software (RevMan 4.1) provided by the Cochrane Collaboration was applied.
   Results: Twenty-seven randomized controlled trials (RCTs) (n=3722), regardless of language or publication status, were identified. Generally, the methodological quality of the trials, assessed by the Jadad scale, was low, except for one with 3 points. Statistical pooling of the results showed that, compared with nitrates, CSP treatment had significant effect on the improvement of angina symptoms (RR=1.13, 95% CI=[1.07, 1.20]), showed greater increased effect on the improvement of electrocardiogram (ECG) results (RR=l.39,95%CI=[l.28,1.50]), and the percentage of patients with adverse events was significantly decreased in the treatment of CSP in comparison with nitrates (2.4% vs. 29.7%).
   Conclusions: CSP has significant effect on the improvement of angina symptoms and ECG results with few adverse events. However, the methodological quality of clinical trials with CSP for SAP needs to be improved, and the outcome measures should include mortality, quality of life, and other endpoints.
C1 Sichuan Univ, W China Hosp, Dept Integrated Tradit Chinese & Western Med, Chengdu 610041, Peoples R China.
   Baylor Coll Med, Dept Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA.
RP Li, TQ (reprint author), Sichuan Univ, W China Hosp, Dept Integrated Tradit Chinese & Western Med, 37 Guoxue St, Chengdu 610041, Peoples R China.
EM wunggang@hotmail.com
CR Chan P, 2002, ACTA PHARMACOL SIN, V23, P1157
   CHEN KJ, 1998, RES CARDIO CEREBROVA, P316
   CHEN KY, 2004, HLTH VOCATIONAL ED, V22, P125
   Chu XB, 2003, HEILONGJIANG J TRADI, V4, P16
   Clarke M, 2000, COCHRANE LIB
   Dong XM, 2001, PRACT CLIN MED, V2, P143
   Egger M, 1997, BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fihn SD, 2001, ANN INTERN MED, V135, P616, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00014
   GAO B, 2000, J BINZHOU MED COLL, V23, P68
   Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29
   Glasser SP, 1998, AM J CARDIOL, V81, p49A, DOI 10.1016/S0002-9149(97)00998-3
   Guo LX, 2001, J LINYI MED COLL, V23, P113
   Guo ZhiXin, 2003, Chinese Journal of Natural Medicines, V1, P124
   HE YZ, 2004, HLTH VOCATIONAL ED, V22, P107
   Huang SW, 2004, MOD DIAGN TREAT, V15, P349
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089
   KJACRGAARD LL, 2001, ANN INTERN MED, V135, P982
   Liu JP, 2002, AM J CHINESE MED, V30, P173, DOI 10.1142/S0192415X0200017X
   Liu YH, 2003, J LIAONING COLL TCM, V5, P354
   LU J, 2001, GANSU J TCM, V14, P22
   McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0
   MICKIE P, 2003, CURRENT THERAPEUTIC, V64, P662
   *MIN PUBL HLTH P R, 1993, GUID DRUGS GOOD CLIN, P46
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3
   Moher D, 2004, CAN MED ASSOC J, V171, P349, DOI 10.1503/cmaj.1040031
   *N ENGL STABL ANG, 1996, BMJ-BRIT MED J, V312, P827
   Niemeyer MG, 1997, ANGIOLOGY, V48, P855, DOI 10.1177/000331979704801002
   Parker JD, 1998, NEW ENGL J MED, V338, P520, DOI 10.1056/NEJM199802193380807
   RONG JH, 2004, J NANTONG MED COLL, V24, P448
   Sampson M, 2003, J CLIN EPIDEMIOL, V56, P943, DOI 10.1016/S0895-4356(03)00110-0
   Schulz KF, 2002, JAMA-J AM MED ASSOC, V288, P2406, DOI 10.1001/jama.288.19.2406
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Shi Y H, 1997, Zhongguo Zhong Xi Yi Jie He Za Zhi, V17, P23
   SILBER S, 1990, EUROPEAN J CLIN PHAR, V3, pS35
   Sun L, 2000, TIANJIN J TRADIT CHI, V17, P6
   SUN YZ, 2002, THEORY PRACT CHIM ME, V8, P995
   Thadani U, 1997, CARDIOVASC DRUG THER, V10, P735, DOI 10.1007/BF00053031
   TODD PA, 1990, DRUGS, V40, P880, DOI 10.2165/00003495-199040060-00009
   Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5
   Wang AM, 2003, ANTIMICROB AGENTS CH, V47, P1836, DOI 10.1128/AAC.47.6.1836-1841.2003
   Wang Jie, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P312
   Wang JS, 2003, CHINESE J INFORMATIO, V10, P58
   WANG L, 2004, CHINESE J INTEGRATIV, V10, P212
   WANG SQ, 1999, J CHANGCHUN COLL TCM, V15, P10
   WANG XL, 2003, ACTA ACAD MED NEIMON, V25, P204
   WU K, 2001, CHIN J MODERN APPL P, V18, P493
   Wu S, 2000, NINGXIA MED J, V22, P407
   Xu XM, 2000, CHIN TRADIT HERBAL D, V31, P44
   YANG SM, 2001, ACTA ACAD MED, V20, P198
   YAO FH, 2002, SHANDONG J TCM, V21, P147
   YAO YX, 2002, J EMERGENCY SYNDROME, V11, P26
   Yuan XL, 2003, SHANDONG YIYAO GONGY, V22, P50
   Zhang GH, 1999, JILIN J TCM, V3, P10
   Zhou W, 2004, MED SCI MONITOR, V10, pRA187
   ZHOU W, 1990, AM J CHINESE MED, V18, P19, DOI 10.1142/S0192415X90000046
   ZHOU YM, 1998, CHIN J NEW DRUGS CLI, V17, P375
   ZHU YQ, 2001, GANSU J TCM, V2, P52
   李雪丽, 2003, [中国老年学杂志, Chinese Journal of Gerontology], V23, P183
   丁晓明, 1999, [苏州医学院学报, Acta Academiae Medicinae Suzhou], V19, P512
NR 61
TC 33
Z9 34
U1 1
U2 14
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JAN
PY 2006
VL 12
IS 1
BP SR1
EP SR7
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 004GR
UT WOS:000234740500018
PM 16369479
DA 2018-10-20
ER

PT S
AU Nusslin, F
AF Nusslin, F.
BE Nimsky, C
   Fahlbusch, R
TI Current status of medical technology
SO Medical Technologies in Neurosurgery
SE ACTA NEUROCHIRURGICA SUPPLEMENTA
LA English
DT Proceedings Paper
CT Joint Convention of the 13th Academia-Eurasiana-Neurochirurgica/9th
   Germany-Academy-of-Neurosurgery
CY SEP 01-03, 2005
CL Bamberg, GERMANY
SP Acad Eurasiana Neurochirurg, German Acad Neurosurg
DE medical technology; health care system; research & development in
   medical technology
AB Background. Medical Technology (MT) provides innovative instrumentation and methods designed for the purpose of I improving prevention. diagnostics, therapy and rehabilitation. NIT rooting in science, engineering and the biosciences is characterized by its inter-and transdisciplinarity.
   Method. The current status of NIT is described emphasizing the five aspects: (1) review of milestones, (2) the impact of MT on the health care system, (3) the economic significance of NIT, (4) the financial resources dedicated to research and development in MT, and (5) the challenges for education and training in MT. The material used is a government issued survey on the situation of MT in Germany, data of health care authorities and congress reports from World Conference on Medical Physics and Biomedical Engineering 2005.
   Results. The following fields of NIT have emerged in recent years and will dominate future development: BioMEMOS, imaging technology. minimally invasive surgery, computer assisted diagnosis, therapy and treatment monitoring, e-health/telemedicine/ networking. and medical engineering for regenerative medicine. Development of MT is driven by the following facts, (1) early and individualized diagnosis enables better treatment, (2) MT enhances cost effectiveness in health care, (3) MT is an economic factor based on fast innovation cycles, a roughly 50% export share and a 6% growth rate in turnover during the last 10 years. A downward tendency of the domestic MT market is a challenge for appropriate measures in improving both the economic and the academic infrastructure, in particular by targeted actions to support research and education.
   Conclusion. The impact of MT on prevention, diagnostics, therapy and rehabilitation is significant and still increasing. Due to a wide spreading in all medical areas, the high innovation rate, and the potential to improve health care, MT is considered one of the key technologies even in the future.
C1 Tech Univ Munich, Klinikum Rechts Isar, Klin Strahlentherapie, D-81675 Munich, Germany.
RP Nusslin, F (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Klin Strahlentherapie, Ismaninger Str 22, D-81675 Munich, Germany.
CR BOENICK U, 2005, WORLD C MED PHYS BIO
   *BUND BILD FORSCH, 2005, STUD SIT MED DEUTSCH
   *FED MIN ED RES, 2000, CENTR COMP MED TECHN
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   *SCI TECHN IND EUR, 2003, 20025 EUR EN
NR 5
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, A-1201 VIENNA, AUSTRIA
SN 0065-1419
BN 3-211-33302-9
J9 ACT NEUR S
JI Acta Neurochir. Suppl.
PY 2006
VL 98
BP 25
EP 31
PG 7
WC Engineering, Biomedical; Clinical Neurology; Surgery
SC Engineering; Neurosciences & Neurology; Surgery
GA BFN42
UT WOS:000243313800005
PM 17009698
DA 2018-10-20
ER

PT B
AU Ene, A
   Mihai, C
AF Ene, A
   Mihai, C
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI New generations of resorbable biomaterials with textile structures
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
AB The researches in the production field of the resobable biomaterials with textile structures have the following main objectives: the ensuring of the biological characteristics and especially of the biocompatibility of the products depending on the category they belong to (implant or medical article for external use); the using within the manufacturing process, of biomaterials that corresponds to the requirements imposed by the European legislation (90/385 EC) and American legislation in the field; the elaborating of the physico-chemical and toxicological testing methodologies depending on the intensity of interaction between the medical product and the human body, in conformity with the requirements of the international standards ISO 10993; the increasing of accuracy, precision, reliability, durability degree of the products.
   Resorbable biomaterials, with textile structures can be used for any type of wound when by the destruction of the skin or of the live tissues, local haemorrhages or/and fluid secretion occur.
   The employing fields of these biomaterials can be also applied to urgent interventions required by naval, road, air accidents, avalanches in areas difficult of access, natural calamities etc.
   The researches regarding the obtaining of these products are part of bilateral collaborations with the Chemistry Centre of Polymers - Zabrze, Poland and the National University of Yokohama - Japan.
   The paper presents the types of resorbable materials used in the making of these types of medical articles, the main results obtained within the experiments of transforming in fibres the biodegradable polymers made by the partner from Poland, the biomedical and biofunctional characteristics of implantable products imposed by the ongoing national and international norms, as well as the terms of manufacturing and marketing on European markets of these types of products.
C1 Res Dev Natl Inst Text & Leather, Bucharest 74674, Romania.
RP Ene, A (reprint author), Res Dev Natl Inst Text & Leather, Str Lucretiu Patrascanu Nr 16 Sector 3, Bucharest 74674, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 23
EP 28
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900002
DA 2018-10-20
ER

PT B
AU Golding, C
   Ekevall, E
   Wallace, SR
   Mather, RR
AF Golding, C
   Ekevall, E
   Wallace, SR
   Mather, RR
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI The effect of degradation on the mechanical properties of biodegradable
   polylactide yarns and textiles
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
DE polylactide yarns; biodegradable fibres; tissue engineering scaffolds;
   medical textiles
AB A large research effort worldwide is directed at reproducing 3D tissue and one recent development in the production of tissue engineering scaffolds is the use of biodegradable materials. This research investigates the possibility of producing biodegradable knitted scaffolds from polylactic acid yams. Degradation in the following biodegradable yams is studied and the effect on their mechanical properties determined: a commercial polylactide (PLA) yam Lactron (Kanebo Gohsen Ltd) and four yams extruded in the Biomedical Textiles Research Centre (BTRC) from a medical grade Poly (L-lactide) (PLLA) polymer (Purac biochem). To determine the degradation effects the mechanical properties were evaluated on a Nene tensile testing rig and samples observed under the scanning electron microscope; before and after the yams were immersed in phosphate buffer solution (pH=7.4) for various lengths of time at 37 degrees C. The yams extruded in-house showed a gradual decline in tenacity over the degradation period, unlike the commercial yam where the tenacity was maintained. This work shows that the degradation process is affected by factors such as extrusion speed and twist. With further knowledge, it may be possible to produce polylactic acid yams with known degradation and cell attachment characteristics for textile tissue engineering scaffolds. In conclusion, polylactic acid yams have good potential and biodegradable textile tissue engineering scaffolds look promising for the future.
CR *BIOCH PURAC, PURASORB MON BIOD PO
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HEIDARAN MA, 2000, IRANIAN BIOMEDICAL J, V4, P1
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   REED AM, 1981, POLYMER, V22, P342
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   WALLACE SR, 2002, UNPUB PRODUCTION PLL
   Yuan XY, 2002, J APPL POLYM SCI, V85, P936, DOI 10.1002/app.10490
NR 10
TC 1
Z9 1
U1 0
U2 4
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 58
EP 66
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900006
DA 2018-10-20
ER

PT B
AU Bide, MJ
   Choi, HM
   Phaneuf, MD
   Quist, WC
   LoGerfo, FW
AF Bide, MJ
   Choi, HM
   Phaneuf, MD
   Quist, WC
   LoGerfo, FW
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI The use of dye-like interactions for developing novel
   infection-resistant materials
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
AB Textile and other polymeric materials are ubiquitous in medical devices, whether used in implanted (e.g. prosthetic arterial grafts, prosthetic valve sewing cuffs), percutaneous (e.g. catheters, sutures) or extra-corporeal (e.g. wound dressings, cardiac bypass pump tubing) devices.
   Depending on the use (in or out of the body, short or long term), these materials can suffer a variety of problems. One of the most significant is that of infection. Infection affects both the biomaterial and the patient. Infection in the biomaterial leads to failure, and the need for replacement with associated cost and risks. For the patient, limb loss and mortality are potential outcomes. The treatment for an infected biomaterial is typically a systemic dosage of antibiotic that represents a potential source of resistant strains of bacteria. For urinary and indwelling catheters the infection rate is as high as 40%. This series of projects began originally to look specifically at prosthetic arterial grafts, and problems of infection associated with them. It has led to a series of projects in which dye-like interactions of several different biomedical materials with bioactive materials have produced potentially useful products.
C1 Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
RP Bide, MJ (reprint author), Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
CR BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   Bide M. J., 2001, AATCC REV, V1, P35
   BIDE MJ, 2001, ACS S SERIES, V792
   CHOI HM, UNPUB J APPL POLYM S
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GROHE K, 1992, CHEM BRIT, V28, P34
   HUANG HX, 2002, THESIS U RHODE ISLAN
   JOKLEK W, 1984, ZINSSER MICROBIOLOGY, pCH9
   MOORE W, 1991, VASCULAR SURG COMPRE, pCH16
   OZAKI CK, 1993, J SURG RES, V55, P543, DOI 10.1006/jsre.1993.1181
   PHANEUF MD, 1999, MERGING BIOMEDICAL T
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SUMNER HH, 1989, THEORY COLORATION TE, pCH4
   WOOD MJ, 1988, BRIT J CLIN PRACT, V42, P469
NR 14
TC 2
Z9 2
U1 0
U2 0
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 136
EP 143
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900016
DA 2018-10-20
ER

PT B
AU Mihai, C
   Ene, A
AF Mihai, C
   Ene, A
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI New generation of vascular prostheses accomplished through weaving
   technologies
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
AB The arterial system is a complex assembly of vessels that direct the blood from heart to other body organs. The identifying of biological requirements of the most complicated mechanism like the human body, connected to the possibilities of actual technique, has led to a successful accomplishment of an extremely varied range of medical products of textile materials.
   At present, there are established and marketed systems of implanting arterial venous prostheses by means of weaving, knitting and extruding technologies. Vascular prostheses accomplished by weaving technologies combine the advantages of knitted grafts with extruded grafts. In view of the athrombogenity of the artificial blood vessels walls there have been created the so called "prostheses-tight" which are obtained by using some biological substances such as: collagen, albumin, gelatin etc. At present, these products are used successfully, in surgical operations that refer to arterial-bifemural by-pass, arterial-femural by-pass; ilio-femural by-pass; femural-popitelial by-pass; axilo-femural by-pass; femural-axial by pass; femural-carotidian by-pass; subclavio-axial by-pass.
   This paper presents the achievements of INCDTP correlated with the evolution at an international level, in the, field of surgical implants, the level of biomedical and biofunctional performances of these implants, the terms of admissibility imposed by the international legislation in the field for the production and marketing of medical implants with textile structures.
C1 Res Dev Natl Inst Text & Leather, Bucharest 74674, Romania.
RP Mihai, C (reprint author), Res Dev Natl Inst Text & Leather, Str Lucretiu Patrascanu,Nr 16,Sector 3, Bucharest 74674, Romania.
NR 0
TC 0
Z9 0
U1 1
U2 5
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 409
EP 416
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900050
DA 2018-10-20
ER

PT B
AU Ajmeri, JR
   Ajmeri, CJ
AF Ajmeri, JR
   Ajmeri, CJ
BE Anand, SC
   Kennedy, JF
   Miraftab, M
   Rajendran, S
TI Surgical sutures: The largest textile implant material
SO Medical Textiles and Biomaterials for Healthcare
SE WOODHEAD PUBLISHING IN TEXTILES
LA English
DT Proceedings Paper
CT International Conference and Exhibition on Healthcare and Medical
   Textiles (MedTex 03)
CY JUL 08-09, 2003
CL Univ Bolton, Ctr Mat Res & Innovat, Bolton, ENGLAND
SP SSL Int plc, Shilo, Vernoncarus, Lantor, nw texnet, TechniTex, Textile Ind, dti, CRC Press
HO Univ Bolton, Ctr Mat Res & Innovat
AB There are numerous opportunities for textiles and related polymeric studies in the discipline of biomaterials science. Biomedical textile products begin with raw materials (polymers) which have been specifically constructed and treated for medical application. Common applications of biomaterials include orthopedic hip and knee replacements, intra-ocular lens, dental implants, heart valves, contact lenses, vascular grafts, blood bags, catheters, surgical gowns and drapes, sutures, drug delivery devices, adhesion prevention, wound dressings, membranes, tendon, and ligaments, etc.
   The use of sutures which is one of the most common practices in the medical field and thus has direct effect on a great majority of the world's population. Thousands of years ago the Egyptians were among the first to use fibrous materials as biomedical devices using naturally derived materials for wound closure. With modem advances in synthetic filaments Sutures are the most common implant material today. The suture market currently exceeds $1.3 billion annually. Since the beginning of surgical history (5000-3000 BC), Sutures have been used as the means of repairing damaged tissues, cut vessels and surgical incisions.
   By definition; a suture is a thread that either replicates and maintains tissues until the natural healing process has provided sufficient level of wound strength or compresses blood vessels in order to stop bleeding.
   The United States Pharmacopoeia (USP), European Pharmacopoeia (EP) and British Pharmacopoeia (BP) are the official compendium for the suture industry. They sets standards and guidelines for suture manufacture. Suture sizes are given by a number representing diameter ranging in descending order from 10 to 1 and then 1-0 to 12-0, 10 being the largest and 12-0 being the smallest at a diameter smaller than a human hair.
   Sutures can be classified into one of two groups, absorbable and non absorbable. For surgical sutures the predominant areas of concern are strength, capillarity, sliding and positioning of knots, knot security and handling characteristics. The recent focus of suture research has been on improving the structure of the braids (two recently proposed products are spiral and lattice-braided materials), reducing the difference in the elongation properties between the core and the sheath yams, using finer denier filaments in the sheath yams and improving knot security and performance by exposing a two-throw square knot to laser beam energy.
C1 Sarvajanik Coll Eng & Tech, Dept Text Technol, Surat, Gujarat, India.
RP Ajmeri, JR (reprint author), Sarvajanik Coll Eng & Tech, Dept Text Technol, Surat, Gujarat, India.
CR Adanur S, 1995, WELLINGTON SEARS HDB
   ADANUR S, 2000, HDB TECHNICAL TEXTIL
   BASU K, 2001, MANTRA B, V19, P2
   BHALERAO S, 1998, ASIAN TEXTILE J DEC, P81
   BRENNAN KW, 1990, Patent No. 4959069
   BRUG KJL, 2001, INT FIBER J     AUG, P38
   CHELLAMANI KP, 1999, SITRA
   DAYAL A, 1999, JTA              NOV, P187
   DOSER M, 2000, NONWOVENS IND TEXTIL, P10
   ELLIS JG, 2000, P TEXT I WORLD C MAN
   GUPTA SS, MED PLASTICS BIO JAN
   Hongu T., 1997, NEW FIBRES
   JACOB M, 1998, INDIAN TEXTILE J OCT, P88
   LEONAS KK, 1996, BIOMEDICAL TEXTILES
   MANKODI H, 2000, INDIAN TEXTILE J NOV, P39
   RIGBY AJ, 2000, HDB TECHNICAL TEXTIL
   Sayed U, 2002, ASIAN TEXTILE J  JUN, P67
   SHISHOO R, 2001, NONWOVENS IND TEXTIL, P24
   1996, ENCY CHEM TECHNOLOGY, V20
   1997, ENCY CHEM TECHNOLOGY, V23
NR 20
TC 3
Z9 3
U1 0
U2 10
PU WOODHEAD PUBL LTD
PI CAMBRIDGE
PA ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND
BN 1-85573-683-7
J9 WOODH PUBL TEXT
PY 2006
BP 432
EP 440
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BDS54
UT WOS:000235184900053
DA 2018-10-20
ER

PT J
AU Lang, E
AF Lang, E.
TI Bioinformatics and its impact on clinical research methods - Findings
   from the section on bioinformatics
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article
DE medical informatics; International Medical Informatics Association;
   yearbook; bioinformatics
ID BIOMEDICAL TEXT; GENE; DISEASE; CLASSIFICATION; EXTRACTION; CANCER;
   HEALTH
AB Objectives: To summarize current excellent research in the field of bioinformatics.
   Method: Synopsis of the articles selected for the IMIA Yearbook 2006.
   Results: Current research in the field of bioinformatics clearly shows ongoing unification of experimental findings and clinical outcomes. Microarray data, gene sequences and clinical data are more and more perceived as different but related facet of one entity. Significant work is done in the area of text and data mining in order to bring together patient data and biochemical phenomena by means of ontologies. A strong trend in the clinical field is performance of exhaustive studies on DNA material derived from patient that suffer from diseases that are already known to be inherited. Examination a appropriate methods covers data and text mining, ontologies as well as machine learning and classification.
   Conclusions: The best paper selection of articles on bioinformatics shows examples of excellent research on methods used for studying inherited diseases and their underlying genetic dispositions. Clinical studies, inclusion of experimental findings like microarray data, and of knowledge representation formats all lead to a better understanding the linkage between gene sequences, biological functions and clinical findings in the form of healthy state or physiological disorders.
C1 Univ Appl Sci Darmstadt, Dept Informat & Kowledge Management, D-64295 Darmstadt, Germany.
RP Lang, E (reprint author), Univ Appl Sci Darmstadt, Dept Informat & Kowledge Management, Haardting 100, D-64295 Darmstadt, Germany.
EM lang@iuw.h-da.de
CR Baumgartner C, 2004, BIOINFORMATICS, V20, P2985, DOI 10.1093/bioinformatics/bth343
   Bott OJ, 2005, METHOD INFORM MED, V44, P473
   Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469
   Gaizauskas R, 2003, BIOINFORMATICS, V19, P135, DOI 10.1093/bioinformatics/19.1.135
   Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900
   Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024
   Ivanciuc O, 2002, BIOINFORMATICS, V18, P1358, DOI 10.1093/bioinformatics/18.10.1358
   Knaup P, 2004, METHOD INFORM MED, V43, P302
   Koike A, 2005, BIOINFORMATICS, V21, P1227, DOI 10.1093/bioinformatics/bti084
   Maojo V, 2004, METHOD INFORM MED, V43, P208
   Ohno-Machado L, 2002, J INTELL FUZZY SYST, V12, P19
   PETRICOIN EF, 2002, BIOTECHNOLOGY S, V20, pS30
   Sharma R, 2004, BIOINFORMATICS, V20, P1074, DOI 10.1093/bioinformatics/bth041
   Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124
   Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296
   Wallqvist A, 2003, BIOINFORMATICS, V19, P2212, DOI 10.1093/bioinformatics/btg302
NR 16
TC 0
Z9 0
U1 1
U2 4
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2006
VL 45
SU 1
BP 104
EP 106
PG 3
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 116AP
UT WOS:000242775200019
DA 2018-10-20
ER

PT J
AU Whitesides, GM
   Wong, AP
AF Whitesides, GM
   Wong, AP
TI The intersection of biology and materials science
SO MRS BULLETIN
LA English
DT Article
DE biological; biomedical; nanoscale
ID SELF-ASSEMBLED MONOLAYERS; TISSUE ENGINEERING MATERIALS; DRUG-DELIVERY;
   ELECTRICAL-STIMULATION; SYSTEMATIC VARIATION; POLYMERIC MATERIALS;
   ARTIFICIAL-ORGANS; QUANTUM DOTS; PROTEINS; BONE
AB This article is based on the plenary address given by George M. Whitesides of Harvard University on March 30, 2005, at the Materials Research Society Spring Meeting in San Francisco. Materials science and biomedicine are arguably two of the most exciting fields in science today. Research at the border between them will inevitably be a major focus, and the applications of materials science to problems in biomedicine-that is, biomaterials science-will bud into an important new branch of materials science. Accelerating the growth of this area requires an understanding of two very different fields, and being both thoughtful and entrepreneurial in considering "Why?" "How?" and "Where?" to put them together. In this fusion, biomedicine will, we believe, set the agenda; materials science will follow, and materials scientists must learn biology to be effective.
C1 Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.
RP Whitesides, GM (reprint author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St,Box 117,Mallinckrodt 238, Cambridge, MA 02138 USA.
EM gwhitesides@gmwgroup.harvard.edu; apwong@fas.harvard.edu
CR Barakat I, 1999, J POLYM SCI POL CHEM, V37, P2401, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2401::AID-POLA14>3.0.CO;2-9
   Barron AE, 1999, CURR OPIN CHEM BIOL, V3, P681, DOI 10.1016/S1367-5931(99)00026-5
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Brunetti P, 2003, ARTIF CELL BLOOD SUB, V31, P127, DOI 10.1081/BIO-120020169
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Chang TMS, 2003, ARTIF CELL BLOOD SUB, V31, P151, DOI 10.1081/BIO-120020173
   Chen DL, 2005, J AM CHEM SOC, V127, P9672, DOI 10.1021/ja052279v
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cui DX, 2003, BIOTECHNOL PROGR, V19, P683, DOI 10.1021/bp025791i
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   de la Fuente JM, 2005, CHEMBIOCHEM, V6, P989, DOI 10.1002/cbic.200500071
   Desgrandchamps F, 1999, EUR UROL, V35, P257
   Driban JB, 2004, ATHLET THER TODAY, V9, P22, DOI 10.1123/att.9.5.22
   El-Hakim IE, 2004, INT J ORAL MAX SURG, V33, P42, DOI 10.1054/ijom.2003.0445
   Famulari A, 2003, ARTIF CELL BLOOD SUB, V31, P163, DOI 10.1081/BIO-120020174
   Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003
   Greenhalgh DG, 2005, J BURN CARE REHABIL, V26, P293, DOI 10.1007/01/BCR.0000169885.66639.B5
   Grigioni M, 2005, J BIOMECH, V38, P1557, DOI 10.1016/j.jbiomech.2004.11.020
   Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010
   Hildebrand KA, 2005, SPORTS MED ARTHROSC, V13, P136, DOI 10.1097/01.jsa.0000173230.61276.f4
   Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c
   Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004
   Hummel R E, 2004, UNDERSTANDING MAT SC
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Kashyap N, 2005, CRIT REV THER DRUG, V22, P107, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
   Kriplani U, 2005, CURR OPIN BIOTECH, V16, P470, DOI 10.1016/j.copbio.2005.07.001
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee BI, 2005, J CERAM PROCESS RES, V6, P31
   Li Z, 2005, J NANOSCI NANOTECHNO, V5, P1199, DOI 10.1166/jnn.2005.220
   LOVRIC J, 2005, J MOL MED, V3, P377
   Lu Y, 2004, ADV DRUG DELIVER REV, V56, P1621, DOI 10.1016/j.addr.2004.05.002
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Malchesky PS, 2004, ARTIF ORGANS, V28, P410, DOI 10.1111/j.1525-1594.2004.07359.x
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   OBERDORSTER G, 2005, J ENV HLTH PERSPECT, V113, P823, DOI DOI 10.1289/EHP.7339
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Park SH, 2004, J ORTHOP RES, V22, P382, DOI 10.1016/j.orthres.2003.08.007
   Pellegrino T, 2005, SMALL, V1, P48, DOI 10.1002/smll.200400071
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ratner B. D., 1997, BIOMATERIALS SCI INT
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Roy I, 2003, CHEM BIOL, V10, P1161, DOI 10.1016/j.chembiol.2003.12.004
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Sanford K, 2005, CURR OPIN BIOTECH, V16, P416, DOI 10.1016/j.copbio.2005.06.002
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Smith DK, 2005, PROG POLYM SCI, V30, P220, DOI 10.1016/j.progpolymsci.2005.01.006
   Stains JP, 2005, BIOCHEM BIOPH RES CO, V328, P721, DOI 10.1016/j.bbrc.2004.11.078
   Standal T, 2004, EXP ONCOL, V26, P179
   Suuronen EJ, 2005, INT REV CYTOL, V244, P137, DOI 10.1016/S0074-7696(05)44004-8
   Takeda S, 2005, BIOCHEM BIOPH RES CO, V328, P697, DOI 10.1016/j.bbrc.2004.11.071
   Tamber H, 2005, ADV DRUG DELIVER REV, V57, P357, DOI 10.1016/j.addr.2004.09.002
   Tan Y, 2005, ACTA CHIM SINICA, V63, P929
   Turner JL, 2005, ADV FUNCT MATER, V15, P1248, DOI 10.1002/adfm.200500005
   van der Woerd M, 2003, J STRUCT BIOL, V142, P180, DOI 10.1016/S1047-8477(03)00049-2
   Weisel J. W., 2005, FIBROUS PROTEINS COI, V70, P247
   Whittlesey KJ, 2004, EXP NEUROL, V190, P1, DOI 10.1016/j.expneurol.2004.06.020
   Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019
   Wissing SA, 2004, ADV DRUG DELIVER REV, V56, P1257, DOI 10.1016/j.addr.2003.12.002
   Wu LQ, 2004, TRENDS BIOTECHNOL, V22, P593, DOI 10.1016/j.tibtech.2004.09.008
   Yamada T, 2005, J BIOSCI BIOENG, V99, P521, DOI 10.1263/jbb.99.521
   Zelenka PS, 2005, EXPERT OPIN THER PAT, V15, P875, DOI 10.1517/13543776.15.7.875
NR 71
TC 28
Z9 28
U1 4
U2 31
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD JAN
PY 2006
VL 31
IS 1
BP 19
EP 27
DI 10.1557/mrs2006.2
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 003IP
UT WOS:000234675500017
DA 2018-10-20
ER

PT J
AU Chu, PK
AF Chu, PK
TI Bioactivity of plasma implanted biomaterials
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Ion Beam Modification of Materials
   (IBMM 2004)
CY SEP 05-10, 2004
CL Pacific Grove, CA
SP Amer Vacuum Soc, NE Calif Chapter
DE NiTi shape memory alloys; plasma implantation; bioactivity; apatite;
   amorphous carbon; blood compatibility; silicon
ID IMMERSION ION-IMPLANTATION; DIAMOND-LIKE CARBON; SIMULATED BODY-FLUID;
   BLOOD COMPATIBILITY; SHAPE-MEMORY; IN-VITRO; BIOLOGICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; SURFACE MODIFICATION; MEDICAL APPLICATIONS
AB Plasma immersion ion implantation and deposition (PIII&D) is an effective technique to enhance the surface bioactivity of materials. In this paper, recent progress made in our laboratory on plasma surface modification of biomedical materials is described. NiTi alloys have unique super-elastic and shape memory properties and are suitable for orthopedic implants but the leaching of toxic Ni may pose health hazards in humans. We have recently investigated the use of acetylene, oxygen and nitrogen PIII&D to prevent out-diffusion of nickel and good results have been obtained. Silicon is the most important material in the microelectronics industry but its surface biocompatibility has not been investigated in details. We have recently performed hydrogen PIII into silicon to improve the surface bioactivity and observed biomimetic growth of apatite on the surface in simulated body fluids. Diamond-like carbon (DLC) is widely used in the industry due to its excellent mechanical properties and chemical inertness and by incorporation of elements such as nitrogen and phosphorus, the surface blood compatibility can be improved. The properties as well as in vitro biological test results are discussed in this article. (c) 2005 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Anders A, 2000, HDB PLASMA IMMERSION, P2
   Badzian A, 1996, DIAM RELAT MATER, V5, P93, DOI 10.1016/0925-9635(96)80011-2
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   CARLISLE EM, 1986, SILICON BIOCH, P123
   Chang YY, 2003, DIAM RELAT MATER, V12, P2077, DOI 10.1016/S0925-9635(03)00290-5
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Chu PK, 2004, J VAC SCI TECHNOL B, V22, P289, DOI 10.1116/1.1632920
   Chu PK, 2003, PLASMA PHYS CONTR F, V45, P555, DOI 10.1088/0741-3335/45/5/304
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   CHU PK, 2004, SURFACE MODIFICATION, P543
   CORBETT JW, 1991, HYDROGEN SEMICONDUCT, P49
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dahmen C, 2003, THIN SOLID FILMS, V427, P201, DOI 10.1016/S0040-6090(02)01228-2
   DALMAU LB, 1984, J PROSTHET DENT, V52, P116
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   ESPANA A, 1989, CONTACT DERMATITIS, V21, P204, DOI 10.1111/j.1600-0536.1989.tb04744.x
   Fan ZN, 2000, IEEE T PLASMA SCI, V28, P371, DOI 10.1109/27.848095
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Grisolia J, 2001, NUCL INSTRUM METH B, V178, P160, DOI 10.1016/S0168-583X(00)00503-6
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hench LL, 1996, THERMOCHIM ACTA, V280, P1, DOI 10.1016/0040-6031(95)02632-0
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HIDEBRAND M, 1993, GENE, V132, P213
   Huang JY, 1996, ACTA MATER, V44, P1781, DOI 10.1016/1359-6454(95)00327-4
   Inaba H, 2002, JPN J APPL PHYS 1, V41, P5730, DOI 10.1143/JJAP.41.5730
   Iwata H, 2000, J CRYST GROWTH, V210, P94, DOI 10.1016/S0022-0248(99)00654-5
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   Kapanen A, 2002, BIOMATERIALS, V23, P3341, DOI 10.1016/S0142-9612(02)00023-6
   Kapanen A, 2002, BIOMATERIALS, V23, P645, DOI 10.1016/S0142-9612(01)00143-0
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   Kola PV, 1996, J MATER PROCESS TECH, V56, P422, DOI 10.1016/0924-0136(95)01856-5
   Kuo MT, 2000, DIAM RELAT MATER, V9, P1222, DOI 10.1016/S0925-9635(99)00305-2
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Kwok SCH, 2004, J BIOMED MATER RES A, V70A, P107, DOI 10.1002/jbm.a.30070
   Lackner JM, 2004, SURF COAT TECH, V180, P585, DOI 10.1016/j.surfcoat.2003.10.099
   LAMSTER IB, 1987, J PERIODONTOL, V58, P486, DOI 10.1902/jop.1987.58.7.486
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Li LH, 2003, REV SCI INSTRUM, V74, P4301, DOI 10.1063/1.1606535
   Liu XY, 2004, SURF COAT TECH, V186, P227, DOI 10.1016/j.surfcoat.2004.02.045
   Liu XY, 2004, BIOMATERIALS, V25, P5575, DOI [10.1016/j.biomarkers.2004.01.015, 10.1016/j.biomaterials.2004.01.015]
   Liu XY, 2002, J BIOMED MATER RES, V59, P259, DOI 10.1002/jbm.1240
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Mandl S, 2002, BIOMOL ENG, V19, P129, DOI 10.1016/S1389-0344(02)00025-4
   Mientus R, 1999, SURF COAT TECH, V116, P1093, DOI 10.1016/S0257-8972(99)00124-3
   Mitura E, 1996, DIAM RELAT MATER, V5, P998, DOI 10.1016/0925-9635(95)00469-6
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Piatkowska A, 1999, APPL SURF SCI, V141, P333, DOI 10.1016/S0169-4332(98)00520-0
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   Poon RWY, 2005, MAT SCI ENG A-STRUCT, V390, P444, DOI 10.1016/j.msea.2004.08.061
   Reboredo FA, 1999, PHYS REV LETT, V82, P4870, DOI 10.1103/PhysRevLett.82.4870
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   Sanford W. E., 1992, NICKEL HUMAN HLTH CU, P123
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Sheeja D, 2004, DIAM RELAT MATER, V13, P184, DOI 10.1016/j.diamond.2003.10.053
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Tan L, 2002, ACTA MATER, V50, P4449, DOI 10.1016/S1359-6454(02)00251-3
   TESSIER PY, 2003, DIAM RELAT MATER, V12, P1233
   Tian XB, 2001, MAT SCI ENG A-STRUCT, V316, P200, DOI 10.1016/S0921-5093(01)01245-X
   Tong QY, 1999, ADV MATER, V11, P1409, DOI 10.1002/(SICI)1521-4095(199912)11:17<1409::AID-ADMA1409>3.0.CO;2-W
   Vaz F, 2004, THIN SOLID FILMS, V447, P449, DOI 10.1016/S0040-6090(03)01123-4
   Wang XH, 2000, SURF COAT TECH, V128, P36, DOI 10.1016/S0257-8972(00)00659-9
   Wu SK, 1997, SCRIPTA MATER, V37, P837, DOI 10.1016/S1359-6462(97)00187-5
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang P, 2003, NUCL INSTRUM METH B, V206, P721, DOI 10.1016/S0168-583X(03)00871-1
   Yokota K, 2002, SURF COAT TECH, V158, P568, DOI 10.1016/S0257-8972(02)00309-2
   ZHANG SB, 1991, PHYS REV B, V43, P12142, DOI 10.1103/PhysRevB.43.12142
   Zhang XW, 2003, DIAM RELAT MATER, V12, P1, DOI 10.1016/S0925-9635(02)00246-7
NR 73
TC 18
Z9 19
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JAN
PY 2006
VL 242
IS 1-2
BP 1
EP 7
DI 10.1016/j.nimb.2005.08.015
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 024VT
UT WOS:000236225200002
DA 2018-10-20
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Yao, ZQ
   Zhou, HF
   Maitz, M
   Leng, Y
   Chu, PK
AF Yang, P
   Huang, N
   Leng, YX
   Yao, ZQ
   Zhou, HF
   Maitz, M
   Leng, Y
   Chu, PK
TI Wettability and biocompatibility of nitrogen-doped hydrogenated
   amorphous carbon films: Effect of nitrogen
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Ion Beam Modification of Materials
   (IBMM 2004)
CY SEP 05-10, 2004
CL Pacific Grove, CA
SP Amer Vacuum Soc, NE Calif Chapter
DE plasma immersion ion implantation-deposition (PIII-D); nitrogen-doped
   hydrogenated amorphous carbon (a-C : H : N); wettability;
   biocompatibility
ID DIAMOND-LIKE CARBON; COATINGS; SURFACE
AB Amorphous carbon films have been applied in biomedical fields as potential biocompatible materials with wettability that can be adjusted by doping with other elements, including F, Si, Ti, O and N. In this study, nitrogen-doped hydrogenated amorphous carbon (a-C:H:N) films were deposited by PIII-D using C2H2 + N-2 gas mixtures. The biocompatibility and anti-thrombotic properties of the films were assessed in vitro. The surface morphology and surface wettability of the films were characterized using atomic force microscopy (AFM) and a contact angle method. The results show no cytotoxicity for all films, and films with appropriate nitrogen doping possess much better endothelial cell growth and anti-thrombotic properties. (c) 2005 Elsevier B.V. All rights reserved.
C1 SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Lab Surface Modificat Artificial Organs, Chengdu 610031, Sichuan, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Rossendorf Inc, Forschungszentrum Rossendorf EV, Inst Ion Beam Phys & Mat Res, D-01314 Dresden, Germany.
   Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Lab Surface Modificat Artificial Organs, Chengdu 610031, Sichuan, Peoples R China.
EM nhuang@263.net
RI Leng, Y.X./C-2278-2012; Maitz, Manfred/E-6749-2010; Leng,
   Yang/B-3187-2010; Leng, Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013
OI Maitz, Manfred/0000-0002-0671-048X; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Grischke M, 1995, SURF COAT TECH, V74-75, P739, DOI 10.1016/0257-8972(94)08201-4
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   Tetard F, 2002, SURF COAT TECH, V151, P184, DOI 10.1016/S0257-8972(01)01574-2
   Zhang P, 2004, DIAM RELAT MATER, V13, P459, DOI 10.1016/S0925-9635(03)00570-3
NR 10
TC 37
Z9 38
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JAN
PY 2006
VL 242
IS 1-2
BP 22
EP 25
DI 10.1016/j.nimb.2005.08.081
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 024VT
UT WOS:000236225200007
DA 2018-10-20
ER

PT J
AU Takahashi, N
   Suzuki, Y
   Ujiie, H
   Hori, T
   Iwaki, M
   Yamada, T
AF Takahashi, N
   Suzuki, Y
   Ujiie, H
   Hori, T
   Iwaki, M
   Yamada, T
TI Biocompatibility of modified ePTFE for an artificial dura mater
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Ion Beam Modification of Materials
   (IBMM 2004)
CY SEP 05-10, 2004
CL Pacific Grove, CA
SP Amer Vacuum Soc, NE Calif Chapter
DE ePTFE; ion-beam; CSF leak; dura mater; in vivo
AB Expanded polytetrafluoroethylene (ePTFE) is one of the biomedical materials and is most extensively used in surgical repair in various anatomical sites. However, ePTFE as an artificial dura mater is often associated with postoperative leakage of the cerebrospinal fluid (CSF) because of its very low adhesiveness to fibrin glue and surrounding tissue. To overcome CSF leakage the effects of ion-beam irradiation to ePTFE surface were examined. The surfaces of ePTFE were irradiated with 50 or 150 keV Ar+-beam with fluences of 1 x 10(14), 5 x 10(14) and 1 x 10(15) ions/cm(2). L929 fibroblasts were cultured for 24 h on the ePTFE that included the irradiated domains and non-irradiated area. It was confirmed that fibroblasts adhered better to the irradiated domains compared with non-irradiated domain, however the difference was not noted among the individual irradiation conditions.
   A dural defect surgically created in a rabbit skull was patched with ion-beam irradiated ePTFE. CSF leakage was observed in the case with non-irradiated ePTFE and 50 keV with 1 x 10(14) and 5 x 10(14) ions/cm(2) irradiated ePTFE, but CSF leakage did not occur in cases with other ion-beam irradiated ePTFE. A histological study indicated that fibroblast-like cells invaded and anchored into the gaps of the ePTFE surface created by ion-beam irradiation. (c) 2005 Published by Elsevier B.V.
C1 Tokyo Univ Sci, Tokyo 1628601, Japan.
   RIKEN, Beam Applicat Team, Wako, Saitama 3510198, Japan.
   Tokyo Womens Med Univ, Tokyo 1628666, Japan.
RP Takahashi, N (reprint author), Tokyo Univ Sci, 1-3 Kagurazaka, Tokyo 1628601, Japan.
CR SUZUKI Y, 1991, NUCL INSTRUM METH B, V59, P698, DOI 10.1016/0168-583X(91)95306-X
   Takahashi N, 2003, NEUROL SURG TOKYO, V31, P1081
   TAKAHASHI N, 2004, T MAT RES SOC JPN, V29, P591
   THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766
   Yamagata Sen, 1993, Neurologia Medico-Chirurgica, V33, P582, DOI 10.2176/nmc.33.582
NR 5
TC 9
Z9 9
U1 2
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JAN
PY 2006
VL 242
IS 1-2
BP 61
EP 64
DI 10.1016/j.nimb.2005.08.105
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 024VT
UT WOS:000236225200017
DA 2018-10-20
ER

PT S
AU Patterson, PE
   Zara, JM
AF Patterson, Paul E.
   Zara, Jason M.
BE Otani, Y
   JanabiSharifi, F
TI Real-time high-displacement amplified bimorph scanning mirror
SO OPTOMECHATRONIC ACTUATORS, MANIPULATION, AND SYSTEMS CONTROL
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optomechatronic Actuators, Manipulation, and Systems
   Control
CY OCT 01-03, 2006
CL Boston, MA
SP SPIE
DE micromirror; polyimide; piezoelectric; MEMS
ID OPTICAL SCANNER; MICROMIRROR
AB This paper provides an overview of recent research in the use of microelectromechanical systems (MEMS) actuators for beam steering applications, including optical coherence tomography (OCT). Prototype scanning devices have been fabricated out of polyimide substrates using conventional integrated circuit technology. The devices utilize piezoelectric bimorphs to mechanically actuate the torsion mirror structure made of polyimide. The material properties of the polyimide allow very large scan angles to be realized in the devices while using low voltages. Prototype devices have demonstrated optical scan angles of over 80 degrees with applied voltages of only 40V. Different device sizes have also been demonstrated with resonant frequencies between 15-60Hz (appropriate for real-time imaging). Analytical models have been developed that predict resonant frequency of the device as well as the angular displacement of the mirror. Further finite element modeling (FEM) has been done using ANSYS. These models closely reflect measured scan angles of the prototype devices. Based upon these models, further refinements can be made to the design to produce specific resonant frequencies for use in a multitude of applications. These models are currently being used to design and fabricate multiple devices on a single wafer with minimal post processing requirements. The ability to fabricate these devices in bulk will reduce their cost and potentially make them disposable to reduce the cost of their use in numerous applications, including patient care when used in biomedical imaging applications.
C1 [Patterson, Paul E.] US Mil Acad, West Point, NY 10996 USA.
   [Patterson, Paul E.; Zara, Jason M.] George Mason Univ, Fairfax, VA 22030 USA.
RP Patterson, PE (reprint author), US Mil Acad, West Point, NY 10996 USA.
CR Ji CH, 2006, J MICROMECH MICROENG, V16, P1033, DOI 10.1088/0960-1317/16/5/021
   PETERSEN KE, 1980, IBM J RES DEV, V24, P631, DOI 10.1147/rd.245.0631
   Smits JG, 2005, J MICROMECH MICROENG, V15, P1285, DOI 10.1088/0960-1317/15/6/021
   Wang ZF, 2006, J PHYS CONF SER, V34, P410, DOI 10.1088/1742-6596/34/1/067
   Yoon YS, 2003, J MICROMECH MICROENG, V13, P922, DOI 10.1088/0960-1317/13/6/315
   Zara JM, 2003, OPT LETT, V28, P628, DOI 10.1364/OL.28.000628
   Zara JM, 2002, SENSOR ACTUAT A-PHYS, V102, P176, DOI 10.1016/S0924-4247(02)00302-3
   Zhou LX, 2006, J MICROELECTROMECH S, V15, P24, DOI 10.1109/JMEMS.2005.863736
   2003, FIBER OPTICS WE 0307
NR 9
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6472-9
J9 PROC SPIE
PY 2006
VL 6374
DI 10.1117/12.686383
PG 9
WC Automation & Control Systems; Engineering, Mechanical; Instruments &
   Instrumentation; Optics
SC Automation & Control Systems; Engineering; Instruments &
   Instrumentation; Optics
GA BFQ93
UT WOS:000243902100010
DA 2018-10-20
ER

PT S
AU Navarro, M
   Aparicio, C
   Charles-Harris, M
   Ginebra, MP
   Engel, E
   Planell, JA
AF Navarro, M.
   Aparicio, C.
   Charles-Harris, M.
   Ginebra, M. P.
   Engel, E.
   Planell, J. A.
BE Vancso, GJ
   Reiter, G
TI Development of a biodegradable composite scaffold for bone tissue
   engineering: Physicochemical, topographical, mechanical, degradation,
   and biological properties
SO ORDERED POLYMERIC NANOSTRUCTURES AT SURFACES
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE bioabsorbable composite scaffold; bone tissue engineering; osteoblast
   cell culture; protein adsorption; wettability
ID CALCIUM-PHOSPHATE GLASSES; LIQUID PHASE-SEPARATION; CONTROLLED
   SOLUBILITY; CELL TRANSPLANTATION; MEDICAL APPLICATIONS; POLYMERIC
   SCAFFOLDS; OSTEOBLASTIC CELLS; POLYLACTIDE FOAMS; ADHESION; SURFACES
AB The development of synthetic materials and their use in tissue engineering applications has attracted much attention in recent years as an option for trabecular bone grafting. Bioabsorbable polyesters of the poly(alpha-hydroxy acids) family, and specifically polylactic acid (PLA), are well known bioabsorbable materials and are currently used for numerous biomedical applications. The incorporation of an inorganic phase, such as a soluble calcium phosphate glass in the P2O5 - CaO - Na2O - TiO2 system, into the polymeric matrix enhances the mechanical integrity of the material. In fact, the flexural elastic modulus increases from 3.2 to 10 GPa with 50 wt/wt% of glass particles. It also improves the biological behavior and modifies the degradation pattern of the polymer. The presence of glass particles accelerates the material degradation and induces the formation of calcium phosphate precipitates in the surface of the composite. Therefore, the combination of a bioabsorbable polymer such as PLA with a soluble calcium phosphate glass leads to a fully degradable composite material with a high bone regenerative potential. The success of a 3D scaffold depends on several parameters that go from the macro- to the nanoscale. The solvent and casting technique, together with particulate leaching, allows the elaboration of 95%-porosity scaffolds with a well interconnected macro- and microporosity. Factors such as surface chemistry, surface energy, and topography can highly affect the cell-material response. Indeed, the addition of glass particles in the PLA matrix modifies the material surface properties such as wettability AI (Area index or real-surface-area/nominal-area ratio) and roughness, improving the cell response and inducing morphological changes in the cytoskeleton of the osteoblasts. This study offers valuable insight into the parameters affecting cell-scaffold behavior, and discusses the special relevance that a comprehensive characterization and manufacturing control of the composite surface can have for monitoring the biological-synthetic interactions.
C1 Tech Univ Catalonia, UPC, Dept Mat Sci & Met, Ctr Reference Bioengn Catalonia,CREBEC, E-08028 Barcelona, Spain.
RP Planell, JA (reprint author), Tech Univ Catalonia, UPC, Dept Mat Sci & Met, Ctr Reference Bioengn Catalonia,CREBEC, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM josep.a.planell@upc.es
RI Engel, Elisabeth/D-4365-2014; Aparicio, Conrado/J-9903-2012; Ginebra,
   Maria-Pau/J-8149-2017
OI Engel, Elisabeth/0000-0003-4855-8874; Aparicio,
   Conrado/0000-0003-2969-6067; Ginebra, Maria-Pau/0000-0002-4700-5621
CR ALBELDA SM, 1990, FASEB J, V4, P2068
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   APARICIO C, 2004, THESIS TU CATALONIA
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4
   Boyan B. D., 2001, TITANIUM MED, P561
   Boyan BD, 1999, BONE ENG, P232
   BURNIE J, 1981, BIOMATERIALS, V2, P244, DOI 10.1016/0142-9612(81)90065-X
   Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Clement J, 1999, J MATER SCI-MATER M, V10, P729, DOI 10.1023/A:1008927222081
   Clement J, 1999, J MATER SCI-MATER M, V10, P437, DOI 10.1023/A:1008935316741
   CLEMENT J, 1998, KEY ENG MATER, V11, P141
   Clement J., 2001, KEY ENG MATER, V192-195, P621
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Horbett Thomas A., 1996, P133
   HUFFMAN KR, 1985, J POLYM SCI POL CHEM, V23, P1939, DOI 10.1002/pol.1985.170230709
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIN ST, 1994, BIOMATERIALS, V15, P1057, DOI 10.1016/0142-9612(94)90091-4
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   MEYER A E, 1988, Journal of Oral Implantology, V14, P363
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Navarro M, 2005, KEY ENG MATER, V284-286, P893, DOI 10.4028/www.scientific.net/KEM.284-286.893
   Navarro M, 2003, J BIOMED MATER RES A, V67A, P1009, DOI 10.1002/jbm.a.20014
   Navarro M, 2003, J AM CERAM SOC, V86, P1345, DOI 10.1111/j.1151-2916.2003.tb03474.x
   Navarro M, 2002, KEY ENG MAT, V218-2, P275, DOI 10.4028/www.scientific.net/KEM.218-220.275
   RAIHA J E, 1992, Clinical Materials, V10, P35, DOI 10.1016/0267-6605(92)90082-5
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   VANWAZER JR, 1958, PHOSPHOROUS ITS COMP
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Vogel J, 1997, GLASTECH BER-GLASS, V70, P220
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   VOGLER EA, 1993, WETTABILITY, P183
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 60
TC 61
Z9 62
U1 2
U2 68
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-31921-2
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
VL 200
BP 209
EP 231
DI 10.1007/12_068
D2 10.1007/11605294
PG 23
WC Polymer Science
SC Polymer Science
GA BES37
UT WOS:000239275000008
DA 2018-10-20
ER

PT J
AU Nersessian, NJ
AF Nersessian, NJ
TI The cognitive-cultural systems of the research laboratory
SO ORGANIZATION STUDIES
LA English
DT Article
DE cognition; model-based reasoning; knowledge construction; practice;
   cognitive-cultural system
AB A central challenge for science studies researchers in developing accounts of knowledge construction in science and engineering is to integrate the cognitive, social, cultural, and material dimensions of practice. Within science studies there is a perceived divide between cognitive practices, on the one hand, and cultural practices, on the other. Any such divide, though at times analytically useful, is artificial. Producing scientific knowledge requires the kind of sophisticated cognition that only rich social, cultural, and material environments can enable. This paper aims to move in the direction of an integrative account of these dimensions of practice. It discusses model-based reasoning practices in biomedical engineering research laboratories construed as 'evolving cognitive-cultural systems'.
C1 Georgia Inst Technol, Interact & Intelligent Comp Div, Coll Comp, Atlanta, GA 30332 USA.
RP Nersessian, NJ (reprint author), Georgia Inst Technol, Interact & Intelligent Comp Div, Coll Comp, Atlanta, GA 30332 USA.
EM nancyn@cc.gatech.edu
CR Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577
   Clancey W. J., 1997, SITUATED COGNITION H
   Donald M., 1991, ORIGINS MODERN MIND
   Dunbar K., 1995, NATURE INSIGHT
   Galison P, 1997, IMAGE LOGIC MAT CULT
   GLENBERG AM, 1992, J MEM LANG, V31, P129, DOI 10.1016/0749-596X(92)90008-L
   Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1
   Gorman ME, 1997, SOC STUD SCI, V27, P583, DOI 10.1177/030631297027004002
   Greeno J. G., 1989, COMPLEX INFORM PROCE
   GREENO JG, 1989, AM PSYCHOL, V44, P134, DOI 10.1037//0003-066X.44.2.134
   Greeno JG, 1998, AM PSYCHOL, V53, P5, DOI 10.1037//0003-066X.53.1.5
   Hutchins E., 1995, COGNITION WILD
   Johnson M., 1987, BODY MIND BODILY BAS
   Klahr D, 1999, PSYCHOL BULL, V125, P524
   Kurz-Milke E., 2004, J COGNITION CULTURE, V4, P663
   Lakoff G., 1998, PHILOS FLESH
   Lakoff G., 1987, WOMEN FIRE DANGEROUS
   Latour B, 1986, LAB LIFE CONSTRUCTIO
   Lave J, 1988, COGNITION PRACTICE M
   LAVE J, 1991, SITUATED LEARNING
   Nersessian N., 1992, MINNESOTA STUDIES PH
   NERSESSIAN NJ, 2002, COGNITIVE BASIS SCI
   NERSESSIAN NJ, 1995, CONSTRUCTING KNOWLED, V10, P194
   NERSESSIAN NJ, 1999, MODEL BASED REASONG
   NEWSLETTER W, 2004, P 6 INT C LEARN SCI
   Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291
   NORMAN DA, 1988, PSYCHOL EVERDAY THIN
   NORMAN Donald, 1991, DESIGNING INTERACTIO
   SHORE B, 1997, CULTURE MIND COGNITI
   STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001
   Suchman L. A., 1987, PLANS SITUATED ACTIO
   Tomasello Michael, 1999, CULTURAL ORIGINS HUM
   TWENEY RD, 2002, MODEL BASED REASONIN
   ZHANG JJ, 1995, COGNITION, V57, P271, DOI 10.1016/0010-0277(95)00674-3
   Zhang JJ, 1997, COGNITIVE SCI, V21, P179
NR 35
TC 54
Z9 57
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0170-8406
J9 ORGAN STUD
PD JAN
PY 2006
VL 27
IS 1
BP 125
EP 145
DI 10.1177/0170840606061842
PG 21
WC Management
SC Business & Economics
GA 013EJ
UT WOS:000235392300006
DA 2018-10-20
ER

PT S
AU Lowik, DWPM
   Ayres, L
   Smeenk, JM
   Van Hest, JCM
AF Lowik, Dennis W. P. M.
   Ayres, Lee
   Smeenk, Jurgen M.
   Van Hest, Jan C. M.
BE Klok, HA
   Schlaad, H
TI Synthesis of bio-inspired hybrid polymers using peptide synthesis and
   protein engineering
SO PEPTIDE HYBRID POLYMERS
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE hybrid polymers; peptides; proteins; controlled polymerization;
   conjugation
ID TRANSFER RADICAL POLYMERIZATION; SIDE-CHAIN POLYMERS; PHARMACOLOGICALLY
   ACTIVE POLYMERS; TRANSFER-RNA SYNTHETASE; NONNATURAL AMINO-ACIDS;
   BLOCK-COPOLYMERS; EFFICIENT INCORPORATION; POLY(ETHYLENE GLYCOL);
   ARTIFICIAL PROTEINS; DIBLOCK COPOLYMERS
AB The construction of well-defined hybrid materials consisting of synthetic polymers and (poly)peptides or proteins has attracted much attention in recent years. Different techniques have become available that allow an efficient synthesis of polymer architectures with (poly)peptides in the side chain as well as the main chain. Oligopeptides modified with monomer or initiator moieties can, for example, be introduced in polymers via contralled (radical) polymerization methods. Ligation methods enable the build up of large peptide structures via a complete organic chemistry approach. The materials scientist's toolbox is enriched with molecular biology techniques, and protein engineering has become a standard synthetic method for the construction of well-defined polypeptides with specific functional handles for the attachment of synthetic polymers. The availability of all these techniques holds much promise for the application of materials in the biomedical field, and especially tissue engineering, targeted drug delivery and diagnostics should in the near future benefit from these recent synthetic achievements.
C1 Radboud Univ Nijmegen, Dept Organ Chem, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands.
RP Van Hest, JCM (reprint author), Radboud Univ Nijmegen, Dept Organ Chem, Inst Mol & Mat, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.
EM j.vanhest@science.ru.nl
RI Lowik, Dennis/D-6913-2012; van Hest, Jan/D-5625-2012
OI Lowik, Dennis/0000-0002-9284-837X; van Hest, Jan/0000-0001-7973-2404
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   ARSHADY R, 1994, ADV POLYM SCI, V111, P1
   ARSHADY R, 1981, MAKROMOL CHEM-RAPID, V2, P573
   ARSHADY R, 1984, MAKROMOL CHEM, V185, P2387
   Ayres L, 2005, BIOMACROMOLECULES, V6, P825, DOI 10.1021/bm049421p
   Ayres L, 2005, MACROMOLECULES, V38, P1699, DOI 10.1021/ma047923p
   Ayres L, 2003, MACROMOLECULES, V36, P5967, DOI 10.1021/ma025727h
   Bailon P, 1998, PHARM SCI TECHNOL TO, V1, P352, DOI 10.1016/S1461-5347(98)00086-8
   Barron AE, 1999, CURR OPIN CHEM BIOL, V3, P681, DOI 10.1016/S1367-5931(99)00026-5
   BATZ HG, 1972, ANGEW CHEM INT EDIT, V11, P1103, DOI 10.1002/anie.197211031
   BATZ HG, 1973, MAKROMOL CHEM, V172, P27
   Becker ML, 2005, BIOMACROMOLECULES, V6, P220, DOI 10.1021/bm049551y
   Becker ML, 2003, CHEM COMMUN, P180, DOI 10.1039/b209557b
   BODANSKY M, 1995, PRACTICE PEPTIDE SYN
   Boerakker MJ, 2002, ANGEW CHEM INT EDIT, V41, P4239, DOI 10.1002/1521-3773(20021115)41:22<4239::AID-ANIE4239>3.0.CO;2-E
   Bontempo D, 2005, J AM CHEM SOC, V127, P6508, DOI 10.1021/ja042230+
   Bontempo D, 2004, J AM CHEM SOC, V126, P15372, DOI 10.1021/ja045063m
   Borgia JA, 2000, TRENDS BIOTECHNOL, V18, P243, DOI 10.1016/S0167-7799(00)01445-1
   Botti P, 2001, TETRAHEDRON LETT, V42, P1831, DOI 10.1016/S0040-4039(01)00036-3
   Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z
   Burkoth TS, 1999, J AM CHEM SOC, V121, P7429, DOI 10.1021/ja991233x
   Burkoth TS, 1998, J AM CHEM SOC, V120, P7655, DOI 10.1021/ja980566b
   Canne LE, 1999, J AM CHEM SOC, V121, P8720, DOI 10.1021/ja9836287
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Cheuk KKL, 2003, MACROMOLECULES, V36, P5947, DOI 10.1021/ma0344543
   Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224
   Cornelissen JJLM, 2001, J POLYM SCI POL CHEM, V39, P4255, DOI 10.1002/pola.10083
   Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427
   Couet J, 2005, ANGEW CHEM INT EDIT, V44, P3297, DOI 10.1002/anie.200462993
   Cunliffe D, 2004, EUR POLYM J, V40, P5, DOI 10.1016/j.eurpolymj.2003.10.020
   Deiters A, 2004, BIOORG MED CHEM LETT, V14, P5743, DOI 10.1016/j.bmcl.2004.09.059
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   Dirks AJT, 2005, CHEM COMMUN, P4172, DOI 10.1039/b508428h
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Duncan R, 2002, BRIT J CANCER, V86, pS12
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   ECKHARDT D, 2005, CHEM COMMUN, V2814
   Fahnestock S.R., 2003, BIOPOLYMERS POLYAMID
   FERRARI FA, 1997, PROTEIN BASED MAT, P37
   Gao GZ, 2003, MACROMOLECULES, V36, P3932, DOI 10.1021/ma021738z
   Godwin A, 2001, ANGEW CHEM INT EDIT, V40, P594, DOI 10.1002/1521-3773(20010202)40:3<594::AID-ANIE594>3.0.CO;2-P
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Hannink JM, 2001, ANGEW CHEM INT EDIT, V40, P4732, DOI 10.1002/1521-3773(20011217)40:24<4732::AID-ANIE4732>3.0.CO;2-P
   He XH, 2002, POLYM BULL, V48, P337, DOI 10.1007/s00289-002-0042-y
   Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109
   Hopkins TE, 2003, MACROMOLECULES, V36, P2206, DOI 10.1021/ma021668w
   IWAI K, 1984, CANCER RES, V44, P2115
   Jackson DC, 1997, VACCINE, V15, P1697, DOI 10.1016/S0264-410X(97)00085-6
   JATZKEWITZ H, 1955, Z NATURFORSCH PT B, V10, P27
   Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7
   Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299
   Kiick KL, 2000, TETRAHEDRON, V56, P9487, DOI 10.1016/S0040-4020(00)00833-4
   Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   MAEDA H, 1985, J MED CHEM, V28, P455, DOI 10.1021/jm00382a012
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   MAEDA H, 1984, J PROTEIN CHEM, V3, P181, DOI 10.1007/BF01040499
   Maynard HD, 2000, MACROMOLECULES, V33, P6239, DOI 10.1021/ma000460c
   Mei Y, 2004, J AM CHEM SOC, V126, P3472, DOI 10.1021/ja039583d
   Merrifield B, 1997, METHOD ENZYMOL, V289, P3
   Molineux G, 2003, PHARMACOTHERAPY, V23, p3S, DOI 10.1592/phco.23.9.3S.32886
   Murata H, 2001, MACROMOL CHEM PHYSIC, V202, P759, DOI 10.1002/1521-3935(20010301)202:6<759::AID-MACP759>3.0.CO;2-8
   Murata H, 1997, MACROMOL CHEM PHYSIC, V198, P2519, DOI 10.1002/macp.1997.021980813
   Nicol A., 1994, BIOTECHNOLOGY BIOACT
   Nilsson BL, 2003, J AM CHEM SOC, V125, P5268, DOI 10.1021/ja029752e
   OBrienSimpson NM, 1997, J AM CHEM SOC, V119, P1183, DOI 10.1021/ja962707k
   Opsteen JA, 2005, CHEM COMMUN, P57, DOI 10.1039/b412930j
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Pechar M, 2002, MACROMOL BIOSCI, V2, P199, DOI 10.1002/1616-5195(200206)2:5<199::AID-MABI199>3.0.CO;2-2
   PERLY B, 1974, CR ACAD SCI C CHIM, V279, P1109
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PLAUE S, 1990, BIOLOGICALS, V18, P147, DOI 10.1016/1045-1056(90)90001-G
   PLESS J, 1963, HELV CHIM ACTA, V46, P1609, DOI 10.1002/hlca.19630460516
   Putnam D, 1995, ADV POLYM SCI, V122, P55
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Rathore O, 2001, MACROMOLECULES, V34, P1477, DOI 10.1021/ma001553x
   Rathore O, 2000, J POLYM SCI POL CHEM, V38, P352, DOI 10.1002/(SICI)1099-0518(20000115)38:2<352::AID-POLA10>3.0.CO;2-P
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   Rettig H, 2004, MACROMOL RAPID COMM, V25, P1251, DOI 10.1002/marc.200400140
   Reynhout IC, 2005, CHEM COMMUN, P602, DOI 10.1039/b413973a
   ROSE K, 1994, J AM CHEM SOC, V116, P30, DOI 10.1021/ja00080a004
   Rosler A, 2003, BIOMACROMOLECULES, V4, P859, DOI 10.1021/bm034058s
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sanda F, 2004, MACROMOLECULES, V37, P8510, DOI 10.1021/ma048391f
   Sanda F, 2002, J POLYM SCI POL CHEM, V40, P2782, DOI 10.1002/pola.10363
   Sanda F, 1999, MACROMOL CHEM PHYSIC, V200, P2651, DOI 10.1002/(SICI)1521-3935(19991201)200:12<2651::AID-MACP2651>3.0.CO;2-P
   Schilli CM, 2003, ACS SYM SER, V854, P603, DOI 10.1021/bk-2003-0854.ch041
   Schwartz EC, 2003, CHEM COMMUN, P2087, DOI 10.1039/b304989m
   Smeenk JM, 2005, ANGEW CHEM INT EDIT, V44, P1968, DOI 10.1002/anie.200462415
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   STROHRIEGL P, 1993, MAKROMOL CHEM, V194, P363
   Theato P, 2004, MACROMOLECULES, V37, P5475, DOI 10.1021/ma035876f
   van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   Velonia K, 2002, J AM CHEM SOC, V124, P4224, DOI 10.1021/ja017809b
   Vriezema DM, 2004, MACROMOLECULES, V37, P4736, DOI 10.1021/ma035789n
   Vriezema DM, 2003, ANGEW CHEM INT EDIT, V42, P772, DOI 10.1002/anie.200390204
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang C, 2001, BIOMACROMOLECULES, V2, P912, DOI 10.1021/bm0155322
   Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Yao JR, 2003, MACROMOLECULES, V36, P7508, DOI 10.1021/ma034573i
   Yeo DSY, 2004, CHEM-EUR J, V10, P4664, DOI 10.1002/chem.200400414
   Zuccarello G, 2002, ADV MATER, V14, P1261, DOI 10.1002/1521-4095(20020916)14:18<1261::AID-ADMA1261>3.0.CO;2-N
NR 113
TC 58
Z9 58
U1 1
U2 28
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-32567-0
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
VL 202
BP 19
EP 52
DI 10.1007/12_081
D2 10.1007/11677208
PG 34
WC Polymer Science
SC Polymer Science
GA BFA27
UT WOS:000240496400002
DA 2018-10-20
ER

PT S
AU Fischer, BM
   Helm, H
   Jepsen, PU
AF Fischer, BM
   Helm, H
   Jepsen, PU
BE Abbott, D
   Kivshar, YS
   RubinszteinDunlop, HH
   Fan, S
TI T-ray spectroscopy of biomolecules: from chemical recognition toward
   biochip analysis-horizons and hurdles
SO PHOTONICS: DESIGN, TECHNOLOGY, AND PACKAGING II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Microelectronics - Design, Technology and Packaging II
CY DEC 12-14, 2005
CL Brisbane, AUSTRALIA
SP SPIE, Queensland Univ Technol
DE THz-TDS; THz-imaging; chemical recognition
ID TIME-DOMAIN SPECTROSCOPY; LOW-FREQUENCY VIBRATIONS; REFLECTION
   SPECTROSCOPY; TERAHERTZ; THZ; MOLECULES; DYNAMICS; MODES; DNA
AB In the recent years, there has been an increased interest in the exploitation of the far-infrared spectral region for applications based on chemical recognition. The fact that on the one hand many packaging materials are transparent for THz radiation and on the other hand the THz-spectra of many pharmaceuticals, illicit drugs, and explosives show very specific fingerprints show the potential that THz spectroscopy holds for identification of concealed substances by comparing the spectral signatures with the entries in a database. Yet, due to the lack of appropriate techniques the far-infrared region had for a long time be relatively unexplored, and therefore a detailed study of the far-infrared spectra and the character of the molecular vibrations that give rise to the characteristic spectral signatures can help to evaluate the applicability of THz spectroscopy and imaging for quality control, chemical recognition and biomedical applications.
C1 Univ Freiburg, Freiburg Mat Res Ctr, Dept Mol & Opt Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.
   Univ Adelaide, Dept Elect & Elect Engn, Adelaide, SA 5005, Australia.
   Tech Univ Denmark, Res Ctr COM, DK-2800 Lyngby, Denmark.
RP Fischer, BM (reprint author), Univ Freiburg, Freiburg Mat Res Ctr, Dept Mol & Opt Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.
EM bernd.fischer@physik.uni-freiburg.de
RI Jepsen, Peter/G-5288-2010; Helm, Hanspeter/G-4723-2011
OI Helm, Hanspeter/0000-0002-6761-5910
CR BARKER DH, 1975, P SOC PHOTO-OPT INS, V67, P27
   BEETZ CP, 1980, SPECTROCHIM ACTA A, V36, P299, DOI 10.1016/0584-8539(80)80135-8
   Chantry G. W., 1971, SUBMILLIMETRE SPECTR
   Clarkson J, 2003, J MOL STRUCT, V648, P203, DOI 10.1016/S0022-2860(03)00024-3
   DAUCHEZ M, 1993, J COMPUT CHEM, V14, P263, DOI 10.1002/jcc.540140303
   FATTINGER C, 1989, APPL PHYS LETT, V54, P490, DOI 10.1063/1.100958
   Federici JF, 2003, APPL PHYS LETT, V83, P2477, DOI 10.1063/1.1610799
   Federici JF, 2005, SEMICOND SCI TECH, V20, pS266, DOI 10.1088/0268-1242/20/7/018
   Ferguson B, 2002, MICROELECTRON J, V33, P1043, DOI 10.1016/S0026-2692(02)00109-X
   Fischer B, 2005, SEMICOND SCI TECH, V20, pS246, DOI 10.1088/0268-1242/20/7/015
   Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319
   Gervasio FL, 1998, J PHYS CHEM A, V102, P2131, DOI 10.1021/jp9724636
   GRUDZKOV YA, 2001, J PHYS CHEM A, V105, P6197
   HINENO M, 1974, SPECTROCHIM ACTA A, VA-30, P411, DOI 10.1016/0584-8539(74)80080-2
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   Jepsen PU, 1996, ULTRAFAST PROCESSES IN SPECTROSCOPY, P645
   Jepsen PU, 2005, OPT LETT, V30, P29, DOI 10.1364/OL.30.000029
   Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549
   Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X
   Mittleman D, 2003, SENSING TERAHERTZ RA
   Nishizawa J, 2005, OPT COMMUN, V246, P229, DOI 10.1016/j.optcom.2004.10.076
   OZEKI K, 1969, ACTA CRYSTALLOGR B, V25, P81045
   SEKKAL M, 1992, SPECTROCHIM ACTA A, V48, P959, DOI 10.1016/0584-8539(92)80172-S
   Shen YC, 2005, SEMICOND SCI TECH, V20, pS254, DOI 10.1088/0268-1242/20/7/016
   SMITH PR, 1988, IEEE J QUANTUM ELECT, V24, P255, DOI 10.1109/3.121
   Strachan CJ, 2004, CHEM PHYS LETT, V390, P20, DOI 10.1016/j.cplett.2004.03.117
   Taday PF, 2003, J PHARM SCI, V92, P831, DOI 10.1002/jps.10358
   THRANE L, 1995, CHEM PHYS LETT, V240, P330, DOI 10.1016/0009-2614(95)00543-D
   Upadhya PC, 2004, VIB SPECTROSC, V35, P139, DOI 10.1016/j.vibspec.2003.12.010
   VANEXTER M, 1990, PHYS REV B, V41, P12140, DOI 10.1103/PhysRevB.41.12140
   Walther M, 2003, CHEM PHYS, V288, P261, DOI 10.1016/S0301-0104(03)00031-4
   Walther M, 2002, BIOPOLYMERS, V67, P310, DOI 10.1002/bip.10106
   Walther M, 2000, CHEM PHYS LETT, V332, P389, DOI 10.1016/S0009-2614(00)01271-9
   Watanabe Y, 2003, APPL PHYS LETT, V83, P800, DOI 10.1063/1.1595132
   Yamaguchi M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857080
   ZELSMANN HR, 2005, OPT COMMUN, V246, P229
   Zhang XC, 1996, ULTRAFAST PROCESSES IN SPECTROSCOPY, P649
NR 37
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6069-9
J9 PROC SPIE
PY 2006
VL 6038
AR 603809
DI 10.1117/12.651748
PG 13
WC Optics
SC Optics
GA BEB11
UT WOS:000236542100005
DA 2018-10-20
ER

PT S
AU Chang, SD
   Sherif, S
   Flueraru, C
AF Chang, Shoude
   Sherif, Sherif
   Flueraru, Costel
BE Mathieu, P
TI Large area full-field Optical Coherence Tomography
SO PHOTONICS NORTH 2006, PTS 1 AND 2
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT International Conference on Applications of Photonic Technology
   (Photonics North 2006)
CY JUN 05-08, 2006
CL Quebec City, CANADA
SP TeraXion, Dev Econ Canada, Quebec Dev Econ, Innovat & Exportat, Soc General Financement, ROBIC, Canadian Assoc Physicists, SPIE, IEEE, Canadian Photon Constortium, Quebec Photon Network
DE full-field optical tomography; optical image processing; phase-shift
   algorithm; 3D imaging
ID INTERFEROMETRY
AB Optical Coherence Tomography (OCT) is a fundamentally new type of optical imaging technology. OCT performs high resolution, cross-sectional tomographic imaging of the internal structure in materials and biological systems. The biomedical applications of the OCT imaging systems have been developed for diagnostics of ophthalmology, dermatology, dentistry and cardiology. Most of existing OCT systems use point-scanning based technology, however, the 3-axis scanning makes the system slow and cumbersome. A few OCT systems working directly on 2D full-field images were reported, however, they are designed to work in a relatively small area, around couple of hundred microns square. In this paper, we present a design and implementation of a full-field OCT imaging system for acquiring tomography and with a working area around 15mm by 15mm. The problems rising from full-field OCT are addressed and analyzed. The algorithms to extract the tomography are proposed. Two applications of multilayer information retrieval and 3D object imaging using full-field OCT are described.
C1 [Chang, Shoude; Sherif, Sherif; Flueraru, Costel] Natl Res Council Canada, Opt Grp, Inst Microstruct Sci, 1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.
RP Chang, SD (reprint author), Natl Res Council Canada, Opt Grp, Inst Microstruct Sci, 1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.
CR Akiba M, 2003, OPT LETT, V28, P816, DOI 10.1364/OL.28.000816
   Beaurepaire E, 1998, OPT LETT, V23, P244, DOI 10.1364/OL.23.000244
   Bouma BE, 2002, HDB OPTICAL COHERENC
   Bourquin S, 2001, OPT LETT, V26, P512, DOI 10.1364/OL.26.000512
   Carre P., 1966, Metrologia, V2, P13, DOI 10.1088/0026-1394/2/1/005
   Chang S, 2005, OPT COMMUN, V246, P579, DOI 10.1016/j.optcom.2004.11.029
   CHANG S, IN PRESS APPL OPTICS
   Dubois A, 2002, APPL OPTICS, V41, P805, DOI 10.1364/AO.41.000805
   Dubois A, 2001, J OPT SOC AM A, V18, P1972, DOI 10.1364/JOSAA.18.001972
   Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI 10.1088/0034-4885/66/2/204
   GREIVENKAMP JE, 1992, OPTICAL SHOP TESTING, pCH14
   HARIHARAN P, 1987, APPL OPTICS, V26, P2504, DOI 10.1364/AO.26.002504
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   WOLF E, 2002, OPTICAL COHERENCE TO, pCH4
NR 14
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6428-7
J9 PROC SPIE
PY 2006
VL 6343
AR 634302
DI 10.1117/12.706543
PG 9
WC Optics
SC Optics
GA BFB78
UT WOS:000240901600002
DA 2018-10-20
ER

PT S
AU Lamela, H
   Cunningham, V
   Macia-Sanahuja, C
   Souto, JAG
   Acedo, P
AF Lamela, H.
   Cunningham, V.
   Macia-Sanahuja, C.
   Souto, J. A. Garcia
   Acedo, P.
BE Oraevsky, AA
   Wang, LV
TI Analysis of photoacoustic signal frequencies in deep tissue phantoms
   using high sensitive interferometric optical sensors
SO PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2006
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 7th Conference on Biomedical Thermoacoustics, Optoacoustics, and
   Acousto-Optics
CY JAN 22-26, 2006
CL San Jose, CA
SP SPIE
AB Laser optoacoustics is based on the interaction of light with materials producing the thermoelastic effect forming acoustic waves which are characteristic of the medium in which they traverse. This technique is currently on trial for use in biomedical imaging applications and is achieving great success. The work presented here develops an innovative technique for wideband acoustic detection using a fibre optic sensor in a high sensitive multi-coil Mach-Zehnder interferometric configuration. A comparative analysis is performed using both electrical and optical detection techniques on gels which are commonly used to mimic human soft tissue. Indications of future work in this area will be presented throughout this paper.
C1 [Lamela, H.; Cunningham, V.; Macia-Sanahuja, C.; Souto, J. A. Garcia; Acedo, P.] Univ Carlos III Madrid, Grp Optoelect & Tecnol Laser, Madrid, Spain.
RP Lamela, H (reprint author), Univ Carlos III Madrid, Grp Optoelect & Tecnol Laser, Madrid, Spain.
RI Acedo, Pablo/L-6592-2014
OI Acedo, Pablo/0000-0002-8053-7363; GARCIA, JOSE
   ANTONIO/0000-0001-9839-2898
CR Beard PC, 2004, PROC SPIE, V5320, P230, DOI 10.1117/12.531332
   BEARD PC, 2000, IEEE T ULTRASONICS F, V47
   BEARD PC, 1998, IEEE ULTR S 5 8 OCT, V2, P1881
   BUMA T, 2002, IEEE ULTR S
   ESENALIEV RO, 1999, IEEE J SELECTED TOPI, V5
   HAMILTON JD, 2000, IEEE T ULTRASONICS F, V47
   Lamela-Rivera H, 2003, J OPT A-PURE APPL OP, V5, P66, DOI 10.1088/1464-4258/5/1/310
   LAMONT L, 2006, ELECT LETT, V42
   MANOHAR S, 2004, J BIOMEDICAL OPTICS, V9
   Viator JA, 2000, PROC SPIE, V3916, P89, DOI 10.1117/12.386309
   Wang GL, 2003, ANNU REV ENV RESOUR, V28, P1, DOI 10.1146/annurev.energy.28.050302.105444
   WANG X, 2004, OPTICS LETT, V29
   Zhang EZ, 2004, PROC SPIE, V5320, P222, DOI 10.1117/12.531160
   Zhao ZM, 2001, MEAS SCI TECHNOL, V12, P2172, DOI 10.1088/0957-0233/12/12/319
NR 14
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6128-8
J9 PROC SPIE
PY 2006
VL 6086
AR 60861
DI 10.1117/12.651758
PG 10
WC Acoustics; Biophysics; Optics; Physics, Applied
SC Acoustics; Biophysics; Optics; Physics
GA BEF42
UT WOS:000237084900053
DA 2018-10-20
ER

PT J
AU Chen, SC
   Zhou, ZX
   Wang, YZ
   Wang, XL
   Yang, KK
AF Chen, SC
   Zhou, ZX
   Wang, YZ
   Wang, XL
   Yang, KK
TI A novel biodegradable poly(p-dioxanone)-grafted poly(vinyl alcohol)
   copolymer with a controllable in vitro degradation
SO POLYMER
LA English
DT Article
DE poly(vinyl alcohol); poly(p-dioxanone); copolymer
ID COMB POLYESTERS; POLYMERIZATION
AB A novel biodegradable copolymer was synthesized from poly(vinyl alcohol) and poly (p-dioxanone) by ring-opening polymerization. The molecular structure of the copolymer was characterized by one- and two-dimensional NMR spectroscopy. The results of differential scanning calorimetry (DSC) show that the amphiphilic and comb grafted structure of the copolymer make its crystalline behavior different from that of the poly(p-dioxanone) homopolymer (PPDO). The in vitro degradation rate of the copolymers can be controlled via adjusting the number and length of PPDO segments of PVA-g-PPDO copolymers. The copolymer has a potential application in biomedical materials or in the controlled release of drug. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Sichuan Univ, Key Lab Green Chem & Technol, Coll Chem, Ctr Degradable & Flame Retardent Polymer Mat, Chengdu 610064, Peoples R China.
RP Wang, YZ (reprint author), Sichuan Univ, Key Lab Green Chem & Technol, Coll Chem, Ctr Degradable & Flame Retardent Polymer Mat, Chengdu 610064, Peoples R China.
EM yzwang@mail.sc.cninfo.net
RI Wang, Yu-Zhong/E-3633-2013; Chen, Si-Chong/M-4034-2018; Yang,
   Ke-Ke/G-6131-2018
OI Wang, Yu-Zhong/0000-0001-7535-7635; Chen, Si-Chong/0000-0001-9230-0892;
   Yang, Ke-Ke/0000-0002-7019-6059
CR Breitenbach A, 2002, POLYM ADVAN TECHNOL, V13, P938, DOI 10.1002/pat.233
   Breitenbach A, 1998, POLYMER, V39, P3261, DOI 10.1016/S0032-3861(97)10077-5
   Breitenbach A, 2000, POLYMER, V41, P4781, DOI 10.1016/S0032-3861(99)00710-7
   BREITENBACH A, 1998, PHARM SCI S, V1, P300
   Doddi N, 1977, US, Patent No. [4, 032, 988, 4032988]
   DOI Y, 1990, MICROBIAL POLYESTER
   FORSCHNER TC, 1997, Patent No. 9721753
   Gholap SG, 2004, POLYMER, V45, P5863, DOI 10.1016/j.polymer.2004.06.032
   Gimenez V, 1996, J POLYM SCI POL CHEM, V34, P925, DOI 10.1002/(SICI)1099-0518(19960430)34:6<925::AID-POLA1>3.3.CO;2-2
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Inotte Y., 1992, PROG POLYM SCI, V17, P571
   Lipinsky ES, 1997, United States patent, Patent No. [US 5, 767, 222, 5767222]
   Nishida H, 2000, MACROMOLECULES, V33, P6982, DOI 10.1021/ma000457t
   Schwach G, 1997, J POLYM SCI POL CHEM, V35, P3431, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3431::AID-POLA10>3.0.CO;2-G
   Wang XL, 2004, J POLYM SCI POL CHEM, V42, P3417, DOI 10.1002/pola.20203
   YANG KK, 2002, J MACROMOL SCI POL C, V43, P373
NR 16
TC 34
Z9 39
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD JAN
PY 2006
VL 47
IS 1
BP 32
EP 36
DI 10.1016/j.polymer.2005.10.008
PG 5
WC Polymer Science
SC Polymer Science
GA 002NG
UT WOS:000234617600007
DA 2018-10-20
ER

PT S
AU Duncan, R
   Ringsdorf, H
   Satchi-Fainaro, R
AF Duncan, R
   Ringsdorf, H
   Satchi-Fainaro, R
BE SatchiFainaro, R
   Duncan, R
TI Polymer therapeutics: Polymers as drugs, drug and protein conjugates and
   gene delivery systems: Past, present and future opportunities
SO POLYMER THERAPEUTICS I: POLYMERS AS DRUGS, CONJUGATES AND GENE DELIVERY
   SYSTEMS
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
ID SYNTHETIC-POLYMERS; COPOLYMER; LIPOSOMES; CARRIERS
AB As the 21st century begins we are witnessing a paradigm shift in medical practice. Whereas the use of polymers in biomedical materials applications - for example, as prostheses, medical devices, contact lenses, dental materials and pharmaceutical excipients - is long established, polymer-based medicines have only recently entered routine clinical practice [1-4]. Importantly, many of the innovative polymer-based therapeutics once dismissed as interesting but impractical scientific curiosities have now shown that they can satisfy the stringent requirements of industrial development and regulatory authority approval. The latter demand on one hand a cost-effective and profitable medicine or diagnostic, and on the other hand, a safe and efficacious profile that justifies administration to patients.
   The first clinical proof of concept with polymer therapeutics has coincided with the explosion of interest in the fashionable area called "nanotechnology". This has resulted in exponential growth in the field, and an increasing number of polymer chemists are turning their attention to the "bio-nano" arena. An attempt to define "nanotechnology" is beyond the scope of this review, but suffice it to say there is widespread agreement that application of nanotechnology to medicine, either via miniaturisation or synthetic polymer and supramolecular chemistry to construct nano-sized assemblies [5,61, offers a unique opportunity to design improved diagnostics, preventative medicines, and more efficacious treatments of life-threatening and debilitating diseases. It is thus timely for this volume of Advances in Polymer Science to review the field that has been named "polymer therapeutics" (Fig. 1).
   The term "polymer therapeutics" [1] has been adopted to encompass several families of constructs all using water-soluble polymers as components for design; polymeric drugs [3, 7], polymer-drug conjugates ( 1, 8], polymer-protein conjugates [2, 9], polymeric micelles to which a drug is covalently bound [10], and those multi-component polyplexes being developed as non-viral vectors [11]. From an industrial standpoint, these nanosized medicines are more like new chemical entities than conventional "drug-delivery systems or formulations" which simply entrap, solubilise or control drug release without resorting to chemical conjugation. In this issue of Advances in Polymer Science, the current status of those technologies in preclinical and clinical development is reviewed, together with presentation of an emerging area of novel synthetic chemistry - the new field of polymer genomics - and also a description of some of the sophisticated analytical methods being developed to characterise complex polymer constructs.
C1 Cardiff Univ, Welsh Sch Pharm, Ctr Polymer Therapeut, Cardiff CF10 3XF, Wales.
   Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany.
   Childrens Hosp, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Vasc Biol Program, Dept Surg,Karp Family Res Labs, Boston, MA 02115 USA.
RP Duncan, R (reprint author), Cardiff Univ, Welsh Sch Pharm, Ctr Polymer Therapeut, Redwood Bldg,King Edward VII Ave, Cardiff CF10 3XF, Wales.
EM DuncanR@cf.ac.uk; DuncanR@cf.ac.uk
RI Satchi-Fainaro, Ronit/F-9137-2011
OI Satchi-Fainaro, Ronit/0000-0002-7360-7837
CR BADER H, 1985, ADV POLYM SCI, V64, P1
   BRESLOW DS, 1976, PURE APPL CHEM, V46, P103, DOI 10.1351/pac197646020103
   Davis FF, 2002, ADV DRUG DELIVER REV, V54, P457, DOI 10.1016/S0169-409X(02)00021-2
   DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9
   DHAL PK, 2002, ENCY POLYM SCI TECHN, P555
   DUNCAN R, 1984, ADV POLYM SCI, V57, P51
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 2003, BOOK ANTICANCER DRUG, P239
   Duncan R., 2005, POLYM DRUG DELIVERY, P1
   DUNCAN R, 2005, IN PRESS ADV DRUG DE
   Duncan R., 2003, HDB ANTICANCER DRUG, P239
   *ESF, 2005, MOD DRUG DISC, P30
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   GEBELEIN CG, 1985, BIOACTIVE POLYM SYST
   Gros L, 1981, ANGEW CHEM INT EDIT, V20, P301
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   JATZKEWITZ H, 1955, Z NATURFORSCH PT B, V10, P27
   Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0
   Lehn J.-M, 1995, SUPRAMOLECULAR CHEM
   MORAWETZ H, 1985, POLYM ORIGINS GROWTH
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   REGELSON W, 1986, J BIOACT COMPAT POL, V1, P84
   Ringsdorf H, 2004, ANGEW CHEM INT EDIT, V43, P1064, DOI 10.1002/anie.200330071
   Ringsdorf H., 1975, J POLYM SCI POLYM S, V51, P135
   Satchi-Fainaro R, 2004, NAT MED, V10, P255, DOI 10.1038/nm1002
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Wagner E, 2004, PHARM RES, V21, P8, DOI 10.1023/B:PHAM.0000012146.04068.56
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   WILLIS RC, 2004, NIH ROADMAP NANOMEDI, P30
   2004, LANCET, P362
NR 30
TC 76
Z9 78
U1 1
U2 73
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-29210-1
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
VL 192
BP 1
EP 8
DI 10.1007/12_037
D2 10.1007/11547761
PG 8
WC Polymer Science
SC Polymer Science
GA BEG41
UT WOS:000237221400001
DA 2018-10-20
ER

PT S
AU Agrawal, SK
   Sardhina, HA
   Aamer, KA
   Sanabria-DeLong, N
   Bhatia, SR
   Tew, GN
AF Agrawal, SK
   Sardhina, HA
   Aamer, KA
   Sanabria-DeLong, N
   Bhatia, SR
   Tew, GN
BE Svenson, S
TI Triblock PLLA-PEO-PLLA hydrogels: Structure and mechanical properties
SO POLYMERIC DRUG DELIVERY II: POLYMERIC MATRICES AND DRUG PARTICLE
   ENGINEERING
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT 226th National Meeting of the American-Chemical-Society
CY SEP 07-11, 2003
CL NEW YORK, NY
SP Amer Chem Soc
ID SOL-GEL TRANSITION; BIODEGRADABLE BLOCK-COPOLYMERS; ENDED POLY(ETHYLENE
   GLYCOL); DRUG-DELIVERY; POLY(L-LACTIC ACID); B-BLOCKS; A-BLOCKS;
   HYDROLYTIC DEGRADATION; PERCOLATION THEORY; INDUCED GELATION
AB Triblock copolymers made from poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) have attracted attention recently because of their ability to form elastic gets, which have potential applications in drug delivery and tissue engineering. We have perfomed rheology studies on several of these gels, formed with varying lengths of the hydrophobic (PLLA) blocks. The elastic moduli of these gels were found to be greater than 10,000 Pa, matching well with the moduli measured for several native human tissues. The strength of the gels is seen to be strongly dependent on the PLLA block length, thus offering a mechanism to control the mechanical properties as desired for particular applications. The gel strength is dependent upon the network structure, which in turn governs the degradation behavior of the gels and hence the release rate of bioactive molecules. Hence we establish the usefulness of these materials for producing tailor-made hydrogels, suitable for specific biomedical applications.
C1 Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
   Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RP Tew, GN (reprint author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
EM tew@mail.pse.umass.edu
RI Bhatia, Surita/B-4536-2008
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   AXELOS MAV, 1990, PHYS REV LETT, V64, P1457, DOI 10.1103/PhysRevLett.64.1457
   Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2
   Chen XH, 1997, MACROMOLECULES, V30, P4295, DOI 10.1021/ma970385e
   Choi SW, 1999, J POLYM SCI POL CHEM, V37, P2207, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2207::AID-POLA35>3.0.CO;2-0
   Daoud M, 2000, MACROMOLECULES, V33, P3019, DOI 10.1021/ma991947s
   DEGENNES PG, 1976, J PHYS LETT-PARIS, V37, pL1
   DOMB AJ, 1994, POLYM BIOMATERIALS, P339
   Erkamp RQ, 1998, ULTRASONIC IMAGING, V20, P17, DOI 10.1177/016173469802000102
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   FRANK EH, 1987, J BIOMECH, V20, P629, DOI 10.1016/0021-9290(87)90283-1
   Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.3.CO;2-8
   GRAHAM NB, 1988, MAKROMOL CHEM-M SYMP, V19, P255, DOI 10.1002/masy.19880190121
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hakkarainen M, 2000, J APPL POLYM SCI, V76, P228, DOI 10.1002/(SICI)1097-4628(20000411)76:2<228::AID-APP12>3.0.CO;2-B
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   Jeong BM, 1999, J POLYM SCI POL CHEM, V37, P751
   KANTOR Y, 1984, PHYS REV LETT, V52, P1891, DOI 10.1103/PhysRevLett.52.1891
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee HT, 2002, MACROMOL RES, V10, P359, DOI 10.1007/BF03218330
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LI YX, 1993, J CONTROL RELEASE, V27, P247
   LI YX, 1994, J CONTROL RELEASE, V32, P121
   LIN YG, 1991, MACROMOLECULES, V24, P850, DOI 10.1021/ma00004a006
   Liu L, 1999, POLYM J, V31, P845, DOI 10.1295/polymj.31.845
   Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1
   MARTIN JE, 1991, ANNU REV PHYS CHEM, V42, P311
   MATSUMOTO T, 1992, MACROMOLECULES, V25, P5430, DOI 10.1021/ma00046a047
   MERRILL EW, 1993, BIOMATERIALS, V14, P1117, DOI 10.1016/0142-9612(93)90154-T
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P4656, DOI 10.1021/ma00202a050
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   Pham QT, 1999, MACROMOLECULES, V32, P5139, DOI 10.1021/ma990215x
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   RICHTERING HW, 1992, MACROMOLECULES, V25, P2429, DOI 10.1021/ma00035a021
   Rubinstein M., 1989, POLYM PREPR AM CHEM, V30, P81
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SCANLAN JC, 1991, MACROMOLECULES, V24, P47, DOI 10.1021/ma00001a008
   Stockwell R., 1979, ADULT ARTICULAR CART
   Tae G, 2001, MACROMOLECULES, V34, P6409, DOI 10.1021/ma0107511
   Tae GY, 2002, MACROMOLECULES, V35, P4448, DOI 10.1021/ma011809e
   WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Yu JM, 1996, MACROMOLECULES, V29, P5384, DOI 10.1021/ma951911+
   YU QL, 1993, AM J PHYSIOL, V265, pH52
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
NR 59
TC 5
Z9 5
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3976-2
J9 ACS SYM SER
PY 2006
VL 924
BP 102
EP 119
PG 18
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Polymer Science
SC Chemistry; Pharmacology & Pharmacy; Polymer Science
GA BEL97
UT WOS:000238059600007
DA 2018-10-20
ER

PT S
AU Schreuder-Gibson, HL
   Gibson, P
AF Schreuder-Gibson, Heidi L.
   Gibson, Phil
BE Reneker, DH
   Fong, H
TI Applications of electrospun nanofibers in current and future materials
SO POLYMERIC NANOFIBERS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT 226th National Meeting of the American-Chemical-Society
CY SEP 07-11, 2003
CL NEW YORK, NY
SP Amer Chem Soc
ID POLYMER; FABRICATION; FIBERS
AB The search for practical applications of electrospun microfibers and nanofibers is primarily concentrated on filters, membranes, and biomedical devices. This chapter reviews current progress towards developing new applications of electrospinning. The production of submicron as well as nanometer sized fibers by electrospinning was reported early in the 20(th) century (1-5). Over the intervening decades, research has continued around the world, resulting in over one hundred patents and publications. Research today continues to focus on new methods of producing nanofibers, including an increased understanding of electrospinning and its applications. These studies have resulted in process improvements that have increased the speed of electrospinning, increased the strength of the resulting nanofiber web, and may lead to better control of electrospun membrane features such as fiber size, fiber orientation and porosity for future applications.
C1 USA, Res Dev & Engn Command, Natick Soldier Ctr, Natick, MA 01760 USA.
RP Schreuder-Gibson, HL (reprint author), USA, Res Dev & Engn Command, Natick Soldier Ctr, Kansas St, Natick, MA 01760 USA.
RI Gibson, Phillip/D-2398-2010
OI Gibson, Phillip/0000-0002-6172-4438
CR Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   BALKUS KJJ, 2003, Patent No. 20030168756
   BAMFORD CH, 1992, J CHROMATOGR, V606, P19, DOI 10.1016/0021-9673(92)85253-P
   Bornat A., 1987, U.S. Patent, Patent No. [US 4689186 A, 4689186]
   BOWLIN GL, 2003, Patent No. 20030088266
   BUNYAN N, 2005, IN PRESS ACS S SER P
   CHU B, 2003, Patent No. 20030054035
   CHU B, 2002, Patent No. 20020175449
   DEITZEL JM, 2001, POLYMER, V43, P3303
   DUBSON A, 2004, Patent No. 2004005406
   DUBSON A, 2004, Patent No. 20040030377
   Fong H, 2001, CHEM MATER, V13, P4123, DOI 10.1021/cm010150o
   FORMHALS A, 1944, Patent No. 2160962
   Formhals A., 1940, US Patent, Patent No. [2,187,306, 2187306]
   Formhals A, 1939, U. S. Patent, Patent No. [US 2160962, 2160962, 2,160,962]
   FORMHALS A, 1943, Patent No. 2160962
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Gibson P, 2003, E POLYM
   GILLINGHAM GR, 2004, Patent No. 6673136
   GOGINS MA, 2004, Patent No. 6716274
   Grafe T., 2003, INT NONWOVENS J, V12, P51
   GREENHALGH K, 2004, Patent No. 20040013873
   Gupta P, 2003, POLYMER, V44, P6353, DOI 10.1016/S0032-3861(03)00616-5
   HOU H, 2004, Patent No. 20040013819
   Ignatious F., 2003, Electrospun Pharmaceutical Compositions, Patent No. [US 2003/0017208 A1, 20030017208]
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   KELLY AD, 2003, Patent No. 6656394
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   LAKSIN O, 2003, Patent No. 20030100944
   LEE WS, 2002, Patent No. 20020100725
   Li D, 2004, NANO LETT, V4, P933, DOI 10.1021/nl049590f
   LO D, 2004, NANO LETT       0330
   Loscertales IG, 2004, J AM CHEM SOC, V126, P5376, DOI 10.1021/ja049443j
   PAVLOVIC JL, 2002, Patent No. 20020128680
   RENEKER D, 2003, Patent No. 20030232195
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Schreuder-Gibson H, 2002, J ADV MATER-COVINA, V34, P44
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   TSAI P, 2003, P INTC2003 INT NONW, P403
   WADSWORTH LC, 2001, P JOINT INDA TAPPI C, P179
   WEBB GW, 1992, J ALLOY COMPD, V183, P109, DOI 10.1016/0925-8388(92)90735-R
   WEGHMANN A, 1982, NONWOVENS IND    NOV, P24
   WNEK GE, 2004, Patent No. 2004018226
   Yarin AL, 2004, POLYMER, V45, P2977, DOI 10.1016/j.polymer.2004.02.066
   Zussman E, 2003, APPL PHYS LETT, V82, P973, DOI 10.1063/1.1544060
NR 46
TC 8
Z9 8
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3919-3
J9 ACS SYM SER
PY 2006
VL 918
BP 121
EP 136
PG 16
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Polymer
   Science
SC Chemistry; Science & Technology - Other Topics; Polymer Science
GA BEM23
UT WOS:000238115600009
DA 2018-10-20
ER

PT S
AU Freier, T
AF Freier, Thomas
BE Werner, C
   Eisseeff, JH
   Fischbach, C
   Freier, T
   Garcia, AJ
   Mooney, DJ
   Pompe, T
   Salchert, K
   Varghese, S
   Werner, C
   Zhang, S
   Zhao, X
TI Biopolyesters in tissue engineering applications
SO POLYMERS FOR REGENERATIVE MEDICINE
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE biocompatibility; biodegradability; mechanical properties;
   poly(hydroxyalkanoate)s; tissue engineering applications
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; POLY-BETA-HYDROXYBUTYRATE;
   BIODEGRADABLE MEDICAL DEVICES; PERIPHERAL-NERVE REGENERATION;
   ARTICULAR-CARTILAGE CHONDROCYTES; SPUN POLYHYDROXYBUTYRATE FIBERS;
   TRILEAFLET HEART-VALVES; IN-VITRO DEGRADATION; MARROW STROMAL CELLS;
   MECHANICAL-PROPERTIES
AB Tissue engineering is a rapidly growing interdisciplinary field of research focused on the development of vital autologous tissue through the use of a combination of biomaterials, cells, and bioactive molecules, for the purposes of repairing damaged or diseased tissue and organs. Due to their biocompatibility and biodegradability, as well as their broad range of mechanical properties, natural polyesters from the group of polyhydroxyalkanoates (PHAs) have emerged as promising materials for various tissue engineering applications, including cardiovascular system, nerve, bone, and cartilage repair applications. Thus far, the majority of research on medical applications of PHAs refers to poly(3-hydroxybutyrate) and its copolymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate). In recent years, other PHAs, such as poly(4-hydroxybutyrate) and poly(3-hydroxyoctanoate-co-3-hydroxyhexanoate), have drawn increasing attention as viable materials for biomedical applications. Copolymers of poly(3-hydroxybutyrate) and medium-chain-length hydroxyalkanoates offer the advantage of having elastomeric properties. This is of particular importance for engineering of elastomeric tissue, such as in the cardiovascular system, and for providing mechanical stimuli, such as in cartilage repair. This review will describe the characteristics of promising biopolyesters for tissue engineering, together with strategies that can be used to adjust the material properties to the clinical requirements; examples of potential applications will also be presented.
C1 Smart Biotech Inc, Toronto, ON M4R 1B1, Canada.
RP Freier, T (reprint author), Smart Biotech Inc, 243 Eglinton Ave,W,Suite 300, Toronto, ON M4R 1B1, Canada.
EM thomas@smart-biotech.com
CR Abdel-Latif SA, 2004, J APPL POLYM SCI, V94, P2257, DOI 10.1002/app.20992
   ABE H, 1994, MACROMOLECULES, V27, P6018, DOI 10.1021/ma00099a013
   ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007
   ABE H, 1994, STUD POLYM SCI, V12, P591
   ABE H, 1994, MACROMOLECULES, V27, P6012, DOI 10.1021/ma00099a012
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Asrar J, 2002, BIOMACROMOLECULES, V3, P1006, DOI 10.1021/bm025543a
   Asrar J, 2002, J APPL POLYM SCI, V83, P457, DOI 10.1002/app.2253
   Asrar J., 2000, US Pat, Patent No. 6127512
   ATALA A, 2002, METHODS TISSUE ENG
   Atala A, 1997, SYNTHETIC BIODEGRADA
   Atkins TW, 1997, J MICROENCAPSUL, V14, P35, DOI 10.3109/02652049709056466
   Avella M, 2000, J MATER SCI, V35, P523, DOI 10.1023/A:1004740522751
   Baltieri RC, 2003, MACROMOL SYMP, V197, P33, DOI 10.1002/masy.200350704
   Baptist J. N., 1965, Method of making absorbable surgical sutures from poly beta hydroxy acids, Patent No. [US3225766 A, 3225766]
   Baptist J.N., 1962, US Patent, Patent No. [3,044,942, 3044942, 3, 044,942]
   Behrend D, 1998, AM J CARDIOL, V82, p4S
   Bibers I, 1999, MECH COMPOS MATER, V35, P169, DOI 10.1007/BF02257247
   BLEDZKI AK, 1994, ANGEW MAKROMOL CHEM, V219, P11, DOI 10.1002/apmc.1994.052190102
   BOEREE NR, 1993, BIOMATERIALS, V14, P793, DOI 10.1016/0142-9612(93)90046-5
   BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   Bowald SF, 1990, A novel surgical material, Patent No. [EP 0349505 A 2, 0349505]
   CarswellPomerantz T, 1996, ACS SYM SER, V620, P11
   CHAPUT C, 1995, BIOMATER LIVING SYST, V3, P19
   CHAPUT C, 1995, BIOMATER LIVING SYST, V3, P29
   Chaput C, 1995, MATER RES SOC SYMP P, V394, P111, DOI 10.1557/PROC-394-111
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Cheng GX, 2003, J MATER SCI-MATER M, V14, P1073, DOI 10.1023/B:JMSM.0000004004.37103.f4
   Choi JS, 2004, POLYM TEST, V23, P455, DOI 10.1016/j.polymertesting.2003.09.005
   Choi MH, 1999, APPL ENVIRON MICROB, V65, P1570
   Chung CW, 2003, INT J BIOL MACROMOL, V32, P17, DOI 10.1016/S0141-8130(03)00020-5
   CLAROTTI G, 1992, BIOMATERIALS, V13, P832, DOI 10.1016/0142-9612(92)90176-O
   COUSSOTRICO P, 1994, EUR POLYM J, V30, P1327, DOI 10.1016/0014-3057(94)90146-5
   Dang MH, 1997, J ENVIRON POLYM DEGR, V5, P49
   DAVIES S, 1995, POLYM PREPR, V36, P103
   DAWES EA, 1973, ADV MICROB PHYSL, V10, P203
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   DOI Y, 1990, INT J BIOL MACROMOL, V12, P106, DOI 10.1016/0141-8130(90)90061-E
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOI Y, 1989, MAKROMOL CHEM-RAPID, V10, P227
   Doi Y., 1990, MICROBIAL POLYESTERS
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   DRECHSEL A, 2005, THESIS U ROSTOCK
   Dufresne A, 2000, MACROMOLECULES, V33, P2998, DOI 10.1021/ma991854a
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   Dvorin EL, 2003, TISSUE ENG, V9, P487, DOI 10.1089/107632703322066660
   El-Taweel SH, 2004, J APPL POLYM SCI, V94, P2528, DOI 10.1002/app.21215
   Eldsater C, 1997, ACTA POLYM, V48, P478, DOI 10.1002/actp.1997.010481103
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Etzrodt D, 1997, Biomed Tech (Berl), V42 Suppl, P445, DOI 10.1515/bmte.1997.42.s2.445
   Fischer JJ, 2004, POLYM DEGRAD STABIL, V83, P453, DOI 10.1016/j.polymdegradstab.2003.08.006
   Foster L. J. R., 1994, Journal of Environmental Polymer Degradation, V2, P185, DOI 10.1007/BF02067444
   Foster LJR, 2005, POLYM DEGRAD STABIL, V87, P1, DOI 10.1016/j.polymdegradstab.2003.11.012
   Foster LJR, 2001, J BIOMAT SCI-POLYM E, V12, P317, DOI 10.1163/156856201750180843
   Franconi F, 2001, THROMB RES, V102, P255, DOI 10.1016/S0049-3848(01)00249-3
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Freier T, 2001, J MATER SCI LETT, V20, P1929, DOI 10.1023/A:1013174400236
   FREIER T, 2002, ANN M GERM SOC BIOM
   FREIER T, 2003, BIOPOLYMERS, V10, P247
   FREIER T, 2002, INT S BIOL POL MUNST
   Fu P, 2004, ASAIO J, V50, P9, DOI 10.1097/01.MAT.0000104815.21056.08
   Fuchs JR, 2003, J PEDIATR SURG, V38, P1348, DOI 10.1016/S0022-3468(03)00394-4
   FUKADA E, 1988, BIORHEOLOGY, V25, P297
   Fuller DE, 2003, PHARMACOTHERAPY, V23, P1205, DOI 10.1592/phco.23.10.1205.32756
   GAGNON KD, 1992, RUBBER WORLD, V207, P32
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   GASSNER F, 1994, POLYMER, V35, P2233, DOI 10.1016/0032-3861(94)90258-5
   GHIYA VP, 1995, POLYM PREPR, V36, P420
   Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P411, DOI 10.1016/j.biopha.2004.08.001
   Giavaresi G, 2004, INT J ARTIF ORGANS, V27, P796
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOTFREDSEN K, 1994, CLIN ORAL IMPLAN RES, V5, P83, DOI 10.1034/j.1600-0501.1994.050204.x
   Grabow N, 2004, ARTIF ORGANS, V28, P971, DOI 10.1111/j.1525-1594.2004.00007.x
   Gross R. A., 2000, POLYM RENEWABLE RESO, P328
   GURAV N, 1994, J MATER SCI-MATER M, V5, P784, DOI 10.1007/BF00213135
   HAMMOND T, 1994, Patent No. 9428061
   Hart AM, 2003, BRIT J PLAST SURG, V56, P444, DOI 10.1016/S0007-1226(03)00134-6
   Hasirci V, 2003, J APPL POLYM SCI, V87, P1285, DOI 10.1002/app.11532
   HASIRCI V, 2000, BIOMATERIALS BIOENGI, P141
   Hazari A, 1999, J HAND SURG-BRIT EUR, V24B, P291, DOI 10.1054/jhsb.1998.0001
   Hazari A, 1999, BRIT J PLAST SURG, V52, P653, DOI 10.1054/bjps.1999.3184
   HEIMERL A, 1989, Patent No. 0336148
   Hein S, 1997, FEMS MICROBIOL LETT, V153, P411, DOI 10.1016/S0378-1097(97)00282-6
   HEROLD A, 1988, HEFTE UNFALLHEILKD, P665
   Hocking P. J., 1994, CHEM TECHNOLOGY BIOD, P48
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   Holmes P. A., 1988, DEV CRYSTALLINE POLY, P1
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   HULL EH, 1990, MED PLASTICS TODAY T, P1
   Immirzi B, 1999, J MATER SCI, V34, P1625, DOI 10.1023/A:1004584802030
   Iordanskii AL, 1999, J APPL POLYM SCI, V74, P595
   ISHIKAWA K, 1991, KOBUNSHI RONBUNSHU, V48, P221, DOI 10.1295/koron.48.221
   ISHIKAWA K, 1996, Patent No. 5480394
   Jendrossek D, 1996, APPL MICROBIOL BIOT, V46, P451, DOI 10.1007/s002530050844
   JONES NL, 2000, SYNTHETIC BIOABSORBA, P69
   Kadner A, 2002, EUR J CARDIO-THORAC, V21, P1055, DOI 10.1016/S1010-7940(02)00079-9
   Kalangos A, 1996, J THORAC CARDIOV SUR, V112, P1401, DOI 10.1016/S0022-5223(96)70164-2
   KANESAWA Y, 1990, MAKROMOL CHEM-RAPID, V11, P679
   Kaviani A, 2002, J PEDIATR SURG, V37, P995, DOI 10.1053/jpsu.2002.33828
   Khosravi A, 2003, MATER SCI FORUM, V426-4, P3067, DOI 10.4028/www.scientific.net/MSF.426-432.3067
   Kimura H, 1999, POLYM INT, V48, P1073, DOI 10.1002/(SICI)1097-0126(199911)48:11<1073::AID-PI270>3.0.CO;2-3
   KIMURA H, 1992, BIOTECHNOL LETT, V14, P445, DOI 10.1007/BF01023164
   KISHIDA A, 1989, CHEM PHARM BULL, V37, P1954
   KNOWLES J C, 1991, Clinical Materials, V8, P155, DOI 10.1016/0267-6605(91)90024-A
   KNOWLES JC, 1992, J MATER SCI-MATER M, V3, P352, DOI 10.1007/BF00705367
   KNOWLES JC, 1991, BIOMATERIALS, V12, P210, DOI 10.1016/0142-9612(91)90202-L
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   KOOSHA F, 1989, CRIT REV THER DRUG, V6, P117
   Korkusuz F, 2001, J BIOMED MATER RES, V55, P217, DOI 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y
   KORSATKO W, 1984, PHARM IND, V46, P952
   KORSATKO W, 1983, PHARM IND, V45, P525
   KORSATKO W, 1983, PHARM IND, V45, P1004
   Kose GT, 2003, J MATER SCI-MATER M, V14, P121
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   Kramp B, 2002, LARYNGO RHINO OTOL, V81, P351, DOI 10.1055/s-2002-28343
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V36, P241, DOI 10.1016/0141-3910(92)90062-A
   KUMAGAI Y, 1992, MAKROMOL CHEM-RAPID, V13, P179
   KUNIOKA M, 1989, MACROMOLECULES, V22, P694, DOI 10.1021/ma00192a031
   KUNIOKA M, 1988, POLYM COMMUN, V29, P174
   Kunze C, 2002, J MATER SCI-MATER M, V13, P1051, DOI 10.1023/A:1020392606225
   Kunze C, 2006, BIOMATERIALS, V27, P192, DOI 10.1016/j.biomaterials.2005.05.095
   KURCOK P, 1995, J MACROMOL SCI PURE, VA32, P875, DOI 10.1080/10601329508010300
   Kusaka S, 1998, J MACROMOL SCI PURE, VA35, P319, DOI 10.1080/10601329808001980
   Labrecque LV, 1997, J APPL POLYM SCI, V66, P1507, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1507::AID-APP11>3.0.CO;2-0
   Lee IS, 2004, MACROMOL RES, V12, P374, DOI 10.1007/BF03218414
   Lee SH, 2000, BIOTECHNOL BIOENG, V67, P240, DOI 10.1002/(SICI)1097-0290(20000120)67:2<240::AID-BIT14>3.0.CO;2-F
   Lee SJ, 2002, MACROMOL RES, V10, P150, DOI 10.1007/BF03218265
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   LEENSTRA TS, 1995, J MATER SCI-MATER M, V6, P445, DOI 10.1007/BF00123368
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Li HY, 2005, POLYM DEGRAD STABIL, V87, P301, DOI 10.1016/j.polymdegradstab.2004.09.001
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Lindstrom L, 2000, SCAND CARDIOVASC J, V34, P331, DOI 10.1080/713783121
   LIU DM, 1997, T TECH UETIKON ZURIC
   Ljungberg C, 1999, MICROSURG, V19, P259, DOI 10.1002/(SICI)1098-2752(1999)19:6<259::AID-MICR1>3.3.CO;2-H
   Lobler M, 2002, J BIOMED MATER RES, V61, P165, DOI 10.1002/jbm.10155
   Lobler M, 2002, BIOMATERIALS, V23, P577, DOI 10.1016/S0142-9612(01)00144-2
   Lootz D, 1997, Biomed Tech (Berl), V42 Suppl, P53, DOI 10.1515/bmte.1997.42.s2.53
   Lootz D, 2001, BIOMATERIALS, V22, P2447, DOI 10.1016/S0142-9612(00)00245-3
   Luklinska ZB, 1997, J MATER SCI-MATER M, V8, P379, DOI 10.1023/A:1018589018205
   Luo S, 1999, J APPL POLYM SCI, V73, P1059, DOI 10.1002/(SICI)1097-4628(19990808)73:6<1059::AID-APP25>3.3.CO;2-H
   Luo S, 2002, POLYMER, V43, P4159, DOI 10.1016/S0032-3861(02)00242-2
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   Mallarde D, 1998, POLYMER, V39, P3387, DOI 10.1016/S0032-3861(97)10172-0
   MALM T, 1994, J THORAC CARDIOV SUR, V107, P628
   MALM T, 1992, J THORAC CARDIOV SUR, V104, P600
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   MALM T, 1992, SCAND J THORAC CARD, V26, P9, DOI 10.3109/14017439209099047
   Marois Y, 1999, J BIOMAT SCI-POLYM E, V10, P469, DOI 10.1163/156856299X00216
   Marois Y, 2000, J BIOMED MATER RES, V49, P216, DOI 10.1002/(SICI)1097-4636(200002)49:2<216::AID-JBM9>3.0.CO;2-X
   Marois Y, 1999, J BIOMAT SCI-POLYM E, V10, P483, DOI 10.1163/156856299X00225
   Marois Y., 2000, SYNTHETIC BIOABSORBA, P12
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Martin DP., 1999, PCT Patent Application, Patent No. [9932536, WO 99/32536]
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   MITOMO H, 1994, POLYM DEGRAD STABIL, V45, P11, DOI 10.1016/0141-3910(94)90173-2
   Miyazaki SS, 2003, MACROMOL SYMP, V197, P57, DOI 10.1002/masy.200350706
   Mohanna PN, 2003, J ANAT, V203, P553, DOI 10.1046/j.1469-7580.2003.00243.x
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035
   NAJIMI A, 1999, INNOV TECH BIOL MED, V20, P187
   NAKAMURA S, 1992, MACROMOLECULES, V25, P4237, DOI 10.1021/ma00043a001
   Nasseri BA, 2003, TISSUE ENG, V9, P291, DOI 10.1089/107632703764664756
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   NELSON T, 1981, J NEUROCHEM, V37, P1345, DOI 10.1111/j.1471-4159.1981.tb04689.x
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Nkere UU, 1998, THORAC CARDIOV SURG, V46, P77, DOI 10.1055/s-2007-1010194
   Noda I, 2004, MACROMOL BIOSCI, V4, P269, DOI 10.1002/mabi.200300093
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   Opitz F, 2004, TISSUE ENG, V10, P611, DOI 10.1089/107632704323061960
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Opitz F, 2004, ANN BIOMED ENG, V32, P212, DOI 10.1023/B:ABME.0000012741.85600.f1
   Ostwald J, 2003, LARYNGO RHINO OTOL, V82, P693
   Park JW, 2004, BIOMACROMOLECULES, V5, P1557, DOI 10.1021/bm0499051
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   Piddubnyak V, 2004, BIOMATERIALS, V25, P5271, DOI 10.1016/j.biomaterials.2003.12.029
   POUTON CW, 1988, P INT S CONTR REL BI, P179
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Renard E, 2004, POLYM DEGRAD STABIL, V85, P779, DOI 10.1016/j.pllymdegradstab.2003.11.019
   Renstad R, 1997, POLYM DEGRAD STABIL, V57, P331, DOI 10.1016/S0141-3910(97)00028-1
   Renstad R, 1999, POLYM DEGRAD STABIL, V63, P201, DOI 10.1016/S0141-3910(98)00092-5
   REUSCH RN, 1992, BIOCHIM BIOPHYS ACTA, V1123, P33, DOI 10.1016/0005-2760(92)90168-U
   Rivard CH, 1996, ANN CHIR, V50, P651
   RIVARD CH, 1995, J APPL BIOMATER, V6, P65, DOI 10.1002/jab.770060109
   Ropero-Miller JD, 1998, CLIN LAB MED, V18, P727
   Rouxhet L, 1998, MACROMOL SYMP, V130, P347, DOI 10.1002/masy.19981300130
   Saad B, 2000, ARTIF ORGANS, V24, P939, DOI 10.1046/j.1525-1594.2000.06664.x
   Saad B, 1996, J MATER SCI-MATER M, V7, P56, DOI 10.1007/BF00121191
   SADOWSKI B, 1988, THESIS U WURZBURG
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   SAITO Y, 1994, INT J BIOL MACROMOL, V16, P99, DOI 10.1016/0141-8130(94)90022-1
   SASS M, 1996, THESIS U ROSTOCK
   Satkowski MM, 2001, BIOPOLYMERS B, V3b, P231
   Savenkova L, 2000, PROCESS BIOCHEM, V35, P573, DOI 10.1016/S0032-9592(99)00107-7
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   SCANDOLA M, 1992, MACROMOLECULES, V25, P1405, DOI 10.1021/ma00031a008
   SCHAFFER J, 1995, Patent No. 4416357
   SCHERER MA, 1992, DEGRADATION PHENOMEN, P77
   Schmack G, 2000, J POLYM SCI POL PHYS, V38, P2841, DOI 10.1002/1099-0488(20001101)38:21<2841::AID-POLB130>3.0.CO;2-#
   Schmack G, 2004, POLYM DEGRAD STABIL, V83, P467, DOI 10.1016/j.polymdegradstab.2003.08.008
   SCHMACK G, 2002, BIOMATERIALIEN, V3, P21
   Schmitz BKP, 2000, ADV ENG MATER, V2, P123, DOI 10.1002/(SICI)1527-2648(200003)2:3<123::AID-ADEM123>3.0.CO;2-P
   SCHUE F, 1993, MAKROMOL CHEM-M SYMP, V73, P217, DOI 10.1002/masy.19930730120
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Sodian R, 1999, TISSUE ENG, V5, P489, DOI 10.1089/ten.1999.5.489
   Sodian R, 2000, CIRCULATION, V102, P22
   Song SS, 1999, BIOTECHNOL LETT, V21, P193, DOI 10.1023/A:1005451810844
   Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Steinbuechel Alexander, 1994, Journal of Environmental Polymer Degradation, V2, P67, DOI 10.1007/BF02074775
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Stock UA, 2001, J CELL BIOCHEM, V81, P220, DOI 10.1002/1097-4644(20010501)81:2<220::AID-JCB1037>3.0.CO;2-O
   Sudesh K, 1999, INT J BIOL MACROMOL, V25, P79, DOI 10.1016/S0141-8130(99)00018-5
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   TEESE M, 2004, WORLD BIOM C SYDN AU
   Tesema Y, 2004, J APPL POLYM SCI, V93, P2445, DOI 10.1002/app.20787
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   TOKIWA Y, 1986, AGR BIOL CHEM TOKYO, V50, P1323, DOI 10.1080/00021369.1986.10867565
   TRECKMANN N, 2005, THESIS U ROSTOCK
   Ueda H, 2003, ADV DRUG DELIVER REV, V55, P501, DOI 10.1016/S0169-409X(03)00037-1
   Unverdorben M, 2002, CARDIOVASC INTER RAD, V25, P127, DOI 10.1007/s00270-001-0118-3
   Unverdorben M, 1998, AM J CARDIOL, V82, p5S
   VACANTI JP, 1999, LANCET S1, V354, P132
   VAINIONPAA S, 1986, ACTA ORTHOP SCAND, V57, P237, DOI 10.3109/17453678608994386
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   VASENIUS J, 1991, BIOMATERIALS DEGRADA, P393
   Volova T, 2003, BIOCHEM ENG J, V16, P125, DOI 10.1016/S1369-703X(03)00038-X
   Wang M, 2000, KEY ENG MAT, V192-1, P741
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   WEBB A, 1986, Patent No. 2166354
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT, P40
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Willing Alison E, 2002, Neurotox Res, V4, P111, DOI 10.1080/10298420290015908
   WINKELTAU GJ, 1993, DIS COLON RECTUM, V36, P154, DOI 10.1007/BF02051171
   WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   YASIN M, 1993, PLAST RUB COMPOS PRO, V19, P15
   YASIN M, 1992, BIOMATERIALS, V13, P9, DOI 10.1016/0142-9612(92)90087-5
   YOSHIOKA S, 1991, J CONTROL RELEASE, V16, P341, DOI 10.1016/0168-3659(91)90011-2
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
   ZHANG LL, 1995, J APPL POLYM SCI, V56, P103, DOI 10.1002/app.1995.070560114
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zhao K, 2002, J MATER SCI-MATER M, V13, P849, DOI 10.1023/A:1016596228316
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   Zheng Z, 2003, J BIOMAT SCI-POLYM E, V14, P615, DOI 10.1163/156856203322274888
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
   Zinner G, 1997, Biomed Tech (Berl), V42 Suppl, P55, DOI 10.1515/bmte.1997.42.s2.55
   Zinner G, 1998, Biomed Tech (Berl), V43 Suppl, P432, DOI 10.1515/bmte.1998.43.s1.432
NR 289
TC 35
Z9 35
U1 1
U2 31
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-33353-3
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
BP 1
EP 61
DI 10.1007/12_073
D2 10.1007/11604228
PG 61
WC Polymer Science
SC Polymer Science
GA BFJ92
UT WOS:000242423000001
DA 2018-10-20
ER

PT S
AU Garcia, AJ
AF Garcia, Andres J.
BE Werner, C
   Eisseeff, JH
   Fischbach, C
   Freier, T
   Garcia, AJ
   Mooney, DJ
   Pompe, T
   Salchert, K
   Varghese, S
   Werner, C
   Zhang, S
   Zhao, X
TI Interfaces to control cell-biomaterial adhesive interactions
SO POLYMERS FOR REGENERATIVE MEDICINE
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE cell adhesion; collagen; fibronectin; focal adhesions; integrins
ID SELF-ASSEMBLED MONOLAYERS; CALVARIAL OSTEOBLAST DIFFERENTIATION; ACUTE
   INFLAMMATORY RESPONSES; INTEGRINS MEDIATE ADHESION;
   EXTRACELLULAR-MATRIX; SURFACE-CHEMISTRY; PROTEIN ADSORPTION; FIBRONECTIN
   CONFORMATION; MOLECULAR SIMULATION; SIGNALING PATHWAYS
AB Cell adhesion to adsorbed proteins and adhesive sequences engineered on surfaces is crucial to cellular and host responses to implanted devices, biological integration of biomaterials and tissue-engineered constructs, and the performance of biosensors, cell-based arrays, and biotechnological cell-culture supports. This review focuses on interfaces controlling cell-adhesive interactions, with particular emphasis on surfaces controlling protein adsorption, biomimetic substrates presenting bioadhesive motifs, and micropatterned surfaces to engineer adhesive areas. These approaches represent promising strategies to engineer cell-material biomolecular interactions in order to elicit specific cellular responses and enhance the biological performance of materials in biomedical and biotechnological applications.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu; andres.garcia@me.gatech.edu
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Capadona JR, 2005, ADV MATER, V17, P2604, DOI 10.1002/adma.200500959
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Holland NB, 1998, NATURE, V392, P799
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867
   Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Merrill E.W., 1992, GLYCOL CHEM BIOTECHN, P199
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169
   SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
NR 101
TC 38
Z9 38
U1 3
U2 51
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-33353-3
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2006
BP 171
EP 190
DI 10.1007/12_071
D2 10.1007/11604228
PG 20
WC Polymer Science
SC Polymer Science
GA BFJ92
UT WOS:000242423000005
DA 2018-10-20
ER

PT S
AU Grant, J
   Allen, C
AF Grant, J.
   Allen, C.
BE Marchessault, RH
   Ravenelle, F
   Zhu, XX
TI Chitosan as a biomaterial for preparation of depot-based delivery
   systems
SO POLYSACCHARIDES FOR DRUG DELIVERY AND PHARMACEUTICAL APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Polysaccharides for Drug Delivery and Pharmaceutical
   Applications held at the 228th ACS National Meeting
CY AUG 22-26, 2004
CL Philadelphia, PA
SP Amer Chem Soc, Div Cellulose & Renewable Mat
ID MUCOSAL DRUG-DELIVERY; IN-VIVO BIOCOMPATIBILITY; PHYSICAL-PROPERTIES;
   CONTROLLED-RELEASE; DEGRADATION RATES; POLYMER BLENDS; PH SENSITIVITY;
   FILMS; CHITIN; VITRO
AB Chitosan is a natural polysaccharide that has become established as a material with great potential for use in biomedical applications. In addition, the recent success of many polymeric depot delivery systems has encouraged further research to identify new materials and develop new systems for use in regional therapy. Several strategies have been developed for preparation of stable chitosan-based depot systems for drug delivery. Chitosan can be physically or chemically crosslinked to prepare microspheres, films and gels. Chitosan has also been blended with a wide range of polymers to produce mostly two-phase systems, which have unique properties that are required for specific applications. These stable chitosan-based depot systems have been investigated for treatment of various diseases including cancer and bacterial infection. This review includes a summary of the favorable chemical, physical and biological properties of chitosan. In addition, the properties of an ideal depot system for use in drug delivery are outlined. Overall, it is hoped that the reader gains an appreciation for the use of chitosan-based systems for the regional or localized delivery of drugs. (c) 2006 American Chemical Society
C1 Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada.
RP Grant, J (reprint author), Univ Toronto, Dept Pharmaceut Sci, 100 Coll St, Toronto, ON M5S 2S2, Canada.
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Aimin C, 1999, Clin Orthop Relat Res, P239, DOI 10.1097/00003086-199909000-00031
   ALLEN LV, 2005, ANSELS PHARM DOSAGE, P738
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   BLAIR HS, 1987, J APPL POLYM SCI, V33, P641, DOI 10.1002/app.1987.070330226
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   Brown CD, 2001, J CONTROL RELEASE, V72, P35, DOI 10.1016/S0168-3659(01)00260-7
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Cao SG, 1998, POLYM BULL, V41, P553, DOI 10.1007/s002890050401
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chaubal M., 2002, DRUG DELIV TECHNOL, V2, P34
   Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cheung MK, 2002, J APPL POLYM SCI, V86, P1253, DOI 10.1002/app.11091
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Dhanikula Anand Babu, 2004, AAPS J, V6, pe27
   Dufresne A, 1999, POLYMER, V40, P1657, DOI 10.1016/S0032-3861(98)00335-8
   ERRINGTON N, 1993, INT J BIOL MACROMOL, V15, P113, DOI 10.1016/0141-8130(93)90008-A
   Fang L, 2000, J APPL POLYM SCI, V76, P1785, DOI 10.1002/(SICI)1097-4628(20000620)76:12<1785::AID-APP8>3.0.CO;2-B
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   FRIEDLAND D, 1993, J NATL CANCER I, V85, P2036, DOI 10.1093/jnci/85.24.2036
   Fulzele SV, 2003, EUR J PHARM SCI, V20, P53, DOI 10.1016/S0928-0987(03)00168-4
   Genta I, 1999, EXS, V87, P305
   GRANT J, 2005, IN PRESS J PHARM SCI
   GRANT J, 2005, UNPUB J APPL POLYM S
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Hedley ML, 2003, EXPERT OPIN BIOL TH, V3, P903, DOI 10.1517/eobt.3.6.903.21268
   Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   HO E, 2005, IN PRESS J CONTROL R
   Honma T, 2003, POLYM INT, V52, P1839, DOI 10.1002/pi.1380
   Hui A, 1997, ARTHRITIS RHEUM, V40, P1073, DOI 10.1002/art.1780400612
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jackson JK, 2000, CANCER RES, V60, P4146
   Jaworska M, 2003, POLYM INT, V52, P198, DOI 10.1002/pi.1159
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Jones DS, 1997, INT J PHARM, V151, P223, DOI 10.1016/S0378-5173(97)04904-1
   Jones DS, 1997, PHARMACEUT RES, V14, P450, DOI 10.1023/A:1012091231023
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Khoo CGL, 2003, EUR J PHARM BIOPHARM, V55, P47, DOI 10.1016/S0939-6411(02)00155-8
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumbar SG, 2003, J APPL POLYM SCI, V87, P1525, DOI 10.1002/app.11552
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lacevic Amela, 2004, Bosn J Basic Med Sci, V4, P73
   LANGER R, 1983, PHARMACOL THERAPEUT, V21, P35, DOI 10.1016/0163-7258(83)90066-9
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Liu CH, 2004, J APPL POLYM SCI, V92, P559, DOI 10.1002/app.20040
   Liu YH, 2003, J APPL POLYM SCI, V89, P2283, DOI 10.1002/app.12102
   Macleod GS, 1999, J CONTROL RELEASE, V58, P303, DOI 10.1016/S0168-3659(98)00168-0
   Messer T, 2002, PSYCHOPHARMAKOTHERAP, V9, P133
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.3.CO;2-P
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Miller ML, 2001, CHEM REC, V1, P195, DOI 10.1002/tcr.1008
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Muzzarelli R. A. A., 1995, ADV CHITIN SCI, P448
   Muzzarelli R.A.A., 2000, CHITOSAN PER OS DIET
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Needleman IG, 1997, J CLIN PERIODONTOL, V24, P394, DOI 10.1111/j.1600-051X.1997.tb00203.x
   Needleman IG, 1998, J CLIN PERIODONTOL, V25, P74, DOI 10.1111/j.1600-051X.1998.tb02366.x
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   Oztop HN, 2002, APPL BIOCHEM BIOTECH, V101, P239, DOI 10.1385/ABAB:101:3:239
   Peppas L. B, 1997, POLYM CONTROLLED DRU, V4, P34
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Perugini P, 2003, INT J PHARM, V252, P1, DOI 10.1016/S0378-5173(02)00602-6
   Qu X, 1999, J APPL POLYM SCI, V74, P3193, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3193::AID-APP23>3.0.CO;2-V
   Rao SB, 1995, J BIOMATER APPL, V10, P136, DOI 10.1177/088532829501000204
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratto JA, 1996, J APPL POLYM SCI, V59, P1451, DOI 10.1002/(SICI)1097-4628(19960228)59:9<1451::AID-APP13>3.0.CO;2-1
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Sampath, 1998, Cancer Control, V5, P130
   Sanford P.A., 1990, AM CHEM SOC DIV POLY, V31, P628
   Sato M, 2004, J APPL POLYM SCI, V93, P1616, DOI 10.1002/app.20610
   SCREENIVASAN K, 1996, POLYM DEGRAD STABIL, V52, P85
   Shu X, 2000, INT J PHARM, V201, P51, DOI 10.1016/S0378-5173(00)00403-8
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Skaugrud O., 1991, DRUG COSMET IND, V148, P24
   SKJKBRK G, 1989, CHITIN CHITOSAN SOUR, P835
   SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Suyatma NE, 2004, J POLYM ENVIRON, V12, P1, DOI 10.1023/B:JOOE.0000003121.12800.4e
   Tirkistani FAA, 1998, POLYM DEGRAD STABIL, V61, P161, DOI 10.1016/S0141-3910(97)00145-6
   Toffey A, 1996, J APPL POLYM SCI, V60, P75, DOI 10.1002/(SICI)1097-4628(19960404)60:1<75::AID-APP9>3.0.CO;2-S
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013
   Yusof NLBM, 2003, J BIOMED MATER RES A, V66A, P224, DOI 10.1002/jbm.a.10545
   Zhang H, 2004, BIOMACROMOLECULES, V5, P2461, DOI 10.1021/bm0496211
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   ZHAO WW, 1995, J MACROMOL SCI PHYS, VB34, P231, DOI 10.1080/00222349508215531
NR 100
TC 7
Z9 7
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3960-6
J9 ACS SYM SER
PY 2006
VL 934
BP 201
EP 225
PG 25
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA BEW10
UT WOS:000239744300010
DA 2018-10-20
ER

PT S
AU Knight, DK
   Shapka, SN
   Amsden, BG
AF Knight, Darryl K.
   Shapka, Stephen N.
   Amsden, Brian G.
BE Marchessault, RH
   Ravenelle, F
   Zhu, XX
TI Characterization of glycol chitosan: A potential material for use in
   biomedical and pharmaceutical applications
SO POLYSACCHARIDES FOR DRUG DELIVERY AND PHARMACEUTICAL APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Polysaccharides for Drug Delivery and Pharmaceutical
   Applications held at the 228th ACS National Meeting
CY AUG 22-26, 2004
CL Philadelphia, PA
SP Amer Chem Soc, Div Cellulose & Renewable Mat
ID BIOLOGICAL-PROPERTIES; PHOTOCROSSLINKABLE CHITOSAN; MOLECULAR-WEIGHT;
   TERTIARY-AMINES; CHITIN; WATER; DEACETYLATION; SPECTROSCOPY;
   ACETYLATION; MICROSPHERES
AB Glycol chitosan, a water soluble chitosan derivative being proposed as a material for pharmaceutical and biomedical engineering applications, was modified to further promote its use in vivo. Initial characterization of the glycol chitosan with H-1 NMR spectroscopy illustrated the presence of both secondary and tertiary amine groups. Fractionation of glycol chitosan with nitrous acid resulted in a significant reduction in the number average molecular weight, specifically, from 210 to approximately 7-8 kDa. However, the structural integrity of the glycol chitosan was lost following fractionation, as the secondary amine groups were converted to N-nitrosamines, which are potentially carcinogenic. An increase in the pH of the reaction limited their formation, but not entirely; therefore, a second approach to reducing the molecular weight was sought. The free radical degradation, initiated with potassium persulfate, was not as effective at reducing the molecular weight, which ranged from 17 to 20 kDa post fractionation, but did retain the structural integrity of the glycol chitosan. (c) 2006 American Chemical Society
C1 Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Amsden, BG (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM amsden@chee.queensu.ca
RI Knight, Darryl/A-7949-2013
CR ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   AMLETTE WG, 1986, CHITIN NATURE TECHNO, P435
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Brugnerotto J, 2001, MACROMOL SYMP, V168, P1, DOI 10.1002/1521-3900(200103)168:1<1::AID-MASY1>3.0.CO;2-W
   CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chellat F, 2000, J BIOMED MATER RES, V53, P592, DOI 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   DIGENIS GA, 1979, BIOORG CHEM, V8, P97, DOI 10.1016/0045-2068(79)90041-5
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hsu SC, 2002, POLYM DEGRAD STABIL, V75, P73, DOI 10.1016/S0141-3910(01)00205-1
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   LEDUNG P, 1994, CARBOHYD POLYM, V24, P209, DOI 10.1016/0144-8617(94)90132-5
   LIJINSKY W, 1972, J NATL CANCER I, V49, P1239
   LOEPPKY RN, 1983, J ORG CHEM, V48, P2751
   Muzzarelli RAA, 1977, CHITIN, P5
   NORDTVEIT RJ, 1994, CARBOHYD POLYM, V23, P253, DOI 10.1016/0144-8617(94)90187-2
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   SMITH PAS, 1967, J AM CHEM SOC, V89, P1147, DOI 10.1021/ja00981a021
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   WADE LG, 1987, ORGANIC CHEM, P910
   Wang W, 2001, LANGMUIR, V17, P631, DOI 10.1021/la001078w
   WILLIAMS DLH, 1983, ADV PHYS ORG CHEM, V19, P381, DOI 10.1016/S0065-3160(08)60225-7
NR 32
TC 5
Z9 5
U1 3
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3960-6
J9 ACS SYM SER
PY 2006
VL 934
BP 227
EP 242
PG 16
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA BEW10
UT WOS:000239744300011
DA 2018-10-20
ER

PT B
AU Ionita, M
   Silvestri, D
   Gautieri, A
   Votta, E
   Ciardelli, G
   Redaelli, A
AF Ionita, Mariana
   Silvestri, Davide
   Gautieri, Alfonso
   Votta, Emiliano
   Ciardelli, Glanluca
   Redaelli, Alberto
GP ASME
TI Molecular modelling of small molecule diffusion in biopolymer blends
   membranes for biomedical applications
SO Proceedings of the 8th Biennial Conference on Engineering Systems Design
   and Analysis, Vol 2
LA English
DT Proceedings Paper
CT 8th Biennial Conference on Engineering Systems Design and Analysis
CY JUL 04-07, 2006
CL Turin, ITALY
SP ASME
ID BIOARTIFICIAL POLYMERIC MATERIALS; DYNAMICS SIMULATION; POLYIMIDE
AB In order to improve the biological performance of synthetic polymers and to enhance the mechanical characteristics by tailoring the permeability properties of biopolymers, a new class of specifically designed materials (bioartificial polymeric materials), consisting of blends of synthetic polymers and biopolymers, has been recently introduced. In this work we present a computational method based on molecular mechanics (MM) and dynamics (MD) techniques, to investigate their permeability to small molecules. The permeability properties was assessed of poly(vinyl alcohol)-(PVA)- dextran-(Dex) and poly(acrylic acid)-(PAA)Dex membranes with different blend composition. Amorphous bulk models of PVA-Dex and PAA-Dex mixtures with 80:20, 60:40, 40:60 (w/w) ratios were generated. Two steps have been performed iteratively, the former using a MM simulation for equilibration and the latter using MD simulations for model refinement. Virtual uniaxial traction tests were performed, adopting the Second Derivative (SD) procedure, in order to assess the mechanical behavior of the bulk models. The diffusion coefficients for H2O were determined via NVT molecular dynamics simulations. Using the data of the motion of water inside the bulk models, the diffusivity constant was calculated applying the Einstein equation. Correlation of diffusion coefficients with free volume, was found. The results of the simulations agree with theoretical considerations: as the content of dextran increases from 80:20 to 40:60 a 86% decrease of the diffusion constant is obtained and the values (range 0.14-56.5 10(-6) cm(2)s(-1)) have the order of magnitude expected, and similar on the diffusion of small molecules in amorphous polymeric membranes.
C1 Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
RP Ionita, M (reprint author), Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
RI redaelli, alberto/K-3137-2018; Ionita, Mariana/C-5664-2012; Gautieri,
   Alfonso/L-7500-2015
OI redaelli, alberto/0000-0002-9020-2188; Gautieri,
   Alfonso/0000-0003-0492-0130
CR BARADWAJ RK, 1999, POLYMER, V40, P4229
   Cascone MG, 1997, J APPL POLYM SCI, V66, P2089, DOI 10.1002/(SICI)1097-4628(19971219)66:11<2089::AID-APP4>3.0.CO;2-D
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   Cristallini C, 2001, MACROMOL CHEM PHYSIC, V202, P2104, DOI 10.1002/1521-3935(20010601)202:10<2104::AID-MACP2104>3.0.CO;2-H
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   Giusti P., 1996, POLYM MAT ENCY, P538
   GREENBERG AR, 1978, J BIOMED MATER RES, V12, P929, DOI 10.1002/jbm.820120612
   Greenfield ML, 1998, MACROMOLECULES, V31, P7068, DOI 10.1021/ma980750h
   Heuchel M, 2002, DESALINATION, V144, P67, DOI 10.1016/S0011-9164(02)00290-4
   Hofmann D, 1996, POLYMER, V37, P4773, DOI 10.1016/S0032-3861(96)00327-8
   Hofmann D, 2000, MACROMOL THEOR SIMUL, V9, P293, DOI 10.1002/1521-3919(20000701)9:6<293::AID-MATS293>3.0.CO;2-1
   Pavel D, 2003, POLYMER, V44, P6713, DOI 10.1016/j.polymer.2003.08.016
   TAKEUCHI H, 1990, J CHEM PHYS, V93, P2062, DOI 10.1063/1.459083
   THEODOROU DN, 1986, MACROMOLECULES, V19, P139, DOI 10.1021/ma00155a022
NR 14
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4249-2
PY 2006
BP 579
EP 586
PG 8
WC Engineering, Biomedical; Engineering, Industrial; Engineering,
   Manufacturing; Engineering, Mechanical
SC Engineering
GA BGP36
UT WOS:000249558100071
DA 2018-10-20
ER

PT B
AU Samyuktha, R
AF Samyuktha, R.
BE Khoo, C
   Singh, D
   Chaudhry, AS
TI Nutraceuticals gateway: A value-added electronic information service
SO Proceedings of the Asia-Pacific Conference on Library & Information
   Education & Practice 2006: PREPARING INFORMATION PROFESSIONALS FOR
   LEADERSHIP IN THE NEW AGE
LA English
DT Proceedings Paper
CT Asia-Pacific Conference on Library and Information Education and
   Practice
CY APR 03-06, 2006
CL Singapore, SINGAPORE
SP Nanyang Technol Univ, Div Informat, Sch Commun & Informat
AB The attributes of education in a digital neighborhood have warranted a community of teachers on one end with shared curriculum and teaching materials and another community of students with distance and distributed learning on the other end. There is a different kind of ecology emerging and the library professionals have the opportunity to create a world without borders, making everything available to everyone anytime, anywhere. Roles of libraries have changed from being traditional to exist as hybrid or electronic libraries. In turn, the Library and Information Science (LIS) professionals have become intelligent filters of information and contribute to the libraries to emerge as 'Knowledge Resource Centers'. Creating successful e-information services for its demanding clientele has become their major challenge. One such case study of e-information services provided by the Science Campus (Guindy Campus) Library of University of Madras is focused in this paper. The Campus Library caters to the research community of Schools of Life, Physical, Chemical, Earth Sciences and an array of researchers (members) from industries. Periodic discussions with experts, faculty and research scholars have necessitated the Library to enhance research with Information Gateways on specific themes. Subject Gateways on Biomedical Sciences, Life, Chemical, Physical and Interdisciplinary Sciences are compiled periodically and made available on the intranet in turn making its clientele access the sources on the internet from their desktop. They not only supplement research but also new popular courses introduced, thrust of the University programs and so on. The Gateway focused here is "Nutraceuticals" which is a component of the Gateways on "Biomedical Sciences". The methodology of information aggregation from the Internet, evaluating their validity and organizing them for access, the strategies used to market the e-service, such as organizing user education and information literacy programs are discussed. Methods of evaluation of the service provided are analysed to improve the same. The challenges of the career to develop essential skills to combat technology have compelled the professionals at the Library to get trained and update their technical expertise. Thus the Library tries to support the evolutionary convergence of Library Services, Technology and the Clientele.
C1 Univ Madras, Madras 600025, Tamil Nadu, India.
CR DEEGAN M, 2002, DIGITAL FUTURES STRA, P162
   MACLEOD RA, 2000, INTERNET RESOURCES
   Nisonger T. E, 2003, EVALUATION LIB COLLE
   Ronan Jana Smith, 2003, CHAT REFERENCE GUIDE
   SHUMAN BA, 2001, ISSUES LIB INFORM SC, P145
   WALKER G, 1999, ONLINE RETRIEVAL DIA
NR 6
TC 0
Z9 0
U1 0
U2 3
PU NANYANG TECHNOLOGICAL UNIV
PI SINGAPORE
PA NANYANG AVENUE, SINGAPORE 639815, SINGAPORE
PY 2006
BP 168
EP 171
PG 4
WC Information Science & Library Science
SC Information Science & Library Science
GA BFO46
UT WOS:000243425500025
DA 2018-10-20
ER

PT S
AU Maguire, PD
   Okpalugo, TIT
   Ahmad, I
AF Maguire, P. D.
   Okpalugo, T. I. T.
   Ahmad, I.
BE Uskokovic, DP
   Milonjic, SK
   Rakovic, DI
TI Plasma coating and surface modification of amorphous carbon for
   biomedical applications
SO RECENT DEVELOPMENTS IN ADVANCED MATERIALS AND PROCESSES
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 7th Conference of the Yugoslav-Materials-Research-Society (Yu-MRS)
CY SEP 12-16, 2005
CL Herceg Novi, SERBIA MONTENEG
SP Yugoslav Mat Res Soc
DE amorphous carbon; interfacial layers; medical devices; plasma coating;
   Raman spectroscopy
ID DLC THIN-FILMS; NANOMECHANICAL PROPERTIES; SI INCORPORATION; SUBSTRATE
   BIAS; RAMAN-SPECTRA; NITROGEN; MICROSTRUCTURE; DEPOSITION
AB Amorphous carbon coatings for implantable medical devices require high mechanical strength, adhesion and uniform biocompatibility response across the devices. Investigation of a-C:H properties and structure variation with thickness and substrate material provides valuable insight into requirements for device coating. A number of devices are coated and the effect of interfacial layers, film doping and the spatial variation in quality is investigated.
C1 Univ Ulster, Nanotechnol Res Inst, Belfast BT37 0QB, Antrim, North Ireland.
   Univ Ulster, N Ireland Bioengn Ctr, Belfast BT37 0QB, Antrim, North Ireland.
RP Maguire, PD (reprint author), Univ Ulster, Nanotechnol Res Inst, Belfast BT37 0QB, Antrim, North Ireland.
EM pd.maguire@ulster.ac.uk
RI MAGUIRE, Paul/D-1568-2009
OI MAGUIRE, PAUL/0000-0002-2725-4647
CR Ahmad I, 2005, THIN SOLID FILMS, V482, P45, DOI 10.1016/j.tsf.2004.11.158
   Ball M, 2004, J BIOMED MATER RES A, V70A, P380, DOI 10.1002/jbm.a.30066
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Magill DP, 2001, J VAC SCI TECHNOL A, V19, P2456, DOI 10.1116/1.1387078
   McCann R, 2005, DIAM RELAT MATER, V14, P1057, DOI 10.1016/j.diamond.2005.01.032
   McLaughlin J, 2000, INT J MOD PHYS B, V14, P167, DOI 10.1142/S0217979200000169
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Ogwu AA, 1999, J PHYS D APPL PHYS, V32, P981, DOI 10.1088/0022-3727/32/9/306
   Okpalugo T.I.T., 2001, TECHNOL HEALTH CARE, V9, P81
   Okpalugo TIT, 2004, DIAM RELAT MATER, V13, P1088, DOI 10.1016/j.diamond.2003.10.064
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Papakonstantinou P, 2002, DIAM RELAT MATER, V11, P1074, DOI 10.1016/S0925-9635(01)00656-2
   Papakonstantinou P, 2001, J PHYS-CONDENS MAT, V13, P2971, DOI 10.1088/0953-8984/13/13/311
   Wu WJ, 1997, THIN SOLID FILMS, V307, P1, DOI 10.1016/S0040-6090(97)00251-4
   Zhao JF, 2000, J PHYS-CONDENS MAT, V12, P9201, DOI 10.1088/0953-8984/12/44/302
   Zhao JF, 2001, DIAM RELAT MATER, V10, P1070, DOI 10.1016/S0925-9635(00)00544-6
   6638569
   2338716
NR 18
TC 5
Z9 5
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2006
VL 518
BP 477
EP 484
DI 10.4028/www.scientific.net/MSF.518.477
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BES77
UT WOS:000239351800078
DA 2018-10-20
ER

PT S
AU Santulli, C
   Finn, TJ
   Seidel, R
   Jeronimidis, G
AF Santulli, C.
   Finn, T. J.
   Seidel, R.
   Jeronimidis, G.
BE Tomasini, EP
TI Scanning LDV for vibration measurement of filiform hairs in crickets in
   response to induced airflow
SO SEVENTH INTERNATIONAL CONFERENCE ON VIBRATION MEASUREMENTS BY LASER
   TECHNIQUES: ADVANCES AND APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 7th International Conference on Vibration Measurements by Laser
   Techniques
CY JUN 19-22, 2006
CL Ancona, ITALY
SP Italian Assoc Laser Velcimetry & Non Invas Diagnost, Univ Politecn March Dipt Meccan
DE biological sensors; airflow vibration; crickets; resonant modes
ID WIND-RECEPTOR HAIRS; GRYLLUS-BIMACULATUS; PERCEPTION
AB Cercal hairs represent in cricket a wind sensitive escape system, able to detect the airflow generated from predating species. These sensors have been studied as a biomimetic concept to allow the development of MEMS for biomedical use. In particular, the behaviour of the hairs, including airflow response, resonant frequency and damping, has been investigated up to a frequency of 20 kHz. The microscopic nature of the hairs, the complex vibrations of excited hairs and the high damping of the system suggested that the use of Laser Doppler vibrometry could possibly improve the test performance.
   Two types of tests were performed: in the first case the hairs were indirectly excited using the signal obtained from a vibrating aluminium plate, whilst in the second case the hairs were directly excited using a white noise chirp. The results from the first experiment indicated that the hairs move in-phase with the exciting signal up to frequencies in the order of 10 kHz, responding to the vibration modes of the plate with a signal attenuation of 12 to 20 dB. The chirp experiment revealed the presence of rotational resonant modes at 6850 and 11300 Hz. No clear effect of hair length was perceivable on the vibration response of the filiform sensors.
   The obtained results proved promising to support the mechanical and vibration characterisation of the hairs and suggest that scanning Laser vibrometry can be used extensively on highly dampened biological materials.
C1 [Santulli, C.; Finn, T. J.; Seidel, R.; Jeronimidis, G.] Univ Reading, Ctr Biomimet, Reading RG6 6AY, Berks, England.
RP Santulli, C (reprint author), Univ Reading, Ctr Biomimet, Reading RG6 6AY, Berks, England.
FU Future and Emergent Technologies arm of the IST Programme of the EU
   [EU-IST-2001-34718]
FX This work has been carried out under the CICADA Project, funded by the
   Future and Emergent Technologies arm of the IST Programme of the EU (n.
   EU-IST-2001-34718).
CR Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347
   Dangles O, 2006, J EXP BIOL, V209, P393, DOI 10.1242/jeb.02000
   Derby CD, 2001, BIOL BULL, V200, P211, DOI 10.2307/1543318
   EDWARDS JS, 1974, PROC R SOC SER B-BIO, V185, P83, DOI 10.1098/rspb.1974.0007
   HUMPHREY JAC, 1993, PHILOS T ROY SOC B, V340, P423, DOI 10.1098/rstb.1993.0083
   Krijnen GJM, 2006, NANOTECHNOLOGY, V17, pS84, DOI 10.1088/0957-4484/17/4/013
   Kumagai T, 1998, J COMP PHYSIOL A, V183, P7, DOI 10.1007/s003590050230
   Shimozawa T, 1998, J COMP PHYSIOL A, V183, P171, DOI 10.1007/s003590050245
   TAUBER E, 1995, J EXP BIOL, V198, P1895
NR 9
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6421-X
J9 PROC SPIE
PY 2006
VL 6345
AR 63450E
DI 10.1117/12.693153
PG 10
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BEX17
UT WOS:000239926800014
DA 2018-10-20
ER

PT B
AU Wu, WJ
   Lee, BS
   Lin, SW
   Shih, WP
AF Wu, Wen Jong
   Lee, Bor Shiun
   Lin, Sheng Wen
   Shih, Wen Pin
BE Bernadou, M
   Cagnol, J
   Ohayon, R
TI Power harvesting from vibrations using a piezoelectric MEMS generator
SO SIXTEENTH INTERNATIONAL CONFERENCE ON ADAPTIVE STRUCTURES AND
   TECHNOLOGIES
LA English
DT Proceedings Paper
CT 16th International Conference on Adaptive Structures and Technologies
CY OCT 09-12, 2005
CL Paris, FRANCE
AB Over the years, there has been a growing interest in the field of power harvesting technologies for low-power electronic devices such as wireless sensor networks and biomedical sensor applications. Of all possible energy sources, the mechanical vibrations have been considered a potential choice for power harvesting in a wide variety of applications. This paper presents the development of a piezoelectric MEMS generator which has the ability to scavenge mechanical energy of ambient vibrations from their surroundings and transform it into electrical energy that can be used in sensor applications. The piezoelectric MEMS generator comprises a beam Structure with laminated lead zirconate titanate (Pb(Zr,Ti)O-3, PZT) material sandwiched between the upper and the lower electrodes to transform mechanical strain energy into electrical charge. A proof mass is built at the end of the beam to adjust the structure resonant frequency of the piezoelectric MEMS generator for most adaptable to the ambient vibration of their Surroundings. To improve the piezoelectric MEMS generator fabrication process, a self-made PZT deposition chamber which could deposit PZT thin film up to tens micron in minutes was used to deposit the piezoelectric layer on the beam structure of the piezoelectric MEMS generator. A feasibility Study of the piezoelectric MEMS generator is performed and the some test results wilt also be presented.
C1 [Wu, Wen Jong; Lee, Bor Shiun] Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10764, Taiwan.
RP Wu, WJ (reprint author), Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10764, Taiwan.
RI Wu, Wen-Jong/C-4246-2013
OI Wu, Wen-Jong/0000-0003-0223-249X
CR AMIRTHARAJAH R, 1999, THESIS MIT
   JEON YB, 2003, CIRP SEM MICR NAN TE
   RAO SS, 1995, MECH VIBRATIONS, P22
   Roundy S, 2004, SMART MATER STRUCT, V13, P1131, DOI 10.1088/0964-1726/13/5/018
   Roundy S, 2004, ENERGY SCAVENGING WI
   Roundy S., 2003, IEEE INT S LOW POW E
   Sodano H. A., 2004, Shock and Vibration Digest, V36, P197, DOI 10.1177/0583102404043275
   Williams CB, 1996, SENSOR ACTUAT A-PHYS, V52, P8, DOI 10.1016/0924-4247(96)80118-X
NR 8
TC 0
Z9 0
U1 0
U2 0
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-932078-57-2
PY 2006
BP 391
EP 400
PG 10
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary;
   Physics, Applied
SC Engineering; Materials Science; Physics
GA BHI02
UT WOS:000253372400048
DA 2018-10-20
ER

PT S
AU Brady, S
   Coyle, S
   Wu, YZ
   Wallace, G
   Diamond, D
AF Brady, Sarah
   Coyle, Shirley
   Wu, Yanzhe
   Wallace, Gordon
   Diamond, Dermot
BE Tao, X
   Troster, G
   Diamond, D
TI Wireless-based monitoring of body movements using wearable sensors
SO Smart Nanotextiles
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Smart Nanotextiles held at the 2006 MRS Spring Meeting
CY APR 18-19, 2006
CL San Francisco, CA
SP Mat Res Soc
ID DEVICES
AB The world is becoming more health conscious and as a result healthcare is evolving in many ways. Wearable computing is assisting with this evolution, finding its place in many biomedical applications where real-time monitoring of general health indicators is required. However, the inconvenience of connecting sensors through-wires, which not only incurs high maintenance, limits the freedom of the person therefore hampering a true reflection of the person's actions. By using sensors attached to wireless sensor nodes, this constraint is removed. Also in order to be "wearable" the sensors must be comfortable, a factor often overlooked by traditional sensors, where functionality and robustness are of higher importance. This work is focused on the use of foam-based pressure sensors and similar textile-based sensors for monitoring the ambulatory movements of the wearer. Characterization of the molecular nature of the materials and their environment are presented. We find these sensors to be successful in detecting the movement events without imposing on the daily activity of the wearer.
C1 Dublin City Univ, Sch Chem Sci, Adapt Informat Cluster, Natl Ctr Sensor Res, Dublin 9, Ireland.
RP Brady, S (reprint author), Dublin City Univ, Sch Chem Sci, Adapt Informat Cluster, Natl Ctr Sensor Res, Dublin 9, Ireland.
OI Wallace, Gordon/0000-0002-0381-7273
CR ADRIAN M, 1995, BIOMECHANICS HUMAN M
   BONATO P, 2005, J NEUROENG REHABIL, V2, P2, DOI DOI 10.1186/1743-0003-2-2
   Brady S, 2005, SYNTHETIC MET, V154, P25, DOI 10.1016/j.synthmet.2005.07.008
   Brady S, 2005, SENSOR ACTUAT A-PHYS, V119, P398, DOI 10.1016/j.sna.2004.10.020
   BRADY S, 2006, BOD SENS NETW 2006 B
   Carpi F, 2005, IEEE T INF TECHNOL B, V9, P295, DOI 10.1109/TITb.2005.854514
   Dunne L. E., 2005, J NEUROENG REHABIL, V2, P4, DOI DOI 10.1186/1743-0003-2-4
   DUNNE LE, 2005, P 2 INT FOR APPL WEA
   Lukowicz P., 2002, P 6 INT S WEAR COMP
   Malinauskas A, 2001, POLYMER, V42, P3957, DOI 10.1016/S0032-3861(00)00800-4
   Wallace G G, 2003, CONDUCTIVE ELECTROAC
   YANG G.-Z, 2006, BODY SENSOR NETWORKS
NR 12
TC 5
Z9 5
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
J9 MATER RES SOC SYMP P
PY 2006
VL 920
BP 85
EP 90
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Textiles
SC Science & Technology - Other Topics; Materials Science
GA BFJ22
UT WOS:000242304000012
DA 2018-10-20
ER

PT S
AU Cheng, XY
   Tsang, HYJ
   Li, Y
   Leung, MY
   Tao, XM
   Cheng, XX
   Xue, P
   Yuen, CWM
AF Cheng, X. Y.
   Tsang, H. Y. J.
   Li, Y.
   Leung, M. Y.
   Tao, X. M.
   Cheng, X. X.
   Xue, P.
   Yuen, C. W. M.
BE Tao, X
   Troster, G
   Diamond, D
TI Polypyrrole-coated large deformation strain fabric sensor and its
   properties study
SO Smart Nanotextiles
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Smart Nanotextiles held at the 2006 MRS Spring Meeting
CY APR 18-19, 2006
CL San Francisco, CA
SP Mat Res Soc
ID ELECTROMECHANICAL ACTUATORS; CONDUCTIVE POLYPYRROLE; POLYESTER FABRICS;
   COMPOSITE; POLYMERS
AB Conductive-polymer coated fabrics have been investigated as intelligent materials in the past years. In this paper, a flexible fabric strain sensor coated with polypyrrole is reported, which is featured with high sensitivity, good stability and large deformation. It is fabricated by chemical vapor deposition at low temperature. The effects of temperature, humidity, acid and alkaline medium have been assessed. The conductivity-strain tests reveal the sensor exhibits a high strain sensitivity of -160 for a deformation as large as 50%, while its good stability is indicated by a small loss of conductivity after the thermal and humidity aging tests, and supported by the slight change in conductivity and sensitivity over a storage of eighteen months. The acid and alkaline solution mainly decreased their initial conductivity but have the slight effect to their sensitivity. The flexible fabric strain sensor is expected to be a promising "soft'.' smart material in the smart garment, wearable hardware and biomedical applications.
C1 Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon 00852, Hong Kong, Peoples R China.
RP Cheng, XY (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon 00852, Hong Kong, Peoples R China.
RI Tao, XiaoMing/A-9992-2010
OI Tao, XiaoMing/0000-0002-2406-0695
CR Jiang XP, 2002, J BIOMED MATER RES, V62, P507, DOI 10.1002/jbm.10240
   Jin G, 2004, CURR APPL PHYS, V4, P366, DOI 10.1016/j.cap.2003.11.050
   Kim HA, 2003, MOL CRYST LIQ CRYST, V405, P161, DOI 10.1080/15421400390263550
   Kim HK, 2002, MOL CRYST LIQ CRYST, V377, P369, DOI 10.1080/10587250290089301
   Kim SH, 2003, J APPL POLYM SCI, V87, P1969, DOI 10.1002/app.11566
   KUHN HH, 1995, SYNTHETIC MET, V71, P2139, DOI 10.1016/0379-6779(94)03198-F
   Lee CY, 2002, POLYM ADVAN TECHNOL, V13, P577, DOI 10.1002/pat.227
   Oh KW, 2003, J APPL POLYM SCI, V88, P1225, DOI 10.1002/app.11783
   Otero TF, 2003, ADV MATER, V15, P279, DOI 10.1002/adma.200390066
   Rossi DD, 1999, MAT SCI ENG C-BIO S, V7, P31
   Scilingo EP, 2003, IEEE SENS J, V3, P460, DOI 10.1109/JSEN.2003.815771
   Spinks GM, 2004, SYNTHETIC MET, V140, P273, DOI 10.1016/S0379-6779(03)00365-5
   Spinks GM, 2003, MACROMOL SYMP, V192, P161, DOI 10.1002/masy.200390025
   Tessier D, 2000, J BIOMAT SCI-POLYM E, V11, P87, DOI 10.1163/156856200743517
   Wallace G G, 2003, CONDUCTIVE ELECTROAC
   Wang LX, 2001, REACT FUNCT POLYM, V47, P125, DOI 10.1016/S1381-5148(00)00079-1
NR 16
TC 2
Z9 2
U1 0
U2 3
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
J9 MATER RES SOC SYMP P
PY 2006
VL 920
BP 127
EP 133
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Textiles
SC Science & Technology - Other Topics; Materials Science
GA BFJ22
UT WOS:000242304000018
DA 2018-10-20
ER

PT S
AU Hooker, SA
AF Hooker, S. A.
BE Armstrong, WD
TI Characterizing reliability of multilayer PZT actuators
SO SMART STRUCTURES AND MATERIALS 2006: ACTIVE MATERIALS: BEHAVIOR AND
   MECHANICS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2006 Conference
CY FEB 27-MAR 02, 2006
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Intelligent Mat Forum, Jet Propuls Lab, Natl Sci Fdn
DE reliability; fatigue; accelerated testing; actuator; multilayer
   actuators; PZT-5A; soft PZT
ID CERAMICS
AB Many new applications are emerging for piezoelectric ceramics including adaptive structures, active-flow-control devices, and vibration and noise suppression systems. Additionally, there are opportunities to use these devices in the biomedical field for miniature pumps, ultrasonic surgical tools, micro-needle arrays, and nanorobotics. In each of these instances, actuator stability is critical, representing a significant challenge for piezoelectric ceramic materials. In particular, the properties of lead zirconate titanate (PZT) have been found to degrade, often significantly, during continuous operation due to a combination of domain pinning, relaxation of interfacial stress, and, in the worst cases, micro-crack formation. This degradation, referred to as actuator fatigue, can be even more pronounced when high voltages are used to achieve maximum displacement or more complex actuator designs are required. For example, multilayer actuators, such as co-fired stacks, are important for many emerging applications and are now being produced with very small physical dimensions, lowering power requirements. However, multilayer components may be highly susceptible to long-term fatigue due to the large number of interfaces involved in their configuration. In this work, we report a method for rapidly characterizing the reliability of multilayer PZT actuators by monitoring degradation in switching polarization over time. To verify this approach, a series of miniature (3 mm x 3 mm x 2 mm) multilayer actuators were characterized over I million cumulative cycles. These actuators were produced commercially from soft PZT materials, and the sintering temperature was varied to tailor the ceramic microstructure and performance characteristics. Evaluation of cyclic polarization degradation was found to be an effective method for illuminating differences among the different actuators tested, as well as serving to predict their long-term resistance to fatigue.
C1 Natl Inst Stand & Technol, Boulder, CO 80305 USA.
RP Hooker, SA (reprint author), Natl Inst Stand & Technol, 325 Broadway, Boulder, CO 80305 USA.
CR Dausch DE, 1997, J AM CERAM SOC, V80, P2355
   DAVIS CL, 2001, P SPIE, V4333
   KARASTAMATIS T, 2001, P SPIE, V4333
   Koh JH, 2004, SENSOR ACTUAT A-PHYS, V112, P232, DOI 10.1016/j.sna.2004.01.001
   Lucato SLDE, 2000, J AM CERAM SOC, V83, P424
   MISTLER RE, 1978, CERAMIC PROCESSING F, P414
   Randall CA, 1998, J AM CERAM SOC, V81, P677
   Reed JS, 1988, INTRO PRINCIPLES CER
   SHROUT TR, 1997, P SPIE, V3241
NR 9
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6223-3
J9 PROC SPIE
PY 2006
VL 6170
AR 61700F
DI 10.1117/12.658878
PG 6
WC Instruments & Instrumentation; Materials Science, Multidisciplinary;
   Materials Science, Characterization & Testing
SC Instruments & Instrumentation; Materials Science
GA BEO52
UT WOS:000238449400011
DA 2018-10-20
ER

PT S
AU Lee, BS
   He, JJ
   Wu, WJ
   Shih, WP
AF Lee, Bor-Shun
   He, Jyun-Jhang
   Wu, Wen-Jong
   Shih, Wen-Pin
BE Clark, WW
   Ahmadian, M
   Lumsdaine, A
TI MEMS generator of power harvesting by vibrations using piezoelectric
   cantilever beam with digitate electrode
SO SMART STRUCTURES AND MATERIALS 2006: DAMPING AND ISOLATION
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2006 Conference
CY FEB 27-MAR 02, 2006
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Intelligent Mat Forum, Jet Propuls Lab, Natl Sci Fdn
DE MEMS generator; PZT deposition; interdigital electrode
AB Over the years, there has been a growing interest in the field of power harvesting technologies for low-power electronic devices, such as wireless sensor networks and biomedical sensor applications. Of all possible energy C sources, the mechanical vibrations have been considered a potential choice for power harvesting in a wide variety of applications. This paper presents the development of a piezoelectric MEMS generator which has the ability to scavencre mechanical energy of ambient vibrations from their surroundings and transform it into electrical energy that can be used in energy storage applications. The piezoelectric MEMS generator comprises a beam structure based on the silicon wafer, and the digitate electrode placed in between the lead zirconate titanate (Pb(Zr,Ti)O-3, PZT) material and the beam structure, to transform mechanical strain energy into electrical charge with using the d(33) mode of PZT. An optional proof mass can be built at the tip of the beam, to adjust the structure resonant frequency of the piezoelectric MEMS generator. for most adaptable frequency matching to the ambient vibration of its surroundings. A theoretical model is also presented to investigate the relations between the charge generation ability and the design parameters of the piezoelectric MEMS generator. To improve the piezoelectric MEMS generator fabrication process, a self-made PZT deposition chamber which could deposit PZT thin film up to tens micron in minutes was used to deposit the piezoelectric layer on the beam structure of the piezoelectric MEMS generator.
C1 [Lee, Bor-Shun; He, Jyun-Jhang; Wu, Wen-Jong] Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10764, Taiwan.
   [Shih, Wen-Pin] Natl Taiwan Univ, Dept Engn Mech, Taipei 10764, Taiwan.
RP Lee, BS (reprint author), Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10764, Taiwan.
EM wjwu@ntu.edu
RI Wu, Wen-Jong/C-4246-2013
OI Wu, Wen-Jong/0000-0003-0223-249X; Shih, Wen-Pin/0000-0002-6855-5024
FU Ministry of Economics Affairs, Taiwan
FX The authors would like to thank X.Y. Wang at National Taiwan University
   for his collaboration and development of the PZT deposition machine. The
   authors gratefully acknowledge the funding support of Technology
   Development Program for Academic by Ministry of Economics Affairs,
   Taiwan.
CR AMIRTHARAJA R, 1999, THESIS MIT
   FENNER RT, 1986, ENG ELASTICITY, P179
   *IEEE, 1978, 176 IEEE
   JEON YB, 2003, CIRP SEM MICR NAN TE
   Roundy S., 2003, IEEE INT S LOW POW E
   Roundy Shad, ENERGY SCAVENGING WI
   Sodano H. A., 2004, Shock and Vibration Digest, V36, P197, DOI 10.1177/0583102404043275
   Williams CB, 1996, SENSOR ACTUAT A-PHYS, V52, P8, DOI 10.1016/0924-4247(96)80118-X
NR 8
TC 4
Z9 5
U1 1
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6222-5
J9 PROC SPIE
PY 2006
VL 6169
AR 61690B
DI 10.1117/12.658584
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEO51
UT WOS:000238446200007
DA 2018-10-20
ER

PT S
AU Zhang, L
   Yang, YW
AF Zhang, Lei
   Yang, Yaowen
BE BarCohen, Y
TI Modeling of ionic polymer-metal composite (IPMC) beam on human tissues
SO SMART STRUCTURES AND MATERIALS 2006: ELECTROACTIVE POLYMER ACTUATORS AND
   DEVICES (EAPAD)
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2006 Conference
CY FEB 27-MAR 02, 2006
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Intelligent Mat Forum, Jet Propuls Lab, Natl Sci Fdn
DE ionic polymer metal composites (IPMCs); actuators; beam; vibration;
   tissues
ID ACTUATION
AB In this paper, a dynamic model of simply supported ionic polymer-metal composite (IPMC) beam resting on human tissues is developed. The IPMC beam is actuated by an alternative electric potential. The bending moment due to electric potential is obtained by Nemat-Nasser's hybrid actuation model. Analytical solution of transverse vibration is obtained to describe the vibration response of IPMC beam to a command of electric potential. Pressure generated by IPMC beam on human tissue is estimated by numerical integration. Comparison shows that the generated pressure is comparable with experimental data from literature. The developed model is useful not only for the biomedical devices that employ IPMC materials but also for any other applications that utilize the vibration of IPMC materials.
C1 [Zhang, Lei; Yang, Yaowen] Nanyang Technol Univ, Sch Civil & Environm Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
RP Yang, YW (reprint author), Nanyang Technol Univ, Sch Civil & Environm Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM lanezhang@pmail.ntu.edti.sg; cywyang@ntu.edu.sg
RI Zhang, Lei/K-4553-2013
OI Zhang, Lei/0000-0002-9794-5849; Yang, Yaowen/0000-0002-7856-2009
CR Nemat-Nasser S, 2000, J APPL PHYS, V87, P3321, DOI 10.1063/1.372343
   Nemat-Nasser S, 2002, J APPL PHYS, V92, P2899, DOI 10.1063/1.1495888
   Newbury KM, 2003, J INTEL MAT SYST STR, V14, P333, DOI 10.1177/104538903034976
   Paquette JW, 2004, IEEE J OCEANIC ENG, V29, P729, DOI 10.1109/JOE.2004.833132
   Shahinpoor M, 2005, SMART MATER STRUCT, V14, P197, DOI 10.1088/0964-1726/14/1/020
   Shahinpoor M, 2001, SMART MATER STRUCT, V10, P819, DOI 10.1088/0964-1726/10/4/327
   Shahinpoor M, 2002, J INTEL MAT SYST STR, V13, P369, DOI 10.1106/104538902030337
NR 7
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6221-7
J9 PROC SPIE
PY 2006
VL 6168
AR 61681D
DI 10.1117/12.658345
PG 9
WC Instruments & Instrumentation; Physics, Condensed Matter; Polymer
   Science
SC Instruments & Instrumentation; Physics; Polymer Science
GA BEO50
UT WOS:000238445800042
DA 2018-10-20
ER

PT S
AU Lamouche, G
   Bisaillon, CE
   Dufour, M
   Gauthier, B
   Maciejko, R
   Monchalin, JP
AF Lamouche, Guy
   Bisaillon, Charles-Etienne
   Dufour, Marc
   Gauthier, Bruno
   Maciejko, Romain
   Monchalin, Jean-Pierre
BE Slangen, P
TI Optical coherence tomography for industrial and biomedical applications
SO SPECKLE06: SPECKLES, FROM GRAINS TO FLOWERS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Speckles, From Grains to Flowers
CY SEP 13-15, 2006
CL Nimes, FRANCE
SP Ecole Mines Ales, Ales Sch Engn, SPIE, European Opt Soc, Soc Francaise Opt, Ctr Natl Rech Sci
DE optical coherence tomography; delay line; speckle
ID DELAY-LINE; SPECKLE
AB An overview of the activities in low-coherence interferometry (LCI) and optical coherence tomography (OCT) at the Industrial Materials Institute are presented. An innovative optical delay line using rhombic prisms is described. A few industrial applications are described: volume loss in a wear test, combination of LCI with laser-induced breakdown spectroscopy, and modification of an existing rheometer to increase its precision. Preliminary results related to the use of speckle to differentiate tissues and materials in OCT are presented. The speckle dimension is shown to be sensitive to low density of scatterers. An additional parameter extracted from the autocorrelation of speckle is also presented.
C1 [Lamouche, Guy; Bisaillon, Charles-Etienne; Dufour, Marc; Gauthier, Bruno; Monchalin, Jean-Pierre] Natl Res Council Canada, Inst Mat Ind, 75 Mortagne, Boucherville, PQ J4B 6Y4, Canada.
   [Bisaillon, Charles-Etienne; Maciejko, Romain] Ecole Polytech, Dept Genie Phys, Lab Optoelect, Montreal, PQ H3C 3A7, Canada.
RP Monchalin, JP (reprint author), Natl Res Council Canada, Inst Mat Ind, 75 Mortagne, Boucherville, PQ J4B 6Y4, Canada.
EM jean-pierre.monchalin@cnrc-nrc.ac.ca
CR Dufour ML, 2005, INSIGHT, V47, P216, DOI 10.1784/insi.47.4.216.63149
   Gossage KW, 2006, PHYS MED BIOL, V51, P1563, DOI 10.1088/0031-9511/51/6/014
   Hillman TR, 2006, OPT LETT, V31, P190, DOI 10.1364/OL.31.000190
   KWONG KF, 1993, OPT LETT, V18, P558, DOI 10.1364/OL.18.000558
   Rollins AM, 2002, HANDBOOK OF OPTICAL COHERENCE TOMOGRAPHY, P99
   Sampson DD, 2004, LASERS CURRENT OPTIC
   Schmitt JM, 2002, HANDBOOK OF OPTICAL COHERENCE TOMOGRAPHY, P175
   Siegman A., 1986, LASERS
   Tearney GJ, 1997, OPT LETT, V22, P1811, DOI 10.1364/OL.22.001811
   Tkaczyk TS, 2002, P SOC PHOTO-OPT INS, V4619, P59, DOI 10.1117/12.470462
NR 10
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-6426-0
J9 PROC SPIE
PY 2006
VL 6341
DI 10.1117/12.695302
PG 6
WC Instruments & Instrumentation; Optics; Imaging Science & Photographic
   Technology
SC Instruments & Instrumentation; Optics; Imaging Science & Photographic
   Technology
GA BFD60
UT WOS:000241191500029
DA 2018-10-20
ER

PT S
AU Shubha, N
AF Shubha, N.
BE Batani, D
   Lontano, M
TI Electrohydrodynamic stability of poorly conducting parallel plasma flows
SO Superstrong Fields in Plasmas
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 3rd International Conference on Superstrong Fields in Plasmas
CY SEP 19-24, 2005
CL Varenna, ITALY
SP European Cooperat Field Sci & Tech Res, Univ Milano Bicocca, Int Ctr Promot Sci & ISPP, Plasma Phys Inst P Caldirola, Natl Res Council
DE electrohydrodynamic; poorly conducting plasma; stability
ID MAGNETOHYDRODYNAMIC STABILITY; SUPERPOSED STREAMS; LIQUIDS; FLUID
AB Aerospace, automobile, structural and biomedical engineering applications require strong and smart materials to minimize the weight and vibrations and maximize the strength to achieve an efficient dynamic response and economic advantages. These materials are usually synthesized using poorly conducting plasma in the presence of a strong electric field. This strong applied electric field produces instabilities known as Electrohydrodynamic instability in a poorly conducting parallel flow of plasma. These instabilities produce impurities in the manufacture of strong smart materials. Therefore to manufacture these materials free from impurities there is a need to know whether this external constraint of electric field either suppress or augments these electrohydrodynamic instabilities. This can be achieved by investigating Electrohydrodynamic stability in the presence of an external constraint of strong electric field. The study of this instability is the main objective of this paper. In this paper, stability of poorly conducting parallel plasma in a rectangular channel is studied in the presence of strong electric field subject to linear stability analysis. The basic flow is a function of electric potential and we found that this potential difference also drives the flow in addition to plasma pressure gradient. The condition for the onset of stability is determined in terms of Electric Reynolds Number using both moment and energy methods combined with Galerkin technique. If the motion is unstable an upperbound for the amplification factor is given. From this analysis we conclude that a proper choice of Electric Reynolds number controls instability of a parallel poorly conducting plasma. This result is useful in the manufacture of strong and smart materials free from impurities.
C1 Bangalore Univ, Dept Math, UGC Ctr Adv Studies Plasma Mech, Bangalore 560001, Karnataka, India.
RP Shubha, N (reprint author), Bangalore Univ, Dept Math, UGC Ctr Adv Studies Plasma Mech, Bangalore 560001, Karnataka, India.
CR Drazin P., 1966, ADVANCES APPLIED MEC, V9, P1, DOI DOI 10.1016/S0065-2156(08)70006-1
   DRAZIN PG, 1995, HYDRODYNAMIC STABILI
   DRAZIN PG, 2001, INTRO HYDRODYNAMIC S
   Goldstein S, 1931, P R SOC LOND A-CONTA, V132, P524, DOI 10.1098/rspa.1931.0116
   LIN CC, 1957, APPL MECH, V2, P136
   LOCK RC, 1955, PROC R SOC LON SER-A, V233, P105, DOI 10.1098/rspa.1955.0249
   MALKUS WVR, 1961, PHYS FLUIDS, V4, P13, DOI 10.1063/1.1706175
   RUDRAIAH N, 1964, APPL SCI RES B-ELEC, V11, P105, DOI 10.1007/BF00384018
   RUDRAIAH N, 1964, APPL SCI RES B-ELEC, V11, P118
   STUART JT, 1954, PROC R SOC LON SER-A, V221, P189, DOI 10.1098/rspa.1954.0015
   SYNGE JL, 1933, T ROY SOC CAN, V3, P27
   Taylor GI, 1931, P R SOC LOND A-CONTA, V132, P499, DOI 10.1098/rspa.1931.0115
NR 12
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0319-8
J9 AIP CONF PROC
PY 2006
VL 827
BP 564
EP 568
PG 5
WC Optics; Physics, Fluids & Plasmas; Physics, Multidisciplinary
SC Optics; Physics
GA BEF00
UT WOS:000237057200061
DA 2018-10-20
ER

PT S
AU Gayathri, MS
AF Gayathri, M. S.
BE Batani, D
   Lontano, M
TI Combined effects of unsteady electric field and uniform magnetic field
   on magnetoelectroconvection in a poorly conducting plasma
SO Superstrong Fields in Plasmas
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 3rd International Conference on Superstrong Fields in Plasmas
CY SEP 19-24, 2005
CL Varenna, ITALY
SP European Cooperat Field Sci & Tech Res, Univ Milano Bicocca, Int Ctr Promot Sci & ISPP, Plasma Phys Inst P Caldirola, Natl Res Council
ID DOUBLE-DIFFUSIVE CONVECTION; TEMPERATURE-GRADIENT; INSTABILITY
AB The magnetoelectroconvective instability of a plane horizontal layer of a poorly conducting plasma subjected to a strong nonuniform electric field and uniform magnetic field is investigated in the combined magnetoelectrohydrodynamic: approximations when charge formation is produced by this convection. The spatio-temporal variation of electric field, density of charge distribution and temperature are found for the quiescent basic state. The influence of combined uniform magnetic field and a time-dependent electric field modulation on the behaviour of a poorly conducting plasma is studied using energy and moment methods along with Galerkin technique. The criterion for the onset of magnetoelectroconvection involving the effects of both strong electric and magnetic fields is computed and the results are compared with these obtained only in the presence of electric field. We found that the combined effect of electric and magnetic fields is more favourable to suppress convection significantly than in the presence of electric field alone. This result is useful in synthesizing smart and strong materials needed for many aeronautical, automobile and biomedical engineering applications to minimize the weight and maximize the strength to achieve the sufficient dynamic advantages.
C1 Bangalore Univ, Dept Math, UGC Ctr Adv Studies Fluid Mech, Bangalore 560001, Karnataka, India.
RP Gayathri, MS (reprint author), Bangalore Univ, Dept Math, UGC Ctr Adv Studies Fluid Mech, Bangalore 560001, Karnataka, India.
CR ARUNACHALAM VS, 1982, MAT PROC SPAC WORKSH, P195
   GROSS MJ, 1966, NATURE, V212, P1343, DOI 10.1038/2121343a0
   LEE C, 1972, PHYS FLUIDS, V15, P789, DOI 10.1063/1.1693986
   LEE CO, 1974, P 5 INT HEAT TRANSF, V3, P173
   RUDRAIAH N, 1986, PRAMANA, V27, P233, DOI 10.1007/BF02846340
   RUDRAIAH N, 1984, INT J HEAT MASS TRAN, V27, P1825, DOI 10.1016/0017-9310(84)90164-9
   Rudraiah N, 2003, ACTA MECH, V166, P217, DOI 10.1007/s00707-003-0018-5
   Rudraiah N, 1998, HEAT MASS TRANSFER, V33, P287, DOI 10.1007/s002310050191
   RUDRAIAH N, 1986, CAN J PHYS, V64, P90, DOI 10.1139/p86-013
   RUDRAIAH N, 1982, WORKSH P IND AC SCI, V4, P245
   RUDRAIAH N, 2003, P WORKSH MOD NAN SMA, P121
   Smorodin BL, 2000, J ELECTROSTAT, V48, P261, DOI 10.1016/S0304-3886(99)00074-1
   TURNBULL RJ, 1968, PHYS FLUIDS, V11, P2597, DOI 10.1063/1.1691865
   TURNBULL RJ, 1969, PHYS FLUIDS, V12, P2255, DOI 10.1063/1.1692339
NR 14
TC 0
Z9 0
U1 1
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0319-8
J9 AIP CONF PROC
PY 2006
VL 827
BP 575
EP 583
PG 9
WC Optics; Physics, Fluids & Plasmas; Physics, Multidisciplinary
SC Optics; Physics
GA BEF00
UT WOS:000237057200063
DA 2018-10-20
ER

PT J
AU Shim, HM
   Oh, KT
   Woo, JY
   Hwang, CJ
   Kim, KN
AF Shim, HM
   Oh, KT
   Woo, JY
   Hwang, CJ
   Kim, KN
TI Surface characteristics of titanium-silver alloys in artificial saliva
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE titanium alloys; electrochemical properties; passive film; XPS;
   biomaterials
ID IMPLANT MATERIALS; STAINLESS-STEEL; INTERFACE; BONE; GROWTH; XPS
AB Titanium and its alloys are widely used in biomedical and dental fields because of their excellent corrosion resistance and biocompatibility. It is well known that titanium is protected from corrosion because of the stability of the passive film that controls and determines the corrosion resistance and biocompatibility of titanium and its alloys. The purpose of this study was to evaluate the electrochemical properties of titanium-silver alloys and the surface characteristics of passive film in artificial saliva.
   We designed titanium-silver alloys with silver contents ranging from 0 to 5 at.%, in 1% increments. These alloys were arc-melted, homogenized, hot-rolled to 2 mm thickness, and finally solution heat-treated for 1 h and quenched. Potentiostatic testing was performed, and the open circuit potentials of the alloys were measured in artificial saliva, at 37 degrees C. The passive films of the titanium-silver alloys were analyzed via XPS.
   Titanium-silver alloys maintained low current density and showed stable passive region and also had high open circuit potential as compared with pure titanium. The open circuit potential of titanium-silver alloys increased as silver addition increased. With regard to the fraction of oxygen species, a component of over 80% was found to be comprised of oxide. Therefore, the titanium surface mainly consisted of titanium oxide and, on the titanium-silver alloys, this film was composed of TiO2, Ti2O3, and TiO. As silver content increased, the TiO2 fraction also increased, as did the thickness of the titanium oxide layer formed. Copyright (C) 2005 John Wiley & Sons, Ltd.
C1 Yonsei Univ, Coll Dent, Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   Yonsei Univ, Coll Dent, Dept Dent Biomat & Bioengn, Seoul 120752, South Korea.
   Coll Dent, Dept Orthodont, Seoul 120752, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Res Inst Dent Biomat & Bioengn, 134 Shinchon Dong, Seoul 120752, South Korea.
EM kimkn@yumc.yonsei.ac.kr
OI Hwang, Chung-Ju/0000-0003-3024-4551
CR ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   Bathias C, 1997, ENG FRACT MECH, V56, P255, DOI 10.1016/0013-7944(95)00256-1
   BHAMBRI SK, 1996, ASTM STP, V1272, P88
   BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P875, DOI 10.1016/0013-4686(89)87123-3
   Boyer R, 1994, MAT PROPERTIES HDB T, P1
   Breme HJ, 1998, METALS BIOMATERIALS, P1
   Brunski JB, 1996, BIOMATERIALS SCI INT, P37
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Demri B, 1997, APPL SURF SCI, V108, P245, DOI 10.1016/S0169-4332(96)00576-4
   EISENBRANDT LL, 1945, J DENT RES, V24, P247, DOI 10.1177/00220345450240050501
   EWERS GJ, 1985, J ORAL REHABIL, V12, P469, DOI 10.1111/j.1365-2842.1985.tb01293.x
   GJERDET NR, 1987, ACTA ODONTOL SCAND, V45, P409, DOI 10.3109/00016358709096365
   GOPEL W, 1984, SURF SCI, V139, P333, DOI 10.1016/0039-6028(84)90054-2
   HIGO Y, 1993, P 3 JAPAN INT SAMPE, V2, P1621
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1996, J ELECTRON SPECTROSC, V81, P237
   Mishra A. K., 1996, ASTM STP, V1272, P96
   Moulder J.F., 1995, HDB XRAY PHOTOELECTR
   NAKAYAMA Y, 1988, P 3 WORLD BIOM C, P202
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Oh K. T., 2002, J KOREAN RES SOC DEN, V29, P221
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROSTOKER W, 1979, J BIOMECH ENG-T ASME, V101, P2
   SCHUTZ RW, 1987, METALS HDB, V13, P669
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
NR 32
TC 9
Z9 9
U1 0
U2 10
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JAN
PY 2006
VL 38
IS 1
BP 25
EP 31
DI 10.1002/sia.2175
PG 7
WC Chemistry, Physical
SC Chemistry
GA 002LB
UT WOS:000234611800004
DA 2018-10-20
ER

PT S
AU Spanoudaki, A
   Fragiadakis, D
   Vartzeli-Nikaki, K
   Pissis, P
   Hernandez, JCR
   Pradas, MM
AF Spanoudaki, Anna
   Fragiadakis, Daniel
   Vartzeli-Nikaki, Kalliopi
   Pissis, Polycarpos
   Hernandez, Jose C. Rodriguez
   Pradas, Manuel Monleon
BE Blitz, JP
   GunKo, VM
TI Nanostructured and nanocomposite hydrogels for biomedical applications
SO SURFACE CHEMISTRY IN BIOMEDICAL AND ENVIRONMENTAL SCIENCE
SE NATO Science Series II-Mathematics Physics and Chemistry
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Surface Chemistry in Biomedical and
   Environmental Science
CY SEP 14-17, 2005
CL Kiev, UKRAINE
SP NATO
DE hydrogels; poly(hydroxyethyl acrylate); nanocomposites; silica
   nanoparticles; water clustering
ID INTERPENETRATING POLYMER NETWORKS; MOLECULAR-DYNAMICS; ACRYLATE)
   HYDROGELS; WATER SORPTION; SILICA; REINFORCEMENT; SPECTROSCOPY;
   COMPOSITES
AB Polymer hydrogels are interesting for biomedical applications due to their biocompatibility and good water sorption/diffusion properties. In previous work their mechanical stability could be improved by combination with a hydrophobic polymer. Instead, here we prepare poly(hydroxyethyl acrylate), PHEA/silica nanocomposites by sol-gel techniques as potential scaffold materials for tissue engineering. Their morphology and properties were investigated by scanning electron microscopy, thermogravimetry, dynamic mechanical analysis, water sorption/desorption, dielectric spectroscopy, and thermally stimulated depolarization currents techniques at various levels of relative humidity/water content. The results show that the nanoparticles are homogeneously distributed, form a continuous phase, and significantly reinforce the matrix, without affecting its hydrophilicity and, thus, biocompatibility. Water is more homogeneously distributed, as compared to pure PHEA matrix, forming smaller clusters. The glass transition temperature is controlled by water content, and less affected by the concentration of silica.
C1 [Spanoudaki, Anna; Fragiadakis, Daniel; Vartzeli-Nikaki, Kalliopi; Pissis, Polycarpos] Natl Tech Univ Athens, Dept Phys, Zografou Campus, Athens 15780, Greece.
   [Hernandez, Jose C. Rodriguez; Pradas, Manuel Monleon] Univ Politecn Valencia, Ctr Biomat, E-46071 Valencia, Spain.
RP Pissis, P (reprint author), Natl Tech Univ Athens, Dept Phys, Zografou Campus, Athens 15780, Greece.
EM ppissis@central.ntua.gr
RI Fragiadakis, Daniel/A-4510-2009
OI MONLEON PRADAS, MANUEL/0000-0001-6457-0414
FU European Social Fund; National Resources (EPEAEK II) PYTHAGORAS.
FX The project is co-founded by the European Social Fund (75%) and National
   Resources (25%) (EPEAEK II) PYTHAGORAS.
CR Bershtein VA, 2002, J POLYM SCI POL PHYS, V40, P1056, DOI 10.1002/polb.10162
   Bignotti F, 2004, J APPL POLYM SCI, V93, P1964, DOI 10.1002/app.20671
   Boisvert JP, 2003, J POLYM SCI POL PHYS, V41, P3127, DOI 10.1002/polb.10768
   Bokobza L, 2004, MACROMOL SYMP, V205, P61, DOI 10.1002/masy.200450106
   BROWN GL, 1980, ACS SYM SER, V127, P441
   Ferrer GG, 2005, COLLOID POLYM SCI, V283, P681, DOI 10.1007/s00396-004-1208-y
   Ferrer GG, 1998, J NON-CRYST SOLIDS, V235, P692, DOI 10.1016/S0022-3093(98)00573-0
   Fragiadakis D, 2005, POLYMER, V46, P6001, DOI 10.1016/j.polymer.2005.05.080
   Kotsilkova R, 2005, J POLYM SCI POL PHYS, V43, P522, DOI 10.1002/polb.20352
   KYRITSIS A, 1995, J POLYM SCI POL PHYS, V33, P1737, DOI 10.1002/polb.1995.090331205
   KYRITSIS A, 1994, J POLYM SCI POL PHYS, V32, P1001, DOI 10.1002/polb.1994.090320605
   Kyritsis A, 1995, POLYM GELS NETW, V3, P445, DOI 10.1016/0966-7822(94)00009-3
   Mamunya YP, 2004, EUR POLYM J, V40, P2323, DOI 10.1016/j.eurpolymj.2004.06.007
   Matejka L, 2000, POLYMER, V41, P1449, DOI 10.1016/S0032-3861(99)00317-1
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   Pethig R, 1979, DIELECTRIC ELECT PRO
   Pradas MM, 2001, COLLOID POLYM SCI, V279, P323, DOI 10.1007/s003960000426
   Ribelles JLG, 1999, J POLYM SCI POL PHYS, V37, P1587
   Runt J. P., 1997, DIELECTRIC SPECTROSC
   STOY V, 1996, HYDROGELS SPECIALITY
NR 20
TC 8
Z9 8
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1568-2609
BN 1-4020-4739-8
J9 NATO SCI SER II-MATH
PY 2006
VL 228
BP 229
EP +
DI 10.1007/1-4020-4741-X_20
PG 3
WC Chemistry, Physical; Engineering, Biomedical; Environmental Sciences;
   Nanoscience & Nanotechnology
SC Chemistry; Engineering; Environmental Sciences & Ecology; Science &
   Technology - Other Topics
GA BFA91
UT WOS:000240547600020
DA 2018-10-20
ER

PT B
AU Handy, R
   Jackson, M
   Goodman, DW
   Rodriguez, M
   Robinson, G
AF Handy, Rodney
   Jackson, Mark
   Goodman, David Wayne
   Rodriguez, Monica
   Robinson, Grant
BE Jackson, MJ
TI Local Exhaust/Dilution Ventilation Considerations for Biological
   Nanoparticle Exhaust during Medical Drilling Applications
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 5th International Surface Engineering Congress (ISEC)
CY MAY 15-17, 2006
CL Seattle, WA
SP ASM Int
DE Biomedical Engineering; Drilling; Nanotechnology; Medical Materials
AB The design considerations relevant to performance of a ventilation system were evaluated with respect to medical drilling applications into teeth and bone with respect to biological nano-particle emissions. The study evaluates several characteristics of a commercial ventilation system to determine the effects of the ventilation system on medical worker exposure in the breathing zone.
C1 [Handy, Rodney] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   Purdue Univ, Coll Technol, W Lafayette, IN 47907 USA.
RP Handy, R (reprint author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
CR *ENV PROT AG, 2006, MOD 3 CHAR PART
   *FED STAND, 1992, 209E FED STAND
   FINKBEINER BL, 2001, J CONT DENT PRACTICE, V2, P3
   GOLDFIELD J, 1985, HEAT-PIPING-AIR COND, V57, P47
   HANDS D, 1996, CHINESE J MECH ENG E, V57, P433
   HE SY, 2003, AM IND HYG ASSOC J, V16, P356
   Heinonen K, 1996, AM IND HYG ASSOC J, V57, P356
   HEWITT PJ, 1986, CHEM ENG MONOGRAPHS, V24, P405
   MADSEN U, 2003, BUILD ENVIRON, V29, P319
   *OCC SAF HLTH ADM, 2006, OSHA TECHN MAN
   STEWART LJ, 1985, DESIGN GUIDELINES EX, P1
   *TERR UN, 2006, LAM FLOW HOOD PROD I
   WEAVER J, 2006, CE 597N NAN DES CLAS
   WEAVER J, 2006, BUILD ADV TECHN WORK, V3
   Whyte W., 1999, CLEANROOM DESIGN
NR 15
TC 0
Z9 0
U1 2
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-843-4
PY 2006
BP 53
EP +
PG 2
WC Materials Science, Biomaterials; Materials Science, Coatings & Films
SC Materials Science
GA BPD40
UT WOS:000278561800010
DA 2018-10-20
ER

PT B
AU Jackson, MJ
   Robinson, GM
   Sein, H
   Ahmed, W
   Taylor, H
AF Jackson, M. J.
   Robinson, G. M.
   Sein, H.
   Ahmed, W.
   Taylor, H.
BE Jackson, MJ
TI Dental Machining and Drilling in Severe Environments
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 5th International Surface Engineering Congress (ISEC)
CY MAY 15-17, 2006
CL Seattle, WA
SP ASM Int
DE Dental Tools; CVD Diamond; Medical Technology; Biomedical Applications;
   Wear; Titanium Nitride
ID CEMENTED TUNGSTEN CARBIDE; CHEMICAL-VAPOR-DEPOSITION; DIAMOND FILMS; CVD
   DIAMOND; CUTTING TOOLS; COATINGS; NUCLEATION; WEAR; BURS; GROWTH
AB The application of diamond coatings on cemented tungsten carbide (WC-Co) tools has the subject of much attention in recent years in order to improve cutting performance and tool life in orthodontic applications. WC-Co tools containing 6% Co metal and 94% WC substrate with an average grain size 1-3 micron were used in this study. In order to improve the adhesion between diamond and WC substrates it is necessary to etch cobalt from the surface and prepare it for subsequent diamond growth. Alternatively, a titanium nitride (TiN) interlayer can be used prior to diamond deposition. Hot filament chemical vapour deposition (H.F.C.V.D.) with a modified vertical filament arrangement has been employed for the deposition of diamond films to TiN and etched WC substrates. Diamond film quality and purity has been characterised using scanning electron microscopy (S.E.M.) and micro Raman spectroscopy. The performance of diamond coated WC-Co tools. uncoated WC-Co tools, and diamond embedded (sintered) tools have been compared by drilling a series of holes into various materials such as human tooth, borosilicate glass, and acrylic tooth materials. Flank wear has been used to assess the wear rates of the tools when machining biomedical materials such as those described above. It is shown that using an interlayer such as TiN prior to diamond deposition provides the best surface preparation for producing dental tools.
C1 [Jackson, M. J.; Robinson, G. M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   [Jackson, M. J.; Robinson, G. M.] Purdue Univ, Coll Technol, W Lafayette, IN 47907 USA.
   [Sein, H.; Ahmed, W.; Taylor, H.] Manchester Metropolitan Univ, Dalton Res Ctr, Dept Chem & Mat, Surface Coatings Res Grp, Manchester M1 5GD, Lancs, England.
RP Jackson, MJ (reprint author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
OI Ahmed, Waqar/0000-0003-4152-5172
CR AGER JW, 1993, PHYS REV B, V48, P2601, DOI 10.1103/PhysRevB.48.2601
   Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5
   Borges CFM, 1999, J PROSTHET DENT, V82, P73, DOI 10.1016/S0022-3913(99)70130-7
   BRADEN M, 1976, BIOPHYSICS TOOTH FRO
   Buck V, 1998, DIAM RELAT MATER, V7, P1544, DOI 10.1016/S0925-9635(98)00237-4
   Cappelli E, 1996, DIAM RELAT MATER, V5, P292, DOI 10.1016/0925-9635(95)00426-2
   CHEN X, 1993, J APPL PHYS, V74, P4168, DOI 10.1063/1.354420
   Endler I, 1999, DIAM RELAT MATER, V8, P834, DOI 10.1016/S0925-9635(98)00359-8
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   INSPEKTOR A, 1994, SURF COAT TECH, V68, P359, DOI 10.1016/0257-8972(94)90186-4
   Kamiya S, 2000, DIAM RELAT MATER, V9, P191, DOI 10.1016/S0925-9635(00)00229-6
   KLASS W, 1997, DIAM RELAT MATER, V6, P240
   LEYENDECKER T, 1991, SURF COAT TECH, V48, P253, DOI 10.1016/0257-8972(91)90013-M
   Lin JC, 1996, HYDROMETALLURGY, V43, P47, DOI 10.1016/0304-386X(96)00023-0
   Lopez JM, 1998, J MATER RES, V13, P2841, DOI 10.1557/JMR.1998.0388
   Lux B, 1996, CERAM INT, V22, P347, DOI 10.1016/0272-8842(95)00109-3
   LUX B, 1991, NATO ADV SCI I B-PHY, V266, P579
   MAY PW, 1994, DIAM RELAT MATER, V3, P810, DOI 10.1016/0925-9635(94)90274-7
   MURAKAWA M, 1991, SURF COAT TECH, V49, P359, DOI 10.1016/0257-8972(91)90083-9
   OAKES J, 1991, SURF COAT TECH, V47, P600, DOI 10.1016/0257-8972(91)90330-Y
   PINES MS, 1979, J AM DENT ASSOC, V99, P831, DOI 10.14219/jada.archive.1979.0403
   Polini R, 2003, SURF COAT TECH, V166, P127, DOI 10.1016/S0257-8972(02)00775-2
   Polo MC, 1997, DIAM RELAT MATER, V6, P579, DOI 10.1016/S0925-9635(96)00643-7
   REINECK I, 1993, SURF COAT TECH, V57, P47, DOI 10.1016/0257-8972(93)90335-L
   SAIJO K, 1990, SURF COAT TECH, V43-4, P30, DOI 10.1016/0257-8972(90)90057-J
   Sein H, 2003, SURF COAT TECH, V163, P196, DOI 10.1016/S0257-8972(02)00618-7
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   TOH H, 1991, J MATER SCI, V26, P370
   Trava-Airoldi VJ, 1998, SURF COAT TECH, V108, P437, DOI 10.1016/S0257-8972(98)00590-8
   WANG DY, 1993, DIAM RELAT MATER, V2, P304, DOI 10.1016/0925-9635(93)90072-A
   Weast R. C., 1989, CRC HDB CHEM PHYS
   YASHIKI T, 1992, SURF COAT TECH, V52, P81, DOI 10.1016/0257-8972(92)90373-I
   ZHU W, 1995, J MATER RES, V10, P1455, DOI 10.1557/JMR.1995.1455
NR 34
TC 0
Z9 0
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-843-4
PY 2006
BP 85
EP +
PG 2
WC Materials Science, Biomaterials; Materials Science, Coatings & Films
SC Materials Science
GA BPD40
UT WOS:000278561800015
DA 2018-10-20
ER

PT B
AU Taylor, K
   Jodoin, B
   Karov, J
AF Taylor, K.
   Jodoin, B.
   Karov, J.
BE Jackson, MJ
TI Utilization of Composite Powders to Apply Ceramic Coatings in Cold Spray
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 5th International Surface Engineering Congress (ISEC)
CY MAY 15-17, 2006
CL Seattle, WA
SP ASM Int
DE Cold Spray; biocompatible; plastic deformation; critical velocity
ID DEPOSITION; TITANIUM
AB Several thermal spray technologies, such as plasma spray and high velocity oxy-fuel (HVOF) have been utilized in order to apply hydroxyapatite (HA) coatings onto titanium and titanium alloys for biomedical applications. A dilemma arises when using thermal spray techniques to apply ceramics coatings such as HA. These materials require significant processing temperatures in order to provide sufficient particle melting to achieve an appropriate coating thickness. This melting often leads to changes in physical and chemical properties of the HA resulting in unknown variations in the coating's biocompatibility. A process such as Cold Gas Dynamic Spray can be utilized to provide coatings of HA, as melting of the feedstock particles is not required.
   Cold Spray offers an innovative deposition process for both ceramics and metals. This line of sight, solid-state process utilizes a supersonic gas stream to accelerate particles beyond a critical velocity. These unheated particles, upon impact with a substrate will plastically deform to create a coating. To date, difficulties have arisen to acquire adequate coating thickness when spraying ceramics due to their brittle nature. The goal of the paper is to show the early developments of using cold spray to apply functionally graded coatings with significant thicknesses of composite titanium and HA.
C1 [Taylor, K.; Jodoin, B.] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
   [Karov, J.] Med Devices Bur, Dept Hlth Canada, Ottawa, ON, Canada.
RP Taylor, K (reprint author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
CR Ajdelsztajn L, 2005, METALL MATER TRANS A, V36A, P657, DOI 10.1007/s11661-005-0182-4
   Choi JM, 1999, J MATER RES, V14, P2980, DOI 10.1557/JMR.1999.0399
   Fauchais P, 2001, J THERM SPRAY TECHN, V10, P44, DOI 10.1361/105996301770349510
   Inagaki M, 2003, J VAC SCI TECHNOL A, V21, P1225, DOI 10.1116/1.1575224
   Jodoin B, 2002, J THERM SPRAY TECHN, V11, P496, DOI 10.1361/105996302770348628
   Kweh SWK, 1999, J MATER PROCESS TECH, V90, P373
   Li H, 2002, BIOMATERIALS, V23, P85, DOI 10.1016/S0142-9612(01)00082-5
   Thian ES, 2002, BIOMATERIALS, V23, P2927, DOI 10.1016/S0142-9612(01)00422-7
   Thian ES, 2001, BIOMATERIALS, V22, P1225, DOI 10.1016/S0142-9612(00)00272-6
   WILLMANN G, 1999, ADV ENG MAT, V1
NR 10
TC 0
Z9 0
U1 0
U2 6
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-843-4
PY 2006
BP 119
EP +
PG 2
WC Materials Science, Biomaterials; Materials Science, Coatings & Films
SC Materials Science
GA BPD40
UT WOS:000278561800021
DA 2018-10-20
ER

PT B
AU Jackson, MJ
   Robinson, GM
   Ali, N
   Kousar, Y
   Mei, S
   Gracio, J
   Taylor, H
   Ahmed, W
AF Jackson, M. J.
   Robinson, G. M.
   Ali, N.
   Kousar, Y.
   Mei, Sen
   Gracio, J.
   Taylor, H.
   Ahmed, W.
BE Jackson, MJ
   Ahmed, W
TI Surface Engineering of Artificial Heart Valve Disks Using Nanostructured
   Thin Films Deposited By Sol-gel and CVD Methods
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Surface Engineering Congress (ISEC)
CY AUG 01-03, 2005
CL St Paul, MN
SP ASM Int
DE Biomedical Applications; Thin Diamond Films; Heart Valves; Surface
   Engineering
ID DIAMOND-LIKE CARBON; IMMERSION ION-IMPLANTATION; NITRIDE FILMS;
   HEMOCOMPATIBILITY; TITANIUM; BIOCOMPATIBILITY; DLC
AB Pyrolytic carbon (PyC) is widely used in manufacturing commercial artificial heart valve disks (HVD). Although, PyC is commonly used in HVD, it is not the best material for this application since its blood compatibility is not ideal for prolonged clinical use. As a result thrombosis often occurs and the patients are required to take anti-coagulation drugs on a regular basis in order to minimise the formation of thrombosis. However, the anti-coagulation therapy gives rise to some detrimental side effects in patients. Therefore, it is extremely urgent that newer and more technically advanced materials with better surface and bulk properties are developed. In this paper, we report the mechanical properties of PyC-HVD, namely, strength, wear resistance and coefficient of friction. The strength of the material was assessed using Brinell indentation tests. Furthermore, wear resistance and the coefficient of friction values were obtained from the pin-on-disk testing. The micro-structural properties of PyC were characterised using XRD, Raman spectroscopy and SEM analysis. Also, in this paper we report the preparation of freestanding nanocrystalline diamond films (FSND) using the time-modulated chemical vapor deposition (TMCVD) process. Furthermore, the sol-gel technique was used to uniformly coat PyC-HVD with dense, nanocrystalline-titanium oxide (nc-TiO2) coatings. The as-grown nc-TiO2 coatings were characterised for microstructure using SEM and XRD analysis.
C1 [Jackson, M. J.; Robinson, G. M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   [Jackson, M. J.; Robinson, G. M.] Purdue Univ, Coll Technol, W Lafayette, IN 47907 USA.
   [Ali, N.; Kousar, Y.; Mei, Sen; Gracio, J.] Univ Aveiro, Dept Mech Engn, P-3810193 Aveiro, Portugal.
   [Taylor, H.; Ahmed, W.] Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
RP Jackson, MJ (reprint author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
OI Ahmed, Waqar/0000-0003-4152-5172; Gracio, Jose/0000-0002-0343-4387
CR Ali N, 2003, J MATER RES, V18, P296, DOI 10.1557/JMR.2003.0041
   ASHFOLD MN, 1994, CHEM SOC REV, P23
   BARTON K, 2001, BIOMED ENG SOC BMES, V25, P3
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Fan CL, 2002, J MATER RES, V17, P1520, DOI 10.1557/JMR.2002.0226
   Fan QH, 1998, J MATER RES, V13, P2787
   Fan QH, 2002, J MATER RES, V17, P1563, DOI 10.1557/JMR.2002.0232
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Kulisch W, 1996, PHYS STATUS SOLIDI A, V154, P155, DOI 10.1002/pssa.2211540113
   Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   LI JG, 1993, BIOMATERIALS, V14, P229, DOI 10.1016/0142-9612(93)90028-Z
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Yan YG, 1996, J AM CERAM SOC, V79, P1061, DOI 10.1111/j.1151-2916.1996.tb08548.x
   YANG J, J EURO CERA IN PRESS
   Yang P, 2002, SURF COAT TECH, V156, P284, DOI 10.1016/S0257-8972(02)00087-7
NR 21
TC 0
Z9 0
U1 0
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-835-9
PY 2006
BP 147
EP +
PG 3
WC Nanoscience & Nanotechnology; Materials Science, Coatings & Films
SC Science & Technology - Other Topics; Materials Science
GA BPY35
UT WOS:000280332900025
DA 2018-10-20
ER

PT B
AU Jackson, MJ
   Ahmed, W
AF Jackson, M. J.
   Ahmed, W.
BE Jackson, MJ
TI Machining Ceramic Orthodontic Materials with HFCVD Diamond Tools
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 5th International Surface Engineering Congress (ISEC)
CY MAY 15-17, 2006
CL Seattle, WA
SP ASM Int
DE Dental burs; CVD Diamond; Micro Tools; Biomedical Applications; Wear;
   Titanium Nitride
ID CEMENTED TUNGSTEN CARBIDE; CHEMICAL-VAPOR-DEPOSITION; CVD DIAMOND;
   CUTTING TOOLS; FILMS; COATINGS; NUCLEATION; WEAR; BURS; GROWTH
AB The application of diamond coatings on cemented tungsten carbide (WC-Co) burs has the subject of much attention in recent years in order to improve cutting performance and tool life. WC-Co burs containing 6% Co and 94% WC substrate with an average grain size 1-3 micron were used in this study. In order to improve the adhesion between diamond and WC substrates it is necessary to etch the surface Co and prepare the surface for subsequent diamond growth. Alternatively, a TiN interlayer can be used prior to diamond deposition. Hot filament chemical vapour deposition (H.F.C.V.D.) with a modified vertical filament arrangement has been employed for the deposition of diamond films to TiN and etched WC substrates. Diamond film quality and purity has been characterised using scanning electron microscopy (S.E.M.) and micro Raman spectroscopy. The performance of diamond coated WC-Co burs, uncoated WC-Co burs, and diamond embedded (sintered) burs have been compared by drilling a series of holes into various materials such as human tooth, borosilicate glass, and acrylic tooth materials. Flank wear has been used to assess the wear rates of the burs when machining biomedical materials such as those described above.
C1 [Jackson, M. J.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   [Ahmed, W.] Univ Ulster, Nanotechnol Res Inst, Newtownabbey BT37 OQB, Antrim, North Ireland.
RP Jackson, MJ (reprint author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
OI Ahmed, Waqar/0000-0003-4152-5172
CR AGER JW, 1993, PHYS REV B, V48, P2601, DOI 10.1103/PhysRevB.48.2601
   Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5
   Borges CFM, 1999, J PROSTHET DENT, V82, P73, DOI 10.1016/S0022-3913(99)70130-7
   BRADEN M, 1976, BIOPHYSICS TOOTH FRO
   Buck V, 1998, DIAM RELAT MATER, V7, P1544, DOI 10.1016/S0925-9635(98)00237-4
   Cappelli E, 1996, DIAM RELAT MATER, V5, P292, DOI 10.1016/0925-9635(95)00426-2
   CHEN X, 1993, J APPL PHYS, V74, P4168, DOI 10.1063/1.354420
   Endler I, 1999, DIAM RELAT MATER, V8, P834, DOI 10.1016/S0925-9635(98)00359-8
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   INSPEKTOR A, 1994, SURF COAT TECH, V68, P359, DOI 10.1016/0257-8972(94)90186-4
   Kamiya S, 2000, DIAM RELAT MATER, V9, P191, DOI 10.1016/S0925-9635(00)00229-6
   KLASS W, 1997, DIAM RELAT MATER, V6, P240
   LEYENDECKER T, 1991, SURF COAT TECH, V48, P253, DOI 10.1016/0257-8972(91)90013-M
   Lin JC, 1996, HYDROMETALLURGY, V43, P47, DOI 10.1016/0304-386X(96)00023-0
   Lopez JM, 1998, J MATER RES, V13, P2841, DOI 10.1557/JMR.1998.0388
   Lux B, 1996, CERAM INT, V22, P347, DOI 10.1016/0272-8842(95)00109-3
   LUX B, 1991, NATO ADV SCI I B-PHY, V266, P579
   MAY PW, 1994, DIAM RELAT MATER, V3, P810, DOI 10.1016/0925-9635(94)90274-7
   MURAKAWA M, 1991, SURF COAT TECH, V49, P359, DOI 10.1016/0257-8972(91)90083-9
   OAKES J, 1991, SURF COAT TECH, V47, P600, DOI 10.1016/0257-8972(91)90330-Y
   PINES MS, 1979, J AM DENT ASSOC, V99, P831, DOI 10.14219/jada.archive.1979.0403
   Polini R, 2003, SURF COAT TECH, V166, P127, DOI 10.1016/S0257-8972(02)00775-2
   Polo MC, 1997, DIAM RELAT MATER, V6, P579, DOI 10.1016/S0925-9635(96)00643-7
   REINECK I, 1993, SURF COAT TECH, V57, P47, DOI 10.1016/0257-8972(93)90335-L
   SAIJO K, 1990, SURF COAT TECH, V43-4, P30, DOI 10.1016/0257-8972(90)90057-J
   Sein H, 2003, SURF COAT TECH, V163, P196, DOI 10.1016/S0257-8972(02)00618-7
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   TOH H, 1991, J MATER SCI, V26, P370
   Trava-Airoldi VJ, 1998, SURF COAT TECH, V108, P437, DOI 10.1016/S0257-8972(98)00590-8
   WANG DY, 1993, DIAM RELAT MATER, V2, P304, DOI 10.1016/0925-9635(93)90072-A
   Weast R. C., 1989, CRC HDB CHEM PHYS
   YASHIKI T, 1992, SURF COAT TECH, V52, P81, DOI 10.1016/0257-8972(92)90373-I
   ZHU W, 1995, J MATER RES, V10, P1455, DOI 10.1557/JMR.1995.1455
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-843-4
PY 2006
BP 186
EP +
PG 3
WC Materials Science, Biomaterials; Materials Science, Coatings & Films
SC Materials Science
GA BPD40
UT WOS:000278561800032
DA 2018-10-20
ER

PT B
AU Jones, AN
   Ahmed, W
   Rego, CA
   Hassan, IU
   Jackson, MJ
AF Jones, A. N.
   Ahmed, W.
   Rego, C. A.
   Hassan, I. U.
   Jackson, M. J.
BE Jackson, MJ
   Ahmed, W
TI Nanocrystalline Diamond Films: Growth and Gas Phase Modeling Studies in
   Inert Gases
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Surface Engineering Congress (ISEC)
CY AUG 01-03, 2005
CL St Paul, MN
SP ASM Int
DE Modelling; Nanocrystalline diamond; HFCVD; gas-phase chemistry
ID CVD DIAMOND; THIN-FILMS; DEPOSITION; CARBON
AB It is highly desirable for biomedical and nanotechnology applications to be able to deposit smooth adherent diamond films on a variety of substrate materials. The properties of these films are however affected profoundly by the process parameters such as deposition temperature, gas composition, pressure, etc. In this study, we present an insight into the gas phase chemistry involved in the chemical vapor deposition of smooth nanocrystalline diamond films using Ar/CH4/H-2 and He/CH4/H-2 precursor mixtures. Experimental results on the growth, surface morphology and crystalline structure are presented. It is evident that the addition of a noble gas such as argon has a considerable effect on the gas surface chemistry. At low Ar concentrations standard polycrystalline diamond is produced. However, at high concentrations of inert gas dilution (>90 vol % Ar) there are significant changes in the diamond crystallinity ranging from sub micron to nanocrystalline facets at Ar concentrations > 98 vol. %. Modelling of the gas phase chemistry using the CHEMKIN modelling package show that the relative concentrations of the important diamond growth species CH3 and C2H (and by implication C-2) prevailing during the deposition process alter significantly as a function of Ar concentration. This, in turn, affects surface morphology and crystallinity of the deposited films.
C1 [Jones, A. N.; Ahmed, W.; Rego, C. A.] Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
   [Hassan, I. U.] Oman Med Coll, Muscat, Oman.
   [Jackson, M. J.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
RP Jones, AN (reprint author), Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
RI Jones, Abbie/A-2763-2012
OI Jones, Abbie/0000-0002-1350-4617; Ahmed, Waqar/0000-0003-4152-5172
CR Ahmed W, 2000, VACUUM, V56, P153, DOI 10.1016/S0042-207X(99)00147-5
   ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   Bachmann PK, 2001, DIAM RELAT MATER, V10, P809, DOI 10.1016/S0925-9635(01)00377-6
   Busmann HG, 1998, CARBON, V36, P529, DOI 10.1016/S0008-6223(98)00049-9
   Erdemir A, 1999, SURF COAT TECH, V120, P565, DOI 10.1016/S0257-8972(99)00443-0
   ERZ R, 1993, DIAM RELAT MATER, V2, P449, DOI 10.1016/0925-9635(93)90099-N
   Forbes IS, 2002, THIN SOLID FILMS, V420, P508, DOI 10.1016/S0040-6090(02)00854-4
   Hassan IU, 1999, THIN SOLID FILMS, V355, P134, DOI 10.1016/S0040-6090(99)00500-3
   Hian LC, 2003, DIAM RELAT MATER, V12, P590, DOI 10.1016/S0925-9635(02)00402-8
   Jones AN, 2003, J PHYS-CONDENS MAT, V15, pS2969, DOI 10.1088/0953-8984/15/39/020
   LEE RJ, 1995, J APPL PHYS, V79, P7264
   Lopez JM, 2002, APPL SURF SCI, V185, P321, DOI 10.1016/S0169-4332(01)00996-5
   Qin LC, 1998, NANOSTRUCT MATER, V10, P649, DOI 10.1016/S0965-9773(98)00092-0
   Sharda T, 2001, DIAM RELAT MATER, V10, P561, DOI 10.1016/S0925-9635(00)00390-3
NR 14
TC 0
Z9 0
U1 0
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-835-9
PY 2006
BP 253
EP +
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Coatings & Films
SC Science & Technology - Other Topics; Materials Science
GA BPY35
UT WOS:000280332900042
DA 2018-10-20
ER

PT B
AU Polini, R
   Kumashiro, S
   Jackson, MJ
   Amar, M
   Ahmed, W
   Sein, H
AF Polini, R.
   Kumashiro, S.
   Jackson, M. J.
   Amar, M.
   Ahmed, W.
   Sein, H.
BE Jackson, MJ
   Ahmed, W
TI A Study of Diamond Synthesis by Hot Filament Chemical Vapour Deposition
   on Nanocomposite Coatings
SO SURFACE ENGINEERING, PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Surface Engineering Congress (ISEC)
CY AUG 01-03, 2005
CL St Paul, MN
SP ASM Int
DE Chemical Vapour Deposition (CVD); TiN/Si3N4; Superhard coatings;
   Nanocomposite; Diamond
ID GAS-PHASE; NUCLEATION; GROWTH; TOOLS
AB Deposition of diamond films onto various substrates can result in significant technological advantages in terms of functionality and improved life and performance of components. Diamond is hard, wear resistant, chemically inert and biocompatible and considered as the ideal material for surfaces of cutting tools and biomedical components. However, it is well known that diamond deposition onto technologically important substrates such as Co-cemented carbides and steels is problematic due to carbon interaction with the substrate, low nucleation densities and poor adhesion. Several papers previously published in the relevant literature have reported the application of interlayer materials such as metal nitrides and carbides to provide bonding between diamond and hostile substrates. In this study we have investigated for the first time the chemical vapour deposition (CVD) of polycrystalline diamond on TiN/SiNx nanocomposite interlayers deposited at relatively low temperatures. The nanocomposite layers were deposited at 70 degrees C or 400 degrees C on silicon substrates by using a dual ion beam deposition system. The results showed that a preliminary seeding pre-treatment with diamond suspension was necessary to achieve large diamond nucleation densities and that diamond nucleation was larger on nanocomposite films than on bare sc-Si submitted to same pre-treatment and CVD process parameters. TiN/SiNx layers synthesized at 70 degrees C or 400 degrees C underwent different nanostructure modifications during diamond CVD. The data also showed that TiN/SiNx films obtained at 400 degrees C are preferable so far as their use as interlayers between hostile substrates and CVD diamond is concerned.
C1 [Polini, R.; Kumashiro, S.] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
   [Jackson, M. J.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.
   [Amar, M.; Ahmed, W.; Sein, H.] Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
RP Polini, R (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
RI Polini, Riccardo/D-2289-2017
OI Polini, Riccardo/0000-0002-6551-0883; Ahmed, Waqar/0000-0003-4152-5172
CR CHEN X, 1993, J APPL PHYS, V74, P4168, DOI 10.1063/1.354420
   Colligon JS, 2004, PHILOS T ROY SOC A, V362, P103, DOI 10.1098/rsta.2003.1303
   Davis R. F., 1993, DIAMOND FILMS COATIN
   Endler I, 1996, DIAM RELAT MATER, V5, P299, DOI 10.1016/0925-9635(95)00352-5
   FAN WD, 1994, J MATER RES, V9, P2850, DOI 10.1557/JMR.1994.2850
   Faure C, 1999, DIAM RELAT MATER, V8, P830, DOI 10.1016/S0925-9635(98)00363-X
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   IIJIMA S, 1991, J MATER RES, V6, P1491, DOI 10.1557/JMR.1991.1491
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   Jentsch HG, 2000, ADV ENG MATER, V2, P369, DOI 10.1002/1527-2648(200006)2:6<369::AID-ADEM369>3.0.CO;2-8
   LI SZ, 1992, PLASMA CHEM PLASMA P, V12, P287
   Liu H. M., 1995, DIAMOND CHEM VAPOR D
   MITSUDA Y, 1993, DIAM RELAT MATER, V2, P333, DOI 10.1016/0925-9635(93)90077-F
   MOLINARI E, 1992, APPL PHYS LETT, V61, P1287, DOI 10.1063/1.107567
   MOLINARI E, 1992, J MATER RES, V7, P1778, DOI 10.1557/JMR.1992.1778
   Nesladek M, 1995, THIN SOLID FILMS, V270, P184, DOI 10.1016/0040-6090(95)06914-3
   Rebouta L, 2000, SURF COAT TECH, V133, P234, DOI 10.1016/S0257-8972(00)00934-8
   Schwarz S, 2003, DIAM RELAT MATER, V12, P701, DOI 10.1016/S0925-9635(03)00061-X
   Silva S, 1999, DIAM RELAT MATER, V8, P1913, DOI 10.1016/S0925-9635(99)00156-9
   Veprek S, 2000, SURF COAT TECH, V133, P152, DOI 10.1016/S0257-8972(00)00957-9
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-835-9
PY 2006
BP 256
EP +
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Coatings & Films
SC Science & Technology - Other Topics; Materials Science
GA BPY35
UT WOS:000280332900043
DA 2018-10-20
ER

PT J
AU Mahendran, M
   Puspanathan, K
AF Mahendran, M
   Puspanathan, K
TI Shape memory effect in ferromagnetic Ni-Mn-Ga alloy
SO SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL
   CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Conference on Nanomaterials (NANO 2005)
CY JUL 13-15, 2005
CL Mepco Schlenk Engn Coll, Sivakasi, INDIA
HO Mepco Schlenk Engn Coll
DE smart materials; ferromagnetic shape memory alloys; electromagnetic
   actuator; hysteresis curve; magnetic band domains; saturation
   magnetization; martensite; austenite
ID MARTENSITIC-TRANSFORMATION; STRESS; AL
AB The martensitic magnetothermoelastic transformation induced by a magnetic field in FSMA has been studied. It has been observed that the shape memory effect is associated with the reversible magnetic field-induced martensite at higher temperatures. It has been noted that upon cooling from the high temperature austenite parent phase the ferromagnetic shape memory alloys exhibit transition from paramagnetism to ferromagnetism. The Ni-25Mn-25Ga (at%) shows the thermomechanical martensitic transformation. The micrograph shows the martensitic transformation of the alloy that strongly depends on the applied magnetic field. The mechanisms of the magnetic microstructure causes the martensite bands, which run diagonally from left to right in the micrograph, have been observed. It is proposed that the FSMAs are very promising candidates for biomedical applications as the new smart material.
C1 Thiagarajar Coll Engn, Dept Phys, Madurai 6250156, Tamil Nadu, India.
   Mahendra Coll Engn, Dept Phys, Thiruchengodu, India.
RP Mahendran, M (reprint author), Thiagarajar Coll Engn, Dept Phys, Madurai 6250156, Tamil Nadu, India.
EM push72@rediffmail.com
CR Chernenko VA, 2003, J APPL PHYS, V93, P2394, DOI 10.1063/1.1539532
   DURIEG T, 1999, MATER SCI ENG, V149, P273
   DURIEG TW, 1990, ENG ASPECTS SHAPE ME
   Efstathiou C, 2004, SCRIPTA MATER, V51, P979, DOI 10.1016/j.scriptamat.2004.07.014
   Feuchtwanger J., 2004, J MAGN MAGN MATER, V2038, P272
   HECKO O, 2005, J MAGN MAGN MATER, V846, P290
   HECKO O, 2005, J MAGN MAGN MATER, V787, P290
   HECZKO O, 2001, J MAGN MAGN MATER, V996, P226
   Hosoda H, 2000, INT J APPL ELECTROM, V12, P9
   Karaca HE, 2004, SCRIPTA MATER, V51, P261, DOI 10.1016/j.scriptamat.2004.04.002
   Karaca HE, 2003, SCRIPTA MATER, V49, P831, DOI 10.1016/S1359-6462(03)00470-6
   Khovailo VV, 2003, J APPL PHYS, V93, P8483, DOI 10.1063/1.1556218
   KIRA T, 2003, MATER SCI FORUM, V2207, P426
   Kokorin VV, 2001, J MAGN MAGN MATER, V234, P25, DOI 10.1016/S0304-8853(01)00244-X
   Liang YC, 2001, SCRIPTA MATER, V45, P569, DOI 10.1016/S1359-6462(01)01061-2
   MARIONI MA, 2005, J MAGN MAGN MATER, V35, P290
   Murakami Y, 2004, MET MATER-INT, V10, P207
   O'Handley RC, 2000, J APPL PHYS, V87, P4712, DOI 10.1063/1.373136
   Oikawa K, 2001, APPL PHYS LETT, V79, P3290, DOI 10.1063/1.1418259
   Otsuka K., 1999, SHAPE MEMORY MAT
   Segui C, 2005, SCRIPTA MATER, V53, P315, DOI 10.1016/j.scriptamat.2005.04.009
   Sullivan MR, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.094427
   SULLIVAN MR, 2004, PHYS REV B, V70, P94428
   Takeuchi I, 2003, NAT MATER, V2, P180, DOI 10.1038/nmat829
   Ullakko K, 1996, APPL PHYS LETT, V69, P1966, DOI 10.1063/1.117637
   ULLAKKO K, 1997, SCRIPTA METALL, V36, P133
   Zheng HX, 2005, J ALLOY COMPD, V387, P265, DOI 10.1016/j.jallcom.2004.06.088
NR 27
TC 2
Z9 2
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1553-3174
J9 SYNTH REACT INORG ME
JI Synth. React. Inorg. Met.-Org. Nano-Metal Chem.
PY 2006
VL 36
IS 1
BP 83
EP 88
DI 10.1080/15533170500478545
PG 6
WC Chemistry, Inorganic & Nuclear; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA 012AI
UT WOS:000235310200015
DA 2018-10-20
ER

PT J
AU Basumallick, A
   Sarkar, J
   Deb, P
AF Basumallick, A
   Sarkar, J
   Deb, P
TI On the preparation of gamma-Fe2O3 nanoparticles via a low-temperature
   nonaqueous precipitation route
SO SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL
   CHEMISTRY
LA English
DT Article
DE nanoparticles; gamma-Fe2O3; kinetic; heat-treatment; nucleation; growth
ID ALPHA-FE2O3 NANOPARTICLES; PRECURSOR; PARTICLES
AB Maghemite (gamma-Fe2O3) is a technologically important compound as it is the most extensively used material for magnetic disks and tapes. Recently downsizing of electronic components and the need to store information in smaller magnetic volumes has created a demand for developing storage media with ultra fine magnetic materials. gamma-Fe2O3 also possesses high potential for use in magneto optical memory devices, ferrofluid and biomedical devices. Therefore, preparation of gamma-Fe2O3 nanoparticles is gaining considerable interest among the scientists and researchers. Despite a number of processing techniques being developed for preparing gamma-Fe2O3 particles in their nanometric form, most processes require high energy and sophisticated instrumentation. In view of these limitations, herein we report on the development of a simple and reliable route for preparing gamma-Fe2O3 nanoparticles from an organic precursor.
C1 Bengal Engn & Sci Univ, Dept Met & Mat Engn, Howrah 711103, India.
   Tezpur Univ, Dept Phys, Tezpur, India.
RP Basumallick, A (reprint author), Bengal Engn & Sci Univ, Dept Met & Mat Engn, Howrah 711103, India.
EM abm_met@yahoo.com
CR Blaskov V, 1996, J MAGN MAGN MATER, V162, P331, DOI 10.1016/S0304-8853(96)00277-6
   Cowburn RP, 1997, APPL PHYS LETT, V71, P2202, DOI 10.1063/1.119381
   Deb P, 2004, J NANOPART RES, V6, P527, DOI 10.1007/s11051-004-3393-5
   Deb P, 2002, J NANOPART RES, V4, P91, DOI 10.1023/A:1020185515393
   Deb P, 2001, APPL SURF SCI, V182, P398, DOI 10.1016/S0169-4332(01)00458-5
   Deb P, 2001, J MATER RES, V16, P3471, DOI 10.1557/JMR.2001.0477
   Deb P, 2001, SCRIPTA MATER, V45, P341, DOI 10.1016/S1359-6462(01)01039-9
   DYER JR, 1987, APPL ABSORPTION SPEC, P22
   Ennas G, 1999, J MATER RES, V14, P1570, DOI 10.1557/JMR.1999.0210
   GLATTER O, 1982, SMALL ANGLE XRAY SCA
   GUINER A, 1955, SMALL AGGLE SCATTERI
   ISHIKAWA T, 1992, J MATER SCI, V27, P4531, DOI 10.1007/BF00541590
   MARTIN TP, 1992, CHEM PHYS LETT, V196, P113, DOI 10.1016/0009-2614(92)85938-7
   Meding B, 2001, CONTACT DERMATITIS, V45, P341, DOI 10.1034/j.1600-0536.2001.450604.x
   MILLER A, 1967, ARZEINMITEL FORSCH, V17, P921
   MORALES MP, 1994, J SOLID STATE CHEM, V108, P158, DOI 10.1006/jssc.1994.1024
   RAJ K, 1990, J MAGN MAGN MATER, V85, P233, DOI 10.1016/0304-8853(90)90058-X
   Sen D, 2000, MATER RES BULL, V35, P1243
   WILSON MK, 1962, DETERMINATION ORGANI, V2
   OPPORTUNITIES NANOST, V2
NR 20
TC 0
Z9 0
U1 0
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1553-3174
J9 SYNTH REACT INORG ME
JI Synth. React. Inorg. Met.-Org. Nano-Metal Chem.
PY 2006
VL 36
IS 2
BP 179
EP 183
DI 10.1080/15533170500524561
PG 5
WC Chemistry, Inorganic & Nuclear; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA 020ZS
UT WOS:000235952600008
DA 2018-10-20
ER

PT B
AU Abakumov, V
   Trapezon, K
AF Abakumov, Valentin
   Trapezon, Kirill
GP LVIV POLYTECH NATL UNIV
TI Electromechanical actuators in a biomedical apparatus
SO TCSET 2006: MODERN PROBLEMS OF RADIO ENGINEERING, TELECOMMUNICATIONS AND
   COMPUTER SCIENCE, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Modern Problems of Radio Engineering,
   Telecommunication and Computer Science
CY FEB 28-MAR 04, 2006
CL Lviv-Slavsko, UKRAINE
SP Lviv Polytechn Natl Univ, IEEE West Ukraine Chapter, AP, MTT, ED, CPMT, KNIBCTAP, Ykptenekom, UIVIC
DE actuator; fabric; material; displacement; strengthening; oscillation
AB The method of analytical calculation of electromechanical actuators is described, the form of which is set by a function D = x(2)/(x(5) + C). For the practical use four is offered as an example as actuators with the very considerable strengthening.
OI Trapezon, Kirill/0000-0001-5873-9519
CR ABAKUMOV VG, 2004, ELEKTRONIKA SVYAZ, P66
   [Anonymous], 1989, PRILOZHENIYA GRUPP L
   [Anonymous], 1985, KOLEBANIYA INZHENERN
   BERGMAN L, 1957, ULTRAZVUK PRIMENENIY
   EYSNER E, 1967, FIZICHESKAYA AKUSTIK, V1, P339
   Ovsyannikov L.V., 1978, GRUPPOVOI ANALIZ DIF
   PISAREVSKY MM, 1958, TR NAUCHN TEKHN SOVE, P54
NR 7
TC 0
Z9 0
U1 0
U2 0
PU LVIV POLYTECH NATL UNIV
PI LVOV
PA 61 V CHOMOVOL AVE, LVOV 79058, UKRAINE
BN 978-1-4244-1321-8
PY 2006
BP 623
EP 627
PG 5
WC Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BHC24
UT WOS:000252164700227
DA 2018-10-20
ER

PT J
AU Haupt, BJ
   Pelling, AE
   Horton, MA
AF Haupt, B. J.
   Pelling, A. E.
   Horton, M. A.
TI Integrated confocal and scanning probe microscopy for biomedical
   research
SO THESCIENTIFICWORLDJOURNAL
LA English
DT Article
DE atomic force microscopy (AFM); confocal microscopy; fluorescence
   microscopy; cell biology; nanomechanics; mechanotransduction;
   mechanobiology
ID ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; STABLE MICROTUBULES;
   BIOLOGICAL SAMPLES; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; ADHESION
   FORCES; LIVING CELLS; IN-VIVO; AFM
AB Atomic force microscopy (AFM) continues to be developed, not only in design, but also in application. The new focus of using AFM is changing from pure material to biomedical studies. More frequently, it is being used in combination with other optical imaging methods, such as confocal laser scanning microscopy (CLSM) and fluorescent imaging, to provide a more comprehensive understanding of biological systems. To date, AFM has been used increasingly as a precise micromanipulator, probing and altering the mechanobiological characteristics of living cells and tissues, in order to examine specific, receptor-ligand interactions, material properties, and cell behavior. In this review, we discuss the development of this new hybrid AFM, current research, and potential applications in diagnosis and the detection of disease.
C1 UCL, Rayne Inst, Dept Med, London Ctr Nanotechnol,Bone & Mineral Ctr, London WC1E 6JJ, England.
RP Haupt, BJ (reprint author), UCL, Rayne Inst, Dept Med, London Ctr Nanotechnol,Bone & Mineral Ctr, Torrington Pl, London WC1E 6JJ, England.
EM belinda.haupt@ucl.ac.uk; a.pelling@ucl.ac.uk; m.horton@ucl.ac.uk
OI Pelling, Andrew/0000-0003-3732-7472
FU Medical Research Council [qA137861b]; Wellcome Trust
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5
   Charras GT, 2001, ULTRAMICROSCOPY, V86, P85, DOI 10.1016/S0304-3991(00)00076-0
   Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680
   DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599
   Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198
   Fantner GE, 2006, ULTRAMICROSCOPY, V106, P881, DOI 10.1016/j.ultramic.2006.01.015
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Formigli L, 2005, J CELL SCI, V118, P1161, DOI 10.1242/jcs.01695
   Frankel DJ, 2006, BIOPHYS J, V90, P2404, DOI 10.1529/biophysj.105.073692
   FRITZ M, 1994, BIOPHYS J, V66, P1328, DOI 10.1016/S0006-3495(94)80963-4
   Fujihira M, 2001, ULTRAMICROSCOPY, V86, P63, DOI 10.1016/S0304-3991(00)00100-5
   Gannepalli A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037197
   Gradinaru CC, 2004, ULTRAMICROSCOPY, V99, P235, DOI 10.1016/j.ultramic.2003.12.009
   GUNDERSEN GG, 1994, J CELL SCI, V107, P645
   GURLAND G, 1993, P NATL ACAD SCI USA, V90, P8827, DOI 10.1073/pnas.90.19.8827
   Haga H, 2000, ULTRAMICROSCOPY, V82, P253, DOI 10.1016/S0304-3991(99)00157-6
   Han SW, 2005, BIOSENS BIOELECTRON, V20, P2120, DOI 10.1016/j.bios.2004.08.023
   Han SW, 2005, BIOCHEM BIOPH RES CO, V332, P633, DOI 10.1016/j.bbrc.2005.04.059
   Hansma HG, 1997, J STRUCT BIOL, V119, P99, DOI 10.1006/jsbi.1997.3855
   HENDERSON E, 1992, SCIENCE, V257, P1944, DOI 10.1126/science.1411511
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Hobbs JK, 2006, ANALYST, V131, P251, DOI 10.1039/b511330j
   HOH JH, 1994, J CELL SCI, V107, P1105
   Horton M, 2002, J RECEPT SIGNAL TR R, V22, P169, DOI 10.1081/RRS-120014594
   Jena BP, 1997, P NATL ACAD SCI USA, V94, P13317, DOI 10.1073/pnas.94.24.13317
   Johnson K. L., 1985, CONTACT MECH
   Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086
   Kassies R, 2005, J MICROSC-OXFORD, V217, P109, DOI 10.1111/j.0022-2720.2005.01428.x
   Lal R, 1997, INT J IMAG SYST TECH, V8, P293, DOI 10.1002/(SICI)1098-1098(1997)8:3<293::AID-IMA7>3.0.CO;2-5
   Lehenkari PP, 2000, ULTRAMICROSCOPY, V82, P289, DOI 10.1016/S0304-3991(99)00138-2
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   LEHENKARI PP, 2000, EXPERT REV MOL MED, P1
   Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003
   Madl J, 2006, ULTRAMICROSCOPY, V106, P645, DOI 10.1016/j.ultramic.2005.12.020
   MARTI O, 1988, J MICROSC-OXFORD, V152, P803, DOI 10.1111/j.1365-2818.1988.tb01452.x
   Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583
   McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   Obataya F, 2005, BIOSENS BIOELECTRON, V20, P1652, DOI 10.1016/j.bios.2004.07.020
   Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399
   OBERLEITHNER H, 1994, P NATL ACAD SCI USA, V91, P9784, DOI 10.1073/pnas.91.21.9784
   OBERLEITHNER H, 1993, PFLUG ARCH EUR J PHY, V425, P506, DOI 10.1007/BF00374878
   Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a
   Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035
   PARPURA V, 1993, J CELL SCI, V104, P427
   Pesen D, 2005, BIOPHYS J, V88, P670, DOI 10.1529/biophysj.104.049965
   Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292
   Poole K, 2004, FEBS LETT, V565, P53, DOI 10.1016/j.febslet.2004.03.095
   Poole K, 2005, BRIT J CANCER, V92, P1499, DOI 10.1038/sj.bjc.6602515
   Puntheeranurak T, 2006, J CELL SCI, V119, P2960, DOI 10.1242/jcs.03035
   PUTMAN CAJ, 1994, BIOPHYS J, V67, P1749, DOI 10.1016/S0006-3495(94)80649-6
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Sharma A, 2005, FEBS LETT, V579, P2001, DOI 10.1016/j.febslet.2005.02.049
   SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286
   SPUDICH A, 1995, P NATL ACAD SCI USA, V92, P6976, DOI 10.1073/pnas.92.15.6976
   Stayton PS, 1999, NATURE, V397, P20, DOI 10.1038/16145
   Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211
   Uehara H, 2004, ULTRAMICROSCOPY, V100, P197, DOI 10.1016/j.ultramic.2004.01.014
   Verbridge SS, 2006, NANO LETT, V6, P2109, DOI 10.1021/nl061397t
   WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040
   Willemsen OH, 1998, BIOPHYS J, V75, P2220, DOI 10.1016/S0006-3495(98)77666-0
   Wu HW, 1998, SCANNING, V20, P389
   Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326
NR 69
TC 31
Z9 32
U1 0
U2 19
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 THESCIENTIFICWORLDJO
JI TheScientificWorldJOURNAL
PY 2006
VL 6
BP 1609
EP 1618
DI 10.1100/tsw.2006.269
PG 10
WC Environmental Sciences; Multidisciplinary Sciences
SC Environmental Sciences & Ecology; Science & Technology - Other Topics
GA 227DF
UT WOS:000250636700009
PM 17173179
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Liang, SY
AF Liang, Steven Y.
BE Fan, KC
   Gao, W
   Yu, X
   Huang, W
   Hu, P
TI Mechanical machining and metrology at micro/nano scale
SO THIRD INTERNATIONAL SYMPOSIUM ON PRECISION MECHANICAL MEASUREMENTS, PTS
   1 AND 2
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 3rd International Symposium on Precision Mechanical Measurements
CY AUG 02-06, 2006
CL Urumqi, PEOPLES R CHINA
SP Hefei Univ Technol, Natl Taiwon Univ, Dept Mech Engn, Tohoku Univ, Ctr Precis Nanosyst, Int Comm Measurements & Instrumentat, Natl Nat Sci Fdn China, Chinese Soc Measurement
DE precision; accuracy; machining; metrology; micro; nano
ID DUCTILE-REGIME
AB Micro-scale machining performed in a mechanical manner is an ultra-precision material removal process to achieve micron form accuracy and a few nanometer finish. It has gained increasing importance in the manufacture of optical, mechanical, biomedical, and electronic components with intricate details in many industry and consumer products, both as a means to produce final products and to create dies and molds for further mass production. The backbone of science and technology for the success of machining at such fine length scales hinges on the understanding of microstructual machining mechanics, precision control of machine tool motions, miniaturization of cutters, miniaturization of machine tools, and the availability of high resolution metrology. This paper examines a number of recent research developments at Georgia Tech in these areas. On microstructual mechanics, cutting at submicron depth to control brittle-ductile transition of material will be discussed. On precision machine control, compensation of micrometer multitooth runout error through the chip load servo will be illustrated. On cutter miniaturization, the concept of magnetic single-grit abrasive as a micro cutting tool for submicron dimensional accuracy will be presented. On machine tool miniaturization, the downsizing of machining center and its associated benefits on precision will be elaborated. On metrology, a micro laser-based system and acoustic emission systems are presented for the measurement of micro cutting tool locations. The presentation of these topics will focus on the underlying fundamentals of fine scale machining and their implications toward ultra-precision engineering and micro/nano manufacturing.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Liang, SY (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM steven.liang@me.gatech.edu
CR BLACKLEY WS, 1994, J ENG IND-T ASME, V116, P263, DOI 10.1115/1.2901940
   Fang F.Z., 1998, CIRP ANN-MANUF TECHN, V47, P45, DOI DOI 10.1016/S0007-8506(07)62782-6
   LIANG SY, 1997, P 2 INT C IND TOOL S, P141
   Liu K, 2003, TRANSACTIONS OF THE NORTH AMERICAN MANUFACTURING RESEARCH INSTITUTION OF SME, VOL XXXI, 2003, P153
   Lu ZN, 1999, INT J MACH TOOL MANU, V39, P1171, DOI 10.1016/S0890-6955(98)00092-3
   MORRIS JC, 1995, J AM CERAM SOC, V78, P2015, DOI 10.1111/j.1151-2916.1995.tb08612.x
   ROWCLIFFE DJ, 1988, MAT SCI ENG A-STRUCT, V106, P299, DOI 10.1016/0025-5416(88)90710-0
   Toh S. B., 1986, Science of Hard Materials. Proceedings of the International Conference, P865
   VOGLER MP, 2001, T N AM MANUFACTURING, P653
   Wang JJJ, 1996, J ENG IND-T ASME, V118, P111, DOI 10.1115/1.2803631
NR 10
TC 2
Z9 2
U1 1
U2 8
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6351-5
J9 PROC SPIE
PY 2006
VL 6280
DI 10.1117/12.715241
PN 1&2
PG 8
WC Engineering, Mechanical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BFN74
UT WOS:000243347900002
DA 2018-10-20
ER

PT S
AU Yamokoski, EA
   Buczynski, BW
   Stojilovic, N
   Seabolt, JW
   Bloe, LM
   Foster, R
   Zito, N
   Kory, MM
   Steiner, RP
   Ramsier, RD
AF Yamokoski, E. A.
   Buczynski, B. W.
   Stojilovic, N.
   Seabolt, J. W.
   Bloe, L. M.
   Foster, R.
   Zito, N.
   Kory, M. M.
   Steiner, R. P.
   Ramsier, R. D.
BE Zardiackas, LD
   Kraay, MJ
   Freese, HL
TI Influence of exposure conditions on bacterial adhesion to zirconium
   alloys
SO TITANIUM, NIOBIUM, ZIRCONIUM, AND TANTALUM FOR MEDICAL AND SURGICAL
   APPLICATIONS
SE American Society for Testing and Materials Selected Technical Papers
LA English
DT Proceedings Paper
CT Symposium on Titanium, Niobium, Zirconium, and Tantalum for Medical and
   Surgical Applications
CY NOV, 2004
CL Washington, DC
DE zirconium alloys; bacterial adhesion; ANOVA; XPS; FTIR; SEM; optical
   microscopy
ID OXIDIZED ZIRCONIUM; SURFACES; SPECTROSCOPY; OXIDATION; CHROMIUM; WEAR
AB In this paper we combine surface analytical techniques (X-ray photoelectron spectroscopy, X-ray diffraction, infrared reflection absorption spectroscopy, optical and electron microscopy) with viable counts and statistical ANOVA methods to determine the propensity for biological adhesion on zirconium alloy surfaces. We compare the adhesion of laboratory and clinical strains of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa to Zircaloy-2 and Zircadyne-705 materials. Thermal oxidation of the alloys prior to exposure to biological species is also investigated. We present data for 72-h incubation of bacteria and alloys in both shaken and stationary environments. The results of our statistical analysis and experimental observations are relevant to the use of zirconium-based materials for biomedical applications.
C1 [Yamokoski, E. A.; Buczynski, B. W.; Kory, M. M.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Stojilovic, N.; Seabolt, J. W.; Bloe, L. M.; Foster, R.; Zito, N.; Ramsier, R. D.] Univ Akron, Dept Phys, Akron, OH 44325 USA.
   [Stojilovic, N.; Seabolt, J. W.; Ramsier, R. D.] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Steiner, R. P.] Univ Akron, Dept Stat, Akron, OH 44325 USA.
   [Ramsier, R. D.] Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
RP Yamokoski, EA (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
FU NIH-NIBIB [EB003397-01]
FX We acknowledge support for this effort through NIH-NIBIB grant number
   EB003397-01, and we are grateful to Wah Chang for providing the Zry-2
   and Zr705 materials free-of-charge. We are also appreciative of the
   assistance provided by Jeannette Killius of the Northeastern Ohio
   Universities College of Medicine with the SEM phases of this work, and
   for access to the optical microscope by Professor George Chase
CR Baek JH, 2002, J NUCL MATER, V304, P107
   Buczynski BW, 2003, COLLOID SURFACE B, V30, P167, DOI 10.1016/S0927-7765(03)00068-7
   Ede SM, 2004, APPL SPECTROSC, V58, P317, DOI 10.1366/000370204322886672
   Filip Z, 2001, EUR J SOIL BIOL, V37, P137, DOI 10.1016/S1164-5563(01)01078-0
   Good V, 2003, J BONE JOINT SURG AM, V85A, P105, DOI 10.2106/00004623-200300004-00013
   Heuer D, 2003, KEY ENG MAT, V240-2, P789, DOI 10.4028/www.scientific.net/KEM.240-242.789
   Huy LD, 2003, MAT SCI ENG B-SOLID, V104, P163, DOI 10.1016/S0921-5107(03)00190-9
   Kim HG, 2002, J NUCL MATER, V306, P44, DOI 10.1016/S0022-3115(02)01226-6
   McNatt JS, 2002, J PHYS D APPL PHYS, V35, P1855, DOI 10.1088/0022-3727/35/15/306
   Morgan JM, 2002, J APPL PHYS, V91, P9375, DOI 10.1063/1.1476079
   REID G, 1995, SURF SCI REP, V21, P251, DOI 10.1016/0167-5729(94)00006-9
   Reiter G, 2002, LANGMUIR, V18, P5761, DOI 10.1021/la011662k
   Ries MD, 2002, J BONE JOINT SURG AM, V84A, P129, DOI 10.2106/00004623-200200002-00018
   Rubio C, 2002, COLLOID SURFACE B, V24, P193, DOI 10.1016/S0927-7765(01)00242-9
   van der Mei HC, 2000, SURF SCI REP, V39, P3
NR 15
TC 0
Z9 0
U1 0
U2 0
PU AMER SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 0066-0558
BN 0-8031-3497-5
J9 AM SOC TEST MATER
PY 2006
VL 1471
BP 225
EP +
DI 10.1520/STP37559S
PG 3
WC Engineering, Biomedical; Metallurgy & Metallurgical Engineering;
   Materials Science, Biomaterials
SC Engineering; Metallurgy & Metallurgical Engineering; Materials Science
GA BEK08
UT WOS:000237508300017
DA 2018-10-20
ER

PT B
AU Otsuka, H
   Satomi, T
   Ueno, K
   Mitamura, Y
   Tateishi, T
AF Otsuka, H.
   Satomi, T.
   Ueno, K.
   Mitamura, Y.
   Tateishi, T.
BE Somiya, S
   Doyama, M
TI Synthesis of polypyridine-graft-PEG copolymer for long-term stability of
   nonfouling character
SO Transactions of the Materials Research Society of Japan, Vol 31, No 3
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT Joint Symposia of the Materials-Research-Society-of-Japan
CY DEC 09-11, 2005
CL Nihon Univ, Tokyo, JAPAN
SP Mat Res Soc Japan
HO Nihon Univ
DE multipoint anchor; pyridine; interfacial stabilization; nonfouling
ID POLY(ETHYLENE OXIDE); PROTEIN ADSORPTION; CHAIN-LENGTH; SURFACE; GOLD;
   MONOLAYERS; DENSITY; COADSORPTION; TEMPERATURE; PYRIDINE
AB Polypyridine grafted with poly(ethyrene glycol) (Py-g-PEG) have been synthesized. Radical copolymerization of methyl-terminated PEG macromonomer with 4-pyridylmethyl methacrylate homogeneously proceeded and the obtained copolymer spontaneously adsorbs from aqueous solution onto gold surfaces, where the pyridine parts act as the multipoint anchor to the surface and the PEG parts provide the strong steric repulsion between the chains. As a result, the highly protein repellent and stable surface was constructed through multipoint pyridine attachment as compared with singlepoint pyridine attachment. Py-g-PEGs thus shynthesized are promising material to functionalize metal and semidconductor material and to self-assemble into micelle in biotechnological and biomedical field.Instructions for the preparation of camera-ready manuscripts for publication are given.
C1 Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan.
RP Otsuka, H (reprint author), Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.
CR Bain C.D., 1989, J AM CHEM SOC, V111, P312
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Bilic A, 2002, J PHYS CHEM B, V106, P6740, DOI 10.1021/jp020590i
   GLASS JE, 1996, HYDROPHILIC POLYM PE
   HARRIS JM, 1992, POLY ETHYLENE GLYCOL
   Leventis N, 2001, J PHYS CHEM B, V105, P3663, DOI 10.1021/jp0107199
   LI YZ, 1992, J AM CHEM SOC, V114, P2428, DOI 10.1021/ja00033a018
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   Skaff H., 2003, CHEM COMMUN, V52
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   TTOGHTON EB, 1988, LANGMUIR, V4, P365
   Uchida K, 2005, ANAL CHEM, V77, P1075, DOI 10.1021/ac0486140
   Wu DY, 2002, J PHYS CHEM A, V106, P9042, DOI 10.1021/jp025970i
NR 20
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
J9 T MRS JAP
PY 2006
VL 31
IS 3
BP 627
EP 631
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BFK71
UT WOS:000242517100017
DA 2018-10-20
ER

PT S
AU Martin, R
   Sharkawy, A
   Humphrey, J
   Kelmelis, EJ
   Prather, DW
AF Martin, Richard
   Sharkawy, Ahmed
   Humphrey, John
   Kelmelis, Eric J.
   Prather, Dennis W.
BE Braun, PV
   Weiss, SM
TI Integrated optical sensor using a dispersion guided photonic crystal
   structure
SO TUNING THE OPTIC RESPONSE OF PHOTONIC BANDGAP STRUCTURES III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Tuning the Optic Response of Photonic Bandgap Structures
   III
CY AUG 14, 2006
CL San Diego, CA
SP SPIE
DE photonic crystals; dispersion guided; chemical sensor; Mach-Zehnder
   interferometer; Integrated Optics
AB There is a growing need for miniature low-cost chemical sensors for use in monitoring environmental conditions. Applications range from environmental pollution monitoring, industrial process control and homeland security threat detection to biomedical diagnostics. Integrated opto-chemical sensors can provide the required functionality by monitoring chemistry induced changes in the refractive, absorptive, or luminescent properties of materials. Mach-Zehnder (MZ) interferometers, using the phase induced from a chemically reactive film, have shown success for such applications but typically are limited to one chemical analysis per sensor. In this paper we present a MZ-Iike sensor using the dispersion properties of a photonic crystal lattice. Properly engineered dispersion guiding enables the creation of multiple parallel MZ-Iike sensors monitoring different chemical reactions in a device much smaller than a typical MZ sensor. The phase shift induced in one arm of the photonic crystal structure by the chemical reaction of a special film induces a change in the sensor output. The use of a dispersion guiding photonic crystal structure enables the use of lower refractive index materials because the creation of a bandgap is not necessary. This in turn increases coupling efficiency into the device. Other advantages of this type of structure include the ability to guide both TE and TM modes as well as reduced sensitivity to fabrication tolerances. Two-dimensional FDTD analysis is used to optimize and model the effectiveness of the structure.
C1 EM Photon, Newark, DE 19711 USA.
RP Martin, R (reprint author), EM Photon, 51 E Main St,Suite 203, Newark, DE 19711 USA.
EM martin@emphotonics.com
CR *BUS COMM CO INC, 2004, NAN
   Chigrin DN, 2003, OPT EXPRESS, V11, P1203, DOI 10.1364/OE.11.001203
   Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173
   Kosaka H, 1999, APPL PHYS LETT, V74, P1212, DOI 10.1063/1.123502
   LAMBECK PV, 1992, SENSOR ACTUAT B-CHEM, V8, P103, DOI 10.1016/0925-4005(92)85016-P
   Prather DW, 2004, OPT LETT, V29, P50, DOI 10.1364/OL.29.000050
   Pustai DM, 2004, OPT EXPRESS, V12, P1823, DOI 10.1364/OPEX.12.001823
   Sensors, 2006, SENS
   Shi SY, 2004, OPT LETT, V29, P617, DOI 10.1364/OL.29.000617
   Soljacic M, 2002, J OPT SOC AM B, V19, P2052, DOI 10.1364/JOSAB.19.002052
   Witzens J, 2002, IEEE J SEL TOP QUANT, V8, P1246, DOI 10.1109/JSTQE.2002.806693
   Wu LJ, 2003, J LIGHTWAVE TECHNOL, V21, P561, DOI 10.1109/JLT.2003.808773
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6401-5
J9 PROC SPIE
PY 2006
VL 6322
AR 63220I
DI 10.1117/12.681136
PG 10
WC Crystallography; Instruments & Instrumentation; Optics
SC Crystallography; Instruments & Instrumentation; Optics
GA BFI33
UT WOS:000241987900012
DA 2018-10-20
ER

PT S
AU Vacas-Jacques, P
   Strojnik, M
   Paez, G
AF Vacas-Jacques, Paulino
   Strojnik, Marija
   Paez, Gonzalo
BE Gamiz, VL
   Idell, PS
   Strojnik, MS
TI Transmission profile function reconstruction for complex transmission
   interferometry: biomedical applications
SO UNCONVENTIONAL IMAGING II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Unconventional Imaging II
CY AUG 13-14, 2006
CL San Diego, CA
SP SPIE
DE complex transmission interferometry; CTI; transmission profile function;
   TPF; material coherence function; MCF; reconstruction; biomedical
   applications; tissue characterization
ID OPTICAL COHERENCE TOMOGRAPHY; TISSUE; LASER; DIAGNOSTICS; METASTASES;
   DOSIMETRY
AB We propose a novel method to reconstruct Transmission Profile Function (TPF) information based on visibility measurements. In specific occasions, V << 1, the TPF is proportional to the visibility squared. Extremely low visibilities (similar to 10(-8)) hinder the capacity of the technique to recover information. We evaluate three biomedical cases to confirm TPF reconstruction. First, we assess a three-dimensional multilayer skin model to demarcate limits on the reconstruction process. A three-dimensional female breast phantom with spherical tumors is evaluated next. We concentrate on technique performance to describe tissue morphology. Reconstructed TPFs with different resolutions are presented. Agreement between modeled and recovered information is demonstrated. Finally, a healthy and a metastatic liver are analyzed. We demonstrate that a reconstructed TPF comparison enables (potentially) diagnosis of alien tissue.
C1 [Vacas-Jacques, Paulino; Strojnik, Marija; Paez, Gonzalo] Ctr Invest Opt, Apartado Postal 1-948, Leon 37000, Guanajuato, Mexico.
RP Vacas-Jacques, P (reprint author), Ctr Invest Opt, Apartado Postal 1-948, Leon 37000, Guanajuato, Mexico.
EM pvj@cio.mx
FU CONACyT [172068]
FX One of the authors (Vacas-Jacques) would like to express his
   gratefulness to Mariano Rivera PhD., Pablo Mayorga MSc., and Servando
   Cardona MD. for providing OCT data for this work. In addition, the same
   author would like to thank CONACyT for financial support (grant 172068).
CR Bordenave E, 2002, APPL OPTICS, V41, P2059, DOI 10.1364/AO.41.002059
   Dehghani H, 2003, APPL OPTICS, V42, P3117, DOI 10.1364/AO.42.003117
   Esenaliev RO, 1997, P SOC PHOTO-OPT INS, V2979, P71, DOI 10.1117/12.280213
   Esenaliev RO, 2001, OPT LETT, V26, P992, DOI 10.1364/OL.26.000992
   FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510
   Germer CT, 1998, LASER SURG MED, V23, P194, DOI 10.1002/(SICI)1096-9101(1998)23:4<194::AID-LSM2>3.3.CO;2-Y
   Granot E, 2003, J OPT SOC AM A, V20, P1595, DOI 10.1364/JOSAA.20.001595
   Holmer C, 2006, LASER SURG MED, V38, P296, DOI 10.1002/lsm.20300
   HOURDAKIS CJ, 1995, PHYS MED BIOL, V40, P351, DOI 10.1088/0031-9155/40/3/002
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   JARRY G, 1995, APPL OPTICS, V34, P2045, DOI 10.1364/AO.34.002045
   KOELZER J, 1994, P SOC PHOTO-OPT INS, V2326, P143
   LAKOWICZ J, 1994, TOPICS FLUORESCENCE, P7
   Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586
   PAEZ G, 2005, P SPIE, V5883
   Rivera M, 2002, LECT NOTES COMPUT SC, V2352, P621
   STROJNIK M, 2005, P SPIE, V5883
   Troy T L, 1996, J Biomed Opt, V1, P342, DOI 10.1117/12.239905
   TUCHIN VV, 1994, OPT ENG, V33, P3178, DOI 10.1117/12.178900
   TUCHIN VV, 2000, TISSUE OPTICS LIGHT, P13
   VACASJACQUES P, 2005, THESIS CENTRO INVEST, P174
NR 21
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6386-8
J9 PROC SPIE
PY 2006
VL 6307
AR 63070P
DI 10.1117/12.679547
PG 12
WC Optics; Imaging Science & Photographic Technology
SC Optics; Imaging Science & Photographic Technology
GA BFI30
UT WOS:000241987300024
DA 2018-10-20
ER

PT B
AU Alexander, DC
AF Alexander, DC
BE Weickert, J
   Hagen, H
TI An introduction to computational diffusion MRI: the diffusion tensor and
   beyond
SO VISUALIZATION AND PROCESSING OF TENSOR FIELDS
LA English
DT Proceedings Paper
CT Perspective Workshop on Visualization and Processing of Tensor Fields
CY APR 18-23, 2004
CL Schloss Dagstuhl, GERMANY
ID BRAIN WHITE-MATTER; FIBER ORIENTATION; FIELD-GRADIENT; WEIGHTED MRI;
   MONTE-CARLO; UNCERTAINTY; STRATEGIES; TRACKING; SCHEMES; TISSUES
AB This chapter gives an introduction to the principles of diffusion magnetic resonance imaging (MRI) with emphasis on the computational aspects. It introduces the philosophies underlying the technique and shows how to sensitize MRI measurements to the motion of particles within a sample material. The main body of the chapter is a technical review of diffusion MRI reconstruction algorithms, which determine features of the material microstructure from diffusion MRI measurements. The focus is on techniques developed for biomedical diffusion MRI, but most of the methods discussed are applicable beyond this domain. The review begins by showing how the standard reconstruction algorithms in biomedical diffusion MRI, diffusion-tensor MRI and diffusion spectrum imaging, arise from the principles of the measurement process. The discussion highlights the weaknesses of the standard approaches to motivate the development of a new generation of reconstruction algorithms and reviews the current state-of-the-art. The chapter concludes with a brief discussion of diffusion MRI applications, in particular fibre tracking, followed by a summary and a glimpse into the future of diffusion MRI acquisition and reconstruction.
C1 UCL, Dept Comp Sci, London WC1E 6BT, England.
RP Alexander, DC (reprint author), UCL, Dept Comp Sci, Gower St, London WC1E 6BT, England.
EM D.Alexander@cs.ucl.ac.uk
CR ALEXANDER D, 2004, P INT SOC MAGN RES M, P90
   Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209
   ALEXANDER DC, 2005, IN PRESS ANN NEW YOR
   Anderson A., 2002, P 10 ANN M ISMRM HON, P440
   ARMITAGE P, 1971, STAT METHODS MED RES
   Assaf Y, 2004, MAGNET RESON MED, V52, P965, DOI 10.1002/mrm.20274
   BARRICK TR, 2004, P 12 ANN M ISMRM KYO, P619
   BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075
   Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609
   BEHRENS TEJ, 2004, P 12 ANN M ISMRM KYO, P621
   BLINKOV SM, 1968, HUMAN BRAIN FIGURES
   Blyth R., 2003, P 11 ANN M ISMRM TOR, P240
   Brihuega-Moreno O, 2004, MAGNET RESON MED, V51, P1048, DOI 10.1002/mrm.20044
   Callaghan P. T, 1991, PRINCIPLES MAGNETIC
   CHEN Y, 2004, P IEEE INT S BIOM IM
   Ciccarelli O, 2003, NEUROIMAGE, V19, P1545, DOI 10.1016/S1053-8119(03)00190-3
   Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022
   COOK PA, 2004, P IEEE INT S BIOM IM
   Dong Q, 2004, J MAGN RESON IMAGING, V19, P6, DOI 10.1002/jmri.10424
   Dou JG, 2002, MAGNET RESON MED, V48, P105, DOI 10.1002/mrm.10188
   Frank LR, 2002, MAGNET RESON MED, V47, P1083, DOI 10.1002/mrm.10156
   Helgason S., 1999, RADON TRANSFORM
   Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99
   Hsu EW, 1999, MAGNET RESON MED, V41, P992, DOI 10.1002/(SICI)1522-2594(199905)41:5<992::AID-MRM19>3.3.CO;2-P
   Inglis BA, 2001, MAGNET RESON MED, V45, P580, DOI 10.1002/mrm.1079
   Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303
   Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033
   Jones DK, 2003, MAGNET RESON MED, V49, P7, DOI 10.1002/mrm.10331
   Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q
   LEBIHAN D, 1985, CR ACAD SCI II, V301, P1109
   Li TQ, 1997, LANGMUIR, V13, P3570, DOI 10.1021/la970045m
   LIN CP, 2003, P 11 ANN M ISMRM TOR, P2120
   Liu CL, 2004, MAGNET RESON MED, V51, P924, DOI 10.1002/mrm.20071
   Lori NF, 2003, J MAGN RESON, V165, P185, DOI 10.1016/j.jmr.2003.08.011
   Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779
   MANSFIELD P, 1994, MAGN RESON IMAGING, V12, P275, DOI 10.1016/0730-725X(94)91535-0
   MERBOLDT KD, 1985, J MAGN RESON, V64, P479, DOI 10.1016/0022-2364(85)90111-8
   MITRA PP, 1995, J MAGN RESON SER A, V113, P94, DOI 10.1006/jmra.1995.1060
   Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781
   Mori S, 2001, MAGN RESON MED, V46, P18, DOI 10.1002/mrm.1155
   Mori S, 2002, ANN NEUROL, V51, P377, DOI 10.1002/ana.10137
   NEUMAN CH, 1974, J CHEM PHYS, V60, P4508, DOI 10.1063/1.1680931
   Ozarslan E, 2003, MAGNET RESON MED, V50, P955, DOI 10.1002/mrm.10596
   OZARSLAN E, 2004, P IEEE INT S BIOM IM
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Parker GJM, 2003, LECT NOTES COMPUT SC, V2732, P684
   PARKER GJM, IN PRESS PHILOS T RO
   PARKER GJM, IN PRESS NEUROIMAGE
   Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209
   PRESS WH, 1988, NUMERICAL RECIPES C
   Sijbers J, 1998, MAGN RESON IMAGING, V16, P87, DOI 10.1016/S0730-725X(97)00199-9
   STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690
   Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037
   Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268
   Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X
   TUCH DS, 2002, DIFFUSION MRI COMPLE
   Ulug AM, 2002, DEVELOPMENTAL SCI, V5, P286, DOI 10.1111/1467-7687.t01-1-00005
   Wang Z, 2003, LECT NOTES COMPUT SC, V2732, P660
   WEDEEN VJ, 1999, P 7 ANN M ISMRM PHIL, P321
NR 61
TC 22
Z9 22
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-25032-8
PY 2006
BP 83
EP +
DI 10.1007/3-540-31272-2_5
PG 28
WC Mathematics, Applied; Imaging Science & Photographic Technology
SC Mathematics; Imaging Science & Photographic Technology
GA BDV07
UT WOS:000235580100005
DA 2018-10-20
ER

PT J
AU Lee, MY
   Lin, HC
   Chiang, HW
   Lee, WX
   Huang, XD
AF Lee, Ming-Yih
   Lin, Hung-Chia
   Chiang, Hung-Wei
   Lee, Wei-Xun
   Huang, Xian-Dong
TI DEVELOPMENT OF A NON-CONTINUOUS MICRO-FLOW OPTO-WETTING DROPLET
   MANIPULATION TECHNOLOGY
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE TiO2; micro-fluidics; manipulation of liquid droplet; opto-wetting
AB The aim of this study is to develop a non-continuous droplet manipulation technology in contrast to conventional continuous flow micro-fluidic systems. The droplets were manipulated based on the proposed opto-wetting effect. In addition, an experimental ultraviolet (UV) light actuated droplet manipulation system was developed for verifying the opto-wetting droplet manipulation. The proposed opto-wetting effect was achieved by utilizing ultraviolet to activate oxidation-reduction mechanism of nano-TiO2 photo catalyst coated base material. The water-affinity of the base material will changed due to the decreased free-energy of the material surface. Therefore, the contact angle between the liquid droplet and base material will also be changed which facilitates droplet manipulability. The main components of the proposed ultraviolet (UV) light actuated droplet manipulation system include ultraviolet masking device, moving platform and main frame structure. System software and user interface were designed by using Microsoft Visual Basic 6.0 toolkit. Upon completion of the proposed system, experiments were carried out to verify system functionalities. Follow by the controlled variable optimization using Taguchi method and liquid droplet manipulation experiments. The experiment results indicate that by exposure to 6.8mW UV light, the surface tension and hydrophilic property of nano-TiO2 (anatase type, 3.5% concentration, PH 1.5, and with average particle size of 69 nm) coated base material will changed. The change of surface tension and hydrophilic property were critical for droplet manipulation. The moving speed of the liquid droplet was measured as 3.33mm/sec. The results suggest that the opto-wetting system may be effective to overcome the shortcoming of traditional opto-electrowetting technique. The proposed opto-wetting droplet manipulation system could potentially applied for manipulating biomedical or pathological test specimens in the future.
C1 [Lee, Ming-Yih; Lin, Hung-Chia] Chang Gung Univ, Grad Inst Med Mechatron, Taoyuan, Taiwan.
   [Chiang, Hung-Wei; Lee, Wei-Xun; Huang, Xian-Dong] Chang Gung Univ, Grad Inst Mech Engn, Taoyuan, Taiwan.
RP Lee, MY (reprint author), Chang Gung Univ, Grad Inst Mech Engn, Taoyuan, Taiwan.
EM leemiy@mail.cgu.edu.tw
CR Aussillous P, 2001, NATURE, V411, P924, DOI 10.1038/35082026
   Carter M. T., 2002, U.S. Patent, Patent No. [6,444,474, 6444474]
   Chiou PY, 2003, PROC IEEE MICR ELECT, P355
   Cho SK, 2002, PROC IEEE MICR ELECT, P32, DOI 10.1109/MEMSYS.2002.984073
   He B, 2003, PROC IEEE MICR ELECT, P120
   McNeely Michael R, 2003, Patent No. 6607907
   Per A, 2003, Patent No. 6653625
   Scott T, 2003, Patent No. 6599409
   Srinivasan V, 2003, IEEE INT
   Taguchi G, 1992, QUALITY ENG SERIES, V1
   Washizu M, 1998, IEEE T IND APPL, V34, P732, DOI 10.1109/28.703965
   Yang Z, 2003, Patent No. 6622746
NR 12
TC 1
Z9 1
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD DEC 25
PY 2005
VL 17
IS 6
BP 293
EP 299
DI 10.4015/S1016237205000445
PG 7
WC Engineering, Biomedical
SC Engineering
GA V98GX
UT WOS:000213389000004
OA Bronze
DA 2018-10-20
ER

PT J
AU Smet, M
   Gottschalk, C
   Skaria, S
   Frey, H
AF Smet, M
   Gottschalk, C
   Skaria, S
   Frey, H
TI Aliphatic hyperbranched copolyesters by combination of ROP and
   AB(2)-polycondensation
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE biomedical materials; dendrimers; hyperbranched polymers; polyesters
ID RING-OPENING POLYMERIZATION; AROMATIC ETHERIMIDE COPOLYMERS;
   EPSILON-CAPROLACTONE; CARBOXYLIC-ACIDS; POLYMERS; POLYESTERS; AB;
   ARCHITECTURE; ALCOHOLS; ESTERS
AB Hyperbranched aliphatic copolyesters have been prepared by the copolymerization of epsilon-caprolactone and 2,2-bis(hydroxymethyl)butyric acid (AB(2)-monomer), catalyzed by (i) HfCl4(THF)(2) and (ii) diphenylammonium trifluoromethanesulfonate (DPAT), respectively. In both cases, copolymerization by combined ROP/AB(2)-polycondensation was achieved. The degree of branching (DB) and consequently the density of functional groups of the resulting copolyesters were controlled by the comonomer ratio in the feed. Molecular weights in the range (M) over bar (n) = 22000-166000 g.mol(-1) (GPC, PS standards) were obtained, with apparent polydispersity indices of 1.20 to 1.95. The DB was in the range 0.03-0.35. Remarkably, HfCl4(THF)(2) appeared to cause no transesterification of the ester bonds in the hyperbranched polymer formed. Further esterification or functionalization of the hydroxyl end groups of the hyperbranched polymers is therefore possible in a convenient two step/one pot process. The prepared hyperbranched polycaprolactones can be used as multifunctional initiators for the ROP of epsilon-caprolactone, which is also catalyzed by HfCl4(THF)(2), resulting in multi-arm star polymers. Diphenylammonium trifluoromethanesulfonate (DPAT) was also found to catalyze the combination of ROP and AB(2) Polycondensation. However, the applicability of this system is restricted due to side reactions that can lead to crosslinking.
C1 Univ Mainz, Inst Organ Chem, Abt Makromol Chem, D-55099 Mainz, Germany.
   Katholieke Univ Leuven, Dept Chem, B-3001 Louvain, Belgium.
RP Frey, H (reprint author), Univ Mainz, Inst Organ Chem, Abt Makromol Chem, Duesbergweg 10-14, D-55099 Mainz, Germany.
EM hfrey@uni-mainz.de
RI Frey, Holger/C-9849-2009
CR Albertsson AC, 2002, ADV POLYM SCI, V157, P1
   Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Choi J, 2003, MACROMOLECULES, V36, P8630, DOI 10.1021/ma034170i
   Edlund U, 2002, ADV POLYM SCI, V157, P67
   FLORY PJ, 1952, J AM CHEM SOC, V74, P2718, DOI 10.1021/ja01131a008
   Frey H, 1999, ACTA POLYM, V50, P67, DOI 10.1002/(SICI)1521-4044(19990201)50:2/3<67::AID-APOL67>3.0.CO;2-W
   Gao C, 2004, PROG POLYM SCI, V29, P183, DOI 10.1016/j.progpolymsci.2003.12.002
   Holter D, 1997, ACTA POLYM, V48, P30, DOI 10.1002/actp.1997.010480105
   Hult A, 1999, ADV POLYM SCI, V143, P1
   Ishihara K, 2000, SCIENCE, V290, P1140, DOI 10.1126/science.290.5494.1140
   Jikei M, 2001, PROG POLYM SCI, V26, P1233, DOI 10.1016/S0079-6700(01)00018-1
   Jikei M, 2000, MACROMOLECULES, V33, P6228, DOI 10.1021/ma000354a
   Kim YH, 1998, J POLYM SCI POL CHEM, V36, P1685, DOI 10.1002/(SICI)1099-0518(199808)36:11<1685::AID-POLA1>3.3.CO;2-4
   Kowalski A, 1998, MACROMOL RAPID COMM, V19, P567, DOI 10.1002/(SICI)1521-3927(19981101)19:11<567::AID-MARC567>3.3.CO;2-K
   KRICHELDORF HR, 1984, MACROMOLECULES, V17, P2173, DOI 10.1021/ma00140a051
   KRICHELDORF HR, COMMUNICATION
   Kumar A, 2000, BIOMACROMOLECULES, V1, P133, DOI 10.1021/bm990510p
   Larock R. C., 1989, COMPREHENSIVE ORGANI, P966
   Liu MJ, 1999, MACROMOLECULES, V32, P6881, DOI 10.1021/ma990785x
   Markoski LJ, 2001, MACROMOLECULES, V34, P2695, DOI 10.1021/ma0010884
   Markoski LJ, 2000, MACROMOLECULES, V33, P5315, DOI 10.1021/ma991987w
   Otera J., 2001, ANGEW CHEM, V113, P2099
   Paulo C, 2001, MACROMOLECULES, V34, P734, DOI 10.1021/ma001467x
   PENCZEK S, 1999, POLYM MAT SCI ENG, V80, P95
   SIMON PF, 2001, MACROMOLECULES, V34, P1674
   Skaria S, 2002, MACROMOL RAPID COMM, V23, P292, DOI 10.1002/1521-3927(20020301)23:4<292::AID-MARC292>3.0.CO;2-5
   Stridsberg KM, 2002, ADV POLYM SCI, V157, P41
   Sunder A, 2000, CHEM-EUR J, V6, P2499, DOI 10.1002/1521-3765(20000717)6:14<2499::AID-CHEM2499>3.3.CO;2-D
   Trollsas M, 1999, MACROMOLECULES, V32, P9062, DOI 10.1021/ma991039v
   Trollsas M, 1998, J AM CHEM SOC, V120, P4644, DOI 10.1021/ja973678w
   Trollsas M, 1999, MACROMOLECULES, V32, P4917, DOI 10.1021/ma990054x
   Voit B, 2000, J POLYM SCI POL CHEM, V38, P2505, DOI 10.1002/1099-0518(20000715)38:14<2505::AID-POLA10>3.0.CO;2-8
   Wakasugi K, 2000, TETRAHEDRON LETT, V41, P5249, DOI 10.1016/S0040-4039(00)00821-2
   Yates CR, 2004, EUR POLYM J, V40, P1257, DOI 10.1016/j.eurpolymj.2004.02.007
NR 34
TC 19
Z9 21
U1 0
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD DEC 22
PY 2005
VL 206
IS 24
BP 2421
EP 2428
DI 10.1002/macp.200500397
PG 8
WC Polymer Science
SC Polymer Science
GA 000MW
UT WOS:000234467200001
DA 2018-10-20
ER

PT J
AU Baranauskas, V
   Ceragioli, HJ
   Peterlevitz, AC
   Fontana, M
AF Baranauskas, V
   Ceragioli, HJ
   Peterlevitz, AC
   Fontana, M
TI Low residual stress diamond coatings on titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE diamond coatings; pure titanium substrates; hot-filament CVD; prostheses
   and implants
ID PURE TITANIUM; ADHESION
AB Diamond coatings on pure titanium substrates are of interest for tribological and biomedical implants, among others, however, due to the different thermal expansion coefficients of the two materials, it is difficult to grow adherent thick diamond layers on Ti. The aim of this work was to investigate the influence of cooling down the substrate from the deposition temperature to the room temperature and then repeat the deposition process several times, on the quality and stress of the deposited diamond. This process intended to allow a partial relaxation of the diamond/Ti thermal stresses by accommodating the diamond nuclei onto the titanium carbide formed interlayer without detachment from the substrate. A hot-filament chemical vapor deposition system fed with ethanol, highly diluted in hydrogen was employed. Coatings of complete surface coverage with faceted grains of lateral size of about 4 mu m and compressive stress as low as 0.38 GPa have been obtained. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Estadual Campinas, Dept Semicond Instrumentos & Foton, Fac Engn Eletr & Computacao, BR-13083970 Campinas, SP, Brazil.
RP Baranauskas, V (reprint author), Univ Estadual Campinas, Dept Semicond Instrumentos & Foton, Fac Engn Eletr & Computacao, Av Albert Einstein N 400, BR-13083970 Campinas, SP, Brazil.
EM vitor@dsif.fee.unicamp.br
RI Fontana, Marcio/C-2018-2012
OI Fontana, Marcio/0000-0001-9917-5887
CR AMSTUTZ HC, 1994, CLIN ORTHOP RELAT R, V276, P7
   ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   BARANAUSKAS V, 1994, APPL SURF SCI, V79-80, P129, DOI 10.1016/0169-4332(94)90400-6
   Barros M.I.D., 2002, DIAM RELAT MATER, V11, P1544
   BARROS MI, 1999, DIAM RELAT MATER, V8, P1022
   BARROS RCM, 1996, DIAM RELAT MATER, V5, P1323
   BOPPART H, 1985, PHYS REV B, V32, P1423, DOI 10.1103/PhysRevB.32.1423
   Catledge SA, 1995, J APPL PHYS, V78, P7053, DOI 10.1063/1.360409
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   CORAT EJ, 1998, KEY ENG MATER, V138, P195
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Fu YQ, 2003, THIN SOLID FILMS, V424, P107, DOI 10.1016/S0040-6090(02)00908-2
   Fu YQ, 2000, MAT SCI ENG A-STRUCT, V282, P38, DOI 10.1016/S0921-5093(99)00782-0
   Yan BB, 1999, SURF COAT TECH, V115, P256, DOI 10.1016/S0257-8972(99)00248-0
   YARBOROUGH WA, 1990, SCIENCE, V241, P688
NR 15
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 21
PY 2005
VL 200
IS 7
BP 2343
EP 2347
DI 10.1016/j.surfcoat.2005.04.020
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 995JO
UT WOS:000234096800039
DA 2018-10-20
ER

PT J
AU Smith, JJ
   Putta, S
   Walker, JA
   Kump, DK
   Samuels, AK
   Monaghan, JR
   Weisrock, DW
   Staben, C
   Voss, SR
AF Smith, JJ
   Putta, S
   Walker, JA
   Kump, DK
   Samuels, AK
   Monaghan, JR
   Weisrock, DW
   Staben, C
   Voss, SR
TI Sal-Site: Integrating new and existing ambystomatid salamander research
   and informational resources
SO BMC GENOMICS
LA English
DT Article
ID TIGER SALAMANDER; GENE-EXPRESSION; MEXICAN AXOLOTL; CONTRIBUTES;
   EVOLUTION; SYSTEM; GENOME; LINE
AB Salamanders of the genus Ambystoma are a unique model organism system because they enable natural history and biomedical research in the laboratory or field. We developed Sal- Site to integrate new and existing ambystomatid salamander research resources in support of this model system. Sal- Site hosts six important resources: 1) Salamander Genome Project: an information-based web- site describing progress in genome resource development, 2) Ambystoma EST Database: a database of manually edited and analyzed contigs assembled from ESTs that were collected from A. tigrinum tigrinum and A. mexicanum, 3) Ambystoma Gene Collection: a database containing full-length protein- coding sequences, 4) Ambystoma Map and Marker Collection: an image and database resource that shows the location of mapped markers on linkage groups, provides information about markers, and provides integrating links to Ambystoma EST Database and Ambystoma Gene Collection databases, 5) Ambystoma Genetic Stock Center: a website and collection of databases that describe an NSF funded salamander rearing facility that generates and distributes biological materials to researchers and educators throughout the world, and 6) Ambystoma Research Coordination Network: a web- site detailing current research projects and activities involving an international group of researchers. Sal- Site is accessible at http:// www. ambystoma. org.
C1 Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.
   Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.
RP Voss, SR (reprint author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.
EM jjsmit3@uky.edu; putta@uky.edu; jawalk@uky.edu; kevinkump@gmail.uky.edu;
   aksamu2@uky.edu; James.Monaghan@uky.edu; weisrock@uky.edu;
   staben@uky.edu; srvoss@uky.edu
RI Staben, Charles/C-1562-2013; Monaghan, James/G-1620-2011; Smith,
   Jeramiah/D-3537-2011; Weisrock, David/G-3587-2015
FU NCRR NIH HHS [P20 RR016481, 5R24RR016344, R24 RR016344, 2P20RR016481-04]
CR Bachvarova RF, 2004, DEV DYNAM, V231, P871, DOI 10.1002/dvdy.20195
   Beetschen JC, 1996, INT J DEV BIOL, V40, P629
   CHICHILNISKY EJ, 2005, J NEUROSCI, V25, P310
   Denz CR, 2004, BIOCHEM BIOPH RES CO, V320, P1291, DOI 10.1016/j.bbrc.2004.06.084
   Ericsson R, 2004, DEV DYNAM, V231, P237, DOI 10.1002/dvdy.20127
   Fitzpatrick BM, 2004, EVOLUTION, V58, P1282
   HABERMAN ET, 2004, GENOME BIOL, V5, pR67
   Hoffman EA, 1999, ECOLOGY, V80, P1076, DOI 10.2307/177041
   Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x
   LICHT LE, 1991, COMP BIOCHEM PHYS B, V100, P83, DOI 10.1016/0305-0491(91)90089-V
   MARCHAND JE, 2004, J COMP NEUROL, V747, P453
   Parichy DM, 1996, DEV BIOL, V175, P265, DOI 10.1006/dbio.1996.0114
   PARK D, 2004, J COMP PHYSIOL A, V190, P145
   Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54
   Riley SPD, 2003, ECOL APPL, V13, P1263, DOI 10.1890/02-5023
   Rubbo MJ, 2005, CONSERV BIOL, V19, P504, DOI 10.1111/j.1523-1739.2005.00101.x
   Samuels AK, 2005, GENE, V349, P43, DOI 10.1016/j.gene.2004.12.037
   Schnapp E, 2005, DEV DYNAM, V232, P162, DOI 10.1002/dvdy.20203
   Smith JJ, 2005, GENETICS, V171, P1161, DOI 10.1534/genetics.105.046433
   Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5
   Voss SR, 2005, GENETICS, V170, P275, DOI 10.1534/genetics.104.038273
   Voss SR, 2003, MOL ECOL, V12, P1217, DOI 10.1046/j.1365-294X.2003.01806.x
   Voss SR, 2001, GENETICS, V158, P735
   WEISROCK DW, IN PRESS MOL ECOL
   XING L, 2000, BIOINFORMATICS, V17, P744
   Zhang C, 2004, TISSUE CELL, V36, P71, DOI 10.1016/j.tice.2003.10.003
   AMBYSTOMA EST DATABA
   AXOLOTL EST DATABASE
   AMBYSTOMA GENETIC MA
   AMBYSTOMA GENE COLLE
NR 30
TC 41
Z9 42
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD DEC 16
PY 2005
VL 6
AR 181
DI 10.1186/1471-2164-6-181
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 005YJ
UT WOS:000234862000001
PM 16359543
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mostafa, NY
AF Mostafa, NY
TI Characterization, thermal stability and sintering of hydroxyapatite
   powders prepared by different routes
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE hydroxyapatite; mechanochemical synthesis; agglomeration; crystallinity;
   sintering
ID CALCIUM-PHOSPHATE APATITES; SOL-GEL TECHNIQUE; MECHANOCHEMICAL
   SYNTHESIS; HYDROTHERMAL SYNTHESIS; ATOMIC RATIO; TEMPERATURE;
   MICROSTRUCTURE; CALCINATION; COMPOSITES; PARTICLES
AB Hydroxyapatite (HAP) powder precursors have been used as starting material for biomedical applications, such as synthetic bone graft materials and scaffold for hard tissue engineering. Considering the numerous applications of hydroxyapatite, three different routes for HAP powders preparations was investigated. Two powders were prepared by chemical precipitation reactions at 100 degrees C and one by mechanochemical reaction. The powders were characterized using chemical analysis, surface area measurements, laser diffraction, X-ray diffraction (XRD) and SEM. The Ca/P ratios were varied from 1.67 to 1.58. The chemical composition, the crystallinity and the agglomeration characters depend on the preparation route. The effect of powder characteristics on the sinterability was investigated. Although, the thermal stability and hence the start of sintering dependents on the Ca/P ratio, the final sintering density and hence the mechanical properties depends on the agglomeration characteristics and the particle size distribution. Hydroxyapatite powder prepared by mechanochemical route have nano-sized crystallites with a uniform smaller agglomerated particle size distribution and have a butter sinterability. (c) 2005 Elsevier B.V. All rights reserved.
C1 Suez Canal Univ, Fac Sci, Dept Chem, Ismailia 41522, Egypt.
RP Mostafa, NY (reprint author), Suez Canal Univ, Fac Sci, Dept Chem, Ismailia 41522, Egypt.
EM nmost69@yahoo.com
CR Bernache-Assollant D, 2003, J EUR CERAM SOC, V23, P229, DOI 10.1016/S0955-2219(02)00186-3
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   BROWN PW, 1996, BIOMEDICAL BIOL APPL, P37
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fanovich MA, 1998, J MATER SCI-MATER M, V9, P53, DOI 10.1023/A:1008834712212
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P1065, DOI 10.1002/1521-4079(200110)36:8/10<1065::AID-CRAT1065>3.0.CO;2-G
   Gultekil G., 2002, MATER LETT, V56, P142
   GUTMAN E, 1997, MECHANOCHEMISTRY MAT
   HATTORI T, 1990, J AM CERAM SOC, V73, P1803, DOI 10.1111/j.1151-2916.1990.tb09841.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kandori K, 1997, J AM CERAM SOC, V80, P1157
   Kim W, 2000, J MATER SCI, V35, P5401, DOI 10.1023/A:1004859231795
   Kosova NV, 1997, SOLID STATE IONICS, V101, P53, DOI 10.1016/S0167-2738(97)00232-4
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   LI SH, 2002, KEY ENG MATER, V218, P35
   Lim GK, 1996, MATER LETT, V28, P431, DOI 10.1016/0167-577X(96)00095-X
   LIUA Y, 2002, MATER LETT, V56, P496
   Martin RI, 1997, J BIOMED MATER RES, V35, P299, DOI 10.1002/(SICI)1097-4636(19970605)35:3<299::AID-JBM4>3.0.CO;2-C
   MURRAY MGS, 1995, J MATER SCI, V30, P3061, DOI 10.1007/BF01209218
   Papargyris AD, 2002, KEY ENG MATER, V206-2, P83, DOI 10.4028/www.scientific.net/KEM.206-213.83
   RANDOLPH AD, 1986, THEORY PARTICULATE P
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   REY C, 1998, CALCIUM PHOSPHATE BI
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Rodriguez-Clemente R, 1998, J EUR CERAM SOC, V18, P1351, DOI 10.1016/S0955-2219(98)00064-8
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Suzuki S, 1998, J MATER SCI LETT, V17, P381, DOI 10.1023/A:1006526915828
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   TenHuisen KS, 1998, BIOMATERIALS, V19, P2209, DOI 10.1016/S0142-9612(98)00131-8
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   Thangamani N, 2002, CERAM INT, V28, P355, DOI 10.1016/S0272-8842(01)00102-X
   Yeong B, 2001, J AM CERAM SOC, V84, P465
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
   Yoshimura M, 1997, SOLID STATE IONICS, V98, P197, DOI 10.1016/S0167-2738(97)00103-3
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
NR 41
TC 140
Z9 147
U1 4
U2 54
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD DEC 15
PY 2005
VL 94
IS 2-3
BP 333
EP 341
DI 10.1016/j.matchemphys.2005.05.011
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 975QO
UT WOS:000232677200028
DA 2018-10-20
ER

PT J
AU Svenson, S
   Tomalia, DA
AF Svenson, S
   Tomalia, DA
TI Commentary - Dendrimers in biomedical applications - reflections on the
   field
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Editorial Material
DE dendrimers; PAMAM; dendrimer synthesis; drug delivery; gene
   transfection; imaging agents; encapsulation; drug release;
   biocompatibility; MRI; cytotoxicity; artificial proteins; targeting;
   folate receptor
ID POLY(PROPYLENE IMINE) DENDRIMERS; POLY(AMIDOAMINE) PAMAM DENDRIMERS;
   IMAGING CONTRAST AGENTS; CACO-2 CELL MONOLAYERS; GENE-TRANSFER AGENTS;
   POLYAMIDOAMINE DENDRIMERS; IN-VITRO; STARBURST DENDRIMERS; ANTISENSE
   OLIGONUCLEOTIDES; DENDRITIC MACROMOLECULES
AB The formation of particulate systems with well-defined sizes and shapes is of eminent interest in certain medical applications such as drug delivery, gene transfection, and imaging. The high level of control possible over the architectural design of dendrimers; their size, shape, branching length/density, and their surface functionality, clearly distinguishes these structures as unique and optimum carriers in those applications. The bioactive agents may be encapsulated into the interior of the dendrimers or chemically attached/physically adsorbed onto the dendrimer surface, with the option of tailoring the carrier to the specific needs of the active material and its therapeutic applications. In this regard, the high density of exo-presented surface groups allows attachment of targeting groups or functionality that may modify the solution behavior or toxicity of dendrimers. Quite remarkably, modified dendrimers have been shown to act as nano-drugs against tumors, bacteria, and viruses. Recent successes in simplifying and optimizing the synthesis of dendrimers such as the 'lego' and 'click' approaches, provide a large variety of structures while at the same time reducing the cost of their production. The reflections on biomedical applications of dendrimers given in this review clearly demonstrate the potential of this new fourth major class of polymer architecture and indeed substantiate the high hopes for the future of dendrimers. (c) 2005 Published by Elsevier B.V.
C1 Dendrit NanoTechnol Inc, Mt Pleasant, MI 48858 USA.
RP Svenson, S (reprint author), Dendrit NanoTechnol Inc, 2625 Denison Dr, Mt Pleasant, MI 48858 USA.
EM svenson@dnanotech.com; tomalia@dnanotech.com
CR Andre S, 2001, CHEMBIOCHEM, V2, P822, DOI 10.1002/1439-7633(20011105)2:11<822::AID-CBIC822>3.0.CO;2-W
   Arima H, 2001, BIOCONJUGATE CHEM, V12, P476, DOI 10.1021/bc000111n
   Baek MG, 2002, BIOORGAN MED CHEM, V10, P11, DOI 10.1016/S0968-0896(01)00248-6
   Balogh L, 2001, NANO LETT, V1, P18, DOI 10.1021/nl005502p
   Battah SH, 2001, BIOCONJUGATE CHEM, V12, P980, DOI 10.1021/bc010027n
   Beezer AE, 2003, TETRAHEDRON, V59, P3873, DOI 10.1016/S0040-4020(03)00437-X
   Benito JM, 2004, J AM CHEM SOC, V126, P10355, DOI 10.1021/ja047864v
   BEZOUSKA K, 2002, REV MOL BIOTECH, V90, P269, DOI DOI 10.1016/S1389-0352(01)00064-2
   Bhadra D, 2003, INT J PHARM, V257, P111, DOI 10.1016/S0378-5173(03)00132-7
   Bielinska AU, 1999, BIOCONJUGATE CHEM, V10, P843, DOI 10.1021/bc990036k
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Boas U, 2001, J ORG CHEM, V66, P2136, DOI 10.1021/jo001573x
   Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y
   Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000
   Broeren MAC, 2004, ANGEW CHEM INT EDIT, V43, P3557, DOI 10.1002/anie.200453707
   Brothers HM, 1998, J CHROMATOGR A, V814, P233, DOI 10.1016/S0021-9673(98)00419-1
   Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J
   Buschhaus B, 2003, TETRAHEDRON, V59, P3899, DOI 10.1016/S0040-4020(03)00459-9
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Chai MH, 2001, J AM CHEM SOC, V123, P4670, DOI 10.1021/ja002824m
   Chasse TL, 2003, TETRAHEDRON, V59, P3853, DOI 10.1016/S0040-4020(03)00435-6
   Chasse TL, 2003, J AM CHEM SOC, V125, P8250, DOI 10.1021/ja035515f
   Chauhan AS, 2003, J CONTROL RELEASE, V90, P335, DOI 10.1016/S0168-3659(03)00200-1
   Chen CZS, 2000, BIOMACROMOLECULES, V1, P473, DOI 10.1021/bm0055495
   Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4
   Chen W, 2000, MACROMOLECULES, V33, P9169, DOI 10.1021/ma000791p
   Chow HF, 2003, TETRAHEDRON, V59, P3815, DOI 10.1016/S0040-4020(03)00431-9
   Dandliker PJ, 1997, HELV CHIM ACTA, V80, P1773, DOI 10.1002/hlca.19970800603
   Dass CR, 2002, J PHARM PHARMACOL, V54, P3, DOI 10.1211/0022357021771887
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   DeMattei CR, 2004, NANO LETT, V4, P771, DOI 10.1021/nl034957m
   *DENDR, 1998, TOPICS CURR CHEM, V197
   *DENDR 2, 2000, TOPICS CURR CHEM, V210
   *DENDR 3, 2001, TOPICS CURR CHEM, V212
   *DENDR 4, 2001, TOPICS CURR CHEM, V217
   *DENDR 5, 2003, TOPICS CURR CHEM, V228
   Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151
   Devarakonda B, 2004, INT J PHARM, V284, P133, DOI 10.1016/j.ijpharm.2004.07.006
   Doubrovin M, 2004, BIOCONJUGATE CHEM, V15, P1376, DOI 10.1021/bc0498572
   Eichman J. D., 2000, PHARM SCI TECHNOL TO, V3, P232, DOI DOI 10.1016/S1461-5347(00)00273-X
   El-Sayed M, 2003, INT J PHARM, V265, P151, DOI 10.1016/S0378-5173(03)00391-0
   El-Sayed M, 2002, J CONTROL RELEASE, V81, P355, DOI 10.1016/S0168-3659(02)00087-1
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Ferruti P, 2002, MACROMOL RAPID COMM, V23, P332, DOI 10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fischer M, 1999, ANGEW CHEM INT EDIT, V38, P885, DOI 10.1002/(SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO;2-K
   FRANANO FN, 1995, MAGN RESON IMAGING, V13, P201, DOI 10.1016/0730-725X(94)00100-H
   Frechet J., 2001, DENDRIMERS OTHER DEN
   Gebhart CL, 2001, J CONTROL RELEASE, V73, P401, DOI 10.1016/S0168-3659(01)00357-1
   Gerhart J, 2000, J CELL BIOL, V149, P825, DOI 10.1083/jcb.149.4.825
   Gillies ER, 2002, J AM CHEM SOC, V124, P14137, DOI 10.1021/ja028100n
   Gong YH, 2002, ANTIVIR RES, V55, P319, DOI 10.1016/S0166-3542(02)00054-2
   Gorman CB, 2001, ACCOUNTS CHEM RES, V34, P60, DOI 10.1021/ar000044c
   Hansen HC, 1997, J AM CHEM SOC, V119, P6974, DOI 10.1021/ja970859p
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   Hay BP, 2004, BIOCONJUGATE CHEM, V15, P1496, DOI 10.1021/bc8370
   Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C
   Herrmann A, 2003, TETRAHEDRON, V59, P3925, DOI 10.1016/S0040-4020(03)00461-7
   Hong MY, 2003, LANGMUIR, V19, P416, DOI 10.1021/a1020431q
   Hudde T, 1999, GENE THER, V6, P939, DOI 10.1038/sj.gt.3300886
   Hughes JA, 1996, PHARMACEUT RES, V13, P404, DOI 10.1023/A:1016044609972
   Jaaskelainen I, 2000, EUR J PHARM SCI, V10, P187, DOI 10.1016/S0928-0987(00)00068-3
   Jaffres PA, 1998, J CHEM SOC DALTON, P2767, DOI 10.1039/a801510d
   JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226
   JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Jiang DL, 1996, CHEM COMMUN, P1523, DOI 10.1039/cc9960001523
   Joester D, 2003, ANGEW CHEM INT EDIT, V42, P1486, DOI 10.1002/anie.200250284
   Juliano RL, 1999, PHARMACEUT RES, V16, P494, DOI 10.1023/A:1011958726518
   Khopade AJ, 2002, BIOMACROMOLECULES, V3, P1154, DOI 10.1021/bm025562k
   Kobayashi H, 2000, EUR J NUCL MED, V27, P1334, DOI 10.1007/s002590000293
   Kobayashi H, 2001, MAGNET RESON MED, V46, P781, DOI 10.1002/mrm.1257.abs
   Kobayashi H, 2003, BIOCONJUGATE CHEM, V14, P388, DOI 10.1021/bc025633c
   Kobayashi H, 2001, MAGNET RESON MED, V46, P457, DOI 10.1002/mrm.1214
   Kobayashi Hisataka, 2003, Mol Imaging, V2, P1, DOI 10.1162/153535003765276237
   Kojima C, 2000, BIOCONJUGATE CHEM, V11, P910, DOI 10.1021/bc0000583
   Kolhe P, 2003, INT J PHARM, V259, P143, DOI 10.1016/S0378-5173(03)00225-4
   Kono K, 1999, BIOCONJUGATE CHEM, V10, P1115, DOI 10.1021/bc990082k
   Kress J, 2000, CHEM-EUR J, V6, P247, DOI 10.1002/(SICI)1521-3765(20000117)6:2<247::AID-CHEM247>3.0.CO;2-M
   Kubasiak L. A., 2004, POLYM GENE DELIVERY, P133
   Kubasiak LA, UNPUB
   Langereis S, 2004, MACROMOLECULES, V37, P3084, DOI 10.1021/ma035983+
   Lebedeva I, 2000, EUR J PHARM BIOPHARM, V50, P101, DOI 10.1016/S0939-6411(00)00088-6
   Lebreton S, 2003, TETRAHEDRON, V59, P10213, DOI 10.1016/j.tet.2003.10.070
   Lee I, 2002, MACROMOLECULES, V35, P4510, DOI 10.1021/ma010354q
   Lindhorst TK, 2002, TOP CURR CHEM, V218, P201
   Liu MJ, 1999, PHARM SCI TECHNOL TO, V2, P393, DOI 10.1016/S1461-5347(99)00203-5
   Lu ZR, 2003, BIOCONJUGATE CHEM, V14, P715, DOI 10.1021/bc0340464
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Majoral JP, 1999, CHEM REV, V99, P845, DOI 10.1021/cr970414j
   Maksimenko AV, 2003, J GENE MED, V5, P61, DOI 10.1002/jgm.319
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010
   Malik N., 2003, US Pat, Patent No. [6,585,956, 6585956]
   Malik N., 2004, US Pat, Patent No. [6,790,437, 6790437]
   Maraval V, 2003, J ORG CHEM, V68, P6043, DOI 10.1021/jo0344438
   Maraval V, 2003, ANGEW CHEM INT EDIT, V42, P1822, DOI 10.1002/anie.200250827
   Margerum LD, 1997, J ALLOY COMPD, V249, P185, DOI 10.1016/S0925-8388(96)02830-7
   Nagahori N, 2002, CHEMBIOCHEM, V3, P836, DOI 10.1002/1439-7633(20020902)3:9<836::AID-CBIC836>3.0.CO;2-2
   NAYLOR AM, 1989, J AM CHEM SOC, V111, P2339, DOI 10.1021/ja00188a079
   Nicolle GM, 2002, CHEM-EUR J, V8, P1040, DOI 10.1002/1521-3765(20020301)8:5<1040::AID-CHEM1040>3.0.CO;2-D
   Nishiyama N, 2003, BIOCONJUGATE CHEM, V14, P58, DOI 10.1021/bc025597h
   Ohsaki M, 2002, BIOCONJUGATE CHEM, V13, P510, DOI 10.1021/bc015525a
   Paul A, 2003, LASER PHYS, V13, P22
   Pieters RJ, 2004, TRENDS GLYCOSCI GLYC, V16, P243, DOI 10.4052/tigg.16.243
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Recker J, 2000, J AM CHEM SOC, V122, P10298, DOI 10.1021/ja001225c
   Rendle PM, 2004, J AM CHEM SOC, V126, P4750, DOI 10.1021/ja031698u
   Richardson SCW, 2001, BIOMACROMOLECULES, V2, P1023, DOI 10.1021/bm010079f
   Rietveld IB, 2003, TETRAHEDRON, V59, P3821, DOI 10.1016/S0040-4020(03)00432-0
   Rietveld IB, 2001, MACROMOLECULES, V34, P8380, DOI 10.1021/ma010363z
   Roberts HC, 1999, J MAGN RESON IMAGING, V9, P204, DOI 10.1002/(SICI)1522-2586(199902)9:2<204::AID-JMRI8>3.0.CO;2-M
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Rockendorf N, 2001, TOP CURR CHEM, V217, P201
   ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Roy R, 2001, J AM CHEM SOC, V123, P1809, DOI 10.1021/ja002596w
   Roy R, 1996, CURR OPIN STRUC BIOL, V6, P692, DOI 10.1016/S0959-440X(96)80037-6
   Roy R., 2002, REV MOL BIOTECH, V90, P291
   Sanchez-Sancho F, 2002, BIOCONJUGATE CHEM, V13, P647, DOI 10.1021/bc0155824
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Sashiwa H, 2003, BIOMACROMOLECULES, V4, P1244, DOI 10.1021/bm030021w
   SayedSweet Y, 1997, J MATER CHEM, V7, P1199, DOI 10.1039/a700860k
   Shah DS, 2000, INT J PHARM, V208, P41, DOI 10.1016/S0378-5173(00)00534-2
   Shaunak S, 2004, NAT BIOTECHNOL, V22, P977, DOI 10.1038/nbt995
   Shukla S, 2003, BIOCONJUGATE CHEM, V14, P158, DOI 10.1021/bc025586o
   Singh P, 1998, BIOCONJUGATE CHEM, V9, P54, DOI 10.1021/bc970048a
   Smith DK, 1999, HELV CHIM ACTA, V82, P1225
   Smith DK, 1998, CHEM COMMUN, P2501, DOI 10.1039/a806596i
   *STARPH LIM, PROD FOC VIV
   Stears RL, 2000, PHYSIOL GENOMICS, V3, P93
   Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P
   Svenson S, 2004, CURR OPIN COLLOID IN, V9, P201, DOI 10.1016/j.cocis.2004.06.008
   Svenson S, 2004, J DISPER SCI TECHNOL, V25, P101, DOI 10.1081/DIS-120030657
   SVENSON S, 2004, ACM S SERIES, V879
   Takahashi M, 2000, TETRAHEDRON LETT, V41, P8485, DOI 10.1016/S0040-4039(00)01488-X
   Takahashi T, 2003, BIOCONJUGATE CHEM, V14, P764, DOI 10.1021/bc025663f
   Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454
   Tansey W, 2004, J CONTROL RELEASE, V94, P39, DOI 10.1016/j.jconrel.2003.09.005
   TOMALIA DA, 1986, MACROMOLECULES, V19, P2466, DOI 10.1021/ma00163a029
   Tomalia DA, 2004, ALDRICHIM ACTA, V37, P39
   TOMALIA DA, 1995, SCI AM, V272, P62, DOI 10.1038/scientificamerican0595-62
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Tomalia DA, 2000, SUPRAMOLECULAR POLYMERS, P359
   Tomalia DA, 1996, MACROMOL SYMP, V101, P243, DOI 10.1002/masy.19961010128
   Tomalia DA, 1997, CHEM IND, V11, P416
   Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X
   Veprek P, 1999, J PEPT SCI, V5, P203, DOI 10.1002/(SICI)1099-1387(199905)5:5<203::AID-PSC181>3.0.CO;2-N
   Wallimann P, 1997, CHEM REV, V97, P1567, DOI 10.1021/cr960373b
   Wallimann P, 1996, HELV CHIM ACTA, V79, P779, DOI 10.1002/hlca.19960790320
   Wang J, 1998, J AM CHEM SOC, V120, P8281, DOI 10.1021/ja980619p
   Watkins DM, 1997, LANGMUIR, V13, P3136, DOI 10.1021/la9620263
   Weyermann P, 1999, ANGEW CHEM INT EDIT, V38, P3215, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3215::AID-ANIE3215>3.3.CO;2-J
   Wiener EC, 1996, J AM CHEM SOC, V118, P7774, DOI 10.1021/ja9536126
   WIENER EC, 1994, MAGNET RESON MED, V31, P1, DOI 10.1002/mrm.1910310102
   WIENER EC, IN PRESS 9 ANN M EXH, P1106
   Witvrouw M, 2000, MOL PHARMACOL, V58, P1100
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Yoo H, 2000, NUCLEIC ACIDS RES, V28, P4225, DOI 10.1093/nar/28.21.4225
   Yordanov AT, 2002, NANO LETT, V2, P595, DOI 10.1021/nl020246x
   Zanini D, 1997, J AM CHEM SOC, V119, P2088, DOI 10.1021/ja963874n
   Zhang GD, 2003, J CONTROL RELEASE, V93, P141, DOI 10.1016/j.jconrel.2003.05.002
   Zimmerman SC, 2002, NATURE, V418, P399, DOI 10.1038/nature00877
   Zinselmeyer BH, 2002, PHARMACEUT RES, V19, P960, DOI 10.1023/A:1016458104359
NR 164
TC 1147
Z9 1186
U1 17
U2 491
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 14
PY 2005
VL 57
IS 15
BP 2106
EP 2129
DI 10.1016/j.addr.2005.09.018
PG 24
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 998ES
UT WOS:000234302000003
PM 16305813
DA 2018-10-20
ER

PT J
AU Duncan, R
   Izzo, L
AF Duncan, R
   Izzo, L
TI Dendrimer biocompatibility and toxicity
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE dendrimer; dendron; biocompatibility; toxicity; polymer therapeutic;
   biomedical use
ID NEUTRON-CAPTURE THERAPY; EPIDERMAL-GROWTH-FACTOR; POLY(AMIDOAMINE) PAMAM
   DENDRIMERS; HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-DELIVERY APPLICATIONS;
   INTRAVENOUS GENE DELIVERY; MRI CONTRAST AGENTS; IN-VITRO; POLYAMIDOAMINE
   DENDRIMERS; ANTISENSE OLIGONUCLEOTIDES
AB The field of biomedical dendrimers is still in its infancy, but the explosion of interest in dendrimers and dendronised polymers as inherently active therapeutic agents, as vectors for targeted delivery of drugs, peptides and oligonucleotides, and as permcability enhancers able to promote oral and transdermal drug delivery makes it timely to review Current knowledge regarding the toxicology of these dendrimer chemistries (currently under development for biomedical applications). Clinical experience with polymeric excipients, plasma expanders, and most recently the development of more 'classical polymer'-derived therapeutics can be used to guide development of "safe" dendritic polymers. Moreover, in future it will only ever be possible to designate a dendruner as "safe" when related to a specific application. The so far limited clinical experience using dendrimers make it impossible to designate any particular chemistry intrinsically "safe" or "toxic". Although there is widespread concern as to the safety of nano-sized particles, preclinical and clinical experience gained during the development of polymeric excipients, biomedical polymers and polymer therapeutics shows that judicious development of dendrimer chemistry for each specific application will ensure development of safe and important materials for biomedical and pharmaceutical use. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Cardiff Wales, Welsh Sch Pharm, Ctr Polymer Therapeut, Cardiff CF10 3XF, Wales.
   Univ Salerno, Dipartimento Chim, I-84081 Baronissi, SA, Italy.
RP Duncan, R (reprint author), Univ Cardiff Wales, Welsh Sch Pharm, Ctr Polymer Therapeut, Cardiff CF10 3XF, Wales.
EM DuncanR@cf.ac.uk
CR Al-Jamal KT, 2003, INT J PHARM, V254, P33, DOI 10.1016/S0378-5173(02)00678-6
   Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329
   Aulenta F, 2003, EUR POLYM J, V39, P1741, DOI 10.1016/S0014-3057(03)00100-9
   Baigude H, 2004, J POLYM SCI POL CHEM, V42, P1400, DOI 10.1002/pola.11031
   BALOGH LP, 2003, J NUCL MED SS, V44, P1094
   Balzani V, 2003, TOP CURR CHEM, V228, P159, DOI 10.1007/b11010
   Barth RF, 2004, APPL RADIAT ISOTOPES, V61, P899, DOI 10.1016/j.apradiso.2004.05.004
   BARTH RF, 1994, BIOCONJUGATE CHEM, V5, P58, DOI 10.1021/bc00025a008
   Bay S, 1997, J PEPT RES, V49, P620
   Beezer AE, 2003, TETRAHEDRON, V59, P3873, DOI 10.1016/S0040-4020(03)00437-X
   BERNSTEIN DI, 2003, ANTIVIR RES, V57, P89
   Bielinska A, 1996, NUCLEIC ACIDS RES, V24, P2176, DOI 10.1093/nar/24.11.2176
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Borm PJA, 2002, INHAL TOXICOL, V14, P311, DOI 10.1080/08958370252809086
   Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000
   BRESLOW DS, 1976, PURE APPL CHEM, V46, P103, DOI 10.1351/pac197646020103
   BUHLEIER E, 1978, SYNTHESIS-STUTTGART, P155
   CAMINADE AM, IN PRESS ADV DRUG DE
   Capala J, 1996, BIOCONJUGATE CHEM, V7, P7, DOI 10.1021/bc950077q
   Chauhan AS, 2003, J CONTROL RELEASE, V90, P335, DOI 10.1016/S0168-3659(03)00200-1
   Chen HT, 2004, J AM CHEM SOC, V126, P10044, DOI 10.1021/ja048548j
   Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   D'Emanuele A, 2004, J CONTROL RELEASE, V95, P447, DOI 10.1016/j.jconrel.2003.12.006
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   Devarakonda B, 2004, INT J PHARM, V284, P133, DOI 10.1016/j.ijpharm.2004.07.006
   Du YG, 2004, TETRAHEDRON, V60, P6345, DOI 10.1016/j.tet.2004.05.086
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Duncan R, 1998, HUM EXP TOXICOL, V17, P93, DOI 10.1191/096032798678908378
   Duncan R, 1991, PROGR MEMBRANE BIOTE, P121
   Duncan R., 2005, POLYM DRUG DELIVERY, P1
   Duncan R., 2003, HDB ANTICANCER DRUG, P239
   DUNCAN R, ENCY MOL CELL BIOL M, P163
   El-Sayed M, 2003, INT J PHARM, V265, P151, DOI 10.1016/S0378-5173(03)00391-0
   El-Sayed M, 2001, PHARM RES-DORDR, V18, P23, DOI 10.1023/A:1011066408283
   Eliyahu H, 2002, GENE THER, V9, P850, DOI 10.1038/sj.gt.3301705
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   ESFAND R, 1999, BIOCONJUG CHEM, V10, P271
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   FLANAGAN PA, 1990, J BIOACT COMPAT POLY, V5, P151
   Frechet J. M. J., 2001, DENDRIMERS OTHER DEN, P647
   Frechet JMJ, 1996, J MACROMOL SCI PURE, VA33, P1399, DOI 10.1080/10601329608014916
   Fuchs S, 2004, CHEM-EUR J, V10, P1167, DOI 10.1002/chem.200305386
   Giles J, 2004, NATURE, V430, P599, DOI 10.1038/430599b
   GILLIES ER, 2002, J AM CHEM SOC, V154, P14137
   GITSOV I, 1993, MACROMOLECULES, V26, P5621, DOI 10.1021/ma00073a014
   GODDARD P, 1991, J BIOACT COMPAT POL, V6, P4, DOI 10.1177/088391159100600102
   Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h
   Guo CY, 2004, PROG BIOCHEM BIOPHYS, V31, P804
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   Herborn CU, 2003, RADIOLOGY, V229, P217, DOI 10.1148/radiol.2291021033
   Higashiyama S, 2004, KOBUNSHI RONBUNSHU, V61, P587, DOI 10.1295/koron.61.587
   Hollins AJ, 2004, PHARM RES, V21, P458, DOI 10.1023/B:PHAM.0000019300.04836.51
   Hong SP, 2004, BIOCONJUGATE CHEM, V15, P774, DOI 10.1021/bc049962b
   Hussain M, 2004, J CONTROL RELEASE, V99, P139, DOI 10.1016/j.jconrel.2004.06.009
   Ihre HR, 2002, BIOCONJUGATE CHEM, V13, P443, DOI 10.1021/bc010102u
   JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226
   Jevprasesphant R, 2004, J CONTROL RELEASE, V97, P259, DOI 10.1016/j.jconrel.2004.03.022
   Jevprasesphant R, 2003, PHARM RES-DORDR, V20, P1543, DOI 10.1023/A:1026166729873
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Kensinger RD, 2004, ANTIMICROB AGENTS CH, V48, P1614, DOI 10.1128/AAC.48.5.1614-1623.2004
   Kihara F, 2003, BIOCONJUGATE CHEM, V14, P342, DOI 10.1021/bc025613a
   KIM HS, 2003, J NUCL MED, V44, P1091
   Kim T, 2004, BIOMACROMOLECULES, V5, P2487, DOI 10.1021/bm049563j
   Kobayashi H, 2001, MAGNET RESON MED, V46, P795, DOI 10.1002/mrm.1259
   Kobayashi H, 2004, CLIN CANCER RES, V10, P7712, DOI 10.1158/1078-0432.CCR-04-1175
   Kobayashi H, 2004, J MAGN RESON IMAGING, V20, P512, DOI 10.1002/jmri.20147
   Kobayashi H, 2002, KIDNEY INT, V61, P1980, DOI 10.1046/j.1523-1755.2002.00364.x
   Kobayashi H, 2004, J NATL CANCER I, V96, P703, DOI 10.1093/jnci/djh124
   Kobayashi H, 2002, RADIOLOGY, V225, P237
   Kobayashi H, 2001, MAGNET RESON MED, V46, P457, DOI 10.1002/mrm.1214
   Kono K, 1999, BIOCONJUGATE CHEM, V10, P1115, DOI 10.1021/bc990082k
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Langereis S, 2004, MACROMOLECULES, V37, P3084, DOI 10.1021/ma035983+
   Lee JH, 2003, BIOCONJUGATE CHEM, V14, P1214, DOI 10.1021/bc034095g
   Li YG, 2004, NAT MATER, V3, P38, DOI 10.1038/nmat1045
   Lloyd JB, 2000, ADV DRUG DELIVER REV, V41, P189, DOI 10.1016/S0169-409X(99)00065-4
   Mackay ME, 2003, CR CHIM, V6, P747, DOI 10.1016/j.crci.2003.05.003
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010
   Manunta M, 2004, NUCLEIC ACIDS RES, V32, P2730, DOI 10.1093/nar/gkh595
   Marano RJ, 2004, EXP EYE RES, V79, P525, DOI 10.1016/j.exer.2004.06.023
   Margerum LD, 1997, J ALLOY COMPD, V249, P185, DOI 10.1016/S0925-8388(96)02830-7
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   McIntyre JO, 2004, BIOCHEM J, V377, P617, DOI 10.1042/BJ20030582
   Moon WK, 2003, BIOCONJUGATE CHEM, V14, P539, DOI 10.1021/bc0340114
   Nakanishi H, 2003, GENE THER, V10, P434, DOI 10.1038/sj.gt.3301912
   NEWKOME GR, 1996, DENDRITIC MOL CONCEP, P1
   Ohana P., 2004, GENE THER MOL BIOL, V8, P181
   Okuda T, 2003, ORG BIOMOL CHEM, V1, P1270, DOI 10.1039/b212086k
   Ooya T, 2004, BIOCONJUGATE CHEM, V15, P1221, DOI 10.1021/bc049814l
   Ota S, 2002, CANCER RES, V62, P1471
   Patri AK, 2004, BIOCONJUGATE CHEM, V15, P1174, DOI 10.1021/bc0499127
   Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437
   Pospisil M, 2001, ADV EXP MED BIOL, V495, P343
   RIHOVA B, 1989, BIOMATERIALS, V10, P335, DOI 10.1016/0142-9612(89)90075-6
   RIHOVA B, 1984, BIOMATERIALS, V5, P143, DOI 10.1016/0142-9612(84)90048-6
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   RIHOVA B, 1983, FOLIA MICROBIOL, V28, P7
   Rihova B., 1985, MAKROMOL CHEM S, V9, P13
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Roesnecker J, 2003, J GENE MED, V5, P49, DOI 10.1002/jgm.291
   Roovers J, 1999, ADV POLYM SCI, V142, P179
   Roy R, 1997, TOP CURR CHEM, V187, P241
   Sanchez-Sancho F, 2002, BIOCONJUGATE CHEM, V13, P647, DOI 10.1021/bc0155824
   Santhakumaran LM, 2004, NUCLEIC ACIDS RES, V32, P2102, DOI 10.1093/nar/gkh526
   Sashiwa H, 2003, BIOMACROMOLECULES, V4, P1244, DOI 10.1021/bm030021w
   Sato N, 2001, MAGNET RESON MED, V46, P1169, DOI 10.1002/mrm.1314
   Schluter AD, 2000, ANGEW CHEM INT EDIT, V39, P864, DOI 10.1002/(SICI)1521-3773(20000303)39:5<864::AID-ANIE864>3.0.CO;2-E
   SEIB FP, 2004, P INT S CONTR REL BI, V31, P717
   SEIB P, 2005, THESIS CARDIFF U
   SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P67
   SHAUNAK S, 2004, NAT BIOTECHNOL, V22, P1
   SIMECKOVA J, 1986, J BIOACT COMPAT POLY, V1, P20
   Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P
   SVENSON S, IN PRESS ADV DRUG DE
   TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Tansey W, 2004, J CONTROL RELEASE, V94, P39, DOI 10.1016/j.jconrel.2003.09.005
   Thomas TP, 2004, BIOMACROMOLECULES, V5, P2269, DOI 10.1021/bm049704h
   TOMALIA DA, 1991, MACROMOLECULES, V24, P1435, DOI 10.1021/ma00006a039
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   TOMALIA DA, 2001, SUPRAMOLECULAR POLYM, P359
   Vannucci L, 2003, INT J ONCOL, V23, P285
   Vincent L, 2003, INT J CANCER, V105, P419, DOI 10.1002/ijc.11105
   WAGNER E, IN PRESS ADV POLYM S
   Wang SJ, 2003, INVEST RADIOL, V38, P662, DOI 10.1097/01.rli.0000084887.47427.75
   Wang ZX, 2003, J BIOSCI BIOENG, V96, P537, DOI 10.1016/S1389-1723(04)70146-2
   Wilbur DS, 1998, BIOCONJUGATE CHEM, V9, P813, DOI 10.1021/bc980055e
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   Witvrouw M, 2000, MOL PHARMACOL, V58, P1100
   Wiwattanapatapee R, 2000, PHARMACEUT RES, V17, P991, DOI 10.1023/A:1007587523543
   XYLOYIANNIS M, 2003, P INT S CONTR REL BI, V30, P149
   Yang WL, 2004, APPL RADIAT ISOTOPES, V61, P981, DOI 10.1016/j.apradiso.2004.05.071
   YEUNG TK, 1991, CANCER CHEMOTH PHARM, V29, P105, DOI 10.1007/BF00687318
   Yordanov AT, 2003, J MATER CHEM, V13, P1523, DOI 10.1039/b304147f
   Zhao H, 2004, FEBS LETT, V563, P241, DOI 10.1016/S0014-5793(04)00284-4
   Zhou M, 2004, ORG LETT, V6, P3561, DOI 10.1021/ol0485262
NR 144
TC 706
Z9 732
U1 14
U2 311
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 14
PY 2005
VL 57
IS 15
BP 2215
EP 2237
DI 10.1016/j.addr.2005.09.019
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 998ES
UT WOS:000234302000009
PM 16297497
DA 2018-10-20
ER

PT J
AU Cunliffe, D
   Kirby, A
   Alexander, C
AF Cunliffe, D
   Kirby, A
   Alexander, C
TI Molecularly imprinted drug delivery systems
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE imprinted polymers; cross-linked matrices; controlled release; molecular
   recognition; drug delivery; MIP
ID SOFT CONTACT-LENSES; OPENING-METATHESIS POLYMERIZATION; MULTIPLE-POINT
   ADSORPTION; MONODISPERSE POLY(DIVINYLBENZENE) MICROSPHERES;
   POLY(ETHYLENE GLYCOL)-CONTAINING HYDROGELS; INIFERTER-MODIFIED SUPPORTS;
   PRECIPITATION POLYMERIZATION; IN-VITRO; HETEROPOLYMER GEL;
   PHARMACEUTICAL APPLICATIONS
AB Imprinted polymers are well established as molecular recognition materials but are now being increasingly considered for active biomedical applications such as drug delivery. In this review some highlights of recent research into molecularly imprinted drug delivery and controlled release systems are presented. The key factors controlling recognition and release by imprinted polymer matrices are discussed, the current limiting factors in their properties arising from the synthesis of these materials are considered, and the future prospects for imprinted polymers in drug delivery are outlined. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England.
   Mol Recognit Mat Ltd, Cardiff CF1 3XF, S Glam, Wales.
   Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
RP Cunliffe, D (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM David.Cunliffe@port.ac.uk
RI Alexander, Cameron/N-7729-2014
OI Alexander, Cameron/0000-0001-8337-1875
CR Aburto J, 2004, MACROMOLECULES, V37, P2938, DOI 10.1021/ma049961e
   Alexander C, 2003, TETRAHEDRON, V59, P2025, DOI 10.1016/S0040-4020(03)00152-2
   Allender CJ, 2000, INT J PHARM, V195, P39, DOI 10.1016/S0378-5173(99)00355-5
   Alvarez-Lorenzo C, 2000, MACROMOLECULES, V33, P8693, DOI 10.1021/ma000603v
   Alvarez-Lorenzo C, 2004, J CHROMATOGR B, V804, P231, DOI 10.1016/j.jchromb.2003.12.032
   Alvarez-Lorenzo C, 2002, J CONTROL RELEASE, V80, P247, DOI 10.1016/S0168-3659(02)00032-9
   Alvarez-Lorenzo C, 2002, J PHARM SCI, V91, P2182, DOI 10.1002/jps.10209
   Alvarez-Lorenzo C, 2001, LANGMUIR, V17, P3616, DOI 10.1021/la001766f
   Ansell RJ, 1997, J CHROMATOGR A, V787, P55, DOI 10.1016/S0021-9673(97)00643-2
   Ansell RJ, 1998, ANALYST, V123, P1611, DOI 10.1039/a801903g
   Bielawski CW, 2001, POLYMER, V42, P4939, DOI 10.1016/S0032-3861(00)00504-8
   Blanco-Lopez MC, 2004, ANAL BIOANAL CHEM, V378, P1922, DOI 10.1007/s00216-003-2330-2
   Bonferoni MC, 2004, EUR J PHARM BIOPHARM, V57, P465, DOI 10.1016/j.ejpb.2003.12.002
   BROWN JP, 1983, J MED CHEM, V26, P1300, DOI 10.1021/jm00363a015
   Bruggemann O, 2000, J CHROMATOGR A, V889, P15, DOI 10.1016/S0021-9673(00)00350-2
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Cacho C, 2004, J CHROMATOGR B, V802, P347, DOI 10.1016/j.jchromb.2003.12.018
   Carter S, 2003, SUPRAMOL CHEM, V15, P213, DOI 10.1080/1061027031000078284
   Carter SR, 2004, ADV FUNCT MATER, V14, P553, DOI 10.1002/adfm.200305069
   Carter SR, 2002, ADV MATER, V14, P667, DOI 10.1002/1521-4095(20020503)14:9<667::AID-ADMA667>3.0.CO;2-3
   Choi TL, 2003, ANGEW CHEM INT EDIT, V42, P1743, DOI 10.1002/anie.200250632
   Cui DX, 2003, BIOTECHNOL PROGR, V19, P683, DOI 10.1021/bp025791i
   D'Oleo R, 2001, MACROMOLECULES, V34, P4965, DOI 10.1021/ma0101557
   de Boer T, 2002, ELECTROPHORESIS, V23, P1296, DOI 10.1002/1522-2683(200205)23:9<1296::AID-ELPS1296>3.0.CO;2-2
   Dickert FL, 1999, TRAC-TREND ANAL CHEM, V18, P192, DOI 10.1016/S0165-9936(98)00123-X
   Downey JS, 1999, MACROMOLECULES, V32, P2838, DOI 10.1021/ma9812027
   Downey JS, 2001, MACROMOLECULES, V34, P4534, DOI 10.1021/ma000386y
   Duncan R, 2000, CLIN CANCER RES, V6, p4475S
   El-Kamel AH, 2002, INT J PHARM, V241, P47, DOI 10.1016/S0378-5173(02)00234-X
   Enoki T, 2000, PHYS REV LETT, V85, P5000, DOI 10.1103/PhysRevLett.85.5000
   Feast WJ, 1999, J FLUORINE CHEM, V100, P117
   Flores A, 2000, J APPL POLYM SCI, V77, P1841, DOI 10.1002/1097-4628(20000822)77:8<1841::AID-APP22>3.0.CO;2-P
   Frank RS, 1998, J POLYM SCI POL CHEM, V36, P2223, DOI 10.1002/(SICI)1099-0518(19980930)36:13<2223::AID-POLA8>3.0.CO;2-U
   Frank RS, 2002, MACROMOLECULES, V35, P2728, DOI 10.1021/ma001927m
   FRANKLIN VJ, 1993, TRENDS POLYM SCI, V1, P9
   Goh ECC, 2002, MACROMOLECULES, V35, P9983, DOI 10.1021/ma0211028
   Gupta SK, 2003, BRIT J CLIN PHARMACO, V56, P131, DOI 10.1046/j.1365-2125.2003.01836.x
   Haupt K, 2003, ANAL CHEM, V75, p376A, DOI 10.1021/ac031385h
   Haupt K, 2003, CHEM COMMUN, P171, DOI 10.1039/b207596b
   Haupt K, 2000, CHEM REV, V100, P2495, DOI 10.1021/cr990099w
   Hiratani H, 2005, BIOMATERIALS, V26, P1293, DOI 10.1016/j.biomaterials.2004.04.030
   Hiratani H, 2004, BIOMATERIALS, V25, P1105, DOI 10.1016/S0142-9612(03)00622-7
   Hiratani H, 2002, J CONTROL RELEASE, V83, P223, DOI 10.1016/S0168-3659(02)00213-4
   Hiratani H, 2001, LANGMUIR, V17, P4431, DOI 10.1021/la010056m
   Ito K, 2004, MACROMOL SYMP, V207, P1, DOI 10.1002/masy.200450301
   Ito K, 2003, PROG POLYM SCI, V28, P1489, DOI 10.1016/j.progpolymsci.2003.07.001
   Kanekiyo Y, 2003, ANGEW CHEM INT EDIT, V42, P3014, DOI 10.1002/anie.200351381
   Kim B, 2003, BIOMED MICRODEVICES, V5, P333, DOI 10.1023/A:1027313931273
   Kim B, 2002, MACROMOLECULES, V35, P9545, DOI 10.1021/ma021201l
   KOMIYAMA M, 2003, MOL IMPRINTING FUNDA
   Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3
   KRIZ D, 1997, ANAL CHEM, V69, P345
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LI K, 1993, J POLYM SCI POL CHEM, V31, P3257, DOI 10.1002/pola.1993.080311313
   Li P, 2003, POLYM INT, V52, P1799, DOI 10.1002/pi.1381
   Li WH, 1999, J POLYM SCI POL CHEM, V37, P2295, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2295::AID-POLA2>3.0.CO;2-J
   Li WH, 1999, J POLYM SCI POL CHEM, V37, P2899, DOI 10.1002/(SICI)1099-0518(19990801)37:15<2899::AID-POLA23>3.0.CO;2-8
   Li WH, 1998, J POLYM SCI POL CHEM, V36, P1543, DOI 10.1002/(SICI)1099-0518(19980730)36:10<1543::AID-POLA7>3.3.CO;2-4
   Liu XY, 2004, MACROMOL BIOSCI, V4, P680, DOI 10.1002/mabi.200400031
   Liu XY, 2004, MACROMOL BIOSCI, V4, P412, DOI 10.1002/mabi.200300057
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Matyjaszewski K, 2003, MACROMOL SYMP, V195, P25, DOI 10.1002/masy.200390131
   MIYAJIMA M, 1994, EUR POLYM J, V30, P827, DOI 10.1016/0014-3057(94)90011-6
   MIYAJIMA M, 1993, INT J PHARM, V95, P153, DOI 10.1016/0378-5173(93)90402-2
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   MIYAWAKI R, 1995, CLAY SCI, V9, P199
   Molineux G, 2003, PHARMACOTHERAPY, V23, p3S, DOI 10.1592/phco.23.9.3S.32886
   Moritani T, 2001, MACROMOLECULES, V34, P7796, DOI 10.1021/ma010646r
   Norell MC, 1998, J MOL RECOGNIT, V11, P98, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<98::AID-JMR399>3.0.CO;2-Y
   Oral E, 2004, J BIOMED MATER RES A, V68A, P439, DOI 10.1002/jbm.a.20076
   Oya T, 1999, SCIENCE, V286, P1543, DOI 10.1126/science.286.5444.1543
   PANDE VS, 1995, MACROMOLECULES, V28, P2218, DOI 10.1021/ma00111a016
   PANDE VS, 1994, P NATL ACAD SCI USA, V91, P12976, DOI 10.1073/pnas.91.26.12976
   Pande VS, 1997, PHYSICA D, V107, P316, DOI 10.1016/S0167-2789(97)00099-7
   PANDE VS, 1994, J PHYS II, V4, P1771, DOI 10.1051/jp2:1994231
   PANDE VS, 1994, J CHEM PHYS, V101, P8246, DOI 10.1063/1.468195
   Parmpi P, 2004, BIOMATERIALS, V25, P1969, DOI 10.1016/j.biomaterials.2003.08.025
   Patel A, 2004, ANAL CHIM ACTA, V504, P53, DOI 10.1016/j.aca.2003.08.069
   Patel A, 2003, CHEM COMMUN, P88, DOI 10.1039/b208922j
   Peppas NA, 2002, PHARM RES-DORDR, V19, P578, DOI 10.1023/A:1015389609344
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Perez N, 2001, MACROMOLECULES, V34, P830, DOI 10.1021/ma001079v
   Perez N, 2000, J APPL POLYM SCI, V77, P1851, DOI 10.1002/1097-4628(20000822)77:8<1851::AID-APP23>3.0.CO;2-J
   Perez-Moral N, 2004, LANGMUIR, V20, P3775, DOI 10.1021/la0356755
   Puoci F, 2004, MACROMOL BIOSCI, V4, P22, DOI 10.1002/mabi.200300035
   Ruckert B, 2002, J MATER CHEM, V12, P2275, DOI 10.1039/b203115a
   Satchi-Fainaro R, 2003, BIOCONJUGATE CHEM, V14, P797, DOI 10.1021/bc020091k
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schrock RR, 1999, TETRAHEDRON, V55, P8141, DOI 10.1016/S0040-4020(99)00304-X
   Sellergren B, 1999, TRAC-TREND ANAL CHEM, V18, P164, DOI 10.1016/S0165-9936(98)00117-4
   Sellergren B, 2002, ADV MATER, V14, P1204, DOI 10.1002/1521-4095(20020903)14:17<1204::AID-ADMA1204>3.0.CO;2-O
   SELLERGREN B, 2001, MOL IMPRINTED POLYM
   Srebnik S, 2004, CHEM MATER, V16, P883, DOI 10.1021/cm034705m
   Sreenivasan K, 1998, J APPL POLYM SCI, V68, P1863, DOI 10.1002/(SICI)1097-4628(19980613)68:11<1863::AID-APP18>3.0.CO;2-V
   Srichana T, 2001, DRUG DEV IND PHARM, V27, P457, DOI 10.1081/DDC-100104321
   Suedee R, 2002, DRUG DEV IND PHARM, V28, P545, DOI 10.1081/DDC-120003450
   Suedee R, 2002, DRUG DELIV, V9, P19, DOI 10.1080/107175402753413145
   Suedee R, 2000, J CONTROL RELEASE, V66, P135, DOI 10.1016/S0168-3659(99)00261-8
   Sulitzky C, 2002, MACROMOLECULES, V35, P79, DOI 10.1021/ma011303w
   Surugiu I, 2000, ANALYST, V125, P13, DOI 10.1039/a908871g
   Tamayo FG, 2003, ANAL CHIM ACTA, V482, P165, DOI 10.1016/S0003-2670(03)00213-7
   Tighe B.J., 1987, HYDROGELS MED PHARM, P53
   Tighe BJ, 1998, ABSTR PAP AM CHEM S, V216, pU850
   Tomlinson R, 2003, BIOCONJUGATE CHEM, V14, P1096, DOI 10.1021/bc030028a
   Tonge SR, 2001, ADV DRUG DELIVER REV, V53, P109, DOI 10.1016/S0169-409X(01)00223-X
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Tuovinen L, 2004, BIOMATERIALS, V25, P4355, DOI 10.1016/j.biomaterials.2003.11.026
   Ubrich N, 2004, J CONTROL RELEASE, V97, P291, DOI 10.1016/j.jconrel.2004.03.023
   Wang JF, 2003, ANGEW CHEM INT EDIT, V42, P5336, DOI 10.1002/anie.200352298
   Watanabe M, 1998, J AM CHEM SOC, V120, P5577, DOI 10.1021/ja973070n
   Watanabe T, 2001, J CHEM PHYS, V115, P1596, DOI 10.1063/1.1375155
   Wiwattanapatapee R, 2003, J CONTROL RELEASE, V88, P1, DOI 10.1016/S0168-3659(02)00461-3
   Wizeman WJ, 2001, BIOMATERIALS, V22, P1485
   WULFF G, 1987, MAKROMOL CHEM, V188, P731
   Wulff G, 2002, CHEM REV, V102, P1, DOI 10.1021/cr980039a
   Yamashita K, 2003, POLYM J, V35, P545, DOI 10.1295/polymj.35.545
   Ye L, 2001, REACT FUNCT POLYM, V48, P149, DOI 10.1016/S1381-5148(01)00050-5
   Ye L, 1999, ANAL COMMUN, V36, P35, DOI 10.1039/a809014i
   Zhang ZH, 2004, ANAL SCI, V20, P291, DOI 10.2116/analsci.20.291
   Zimmerman SC, 2004, CHEM COMMUN, P5, DOI 10.1039/b304720b
NR 121
TC 166
Z9 172
U1 11
U2 91
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 6
PY 2005
VL 57
IS 12
BP 1836
EP 1853
DI 10.1016/j.addr.2005.07.015
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 993IH
UT WOS:000233947300007
PM 16226341
DA 2018-10-20
ER

PT J
AU Suzuki, D
   Kawaguchi, H
AF Suzuki, D
   Kawaguchi, H
TI Gold nanoparticle localization at the core surface by using
   thermosensitive core-shell particles as a template
SO LANGMUIR
LA English
DT Article
ID PHOTONIC-BAND-GAP; MACROSCOPIC MATERIALS; HYBRID MICROGELS; HOLLOW
   SPHERES; NANOSHELLS; MICROSPHERES; CRYSTALS;
   POLY(N-ISOPROPYLACRYLAMIDE); COLLOIDS; CLUSTERS
AB We report novel thermosensitive hybrid core-shell particles via in situ gold nanoparticle formation using thermosensitive core-shell particles as a template. This method for the in situ synthesis of gold nanoparticles with microgel interiors offers the advantage of eliminating or significantly reducing particle aggregation. In addition, by using thermosensitive microgel structures in which the shell has thermosensitive and gel properties in water-whereas the core itself is a water-insoluble polymer - we wereable to synthesize the gold nanoparticles only at the surface of the core, which had reactive sites to bind metal ions. After the gold nanoparticles were synthesized, electroless gold plating was carried out to control the thickness of the gold nanoshells. The dispersions of the obtained hybrid particles were characterized by dynamic light scattering and UV-vis absorption spectroscopy, and the dried particles were also observed by electron microscopy. Adaptation of the technique shown here will create a number of applications asoptical, electronic, and biomedical functional materials.
C1 Keio Univ, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Kawaguchi, H (reprint author), Keio Univ, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
EM haruma@applc.keio.ac.jp
CR Boal AK, 2000, NATURE, V404, P746
   Breulmann M, 1998, ADV MATER, V10, P237, DOI 10.1002/(SICI)1521-4095(199802)10:3<237::AID-ADMA237>3.0.CO;2-6
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Dokoutchaev A, 1999, CHEM MATER, V11, P2389, DOI 10.1021/cm9900352
   Dong AG, 2002, CHEM COMMUN, P350, DOI 10.1039/b110164c
   Fernandez-Nieves A, 2000, MACROMOLECULES, V33, P2114, DOI 10.1021/ma991520l
   Gittins DI, 2002, ADV MATER, V14, P508, DOI 10.1002/1521-4095(20020404)14:7<508::AID-ADMA508>3.3.CO;2-K
   Gittins DI, 1999, ADV MATER, V11, P737, DOI 10.1002/(SICI)1521-4095(199906)11:9<737::AID-ADMA737>3.0.CO;2-1
   Gorelikov I, 2004, J AM CHEM SOC, V126, P15938, DOI 10.1021/ja0448869
   Graf C, 2002, LANGMUIR, V18, P524, DOI 10.1021/la011093g
   Hirsch LR, 2003, ANAL CHEM, V75, P2377, DOI 10.1021/ac0262210
   Holm R., 1980, Surface and Interface Analysis, V2, P96, DOI 10.1002/sia.740020305
   Hu ZB, 2001, ADV MATER, V13, P1708, DOI 10.1002/1521-4095(200111)13:22<1708::AID-ADMA1708>3.3.CO;2-C
   Ji TH, 2001, ADV MATER, V13, P1253, DOI 10.1002/1521-4095(200108)13:16<1253::AID-ADMA1253>3.0.CO;2-T
   Jones CD, 2003, MACROMOLECULES, V36, P1988, DOI 10.1021/ma021079q
   KATO T, 1994, POLYM GELS NETW, V2, P307, DOI 10.1016/0966-7822(94)90015-9
   Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808
   Kroll E, 1996, CHEM MATER, V8, P1594, DOI 10.1021/cm960095x
   Liang ZJ, 2003, CHEM MATER, V15, P3176, DOI 10.1021/cm031014h
   Lyon LA, 2004, J PHYS CHEM B, V108, P19099, DOI 10.1021/jp048486j
   Maeda Y, 2001, LANGMUIR, V17, P6855, DOI 10.1021/la0106438
   Maye MM, 2002, J AM CHEM SOC, V124, P4958, DOI 10.1021/ja025724k
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Moroz A, 2000, EUROPHYS LETT, V50, P466, DOI 10.1209/epl/i2000-00292-4
   Moroz A, 1999, PHYS REV LETT, V83, P5274, DOI 10.1103/PhysRevLett.83.5274
   MUSICK MD, 1997, J CHEM MAT, V9, P1499
   OHSHIMA H, 1993, J COLLOID INTERF SCI, V159, P512, DOI 10.1006/jcis.1993.1356
   Oldenburg SJ, 1999, APPL PHYS LETT, V75, P2897, DOI 10.1063/1.125183
   Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2
   Pham T, 2002, LANGMUIR, V18, P4915, DOI 10.1021/la015561y
   PROAN E, 2003, SCIENCE, V302, P419
   Salgueirino-Maceira V, 2003, J PHYS CHEM B, V107, P10990, DOI 10.1021/jp034302+
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Shenton W, 1999, ADV MATER, V11, P449, DOI 10.1002/(SICI)1521-4095(199904)11:6<449::AID-ADMA449>3.0.CO;2-A
   Shi WL, 2005, LANGMUIR, V21, P1610, DOI 10.1021/la047628y
   Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L
   Suzuki D, 2005, LANGMUIR, V21, P8175, DOI 10.1021/la0504356
   Tsuji S, 2005, LANGMUIR, V21, P2434, DOI 10.1021/la047477z
   Tsuji S, 2004, LANGMUIR, V20, P2449, DOI 10.1021/la030333k
   Virtanen J, 2001, J POLYM SCI POL CHEM, V39, P3716, DOI 10.1002/pola.10017
   Wang ZL, 1998, ADV MATER, V10, P13, DOI 10.1002/(SICI)1521-4095(199801)10:1<13::AID-ADMA13>3.0.CO;2-W
   Weissman JM, 1996, SCIENCE, V274, P959, DOI 10.1126/science.274.5289.959
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
   Westcott SL, 1998, LANGMUIR, V14, P5396, DOI 10.1021/la980380q
   Xu SQ, 2003, ADV FUNCT MATER, V13, P468, DOI 10.1002/adfm.200304338
   YAMAMOTO F, 1979, J POLYM SCI POL PHYS, V17, P1581, DOI 10.1002/pol.1979.180170910
   Zhang JG, 2004, J AM CHEM SOC, V126, P7908, DOI 10.1021/ja031523k
   Zhang WY, 2000, PHYS REV LETT, V84, P2853, DOI 10.1103/PhysRevLett.84.2853
NR 50
TC 87
Z9 91
U1 3
U2 76
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 6
PY 2005
VL 21
IS 25
BP 12016
EP 12024
DI 10.1021/la0516882
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 990GC
UT WOS:000233730200071
PM 16316147
DA 2018-10-20
ER

PT J
AU Bodecchi, LM
   Cocchi, M
   Malagoli, M
   Manfredini, M
   Marchetti, A
AF Bodecchi, LM
   Cocchi, M
   Malagoli, M
   Manfredini, M
   Marchetti, A
TI Application of infrared spectroscopy and multivariate quality-control
   methods in PVC manufacturing
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE PVC; industrial manufacturing; FTIR/ATR; quality-control method;
   multivariate control charts; 3-way PCA
ID BIOMEDICAL DISPOSABLE DEVICES; PRINCIPAL COMPONENT ANALYSIS;
   RADIATION-INDUCED MIGRATION; MONITORING BATCH PROCESSES; VALIDATION;
   ADDITIVES; CHARTS
AB This work aims at exploring the potentiality of the Fourier transform IR spectroscopy (FTIR) to study the effects that can be generated on plastic materials based on poly(vinyl chloride) (PVC) used for extra-corporal medical disposables, after industrial processes such as extrusion, sterilization and conservation. In particular, FTIR equipped with a single attenuated total reflection accessory (ATR) mounted on an infrared microscope (Mic-IR) has been used. At the same time, this paper proposes a quality-control method for semi-finished blood circuits' components, based on the chemometric evaluation of surface-selective spectroscopic signals, i.e. Mic-IR/ATR spectra. Results suggest that IR spectroscopic technique coupled with a multivariate approach might represent a simple and powerful method for quality control of industrial processes. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy.
   Gambro Dasco SpA, I-41036 Modena, Italy.
RP Marchetti, A (reprint author), Univ Modena & Reggio Emilia, Dept Chem, Via G Campi, I-41100 Modena, Italy.
EM marchetti.andrea@unimore.it
RI Cocchi, Marina/B-9006-2013
OI Cocchi, Marina/0000-0001-8764-4981
CR *AAMI TIR, 1997, 17 AAMI TIR
   Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X
   ANDREW KN, 1995, PROCESS ANAL CHEM
   Atzei D, 2003, SURF INTERFACE ANAL, V35, P673, DOI 10.1002/sia.1590
   Bacalogulu R., 2001, PVC STABILIZERS PLAS, P428
   BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201
   Barthus RC, 2002, SPECTROSC LETT, V35, P729, DOI 10.1081/SL-120014943
   Cho J, 1997, ANAL CHIM ACTA, V348, P303, DOI 10.1016/S0003-2670(97)00094-9
   Coates PD, 2003, POLYMER, V44, P5937, DOI 10.1016/S0032-3861(03)00544-5
   Fisch M, 1998, J VINYL ADDIT TECHN, V4, P4, DOI 10.1002/vnl.10002
   Flaten GR, 2004, CHEMOMETR INTELL LAB, V72, P101, DOI 10.1016/j.chemolab.2004.03.003
   GELADI P, 1989, CHEMOMETR INTELL LAB, V7, P11, DOI 10.1016/0169-7439(89)80108-X
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302
   JACKSON JE, 1979, TECHNOMETRICS, V21, P341, DOI 10.2307/1267757
   KRESTA JV, 1991, CAN J CHEM ENG, V69, P35, DOI 10.1002/cjce.5450690105
   Louwerse DJ, 1999, J CHEMOMETR, V13, P491, DOI 10.1002/(SICI)1099-128X(199909/10)13:5<491::AID-CEM537>3.3.CO;2-U
   Manfredini M, 2003, SURF INTERFACE ANAL, V35, P395, DOI 10.1002/sia.1547
   NOMIKOS P, 1994, AICHE J, V40, P1361, DOI 10.1002/aic.690400809
   NOMIKOS P, 1995, TECHNOMETRICS, V37, P41, DOI 10.2307/1269152
   Rannar S, 1998, CHEMOMETR INTELL LAB, V41, P73, DOI 10.1016/S0169-7439(98)00024-0
   Reis MM, 2004, MACROMOL SYMP, V206, P165, DOI 10.1002/masy.200450213
   Shield SR, 2003, J APPL POLYM SCI, V88, P1653, DOI 10.1002/app.11849
   SMILDE AK, 1992, CHEMOMETR INTELL LAB, V15, P143, DOI 10.1016/0169-7439(92)85005-N
   Tates AA, 1999, IND ENG CHEM RES, V38, P4769, DOI 10.1021/ie9901067
   Thissen U, 2001, ANAL CHIM ACTA, V446, P371
   TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464
   van Sprang ENM, 2002, CHEM ENG SCI, V57, P3979, DOI 10.1016/S0009-2509(02)00338-X
   Vanderburgh PM, 1998, MEAS PHYS ED EXERC S, V2, P153
   Westerhuis JA, 2000, ANAL CHEM, V72, P5322, DOI 10.1021/ac000532y
   Westerhuis JA, 1999, J CHEMOMETR, V13, P397, DOI 10.1002/(SICI)1099-128X(199905/08)13:3/4<397::AID-CEM559>3.0.CO;2-I
   Wilson RH, 1999, TRAC-TREND ANAL CHEM, V18, P85, DOI 10.1016/S0165-9936(98)00107-1
   Woo L, 1998, THERMOCHIM ACTA, V324, P179, DOI 10.1016/S0040-6031(98)00534-6
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
   2002, EUROPEAN PHARMACOPOE, V4
NR 35
TC 12
Z9 12
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD DEC 4
PY 2005
VL 554
IS 1-2
BP 207
EP 217
DI 10.1016/j.aca.2005.08.023
PG 11
WC Chemistry, Analytical
SC Chemistry
GA 987CO
UT WOS:000233496200030
DA 2018-10-20
ER

PT J
AU Kim, HW
   Song, JH
   Kim, HE
AF Kim, HW
   Song, JH
   Kim, HE
TI Nanoriber generation of gelatin-hydroxyapatite biomimetics for guided
   tissue regeneration
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID SCAFFOLDS; MINERALIZATION; COLLAGEN; BONE; NANOCOMPOSITES
AB The development of biomimetic bone matrices is one of the major goals in the bone-regeneration and tissue-engineering fields. Nanocomposites consisting of a natural polymer and hydroxyapatite (HA) nanocrystals, which mimic the human bone matrix, are thus regarded as promising bone regenerative materials. Herein, we developed a biomimetic nanocomposite with a novel nanofibrous structure by employing an electrospinning (ES) method. The HA precipitate/gelatin matrix nanocomposites are lyophilized and dissolved in an organic solvent, and then electrospun under controlled conditions. With this process, we can successfully generate a continuous fiber with a diameter of the order of hundreds of nanometers. The internal structure of the nanofiber features a typical nanocomposite, i.e., HA nanocrystals well distributed within a gelatin matrix. These nanocomposite fibers improve the bone-derived cellular activity significantly when compared to the pure gelatin equivalent. This method of generating a nanofiber of the biomimetic nanocomposite was effective in producing a biomedical membrane with a composition gradient, which is potentially applicable in the field of guided tissue regeneration (GTR).
C1 Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151742, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Coll Dent, Dept Dent Biomat, Seoul 330714, South Korea.
EM hwkim@snu.ac.kr
RI Xu, Qingguo/C-1962-2014; Song, Juha/P-1927-2017
OI Xu, Qingguo/0000-0003-3191-0771; Song, Juha/0000-0002-3503-680X
CR BOSKEY AL, 1989, J PHYS CHEM-US, V93, P1628, DOI 10.1021/j100341a086
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M
   RODAN GA, 1984, BONE MINERAL RES ANN, V2, P244
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   WORD GA, 1977, SCI TECHNOLOGY GELAT
   Yamauchi K, 2004, BIOMATERIALS, V25, P5481, DOI 10.1016/j.biomaterials.2003.12.057
NR 18
TC 260
Z9 270
U1 10
U2 126
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD DEC
PY 2005
VL 15
IS 12
BP 1988
EP 1994
DI 10.1002/adfm.200500116
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 994EH
UT WOS:000234012900011
DA 2018-10-20
ER

PT J
AU Einstein, DR
   Freed, AD
   Stander, N
   Fata, B
   Vesely, I
AF Einstein, DR
   Freed, AD
   Stander, N
   Fata, B
   Vesely, I
TI Inverse parameter fitting of biological tissues: A response surface
   approach
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT International Biofluids Mechanics Symposium
CY DEC 12-14, 2003
CL Pasadena, CA
SP US Natl Comm Biomech, Biomed Engn Soc, Int Federat Med & Biol Engn
DE LS-OPT; nonlinear continuum mechanics; finite element analysis
ID FINITE-ELEMENT CHARACTERIZATION; SOFT-TISSUES; OPTIMIZATION
AB In this paper, we present the application of a semiglobal inverse method for determining material parameters of biological tissues. The approach is based on the successive response surface method, and is illustrated by fitting constitutive parameters to two nonlinear anisotropic constitutive equations, one for aortic sinus and aorticwall, the other for aortic valve tissue. Material test data for the aortic sinus consisted of two independent orthogonal uniaxial tests. Material test data for the aortic valve was obtained from a dynamic inflation test. In each case, a numerical simulation of the experiment was performed and predictions were compared to the real data. For the uniaxial test simulation, the experimental targets were force at a measured displacement. For the inflation test, the experimental targets were the three-dimensional coordinates of material markers at a given pressure. For both sets of tissues, predictions with converged parameters showed excellent agreement with the data, and we found that the method was able to consistently identify model parameters. We believe the method will find wide application in biomedical material characterization and in diagnostic imaging.
C1 Pacific NW Normal Lab, Richland, WA 99354 USA.
   NASA, John H Glenn Res Ctr, Biosci & Technol Branch, Cleveland, OH USA.
   Livermore Software Technol Corp, Livermore, CA USA.
   Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.
   Univ So Calif, Keck Sch Med, Los Angeles, CA USA.
   Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.
RP Einstein, DR (reprint author), Pacific NW Normal Lab, 790 6th St,MS P7-56, Richland, WA 99354 USA.
EM daniel.einstein@pnl.gov
OI Freed, Alan/0000-0002-3492-0628
CR Adamczyk MM, 2002, J HEART VALVE DIS, V11, P688
   BATHE KJ, 2004, ADINA THEORY MODELIN
   Cox SE, 2001, J GLOBAL OPTIM, V21, P415, DOI 10.1023/A:1012782825166
   Freed AD, 2005, BIOMECH MODEL MECHAN, V4, P100, DOI 10.1007/s10237-005-0069-8
   FREED AD, 2005, ASME J, V127, P587
   Goldberg D. E, 1989, GENETIC ALGORITHMS S
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Kauer M, 2002, MED IMAGE ANAL, V6, P275, DOI 10.1016/S1361-8415(02)00085-3
   Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968
   MOULTON MJ, 1995, J BIOMECH, V28, P935, DOI 10.1016/0021-9290(94)00144-S
   Myers R. H., 2002, RESPONSE SURFACE MET
   Roux WJ, 1998, INT J NUMER METH ENG, V42, P517, DOI 10.1002/(SICI)1097-0207(19980615)42:3<517::AID-NME370>3.0.CO;2-L
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   Seshaiyer P, 2003, J BIOMECH ENG-T ASME, V125, P363, DOI 10.1115/1.1574333
   Snyman JA, 2000, COMPUT MATH APPL, V40, P1085, DOI 10.1016/S0898-1221(00)85018-X
   SPENCER AJ, 1972, DEFORMATIONS FIBRE R
   Stander N, 2002, ENG COMPUTATION, V19, P431, DOI 10.1108/02644400210430190
   STANDER N, 2005, STRUCT MULTIDISCIP O, V29, P92
   STANDER N, 2004, LS OPT USERS MANUAL
   SUSSMAN T, 1987, COMPUT STRUCT, V26, P357, DOI 10.1016/0045-7949(87)90265-3
   WOOD GA, 1986, J BIOMECH, V19, P781, DOI 10.1016/0021-9290(86)90201-0
NR 21
TC 20
Z9 20
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2005
VL 33
IS 12
BP 1819
EP 1830
DI 10.1007/s10439-005-8338-3
PG 12
WC Engineering, Biomedical
SC Engineering
GA 999NC
UT WOS:000234395300020
PM 16389530
DA 2018-10-20
ER

PT J
AU Boccafoschi, F
   Habermehl, J
   Vesentini, S
   Mantovani, D
AF Boccafoschi, F
   Habermehl, J
   Vesentini, S
   Mantovani, D
TI Biological performances of collagen-based scaffolds tor vascular tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE collagen; blood compatibility; endothelial cells; smooth muscle cells;
   platelet adhesion
ID SMOOTH-MUSCLE-CELLS; GRAFT PROSTHESES; CROSS-LINKING; IN-VITRO;
   BIOMATERIALS; MECHANISMS; INVITRO; MODEL
AB Collagen is widely used for biomedical applications and it could represent a valid alternative scaffold material for vascular tissue engineering. In this work, reconstituted collagen films were prepared from neutralized acid-soluble solutions for subsequent haemocompatibility and cell viability performance assays. First, haemoglobin-free, thrombelastography and platelet adhesion tests were performed in order to investigate the blood contact performance. Secondly, specimens were seeded with endothelial cells and smooth muscle cells, and cell viability tests were carried out by MTT and SEM. Results show that neutralized acid-soluble type I collagen films do not enhance blood coagulation, do not alter normal viscoelastic properties of blood and slightly activate platelet adhesion and aggregation. Cell culture shows that the samples are adequate substrates to support the adhesion and proliferation of endothelial and smooth muscle cells. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Laval, Lab Biomat & Bioengn, Ste Foy, PQ G1K 7P4, Canada.
   Univ Piemonte Orientale, Res Ctr Biocompatibil, Human Anat Lab, Novara, Italy.
   Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
RP Mantovani, D (reprint author), Univ Laval, Lab Biomat & Bioengn, Ste Foy, PQ G1K 7P4, Canada.
EM diego.mantovani@gmn.ulaval.ca
OI Boccafoschi, Francesca/0000-0002-6734-5447; Mantovani,
   Diego/0000-0001-9672-895X
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Bernardo A, 2004, J THROMB HAEMOST, V2, P660, DOI 10.1111/j.1538-7836.2004.00661.x
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Bou-Gharios G, 2004, CELL PROLIFERAT, V37, P207, DOI 10.1111/j.1365-2184.2004.00306.x
   BRUCK SD, 1983, BIOMATER ARTIF CELL, V11, P271, DOI 10.3109/10731198309118813
   CALLOW AD, 1988, INT ANGIOL, V7, P246
   Carrillo A, 2002, VET IMMUNOL IMMUNOP, V89, P91, DOI 10.1016/S0165-2427(02)00170-8
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Kahn ML, 2004, SEMIN THROMB HEMOST, V30, P419, DOI 10.1055/s-2004-833477
   Kanda K, 1993, ASAIO J, V39, pM561
   KAWAMOTO Y, 1990, BIOCHIM BIOPHYS ACTA, V1035, P361, DOI 10.1016/0304-4165(90)90101-2
   Kopp J., 2004, CELL TISSUE BANK, V5, P81, DOI 10.1023/B:CATB.0000034082.29214.3d
   KOTTKEMARCHANT K, 1986, BIOMATERIALS, V7, P441, DOI 10.1016/0142-9612(86)90032-3
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   Naughton GK, 1999, CLIN PLAST SURG, V26, P579
   Nicolas FL, 1997, BIOMATERIALS, V18, P815, DOI 10.1016/S0142-9612(97)00003-3
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Savage B, 1999, BLOOD, V94, P2704
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   SIXMA JJ, 1991, J BIOMAT SCI-POLYM E, V3, P17
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   Song J, 2000, IN VITRO CELL DEV-AN, V36, P600
   TOMOKIYO K, 2004, IN PRESS BLOOD 1 EDI
   UMEMURA Y, 1988, BIOMATERIALS, V9, P133, DOI 10.1016/0142-9612(88)90111-1
   Varela O, 1998, EUR J CLIN INVEST, V28, P313
   Vig S, 2001, BLOOD COAGUL FIBRIN, V12, P555, DOI 10.1097/00001721-200110000-00008
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   World Health Organization, 2003, WORLD HLTH REP
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
NR 32
TC 117
Z9 122
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 35
BP 7410
EP 7417
DI 10.1016/j.biomaterials.2005.05.052
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 962RP
UT WOS:000231750200022
PM 15998538
DA 2018-10-20
ER

PT J
AU Santerre, JP
   Woodhouse, K
   Laroche, G
   Labow, RS
AF Santerre, JP
   Woodhouse, K
   Laroche, G
   Labow, RS
TI Understanding the biodegradation of polyurethanes: From classical
   implants to tissue engineering materials
SO BIOMATERIALS
LA English
DT Review
DE degradation; biodegradation; polyurethanes; oxidation; hydrolysis;
   enzymes; implants; polymers; macrophages; bioresorbable; biostability;
   tissue regeneration; scaffolds
ID MONOCYTE-DERIVED MACROPHAGES; SURFACE-MODIFYING MACROMOLECULES; POROUS
   POLYESTERURETHANE FOAM; ENZYME-INDUCED BIODEGRADATION; HUMAN NEUTROPHILS
   ADHERENT; HARD-SEGMENT CHEMISTRY; CARDIAC PACING LEADS; IN-VITRO
   DEGRADATION; CHOLESTEROL ESTERASE; POLY(ETHERURETHANE UREA)
AB After almost half a century of use in the health field, polyurethanes (PUs) remain one of the most popular group of biomaterials applied for medical devices. Their popularity has been sustained as a direct result of their segmented block copolymeric character, which endows them with a wide range of versatility in terms of tailoring their physical properties, blood and tissue compatibility, and more recently their biodegradation character. While they became recognized in the 1970s and 1980s as the blood contacting material of choice in a wide range of cardiovascular devices their application in long-term implants fell under scrutiny with the failure of pacemaker leads and breast implant coatings containing PUs in the late 1980s. During the next decade PUs became extensively researched for their relative sensitivity to biodegradation and the desire to further understand the biological mechanisms for in vivo biodegradation. The advent of molecular biology into mainstream biomedical engineering permitted the probing of molecular pathways leading to the biodegradation of these materials. Knowledge gained throughout the 1990s has not only yielded novel PUs that contribute to the enhancement of biostability for in vivo long-term applications, but has also been translated to form a new class of bioresorbable materials with all the versatility of PUs in terms of physical properties but now with a more integrative nature in terms of biocompatibility. The current review will briefly survey the literature, which initially identified the problem of PU degradation in vivo and the subsequent studies that have led to the field's further understanding of the biological processes mediating the breakdown. An overview of research emerging on PUs sought for use in combination (drug+ polymer) products and tissue regeneration applications will then be presented. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Fac Dent, Biomat Discipline, Toronto, ON M5G 1G6, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   Univ Laval, Dept Min Met & Mat Engn, Ste Foy, PQ G1K 7P4, Canada.
   CHUQ, Hop St Francois, Ctr Rech, Unite Biotechnol & Bioingn, Quebec City, PQ G1L 3L5, Canada.
   Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Biomat Discipline, 124 Edward St, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@utoronto.ca
CR AITHAL US, 1990, J MACROMOL SCI R M C, VC30, P43
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1992, BIODEGRADABLE POLYM, P122
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BATHICH C, 1989, J BIOMED MATER RES, V23, P311
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   BUCKY LP, 1994, PLAST RECONSTR SURG, V93, P1123, DOI 10.1097/00006534-199405000-00002
   BURKE JJ, 1973, BLOCK GRAFT COPOLYME, P157
   CARDY RH, 1979, J NATL CANCER I, V62, P1107
   Casas J, 1999, J BIOMED MATER RES, V46, P475, DOI 10.1002/(SICI)1097-4636(19990915)46:4<475::AID-JBM5>3.0.CO;2-J
   CHAWLA AS, 1988, BIOMATER ARTIF CELL, V16, P785, DOI 10.3109/10731198809117569
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Cohn D, 2002, J BIOMED MATER RES, V59, P273, DOI 10.1002/jbm.1242
   Elliott S, 2002, J BIOMAT SCI-POLYM E, V13, P691, DOI 10.1163/156856202320269166
   Erfle DJ, 1997, CARDIOVASC PATHOL, V6, P333, DOI 10.1016/S1054-8807(97)00031-8
   Ernsting MJ, 2003, J BIOMAT SCI-POLYM E, V14, P1411, DOI 10.1163/156856203322599743
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   GANTA SR, 2003, J BIOMED MATER RES, V64, P238
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   GUNATILLAKE PA, 1995, Patent No. 540391
   GUNATILLAKE PA, 1996, Patent No. 970619
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HITUNEN K, 1994, MACROMOLECULES, V30, P373
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jahangir R, 2003, BIOMATERIALS, V24, P121, DOI 10.1016/S0142-9612(02)00269-7
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   KAO WJ, 1994, J BIOMED MATER RES, V28, P515
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   LABOW RS, UNPUB BIOMATERIALS, DOI DOI 10.1016/J.BIOMATERIALS.2005.05.048
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lelah M. D., 1986, POLYURETHANES MED
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Mackay TG, 1996, ARTIF ORGANS, V20, P1017, DOI 10.1111/j.1525-1594.1996.tb04589.x
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   Nakaoka R, 2000, J BIOMED MATER RES, V49, P99, DOI 10.1002/(SICI)1097-4636(200001)49:1<99::AID-JBM12>3.3.CO;2-2
   PANDE GS, 1983, PACE, V6, P858
   PARINS DJ, 1985, ASTM STP, V859, P322
   PAYNTER RW, 1988, J BIOMED MATER RES, V22, P687, DOI 10.1002/jbm.820220803
   Phillips R E, 1988, J Biomater Appl, V3, P207, DOI 10.1177/088532828800300204
   Pinchuk L, 1988, J Biomater Appl, V3, P260, DOI 10.1177/088532828800300206
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Saad B, 2000, ARTIF ORGANS, V24, P939, DOI 10.1046/j.1525-1594.2000.06664.x
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   SABOORI AM, 1990, J BIOL CHEM, V265, P19792
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SANTERRE JP, 2004, 7 WORLD BIOM C SYDN
   SANTERRE JP, 1995, J AM CHEM SOC, P352
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOENTA.R, 1968, NATURE, V219, P1162, DOI 10.1038/2191162a0
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   SLADE CL, 1982, PLAST RECONSTR SURG, V70, P379, DOI 10.1097/00006534-198209000-00018
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   Smith T. L., 1976, RUBBER CHEM TECH, V49, P64
   SMITH TL, 1977, POLYM ENG SCI, V17, P129, DOI 10.1002/pen.760170302
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   Tang YW, 2003, BIOMATERIALS, V24, P2805, DOI 10.1016/S0142-9612(03)00081-4
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   Thakahara A., 1991, J BIOMED MATER RES, V25, P341
   Thakahara A., 1992, J BIOMED MATER RES, V26, P801
   Vandecasteele SJ, 2004, J BACTERIOL, V186, P2236, DOI 10.1128/JB.186.8.2236-2239.2004
   WAGNER H, 1977, PLAST RECONSTR SURG, V60, P49, DOI 10.1097/00006534-197707000-00007
   Wang GB, 1997, J BIOMED MATER RES, V36, P407, DOI 10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.3.CO;2-U
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   Wang GB, 2000, MACROMOLECULES, V33, P7321, DOI 10.1021/ma990882q
   WARD RS, 1989, IEEE ENG MED BIO JUN, P22
   WARD RS, 1987, POLYURETHANES BIOMED, P213
   Wen JM, 1997, MACROMOLECULES, V30, P7206, DOI 10.1021/ma961442r
   WHITE KA, 1996, BIOMATERIALS SCI, P27
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   WOODHOUSE K, COMMUNICATION
   WU YK, 1994, J BIOMED MATER RES, V28, P515, DOI 10.1002/jbm.820280414
   Yang ML, 2001, BIOMACROMOLECULES, V2, P134, DOI 10.1021/bm000087g
   Zhang JY, 2000, BIOMATERIALS, V21, P1247, DOI 10.1016/S0142-9612(00)00005-3
   Zhang JY, 2003, TISSUE ENG, V9, P1143, DOI 10.1089/10763270360728053
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
   ZHAO Q, 1987, POLYMER, V35, P328
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 117
TC 415
Z9 441
U1 22
U2 323
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2005
VL 26
IS 35
BP 7457
EP 7470
DI 10.1016/j.biomaterials.2005.05.079
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 962RP
UT WOS:000231750200027
PM 16024077
DA 2018-10-20
ER

PT J
AU Mata, A
   Fleischman, AJ
   Roy, S
AF Mata, A
   Fleischman, AJ
   Roy, S
TI Characterization of polydimethylsiloxane (PDMS) properties for
   biomedical micro/nanosystems
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE polydimethylsiloxane; PDMS; poly(dimethylsiloxane); mechanical
   properties; micromachining; microfabrication; MEMS; microsystems;
   contact angle; sterilization; tensile strength; structural properties;
   nanotechnology; nanosystems
ID SOFT LITHOGRAPHY; MICROFLUIDIC SYSTEMS; MECHANICAL-PROPERTIES; SURFACE
   MODIFICATION; DRUG-DELIVERY; POLY(DIMETHYLSILOXANE); DEVICES;
   MICROFABRICATION; CELLS; MEMS
AB Polydimethylsiloxane (PDMS Sylgard(R) 184, Dow Corning Corporation) pre-polymer was combined with increasing amounts of cross-linker (5.7, 10.0, 14.3, 21.4, and 42.9 wt.%) and designated PDMS1, PDMS2, PDMS3, PDMS4, and PDMS5, respectively. These materials were processed by spin coating and subjected to common. microfabrication, micromachining, and biomedical processes: chemical immersion, oxygen plasma treatment, sterilization, and exposure to tissue culture media. The PDMS formulations were analyzed by gravimetry, goniometry, tensile testing, nanoindentation, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), and X-ray photoelectron spectroscopy (XPS). Spin coating of PDMS was formulation dependent with film thickness ranging from 308 mu m on PDMS1 to 171 mu m on PDMS5 at 200 revolutions per minute (rpm). Ultimate tensile stress (UTS) increased from 3.9 MPa (PDMS1) to 10.8 MPa (PDMS3), and then decreased down to 4.0 MPa (PDMS5). Autoclave sterilization (AS) increased the storage modulus (sigma) and UTS in all formulations, with the highest increase in UTS exhibited by PDMS5 (218%). PDMS surface hydrophilicity and micro-textures were generally unaffected when exposed to the different chemicals, except for micro-texture changes after immersion in potassium hydroxide and buffered hydrofluoric, nitric, sulfuric, and hydrofluoric acids; and minimal changes in contact angle after immersion in hexane, hydrochloric acid, photoresist developer, and toluene. Oxygen plasma treatment decreased the contact angle of PDMS2 from 109 degrees to 60 degrees. Exposure to tissue culture media resulted in increased PDMS surface element concentrations of nitrogen and oxygen.
C1 Cleveland Clin Fdn, Dept Biomed Engn, BioMEMS Lab, Lerner Res Inst, Cleveland, OH 44120 USA.
   Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.
RP Roy, S (reprint author), Cleveland Clin Fdn, Dept Biomed Engn, BioMEMS Lab, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44120 USA.
EM roys@ccf.org
RI Mata, Alvaro/D-6028-2015
OI Mata, Alvaro/0000-0002-6739-9111
CR Armani D, 1999, 12 IEEE INT C MICR E, P222
   Bashir R, 2004, ADV DRUG DELIVER REV, V56, P1565, DOI 10.1016/j.addr.2004.03.002
   Berdichevsky Y, 2004, SENSOR ACTUAT B-CHEM, V97, P402, DOI 10.1016/j.snb.2003.09.022
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   Brugger J, 1998, SENSOR ACTUAT A-PHYS, V70, P191, DOI 10.1016/S0924-4247(98)00132-0
   Chung S, 2003, BIOMED MICRODEVICES, V5, P311, DOI 10.1023/A:1027309830365
   Deng T, 2000, ANAL CHEM, V72, P3176, DOI 10.1021/ac991343m
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Despa MS, 1999, MICROSYST TECHNOL, V6, P60, DOI 10.1007/s005420050176
   *DOW CORN CORP, SYLGARD 184 SILICONE
   *DOW CORN CORP, MAT SAF DAT SHEET MS
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Ferrara LA, 2003, MED ENG PHYS, V25, P483, DOI 10.1016/S1350-4533(03)00031-6
   Fritz JL, 1995, J ADHESION, V54, P33, DOI 10.1080/00218469508014379
   Fujii T, 2002, MICROELECTRON ENG, V61-2, P907, DOI 10.1016/S0167-9317(02)00494-X
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Horbett Thomas A., 1996, P133
   ITOHY, 1999, BIOMATERIALS, V20, P2333
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   Kowalski JB, 1996, BIOMATERIALS SCI INT, P415
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lee LJ, 2001, BIOMED MICRODEVICES, V3, P339, DOI 10.1023/A:1012469017354
   Lin L, 1998, MICROSYST TECHNOL, V4, P113, DOI 10.1007/s005420050109
   LINDERHOLM P, 2000, 3D PDMS MULTILAYER S
   Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017
   Mastrangelo CH, 1998, P IEEE, V86, P1769, DOI 10.1109/5.704282
   Mata A, 2003, IEEE T NANOBIOSCI, V2, P287, DOI 10.1109/TNB.2003.820268
   Mata A, 2002, BIOMED MICRODEVICES, V4, P267, DOI 10.1023/A:1020950022074
   Mata A, 2002, J BIOMED MATER RES, V62, P499, DOI 10.1002/jbm.10353
   MATA A, 1999, THESIS U STRATHCLYDE
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Murakami T, 1998, J COLLOID INTERF SCI, V202, P37, DOI 10.1006/jcis.1997.5386
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nowicki M, 2003, POLYMER, V44, P6599, DOI 10.1016/S0032-3861(03)00729-8
   Oh HK, 2001, POLYMER, V42, P6305, DOI 10.1016/S0032-3861(01)00073-8
   Paranjape M, 2003, SENSOR ACTUAT A-PHYS, V104, P195, DOI 10.1016/S0924-4247(03)00049-9
   Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536
   Rau K, 2002, MATER RES INNOV, V5, P151, DOI 10.1007/s10019-002-8640-8
   Rebello KJ, 2004, P IEEE, V92, P43, DOI 10.1109/JPROC.2003.820536
   Roy S, 2001, NEUROSURGERY, V49, P779, DOI 10.1097/00006123-200110000-00003
   Santini JT, 1999, NATURE, V397, P335
   Schnyder B, 2003, SURF SCI, V532, P1067, DOI 10.1016/S0039-6028(03)00148-1
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   TIFFANY JE, 1998, THESIS ARIZONA STATE
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Visser SA, 1996, POLYM BIOMATERIALS S, P50
   Wei GH, 2005, J VAC SCI TECHNOL A, V23, P811, DOI 10.1116/1.1861937
   White CC, 2005, J POLYM SCI POL PHYS, V43, P1812, DOI 10.1002/polb.20455
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Ziaie B, 2004, ADV DRUG DELIVER REV, V56, P145, DOI 10.1016/j.addr.2003.09.001
NR 58
TC 487
Z9 492
U1 34
U2 447
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2005
VL 7
IS 4
BP 281
EP 293
DI 10.1007/s10544-005-6070-2
PG 13
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 001DA
UT WOS:000234512600003
PM 16404506
DA 2018-10-20
ER

PT J
AU Romano, P
   Dawyndt, P
   Piersigilli, F
   Swings, J
AF Romano, P
   Dawyndt, P
   Piersigilli, F
   Swings, J
TI Improving interoperability between microbial information and sequence
   databases
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Italian-Society-of-Bioinformatics
CY MAR 17-19, 2005
CL Milan, ITALY
SP Italian Soc Bioinformat
AB Background: Biological resources are essential tools for biomedical research. Their availability is promoted through on-line catalogues. Common Access to Biological Resources and Information (CABRI) is a service for distribution of biological resources and related data collected by 28 European culture collections. Linking this information to bioinformatics databanks can make the collections' holdings more visible after a search in molecular biology databanks and vice-versa. Identification of links to sequence databases can be useful, but annotation and indexing problems, together with compilation errors, immediately arise. In this paper, we present our efforts for the identification of cross-references between CABRI catalogues and the EMBL Data Library and related results.
   Results: An SRS site with both EMBL and CABRI catalogues has been set up. Ad-hoc changes in indexing scripts allowed to achieve homogeneous index keys and SRS link features have been used to identify links between databases. After manual checking and comparison with an alternative procedure, about 67,500 valid cross-references were identified, added to the EMBL Data Library and are now distributed with it. HTML links can be established from EMBL to CABRI network service. Procedures can be executed whenever needed.
   Conclusion: Links between EMBL and CABRI catalogues constitute an improved access to microorganisms of certified quality and can produce positive effects on biomedical research. Further links between CABRI catalogues and other bioinformatics databases can now easily be defined by using these cross-references. Linking genetic information onto natural resources information may stand model for the integration of other databases containing empirical data on these materials.
C1 Natl Inst Canc Res, I-16132 Genoa, Italy.
   Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium.
   Univ Camerino, Dept Math & Comp Sci, I-62032 Camerino, MC, Italy.
   Univ Ghent, BCCMTM Bacteria Collect, B-9000 Ghent, Belgium.
RP Romano, P (reprint author), Natl Inst Canc Res, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.
EM paolo.romano@istge.it; peter.dawyndt@ugent.be;
   francesca.piersigilli@unicam.it; jean.swings@ugent.be
RI Romano, Paolo/M-8669-2013; Dawyndt, Peter/A-1566-2013; Romano,
   Paolo/A-5526-2009
OI Romano, Paolo/0000-0003-4694-3883; Dawyndt, Peter/0000-0002-1623-9070
CR *CABRI, CABRI GUID CAT PROD
   Dawyndt P, 2005, IEEE T KNOWL DATA EN, V17, P1111, DOI 10.1109/TKDE.2005.131
   Etzold T, 1996, METHOD ENZYMOL, V266, P114
   Romano Paolo, 2005, Appl Bioinformatics, V4, P175, DOI 10.2165/00822942-200504030-00002
   *WFCC MIRCEN, WORLD DAT CTR MICR W
   Zhu SY, 2005, J CLIN ULTRASOUND, V33, P29, DOI 10.1002/jcu.20083
   COMMON ACCESS BIOL R
   INTERCONNECTED BIOL
NR 8
TC 3
Z9 3
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD DEC 1
PY 2005
VL 6
SU 4
AR S23
DI 10.1186/1471-2105-6-S4-S23
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 022OF
UT WOS:000236064600023
PM 16351750
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, LJ
   Zeng, CC
   Cao, X
   Han, XM
   Shen, J
   Xu, GJ
AF Lee, LJ
   Zeng, CC
   Cao, X
   Han, XM
   Shen, J
   Xu, GJ
TI Polymer nanocomposite foams
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Review
DE polymer nanocomposite; nanocomposite foam; nucleation; bubble growth;
   cell size; cell density
ID LAYERED-SILICATE NANOCOMPOSITES; POLY(VINYL CHLORIDE)/MONTMORILLONITE
   NANOCOMPOSITES; MICROCELLULAR THERMOPLASTIC FOAM; POLYPROPYLENE-CLAY
   HYBRIDS; IN-SITU POLYMERIZATION; MECHANICAL-PROPERTIES; CARBON
   NANOTUBES; EMULSION POLYMERIZATION; EXPANDABLE POLYSTYRENE;
   MELT-INTERCALATION
AB Polymer nanocomposite foams have received increasingly attention in both scientific and industrial communities. The combination of functional nanoparticles and supercritical fluid foaming technology has a high potential to generate a new class of materials that are lightweight, high strength and multifunctional. A small amount of well-dispersed nanoparticles in the polymer domain may serve as the nucleation sites to facilitate the bubble nucleation process. Moreover, the nano-scaled particles are suitable for microscaled reinforcement, thus achieving the macroscopic mechanical enhancement. In this paper, we will first briefly review the synthesis and processing techniques of nanocomposites based on polymers that are important in the foam industry. Both thermoplastic and thermoset nanocomposite foams will be addressed. This is followed by an introduction of various foaming techniques. The effect of nanoparticles on the foam morphology and properties is then discussed. We conclude with the current and future trends of nanocomposite foams in both industrial and biomedical applications. (c) 206 Elsevier Ltd. All rights reserved.
C1 Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
RP Lee, LJ (reprint author), Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
EM lee.31@osu.edu
CR ABIKO T, 2003, IDEMITSU GIHO, V46, P281
   Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   Alexandre M, 2002, POLYMER, V43, P2123, DOI 10.1016/S0032-3861(02)00036-8
   Baker RW, 2000, MEMBRANE TECHNOLOGY
   Bandyopadhyay S., 2000, POLYM MAT SCI ENG, V82, P208
   Bergman JS, 1999, CHEM COMMUN, P2179, DOI 10.1039/a905540a
   BIASCI L, 1994, POLYMER, V35, P3296, DOI 10.1016/0032-3861(94)90138-4
   Billingham J, 1997, VIB SPECTROSC, V14, P19, DOI 10.1016/S0924-2031(96)00074-4
   BLANDER M, 1975, AICHE J, V21, P833, DOI 10.1002/aic.690210502
   Brittain W., 2002, PVC NANOCOMPOSITES, V43, P1019
   CAO X, 2004, POLYURETHANE CLAY NA, V2, P1896
   CHANDRA A, 2004, POLYM ENG SCI, V45, P52
   Chen L, 2002, POLYM ENG SCI, V42, P1151, DOI 10.1002/pen.11019
   Chen L., 2001, SPE ANTEC TECH PAPER, V59, P1732
   Cho JW, 2001, POLYMER, V42, P1083, DOI 10.1016/S0032-3861(00)00380-3
   COLTON JS, 1987, POLYM ENG SCI, V27, P500, DOI 10.1002/pen.760270704
   COLTON JS, 1987, POLYM ENG SCI, V27, P485, DOI 10.1002/pen.760270702
   COLTON JS, 1987, POLYM ENG SCI, V27, P493, DOI 10.1002/pen.760270703
   Cooper CA, 2002, COMPOS SCI TECHNOL, V62, P1105, DOI 10.1016/S0266-3538(02)00056-8
   Crevecoeur JJ, 1999, POLYMER, V40, P3685, DOI 10.1016/S0032-3861(98)00617-X
   Crevecoeur JJ, 1999, POLYMER, V40, P3691, DOI 10.1016/S0032-3861(98)00619-3
   Crevecoeur JJ, 1999, POLYMER, V40, P3697, DOI 10.1016/S0032-3861(98)00621-1
   Dennis HR, 2001, POLYMER, V42, P9513, DOI 10.1016/S0032-3861(01)00473-6
   Di YW, 2005, J POLYM SCI POL PHYS, V43, P689, DOI 10.1002/polb.20366
   Doh JG, 1998, POLYM BULL, V41, P511, DOI 10.1007/s002890050395
   DU J, 2002, POLYM DEGRAD STABIL, V79, P319
   FLETCHER NH, 1958, J CHEM PHYS, V29, P572, DOI 10.1063/1.1744540
   Fornes TD, 2001, POLYMER, V42, P9929, DOI 10.1016/S0032-3861(01)00552-3
   Fu X, 2000, MATER LETT, V42, P12, DOI 10.1016/S0167-577X(99)00151-2
   Galgali G, 2001, MACROMOLECULES, V34, P852, DOI 10.1021/ma000565f
   Garcia JL, 2004, J VINYL ADDIT TECHN, V10, P17, DOI 10.1002/vnl.20004
   Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104
   Gibbs JW, 1993, THERMODYNAMICS
   Gilman JW, 2000, CHEM MATER, V12, P1866, DOI 10.1021/cm0001760
   Ginzburg VV, 2000, ADV MATER, V12, P1805, DOI 10.1002/1521-4095(200012)12:23<1805::AID-ADMA1805>3.0.CO;2-Z
   GINZBURG VV, 2002, ACS S SERIES POLYM N, V804, P57
   GLUCK G, 1999, Patent No. 9948936
   Gong FL, 2004, POLYM TEST, V23, P847, DOI 10.1016/j.polymertesting.2004.02.004
   Gong FL, 2004, POLYM DEGRAD STABIL, V84, P289, DOI 10.1016/j.polymdegradstab.2003.11.003
   Gong FL, 2004, J MATER SCI, V39, P293, DOI 10.1023/B:JMSC.0000007758.00802.1a
   Gong XY, 2000, CHEM MATER, V12, P1049, DOI 10.1021/cm9906396
   Hammel E, 2004, CARBON, V42, P1153, DOI 10.1016/j.carbon.2003.12.043
   HAN JH, 1990, J POLYM SCI POL PHYS, V28, P743, DOI 10.1002/polb.1990.090280510
   Han XM, 2003, POLYM ENG SCI, V43, P1261, DOI 10.1002/pen.10107
   HANNECART E, 2004, Patent No. 2851567
   Hasegawa N, 1998, J APPL POLYM SCI, V67, P87
   Hedrick JL, 1999, ADV POLYM SCI, V141, P1
   Hill DE, 2002, MACROMOLECULES, V35, P9466, DOI 10.1021/ma020855r
   Hu HY, 2004, POLYM INT, V53, P225, DOI 10.1002/pi.1309
   HU HY, 2004, GAOFENZI CAILIAO KEX, V20, P162
   Huang XY, 2001, MACROMOLECULES, V34, P3255, DOI 10.1021/ma001670s
   Huang XY, 2000, MACROMOLECULES, V33, P2000, DOI 10.1021/ma991709x
   Jacobasch HJ, 1997, PROG COLL POL SCI S, V105, P44, DOI 10.1007/BF01188924
   JACOBSEN K, 2000, SPE ANTEC, P1929
   Javni I, 2002, J CELL PLAST, V38, P229, DOI 10.1106/002195502026139
   JAVNI I, 2001, C P POLY EXP COL OH, P557
   Joshi K, 1998, J APPL POLYM SCI, V67, P1353, DOI 10.1002/(SICI)1097-4628(19980222)67:8<1353::AID-APP2>3.0.CO;2-D
   KASSEH A, 2004, Patent No. 063259
   Kato M, 1997, J APPL POLYM SCI, V66, P1781, DOI 10.1002/(SICI)1097-4628(19971128)66:9<1781::AID-APP17>3.0.CO;2-Y
   Kawasumi M, 1997, MACROMOLECULES, V30, P6333, DOI 10.1021/ma961786h
   Klempner D., 1991, HDB POLYM FOAMS FOAM
   KNUDSON MI, 2002, Patent No. 070589
   KOVAROVA L, 2004, PLASTY KAUCUK, V41, P6
   KRESTA JE, 2002, Patent No. 1209189
   KRISHNAMURTHI B, 2001, C P POL EXP COL OH, P239
   KUMAR V, 1995, SPE ANTEC TECH PAPER, V41, P2189
   Kymakis E, 2002, SYNTHETIC MET, V127, P59, DOI 10.1016/S0379-6779(01)00592-6
   Lee DC, 1996, J APPL POLYM SCI, V61, P1117, DOI 10.1002/(SICI)1097-4628(19960815)61:7<1117::AID-APP7>3.0.CO;2-P
   LEE M, 2004, Patent No. 407435M
   Lee S. T., 2000, FOAM EXTRUSION PRINC
   LEE ST, 1993, POLYM ENG SCI, V33, P418, DOI 10.1002/pen.760330707
   LEES GC, 2004, Patent No. 2400107
   Lepoittevin B, 2003, POLYMER, V44, P2033, DOI 10.1016/S0032-3861(03)00076-4
   Li HB, 2004, IND ENG CHEM RES, V43, P509, DOI 10.1021/ie034092n
   Liang ZM, 2004, J APPL POLYM SCI, V92, P567, DOI 10.1002/app.20041
   Liao K, 2001, APPL PHYS LETT, V79, P4225, DOI 10.1063/1.1428116
   Lincoln DM, 2001, POLYMER, V42, P1621, DOI 10.1016/S0032-3861(00)00414-6
   Liu LM, 1999, J APPL POLYM SCI, V71, P1133, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1133::AID-APP11>3.0.CO;2-N
   Ma HM, 2003, COMPOS SCI TECHNOL, V63, P1617, DOI 10.1016/S0266-3538(03)00071-X
   Mahfuz H, 2004, COMPOS PART A-APPL S, V35, P453, DOI 10.1016/j.compositesa.2003.10.009
   Manias E, 2000, MACROMOLECULES, V33, P7955, DOI 10.1021/ma0009552
   Martini JE, 1984, US Patent, Patent No. [4473665, 4473665 US]
   MESSERSMITH PB, 1995, J POLYM SCI POL CHEM, V33, P1047, DOI 10.1002/pola.1995.080330707
   Mikos AG, 2000, J BIOTECHNOL, V3, P1
   Mitchell CA, 2002, MACROMOLECULES, V35, P8825, DOI 10.1021/ma020890y
   Mitsunaga M, 2003, MACROMOL MATER ENG, V288, P543, DOI 10.1002/mame.200300097
   MOORE S, 2001, MOD PLAST        NOV, P23
   MURAI S, 2003, Patent No. 261781
   Nam PH, 2002, POLYM ENG SCI, V42, P1907, DOI 10.1002/pen.11083
   Nam PH, 2001, POLYMER, V42, P9633, DOI 10.1016/S0032-3861(01)00512-2
   Noh MW, 1999, POLYM BULL, V42, P619, DOI 10.1007/s002890050510
   Ogata N, 1997, J APPL POLYM SCI, V66, P573, DOI 10.1002/(SICI)1097-4628(19971017)66:3<573::AID-APP19>3.0.CO;2-W
   Okamoto M, 2000, POLYMER, V41, P3887, DOI 10.1016/S0032-3861(99)00655-2
   Okamoto M, 2001, NANO LETT, V1, P503, DOI 10.1021/nl010051+
   Pallay J, 2000, MACROMOL MATER ENG, V275, P18, DOI 10.1002/(SICI)1439-2054(20000201)275:1<18::AID-MAME18>3.0.CO;2-3
   Pallay J, 2002, CELL POLYM, V21, P1
   Pan MW, 2004, J APPL POLYM SCI, V94, P277, DOI 10.1002/app.20896
   PARK CB, 1995, POLYM ENG SCI, V35, P432, DOI 10.1002/pen.760350509
   Park CB, 1997, ACS SYM SER, V669, P115
   Pinnavaia TJ, 1996, ACS SYM SER, V622, P250
   Pozsgay A, 2004, MATER RES INNOV, V8, P138, DOI 10.1080/14328917.2004.11784847
   Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500
   RAMESH NS, 1994, POLYM ENG SCI, V34, P1685, DOI 10.1002/pen.760342206
   Ray SS, 2003, MACROMOL MATER ENG, V288, P936, DOI 10.1002/mame.200300156
   Reichert P, 2000, MACROMOL MATER ENG, V275, P8, DOI 10.1002/(SICI)1439-2054(20000201)275:1<8::AID-MAME8>3.0.CO;2-6
   Safadi B, 2002, J APPL POLYM SCI, V84, P2660, DOI 10.1002/app.10436
   Sandler J, 1999, POLYMER, V40, P5967, DOI 10.1016/S0032-3861(99)00166-4
   Shafi MA, 1997, CHEM ENG SCI, V52, P635, DOI 10.1016/S0009-2509(96)00433-2
   Shen J, 2005, POLYMER, V46, P5218, DOI 10.1016/j.polymer.2005.04.010
   Shen J, 2004, 62 ANN TECHN C, V2, P1836
   SHEN J, 2005, ANN TECHN C SOC PLAS, P1896
   Sheptalin R.A., 2004, PLAST MASSY, P20
   SHI X, 2004, GAOFENZI XUEBAO, P149
   SNIJDERS EA, 2003, WATER EXPANDABLE POL
   Spitael P, 2004, MACROMOLECULES, V37, P6874, DOI 10.1021/ma049712q
   Strauss W, 2004, J CELL PLAST, V40, P229, DOI 10.1177/0021955X04043720
   Svoboda P, 2002, J APPL POLYM SCI, V85, P1562, DOI 10.1002/app.10789
   Taki K, 2004, POLYM ENG SCI, V44, P1004, DOI 10.1002/pen.20093
   THENG BKG, 1974, CHEM CLAY ORGANIC RE
   TRLICA J, 2001, ANN TECHN C, V2, P2161
   TSCHRITTER H, 2003, Patent No. 016370
   TUDOR J, 1996, CHEM COMMUN, V17, P2031
   USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179
   Vaia RA, 1997, MACROMOLECULES, V30, P8000, DOI 10.1021/ma9603488
   Vaia RA, 1996, CHEM MATER, V8, P2628, DOI 10.1021/cm960102h
   Vaia RA, 1997, J POLYM SCI POL PHYS, V35, P59
   Vaia RA, 2001, MRS BULL, V26, P394, DOI 10.1557/mrs2001.93
   Vaia RA, 1997, MACROMOLECULES, V30, P7990, DOI 10.1021/ma9514333
   VAIA RA, 1995, POLYM MELT INTERCALA
   Velasco-Santos C, 2003, CHEM MATER, V15, P4470, DOI 10.1021/cm034243c
   WAN C, 2003, ZHONGUO SULIAO, V17, P39
   WAN C, 2003, METHODS PREPARING PO
   Wang DY, 2001, J VINYL ADDIT TECHN, V7, P203, DOI 10.1002/vnl.10292
   Wang DY, 2002, J VINYL ADDIT TECHN, V8, P139, DOI 10.1002/vnl.10354
   Weimer MW, 1999, J AM CHEM SOC, V121, P1615, DOI 10.1021/ja983751y
   WU D, 2004, POLYM MAT SCI ENG, V91, P702
   Wu S, 1982, POLYM INTERFACE ADHE
   Xie XL, 2004, POLYMER, V45, P6665, DOI 10.1016/j.polymer.2004.07.045
   Xie XL, 2004, POLYMER, V45, P2793, DOI 10.1016/j.polymer.2004.02.028
   Xu J., 2001, SPE ANTEC, P449
   Xu WB, 2004, J THERM ANAL CALORIM, V78, P91, DOI 10.1023/B:JTAN.0000042157.96074.44
   XU Y, 2002, POLYM LAYERED SILICA, V43, P1312
   Yalcin B, 2004, POLYMER, V45, P6623, DOI 10.1016/j.polymer.2004.06.061
   Ying Z, 2002, INT J NANOSCI SER, V1, P425, DOI 10.1142/S0219581X02000449
   Yoo Y, 2004, POLYM BULL, V52, P373, DOI 10.1007/s00289-004-0296-7
   Yuan MJ, 2004, POLYM ENG SCI, V44, P673, DOI 10.1002/pen.20061
   ZENG C, 2003, POLYM NANOCOMPOSITES
   ZENG C, 2002, ANN TECHN C, V2, P1504
   Zeng CC, 2003, ADV MATER, V15, P1743, DOI 10.1002/adma.200305065
   Zeng CC, 2001, MACROMOLECULES, V34, P4098, DOI 10.1021/ma010061x
   Zettlemoyer A.C., 1969, NUCLEATION
   Zhu J, 2003, NANO LETT, V3, P1107, DOI 10.1021/nl0342489
   Zhulina E, 1999, LANGMUIR, V15, P3935, DOI 10.1021/la981406g
NR 153
TC 393
Z9 413
U1 22
U2 346
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD DEC
PY 2005
VL 65
IS 15-16
SI SI
BP 2344
EP 2363
DI 10.1016/j.compscitech.2005.06.016
PG 20
WC Materials Science, Composites
SC Materials Science
GA 981GR
UT WOS:000233076100007
DA 2018-10-20
ER

PT J
AU Wang, W
   Omori, M
   Watari, F
   Yokoyama, A
AF Wang, W
   Omori, M
   Watari, F
   Yokoyama, A
TI Novel bulk carbon nanotube materials for implant by spark plasma
   sintering
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE carbon nanotubes; spark plasma sintering; biomaterials
ID ABSORPTION FINE-STRUCTURE; BIOMEDICAL APPLICATION; PULMONARY TOXICITY;
   NANOFIBERS; CERAMICS; TITANIUM; SURFACE; BIOCOMPATIBILITY;
   DENSIFICATION; NANOMATERIALS
AB Novel, bulk multiwall carbon nanotubes (MWCNTs) sintered with polycarbosilane (PCs) as a binder agent were fabricated by spark plasma sintering (SPS), and their microstructure and properties were investigated. Sintering was clone with 20-60 MPa pressure at 1200 degrees C. SEM and TEM observations showed that the nanosized tube microstructure was preserved even after sintering, and tubes adhered to each other with the nanosized nodules of SiC pyrolyzed form PCs as revealed by X-ray diffraction. Bulk density and Vickers hardness were found to increase, whereas the specific surface area decreased, as PCs content and sintering pressure increased. Through animal experiments, the inflammatory reaction of GNTs/PCS material was found to be slightly increased with increasing PCs content. fit conclusion, sintered CNTs had physical and mechanical properties close to bone, and their good biocompatibility based on tissue response served to pave their way as a suitable implant material in the future.
C1 Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido 0608586, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Wang, W (reprint author), Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido 0608586, Japan.
EM watari@den.hokudai.ac.jp
RI Yokoyama, Atsuro/F-6418-2012
CR AJIAYAN PM, 1999, CHEM REV, V99, P1787
   Akasaka T, 2005, CHEM LETT, V34, P826, DOI 10.1246/cl.2005.826
   AKASAKA T, IN PRESS MAT SCI E C
   Asakura K, 2005, CHEM LETT, V34, P382, DOI 10.1246/cl.2005.382
   BOEDER H, 1970, CARBON, V8, P453
   Cheng HM, 1997, CARBON, V35, P869, DOI 10.1016/S0008-6223(97)00014-6
   Colombo P, 1997, J AM CERAM SOC, V80, P2333
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Conrad H, 2000, MAT SCI ENG A-STRUCT, V287, P276, DOI 10.1016/S0921-5093(00)00786-3
   De Jong KP, 2000, CATAL REV, V42, P481, DOI 10.1081/CR-100101954
   Ebbesen T. W., 1997, CARBON FIBERS NANOTU, P42
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Feng F., 2005, MAT SCI ENG A-STRUCT, V397, P92
   Fugetsu B, 2004, ENVIRON SCI TECHNOL, V38, P6890, DOI 10.1021/es049554i
   Fugetsu B, 2004, ANALYST, V129, P565, DOI 10.1039/b405325g
   Fugetsu B, 2004, B CHEM SOC JPN, V77, P1945, DOI 10.1246/bcsj.77.1945
   Hoshii S, 2000, CARBON, V38, P1896, DOI 10.1016/S0008-6223(00)00145-7
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Idesaki A, 2001, J MATER SCI, V36, P5565, DOI 10.1023/A:1012549228826
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   INAGAKI M, 2000, OLD NEW MAT CARBONS, P1
   Kim HY, 1999, J BIOMED MATER RES, V48, P135, DOI 10.1002/(SICI)1097-4636(1999)48:2<135::AID-JBM7>3.0.CO;2-6
   Kondo H, 2004, MATER TRANS, V45, P3156, DOI 10.2320/matertrans.45.3156
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Marsh H, 1997, INTRO CARBON TECHNOL, P1
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   Nygren M, 2003, SOLID STATE SCI, V5, P125, DOI 10.1016/S1293-2558(02)00086-9
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   PRICE RL, 2002, MATER RES SOC S P, V711
   Sato Y, 2005, MOL BIOSYST, V1, P142, DOI 10.1039/b501222h
   Service RF, 2003, SCIENCE, V300, P243
   STAO Y, 2005, MOL BIOSYST
   Takeuchi T, 1999, J AM CERAM SOC, V82, P939, DOI 10.1111/j.1151-2916.1999.tb01857.x
   Tamura K, 2002, MATER TRANS, V43, P3052, DOI 10.2320/matertrans.43.3052
   Uo M, 2005, CHEM LETT, V34, P776, DOI 10.1246/cl.2005.776
   Wang YC, 2002, MAT SCI ENG B-SOLID, V90, P34
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   WATARI F, 2005, TISSUE REACTION BIOM, P1
   WEBATER TJ, 2000, J BIOMED MATER RES, V51, P475
   Wielage B, 2003, J MATER PROCESS TECH, V132, P313, DOI 10.1016/S0924-0136(02)00951-2
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Zhou Y, 2000, J AM CERAM SOC, V83, P654
NR 45
TC 19
Z9 19
U1 0
U2 8
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD DEC
PY 2005
VL 24
IS 4
BP 478
EP 486
DI 10.4012/dmj.24.478
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 015CE
UT WOS:000235528700002
PM 16445007
OA Bronze
DA 2018-10-20
ER

PT J
AU Simmons, D
   Mckenzie, A
   Eaton, S
   Shaw, J
   Zimmet, P
AF Simmons, D
   Mckenzie, A
   Eaton, S
   Shaw, J
   Zimmet, P
TI Prevalence of diabetes in rural Victoria
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE type 2 diabetes; rural health; Australia; impaired glucose tolerance;
   access; screening
ID IMPAIRED GLUCOSE-TOLERANCE; FASTING GLUCOSE; MELLITUS; CRITERION;
   AUSTRALIA
AB Aims: To compare the prevalence of diabetes in adults in small and medium sized towns in a part of rural Victoria
   Materials and methods: Participants were usual residents, aged >= 25 years, from randomly selected households in the crossroads undiagnosed disease study (CUDS: six small rural towns and their regional center in rural Victoria). Response rates to an initial census at the household and attendance at a subsequent biomedical examination involved were 70% and 61% (1454), respectively. All non-diabetic participants had an oral glucose tolerance test.
   Results: Prevalence of diabetes, IGT, IFG were 7.3 (5.5-9.5)%, 6.9 (5.1-9.9)% and 3.2 (2.0-4.7)% respectively in the regional center and 8.9 (6.9-11.1)%,4.9 (3.5-6.7)%, 3.0 (1.9-4.5)% in the Shire Capitals. Overall, 31/118 (26.3%) of those with diabetes were previously undiagnosed. Most (83.9%) of those with undiagnosed diabetes remembered having been screened for diabetes in the previous 2 years. Overall screening rates for diabetes were higher than across Victoria as a whole.
   Conclusions: The prevalence of diabetes has probably doubled over the last 15 years in this area. Undiagnosed diabetes is less common than expected, possibly as a result of a more vigorous approach to screening in general practice and in spite of the lower numbers of GPs in the area. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Auckland, Waikato Clin Sch, Hamilton 3200, New Zealand.
   Univ Melbourne, Dept Rural Hlth, Shepparton, Vic, Australia.
   Northumbria Healthcare NHS Trust, N Shields, England.
   Int Diabet Inst, Caulfield, Vic, Australia.
RP Simmons, D (reprint author), Univ Auckland, Waikato Clin Sch, Private Bag 3200,Pembroke St, Hamilton 3200, New Zealand.
EM simmonsd@waikatodhb.govt.nz
RI Shaw, Jonathan/E-7388-2010
OI Shaw, Jonathan/0000-0002-6187-2203; Simmons, David/0000-0003-0560-0761
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   *AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS5, DOI DOI 10.2337/DIACARE.27.2007.S5
   *AUSTR BUR STAT, 2001, CENS POP HOUS
   *CDCP, 1999, PREV DIAB IMP FAST G
   Davidson MB, 2003, DIABETES CARE, V26, P3329, DOI 10.2337/diacare.26.12.3329
   Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829
   Genuth S, 2003, DIABETES CARE, V26, P3331, DOI 10.2337/diacare.26.12.3331
   GLATTHAAR C, 1985, MED J AUSTRALIA, V143, P436
   Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335
   GUEST CS, 1992, DIABETES RES CLIN PR, V15, P227, DOI 10.1016/0168-8227(92)90029-Q
   Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0
   VICTORIA DHS, 2002, VICTORIAN POPULATION
   Welborn TA, 1997, METABOLISM, V46, P35, DOI 10.1016/S0026-0495(97)90315-2
   Wilkinson D, 2000, AUST NZ J PUBL HEAL, V24, P71, DOI 10.1111/j.1467-842X.2000.tb00726.x
NR 14
TC 14
Z9 14
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD DEC
PY 2005
VL 70
IS 3
BP 287
EP 290
DI 10.1016/j.diabres.2005.04.004
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 987VX
UT WOS:000233546700012
PM 15946759
DA 2018-10-20
ER

PT J
AU Hassan, SSM
   Elnemma, EM
   Mohamed, AHK
AF Hassan, SSM
   Elnemma, EM
   Mohamed, AHK
TI Novel biomedical sensors for flow injection potentiometric determination
   of creatinine in human serum
SO ELECTROANALYSIS
LA English
DT Article
DE potentiometry; creatinine; human serum; flow injection analysis;
   biomedical analysis; PVC membrane sensors
ID ION-SELECTIVE ELECTRODES; AMPEROMETRIC BIOSENSORS; MEMBRANE SENSORS;
   LIQUID; DEIMINASE; AMMONIA; ACID
AB Coated-wire (CW) and tubular (Tu) type membrane sensors for creatinine are developed. These consist of creatinine tungstophosphate(CTP), creatinine molybdophosphate (CMP) and creatinine picrolonate (CPC) ion-pair complexes as electroactive materials dispersed in plasticized poly(vinyl chloride) matrix membranes. Electrochemical evaluation of these sensors under static (batch) mode of operation reveals near-Nernstian response with slopes of 62.9, 58.1, and 55.2 mV decade(-1) over the concentration range 1 x 10(-2) - 5.0 x 10(-6), 1 x 10(-2) - 7.5 x 10(-5), and 1 x 10(-2) - 3.1 x 10(-5) mol L-1. The lower detection limits are 0.39, 3.49, and 2.20 mu g mL(-1) creatinine with CTP, CMP and CPC membrane based sensors plasticized with o-NPOE, respectively. Tubular and coated wire CTP membrane sensors are incorporated in flow-through cells and used as detectors for flow injection analysis (FIA) of creatinine. The intrinsic characteristics of the detectors under hydrodynamic mode of operation in a low dispersion manifold are determined and compared with data obtained under static mode of operation. With 10(-2) mol L-1 phosphate buffer of pH 4.5 as a carrier solution, the tubular and coated wire CTP detectors exhibit rapid response of 58.9 and 50.7 mV decade(-1) over the concentration range 1 x 10(-2) - 1 x 10(-5) mol L-1 and detection limits of 0.39 mu g mL(-1) and 0.85 mu g mL(-1), respectively. Validation of the assay methods with the proposed sensors by measuring the lower detection limit, range, accuracy, precision, repeatability and between-day-variability reveals good performance characteristics confirming applicability for continuous determination of creatinine. The sensors are used for determining creatinine in human blood serum at an input rate of 40 samples per hour. No interferences are caused by creatine, most common anions, cations and organic species normally present in biological fluids. The results favorably compare with data obtained using the standard spectrophotometric method.
C1 Ain Shams Univ, Fac Sci, Dept Chem, Cairo, Egypt.
   Qatar Univ, Fac Sci, Dept Chem, Doha, Qatar.
RP Hassan, SSM (reprint author), Ain Shams Univ, Fac Sci, Dept Chem, Cairo, Egypt.
EM saadsmhassan@yahoo.com
OI H. Kamel, Ayman/0000-0001-7502-6668
CR Choi SH, 2002, ANAL CHIM ACTA, V461, P251, DOI 10.1016/S0003-2670(02)00281-7
   CHRISTOPOULOS TK, 1987, ANALYST, V112, P1293, DOI 10.1039/an9871201293
   Clark EA, 2001, J PHARMACEUT BIOMED, V25, P795, DOI 10.1016/S0731-7085(01)00340-5
   Greenwald I, 1928, J BIOL CHEM, V80, P103
   Hasan SSM, 2003, TALANTA, V60, P81, DOI 10.1016/S0039-9140(03)00038-9
   Hassan SS, 1998, TALANTA, V46, P1395, DOI 10.1016/S0039-9140(98)00008-3
   Hassan SSM, 2003, J PHARMACEUT BIOMED, V32, P175, DOI 10.1016/S0731-7085(03)00015-3
   Hassan SSM, 2004, ELECTROANAL, V16, P298, DOI 10.1002/elan.200402840
   Hassan SSM, 2003, ANAL CHIM ACTA, V482, P9, DOI 10.1016/S0003-2670(03)00172-7
   Hassan SSM, 1997, ANALYST, V122, P815, DOI 10.1039/a701038i
   HASSAN SSM, 2004, MIKROCHIM ACTA, V114, P363
   Ho WO, 1999, ANAL CHEM, V71, P1940, DOI 10.1021/ac981367d
   Johns BA, 2001, J CHROMATOGR B, V759, P343, DOI 10.1016/S0378-4347(01)00229-8
   Khan GF, 1997, ANAL CHIM ACTA, V351, P151, DOI 10.1016/S0003-2670(97)00362-0
   KIHARA K, 1986, ANAL CHIM ACTA, V183, P75, DOI 10.1016/0003-2670(86)80076-9
   Killard AJ, 2000, TRENDS BIOTECHNOL, V18, P433, DOI 10.1016/S0167-7799(00)01491-8
   Kochansky CJ, 2000, J CHROMATOGR B, V747, P217, DOI 10.1016/S0378-4347(00)00119-5
   MA TS, 1982, ORGANIC ANAL USING I, V1
   Madaras MB, 1996, ANAL CHEM, V68, P3832, DOI 10.1021/ac960239r
   MUNKHOMM C, 1999, Patent No. 5958786
   Pandey PC, 2004, SENSOR ACTUAT B-CHEM, V99, P230, DOI 10.1016/j.snb.2003.11.016
   Soldatkin AP, 2002, MAT SCI ENG C-BIO S, V21, P75, DOI 10.1016/S0928-4931(02)00062-0
   Soldatkin AP, 2002, TALANTA, V58, P351, DOI 10.1016/S0039-9140(02)00283-7
   Stefan RI, 2003, TALANTA, V60, P1223, DOI 10.1016/S0039-9140(03)00230-3
   Stokes P, 2003, J CHROMATOGR B, V794, P125, DOI 10.1016/S1570-0232(03)00424-0
   Suzuki H, 2004, SENSOR ACTUAT B-CHEM, V98, P101, DOI 10.1016/j.snb.2003.08.018
   TAYLOR JK, 1987, QUALITY ASSURANCE CH
   Umezawa Y, 2000, PURE APPL CHEM, V72, P1851, DOI 10.1351/pac200072101851
   Walsh DA, 2002, ANAL CHIM ACTA, V459, P187, DOI 10.1016/S0003-2670(02)00110-1
   WINQUIST F, 1986, ANAL CHEM, V58, P145, DOI 10.1021/ac00292a035
NR 30
TC 12
Z9 12
U1 1
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1040-0397
EI 1521-4109
J9 ELECTROANAL
JI Electroanalysis
PD DEC
PY 2005
VL 17
IS 24
BP 2246
EP 2253
DI 10.1002/elan.200503363
PG 8
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 999WC
UT WOS:000234420600007
DA 2018-10-20
ER

PT J
AU Martin, JLR
   Perez, V
   Sacristan, M
   Alvarez, E
AF Martin, JLR
   Perez, V
   Sacristan, M
   Alvarez, E
TI Is grey literature essential for a better control of publication bias in
   psychiatry? An example from three meta-analyses fo schizophrenia
SO EUROPEAN PSYCHIATRY
LA English
DT Article
DE grey literature; publication bias; systematic reviews; schizophrenia
ID SYSTEMATIC REVIEWS; RANDOMIZED TRIALS; CLINICAL-TRIALS; QUALITY;
   STATEMENT
AB Systematic reviews in mental health have become useful tools for health professionals in view of the massive amount and heterogeneous nature of biomedical information available today. In order to determine the risk of bias in the studies Militated and to avoid bias in generalizing, conclusions from the reviews it is therefore important to use a very strict methodology in systematic reviews. One bias which may affect the generalization of results is publication bias, which is determined by the nature and direction of the studs results, To control or minimize this type of bias. the authors of systematic reviews undertake comprehensive searched of medical databases and expand oil the findings, often undertakim, searches of grey literature (material which is not formally Published). This paper attempts to show the consequences (and risk) of generalizing the implications of grey literature in the control of publication bias as was proposed in a recent systematic work, By repeating the analyses for the same Outcome from three different systematic reviews that included both puhlishcd and grey literature out results showed that confusion between grey literature and publication bias may affect the results of a concrete meta-analysis. (c) 2005 Elsevier SAS. All rights reserved.
C1 Fdn Hlth Res Catilla La Mancha, FISCAM, Dept Clin Res, Toledo 45003, Castilla La Man, Spain.
   Hosp Santa Cruz & San Pablo, Dept Psychiat, E-08025 Barcelona, Spain.
RP Martin, JLR (reprint author), Fdn Hlth Res Catilla La Mancha, FISCAM, Dept Clin Res, Edif Bulevar C-Berna 2,Local 0-2, Toledo 45003, Castilla La Man, Spain.
EM jlmartin@jccm.es
OI Alvarez Martinez, Enric/0000-0002-5180-5541
CR Clarke M, 2003, COCHRANE REVIEWERS H
   COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749
   Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516
   Duggan L, 2004, COCHRANE LIB
   Egger M, 1998, BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61
   Egger M, 2003, Health Technol Assess, V7, P1
   Heres S, 2004, EUR PSYCHIAT, V19, P230, DOI 10.1016/j.eurpsy.2003.09.011
   HOPEWELL S, 2003, GREY LIT META ANAL R
   HUNTER RH, 2004, RISPERIDONE VERSUS T
   Jakovljevic M, 1999, PSYCHIAT DANUB, V11, P3
   Juni P, 2001, BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42
   Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Schulz KF, 1996, LANCET, V348, P596, DOI 10.1016/S0140-6736(96)01201-9
   SRISURAPANONT M, 2004, QUETIAPINE SCHIZOPHR
NR 17
TC 22
Z9 22
U1 0
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0924-9338
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD DEC
PY 2005
VL 20
IS 8
BP 550
EP 553
DI 10.1016/j.eurpsy.2005.03.011
PG 4
WC Psychiatry
SC Psychiatry
GA 996SV
UT WOS:000234195900004
PM 15994063
DA 2018-10-20
ER

PT J
AU Wiersma, S
   Taylor, D
AF Wiersma, S
   Taylor, D
TI Fatigue of materials used in microscopic components
SO FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES
LA English
DT Article
DE 316L stainless steel; crack closure; fatigue limit; fatigue threshold;
   microscopic components; non-propagating cracks
AB This paper discusses the fatigue behaviour of materials used in microscopic components, which are defined as components in which the section size is between one and ten grain diameters. Experimental data were obtained on microscopic and conventional (macroscopic) notched specimens of 316L stainless steel, which is used in many biomedical components including the cardiovascular stent. Microscopic specimens showed unusual behaviour: low threshold values and very flat stress-life(S-N) curves. The low threshold values were attributed to the extremely small thickness, which may be preventing closure; a secondary contribution may be coming from a change in the length of non-propagating cracks. Good predictions could be achieved using the Smith-Miller approach and the theory of critical distances (TCD) if this reduced threshold was taken into account or if, alternatively, the critical distance was made equal to the grain size.
C1 Trinity Coll Dublin, Dept Mech Engn, Dublin, Ireland.
RP Taylor, D (reprint author), Trinity Coll Dublin, Dept Mech Engn, Dublin, Ireland.
EM dtaylor@tcd.ie
CR Elber W., 1970, Engineering Fracture Mechanics, V2, P37
   Matsuda Yasutaka, 1993, Clinical Materials, V12, P41, DOI 10.1016/0267-6605(93)90026-4
   Murakami Y., 1987, STRESS INTENSITY FAC
   Neuber H., 1958, THEORY NOTCH STRESSE
   Peterson R. E., 1959, METAL FATIGUE, P293
   SHARPE WN, 2002, FATIGUE 2002 P 8 INT, P2197
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   SMITH RA, 1978, INT J MECH SCI, V20, P201, DOI 10.1016/0020-7403(78)90082-6
   TANAKA K, 1984, FATIGUE CRACK GROWTH
   Taylor D, 1999, INT J FATIGUE, V21, P413, DOI 10.1016/S0142-1123(99)00007-9
   Taylor D, 2001, FATIGUE FRACT ENG M, V24, P215, DOI 10.1046/j.1460-2695.2001.00401.x
   TAYLOR D, 1993, SOURCE BOOK FATIGUE
   WIERSMA SA, 2004, EFFECT STRESS CONCEN
NR 13
TC 21
Z9 21
U1 1
U2 3
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 8756-758X
J9 FATIGUE FRACT ENG M
JI Fatigue Fract. Eng. Mater. Struct.
PD DEC
PY 2005
VL 28
IS 12
BP 1153
EP 1160
DI 10.1111/j.1460-2695.2005.00952.x
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 998UR
UT WOS:000234345900006
DA 2018-10-20
ER

PT J
AU Shoji, M
   Kondo, T
   Honoki, H
   Nakajima, T
   Muraguchi, A
   Saito, M
AF Shoji, M
   Kondo, T
   Honoki, H
   Nakajima, T
   Muraguchi, A
   Saito, M
TI A case study of the estimation of occupational internal dose using
   urinary obtained in a biomedical research facility
SO HEALTH PHYSICS
LA English
DT Article
DE bioassay; dose; internal; excretion; urinary; exposure occupational
AB This paper presents a fundamental investigation of the screening of intakes and the estimation of internal doses for workers at a biomedical research facility from their urinary excretion data. Urine samples from the workers were collected immediately before and several days after handling radioactive materials, and 5-mL portions were measured directly with a sodium iodide scintillation detector or a liquid scintillation detector. Intakes of radionuclides and effective doses were estimated from the data using the Internal Dose Easy Calculation code. Blank levels of radioactivity and detection limits for this method were determined from the radioactivity contained in urine samples collected from volunteers working outside the controlled area (control samples). Most of the radioactivity in the control samples was attributed to K-40. Under the present experimental conditions, the detection limits for the committed effective doses were 7.5 X 10(-4) mSv for I-125 and 6.9 X 10(-2) mSv for S-35 in the case of samples collected Id after handling. Accordingly, it can be determined whether workers were exposed more than the recording level (1 mSv of committed effective dose) or not. No workers in the surveyed facility were found to suffer internal exposure beyond the recording levels, and their intakes were estimated to be below the detection limits in the 2-y investigation period. In an ordinary facility of biomedical research, the amount of unsealed radioactivity handled at one time is within 10 MBq in many cases, and the air ventilation and filtering systems work adequately. Under such circumstances, the present results suggest that individual monitoring, such as urine analysis, is omissible in many cases as a routine monitoring of internal exposure for workers.
C1 Toyama Med & Pharmaceut Univ, Fac Med, Toyama 9300194, Japan.
   Kyoto Univ, Kumatori, Osaka 5900403, Japan.
RP Shoji, M (reprint author), Toyama Med & Pharmaceut Univ, Fac Med, Sugitani 2630, Toyama 9300194, Japan.
EM shojim@ms.toyama-mpu.ac.jp
CR Firestone R. B., 1996, TABLE ISOTOPES, VII
   ICRP, 1975, ICRP PUBL, V23
   ICRP, 1995, ICRP PUBL, V69
   ICRP, 1980, ICRP PUBL, V30
   ICRP, 1995, ICRP PUBL, V71
   ICRP, 1997, ICRP PUBL, V78
   ICRP, 1994, ICRP PUBL, V66
   *ICRP, 1991, ICRP PUBL, V60
   *ICRP, 1995, ICRP PUBL, V70
   *ICRP, 1993, ICRP PUBL, V67
   *ICRP, 1989, ICRP PUBL, V56
   International Commission on Radiological Protection (ICRP), 2002, ICRP PUBL, V89
   Johnson LR., 1998, ESSENTIAL MED PHYSL
   Kinase S, 1999, J NUCL SCI TECHNOL, V36, P952, DOI 10.1080/18811248.1999.9726285
   MEISENHELDER J, 1988, NATURE, V335, P120, DOI 10.1038/335120a0
   *MIN ED CULT SPORT, 2002, MIN ED CULT SPORT SC, P68
   *MIN ED CULT SPORT, 2000, INT DOS EAS CALC COD
   The International Commission on Radiological Protection, 1997, ICRP PUBL, V75
   WELSHMAN SG, 1975, BRIT J UROL, V47, P237, DOI 10.1111/j.1464-410X.1975.tb03956.x
NR 19
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD DEC
PY 2005
VL 89
IS 6
BP 618
EP 627
DI 10.1097/01.HP.0000171593.62623.96
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 991CI
UT WOS:000233789400007
PM 16282795
DA 2018-10-20
ER

PT J
AU Sorvoja, H
   Kokko, VM
   Myllyla, R
AF Sorvoja, H
   Kokko, VM
   Myllyla, R
TI Use of EMFi as a blood pressure pulse transducer
SO IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
LA English
DT Article
DE blood pressure monitoring; noninvasive; pressure transducer array; pulse
   transit time; pulse wave velocity; radial artery pulsation
ID ELECTROMECHANICAL FILM EMFI; ELECTROTHERMOMECHANICAL FILM; ELECTRET;
   POLYMERS; ETMF
AB This paper describes and tests two prototype series of pressure transducer arrays based on electromechanical film (EMFi). By offering high (similar to T Omega) resistance, EMFi is an excellent material for low-current long-term measurement applications. About 50 transducer arrays were designed and tested using different configurations and electrode materials to sense low-frequency pressure pulsations on the radial artery in the wrist. Essential requirements included an adequate linear response in the desired temperature range and uniform quality. Transducer sensitivity was tested as a function of temperature in the range of 25 degrees C-45 degrees C at varying dc and ac pressures. The average sensitivity of the EMFi used in the transducers proved adequate (similar to 2.2 mV/mmHg and similar to 7 mV/mmHg for normal and high-sensitive films) for the intended purpose. Moreover, EMFi's spectral response covered the required range for biomedical applications, but it was unable to measure static pressure (f(3), dB approximate to 38 mu Hz). The sensitivity of the EMFi material was sufficiently constant for measuring blood pressure pulses in the desired range (0-300 mmHg), and the best achieved deviation in sensitivity was +/- 5.1%. It was also established that in addition to sensitivity and its standard deviation, crosstalk between electrode elements also depends strongly on electrode thickness.
C1 Oulu Univ, Dept Elect Engn Optoelect, FIN-90014 Oulu, Finland.
   Oulu Univ, Measurement Tech Lab, FIN-90014 Oulu, Finland.
   Infotech Oulu, FIN-90014 Oulu, Finland.
RP Sorvoja, H (reprint author), Oulu Univ, Dept Elect Engn Optoelect, FIN-90014 Oulu, Finland.
EM hannu.sorvoja@ee.oulu.fi
CR ALAMETSA J, 2001, P INT FED MED BIOL E, V1, P289
   ANTILA M, 1997, P ACT 97 BUD 21 23 A, P607
   ANTILA M, 1998, P ACT 6 INT C NEW AC, P96
   ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485
   BACKMAN J, 1990, J AUDIO ENG SOC, V38, P364
   BACKMAN J, 1990, P IEEE INT C AC SPEE, V2, P1173
   Geddes L, 1991, HDB BLOOD PRESSURE M
   GEDDES LA, 1981, MED BIOL ENG COMPUT, V19, P671, DOI 10.1007/BF02442787
   Gerhard-Multhaupt R, 2002, IEEE T DIELECT EL IN, V9, P850, DOI 10.1109/TDEI.2002.1038668
   GERHARDMULTHAUP.R, 2002, P 11 INT S EL, P36
   GERHARDMULTHAUP.R, P 2002 ANN REP C EL, P299
   Hamalainen MK, 1996, REV SCI INSTRUM, V67, P1598
   Heikkinen LM, 1997, SCAND J LAB ANIM SCI, V24, P85
   Kerola J, 1997, P IEEE EMBS, V18, P1308, DOI 10.1109/IEMBS.1996.652825
   Kirjavainen K, 1987, U S Patent, Patent No. [4,654,546, 4654546]
   Lekkala J., 1999, P 10 INT S EL IEEE S, P743
   Lekkala J., 1996, MED BIOL ENG COMPUT, V34, P67
   LEKKALA J, 1997, IND HORIZONS     DEC, P12
   Lindner M, 2002, J APPL PHYS, V91, P5283, DOI 10.1063/1.1459751
   Neugschwandtner GS, 2001, J APPL PHYS, V89, P4503, DOI 10.1063/1.1355719
   Nissila S, 1998, P ANN INT IEEE EMBS, V20, P1723, DOI 10.1109/IEMBS.1998.746916
   NISSILA S, 2000, Patent No. 1034736
   Nykanen H, 1999, PROCEEDINGS OF ACTIVE 99: THE INTERNATIONAL SYMPOSIUM ON ACTIVE CONTROL OF SOUND AND VIBRATION, VOLS 1 & 2, P1159
   Paajanen M, 2000, SENSOR ACTUAT A-PHYS, V84, P95, DOI 10.1016/S0924-4247(99)00269-1
   Paajanen M, 2000, J ELECTROSTAT, V48, P193, DOI 10.1016/S0304-3886(99)00065-0
   Paajanen M, 2001, IEEE T DIELECT EL IN, V8, P629, DOI 10.1109/94.946715
   Paajanen M, 2001, J PHYS D APPL PHYS, V34, P2482, DOI 10.1088/0022-3727/34/16/313
   Paajanen M., 2002, P 11 INT S EL, P191
   PAAJANEN M, 2001, THESIS TAMPERE U FIN
   PAAJANEN M, P 2001 ANN REP C EL, P24
   Paajanen M., 1999, P 10 INT S EL DELPH, P735
   PELTONEN J, 2000, AM J APPL PHYS, V88, P4769
   PIRTTIKANGAS S, 2004, P PERV 2004 2 INT C, P5
   RAISANEN L, 1992, PHARMACOL TOXICOL, V70, P230
   RAUKOLA J, 2002, P 11 INT S EL MELB A, P195
   RUHA A, 1996, P BIOS BRNO CZECH RE, V1, P198
   RUHA A, 1998, THESIS U OULU OULU F
   SAVOLAINEN A, 1990, POLYM ENG SCI, V30, P1258, DOI 10.1002/pen.760301910
   SAVOLAINEN A, 1989, J MACROMOL SCI CHEM, VA26, P583, DOI 10.1080/00222338908051994
   SIIVOLA J, 1993, MED BIOL ENG COMPUT, V31, P634, DOI 10.1007/BF02441813
   SORVOJA H, 2004, MOL QUANT ACOUST, V24, P169
   SORVOJA H, 2001, P 23 ANN INT C IEEE, V1, P222
   SORVOJA H, 2004, TECHNOL HEALTH CARE, V12, P145
   SORVOJA H, 2001, P 23 ANN INT C IEEE, V1, P3255
   STREICHER A, 2003, P IEEE ULTR S, P1364
   TERRY S, 1990, SENSOR ACTUAT A-PHYS, V23, P1070, DOI 10.1016/0924-4247(90)87091-V
   VIERIGASHI E, 2000, P ISIK2000 WORKSH BI, P101
   VIERIGASHI E, 2001, P 23 ANN INT C IEEE, V1, P3259
   Wegener M, 2003, IEEE T ULTRASON FERR, V50, P921, DOI 10.1109/TUFFC.2003.1214511
   WEGENER M, 2002, P 11 INT S EL, P36
   WEGENER M, 2003, P 2003 ANN REP C EL, P36
NR 51
TC 30
Z9 34
U1 1
U2 12
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9456
EI 1557-9662
J9 IEEE T INSTRUM MEAS
JI IEEE Trans. Instrum. Meas.
PD DEC
PY 2005
VL 54
IS 6
BP 2505
EP 2512
DI 10.1109/TIM.2005.853345
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 986HU
UT WOS:000233441500050
DA 2018-10-20
ER

PT J
AU Usman, S
   Shoaib, L
   Anno, JN
AF Usman, S
   Shoaib, L
   Anno, JN
TI Gamma-ray induced photoconductivity in Pyrex, Quartz, and Vycor
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical applications of radiation; gamma-ray effects;
   photoconductivity; substrates materials
ID GLASSES; RADIATION
AB Results of an experimental investigation are reported on photoconductive response of Pyrex, Quartz and Vycor. This research was conducted as a feasibility study for developing a new gamma dose measurement device based on the principle of photoconductivity. However, data collected in this study are equally valuable for various other applications where these materials are to be used in high radiation field. Our experiments and analyzes indicated that the selected dosimeter materials exhibit photoconductivity and respond to changes in gamma dose rate within a useful range. Pyrex glass suffered radiation damage at a relatively high dose rate of 0.25 Gys(-1). Quartz and Vycor exhibit significant advantages over Pyrex as dosimeter material. However, their limit of operability was found to be at a dose rate of approximately 28 mGy s(-1). Vycor dosimeter in particular appears promising for gamma measurement applications. From an endurance point of view, Quartz appears to be the most suitable material for applications in high dose rate conditions, in that photo-currents in Quartz were observed to be minimum.
C1 Univ Cincinnati, Cincinnati, OH 45220 USA.
RP Usman, S (reprint author), Univ Missouri, Rolla, MO 65409 USA.
EM usmans@umr.edu
CR ALLRED CL, 2003, THESIS MAT SCI ENG M
   ANNO JN, 1966, NUCL APPL, V2, P371, DOI 10.13182/NT66-A27613
   ANNO JN, 1984, NOTES RAD EFFECTS MA, P76
   CHRIEN RE, 1952, THESIS RENSSELAER PO
   COOKE D, TRANSIENT PHOTOCONDU
   CULLER VE, 1960, AIEE C
   DOWEIDAR H, 1991, J PHYS D APPL PHYS, V24, P2222, DOI 10.1088/0022-3727/24/12/015
   Federici JF, 2001, J SUPERCOND, V14, P331, DOI 10.1023/A:1007844909559
   HUETTENRAUCH R, 1971, P 2 C APPL PHYS CHEM, P635
   JOSHI NV, 1992, SELECTED PAPERS PHOT
   Kang YX, 2005, IEEE T NUCL SCI, V52, P38, DOI 10.1109/TNS.2004.843135
   KNOLL FG, 2000, RAD DETECTION RAD, P103
   LAZO MS, 1986, SPACE NUCL POWER SYS
   Mathew G, 1999, PRAMANA-J PHYS, V53, P891, DOI 10.1007/s12043-999-0123-7
   MCILVAINE JE, 1997, MED PLASTICS BIOMATE, P49
   RILEY WC, 1958, RAD EFFECTS INFORM N, V9
   SHOAJB L, 1995, THESIS U CINCINNATI
   Singh S, 2004, J OPTOELECTRON ADV M, V6, P769
   Weber WJ, 1997, J MATER RES, V12, P1946, DOI 10.1557/JMR.1997.0266
   WINSLOW JW, 1959, USNRDLTR326
NR 20
TC 1
Z9 1
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD DEC
PY 2005
VL 52
IS 6
BP 3054
EP 3058
DI 10.1109/TNS.2005.861419
PN 2
PG 5
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 012WP
UT WOS:000235371900053
DA 2018-10-20
ER

PT J
AU Pelletier, J
   Anders, A
AF Pelletier, J
   Anders, A
TI Plasma-blased ion implantation and deposition: A review of physics,
   technology, and applications
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Review
DE ion-assisted thin film deposition; plasma-based ion implantation; pulsed
   bias
ID AUSTENITIC STAINLESS-STEEL; CYCLOTRON-RESONANCE PLASMA; ULTRA-SHALLOW
   JUNCTIONS; DISCHARGE CATHODE MATERIALS; INNER SURFACE MODIFICATION;
   VOLTAGE PULSE-GENERATOR; SMALL CYLINDRICAL BORE; THIN-FILM DEPOSITION;
   AISI M2 STEEL; VACUUM-ARC
AB After pioneering work in the 1980s, plasma-based ion implantation (PBII) and plasma-based ion implantation and deposition (PBIID) can now be considered mature technologies for surface modification and thin film deposition. This review starts by looking at the historical development and recalling the basic ideas of PBII. Advantages and disadvantages are compared to conventional ion beam implantation and physical vapor deposition for PBII and PBIID, respectively, followed by a summary of the physics of sheath dynamics, plasma and pulse specifications, plasma diagnostics, and process modeling. The review moves on to technology considerations for plasma sources and process reactors. PBII surface modification and PBIID coatings are applied in a wide range of situations. They include the by-now traditional tribological applications of reducing wear and corrosion through the formation of hard, tough, smooth, low-friction, and chemically inert phases and coatings, e.g., for engine components. PBII has become viable for the formation of shallow junctions and other applications in microelectronics. More recently, the rapidly growing field of biomaterial synthesis makes use of PBII and PBIID to alter surfaces of or produce coatings on surgical implants and other biomedical devices. With limitations, also nonconducting materials such as plastic sheets can be treated. The major interest in PBII processing originates from its flexibility in ion energy (from a few electron volts up to about 100 keV), and the capability to efficiently treat, or deposit on, large areas, and (within limits) to process nonflat, three-dimensional workpieces, including forming and modifying metastable phases and nanostructures.
C1 CNRS, Ctr Rech Plasmas Mat Nanostruct, LPSC, F-38026 St Martin Dheres, France.
   Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
RP Pelletier, J (reprint author), CNRS, Ctr Rech Plasmas Mat Nanostruct, LPSC, F-38026 St Martin Dheres, France.
EM jacques.pelletier@ujf-grenoble.fr; aanders@lbl.gov
RI Anders, Andre/B-8580-2009
OI Anders, Andre/0000-0002-5313-6505
CR ADLER RJ, 1985, NUCL INSTRUM METH B, V6, P123, DOI 10.1016/0168-583X(85)90621-4
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   ANDERS A, 1995, NUCL INSTRUM METH B, V102, P132, DOI 10.1016/0168-583X(94)00797-7
   Anders A, 2002, SURF COAT TECH, V156, P3, DOI 10.1016/S0257-8972(02)00066-X
   Anders A, 2002, J APPL PHYS, V91, P4824, DOI 10.1063/1.1459619
   Anders A, 2001, SURF COAT TECH, V136, P111, DOI 10.1016/S0257-8972(00)01038-0
   Anders A, 2001, SURF COAT TECH, V136, P85, DOI 10.1016/S0257-8972(00)01017-3
   Anders A, 2000, APPL PHYS LETT, V76, P28, DOI 10.1063/1.125645
   Anders A, 2000, HDB PLASMA IMMERSION, P2
   Anders S, 1997, SURF COAT TECH, V94-5, P189, DOI 10.1016/S0257-8972(97)00346-0
   Bechu S, 2004, SURF COAT TECH, V186, P170, DOI 10.1016/j.surfcoat.2004.04.036
   BIERSACK JP, 1991, NUCL INSTRUM METH B, V59, P21, DOI 10.1016/0168-583X(91)95167-C
   Bilek MMM, 2004, SURF COAT TECH, V186, P21, DOI 10.1016/j.surfcoat.2004.04.051
   Bilek MMM, 2000, J APPL PHYS, V87, P4198, DOI 10.1063/1.373052
   Bilek MMM, 2003, IEEE T PLASMA SCI, V31, P939, DOI 10.1109/TPS.2003.818409
   Blawert C, 1996, SURF COAT TECH, V85, P15, DOI 10.1016/0257-8972(96)02880-0
   Blawert C, 1996, SURF COAT TECH, V83, P228, DOI 10.1016/0257-8972(95)02794-7
   Blawert C, 1997, NUCL INSTRUM METH B, V127, P873, DOI 10.1016/S0168-583X(97)00065-7
   Blawert C, 1997, SURF COAT TECH, V93, P274, DOI 10.1016/S0257-8972(97)00060-1
   BOHM G, 1994, J VAC SCI TECHNOL B, V12, P821, DOI 10.1116/1.587352
   Booske JH, 1997, J MATER RES, V12, P1356, DOI 10.1557/JMR.1997.0185
   Boxman R. L., 1995, HDB VACUUM ARC SCI T
   Brown I G, 1989, PHYS TECHNOLOGY ION
   BROWN IG, 1991, IEEE T PLASMA SCI, V19, P713, DOI 10.1109/27.108403
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   Brown IG, 1995, NUCL INSTRUM METH B, V106, P646, DOI 10.1016/0168-583X(95)00781-4
   BROWN IG, 1991, APPL PHYS LETT, V58, P1392, DOI 10.1063/1.104318
   Brundle C. Richard, 1992, ENCY MAT CHARACTERIZ
   Brutscher J, 1996, PLASMA SOURCES SCI T, V5, P54, DOI 10.1088/0963-0252/5/1/007
   Brutscher J, 1996, REV SCI INSTRUM, V67, P2621, DOI 10.1063/1.1147225
   CHEN J, 1992, SURF COAT TECH, V53, P267, DOI 10.1016/0257-8972(92)90385-N
   Cheung NW, 2002, SURF COAT TECH, V156, P24, DOI 10.1016/S0257-8972(02)00068-3
   CHEUNG NW, 1991, NUCL INSTRUM METH B, V55, P811, DOI 10.1016/0168-583X(91)96285-S
   Chhowalla M, 1997, J APPL PHYS, V81, P139, DOI 10.1063/1.364000
   Chu PK, 2002, SURF COAT TECH, V156, P244, DOI 10.1016/S0257-8972(02)00100-7
   Chung P.M., 1975, ELECT PROBES STATION
   Collins GA, 1994, PLASMA SOURCES SCI T, V3, P10, DOI 10.1088/0963-0252/3/1/002
   COLLINS GA, 1995, SURF COAT TECH, V74-5, P417, DOI 10.1016/0257-8972(95)08370-7
   Collins GA, 1997, SURF COAT TECH, V93, P181, DOI 10.1016/S0257-8972(97)00041-8
   Collins GA, 1996, SURF COAT TECH, V84, P537, DOI 10.1016/S0257-8972(95)02792-0
   COLLINS GA, 1994, J VAC SCI TECHNOL B, V12, P875, DOI 10.1116/1.587363
   COLLINS GA, 1991, MAT SCI ENG A-STRUCT, V139, P171, DOI 10.1016/0921-5093(91)90613-R
   CONRAD JR, 1990, J VAC SCI TECHNOL A, V8, P3146, DOI 10.1116/1.576598
   CONRAD JR, 1989, MAT SCI ENG A-STRUCT, V116, P197, DOI 10.1016/0921-5093(89)90146-9
   CONRAD JR, 1988, SURF COAT TECH, V36, P927, DOI 10.1016/0257-8972(88)90033-3
   CONRAD JR, 1987, J APPL PHYS, V62, P777, DOI 10.1063/1.339858
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Current MI, 2001, SURF COAT TECH, V136, P138, DOI 10.1016/S0257-8972(00)01043-4
   DAVIS WD, 1969, J APPL PHYS, V40, P2212, DOI 10.1063/1.1657960
   Dong H, 2000, J MATER SCI LETT, V19, P1147, DOI 10.1023/A:1006755008958
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   ELMOURSI AA, 1991, NUCL INSTRUM METH B, V62, P293, DOI 10.1016/0168-583X(91)95914-Y
   EMMERT GA, 1994, J VAC SCI TECHNOL B, V12, P880, DOI 10.1116/1.587364
   Ensinger W, 2001, SURF COAT TECH, V136, P202, DOI 10.1016/S0257-8972(00)01056-2
   Felch SB, 2002, SURF COAT TECH, V156, P229, DOI 10.1016/S0257-8972(02)00097-X
   Forrester A. T., 1988, LARGE ION BEAMS
   FRANKLYN CB, 1994, J VAC SCI TECHNOL B, V12, P923, DOI 10.1116/1.587328
   Gan BK, 2004, J PHYS-CONDENS MAT, V16, P1751, DOI 10.1088/0953-8984/16/10/007
   Gaudreau MPJ, 1999, J VAC SCI TECHNOL B, V17, P888, DOI 10.1116/1.590657
   Goebel D. M, 2000, HDB PLASMA IMMERSION, P467
   GOEBEL DM, 1994, J VAC SCI TECHNOL B, V12, P838, DOI 10.1116/1.587356
   Goeckner MJ, 1999, J VAC SCI TECHNOL B, V17, P2290, DOI 10.1116/1.590906
   Gunzel R, 2002, SURF COAT TECH, V156, P54, DOI 10.1016/S0257-8972(02)00112-3
   GUNZEL R, 1994, J VAC SCI TECHNOL B, V12, P927, DOI 10.1116/1.587329
   Gunzel R, 1999, SURF COAT TECH, V112, P307, DOI 10.1016/S0257-8972(98)00776-2
   Ha JM, 2001, SURF COAT TECH, V136, P157, DOI 10.1016/S0257-8972(00)01047-1
   Han S, 1997, SURF COAT TECH, V93, P261, DOI 10.1016/S0257-8972(97)00057-1
   He XM, 1999, J VAC SCI TECHNOL B, V17, P822, DOI 10.1116/1.590662
   He XM, 1999, J VAC SCI TECHNOL A, V17, P2525, DOI 10.1116/1.581991
   Hirvonen JP, 1997, NUCL INSTRUM METH B, V127, P922, DOI 10.1016/S0168-583X(97)00032-3
   Hopwood J.A., 2000, IONIZED PHYS VAPOR D
   Horling A, 2005, SURF COAT TECH, V191, P384, DOI 10.1016/j.surfcoat.2004.04.056
   Horling A, 2002, J VAC SCI TECHNOL A, V20, P1815, DOI 10.1116/1.1503784
   HUTCHINGS R, 1992, SURF COAT TECH, V51, P489, DOI 10.1016/0257-8972(92)90287-K
   Iskanderova Z, 2000, SURF COAT TECH, V127, P18, DOI 10.1016/S0257-8972(99)00673-8
   Iskanderova Z, 1997, NUCL INSTRUM METH B, V127, P702, DOI 10.1016/S0168-583X(96)01161-5
   Iskanderova ZA, 1999, NUCL INSTRUM METH B, V148, P1090, DOI 10.1016/S0168-583X(98)00797-6
   Johns SM, 1996, SURF COAT TECH, V85, P7, DOI 10.1016/0257-8972(96)02884-8
   Keller G, 2001, SURF COAT TECH, V136, P117, DOI 10.1016/S0257-8972(00)01039-2
   KIM SH, 2000, FIBER POLYM, V1, P83
   KLEIN J, 1995, MEAS SCI TECHNOL, V6, P550, DOI 10.1088/0957-0233/6/5/015
   Kondyurin A, 2001, VACUUM, V64, P105, DOI 10.1016/S0042-207X(01)00381-5
   Kwok DTK, 2001, SURF COAT TECH, V136, P146, DOI 10.1016/S0257-8972(00)01045-8
   Lacoste A, 2002, SURF COAT TECH, V156, P225, DOI 10.1016/S0257-8972(02)00093-2
   Lacoste A, 2002, SURF COAT TECH, V156, P125, DOI 10.1016/S0257-8972(02)00076-2
   Lacoste A, 2001, SURF COAT TECH, V135, P268, DOI 10.1016/S0257-8972(00)00993-2
   Lallement F, 2004, SURF COAT TECH, V186, P17, DOI 10.1016/j.surfcoat.2004.04.004
   Le Coeur F, 1998, REV SCI INSTRUM, V69, P831, DOI 10.1063/1.1148530
   Le Coeur F, 2000, SURF COAT TECH, V125, P71, DOI 10.1016/S0257-8972(99)00554-X
   LeCoeur F, 1997, SURF COAT TECH, V93, P265, DOI 10.1016/S0257-8972(97)00058-3
   Lee DH, 1998, APPL PHYS LETT, V73, P2423, DOI 10.1063/1.122469
   Lee Y, 2001, J ADHES SCI TECHNOL, V15, P1079, DOI 10.1163/156856101317035495
   Lee Y, 1998, J VAC SCI TECHNOL A, V16, P1710, DOI 10.1116/1.581289
   Lenoble D, 2002, SURF COAT TECH, V156, P262, DOI 10.1016/S0257-8972(02)00105-6
   Li MS, 2003, SURF COAT TECH, V167, P197, DOI 10.1016/S0257-8972(02)00895-2
   Liao J, 2005, SURF COAT TECH, V191, P90, DOI 10.1016/j.surfcoat.2004.06.039
   Liao JX, 2004, SURF COAT TECH, V183, P157, DOI 10.1016/j.surfcoat.2003.10.003
   LIEBERMAN MA, 1989, J APPL PHYS, V66, P2926, DOI 10.1063/1.344172
   Lim H, 2001, J VAC SCI TECHNOL A, V19, P1490, DOI 10.1116/1.1382650
   Lim SHN, 2005, J PHYS-CONDENS MAT, V17, P2791, DOI 10.1088/0953-8984/17/17/029
   Lim SHN, 2003, J APPL PHYS, V93, P4283, DOI 10.1063/1.1558995
   LOSSY R, 1992, APPL PHYS LETT, V61, P171, DOI 10.1063/1.108208
   Lu X, 1997, APPL PHYS LETT, V71, P2767, DOI 10.1063/1.120127
   Ma XX, 2004, SURF COAT TECH, V186, P88, DOI 10.1016/j.surfcoat.2004.04.018
   Macak K, 2000, J VAC SCI TECHNOL A, V18, P1533, DOI 10.1116/1.582380
   Malaczynski GW, 1997, J MATER ENG PERFORM, V6, P223, DOI 10.1007/s11665-997-0019-y
   MALIK SM, 1994, J VAC SCI TECHNOL B, V12, P843, DOI 10.1116/1.587357
   Mandl S, 2002, BIOMOL ENG, V19, P129, DOI 10.1016/S1389-0344(02)00025-4
   Mandl S, 2004, SURF COAT TECH, V186, P82, DOI 10.1016/j.surfcoat.2004.04.017
   Mandl S, 2001, SURF COAT TECH, V136, P176, DOI 10.1016/S0257-8972(00)01053-7
   Mandl S, 1998, SURF COAT TECH, V100, P372, DOI 10.1016/S0257-8972(97)00651-8
   Mandl S, 1997, SURF COAT TECH, V93, P229, DOI 10.1016/S0257-8972(97)00050-9
   MATOSSIAN J, 2000, HDB PLASMA IMMERSION, P343
   MATOSSIAN JN, 1994, J VAC SCI TECHNOL B, V12, P850, DOI 10.1116/1.587358
   Matossian JN, 1996, SURF COAT TECH, V85, P111, DOI 10.1016/0257-8972(96)02873-3
   MATOSSIAN JN, 1993, SURF COAT TECH, V62, P595, DOI 10.1016/0257-8972(93)90305-8
   MATOSSIAN JN, 1994, SURFACE POTENTIAL CO
   Maulat O, 1999, J VAC SCI TECHNOL B, V17, P879, DOI 10.1116/1.590655
   McKenzie DR, 2004, SURF COAT TECH, V186, P239, DOI 10.1016/j.surfcoat.2004.04.093
   McKenzie DR, 2001, THIN SOLID FILMS, V382, P280, DOI 10.1016/S0040-6090(00)01702-8
   Miyagawa Y, 2004, SURF COAT TECH, V186, P2, DOI 10.1016/j.surfcoat.2004.04.043
   MIZUNO B, 1988, APPL PHYS LETT, V53, P2059, DOI 10.1063/1.100318
   Moller W, 1999, SURF COAT TECH, V116, P1, DOI 10.1016/S0257-8972(99)00144-9
   Moller W, 1999, NATO ASI 3 HIGH TECH, V67, P191
   MOLLER W, 1984, NUCL INSTRUM METH B, V2, P814, DOI 10.1016/0168-583X(84)90321-5
   Mukherjee S, 2002, SURF COAT TECH, V157, P111, DOI 10.1016/S0257-8972(02)00149-4
   Mukherjee S, 1997, SURF COAT TECH, V93, P188, DOI 10.1016/S0257-8972(97)00042-X
   Murakami N, 2001, SURF COAT TECH, V136, P265, DOI 10.1016/S0257-8972(00)01028-8
   Oates TWH, 2002, SURF COAT TECH, V156, P332, DOI 10.1016/S0257-8972(02)00107-X
   QIAN XY, 1991, APPL PHYS LETT, V59, P348, DOI 10.1063/1.106392
   QIAN XY, 1991, NUCL INSTRUM METH B, V55, P821, DOI 10.1016/0168-583X(91)96286-T
   QIN S, 1994, J VAC SCI TECHNOL B, V12, P962, DOI 10.1116/1.587336
   Qin S, 1992, PLASMA SOURCES SCI T, V1, P1, DOI 10.1088/0963-0252/1/1/001
   QIU X, 1991, NUCL INSTRUM METH B, V59, P951, DOI 10.1016/0168-583X(91)95740-5
   REASS WA, 1994, J VAC SCI TECHNOL B, V12, P854, DOI 10.1116/1.587359
   Redondo LM, 2002, SURF COAT TECH, V156, P61, DOI 10.1016/S0257-8972(02)00113-5
   Redondo LM, 2001, SURF COAT TECH, V136, P51, DOI 10.1016/S0257-8972(00)01010-0
   REDSTEN AM, 1992, J MATER PROCESS TECH, V30, P253, DOI 10.1016/0924-0136(92)90218-H
   REJ DJ, 1994, J VAC SCI TECHNOL B, V12, P861, DOI 10.1116/1.587360
   Rossi JO, 2001, SURF COAT TECH, V136, P43, DOI 10.1016/S0257-8972(00)01008-2
   ROSSNAGEL SM, 1994, J VAC SCI TECHNOL B, V12, P449, DOI 10.1116/1.587142
   SAMANDI M, 1992, SURF COAT TECH, V55, P447
   SAMANDI M, 1993, SURF COAT TECH, V59, P261, DOI 10.1016/0257-8972(93)90094-5
   SCHEUER JT, 1990, J APPL PHYS, V67, P1241, DOI 10.1063/1.345722
   Schoser S, 1997, SURF COAT TECH, V93, P339, DOI 10.1016/S0257-8972(97)00072-8
   SHAMIM M, 1991, J APPL PHYS, V69, P2904, DOI 10.1063/1.348600
   SHAMIM MM, 1991, J APPL PHYS, V70, P4756, DOI 10.1063/1.349067
   Shang ZK, 1996, SURF COAT TECH, V85, P105, DOI 10.1016/0257-8972(96)02861-7
   Sheridan TE, 1996, PHYS PLASMAS, V3, P3507, DOI 10.1063/1.871501
   SHERIDAN TE, 1993, J APPL PHYS, V74, P4903, DOI 10.1063/1.354323
   Sheridan TE, 1996, J APPL PHYS, V80, P66, DOI 10.1063/1.362771
   Shi W, 2001, WEAR, V250, P544, DOI 10.1016/S0043-1648(01)00636-6
   SMITH PP, 1994, J VAC SCI TECHNOL B, V12, P940, DOI 10.1116/1.587332
   SRIDHARAN K, 1990, MAT SCI ENG A-STRUCT, V128, P259, DOI 10.1016/0921-5093(90)90234-T
   SRIDHARAN K, 2000, HDB PLASMA IMMERSION, pCH10
   Sun M, 1998, J MATER RES, V13, P1823, DOI 10.1557/JMR.1998.0258
   Sun M, 1998, J VAC SCI TECHNOL A, V16, P2718, DOI 10.1116/1.581406
   Sun M, 1996, J VAC SCI TECHNOL A, V14, P367, DOI 10.1116/1.579902
   SZAPIRO B, 1988, APPL PHYS LETT, V53, P358, DOI 10.1063/1.100401
   SZAPIRO B, 1989, J APPL PHYS, V65, P3713, DOI 10.1063/1.342600
   Tan IH, 2004, SURF COAT TECH, V186, P234, DOI 10.1016/j.surfcoat.2004.04.029
   TANG BY, 1994, J VAC SCI TECHNOL B, V12, P867, DOI 10.1116/1.587361
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   THOMAE RW, 1995, NUCL INSTRUM METH B, V99, P569, DOI 10.1016/0168-583X(95)00228-6
   Tian XB, 2004, SURF COAT TECH, V186, P47, DOI 10.1016/j.surfcoat.2004.04.008
   Tonosaki M, 2002, SURF COAT TECH, V156, P338, DOI 10.1016/S0257-8972(02)00108-1
   Tonosaki M, 2001, SURF COAT TECH, V136, P249, DOI 10.1016/S0257-8972(00)01024-0
   Torregrosa F, 2004, SURF COAT TECH, V186, P93, DOI 10.1016/j.surfcoat.2004.04.046
   Uglov VV, 1999, J VAC SCI TECHNOL B, V17, P836, DOI 10.1116/1.590665
   Uglov VV, 2001, SURF COAT TECH, V136, P226, DOI 10.1016/S0257-8972(00)01019-7
   VAHEDI V, 1991, J APPL PHYS, V69, P2008, DOI 10.1063/1.348774
   Vempaire D, 2005, PLASMA PHYS CONTR F, V47, pA153, DOI 10.1088/0741-3335/47/5A/011
   Vempaire D, 2004, SURF COAT TECH, V186, P245, DOI 10.1016/j.surfcoat.2004.04.030
   Vetter J, 1999, SURF COAT TECH, V120, P709, DOI 10.1016/S0257-8972(99)00363-1
   Volz K, 2002, SURF COAT TECH, V156, P237, DOI 10.1016/S0257-8972(02)00098-1
   Volz K, 2001, SURF COAT TECH, V136, P80, DOI 10.1016/S0257-8972(00)01016-1
   Walter KC, 1995, NUCL INSTRUM METH B, V106, P522, DOI 10.1016/0168-583X(95)00763-6
   Walter KC, 1997, SURF COAT TECH, V93, P287, DOI 10.1016/S0257-8972(97)00062-5
   Walter KC, 1996, SURF COAT TECH, V85, P1, DOI 10.1016/0257-8972(96)02886-1
   WALTER KC, 1994, J VAC SCI TECHNOL B, V12, P945, DOI 10.1116/1.587333
   Walther SR, 2004, SURF COAT TECH, V186, P68, DOI 10.1016/j.surfcoat.2004.04.014
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
   Wang SY, 1997, SURF COAT TECH, V93, P309, DOI 10.1016/S0257-8972(97)00066-2
   WANG YF, 1979, THIN SOLID FILMS, V63, P11, DOI 10.1016/0040-6090(79)90092-0
   Wei R, 1996, SURF COAT TECH, V83, P235, DOI 10.1016/0257-8972(95)02825-0
   Weldon MK, 1997, J VAC SCI TECHNOL B, V15, P1065, DOI 10.1116/1.589416
   WIDNER M, 1970, PHYS FLUIDS, V13, P2532, DOI 10.1063/1.1692823
   Wolf B. H., 1995, HDB ION SOURCES
   WOOD BP, 1995, NUCL INSTRUM METH B, V96, P429, DOI 10.1016/0168-583X(94)00534-6
   WOOD BP, 1994, J VAC SCI TECHNOL B, V12, P870, DOI 10.1116/1.587362
   WOOD BP, 2000, HDB PLASMA IMMERSION, pCH4
   Woods RH, 1997, NUCL INSTRUM METH B, V127, P1004, DOI 10.1016/S0168-583X(97)00048-7
   Wu Z., 1995, Surface Engineering, V11, P53
   Yang P, 2004, SURF COAT TECH, V186, P125, DOI 10.1016/j.surfcoat.2004.04.039
   Yankov RA, 2001, ANN PHYS-BERLIN, V10, P279, DOI 10.1002/1521-3889(200104)10:4<279::AID-ANDP279>3.0.CO;2-R
   YU C, 1994, IEEE ELECTR DEVICE L, V15, P196, DOI 10.1109/55.286690
   Yukimura K, 2004, SURF COAT TECH, V186, P73, DOI 10.1016/j.surfcoat.2004.04.015
   Yukimura K, 2002, SURF COAT TECH, V156, P66, DOI 10.1016/S0257-8972(02)00114-7
   Zeng XC, 1997, PHYS PLASMAS, V4, P4431, DOI 10.1063/1.872607
   Zeng XC, 1997, APPL PHYS LETT, V71, P1035, DOI 10.1063/1.119719
   Zeng XC, 2001, THIN SOLID FILMS, V390, P145, DOI 10.1016/S0040-6090(01)00950-6
   Zeng ZM, 1999, J APPL PHYS, V86, P120, DOI 10.1063/1.370708
   Ziegler J F, 1985, STOPPING RANGE IONS
NR 205
TC 89
Z9 94
U1 3
U2 76
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0093-3813
EI 1939-9375
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD DEC
PY 2005
VL 33
IS 6
BP 1944
EP 1959
DI 10.1109/TPS.2005.860079
PN 1
PG 16
WC Physics, Fluids & Plasmas
SC Physics
GA 994XO
UT WOS:000234064700014
DA 2018-10-20
ER

PT J
AU Engleman, PG
   Kurella, A
   Samant, A
   Blue, CA
   Dahotre, NB
AF Engleman, PG
   Kurella, A
   Samant, A
   Blue, CA
   Dahotre, NB
TI The application of laser-induced multi-scale surface texturing
SO JOM
LA English
DT Article
ID THERMAL-CONDUCTIVITY; HEAT-CAPACITY; POLYMERS
AB Recently, there has been. interest in controlling microstructure and surface texture on smaller and smaller scales. However, in nature, materials are organized at? length scales varying from the nano- to the micro- and larger It? order to realize hiercirchical structuring for use in biomedical and mechanical systems, two methods for producing multi-scale surface microstructures and physical textures are explained. The first investigates the use of a marking laser to produce multi-scale texturing of zirconia coatings on T-6Al-4V substrates and the second method discusses the design and challenges associated with laser interference surface texturing along with process and material factors controlling surface structures.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Oak Ridge Natl Lab, Div Met & Ceram, Mat Proc Grp, Oak Ridge, TN 37831 USA.
RP Dahotre, NB (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM ndahotre@utk.edu
CR ANDERSON BL, 1995, APPL OPTICS, V34, P7443, DOI 10.1364/AO.34.007443
   Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Blatter A, 1999, WEAR, V232, P226, DOI 10.1016/S0043-1648(99)00150-7
   Daniel C, 2005, APPL SURF SCI, V242, P140, DOI 10.1016/j.apsusc.2004.08.008
   Daniel C, 2003, APPL SURF SCI, V208, P317, DOI 10.1016/S0169-4332(02)01381-8
   Dumitru G, 2000, APPL PHYS A-MATER, V70, P485, DOI 10.1007/s003390051073
   EIERMANN K, 1962, J POLYM SCI, V57, P99, DOI 10.1002/pol.1962.1205716508
   Ezugwu EO, 1997, J MATER PROCESS TECH, V68, P262, DOI 10.1016/S0924-0136(96)00030-1
   Jager I, 2000, BIOPHYS J, V79, P1737
   Jung YG, 1997, J MATER SCI, V32, P3841, DOI 10.1023/A:1018640126751
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   KURELLA A, IN PRESS J MAT SCI M
   Li P, 2003, IEEE T NANOBIOSCI, V2, P138, DOI 10.1109/TNB.2003.816228
   Madou M. J., 2002, FUNDAMENTALS MICROFA
   Minakov AA, 1998, THERMOCHIM ACTA, V317, P117, DOI 10.1016/S0040-6031(98)00380-3
   Mucklich F, 2005, INTERMETALLICS, V13, P437, DOI 10.1016/j.intermet.2004.07.005
   PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417
   PATTERSON U, 2003, TRIBO INT, V36, P857
   Ravichandran KS, 1999, J AM CERAM SOC, V82, P673
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Wakuda M, 2003, WEAR, V254, P356, DOI 10.1016/S0043-1648(03)00004-8
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
NR 22
TC 13
Z9 13
U1 2
U2 17
PU MINERALS METALS MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD DEC
PY 2005
VL 57
IS 12
BP 46
EP 50
DI 10.1007/s11837-005-0182-2
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 996PF
UT WOS:000234185800006
DA 2018-10-20
ER

PT J
AU Zhang, JQY
   Sullivan, JM
   Ghadyani, H
AF Zhang, JQY
   Sullivan, JM
   Ghadyani, H
TI MRI guided 3D mesh generation and registration for biological modeling
SO JOURNAL OF COMPUTING AND INFORMATION SCIENCE IN ENGINEERING
LA English
DT Article
ID IMAGES; RECONSTRUCTION; ALGORITHM; GRIDS
AB An accurate three-dimensional (3D) mesh of biological models is fundamental for analysis and treatment simulations. Generally noninvasive magnetic resonance image (MRI) data are taken as the input for the simulation. The topologic relationship of anatomy is extracted from MR images through segmentation processes. To accelerate the biological modeling phase, template surface and volume meshes are generated based on MR images and/or anatomical atlases (e.g., brain atlas, etc.). The boundary surfaces are extracted from segmented regions on the image slices, which are used as the input for 3D volume mesh generation. An intuitive graphic user interface was developed for biomedical applications. It integrated MRI data manipulation with surface mesh and volume mesh generators. Image volume and mesh geometries are registered in the MRI working space. As the core component of the system, a robust 3D mesh generation approach is presented. It is capable of describing irregular geometries exhibiting concave and convex surfaces. It uses deltahedral building blocks for volume mesh generation and creates high-quality, regular-shaped tetrahedral mesh elements. The approach supports multiple levels of localized refinement without reducing the overall mesh quality The validity of this new mesh generation strategy and implementation is demonstrated via the medical applications in brain vasculature modeling, multimodality imaging for breast cancer detection, and numerous anatomically accurate models presented Multiple material boundaries are preserved in each mesh with fidelity.
C1 Worcester Polytech Inst, Worcester, MA 01609 USA.
   Univ Rhode Isl, Kingston, RI 02881 USA.
RP Zhang, JQY (reprint author), Worcester Polytech Inst, Worcester, MA 01609 USA.
EM zqy@wpi.edu; hamid@wpi.edu; dmmeyer@egr.uri.edu
RI Meyer, DML/B-4278-2014
CR BAKER TJ, 1989, ENG COMPUT, V5, P161, DOI 10.1007/BF02274210
   Beek M, 2000, J BIOMECH, V33, P307, DOI 10.1016/S0021-9290(99)00168-2
   Berti G., 2004, EUR C COMP METH APPL
   BOISSONNAT JD, 1988, COMPUT VISION GRAPH, V44, P1, DOI 10.1016/S0734-189X(88)80028-8
   BURATYNSKI EK, 1988, P NUM GRID GEN COMP, P621
   Cebral JR, 2001, INT J NUMER METH ENG, V51, P985, DOI 10.1002/nme.205
   Cody DD, 1999, J BIOMECH, V32, P1013, DOI 10.1016/S0021-9290(99)00099-8
   Ferrant M, 2002, MED IMAGE ANAL, V6, P337, DOI 10.1016/S1361-8415(02)00060-9
   FUCHS A, 1998, 7 INT MESH ROUNDT, P133
   GASSON PC, 1983, GEOMETRY SPATIAL FOR
   HUANG W, 2004, P 1I INT SOC MAG RES
   Lin CL, 1999, COMPUT METH PROG BIO, V59, P187, DOI 10.1016/S0169-2607(99)00004-8
   LOHNER R, 1988, INT J NUMER METH FL, V8, P1135, DOI 10.1002/fld.1650081003
   Miga MI, 2001, NEUROSURGERY, V49, P75, DOI 10.1097/00006123-200107000-00012
   Naylor DJ, 1999, INT J NUMER METH ENG, V44, P1383, DOI 10.1002/(SICI)1097-0207(19990410)44:10<1383::AID-NME616>3.3.CO;2-9
   NIELSON GM, 1997, IEEE VIS P 8 C VIS
   OWEN SJ, 2002, 11 INT MESH ROUNDT
   Paulsen KD, 1999, IEEE T MED IMAGING, V18, P496, DOI 10.1109/42.781015
   Rick KR, 2003, P SOC PHOTO-OPT INS, V5029, P210, DOI 10.1117/12.479761
   SAXENA R, 1999, COMPUT METHOD BIOMEC, V2, P285
   SCHNEIDERS R, 1995, 4 INT MESH ROUNDT, P103
   Senechal M., 1981, MATH MAG, V54, P227, DOI 10.2307/2689983
   Sullivan JM, 1997, FINITE ELEM ANAL DES, V25, P219, DOI 10.1016/S0168-874X(96)00027-3
   SULLIVAN JM, 1997, J FINITE ELEMENT ANA, V25, P275
   Taubin G, 1996, P 4 EUR C COMP VIS, VI, P283
   UNGOR A, 2001, P CAN C COMP GEOM AU
   Van Houten EEW, 2001, MAGNET RESON MED, V45, P827, DOI 10.1002/mrm.1111
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028
   Wu Z, 2003, INT J NUMER METH ENG, V58, P189, DOI 10.1002/nme.775
   ZHANG JQ, 2004, P 1I INT SOC MAG RES
   ZHANG JQ, 2005, SPIE INT S MED IM
NR 31
TC 6
Z9 7
U1 0
U2 1
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1530-9827
J9 J COMPUT INF SCI ENG
JI J. Comput. Inf. Sci. Eng.
PD DEC
PY 2005
VL 5
IS 4
BP 283
EP 290
DI 10.1115/1.2052828
PG 8
WC Computer Science, Interdisciplinary Applications; Engineering,
   Manufacturing
SC Computer Science; Engineering
GA 989VI
UT WOS:000233701600004
DA 2018-10-20
ER

PT J
AU Liu, HS
   Yan, BH
   Huang, FY
   Qiu, KH
AF Liu, HS
   Yan, BH
   Huang, FY
   Qiu, KH
TI A study on the characterization of high nickel alloy micro-holes using
   micro-EDM and their applications
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE high nickel alloy; micro-EDM; MEMS; micro-hole; micro-tool; biomedical
   analysis
ID FABRICATION
AB In this study, the feasibility of fabricating micro-holes in the high nickel alloy using micro-electro-discharge machining (micro-EDM) was investigated. The high nickel alloy is a material with high magnetic permeability. It can be used to shield MEMS prevent interference of the magnetic field. Micro-systems can be assembled and micro-wires can be connected through micro-holes that are drilled in the workpiece. In this way, the internal electronic system can communicate with external system without magnetic wave disturbance. However, since the high nickel alloy is tough and can easily cause cutting tool wear, it is difficult to fabricate micro-holes by the conventional machining methods. In this work, a two-stage cylindrical cutting tool of high hardness was first fashioned. The tool was precisely shaped with a first stage (i.e., tip) having a smaller diameter, and a helically grooved second stage with a larger diameter by the wire electro-discharge grinding (WEDG) process. The first stage of the tool electrode was then used to drill a micro-hole in a plate using micro-EDM process. To improve the roughness of micro-holes, the second stage with helical groove was used for in situ grind machining with SiC particles. Our experimental results show that by optimizing EDM machining parameters, i.e., discharge current of 500 mA, pulse duration of around 4 mu s, etc., favorable diameter variation between the entrances and the exits (DVEE), good material removal rate (MRR) and good electrode wear rate (EWR) could be obtained. The addition of the in situ grind machining leads to precise contours, and the surface roughness of micro-holes is reduced to 0.85 mu m R-max, as revealed by SEM photographs. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Cent Univ, Dept Mech Engn, Chungli 32054, Taiwan.
RP Yan, BH (reprint author), Natl Cent Univ, Dept Mech Engn, Chungli 32054, Taiwan.
EM bhyen@cc.ncu.edu.tw
CR Allen DM, 1996, J MATER PROCESS TECH, V58, P53, DOI 10.1016/0924-0136(95)02107-8
   Choi SS, 1998, MICROELECTRON ENG, V42, P167, DOI 10.1016/S0167-9317(98)00037-9
   EHRFELD W, 1995, RADIAT PHYS CHEM, V45, P349, DOI 10.1016/0969-806X(93)E0007-R
   KAGAYA K, 1990, PRECIS ENG, V12, P213, DOI 10.1016/0141-6359(90)90063-5
   KAGAYA K, 1986, PRECIS ENG, V8, P156
   KUO L, 1991, P IEEE MEMS 91, P80
   LYMAN T, 1975, PROPERTIES SELECTION, V1, P785
   Masuzawa T, 1985, ANN CIRP, V34, P431
   Masuzawa T., 1989, P ISEM, V9, P86
   Masuzawa T., 1989, ANN CIRP, V38, P195
   MASUZAWA T, 1985, ANN CIRP, V34, P419
   Reynaerts D, 1997, SENSOR ACTUAT A-PHYS, V60, P212, DOI 10.1016/S0924-4247(97)01359-9
   Sun XQ, 1996, SENSOR ACTUAT A-PHYS, V57, P159, DOI 10.1016/S0924-4247(97)80107-0
NR 13
TC 66
Z9 68
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD DEC 1
PY 2005
VL 169
IS 3
BP 418
EP 426
DI 10.1016/j.jmatprotec.2005.04.084
PG 9
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 983RH
UT WOS:000233249300013
DA 2018-10-20
ER

PT J
AU Haik, Y
   Chatterjee, J
   Chen, CJ
AF Haik, Y
   Chatterjee, J
   Chen, CJ
TI Synthesis and stabilization of Fe-Nd-B nanoparticles for biomedical
   applications
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE iron-neodymium-boron particles; magnetic nanoparticles; silica coated
   particles; biomedical applications
ID MAGNETIC-MATERIALS; PERMANENT-MAGNETS; AQUEOUS-SOLUTION; ALLOY
   PARTICLES; METAL-IONS; REDUCTION; BOROHYDRIDE; POWDERS; PR
AB Stable composition of Iron Neodymium Boron nanoparticles are formed by a chemical method. Conventional borohydride reduction method was used. The particles are in the size range of 30-100 nm. Silica coating was applied to stabilize and prepare the particles for in vitro applications such as cell separation and diagnostics. Morphology of particles has been studied along with the structure and magnetic properties.
C1 Florida State Univ, Ctr Nanomagnet & Biotechnol, Tallahassee, FL 32306 USA.
   United Arab Emirates Univ, Dept Mech Engn, Al Ain, U Arab Emirates.
RP Haik, Y (reprint author), Florida State Univ, Ctr Nanomagnet & Biotechnol, Tallahassee, FL 32306 USA.
EM haik@eng.fsu.edu
CR CORRIAS A, 1990, CHEM MATER, V2, P363, DOI 10.1021/cm00010a010
   CROAT JJ, 1984, J APPL PHYS, V55, P2078, DOI 10.1063/1.333571
   Dong XL, 2001, J MATER RES, V16, P1083, DOI 10.1557/JMR.2001.0150
   KOCH CB, 1991, NATO ADV SCI I B-PHY, V259, P559
   KOON NC, 1984, J APPL PHYS, V55, P2063, DOI 10.1063/1.333568
   Lin JH, 1997, J ALLOY COMPD, V249, P237, DOI 10.1016/S0925-8388(96)02741-7
   OHMORI M, 1992, J COLLOID INTERF SCI, V150, P594, DOI 10.1016/0021-9797(92)90229-F
   Okajima Y, 1987, US Patent No, Patent No. [4,681,623, 4681623]
   SAGAWA M, 1984, J APPL PHYS, V55, P2083, DOI 10.1063/1.333572
   SCHLESINGER HI, 1953, J AM CHEM SOC, V75, P215, DOI 10.1021/ja01097a057
   SELLMYER DJ, 1984, J APPL PHYS, V55, P2088, DOI 10.1063/1.333573
   SHEN JY, 1993, J PHYS CHEM-US, V97, P8504, DOI 10.1021/j100134a020
   WELLS S, 1989, J PHYS-CONDENS MAT, V1, P8199, DOI 10.1088/0953-8984/1/43/019
   YIPING L, 1989, J MAGN MAGN MATER, V79, P321, DOI 10.1016/0304-8853(89)90186-8
   Zysler RD, 2001, J MATER SCI, V36, P2291, DOI 10.1023/A:1017524923761
NR 15
TC 21
Z9 22
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD DEC
PY 2005
VL 7
IS 6
BP 675
EP 679
DI 10.1007/s11051-005-5467-4
PG 5
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 990JA
UT WOS:000233737800010
DA 2018-10-20
ER

PT J
AU Melnig, V
   Obreja, L
   Garlea, A
AF Melnig, V
   Obreja, L
   Garlea, A
TI In vitro degradation and erosion of degradable lactate segmented
   polyurethanes
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article; Proceedings Paper
CT 8th Romanian Biophysics Conference
CY MAY 26-28, 2005
CL Iasi, ROMANIA
DE poly(lactateurethane); poly(esterurethane); water hydrolysis;
   erosion-diffusion mechanism
AB A significant number of studies for improving the biocompatibility of polyurethanes have been concentrated on bulk and surface modifications. In this view, the knowledge of polymer degradation in body solvent-fluids (aqua), and the subsequent physical properties changes, is the first step for a better designing of polyurethanes used in biomedical applications. In this paper, the dynamics of water non-enzymatic hydrolysis of poly(lactateurethane) are analysed and the results revealed characteristics more suitable for biomedical applications, than poly(esterurethane) materials, due to the incorporation of a soft lactate segment.
C1 Al I Cuza Univ, Fac Phys, Iasi 700506, Romania.
RP Melnig, V (reprint author), Al I Cuza Univ, Fac Phys, Bd Carol I,Nr 11A, Iasi 700506, Romania.
EM vmelnig@uaic.ro
RI Cuza, UAIC/D-2604-2009; Cazacu, Ana/E-8009-2013
CR APOSTU MO, 2003, TIMISOARTA MED J, V53, P39
   Burkoth TS, 2002, CHEM BIOL, V9, P647, DOI 10.1016/S1074-5521(02)00140-0
   GORMA K, 2001, EUROPEAN CELL MAT, V1, P59
   MELNIG V, 2005, J MEMBRANE SCI  0707
   Startsev O. V., 1993, POLYM YB, V11, P91
   TURA V, 1 INT C BIOM BIOM ME, P80
   Vaidya A, 2002, J COLLOID INTERF SCI, V249, P235, DOI 10.1006/jcis.2002.8262
NR 7
TC 4
Z9 4
U1 1
U2 3
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD DEC
PY 2005
VL 7
IS 6
BP 2803
EP 2808
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 994JG
UT WOS:000234027300002
DA 2018-10-20
ER

PT J
AU Forster, C
   Cimalla, V
   Bruckner, K
   Hein, M
   Pezoldt, J
   Ambacher, O
AF Forster, C
   Cimalla, V
   Bruckner, K
   Hein, M
   Pezoldt, J
   Ambacher, O
TI Micro-electromechanical systems based on 3C-SiC/Si heterostructures
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Current Trends in Nanoscience - From Materials to
   Applications held at the 2004 EMRS Spring Meeting
CY MAY 24-28, 2004
CL Strasbourg, FRANCE
SP European Mat Res Soc
DE microelectromechanical systems; nanoelectromechanical systems; silicon
   carbide; silicon; etching; epitaxy
ID SILICON-CARBIDE; MEMS
AB Wide band gap semiconductors like SiC are excellent materials for high temperature, high frequency and high power applications. Furthermore, the properties of SiC fulfil the requirements for modem applications in micro-sensors, micro-actuators as well as in micro- and nano-electromechanical systems (MEMS and NEMS). Novel applications of SiC/Si based MEMS and NEMS are dosing and sensor systems for micro- and nano-fluidic systems, e.g. for fast and reliable biomedical testing and analysis. We have developed a technology for processing SiC/Si-based MEMS and NEMS. A micro dosing head for pulmonary amounts of water-based liquids was realized. This dosing head consist of parallel operating multi micro pipes running at a defined pressure. Furthermore, we used 3C-SiC/Si heterostructures to process resonator bars having geometries in the mu m range and a thickness of 250 nm. These bars open the possibility to evaluate the viscosity of water nanodroplets, to measure the mass of biomolecules, especially proteins, positioned on the bars. The used 3C-SiC layers were grown by a special chemical vapor deposition under ultra high vacuum (UHVCVD) conditions. This kind of deposition process allows us to grow the cubic silicon carbide polytype at relatively low temperature (below 900 degrees C). Such growth conditions allow reducing the internal stress of the grown monocrystalline layers, which is an important precondition for fabrication of reliable MEMS and NEMS structures based on silicon carbide. (c) 2005 Published by Elsevier B.V.
C1 Tech Univ Ilmenau, Dept Nanotechnol, Ctr Micro & Nanotechnol, D-98693 Ilmenau, Germany.
   Tech Univ Ilmenau, Dept RF & Microwave Techniques, D-98693 Ilmenau, Germany.
RP Forster, C (reprint author), Tech Univ Ilmenau, Dept Nanotechnol, Ctr Micro & Nanotechnol, PF100565, D-98693 Ilmenau, Germany.
EM christian.forester@tu-ilmenau.de
RI Pezoldt, Jorg/A-3862-2008
CR CHU TL, 1965, J ELECTROCHEM SOC, V112, P955, DOI 10.1149/1.2423742
   HARRIS GL, 1992, J MATER SCI-MATER EL, V3, P162, DOI 10.1007/BF00695513
   Karklina M. I., 1972, Izvestiya Akademii Nauk SSSR, Neorganicheskie Materialy, V8, P378
   Mehregany M, 1999, THIN SOLID FILMS, V355, P518, DOI 10.1016/S0257-8972(99)00374-6
   MEHREGANY M, 1999, THIN SOLID FILMS, V356, P518
   Sarro PM, 2000, SENSOR ACTUAT A-PHYS, V82, P210, DOI 10.1016/S0924-4247(99)00335-0
   SHOR JS, 1993, J ELECTROCHEM SOC, V140, pL123, DOI 10.1149/1.2220722
   SUZUKI K, 1977, JPN J APPL PHYS, V16, P1979, DOI 10.1143/JJAP.16.1979
   Xie ZY, 2000, J CRYST GROWTH, V217, P115, DOI 10.1016/S0022-0248(00)00480-2
   Yang YT, 2001, APPL PHYS LETT, V78, P162, DOI 10.1063/1.1338959
   Yih PH, 1997, PHYS STATUS SOLIDI B, V202, P605, DOI 10.1002/1521-3951(199707)202:1<605::AID-PSSB605>3.0.CO;2-Y
NR 11
TC 14
Z9 14
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC
PY 2005
VL 25
IS 5-8
SI SI
BP 804
EP 808
DI 10.1016/j.msec.2005.07.016
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 991AP
UT WOS:000233784800051
DA 2018-10-20
ER

PT J
AU Krsko, P
   Libera, M
AF Krsko, Peter
   Libera, Matthew
TI Biointeractive hydrogels
SO MATERIALS TODAY
LA English
DT Article
AB PEG is a remarkable material. It is nontoxic, biocompatible, and has been approved by the US Food and Drug Administration for both oral and topical applications. It can be found in a variety of cosmetics, soaps, biomedical devices, and drug formulations. Also, despite the fact that it has been produced commercially for many decades(1) and reviewed extensively(2,3), PEG continues to be investigated in the context of biomaterials science because of its ability to control the bioactivity of surfaces and bulk materials.
C1 [Krsko, Peter; Libera, Matthew] Stevens Inst Technol, Dept Chem Biomed & Mat Engn, Hoboken, NJ 07030 USA.
RP Libera, M (reprint author), Stevens Inst Technol, Dept Chem Biomed & Mat Engn, Hoboken, NJ 07030 USA.
EM mlibera@stevens.edu
FU US Army Research Office; National Science Foundation; National
   Institutes of Health, through RESBIO-The National Resource for Polymeric
   Biomaterials
FX The Libera group has received generous support from the US Army Research
   Office and the National Science Foundation for work on electron-polymer
   interactions, and from the National Institutes of Health, through
   RESBIO-The National Resource for Polymeric Biomaterials, for work on
   polymeric biomaterials.
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Amabile-Cuevas C. F., 2003, MULTIPLE DRUG RESIST
   AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   Andreopoulos FM, 1998, BIOMATERIALS, V19, P1343, DOI 10.1016/S0142-9612(97)00219-6
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Brittain S, 1998, PHYS WORLD, V11, P31
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Brydson J.A., 1989, PLASTIC MAT
   Bubb DM, 2001, APPL PHYS A-MATER, V73, P121, DOI 10.1007/s003390100884
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Burmania JA, 2003, BIOMATERIALS, V24, P3921, DOI 10.1016/S0142-9612(03)00270-9
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Flory P. J., 1990, PRINCIPLES POLYM CHE
   Ghosh P, 1999, ANGEW CHEM INT EDIT, V38, P1592, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1592::AID-ANIE1592>3.0.CO;2-I
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAHAM NB, 1984, BIOMATERIALS, V5, P27, DOI 10.1016/0142-9612(84)90063-2
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hong Y, 2004, LANGMUIR, V20, P11123, DOI 10.1021/la048651m
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   Ichi T, 2001, BIOMACROMOLECULES, V2, P204, DOI 10.1021/bm005617n
   Iza M, 1998, J CONTROL RELEASE, V52, P41, DOI 10.1016/S0168-3659(97)00191-0
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Jun Y, 2004, BIOMATERIALS, V25, P3503, DOI 10.1016/j.biomaterials.2003.10.053
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kao W. J., 2000, BIOTECHNOL BIOENG, V59, P2
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   Kofinas P, 1996, BIOMATERIALS, V17, P1547, DOI 10.1016/0142-9612(96)89781-X
   Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740
   Krsko P, 2003, LANGMUIR, V19, P5618, DOI 10.1021/la034157r
   Krsko P., 2005, BIOMATERIALS UNPUB
   Krsko P., 2005, MATER RES SOC S P, P845
   Kusnezow W, 2003, J MOL RECOGNIT, V16, P165, DOI 10.1002/jmr.625
   Kusnezow W., 2002, BIOTECHNIQUES, V33, pS13
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee SW, 1998, BIOMATERIALS, V19, P1669, DOI 10.1016/S0142-9612(98)00044-1
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   Lu SX, 2000, MACROMOLECULES, V33, P2509, DOI 10.1021/ma9915024
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Materials Today, 2004, MAT TODAY, V7
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   MERRILL EW, 1987, ANN NY ACAD SCI, V516, P196, DOI 10.1111/j.1749-6632.1987.tb33041.x
   MERRILL EW, 1993, BIOMATERIALS, V14, P1117, DOI 10.1016/0142-9612(93)90154-T
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Micic M, 2003, COLLOID SURFACE B, V27, P147, DOI 10.1016/S0927-7765(02)00051-6
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   O'Connor S. M., 1997, BIOARTIFICIAL ORGANS, P476
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Popat KC, 2002, SURF COAT TECH, V154, P253, DOI 10.1016/S0257-8972(02)00019-1
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Ramanathan Y, 2002, GENOME RES, V12, P1175, DOI 10.1101/gr.156002
   Ravichandran P, 1997, INT J PHARM, V154, P89, DOI 10.1016/S0378-5173(97)00131-2
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Saaem I., 2005, ANAL CHEM UNPUB
   Sawhney A. S., 2001, RADTECH REPORT, P14
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Sharma S, 2005, J NANOSCI NANOTECHNO, V5, P235, DOI 10.1166/jnn.2005.030
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   Sukumar VS, 2002, MACROMOLECULES, V35, P10189, DOI 10.1021/ma0213753
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Watanabe J, 2002, BIOMATERIALS, V23, P4041, DOI 10.1016/S0142-9612(02)00122-9
   Watkins AW, 2005, MACROMOLECULES, V38, P1326, DOI 10.1021/ma0475232
   Yadavalli VK, 2004, SENSOR ACTUAT B-CHEM, V97, P290, DOI 10.1016/j.snb.2003.08.030
   Zhang H, 2002, ADV MATER, V14, P1472, DOI 10.1002/1521-4095(20021016)14:20<1472::AID-ADMA1472>3.0.CO;2-E
   ZHANG LH, 1992, RADIAT PHYS CHEM, V40, P501
   Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4
NR 101
TC 78
Z9 79
U1 3
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD DEC
PY 2005
VL 8
IS 12
BP 36
EP 44
DI 10.1016/S1369-7021(05)71223-2
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32EA
UT WOS:000208933300030
OA Other Gold
DA 2018-10-20
ER

PT J
AU Vidal-Serp, DS
   Wandrey, C
AF Vidal-Serp, D. Sainz
   Wandrey, C.
TI Purification of natural anionic polymers
SO MINERVA BIOTECNOLOGICA
LA English
DT Article
DE purification; endotoxin removal; alginate; cellulose sulphate;
   biomaterials
ID IMMOBILIZATION MATERIAL; PANCREATIC-ISLETS; MANNURONIC ACID; ALGINATE;
   MICROENCAPSULATION; BIOCOMPATIBILITY; MICROCAPSULES; IMMUNOISOLATION;
   SPECTROSCOPY; MEMBRANE
AB Aim. in this work, a study about the influence of experimental conditions on the yield of the purification process based on filtration and precipitation steps is presented. Furthermore, the contribution of different purification steps to the contaminant reduction was quantified.
   Methods. The application of biopolymers and derivatives thereof in biotechnology, medicine and pharmacy requires the availability of highly purified and standardized materials. Purification processes and complementary analytics can be quite complex and expensive. For this reason, the down-stream processes required to produce biomedical-grade polymers are not always included in current polymer production. Consequently, the majority of basic polymeric components applied in cell encapsulation is usually not commercially available, or at a very high cost, at the purity and chemical standardization necessary for medical use.
   Results. The purification procedure described here for the polyanions sodium alginate and sodium cellulose sulphate is simple and effective to reduce endotoxmis, proteins and polyphenols to a very low level, e.g. 0.5%, 3% and 20% of the initial content, respectively, without major effect on polymer structural and macromolecular characteristics.
   Conclusion. This procedure can be used to purify commercial polymers in a standard laboratory and can be easily scaled up for industrial production.
C1 Ecole Polytech Fed Lausanne, SB, Inst Sci Ingn Chim, LMRPZ, CH-1015 Lausanne, Switzerland.
RP Wandrey, C (reprint author), Ecole Polytech Fed Lausanne, SB, Inst Sci Ingn Chim, LMRPZ, AAB042,Stn 15, CH-1015 Lausanne, Switzerland.
EM Christine.Wandrey@epfl.ch
CR Al-Shafi SM, 2002, SAUDI MED J, V23, P221
   CLAYTON HA, 1993, ACTA DIABETOL, V30, P181, DOI 10.1007/BF00569928
   Cochrum K, 1995, TRANSPLANT P, V27, P3297
   Dautzenberg H, 1996, BER BUNSEN PHYS CHEM, V100, P1045, DOI 10.1002/bbpc.19961000657
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698
   *FDA, 1987, FDA GUID USP BACT EN
   *FDA, 1991, FDA GUID USP BACT EN
   GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3
   GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7
   Hasse C, 2000, WORLD J SURG, V24, P1361, DOI 10.1007/s002680010225
   Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Moran AP, 1996, FEMS IMMUNOL MED MIC, V15, P43, DOI 10.1016/0928-8244(96)00043-0
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   Petruzzo P, 1997, TRANSPLANT P, V29, P2129, DOI 10.1016/S0041-1345(97)00290-X
   Prokop A, 1997, ANN NY ACAD SCI, V831, P223
   Prokop A, 1998, ADV POLYM SCI, V136, P53
   SKJAKBRAEK G, 1989, BIOTECHNOL BIOENG, V33, P90, DOI 10.1002/bit.260330112
   Wandrey C, 2003, J MICROENCAPSUL, V20, P597, DOI 10.1080/0265204031000148022
   Wandrey C, 2001, ANN NY ACAD SCI, V944, P187
   Wandrey C, 1999, LANGMUIR, V15, P4062, DOI 10.1021/la981089d
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   Zimmermann U, 2000, BIOTECHNIQUES, V29, P564, DOI 10.2144/00293rv01
   ZIMMERMANN U, 1992, ELECTROPHORESIS, V13, P269, DOI 10.1002/elps.1150130156
   ZIMMERMANN U, 1999, FUNDAMENTALS APPL CE
NR 30
TC 2
Z9 3
U1 0
U2 11
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 1120-4826
EI 1827-160X
J9 MINERVA BIOTECNOL
JI Minerva Biotechnol.
PD DEC
PY 2005
VL 17
IS 4
BP 215
EP 229
PG 15
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 054JJ
UT WOS:000238372300003
DA 2018-10-20
ER

PT J
AU Lee, CC
   MacKay, JA
   Frechet, JMJ
   Szoka, FC
AF Lee, CC
   MacKay, JA
   Frechet, JMJ
   Szoka, FC
TI Designing dendrimers for biological applications
SO NATURE BIOTECHNOLOGY
LA English
DT Review
ID DRUG-DELIVERY SYSTEMS; IN-VIVO EVALUATION; POLYESTER DENDRITIC SYSTEMS;
   IMAGING CONTRAST AGENTS; POLYAMIDOAMINE DENDRIMERS; POLY(ETHYLENE
   GLYCOL); HYPERBRANCHED POLYMERS; ALIPHATIC POLYESTERS; DENDRONIZED
   POLYMERS; CANCER-CHEMOTHERAPY
AB Dendrimers are branched, synthetic polymers with layered architectures that show promise in several biomedical applications. By regulating dendrimer synthesis, it is possible to precisely manipulate both their molecular weight and chemical composition, thereby allowing predictable tuning of their biocompatibility and pharmacokinetics. Advances in our understanding of the role of molecular weight and architecture on the in vivo behavior of dendrimers, together with recent progress in the design of biodegradable chemistries, has enabled the application of these branched polymers as anti-viral drugs, tissue repair scaffolds, targeted carriers of chemotherapeutics and optical oxygen sensors. Before such products can reach the market, however, the field must not only address the cost of manufacture and quality control of pharmaceutical-grade materials, but also assess the long-term human and environmental health consequences of dendrimer exposure in vivo.
C1 Univ Calif San Francisco, Dept Biopharmaceut Sci & Pharmaceut Chem, San Francisco, CA 94143 USA.
   Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
RP Szoka, FC (reprint author), Univ Calif San Francisco, Dept Biopharmaceut Sci & Pharmaceut Chem, San Francisco, CA 94143 USA.
EM szoka@cgl.ucsf.edu
RI Zdilla, Michael/B-4145-2011; Wunder, Stephanie/B-5066-2012
OI Frechet, Jean/0000-0001-6419-0163
FU NCI NIH HHS [R01 CA107268]; NIBIB NIH HHS [R01 EB002047, EB 002047];
   NIGMS NIH HHS [GM 65361]
CR Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Amir RJ, 2003, ANGEW CHEM INT EDIT, V42, P4494, DOI 10.1002/anie.200351962
   Andre S, 2003, ORG BIOMOL CHEM, V1, P3909, DOI 10.1039/b307802g
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583
   Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000
   Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200
   Brinas RP, 2005, J AM CHEM SOC, V127, P11851, DOI 10.1021/ja052947c
   BrochardWyart F, 1996, CR ACAD SCI II B, V323, P473
   BUHLEIER E, 1978, SYNTHESIS-STUTTGART, P155
   Chen HT, 2004, J AM CHEM SOC, V126, P10044, DOI 10.1021/ja048548j
   Choe YH, 2002, J CONTROL RELEASE, V79, P55, DOI 10.1016/S0168-3659(01)00470-9
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   Cordova A, 2001, J AM CHEM SOC, V123, P8248, DOI 10.1021/ja001819f
   de Groot FMH, 2003, ANGEW CHEM INT EDIT, V42, P4490, DOI 10.1002/anie.200351942
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   DEBRABANDERVANDENBERG EMM, 1993, ANGEW CHEM INT EDIT, V32, P1308, DOI 10.1002/anie.199313081
   DEFOORT JP, 1992, P NATL ACAD SCI USA, V89, P3879, DOI 10.1073/pnas.89.9.3879
   Denkewalter R. G., 1981, US Patent No, Patent No. [4(289):872, 4289872, 4, 289, 872]
   DROBNIK J, 1984, ADV POLYM SCI, V57, P1
   Drummond DC, 1999, PHARMACOL REV, V51, P691
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 1999, PHARM SCI TECHNOL TO, V2, P441, DOI DOI 10.1016/S1461-5347(99)00211-4
   Dunphy I, 2002, ANAL BIOCHEM, V310, P191, DOI 10.1016/S0003-2697(02)00384-6
   Frechet J., 2001, DENDRIMERS OTHER DEN
   Fuchs S, 2004, CHEM-EUR J, V10, P1167, DOI 10.1002/chem.200305386
   Gillies ER, 2005, MOL PHARMACEUT, V2, P129, DOI 10.1021/mp049886u
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3
   Gillies ER, 2002, J AM CHEM SOC, V124, P14137, DOI 10.1021/ja028100n
   Gossl I, 2002, J AM CHEM SOC, V124, P6860, DOI 10.1021/ja017828I
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Haba K, 2005, ANGEW CHEM INT EDIT, V44, P716, DOI 10.1002/anie.200461657
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C
   Hong SP, 2004, BIOCONJUGATE CHEM, V15, P774, DOI 10.1021/bc049962b
   Hussain M, 2004, J CONTROL RELEASE, V99, P139, DOI 10.1016/j.jconrel.2004.06.009
   Ihre H, 1996, J AM CHEM SOC, V118, P6388, DOI 10.1021/ja954171t
   Ihre HR, 2002, BIOCONJUGATE CHEM, V13, P443, DOI 10.1021/bc010102u
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207
   King HD, 2002, J MED CHEM, V45, P4336, DOI 10.1021/jm020149g
   Kobayashi Hisataka, 2003, Mol Imaging, V2, P1, DOI 10.1162/153535003765276237
   Kojima C, 2000, BIOCONJUGATE CHEM, V11, P910, DOI 10.1021/bc0000583
   Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921
   Kuo JHS, 2005, J PHARM PHARMACOL, V57, P489, DOI 10.1211/0022357055803
   Lee CC, 2005, BIOCONJUGATE CHEM, V16, P535, DOI 10.1021/bc0497665
   Lee CC, 2004, J POLYM SCI POL CHEM, V42, P3563, DOI 10.1002/pola.20216
   Li S, 2003, J AM CHEM SOC, V125, P10516, DOI 10.1021/ja0349960
   Li YG, 2005, NAT BIOTECHNOL, V23, P885, DOI 10.1038/nbt1106
   Li YG, 2004, NAT MATER, V3, P38, DOI 10.1038/nmat1045
   Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   Margerum LD, 1997, J ALLOY COMPD, V249, P185, DOI 10.1016/S0925-8388(96)02830-7
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Morgan MT, 2003, J AM CHEM SOC, V125, P15485, DOI 10.1021/ja0347383
   Neerman MF, 2004, INT J PHARM, V281, P129, DOI 10.1016/j.ijpharm.2004.04.023
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Nilsen TW, 1997, J THEOR BIOL, V187, P273, DOI 10.1006/jtbi.1997.0446
   Nishikawa M, 1996, ADV DRUG DELIVER REV, V21, P135, DOI 10.1016/S0169-409X(96)00403-6
   Ohlson M, 2001, AM J PHYSIOL-RENAL, V281, pF103
   Pasut G, 2005, J BIOACT COMPAT POL, V20, P213, DOI 10.1177/0883911505053377
   Rendle PM, 2004, J AM CHEM SOC, V126, P4750, DOI 10.1021/ja031698u
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Roy R., 2002, REV MOL BIOTECH, V90, P291
   Rozhkov V, 2002, MACROMOLECULES, V35, P1991, DOI 10.1021/ma0121161
   Sadler Kristen, 2002, J Biotechnol, V90, P195
   Schluter AD, 2000, ANGEW CHEM INT EDIT, V39, P864, DOI 10.1002/(SICI)1521-3773(20000303)39:5<864::AID-ANIE864>3.0.CO;2-E
   Seebach D, 1996, ANGEW CHEM INT EDIT, V35, P2795, DOI 10.1002/anie.199627951
   Shum P, 2001, ADV DRUG DELIVER REV, V53, P273, DOI 10.1016/S0169-409X(01)00232-0
   Smet M, 2000, ORG LETT, V2, P511, DOI 10.1021/ol991373b
   Steffensen MB, 2004, ANGEW CHEM INT EDIT, V43, P5178, DOI 10.1002/anie.200460031
   Stevelmans S, 1996, J AM CHEM SOC, V118, P7398, DOI 10.1021/ja954207h
   Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P
   Sunder A, 2000, CHEM-EUR J, V6, P2499, DOI 10.1002/1521-3765(20000717)6:14<2499::AID-CHEM2499>3.3.CO;2-D
   Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529
   Szalai ML, 2003, J AM CHEM SOC, V125, P15688, DOI 10.1021/ja0386694
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   TURNBULL WB, 2002, REV MOL BIOTECHNOL, V90, P231
   Velazquez AJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P867, DOI 10.1001/archopht.122.6.867
   Vincent L, 2003, INT J CANCER, V105, P419, DOI 10.1002/ijc.11105
   Voit B, 2000, J POLYM SCI POL CHEM, V38, P2505, DOI 10.1002/1099-0518(20000715)38:14<2505::AID-POLA10>3.0.CO;2-8
   Watanabe S, 2000, J AM CHEM SOC, V122, P12588, DOI 10.1021/ja001768m
   Wathier M, 2004, J AM CHEM SOC, V126, P12744, DOI 10.1021/ja045870l
   WIENER EC, 1994, MAGNET RESON MED, V31, P1, DOI 10.1002/mrm.1910310102
   WOOLEY KL, 1993, J AM CHEM SOC, V115, P11496, DOI 10.1021/ja00077a055
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
   Zhang W, 2003, J AM CHEM SOC, V125, P5086, DOI 10.1021/ja0210906
   Ziemer LS, 2005, J APPL PHYSIOL, V98, P1503, DOI 10.1152/japplphysiol.01140.2004
NR 94
TC 1386
Z9 1423
U1 50
U2 819
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1087-0156
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD DEC
PY 2005
VL 23
IS 12
BP 1517
EP 1526
DI 10.1038/nbt1171
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 992ED
UT WOS:000233866300028
PM 16333296
DA 2018-10-20
ER

PT J
AU Zhao, L
   Cui, TJ
AF Zhao, L
   Cui, TJ
TI Enhancement of specific absorption rate in lossy dielectric objects
   using a slab of left-handed material
SO PHYSICAL REVIEW E
LA English
DT Article
ID HUMAN HEAD; HYPERTHERMIA; OPTIMIZATION; SCATTERING; REFRACTION;
   TELEPHONE; MODEL; INDEX; WAVES; POWER
AB An enhancement of the specific absorption rate (SAR) inside a lossy dielectric object has been investigated theoretically based on a slab of left-handed medium (LHM). In order to make an accurate analysis of SAR distribution, a proper Green's function involved in the LHM slab is proposed, from which an integral equation for the electric field inside the dielectric object is derived. Such an integral equation has been solved accurately and efficiently using the conjugate gradient method and the fast Fourier transform. We have made a lot of numerical experiments on the SAR distributions inside the dielectric object excited by a line source with and without the LHM slab. Numerical experiments show that SAR can be enhanced tremendously when the LHM slab is involved due to the proper usage of strong surface waves, which will be helpful in the potential biomedical applications for hyperthermia. The physical insight for such a phenomenon has also been discussed.
C1 SE Univ, Dept Radiol Engn, Ctr Computat Electromagnet, Nanjing 210096, Peoples R China.
   SE Univ, Dept Radio Engn, State Key Lab Millimeter Waves, Nanjing 210096, Peoples R China.
RP Zhao, L (reprint author), SE Univ, Dept Radiol Engn, Ctr Computat Electromagnet, Nanjing 210096, Peoples R China.
EM tjcui@seu.edu.cn
RI Zhao, Lei/J-2926-2017
OI Zhao, Lei/0000-0002-0717-8050
CR ARCANGELI G, 1984, IEEE T BIO-MED ENG, V31, P47, DOI 10.1109/TBME.1984.325369
   CATEDRA MF, 1989, IEEE T ANTENN PROPAG, V37, P528, DOI 10.1109/8.24180
   Cheng Q, 2005, PHYS LETT A, V336, P235, DOI 10.1016/j.physleta.2004.12.088
   Chew W. C., 1990, WAVES FIELDS INHOMOG
   Cui TJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045114
   Cui TJ, 2004, PHYS LETT A, V323, P484, DOI 10.1016/j.physelta.2004.02.033
   Cui TJ, 1999, IEEE T GEOSCI REMOTE, V37, P2597, DOI 10.1109/36.789654
   Cui TJ, 2001, IEEE T GEOSCI REMOTE, V39, P339, DOI 10.1109/36.905242
   DEPOORTER J, 1998, IEEE T ELECTROMAGN C, V40, P547
   DEWAGTER C, 1986, IEEE T MICROW THEORY, V34, P589, DOI 10.1109/TMTT.1986.1133397
   Gandhi OP, 1995, IEEE T ELECTROMAGN C, V37, P547, DOI 10.1109/15.477340
   Garcia N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207403
   Hand J., 1986, PHYS TECHNIQUES CLIN
   Hombach V, 1996, IEEE T MICROW THEORY, V44, P1865, DOI 10.1109/22.539945
   JOUVIE F, 1986, IEEE T MICROW THEORY, V34, P495, DOI 10.1109/TMTT.1986.1133382
   KING RWP, 1995, RADIO SCI, V30, P267, DOI 10.1029/94RS00510
   MARTENS L, 1995, RADIO SCI, V30, P283, DOI 10.1029/94RS00508
   MEYER JL, 1984, CANCER RES, V44, P4745
   Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9
   Okoniewski M, 1996, IEEE T MICROW THEORY, V44, P1855, DOI 10.1109/22.539944
   Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773
   Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966
   Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847
   Siauve N, 2004, IEEE T MAGN, V40, P1264, DOI 10.1109/TMAG.2004.825432
   Smith DR, 2003, APPL PHYS LETT, V82, P1506, DOI 10.1063/1.1554779
   Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184
   STROHBEHN JW, 1989, INT J RADIAT ONCOL, V16, P589, DOI 10.1016/0360-3016(89)90474-4
   VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699
NR 28
TC 5
Z9 5
U1 0
U2 6
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2470-0045
EI 2470-0053
J9 PHYS REV E
JI Phys. Rev. E
PD DEC
PY 2005
VL 72
IS 6
AR 061911
DI 10.1103/PhysRevE.72.061911
PN 1
PG 8
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 008TY
UT WOS:000235064800059
PM 16485978
DA 2018-10-20
ER

PT J
AU Foest, R
   Kindel, E
   Ohl, A
   Stieber, M
   Weltmann, KD
AF Foest, R
   Kindel, E
   Ohl, A
   Stieber, M
   Weltmann, KD
TI Non-thermal atmospheric pressure discharges for surface modification
SO PLASMA PHYSICS AND CONTROLLED FUSION
LA English
DT Article; Proceedings Paper
CT 32nd European-Physical-Society Conference on Plasma Physics
CY JUN 27-JUL 01, 2005
CL Tarragona, SPAIN
SP European Phys Soc
ID DIELECTRIC-BARRIER; GLOW-DISCHARGE; PLASMA SOURCE
AB A series of different discharge configurations suitable for surface treatment at atmospheric pressure is discussed, including a non-thermal modular radio frequency (13.56, 27.12 or 40.78 MHz) jet plasma.
   The capacitively coupled configuration allows the operation with both rare gases (e.g. Ar) and reactive gases (N-2, air, reactive admixtures of silicon-containing compounds). Several capillaries are arranged in an array to allow plasma assisted treatment of surfaces including non-flat geometries. Optical emission spectroscopy, mass spectrometry and measurements of the axial and radial temperature profiles are used to characterize the discharge.
   The surface energy of different polymer materials is significantly enhanced after plasma treatment. Many applications are possible, such as plasma activation of surfaces for adhesion control, surface cleaning, plasma enhanced CVD, plasma cleaning, plasma activation and biomedical applications.
C1 Inst Niedertemp Plasma Phys, Greifswald, Germany.
RP Foest, R (reprint author), Inst Niedertemp Plasma Phys, FL Jahnstr 19, Greifswald, Germany.
EM foest@inp-greifswald.de
CR ADLER F, 2004, P 15 INT C GAS DISCH
   Bardos L, 1997, SURF COAT TECH, V97, P723, DOI 10.1016/S0257-8972(97)00291-0
   Basner R, 1997, INT J MASS SPECTROM, V171, P83, DOI 10.1016/S0168-1176(97)00063-3
   Ehlbeck J, 2003, SURF COAT TECH, V174, P493, DOI 10.1016/S0157-8972(03)00652-2
   Foest R, 2003, SURF COAT TECH, V163, P323, DOI 10.1016/S0257-8972(02)00487-5
   FOEST R, 2003, P 5 INT WORKSH MICR, P201
   Hubicka Z, 2002, PLASMA SOURCES SCI T, V11, P195, DOI 10.1088/0963-0252/11/2/311
   IGNATKOV A, 2002, CONTRIBUTED PAPERS H, V1, P58
   KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Massines F, 1998, J APPL PHYS, V83, P2950, DOI 10.1063/1.367051
   Penache C, 2004, IEE Proc Nanobiotechnol, V151, P139, DOI 10.1049/ip-nbt:20040836
   Schoenbach KH, 1996, APPL PHYS LETT, V68, P13, DOI 10.1063/1.116739
   Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887
   Selwyn GS, 2001, CONTRIB PLASM PHYS, V41, P610, DOI 10.1002/1521-3986(200111)41:6<610::AID-CTPP610>3.0.CO;2-L
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
   Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0
NR 20
TC 120
Z9 123
U1 0
U2 52
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0741-3335
EI 1361-6587
J9 PLASMA PHYS CONTR F
JI Plasma Phys. Control. Fusion
PD DEC
PY 2005
VL 47
SU 12B
SI SI
BP B525
EP B536
DI 10.1088/0741-3335/47/12B/S38
PG 12
WC Physics, Fluids & Plasmas
SC Physics
GA 999WD
UT WOS:000234420700040
DA 2018-10-20
ER

PT J
AU Zou, KH
   Greve, DN
   Wang, M
   Pieper, SD
   Warfield, SK
   White, NS
   Manandhar, S
   Brown, GG
   Vangel, MG
   Kikinis, R
   Wells, WM
AF Zou, KH
   Greve, DN
   Wang, M
   Pieper, SD
   Warfield, SK
   White, NS
   Manandhar, S
   Brown, GG
   Vangel, MG
   Kikinis, R
   Wells, WM
CA FIRST BIRN Res Grp
TI Reproducibility of functional MR imaging: Preliminary results of
   prospective multi-institutional study performed by biomedical
   informatics research network
SO RADIOLOGY
LA English
DT Article
ID TEST-RETEST RELIABILITY; SURFACE-BASED ANALYSIS; CORTICAL SURFACE;
   HEMODYNAMIC-RESPONSE; COORDINATE SYSTEM; WORKING-MEMORY; VARIABILITY;
   SEGMENTATION; VALIDATION; ACTIVATION
AB PURPOSE: To prospectively investigate the factors-including subject, brain hemisphere, study site, field strength, imaging unit vendor, imaging run, and examination visit-affecting the reproducibility of functional magnetic resonance (MR) imaging activations based on a repeated sensory-motor (SM) task.
   MATERIALS AND METHODS: The institutional review boards of all participating sites approved this HIPAA-compliant study. All subjects gave informed consent. Functional MR imaging data were repeatedly acquired from five healthy men aged 20-29 years who performed the same SM task at 10 sites. Five 1.5-T MR imaging units, four 3.0-T units, and one 4.0-T unit were used. The subjects performed bilateral finger tapping on button boxes with a 3-Hz audio cue and a reversing checkerboard. In a block design, 15-second epochs of alternating baseline and tasks yielded 85 acquisitions per run. Functional MR images were acquired with block-design echo-planar or spiral gradient-echo sequences. Brain activation maps standardized in a unit-sphere for the left and right hemispheres of each subject were constructed. Areas under the receiver operating characteristic curve, intraclass correlation coefficients, multiple regression analysis, and paired Student t tests were used for statistical analyses.
   RESULTS: Significant factors were subject (P < .005), k-space (P < .005), and field strength (P = .02) for sensitivity and subject (P = .03) and k-space (P = .05) for specificity. At 1.5-T MR imaging, mean sensitivities ranged from 7% to 32% and mean specificities were higher than 99%. At 3.0 T, mean sensitivities and specificities ranged from 42% to 85% and from 96% to 99%, respectively. At 4.0 T, mean sensitivities and specificities ranged from 41% to 73% and from 95% to 99%, respectively. Mean areas under the receiver operating characteristic curve (+/- their standard errors) were 0.77 0.05 at 1.5 T, 0.90 +/- 0.09 at 3.0 T, and 0.95 +/- 0.02 at 4.0 T, with significant differences between the 1.5- and 3.0-T examinations and between the 1.5- and 4.0-T examinations (P < .01 for both comparisons). Intraclass correlation coefficients ranged from 0.49 to 0.71.
   CONCLUSION: MR imaging at 3.0- and 4.0-T yielded higher reproducibility across sites and significantly better results than 1.5-T imaging. The effects of subject, k-space, and field strength on examination reproducibility were significant. (c) RSNA, 2005.
C1 Brigham & Womens Hosp, Surg Planning Lab, Dept Radiol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Engn, Dept Radiol,Massachesetts Gen Hosp, Boston, MA 02115 USA.
   Isomics, Cambridge, MA USA.
   MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA.
   Brigham & Womens Hosp, Computat Radiol Lab, Dept Radiol, Boston, MA 02115 USA.
   Childrens Hosp, Dept Radiol, Boston, MA 02115 USA.
   Univ Calif San Diego, Lab Cognit Imaging, Dept Psychiat, La Jolla, CA 92093 USA.
   Vet Affairs San Diego Hlth Care Syst, San Diego, CA USA.
RP Zou, KH (reprint author), Brigham & Womens Hosp, Surg Planning Lab, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.
EM zou@bwh.harvard.edu
RI Warfield, Simon/B-3352-2009
OI Warfield, Simon/0000-0002-7659-3880
FU NIMH NIH HHS [R21 MH067054, R21MH67054]; NCRR NIH HHS [P41 RR013218, P41
   RR014075, P41RR14075, P41RR13218]; NLM NIH HHS [R01 LM007861-03,
   R01LM007861-01A1, R01 LM007861]; AHRQ HHS [R03 HS013234,
   R03HS013234-01]; NCI NIH HHS [R21CA89449-01]
CR Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369
   Brannen JH, 2001, AM J NEURORADIOL, V22, P1711
   Casey BJ, 1998, NEUROIMAGE, V8, P249, DOI 10.1006/nimg.1998.0360
   Cohen MS, 1999, JMRI-J MAGN RESON IM, V10, P33, DOI 10.1002/(SICI)1522-2586(199907)10:1<33::AID-JMRI5>3.0.CO;2-N
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   Duann JR, 2002, NEUROIMAGE, V15, P823, DOI 10.1006/nimg.2001.1049
   Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4
   Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396
   Genovese CR, 1997, MAGNET RESON MED, V38, P497, DOI 10.1002/mrm.1910380319
   Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037
   Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074
   Le TH, 1997, NMR BIOMED, V10, P160, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<160::AID-NBM458>3.0.CO;2-A
   Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q
   Maitra R, 2002, MAGN RESON MED, V48, P62, DOI 10.1002/mrm.10191
   McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562
   Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568
   Neumann J, 2003, NEUROIMAGE, V19, P784, DOI 10.1016/S1053-8119(03)00177-0
   Noll DC, 1997, MAGN RESON MED, V38, P508, DOI 10.1002/mrm.1910380320
   Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898
   Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186
   Stark R, 2004, NEUROPSYCHOBIOLOGY, V50, P108, DOI 10.1159/000077948
   Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354
   Wei XC, 2004, NEUROIMAGE, V21, P1000, DOI 10.1016/j.neuroimage.2003.10.039
   Yetkin FZ, 1996, AM J NEURORADIOL, V17, P95
   Zou KH, 2004, STAT MED, V23, P1259, DOI 10.1002/sim.1723
   Zou KH, 2003, ACAD RADIOL, V10, P1359, DOI 10.1016/S1076-6332(03)00538-5
   Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/
   ZOU KH, 2004, P 7 INT MED COMP COM, P767
NR 30
TC 73
Z9 73
U1 0
U2 4
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JAN
PY 2006
VL 237
IS 3
BP 781
EP 789
DI 10.1148/radiol.2373041630
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 985LV
UT WOS:000233380100004
PM 16304101
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, EL
   Yang, K
AF Zhang, EL
   Yang, K
TI Biomimetic coating of calcium phosphate on biometallic materials
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE hydroxyapatite coating; biomedical application; biornimetic coating;
   biometallic materials; surface modification
ID CHEMICALLY TREATED TITANIUM; SIMULATED BODY-FLUID; CA-P COATINGS;
   OCTACALCIUM PHOSPHATE; APATITE FORMATION; HYDROXYAPATITE COATINGS;
   METALS; ALKALI; STRENGTH; IMPLANTS
AB The biomimetic coating process in comparison with other processes is reviewed. This processing shows advantages in the surface bio-modification, such as low cost and flexible processing, wide range of apatite composition and thickness, non-line-of-sight characteristic and possibility to coat polymers and porous implants. The biomimetic apatite coating is made up of larger number of globules with size of 1 - 5 mu m. Each globule is a group of numerous flakes with a size range of 100 - 200 nm to 30 mu m in length and 0.1 - 1 mu m in thickness. In-vitro and in-vivo studies show that the biomimetic apatite coating can promote an early and strong bonding to bone or promote the bone in-growth into the porous structure, which will be beneficial to the cementless stable fixation of orthopaedic implants, Recently developed co-precipitation of a kind of protein molecules into the HA coating shows much promising.
C1 Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
RP Zhang, EL (reprint author), Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
EM erlin.zhang@imr.ac.cn
RI Zhang, Erlin/N-6608-2014
OI Zhang, Erlin/0000-0002-6152-6546
CR Ban S, 1997, J BIOMED MATER RES, V36, P9, DOI 10.1002/(SICI)1097-4636(199707)36:1<9::AID-JBM2>3.0.CO;2-P
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Barrere F, 2000, MATER RES SOC SYMP P, V599, P135
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Ding SJ, 2001, BIOMATERIALS, V22, P833, DOI 10.1016/S0142-9612(00)00247-7
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   Guipont V, 2002, MAT SCI ENG A-STRUCT, V325, P9, DOI 10.1016/S0921-5093(01)01414-9
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1
   HELEN A, 1998, J MATER CHEM, P405
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   KOKUBO T, 2003, BIOMATERIALS, V24, P2167
   Kumar M, 1999, J BIOMED MATER RES, V45, P302, DOI 10.1002/(SICI)1097-4636(19990615)45:4<302::AID-JBM4>3.0.CO;2-A
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Liu Y, 2003, BIOMATERIALS, V24, P65, DOI 10.1016/S0142-9612(02)00252-1
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Wei M, 2002, MAT SCI ENG C-BIO S, V20, P125, DOI 10.1016/S0928-4931(02)00022-X
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   ZHANG EL, IN PRESS NONFERROUS
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 39
TC 13
Z9 15
U1 0
U2 5
PU ALLERTON PRESS INC
PI NEW YORK
PA 18 WEST 27TH ST, NEW YORK, NY 10001 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD DEC
PY 2005
VL 15
IS 6
BP 1199
EP 1205
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 001LO
UT WOS:000234534800001
DA 2018-10-20
ER

PT J
AU Jaeggi, C
   Kern, P
   Michler, J
   Zehnder, T
   Siegenthaler, H
AF Jaeggi, C
   Kern, P
   Michler, J
   Zehnder, T
   Siegenthaler, H
TI Anodic thin films on titanium used as masks for surface micropatterning
   of biomedical devices
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 32nd International Conference on Metallurgical Coatings and Thin Film
CY MAY 02-06, 2005
CL San Diego, CA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE titanium oxide; anodizing; impedance spectroscopy; laser; ion
   implantation; surface micropatterning
ID OXIDE-FILMS; DIELECTRIC-PROPERTIES; IMPEDANCE; TIO2; CRYSTALLIZATION;
   HYDROGEN
AB Ceramic oxide films like TiO2 are used on medical implants to improve biocompatibility and corrosion behavior. Along with the chemical composition, the topography of implants with surface features in the tens of microns range is known to promote osteointegration. In this work, the prospective of anodically gown TiO2 thin films as mask material for subsequent electrochemical micro/nanopatterning of medical implant surfaces sensitized by He-ion beam and YAG-laser irradiation is investigated.
   Electrochemical impedance spectroscopy was used to characterize resistance and capacitance of oxide films anodized under various conditions. The resistance obtained by fitting to an appropriate equivalent circuit was compared to the film stability in electrochemical pitting experiments. Film thickness, composition and microstructure were analyzed by glow discharge optical emission spectroscopy (GDOES), Xray photoelectron spectroscopy, scanning and transmission electron microscopy and Raman spectroscopy.
   An increasing film resistance of the porous part of the oxide was found to correlate to increasing pitting resistance. GDOES revealed a low carbon and sulfur concentration in the film as well as an accumulation of hydrogen at the oxide/metal interface. Based on the performance in pitting tests, suitable anatase TiO2 films were used for laser micropatterning, and thinner mainly amorphous films were used for He-ion beam micropatterning experiments. YAG-laser treatment led to preferential dissolution of the irradiated sites during the subsequent etching step. Both preferential and reduced dissolution was observed in case of He-ion implantation. Potential physico-chemical mechanisms for observed micropatteming effects are discussed. (c) 2005 Elsevier B.V. All rights reserved.
C1 EMPA Mat Sci & Technol, CH-3602 Thun, Switzerland.
   Ion Beam Anal Ctr, CH-2400 Le Locle, Switzerland.
   Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.
RP Kern, P (reprint author), EMPA Mat Sci & Technol, Feuerwerkerstr 39, CH-3602 Thun, Switzerland.
EM philippe.kern@empa.ch
RI Michler, Johann/B-4672-2010
OI Michler, Johann/0000-0001-8860-4068
CR Alexandrov P, 1996, VACUUM, V47, P1333, DOI 10.1016/S0042-207X(96)00196-0
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   BLONDEAU G, 1977, THIN SOLID FILMS, V42, P147, DOI 10.1016/0040-6090(77)90411-4
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Chauvy PF, 2003, APPL SURF SCI, V208, P165, DOI 10.1016/S0169-4332(02)01361-2
   Habazaki H, 2003, CORROS SCI, V45, P2063, DOI 10.1016/S0010-938X(03)00040-4
   Hashimoto S, 2004, SURF SCI, V556, P22, DOI 10.1016/j.susc.2004.03.002
   JOHNSON PB, 1991, NATO ADV SCI I B-PHY, V279, P167
   KERREC O, 1995, ELECTROCHIM ACTA, V40, P719, DOI 10.1016/0013-4686(94)00330-4
   Landolt D, 2003, ELECTROCHIM ACTA, V48, P3185, DOI 10.1016/S0013-4686(03)00368-2
   LeMercier T, 1997, J PHYS CHEM SOLIDS, V58, P679, DOI 10.1016/S0022-3697(96)00196-5
   Madore C, 1999, J ELECTROCHEM SOC, V146, P2526, DOI 10.1149/1.1391966
   Marsh J, 1998, ELECTROCHIM ACTA, V43, P659, DOI 10.1016/S0013-4686(97)00210-7
   Michler J, 2004, THIN SOLID FILMS, V447, P278, DOI 10.1016/S0040-6090(03)01105-2
   MULLER Y, 2000, ELECTROCHEM SOC P 20, P294
   NAKAJIMA S, 2003, T MAT RES SOC JPN, V28, P499
   Orazem ME, 2002, ELECTROCHIM ACTA, V47, P2027, DOI 10.1016/S0013-4686(02)00065-8
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   SCHILLER CA, 1995, ELECTROCHEM APPL, V1, P1
   Schultze JW, 2001, ELECTROCHIM ACTA, V47, P3, DOI 10.1016/S0013-4686(01)00584-9
   SHIBATA T, 1995, CORROS SCI, V37, P253, DOI 10.1016/0010-938X(94)00133-Q
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Teter DF, 2001, ACTA MATER, V49, P4313, DOI 10.1016/S1359-6454(01)00301-9
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
NR 26
TC 23
Z9 23
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV 21
PY 2005
VL 200
IS 5-6
BP 1913
EP 1919
DI 10.1016/j.surfcoat.2005.08.021
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 995JM
UT WOS:000234096600117
DA 2018-10-20
ER

EF